Citrus Sinensis ID: 039817
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 725 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.948 | 0.826 | 0.328 | 1e-102 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.96 | 0.798 | 0.284 | 5e-77 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.942 | 0.824 | 0.286 | 1e-70 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.882 | 0.803 | 0.298 | 1e-70 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.873 | 0.763 | 0.298 | 1e-68 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.845 | 0.750 | 0.278 | 7e-67 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.364 | 0.321 | 0.403 | 2e-57 | |
| O64782 | 805 | G-type lectin S-receptor- | no | no | 0.891 | 0.802 | 0.273 | 6e-57 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.878 | 0.764 | 0.270 | 8e-57 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.913 | 0.778 | 0.250 | 1e-56 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 374 bits (959), Expect = e-102, Method: Compositional matrix adjust.
Identities = 271/824 (32%), Positives = 386/824 (46%), Gaps = 136/824 (16%)
Query: 5 ILLIWSLVFFLSFCSLPQMTTNNIELGSNIIAGTN----STWPSTSGDFAFGFYPLV-SG 59
++LI L F F + ++ +G ++ A + S+W S SGDFAFGF + +
Sbjct: 11 LVLILQLQTFFVFSQ--NIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPND 68
Query: 60 LFLVGIWFDKISERTLVWSANRDDPAQV----GSSINLTVTGQLVLTHSNGTQ-FKIYNG 114
F + IWFDKIS++T+VW A + GS + LT G LV+ G + ++ +G
Sbjct: 69 GFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRALSG 128
Query: 115 TLTVSALMQDSGNF-------------LYSNANGSVD----------------------Y 139
D GNF L+S+ D +
Sbjct: 129 GSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSF 188
Query: 140 STGRFVLEIQMDGNVVLSAFRFADPA------YWYTSTRGDQN---VSLIFNQSTSFLYV 190
GRF L ++ DGN+ L + + +Y S D N + L+FNQS +YV
Sbjct: 189 KKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVFNQSGE-IYV 247
Query: 191 RNKTTIRYPMTTQVP--TPTEDYYHRATISDHGNFQQWVHNKRDGNGWAVVWEAITEPCT 248
+ R+ + + P + +Y + G + + + P
Sbjct: 248 LQRNNSRFVVKDRDPDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLGLCRDNMCSPDD 307
Query: 249 V--NTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSKGCYPDVLVDFCDTKSSPADFT 306
N CG C+ NNK CEC + DP++ C PD + C ++ A+
Sbjct: 308 ALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSD 367
Query: 307 VE-----AIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAA---GVWREVVCLKKK 358
V ++ + P GD A D C+ + + DC CAA G R++ C KKK
Sbjct: 368 VNLYEFITLEKTNWPFGDYESYANY---DEERCKASCLSDCLCAAVIFGTNRDLKCWKKK 424
Query: 359 MPLLNARRSNPSTNKMAAFIKVPKINNSQGQDNDSPSRVVLLAGFL-SCSMLA-----LL 412
PL + RS FIKV N S + +R L + +CS+L ++
Sbjct: 425 FPLSHGERS--PRGDSDTFIKVR--NRSIADVPVTGNRAKKLDWLIIACSVLLGTSAFVI 480
Query: 413 FGSIVIYYHPLTRPYMCV-------QPSPKPKPPEINMKVFSYQELREATNVF------- 458
F + Y M + + E+N++VF+Y EL EAT F
Sbjct: 481 FDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRG 540
Query: 459 -------------DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE 505
G EV VAVK+L+++ D EK F EV+VIG+ HHKNLV+L+GFC E
Sbjct: 541 AFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNE 600
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
Q++VYE + GTL+ FLFR+ P+W+ R IA+ IARG+LYLHEEC QIIHCDIKP
Sbjct: 601 GQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKP 660
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
QN+LL D Y +I+DFGLAKLL +QT T T IRGT GY+APEW RN+P+T+K
Sbjct: 661 QNILL-------DEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSK 713
Query: 626 VDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL----------- 674
VDVYS+GVMLLEI+ CK+ +L + +IL +W C R G L
Sbjct: 714 VDVYSYGVMLLEIVCCKKAVDLE--------DNVILINWAYDCFRQGRLEDLTEDDSEAM 765
Query: 675 -GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPP 717
ER + +WCI + +RP+M+ V QMLEG +V PP
Sbjct: 766 NDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPP 809
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 289 bits (740), Expect = 5e-77, Method: Compositional matrix adjust.
Identities = 235/825 (28%), Positives = 376/825 (45%), Gaps = 129/825 (15%)
Query: 3 PSILLIWSLVFFLSFCSLPQMTTNNIELGSNIIAGT-NSTWPSTSGDFAFGFYPLV-SGL 60
PS+ L FFL + T +I LGS + A N W S +G FA GF +
Sbjct: 9 PSVGLFSFFCFFL----VSLATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDR 64
Query: 61 FLVGIWFDKI-SERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLTV- 118
FL+ IWF ++ + T+VWS NR+ P + + L TG LVL+ N + V
Sbjct: 65 FLLSIWFAQLPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSDQNTVVWTSNTSNHGVE 124
Query: 119 SALMQDSGNFLY-----------------------------------SNANGSVDYSTGR 143
SA+M +SGNFL SN + S
Sbjct: 125 SAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSL 184
Query: 144 FVLEIQMDGNVVLSAFRFADP----AYW----YTSTRGDQNVSLIFNQSTSFLYVRNKTT 195
+L+ ++ L+ DP +YW ++ GD V+ + + + SF V +++
Sbjct: 185 KMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGD--VTAVLDDTGSFKIVYGESS 242
Query: 196 IRYPMTTQVPTPTEDYYH--------------RATISDHGNFQ--QWVHNKRDGNGWAVV 239
I + P Y+ R + ++GN + +W ++ + W
Sbjct: 243 IGAVYVYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPE 302
Query: 240 WEAITEPCTVNTICGVFGFCTSDNNKE-VTCECLRGYSPVDPNSPSKGCYPDV-LVDFCD 297
W A++ PC + ICG G C D K+ C CL G + +K C + LV C+
Sbjct: 303 WAAVSNPCDIAGICGN-GVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECE 361
Query: 298 TK-SSPADFTVEAIDDADIPNGDLRDMARIT-TTDVNECRKAVMDDCFCAAGVW----RE 351
+ + F + + + + + + I+ ++V +C + + DC C A V+ +
Sbjct: 362 SNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEK 421
Query: 352 VVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNSQG----------QDNDSPSRVVLLA 401
C K R ST F+K + + + +V+++
Sbjct: 422 PYCWILKSLNFGGFRDPGST----LFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLVIP 477
Query: 402 GFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREATNVFD-- 459
+ +L L G ++ Y+ L R + + + F+Y++L+ TN F
Sbjct: 478 IVVGMLVLVALLG--MLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQL 535
Query: 460 --------------GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE 505
E VAVK+L++ GE+ F+ EV IG HH NLV+L G+C E
Sbjct: 536 LGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSE 595
Query: 506 QNHQLLVYELMKNGTLSAFLFRQE----IPTWDKRVEIALGIARGLLYLHEECETQIIHC 561
+H+LLVYE M NG+L ++F E + W R EIA+ A+G+ Y HE+C +IIHC
Sbjct: 596 DSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHC 655
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP 621
DIKP+N+LLD+N+ K++DFGLAK++ ++ + TMIRGT GY+APEW+ N P
Sbjct: 656 DIKPENILLDDNFCP-------KVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRP 708
Query: 622 VTAKVDVYSFGVMLLEIIFCKRHTELHRVDE----PTLANGMILTDWVLYCVRTGNLGAT 677
+T K DVYS+G++LLEI+ +R+ ++ E P A + L V G
Sbjct: 709 ITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVA 768
Query: 678 KFERIT---MVGLWCICPQPTLRPSMKQVLQMLEGTS-EVGVPPV 718
+ E + V WCI + ++RPSM +V+++LEGTS E+ +PP+
Sbjct: 769 EEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPM 813
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 228/796 (28%), Positives = 362/796 (45%), Gaps = 113/796 (14%)
Query: 10 SLVFFLSFCSLPQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFY-PLVSGLFLVGIWFD 68
+L F C ++ + + + T S+ G + GF+ P S F +G+W+
Sbjct: 6 TLTSFFFICFFIHGSSAVDTISGDFTLSGDQTIVSSDGTYEMGFFKPGSSSNFYIGMWYK 65
Query: 69 KISERTLVWSANRDDP-AQVGSSINLTVTGQLVLTHSNGTQFKIY----NGTLTVSAL-- 121
++S+ T++W ANRD + SS+ G L+L N Q ++ N T +VSAL
Sbjct: 66 QLSQ-TILWVANRDKAVSDKNSSVFKISNGNLILLDGN-YQTPVWSTGLNSTSSVSALEA 123
Query: 122 -MQDSGNFLYSNANGSV---------DYSTGRFV--LEIQMDGNV-----VLSAFRFADP 164
+QD GN + S+ D+ ++ ++I++D + S DP
Sbjct: 124 VLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDP 183
Query: 165 AYWYTSTRGDQNVS--LIFNQSTSFLYVRN------------KTTIRYPMTTQVPTPTED 210
+ S D++ + +++N S + + + Y + T D
Sbjct: 184 SPGLFSLELDESTAYKILWNGSNEYWSSGPWNPQSRIFDSVPEMRLNYIYNFSFFSNTTD 243
Query: 211 YYHRATISDHGNFQQWVHNKR---------DGN-GWAVVWEAITEPCTVNTICGVFGFCT 260
Y +I + N ++V + +GN W + W + C V CG FG C+
Sbjct: 244 SYFTYSIYNQLNVSRFVMDVSGQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICS 303
Query: 261 SDNNKEVTCECLRGYSPVDPNSPSKGCYPDVLVDFCDTKSSPADFTVEAIDDADIPNGDL 320
+ E C C +G+ P+ Y V + + S D +PN L
Sbjct: 304 --DKSEPFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDIN----QFFRLPNMKL 357
Query: 321 RDMARI-TTTDVNECRKAVMDDCFCAAGVWRE--VVCLKKKMPLLNARRSNPSTNKMAAF 377
D + + T T ++ C A DC C A + E CL +LN ++ ++ F
Sbjct: 358 ADNSEVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIF 417
Query: 378 I------KVPKINNSQGQDNDSPSRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQ 431
VP + S +N G + ++L L +++ + +
Sbjct: 418 YLRLAASDVPNVGASGKSNN---------KGLIFGAVLGSLGVIVLVLLVVILILRYRRR 468
Query: 432 PSPKPKPPEINMKVFSYQELREAT-------------NVFDG---QEVEVAVKQLEKVTG 475
+ + + + FSY+EL+ AT +VF G ++AVK+LE ++
Sbjct: 469 KRMRGEKGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGIS- 527
Query: 476 DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPT--- 532
GEK F EV IG H NLV+L GFC E + +LLVY+ M NG+L + LF ++
Sbjct: 528 QGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIV 587
Query: 533 --WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590
W R +IALG ARGL YLH+EC IIHCDIKP+N+LLD+ + K+ADFGL
Sbjct: 588 LGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCP-------KVADFGL 640
Query: 591 AKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRV 650
AKL+ +D +R T +RGT GY+APEW+ +TAK DVYS+G+ML E++ +R+TE
Sbjct: 641 AKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSEN 700
Query: 651 DE----PTLANGMILTDWVLYCVRTGNL--GATKFERIT---MVGLWCICPQPTLRPSMK 701
++ P+ A ++ D + + L A E +T V WCI + + RP+M
Sbjct: 701 EKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMS 760
Query: 702 QVLQMLEGTSEVGVPP 717
QV+Q+LEG EV PP
Sbjct: 761 QVVQILEGVLEVNPPP 776
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 226/756 (29%), Positives = 350/756 (46%), Gaps = 116/756 (15%)
Query: 32 SNIIAGTNSTWPSTSGDFAFGFYPLVSGL--FLVGIWFDKISERTLVWSANRDDPAQV-- 87
S +I N T S F GF+ +G + +GI + + T VW ANR P
Sbjct: 23 SKVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPD 82
Query: 88 GSSINLTVTGQLVLTH-SNGTQFKIYNGTLTVSALMQDSGNFLYSNANGS-----VDYST 141
S++ LT TG L++++ +G ++ N ++GN + N +GS D T
Sbjct: 83 SSTLELTSTGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPT 142
Query: 142 GRFVLEIQMDGNVVLSAFR-FADPAYWYTSTR---GDQNVSLIFNQSTSFLYVRNKTT-- 195
++ + + G ++++R DP+ + S R L++ +T + N T
Sbjct: 143 DTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTPYWSTGNWTGEA 202
Query: 196 -IRYPMTTQVP-----------TPTEDYYH--------------RATISDHGNFQQWVHN 229
+ P T +P TPT +++ R + +G +Q+ +
Sbjct: 203 FVGVPEMT-IPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWD 261
Query: 230 KRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSKGCYP 289
+ W + W +PC V +CG GFC+S+ K C C+RG+ P + + Y
Sbjct: 262 PQT-QSWNMFWLQPEDPCRVYNLCGQLGFCSSELLKP--CACIRGFRPRNDAAWRSDDYS 318
Query: 290 DVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVW 349
D +D T EA+ D +GD++ M+R+ + + C K + + C
Sbjct: 319 DGCRRENGDSGEKSD-TFEAVGDLRY-DGDVK-MSRLQVSK-SSCAKTCLGNSSCVGFYH 374
Query: 350 REVVCLKKKMPLLNARRSNPSTNKMAAFIKVPK-INNSQGQDNDSPSRVVLLAGFLSCSM 408
+E +N ++ P + NS+G N S S ++L + S S+
Sbjct: 375 KE------------------KSNLCKILLESPNNLKNSKG--NISKSIIILCSVVGSISV 414
Query: 409 LAL-LFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREATNVFD-------- 459
L L +++ R Q + +N+KVFS++EL+ ATN F
Sbjct: 415 LGFTLLVPLILLKRSRKRKKTRKQD--EDGFAVLNLKVFSFKELQSATNGFSDKVGHGGF 472
Query: 460 ---------GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL 510
G VAVK+LE+ G GE F EV IG H NLV+L GFC E H+L
Sbjct: 473 GAVFKGTLPGSSTFVAVKRLER-PGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRL 531
Query: 511 LVYELMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
LVY+ M G+LS++L R ++ +W+ R IALG A+G+ YLHE C IIHCDIKP+N+
Sbjct: 532 LVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENI 591
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
LLD++Y K++DFGLAKLL +D +R +RGT GY+APEW+ P+T K DV
Sbjct: 592 LLDSDYNA-------KVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADV 644
Query: 629 YSFGVMLLEIIFCKRH------------TELHRVDEPTLANGMIL---TDWVLYCVRTGN 673
YSFG+ LLE+I +R+ TE + P A I+ D V+ G
Sbjct: 645 YSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGE 704
Query: 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709
+ R+ V +WCI +RP+M V++MLEG
Sbjct: 705 YNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (668), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 237/795 (29%), Positives = 349/795 (43%), Gaps = 162/795 (20%)
Query: 28 IELGSNIIA-GTNSTWPSTSGDFAFGFYPLVS-GLFLVGIWFDKISERTLVWSANRDDPA 85
I LGS I A G+N WPS + F+ F P S FL + F + +WSA D
Sbjct: 27 IPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSF---AGSVPIWSAGTVDSR 83
Query: 86 QVGSSINLTVTGQLVLTHSNGTQ-FKIYNGTLTV-SALMQDSGNFLYSNANG-------- 135
S+ L +G L LT+ +GT + L V S ++D+G F+ N
Sbjct: 84 ---GSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFD 140
Query: 136 --------SVDYSTGR------FVLEIQMDGNVVLSAFRFADPAYWYTSTRGDQNVSLIF 181
S +++ G+ + +++ GN+ L W TS ++ +
Sbjct: 141 NPTDTIVQSQNFTAGKILRSGLYSFQLERSGNLTLR---------WNTS-------AIYW 184
Query: 182 NQSTSFLYVRNKTTIRYPMTTQVPTP--------------TEDYYHRAT-----ISDHGN 222
N + + N ++ R + T + DY T + D GN
Sbjct: 185 NHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGN 244
Query: 223 FQQWVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCEC-LRGYSPVDPN 281
+ + R+ W A+ + C V CG FG C S N+ C C R + VD N
Sbjct: 245 LRIYSSASRNSGPVNAHWSAVDQ-CLVYGYCGNFGIC-SYNDTNPICSCPSRNFDFVDVN 302
Query: 282 SPSKGCYPDVLVDFCDTKSSPAD------FTVEAIDDADIPNGDLRDMARITTTDVNECR 335
KGC V + C ++ D FT E D PN + + CR
Sbjct: 303 DRRKGCKRKVELSDCSGNTTMLDLVHTRLFTYE-----DDPNSESFFAGS------SPCR 351
Query: 336 KAVMDDCFCAAGVWRE---VVCLKKKMPLLNARRSNPSTNKMAAFIKV--PKINNS---- 386
+ C A V C +K PS +++KV P + N+
Sbjct: 352 ANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSV-PSTSYVKVCGPVVANTLERA 410
Query: 387 -QGQDNDSPSRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKV 445
+G DN+S + ++A + +L L+ I +++ C + +P+ + +
Sbjct: 411 TKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWW-------CCCRKNPRFGTLSSHYTL 463
Query: 446 ----------FSYQELREATNVFDGQ----------------EVEVAVKQLEKVTGDGEK 479
F+Y+EL+ T F + VAVKQLE + GEK
Sbjct: 464 LEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIE-QGEK 522
Query: 480 SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF---RQEIPTWDKR 536
F EV I THH NLV+L+GFC + H+LLVYE M+NG+L FLF + TW+ R
Sbjct: 523 QFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYR 582
Query: 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK- 595
IALG A+G+ YLHEEC I+HCDIKP+N+L +D+N+ K++DFGLAKLL
Sbjct: 583 FNIALGTAKGITYLHEECRDCIVHCDIKPENIL-------VDDNFAAKVSDFGLAKLLNP 635
Query: 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL 655
KD + +RGT GY+APEWL N P+T+K DVYS+G++LLE++ KR+ + V E T
Sbjct: 636 KDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFD---VSEKT- 691
Query: 656 ANGMILTDWVLYCVRTGNLGA--------------TKFERITMVGLWCICPQPTLRPSMK 701
N + W GN A + R+ WCI QP RP+M
Sbjct: 692 -NHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMG 750
Query: 702 QVLQMLEGTSEVGVP 716
+V+QMLEG +E+ P
Sbjct: 751 KVVQMLEGITEIKNP 765
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 255 bits (652), Expect = 7e-67, Method: Compositional matrix adjust.
Identities = 208/747 (27%), Positives = 339/747 (45%), Gaps = 134/747 (17%)
Query: 11 LVFFLSFCSLPQMTTNNIELGSNIIAGT--NSTWPSTSGDFAFGFYPLVSGLFLVGIWFD 68
L FF++ + + + LGS+++ + +ST S+ G F+ GFY + + F +W+
Sbjct: 15 LSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHAFTFSVWYS 74
Query: 69 KI-----SERTLVWSANRDDPAQVG-SSINLTVTGQLVLTHSNGTQFKIYNG---TLTVS 119
K + +T+VWSAN D P S++ L G +VLT +G +G T
Sbjct: 75 KTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQR 134
Query: 120 ALMQDSGNFLYSNANG-----SVDYSTGRFV--------------LEIQMDGNVVLSAFR 160
A + D+GN + ++ G S D T F+ + + GN + FR
Sbjct: 135 ARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYI---FR 191
Query: 161 FADPA--------------YW-------YTSTRGDQNVSLIFNQSTSFLYVRNKTTIRYP 199
F+D + YW Y R N + + + S + +
Sbjct: 192 FSDLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASSDFADGQA 251
Query: 200 MTTQVPTPTEDYYHRATISDHGNFQQWVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFC 259
+ P R T+ GN + + N DG+ W+V A+T+PC ++ +CG G C
Sbjct: 252 LVASDVGP--GVKRRLTLDPDGNLRLYSMNDSDGS-WSVSMVAMTQPCNIHGLCGPNGIC 308
Query: 260 TSDNNKEVTCECLRGYSPVDPNSPSKGCYPDVLVDFCDTKSSPADFTVEAIDDADIPNGD 319
+ TC C GY+ +P + ++GC ++ CD + ++ +PN D
Sbjct: 309 --HYSPTPTCSCPPGYATRNPGNWTEGCMA-IVNTTCDR------YDKRSMRFVRLPNTD 359
Query: 320 L--RDMARITTTDVNECRKAVMDDCFCAAGVWREVVCLKKKMPLLNARRSNPSTNKMAAF 377
D + + + CR + DC C ++E L + R+ P+++ +
Sbjct: 360 FWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSDVRTIY 419
Query: 378 IKVP---KINNS------------QGQDNDSPSRVV----------------------LL 400
+K+P ++N+ + D D ++ + +
Sbjct: 420 LKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWFYFYGFI 479
Query: 401 AGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREATNVFDG 460
A F + + F + L RP K N + +SY+EL +AT F
Sbjct: 480 AAFFVVEVSFISFAWFFVLKREL-RPSELWASEKGYKAMTSNFRRYSYRELVKATRKFKV 538
Query: 461 Q----------------EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
+ + VAVK+LE V G++ F E+ VIGR +H NLV++ GFC
Sbjct: 539 ELGRGESGTVYKGVLEDDRHVAVKKLENVR-QGKEVFQAELSVIGRINHMNLVRIWGFCS 597
Query: 505 EQNHQLLVYELMKNGTLSAFLFRQE---IPTWDKRVEIALGIARGLLYLHEECETQIIHC 561
E +H+LLV E ++NG+L+ LF + + W+ R IALG+A+GL YLH EC +IHC
Sbjct: 598 EGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWVIHC 657
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD-QTRTSTMIRGTMGYMAPEWLRNA 620
D+KP+N+LLD + KI DFGL KLL + T+ + +RGT+GY+APEW+ +
Sbjct: 658 DVKPENILLDQAFEP-------KITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSL 710
Query: 621 PVTAKVDVYSFGVMLLEIIFCKRHTEL 647
P+TAKVDVYS+GV+LLE++ R +EL
Sbjct: 711 PITAKVDVYSYGVVLLELLTGTRVSEL 737
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (572), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 121/300 (40%), Positives = 178/300 (59%), Gaps = 36/300 (12%)
Query: 446 FSYQELREATNVFD---GQE-------------VEVAVKQLEKVTGDGEKSFLREVQVIG 489
F+Y++L+ ATN F GQ +AVK+LE + G G+K F EV +IG
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGI-GQGKKEFRAEVSIIG 541
Query: 490 RTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE----IPTWDKRVEIALGIAR 545
HH +LV+L GFC E H+LL YE + G+L ++FR++ + WD R IALG A+
Sbjct: 542 SIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAK 601
Query: 546 GLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605
GL YLHE+C+ +I+HCDIKP+N+LLD+N+ K++DFGLAKL+ ++Q+ T +
Sbjct: 602 GLAYLHEDCDARIVHCDIKPENILLDDNFNA-------KVSDFGLAKLMTREQSHVFTTM 654
Query: 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDE----PTLANGMI- 660
RGT GY+APEW+ N ++ K DVYS+G++LLE+I +++ + E P+ A +
Sbjct: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKME 714
Query: 661 ---LTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPP 717
L D V ++ ++ + +R LWCI RPSM +V+QMLEG V PP
Sbjct: 715 EGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64782|SD129_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-29 OS=Arabidopsis thaliana GN=SD129 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 212/775 (27%), Positives = 332/775 (42%), Gaps = 129/775 (16%)
Query: 41 TWPSTSGDFAFGFY-PLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQL 99
T S G + GF+ P + VGIWF KI R +VW ANRD P S+ NLT++
Sbjct: 34 TLSSPGGFYELGFFSPNNTQNQYVGIWFKKIVPRVVVWVANRDTPV-TSSAANLTISSNG 92
Query: 100 VLTHSNGTQFKIYNGTLTVS-----ALMQDSGNF-------------------------- 128
L +G Q I++ + A + D+GNF
Sbjct: 93 SLILLDGKQDVIWSTGKAFTSNKCHAELLDTGNFVVIDDVSGNKLWQSFEHLGNTMLPQS 152
Query: 129 --LYSNANG----------SVDYSTGRFVLEI--QMDGNVVLSAFRFADPAYWYTSTRGD 174
+Y +NG + D S G F LEI Q+ ++ R YW
Sbjct: 153 SLMYDTSNGKKRVLTTWKSNSDPSPGEFSLEITPQIPTQGLI---RRGSVPYWRCGPWAK 209
Query: 175 QNVSLIFNQSTSFLYVRNKTTIRYPMTTQVPTPTEDYYHRA--TISDHGNFQ-QWVHNKR 231
S I S++ + T T Y+ + T++ G + W
Sbjct: 210 TRFSGISGIDASYVSPFSVVQDTAAGTGSFSYSTLRNYNLSYVTLTPEGKMKILW----D 265
Query: 232 DGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSKGCYPDV 291
DGN W + PC + CG +G C + + CECL+G+ P KG +
Sbjct: 266 DGNNWKLHLSLPENPCDLYGRCGPYGLCVRSDPPK--CECLKGFVPKSDEEWGKGNWTSG 323
Query: 292 LVD----FCDTKSSPADFTVEAIDD------ADIPNGDLRDMARITTTDVNECRKAVMDD 341
V C KSS + D D+ DL A + +C + + +
Sbjct: 324 CVRRTKLSCQAKSS---MKTQGKDTDIFYRMTDVKTPDLHQFASFLNAE--QCYQGCLGN 378
Query: 342 CFCAAGVW-REVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNSQGQDNDSPSRVVLL 400
C C A + + CL L + + S + FI++ + + S R +++
Sbjct: 379 CSCTAFAYISGIGCLVWNGELADTVQFLSSGEFL--FIRL-----ASSELAGSSRRKIIV 431
Query: 401 AGFLSCSM-LALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREATN--- 456
+S S+ L L+F +I+++ + + + +N F +R ATN
Sbjct: 432 GTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNF--FEMHTIRTATNNFS 489
Query: 457 ------------VFDGQEV---EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLG 501
V+ G+ V E+ VK+L +G G + F+ E+ +I + H+NLV+LLG
Sbjct: 490 PSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNEITLISKLQHRNLVRLLG 549
Query: 502 FCIEQNHQLLVYELMKNGTLSAFLFRQEIP---TWDKRVEIALGIARGLLYLHEECETQI 558
+CI+ +LL+YE M N +L F+F + W KR I GIARGLLYLH + ++
Sbjct: 550 YCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSRLRV 609
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST-MIRGTMGYMAPEWL 617
IH D+K N+LL D+ KI+DFGLA++ + Q + +T + GT+GYM+PE+
Sbjct: 610 IHRDLKVSNILL-------DDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYA 662
Query: 618 RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN---- 673
+ K D+YSFGV++LEII KR + DE + G++ W +C G+
Sbjct: 663 WAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDE---SKGLLAYTWDSWCETGGSNLLD 719
Query: 674 ------LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP--PVVA 720
A + R +GL C+ + RP+ QVL ML +++ VP P+ A
Sbjct: 720 RDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQPIFA 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 8e-57, Method: Compositional matrix adjust.
Identities = 210/777 (27%), Positives = 324/777 (41%), Gaps = 140/777 (18%)
Query: 44 STSGDFAFGFYPLV-SGLFLVGIWFDKISERTLVWSANRDDPAQVGSS-INLTVTGQLVL 101
S FAFGF+ L S L VGIW+ +IS++T+VW ANRD P S + + G L +
Sbjct: 36 SAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPINDTSGMVKFSNRGNLSV 95
Query: 102 THSNGTQFKIYNGTL-------TVSALMQDSGNF-LYSNANG-----SVDYST------- 141
S+ I++ + T+ A + D GN L+ G S D+ T
Sbjct: 96 YASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGRSFWESFDHPTDTFLPFM 155
Query: 142 -------------------------GRFVLEIQMDGNVVLSAFRFADPAYWYTSTRG--- 173
G +L ++ G L ++ P + S G
Sbjct: 156 RLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHRW 215
Query: 174 ----DQNVSLIFNQSTSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNFQQWVHN 229
+ + IFN SF+ ++ + Y +T R +++ G ++
Sbjct: 216 SGVPEMPIGYIFN--NSFVNNEDEVSFTYGVTDA------SVITRTMVNETGTMHRFTWI 267
Query: 230 KRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPN-----SPS 284
RD W W E C CG G+C S ++K C CL G+ P P S
Sbjct: 268 ARDKR-WNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSS 326
Query: 285 KGCYPDVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFC 344
GC C K I D + D+ + EC++ + +C C
Sbjct: 327 GGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDM-------NITLKECKQRCLKNCSC 379
Query: 345 AA--GVWRE-----VVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNSQGQDN--DSPS 395
A + E + CLK +L+AR S +I+V K ++ N
Sbjct: 380 VAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDF--YIRVDKEELARWNRNGLSGKR 437
Query: 396 RVVL-LAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEIN------------ 442
RV+L L ++ ML + V+ + + + P P + +
Sbjct: 438 RVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARN 497
Query: 443 --MKVFSYQELREATNVFDGQ------------------EVEVAVKQLEKVTGDGEKSFL 482
+ +F + ATN F Q +E+AVK+L + +G G + F
Sbjct: 498 RELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFK 557
Query: 483 REVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPT---WDKRVEI 539
EV++I + H+NLV++LG C+E ++LVYE + N +L F+F +E W KR+EI
Sbjct: 558 NEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEI 617
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599
GIARG+LYLH++ +IIH D+K N+LL D+ I KI+DFG+A++ +Q
Sbjct: 618 VRGIARGILYLHQDSRLRIIHRDLKASNILL-------DSEMIPKISDFGMARIFGGNQM 670
Query: 600 RTST-MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANG 658
T + GT GYMAPE+ + K DVYSFGV++LEII K+++ H +E + G
Sbjct: 671 EGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVG 728
Query: 659 MILTDW----VLYCVRTGNLGATKFERITM----VGLWCICPQPTLRPSMKQVLQML 707
I W + T ER M +GL C+ + R M V+ ML
Sbjct: 729 HIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIML 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (564), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 204/814 (25%), Positives = 343/814 (42%), Gaps = 152/814 (18%)
Query: 23 MTTNNIELGSNIIAGTNSTWPSTSGDFAFGFY-PLVSGLFLVGIWFDKISERTLVWSANR 81
++ N + ++ +N+T S F GF+ P + + +GIW+ IS+RT VW ANR
Sbjct: 27 ISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANR 86
Query: 82 DDP--AQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLT-------VSALMQDSGNFLYSN 132
D P + +G+ + ++ + +VL S+ +++ LT + A + D+GNF+ +
Sbjct: 87 DTPLSSSIGT-LKISDSNLVVLDQSDTP---VWSTNLTGGDVRSPLVAELLDNGNFVLRD 142
Query: 133 ANGSV---------DYSTGRFVLEIQMDGNVVLSAFRFA-------DPAY----WYTSTR 172
+ S D+ T + E+++ + RF DP+ + T
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202
Query: 173 GDQNVSLIFNQSTSF--------------------LYVRNKTTIRYPMTTQVPTPTEDYY 212
G + L +S + V N TT + +T D Y
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVY 262
Query: 213 HRATISDHGNFQQ--WVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCE 270
R +IS G Q+ W+ ++ W W A + C CGV+G+C D+N C
Sbjct: 263 SRLSISSSGLLQRFTWIETAQN---WNQFWYAPKDQCDEYKECGVYGYC--DSNTSPVCN 317
Query: 271 CLRGYSPVDPN-----SPSKGCYPDVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMAR 325
C++G+ P +P S GC L+ C + D + D
Sbjct: 318 CIKGFKPRNPQVWGLRDGSDGCVRKTLLS-CGGGDGFVRLKKMKLPDTTTASVD------ 370
Query: 326 ITTTDVNECRKAVMDDCFCAAGVWREVV-----CLKKKMPLLNARRSNPSTNKMAAFIKV 380
V EC + + DC C A ++ C+ L + R N + ++++
Sbjct: 371 -RGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIR--NYAKGGQDLYVRL 427
Query: 381 PKINNSQGQDNDSPSRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQP-------- 432
+ +D + S ++ + +L L F ++ R + P
Sbjct: 428 AA---TDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRS 484
Query: 433 ----------------SPKPKPPEINMKVFSYQELREATNVF------------------ 458
S + ++ + + ++E+ ATN F
Sbjct: 485 RDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGK 544
Query: 459 --DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
DGQE+ AVK+L K + G F EV++I R H NLV+LL C++ ++L+YE +
Sbjct: 545 LLDGQEM--AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYL 602
Query: 517 KNGTLSAFLF---RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
+N +L + LF R W R +I GIARGLLYLH++ +IIH D+K N+LLD
Sbjct: 603 ENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLD-K 661
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTM-IRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
Y+T KI+DFG+A++ +D+T +T + GT GYM+PE+ + + K DV+SFG
Sbjct: 662 YMT------PKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFG 715
Query: 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWV----------LYCVRTGNLGATKFERI 682
V+LLEII KR+ + D G + +W + + + R
Sbjct: 716 VLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRC 775
Query: 683 TMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP 716
+GL C+ + RP+M V+ ML G+ +P
Sbjct: 776 IQIGLLCVQERAEDRPTMSLVILML-GSESTTIP 808
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 725 | ||||||
| 224123812 | 789 | predicted protein [Populus trichocarpa] | 0.982 | 0.902 | 0.625 | 0.0 | |
| 225432640 | 770 | PREDICTED: G-type lectin S-receptor-like | 0.96 | 0.903 | 0.586 | 0.0 | |
| 147827611 | 800 | hypothetical protein VITISV_037412 [Viti | 0.915 | 0.83 | 0.596 | 0.0 | |
| 147827610 | 785 | hypothetical protein VITISV_037411 [Viti | 0.977 | 0.903 | 0.529 | 0.0 | |
| 225432626 | 785 | PREDICTED: G-type lectin S-receptor-like | 0.935 | 0.863 | 0.539 | 0.0 | |
| 225432634 | 787 | PREDICTED: G-type lectin S-receptor-like | 0.950 | 0.875 | 0.536 | 0.0 | |
| 225432630 | 782 | PREDICTED: G-type lectin S-receptor-like | 0.943 | 0.874 | 0.532 | 0.0 | |
| 356524214 | 783 | PREDICTED: G-type lectin S-receptor-like | 0.964 | 0.892 | 0.513 | 0.0 | |
| 359477337 | 749 | PREDICTED: G-type lectin S-receptor-like | 0.92 | 0.890 | 0.522 | 0.0 | |
| 224123816 | 787 | predicted protein [Populus trichocarpa] | 0.980 | 0.903 | 0.487 | 0.0 |
| >gi|224123812|ref|XP_002319170.1| predicted protein [Populus trichocarpa] gi|222857546|gb|EEE95093.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 994 bits (2569), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/794 (62%), Positives = 589/794 (74%), Gaps = 82/794 (10%)
Query: 6 LLIWSLVFFLSF-CSL--PQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFL 62
+++W L F LSF CSL PQ+TTN I LG++I AGTNS+W S SGDFAFGFYPL++G+FL
Sbjct: 4 IVLWCLPFVLSFLCSLAQPQITTNTINLGASITAGTNSSWRSPSGDFAFGFYPLLNGMFL 63
Query: 63 VGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLTVS-AL 121
VGIWFDKI ERTLVWSANRDDPA+ GS+IN T+ GQLVLTHSNGT + IYNGT S AL
Sbjct: 64 VGIWFDKIPERTLVWSANRDDPARTGSTINFTLDGQLVLTHSNGTGYLIYNGTFGASSAL 123
Query: 122 MQDSGNF--------------------------------LYSNANGSVDYSTGRFVLEIQ 149
MQ+ GNF LYSNANG+VDYSTG+++LE+Q
Sbjct: 124 MQNDGNFVVKTNSSEVIWQSFDSPTNTILLGQVLVMGKKLYSNANGTVDYSTGQYMLELQ 183
Query: 150 MDGNVVLSAFRFADPAYWYTSTRGDQNVSLIFNQSTSFLYVRNKTTIRYPMTTQVPTPTE 209
MDGNVV+SA++FADP YW+T T G+QNVSLIFNQST+F+YV N T+I Y MT+QVPTP
Sbjct: 184 MDGNVVMSAYKFADPGYWFTLTEGNQNVSLIFNQSTAFMYVVNHTSITYRMTSQVPTPIG 243
Query: 210 DYYHRATISDHGNFQQWVHNKRDGNGWAVVWEAIT---EPCTVNTICGVFGFCTSDNNKE 266
DYYHRATI+DHGN QQ+V++K +G+GW VVWE + EPC ICGV+GFCTS +N
Sbjct: 244 DYYHRATINDHGNLQQFVYHKENGSGWTVVWEPESIKAEPCIPFNICGVYGFCTSIDNTT 303
Query: 267 VTCECLRGYSPVDPNSPSKGCYPDVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARI 326
+ C+CL GYSP DP+ PSKGCYPD ++DFC SS ++FT+E ID+AD PNG DMAR+
Sbjct: 304 INCDCLPGYSPWDPSIPSKGCYPDTVIDFCAPNSSASNFTLEEIDNADFPNGAFADMARV 363
Query: 327 TTTDVNECRKAVMDDCFCAAGVWREVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNS 386
T DV ECRKA+MDDCF AGV E VC KK+ PLLNARRS PSTN + AFIK+PK NN+
Sbjct: 364 TPADVEECRKAIMDDCFAVAGVLVESVCYKKRTPLLNARRSIPSTNNIVAFIKIPKANNN 423
Query: 387 ---QGQDNDSPSRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINM 443
Q +D+DSPS + LLAG L CS++ LLF +I IY+HPL +PY+ + P PKP EIN+
Sbjct: 424 NQIQDKDDDSPSWIALLAGLLLCSIMTLLFATISIYHHPLAQPYISKKQLPVPKPVEINL 483
Query: 444 KVFSYQELREATN-------------------VFDGQEVEVAVKQLEKVTGDGEKSFLRE 484
K FS+QEL +ATN + +EVE+AVK+LEKV GEK FL E
Sbjct: 484 KAFSFQELLQATNGLRNKLGRGAFGTVYSGVLTLEAEEVEIAVKKLEKVIEQGEKEFLTE 543
Query: 485 VQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE-IPTWDKRVEIALGI 543
VQVIG THHKNLV+L+GFC E+NH+LLVYEL+KNGTLS FLF +E P+WD+R E GI
Sbjct: 544 VQVIGLTHHKNLVRLVGFCNEKNHRLLVYELVKNGTLSDFLFGEERRPSWDQRAETVYGI 603
Query: 544 ARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603
ARGLLYLHEECETQIIHCDIKPQNVLL D NY KIADFGLAKLLKKDQTRTST
Sbjct: 604 ARGLLYLHEECETQIIHCDIKPQNVLL-------DKNYTAKIADFGLAKLLKKDQTRTST 656
Query: 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTD 663
+RGTMGYMAPEWL+NAPVT KVDVYSFGV+LLEIIFC++H ELH+V+E T N MIL D
Sbjct: 657 KVRGTMGYMAPEWLKNAPVTTKVDVYSFGVVLLEIIFCRKHIELHQVNESTEDNEMILID 716
Query: 664 WVLYCVRTGNLGAT------------KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711
WVL VR GNL A +FER+ +VGLWCICP PTLRPSM +V QMLEGTS
Sbjct: 717 WVLCNVRAGNLHAIVSHDSEVLEDFCRFERMVLVGLWCICPNPTLRPSMNKVTQMLEGTS 776
Query: 712 EVGVPPVVADAQMF 725
EV PP++ DAQ+F
Sbjct: 777 EVDDPPLI-DAQIF 789
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432640|ref|XP_002278282.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2357), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/788 (58%), Positives = 554/788 (70%), Gaps = 92/788 (11%)
Query: 1 MAPSILLIWSLVFFLSFCSLPQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGL 60
M + +L+ SLVF LS TT+N LGS I AGT+S+W S SG FAFGFY L SG
Sbjct: 1 MVAAGVLVCSLVFALSLFVCSAQTTSNKNLGSGITAGTDSSWKSPSGHFAFGFYRLDSGC 60
Query: 61 FLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLTVSA 120
FLVGIWFDKI E TLVWSANRDDPA++GS++NLT++GQLVLTHSNGT+ IYNGTL SA
Sbjct: 61 FLVGIWFDKIQENTLVWSANRDDPARIGSTVNLTLSGQLVLTHSNGTKLLIYNGTLASSA 120
Query: 121 LMQDSGNF--------------------------------LYSNANGSVDYSTGRFVLEI 148
M+D GNF LYSN NG+VDYSTGRF+LE+
Sbjct: 121 SMEDDGNFVLRDSSSKIVWQSFAFPTDTVLPGQVLVMGQKLYSNINGTVDYSTGRFMLEL 180
Query: 149 QMDGNVVLSAFRFADPAYWYTSTRGDQNVSLIFNQSTSFLYVRNKTTIRY--PMTTQVPT 206
QMDGNVV+S+F+FADP YW+T T GD+N+SL+FN ST+F+YV N T+IRY M +VPT
Sbjct: 181 QMDGNVVISSFQFADPGYWFTLTEGDKNISLVFNASTAFMYVMNTTSIRYRMGMEREVPT 240
Query: 207 PTEDYYHRATISDHGNFQQWVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKE 266
P DYYHRA I+D+GN QQ V+ K W VVWEA+TEPC V ICGV+GFCTS +NK
Sbjct: 241 PITDYYHRAVINDYGNLQQMVYKKGSVGRWKVVWEAVTEPCIVYNICGVYGFCTSPDNKT 300
Query: 267 VTCECLRGYSPVDPNSPSKGCYPDVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARI 326
VTC CLRGYSP DPN PSKGCYP+ +VDFC S +D +E +D+ D PNG DMA+
Sbjct: 301 VTCTCLRGYSPWDPNVPSKGCYPNEMVDFCAPNSLASDLILEEMDNTDFPNGAFGDMAKS 360
Query: 327 TTTDVNECRKAVMDDCFCAAGVWREVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNS 386
+D+ CRKAVMDDC C AGVW E VC KK++ + + R + + N S
Sbjct: 361 APSDLVSCRKAVMDDCSCMAGVWVESVCYKKRIVVTSRVR-----------LGIYDHNES 409
Query: 387 QGQDNDSPSRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPK-PPEINMKV 445
+ +PSR VLLAG LSCS+LA+LF + IY+HPL +PY+ P P K P EIN+K
Sbjct: 410 R-----APSRAVLLAGLLSCSILAVLFAASAIYHHPLAQPYIRKHPPPTLKVPVEINLKA 464
Query: 446 FSYQELREATNVF-------------------DGQEVEVAVKQLEKVTG-DGEKSFLREV 485
FS+QELRE TN F + +EVE+AVKQL+KV GEK F+ EV
Sbjct: 465 FSFQELREGTNGFKNKLGGGAFGTVYGGVLTIEDEEVEIAVKQLDKVIDQQGEKEFMNEV 524
Query: 486 QVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIA 544
+VIG THHKNLV+LLGFC + NH+LLVYELMKNG LS+FLF + + P+WD+R +I LGI+
Sbjct: 525 RVIGLTHHKNLVRLLGFCNQHNHRLLVYELMKNGALSSFLFDEGKKPSWDQRAQIVLGIS 584
Query: 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604
RGLLYLHEECETQIIHCDIKPQNVLL D+NY KIADFGLAKLLKKDQTRTST
Sbjct: 585 RGLLYLHEECETQIIHCDIKPQNVLL-------DSNYTAKIADFGLAKLLKKDQTRTSTN 637
Query: 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRV-DEPTLANGMILTD 663
+RGTMGYMAPEWL+NAPVT KVDVYS+GVMLLEIIFC++H ELHR+ DE T + MIL D
Sbjct: 638 VRGTMGYMAPEWLKNAPVTTKVDVYSYGVMLLEIIFCRKHLELHRIEDEETGGDDMILVD 697
Query: 664 WVLYCVRTGNLGAT------------KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711
WVL CVR G L A +FER+ MVGLWC+CP PTLRPSMK V+QMLEG+
Sbjct: 698 WVLCCVRDGKLEAVVSHDTELLCDYKRFERMAMVGLWCVCPNPTLRPSMKMVMQMLEGSI 757
Query: 712 EVGVPPVV 719
+VG+PP++
Sbjct: 758 DVGIPPLI 765
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147827611|emb|CAN77457.1| hypothetical protein VITISV_037412 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2296), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/776 (59%), Positives = 545/776 (70%), Gaps = 112/776 (14%)
Query: 24 TTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDD 83
TT+N LGS I AGT+S+W S SG FAFGFY L SG FLVGIWFDKI E+TLVWSANRDD
Sbjct: 63 TTSNKNLGSGITAGTDSSWKSPSGHFAFGFYRLDSGCFLVGIWFDKIQEKTLVWSANRDD 122
Query: 84 PAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLTVSALMQDSGNF--------------- 128
PA++GS++NLT++GQLVLTHSNGT+ IYNGTL SA M+D+GNF
Sbjct: 123 PARIGSTVNLTLSGQLVLTHSNGTKLLIYNGTLARSASMEDNGNFVLRNSSSKIIWQSFD 182
Query: 129 -----------------LYSNANGSVDYSTGRFVLEIQ-MDGNVVLSAFRFADPAYWYTS 170
LYSN NG+VDYSTGRF+LE+Q MDGNVVLS+FRFADP YWYTS
Sbjct: 183 FPTDTILPGQVLVMGQKLYSNTNGTVDYSTGRFMLEVQIMDGNVVLSSFRFADPGYWYTS 242
Query: 171 TRGDQNVSLIFNQSTSFLYVRNKTTIRYPMT-TQVPTPTEDYYHRATISDHGNFQQWVHN 229
T GD+N+SL+FN S + +YV N T+IRY M+ ++PT DYYHRA I+D+GN QQ V+
Sbjct: 243 TAGDKNISLVFNNSNALMYVMNTTSIRYNMSREELPTSITDYYHRAVINDYGNLQQMVYK 302
Query: 230 KRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSKGCYP 289
K W VVWEAITEPCTVN ICGVFGFCTS +N VTC CL GYSP DPN PSKGCYP
Sbjct: 303 KGSVGQWKVVWEAITEPCTVNNICGVFGFCTSPDNNIVTCTCLPGYSPWDPNVPSKGCYP 362
Query: 290 DVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVW 349
+ +VDFC SS +DFT+E +D+ D PNG+ +
Sbjct: 363 NEMVDFCAPNSSASDFTLEEMDNTDFPNGE-----------------------------Y 393
Query: 350 REVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNSQGQDND----SPSRVVLLAGFLS 405
E VC KK+MPLLNAR S+ STN AFIKVPK+NNS G D+ +PSR VLLAG LS
Sbjct: 394 AESVCYKKRMPLLNARSSS-STNNRIAFIKVPKVNNSWGIDDRPKRRTPSRGVLLAGLLS 452
Query: 406 CSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPP-EINMKVFSYQELREATNVF------ 458
CS+LA+LF + IY+HPL +PY+ P P PK P EIN+K FS+QELR TN F
Sbjct: 453 CSILAVLFAASAIYHHPLAQPYIRKHPPPTPKVPVEINLKAFSFQELRGGTNGFKNKLGG 512
Query: 459 -------------DGQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCI 504
+ +EVE+AVKQL+KV GEK F+ EV+VIG THHKNLV+LLGFC
Sbjct: 513 GAFGTVYGGVITIEDEEVEIAVKQLDKVIDQQGEKEFMNEVRVIGLTHHKNLVRLLGFCN 572
Query: 505 EQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ NH+LLVYELM NG LS+FLF + + P+WD+R +I LGIARGLLYLHEECETQIIHCDI
Sbjct: 573 QHNHRLLVYELMNNGALSSFLFDEGKKPSWDQRAQIVLGIARGLLYLHEECETQIIHCDI 632
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
KPQNVLLD+NY KIADFGLAKLLKKDQTRT+T +RGTMGYMAPEWL+NAPVT
Sbjct: 633 KPQNVLLDSNYTA-------KIADFGLAKLLKKDQTRTNTNVRGTMGYMAPEWLKNAPVT 685
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRV-DEPTLANGMILTDWVLYCVRTGNLGAT----- 677
KVDVYSFGVM+LEIIFC+RH ELHR+ DE T + MIL DWVL CVR G L A
Sbjct: 686 TKVDVYSFGVMMLEIIFCRRHLELHRIEDEETGGDDMILIDWVLCCVRDGKLEAVVSHDT 745
Query: 678 -------KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE-VGVPPVVADAQMF 725
FER+ MVGLWC+CP PTLRPSM V++MLEG+ E VG+PP + + QMF
Sbjct: 746 ELLCHYKMFERMAMVGLWCVCPNPTLRPSMNMVMKMLEGSIEVVGIPPPI-ETQMF 800
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147827610|emb|CAN77456.1| hypothetical protein VITISV_037411 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/788 (52%), Positives = 525/788 (66%), Gaps = 79/788 (10%)
Query: 1 MAPSILLIWSLVFFLSFCSLPQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGL 60
MA ++++ W LV F SF NI LGS+I AG+N++W S SGDFAFGFY L SGL
Sbjct: 1 MAVALMISWLLVLFSSFHGFYAQIPQNISLGSSITAGSNASWRSPSGDFAFGFYHLTSGL 60
Query: 61 FLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLTVS- 119
+LVGIWFD+ISERTLVWSANRD PA+ GS++ LT GQL L++ NG+ IY+G+ S
Sbjct: 61 YLVGIWFDEISERTLVWSANRDKPAETGSTVQLTSDGQLELSYVNGSTQSIYSGSDAASL 120
Query: 120 ALMQDSGNF--------------------------------LYSNANGSVDYSTGRFVLE 147
MQD+GNF LYSN SV+YSTG F+L
Sbjct: 121 GFMQDNGNFVLKDANSFDIWQSFSFPTDTLLPGQVVNQTQKLYSNEKESVNYSTGNFMLA 180
Query: 148 IQMDGNVVLSAFRFADPAYWYTSTRGDQNVSLIFNQSTSFLYVRNKTTIR-YPMTTQVPT 206
+Q DGN+VLSA+ FADP YW TST VSL+F++ T+ +Y+ N + + +P+T + T
Sbjct: 181 MQSDGNLVLSAYHFADPGYWDTSTFV-STVSLVFDEQTALMYLVNSSNVNIWPLTKNIST 239
Query: 207 PTEDYYHRATISDHGNFQQWVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKE 266
P EDYYHRATI DHGNFQQ+V+ K +G W VW A+ EPC VN+ICGV+GFCTS +N+
Sbjct: 240 PVEDYYHRATIDDHGNFQQYVYPKVNGRNWERVWRAVEEPCLVNSICGVYGFCTSPDNET 299
Query: 267 VTCECLRGYSPVDPNSPSKGCYPDVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARI 326
V+C CL GY P+DPN SKGC P++++++C S +FTVE IDDAD P + D+AR+
Sbjct: 300 VSCSCLPGYIPLDPNDLSKGCRPEIVLNYC-ADPSMRNFTVEVIDDADFPFENSADLARV 358
Query: 327 TTTDVNECRKAVMDDCFCAAGVWREVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNS 386
DV C+KAVMDDC+ A + C+KKKMPLLNAR+S ST + A IKVP N
Sbjct: 359 RNVDVEGCKKAVMDDCYTLAAALVDSRCIKKKMPLLNARKS-VSTKGIKALIKVPMKIND 417
Query: 387 QG---QDNDSPSRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINM 443
G + +S RV L GF++ +LA+L + +YYHP+ R + + IN
Sbjct: 418 PGMLPKKKNSNDRVYLTVGFITSGVLAVLSAAFAVYYHPVARRLVKRKHFQNANAIGINF 477
Query: 444 KVFSYQELREATN-------------VFDG------QEVEVAVKQLEKVTGDGEKSFLRE 484
+ F++QEL EATN VF G +E+AVK+LEK GEK F+ E
Sbjct: 478 RQFTFQELHEATNGFSKTIGRGSSGKVFSGILSSKDLHIEIAVKKLEKAIEKGEKEFVTE 537
Query: 485 VQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF-RQEIPTWDKRVEIALGI 543
+++IGRTHHKNLV+LLGFCIE HQLLVYELMKNGTLS FLF ++E P W +R E+ALGI
Sbjct: 538 LKIIGRTHHKNLVRLLGFCIEDGHQLLVYELMKNGTLSDFLFGKEEKPIWIQRAEMALGI 597
Query: 544 ARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603
ARGLLYLHEECETQIIHCDIKPQNVLL D NY KIADFGL+KLL KDQT+T T
Sbjct: 598 ARGLLYLHEECETQIIHCDIKPQNVLL-------DANYTAKIADFGLSKLLNKDQTKTIT 650
Query: 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTD 663
IRGTMGY+APEWLRNA VTAKVD+YSFGVMLLEII +RH EL RV+E T + +++TD
Sbjct: 651 NIRGTMGYLAPEWLRNAAVTAKVDIYSFGVMLLEIICGRRHIELSRVEEETEDDDLVITD 710
Query: 664 WVLYCVRTGNLGA------------TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711
WVL C+ + L +FER+ +VGLWC+ P P LRPS+K+V QMLEGT
Sbjct: 711 WVLSCMISRKLEKLVGHDSEVLDDFKRFERMALVGLWCVHPDPILRPSIKKVTQMLEGTV 770
Query: 712 EVGVPPVV 719
EVG+PP++
Sbjct: 771 EVGIPPLL 778
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432626|ref|XP_002278028.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/769 (53%), Positives = 524/769 (68%), Gaps = 91/769 (11%)
Query: 27 NIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQ 86
NI LGS+ TNS+W S SGDFAFGFYPL GLFL+GIWF+KI E+T+VWSANRD PA
Sbjct: 27 NISLGSSFDTHTNSSWLSLSGDFAFGFYPLPGGLFLLGIWFNKIPEKTVVWSANRDAPAP 86
Query: 87 VGSSINLTVTGQLVLTHSNGTQFKIYNGTLTV-SALMQDSGNF----------------- 128
GSS+NLT+ G LVLT NGT +I NG SA +Q++GN
Sbjct: 87 AGSSVNLTLAGSLVLTFPNGTVSQISNGASAANSASLQNNGNLVLRNFVSSVVWQSFDNP 146
Query: 129 ---------------LYSNANGSVDYSTGRFVLEIQMDGNVVLSAFRFADPAYWYTSTRG 173
LYSNANG+VDYSTG+F+LE+ DGNVVL+ FR+AD YW+T T
Sbjct: 147 TDTLLLGQKVPWDHRLYSNANGTVDYSTGKFMLEVGTDGNVVLATFRWADSGYWWTDTI- 205
Query: 174 DQNVSLIFNQSTSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNFQQWVHNKRDG 233
NVSL+FN+ST+ +YV N T+I Y +TT VPTP + YYHRAT+ D GNFQQ+++ K +G
Sbjct: 206 QPNVSLVFNESTALMYVTNLTSIIYRLTTNVPTPVDRYYHRATVEDTGNFQQYIYPKVNG 265
Query: 234 NGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSKGCYPDVLV 293
+GW VW+A TEPC+VN ICGV+G+CTS +N+ VTC CL GYS +DPN PSKGCYP+V
Sbjct: 266 SGWTSVWKAATEPCSVNGICGVYGYCTSPDNQNVTCSCLPGYSLMDPNVPSKGCYPNVPP 325
Query: 294 DFCDTKSSPADFT---VEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFC-AAGVW 349
C SP+D T +E ID+ADI N +M R+ +D+ +CR+AVMDDC+C AA +
Sbjct: 326 QQC--SKSPSDVTNYNIEVIDNADIVNNLFTEMTRLYNSDLEKCREAVMDDCYCMAATLT 383
Query: 350 REVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNSQGQDN------DSPSRVVLLAGF 403
+ VC KK++P +NAR+S+PSTN + IKVP + QG+ + P ++L
Sbjct: 384 ADNVCRKKRIPFMNARQSSPSTNGIQTIIKVPVV--EQGKTDGLIAGKKEPRSQMILKVC 441
Query: 404 LSCS-MLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREATNVF---- 458
LS S MLALLF + I Y+P+ R + P EIN+K F+Y+EL EAT+ F
Sbjct: 442 LSISTMLALLFAAFAI-YNPIAR--LSRARKFLANPAEINLKKFTYRELHEATDGFKNKI 498
Query: 459 ---------------DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
+ +++++AVK+LE+V G+K FL E++VIG+THHKNLV+LLGFC
Sbjct: 499 GRGSFGTVYSGILNLEDKQIKIAVKKLERVMEQGDKEFLTELRVIGQTHHKNLVKLLGFC 558
Query: 504 IEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
EQ+H+LLVYELM NGTLS FLF + E P WD R +I L IARGL YLH+ECETQIIHCD
Sbjct: 559 DEQSHRLLVYELMTNGTLSGFLFSEGEKPCWDHRAQIVLAIARGLSYLHDECETQIIHCD 618
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV 622
IKPQNVLL D+ + KIA+FGLAKLL KDQTRTST +RGTMGYMAPEWL+N PV
Sbjct: 619 IKPQNVLL-------DSQFNPKIAEFGLAKLLMKDQTRTSTNVRGTMGYMAPEWLKNVPV 671
Query: 623 TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT----- 677
TAKVDVYSFGV+LLEII C++H EL+RV+E + + +IL DWVL CVR G L A
Sbjct: 672 TAKVDVYSFGVLLLEIICCRKHIELNRVEEESEEDDLILVDWVLTCVRKGKLEAVVKHDP 731
Query: 678 -------KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVV 719
+FER+ MVGLWC+ P P LRP+MK+V+QMLEGT EV VPP+V
Sbjct: 732 EVSDDFKRFERMAMVGLWCVHPDPVLRPTMKKVIQMLEGTVEVAVPPLV 780
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432634|ref|XP_002278198.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/764 (53%), Positives = 514/764 (67%), Gaps = 75/764 (9%)
Query: 24 TTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDD 83
T NI LGS + T+STW S SGDFAFGFYPL SGLFL+GIWF+KI E TLVWSANRD+
Sbjct: 26 TPENISLGSGLTTTTDSTWLSPSGDFAFGFYPLDSGLFLLGIWFNKIPEETLVWSANRDN 85
Query: 84 PAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLTVSALMQDSGNF--------------- 128
PA GS+INLT +G L+LT+ NG+ IY SA M D+GNF
Sbjct: 86 PAPEGSTINLTASGYLLLTYPNGSLDHIYEDAAASSASMLDNGNFVLWSSVSRVLWQSFE 145
Query: 129 ------------------LYSNANGSVDYSTGRFVLEIQ-MDGNVVLSAFRFADPAYWYT 169
L+SN NG+VDYS G F LE+Q +DGN+ L AFRF+D YW++
Sbjct: 146 HPTDTLLPGQTIPAGDTRLFSNTNGTVDYSKGNFQLEVQSVDGNMGLFAFRFSDSGYWWS 205
Query: 170 STRGDQNVSLIFNQSTSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNFQQWVHN 229
+T NVSL+FN++T+ +Y+ N T+I + MT VPTP YYHRATI D GNFQQ+V+N
Sbjct: 206 NTTQQTNVSLVFNETTASMYMTNLTSIIFRMTRDVPTPVNIYYHRATIEDTGNFQQYVYN 265
Query: 230 KRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSKGCYP 289
K +G GW +W AI EPCTVN ICGV+G+CTS N+ TC CL GYS +DPN PSKGC P
Sbjct: 266 KVNGTGWRSIWRAIEEPCTVNGICGVYGYCTSPRNQNATCSCLPGYSLIDPNIPSKGCRP 325
Query: 290 DVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVW 349
DV V+ C S ++ VE IDDADI N ++ R+ D++ C KAV DDC+C A +
Sbjct: 326 DVPVEQCANTPSETEYRVEVIDDADIKNDIFAELTRLYGYDLDGCIKAVQDDCYCVAATY 385
Query: 350 -REVVCLKKKMPLLNARRSNPSTNKMAAFIKVP-KINNSQGQDNDSPSRVVLLAGFLSCS 407
+ VC KK++P +NAR+S PST + A IKVP KI + N+S +VV+L S
Sbjct: 386 TTDNVCRKKRIPFMNARKSIPSTTGIKAIIKVPVKIEDPIKGTNNSRPQVVVLVCLSVVS 445
Query: 408 MLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREATN----------- 456
LALLF +I+IY + + + + +P + +IN++ F+YQEL +AT+
Sbjct: 446 FLALLFATIIIYQNLVVPRFGLSKLAPSTQSADINLRTFTYQELHKATDGFRNRLGRGAS 505
Query: 457 --------VFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH 508
F+ +E+E+AVK+LE+V G++ FL EV+ IG+THH+NLV+LLGFC EQ+H
Sbjct: 506 GSVYSGTLRFEDKEMEIAVKKLERVIEQGDREFLAEVRAIGQTHHRNLVRLLGFCNEQSH 565
Query: 509 QLLVYELMKNGTLSAFLF-RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
+LLVYELMKNG LS+FLF + E P WD R EI L IARGLLYLHEECET+IIHCDIKPQN
Sbjct: 566 RLLVYELMKNGPLSSFLFSKGEKPCWDHRAEIVLAIARGLLYLHEECETRIIHCDIKPQN 625
Query: 568 VLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVD 627
VLL D +Y KIADFGLAKLL+KDQTRTST RGTMGYMAPEWL+ APVTAKVD
Sbjct: 626 VLL-------DQHYNAKIADFGLAKLLRKDQTRTSTNARGTMGYMAPEWLKCAPVTAKVD 678
Query: 628 VYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT---------- 677
V+SFGVMLLEII C+RH EL R++E T + +ILTDWVL C+R G L
Sbjct: 679 VHSFGVMLLEIICCRRHIELDRIEEETEDDDLILTDWVLNCLRLGKLEVVVKHDPEVLGD 738
Query: 678 --KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVV 719
+FER+ MVGLWC+ P P LRP+MK+V+QMLEGT E GVPP+V
Sbjct: 739 FKRFERMAMVGLWCVNPDPILRPTMKRVIQMLEGTIEAGVPPLV 782
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432630|ref|XP_002278071.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/763 (53%), Positives = 505/763 (66%), Gaps = 79/763 (10%)
Query: 27 NIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQ 86
NI LGS+ TNS+W S SG+FAFGFYPL GLFLVGIWFDKI E+T+VWSANRDDPA
Sbjct: 24 NISLGSSFDTNTNSSWLSPSGEFAFGFYPLAGGLFLVGIWFDKIPEKTVVWSANRDDPAP 83
Query: 87 VGSSINLTVTGQLVLTHSNGTQFKIYNGTLTV--SALMQDSGNF---------------- 128
GSSIN TV G LV+T NGT +IYNG SA +Q++GN
Sbjct: 84 AGSSINFTVAGSLVMTVPNGTVTQIYNGDTNAANSASLQNNGNLVLWSSVSRVLWQSFEH 143
Query: 129 -----------------LYSNANGSVDYSTGRFVLEIQ-MDGNVVLSAFRFADPAYWYTS 170
L+SN NG+VDYS G F LE+Q +DGN+ L AFRF+D YW+++
Sbjct: 144 PTDTLLPGQTIPAGDTRLFSNTNGTVDYSKGNFQLEVQSVDGNMGLFAFRFSDSGYWWSN 203
Query: 171 TRGDQNVSLIFNQSTSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNFQQWVHNK 230
T NVSL+FN++T+ +Y+ N T+I + MT VPTP YYHRATI D GNFQQ+V+NK
Sbjct: 204 TTQQTNVSLVFNETTASMYMTNLTSIIFRMTRDVPTPVNIYYHRATIEDTGNFQQYVYNK 263
Query: 231 RDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSKGCYPD 290
+G GW +W AI EPCTVN ICGV+G+CTS N+ TC CL GYS +DPN PSKGC PD
Sbjct: 264 VNGTGWRSIWRAIEEPCTVNGICGVYGYCTSPRNQNATCSCLPGYSLIDPNIPSKGCRPD 323
Query: 291 VLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVW- 349
V V+ C S ++ VE IDDADI N ++ R+ D++ C KAV DDC+C A +
Sbjct: 324 VPVEQCANTPSETEYRVEVIDDADIKNDIFAELTRLYGYDLDGCIKAVQDDCYCVAATYT 383
Query: 350 REVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNSQGQDNDSPSRVVLLAGFLSCSML 409
+ VC KK++P +NAR+S+PST+ + A IKVP + Q P ++L LS S +
Sbjct: 384 TDNVCRKKRIPFMNARKSSPSTDGIQAIIKVPVKTDVQIAGKKEPRSQMILKVCLSISAI 443
Query: 410 ALLFGSIVIYY-HPLTRPYMCVQPSPKPKPPEINMKVFSYQELREATNVF---------- 458
+ Y HP+ R + P EIN+ F+Y+EL EAT+ F
Sbjct: 444 LAFLFAAAAIYNHPIARRSRARKVLANPA--EINLNKFTYRELHEATDGFKNKIGRGSFG 501
Query: 459 ---------DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
+ +++++AVK+LE+V G+K FL EV+VIG+THHKNLV+LLGFC EQ+H+
Sbjct: 502 TVYSGILNLEDKQIKIAVKKLERVMEQGDKEFLTEVRVIGQTHHKNLVKLLGFCDEQSHR 561
Query: 510 LLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
LLVYELM NGTLS FLF + E P WD R +I L IARGL YLH+ECETQIIHCDIKPQNV
Sbjct: 562 LLVYELMTNGTLSGFLFAEGEKPCWDHRAQIVLAIARGLSYLHDECETQIIHCDIKPQNV 621
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
LL D+ + KIADFGLAKLL KDQTRTST +RGTMGYMAPEWL+NAPVTAKVDV
Sbjct: 622 LL-------DSQFNAKIADFGLAKLLMKDQTRTSTNVRGTMGYMAPEWLKNAPVTAKVDV 674
Query: 629 YSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT----------- 677
YSFGV+LLEII C+RH EL+RV+E + + +IL DWVL CVR G L A
Sbjct: 675 YSFGVLLLEIICCRRHIELNRVEEESEEDDLILMDWVLTCVRKGKLEAVVKHDPEVSDDF 734
Query: 678 -KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVV 719
+FER+ MVGLWC+ P P LRP+MK+V+QMLEGT EV VPP+V
Sbjct: 735 KRFERMAMVGLWCVHPDPVLRPTMKKVIQMLEGTVEVAVPPLV 777
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524214|ref|XP_003530726.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/786 (51%), Positives = 509/786 (64%), Gaps = 87/786 (11%)
Query: 11 LVFFLSF--CSLPQMTTNNIELGSNIIAGTN-STWPSTSGDFAFGFYPLVSGLFLVGIWF 67
LV F+SF CS N+IELGS+I+AGTN S+W S++GD+AFGFY L+SG +LVGIWF
Sbjct: 6 LVLFVSFFLCSSVLRNANSIELGSSIVAGTNNSSWRSSNGDYAFGFYHLLSGHYLVGIWF 65
Query: 68 DKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLT--VSALMQDS 125
DK+ +TLVWSANRD+P ++GS+INLT +G+ +L G F+IY GT T +A M+D+
Sbjct: 66 DKVPNKTLVWSANRDNPVEIGSTINLTSSGEFLLQPVKGATFQIYKGTNTPAATAKMEDN 125
Query: 126 GNF--------------------------------LYSNANGSVDYSTGRFVLEIQM-DG 152
GN LYSNANGSVDYS G++ LEIQ DG
Sbjct: 126 GNLVLRNSLSEFIWQSFDSPTDTLLLGQTLKMGQKLYSNANGSVDYSKGQYSLEIQQSDG 185
Query: 153 NVVLSAFRFADPAYWYTSTRGDQNVSLIFNQSTSFLYVRNKT--TIRYPMTTQVPTPTED 210
N+VL AFRF D YW + T + +V ++FN +T+FLY N T TI + ED
Sbjct: 186 NIVLKAFRFTDAGYWSSGTNQNTDVRIVFNSTTAFLYAVNGTNQTIHNMTVDPLTGAIED 245
Query: 211 YYHRATISDHGNFQQWVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCE 270
YYHR I D GN Q+ +H K +G+ W VW AI PC V +CGV+GFC S +N+ +CE
Sbjct: 246 YYHRVLIDDRGNLQKLIHPKENGSDWTSVWNAIELPCRVTALCGVYGFCNSSDNQSYSCE 305
Query: 271 CLRGYSPVDPNSPSKGCYPDVLVD-FCDTKSSPADFTVEAIDDADIPNGDLR--DMARIT 327
CL GY+ +DPN PSKGCY + C SS + V+AI DADIPN D D+ I
Sbjct: 306 CLPGYTHLDPNVPSKGCYLSTEANGLCAANSSKVE--VKAIQDADIPNNDYFYFDLQVIN 363
Query: 328 TTDVNECRKAVMDDCFCAAGVWREVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINNSQ 387
D+ C++ +MDDC C A V+ C KK P++NA + P T+ IKVP ++N
Sbjct: 364 NMDLESCKRELMDDCLCMAAVFYGSDCHKKTWPVINAIKIFPDTSNRVMLIKVPLLDNDM 423
Query: 388 GQDNDSPSRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSP-KPKPPEINMKVF 446
+ DS S VVL+ +SCS+LA+LF + IY+HP+ ++ + P KPKP +IN+K F
Sbjct: 424 ENEKDSQSLVVLIVALVSCSLLAVLFAATFIYHHPIICQHLIHKGEPPKPKPMDINLKAF 483
Query: 447 SYQELREATNVF-------------------DGQEVEVAVKQLEKVTGDGEKSFLREVQV 487
S+Q+LREATN F +GQ+VEVAVKQLE+V GEK F+ EVQV
Sbjct: 484 SFQQLREATNGFKDKLGRGAYGTVYSGVLNLEGQQVEVAVKQLEQVEEQGEKEFVTEVQV 543
Query: 488 IGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--EIPTWDKRVEIALGIAR 545
I THH+NLV LLG+C EQNH+LLVYE M+NGTLS FLF + P+W+ RV I + IAR
Sbjct: 544 IAHTHHRNLVGLLGYCNEQNHRLLVYEKMENGTLSNFLFGEGNHRPSWESRVRIVIEIAR 603
Query: 546 GLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605
GLLYLHEEC+ QIIHCDIKPQNVLLD++Y KI+DFGLAKLL KD+TRTST
Sbjct: 604 GLLYLHEECDQQIIHCDIKPQNVLLDSSYTA-------KISDFGLAKLLMKDKTRTSTNA 656
Query: 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRV-DEPTLANGMILTDW 664
RGT+GYMAPEWL+NAPVT KVD+YSFGV+LLE IFC+RH ELHR+ DE T + MIL DW
Sbjct: 657 RGTVGYMAPEWLKNAPVTTKVDIYSFGVVLLETIFCRRHIELHRINDETTGGDDMILIDW 716
Query: 665 VLYCVRTGNLGAT------------KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712
VLY + +L A +FER+ MVGLWC+ P TLRPSMK V QMLEG E
Sbjct: 717 VLYLAKENSLRAAVVDDLEVESDFKRFERMVMVGLWCVYPNSTLRPSMKVVAQMLEGNIE 776
Query: 713 VGVPPV 718
VGVPP+
Sbjct: 777 VGVPPL 782
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477337|ref|XP_002278047.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/783 (52%), Positives = 517/783 (66%), Gaps = 116/783 (14%)
Query: 12 VFFLSFCSLPQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKIS 71
V+FLS S Q+ NI LGS+ TNS+W S SGDFAFGFYPL GLFL+GIWFDKI+
Sbjct: 14 VYFLS-GSHAQLQ-GNISLGSSFDTETNSSWLSPSGDFAFGFYPLPGGLFLLGIWFDKIT 71
Query: 72 ERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLT-------------- 117
E+T+VWSANRDDPA GSS+NLT+TG LVLT NGT +I++G
Sbjct: 72 EKTVVWSANRDDPAPAGSSVNLTLTGSLVLTFPNGTVIQIHDGATNPANSASFQNNGLLW 131
Query: 118 ----------VSALMQD--SGNFLYSNANGSVDYSTGRFVLEIQMDGNVVLSAFRFADPA 165
+S L+Q S LYSNANG+VDYSTG+F+LE+ DGNVVL+ FR+AD
Sbjct: 132 YLPNIPTAKLMSGLVQTVPSDRRLYSNANGTVDYSTGKFMLEVGTDGNVVLATFRWADSG 191
Query: 166 YWYTSTRGDQNVSLIFNQSTSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNFQQ 225
YW+T+T NVSL+FN+ST+ +YV N T+I Y +TT V TP + YYHRAT+ D GNFQQ
Sbjct: 192 YWWTNTI-QPNVSLVFNESTALMYVTNLTSIIYRLTTNVSTPVDRYYHRATVEDTGNFQQ 250
Query: 226 WVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSK 285
+++ K +G+GW VW+A+T+PC+VN ICGV+G+CTS +N+ VTC CL GYS +DPN PSK
Sbjct: 251 YIYPKVNGSGWTSVWKAVTQPCSVNGICGVYGYCTSADNQNVTCSCLPGYSLMDPNVPSK 310
Query: 286 GCYPDVLVDFCD-TKSSPADFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFC 344
GCYP+V C + S+ ++T+E I DADI N + +M R+ D+ +CR++ MDDC+C
Sbjct: 311 GCYPNVPPQQCSKSPSNVTNYTIEVIGDADIVNNEFAEMTRLYNYDLEKCRQSCMDDCYC 370
Query: 345 -AAGVWREVVCLKKKMPLLNARRSNPSTNKMAAFIKVP---------KINNSQGQDNDSP 394
AA + + VC KK++P +NAR+S+PSTN + IKVP +I + + S
Sbjct: 371 MAATLTADNVCRKKRIPFMNARQSSPSTNGIQTIIKVPVVEPGKTDGQIEGKKSEARRSR 430
Query: 395 SRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREA 454
+R VL P EIN+K F+Y+EL EA
Sbjct: 431 ARKVL------------------------------------ANPAEINLKKFTYRELHEA 454
Query: 455 TNV-------------------FDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKN 495
T+ F+ +E+E+AVK+L+KV G+K FL EV VIG+THHKN
Sbjct: 455 TDGFKNKIGSGSFGTVYSGVLNFEDKEIEIAVKKLKKVMEQGDKEFLTEVMVIGQTHHKN 514
Query: 496 LVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEEC 554
LV+LLGFC EQ+H+LLVYELM NGTLS FLF + E P WD R +I L +ARGL YLH+EC
Sbjct: 515 LVKLLGFCDEQSHRLLVYELMTNGTLSGFLFAEGEKPCWDHRAQIVLAVARGLSYLHDEC 574
Query: 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAP 614
ETQIIHCDIKPQNVLL D+ + KIADFGLAKLL KDQTRTST +RGTMGYMAP
Sbjct: 575 ETQIIHCDIKPQNVLL-------DSQFNPKIADFGLAKLLMKDQTRTSTNVRGTMGYMAP 627
Query: 615 EWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674
EWL+N PVTAKVDVYSFGV+LLEII C+RH EL+RV+E + + +IL DWVL CV G L
Sbjct: 628 EWLKNVPVTAKVDVYSFGVLLLEIICCRRHIELNRVEEESEEDDLILVDWVLTCVIRGKL 687
Query: 675 GAT------------KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVVADA 722
A +FER+ MVGLWC+ P P LRP+MK+V+QMLEGT EV VPP +A A
Sbjct: 688 EAVVKHDPEVSDDFKRFERMAMVGLWCVHPDPILRPTMKKVIQMLEGTVEVAVPP-LAHA 746
Query: 723 QMF 725
F
Sbjct: 747 PTF 749
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123816|ref|XP_002319171.1| predicted protein [Populus trichocarpa] gi|222857547|gb|EEE95094.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/791 (48%), Positives = 501/791 (63%), Gaps = 80/791 (10%)
Query: 1 MAPSILLIWSLVFFLSFCSLPQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGL 60
M +L + L+ FL F L NI LGS+I AG+ ++W S S +FAFGFY L + L
Sbjct: 1 MTIQKILPFLLLQFLYFHELHAQIPPNISLGSSIKAGSGNSWRSLSDEFAFGFYSLPNNL 60
Query: 61 FLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLTVSA 120
+LVGIWF+KI E+TLVWSANRD PA GS++ LT GQL LTH NG+ IY G
Sbjct: 61 YLVGIWFNKIPEKTLVWSANRDSPAAAGSTVRLTFDGQLTLTHLNGSIQSIYRGRRAGLG 120
Query: 121 LMQDSGNF--------------------------------LYSNANGSVDYSTGRFVLEI 148
M + GNF LYSNANG+VDYSTG F+L++
Sbjct: 121 FMLNDGNFVLRDDSSSVIWQSFNSPTDTILPGQVLSDDQKLYSNANGTVDYSTGNFMLQM 180
Query: 149 QMDGNVVLSAFRFADPAYWYTSTRGDQNVSLIFNQSTSFLYVRNKTTIR-YPMTTQVPTP 207
Q DGN+VLSA+ F+DP YWYT T + NVSL+F+ T F+Y+ N T YP+T V TP
Sbjct: 181 QFDGNLVLSAYHFSDPGYWYTGTVRN-NVSLVFSNHTFFMYLVNSTGDNIYPLTRNVSTP 239
Query: 208 TEDYYHRATISDHGNFQQWVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEV 267
DYYHRATI+DHG+FQQ+ ++K + +GW VW AI EPC VN ICGV+G C S NN+
Sbjct: 240 VGDYYHRATINDHGDFQQFAYHKSNSSGWTRVWRAIDEPCVVNAICGVYGMCFSLNNETA 299
Query: 268 TCECLRGYSPVDPNSPSKGCYPDVLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARIT 327
TC+C+ GY P+DPN SKGC P+ +V++C S +FT+ IDDAD P D+AR+
Sbjct: 300 TCKCIPGYIPLDPNHVSKGCRPETVVNYC-ADPSMRNFTINVIDDADFPFESDADLARVK 358
Query: 328 TTDVNECRKAVMDDCFCAAGVWREVVCLKKKMPLLNARRSNPSTNKMAAFIKVPKINN-- 385
D+ C+KA+MDDC+ + + C+KK+MPLLNAR+S ST A +KVP +N
Sbjct: 359 NVDLEGCKKALMDDCYSLSASLVDSRCIKKRMPLLNARKSF-STKGRQALVKVPMKSNPG 417
Query: 386 --SQGQDNDSPSRVVLLAGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINM 443
++ND +RV L + + LA FG IYYHP R ++ + IN
Sbjct: 418 IQEHKKNNDFDTRVFLKISLIVTATLAFCFGVSAIYYHPAPRRFIKRKRYSNANSIGINF 477
Query: 444 KVFSYQELREATNVFDGQ-------------------EVEVAVKQLEKVTGDGEKSFLRE 484
+ F Y EL++ATN F ++++AVK L K GEK F+ E
Sbjct: 478 QEFKYLELQKATNGFSKTLGRGSSAKVYSGILSMKDIQIDIAVKVLTKSIEKGEKEFMTE 537
Query: 485 VQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--EIPTWDKRVEIALG 542
+++IGRT+HKNLV+LLGFC+E + QLLVYELM NG+L+ LF + E P W +R E+ L
Sbjct: 538 LKIIGRTYHKNLVRLLGFCVENDQQLLVYELMANGSLANLLFGKGSERPNWVRRAEMVLE 597
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
IARGLLYLH+ECE QIIHCDIKP+NVL IDNNY K+ADFGL+KLL KDQTRT
Sbjct: 598 IARGLLYLHDECEAQIIHCDIKPENVL-------IDNNYTAKLADFGLSKLLNKDQTRTD 650
Query: 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILT 662
T +RGT+GY+APEW+RN VT+KVDVYSFGVMLLEI+ C+RH E RV+E + + ++L+
Sbjct: 651 TNLRGTVGYLAPEWIRNERVTSKVDVYSFGVMLLEILCCRRHIEPSRVEEESEEDDLVLS 710
Query: 663 DWVLYCVRTGNLGAT------------KFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710
DWV+ C+ G LG +FER+T+VGLWCI P RPSMK+V QMLEGT
Sbjct: 711 DWVISCMAAGKLGTVVGHDPEVLSDFKRFERMTLVGLWCIHPDAMSRPSMKKVTQMLEGT 770
Query: 711 SEVGVPPVVAD 721
SE+G+PP ++D
Sbjct: 771 SEIGIPPSLSD 781
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 725 | ||||||
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.637 | 0.557 | 0.345 | 5.3e-73 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.329 | 0.288 | 0.448 | 6.2e-60 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.344 | 0.296 | 0.356 | 3.7e-52 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.344 | 0.294 | 0.346 | 6.5e-52 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.364 | 0.321 | 0.393 | 2.6e-51 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.347 | 0.309 | 0.358 | 2.7e-50 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.344 | 0.295 | 0.356 | 1.8e-47 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.662 | 0.606 | 0.278 | 3.2e-47 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.235 | 0.196 | 0.444 | 3.9e-45 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.337 | 0.305 | 0.366 | 9.6e-45 |
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 5.3e-73, Sum P(2) = 5.3e-73
Identities = 182/527 (34%), Positives = 261/527 (49%)
Query: 232 DGN-GWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVDPNSPSKGCYPD 290
+GN W + W + C V CG FG C SD + E C C +G+ P+ Y
Sbjct: 274 EGNKAWNLFWSQPRQQCQVYRYCGSFGIC-SDKS-EPFCRCPQGFRPMSQKDWDLKDYSA 331
Query: 291 VLVDFCDTKSSPADFTVEAIDDADIPNGDLRDMARITT-TDVNECRKAVMDDCFCAAGVW 349
V + + S D +PN L D + + T T ++ C A DC C A +
Sbjct: 332 GCVRKTELQCSRGDIN----QFFRLPNMKLADNSEVLTRTSLSICASACQGDCSCKAYAY 387
Query: 350 RE--VVCLKKKMPLLNARR---SNPSTN----KMAAFIKVPKINNSQGQDNDSPSRVVLL 400
E CL +LN ++ N N ++AA VP + S G+ N+ +
Sbjct: 388 DEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAAS-DVPNVGAS-GKSNNKGLIFGAV 445
Query: 401 AGFLSCSMLALLFGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREAT----- 455
G L +L LL +++ Y R M + + + + FSY+EL+ AT
Sbjct: 446 LGSLGVIVLVLLVVILILRYR--RRKRM------RGEKGDGTLSAFSYRELQNATKNFSD 497
Query: 456 --------NVFDG---QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
+VF G ++AVK+LE ++ GEK F EV IG H NLV+L GFC
Sbjct: 498 KLGGGGFGSVFKGALPDSSDIAVKRLEGIS-QGEKQFRTEVVTIGTIQHVNLVRLRGFCS 556
Query: 505 EQNHQLLVYELMKNGTLSAFLFRQEIPT-----WDKRVEIALGIARGLLYLHEECETQII 559
E + +LLVY+ M NG+L + LF ++ W R +IALG ARGL YLH+EC II
Sbjct: 557 EGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCII 616
Query: 560 HCDIKPQNVXXXXXXXXXXXXXXXKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN 619
HCDIKP+N+ K+ADFGLAKL+ +D +R T +RGT GY+APEW+
Sbjct: 617 HCDIKPENILLDSQFCP-------KVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISG 669
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDE----PTLANGMILTDWVLYCVRTGNL- 674
+TAK DVYS+G+ML E++ +R+TE ++ P+ A ++ D + + L
Sbjct: 670 VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLE 729
Query: 675 G-ATKFERITM---VGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPP 717
G A E +T V WCI + + RP+M QV+Q+LEG EV PP
Sbjct: 730 GDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPP 776
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 527 (190.6 bits), Expect = 6.2e-60, Sum P(2) = 6.2e-60
Identities = 121/270 (44%), Positives = 157/270 (58%)
Query: 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524
VAVKQLE + GEK F EV I THH NLV+L+GFC + H+LLVYE M+NG+L F
Sbjct: 509 VAVKQLEGIE-QGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNF 567
Query: 525 LFRQEIP---TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVXXXXXXXXXXXXX 581
LF + TW+ R IALG A+G+ YLHEEC I+HCDIKP+N+
Sbjct: 568 LFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAA----- 622
Query: 582 XXKIADFGLAKLLK-KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
K++DFGLAKLL KD + +RGT GY+APEWL N P+T+K DVYS+G++LLE++
Sbjct: 623 --KVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVS 680
Query: 641 CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA---TKFE-----------RITMVG 686
KR+ + V E T N + W GN A T+ R+
Sbjct: 681 GKRNFD---VSEKT--NHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTS 735
Query: 687 LWCICPQPTLRPSMKQVLQMLEGTSEVGVP 716
WCI QP RP+M +V+QMLEG +E+ P
Sbjct: 736 FWCIQEQPLQRPTMGKVVQMLEGITEIKNP 765
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 396 (144.5 bits), Expect = 3.7e-52, Sum P(3) = 3.7e-52
Identities = 98/275 (35%), Positives = 153/275 (55%)
Query: 457 VFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
+ DG+E+ AVK+L K++ G F+ EV++I + H NLV+LLG C+++ ++L+YE +
Sbjct: 538 LLDGKEI--AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYL 595
Query: 517 KNGTLSAFLFRQEIPT---WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVXXXXX 573
+N +L + LF Q + W KR +I GIARGLLYLH++ +IIH D+K NV
Sbjct: 596 ENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKN 655
Query: 574 XXXXXXXXXXKIADFGLAKLLKKDQTRTSTM-IRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
KI+DFG+A++ +++T +T + GT GYM+PE+ + + K DV+SFG
Sbjct: 656 MTP-------KISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFG 708
Query: 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWV----LYCVRTGNLGA--TKFE-----R 681
V+LLEII KR+ + + G + W L V N+ + +KF R
Sbjct: 709 VLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILR 768
Query: 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP 716
+GL C+ + RP M V+ ML G+ +P
Sbjct: 769 CIQIGLLCVQERAEDRPVMSSVMVML-GSETTAIP 802
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 382 (139.5 bits), Expect = 6.5e-52, Sum P(3) = 6.5e-52
Identities = 95/274 (34%), Positives = 147/274 (53%)
Query: 457 VFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
+ DGQE+ AVK+L K + G F EV++I R H NLV+LL C++ ++L+YE +
Sbjct: 545 LLDGQEM--AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYL 602
Query: 517 KNGTLSAFLF---RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVXXXXX 573
+N +L + LF R W R +I GIARGLLYLH++ +IIH D+K N+
Sbjct: 603 ENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKY 662
Query: 574 XXXXXXXXXXKIADFGLAKLLKKDQTRTSTM-IRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
KI+DFG+A++ +D+T +T + GT GYM+PE+ + + K DV+SFG
Sbjct: 663 MTP-------KISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFG 715
Query: 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDW-------VLYCVRTGNLGATKFERIT-- 683
V+LLEII KR+ + D G + +W ++ + T + + I
Sbjct: 716 VLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRC 775
Query: 684 -MVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP 716
+GL C+ + RP+M V+ ML G+ +P
Sbjct: 776 IQIGLLCVQERAEDRPTMSLVILML-GSESTTIP 808
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 2.6e-51, Sum P(2) = 2.6e-51
Identities = 118/300 (39%), Positives = 173/300 (57%)
Query: 446 FSYQELREATNVFD---GQ----EV---------EVAVKQLEKVTGDGEKSFLREVQVIG 489
F+Y++L+ ATN F GQ V +AVK+LE + G G+K F EV +IG
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGI-GQGKKEFRAEVSIIG 541
Query: 490 RTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE----IPTWDKRVEIALGIAR 545
HH +LV+L GFC E H+LL YE + G+L ++FR++ + WD R IALG A+
Sbjct: 542 SIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAK 601
Query: 546 GLLYLHEECETQIIHCDIKPQNVXXXXXXXXXXXXXXXKIADFGLAKLLKKDQTRTSTMI 605
GL YLHE+C+ +I+HCDIKP+N+ K++DFGLAKL+ ++Q+ T +
Sbjct: 602 GLAYLHEDCDARIVHCDIKPENILLDDNFNA-------KVSDFGLAKLMTREQSHVFTTM 654
Query: 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDE----PTLANGMIL 661
RGT GY+APEW+ N ++ K DVYS+G++LLE+I +++ + E P+ A +
Sbjct: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKME 714
Query: 662 TDWVLYCV--RTGNLGAT--KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPP 717
++ V + N+ T + +R LWCI RPSM +V+QMLEG V PP
Sbjct: 715 EGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 2.7e-50, Sum P(3) = 2.7e-50
Identities = 101/282 (35%), Positives = 156/282 (55%)
Query: 456 NVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515
N+ DG+E+ A+K+L +G G + F+ E+ +I + H+NLV+LLG CIE +LL+YE
Sbjct: 519 NLQDGKEI--AIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEF 576
Query: 516 MKNGTLSAFLF----RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVXXX 571
M N +L+ F+F + E+ W KR EI GIA GLLYLH + +++H D+K N+
Sbjct: 577 MANKSLNTFIFDSTKKLELD-WPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLD 635
Query: 572 XXXXXXXXXXXXKIADFGLAKLLKKDQTRTSTM-IRGTMGYMAPEWLRNAPVTAKVDVYS 630
KI+DFGLA++ + Q + +T + GT+GYM+PE+ + K D+Y+
Sbjct: 636 EEMNP-------KISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYA 688
Query: 631 FGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN---------LGA-TKFE 680
FGV+LLEII KR + +E ++ W +C G+ G+ ++
Sbjct: 689 FGVLLLEIITGKRISSFTIGEE---GKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVA 745
Query: 681 RITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP--PVVA 720
R +GL CI Q RP++ QV+ ML T ++ P PV A
Sbjct: 746 RCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKPKQPVFA 787
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 1.8e-47, Sum P(3) = 1.8e-47
Identities = 98/275 (35%), Positives = 151/275 (54%)
Query: 457 VFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
+ DG+E+ AVK+L K++ G F+ EV++I + H NLV+LLG C+++ ++L+YE +
Sbjct: 542 LLDGKEI--AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYL 599
Query: 517 KNGTLSAFLFRQEIPT---WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVXXXXX 573
+N +L + LF Q + W KR +I GIARGLLYLH++ +IIH D+K NV
Sbjct: 600 ENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKN 659
Query: 574 XXXXXXXXXXKIADFGLAKLLKKDQTRTSTM-IRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
KI+DFG+A++ +++T +T + GT GYM+PE+ + + K DV+SFG
Sbjct: 660 MTP-------KISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFG 712
Query: 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWV----LYCVRTGNLGATKFE-------R 681
V+LLEII KR+ + + G + W L V N+ A E R
Sbjct: 713 VLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILR 772
Query: 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP 716
+GL C+ + RP M V+ ML G+ +P
Sbjct: 773 CIQIGLLCVQERAEDRPVMSSVMVML-GSETTAIP 806
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 3.2e-47, Sum P(2) = 3.2e-47
Identities = 152/546 (27%), Positives = 255/546 (46%)
Query: 210 DY-YHRATISDHGNFQQWVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCT-SDNNKEV 267
DY R ++ G+ + +N D W +E C + +CG FGFC SD K
Sbjct: 240 DYKLSRIMLTSEGSMKVLRYNGLD---WKSSYEGPANSCDIYGVCGPFGFCVISDPPK-- 294
Query: 268 TCECLRGYSPVDPNSPSKGCYPDVLVD----FCDTKSSPADFTV-EAIDDADIPNGDLRD 322
C+C +G+ P +G + C S+ D V + + P D +
Sbjct: 295 -CKCFKGFVPKSIEEWKRGNWTSGCARRTELHCQGNSTGKDANVFHTVPNIKPP--DFYE 351
Query: 323 MARITTTDVNECRKAVMDDCFCAAGVWREVV-CLKKKMPLLNARRSNPSTNKMAAFIKVP 381
A + D C ++ + +C C A + + CL L++ T + +A ++
Sbjct: 352 YAN--SVDAEGCYQSCLHNCSCLAFAYIPGIGCLMWSKDLMD-------TMQFSAGGEIL 402
Query: 382 KINNSQGQDNDSPSRVVLLAGFLSCSMLALL-FGSIVIY-----YHPLTRPYMCVQPSPK 435
I + + + ++ ++A +S ++ +L F + + +H R + Q P
Sbjct: 403 SIRLAHSELDVHKRKMTIVASTVSLTLFVILGFATFGFWRNRVKHHDAWRNDLQSQDVPG 462
Query: 436 PKPPEINM-----KVFSYQ-ELREAT--NVFDG--QEV-EVAVKQLEKVTGDGEKSFLRE 484
+ E+N FS +L +V+ G Q+ E+AVK+L + G++ F+ E
Sbjct: 463 LEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQEFMNE 522
Query: 485 VQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF--RQEIPT-WDKRVEIAL 541
+ +I + H+NLV++LG C+E +LL+YE MKN +L F+F R+ + W KR +I
Sbjct: 523 IVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQ 582
Query: 542 GIARGLLYLHEECETQIIHCDIKPQNVXXXXXXXXXXXXXXXKIADFGLAKLLKKDQTRT 601
GI RGLLYLH + ++IH D+K N+ KI+DFGLA+L + Q +
Sbjct: 583 GIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNP-------KISDFGLARLFQGSQYQD 635
Query: 602 STM-IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMI 660
T + GT+GYM+PE+ + K D+YSFGV+LLEII ++ + +E ++
Sbjct: 636 KTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISRFSYGEE---GKALL 692
Query: 661 LTDWVLYCVRTG-NL---------GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710
W +C G NL + R +GL C+ QP RP+ ++L ML T
Sbjct: 693 AYVWECWCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTT 752
Query: 711 SEVGVP 716
S++ +P
Sbjct: 753 SDLPLP 758
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 402 (146.6 bits), Expect = 3.9e-45, Sum P(3) = 3.9e-45
Identities = 80/180 (44%), Positives = 112/180 (62%)
Query: 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
E +AVK++ G + F E+ +IG H NLV+L GFC LLVYE M +G+L
Sbjct: 537 ETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSL 596
Query: 522 SAFLFRQEIPT--WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVXXXXXXXXXXX 579
LF P W +R +IALG ARGL YLH C+ +IIHCD+KP+N+
Sbjct: 597 EKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQP--- 653
Query: 580 XXXXKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
KI+DFGL+KLL ++++ T +RGT GY+APEW+ NA ++ K DVYS+G++LLE++
Sbjct: 654 ----KISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELV 709
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 9.6e-45, Sum P(3) = 9.6e-45
Identities = 100/273 (36%), Positives = 150/273 (54%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
DG+E+ AVK+L +G G++ F+ E+ +I + H NLV++LG CIE +LLVYE M N
Sbjct: 510 DGKEI--AVKRLSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVN 567
Query: 519 GTLSAFLF--RQEIPT-WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVXXXXXXX 575
+L F+F R+ + W KR I GIARGLLYLH + +IIH D+K N+
Sbjct: 568 KSLDTFIFDSRKRVEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMN 627
Query: 576 XXXXXXXXKIADFGLAKLLKKDQTRTSTM-IRGTMGYMAPEWLRNAPVTAKVDVYSFGVM 634
KI+DFGLA++ + + + +T I GT+GYM+PE+ + K D YSFGV+
Sbjct: 628 P-------KISDFGLARMYEGTKYQDNTRRIVGTLGYMSPEYAWTGVFSEKSDTYSFGVL 680
Query: 635 LLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG-----AT------KFERIT 683
LLE+I ++ + R ++ W +C G +G AT + R
Sbjct: 681 LLEVISGEK---ISRFSYDKERKNLLAYAWESWC-ENGGVGFLDKDATDSCHPSEVGRCV 736
Query: 684 MVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP 716
+GL C+ QP RP+ ++L ML TS++ +P
Sbjct: 737 QIGLLCVQHQPADRPNTLELLSMLTTTSDLPLP 769
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3288 | 0.9489 | 0.8269 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 725 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-11 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-09 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.001 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-49
Identities = 69/189 (36%), Positives = 105/189 (55%), Gaps = 15/189 (7%)
Query: 453 EATNVFDGQEVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
A + G++V A+K ++K LRE++++ + +H N+V+L G ++NH L
Sbjct: 11 LARDKKTGKKV--AIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYL 68
Query: 512 VYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
V E + G+L L E + D+ + I L I GL YLH IIH D+KP+N+LL
Sbjct: 69 VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILL 125
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-WLRNAPVTAKVDVY 629
D++ + K+ADFGL+KLL D++ T I GT YMAPE L + K D++
Sbjct: 126 DSDNGKV------KLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 630 SFGVMLLEI 638
S GV+L E+
Sbjct: 179 SLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-46
Identities = 85/269 (31%), Positives = 132/269 (49%), Gaps = 33/269 (12%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEK--SFLREVQVIGRTHHKNLVQLLGFCI 504
S+ + +A + G+ V AVK L+K + +K + RE++++ R H N+V+L+
Sbjct: 11 SFGTVYKAKHKGTGKIV--AVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFE 68
Query: 505 EQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
+++H LV E + G L +L R + D+ +IAL I RGL YLH IIH D+K
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRDLK 125
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA-PVT 623
P+N+L +D N + KIADFGLAK L K + +T GT YMAPE L
Sbjct: 126 PENIL-------LDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 624 AKVDVYSFGVMLLEIIF-------CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676
KVDV+S GV+L E++ +L + ++ +G+ A
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR----ILGPPLEFDEPKWSSGSEEA 233
Query: 677 TKFERITMVGLWCICPQPTLRPSMKQVLQ 705
I C+ P+ RP+ +++LQ
Sbjct: 234 KDL--IK----KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 15/192 (7%)
Query: 452 REATNVFDGQEVEVAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL 510
A + G+ V A+K ++K + + LRE++++ + H N+V+L +++
Sbjct: 16 YLARDKKTGKLV--AIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLY 73
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
LV E + G L L ++ + D+ I L YLH + I+H D+KP+N+LL
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---GIVHRDLKPENILL 130
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYS 630
D + K+ADFGLA+ L + T+ + GT YMAPE L VD++S
Sbjct: 131 DEDGHV-------KLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKAVDIWS 181
Query: 631 FGVMLLEIIFCK 642
GV+L E++ K
Sbjct: 182 LGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 75/262 (28%), Positives = 126/262 (48%), Gaps = 30/262 (11%)
Query: 453 EATNVFDGQEVEVAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
+ ++VEVAVK L++ + + + FLRE +++ + H N+V+LLG C E+ +
Sbjct: 19 KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYI 78
Query: 512 VYELMKNGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
V E M+ G L ++L + + + AL IARG+ YL + IH D+ +N L
Sbjct: 79 VMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCL- 134
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYS 630
+ N + KI+DFGL++ L D + + +MAPE L+ T+K DV+S
Sbjct: 135 ------VGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWS 188
Query: 631 FGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL-----GATKFERITMV 685
FGV+L EI ++P GM + VL ++ G + +
Sbjct: 189 FGVLLWEI--------FTLGEQP--YPGMSNEE-VLEYLKNGYRLPQPPNCP--PELYDL 235
Query: 686 GLWCICPQPTLRPSMKQVLQML 707
L C P RP+ +++++L
Sbjct: 236 MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 82/262 (31%), Positives = 126/262 (48%), Gaps = 29/262 (11%)
Query: 453 EATNVFDGQEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
DG+EVEVAVK L E + + FLRE +++ + H N+V+LLG C E+ ++
Sbjct: 19 TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78
Query: 512 VYELMKNGTLSAFLFRQEIP---TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
V E M G L +L R+ P + + AL IARG+ YL + IH D+ +N
Sbjct: 79 VMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNC 134
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
L + N + KI+DFGL++ L D + + +MAPE L+ T+K DV
Sbjct: 135 L-------VGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDV 187
Query: 629 YSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL---GATKFERITMV 685
+SFGV+L EI +EP GM + VL ++ G + +
Sbjct: 188 WSFGVLLWEI--------FTLGEEP--YPGMSNAE-VLEYLKKGYRLPKPPNCPPELYKL 236
Query: 686 GLWCICPQPTLRPSMKQVLQML 707
L C P RP+ +++++L
Sbjct: 237 MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 47/265 (17%)
Query: 459 DGQEVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+G E +VAVK L++ + E+ FL E ++ + H N+V+LLG C + +V E M
Sbjct: 25 EGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMP 84
Query: 518 NGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G L FL E T +++AL IA+G+ YL + +H D+ +N L+
Sbjct: 85 GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAARNCLV------ 135
Query: 577 IDNNYITKIADFGLAKLLKKD---QTRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYSF 631
N + KI+DFGL++ + +D + R I+ +MAPE L++ T+K DV+SF
Sbjct: 136 -TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPESLKDGKFTSKSDVWSF 190
Query: 632 GVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-----LGATKFERI 682
GV+L EI TL GM + VL + G + +
Sbjct: 191 GVLLWEIF--------------TLGEQPYPGMSNEE-VLELLEDGYRLPRPENCP--DEL 233
Query: 683 TMVGLWCICPQPTLRPSMKQVLQML 707
+ L C P RP+ ++++ L
Sbjct: 234 YELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 51/272 (18%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
DG+ EVAVK L++ + E+ FL+E +V+ + H N+V+LLG C E+ LV E M+
Sbjct: 20 DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79
Query: 518 NGTLSAFL---------FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
G L +L + + + A+ IA+G+ YL + + +H D+ +N
Sbjct: 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNC 136
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM-----IRGTMGYMAPEWLRNAPVT 623
L+ + + KI+DFGL++ + D IR +MAPE L++ T
Sbjct: 137 LVGEDLVV-------KISDFGLSRDVYDDDYYRKKTGGKLPIR----WMAPESLKDGIFT 185
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLYCVRTGN-LGATK 678
+K DV+SFGV+L EI TL G+ + VL +R G L +
Sbjct: 186 SKSDVWSFGVLLWEIF--------------TLGATPYPGLSNEE-VLEYLRKGYRLPKPE 230
Query: 679 F--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + + + L C P RP+ ++++ LE
Sbjct: 231 YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 453 EATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCI--EQNH 508
A + G+ + AVK +E E ++ RE++++ H N+V+ G E+N
Sbjct: 18 LALDKDTGELM--AVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT 75
Query: 509 QLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL------GIARGLLYLHEECETQIIHCD 562
+ E + G+LS+ L + ++ + I GL YLH I+H D
Sbjct: 76 LNIFLEYVSGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRD 126
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM-IRGTMGYMAPEWLRNAP 621
IK N+L +D++ + K+ADFG AK L +T T +RGT +MAPE +R
Sbjct: 127 IKGANIL-------VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 622 VTAKVDVYSFGVMLLEII 639
D++S G ++E+
Sbjct: 180 YGRAADIWSLGCTVIEMA 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 8e-29
Identities = 72/270 (26%), Positives = 117/270 (43%), Gaps = 28/270 (10%)
Query: 455 TNVFDGQEVE-VAVKQLEK---VTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQ 509
V+ ++ + VA+K L K + FLRE+Q++ H N+V+L F ++
Sbjct: 14 GEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL 73
Query: 510 LLVYELMKNGTLSAFL---FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQ 566
LV E + G+L L R+ + + + I I L YLH + IIH DIKP+
Sbjct: 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPE 130
Query: 567 NVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS-----TMIRGTMGYMAPEWLR--- 618
N+LLD + + K+ DFGLAKLL + +S + GT GYMAPE L
Sbjct: 131 NILLD------RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR---TGNLG 675
A ++ D++S G+ L E++ E + T I+ + + + +
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNP 244
Query: 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQ 705
+ + + + P R S L
Sbjct: 245 ELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 29/199 (14%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+ E+ +A + G+EV A+K ++ + + ++ + E+Q++ + H N+V+ G +
Sbjct: 12 GFGEVYKARHKRTGKEV--AIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SYLK 68
Query: 507 NHQL-LVYELMKNGTLSAF-------LFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558
+L +V E G+L L +I + + +GL YLH I
Sbjct: 69 KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY------VCKELLKGLEYLHSN---GI 119
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
IH DIK N+LL ++ K+ DFGL+ L + R + + GT +MAPE +
Sbjct: 120 IHRDIKAANILLTSDGEV-------KLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVIN 170
Query: 619 NAPVTAKVDVYSFGVMLLE 637
P K D++S G+ +E
Sbjct: 171 GKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 60/182 (32%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
VAVK L+ T D K FL E Q++ + H L+QL C + +V ELMK G+L
Sbjct: 31 TPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89
Query: 523 AFLFRQE-----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
+L +P +++A +A G+ YL + IH D+ +NVL +
Sbjct: 90 EYLQGGAGRALKLPQ---LIDMAAQVASGMAYLEAQ---NYIHRDLAARNVL-------V 136
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
N I K+ADFGLA+++K+D + + + APE + K DV+SFG++L E
Sbjct: 137 GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTE 196
Query: 638 II 639
I+
Sbjct: 197 IV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 65/254 (25%), Positives = 127/254 (50%), Gaps = 24/254 (9%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
AT+ G+EV A+K++ ++ ++ + E+ ++ H N+V + + +V
Sbjct: 38 ATDRATGKEV--AIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
E M G+L+ + + + + ++ + + +GL YLH +IH DIK N+LL
Sbjct: 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSK 151
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
+ ++ K+ADFG A L K++++ ++++ GT +MAPE ++ KVD++S G
Sbjct: 152 DG-SV------KLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIWSLG 203
Query: 633 VMLLEIIFCKRHTELHRVDEPTL-ANGMILTDWVLYCVRTGNLGATKFERITMVGLWCIC 691
+M +E+ E + EP L A +I T + ++ + +F+ C+
Sbjct: 204 IMCIEMA----EGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEFKDFLN---KCLV 255
Query: 692 PQPTLRPSMKQVLQ 705
P RPS +++LQ
Sbjct: 256 KDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 63/182 (34%), Positives = 94/182 (51%), Gaps = 19/182 (10%)
Query: 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
+VAVK L+ T E +FL+E Q++ + H LVQL C E+ +V E M G+L
Sbjct: 31 TKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89
Query: 523 AFLFRQE-----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
FL E +P + V++A IA G+ YL IH D+ +N+L +
Sbjct: 90 DFLKSGEGKKLRLP---QLVDMAAQIAEGMAYLESR---NYIHRDLAARNIL-------V 136
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
N + KIADFGLA+L++ D+ + + + APE T K DV+SFG++L E
Sbjct: 137 GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTE 196
Query: 638 II 639
I+
Sbjct: 197 IV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 63/177 (35%), Positives = 91/177 (51%), Gaps = 19/177 (10%)
Query: 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524
VAVK L K ++FL E V+ H NLVQLLG ++ N +V E M G+L +
Sbjct: 32 VAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY 90
Query: 525 LF---RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
L R I T +++ AL + G+ YL E+ +H D+ +NVL+ D
Sbjct: 91 LRSRGRAVI-TLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSE-----DL-- 139
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ K++DFGLAK + Q ++ T APE LR + K DV+SFG++L EI
Sbjct: 140 VAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 29/185 (15%)
Query: 465 VAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
+K+ L ++ + L EV+++ + +H N+++ E+ +V E G LS
Sbjct: 28 YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS 87
Query: 523 AFLFRQ----------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
+ +Q +I D V++ L L YLH +I+H DIKPQN+ L +
Sbjct: 88 QKIKKQKKEGKPFPEEQI--LDWFVQLCLA----LKYLHSR---KILHRDIKPQNIFLTS 138
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
N + K+ DFG++K+L T++ GT Y++PE +N P K D++S G
Sbjct: 139 NGLV-------KLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYNYKSDIWSLG 190
Query: 633 VMLLE 637
+L E
Sbjct: 191 CVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 64/187 (34%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 462 EVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
+ VAVK L K D EK FL+E ++ +H N+V+LLG C+ Q ++ ELM+ G
Sbjct: 26 PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGD 85
Query: 521 LSAFL-------FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
L ++L F + T + ++I L +A+G +YL + IH D+ +N L+
Sbjct: 86 LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEK 142
Query: 574 YITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
D + + KI DFGLA+ + K D R + +MAPE L + T + DV+SFG
Sbjct: 143 --GYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG 200
Query: 633 VMLLEII 639
V++ EI+
Sbjct: 201 VLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 59/184 (32%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLL-GFCIEQNHQLLVYELMKNGTL 521
A+K L+K + + L E ++ R +H +V+L F + LV E G L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-QTEEKLYLVLEYAPGGEL 80
Query: 522 SAFLFRQEIPTWDKRV-----EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
+E ++R EI L + YLH II+ D+KP+N+LLD
Sbjct: 81 -FSHLSKEGRFSEERARFYAAEIVLALE----YLHSL---GIIYRDLKPENILLD----- 127
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
+ +I K+ DFGLAK L + +RT+T GT Y+APE L VD +S GV+L
Sbjct: 128 -ADGHI-KLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLY 184
Query: 637 EIIF 640
E++
Sbjct: 185 EMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 25/222 (11%)
Query: 451 LREATNVFDGQEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
L E FDGQ V VAVK L VT FL+E++++ R + N+++LLG C+ +
Sbjct: 33 LGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL 92
Query: 510 LLVYELMKNGTLSAFLFRQEIP------------TWDKRVEIALGIARGLLYLHEECETQ 557
++ E M+NG L+ FL ++EI + + +A+ IA G+ YL
Sbjct: 93 CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLN 149
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEW 616
+H D+ +N L+ N+Y TI KIADFG+++ L D R + +MA E
Sbjct: 150 FVHRDLATRNCLVGNHY-TI------KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES 202
Query: 617 LRNAPVTAKVDVYSFGVMLLEI-IFCKRHTELHRVDEPTLAN 657
+ T DV++FGV L E+ CK DE + N
Sbjct: 203 ILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 77/266 (28%), Positives = 120/266 (45%), Gaps = 38/266 (14%)
Query: 459 DGQEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
D E++VAVK L E + E FL E ++ + +H+N+V+L+G E+ + ++ ELM
Sbjct: 33 DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMA 92
Query: 518 NGTLSAFLFRQEIPTWDKR--------VEIALGIARGLLYLHEECETQIIHCDIKPQNVL 569
G L +FL R+ P ++ + A +A+G YL E IH DI +N L
Sbjct: 93 GGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCL 148
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRG--TM---GYMAPEWLRNAPVTA 624
L + KIADFG+A +D R S +G M +M PE + T+
Sbjct: 149 LT----CKGPGRVAKIADFGMA----RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTS 200
Query: 625 KVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF--ERI 682
K DV+SFGV+L EI L + P N ++ + G L K +
Sbjct: 201 KTDVWSFGVLLWEIF------SLGYMPYPGRTNQEVME----FVTGGGRLDPPKGCPGPV 250
Query: 683 TMVGLWCICPQPTLRPSMKQVLQMLE 708
+ C P RP+ +L+ ++
Sbjct: 251 YRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 15/179 (8%)
Query: 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
V VA+K L+ ++ F +EVQ + R HK+L+ L C ++ ELM+ G+L
Sbjct: 31 VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90
Query: 523 AFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
AFL E + +++A +A G+ YL E+ IH D+ +N+L + +
Sbjct: 91 AFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNIL-------VGED 140
Query: 581 YITKIADFGLAKLLKKD-QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ K+ADFGLA+L+K+D + I + APE + + K DV+SFG++L E+
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 22/231 (9%)
Query: 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCI 504
F EL + D +VAVK L + +S F RE++++ H+N+V+ G C
Sbjct: 17 FGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCE 76
Query: 505 EQNHQ--LLVYELMKNGTLSAFLFRQEIPTWDKR-VEIALGIARGLLYLHEECETQIIHC 561
+ + L+ E + +G+L +L R KR + + I +G+ YL + + IH
Sbjct: 77 KPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHR 133
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLL--KKDQTRTSTMIRGTMGYMAPEWLRN 619
D+ +N+L +++ + KI+DFGLAK+L KD + + APE LR
Sbjct: 134 DLAARNIL-------VESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANG-----MILTDWV 665
+ ++ DV+SFGV L E+ + E G MI+T +
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPS-QSPPAEFLRMIGIAQGQMIVTRLL 236
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 53/176 (30%), Positives = 95/176 (53%), Gaps = 12/176 (6%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VA+K + + E+ F+ E QV+ + H LVQL G C E++ LV+E M++G LS
Sbjct: 30 KVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88
Query: 524 FLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
+L Q + + + + L + G+ YL +IH D+ +N L + N +
Sbjct: 89 YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCL-------VGENQV 138
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
K++DFG+ + + DQ +ST + + + +PE + ++K DV+SFGV++ E+
Sbjct: 139 VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 58/261 (22%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
VA+KQ+ E KS ++E+ ++ H N+V+ +G + ++ E +NG+L
Sbjct: 28 VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSL- 86
Query: 523 AFLFRQEIPTWDKRVE--IALGIA---RGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
RQ I + E +A+ + +GL YLHE+ +IH DIK N+L T
Sbjct: 87 ----RQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANIL-----TTK 134
Query: 578 DNNYITKIADFGLA-KLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
D K+ADFG+A KL + S + GT +MAPE + + + D++S G ++
Sbjct: 135 DGV--VKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVI 190
Query: 637 EIIFCK-------RHTELHRV---DEPTLANGM--ILTDWVLYCVRTGNLGATKFERITM 684
E++ L R+ D P L G+ L D+++ C F++
Sbjct: 191 ELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC----------FQK--- 237
Query: 685 VGLWCICPQPTLRPSMKQVLQ 705
P LRP+ KQ+L+
Sbjct: 238 --------DPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 55/186 (29%), Positives = 102/186 (54%), Gaps = 21/186 (11%)
Query: 461 QEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+E++VA+K L+ + D ++ FL E ++G+ H N+++L G + +++ E M+NG
Sbjct: 31 KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENG 90
Query: 520 TLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
+L FL + T + V + GIA G+ YL E +H D+ +N+L ++
Sbjct: 91 SLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNIL-------VN 140
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTM-----IRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
+N + K++DFGL++ L+ + +T IR T APE + T+ DV+SFG+
Sbjct: 141 SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGI 196
Query: 634 MLLEII 639
++ E++
Sbjct: 197 VMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 49/180 (27%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
++VA+K + + E F+ E +V+ + H NLVQL G C +Q +V E M NG L
Sbjct: 29 IDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87
Query: 523 AFLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
+L ++ + +++ + + YL IH D+ +N L + +
Sbjct: 88 NYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCL-------VGEDN 137
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
+ K++DFGLA+ + DQ +S + + + PE + ++K DV+SFGV++ E+
Sbjct: 138 VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 66/183 (36%), Positives = 101/183 (55%), Gaps = 16/183 (8%)
Query: 459 DGQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
G+EVEVAVK L++ G+K FLRE V+ + H +V+L+G C + +LV EL
Sbjct: 20 SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAP 78
Query: 518 NGTLSAFLF-RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G L +L R+EIP D + E+A +A G+ YL E +H D+ +NVLL
Sbjct: 79 LGPLLKYLKKRREIPVSDLK-ELAHQVAMGMAYL-ESK--HFVHRDLAARNVLL------ 128
Query: 577 IDNNYITKIADFGLAKLLKKDQT--RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVM 634
++ + KI+DFG+++ L R +T R + + APE + ++K DV+S+GV
Sbjct: 129 VNRHQA-KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVT 187
Query: 635 LLE 637
L E
Sbjct: 188 LWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 17/194 (8%)
Query: 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN 507
Y E+ E V+ + VAVK L++ T + E+ FL+E V+ H NLVQLLG C +
Sbjct: 19 YGEVYEG--VWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREP 75
Query: 508 HQLLVYELMKNGTLSAFLF---RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
++ E M G L +L RQE+ + +A I+ + YL ++ IH D+
Sbjct: 76 PFYIITEFMTYGNLLDYLRECNRQEVNAV-VLLYMATQISSAMEYLEKK---NFIHRDLA 131
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTA 624
+N L + N++ K+ADFGL++L+ D + + + APE L +
Sbjct: 132 ARNCL-------VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 625 KVDVYSFGVMLLEI 638
K DV++FGV+L EI
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 25/199 (12%)
Query: 454 ATNVFDGQ-EVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
A V G+ E VA+K + + E+ FL E V+ + ++V+LLG L+
Sbjct: 27 AKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86
Query: 512 VYELMKNGTLSAFLFRQE-----------IPTWDKRVEIALGIARGLLYLHEECETQIIH 560
V ELM G L ++L R PT K +++A IA G+ YL + +H
Sbjct: 87 VMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVH 142
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTMIRGTMGYMAPEWLRN 619
D+ +N ++ +T+ KI DFG+ + + + D R + +MAPE L++
Sbjct: 143 RDLAARNCMV-AEDLTV------KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195
Query: 620 APVTAKVDVYSFGVMLLEI 638
T K DV+SFGV+L E+
Sbjct: 196 GVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 59/182 (32%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
+V +A+K++ + + E+ + H+N+VQ LG E + E + G+L
Sbjct: 33 QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92
Query: 522 SAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
SA L + P D I I GL YLH+ QI+H DIK NVL+ N Y
Sbjct: 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLV-NTY---- 144
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP--VTAKVDVYSFGVMLL 636
+ + KI+DFG +K L T T GT+ YMAPE + P A D++S G ++
Sbjct: 145 -SGVVKISDFGTSKRLAGINPCTETF-TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIV 202
Query: 637 EI 638
E+
Sbjct: 203 EM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 18/178 (10%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
+AVK + ++ + K LRE+ ++ + + +V G + E M G+L
Sbjct: 29 MAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87
Query: 523 AFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
L + IP +IA+ + +GL YLHE+ +IIH D+KP N+L+ N+ I
Sbjct: 88 KILKEVQGRIPE-RILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILV-NSRGQI--- 140
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
K+ DFG++ L +T GT YMAPE ++ + K D++S G+ L+E+
Sbjct: 141 ---KLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQ-LLVYELM 516
DGQ++ AVK L ++T E FL+E ++ H N++ LLG C+ L+V M
Sbjct: 20 DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79
Query: 517 KNGTLSAFLFRQEI--PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
K+G L F+ R E PT + L +A+G+ YL + + +H D+ +N +LD ++
Sbjct: 80 KHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESF 135
Query: 575 ITIDNNYITKIADFGLAK-LLKKD--QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631
K+ADFGLA+ + K+ T + + +MA E L+ T K DV+SF
Sbjct: 136 TV-------KVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSF 188
Query: 632 GVMLLEII 639
GV+L E++
Sbjct: 189 GVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 59/179 (32%), Positives = 95/179 (53%), Gaps = 21/179 (11%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLG-FCIEQNHQL-LVYELMKNGT 520
A+K++ V GD E K LRE++ + +V+ G F + ++ +V E M G+
Sbjct: 29 YALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY--KEGEISIVLEYMDGGS 85
Query: 521 LSAFLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L+ L +++ + V IA I +GL YLH + IIH DIKP N+L I
Sbjct: 86 LADLL--KKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLL-----INSK 136
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
KIADFG++K+L+ + +T + GT+ YM+PE ++ + D++S G+ LLE
Sbjct: 137 GE--VKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 70/228 (30%), Positives = 103/228 (45%), Gaps = 32/228 (14%)
Query: 448 YQELREATNVFDGQEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+ E A N V VAVK L + + + FL+EV+++ R N+ +LLG C
Sbjct: 32 FSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD 91
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKR-----------VEIALGIARGLLYLHEECE 555
++ E M+NG L+ FL + T + +A IA G+ YL
Sbjct: 92 PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---S 148
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK-LLKKD----QTRTSTMIRGTMG 610
+H D+ +N L+ NY TI KIADFG+++ L D Q R IR
Sbjct: 149 LNFVHRDLATRNCLVGKNY-TI------KIADFGMSRNLYSSDYYRVQGRAPLPIR---- 197
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVMLLEII-FCKRHTELHRVDEPTLAN 657
+MA E + T K DV++FGV L EI+ C+ H D+ + N
Sbjct: 198 WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 59/178 (33%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 479 KSFLREVQVIGRTHHKNLVQL-LGFCIEQNHQLLVYELMKNGTLSAFLFRQE------IP 531
++ L E +++ +H LV L F E+N LV +L+ G L L ++ +
Sbjct: 45 RNVLNERRILQELNHPFLVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEEQVK 103
Query: 532 TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591
W EI L + YLH + IIH DIKP N+LLD ++ I DF +A
Sbjct: 104 FW--ICEIVLALE----YLHSK---GIIHRDIKPDNILLDEQ------GHV-HITDFNIA 147
Query: 592 KLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHR 649
+ D TST GT GYMAPE L + VD +S GV E + KR H
Sbjct: 148 TKVTPDTLTTSTS--GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 57/188 (30%), Positives = 83/188 (44%), Gaps = 22/188 (11%)
Query: 466 AVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
AVK++ D + K E++V+ H NLV+ G + + + E GTL
Sbjct: 29 AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE 88
Query: 524 FLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
L I D+ V L + GL YLH I+H DIKP N+ LD+N +
Sbjct: 89 LLEHGRIL--DEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVI----- 138
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMG---YMAPEWLRNAPVTAK---VDVYSFGVML 635
K+ DFG A LK + T ++ G YMAPE + D++S G ++
Sbjct: 139 --KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196
Query: 636 LEIIFCKR 643
LE+ KR
Sbjct: 197 LEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 28/192 (14%)
Query: 465 VAVKQLEKV---TGDGEK---SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
+AVKQ+ V + + E+ + +E++++ R +H +++++LG E +H L E M
Sbjct: 28 MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAG 87
Query: 519 GTLSAFL-----FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
G++S L F++ + + + RGL YLHE QIIH D+K N+L+D+
Sbjct: 88 GSVSHLLSKYGAFKEAV-----IINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDST 139
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTM---IRGTMGYMAPEWLRNAPVTAKVDVYS 630
+IADFG A L T + GT+ +MAPE LR DV+S
Sbjct: 140 ------GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWS 193
Query: 631 FGVMLLEIIFCK 642
G +++E+ K
Sbjct: 194 VGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 61/293 (20%)
Query: 444 KVFSYQELREATNVFDGQEVE-VAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLG 501
KVF L E ++ + E VAVK L++ D K F RE +++ H+N+V+ G
Sbjct: 20 KVF----LGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYG 75
Query: 502 FCIEQNHQLLVYELMKNGTLSAFLFRQEIP---------------TWDKRVEIALGIARG 546
C E + ++V+E M++G L+ FL R P T + ++IA+ IA G
Sbjct: 76 VCTEGDPPIMVFEYMEHGDLNKFL-RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASG 134
Query: 547 LLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRT--ST 603
++YL + +H D+ +N L + + + KI DFG+++ + D R T
Sbjct: 135 MVYLASQ---HFVHRDLATRNCL-------VGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 604 M--IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII-FCKRHTELHRVDEPTLANGMI 660
M IR +M PE + T + DV+SFGV+L EI + K+ +E
Sbjct: 185 MLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------- 232
Query: 661 LTDWVLYCVRTGNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
V+ C+ G L M+G W P R ++K + + L+
Sbjct: 233 ----VIECITQGRLLQRPRTCPSEVYDIMLGCW--KRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 11/185 (5%)
Query: 464 EVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
V +KQ+ E++T D + E QV+ H N+++ +E ++V E GTL
Sbjct: 27 LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86
Query: 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
+ ++ ++ D+ I + LL LH I+H D+K QN+LLD +
Sbjct: 87 AEYIQKRCNSLLDED-TILHFFVQILLALHHVHTKLILHRDLKTQNILLDK------HKM 139
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
+ KI DFG++K+L +++ T++ GT Y++PE P K D+++ G +L E+
Sbjct: 140 VVKIGDFGISKILSS-KSKAYTVV-GTPCYISPELCEGKPYNQKSDIWALGCVLYELASL 197
Query: 642 KRHTE 646
KR E
Sbjct: 198 KRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 19/191 (9%)
Query: 459 DGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ ++ VA+K L + T K L E V+ H ++V+LLG C+ Q L+ +LM
Sbjct: 33 EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMP 91
Query: 518 NGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN-NY 574
G L ++ R + + + IA+G+ YL E+ +++H D+ +NVL+ +
Sbjct: 92 LGCLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQH 147
Query: 575 ITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
+ KI DFGLAKLL D+ + + + +MA E + + T K DV+S+GV
Sbjct: 148 V--------KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGV 199
Query: 634 MLLEII-FCKR 643
+ E++ F +
Sbjct: 200 TVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 56/278 (20%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
SY + + + D Q + L ++ + + E++++ +H N++ ++
Sbjct: 12 SYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71
Query: 507 NHQLLVYELMKNGTLSAFLFRQE-----IPT---WDKRVEIALGIARGLLYLHEECETQI 558
N +V E G LS + +++ IP W I + + RGL LHE+ +I
Sbjct: 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQALHEQ---KI 124
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
+H D+K N+LL N + KI D G++K+LKK+ +T GT YMAPE +
Sbjct: 125 LHRDLKSANILLVANDLV-------KIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWK 174
Query: 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA---NGMILTDWVLYCVRTGNLG 675
P + K D++S G +L E+ T A + D + Y V+ G
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMA--------------TFAPPFEARSMQD-LRYKVQRG--- 216
Query: 676 ATKFERI--------TMVGLWCICPQPTLRPSMKQVLQ 705
K+ I + +P LRP+ ++L
Sbjct: 217 --KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 61/192 (31%), Positives = 103/192 (53%), Gaps = 25/192 (13%)
Query: 453 EATNVFDGQEV--EVAVKQLE-KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
E V G+ +VAVK ++ VT ++FL E V+ + HHKNLV+LLG I N
Sbjct: 18 EFGAVLQGEYTGQKVAVKNIKCDVTA---QAFLEETAVMTKLHHKNLVRLLG-VILHNGL 73
Query: 510 LLVYELMKNGTLSAFLF---RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQ 566
+V ELM G L FL R + + ++ +L +A G+ YL + +++H D+ +
Sbjct: 74 YIVMELMSKGNLVNFLRTRGRALVSV-IQLLQFSLDVAEGMEYLESK---KLVHRDLAAR 129
Query: 567 NVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKV 626
N+L + + + K++DFGLA++ + ++ T APE L++ ++K
Sbjct: 130 NIL-------VSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 627 DVYSFGVMLLEI 638
DV+S+GV+L E+
Sbjct: 179 DVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 56/192 (29%), Positives = 94/192 (48%), Gaps = 17/192 (8%)
Query: 452 REATNVFDGQEVEVAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
+A + G+ V A+K+ L ++ G LRE++ + H +V+LL +
Sbjct: 17 FKAKDRETGETV--ALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74
Query: 510 LLVYELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNV 568
+LV E M LS L +E P + +V+ + +G+ Y+H I+H D+KP N+
Sbjct: 75 VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANL 130
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP-VTAKVD 627
L I + + KIADFGLA+L +++ R + T Y APE L A VD
Sbjct: 131 L-------ISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183
Query: 628 VYSFGVMLLEII 639
+++ G + E++
Sbjct: 184 LWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 30/199 (15%)
Query: 459 DGQEVEVAVKQL-EKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELM 516
DG ++ A+K++ E + D + F E++V+ + HH N++ LLG C + + L E
Sbjct: 31 DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIA----------------LGIARGLLYLHEECETQIIH 560
+G L FL + + D IA +ARG+ YL ++ Q IH
Sbjct: 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIH 147
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620
D+ +N+L + NY+ KIADFGL++ ++ TM R + +MA E L +
Sbjct: 148 RDLAARNIL-------VGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYS 198
Query: 621 PVTAKVDVYSFGVMLLEII 639
T DV+S+GV+L EI+
Sbjct: 199 VYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 51/227 (22%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGR-THHKNLVQLLGF 502
S+ + A +E A+K L+K + K E +V+ R H +++L +
Sbjct: 13 SFSTVVLAKEKETNKEY--AIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY-Y 69
Query: 503 CIEQNHQL-LVYELMKNGTLSAFLFRQEIPTWDKRV------EIALGIARGLLYLHEECE 555
+ L V E NG L ++ ++ + D++ EI L + YLH +
Sbjct: 70 TFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALE----YLHSK-- 121
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL--------------------K 595
IIH D+KP+N+LLD + +I KI DFG AK+L +
Sbjct: 122 -GIIHRDLKPENILLD------KDMHI-KITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK 642
K++ R ++ + GT Y++PE L P D+++ G ++ +++ K
Sbjct: 174 KNRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 51/176 (28%), Positives = 91/176 (51%), Gaps = 12/176 (6%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VA+K + K E F+ E +V+ + H+ LVQL G C +Q +V E M NG L
Sbjct: 30 DVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88
Query: 524 FLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
+L + + +E+ + G+ YL + Q IH D+ +N L +D+
Sbjct: 89 YLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCL-------VDDQGC 138
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
K++DFGL++ + D+ +S + + + PE L + ++K DV++FGV++ E+
Sbjct: 139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 23/169 (13%)
Query: 478 EKSFLREVQVIGRTHHKNLVQLLG-FCIEQNHQL-LVYELMKNGTLSAFLFRQEIPTWDK 535
+K LRE+++ +V+ G F E + + + E + G+L + +++
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY--KKVKKRGG 100
Query: 536 RV------EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589
R+ +IA + +GL YLH +IIH DIKP N+LL K+ DFG
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQV-------KLCDFG 150
Query: 590 LAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
++ L T T GT YMAPE ++ P + DV+S G+ LLE+
Sbjct: 151 VSGELVNSLAGTFT---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 461 QEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
Q V VAVK L E + FL+E++++ R N+++LL CI + ++ E M+NG
Sbjct: 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 520 TLSAFLFRQEIP-----------TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
L+ FL R E ++ + +A IA G+ YL +H D+ +N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNC 161
Query: 569 LLDNNYITIDNNYITKIADFGLAK-LLKKD----QTRTSTMIRGTMGYMAPEWLRNAPVT 623
L + NY KIADFG+++ L D Q R IR +M+ E + T
Sbjct: 162 L-------VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMSWESILLGKFT 210
Query: 624 AKVDVYSFGVMLLEII-FCKRHTELHRVDEPTLAN 657
DV++FGV L EI+ CK DE + N
Sbjct: 211 TASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 33/200 (16%)
Query: 461 QEVEVAVKQLEKVTGDGE-KSFLREVQV---IGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
+ VAVK L+ + + + E+++ IG+ HKN++ LLG C ++ +V E
Sbjct: 41 ETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGVCTQEGPLYVVVEYA 98
Query: 517 KNGTLSAFLFRQEIP----------------TWDKRVEIALGIARGLLYLHEECETQIIH 560
+G L FL + P T V A +ARG+ +L + + IH
Sbjct: 99 AHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIH 155
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK-DQTRTSTMIRGTMGYMAPEWLRN 619
D+ +NVL + +++ KIADFGLA+ + D R +T R + +MAPE L +
Sbjct: 156 RDLAARNVL-------VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD 208
Query: 620 APVTAKVDVYSFGVMLLEII 639
T + DV+SFGV+L EI
Sbjct: 209 RVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 440 EINMKVFSYQELREATNVFDGQE-VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQ 498
E+ F L E N+ Q+ + VAVK L+ + + K F RE +++ H+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 499 LLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP--------------TWDKRVEIALGIA 544
G C+E + ++V+E MK+G L+ FL R P T + + IA IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFL-RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTST 603
G++YL + +H D+ +N L + N + KI DFG+++ + D R
Sbjct: 131 AGMVYLASQ---HFVHRDLATRNCL-------VGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ +M PE + T + DV+S GV+L EI
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 53/183 (28%), Positives = 98/183 (53%), Gaps = 14/183 (7%)
Query: 461 QEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+EV VA+K L+ T + FL E ++G+ H N+++L G + +++ E M+NG
Sbjct: 32 KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENG 91
Query: 520 TLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L +L + + + V + GIA G+ YL + +H D+ +N+L ++
Sbjct: 92 ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNIL-------VN 141
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMG--YMAPEWLRNAPVTAKVDVYSFGVMLL 636
+N K++DFGL+++L+ D T T G + + APE + T+ DV+SFG+++
Sbjct: 142 SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201
Query: 637 EII 639
E++
Sbjct: 202 EVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 54/183 (29%), Positives = 100/183 (54%), Gaps = 14/183 (7%)
Query: 461 QEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+E+ VA+K L+ T + FL E ++G+ H N++ L G + ++V E M+NG
Sbjct: 31 REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENG 90
Query: 520 TLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
+L AFL + + T + V + GIA G+ YL + +H D+ +N+L ++
Sbjct: 91 SLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL-------VN 140
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMG--YMAPEWLRNAPVTAKVDVYSFGVMLL 636
+N + K++DFGL+++L+ D T G + + APE + T+ DV+S+G+++
Sbjct: 141 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 200
Query: 637 EII 639
E++
Sbjct: 201 EVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-17
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 19/188 (10%)
Query: 460 GQEVEVAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLL--GFCIEQNHQLLVYELM 516
G EV + + + + + + F RE + R +H N+V LL G V+E +
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
TL L + + L + L H + I+H D+KPQN+++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS----Q 114
Query: 577 IDNNYITKIADFGLAKLL-------KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY 629
K+ DFG+ LL TRT+ ++ GT Y APE LR PVT D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLY 173
Query: 630 SFGVMLLE 637
++G++ LE
Sbjct: 174 AWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 40/264 (15%)
Query: 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
++ VK++ V E+ +G+ H N+V+L+G C + L++E ++ L
Sbjct: 715 GMQFVVKEINDVNSIPSS----EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770
Query: 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
S L +W++R +IA+GIA+ L +LH C ++ ++ P+ I ID
Sbjct: 771 SEVLRNL---SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK-------IIIDGKD 820
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
+ L LL D + Y+APE +T K D+Y FG++L+E++
Sbjct: 821 EPHLR-LSLPGLLCTDTKCFI-----SSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874
Query: 642 KRHTELHRVDEPTLANGMILTDWVLYCVR------------TGNLGATKFERI-TM-VGL 687
K D +G I+ +W YC G++ + E + M + L
Sbjct: 875 KSPA-----DAEFGVHGSIV-EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL 928
Query: 688 WCICPQPTLRPSMKQVLQMLEGTS 711
C PT RP VL+ LE S
Sbjct: 929 HCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 447 SYQELREATNVFDGQEVEVAVKQL-EKVTGDGEKSF-LREVQVIGRTHHKNLVQLLGFCI 504
+Y + +A + G+ V A+K++ + +G LRE++++ +H N+++LL
Sbjct: 11 TYGVVYKARDKLTGEIV--AIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR 68
Query: 505 EQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDI 563
+ LV+E M L + ++ + ++ + +GL + H I+H D+
Sbjct: 69 HKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDL 124
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV- 622
KP+N+L I+ + K+ADFGLA+ R T T Y APE L
Sbjct: 125 KPENLL-------INTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGY 176
Query: 623 TAKVDVYSFGVMLLEII 639
+ VD++S G + E++
Sbjct: 177 STPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 58/183 (31%), Positives = 92/183 (50%), Gaps = 19/183 (10%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMK 517
D + +VAVK ++ ++FL E V+ + H NLVQLLG +E+ L +V E M
Sbjct: 26 DYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83
Query: 518 NGTLSAFLFR--QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
G+L +L + + D ++ +L + + YL +H D+ +NVL +
Sbjct: 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVL-----V 135
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635
+ DN + K++DFGL K Q ++ T APE LR + K DV+SFG++L
Sbjct: 136 SEDN--VAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILL 189
Query: 636 LEI 638
EI
Sbjct: 190 WEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 36/199 (18%)
Query: 465 VAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
VAVK L E+ + D + F RE ++ H N+V+LLG C L++E M G L+
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 524 FLFRQEIPTWD-----------------------KRVEIALGIARGLLYLHEECETQIIH 560
FL R P +++ IA +A G+ YL E + +H
Sbjct: 98 FL-RHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVH 153
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLA-KLLKKDQTRTSTMIRGTMGYMAPEWLRN 619
D+ +N L + N + KIADFGL+ + D + S + +M PE +
Sbjct: 154 RDLATRNCL-------VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY 206
Query: 620 APVTAKVDVYSFGVMLLEI 638
T + DV+++GV+L EI
Sbjct: 207 NRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 57/181 (31%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VAVK L+ T E SFL E Q++ + H LVQL + + +V E M G+L
Sbjct: 32 KVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLD 89
Query: 524 FLFRQE-----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
FL E +P V++A +A G+ Y+ IH D++ N+L +
Sbjct: 90 FLKDGEGRALKLP---NLVDMAAQVAAGMAYIER---MNYIHRDLRSANIL-------VG 136
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ + KIADFGLA+L++ ++ + + + APE T K DV+SFG++L E+
Sbjct: 137 DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 639 I 639
+
Sbjct: 197 V 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 27/181 (14%)
Query: 478 EKSFL-REVQVIGRTHHKNLVQLLG-FCIEQNHQL-LVYELMKNGTLSAFL--FRQEIPT 532
EK L EV ++ H N+V+ N L +V E + G L+ + ++E
Sbjct: 42 EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE--- 98
Query: 533 WDKRVE--IALGIARGLLYLHEEC------ETQIIHCDIKPQNVLLDNNYITIDNNYITK 584
K +E I LL EC ++H D+KP N+ LD N K
Sbjct: 99 -RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV-------K 150
Query: 585 IADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRH 644
+ DFGLAK+L D + T + GT YM+PE L + K D++S G ++ E+ C
Sbjct: 151 LGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL--CALS 207
Query: 645 T 645
Sbjct: 208 P 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
A + G+ V A+K++ + + LRE+ ++ H N+V+LL + L
Sbjct: 18 ARDKKTGEIV--ALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYL 75
Query: 512 VYELMKNGTLSAFL--FRQEIPT-WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
V+E L +L + K I + RGL Y H +I+H D+KPQN+
Sbjct: 76 VFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSH---RILHRDLKPQNI 129
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLK-KDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKV 626
L I+ + + K+ADFGLA+ +T T ++ T+ Y APE L + + V
Sbjct: 130 L-------INRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHYSTAV 180
Query: 627 DVYSFGVMLLEII 639
D++S G + E+I
Sbjct: 181 DIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 52/178 (29%), Positives = 97/178 (54%), Gaps = 13/178 (7%)
Query: 464 EVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
EVAVK + D ++ FL+E +++ + H N+V+L+G C+++ +V EL+ G+L
Sbjct: 21 EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80
Query: 523 AFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
FL +++ T K ++++L A G+ YL + IH D+ +N L + N
Sbjct: 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCL-------VGENN 130
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGT-MGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ KI+DFG+++ + S ++ + + APE L T++ DV+S+G++L E
Sbjct: 131 VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 35/200 (17%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS---FLREVQVIGRTHHKNLVQLLGFCIEQNHQ------ 509
DG +++VAVK + K+ FL E + H N+++L+G C E +
Sbjct: 24 DGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82
Query: 510 LLVYELMKNGTLSAFLFR-------QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
+++ MK+G L +FL +++P ++ + IA G+ YL IH D
Sbjct: 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPL-QTLLKFMVDIALGMEYLSNR---NFIHRD 138
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD----QTRTSTMIRGTMGYMAPEWLR 618
+ +N +L + +ADFGL+K + Q R + M + ++A E L
Sbjct: 139 LAARNCMLREDMTVC-------VADFGLSKKIYSGDYYRQGRIAKM---PVKWIAIESLA 188
Query: 619 NAPVTAKVDVYSFGVMLLEI 638
+ T+K DV++FGV + EI
Sbjct: 189 DRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 80/283 (28%), Positives = 125/283 (44%), Gaps = 69/283 (24%)
Query: 461 QEVEVAVKQLEKVTGDGEKSFL----REVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
Q V VAVK L+ D + + L +++IG+ HKN++ LLG C ++ ++ E
Sbjct: 43 QTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYA 100
Query: 517 KNGTLSAFLFRQEIPTWDKRVEI----------------ALGIARGLLYLHEECETQIIH 560
G L FL + P D +I A +ARG+ YL + IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIH 157
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK-DQTRTSTMIRGTMGYMAPEWLRN 619
D+ +NVL +T DN + KIADFGLA+ + D + ++ R + +MAPE L +
Sbjct: 158 RDLAARNVL-----VTEDN--VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD 210
Query: 620 APVTAKVDVYSFGVMLLEII--------------FCKRHTELHRVDEPTLANGMILTDWV 665
T + DV+SFG+++ EI K E HR+D+P+
Sbjct: 211 RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPS----------- 259
Query: 666 LYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
C + M+ C PT RP+ KQ+++ L+
Sbjct: 260 -NCT----------HELYMLMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 444 KVFSYQELREATNVFDGQE-VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGF 502
KVF L E N+ Q+ + VAVK L++ + + F RE +++ H+++V+ G
Sbjct: 20 KVF----LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGV 75
Query: 503 CIEQNHQLLVYELMKNGTLSAFLFRQEIP----------------TWDKRVEIALGIARG 546
C E L+V+E M++G L+ FL R P T + + IA IA G
Sbjct: 76 CTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASG 134
Query: 547 LLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMI 605
++YL +H D+ +N L + + KI DFG+++ + D R
Sbjct: 135 MVYL---ASLHFVHRDLATRNCL-------VGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ +M PE + T + D++SFGV+L EI
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 30/199 (15%)
Query: 459 DGQEVEVAVKQLEKVTGDGE-KSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELM 516
DG ++ A+K L++ + + + F E++V+ + HH N++ LLG C + + + E
Sbjct: 26 DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA 85
Query: 517 KNGTLSAFLFRQEI----PTWDKR------------VEIALGIARGLLYLHEECETQIIH 560
G L FL + + P + K ++ A +A G+ YL E+ Q IH
Sbjct: 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIH 142
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620
D+ +NVL + N +KIADFGL++ ++ TM R + +MA E L +
Sbjct: 143 RDLAARNVL-------VGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWMAIESLNYS 193
Query: 621 PVTAKVDVYSFGVMLLEII 639
T K DV+SFGV+L EI+
Sbjct: 194 VYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 29/192 (15%)
Query: 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524
VAVK L+ T K F RE +++ H+++V+ G C + + ++V+E MK+G L+ F
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 525 LFRQEIPT-----------------WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
L R P + + IA IA G++YL + +H D+ +N
Sbjct: 98 L-RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRN 153
Query: 568 VLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKV 626
L + N + KI DFG+++ + D R + +M PE + T +
Sbjct: 154 CL-------VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206
Query: 627 DVYSFGVMLLEI 638
DV+SFGV+L EI
Sbjct: 207 DVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 22/201 (10%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
VA+K L+ T E +FL+E QV+ + H+ LVQL + + +V E M G+L
Sbjct: 32 RVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD 89
Query: 524 FLFRQEIPTW---DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
FL + E+ + + V++A IA G+ Y+ +H D++ N+L + N
Sbjct: 90 FL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANIL-------VGEN 138
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
+ K+ADFGLA+L++ ++ + + + APE T K DV+SFG++L E+
Sbjct: 139 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-- 196
Query: 641 CKRHTELHRVDEPTLANGMIL 661
T RV P + N +L
Sbjct: 197 ----TTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 19/187 (10%)
Query: 458 FDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ +VAVK L+ T + +FL E ++ H LV+L ++ ++ E M
Sbjct: 26 YYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84
Query: 518 NGTLSAFLFRQE-----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
G+L FL E +P K ++ + IA G+ Y+ + IH D++ NVL
Sbjct: 85 KGSLLDFLKSDEGGKVLLP---KLIDFSAQIAEGMAYIERK---NYIHRDLRAANVL--- 135
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
+ + + KIADFGLA++++ ++ + + + APE + T K DV+SFG
Sbjct: 136 ----VSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 191
Query: 633 VMLLEII 639
++L EI+
Sbjct: 192 ILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 57/189 (30%), Positives = 102/189 (53%), Gaps = 24/189 (12%)
Query: 461 QEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+E+ VA+K L+ T + FL E ++G+ H N++ L G + +++ E M+NG
Sbjct: 31 REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENG 90
Query: 520 TLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L +FL + + T + V + GIA G+ YL E +H D+ +N+L ++
Sbjct: 91 ALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNIL-------VN 140
Query: 579 NNYITKIADFGLAKLLKK---DQTRTSTM-----IRGTMGYMAPEWLRNAPVTAKVDVYS 630
+N + K++DFGL++ L+ D T TS++ IR T APE + T+ DV+S
Sbjct: 141 SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT----APEAIAYRKFTSASDVWS 196
Query: 631 FGVMLLEII 639
+G+++ E++
Sbjct: 197 YGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 49/179 (27%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
+++VA+K + + E+ F+ E +V+ + H LVQL G C +Q +V E M+NG L
Sbjct: 28 QIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86
Query: 522 SAFLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
+L RQ K + + + G+ YL IH D+ +N L + +
Sbjct: 87 LNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCL-------VSS 135
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ K++DFG+ + + D+ +S+ + + + PE + ++K DV+SFGV++ E+
Sbjct: 136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 58/180 (32%), Positives = 87/180 (48%), Gaps = 19/180 (10%)
Query: 466 AVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A K+L+K GE+ L E +++ + + +V L + E L LV LM G L
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDL 80
Query: 522 SAFLFRQEIPTWDKRVEI--ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
++ P + + I A I GL +LH+ +I++ D+KP+NVLLD+
Sbjct: 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDD-----HG 132
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
N +I+D GLA LK + GT GYMAPE L+ VD ++ G L E+I
Sbjct: 133 N--VRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 54/178 (30%), Positives = 94/178 (52%), Gaps = 14/178 (7%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VA+K L++ + E +FL E ++ + H LV+L + Q ++ E M+NG+L
Sbjct: 32 KVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVD 89
Query: 524 FLFRQEIP--TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
FL E T +K +++A IA G+ ++ + IH D++ N+L +
Sbjct: 90 FLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANIL-------VSETL 139
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
KIADFGLA+L++ ++ + + + APE + T K DV+SFG++L EI+
Sbjct: 140 CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 81/283 (28%), Positives = 124/283 (43%), Gaps = 69/283 (24%)
Query: 461 QEVEVAVKQLEKVTGDGEKSFL----REVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
+ V VAVK L+ D + S L +++IG+ HKN++ LLG C + ++ E
Sbjct: 43 KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYA 100
Query: 517 KNGTLSAFLFRQEIP----------------TWDKRVEIALGIARGLLYLHEECETQIIH 560
G L +L + P T+ V A +ARG+ YL + + IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIH 157
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK-DQTRTSTMIRGTMGYMAPEWLRN 619
D+ +NVL +T DN + KIADFGLA+ + D + +T R + +MAPE L +
Sbjct: 158 RDLAARNVL-----VTEDN--VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD 210
Query: 620 APVTAKVDVYSFGVMLLEII--------------FCKRHTELHRVDEPTLANGMILTDWV 665
T + DV+SFGV+L EI K E HR+D+P
Sbjct: 211 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP------------ 258
Query: 666 LYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
A + M+ C P+ RP+ KQ+++ L+
Sbjct: 259 ----------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 29/202 (14%)
Query: 474 TGDGEK--SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP 531
E+ F+ E+ ++ H N+V L +N ++ E G L + + E
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99
Query: 532 -TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590
T + + + L +LH ++IH D+K N+LL T+D + K+ADFG+
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILL-----TLDGD--VKLADFGV 149
Query: 591 AKLLKKDQTRTSTMIRGTMGYMAPEWL-----RNAPVTAKVDVYSFGVMLLEIIFCK-RH 644
+ K + T I GT +MAPE + ++ P K D++S G+ L+E+ + H
Sbjct: 150 SAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208
Query: 645 TELH--RV-------DEPTLAN 657
EL+ RV + PTL
Sbjct: 209 HELNPMRVLLKILKSEPPTLDQ 230
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 456 NVFDGQEVEVAVKQLE-KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYE 514
NV G+ + VAVK L + FL+EV+++ R N+++LLG C++++ ++ E
Sbjct: 40 NVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITE 99
Query: 515 LMKNGTLSAFLFRQEI-------------------PTWDKRVEIALGIARGLLYLHEECE 555
M+NG L+ FL + ++ + +AL IA G+ YL
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SS 156
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL-----KKDQTRTSTMIRGTMG 610
+H D+ +N L + N KIADFG+++ L + Q R IR
Sbjct: 157 LNFVHRDLATRNCL-------VGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR---- 205
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVMLLEII-FCKRHTELHRVDEPTLAN 657
+MA E + T DV++FGV L EI+ CK DE + N
Sbjct: 206 WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 42/216 (19%)
Query: 448 YQELREATN-----VFDGQEVE----VAVKQLEKVTGDGE---KSFLREVQV---IGRTH 492
Y+EL E V+ +++ VA+K++ +V E S LRE+ + +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 493 HKNLVQLLGFCIEQNHQL-------LVYELMKNGTLSAFLFR---QEIPTWDKRVEIALG 542
H N+V+LL C + LV+E + L+ +L + +P + ++
Sbjct: 60 HPNIVRLLDVC--HGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQ 115
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
+ RG+ +LH I+H D+KPQN+L + ++ KIADFGLA++ + TS
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNIL-------VTSDGQVKIADFGLARIYSFEMALTS 165
Query: 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
++ T+ Y APE L + VD++S G + E+
Sbjct: 166 VVV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 454 ATNVFDGQ-EVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
A ++ G+ E VAVK + + E+ FL E V+ ++V+LLG + L+
Sbjct: 27 ARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV 86
Query: 512 VYELMKNGTLSAFL--FRQE--------IPTWDKRVEIALGIARGLLYLHEECETQIIHC 561
V ELM +G L ++L R E PT + +++A IA G+ YL+ + + +H
Sbjct: 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHR 143
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG-----YMAPEW 616
D+ +N + + +++ KI DFG+ + D T +G G +MAPE
Sbjct: 144 DLAARNCM-------VAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMAPES 192
Query: 617 LRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676
L++ T D++SFGV+L EI T L L+N +L + + G L
Sbjct: 193 LKDGVFTTSSDMWSFGVVLWEI------TSLAEQPYQGLSNEQVLK----FVMDGGYLDQ 242
Query: 677 TKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
ER+T + C P +RP+ +++ +L+
Sbjct: 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 57/186 (30%), Positives = 92/186 (49%), Gaps = 16/186 (8%)
Query: 459 DGQEVEVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ--LLVYEL 515
DG VAVK L++ G + +E+ ++ +H+N+V+ G C EQ + L+ E
Sbjct: 30 DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89
Query: 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
+ G+L +L + ++ + + A I G+ YLH + IH D+ +NVLLDN
Sbjct: 90 VPLGSLRDYLPKHKL-NLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDN--- 142
Query: 576 TIDNNYITKIADFGLAKLLKKDQT--RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
D + KI DFGLAK + + R + + A E L+ + DV+SFGV
Sbjct: 143 --DR--LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGV 198
Query: 634 MLLEII 639
L E++
Sbjct: 199 TLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 36/195 (18%)
Query: 465 VAVKQLEKVTGDGE-----KSFL----REVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515
+AVKQ+E + +S L RE+ ++ H+N+VQ LG ++ +H + E
Sbjct: 28 MAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEY 87
Query: 516 MKNGTLSAFLFRQEIPTWDKRVEIAL------GIARGLLYLHEECETQIIHCDIKPQNVL 569
+ G+++A L E L I +GL YLH IIH DIK N+L
Sbjct: 88 VPGGSVAALL------NNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANIL 138
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTST-----MIRGTMGYMAPEWLRNAPVTA 624
+DN KI+DFG++K L+ + T T ++G++ +MAPE ++ T
Sbjct: 139 -------VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTR 191
Query: 625 KVDVYSFGVMLLEII 639
K D++S G +++E++
Sbjct: 192 KADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 465 VAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
VA+K L E ++ F +E +++ H N+V LLG C ++ +++E + +G L
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97
Query: 524 FLFR----------------QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
FL R + + IA+ IA G+ YL +H D+ +N
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARN 154
Query: 568 VLLDNNYITIDNNYITKIADFGLAKLL-----KKDQTRTSTMIRGTMGYMAPEWLRNAPV 622
L + KI+DFGL++ + + Q+++ +R +M PE +
Sbjct: 155 CL-------VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR----WMPPEAILYGKF 203
Query: 623 TAKVDVYSFGVMLLEI 638
T + D++SFGV+L EI
Sbjct: 204 TTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 30/199 (15%)
Query: 459 DGQEVEVAVKQLEKVTGDGE-KSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELM 516
DG ++ A+K++++ + + F E++V+ + HH N++ LLG C + + L E
Sbjct: 19 DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78
Query: 517 KNGTLSAFLFRQEIPTWD----------------KRVEIALGIARGLLYLHEECETQIIH 560
+G L FL + + D + + A +ARG+ YL ++ Q IH
Sbjct: 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIH 135
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620
D+ +N+L + NY+ KIADFGL++ ++ TM R + +MA E L +
Sbjct: 136 RDLAARNIL-------VGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYS 186
Query: 621 PVTAKVDVYSFGVMLLEII 639
T DV+S+GV+L EI+
Sbjct: 187 VYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 36/203 (17%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
SY + +A + GQ V A+K + V D + ++E+ ++ + +V+ G +
Sbjct: 15 SYGSVYKAIHKETGQVV--AIKVVP-VEEDLQ-EIIKEISILKQCDSPYIVKYYGSYFKN 70
Query: 507 NHQLLVYE---------LMK--NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECE 555
+V E +MK N TL+ +EI I +GL YLH
Sbjct: 71 TDLWIVMEYCGAGSVSDIMKITNKTLT----EEEIAA------ILYQTLKGLEYLHSN-- 118
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE 615
+ IH DIK N+LL+ K+ADFG++ L + +T+I GT +MAPE
Sbjct: 119 -KKIHRDIKAGNILLNEEGQA-------KLADFGVSGQLTDTMAKRNTVI-GTPFWMAPE 169
Query: 616 WLRNAPVTAKVDVYSFGVMLLEI 638
++ K D++S G+ +E+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 33/203 (16%)
Query: 465 VAVKQLEKVTGDGEK-----SFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMK 517
VA+K K+ + EK + +RE++++ + H N+V+L + +V+E M
Sbjct: 27 VALK---KIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83
Query: 518 NGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
+ L+ L E+ + +++ + GL YLH I+H DIK N+L
Sbjct: 84 H-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNIL------- 132
Query: 577 IDNNYITKIADFGLAKLLKKDQTR--TSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGV 633
I+N+ + K+ADFGLA+ K + T+ +I T+ Y PE L A +VD++S G
Sbjct: 133 INNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELLLGATRYGPEVDMWSVGC 190
Query: 634 MLLEI-----IFCKRHTELHRVD 651
+L E+ IF TEL +++
Sbjct: 191 ILAELFLGKPIFQGS-TELEQLE 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 36/201 (17%)
Query: 465 VAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
VAVK L++ E + L E ++ + +H ++++L G C + LL+ E K G+L +
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 524 FL--FRQEIPTW---------------DKR-------VEIALGIARGLLYLHEECETQII 559
FL R+ P++ D+R + A I+RG+ YL E +++
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLV 149
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEWLR 618
H D+ +NVL+ KI+DFGL++ + ++D + R + +MA E L
Sbjct: 150 HRDLAARNVLVAEGRKM-------KISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202
Query: 619 NAPVTAKVDVYSFGVMLLEII 639
+ T + DV+SFGV+L EI+
Sbjct: 203 DHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 47/226 (20%)
Query: 464 EVAVKQLEKVTGDGEKSFL----REVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+VAVK L+ + + S L +++IG+ HKN++ LLG C + ++ E G
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 520 TLSAFLFRQEIP----------------TWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
L +L + P ++ V A +ARG+ YL + + IH D+
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDL 166
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKK-DQTRTSTMIRGTMGYMAPEWLRNAPV 622
+NVL +T DN + KIADFGLA+ + D + +T R + +MAPE L +
Sbjct: 167 AARNVL-----VTEDN--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219
Query: 623 TAKVDVYSFGVMLLEII--------------FCKRHTELHRVDEPT 654
T + DV+SFGV+L EI K E HR+D+P+
Sbjct: 220 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 265
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 15/179 (8%)
Query: 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNGTLS 522
VAVK+L+ T + + F RE++++ H N+V+ G C + + LV E + G+L
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
+L + +E K + A I +G+ YL + + +H D+ +N+L +++
Sbjct: 96 DYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNIL-------VESEN 145
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGT--MGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
KI DFGL K+L +D+ G + + APE L + + DV+SFGV+L E+
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 466 AVKQLEKVTGDGEKSF---LREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A K+L K K + + E +++ + H + +V L + + L LV +M G L
Sbjct: 22 ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDL 80
Query: 522 SAFLFR--QEIPTWD--KRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
++ +E P + + I GL +LH+ +II+ D+KP+NVLLDN
Sbjct: 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDN----- 132
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
D N +I+D GLA LK Q++T GT G+MAPE L+ VD ++ GV L E
Sbjct: 133 DGN--VRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDFSVDYFALGVTLYE 189
Query: 638 IIFCKR--HTELHRVDEPTLANGMILTDWVLYCVR 670
+I + +V+ L IL D V Y +
Sbjct: 190 MIAARGPFRARGEKVENKELKQ-RILNDSVTYPDK 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSF-----LREVQVIGR-THHKNLVQLL 500
++ + A N G+ V A+K+++K S+ LREV+ + + H N+V+L
Sbjct: 11 TFGSVYLARNKETGELV--AIKKMKKKF----YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 501 GFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQII 559
E + V+E M+ R+ P + + I I +GL ++H+
Sbjct: 65 EVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFF 121
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-WLR 618
H D+KP+N+L + + KIADFGLA+ ++ T + T Y APE LR
Sbjct: 122 HRDLKPENLL-------VSGPEVVKIADFGLAREIRSRPPYTDYV--STRWYRAPEILLR 172
Query: 619 NAPVTAKVDVYSFGVMLLEI 638
+ ++ VD+++ G ++ E+
Sbjct: 173 STSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 62/195 (31%), Positives = 100/195 (51%), Gaps = 24/195 (12%)
Query: 466 AVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A K+LEK GE L E Q++ + + + +V L + E L LV LM G L
Sbjct: 29 ACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL 87
Query: 522 SAFLFRQEIPTWDKRVEI--ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
++ +++ + A I GL LH+E +I++ D+KP+N+LLD D+
Sbjct: 88 KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLD------DH 138
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+I +I+D GLA + + QT + GT+GYMAPE ++N T D ++ G +L E+I
Sbjct: 139 GHI-RISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195
Query: 640 -----FCKRHTELHR 649
F +R ++ R
Sbjct: 196 AGQSPFQQRKKKIKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 57/177 (32%), Positives = 93/177 (52%), Gaps = 15/177 (8%)
Query: 465 VAVKQLEKVTGDG--EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
VAVK L+ D + LRE V+ + + +V+++G C E +LV EL + G L+
Sbjct: 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLN 83
Query: 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
FL + + T E+ ++ G+ YL E T +H D+ +NVLL + +Y
Sbjct: 84 KFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLL------VTQHY- 133
Query: 583 TKIADFGLAKLLKKDQT--RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
KI+DFGL+K L D+ + T + + + APE + ++K DV+SFGV++ E
Sbjct: 134 AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 30/184 (16%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
DGQ + AVKQLE +E+ ++ + H N+VQ LG E+++ + EL+
Sbjct: 38 DGQTGQEAVKQLE-----------QEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPG 86
Query: 519 GTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
G+L+ L ++ ++ + V I L I GL YLH+ +H DIK N+L
Sbjct: 87 GSLAKLL--KKYGSFPEPV-IRLYTRQILLGLEYLHDR---NTVHRDIKGANIL------ 134
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL-RNAPVTAKVDVYSFGVM 634
+D N + K+ADFG+AK + + S +G+ +MAPE + + D++S G
Sbjct: 135 -VDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 635 LLEI 638
+LE+
Sbjct: 192 VLEM 195
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 68/271 (25%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSF---LREVQVIGRT-HHKNLVQLL 500
V+ ++ N+ +E+ V K + +KS + EV +I H N+V+
Sbjct: 16 VYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY 75
Query: 501 GFCIEQNHQLLVYELMKNGTL----SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECET 556
+E + +V +L++ L ++ +++ T ++ I + + L YLH+E
Sbjct: 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--K 133
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEW 616
+I+H D+ P N++L +++ +T I DFGLAK +K T + GT+ Y PE
Sbjct: 134 RIVHRDLTPNNIMLG------EDDKVT-ITDFGLAK--QKQPESKLTSVVGTILYSCPEI 184
Query: 617 LRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676
++N P K DV++FG +L ++ C + + +LA + + V + G
Sbjct: 185 VKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSLA--TKIVEAVYEPLPEG---- 236
Query: 677 TKFERITMVGLWCICPQPTLRPSMKQVLQML 707
E +T V C+ P RP + QV M+
Sbjct: 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 35/192 (18%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LV 512
A + ++ V +KQ+E V EK L+ ++ H LV L G + + L LV
Sbjct: 30 ALKILSKAKI-VKLKQVEHVLN--EKRILQSIR------HPFLVNLYG-SFQDDSNLYLV 79
Query: 513 YELMKNGTLSAFLFR-QEIPTWDKRV---EIALGIARGLLYLHEECETQIIHCDIKPQNV 568
E + G L + L + P R ++ L L YLH I++ D+KP+N+
Sbjct: 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLHSL---DIVYRDLKPENL 132
Query: 569 LLDNN-YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVD 627
LLD++ YI KI DFG AK +K RT T+ GT Y+APE + + VD
Sbjct: 133 LLDSDGYI--------KITDFGFAKRVKG---RTYTLC-GTPEYLAPEIILSKGYGKAVD 180
Query: 628 VYSFGVMLLEII 639
++ G+++ E++
Sbjct: 181 WWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 22/228 (9%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL 541
L E+ ++ H N++ ++ N L+ E GTL + RQ+ +++ + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 542 --GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599
I + Y+H+ I+H DIK N+ L T + K+ DFG++K+L + +
Sbjct: 107 LFQIVSAVSYIHKA---GILHRDIKTLNIFL-----TKAG--LIKLGDFGISKILGSEYS 156
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM 659
T++ GT YM+PE + K D+++ G +L E++ KR + N +
Sbjct: 157 MAETVV-GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD--------ATNPL 207
Query: 660 ILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707
L ++ T + E I++V + P RP+ +VL
Sbjct: 208 NLVVKIVQGNYTPVVSVYSSELISLVHS-LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 47/228 (20%)
Query: 461 QEVEVAVKQLEKVTGDGEKSFL----REVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
+ V VAVK L+ + + S L +++IG+ HKN++ LLG C + ++ E
Sbjct: 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYA 103
Query: 517 KNGTLSAFLFRQEIP----------------TWDKRVEIALGIARGLLYLHEECETQIIH 560
G L +L + P T+ V +ARG+ YL + + IH
Sbjct: 104 SKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIH 160
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK-DQTRTSTMIRGTMGYMAPEWLRN 619
D+ +NVL + N + KIADFGLA+ + D + +T R + +MAPE L +
Sbjct: 161 RDLAARNVL-------VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD 213
Query: 620 APVTAKVDVYSFGVMLLEII--------------FCKRHTELHRVDEP 653
T + DV+SFGV++ EI K E HR+D+P
Sbjct: 214 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 261
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 27/237 (11%)
Query: 479 KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE 538
K LRE+Q++ +V G + +N+ + E M G+L ++++ P VE
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPI---PVE 103
Query: 539 ----IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594
IA+ + GL YL+ +I+H DIKP N+L+ N+ I K+ DFG++ L
Sbjct: 104 ILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILV-NSRGQI------KLCDFGVSGEL 154
Query: 595 KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT 654
T GT YM+PE ++ T K DV+S G+ ++E+ K +D+
Sbjct: 155 INSIADTFV---GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 655 LANGMILTDWVLYCV---RTGNLGATKFERIT--MVGLWCICPQPTLRPSMKQVLQM 706
+ M + D +L + L ++ F V C+ PT RP+ +Q+ M
Sbjct: 212 QDDPMGILD-LLQQIVQEPPPRLPSSDFPEDLRDFVDA-CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 69/274 (25%), Positives = 115/274 (41%), Gaps = 44/274 (16%)
Query: 448 YQELREATNVFDGQEVEV-AVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+ + +A + DG+ V + V+ E + + L+E+ ++ + H N+++ L IE
Sbjct: 15 FSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN 74
Query: 507 NHQLLVYELMKNGTLSAFL--FRQ------EIPTWDKRVEIALGIARGLLYLHEECETQI 558
N +V EL G LS + F++ E W V++ L ++H + +I
Sbjct: 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHSK---RI 127
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
+H DIKP NV I + K+ D GL + T +++ GT YM+PE +
Sbjct: 128 MHRDIKPANVF-------ITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN----- 673
K D++S G +L E+ + P + M L C +
Sbjct: 180 ENGYNFKSDIWSLGCLLY---------EMAALQSPFYGDKMNLYS---LCKKIEKCDYPP 227
Query: 674 LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQ 705
L A + E +V CI P P RP + VLQ
Sbjct: 228 LPADHYSEELRDLVSR-CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 25/184 (13%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
VA+K+ ++ D + K+ LREV+V+ + H+N+V L + LV+E ++ L
Sbjct: 29 VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL- 87
Query: 523 AFLFRQEIPTWDKRVEIAL------GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
+ + + + + + Y H IIH DIKP+N+L
Sbjct: 88 -----ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENIL------- 132
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK-VDVYSFGVML 635
+ + + K+ DFG A+ L+ T T Y APE L K VDV++ G ++
Sbjct: 133 VSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIM 192
Query: 636 LEII 639
E++
Sbjct: 193 AELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-14
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 5/105 (4%)
Query: 37 GTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVT 96
+ T S + F GF+ L+ I + S RT+VW ANRD+P ++ L
Sbjct: 5 SSGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSD 63
Query: 97 GQLVLTHSNGT---QFKIYNGTLTVSALMQDSGNF-LYSNANGSV 137
G LVL +G ++ D GN +Y + +
Sbjct: 64 GNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFL 108
|
Length = 114 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 37/193 (19%)
Query: 465 VAVKQLEKVTGD---GEKSFLR---EVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
+AVKQ+E T + EK + + EV ++ H N+VQ LG C++ N + E +
Sbjct: 27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG 86
Query: 519 GTLSAFLFRQEIPTWDKRVEIAL-----GIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
G++S+ L R + E I G+ YLH C ++H DIK NV+L
Sbjct: 87 GSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVML--- 135
Query: 574 YITIDNNYITKIADFGLAKLL--------KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
N I K+ DFG A+ L + ++ + GT +MAPE + + K
Sbjct: 136 ----MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS---MHGTPYWMAPEVINESGYGRK 188
Query: 626 VDVYSFGVMLLEI 638
D++S G + E+
Sbjct: 189 SDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 53/186 (28%), Positives = 96/186 (51%), Gaps = 15/186 (8%)
Query: 457 VFDG---QEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLV 512
VF G + VAVK E + + + FL E +++ + H N+V+L+G C ++ +V
Sbjct: 11 VFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70
Query: 513 YELMKNGTLSAFLFRQEIPTWDKR-VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLD 571
EL+ G +FL +++ K+ V+ AL A G+ YL + IH D+ +N L
Sbjct: 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCL-- 125
Query: 572 NNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631
+ N + KI+DFG+++ +S + + + + APE L +++ DV+S+
Sbjct: 126 -----VGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSY 180
Query: 632 GVMLLE 637
G++L E
Sbjct: 181 GILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 30/198 (15%)
Query: 457 VFDGQEVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515
V D E VA+K + + E+ FL E V+ + ++V+LLG + L++ EL
Sbjct: 31 VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90
Query: 516 MKNGTLSAFLFR----------QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
M G L ++L Q P+ K +++A IA G+ YL+ + +H D+
Sbjct: 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAA 147
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG-----YMAPEWLRNA 620
+N + + ++ KI DFG+ + D T +G G +M+PE L++
Sbjct: 148 RNCM-------VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDG 196
Query: 621 PVTAKVDVYSFGVMLLEI 638
T DV+SFGV+L EI
Sbjct: 197 VFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 26/203 (12%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VA+K L+ T E +FL+E Q++ + H LV L + + +V E M G+L
Sbjct: 32 KVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLD 89
Query: 524 FLFRQE-----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
FL + +P + V++A IA G+ Y+ IH D++ N+L +
Sbjct: 90 FLKEGDGKYLKLP---QLVDMAAQIADGMAYIER---MNYIHRDLRAANIL-------VG 136
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+N + KIADFGLA+L++ ++ + + + APE T K DV+SFG++L E+
Sbjct: 137 DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 639 IFCKRHTELHRVDEPTLANGMIL 661
+ RV P + N +L
Sbjct: 197 V------TKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 39/220 (17%)
Query: 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQ 506
Y ++ +A + GQ V A+K ++ + D E+ E ++ + ++H N+ G I++
Sbjct: 19 YGKVYKARHKKTGQLV--AIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75
Query: 507 NH-----QL-LVYELMKNGTLSAFLFRQEIPTWDKRVE------IALGIARGLLYLHEEC 554
N QL LV EL G+++ + + + KR++ I RGL YLHE
Sbjct: 76 NPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGLAYLHEN- 132
Query: 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAP 614
++IH DIK QN+LL N K+ DFG++ L R +T I GT +MAP
Sbjct: 133 --KVIHRDIKGQNILL-------TKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAP 182
Query: 615 EWL-----RNAPVTAKVDVYSFGVMLLEII-----FCKRH 644
E + +A A+ DV+S G+ +E+ C H
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 62/183 (33%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 466 AVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A K+LEK GE L E Q++ + + + +V L + E L LV LM G L
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL 87
Query: 522 SAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
++ P +D+ V A I GL LH E +I++ D+KP+N+LLD D
Sbjct: 88 KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLD------DY 138
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRG---TMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
+I +I+D GLA + + +T IRG T+GYMAPE ++N T D + G ++
Sbjct: 139 GHI-RISDLGLAVEIPEGET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIY 192
Query: 637 EII 639
E+I
Sbjct: 193 EMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 32/269 (11%)
Query: 448 YQELREATNVFDGQEVEVA-VKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+ E+ AT + D + V + V+ E + + ++E+ ++ + +H N+++ L IE
Sbjct: 15 FSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED 74
Query: 507 NHQLLVYELMKNGTLSAFL--FRQE---IP---TWDKRVEIALGIARGLLYLHEECETQI 558
N +V EL G LS + F+++ IP W V++ + ++H ++
Sbjct: 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE----HMHSR---RV 127
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
+H DIKP NV +IT + K+ D GL + T +++ GT YM+PE +
Sbjct: 128 MHRDIKPANV-----FITATG--VVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678
K D++S G +L E+ + +++ +L + D Y + K
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD---YPPLPTEHYSEK 236
Query: 679 F-ERITMVGLWCICPQPTLRPSMKQVLQM 706
E ++M CI P P RP + V Q+
Sbjct: 237 LRELVSM----CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 51/184 (27%), Positives = 94/184 (51%), Gaps = 20/184 (10%)
Query: 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
+ +VAVK ++ + E +FL E V+ H LV+L + + ++ E M G+
Sbjct: 29 KHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGS 86
Query: 521 LSAFL-----FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
L FL +Q +P K ++ + IA G+ ++ + IH D++ N+L
Sbjct: 87 LLDFLKSDEGSKQPLP---KLIDFSAQIAEGMAFIEQR---NYIHRDLRAANIL------ 134
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635
+ + + KIADFGLA++++ ++ + + + APE + T K DV+SFG++L
Sbjct: 135 -VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 193
Query: 636 LEII 639
+EI+
Sbjct: 194 MEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
A+K ++K V ++ E +++ +H +V+L ++ + ++ E G L
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 523 AFLF-RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNN 580
L R + R IA + YLH II+ D+KP+N+LLD+N Y+
Sbjct: 82 TILRDRGLFDEYTARFYIA-CVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYV----- 132
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
K+ DFG AK LK Q +T T GT Y+APE + N VD +S G++L E++
Sbjct: 133 ---KLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 24/177 (13%)
Query: 470 LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ- 528
L K+ +++ +EV ++ + H N+V E +V E G L + RQ
Sbjct: 35 LTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQR 94
Query: 529 -------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
+I +W V+I+LG L ++H+ +I+H DIK QN+ L N
Sbjct: 95 GVLFSEDQILSW--FVQISLG----LKHIHDR---KILHRDIKSQNIFLSKN------GM 139
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ K+ DFG+A+ L D + GT Y++PE +N P K D++S G +L E+
Sbjct: 140 VAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 28/190 (14%)
Query: 460 GQEVEVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
G+ + VAVK L +K++ D FL+E ++ H+NL++L G + ++V EL
Sbjct: 21 GKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAP 78
Query: 518 NGTLSAFLFRQE------IPT-WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
G+L L R++ I T D V+IA G+ YL + + IH D+ +N+LL
Sbjct: 79 LGSLLDRL-RKDALGHFLISTLCDYAVQIANGMR----YLESK---RFIHRDLAARNILL 130
Query: 571 DNNYITIDNNYITKIADFGLAKLLK--KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
++ KI DFGL + L +D ++ + APE LR + DV
Sbjct: 131 ASDDKV-------KIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDV 183
Query: 629 YSFGVMLLEI 638
+ FGV L E+
Sbjct: 184 WMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ------EIPTWDK 535
+ E +V+ + +++ +++ +V E +NG L L Q E W
Sbjct: 47 IDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRF 106
Query: 536 RVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595
++I LG+A +LH + +I+H DIK N+ LD DN KI D G+AKLL
Sbjct: 107 FIQILLGLA----HLHSK---KILHRDIKSLNLFLDAY----DN---VKIGDLGVAKLLS 152
Query: 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
D T + I GT Y++PE + P K DV++ GV+L E
Sbjct: 153 -DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 29/188 (15%)
Query: 463 VEVAVKQLEKVTGDGEK-SFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYELMKN 518
++VAVK L+ E+ + + E++++ +H H+N+V LLG C L++ E
Sbjct: 66 MKVAVKMLKPTAHSSEREALMSELKIM--SHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 519 GTLSAFLFRQE---IPTWDKRVEIALGIARGLLYL-HEECETQIIHCDIKPQNVLLDNNY 574
G L FL R+ + D + + +A+G+ +L + C IH D+ +NVLL +
Sbjct: 124 GDLLNFLRRKRESFLTLED-LLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGK 178
Query: 575 ITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGT----MGYMAPEWLRNAPVTAKVDVYS 630
I KI DFGLA+ + D ++ +++G + +MAPE + N T + DV+S
Sbjct: 179 IV-------KICDFGLARDIMND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 228
Query: 631 FGVMLLEI 638
+G++L EI
Sbjct: 229 YGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 30/201 (14%)
Query: 465 VAVKQLEKVTGDGEK-----SFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMK 517
VA+K KV D E+ S LRE+ ++ H N+V+L + + + LV E +
Sbjct: 35 VALK---KVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91
Query: 518 NGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
L++ L P + +V+ + L + RGL YLHE IIH D+K N+LL
Sbjct: 92 Q-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLL------ 141
Query: 577 IDNNYITKIADFGLAKLLKK-DQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVM 634
+ KIADFGLA+ + T ++ T+ Y APE L T +D+++ G +
Sbjct: 142 -TDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCI 198
Query: 635 LLEII----FCKRHTELHRVD 651
L E++ +E+ ++D
Sbjct: 199 LAELLAHKPLLPGKSEIEQLD 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
SY E+ + DG++ + L + K+ +E Q++ + H N+V +
Sbjct: 12 SYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71
Query: 507 NHQL-LVYELMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ L +V + G L L Q ++ ++ VE + IA L YLHE+ I+H D+
Sbjct: 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDL 128
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
K QNV L T N I K+ D G+A++L+ ST+I GT YM+PE N P
Sbjct: 129 KTQNVFL-----TRTN--IIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYN 180
Query: 624 AKVDVYSFGVMLLEIIFCKR-------HTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676
K DV++ G + E+ K ++ ++R+ E L + D Y G L A
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKD---YSPELGELIA 235
Query: 677 TKFERITMVGLWCICPQPTLRPSMKQVLQ 705
T + +P RPS+K +L+
Sbjct: 236 TM-----------LSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 45/143 (31%), Positives = 66/143 (46%), Gaps = 29/143 (20%)
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRV------EIALGIARGLLYLHEECETQIIHCDIK 564
LV E + G L++ L + + + D+ V EI L + YLH IIH D+K
Sbjct: 70 LVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALE----YLHS---NGIIHRDLK 120
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAK-------LLKKDQTRTSTMIRGTMGYMAPEWL 617
P N+L ID+N K+ DFGL+K + D + I GT Y+APE +
Sbjct: 121 PDNIL-------IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 618 RNAPVTAKVDVYSFGVMLLEIIF 640
+ VD +S G +L E +
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 459 DGQEVEVAVK--QLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
E VA+K LEK + +EVQ + + +H N+V+ + + LV +
Sbjct: 24 PNNEK-VAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81
Query: 517 KNGTLSAFLFRQEIPT--WDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLLD 571
G+L + + P D+ + IA + +GL YLH IH DIK N+LL
Sbjct: 82 SGGSL-LDIMKSSYPRGGLDEAI-IATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLG 136
Query: 572 NNYITIDNNYITKIADFGLAKLLKKDQTRTSTM---IRGTMGYMAPEWLRNAP-VTAKVD 627
++ + KIADFG++ L RT + GT +MAPE + K D
Sbjct: 137 ------EDGSV-KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKAD 189
Query: 628 VYSFGVMLLEII 639
++SFG+ +E+
Sbjct: 190 IWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 56/188 (29%), Positives = 98/188 (52%), Gaps = 28/188 (14%)
Query: 462 EVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
++ VA+K L + TG F+ E ++ H +LV+LLG C+ Q LV +LM +G
Sbjct: 36 KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGC 94
Query: 521 LSAFLFR-------QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN- 572
L ++ Q + W + IA+G++YL E +++H D+ +NVL+ +
Sbjct: 95 LLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSP 145
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631
N++ KI DFGLA+LL+ D+ + + + +MA E + T + DV+S+
Sbjct: 146 NHV--------KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY 197
Query: 632 GVMLLEII 639
GV + E++
Sbjct: 198 GVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 51/185 (27%), Positives = 96/185 (51%), Gaps = 23/185 (12%)
Query: 461 QEVEVAVKQLEKVTGDGEKS----FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
++++VA+K L+ EKS +RE +++ + + +V+++G C E +LV E+
Sbjct: 21 KQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMA 76
Query: 517 KNGTLSAFLF--RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
G L+ FL + EI VE+ ++ G+ YL + +H D+ +NVLL N +
Sbjct: 77 SGGPLNKFLSGKKDEITV-SNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQH 132
Query: 575 ITIDNNYITKIADFGLAKLLKKDQT--RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
KI+DFGL+K L D + + + + + + APE + +++ DV+S+G
Sbjct: 133 YA-------KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 185
Query: 633 VMLLE 637
+ + E
Sbjct: 186 ITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 48/176 (27%), Positives = 91/176 (51%), Gaps = 12/176 (6%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VAVK+++ + EV ++ HH+N+V + + + +V E ++ G L+
Sbjct: 49 QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108
Query: 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583
+ + ++ + L + R L YLH + +IH DIK ++LL T D
Sbjct: 109 IVTHTRMNE-EQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILL-----TSDGR--I 157
Query: 584 KIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
K++DFG + K+ + +++ GT +MAPE + P +VD++S G+M++E+I
Sbjct: 158 KLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 27/197 (13%)
Query: 456 NVFDGQEVE----VAVKQL----EKVTGDG-EKSFLREVQVIGRTHHKNLVQLLG-FCIE 505
V+ ++ E VA+K++ K DG + LRE++++ H N++ LL F +
Sbjct: 15 VVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK 74
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIK 564
N L V+E M+ L + + I ++ L RGL YLH I+H D+K
Sbjct: 75 SNINL-VFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLK 129
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPV- 622
P N+L I ++ + K+ADFGLA+ + T ++ T Y APE L A
Sbjct: 130 PNNLL-------IASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELLFGARHY 180
Query: 623 TAKVDVYSFGVMLLEII 639
VD++S G + E++
Sbjct: 181 GVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 54/174 (31%), Positives = 89/174 (51%), Gaps = 16/174 (9%)
Query: 468 KQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR 527
K+L+K +G EK L E +++ + + +V L + H LV LM G L ++
Sbjct: 29 KRLKKKSG--EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN 86
Query: 528 --QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585
+ ++ + + I G+L+LH I++ D+KP+NVLLD+ N ++
Sbjct: 87 VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQ-----GN--CRL 136
Query: 586 ADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+D GLA LK +T T GT GYMAPE L+ P + VD ++ G + E++
Sbjct: 137 SDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTLSA 523
VA+K ++ GD + +E+ ++ H N+V G + +L +V E G+L
Sbjct: 31 VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG-SYLRRDKLWIVMEYCGGGSLQD 89
Query: 524 FLFRQEIPTWDKRVEIALGIAR----GLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
P ++IA + R GL YLH ET IH DIK N+LL T D
Sbjct: 90 IYQVTRGPL--SELQIAY-VCRETLKGLAYLH---ETGKIHRDIKGANILL-----TEDG 138
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL---RNAPVTAKVDVYSFGVMLL 636
+ K+ADFG++ L + + I GT +MAPE R K D+++ G+ +
Sbjct: 139 D--VKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAI 195
Query: 637 E 637
E
Sbjct: 196 E 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 53/184 (28%), Positives = 97/184 (52%), Gaps = 17/184 (9%)
Query: 465 VAVKQLEKVTGDGEKSFL-REVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTL 521
VAVK L+ +G + L +E++++ +H+N+V+ G C E N L+ E + +G+L
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 522 SAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
+L R + ++++ A+ I +G+ YL Q +H D+ +NVL +++
Sbjct: 96 KEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVL-------VESE 145
Query: 581 YITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ KI DFGL K ++ D+ + + + + APE L + DV+SFGV L E+
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205
Query: 639 I-FC 641
+ +C
Sbjct: 206 LTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 457 VFDGQEVEVAVKQLEKV----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLV 512
V+ Q E V KV + + + ++ E+ ++ H N+V+LL +N+ ++
Sbjct: 21 VYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80
Query: 513 YELMKNGTLSAFLFRQEIPTWDKRVEIALG-IARGLLYLHEECETQIIHCDIKPQNVLLD 571
E G + A + E P + ++ + L YLH E +IIH D+K N+L
Sbjct: 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILF- 136
Query: 572 NNYITIDNNYITKIADFGL-AKLLKKDQTRTSTMIRGTMGYMAPEWL-----RNAPVTAK 625
T+D + K+ADFG+ AK + Q R S + GT +MAPE + ++ P K
Sbjct: 137 ----TLDGD--IKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPYDYK 188
Query: 626 VDVYSFGVMLLEIIFCK-RHTELH---------RVDEPTLA 656
DV+S G+ L+E+ + H EL+ + + PTLA
Sbjct: 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA 229
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 73/265 (27%), Positives = 108/265 (40%), Gaps = 42/265 (15%)
Query: 464 EVAVKQLE-KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
V VK+L T D + FL+EVQ +H N++Q LG CIE LLV E G L
Sbjct: 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83
Query: 523 AFLFRQEI-----PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
+L D +A +A GLL+LH + IH D+ +N L T
Sbjct: 84 NYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQL-----TA 135
Query: 578 DNNYITKIADFGLA-KLLKKDQTRTSTMIRGTMGYMAPEW-------LRNAPVTAKVDVY 629
D + KI D+GLA + +D T + ++APE L T K +++
Sbjct: 136 DLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIW 193
Query: 630 SFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-------TGNLGATKFERI 682
S GV + E+ P L++ +L VR L +R
Sbjct: 194 SLGVTMWEL------FTAADQPYPDLSDEQVLK----QVVREQDIKLPKPQLDLKYSDRW 243
Query: 683 TMVGLWCICPQPTLRPSMKQVLQML 707
V +C P RP+ ++V ++L
Sbjct: 244 YEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 21/190 (11%)
Query: 457 VFDGQ----EVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
VF G+ VAVK E + D + FL+E +++ + H N+V+L+G C ++ +
Sbjct: 11 VFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70
Query: 512 VYELMKNGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVL 569
V EL++ G FL R E P + +++ A G+ YL + IH D+ +N L
Sbjct: 71 VMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCL 126
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTST--MIRGTMGYMAPEWLRNAPVTAKVD 627
+T N + KI+DFG+++ ++D ST M + + + APE L +++ D
Sbjct: 127 -----VTEKN--VLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 628 VYSFGVMLLE 637
V+SFG++L E
Sbjct: 179 VWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLE--KVTGDGEKSFLR--------EVQVIGRTHHKNL 496
+Y + A NV G+ + AVKQ+E S + E++ + H N+
Sbjct: 13 TYGRVYLALNVTTGEMM--AVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI 70
Query: 497 VQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECE 555
VQ LGF + + + E + G++ + R ++ V + GL YLH +
Sbjct: 71 VQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQVLEGLAYLHSK-- 127
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM-IRGTMGYMAP 614
I+H D+K N+L+D + I KI+DFG++K M ++G++ +MAP
Sbjct: 128 -GILHRDLKADNLLVDADGIC-------KISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 615 EWLRNAP--VTAKVDVYSFGVMLLEIIFCKR 643
E + + +AKVD++S G ++LE+ +R
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 12/181 (6%)
Query: 461 QEVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+E+ VA+ L D ++ FL E +G+ H N+V+L G N ++V E M NG
Sbjct: 32 RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG 91
Query: 520 TLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L +FL + E + + + G+A G+ YL E +H + VL ++
Sbjct: 92 ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVL-------VN 141
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
++ + KI+ F + K + T+ + + + APE ++ ++ DV+SFG+++ E+
Sbjct: 142 SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201
Query: 639 I 639
+
Sbjct: 202 M 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 58/181 (32%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 466 AVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A K+LEK GE L E Q++ + + + +V L + E L LV +M G L
Sbjct: 29 ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDL 87
Query: 522 SAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
++ P +++ + A I GL LH E ++ D+KP+N+LLD D
Sbjct: 88 KFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLD------DY 138
Query: 580 NYITKIADFGLA-KLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+I +I+D GLA K+ + + R GT+GYMAPE L N T D + G ++ E+
Sbjct: 139 GHI-RISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEM 194
Query: 639 I 639
I
Sbjct: 195 I 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 70/268 (26%), Positives = 113/268 (42%), Gaps = 39/268 (14%)
Query: 459 DGQEVEVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ------L 510
DG +VAVK L + + + FLRE + H N+++L+G + + +
Sbjct: 24 DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83
Query: 511 LVYELMKNGTLSAFLFRQEIP------TWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
++ MK+G L FL I V + IA G+ YL + IH D+
Sbjct: 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLA 140
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLA-KLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
+N +L+ N +ADFGL+ K+ D R + + ++A E L + T
Sbjct: 141 ARNCMLNENMTVC-------VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT 193
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERIT 683
DV++FGV + EI+ + T V+ + N +I GN + +
Sbjct: 194 THSDVWAFGVTMWEIM-TRGQTPYAGVENSEIYNYLI----------KGNRLKQPPDCLE 242
Query: 684 MV-GLWCIC--PQPTLRPSMKQVLQMLE 708
V L C C P+P RPS + + LE
Sbjct: 243 DVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 45/176 (25%), Positives = 90/176 (51%), Gaps = 12/176 (6%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VAVK+++ + EV ++ H N+V++ + + +V E ++ G L+
Sbjct: 46 QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105
Query: 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583
+ + ++ + L + + L +LH + +IH DIK ++LL T D
Sbjct: 106 IVTHTRM-NEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILL-----TSDGR--V 154
Query: 584 KIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
K++DFG + K+ R +++ GT +MAPE + P +VD++S G+M++E++
Sbjct: 155 KLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 45/182 (24%), Positives = 88/182 (48%), Gaps = 13/182 (7%)
Query: 460 GQEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
+++ VAVK + + + FL+E ++ + H ++V+L+G +N +V EL
Sbjct: 32 NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPL 90
Query: 519 GTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
G L ++L + + + ++ L YL + +H DI +NVL +
Sbjct: 91 GELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVL-------V 140
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+ K+ DFGL++ L+ + ++ + + +MAPE + T+ DV+ FGV + E
Sbjct: 141 SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 200
Query: 638 II 639
I+
Sbjct: 201 IL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 56/180 (31%), Positives = 91/180 (50%), Gaps = 19/180 (10%)
Query: 466 AVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A K+LEK GE L E +++ + + + +V L + E L LV +M G L
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDL 87
Query: 522 SAFLFRQEIPTWDKRVEI--ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
++ P +D++ I A + GL L E +I++ D+KP+N+LLD D
Sbjct: 88 KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLD------DR 138
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+I +I+D GLA + + +T + GT+GYMAPE + N T D + G ++ E+I
Sbjct: 139 GHI-RISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 29/192 (15%)
Query: 464 EVAVKQLEKVTGDGE-----KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY-ELMK 517
E+AVKQ+ E + E+Q++ H+ +VQ G C+ + L ++ E M
Sbjct: 29 ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMP 87
Query: 518 NGTLSAFLFRQEIPTWDKRVEIALG-----IARGLLYLHEECETQIIHCDIKPQNVLLDN 572
G++ + ++ + E I G+ YLH I+H DIK N+L D+
Sbjct: 88 GGSV-----KDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDS 139
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYS 630
N K+ DFG +K L+ + + M + GT +M+PE + K DV+S
Sbjct: 140 A-----GN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWS 192
Query: 631 FGVMLLEIIFCK 642
G ++E++ K
Sbjct: 193 VGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 59/179 (32%), Positives = 77/179 (43%), Gaps = 22/179 (12%)
Query: 493 HKNLVQLLGFCIEQ--NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYL 550
H L QL Q + V E + G L + R + A I GL +L
Sbjct: 55 HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK--LLKKDQTRTSTMIRGT 608
HE II+ D+K NVLLD+ +I KIADFG+ K +L T T GT
Sbjct: 113 HER---GIIYRDLKLDNVLLDSE------GHI-KIADFGMCKEGILGGVTTSTFC---GT 159
Query: 609 MGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY 667
Y+APE L P VD ++ GV+L E++ + DE L IL D V Y
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLA--GQSPFEGDDEDELFQS-ILEDEVRY 215
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 28/199 (14%)
Query: 457 VFDGQEV---EVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQN----- 507
V+ G+ V ++A ++ VTGD E+ +E+ ++ + +HH+N+ G I++N
Sbjct: 22 VYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81
Query: 508 HQL-LVYELMKNGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIK 564
QL LV E G+++ + + T + I I RGL +LH+ ++IH DIK
Sbjct: 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIK 138
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR-----N 619
QNVLL N K+ DFG++ L + R +T I GT +MAPE + +
Sbjct: 139 GQNVLL-------TENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPD 190
Query: 620 APVTAKVDVYSFGVMLLEI 638
A K D++S G+ +E+
Sbjct: 191 ATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 45/175 (25%), Positives = 89/175 (50%), Gaps = 12/175 (6%)
Query: 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524
VAVK+++ + EV ++ H+N+V++ + + +V E ++ G L+
Sbjct: 48 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107
Query: 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584
+ + ++ + L + + L LH + +IH DIK ++LL T D K
Sbjct: 108 VTHTRMNE-EQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILL-----THDGR--VK 156
Query: 585 IADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
++DFG + K+ R +++ GT +MAPE + P +VD++S G+M++E++
Sbjct: 157 LSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 37/98 (37%), Positives = 56/98 (57%), Gaps = 11/98 (11%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
I RGL YLH I+H DIKP N+L +++N + KI DFGLA++ + D+++
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLL-------VNSNCVLKICDFGLARVEEPDESKHM 161
Query: 603 TMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEII 639
T T Y APE L + T+ VD++S G + E++
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 22/190 (11%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
A +V GQEV A+KQ+ ++ + E+ V+ H N+V L + + +V
Sbjct: 38 AIDVATGQEV--AIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLL----YLHEECETQIIHCDIKPQNVL 569
E + G+L+ + T +IA + R L +LH Q+IH DIK N+L
Sbjct: 96 EYLAGGSLTDVV----TETCMDEGQIA-AVCRECLQALEFLHSN---QVIHRDIKSDNIL 147
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY 629
L +D + K+ DFG + +Q++ STM+ GT +MAPE + KVD++
Sbjct: 148 LG-----MDGS--VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 630 SFGVMLLEII 639
S G+M +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 47/189 (24%), Positives = 86/189 (45%), Gaps = 19/189 (10%)
Query: 457 VFDGQEV----EVAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL 510
V+ + VA+K LE+ + E +E+Q + + + + G ++ +
Sbjct: 17 VYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYYGSFLKGSKLW 75
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
++ E G+ L ++ I + GL YLHEE IH DIK N+LL
Sbjct: 76 IIMEYCGGGSCLDLLKPGKLDE-TYIAFILREVLLGLEYLHEE---GKIHRDIKAANILL 131
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYS 630
+ + K+ADFG++ L ++ +T + GT +MAPE ++ + K D++S
Sbjct: 132 -SEEGDV------KLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKADIWS 183
Query: 631 FGVMLLEII 639
G+ +E+
Sbjct: 184 LGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 44/176 (25%), Positives = 90/176 (51%), Gaps = 12/176 (6%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VAVK ++ + EV ++ H+N+V++ + ++ E ++ G L+
Sbjct: 48 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107
Query: 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583
+ + + ++ + + + L YLH + +IH DIK ++LL T+D
Sbjct: 108 IVSQTRL-NEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILL-----TLDGR--V 156
Query: 584 KIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
K++DFG + KD + +++ GT +MAPE + P +VD++S G+M++E++
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 22/190 (11%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
A +V GQEV A+KQ+ ++ + E+ V+ + N+V L + + +V
Sbjct: 38 AIDVATGQEV--AIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIALGIAR----GLLYLHEECETQIIHCDIKPQNVL 569
E + G+L+ + T +IA + R L +LH Q+IH DIK NVL
Sbjct: 96 EYLAGGSLTDVV----TETCMDEAQIA-AVCRECLQALEFLHA---NQVIHRDIKSDNVL 147
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY 629
L +D + K+ DFG + +Q++ STM+ GT +MAPE + KVD++
Sbjct: 148 LG-----MDGS--VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 630 SFGVMLLEII 639
S G+M +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 29/186 (15%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHH-KNLVQLLGFCIEQNHQLLVYELMKNGTL 521
+AVKQ+ + TG+ E K L ++ V+ ++H +V+ G+ I + + ELM T
Sbjct: 43 MAVKQMRR-TGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STC 99
Query: 522 SAFLFR---QEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
L + IP + + ++ + I + L YL E+ +IH D+KP N+LLD
Sbjct: 100 LDKLLKRIQGPIP---EDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLD----- 149
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK----VDVYSFG 632
+ + K+ DFG++ L + +T + G YMAPE + K DV+S G
Sbjct: 150 -ASGNV-KLCDFGISGRLVDSKAKTRS--AGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205
Query: 633 VMLLEI 638
+ L+E+
Sbjct: 206 ISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 28/202 (13%)
Query: 448 YQELREATNVFDGQEVEVAVKQLE---KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
+ E+ AT + DG V VA+K+++ + ++E+ ++ + +H N+++ I
Sbjct: 15 FSEVYRATCLLDG--VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72
Query: 505 EQNHQLLVYELMKNGTLSAFL--FRQE---IP---TWDKRVEIALGIARGLLYLHEECET 556
E N +V EL G LS + F+++ IP W V++ L ++H
Sbjct: 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMHSR--- 125
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEW 616
+++H DIKP NV +IT + K+ D GL + T +++ GT YM+PE
Sbjct: 126 RVMHRDIKPANV-----FITATG--VVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 617 LRNAPVTAKVDVYSFGVMLLEI 638
+ K D++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 23/255 (9%)
Query: 456 NVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515
V GQEV V +K L D +F ++ + HK+LV+L G C+ + +V E
Sbjct: 24 IVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEY 81
Query: 516 MKNGTLSAFLFRQEIPTWDK-RVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
+K G L FL R++ ++++A +A L YL ++ +++H ++ +N+L+
Sbjct: 82 VKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYG 138
Query: 575 ITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN--APVTAKVDVYSFG 632
+ K++D G+ + + R + ++APE +RN A +T D +SFG
Sbjct: 139 LNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWIAPECIRNGQASLTIAADKWSFG 193
Query: 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICP 692
LLEI +EP + + ++ + L + + C
Sbjct: 194 TTLLEICS--------NGEEPL--STLSSSEKERFYQDQHRLPMPDCAELANLINQCWTY 243
Query: 693 QPTLRPSMKQVLQML 707
PT RPS + +L+ L
Sbjct: 244 DPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 19/180 (10%)
Query: 466 AVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525
A K +E + + + ++ E++++ +H +V+LLG ++ E G + A +
Sbjct: 41 AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM 100
Query: 526 FRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584
+ + +++ I + L YLH +IIH D+K NVLL T+D + K
Sbjct: 101 LELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLL-----TLDGD--IK 150
Query: 585 IADFGL-AKLLKKDQTRTSTMIRGTMGYMAPE-----WLRNAPVTAKVDVYSFGVMLLEI 638
+ADFG+ AK +K Q R S + GT +MAPE +++ P K D++S G+ L+E+
Sbjct: 151 LADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 464 EVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
+V VK+L E+ FL E Q H NL+Q LG C E LLV E G L
Sbjct: 24 QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 523 AFLFRQ---EIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
+L E+ T D +A IA GLL+LH+ IH D+ +N LL + +T+
Sbjct: 84 GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTAD-LTV 139
Query: 578 DNNYITKIADFGLAKL-LKKDQTRTSTMIRGTMGYMAPEWLRN-------APVTAKVDVY 629
KI D+GL+ K+D T + + ++APE + T + +V+
Sbjct: 140 ------KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVW 193
Query: 630 SFGVMLLEIIFCKRHTELHRVDEPTLA 656
S GV + E+ H DE L
Sbjct: 194 SLGVTIWELFELGSQPYRHLSDEQVLT 220
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 27/192 (14%)
Query: 463 VEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ------LLVYE 514
++VAVK ++ T + FL E + H N+++L+G C++ +++
Sbjct: 27 LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILP 86
Query: 515 LMKNGTLSAFLFR-------QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
MK+G L +FL Q +PT V+ IA G+ YL + IH D+ +N
Sbjct: 87 FMKHGDLHSFLLYSRLGDCPQYLPT-QMLVKFMTDIASGMEYLSSK---SFIHRDLAARN 142
Query: 568 VLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKV 626
+L+ N +ADFGL+K + D R + + + ++A E L + T K
Sbjct: 143 CMLNENMNVC-------VADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKS 195
Query: 627 DVYSFGVMLLEI 638
DV+SFGV + EI
Sbjct: 196 DVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 26/163 (15%)
Query: 483 REVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTLSAFLFRQEIPTWDKRVEIAL 541
RE++++ +H N+V+ + N ++ ++ E M G+L E D +A
Sbjct: 121 REIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD----VAR 175
Query: 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK--DQT 599
I G+ YLH I+H DIKP N+L I++ KIADFG++++L + D
Sbjct: 176 QILSGIAYLHRR---HIVHRDIKPSNLL-------INSAKNVKIADFGVSRILAQTMDPC 225
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKV-----DVYSFGVMLLE 637
+S GT+ YM+PE + D++S GV +LE
Sbjct: 226 NSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 63/268 (23%), Positives = 109/268 (40%), Gaps = 45/268 (16%)
Query: 460 GQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
G E V VK L+K + +S F RE+ + + HKN+V+LLG C E ++ E
Sbjct: 33 GGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDL 92
Query: 519 GTLSAFLF--RQEIPTWD-------KRVEIALGIARGLLYLHEECETQIIHCDIKPQNVL 569
G L FL + + ++V + IA G+ +L + +H D+ +N L
Sbjct: 93 GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCL 149
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY 629
+ + K++ L+K + + + ++APE ++ + K DV+
Sbjct: 150 -------VSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVW 202
Query: 630 SFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE--------- 680
SFGV++ E+ EL L++ +L L A K E
Sbjct: 203 SFGVLMWEVF---TQGEL---PFYGLSDEEVLNR----------LQAGKLELPVPEGCPS 246
Query: 681 RITMVGLWCICPQPTLRPSMKQVLQMLE 708
R+ + C P RPS +++ L
Sbjct: 247 RLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
VA+K+ + D K +RE++++ + H+NLV L+ + LV+E + + L
Sbjct: 29 VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD 88
Query: 523 AFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
L + + RV L I RG+ + H IIH DIKP+N+L + +
Sbjct: 89 D-LEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENIL-------VSQSG 137
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK-VDVYSFGVMLLEII 639
+ K+ DFG A+ L T T Y APE L + VD+++ G ++ E++
Sbjct: 138 VVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 23/182 (12%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIG-RTHHKNLVQLLGFCIEQ--NHQLLVYELMKNG 519
A+K L+K + D + + E +V+ H L L FC Q H V E + G
Sbjct: 24 AIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL--FCTFQTKEHLFFVMEYLNGG 81
Query: 520 TLSAFLFRQEIPTWD-KRVEI-ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
L + Q +D R A I GL +LH++ II+ D+K NVLLD +
Sbjct: 82 DLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKD---- 132
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+I KIADFG+ K + + ST GT Y+APE L+ VD +SFGV+L E
Sbjct: 133 --GHI-KIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNESVDWWSFGVLLYE 188
Query: 638 II 639
++
Sbjct: 189 ML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 28/191 (14%)
Query: 459 DGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ ++ VA+K+L + T K L E V+ + ++ +LLG C+ QL + +LM
Sbjct: 33 EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMP 91
Query: 518 NGTLSAFLFR-------QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
G L ++ Q + W + IA+G+ YL E +++H D+ +NVL+
Sbjct: 92 FGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEER---RLVHRDLAARNVLV 142
Query: 571 DN-NYITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
++ KI DFGLAKLL D+ + + + +MA E + + T + DV
Sbjct: 143 KTPQHV--------KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 194
Query: 629 YSFGVMLLEII 639
+S+GV + E++
Sbjct: 195 WSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 51/186 (27%), Positives = 92/186 (49%), Gaps = 14/186 (7%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
A ++ GQEV A+KQ+ ++ + E+ V+ + N+V L + + +V
Sbjct: 38 AIDIATGQEV--AIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
E + G+L+ + + + + + L +LH Q+IH DIK N+LL
Sbjct: 96 EYLAGGSLTDVVTETCMDE-GQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLG-- 149
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
+D + K+ DFG + +Q++ STM+ GT +MAPE + KVD++S G+
Sbjct: 150 ---MDGS--VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 634 MLLEII 639
M +E++
Sbjct: 204 MAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-11
Identities = 37/136 (27%), Positives = 56/136 (41%), Gaps = 27/136 (19%)
Query: 37 GTNSTWPSTSGDFAFGFYPLV-SGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTV 95
+ T S+ F GF+ L+ I + S RT+VW ANRD+P+ ++ L
Sbjct: 5 SSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQS 63
Query: 96 TGQLVLTHSNGTQFKIYNGTLTVSALMQDSGNFLYSNANGSVDYSTGRFVLEIQMDGNVV 155
G LV IY+G SG ++S+ V G +VL + DGN+V
Sbjct: 64 DGNLV----------IYDG----------SGTVVWSSNTTRV---NGNYVLVLLDDGNLV 100
Query: 156 LSAFRFADPAYWYTST 171
L + W +
Sbjct: 101 L--YDSDGNFLWQSFD 114
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 463 VEVAVKQLEKVTGDGE-KSFLREVQVIGRTHH-KNLVQLLGFCIEQNHQLLVYELMKNGT 520
+AVK++ + E K L ++ V+ R+ +V+ G + + ELM
Sbjct: 30 TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM---D 86
Query: 521 LSAFLF--------RQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
+S F + IP + + +IA+ + L YL EE +IIH D+KP N+LL
Sbjct: 87 ISLDKFYKYVYEVLKSVIP---EEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILL 141
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL---RNAPVTAKVD 627
D N I K+ DFG++ L + T G YMAPE + + D
Sbjct: 142 D------RNGNI-KLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSARDGYDVRSD 192
Query: 628 VYSFGVMLLEI 638
V+S G+ L E+
Sbjct: 193 VWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 22/165 (13%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL 541
+RE+ ++ H N+V L ++++ L++E + ++ + +P + ++ L
Sbjct: 47 IREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPK-GQYMDAEL 102
Query: 542 ------GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595
I +G+L+ H +++H D+KPQN+L IDN + K+ADFGLA+
Sbjct: 103 VKSYLYQILQGILFCHSR---RVLHRDLKPQNLL-------IDNKGVIKLADFGLARAFG 152
Query: 596 KDQTRTSTMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEII 639
R T T+ Y APE L +P + VD++S G + E+
Sbjct: 153 I-PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 48/179 (26%), Positives = 86/179 (48%), Gaps = 18/179 (10%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
VA+K+ + + E ++ LRE++++ +N+V+L + LV+E ++ L
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 523 AFLFRQEIPTW---DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
+E+P +K + + + + H+ I+H DIKP+N+L I +
Sbjct: 89 LL---EEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLL-------ISH 135
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
N + K+ DFG A+ L + T T Y +PE L AP VD++S G +L E+
Sbjct: 136 NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 7e-11
Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 23/186 (12%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCI-----EQNHQLLVYELMK 517
VA+K++ V D K LRE++++ H+N++ LL + N +V ELM
Sbjct: 28 VAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM- 86
Query: 518 NGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
T + + P D ++ I RGL YLH +IH D+KP N+L++
Sbjct: 87 -ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVN----- 137
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRG--TMGYMAPEWLRNAP-VTAKVDVYSFGV 633
N + KI DFGLA+ + D+ + T Y APE L ++ T +D++S G
Sbjct: 138 -SNCDL-KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195
Query: 634 MLLEII 639
+ E++
Sbjct: 196 IFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 52/187 (27%), Positives = 95/187 (50%), Gaps = 20/187 (10%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKSFLR---EVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515
D ++ VA+K ++ +G ++F + +G H +V+LLG C + QL V +L
Sbjct: 33 DSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQL 89
Query: 516 MKNGTLSAFLFRQEIPTWDKRVEIALG--IARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
G+L + RQ + D + + IA+G+ YL E ++H ++ +N+LL ++
Sbjct: 90 SPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSD 145
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
I +IADFG+A LL D + + + + +MA E + T + DV+S+G
Sbjct: 146 SIV-------QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 633 VMLLEII 639
V + E++
Sbjct: 199 VTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 52/186 (27%), Positives = 92/186 (49%), Gaps = 14/186 (7%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
A +V GQEV A++Q+ ++ + E+ V+ + N+V L + + +V
Sbjct: 39 AMDVATGQEV--AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
E + G+L+ + + + + + L +LH Q+IH DIK N+LL
Sbjct: 97 EYLAGGSLTDVVTETCMDE-GQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLG-- 150
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
+D + K+ DFG + +Q++ STM+ GT +MAPE + KVD++S G+
Sbjct: 151 ---MDGS--VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 634 MLLEII 639
M +E+I
Sbjct: 205 MAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 65/253 (25%), Positives = 115/253 (45%), Gaps = 44/253 (17%)
Query: 465 VAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
VA+K ++ + E + +E+ V+ + + + G ++ ++ E + G SA
Sbjct: 32 VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG--SA 89
Query: 524 FLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
+ P + ++ L I +GL YLH E + IH DIK NVLL +
Sbjct: 90 LDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEV------ 140
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK 642
K+ADFG+A L Q + +T + GT +MAPE ++ + +K D++S G+ +E+ +
Sbjct: 141 -KLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
Query: 643 -RHTELH---------RVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICP 692
H+ELH + + PTL GN E + C+
Sbjct: 199 PPHSELHPMKVLFLIPKNNPPTL---------------EGNYSKPLKEFVEA----CLNK 239
Query: 693 QPTLRPSMKQVLQ 705
+P+ RP+ K++L+
Sbjct: 240 EPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 45/199 (22%)
Query: 470 LEKVTGDGEK-----SFLREVQVIGRTHHKNLVQLLGFCIEQNHQL----------LVYE 514
L+KV D EK + +RE++++ + +H+N+V L ++ L LV+E
Sbjct: 37 LKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE 96
Query: 515 LMKN---GTLSAFLF---RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
M + G L + L I ++ K+ + GL Y H+ +H DIK N+
Sbjct: 97 YMDHDLMGLLESGLVHFSEDHIKSFMKQ------LLEGLNYCHK---KNFLHRDIKCSNI 147
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL----RNAPVTA 624
LL NN I K+ADFGLA+L +++R T T+ Y PE L R P
Sbjct: 148 LL-NNKGQI------KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPA-- 198
Query: 625 KVDVYSFGVMLLEIIFCKR 643
+DV+S G +L E +F K+
Sbjct: 199 -IDVWSCGCILGE-LFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 30/193 (15%)
Query: 459 DGQEVE--VAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515
DG+ V+ VA+K L E + K L E V+ + +LLG C+ QL V +L
Sbjct: 31 DGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQL 89
Query: 516 MKNGTLSAF-------LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
M G L + + Q++ W + IA+G+ YL E +++H D+ +NV
Sbjct: 90 MPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE---VRLVHRDLAARNV 140
Query: 569 LLDN-NYITIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKV 626
L+ + N++ KI DFGLA+LL D+T + + + +MA E + + T +
Sbjct: 141 LVKSPNHV--------KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192
Query: 627 DVYSFGVMLLEII 639
DV+S+GV + E++
Sbjct: 193 DVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 52/171 (30%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 483 REVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL-------SAFLFRQEIPTWDK 535
+EV V+ H N+VQ E + +V + + G L LF E D
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF-PEDQILDW 106
Query: 536 RVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595
V+I L L ++H+ +I+H DIK QN+ L T D K+ DFG+A++L
Sbjct: 107 FVQICLA----LKHVHDR---KILHRDIKSQNIFL-----TKDG--TIKLGDFGIARVLN 152
Query: 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTE 646
T I GT Y++PE N P K D+++ G +L E+ K E
Sbjct: 153 STVELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 55/183 (30%), Positives = 80/183 (43%), Gaps = 20/183 (10%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQV---IGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
A+K L+K + D +S + E ++ H LV L ++H V E G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 520 TLSAFLFRQEIPTWDKRVEI-ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L + R A + GL YLHE +I++ D+K N+LLD
Sbjct: 88 DLMMHIHTDVFSE--PRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTE----- 137
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
++ KIADFGL K RTST GT ++APE L T VD + GV++ E+
Sbjct: 138 -GFV-KIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
Query: 639 IFC 641
+
Sbjct: 195 LVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 15/102 (14%)
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK--LLKKD 597
A IA GL +LH + II+ D+K NV+LD +I KIADFG+ K +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAE------GHI-KIADFGMCKENIFGGK 156
Query: 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
TRT GT Y+APE + P VD ++FGV+L E++
Sbjct: 157 TTRTFC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR-QEIPTWDKRVEIA 540
+RE++V+ + +V G + E M G+L L + IP + +I+
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-NILGKIS 105
Query: 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600
+ + RGL YL E+ +I+H D+KP N+L +++ K+ DFG++ L D
Sbjct: 106 IAVLRGLTYLREK--HKIMHRDVKPSNIL-------VNSRGEIKLCDFGVSGQLI-DSMA 155
Query: 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
S + GT YM+PE L+ T + D++S G+ L+E+
Sbjct: 156 NSFV--GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 40/211 (18%)
Query: 448 YQELRE-----------ATNVFDGQEVEVAVKQLE---KVTGDGEKSFLREVQVIGRTHH 493
+ +LRE A +V + V A+K++ K + + + ++EV+ + + H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVV--AIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 494 KNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA---LGIARGLLYL 550
N ++ G + ++ LV E G+ S L + P + VEIA G +GL YL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPL--QEVEIAAICHGALQGLAYL 131
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H IH DIK N+LL K+ADFG A L+ + GT
Sbjct: 132 HSHER---IHRDIKAGNILL-------TEPGTVKLADFGSASLVSPANS-----FVGTPY 176
Query: 611 YMAPE---WLRNAPVTAKVDVYSFGVMLLEI 638
+MAPE + KVDV+S G+ +E+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 17/182 (9%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A+K L+K + D L E +V+ T H L L + + + +L V E G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL 82
Query: 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
L R+ + + D+ I L YLH +++ D+K +N++LD + +
Sbjct: 83 FFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKD------GH 133
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
I KI DFGL K D T GT Y+APE L + VD + GV++ E++ C
Sbjct: 134 I-KITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-C 190
Query: 642 KR 643
R
Sbjct: 191 GR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 479 KSFLREVQVIGRTHHKNLVQLLG-FCIEQNHQLLVY---ELMKNGTLSAFLFRQEIPTWD 534
K LRE++++ H N++ + VY +LM++ L + + P +
Sbjct: 49 KRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ-PLTE 106
Query: 535 KRVEIALG-IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593
+ + L + RGL Y+H +IH D+KP N+L ++ + +I DFG+A+
Sbjct: 107 EHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLL-------VNEDCELRIGDFGMARG 156
Query: 594 L---KKDQTRTSTMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEII 639
L + T T Y APE L + P T +D++S G + E++
Sbjct: 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 54/184 (29%), Positives = 80/184 (43%), Gaps = 18/184 (9%)
Query: 466 AVKQLEK-VTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTLS 522
A+K ++K V E SF E + I + + L + + L LV E G L
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
+ L R E + + L A +L +H + +H DIKP+NVL ID
Sbjct: 90 SLLNRYEDQFDEDMAQFYL--AELVLAIHSVHQMGYVHRDIKPENVL-------IDRTGH 140
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR------NAPVTAKVDVYSFGVMLL 636
K+ADFG A L ++ S + GT Y+APE L + D +S GV+
Sbjct: 141 IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200
Query: 637 EIIF 640
E+I+
Sbjct: 201 EMIY 204
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599
A IA L YLH II+ D+KP+N+LLD ++ + DFGL K +
Sbjct: 102 AAEIASALGYLHS---LNIIYRDLKPENILLD------SQGHVV-LTDFGLCKEGIEHSK 151
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF------CKRHTELH 648
TST GT Y+APE LR P VD + G +L E+++ + E++
Sbjct: 152 TTSTFC-GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 36/166 (21%)
Query: 492 HHKNLVQLLGFCIEQNHQLLV-YELMKNGTLSAFL---------FRQEIPTWDKRVEIAL 541
H+N++ +L CIE V Y M G L FL Q + T V +A+
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ-LVHMAI 124
Query: 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK--------L 593
IA G+ YLH+ +IH DI +N + ID KI D L++
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCV-------IDEELQVKITDNALSRDLFPMDYHC 174
Query: 594 LKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
L ++ R + +MA E L N ++ DV+SFGV+L E++
Sbjct: 175 LGDNENRP-------VKWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR-QEIPTWDKRVEIA 540
+RE+QV+ + +V G + E M G+L L + IP + +++
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVS 109
Query: 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600
+ + RGL YL E+ QI+H D+KP N+L +++ K+ DFG++ L
Sbjct: 110 IAVLRGLAYLREK--HQIMHRDVKPSNIL-------VNSRGEIKLCDFGVSGQLIDSMAN 160
Query: 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ GT YM+PE L+ + + D++S G+ L+E+
Sbjct: 161 SFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 52/200 (26%)
Query: 464 EVAVKQLEKVTGD--GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ------LLVYEL 515
+VA+K++ + K LRE++++ H+N++ + + H+ +VYEL
Sbjct: 32 KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYEL 90
Query: 516 M---------KNGTLSA-----FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHC 561
M + TLS FL++ + RGL Y+H ++H
Sbjct: 91 MDTDLHQIIRSSQTLSDDHCQYFLYQ---------------LLRGLKYIHS---ANVLHR 132
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKL-LKKDQTRTSTMIRGTMGYMAPEWLRN- 619
D+KP N+LL+ N D KI DFGLA+ +K T ++ T Y APE L N
Sbjct: 133 DLKPSNLLLNAN---CD----LKICDFGLARTTSEKGDFMTEYVV--TRWYRAPELLLNC 183
Query: 620 APVTAKVDVYSFGVMLLEII 639
+ T +DV+S G + E++
Sbjct: 184 SEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 56/193 (29%), Positives = 81/193 (41%), Gaps = 35/193 (18%)
Query: 527 RQEIPTWDKRV------EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
RQEI + K E L + LL +H +IH DIK N+LL +N +
Sbjct: 127 RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV---- 182
Query: 581 YITKIADFGLAKL----LKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
K+ DFG +K+ + D RT GT Y+APE R P + K D++S GV+L
Sbjct: 183 ---KLGDFGFSKMYAATVSDDVGRTFC---GTPYYVAPEIWRRKPYSKKADMFSLGVLLY 236
Query: 637 EIIFCKR---HTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQ 693
E++ KR + V TLA R L + + + +
Sbjct: 237 ELLTLKRPFDGENMEEVMHKTLAG------------RYDPLPPSISPEMQEIVTALLSSD 284
Query: 694 PTLRPSMKQVLQM 706
P RPS ++L M
Sbjct: 285 PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 32/97 (32%), Positives = 45/97 (46%), Gaps = 19/97 (19%)
Query: 546 GLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK--LLKKDQTRTST 603
G+ LH+ IIH DIKP+N+L ID K+ DFGL++ L K
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLL-------IDQTGHLKLTDFGLSRNGLENKK------ 152
Query: 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
GT Y+APE + D +S G ++ E +F
Sbjct: 153 -FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 43/222 (19%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSF------------LREVQVIGRTHHK 494
+Y ++ +A + G+ V + ++ +++ D K LRE++++ H+
Sbjct: 21 TYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE 80
Query: 495 NLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEE 553
N++ L+ +E + LV ++M L + ++I + +V+ I L I GL LH
Sbjct: 81 NIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGLNVLH-- 136
Query: 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA---------------KLLKKDQ 598
+ +H D+ P N+ I++ I KIADFGLA + +++ +
Sbjct: 137 -KWYFMHRDLSPANIF-------INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 599 TRTSTMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEII 639
TS ++ T+ Y APE L A VD++S G + E++
Sbjct: 189 EMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 28/199 (14%)
Query: 457 VFDGQEV---EVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE-----QN 507
V+ G+ V ++A ++ VT D E+ E+ ++ + +HH+N+ G I+ +
Sbjct: 32 VYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91
Query: 508 HQL-LVYELMKNGTLSAFLFRQEIPTW--DKRVEIALGIARGLLYLHEECETQIIHCDIK 564
QL LV E G+++ + + D I I RGL +LH ++IH DIK
Sbjct: 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIK 148
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR-----N 619
QNVLL N K+ DFG++ L + R +T I GT +MAPE + +
Sbjct: 149 GQNVLL-------TENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPD 200
Query: 620 APVTAKVDVYSFGVMLLEI 638
A + D++S G+ +E+
Sbjct: 201 ATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+Y + +A N G+ V + +L+ T + +RE+ ++ +H N+V+LL +
Sbjct: 12 TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71
Query: 507 NHQLLVYELMKNGTLSAFL---FRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCD 562
N LV+E + + L F+ IP ++ L + +GL + H +++H D
Sbjct: 72 NKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCHSH---RVLHRD 125
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV 622
+KPQN+L I+ K+ADFGLA+ RT T T+ Y APE L
Sbjct: 126 LKPQNLL-------INTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 623 -TAKVDVYSFGVMLLEII 639
+ VD++S G + E++
Sbjct: 178 YSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 46/168 (27%), Positives = 70/168 (41%), Gaps = 48/168 (28%)
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEI--PTWDK--RVEIALGIARGLLYLHEECETQIIHC 561
+ H LV E M G L L R+++ + E+ L + +H+ IH
Sbjct: 73 EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD----SVHK---LGFIHR 125
Query: 562 DIKPQNVLLD-NNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR-------------- 606
DIKP N+L+D + +I K+ADFGL K + K + R +
Sbjct: 126 DIKPDNILIDADGHI--------KLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 607 --------------GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
GT Y+APE LR P + D +S GV+L E+++
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 38/207 (18%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEK-SFLREVQVIGR-THHKNLVQLLGFCI 504
++ E+ +A + G+ A+K ++K E+ + LRE+Q + R + H N+++L+
Sbjct: 11 TFSEVLKAQSRKTGKYY--AIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLF 68
Query: 505 EQNHQLL----------VYELMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEE 553
++ L +YEL+K ++ +P +KRV+ + + + L ++H
Sbjct: 69 DRKTGRLALVFELMDMNLYELIKGR-------KRPLP--EKRVKSYMYQLLKSLDHMHRN 119
Query: 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMA 613
I H DIKP+N+L+ ++ I K+ADFG + + T + T Y A
Sbjct: 120 ---GIFHRDIKPENILIKDD--------ILKLADFGSCRGIYSKPPYTEYI--STRWYRA 166
Query: 614 PE-WLRNAPVTAKVDVYSFGVMLLEII 639
PE L + K+D+++ G + EI+
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 19/107 (17%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597
+IA+ I + L YLH + +IH D+KP NVL I+ N K+ DFG++ L
Sbjct: 107 KIAVSIVKALEYLHSK--LSVIHRDVKPSNVL-------INRNGQVKLCDFGISGYLVDS 157
Query: 598 QTRTSTMIRGTMGYMAPEWLRNAPVT------AKVDVYSFGVMLLEI 638
+ T+ G YMAPE R P K DV+S G+ ++E+
Sbjct: 158 VAK--TIDAGCKPYMAPE--RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 457 VFDGQEVE----VAVKQLEKVTGDGEKSFL-REVQVIGRTHH---KNLVQLLGFCIEQNH 508
V+ G+ V VA+K + T D + S + REV ++ + N+ + G ++
Sbjct: 17 VYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76
Query: 509 QLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLL----YLHEECETQIIHCDIK 564
++ E + G++ + I I++ I R +L Y+H+ +IH DIK
Sbjct: 77 LWIIMEYAEGGSVRTLMKAGPI----AEKYISV-IIREVLVALKYIHK---VGVIHRDIK 128
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-T 623
N+L +T N K+ DFG+A LL ++ ++ ST + GT +MAPE +
Sbjct: 129 AANIL-----VTNTGN--VKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 624 AKVDVYSFGVMLLEII 639
K D++S G+ + E+
Sbjct: 181 TKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 70/277 (25%), Positives = 107/277 (38%), Gaps = 79/277 (28%)
Query: 465 VAVKQL-EKVTGDGEKSFLREVQV-IGRTHHKNLVQLLGFCIEQNHQLLV-YELMKNGTL 521
VAVK L E T K+ + E+++ I +H N+V LLG C + N L+V E K G L
Sbjct: 40 VAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99
Query: 522 SAFL---------FRQEIPTWDKRVEIAL-----------GIARGLLYLHEECETQIIHC 561
S FL +R++ P R + G A L + + +
Sbjct: 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159
Query: 562 DIKPQNV---------------------------------LLDNNYITIDNNYITKIADF 588
+ ++ L N + +NN + KI DF
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDF 218
Query: 589 GLAKLLKKDQ--TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII------- 639
GLA+ + KD R + R + +MAPE + + T + DV+SFGV+L EI
Sbjct: 219 GLARDIYKDPDYVRKGSA-RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
Query: 640 --------FCKRHTELHRVDEPTLAN----GMILTDW 664
FC+R + R+ P A ++L W
Sbjct: 278 PGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACW 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 28/177 (15%)
Query: 480 SFLREVQVIGRTH---HKNLVQLLGFCI-----EQNHQLLVYELMKNGTLSAFLFRQEIP 531
S +REV ++ R H N+V+L+ C + LV+E + + L +L + P
Sbjct: 45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPP 103
Query: 532 TW--DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589
+ ++ RGL +LH C I+H D+KP+N+L + + K+ADFG
Sbjct: 104 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL-------VTSGGQVKLADFG 153
Query: 590 LAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI-----IFC 641
LA++ T ++ T+ Y APE L + VD++S G + E+ +FC
Sbjct: 154 LARIYSCQMALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 45/214 (21%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA--DFGLAKLLKKDQTR 600
A L L + +I+ D+KP+N+LLD Y IA DFGL KL KD +
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLD---------YQGHIALCDFGLCKLNMKDDDK 149
Query: 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII------FCKRHTELHR--VDE 652
T+T GT Y+APE L T VD ++ GV+L E++ + + E++R + E
Sbjct: 150 TNTFC-GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
Query: 653 P------------TLANGMILTDWVLYCVRTGNLGATK------FERITMVGLWCICPQP 694
P L G++ D R G GA + F +++ L QP
Sbjct: 209 PLRFPDGFDRDAKDLLIGLLSRDPTR---RLGYNGAQEIKNHPFFSQLSWKKLLMKGIQP 265
Query: 695 TLRPSMKQVLQML----EGTSEVGVPPVVADAQM 724
+P++ + E T E + VV D+ +
Sbjct: 266 PFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSHL 299
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 40/173 (23%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
I +GL YLH E + IH DIK NVLL K+ADFG+A L Q + +
Sbjct: 110 ILKGLDYLHSE---KKIHRDIKAANVLLSEQGDV-------KLADFGVAGQLTDTQIKRN 159
Query: 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILT 662
T + GT +MAPE ++ + +K D++S G+ + EL + + P N +
Sbjct: 160 TFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAI---------ELAKGEPP---NSDMHP 206
Query: 663 DWVLYCVRTGNLGATKFERITMVGLW----------CICPQPTLRPSMKQVLQ 705
VL+ + K T+ G + C+ P+ RP+ K++L+
Sbjct: 207 MRVLFLI-------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-09
Identities = 36/109 (33%), Positives = 48/109 (44%), Gaps = 12/109 (11%)
Query: 72 ERTLVWSANRDDPAQVGSS-INLTVTGQLVLTHSNGTQF---KIYNGTLTVSALMQDSGN 127
+T+VW ANR +P S + L G LVL NG A++QD GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 128 F-LYSNANG----SVDYSTGRFVLEIQMDGNVVLSAFRFADPAYWYTST 171
LY N+ S D+ T +L Q DGNVV+ R W ++T
Sbjct: 61 LVLYDNSGKVLWQSFDHPT-DTLLPGQKDGNVVIGGSRR--LTSWKSNT 106
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 26/199 (13%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDG--EKSFLREVQVIGRTH---HKNLVQLLGFCI---E 505
A N +E VA+K++ V K LRE++++ H HKN+ L I
Sbjct: 19 ARNAETSEEETVAIKKITNVFSKKILAKRALRELKLL--RHFRGHKNITCLYDMDIVFPG 76
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIK 564
++L +YE + L + R P D + + I GL Y+H ++H D+K
Sbjct: 77 NFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLK 132
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRG---TMGYMAPE-WLRNA 620
P N+L ++ + KI DFGLA+ ++ + + T Y APE L
Sbjct: 133 PGNLL-------VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185
Query: 621 PVTAKVDVYSFGVMLLEII 639
T +DV+S G +L E++
Sbjct: 186 SYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 31/194 (15%)
Query: 465 VAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
VA+K L+ + + F +E ++ HH N+V LLG ++ +++E + G L
Sbjct: 37 VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHE 96
Query: 524 FLFRQEIPTWD------------------KRVEIALGIARGLLYLHEECETQIIHCDIKP 565
FL + P D + IA+ IA G+ YL +H D+
Sbjct: 97 FLIMRS-PHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAA 152
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTA 624
+N+L I KI+D GL++ + D R + +M PE + ++
Sbjct: 153 RNIL-------IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205
Query: 625 KVDVYSFGVMLLEI 638
D++SFGV+L EI
Sbjct: 206 DSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 13/99 (13%)
Query: 546 GLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605
G+ Y+H+ +I+H D+K +N+ L NN + KI DFG+++LL +T
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNN--------LLKIGDFGVSRLLM-GSCDLATTF 165
Query: 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRH 644
GT YM+PE L++ +K D++S G +L E+ C H
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC-CLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 37/173 (21%)
Query: 478 EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRV 537
E S L+E+ +H N+V+LL +N LV+E + + L ++ D
Sbjct: 48 EISLLKEL------NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM--------DSSP 92
Query: 538 EIALG----------IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587
L + +G+ Y H +++H D+KPQN+L ID K+AD
Sbjct: 93 LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLL-------IDREGALKLAD 142
Query: 588 FGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEII 639
FGLA+ RT T T+ Y APE L + + VD++S G + E++
Sbjct: 143 FGLARAFGV-PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 43/182 (23%), Positives = 87/182 (47%), Gaps = 10/182 (5%)
Query: 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
+E++V +K L+ D +F ++ + HK++V L G C+ ++V E ++ G
Sbjct: 31 KEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 521 LSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
L F+ R+ T + ++A +A L YL ++ ++H ++ +N+LL I +
Sbjct: 91 LDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEI 638
K++D G+ + Q + ++APE + ++ + D +SFG L EI
Sbjct: 148 GPFIKLSDPGIPITVLSRQECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 639 IF 640
+
Sbjct: 203 CY 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA- 540
+RE+ ++ H N+V+L + LV+E + L P + K +
Sbjct: 49 IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIK 105
Query: 541 ---LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597
I RG+ Y H +++H D+KPQN+L+D K+ADFGLA+
Sbjct: 106 TYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDR------RTNALKLADFGLARAFGI- 155
Query: 598 QTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEII 639
RT T T+ Y APE L + + VD++S G + E++
Sbjct: 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 46/182 (25%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQ-----LLVYELM--------KNGTLSA----- 523
LRE++++ R H+N++ +L + + +V ELM K LS
Sbjct: 51 LREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY 110
Query: 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583
FL++ I RGL Y+H ++H D+KP N+LL+ N D
Sbjct: 111 FLYQ---------------ILRGLKYIHS---ANVLHRDLKPSNLLLNTN---CD----L 145
Query: 584 KIADFGLAKL--LKKDQTRTSTMIRGTMGYMAPE-WLRNAPVTAKVDVYSFGVMLLEIIF 640
KI DFGLA++ + D T T T Y APE L + T +D++S G +L E++
Sbjct: 146 KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
Query: 641 CK 642
+
Sbjct: 206 NR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 50/175 (28%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524
+ +KQ + V EK L+EV H +++L +Q ++ E + G L ++
Sbjct: 40 IRLKQEQHV--HNEKRVLKEVS------HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSY 91
Query: 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584
L + + A I L YLH + +I++ D+KP+N+LLD +I K
Sbjct: 92 LRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKE------GHI-K 141
Query: 585 IADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+ DFG AK L+ RT T+ GT Y+APE +++ VD ++ G+++ E++
Sbjct: 142 LTDFGFAKKLRD---RTWTLC-GTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 465 VAVKQLEKVTGDGEKSF---LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
VA+K+ EK +K E +++ +H V L G ++++ LV E + G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
FL R + D A I YL I++ D+KP+N+LLD + +
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKD------GF 169
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
I K+ DFG AK++ TRT T+ GT Y+APE L N D ++ G+ + EI+
Sbjct: 170 I-KMTDFGFAKVV---DTRTYTLC-GTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 42/131 (32%), Positives = 62/131 (47%), Gaps = 28/131 (21%)
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK--D 597
+ +ARG+ +L + IH D+ +N+LL N + KI DFGLA+ + K D
Sbjct: 179 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVV-------KICDFGLARDIYKDPD 228
Query: 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII---------------FCK 642
R R + +MAPE + + T + DV+SFGV+L EI FC+
Sbjct: 229 YVRKGDA-RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287
Query: 643 RHTELHRVDEP 653
R E R+ P
Sbjct: 288 RLKEGTRMRAP 298
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
S+ E+ + + + V + + LE+ + E +E+ V+ + + + G ++
Sbjct: 16 SFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYGSYLKG 74
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKP 565
++ E + G SA + P + + L I +GL YLH E + IH DIK
Sbjct: 75 TKLWIIMEYLGGG--SALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKA 129
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
NVLL K+ADFG+A L Q + +T + GT +MAPE ++ + K
Sbjct: 130 ANVLLSEQGDV-------KLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 626 VDVYSFGVMLLEI 638
D++S G+ +E+
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 481 FLREVQVIGRTHHKNLVQLLGFCIEQNHQL----LVYELMKNGTLSAFLFRQEIPTWDKR 536
E++ + R N++++ GF I+ L L+ E G L L +++ ++ +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTK 124
Query: 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596
+++A+ +GL L++ KP L +++ + NY KI GL K+L
Sbjct: 125 LDMAIDCCKGLYNLYKY--------TNKPYKNLTSVSFL-VTENYKLKIICHGLEKILSS 175
Query: 597 DQTRTSTMIRGTMGYMAPEWLRN--APVTAKVDVYSFGVMLLEII 639
+ M Y + + L + + T K D+YS GV+L EI
Sbjct: 176 PPFKNVNF----MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 40/100 (40%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599
A IA GL +LH + II+ D+K NV+LD+ +I KIADFG+ K D
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSE------GHI-KIADFGMCKENMWDGV 156
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
T T GT Y+APE + P VD ++FGV+L E++
Sbjct: 157 TTKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599
A +A + YLH II+ D+KP+N+LLD+ + + DFGL K + +
Sbjct: 102 AAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVV-------LTDFGLCKEGVEPEE 151
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
TST GT Y+APE LR P VD + G +L E+++
Sbjct: 152 TTSTFC-GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 46/195 (23%)
Query: 465 VAVKQL--EKVTGDGEKSF----LREVQVIGRTHHKNLVQL----LGFCIEQNHQLLVYE 514
VA+K+L EK +G F LRE+ ++ + H N+V + +G + +V E
Sbjct: 33 VALKKLKMEKE-KEG---FPITSLREINILLKLQHPNIVTVKEVVVG--SNLDKIYMVME 86
Query: 515 --------LMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
LM+ F Q E+ + L + G+ +LH+ I+H D+K
Sbjct: 87 YVEHDLKSLMETMKQP---FLQSEVKC------LMLQLLSGVAHLHDN---WILHRDLKT 134
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TA 624
N+LL +N I KI DFGLA+ + T + T+ Y APE L A +
Sbjct: 135 SNLLL-------NNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 625 KVDVYSFGVMLLEII 639
+D++S G + E++
Sbjct: 187 AIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 50/194 (25%), Positives = 101/194 (52%), Gaps = 19/194 (9%)
Query: 452 REATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
RE + + + EV +K L+K + +SF ++ + HK+LV G C+ + ++
Sbjct: 17 REVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76
Query: 512 VYELMKNGTLSAFLFRQE--IP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
V E +K G+L +L + + I +W ++E+A +A L +L ++ + H ++ +NV
Sbjct: 77 VQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNVCAKNV 131
Query: 569 LL--DNNYITIDNNYITKIADFGLA-KLLKKDQTRTSTMIRGTMGYMAPEWLRNAP-VTA 624
LL + + T + +I K++D G++ +L K+ ++ + ++ PE + N ++
Sbjct: 132 LLIREEDRKTGNPPFI-KLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSL 184
Query: 625 KVDVYSFGVMLLEI 638
D +SFG L EI
Sbjct: 185 AADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 23/169 (13%)
Query: 480 SFLREVQVIGRTH---HKNLVQLLGFCI-----EQNHQLLVYELMKNGTLSAFLFRQEIP 531
S +REV V+ H N+V+L C + LV+E + + L+ +L + P
Sbjct: 47 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEP 105
Query: 532 TWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589
++ + RGL +LH +++H D+KPQN+L + ++ K+ADFG
Sbjct: 106 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNIL-------VTSSGQIKLADFG 155
Query: 590 LAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
LA++ TS ++ T+ Y APE L + VD++S G + E+
Sbjct: 156 LARIYSFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 32/194 (16%)
Query: 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-------------- 510
VAVK++ K LRE+++I R H N+V++ L
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
+V E M+ L+ L + + R+ + RGL Y+H ++H D+KP NV +
Sbjct: 93 IVQEYMET-DLANVLEQGPLSEEHARL-FMYQLLRGLKYIH---SANVLHRDLKPANVFI 147
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRG--TMGYMAPEWL---RNAPVTAK 625
+ + + KI DFGLA+++ + + G T Y +P L N T
Sbjct: 148 NT------EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN--YTKA 199
Query: 626 VDVYSFGVMLLEII 639
+D+++ G + E++
Sbjct: 200 IDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598
I + +GL +L EE IIH D+KP NVL ++ N K+ DFG++ L
Sbjct: 107 ITYAVVKGLKFLKEE--HNIIHRDVKPTNVL-------VNGNGQVKLCDFGVSGNLVASL 157
Query: 599 TRTSTMIRGTMGYMAPEWLR------NAPVTAKVDVYSFGVMLLEI 638
+T+ G YMAPE ++ N T + DV+S G+ +LE+
Sbjct: 158 AKTNI---GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 27/183 (14%)
Query: 465 VAVKQLE---KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
VAVK++ K T + + ++EV+ + + H N ++ G ++++ LV E G+
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSA 107
Query: 522 SAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
S L + P + VEIA G +GL YLH +IH DIK N+LL
Sbjct: 108 SDLLEVHKKPL--QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILL-------T 155
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE---WLRNAPVTAKVDVYSFGVML 635
K+ADFG A + + GT +MAPE + KVDV+S G+
Sbjct: 156 EPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 210
Query: 636 LEI 638
+E+
Sbjct: 211 IEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 53/183 (28%), Positives = 83/183 (45%), Gaps = 28/183 (15%)
Query: 465 VAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
VA+K++ K T K RE++++ H+N++ L I + V EL+ GT
Sbjct: 38 VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTD 95
Query: 522 SAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
L P + ++ I RGL Y+H ++H D+KP N+L I+ N
Sbjct: 96 LHRLLTSR-PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNIL-------INEN 144
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE----WLRNAPVTAKVDVYSFGVMLL 636
KI DFGLA++ Q T T Y APE W + +VD++S G +
Sbjct: 145 CDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQK---YDVEVDIWSAGCIFA 197
Query: 637 EII 639
E++
Sbjct: 198 EML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 492 HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLH 551
+ N ++L +L+ + +K+G L L ++ + + +I + L LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGY 611
+ IIH DIK +NVL D I + D+GL K++ T + GT+ Y
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRI------YLCDYGLCKIIG-----TPSCYDGTLDY 172
Query: 612 MAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+PE ++ D ++ GV+ E++
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELL 200
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 45/208 (21%)
Query: 465 VAVKQLEKVTGDGE---KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM---KN 518
VA+K++ + + K FLRE ++ H +V + C + + VY M +
Sbjct: 30 VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTMPYIEG 86
Query: 519 GTLSAFL---FRQEIPTWDKRVEIALGIARGLLYLHEECET-------QIIHCDIKPQNV 568
TL + L +++E + K + + L H+ C T ++H D+KP N+
Sbjct: 87 YTLKSLLKSVWQKESLS--KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNI 144
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQ------------TRTSTM-----IRGTMGY 611
LL + I D+G A K ++ S+M I GT Y
Sbjct: 145 LLGLFGEVV-------ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDY 197
Query: 612 MAPEWLRNAPVTAKVDVYSFGVMLLEII 639
MAPE L P + D+Y+ GV+L +++
Sbjct: 198 MAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 15/184 (8%)
Query: 461 QEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELM 516
+E AVK L+K + EK + E V+ + + L F + +L V + +
Sbjct: 19 EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G L L R+ + A IA L YLH I++ D+KP+N+LLD+
Sbjct: 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHI 135
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
+ + DFGL K + TST GT Y+APE L P VD + G +L
Sbjct: 136 V-------LTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYDRTVDWWCLGAVLY 187
Query: 637 EIIF 640
E+++
Sbjct: 188 EMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 43/186 (23%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
+G+E+ V +K L+ D +F ++ + H +L + G C+ + ++V E +++
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 519 GTLSAFLFRQE--IPT-WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
G L L +++ +P W ++ +A +A L YL ++ ++H ++ +N+LL +
Sbjct: 101 GPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVM 634
+ K++D G++ + R + ++APE + ++ D +SFG
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGTT 210
Query: 635 LLEIIF 640
LLEI F
Sbjct: 211 LLEICF 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 52/152 (34%), Positives = 74/152 (48%), Gaps = 17/152 (11%)
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWD--KRVEIALGIARGLLYLHEECETQIIHCDI 563
+ H V E + G L + Q+ +D + A I GL +LH + II+ D+
Sbjct: 68 KEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDL 122
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
K NV+LD + +I KIADFG+ K R ST GT Y+APE L+ T
Sbjct: 123 KLDNVMLDRD------GHI-KIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYT 174
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL 655
VD +SFGV+L E++ + + H DE L
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ--SPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 26/127 (20%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
+A+G+ +L + IH D+ +N+LL +NN + KI DFGLA+ + KD
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLS------ENN-VVKICDFGLARDIYKDPDYVR 237
Query: 603 TM-IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII---------------FCKRHTE 646
R + +MAPE + + T + DV+SFGV+L EI FC+R E
Sbjct: 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297
Query: 647 LHRVDEP 653
R+ P
Sbjct: 298 GTRMRAP 304
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 484 EVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTLSAFLFRQEIPTWDKRVEIALG 542
E QV+ + L + + + +L L+ + + G L L ++E ++ V+I G
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-EQEVQIYSG 112
Query: 543 -IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601
I L +LH+ II+ DIK +N+LLD+N + + DFGL+K +D+
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVV-------LTDFGLSKEFHEDEVER 162
Query: 602 STMIRGTMGYMAPEWLRNAPV--TAKVDVYSFGVMLLEII 639
+ GT+ YMAP+ +R VD +S GV++ E++
Sbjct: 163 AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 48/184 (26%)
Query: 478 EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ--LLVYELM--------KNGTLSAFLFR 527
E FL+E+ H N+V+LL +N + LV+E M + L
Sbjct: 56 EIMFLQEL-----GDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL------ 104
Query: 528 QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587
+++ KR I + + L Y+H +IH D+KP N+LL+++ + K+AD
Sbjct: 105 EDV---HKRY-IMYQLLKALKYIHS---GNVIHRDLKPSNILLNSD-CRV------KLAD 150
Query: 588 FGLAKLLKKDQTRTSTMIRGTMG-YMAPEWLRNAP--------VTAKVDVYSFGVMLLEI 638
FGLA+ L + Y+A W R AP T VD++S G +L E+
Sbjct: 151 FGLARSL---SELEENPENPVLTDYVATRWYR-APEILLGSTRYTKGVDMWSVGCILGEM 206
Query: 639 IFCK 642
+ K
Sbjct: 207 LLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 11/97 (11%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
+A L +LH II+ D+KP+N+LLD + +I K+ DFGL+K + +
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLD------EEGHI-KLTDFGLSKESIDHEKKAY 156
Query: 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+ GT+ YMAPE + T D +SFGV++ E++
Sbjct: 157 SFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 14/91 (15%)
Query: 549 YLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGT 608
YLH + II+ D+KP+N+LLDN + K+ DFG A KK RT T+ GT
Sbjct: 133 YLHSK---DIIYRDLKPENLLLDN-----KGH--VKVTDFGFA---KKVPDRTFTLC-GT 178
Query: 609 MGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
Y+APE +++ VD ++ GV+L E I
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599
A I GL +LH + I++ D+K N+LLD + +I KIADFG+ K
Sbjct: 102 AAEIICGLQFLHSK---GIVYRDLKLDNILLDTD------GHI-KIADFGMCKENMLGDA 151
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL 655
+T T GT Y+APE L VD +SFGV+L E++ + + H DE L
Sbjct: 152 KTCTFC-GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ--SPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 39/194 (20%)
Query: 462 EVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLG-FC----IEQNHQL-LVY 513
+VA+K+L + K RE++++ H+N++ LL F +E + LV
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
LM L+ + + + + D + I RGL Y+H IIH D+KP N
Sbjct: 100 HLM-GADLNNIV-KCQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSN------ 148
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP--------VTAK 625
I ++ + KI DFGLA+ + T GY+A W R AP
Sbjct: 149 -IAVNEDCELKILDFGLARHTDDEMT----------GYVATRWYR-APEIMLNWMHYNQT 196
Query: 626 VDVYSFGVMLLEII 639
VD++S G ++ E++
Sbjct: 197 VDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 42/160 (26%), Positives = 80/160 (50%), Gaps = 18/160 (11%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRV--E 538
+RE+QV+ + +V G + E M G+L L + IP +++ +
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGK 107
Query: 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598
+++ + +GL YL E+ +I+H D+KP N+L +++ K+ DFG++ L
Sbjct: 108 VSIAVIKGLTYLREK--HKIMHRDVKPSNIL-------VNSRGEIKLCDFGVSGQLIDSM 158
Query: 599 TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ GT YM+PE L+ + + D++S G+ L+E+
Sbjct: 159 ANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 14/132 (10%)
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALG-IARGLLYLHEECETQIIHCDIKPQNVL 569
L+ + + G L L+++E T + V + + I L +LH+ II+ DIK +N+L
Sbjct: 82 LILDYVNGGELFTHLYQREHFT-ESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENIL 137
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV--TAKVD 627
LD+ ++ + DFGL+K ++ + GT+ YMAPE +R VD
Sbjct: 138 LDSE------GHV-VLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVD 190
Query: 628 VYSFGVMLLEII 639
+S GV+ E++
Sbjct: 191 WWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 38/100 (38%), Positives = 54/100 (54%), Gaps = 11/100 (11%)
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599
A I+ GL +LH II+ D+K NV+LD+ +I KIADFG+ K D
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSE------GHI-KIADFGMCKEHMVDGV 156
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
T T GT Y+APE + P VD +++GV+L E++
Sbjct: 157 TTRTFC-GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
IA L YLH I++ D+KP+N+LLD+ + + DFGL K Q+ T+
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVV-------LTDFGLCKE-GIAQSDTT 153
Query: 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
T GT Y+APE +R P VD + G +L E+++
Sbjct: 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 465 VAVKQLE---KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
VA+K++ K + + + ++EV+ + R H N ++ G + ++ LV E G+
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSA 111
Query: 522 SAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
S L + P + VEIA G +GL YLH +IH DIK N+LL
Sbjct: 112 SDLLEVHKKPL--QEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILL-------T 159
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE---WLRNAPVTAKVDVYSFGVML 635
K+ADFG A + + GT +MAPE + KVDV+S G+
Sbjct: 160 EPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214
Query: 636 LEI 638
+E+
Sbjct: 215 IEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A+K L+K V D L E +V+ + H L L + + + +L V E G L
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL 82
Query: 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
L R+ + + D+ I L YLH E +++ D+K +N++LD + +
Sbjct: 83 FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD------GH 134
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
I KI DFGL K KD T GT Y+APE L + VD + GV++ E++ C
Sbjct: 135 I-KITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-C 191
Query: 642 KR 643
R
Sbjct: 192 GR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 15/181 (8%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
A+K L+K + D L E +V+ T H L L ++ V E + G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF 83
Query: 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
L R+ + + D+ I L YLH +I++ D+K +N++LD + +I
Sbjct: 84 FHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKD------GHI 134
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK 642
KI DFGL K D T GT Y+APE L + VD + GV++ E++ C
Sbjct: 135 -KITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CG 191
Query: 643 R 643
R
Sbjct: 192 R 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 47/188 (25%), Positives = 89/188 (47%), Gaps = 22/188 (11%)
Query: 453 EATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLV 512
+A ++ + + V V L+ +T + +K + E++++ + ++ G +N +
Sbjct: 19 KAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77
Query: 513 YELMKNGTLSAFLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
E M G+L + ++IP + V IA+ + +GL YL +I+H D+KP N+L
Sbjct: 78 TEFMDGGSLDVY---RKIP---EHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNML- 127
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYS 630
++ K+ DFG++ L +T GT YMAPE + DV+S
Sbjct: 128 ------VNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQYGIHSDVWS 178
Query: 631 FGVMLLEI 638
G+ +E+
Sbjct: 179 LGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 40/199 (20%)
Query: 464 EVAVKQLE--KVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL--LVYELMKN 518
E A+K+ + K G +S RE+ ++ H+N+V L+ +E + L+++ ++
Sbjct: 29 EYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH 88
Query: 519 GTLSAFLFRQEIPTW---DKRVEIALGIAR--------GLLYLHEECETQIIHCDIKPQN 567
+I + KRV I + + G+ YLH ++H D+KP N
Sbjct: 89 DLW-------QIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPAN 138
Query: 568 VLLDNNYITIDNNY--ITKIADFGLAKL----LKKDQTRTSTMIRGTMGYMAPEWLRNAP 621
+L + + + KI D GLA+L LK ++ T+ Y APE L A
Sbjct: 139 IL-----VMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV--TIWYRAPELLLGAR 191
Query: 622 -VTAKVDVYSFGVMLLEII 639
T +D+++ G + E++
Sbjct: 192 HYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 54/182 (29%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A+K L K + D + E +V+ T H L L + + + +L V E G L
Sbjct: 24 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL 82
Query: 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
L R+ + T ++ I L YLH +++ DIK +N++LD + +
Sbjct: 83 FFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD------GH 133
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
I KI DFGL K D T GT Y+APE L + VD + GV++ E++ C
Sbjct: 134 I-KITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-C 190
Query: 642 KR 643
R
Sbjct: 191 GR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 52/184 (28%), Positives = 77/184 (41%), Gaps = 43/184 (23%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIE-----QNHQLLVYELM--KNGTLSAFLFRQEIPTWD 534
LRE++++ + H N+V L+ +E + + VY + + LS L +
Sbjct: 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---- 110
Query: 535 KRVE------IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADF 588
++ L + G+ YLHE I+H DIK N+L IDN I KIADF
Sbjct: 111 -KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANIL-------IDNQGILKIADF 159
Query: 589 GLAKLLKKDQ----------TRTSTMIRGTMGYMAPEWL---RNAPVTAKVDVYSFGVML 635
GLA+ TR T + T Y PE L R T VD++ G +
Sbjct: 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR--YTTAVDIWGIGCVF 217
Query: 636 LEII 639
E+
Sbjct: 218 AEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 465 VAVKQLE---KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
VA+K++ K + + + ++EV+ + + H N +Q G + ++ LV E G+
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 101
Query: 522 SAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
S L + P + VEIA G +GL YLH +IH D+K N+LL
Sbjct: 102 SDLLEVHKKPL--QEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILL-------S 149
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE---WLRNAPVTAKVDVYSFGVML 635
+ K+ DFG A ++ GT +MAPE + KVDV+S G+
Sbjct: 150 EPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 636 LEI 638
+E+
Sbjct: 205 IEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 23/69 (33%), Positives = 36/69 (52%), Gaps = 7/69 (10%)
Query: 211 YYHRATISDHGNFQQ--WVHNKRDGNGWAVVWEAITEPCTVNTICGVFGFCTSDNNKEVT 268
Y R T+S G+ ++ W+ N +D W + W A + C V CG +G+C D N
Sbjct: 45 IYSRLTLSSEGSLERFTWIPNSQD---WNLFWSAPKDQCDVYGRCGPYGYC--DVNTSPK 99
Query: 269 CECLRGYSP 277
C C++G+ P
Sbjct: 100 CNCIKGFVP 108
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEK-----SFLREVQVIGRTHHKNLVQLLG 501
++ E+ +A + Q V L+KV + EK + LRE++++ H+N+V L+
Sbjct: 24 TFGEVFKARHKKTKQIV-----ALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 502 FCIEQNHQ--------LLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHE 552
C + LV+E ++ L+ L + + T + ++ + GL Y+H
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR 137
Query: 553 ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK---LLKKDQTRTSTMIRGTM 609
+I+H D+K N+L I + I K+ADFGLA+ L K + T T+
Sbjct: 138 ---NKILHRDMKAANIL-------ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 610 GYMAPEWL---RN-APVTAKVDVYSFGVMLLE 637
Y PE L R+ P +D++ G ++ E
Sbjct: 188 WYRPPELLLGERDYGP---PIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLD-NNYITIDNNYITKIADFGLAKLLKKDQTRT 601
IA +L L + I++ D+KP+N+LLD +I + DFGL+K D T
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIA--------LCDFGLSKANLTDNKTT 153
Query: 602 STMIRGTMGYMAPE-WLRNAPVTAKVDVYSFGVMLLEI 638
+T GT Y+APE L T VD +S GV++ E+
Sbjct: 154 NTFC-GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
+ +LM G L L + + + + A I GL ++H +++ D+KP N+LL
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILL 130
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVY 629
D ++ ++ +I+D GLA K + S GT GYMAPE L+ + D +
Sbjct: 131 D------EHGHV-RISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYDSSADWF 180
Query: 630 SFGVMLLEII-----FCKRHT-ELHRVDEPTLANGMILTD 663
S G ML +++ F + T + H +D TL + L D
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 42/175 (24%)
Query: 480 SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYE-----LMK-----NGTLSA-----F 524
S LRE+ ++ HKN+V+L LV+E L K NG + F
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104
Query: 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584
+F+ + +GL + H ++H D+KPQN+L I+ N K
Sbjct: 105 MFQ---------------LLKGLAFCHSH---NVLHRDLKPQNLL-------INKNGELK 139
Query: 585 IADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEI 638
+ADFGLA+ S + T+ Y P+ L A + + +D++S G + E+
Sbjct: 140 LADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 26/178 (14%)
Query: 469 QLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL------- 521
+L K + E S +E ++ + H N+V H +V E G L
Sbjct: 34 RLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ 92
Query: 522 SAFLF-RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
LF I W V++ LG+ ++HE+ +++H DIK +N+ L N
Sbjct: 93 RGKLFPEDTILQW--FVQMCLGVQ----HIHEK---RVLHRDIKSKNIFLTQNGKV---- 139
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
K+ DFG A+LL T + GT Y+ PE N P K D++S G +L E+
Sbjct: 140 ---KLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 450 ELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIE 505
L+E+ ++ AVK L+K + D + + E +++ H L QL +C
Sbjct: 15 RLKESGRLY-------AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL--YCCF 65
Query: 506 QNHQLL--VYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
Q L V E + G L + + + A I L++LH++ II+ D+
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDL 122
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
K NVLLD+ + + K+ADFG+ K + TST GT Y+APE L+
Sbjct: 123 KLDNVLLDH-----EGH--CKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYG 174
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY 667
VD ++ GV+L E++ C H +E L IL D V+Y
Sbjct: 175 PSVDWWAMGVLLYEML-CG-HAPFEAENEDDLFEA-ILNDEVVY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
+ +LM G L L + + + + A I GL ++H +++ D+KP N+LL
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILL 130
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL-RNAPVTAKVDVY 629
D ++ ++ +I+D GLA K + S GT GYMAPE L + + D +
Sbjct: 131 D------EHGHV-RISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWF 180
Query: 630 SFGVMLLEIIFCKRHTELHRVDEPTLANGMILT 662
S G ML +++ H+ + + M LT
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 465 VAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
V VK+L+ E+ FL++ H N++Q LG C+E LLV+E + G L +
Sbjct: 25 VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKS 84
Query: 524 FLFRQEIPTWDKRV----EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
+L +++ + ++ +A IA G+ ++H+ +H D+ L N ++T D
Sbjct: 85 YLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLA-----LRNCFLTSDL 136
Query: 580 NYITKIADFGLA-KLLKKDQTRTSTMIRGTMGYMAPEW-------LRNAPVTAKVDVYSF 631
K+ D+G+ K+D T + ++APE L A T +V++
Sbjct: 137 T--VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL 194
Query: 632 GVMLLEIIFCKRHTELHRVDEPTL 655
GV L E+ H D L
Sbjct: 195 GVTLWELFENAAQPYSHLSDREVL 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 48/196 (24%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+Y ++ +A NV G+ + V +LE G+ +E+ ++ H N+V G + +
Sbjct: 21 TYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKP 565
+ + E G+L ++ P + ++ ++ +GL YLH + + +H DIK
Sbjct: 79 DKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDIKG 134
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL---RNAPV 622
N+LL DN ++ K+ADFG++ + + + I GT +MAPE R
Sbjct: 135 ANILL------TDNGHV-KLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGY 186
Query: 623 TAKVDVYSFGVMLLEI 638
D+++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 20/182 (10%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
GQ V +K +K + L E ++ +H +++++ + +V +
Sbjct: 88 PGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141
Query: 519 GTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
L +L ++ P D+ + I I GL YLH + +IIH D+K +N+ +++ +
Sbjct: 142 -DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFIND----V 193
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
D I D G A+ + GT+ APE L +K D++S G++L E
Sbjct: 194 DQ---VCIGDLGAAQFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFE 248
Query: 638 II 639
++
Sbjct: 249 ML 250
|
Length = 357 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 20/144 (13%)
Query: 505 EQNHQLLVYELMKNGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
++N+ LV + G L L F +P R IA +L +H + +H D
Sbjct: 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQLHYVHRD 127
Query: 563 IKPQNVLLD-NNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN-- 619
IKP NVLLD N +I ++ADFG + +D T S++ GT Y++PE L+
Sbjct: 128 IKPDNVLLDMNGHI--------RLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 620 ---APVTAKVDVYSFGVMLLEIIF 640
+ D +S GV + E+++
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLY 203
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVI-GRTHHKNLVQLLGFCIE 505
+Y ++ + TN DG AVK L+ ++ D ++ E ++ +H N+V+ G +
Sbjct: 34 TYGKVYKVTNKKDGSLA--AVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90
Query: 506 QNH----QL-LVYELMKNGTLSAFLFRQEIPTWDKRVE------IALGIARGLLYLHEEC 554
+ QL LV EL G+++ + + + +R++ I G GL +LH
Sbjct: 91 ADKLVGGQLWLVLELCNGGSVTELV--KGLLICGQRLDEAMISYILYGALLGLQHLHN-- 146
Query: 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAP 614
+IIH D+K N+LL T + K+ DFG++ L + R +T + GT +MAP
Sbjct: 147 -NRIIHRDVKGNNILL-----TTEGG--VKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAP 197
Query: 615 EWLR-----NAPVTAKVDVYSFGVMLLEI 638
E + + A+ DV+S G+ +E+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 503 CIEQNHQL-LVYELMKNGTLSAFLFRQ-EIPTWDKR---VEIALGIARGLLYLHEECETQ 557
C + +L V E + G L + RQ ++P R EI+L L +LHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHER---G 116
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617
II+ D+K NVLLD +I K+ D+G+ K + TST GT Y+APE L
Sbjct: 117 IIYRDLKLDNVLLDAE------GHI-KLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEIL 168
Query: 618 RNAPVTAKVDVYSFGVMLLEII 639
R VD ++ GV++ E++
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 447 SYQELR---EAT--NVFDGQEVE----VAVKQLEKVTGDGEKSF-LREVQVIGRTHHKNL 496
++++L E T V+ G+ VA+K++ +G S +RE+ ++ H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 497 VQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIAR--------GLL 548
V+L +N +LV+E M ++ + T R + + G+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD------LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 549 YLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGT 608
+ HE +++H D+KPQN+L I+ K+ADFGLA+ S + T
Sbjct: 115 FCHEN---RVLHRDLKPQNLL-------INKRGELKLADFGLARAFGIPVNTFSNEVV-T 163
Query: 609 MGYMAPEWLRNAPV-TAKVDVYSFGVMLLEII 639
+ Y AP+ L + + +D++S G ++ E+I
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 27/155 (17%)
Query: 496 LVQLLGFCIEQN--HQLLVYELMKNGTLSAFLFRQEIP-TWDK--RVEIALGIARGLLYL 550
+VQL Q+ + +V E M G L + +IP W + E+ L + +
Sbjct: 105 IVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDA----I 158
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA-KLLKKDQTRTSTMIRGTM 609
H IH D+KP N+LLD + ++ K+ADFG K+ R T + GT
Sbjct: 159 HS---MGFIHRDVKPDNMLLDK------SGHL-KLADFGTCMKMDANGMVRCDTAV-GTP 207
Query: 610 GYMAPEWLRNAPVTA----KVDVYSFGVMLLEIIF 640
Y++PE L++ + D +S GV L E++
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 464 EVAVKQL----EKVTGDGEKSFLR-EVQVIGRTHHKNLVQLLGFCIEQNHQLL--VYELM 516
E+AVKQ+ E E + L E+Q++ H+ +VQ G + + L E M
Sbjct: 29 ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHM 88
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G++ L T + + I G+ YLH I+H DIK N+L D +
Sbjct: 89 PGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRD----S 141
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYSFGVM 634
+ N K+ DFG +K L+ + M + GT +M+PE + K D++S G
Sbjct: 142 VGN---VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCT 198
Query: 635 LLEII 639
++E++
Sbjct: 199 VVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 40/132 (30%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALG-IARGLLYLHEECETQIIHCDIKPQNVL 569
L+ + + G + L++++ + D+ V G I L +LH+ I++ DIK +N+L
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDE-VRFYSGEIILALEHLHK---LGIVYRDIKLENIL 137
Query: 570 LDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK-VD 627
LD+ + + DFGL+K L +++ RT + GT+ YMAPE +R K VD
Sbjct: 138 LDSEGHVV-------LTDFGLSKEFLSEEKERTYSFC-GTIEYMAPEIIRGKGGHGKAVD 189
Query: 628 VYSFGVMLLEII 639
+S G+++ E++
Sbjct: 190 WWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 47/139 (33%), Positives = 68/139 (48%), Gaps = 14/139 (10%)
Query: 503 CIEQNHQL-LVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIH 560
C + +L LV E + G L + RQ ++P R A I L +LHE II+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER---GIIY 119
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620
D+K NVLLD + +I K+ D+G+ K TST GT Y+APE LR
Sbjct: 120 RDLKLDNVLLDAD------GHI-KLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGE 171
Query: 621 PVTAKVDVYSFGVMLLEII 639
VD ++ GV++ E++
Sbjct: 172 EYGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 479 KSFLREVQVIGRTHHKNLVQLLG-FCIEQNHQ-----LLVYELMKNGTLSAFLFRQEIPT 532
K RE++++ H+N++ LL F + + LV M GT L + E +
Sbjct: 59 KRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLS 116
Query: 533 WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592
D+ + + +GL Y+H IIH D+KP N + ++ + KI DFGLA+
Sbjct: 117 EDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGN-------LAVNEDCELKILDFGLAR 166
Query: 593 LLKKDQTRTSTMIRGTMGYMAPE----WLRNAPVTAKVDVYSFGVMLLEIIFCK 642
+ D T ++ T Y APE W+ T VD++S G ++ E++ K
Sbjct: 167 --QTDSEMTGYVV--TRWYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 30/173 (17%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
+A+G+ +L + IH D+ +N+LL + IT KI DFGLA+ ++ D ++
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRIT-------KICDFGLARDIRND---SN 269
Query: 603 TMIRGT----MGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANG 658
+++G + +MAPE + N T + DV+S+G++L EI L P G
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF------SLGSSPYP----G 319
Query: 659 MILTDWVLYCVRTG-NLGATKFERITMVGLWCIC--PQPTLRPSMKQVLQMLE 708
M + ++ G + + + M + C P RP+ KQ++Q++E
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 41/193 (21%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518
D Q +V VK G K+ RE+ ++ H+ ++ L+ +
Sbjct: 116 DEQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLI-------------HAYRW 157
Query: 519 GTLSAFL---FRQEIPTWDKRV-----EIALGIARGLL----YLHEECETQIIHCDIKPQ 566
+ + ++ ++ T+ R E A+ I R LL YLH IIH D+K +
Sbjct: 158 KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTE 214
Query: 567 NVLLDNNYITIDNNYITKIADFGLA-KLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
N+ LD N + + DFG A KL T GT+ +PE L P AK
Sbjct: 215 NIFLDEP-----ENAV--LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK 267
Query: 626 VDVYSFGVMLLEI 638
D++S G++L E+
Sbjct: 268 TDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 42/129 (32%), Positives = 65/129 (50%), Gaps = 11/129 (8%)
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
L+ E + G L L R+ I D I+ L +LH++ II+ D+KP+N+LL
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILL 133
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYS 630
D ++ K+ DFGL K + T T T GT+ YMAPE L + VD +S
Sbjct: 134 DAQ------GHV-KLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMRSGHGKAVDWWS 185
Query: 631 FGVMLLEII 639
G ++ +++
Sbjct: 186 LGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 491 THHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLY 549
++H LV L ++ V E + G L + RQ ++P R A I+ L Y
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNY 111
Query: 550 LHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTM 609
LHE II+ D+K NVLLD+ +I K+ D+G+ K + TST GT
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSE------GHI-KLTDYGMCKEGLRPGDTTSTFC-GTP 160
Query: 610 GYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
Y+APE LR VD ++ GV++ E++
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 68/263 (25%), Positives = 106/263 (40%), Gaps = 65/263 (24%)
Query: 413 FGSIVIYYHPLTRPYMCVQPSPKPKPPEINMKVFSYQELREATNVFDGQEVEVAVKQLEK 472
FG + + H T+ + C K SY+ L+E
Sbjct: 26 FGEVFLVKHKRTQEFFC-------------WKAISYRGLKER------------------ 54
Query: 473 VTGDGEKSFLR-EVQVIGRTHHKNLVQLLG-FCIEQNHQL-LVYELMKNGTLSAFLFRQE 529
EKS L EV V+ HKN+V+ + F + N +L ++ E G LS + ++
Sbjct: 55 -----EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI-QKC 108
Query: 530 IPTWDKRVEIAL-GIARGLLYLHEECET--------QIIHCDIKPQNVLLDNNY-----I 575
+ K E A+ I R LL+ C +++H D+KPQN+ L I
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168
Query: 576 TIDNNY-----ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL--RNAPVTAKVDV 628
T N I KI DFGL+K + + S + GT Y +PE L K D+
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDM 226
Query: 629 YSFGVMLLEIIFCKRHTELHRVD 651
++ G ++ E+ C T H+ +
Sbjct: 227 WALGCIIYEL--CSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 40/199 (20%)
Query: 458 FDGQE-VEVAVKQLEKVTGD--GEKSFLREVQVIGRTHHKNLVQLLGFCI------EQNH 508
FD + + VAVK+L + K RE++++ H+N++ LL E N
Sbjct: 37 FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96
Query: 509 QLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKPQN 567
LV LM L+ + Q++ D V+ + I RGL Y+H IIH D+KP N
Sbjct: 97 VYLVTHLM-GADLNNIVKCQKLT--DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSN 150
Query: 568 VLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV----- 622
+ ++ + KI DFGLA+ + T GY+A W R +
Sbjct: 151 -------LAVNEDCELKILDFGLARHTDDEMT----------GYVATRWYRAPEIMLNWM 193
Query: 623 --TAKVDVYSFGVMLLEII 639
VD++S G ++ E++
Sbjct: 194 HYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 34/110 (30%), Positives = 57/110 (51%), Gaps = 15/110 (13%)
Query: 532 TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591
++ V + +A G+ +L + +H D+ +NVL I + KI DFGLA
Sbjct: 237 SYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL-------ICEGKLVKICDFGLA 286
Query: 592 KLLKKDQ---TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ + +D ++ ST + + +MAPE + N T DV+SFG++L EI
Sbjct: 287 RDIMRDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 18/196 (9%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+Y ++ +A N+ G+ V + +LE GD +E+ ++ H N+V G + +
Sbjct: 21 TYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKP 565
+ E G+L ++ P + ++ + +GL YLH + + +H DIK
Sbjct: 79 EKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRDIKG 134
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL---RNAPV 622
N+LL DN + K+ADFG+A + + + I GT +MAPE +N
Sbjct: 135 ANILL------TDNGDV-KLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGY 186
Query: 623 TAKVDVYSFGVMLLEI 638
D+++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 60/208 (28%)
Query: 465 VAVKQLEK----VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYE 514
VA+K+L + VT K RE+ ++ +HKN++ LL Q LV E
Sbjct: 44 VAIKKLSRPFQNVTH--AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101
Query: 515 LMK------------NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
LM + +S L++ + G+ +LH IIH D
Sbjct: 102 LMDANLCQVIQMDLDHERMSYLLYQ---------------MLCGIKHLHS---AGIIHRD 143
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRG---TMGYMAPEWLRN 619
+KP N I + ++ KI DFGLA+ TS M+ T Y APE +
Sbjct: 144 LKPSN-------IVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILG 191
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRHTEL 647
VD++S G ++ E+I R T L
Sbjct: 192 MGYKENVDIWSVGCIMGEMI---RGTVL 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 21/198 (10%)
Query: 450 ELREAT--NVFDGQ----EVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGF 502
+L E T VF G+ E VA+K++ +G + +REV ++ H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 503 CIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHC 561
+ LV+E + + L +L V+I + + RGL Y H+ +I+H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHR 127
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-WLRNA 620
D+KPQN+L I+ K+ADFGLA+ K T+T + T+ Y P+ L +
Sbjct: 128 DLKPQNLL-------INEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 621 PVTAKVDVYSFGVMLLEI 638
+ +D++ G +L E+
Sbjct: 180 EYSTPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 34/175 (19%)
Query: 543 IARGLLYL-HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601
+A+G+ +L + C IH D+ +NVLL + + KI DFGLA+ + D +
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVA-------KICDFGLARDIMND---S 266
Query: 602 STMIRGT----MGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN 657
+ +++G + +MAPE + + T + DV+S+G++L EI L + P
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------SLGKSPYPG--- 317
Query: 658 GMILTDWVLY-CVRTG-NLGATKFERITMVGLWCIC--PQPTLRPSMKQVLQMLE 708
IL + Y V+ G + F + + +C +PT RP+ Q+ Q+++
Sbjct: 318 --ILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 12/99 (12%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
+ R L Y+H + I H D+KPQN+L+D N T+ K+ DFG AK L Q S
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTL------KLCDFGSAKNLLAGQRSVS 229
Query: 603 TMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEIIF 640
+ + Y APE + A T +D++S G ++ E+I
Sbjct: 230 YIC--SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
|
Length = 440 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 49/213 (23%)
Query: 449 QELREAT--NVFDGQ----EVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLG 501
++L E T VF G+ E VA+K++ +G + +REV ++ H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 502 FCIEQNHQLLVYE---------------LMKNGTLSAFLFRQEIPTWDKRVEIALGIARG 546
LV+E +M + FL++ I RG
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQ---------------ILRG 116
Query: 547 LLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606
L Y H +++H D+KPQN+L I+ K+ADFGLA+ K T+T +
Sbjct: 117 LAYCHRR---KVLHRDLKPQNLL-------INERGELKLADFGLAR-AKSVPTKTYSNEV 165
Query: 607 GTMGYMAPE-WLRNAPVTAKVDVYSFGVMLLEI 638
T+ Y P+ L ++ + ++D++ G + E+
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 11/83 (13%)
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617
IH D+KP+N L+D + +I K+ DFGL+K T ++++ G+ YMAPE L
Sbjct: 122 YIHRDLKPENFLIDAS------GHI-KLTDFGLSK---GIVTYANSVV-GSPDYMAPEVL 170
Query: 618 RNAPVTAKVDVYSFGVMLLEIIF 640
R VD +S G ML E +
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 14/160 (8%)
Query: 484 EVQVIGRTHHKNLVQLLGFCIEQNHQLLV--YELMKNGTLSAFLFRQEIPTWDKRVEIAL 541
E+Q++ H+ +VQ G ++ + L E M G++ L T +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601
I G+ YLH I+H DIK N+L D + N K+ DFG +K L+
Sbjct: 114 QILEGMSYLHS---NMIVHRDIKGANILRD----SAGN---VKLGDFGASKRLQTICMSG 163
Query: 602 STM--IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+ + + GT +M+PE + K DV+S G ++E++
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 27/183 (14%)
Query: 467 VKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--HQLLVYELMKNGTLSAF 524
+ + E + F E ++ + +VQL FC Q+ + +V E M G L
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 525 LFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583
+ ++P W K A +L L +IH D+KP N+LLD + ++
Sbjct: 134 MSNYDVPEKWAK-----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK------HGHL- 181
Query: 584 KIADFGLAKLLKKDQT---RTSTMIRGTMGYMAPEWLR----NAPVTAKVDVYSFGVMLL 636
K+ADFG +K D+T R T + GT Y++PE L+ + + D +S GV L
Sbjct: 182 KLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 637 EII 639
E++
Sbjct: 239 EML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 39/123 (31%), Positives = 62/123 (50%), Gaps = 14/123 (11%)
Query: 547 LLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606
L++LH +I+ D+K N+LLD + + K+ADFG+ K + T+T
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDA-----EGH--CKLADFGMCKEGILNGVTTTTFC- 157
Query: 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL 666
GT Y+APE L+ VD ++ GV++ E++ + E D+ + IL D VL
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES---ILHDDVL 214
Query: 667 YCV 669
Y V
Sbjct: 215 YPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 15/99 (15%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ---T 599
+ARG+ +L + +H D+ +NVLL I KI DFGLA+ + D +
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIV-------KICDFGLARDIMHDSNYVS 295
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+ ST + + +MAPE + + T DV+S+G++L EI
Sbjct: 296 KGSTFL--PVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 22/182 (12%)
Query: 465 VAVKQLEKVTGDG--EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
VA+K+ + D +K LRE++++ + H NLV L+ + LV+E + L+
Sbjct: 29 VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLN 88
Query: 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
+I + + + H+ IH D+KP+N+L I
Sbjct: 89 ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENIL-------ITKQGQ 138
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL-----RNAPVTAKVDVYSFGVMLLE 637
K+ DFG A++L T T Y APE L P VDV++ G + E
Sbjct: 139 IKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGDTQYGPP----VDVWAIGCVFAE 193
Query: 638 II 639
++
Sbjct: 194 LL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 11/159 (6%)
Query: 484 EVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGI 543
E ++ +H +++QL G L+ K ++ I D + I +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDI-LAIERSV 191
Query: 544 ARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603
R + YLHE +IIH DIK +N+ I++ + DFG A
Sbjct: 192 LRAIQYLHE---NRIIHRDIKAENIF-------INHPGDVCLGDFGAACFPVDINANKYY 241
Query: 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK 642
GT+ APE L P VD++S G++L E+ C
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 14/88 (15%)
Query: 559 IHCDIKPQNVLLD-NNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617
+H DIKP NVLLD N +I ++ADFG L D T S + GT Y++PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHI--------RLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 618 R-----NAPVTAKVDVYSFGVMLLEIIF 640
+ + D +S GV + E+++
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLY 203
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
SY + + + +G+ V + V +L++ G + +RE ++ H N+V L +
Sbjct: 17 SYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLHDIIHTK 75
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKP 565
LV+E + L ++ + + V++ L + RGL Y+H+ I+H D+KP
Sbjct: 76 ETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKP 131
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-WLRNAPVTA 624
QN+L I + K+ADFGLA+ K + T + T+ Y P+ L + +
Sbjct: 132 QNLL-------ISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 625 KVDVYSFGVMLLEII 639
+D++ G + +E+I
Sbjct: 184 CLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 465 VAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
VA+K++ +G + +REV ++ H N+V L + LV+E + + L
Sbjct: 34 VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQ 92
Query: 524 FLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
+L V++ L + RGL Y H +++H D+KPQN+L I+
Sbjct: 93 YLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLL-------INERGE 142
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-WLRNAPVTAKVDVYSFGVMLLEII 639
K+ADFGLA+ K T+T + T+ Y P+ L + + ++D++ G + E+
Sbjct: 143 LKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 41/193 (21%)
Query: 464 EVAVKQLEKVTGD--GEKSFLREVQVIGRTHHKNLVQLL-----GFCIEQ-NHQLLVYEL 515
+VAVK+L + + RE++++ H+N++ LL IE N LV L
Sbjct: 42 KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL 101
Query: 516 MKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
M L+ + Q++ D+ V+ + + RGL Y+H IIH D+KP NV
Sbjct: 102 M-GADLNNIVKCQKLS--DEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNV------ 149
Query: 575 ITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP--------VTAKV 626
++ + +I DFGLA+ + T GY+A W R AP V
Sbjct: 150 -AVNEDCELRILDFGLARQADDEMT----------GYVATRWYR-APEIMLNWMHYNQTV 197
Query: 627 DVYSFGVMLLEII 639
D++S G ++ E++
Sbjct: 198 DIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 35/210 (16%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVI-GRTHHKNLVQLLGFCIE 505
+Y ++ + N +G + AVK L+ + D ++ E ++ + H N+V+ G +
Sbjct: 30 TYGKVFKVLNKKNGSKA--AVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86
Query: 506 QN----HQL-LVYELMKNGTLS----AFLFRQEIPTWDKRVE---IALGIARGLLYLHEE 553
++ QL LV EL G+++ FL R E R+E IA + L+ L
Sbjct: 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE------RMEEPIIAYILHEALMGLQHL 140
Query: 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMA 613
+ IH D+K N+LL T + K+ DFG++ L + R +T + GT +MA
Sbjct: 141 HVNKTIHRDVKGNNILL-----TTEGG--VKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192
Query: 614 PEWLR-----NAPVTAKVDVYSFGVMLLEI 638
PE + ++ A+ DV+S G+ +E+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 19/100 (19%)
Query: 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL----LKKDQTR 600
+G+ + H+ ++H D+KPQN+L+D + KIAD GL + +K
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVD------KQKGLLKIADLGLGRAFSIPVKS---Y 168
Query: 601 TSTMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEII 639
T ++ T+ Y APE L + + VD++S G + E+
Sbjct: 169 THEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 25/186 (13%)
Query: 463 VEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGF-----CIEQNHQL-LVYE 514
+ VAVK+L + + K RE+ ++ +HKN++ LL +E+ + LV E
Sbjct: 47 INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106
Query: 515 LMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
LM + +R+ L + G+ +LH IIH D+KP N
Sbjct: 107 LMDANLCQVIHMELD----HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSN------ 153
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
I + ++ KI DFGLA+ + T ++ T Y APE + VD++S G
Sbjct: 154 -IVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGC 210
Query: 634 MLLEII 639
++ E++
Sbjct: 211 IMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 21/186 (11%)
Query: 464 EVAVKQLEKVTGDGEKS-----FLREVQVIGRTHHKNLVQLLGFCI---EQNHQLLVYEL 515
E+AVKQ+ E S E+Q++ H +VQ G C+ E+ + E
Sbjct: 29 ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEY 87
Query: 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
M G++ L T + I +G+ YLH I+H DIK N+L D+
Sbjct: 88 MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSA-- 142
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
N K+ DFG +K ++ + + + GT +M+PE + K DV+S
Sbjct: 143 ---GN--VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVAC 197
Query: 634 MLLEII 639
++E++
Sbjct: 198 TVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 49/212 (23%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQL------- 499
SY + + + +GQ V + V ++ G + +RE ++ H N+V L
Sbjct: 17 SYATVYKGISRINGQLVALKVISMKTEEGVPFTA-IREASLLKGLKHANIVLLHDIIHTK 75
Query: 500 --LGFCIEQNH-QLLVYELMKNGTLSA-----FLFRQEIPTWDKRVEIALGIARGLLYLH 551
L F E H L Y + G L F+F+ + RGL Y+H
Sbjct: 76 ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ---------------LLRGLAYIH 120
Query: 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYI--TKIADFGLAKLLK-KDQTRTSTMIRGT 608
+ I+H D+KPQN+L+ +Y+ K+ADFGLA+ QT +S ++ T
Sbjct: 121 GQ---HILHRDLKPQNLLI---------SYLGELKLADFGLARAKSIPSQTYSSEVV--T 166
Query: 609 MGYMAPEWLRNAP-VTAKVDVYSFGVMLLEII 639
+ Y P+ L A ++ +D++ G + +E++
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 62/209 (29%)
Query: 465 VAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCI-----EQNHQLLVYELM 516
VA+K++ V D + LRE++++ H ++V++ + E +V+ELM
Sbjct: 28 VAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 86
Query: 517 K---------NGTLSA-----FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
+ N L+ FL++ + R L Y+H + H D
Sbjct: 87 ESDLHQVIKANDDLTPEHHQFFLYQ---------------LLRALKYIHT---ANVFHRD 128
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP- 621
+KP+N+L + + KI DFGLA++ D T T I T Y+A W R AP
Sbjct: 129 LKPKNIL-------ANADCKLKICDFGLARVAFND---TPTAIFWT-DYVATRWYR-APE 176
Query: 622 --------VTAKVDVYSFGVMLLEIIFCK 642
T +D++S G + E++ K
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 57/215 (26%)
Query: 466 AVKQLEKVTGDGEKSFLR---EVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
A+K L+K R E +++ H L L + + LV + G L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 523 AFLFRQEIPTWDKRVEIALGIAR--------GLLYLHEECETQIIHCDIKPQNVLLDNN- 573
L RQ K + +AR L YLH I++ D+KP+N+LL +
Sbjct: 90 RLLQRQP----GKCLSEE--VARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESG 140
Query: 574 YITIDNNYITKIADFGLAKLLKK----------DQTRTSTMIR----------------- 606
+I + +DF L+K +R S++
Sbjct: 141 HIML--------SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSF 192
Query: 607 -GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
GT Y+APE + + VD ++ G++L E+++
Sbjct: 193 VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 47/193 (24%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 459 DGQE-VEVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ--LLVYE 514
DG++ + A+KQ+E G G S RE+ ++ H N++ L + + L+++
Sbjct: 24 DGKDDRDYALKQIE---GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80
Query: 515 LMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLY-----LHEECETQIIHCDIKPQNVL 569
++ F + K V++ G+ + LLY +H ++H D+KP N+L
Sbjct: 81 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 140
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEWLRNAP-VTAKV 626
+ KIAD G A+L + + + T Y APE L A T +
Sbjct: 141 VMGEG---PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197
Query: 627 DVYSFGVMLLEII 639
D+++ G + E++
Sbjct: 198 DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 47/193 (24%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 459 DGQ-EVEVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ--LLVYE 514
DG+ E E A+KQ+E G G S RE+ ++ H N++ L + + + L+++
Sbjct: 24 DGKDEKEYALKQIE---GTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80
Query: 515 LMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLY-----LHEECETQIIHCDIKPQNVL 569
++ F + K +++ + + LLY +H ++H D+KP N+L
Sbjct: 81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 140
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEWLRNAP-VTAKV 626
+ KIAD G A+L + + + T Y APE L A T +
Sbjct: 141 VMGEG---PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197
Query: 627 DVYSFGVMLLEII 639
D+++ G + E++
Sbjct: 198 DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 20/91 (21%)
Query: 559 IHCDIKPQNVLLD-NNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617
+H DIKP N+L+D N +I ++ADFG L +D T S++ GT Y++PE L
Sbjct: 124 VHRDIKPDNILMDMNGHI--------RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 618 --------RNAPVTAKVDVYSFGVMLLEIIF 640
+ P + D +S GV + E+++
Sbjct: 176 QAMEDGKGKYGP---ECDWWSLGVCMYEMLY 203
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 41/185 (22%), Positives = 83/185 (44%), Gaps = 32/185 (17%)
Query: 484 EVQVIGRTHHKNLVQL--------LGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDK 535
E+ +GR +H+N++++ + I Q + +Y M + AF ++
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE---AFDWKDRPLLKQT 269
Query: 536 RVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595
R I + + Y+H++ ++IH DIK +N+ L+ + + + DFG A +
Sbjct: 270 R-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIV-------LGDFGTAMPFE 318
Query: 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII---FC-------KRHT 645
K++ GT+ +PE L D++S G++LL+++ FC K
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378
Query: 646 ELHRV 650
+L ++
Sbjct: 379 QLLKI 383
|
Length = 501 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 28/196 (14%)
Query: 461 QEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
Q VA+K L +K G + F E + R H N+V LLG ++ +++ +
Sbjct: 34 QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 520 TLSAFLFRQEI-----PTWDKR-----------VEIALGIARGLLYLHEECETQIIHCDI 563
L FL + T D + V I IA G+ +L ++H D+
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDL 150
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEWLRNAPV 622
+NVL + + KI+D GL + + D + + +M+PE +
Sbjct: 151 ATRNVL-------VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF 203
Query: 623 TAKVDVYSFGVMLLEI 638
+ D++S+GV+L E+
Sbjct: 204 SIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 42/173 (24%), Positives = 63/173 (36%), Gaps = 52/173 (30%)
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
L+ E + G + L +++ T + E IA +L + + IH DIKP N+LL
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEE---ETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL 134
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRT------------------STMIR------ 606
D +I K++DFGL LKK M
Sbjct: 135 DA------KGHI-KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187
Query: 607 -------------GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII-----FC 641
GT Y+APE + D +S GV++ E++ FC
Sbjct: 188 WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELM 516
VA+K+L + + K RE+ ++ +HKN++ LL Q LV ELM
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
+ ++ + + G+ +LH IIH D+KP N I
Sbjct: 105 DANLCQVIQMELD---HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSN-------IV 151
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
+ ++ KI DFGLA+ T ++ T Y APE + VD++S G ++
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 637 EIIFCKRH 644
E++ RH
Sbjct: 210 EMV---RH 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 19/179 (10%)
Query: 467 VKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526
+ + E + F E ++ + +VQL + + +V E M G L +
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 135
Query: 527 RQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585
++P W + A +L L IH D+KP N+LLD + ++ K+
Sbjct: 136 NYDVPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS------GHL-KL 183
Query: 586 ADFGLAKLLKKD-QTRTSTMIRGTMGYMAPEWLR----NAPVTAKVDVYSFGVMLLEII 639
ADFG + K+ R T + GT Y++PE L+ + + D +S GV L E++
Sbjct: 184 ADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 23/186 (12%)
Query: 462 EVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGF-----CIEQNHQL-LVY 513
E VA+K+L + + K RE+ ++ +HKN++ LL +E+ + +V
Sbjct: 49 ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
ELM + ++ + + G+ +LH IIH D+KP N
Sbjct: 109 ELMDANLCQVIQMELD---HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSN------ 156
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
I + ++ KI DFGLA+ T ++ T Y APE + VD++S G
Sbjct: 157 -IVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 634 MLLEII 639
++ E+I
Sbjct: 214 IMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 12/96 (12%)
Query: 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604
RGL Y H+ +++H D+KPQN+L I K+ADFGLA+ K ++T +
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLL-------ISERGELKLADFGLAR-AKSVPSKTYSN 162
Query: 605 IRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEII 639
T+ Y P+ L + + +D++ G + E+
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 19/102 (18%)
Query: 543 IARGLL----YLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598
+AR LL Y+H E IIH DIK +NVL++ ++ + DFG A +
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVN----GPED---ICLGDFGAACFARG-- 312
Query: 599 TRTSTM---IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+ ++ I GT+ APE L P T VD++S G+++ E
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 15/96 (15%)
Query: 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604
GL Y+H IIH D+KP N + ++ + KI DFGLA+ D T +
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGN-------LAVNEDCELKILDFGLAR--HADAEMTGYV 175
Query: 605 IRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEII 639
+ T Y APE + N VD++S G ++ E++
Sbjct: 176 V--TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 19/88 (21%), Positives = 33/88 (37%), Gaps = 10/88 (11%)
Query: 296 CDTKSSPADFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVWREVV-- 353
C S F + D +P+ IT + ECR+A + +C C A +
Sbjct: 5 CGGDGSTDGFLK--LPDVKLPDNASA----ITAISLEECREACLSNCSCTAYAYNNGSGG 58
Query: 354 CLKKKMPLLNARRSNPSTNKMAAFIKVP 381
CL L N R + + ++++
Sbjct: 59 CLLWNGLLNNLRSLSSGGGTL--YLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 725 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.87 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.82 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.74 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.62 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.61 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.59 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.59 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.59 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.57 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.57 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.56 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.51 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.35 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.34 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.33 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.31 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.29 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.29 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.26 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.25 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.21 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.2 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.16 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.06 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.76 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.7 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.64 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.57 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.54 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.31 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.24 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.09 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.82 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.67 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.55 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.25 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.96 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.93 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.81 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.5 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.19 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.9 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 95.62 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.53 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.11 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.07 | |
| smart00223 | 79 | APPLE APPLE domain. Four-fold repeat in plasma kal | 93.8 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.56 | |
| PLN02236 | 344 | choline kinase | 93.5 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.03 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.93 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.78 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.55 | |
| PF14295 | 51 | PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A. | 92.02 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 90.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 90.7 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 90.53 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 90.23 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 89.65 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 88.97 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 87.98 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=403.97 Aligned_cols=259 Identities=44% Similarity=0.790 Sum_probs=217.8
Q ss_pred CcccccHHHHHHHhcccC------------------CcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEE
Q 039817 442 NMKVFSYQELREATNVFD------------------GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503 (725)
Q Consensus 442 ~~~~~~~~~l~~a~~~~~------------------~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 503 (725)
..+.|+|.++.+||++|+ .++..||||++.....+..++|.+|++++++++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 578899999999999997 23368999998765443256799999999999999999999999
Q ss_pred EcCC-ceeeeeecccCCChhhhhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCC
Q 039817 504 IEQN-HQLLVYELMKNGTLSAFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580 (725)
Q Consensus 504 ~~~~-~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~ 580 (725)
.+.+ +.+||||||++|+|+++|+... .++|.+|++|+.++|+||+|||+.|.++|||||||++|||||+ +
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-------~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-------D 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-------C
Confidence 9999 5999999999999999999875 8999999999999999999999999999999999999999987 8
Q ss_pred CceEEeeccCccccCc-CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCc
Q 039817 581 YITKIADFGLAKLLKK-DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM 659 (725)
Q Consensus 581 ~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~ 659 (725)
+++||+|||+|+.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+..... ...
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~-----~~~ 287 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-----GEL 287 (361)
T ss_pred CCEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc-----ccc
Confidence 9999999999976554 22211111 6999999999999999999999999999999999999887754421 123
Q ss_pred chHHHHHHHHHcC-------------CCCh-hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 660 ILTDWVLYCVRTG-------------NLGA-TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 660 ~~~~~~~~~~~~~-------------~~~~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
.+.+|+...+..+ ..+. ....++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 288 SLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 3666665555443 2222 4677899999999999999999999999999766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.82 Aligned_cols=247 Identities=33% Similarity=0.442 Sum_probs=202.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCcc--HHHHHHHHHHHhccCcCCccceeeEEEcCC-ceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDG--EKSFLREVQVIGRTHHKNLVQLLGFCIEQN-HQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~gs 520 (725)
...+|++++++... |. ..||||.+....... .++|.+|+.+|++++|||||+++|+|.+.. ..++|||||++|+
T Consensus 50 G~G~~g~V~~~~~~--g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 50 GSGSFGTVYKGKWR--GT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred ccCCceeEEEEEeC--Cc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 34556666644432 21 239999987543222 569999999999999999999999999988 8999999999999
Q ss_pred hhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhhcccCCc-eeecCCccceEEeccCccccCCCC-ceEEeeccCccccCc
Q 039817 521 LSAFLFR--QEIPTWDKRVEIALGIARGLLYLHEECETQ-IIHCDIKPQNVLLDNNYITIDNNY-ITKIADFGLAKLLKK 596 (725)
Q Consensus 521 L~~~l~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivH~dik~~NIll~~~~~~~~~~~-~~kl~Dfgla~~~~~ 596 (725)
|.+++++ ...+++..+++|+.|||+||.|||+. + ||||||||+||||+. ++ ++||+|||+++....
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~-------~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDL-------KGKTLKIADFGLSREKVI 196 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcC-------CCCEEEECCCccceeecc
Confidence 9999988 57899999999999999999999999 7 999999999999988 65 999999999987654
Q ss_pred CCCccccccccCccccchhccc--CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLR--NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
.. ...+...||+.|||||.+. ...++.|+||||||++||||+||+.||+.... ......+........+
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGGLRPPI 267 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCCCC
Confidence 32 2233356999999999999 56999999999999999999999999985532 1122222222334455
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+....+.+..++.+||+.||.+||++.+++..|+.+..
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 66688999999999999999999999999999997654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.27 Aligned_cols=226 Identities=27% Similarity=0.373 Sum_probs=191.3
Q ss_pred ceEEEEEEcc-cccCccHHHHHHHHHHHhccCcCCccceeeEEEcCC-ceeeeeecccCCChhhhhccCCCCCHHHHHHH
Q 039817 462 EVEVAVKQLE-KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-HQLLVYELMKNGTLSAFLFRQEIPTWDKRVEI 539 (725)
Q Consensus 462 ~~~vavk~l~-~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i 539 (725)
+..+|+|.+. ..+....+++.+|++++++.+||+||.+||.|..+. ...|+||||++|||++++...+.+++...-+|
T Consensus 104 ~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~i 183 (364)
T KOG0581|consen 104 GKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKI 183 (364)
T ss_pred CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHH
Confidence 4567888873 334455688999999999999999999999999988 59999999999999999998899999999999
Q ss_pred HHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhccc
Q 039817 540 ALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618 (725)
Q Consensus 540 ~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 618 (725)
+.+|++||.|||+ . +||||||||+|||++. .+.+||+|||.++.+.+. ....+.||..|||||.+.
T Consensus 184 a~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNs-------kGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~ 250 (364)
T KOG0581|consen 184 ARAVLRGLSYLHEER---KIIHRDIKPSNLLVNS-------KGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERIS 250 (364)
T ss_pred HHHHHHHHHHHhhcc---CeeeccCCHHHeeecc-------CCCEEeccccccHHhhhh---hcccccccccccChhhhc
Confidence 9999999999996 5 9999999999999988 899999999999976554 223467999999999999
Q ss_pred CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChh-HHHHHHHHHHHccCCCCC
Q 039817 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGAT-KFERITMVGLWCICPQPT 695 (725)
Q Consensus 619 ~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~l~~l~~~cl~~dp~ 695 (725)
+..|+.++||||||++++|+.+|+.|+...... .....+.+..... ...++.. ..++++.++..||++||.
T Consensus 251 g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~------~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~ 324 (364)
T KOG0581|consen 251 GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP------YLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPS 324 (364)
T ss_pred CCcCCcccceecccHHHHHHhhCCCCCCCcCCC------CCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcc
Confidence 999999999999999999999999998765211 2222333333222 1234444 788999999999999999
Q ss_pred CCCCHHHHHHH
Q 039817 696 LRPSMKQVLQM 706 (725)
Q Consensus 696 ~RPs~~evl~~ 706 (725)
+||+++|+++|
T Consensus 325 ~R~s~~qLl~H 335 (364)
T KOG0581|consen 325 ERPSAKQLLQH 335 (364)
T ss_pred cCCCHHHHhcC
Confidence 99999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=345.56 Aligned_cols=230 Identities=29% Similarity=0.442 Sum_probs=196.4
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc--CCCCCHHHHHHHH
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR--QEIPTWDKRVEIA 540 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~ 540 (725)
..||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|.+||.. ...+...+.+.++
T Consensus 231 ~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a 309 (468)
T KOG0197|consen 231 TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFA 309 (468)
T ss_pred CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHH
Confidence 47899988764 44567899999999999999999999999999999999999999999999986 4678999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 620 (725)
.|||+||+||+++ ++|||||.++||||++ +..+||+|||||+...++.........-+..|.|||.+..+
T Consensus 310 ~qIaeGM~YLes~---~~IHRDLAARNiLV~~-------~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~ 379 (468)
T KOG0197|consen 310 AQIAEGMAYLESK---NYIHRDLAARNILVDE-------DLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG 379 (468)
T ss_pred HHHHHHHHHHHhC---Cccchhhhhhheeecc-------CceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhC
Confidence 9999999999999 9999999999999988 88999999999997766666555555667899999999999
Q ss_pred CCCCccceehhHHHHHHHHhCC-cCCCCCCCCccccccCcchHHHHHHHHHcCCC--ChhHHHHHHHHHHHccCCCCCCC
Q 039817 621 PVTAKVDVYSFGVMLLEIIFCK-RHTELHRVDEPTLANGMILTDWVLYCVRTGNL--GATKFERITMVGLWCICPQPTLR 697 (725)
Q Consensus 621 ~~~~ksDv~S~G~vl~elltg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~R 697 (725)
.++.|||||||||+||||+|.. .|+. ++...+.+....+...+ |...++.+.+++..||+.+|++|
T Consensus 380 ~FS~kSDVWSFGVlL~E~fT~G~~py~-----------~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~R 448 (468)
T KOG0197|consen 380 KFSSKSDVWSFGVLLWELFTYGRVPYP-----------GMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDR 448 (468)
T ss_pred CcccccceeehhhhHHHHhccCCCCCC-----------CCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccC
Confidence 9999999999999999999854 4433 23333444443333333 44678999999999999999999
Q ss_pred CCHHHHHHHhcCCCCCC
Q 039817 698 PSMKQVLQMLEGTSEVG 714 (725)
Q Consensus 698 Ps~~evl~~L~~~~~~~ 714 (725)
||++.+...|+.+....
T Consensus 449 PtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 449 PTFETLREVLEDFFTST 465 (468)
T ss_pred CCHHHHHHHHHHhhhcc
Confidence 99999999998876543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=361.51 Aligned_cols=245 Identities=29% Similarity=0.430 Sum_probs=206.4
Q ss_pred ccHHHHHHHhc---ccCCcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATN---VFDGQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~---~~~~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..|++|++|.- ...++...||||.|+..... ..++|++|+++++.++|||||+|+|+|.+++..+||+|||..|+|
T Consensus 497 gaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL 576 (774)
T KOG1026|consen 497 GAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDL 576 (774)
T ss_pred chhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccH
Confidence 45777877764 33467889999999876655 778999999999999999999999999999999999999999999
Q ss_pred hhhhccC----------C----CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 522 SAFLFRQ----------E----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 522 ~~~l~~~----------~----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
.+||... . .++..+.++|+.|||.||.||-+. .+|||||..+|+||.+ +..|||+|
T Consensus 577 ~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge-------~l~VKIsD 646 (774)
T KOG1026|consen 577 HEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE-------NLVVKISD 646 (774)
T ss_pred HHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc-------ceEEEecc
Confidence 9999632 1 277889999999999999999999 9999999999999988 88999999
Q ss_pred ccCcccc-CcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHH
Q 039817 588 FGLAKLL-KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWV 665 (725)
Q Consensus 588 fgla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 665 (725)
|||++-. ..+.........-+.+|||||.|..++++.+||||||||||||+++ |+.|+.... .+.+
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS------------n~EV 714 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS------------NQEV 714 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc------------hHHH
Confidence 9999854 4444443333345779999999999999999999999999999997 666765433 2234
Q ss_pred HHHHHcCC---CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 666 LYCVRTGN---LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 666 ~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+.++.+. -+...+.++++|+..||+.+|++||+++||-..|+...+
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 45555554 355778999999999999999999999999999988653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=327.75 Aligned_cols=242 Identities=25% Similarity=0.368 Sum_probs=197.6
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCc-------cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeec
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGD-------GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 515 (725)
+....|+.++.|.+.-+++ .||||.+.+..-. ......+|+++|++|+|||||++++++...+..||||||
T Consensus 180 LGsGafg~Vkla~e~~tgk--~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~ 257 (475)
T KOG0615|consen 180 LGSGAFGLVKLAYEKKTGK--QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEY 257 (475)
T ss_pred ecCCceeEEEEEEEcccCc--EEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEE
Confidence 3456678888888776664 5777777542111 122346999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
|++|.|.+++-.++.+.+..-..++.|++.|+.|||+. +|+||||||+|||+..+. ++..+||+|||+|+..+
T Consensus 258 v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~----e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 258 VEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDA----EDCLLKITDFGLAKVSG 330 (475)
T ss_pred ecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCC----cceEEEecccchhhccc
Confidence 99999999999999999999999999999999999999 999999999999998853 36789999999999876
Q ss_pred cCCCccccccccCccccchhcccCCC---CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAP---VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
. ...+...+||+.|.|||++.++. +..|.|+||+|||||-+++|.+||.....+. .+.++ +.++
T Consensus 331 ~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------sl~eQ----I~~G 397 (475)
T KOG0615|consen 331 E--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------SLKEQ----ILKG 397 (475)
T ss_pred c--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------cHHHH----HhcC
Confidence 3 33455678999999999997663 3347899999999999999999998654332 12222 2233
Q ss_pred CCC------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLG------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+. ....++..+++.+||..||++|||++|++++
T Consensus 398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 332 2568899999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=332.15 Aligned_cols=236 Identities=29% Similarity=0.390 Sum_probs=200.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+|...+++++.-+| ..||+|.+.+. .....+...+||++.++|+|||||+++++|++.+..|||.|+|++++|.
T Consensus 29 GgFA~cYe~~~~~tg--e~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~ 106 (592)
T KOG0575|consen 29 GGFARCYEARDLDTG--EVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLM 106 (592)
T ss_pred CcceEEEEEEEcCCC--cEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHH
Confidence 445555555554444 46788877542 3445677899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
.++.+.+.+++.++..++.||+.||.|||+. +|+|||||..|+||++ +.++||+|||||..+..+..+..
T Consensus 107 el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~-------~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 107 ELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNE-------NMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred HHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecC-------cCcEEecccceeeeecCcccccc
Confidence 9999889999999999999999999999999 9999999999999988 88999999999998876655443
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFE 680 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 680 (725)
+ .+||+.|.|||++....++..+||||+|||||-|+.|++||+..... .....+.. -.+|.....
T Consensus 177 T-lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------------ety~~Ik~~~Y~~P~~ls~ 243 (592)
T KOG0575|consen 177 T-LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------------ETYNKIKLNEYSMPSHLSA 243 (592)
T ss_pred e-ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------------HHHHHHHhcCcccccccCH
Confidence 3 67999999999999999999999999999999999999999855321 12222222 245667788
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+..+||.++|++||.+|||+++|+.+
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 89999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.44 Aligned_cols=198 Identities=29% Similarity=0.433 Sum_probs=172.9
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+...+|+.|++|....++ ..||||.+.+. .....+.+..|+++|+.++|||||++++++..++..+||||||.+|+
T Consensus 18 iG~GsfavVykg~h~~~~--~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSG--TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred ccCcceEEEEEeEeccCC--ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 345677788888777666 78999998755 45566778999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+|+++.+.+++.....++.|+|.||++||++ +||||||||+||||+..... +..-.+||+|||+|+.+....
T Consensus 96 Ls~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~-~~~~~LKIADFGfAR~L~~~~-- 169 (429)
T KOG0595|consen 96 LSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARN-DTSPVLKIADFGFARFLQPGS-- 169 (429)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCC-CCCceEEecccchhhhCCchh--
Confidence 999999999999999999999999999999999 99999999999999874110 001679999999999886432
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCC
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELH 648 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~ 648 (725)
.....+|++-|||||++...+|+.|+|+||+|++||++++|+.||...
T Consensus 170 ~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 234477999999999999999999999999999999999999999743
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=309.06 Aligned_cols=244 Identities=24% Similarity=0.369 Sum_probs=198.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcc--cccCccHHHHHHHHHHHhccCcCCccceee-EEEcCCc-eeeeeecccCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLE--KVTGDGEKSFLREVQVIGRTHHKNLVQLLG-FCIEQNH-QLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~e~~~~g 519 (725)
.+.+|++++++....++. .+|.|.+. ..+.+..+....|+.+|++|+|||||++++ .+.++.+ .+||||++..|
T Consensus 28 G~GsFg~vykv~~~~~g~--l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~G 105 (375)
T KOG0591|consen 28 GRGSFGEVYKVQCLLDGK--LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAG 105 (375)
T ss_pred cCCcchheEEeeeccCcc--hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhccc
Confidence 456788888888887764 66777765 345556678999999999999999999999 4555555 89999999999
Q ss_pred Chhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccC-CceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 520 TLSAFLFR----QEIPTWDKRVEIALGIARGLLYLHEECE-TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 520 sL~~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~-~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
+|...+.. ++.++++.+++++.|+++||.++|.+.+ .-|+||||||.||+|+. ++.+||+||||++.+
T Consensus 106 DLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-------~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 106 DLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-------NGVVKLGDFGLGRFL 178 (375)
T ss_pred CHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-------CCceeeccchhHhHh
Confidence 99998853 3678999999999999999999999422 13999999999999987 899999999999988
Q ss_pred CcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
....... ...+||+.||+||.+.+.+|+.||||||+||++|||+.-+.||..... . .+...+.+++.
T Consensus 179 ~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-----------~-~L~~KI~qgd~ 245 (375)
T KOG0591|consen 179 SSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-----------L-SLCKKIEQGDY 245 (375)
T ss_pred cchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-----------H-HHHHHHHcCCC
Confidence 7655443 346799999999999999999999999999999999999999986521 1 12223334444
Q ss_pred C----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 675 G----ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 675 ~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+ ...+..+..|+..|+..||+.||+...++..+..
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3 4678899999999999999999985555554443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.24 Aligned_cols=230 Identities=26% Similarity=0.395 Sum_probs=194.0
Q ss_pred cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHH
Q 039817 461 QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVE 538 (725)
Q Consensus 461 ~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~ 538 (725)
+.+.||||.|+... +..+.+|+.|+.+|.+++||||++|.|+.......+||.|||+||+|+.||..+ +.+++.+..-
T Consensus 656 re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVg 735 (996)
T KOG0196|consen 656 REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVG 735 (996)
T ss_pred cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHH
Confidence 46799999998653 455678999999999999999999999999999999999999999999999876 6799999999
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc--cccCccccchhc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEW 616 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~--~~gt~~y~aPE~ 616 (725)
++++||.||.||-+. ++|||||.++|||++. +..+||+||||++.+.++.....+. ..-+.+|.|||.
T Consensus 736 MLrGIAsGMkYLsdm---~YVHRDLAARNILVNs-------nLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEA 805 (996)
T KOG0196|consen 736 MLRGIASGMKYLSDM---NYVHRDLAARNILVNS-------NLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEA 805 (996)
T ss_pred HHHHHHHHhHHHhhc---Cchhhhhhhhheeecc-------ceEEEeccccceeecccCCCccccccCCccceeecChhH
Confidence 999999999999998 9999999999999988 8999999999999876665333222 234568999999
Q ss_pred ccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHHHHHHHHHccCCC
Q 039817 617 LRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFERITMVGLWCICPQ 693 (725)
Q Consensus 617 ~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~d 693 (725)
|...+++.+|||||||+||||+++ |.+|+=. +...+.+..... +-+.|.+.+.-|.+|+++|||+|
T Consensus 806 Ia~RKFTsASDVWSyGIVmWEVmSyGERPYWd-----------mSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkd 874 (996)
T KOG0196|consen 806 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-----------MSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKD 874 (996)
T ss_pred hhhcccCchhhccccceEEEEecccCCCcccc-----------cchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999999996 5555522 111222222221 12455678899999999999999
Q ss_pred CCCCCCHHHHHHHhcCCC
Q 039817 694 PTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 694 p~~RPs~~evl~~L~~~~ 711 (725)
-.+||++.||+.+|+++.
T Consensus 875 R~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 875 RNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred hhcCCCHHHHHHHHHHHh
Confidence 999999999999998864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.00 Aligned_cols=222 Identities=28% Similarity=0.409 Sum_probs=189.8
Q ss_pred cceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
.+..||||++........+-+++|+.+|+..+|+|||.++..+..++++++|||||++|+|.+.+... .+++.++..|+
T Consensus 297 ~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Ic 375 (550)
T KOG0578|consen 297 TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAIC 375 (550)
T ss_pred CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHH
Confidence 34569999997665555667899999999999999999999999999999999999999999998554 48999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 620 (725)
.+++.||+|||.+ +|+|||||.+|||++. ++.+||+|||++..+........+ ..||+.|||||.+...
T Consensus 376 re~l~aL~fLH~~---gIiHrDIKSDnILL~~-------~g~vKltDFGFcaqi~~~~~KR~T-mVGTPYWMAPEVvtrk 444 (550)
T KOG0578|consen 376 REILQGLKFLHAR---GIIHRDIKSDNILLTM-------DGSVKLTDFGFCAQISEEQSKRST-MVGTPYWMAPEVVTRK 444 (550)
T ss_pred HHHHHHHHHHHhc---ceeeeccccceeEecc-------CCcEEEeeeeeeeccccccCcccc-ccCCCCccchhhhhhc
Confidence 9999999999999 9999999999999988 888999999999887766554333 5599999999999999
Q ss_pred CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCC----CChhHHHHHHHHHHHccCCCCC
Q 039817 621 PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGN----LGATKFERITMVGLWCICPQPT 695 (725)
Q Consensus 621 ~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~l~~l~~~cl~~dp~ 695 (725)
.|.+|.||||||++++||+-|.+|+..+.... +..++. .+. .+......+++++.+||+.|++
T Consensus 445 ~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------------AlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~ 512 (550)
T KOG0578|consen 445 PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------------ALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVE 512 (550)
T ss_pred ccCccccchhhhhHHHHHhcCCCCccCCChHH------------HHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchh
Confidence 99999999999999999999999997532211 111121 222 2345678899999999999999
Q ss_pred CCCCHHHHHHH
Q 039817 696 LRPSMKQVLQM 706 (725)
Q Consensus 696 ~RPs~~evl~~ 706 (725)
+|+++.|+++|
T Consensus 513 ~RasA~eLL~H 523 (550)
T KOG0578|consen 513 QRASAKELLEH 523 (550)
T ss_pred cCCCHHHHhcC
Confidence 99999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.33 Aligned_cols=247 Identities=30% Similarity=0.462 Sum_probs=200.9
Q ss_pred cccHHHHHHHhcc-cCCc--ceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNV-FDGQ--EVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~-~~~~--~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...|++|++++-. ..++ ...||||.+.+. +.+...+|++|..+|+.++|||||+++|+|......+|++|||++|+
T Consensus 702 ~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGD 781 (1025)
T KOG1095|consen 702 KGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGD 781 (1025)
T ss_pred cccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCc
Confidence 3457788877642 3333 678999999764 45567789999999999999999999999999999999999999999
Q ss_pred hhhhhccC-------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 521 LSAFLFRQ-------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 521 L~~~l~~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
|..||.+. ..++....+.++.|||+|+.|||++ ++|||||.++|+||+. ...+||+|||||+-
T Consensus 782 L~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~-------~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 782 LLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDE-------RRVVKIADFGLARD 851 (1025)
T ss_pred HHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecc-------cCcEEEcccchhHh
Confidence 99999765 3578999999999999999999999 9999999999999988 78999999999993
Q ss_pred -cCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 594 -LKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 594 -~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
+..+..+......-+..|||||.+..+.++.|+|||||||+|||++| |..|+..... .+.+......
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------~~v~~~~~~g 920 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------FEVLLDVLEG 920 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------HHHHHHHHhC
Confidence 34333333222234578999999999999999999999999999998 4455543321 1122222333
Q ss_pred CC--CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 672 GN--LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 672 ~~--~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+. .+...++.+.+|+..||+.+|++||++..+++.++.+.+
T Consensus 921 gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 921 GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 33 445678999999999999999999999999998887653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.68 Aligned_cols=245 Identities=29% Similarity=0.369 Sum_probs=195.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCC--ceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--HQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~~~gsL 521 (725)
.+.+|+.++.+++.-+ +...|||.....+....+.+.+|+++|++++|||||+++|...... .+++.|||+++|||
T Consensus 26 G~Gs~G~V~l~~~~~~--g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL 103 (313)
T KOG0198|consen 26 GRGSFGSVYLATNKKT--GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSL 103 (313)
T ss_pred cCccceEEEEEEecCC--CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcH
Confidence 4466777777776655 4567888776543333677899999999999999999999855444 68999999999999
Q ss_pred hhhhccCC-CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc--CC
Q 039817 522 SAFLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK--DQ 598 (725)
Q Consensus 522 ~~~l~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~--~~ 598 (725)
.+++.+.+ .+++..+..+..|+++||.|||++ +|+||||||+|||++.. ++.+||+|||+++.... ..
T Consensus 104 ~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~------~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 104 SDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPS------NGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCC------CCeEEeccCcccccccccccc
Confidence 99998876 799999999999999999999999 99999999999999862 47999999999987663 22
Q ss_pred CccccccccCccccchhcccCCC-CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCC
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNL 674 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 674 (725)
........||+.|||||++.++. ...++|||||||++.||+||+.||... . ............ ..+
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~---------~~~~~~~~ig~~~~~P~i 244 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F---------EEAEALLLIGREDSLPEI 244 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c---------chHHHHHHHhccCCCCCC
Confidence 22233467999999999998643 335999999999999999999999753 0 011112222212 245
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+...++...+++.+|++.||++|||+++++++.--
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 66778899999999999999999999999998643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=300.75 Aligned_cols=237 Identities=24% Similarity=0.238 Sum_probs=196.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|....+. ..+...|+|.+++. .....+..++|..+|.+++||.||+++-.|++++.+|||+||+.||.
T Consensus 34 GkG~fGkV~~Vrk~--dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGe 111 (357)
T KOG0598|consen 34 GKGSFGKVFQVRKK--DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGE 111 (357)
T ss_pred eccCCceEEEEEEc--ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCcc
Confidence 34567777666665 45567899888653 23346678999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|..+|.+.+.+++..+.-++..|+.||.|||+. +||||||||+|||||. .|.++|+||||++........
T Consensus 112 Lf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~-------~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 112 LFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDE-------QGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred HHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecC-------CCcEEEeccccchhcccCCCc
Confidence 999999999999999999999999999999999 9999999999999988 999999999999965444333
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC-C-CChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG-N-LGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~ 678 (725)
...++||+.|||||++.+..|+..+|.||+|+++|||++|.+||..... .++........ . .+...
T Consensus 182 -t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----------~~~~~~I~~~k~~~~p~~l 249 (357)
T KOG0598|consen 182 -TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----------KKMYDKILKGKLPLPPGYL 249 (357)
T ss_pred -cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----------HHHHHHHhcCcCCCCCccC
Confidence 2337899999999999999999999999999999999999999986532 22222222222 2 23336
Q ss_pred HHHHHHHHHHccCCCCCCCC----CHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRP----SMKQVL 704 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RP----s~~evl 704 (725)
..+.++++...++.||++|. .+.+|.
T Consensus 250 s~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 250 SEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred CHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 78899999999999999995 455544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.26 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=204.1
Q ss_pred cccccHHHHHHHhcccCCc-c-eEEEEEEccc---ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 443 MKVFSYQELREATNVFDGQ-E-VEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~-~-~~vavk~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
+....|++|+.++-...+. . ..||||..+. .......+|++|+++|++++|||||++||++......++|||+|.
T Consensus 165 LGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~ 244 (474)
T KOG0194|consen 165 LGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCN 244 (474)
T ss_pred eecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecC
Confidence 3456788888877665543 2 2389999874 345667899999999999999999999999999999999999999
Q ss_pred CCChhhhhccCC-CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 518 NGTLSAFLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 518 ~gsL~~~l~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
||+|++||.+.+ .++..++..++.++|+||+|||++ +++||||.++|+|++. +..+||+||||++.-..
T Consensus 245 gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~-------~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 245 GGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSK-------KGVVKISDFGLSRAGSQ 314 (474)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecC-------CCeEEeCccccccCCcc
Confidence 999999998886 599999999999999999999999 9999999999999987 67799999999886431
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG 675 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (725)
.........-+..|+|||.+....++.++|||||||++||+++ |..|+...... ....++......-..+
T Consensus 315 -~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 315 -YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRMPIP 385 (474)
T ss_pred -eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccCCCC
Confidence 1111111235678999999999999999999999999999998 67776543211 1222221111123445
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCC
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP 716 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~p 716 (725)
...+..+..++..||..+|++||+|.++.+.|+.+.....+
T Consensus 386 ~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 386 SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 56788899999999999999999999999999887654443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.02 Aligned_cols=238 Identities=28% Similarity=0.420 Sum_probs=195.6
Q ss_pred cccHHHHHHHhcccCCc----------ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeee
Q 039817 445 VFSYQELREATNVFDGQ----------EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYE 514 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~----------~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 514 (725)
.+.|++|-.-...-+|. +..||||+++... ..+|+-|++|+|+||+.+.|+|.....++||||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 44566665544433332 4567777664322 246788999999999999999999999999999
Q ss_pred cccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 515 LMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 515 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
||..|-|...|...+.++-.....|..+||.||.|||.+ .|||||||.-||||.. +..+||+|||-++..
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~-------~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISY-------DDVVKISDFGTSKEL 262 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeec-------cceEEeccccchHhh
Confidence 999999999999999999999999999999999999999 9999999999999987 778999999999876
Q ss_pred CcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
... .....+.||..|||||+|.+.+.++|.||||||||||||+||..|+............+.. ...-.+
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN--------sL~Lpv 332 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN--------SLHLPV 332 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC--------cccccC
Confidence 543 2334578999999999999999999999999999999999999999765443322211111 112356
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+...++-+.-|+++||+..|..||++.+++.||+-
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 66788889999999999999999999999999963
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.09 Aligned_cols=229 Identities=23% Similarity=0.282 Sum_probs=185.7
Q ss_pred ceEEEEEEcccccCcc---HHHHHHHHHHHhccCcCCccceeeEEEc----CCceeeeeecccCCChhhhhccCCCCCHH
Q 039817 462 EVEVAVKQLEKVTGDG---EKSFLREVQVIGRTHHKNLVQLLGFCIE----QNHQLLVYELMKNGTLSAFLFRQEIPTWD 534 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~l~~~ 534 (725)
+..||||.++...... .+.|.+|+++|++++||||++++|++.+ ....++||||+++|+|.+++.+.+.+++.
T Consensus 43 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~ 122 (283)
T PHA02988 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122 (283)
T ss_pred CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChh
Confidence 5689999987543333 4678899999999999999999999876 34678999999999999999888889999
Q ss_pred HHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccch
Q 039817 535 KRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAP 614 (725)
Q Consensus 535 ~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP 614 (725)
...+++.|++.||.|||+. .+++||||||+||+++. ++.+||+|||+++...... ....++..|+||
T Consensus 123 ~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~-------~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aP 189 (283)
T PHA02988 123 TKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTE-------NYKLKIICHGLEKILSSPP----FKNVNFMVYFSY 189 (283)
T ss_pred HHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECC-------CCcEEEcccchHhhhcccc----ccccCcccccCH
Confidence 9999999999999999973 16789999999999987 7899999999998654322 123478899999
Q ss_pred hcccC--CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCC
Q 039817 615 EWLRN--APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICP 692 (725)
Q Consensus 615 E~~~~--~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 692 (725)
|++.+ ..++.++||||||+++|||++|+.||...... .....+.........+...++.+.+++.+||+.
T Consensus 190 E~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 261 (283)
T PHA02988 190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH 261 (283)
T ss_pred HHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence 99976 68999999999999999999999999743211 111111111112233445678899999999999
Q ss_pred CCCCCCCHHHHHHHhcCCC
Q 039817 693 QPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 693 dp~~RPs~~evl~~L~~~~ 711 (725)
||++|||++||++.|+.+.
T Consensus 262 dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 262 DSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CcccCcCHHHHHHHHHHHH
Confidence 9999999999999998754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=293.42 Aligned_cols=240 Identities=21% Similarity=0.337 Sum_probs=207.3
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
+...+|+.++.|++.+.| +.||||.+++. +.++.-.+++|+++|+.|+||||+.++.+|+..+...|||||..+|
T Consensus 61 LGkGTYGKVk~A~e~~sg--R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~G 138 (668)
T KOG0611|consen 61 LGKGTYGKVKLAYEHKSG--REVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGG 138 (668)
T ss_pred hcCCcccceeehhhccCC--cEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCc
Confidence 456789999999998876 47888888653 3455567899999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
.|.+|+.+.+.+++....+++.||++|+.|+|++ +++|||||.+|||||. ++++||+||||+-++.....
T Consensus 139 eLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~-------N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 139 ELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQ-------NNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred cHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecC-------CCCeeeeccchhhhhccccH
Confidence 9999999999999999999999999999999999 9999999999999988 89999999999998765433
Q ss_pred ccccccccCccccchhcccCCCCC-CccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVT-AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
.+.++|++.|.+||.+.+.+|. +..|-||||++||-|+.|.-||+..+ ....+++.....-...+.
T Consensus 209 --LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----------hk~lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 209 --LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----------HKRLVRQISRGAYREPET 275 (668)
T ss_pred --HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----------HHHHHHHhhcccccCCCC
Confidence 3457899999999999999885 78999999999999999999998653 233344443333334456
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
+....-||+|||..||++|-|+.+|..+.
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 66788899999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.02 Aligned_cols=231 Identities=28% Similarity=0.423 Sum_probs=187.1
Q ss_pred ceEEEEEEcccccCcc-HHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCC--CCHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEI--PTWDKRVE 538 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--l~~~~~~~ 538 (725)
...||||.++...... +++|.+|+++|.+++|||||+|+|+|..++.+++|+|||++|+|.+|+.++.. +.-..-.+
T Consensus 562 ~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vs 641 (807)
T KOG1094|consen 562 PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVS 641 (807)
T ss_pred ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHH
Confidence 4689999998765444 48999999999999999999999999999999999999999999999988743 34556778
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc-CcCCCccccccccCccccchhcc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTMIRGTMGYMAPEWL 617 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~-~~~~~~~~~~~~gt~~y~aPE~~ 617 (725)
|+.|||+||+||.+. ++|||||.++|+|+|. ++++||+|||+++-+ ..+.....-...-+.+|||||.+
T Consensus 642 i~tqiasgmaYLes~---nfVHrd~a~rNcLv~~-------e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsi 711 (807)
T KOG1094|consen 642 ICTQIASGMAYLESL---NFVHRDLATRNCLVDG-------EFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESI 711 (807)
T ss_pred HHHHHHHHHHHHHhh---chhhccccccceeecC-------cccEEecCcccccccccCCceeeecceeeeeeehhHHHH
Confidence 999999999999998 9999999999999987 999999999999954 33333333345567899999999
Q ss_pred cCCCCCCccceehhHHHHHHHHh--CCcCCCCCCCCccccccCcchHHHHHHHHHc------CCCChhHHHHHHHHHHHc
Q 039817 618 RNAPVTAKVDVYSFGVMLLEIIF--CKRHTELHRVDEPTLANGMILTDWVLYCVRT------GNLGATKFERITMVGLWC 689 (725)
Q Consensus 618 ~~~~~~~ksDv~S~G~vl~ellt--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~c 689 (725)
..++++.+||||+||+.|||+++ ..+|++....+. ..+..-..... ...|...+..+.+++..|
T Consensus 712 llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--------vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~C 783 (807)
T KOG1094|consen 712 LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--------VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRC 783 (807)
T ss_pred HhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--------HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHH
Confidence 99999999999999999999974 555665332211 11111111111 123446678899999999
Q ss_pred cCCCCCCCCCHHHHHHHhcCC
Q 039817 690 ICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 690 l~~dp~~RPs~~evl~~L~~~ 710 (725)
|..|-++||+++++...|+..
T Consensus 784 w~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 784 WRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hchhhhcCCCHHHHHHHHHHh
Confidence 999999999999999999753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.47 Aligned_cols=222 Identities=23% Similarity=0.310 Sum_probs=180.7
Q ss_pred eEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC--CCCCHHHHHHH
Q 039817 463 VEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--EIPTWDKRVEI 539 (725)
Q Consensus 463 ~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i 539 (725)
..||||++.-.... ..+.+++|+..|+.++||||++++-.|..+..+++||.||.+||+.+.++.. ..+++..+..|
T Consensus 52 e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~i 131 (516)
T KOG0582|consen 52 EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATI 131 (516)
T ss_pred CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHH
Confidence 57888887533222 3588999999999999999999999999999999999999999999999765 56899999999
Q ss_pred HHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc---cccccCccccchhc
Q 039817 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS---TMIRGTMGYMAPEW 616 (725)
Q Consensus 540 ~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~---~~~~gt~~y~aPE~ 616 (725)
+.++++||.|||++ +.||||||+.||||+. +|.+||+|||.+-.+.....+.. ..+.||+.|||||+
T Consensus 132 Lre~LkaL~YLH~~---G~IHRdvKAgnILi~~-------dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEv 201 (516)
T KOG0582|consen 132 LREVLKALDYLHQN---GHIHRDVKAGNILIDS-------DGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEV 201 (516)
T ss_pred HHHHHHHHHHHHhc---CceecccccccEEEcC-------CCcEEEcCceeeeeecccCceeeEeeccccCcccccChHH
Confidence 99999999999999 9999999999999988 89999999998765543322221 34579999999999
Q ss_pred ccC--CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC--------Ch----hHHHHH
Q 039817 617 LRN--APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL--------GA----TKFERI 682 (725)
Q Consensus 617 ~~~--~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~----~~~~~l 682 (725)
+.. ..|+.|+||||||+...||.+|..||..... .+.+...++ +.. +. .....+
T Consensus 202 l~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----------mkvLl~tLq-n~pp~~~t~~~~~d~~k~~~ksf 269 (516)
T KOG0582|consen 202 LMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----------MKVLLLTLQ-NDPPTLLTSGLDKDEDKKFSKSF 269 (516)
T ss_pred hhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----------HHHHHHHhc-CCCCCcccccCChHHhhhhcHHH
Confidence 543 4799999999999999999999999974321 111111111 111 11 234578
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++++..||++||++|||+++++++
T Consensus 270 ~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 270 REMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHHHHHhhcCcccCCCHHHHhcc
Confidence 899999999999999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=303.12 Aligned_cols=243 Identities=25% Similarity=0.287 Sum_probs=204.2
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
+...+|+.|..|++.-.+ ..+|||.+.+. .+.-.+....|-++|.+| .||.|++|+--|+++..+|+|+||+++
T Consensus 81 lGeGSYStV~~A~~~~t~--keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~n 158 (604)
T KOG0592|consen 81 LGEGSYSTVVLAREKATG--KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPN 158 (604)
T ss_pred eccccceeEEEeeecCCC--ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCC
Confidence 455678888889887754 57788887642 223345577899999999 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
|.|.++|.+.+.+++.....++.+|+.||+|||+. +||||||||+|||||. ++.+||+|||-|+.+....
T Consensus 159 Gdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~-------dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 159 GDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDK-------DGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred CcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcC-------CCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999 9999999999999988 8999999999999875322
Q ss_pred Cc----------cc--cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHH
Q 039817 599 TR----------TS--TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL 666 (725)
Q Consensus 599 ~~----------~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (725)
.. .. ..++||..|.+||.+..+..+..+|+|+|||+||.|+.|++||.... +...-+.+.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--------eyliFqkI~ 300 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--------EYLIFQKIQ 300 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--------HHHHHHHHH
Confidence 21 11 34789999999999999999999999999999999999999997542 122222222
Q ss_pred HHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 667 YCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 667 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
. ..-.++...++.+.+|+.+.|..||.+|+|.+||.+|.
T Consensus 301 ~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 301 A--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred H--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1 23456777789999999999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=299.51 Aligned_cols=261 Identities=25% Similarity=0.266 Sum_probs=202.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~g 519 (725)
...+|++|++|.+.-+++ .||+|++.... ..-..-..+||.+|++|.||||++|.+...+. ..+|||+|||+.
T Consensus 126 GeGTyg~VYkAr~~~tgk--ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh- 202 (560)
T KOG0600|consen 126 GEGTYGQVYKARDLETGK--IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH- 202 (560)
T ss_pred cCcchhheeEeeecccCc--EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-
Confidence 457899999999887764 67888875433 44455678999999999999999999998876 689999999998
Q ss_pred ChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 520 TLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 520 sL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+|.-++... -.++..++..++.|++.||.|+|.. +|+|||||.+|||||+ ++.+||+|||||+++....
T Consensus 203 DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn-------~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 203 DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDN-------NGVLKIADFGLARFYTPSG 272 (560)
T ss_pred hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcC-------CCCEEeccccceeeccCCC
Confidence 888888664 4789999999999999999999999 9999999999999988 8999999999999888777
Q ss_pred CccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccc-----cccCcchHHHHHHHHHcC
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT-----LANGMILTDWVLYCVRTG 672 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 672 (725)
....+..+-|.-|.|||.+.+. .|+.+.|+||.||||.||++|++.+.....-++. +-.......|- ..
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-----~~ 347 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-----VS 347 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-----cc
Confidence 6666767789999999999875 7999999999999999999999988754322110 00000000011 00
Q ss_pred CCC-------------------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCCCCccccC
Q 039817 673 NLG-------------------ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVVADAQ 723 (725)
Q Consensus 673 ~~~-------------------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~p~~~~~~~ 723 (725)
.++ ...++...+|+..+|..||.+|.|+.++++.= =+..-+.|..|++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se-yF~t~p~~~~p~~Lp 416 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE-YFTTEPLPCDPSSLP 416 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc-ccccCCCCCCcccCC
Confidence 111 12345677889999999999999999998642 112344444444443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.87 Aligned_cols=247 Identities=27% Similarity=0.383 Sum_probs=191.9
Q ss_pred ccccHHHHHHHhccc---CCcceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcC-Cceeeeeeccc
Q 039817 444 KVFSYQELREATNVF---DGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQ-NHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~lV~e~~~ 517 (725)
...+|+.|++|.... ......||||.+..... ...+.+.+|++++.++ +||||++++++|... +..++||||++
T Consensus 16 G~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~ 95 (338)
T cd05102 16 GHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCK 95 (338)
T ss_pred ccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCC
Confidence 345677888776421 22345799999864332 3346799999999999 899999999998764 46889999999
Q ss_pred CCChhhhhccC--------------------------------------------------------------CCCCHHH
Q 039817 518 NGTLSAFLFRQ--------------------------------------------------------------EIPTWDK 535 (725)
Q Consensus 518 ~gsL~~~l~~~--------------------------------------------------------------~~l~~~~ 535 (725)
+|+|.+++... ..+++..
T Consensus 96 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 175 (338)
T cd05102 96 YGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED 175 (338)
T ss_pred CCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHH
Confidence 99999998642 2367788
Q ss_pred HHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc-ccccccCccccch
Q 039817 536 RVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAP 614 (725)
Q Consensus 536 ~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aP 614 (725)
+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++......... .....++..|+||
T Consensus 176 ~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~-------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 176 LICYSFQVARGMEFLASR---KCIHRDLAARNILLSE-------NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred HHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcC-------CCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 899999999999999998 9999999999999987 7889999999998654322211 1123456789999
Q ss_pred hcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCChhHHHHHHHHHHHcc
Q 039817 615 EWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGATKFERITMVGLWCI 690 (725)
Q Consensus 615 E~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl 690 (725)
|.+.+..++.++||||||+++|||++ |..|+....... ........ ...+...++.+.+++.+||
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----------EFCQRLKDGTRMRAPENATPEIYRIMLACW 314 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 99999999999999999999999997 888886532211 01111111 1223455678999999999
Q ss_pred CCCCCCCCCHHHHHHHhcCCC
Q 039817 691 CPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 691 ~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.||++|||+.||++.|+.+.
T Consensus 315 ~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 315 QGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred cCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.98 Aligned_cols=238 Identities=23% Similarity=0.366 Sum_probs=196.4
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc----cC-ccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecc
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV----TG-DGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
+...+|+.++.|....++ ..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++......++||||+
T Consensus 25 lG~GsfgkV~~a~~~~t~--~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~ 102 (370)
T KOG0583|consen 25 LGSGSFGKVKLAKHRLTG--EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYC 102 (370)
T ss_pred ecCCCCeeEEEeeeccCC--CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEec
Confidence 345567788888777766 56778865442 11 33556778999999998 999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCC-CceEEeeccCccccC
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN-YITKIADFGLAKLLK 595 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~-~~~kl~Dfgla~~~~ 595 (725)
.+|.|.+++.+.+++.+.....++.|+++|++|+|+. +|+||||||+|||++. + +++||+|||++....
T Consensus 103 ~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~-------~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 103 SGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG-------NEGNLKLSDFGLSAISP 172 (370)
T ss_pred CCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC-------CCCCEEEeccccccccC
Confidence 9999999999988999999999999999999999999 9999999999999987 5 899999999999874
Q ss_pred cCCCccccccccCccccchhcccCCC-CC-CccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC-
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAP-VT-AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG- 672 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 672 (725)
.........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ...... +..+
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----------~~l~~k-i~~~~ 239 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----------PNLYRK-IRKGE 239 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----------HHHHHH-HhcCC
Confidence 1222334567999999999999877 76 789999999999999999999986321 111111 2233
Q ss_pred -CCChhH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 673 -NLGATK-FERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 673 -~~~~~~-~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
.++... ...+..++.+|++.||.+|+|+.++++
T Consensus 240 ~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 344445 889999999999999999999999993
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.02 Aligned_cols=241 Identities=32% Similarity=0.482 Sum_probs=187.0
Q ss_pred ccHHHHHHHhcc--cCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNV--FDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~--~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|+++++|+.. -......|+||.++... ....+.|.+|++.+++++||||++++|+|...+..++||||+++|+|.
T Consensus 10 G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~ 89 (259)
T PF07714_consen 10 GSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLD 89 (259)
T ss_dssp ESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHH
T ss_pred CCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccc
Confidence 445566666655 34567899999996533 334688999999999999999999999999888899999999999999
Q ss_pred hhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-
Q 039817 523 AFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT- 599 (725)
Q Consensus 523 ~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~- 599 (725)
++|... ..+++..+..|+.|+++||.|||+. +++|++|+++||+++. ++.+||+|||++........
T Consensus 90 ~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~-------~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 90 DYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDS-------NGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp HHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEET-------TTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccc---cccccccccccccccc-------ccccccccccccccccccccc
Confidence 999886 6789999999999999999999999 9999999999999988 78999999999987632222
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCCh
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGA 676 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 676 (725)
...........|+|||.+....++.++||||||+++|||++ |+.|+.... ..+....... ....+.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----------~~~~~~~~~~~~~~~~~~ 228 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----------NEEIIEKLKQGQRLPIPD 228 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----------HHHHHHHHHTTEETTSBT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-----------cccccccccccccceecc
Confidence 12222446778999999998889999999999999999999 567654321 1111222211 122344
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
..+..+.+++..||+.+|++|||+.++++.|
T Consensus 229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 5678899999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.04 Aligned_cols=240 Identities=25% Similarity=0.319 Sum_probs=202.2
Q ss_pred CcccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccC
Q 039817 442 NMKVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 442 ~~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
.+...+-+-++.|++..+|+ .+|||.+.+. .......+.+|+-+|+.+.|||++++|++++++.++|+|.||+++
T Consensus 19 TLG~Gstg~vrlakh~~TGq--laaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 19 TLGKGSTGCVRLAKHAETGQ--LAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccCCCCceehhhhcccccc--eeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 34455667788888888775 5677766443 333455688999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
|-|.+++.+++.+++....+++.||+.|+.|+|.. +|+|||+||+|+|||. .+++||+|||+|.+-..+.
T Consensus 97 GELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~-------~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 97 GELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDV-------KNNIKIADFGMASLEVPGK 166 (786)
T ss_pred chhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhc-------ccCEeeeccceeecccCCc
Confidence 99999999999999999999999999999999999 9999999999999988 6679999999998765443
Q ss_pred CccccccccCccccchhcccCCCCC-CccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCC
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNAPVT-AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLG 675 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 675 (725)
-. ..-+|.+.|.+||.+.+.+|. .++||||.||+||.|++|+.||+... +.. +....++| .+|
T Consensus 167 lL--eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----------ir~-LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 167 LL--ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----------IRV-LLLKVQRGVFEMP 232 (786)
T ss_pred cc--cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----------HHH-HHHHHHcCcccCC
Confidence 32 335699999999999999886 68999999999999999999998332 111 22223334 466
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
...+.+.++|+.+|+..||..|.|++||++|-
T Consensus 233 s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 233 SNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred CcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 78889999999999999999999999999984
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=298.82 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=195.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHH-HHHHHHHHhccC-cCCccceeeEEEcCC-ceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTH-HKNLVQLLGFCIEQN-HQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~-f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV~e~~~~gs 520 (725)
...+|++|+.|.....++. ||||++++....-++. =++|+..|++|. |||||+|..++.+.+ .+++|||||+. +
T Consensus 19 GDGTfGsV~la~~~~~~~~--VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-N 95 (538)
T KOG0661|consen 19 GDGTFGSVYLAKSKETGEL--VAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-N 95 (538)
T ss_pred cCCcceeEEEeeecCCCce--eeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-h
Confidence 4568999999999888764 8999997655443332 379999999998 999999999999988 99999999986 8
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+.+..+ +.+++..+..|+.||++||+|+|++ ++.|||+||+|||+.. ...+||+|||+||......
T Consensus 96 LYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~-------~~~iKiaDFGLARev~Skp- 164 (538)
T KOG0661|consen 96 LYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISG-------NDVIKIADFGLAREVRSKP- 164 (538)
T ss_pred HHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecc-------cceeEecccccccccccCC-
Confidence 99998765 6789999999999999999999999 9999999999999976 6789999999999875433
Q ss_pred ccccccccCccccchhccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----ccCcchHHHHH--HH--H
Q 039817 600 RTSTMIRGTMGYMAPEWLR-NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----ANGMILTDWVL--YC--V 669 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~~~~~~~~~~--~~--~ 669 (725)
.-+..+.|.-|+|||++. .+.|+.+.|+|++||+++|+.+-++.|.+....++.. ........|.. .+ .
T Consensus 165 -PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 165 -PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred -CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 234456889999999874 6789999999999999999999999887654322110 00000111111 00 0
Q ss_pred HcCCC-----------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 670 RTGNL-----------GATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 670 ~~~~~-----------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
..-.+ ......+..+++..|++.||.+|||++|++++-
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00111 113567889999999999999999999999874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.46 Aligned_cols=242 Identities=28% Similarity=0.332 Sum_probs=201.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
-..|+|++.+... .-...||||.|+. +.-..++|+.|+.+|+.++|||+|+|+|+|..+..+|||+|||.+|+|.+|
T Consensus 277 GGQYGeVYeGvWK--kyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdY 353 (1157)
T KOG4278|consen 277 GGQYGEVYEGVWK--KYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDY 353 (1157)
T ss_pred CCcccceeeeeee--ccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHH
Confidence 3567888776533 3357899999965 345678999999999999999999999999999999999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
|.+. ..++--..+.++.||++||.||..+ ++|||||.++|+|+.+ +..+||+||||++++..+.....
T Consensus 354 LRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgE-------nhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 354 LRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGE-------NHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred HHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccc-------cceEEeeccchhhhhcCCceecc
Confidence 9765 3456677889999999999999999 9999999999999988 88999999999999988876655
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhC-CcCCCCCCCCccccccCcchHHHHHHHHHcC---CCChhH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC-KRHTELHRVDEPTLANGMILTDWVLYCVRTG---NLGATK 678 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 678 (725)
....-++.|.|||-+....++.|+|||+|||+||||.|- -.|+..- . ...+..++.++ .-+...
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----------d-lSqVY~LLEkgyRM~~PeGC 491 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------D-LSQVYGLLEKGYRMDGPEGC 491 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----------c-HHHHHHHHhccccccCCCCC
Confidence 444557789999999999999999999999999999984 4454322 1 22333333332 345577
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
++.+.+|++.||+.+|.+||++.|+-+.+|.+.
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 899999999999999999999999999887653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.39 Aligned_cols=238 Identities=23% Similarity=0.236 Sum_probs=191.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|+.++.+.+..+ +..+|+|.+.... ......+.+|++++++++||||+++++++..++..++||||+++++|.
T Consensus 6 G~~g~Vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 83 (323)
T cd05571 6 GTFGKVILVREKAT--GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83 (323)
T ss_pred CCCeEEEEEEECCC--CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHH
Confidence 34555666655444 3578888876432 233456889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+.+.+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....... ..
T Consensus 84 ~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~-------~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 84 FHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDK-------DGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECC-------CCCEEEeeCCCCcccccCCC-cc
Confidence 9998888899999999999999999999999 9999999999999987 78899999999875322211 12
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ......++....+.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~--~~~~~~~p~~~~~~~ 222 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELI--LMEEIRFPRTLSPEA 222 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHH--HcCCCCCCCCCCHHH
Confidence 2356899999999999999999999999999999999999998643211 011111 111223455667889
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999999 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.91 Aligned_cols=231 Identities=27% Similarity=0.431 Sum_probs=185.7
Q ss_pred EEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHHHH
Q 039817 464 EVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIA 540 (725)
Q Consensus 464 ~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~ 540 (725)
.||||.|+-. ..+..+.|++|+.++++-+|.||+-+.|+|..... .||+.+|++.+|..+|+-. ..+...+...|+
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIA 494 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIA 494 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHH
Confidence 6899988643 33456789999999999999999999999999888 9999999999999999866 578999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC-CccccccccCccccchhcccC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ-TRTSTMIRGTMGYMAPEWLRN 619 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~ 619 (725)
.|||.||.|||.+ +|||||||..||||.+ ++.|||+||||+..-..-. ........|...|||||++..
T Consensus 495 qQiaqGM~YLHAK---~IIHrDLKSnNIFl~~-------~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRm 564 (678)
T KOG0193|consen 495 QQIAQGMDYLHAK---NIIHRDLKSNNIFLHE-------DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRM 564 (678)
T ss_pred HHHHHhhhhhhhh---hhhhhhccccceEEcc-------CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhh
Confidence 9999999999999 9999999999999987 7899999999987543221 111222347889999999863
Q ss_pred ---CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc--cCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCC
Q 039817 620 ---APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--NGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQP 694 (725)
Q Consensus 620 ---~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp 694 (725)
.+|++.+||||||+|+|||++|..|+.....+..... .+....+. ........+.|.+|+..||..++
T Consensus 565 qd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~-------s~~~s~~pk~mk~Ll~~C~~~~~ 637 (678)
T KOG0193|consen 565 QDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL-------SKIRSNCPKAMKRLLSDCWKFDR 637 (678)
T ss_pred cccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc-------hhhhccCHHHHHHHHHHHHhcCc
Confidence 4799999999999999999999999984333221111 11111111 11222456789999999999999
Q ss_pred CCCCCHHHHHHHhcCCCC
Q 039817 695 TLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 695 ~~RPs~~evl~~L~~~~~ 712 (725)
++||.+.+|+..|+.+..
T Consensus 638 ~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 638 EERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccCccHHHHHHHHHHhhh
Confidence 999999999998887764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.67 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=191.4
Q ss_pred ccccHHHHHHHhcc---cCCcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccC
Q 039817 444 KVFSYQELREATNV---FDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~---~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
...+|+.|++++.. ..+....||||.++... ....+.+.+|++++..+ +||||++++++|..++..++||||+++
T Consensus 44 G~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~ 123 (375)
T cd05104 44 GAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCY 123 (375)
T ss_pred cCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccC
Confidence 34567777777532 22345689999986432 33456789999999999 899999999999999999999999999
Q ss_pred CChhhhhccCC---------------------------------------------------------------------
Q 039817 519 GTLSAFLFRQE--------------------------------------------------------------------- 529 (725)
Q Consensus 519 gsL~~~l~~~~--------------------------------------------------------------------- 529 (725)
|+|.+++....
T Consensus 124 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (375)
T cd05104 124 GDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEI 203 (375)
T ss_pred CcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHH
Confidence 99999985421
Q ss_pred ------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc-c
Q 039817 530 ------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-S 602 (725)
Q Consensus 530 ------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-~ 602 (725)
.+++..+.+++.|+++||.|||+. +|+||||||+|||++. +..+||+|||+++......... .
T Consensus 204 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~-------~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 204 LEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTH-------GRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEEC-------CCcEEEecCccceeccCccccccc
Confidence 367888999999999999999998 9999999999999987 7789999999998654332211 1
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ...+.+.... ....+...+.+
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~ 345 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------KFYKMIKEGY-RMLSPECAPSE 345 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------HHHHHHHhCc-cCCCCCCCCHH
Confidence 12235667999999999999999999999999999998 777765322111 1111111110 01122334578
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
+.+|+.+||+.||++||++.||+++|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=296.75 Aligned_cols=240 Identities=24% Similarity=0.344 Sum_probs=198.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCc-eeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH-QLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~e~~~~gsL~~ 523 (725)
+..|+......+..++....++.+.+.......++...+|+.++++++|||||.+++.+.+++. .+|||+|++||+|.+
T Consensus 14 ~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~ 93 (426)
T KOG0589|consen 14 RGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQ 93 (426)
T ss_pred ccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHH
Confidence 3445555555554445444444445555556666788999999999999999999999999998 999999999999999
Q ss_pred hhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+.+++ .++++++..++.|++.|+.|||++ .|+|||||+.|||++. +..+||+|||+|+.+..+....
T Consensus 94 ~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk-------~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 94 LIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTK-------DKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred HHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccc-------cCceeecchhhhhhcCCchhhh
Confidence 998764 579999999999999999999998 9999999999999987 7778999999999987765333
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 679 (725)
....||+.||.||.+.+.+|..|+|||||||++|||++-+++|..... ...+..... -..++..+.
T Consensus 164 -~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----------~~Li~ki~~~~~~Plp~~ys 231 (426)
T KOG0589|consen 164 -STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----------SELILKINRGLYSPLPSMYS 231 (426)
T ss_pred -heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------HHHHHHHhhccCCCCCcccc
Confidence 335699999999999999999999999999999999999999975432 222222222 245677888
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..++.++..|++.+|..||++.+++.+
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999999999876
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=292.81 Aligned_cols=248 Identities=22% Similarity=0.281 Sum_probs=194.5
Q ss_pred ccccHHHHHHHhccc-CCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVF-DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~-~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.|++|+... ......||+|.++... ....+.|.+|+.++++++||||++++|++..++..++||||+++|+|
T Consensus 14 g~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
T cd05064 14 GTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93 (266)
T ss_pred cccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcH
Confidence 344567777766443 2356789999987542 23345799999999999999999999999999999999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++.+. ..+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+|++|||.+.........
T Consensus 94 ~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~-------~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 94 DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNS-------DLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcC-------CCcEEECCCcccccccccchh
Confidence 9999764 5789999999999999999999999 9999999999999987 789999999987654322211
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
......++..|+|||.+.+..++.++||||||+++||+++ |+.|+...... ...+.+... .....+...+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~-~~~~~~~~~~ 234 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDG-FRLPAPRNCP 234 (266)
T ss_pred cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCC-CCCCCCCCCC
Confidence 1112335678999999999999999999999999999875 88887543211 011111110 0112344566
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..+.+++..||+.+|.+||++++|++.|+++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 7899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=285.04 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=188.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhc--cCcCCccceeeEEEcCC----ceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR--THHKNLVQLLGFCIEQN----HQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e~~~~g 519 (725)
..|+.|++|.- .++.||||++. .+..+.|.+|-++++. ++|+||+++++.-..+. +++||+||.++|
T Consensus 221 Grfg~V~KaqL----~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kG 293 (534)
T KOG3653|consen 221 GRFGCVWKAQL----DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKG 293 (534)
T ss_pred Cccceeehhhc----cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCC
Confidence 34444444432 24789999994 5667889999999875 68999999999987655 889999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcc------cCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEE------CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
||.+||. ...++|....+|+..+++||+|||+. .+|+|+|||||++||||.+ +++..|+|||||..
T Consensus 294 sL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-------DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 294 SLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-------DLTCCIADFGLALR 365 (534)
T ss_pred cHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-------CCcEEeeccceeEE
Confidence 9999995 45689999999999999999999976 4578999999999999988 89999999999998
Q ss_pred cCcCCCcccc-ccccCccccchhcccCCC-CC-----CccceehhHHHHHHHHhCCcCCCCCCCCc------cccccCc-
Q 039817 594 LKKDQTRTST-MIRGTMGYMAPEWLRNAP-VT-----AKVDVYSFGVMLLEIIFCKRHTELHRVDE------PTLANGM- 659 (725)
Q Consensus 594 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~-~~-----~ksDv~S~G~vl~elltg~~~~~~~~~~~------~~~~~~~- 659 (725)
+......... ..+||.+|||||++.+.- +. .+.||||+|.|||||++.-.........+ ..+....
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 7654443322 356999999999997652 22 35899999999999998665443111000 0011111
Q ss_pred --chHHHHHHHHHcCCCCh-----hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 660 --ILTDWVLYCVRTGNLGA-----TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 660 --~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+.+.+.....+..++. ..+..+++.+..||..||+.|.|+.=|-+.+..+..
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 12222222222233332 456789999999999999999999888777766543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=299.91 Aligned_cols=236 Identities=22% Similarity=0.227 Sum_probs=189.7
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|+.++++.+.-+ +..||+|.+... .......+.+|++++++++||||+++++++..++..++||||+++|+|.+
T Consensus 5 ~~g~Vy~~~~~~~--~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 82 (312)
T cd05585 5 SFGKVMQVRKRDT--QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH 82 (312)
T ss_pred CCeEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHH
Confidence 4556666665433 457889987542 23445678899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
++.+...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++....... ...
T Consensus 83 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~-------~~~~kl~Dfg~~~~~~~~~~-~~~ 151 (312)
T cd05585 83 HLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDY-------QGHIALCDFGLCKLNMKDDD-KTN 151 (312)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECC-------CCcEEEEECcccccCccCCC-ccc
Confidence 998888899999999999999999999999 9999999999999987 78999999999986433222 122
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 682 (725)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+....... ...++....+.+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 220 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------NEMYRKILQEPLRFPDGFDRDA 220 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----------HHHHHHHHcCCCCCCCcCCHHH
Confidence 34589999999999999999999999999999999999999864321 111111111 123445567789
Q ss_pred HHHHHHccCCCCCCCCC---HHHHHHH
Q 039817 683 TMVGLWCICPQPTLRPS---MKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs---~~evl~~ 706 (725)
.+++.+||+.||++||+ +.|++++
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 99999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=306.68 Aligned_cols=250 Identities=27% Similarity=0.356 Sum_probs=192.6
Q ss_pred ccccHHHHHHHhcccC---CcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccC
Q 039817 444 KVFSYQELREATNVFD---GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~---~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
....|+.++++.+.-. .....||||.+.... ......+.+|+++++++ +|+|||+++++|...+..++||||+++
T Consensus 47 G~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~ 126 (374)
T cd05106 47 GAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126 (374)
T ss_pred cCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccC
Confidence 3456777777664322 234579999986533 23345688999999999 899999999999999999999999999
Q ss_pred CChhhhhccC----------------------------------------------------------------------
Q 039817 519 GTLSAFLFRQ---------------------------------------------------------------------- 528 (725)
Q Consensus 519 gsL~~~l~~~---------------------------------------------------------------------- 528 (725)
|+|.+++.+.
T Consensus 127 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (374)
T cd05106 127 GDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDS 206 (374)
T ss_pred CcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCC
Confidence 9999988532
Q ss_pred CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc-cccccc
Q 039817 529 EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-STMIRG 607 (725)
Q Consensus 529 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~g 607 (725)
..+++..+.+++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++......... .....+
T Consensus 207 ~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~-------~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 207 WPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTD-------GRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred CCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeC-------CCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 1367888999999999999999998 9999999999999987 7789999999998654332211 112235
Q ss_pred CccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHH
Q 039817 608 TMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG 686 (725)
Q Consensus 608 t~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 686 (725)
+..|+|||++.+..++.++||||||+++|||++ |+.|+....... ........ ......+...+..+.+++
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~-~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKR-GYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHc-ccCccCCCCCCHHHHHHH
Confidence 668999999998899999999999999999997 998886432111 11111111 011122333467899999
Q ss_pred HHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 687 LWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 687 ~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+||+.||++|||+.+|+++|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=296.92 Aligned_cols=237 Identities=25% Similarity=0.336 Sum_probs=200.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|+.+|++++..+. ..||+|.+.+. .....+.+++|++++++++|||||.++++|+...+.++|.||+.+ +|.
T Consensus 12 ~Gsfg~VYKgrrK~t~--~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~ 88 (808)
T KOG0597|consen 12 EGSFGRVYKGRRKYTI--QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLF 88 (808)
T ss_pred CCccceeeecccccce--eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHH
Confidence 4567777777776654 57889888643 334456789999999999999999999999999999999999987 999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
.+|...+.++++.+..|+.|++.||.|||+. +|+|||+||+|||++. .+.+|++|||+|+.+.... ...
T Consensus 89 ~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~-------~~~~KlcdFg~Ar~m~~~t-~vl 157 (808)
T KOG0597|consen 89 TILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEK-------GGTLKLCDFGLARAMSTNT-SVL 157 (808)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecC-------CCceeechhhhhhhcccCc-eee
Confidence 9999999999999999999999999999999 9999999999999987 8999999999999876533 334
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-CCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT-GNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 681 (725)
+.+.||+-|||||...+++|+..+|.||+||++||+++|++||.... +.+.+...... ...+......
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----------i~~Lv~~I~~d~v~~p~~~S~~ 226 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----------ITQLVKSILKDPVKPPSTASSS 226 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----------HHHHHHHHhcCCCCCcccccHH
Confidence 56789999999999999999999999999999999999999997432 12222222222 1234466778
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+++++.-.+++||.+|.|..+++.|
T Consensus 227 f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 227 FVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHHhhcChhhcccHHHHhcC
Confidence 9999999999999999999999865
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.52 Aligned_cols=232 Identities=26% Similarity=0.383 Sum_probs=180.8
Q ss_pred CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC----------
Q 039817 460 GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ---------- 528 (725)
Q Consensus 460 ~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---------- 528 (725)
+....||+|.+.... .....+|.+|++++.+++||||+++++++...+..++||||+++++|.+++...
T Consensus 44 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 123 (304)
T cd05096 44 GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123 (304)
T ss_pred CcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccc
Confidence 445689999886532 334567999999999999999999999999999999999999999999988543
Q ss_pred ---------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 529 ---------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 529 ---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
..+++..+.+++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 124 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~-------~~~~kl~DfG~~~~~~~~~~ 193 (304)
T cd05096 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGE-------NLTIKIADFGMSRNLYAGDY 193 (304)
T ss_pred cccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchhheEEcC-------CccEEECCCccceecccCce
Confidence 2367889999999999999999999 9999999999999987 78999999999986533222
Q ss_pred cc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCC--cCCCCCCCCccccccCcchHHHHHHHHHc-----
Q 039817 600 RT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK--RHTELHRVDEPTLANGMILTDWVLYCVRT----- 671 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 671 (725)
.. .....++..|+|||++.++.++.++||||||+++|||+++. .|+...... ...+........
T Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~~~ 265 (304)
T cd05096 194 YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE--------QVIENAGEFFRDQGRQV 265 (304)
T ss_pred eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH--------HHHHHHHHHhhhccccc
Confidence 11 12233577899999998889999999999999999999754 444422111 111111111111
Q ss_pred -CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 672 -GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 672 -~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
...+...++.+.+++.+||+.+|++|||+.||.+.|+.
T Consensus 266 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 266 YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 11223456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=275.49 Aligned_cols=248 Identities=22% Similarity=0.246 Sum_probs=190.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|+.+.+..+.-+ ++.||||++.... +...+-.++|+++|++++|+|+|.|+.+|......+||+||++..-|+
T Consensus 12 EGSYGvV~KCrnk~T--gqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~ 89 (396)
T KOG0593|consen 12 EGSYGVVMKCRNKDT--GQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLH 89 (396)
T ss_pred cCcceEEEEeccCCc--ccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHH
Confidence 445666666665544 4689999985432 233455789999999999999999999999999999999999986666
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+.-......+.+.+.+++.|++.|+.|+|++ ++|||||||+|||++. ++.+||+|||.|+.+... ...-
T Consensus 90 eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~-------~gvvKLCDFGFAR~L~~p-gd~Y 158 (396)
T KOG0593|consen 90 ELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQ-------NGVVKLCDFGFARTLSAP-GDNY 158 (396)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEec-------CCcEEeccchhhHhhcCC-cchh
Confidence 6655557789999999999999999999999 9999999999999988 899999999999987752 2233
Q ss_pred cccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHHHHHHHcC-----
Q 039817 603 TMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLYCVRTG----- 672 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~----- 672 (725)
+..+.|..|+|||.+.+ .+|....|||++||++.||++|.+.|.....-++-.. -+..+... ...+...
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh-q~iF~~N~~F~G 237 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH-QSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH-HHHhccCCceee
Confidence 44567889999999987 6899999999999999999999998876543221000 00011111 1111111
Q ss_pred -CCCh------------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 -NLGA------------TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 -~~~~------------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+|. .....+.+++..|++.||.+|++-+|++.+
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0111 234568899999999999999999999854
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.05 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=191.9
Q ss_pred ccHHHHHHHhcccCC---cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDG---QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~---~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..++.++.+.....+ ....|++|.+.... ......|.+|++++++++||||+++++++...+..+++|||+++++|
T Consensus 16 G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L 95 (283)
T cd05048 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95 (283)
T ss_pred ccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcH
Confidence 345556655543322 34578999886432 23456799999999999999999999999999999999999999999
Q ss_pred hhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEE
Q 039817 522 SAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585 (725)
Q Consensus 522 ~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl 585 (725)
.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~-------~~~~~L 165 (283)
T cd05048 96 HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE-------GLTVKI 165 (283)
T ss_pred HHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC-------CCcEEE
Confidence 9999654 3478889999999999999999999 9999999999999987 788999
Q ss_pred eeccCccccCcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHH
Q 039817 586 ADFGLAKLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTD 663 (725)
Q Consensus 586 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~ 663 (725)
+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--------~~~~ 237 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------EVIE 237 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHH
Confidence 99999986533221 11223346788999999998899999999999999999998 88887643211 1111
Q ss_pred HHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 664 WVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+... .....+...+.++.+|+.+||+.||.+||+++||+++|+++
T Consensus 238 ~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 MIRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11110 01123445678999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=287.73 Aligned_cols=230 Identities=21% Similarity=0.361 Sum_probs=181.1
Q ss_pred CcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc-CCCCCHHHHHH
Q 039817 460 GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR-QEIPTWDKRVE 538 (725)
Q Consensus 460 ~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~ 538 (725)
+....|++|.+.........+|.+|++++++++|+||++++++|..+...++||||+++|+|..++.+ ...+++..+..
T Consensus 42 ~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~ 121 (274)
T cd05076 42 GRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121 (274)
T ss_pred CeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHH
Confidence 44568999998765555566899999999999999999999999999999999999999999999965 46789999999
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhccc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 618 (725)
++.|+++||+|||+. +|+||||||+||+++...........+|++|||++....... ...++..|+|||.+.
T Consensus 122 i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~ 193 (274)
T cd05076 122 VAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCcccccccccc-----ccccCCcccCchhhc
Confidence 999999999999999 999999999999997632211223458999999886443221 123677899999887
Q ss_pred C-CCCCCccceehhHHHHHHHH-hCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCC
Q 039817 619 N-APVTAKVDVYSFGVMLLEII-FCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTL 696 (725)
Q Consensus 619 ~-~~~~~ksDv~S~G~vl~ell-tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~ 696 (725)
+ ..++.++||||||+++|||+ +|+.|+....... .... .......+......+.+++.+||+.+|++
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 262 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--------KERF---YEKKHRLPEPSCKELATLISQCLTYEPTQ 262 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--------HHHH---HHhccCCCCCCChHHHHHHHHHcccChhh
Confidence 5 56899999999999999995 6777775432111 1111 11122333444567899999999999999
Q ss_pred CCCHHHHHHHhc
Q 039817 697 RPSMKQVLQMLE 708 (725)
Q Consensus 697 RPs~~evl~~L~ 708 (725)
|||+.+|++.|+
T Consensus 263 Rps~~~il~~L~ 274 (274)
T cd05076 263 RPSFRTILRDLT 274 (274)
T ss_pred CcCHHHHHHhhC
Confidence 999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.78 Aligned_cols=239 Identities=23% Similarity=0.230 Sum_probs=191.0
Q ss_pred ccHHHHHHHhccc-CCcceEEEEEEcccc----cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 446 FSYQELREATNVF-DGQEVEVAVKQLEKV----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 446 ~~~~~l~~a~~~~-~~~~~~vavk~l~~~----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
.+|++++.+.+.. ...+..||||.++.. .......+.+|++++++++||||+++++.+..++..++||||+++++
T Consensus 7 G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (323)
T cd05584 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 86 (323)
T ss_pred cCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCch
Confidence 3455555554432 234578999988642 12334567899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 87 LFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDA-------QGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC-------CCCEEEeeCcCCeecccCCC-
Confidence 999998888889999999999999999999999 9999999999999987 78999999999875432221
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 679 (725)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ........ ....++....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~ 224 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----------KKTIDKILKGKLNLPPYLT 224 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCCC
Confidence 12234589999999999988899999999999999999999999864321 11111111 1223445567
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
+.+.+++.+|++.+|++|| ++.+++++
T Consensus 225 ~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 225 PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 7899999999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=285.77 Aligned_cols=245 Identities=24% Similarity=0.317 Sum_probs=193.1
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..|+.++++.....+.+..+|+|.++... ....++|.+|+.++++++|+||+++++++. .+..++||||+++++|.+
T Consensus 6 G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~ 84 (257)
T cd05116 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNK 84 (257)
T ss_pred cCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHH
Confidence 34566666654444556789999886433 234568999999999999999999999985 456789999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc--
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-- 601 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-- 601 (725)
++.+...+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++.........
T Consensus 85 ~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~-------~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 85 FLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVT-------QHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcC-------CCeEEECCCccccccCCCCCeeee
Confidence 998778899999999999999999999998 9999999999999987 7789999999998765433211
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (725)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+...... ...+.+.. ......+...++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~-~~~~~~~~~~~~ 225 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIES-GERMECPQRCPP 225 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHC-CCCCCCCCCCCH
Confidence 112234578999999988889999999999999999998 88888643211 11111111 111234445678
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+.+++.+||+.||++||++++|++.|++.
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=290.72 Aligned_cols=248 Identities=21% Similarity=0.232 Sum_probs=187.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.++++.+..+ +..+|+|.+... .....+.+.+|++++++++|+||+++++++..++..++||||++++.|..+
T Consensus 13 ~~~~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~ 90 (287)
T cd07848 13 AYGVVLKCRHKET--KEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELL 90 (287)
T ss_pred CCEEEEEEEECCC--CcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHH
Confidence 4455555555433 456888887643 233456788999999999999999999999999999999999999888766
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
......+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++.............
T Consensus 91 ~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 91 EEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISH-------NDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC-------CCcEEEeeccCcccccccccccccc
Confidence 65556789999999999999999999998 9999999999999987 7899999999998764433322333
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc--c--cCcchHHHHHHHHHcC--------
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL--A--NGMILTDWVLYCVRTG-------- 672 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~-------- 672 (725)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... . ......+.........
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 558999999999998889999999999999999999999986532211000 0 0000000000000000
Q ss_pred ----------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 ----------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ----------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......+..+.+++.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0011235579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=294.83 Aligned_cols=237 Identities=24% Similarity=0.264 Sum_probs=190.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|+.++.+.+..+ +..||+|.+... .......+.+|++++++++||||+++++++..++..++||||+++|+|.+
T Consensus 7 ~~g~Vy~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~ 84 (328)
T cd05593 7 TFGKVILVREKAS--GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFF 84 (328)
T ss_pred CCEEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHH
Confidence 4455555554433 457889988643 23345678899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
++.....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....... ...
T Consensus 85 ~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~-------~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 85 HLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDK-------DGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECC-------CCcEEEecCcCCccCCCccc-ccc
Confidence 998888899999999999999999999999 9999999999999987 78999999999875432211 122
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERIT 683 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 683 (725)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ......++......+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~--~~~~~~~p~~~~~~~~ 223 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELI--LMEDIKFPRTLSADAK 223 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHh--ccCCccCCCCCCHHHH
Confidence 3468999999999999899999999999999999999999986432111 00000 0112234556678899
Q ss_pred HHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 684 MVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 684 ~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
+++.+||+.||++|| ++.|++++
T Consensus 224 ~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 224 SLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=330.13 Aligned_cols=226 Identities=27% Similarity=0.516 Sum_probs=178.1
Q ss_pred cceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
.+..||||.+...... ..+|++.+++++|||||+++|+|.+++..++||||+++|+|.+++. .++|..+.+|+
T Consensus 714 ~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~ 786 (968)
T PLN00113 714 NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIA 786 (968)
T ss_pred CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHH
Confidence 3568899988643322 2356889999999999999999999999999999999999999995 38999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 620 (725)
.|+|+||+|||..+.++|+||||||+||+++. +..+++. |+......... ...++..|+|||++.+.
T Consensus 787 ~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~-------~~~~~~~-~~~~~~~~~~~-----~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-------KDEPHLR-LSLPGLLCTDT-----KCFISSAYVAPETRETK 853 (968)
T ss_pred HHHHHHHHHhccCCCCCeecCCCCHHhEEECC-------CCceEEE-eccccccccCC-----CccccccccCcccccCC
Confidence 99999999999777779999999999999987 5566664 66554332211 12478899999999999
Q ss_pred CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--------------cCCCChhHHHHHHHHH
Q 039817 621 PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--------------TGNLGATKFERITMVG 686 (725)
Q Consensus 621 ~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~l~ 686 (725)
.++.|+||||||+++|||++|+.|++..... .....+|...... ....+.....++.+++
T Consensus 854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 927 (968)
T PLN00113 854 DITEKSDIYGFGLILIELLTGKSPADAEFGV------HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA 927 (968)
T ss_pred CCCcccchhhHHHHHHHHHhCCCCCCcccCC------CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHH
Confidence 9999999999999999999999998533211 1122233222111 0112335566788999
Q ss_pred HHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 687 LWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 687 ~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+||+.+|++||||+||+++|+++.+
T Consensus 928 ~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 928 LHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999998754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.67 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=200.6
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEccc-ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
+.+.+|++|++|.++..++. ||+|.+.- ......+.+.+|+.++++++|+||.++||.+..+..++++||||.+|++
T Consensus 21 IgrGsfG~Vyk~~d~~t~k~--vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 21 IGRGSFGEVYKAIDNKTKKV--VAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred ccccccceeeeeeeccccce--EEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 35678999999999887765 55555532 2344567889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+.|.....+.+....-|+.++..||.|||.+ +.+|||||+.|||+.. .+.+|++|||.+-.........
T Consensus 99 ~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~-------~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 99 LDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSE-------SGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEec-------cCcEEEEecceeeeeechhhcc
Confidence 99998888778889999999999999999999 9999999999999987 7899999999998776665554
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
..++||+.|||||+++...|+.|+||||||++.+||.+|.+|+.....-.- ..+. .......+.......
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----lflI----pk~~PP~L~~~~S~~ 238 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----LFLI----PKSAPPRLDGDFSPP 238 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----EEec----cCCCCCccccccCHH
Confidence 456799999999999988999999999999999999999999875443110 0000 000011222255667
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+++++..||++||+.||++.+++++
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhh
Confidence 9999999999999999999999875
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=284.14 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=192.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...|+.++.+.....+.+..||+|.+..... ...+.|.+|+.++++++|+||+++++++. ....++||||+++++|.+
T Consensus 5 ~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~ 83 (257)
T cd05115 5 SGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNK 83 (257)
T ss_pred CCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHH
Confidence 3456667766655555667899998865432 33467999999999999999999999885 457899999999999999
Q ss_pred hhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.. ...+++..+.+++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++...........
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~-------~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 84 FLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVN-------QHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcC-------CCcEEeccCCccccccCCcccee
Confidence 9975 45789999999999999999999999 9999999999999987 78899999999986544332211
Q ss_pred --cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCCh
Q 039817 603 --TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGA 676 (725)
Q Consensus 603 --~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 676 (725)
....++..|+|||.+....++.++||||||+++||+++ |..|+..... .+. ...... ...+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~-~~~~~~~~~~~~~~ 221 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----------PEV-MSFIEQGKRLDCPA 221 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----------HHH-HHHHHCCCCCCCCC
Confidence 11224578999999988889999999999999999996 8888764321 111 111111 22334
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
...+.+.+++..||+.+|++||++.+|.+.|+..
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 5578899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.74 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=189.9
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR 527 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 527 (725)
++.++++... ..+..|++|.+... ....+++.+|++++++++|+||+++++++..++..++||||+++++|.+++..
T Consensus 19 ~~~v~~~~~~--~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 95 (263)
T cd05052 19 YGEVYEGVWK--KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 95 (263)
T ss_pred cceEEEEEEe--cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHh
Confidence 4444444433 23457889988643 34467899999999999999999999999999999999999999999999865
Q ss_pred C--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 528 Q--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 528 ~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
. ..+++..+..++.|+++||+|||+. +++||||||+||++++ ++.+||+|||++..............
T Consensus 96 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~-------~~~~kl~df~~~~~~~~~~~~~~~~~ 165 (263)
T cd05052 96 CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGE-------NHLVKVADFGLSRLMTGDTYTAHAGA 165 (263)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcC-------CCcEEeCCCccccccccceeeccCCC
Confidence 4 4589999999999999999999998 9999999999999987 78899999999987654332222222
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITM 684 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 684 (725)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+....... ........ .....+...+..+.+
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~~~ 236 (263)
T cd05052 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKG-YRMERPEGCPPKVYE 236 (263)
T ss_pred CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCC-CCCCCCCCCCHHHHH
Confidence 34568999999998999999999999999999998 777775332110 11111110 012334455678999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 685 VGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 685 l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
++.+||+.+|++||++.+++++|+.+
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=294.34 Aligned_cols=236 Identities=23% Similarity=0.239 Sum_probs=189.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.|+.++.+.+..+ +..||+|.+... .......+.+|++++++++||||+++++.+...+..++||||+++|+|.+
T Consensus 7 ~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~ 84 (323)
T cd05595 7 TFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 84 (323)
T ss_pred CCEEEEEEEECCC--CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHH
Confidence 4555555554433 457888888643 22344567889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... ...
T Consensus 85 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 85 HLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDK-------DGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcC-------CCCEEecccHHhccccCCCC-ccc
Confidence 998888899999999999999999999999 9999999999999987 78999999999875322211 122
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH-HHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-VRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 682 (725)
...|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... .....++....+.+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----------~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------RLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhcCCCCCCCCCCHHH
Confidence 345899999999999999999999999999999999999998643211 111111 11223455667889
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 9999999999999998 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=289.30 Aligned_cols=230 Identities=27% Similarity=0.440 Sum_probs=188.1
Q ss_pred cceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC------------
Q 039817 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ------------ 528 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~------------ 528 (725)
....+++|.+........+.+.+|++++++++|+||+++++++...+..++||||+++++|.+++...
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (291)
T cd05094 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113 (291)
T ss_pred cceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCccccccccccc
Confidence 34678999987665556678999999999999999999999999999999999999999999998643
Q ss_pred ----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-ccc
Q 039817 529 ----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TST 603 (725)
Q Consensus 529 ----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~~~ 603 (725)
..+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+|||+++........ ...
T Consensus 114 ~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~-------~~~~~l~dfg~a~~~~~~~~~~~~~ 183 (291)
T cd05094 114 RQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA-------NLLVKIGDFGMSRDVYSTDYYRVGG 183 (291)
T ss_pred ccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc-------CCcEEECCCCcccccCCCceeecCC
Confidence 2378999999999999999999999 9999999999999987 789999999999765432211 122
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCC---CChhHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGN---LGATKF 679 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 679 (725)
...++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .......+. .+...+
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~~ 251 (291)
T cd05094 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------------VIECITQGRVLERPRVCP 251 (291)
T ss_pred CCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------------HHHHHhCCCCCCCCccCC
Confidence 2346788999999999999999999999999999999 888875432110 111112221 223456
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
..+.+++.+||+.+|++||++.+|+++|+++.+
T Consensus 252 ~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 252 KEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.51 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=200.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeE-EEc------CCceeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGF-CIE------QNHQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~-~~~------~~~~~lV~e~ 515 (725)
...+|..|+.|.+...+ ..+|+|++-..++.+.+..++||++|++|+ |+|||.+++. ... .-+.+|+|||
T Consensus 46 AEGGFa~VYla~~~~~~--~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEy 123 (738)
T KOG1989|consen 46 AEGGFAQVYLAQDVKGG--KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEY 123 (738)
T ss_pred ccCCcEEEEEEEecCCC--ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhh
Confidence 34567777878777665 788999987778888899999999999997 9999999994 321 1367899999
Q ss_pred ccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 516 MKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 516 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
|++|+|-|++..+ ..|++.++++|+.|+++|+++||. +.++|||||||.+||||+. ++..||||||.+..
T Consensus 124 C~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~-------~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 124 CKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSA-------DGNYKLCDFGSATT 195 (738)
T ss_pred ccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcC-------CCCEEeCccccccc
Confidence 9999999999754 569999999999999999999998 4778999999999999988 88999999999875
Q ss_pred cCcCCCcccc--------ccccCccccchhcc---cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchH
Q 039817 594 LKKDQTRTST--------MIRGTMGYMAPEWL---RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILT 662 (725)
Q Consensus 594 ~~~~~~~~~~--------~~~gt~~y~aPE~~---~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~ 662 (725)
.......... ...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....... +. .
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-ln-----g 269 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-LN-----G 269 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-Ee-----c
Confidence 4322211110 12368999999987 477899999999999999999999999986522110 00 0
Q ss_pred HHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCC
Q 039817 663 DWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVP 716 (725)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~p 716 (725)
.+ .-.....+..+|.+||+.||+.||.+||++-||+..+-.+...+.|
T Consensus 270 ~Y------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 270 NY------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred cc------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 00 0112247889999999999999999999999999999877654433
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.54 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=208.1
Q ss_pred cccHHHHHHHhc--ccCCcceEEEEEEccc-ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATN--VFDGQEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~--~~~~~~~~vavk~l~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...|+++++++- -..|+...||||.-+. ...+..+.|++|..+|++++|||||+|+|+|.+. ..+||||.++-|-|
T Consensus 399 ~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GEL 477 (974)
T KOG4257|consen 399 EGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGEL 477 (974)
T ss_pred CCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhH
Confidence 345777777653 3357788999999875 4455678899999999999999999999999765 67899999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
..||..+ ..++......++.|++.||+|||+. .+|||||..+|||+.. ...+|++||||++.+..+...
T Consensus 478 r~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsS-------p~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 478 REYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSS-------PQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred HHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecC-------cceeeecccchhhhccccchh
Confidence 9999876 5789999999999999999999999 9999999999999987 778999999999999887777
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccc--cccCcchHHHHHHHHHcCCCChh
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPT--LANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
..+...-+..|||||.+.-.+++.+||||-|||.+||+++ |..||......+-. ++++ .+.+.|..
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-----------eRlP~P~n 616 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-----------ERLPCPPN 616 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-----------CCCCCCCC
Confidence 6666667889999999999999999999999999999985 88899876544311 1111 12356778
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.++.+..|+.+||..||.+||++.|+...|+.+.
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 8999999999999999999999999998886654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.96 Aligned_cols=242 Identities=26% Similarity=0.425 Sum_probs=192.9
Q ss_pred ccHHHHHHHhcccC---CcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFD---GQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~---~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+++.++.++.... .....|+||.+...... ..+.|.+|++++++++|+||+++++++..+...++||||+++++|
T Consensus 16 g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 95 (280)
T cd05049 16 GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDL 95 (280)
T ss_pred cCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCH
Confidence 45566666654332 34568999998765443 457899999999999999999999999999999999999999999
Q ss_pred hhhhccC--------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 522 SAFLFRQ--------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 522 ~~~l~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|
T Consensus 96 ~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~-------~~~~kl~d 165 (280)
T cd05049 96 NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY-------DLVVKIGD 165 (280)
T ss_pred HHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC-------CCeEEECC
Confidence 9999643 2468889999999999999999999 9999999999999987 78999999
Q ss_pred ccCccccCcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHH
Q 039817 588 FGLAKLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWV 665 (725)
Q Consensus 588 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 665 (725)
||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... + .
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----------~-~ 233 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----------E-V 233 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------H-H
Confidence 999975433221 11122335678999999999999999999999999999998 88887543211 1 1
Q ss_pred HHHHHcCC---CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 666 LYCVRTGN---LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 666 ~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
......+. .+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111222 233556789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.20 Aligned_cols=234 Identities=23% Similarity=0.214 Sum_probs=190.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.++.+.+..+ +..||+|.+... .....+.+.+|++++++++||||+++++++..++..++||||+++++|
T Consensus 28 ~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 105 (329)
T PTZ00263 28 TGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL 105 (329)
T ss_pred ecCCeEEEEEEECCC--CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChH
Confidence 345556666655443 357888887542 223456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...+++.....++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 106 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~-------~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 106 FTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDN-------KGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECC-------CCCEEEeeccCceEcCCCc---
Confidence 99998888899999999999999999999999 9999999999999987 7899999999998654322
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 679 (725)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... + .......+ .++....
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----------~-~~~~i~~~~~~~p~~~~ 239 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----------R-IYEKILAGRLKFPNWFD 239 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----------H-HHHHHhcCCcCCCCCCC
Confidence 2245899999999999999999999999999999999999998643210 0 11111122 2334456
Q ss_pred HHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
..+.+++.+||+.||++||+ ++++++|
T Consensus 240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 78899999999999999996 7888866
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=290.33 Aligned_cols=245 Identities=27% Similarity=0.444 Sum_probs=194.0
Q ss_pred ccHHHHHHHhccc---CCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVF---DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+|+.++.+.... .+....+++|.+........+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 16 G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 95 (288)
T cd05093 16 GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95 (288)
T ss_pred cCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHH
Confidence 3455555554321 2345678999987665556678999999999999999999999999999999999999999999
Q ss_pred hhhccCC-------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeecc
Q 039817 523 AFLFRQE-------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589 (725)
Q Consensus 523 ~~l~~~~-------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfg 589 (725)
+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||
T Consensus 96 ~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~-------~~~~kl~dfg 165 (288)
T cd05093 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE-------NLLVKIGDFG 165 (288)
T ss_pred HHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc-------CCcEEeccCC
Confidence 9986432 489999999999999999999999 9999999999999987 7899999999
Q ss_pred CccccCcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHH
Q 039817 590 LAKLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLY 667 (725)
Q Consensus 590 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (725)
+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..|+...... + ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-----------~-~~~ 233 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-----------E-VIE 233 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------H-HHH
Confidence 9986543221 11122335678999999998899999999999999999998 77777533211 1 111
Q ss_pred HHHcCC---CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 668 CVRTGN---LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 668 ~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
....+. .+...+..+.+++.+||+.+|.+|||+.+|++.|+++..
T Consensus 234 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111221 223456789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=285.03 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=195.6
Q ss_pred ccccHHHHHHHhcccC-CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFD-GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.+++|..... ++...|+||.+.... ......|.+|+.++++++|+||+++++++..++..++||||+++++|
T Consensus 13 g~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 92 (266)
T cd05033 13 GGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL 92 (266)
T ss_pred cCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCH
Confidence 3455667777765444 345689999886533 33456799999999999999999999999999999999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||+++........
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~-------~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 93 DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNS-------NLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC-------CCCEEECccchhhcccccccc
Confidence 9999764 4689999999999999999999998 9999999999999987 788999999999977522211
Q ss_pred -cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 601 -TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 601 -~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
......++..|+|||.+.+..++.++||||||++++||++ |..|+...... ...+...... ....+...
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~ 233 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGY-RLPPPMDC 233 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCC-CCCCCCCC
Confidence 1112335678999999998899999999999999999998 88877432111 1111111100 11223345
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
++.+.+++.+|++.+|++||+++||+++|+++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 67899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=297.55 Aligned_cols=237 Identities=23% Similarity=0.226 Sum_probs=190.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|+.+++|.+.-++ ..||||.+.... ....+.+.+|++++.+++||||+++++++..++..++||||+++++|.
T Consensus 12 G~~g~Vy~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (333)
T cd05600 12 GGYGQVFLAKKKDTG--EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFR 89 (333)
T ss_pred cCCeEEEEEEECCCC--CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHH
Confidence 345666666654433 578999886432 234567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.... ..
T Consensus 90 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~-------~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 90 TLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDA-------SGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECC-------CCCEEEEeCcCCccccc----cc
Confidence 9998888899999999999999999999999 9999999999999987 78999999999986543 12
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH---HHcCCCC---h
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC---VRTGNLG---A 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~ 676 (725)
....|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+... ....... .
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~~~ 227 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQRPVYDDPRF 227 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhccccccCCCCCcccc
Confidence 23458999999999999999999999999999999999999986432211 00001000 0001111 1
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+.+.+++.+|++.+|.+||++++++++
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 346788999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.54 Aligned_cols=247 Identities=22% Similarity=0.227 Sum_probs=187.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC--------------ccHHHHHHHHHHHhccCcCCccceeeEEEc--CC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG--------------DGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QN 507 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--------------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~ 507 (725)
....|+.|+.|.+.-++ ..||||.+.+... ...+..++|+.+|++++|+|||+|+.+..+ .+
T Consensus 106 G~G~yGkVkLar~~~~~--~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~ 183 (576)
T KOG0585|consen 106 GSGQYGKVKLARDEVDG--KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESD 183 (576)
T ss_pred cCCccceEEEEeecCCC--cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccC
Confidence 34556666666665444 5788888754211 112478899999999999999999999876 46
Q ss_pred ceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 508 HQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 508 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
..|||+|||..|.+...-.....+++.+..+++.+++.||.|||.+ +||||||||+|+||++ ++++||+|
T Consensus 184 ~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~-------~g~VKIsD 253 (576)
T KOG0585|consen 184 KLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS-------DGTVKISD 253 (576)
T ss_pred ceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC-------CCcEEeec
Confidence 8999999999988765543334489999999999999999999999 9999999999999988 89999999
Q ss_pred ccCccccCcCCCc----cccccccCccccchhcccCCC----CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCc
Q 039817 588 FGLAKLLKKDQTR----TSTMIRGTMGYMAPEWLRNAP----VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM 659 (725)
Q Consensus 588 fgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~ 659 (725)
||.+..+...... ......||+.|+|||...++. ...+.||||+||+||.|+.|+.||.....-
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-------- 325 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-------- 325 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--------
Confidence 9999876322111 122356999999999987632 356799999999999999999999754211
Q ss_pred chHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 660 ILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+.+-+......-....+..+.+.+|++++|++||++|.+..+|..|.--.
T Consensus 326 ~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 111111111111112224678999999999999999999999999887433
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.87 Aligned_cols=235 Identities=23% Similarity=0.236 Sum_probs=191.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...|++++.|...-. ....||+|.+... .....+.+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 40 ~G~~g~Vy~a~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L 118 (340)
T PTZ00426 40 TGSFGRVILATYKNE-DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118 (340)
T ss_pred ecCCeEEEEEEEECC-CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcH
Confidence 345666666654322 2357899988542 223456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 119 ~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~-------~~~ikL~DFG~a~~~~~~---- 184 (340)
T PTZ00426 119 FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDK-------DGFIKMTDFGFAKVVDTR---- 184 (340)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECC-------CCCEEEecCCCCeecCCC----
Confidence 99998888899999999999999999999999 9999999999999987 789999999999865432
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 679 (725)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... ........ ..++....
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------------~~~~~i~~~~~~~p~~~~ 252 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------------LIYQKILEGIIYFPKFLD 252 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------------HHHHHHhcCCCCCCCCCC
Confidence 12345899999999999888999999999999999999999999643211 01111111 22344556
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
+.+.+++.+|++.||++|+ ++++++++
T Consensus 253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 7789999999999999995 89999887
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=292.78 Aligned_cols=235 Identities=20% Similarity=0.194 Sum_probs=191.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.++++.+..++ ..||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 11 ~G~~g~Vy~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 88 (291)
T cd05612 11 TGTFGRVHLVRDRISE--HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL 88 (291)
T ss_pred cCCCeEEEEEEEcCCC--CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCH
Confidence 3456667776665443 568888875322 23456688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++...+.+++.....++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~-------~~~~kl~Dfg~~~~~~~~~--- 155 (291)
T cd05612 89 FSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDK-------EGHIKLTDFGFAKKLRDRT--- 155 (291)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECC-------CCCEEEEecCcchhccCCc---
Confidence 99998888899999999999999999999999 9999999999999987 7899999999998654321
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 680 (725)
....|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... +...... ....++.....
T Consensus 156 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~ 223 (291)
T cd05612 156 -WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----------GIYEKILAGKLEFPRHLDL 223 (291)
T ss_pred -ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhCCcCCCccCCH
Confidence 2245899999999999989999999999999999999999998643211 1111111 11234445567
Q ss_pred HHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
.+.+++.+||+.||.+||+ +++++++
T Consensus 224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 8999999999999999995 8998877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.83 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=189.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+|+.++++.+..++ ..+|+|.+... .....+.+.+|++++++++|+||+++++++..++..++||||+++++|.++
T Consensus 16 G~~g~V~~~~~~~~~--~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 93 (331)
T cd06649 16 GNGGVVTKVQHKPSG--LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 93 (331)
T ss_pred CCCEEEEEEEECCCC--cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHH
Confidence 345555555554433 56788877543 223456799999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.+...+++..+..++.|++.||.|||+. .+|+||||||+||+++. ++.+||+|||++....... ...
T Consensus 94 l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~---~~~ 161 (331)
T cd06649 94 LKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNS-------RGEIKLCDFGVSGQLIDSM---ANS 161 (331)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcC-------CCcEEEccCcccccccccc---ccc
Confidence 98888899999999999999999999985 15999999999999987 7889999999987653322 123
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--c---------------------------
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--L--------------------------- 655 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--~--------------------------- 655 (725)
..|+..|+|||.+.+..++.++||||||+++|||++|+.|+......+.. .
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccc
Confidence 45899999999999999999999999999999999999998643211000 0
Q ss_pred ------ccCcchHHHHHHHHHcCCC----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 656 ------ANGMILTDWVLYCVRTGNL----GATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 656 ------~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
.......+... ....... .......+++|+.+||+.||++|||++|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 242 GHGMDSRPAMAIFELLD-YIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccchhHHHHHH-HHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000001111 1111111 113467899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=264.44 Aligned_cols=241 Identities=22% Similarity=0.328 Sum_probs=198.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
...|+.+++..+.-+|++..+++..+.+....+.+++.+|+++.+.|+|||||+|.....+.+..+||+|+|+++.|..-
T Consensus 21 kG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~e 100 (355)
T KOG0033|consen 21 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 100 (355)
T ss_pred cCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHH
Confidence 45577778877777776655444444444556788899999999999999999999999999999999999999999887
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+-.+...++...-+...||+++|.|.|.+ +|||||+||+|++|..+. ...-+||+|||+|...+.. ..-..
T Consensus 101 IV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~----~~A~vKL~~FGvAi~l~~g--~~~~G 171 (355)
T KOG0033|consen 101 IVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKA----KGAAVKLADFGLAIEVNDG--EAWHG 171 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeecc----CCCceeecccceEEEeCCc--ccccc
Confidence 76666678888999999999999999999 999999999999997742 3567899999999987722 22234
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC------hhH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG------ATK 678 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 678 (725)
..||++|||||++...+|+..+|||+-||+||-|+.|..||..+.. ..+.+.+..+.+. ...
T Consensus 172 ~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------------~rlye~I~~g~yd~~~~~w~~i 239 (355)
T KOG0033|consen 172 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------------HRLYEQIKAGAYDYPSPEWDTV 239 (355)
T ss_pred ccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH------------HHHHHHHhccccCCCCcccCcC
Confidence 6699999999999999999999999999999999999999975432 1233333334332 245
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.++.++|+++||..||.+|.|+.|.+++
T Consensus 240 s~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 240 TPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 7889999999999999999999998865
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.29 Aligned_cols=243 Identities=28% Similarity=0.380 Sum_probs=191.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.+|+.++++...-++....+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++++|.+
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (270)
T cd05047 6 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85 (270)
T ss_pred CCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHH
Confidence 4566777777666666678899988643 234456799999999999 89999999999999999999999999999999
Q ss_pred hhccCC----------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 524 FLFRQE----------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 524 ~l~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
++.... .+++.++..++.|++.||+|||+. +++|+||||+||+++. ++.+||+|
T Consensus 86 ~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~-------~~~~kl~d 155 (270)
T cd05047 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE-------NYVAKIAD 155 (270)
T ss_pred HHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcC-------CCeEEECC
Confidence 986532 468899999999999999999998 9999999999999987 78999999
Q ss_pred ccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHH
Q 039817 588 FGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVL 666 (725)
Q Consensus 588 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (725)
||++...... ........+..|+|||++....++.++||||||++++||++ |..|+...... +...
T Consensus 156 fgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----------~~~~ 222 (270)
T cd05047 156 FGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----------ELYE 222 (270)
T ss_pred CCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----------HHHH
Confidence 9998632211 11111224567999999988889999999999999999997 88887532211 1111
Q ss_pred HHHH--cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 667 YCVR--TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 667 ~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.... ....+......+.+++.+|++.+|.+|||+.++++.|+.+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111 11223344567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=300.15 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=192.4
Q ss_pred ccccHHHHHHHhcccC---CcceEEEEEEcccccC-ccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccC
Q 039817 444 KVFSYQELREATNVFD---GQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~---~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
...+|+.|+++++.-. .....||||.+..... ...+.|.+|+++++++. ||||++++++|.+.+..+|||||+++
T Consensus 46 G~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~ 125 (400)
T cd05105 46 GSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125 (400)
T ss_pred cCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCC
Confidence 3455667776665322 2235799999965332 33467999999999996 99999999999999999999999999
Q ss_pred CChhhhhccC----------------------------------------------------------------------
Q 039817 519 GTLSAFLFRQ---------------------------------------------------------------------- 528 (725)
Q Consensus 519 gsL~~~l~~~---------------------------------------------------------------------- 528 (725)
|+|.+++.+.
T Consensus 126 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (400)
T cd05105 126 GDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQR 205 (400)
T ss_pred CcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhccc
Confidence 9999987542
Q ss_pred --------------------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCc
Q 039817 529 --------------------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582 (725)
Q Consensus 529 --------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~ 582 (725)
..+++..+..++.|+++||.|||+. +|+|+||||+|||++. ++.
T Consensus 206 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~-------~~~ 275 (400)
T cd05105 206 SNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ-------GKI 275 (400)
T ss_pred CcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC-------CCE
Confidence 1367788899999999999999998 9999999999999987 778
Q ss_pred eEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcc
Q 039817 583 TKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMI 660 (725)
Q Consensus 583 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~ 660 (725)
+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+. .
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-------~ 348 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-------T 348 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-------H
Confidence 9999999998654332211 122346778999999998899999999999999999997 888876432111 0
Q ss_pred hHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 661 LTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
....+... .....+...+..+.+++.+||+.+|++||++.+|.++|+.+.+
T Consensus 349 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYNKIKSG-YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHhcC-CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00111100 0112233456789999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=282.59 Aligned_cols=242 Identities=28% Similarity=0.392 Sum_probs=193.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..+++++.|...- +..+++|.+..........+.+|++++++++|+||+++++++...+..++||||+++++|.+++
T Consensus 17 g~~~~vy~~~~~~---~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (261)
T cd05148 17 GYFGEVWEGLWKN---RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL 93 (261)
T ss_pred CCCccEEEeEecC---CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHH
Confidence 3445555555433 5678999987665556778999999999999999999999999999999999999999999999
Q ss_pred ccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++.......... .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~-------~~~~kl~d~g~~~~~~~~~~~~-~ 162 (261)
T cd05148 94 RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGE-------DLVCKVADFGLARLIKEDVYLS-S 162 (261)
T ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcC-------CceEEEccccchhhcCCccccc-c
Confidence 764 4689999999999999999999998 9999999999999987 7889999999998664332221 2
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
...++..|+|||.+.+..++.++||||||+++++|++ |+.|+...... ......... .....+...++.+
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~ 233 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAG-YRMPCPAKCPQEI 233 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhC-CcCCCCCCCCHHH
Confidence 2335678999999988899999999999999999998 77777543211 111111111 1123344567889
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+++.+|++.+|++|||++++++.|+.+
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 9999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=279.37 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=187.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..|+.++.+... +...+++|.+... ....+.|.+|++++++++||||+++++++..++..++||||+++|+|.+++
T Consensus 15 G~~~~vy~~~~~---~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 90 (256)
T cd05114 15 GQFGVVHLGKWR---AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL 90 (256)
T ss_pred CcCceEEEEEec---cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence 344555555332 2346899987643 334578999999999999999999999999999999999999999999998
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++............
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~-------~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 91 RQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSS-------TGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred HhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcC-------CCeEEECCCCCccccCCCceeccCC
Confidence 754 5689999999999999999999999 9999999999999987 7889999999988654333222222
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERIT 683 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 683 (725)
..++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....+.... ....+......+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~-~~~~~~~~~~~~~ 231 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--------EVVEMISRGF-RLYRPKLASMTVY 231 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCC-CCCCCCCCCHHHH
Confidence 335668999999998889999999999999999999 78877533211 1111111100 1112334556789
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 684 MVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 684 ~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
+++.+||+.+|++||+++++++.|.
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=279.06 Aligned_cols=228 Identities=21% Similarity=0.385 Sum_probs=178.6
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIA 540 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~ 540 (725)
...|++|.+..........|.+|+.++++++||||+++++++..+...++||||+++++|..++.+. ..+++..+..++
T Consensus 32 ~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~ 111 (262)
T cd05077 32 EIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVA 111 (262)
T ss_pred ceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHH
Confidence 4578999887655555668999999999999999999999999999999999999999999998754 568999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhccc-C
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR-N 619 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~ 619 (725)
.|+++||+|||+. +|+||||||+|||++.+.........+|++|||++....... ...++..|+|||.+. +
T Consensus 112 ~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~ 183 (262)
T cd05077 112 KQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-----ECVERIPWIAPECVEDS 183 (262)
T ss_pred HHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcc-----cccccccccChhhhcCC
Confidence 9999999999999 999999999999997633211223348999999987553221 234678899999887 4
Q ss_pred CCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC
Q 039817 620 APVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP 698 (725)
Q Consensus 620 ~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 698 (725)
..++.++||||||+++|||++ |..|+......+ ..... ...........+.+.+|+.+||+.||++||
T Consensus 184 ~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 252 (262)
T cd05077 184 KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---------KERFY--EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252 (262)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---------HHHHH--hcCccCCCCChHHHHHHHHHHcCCChhhCc
Confidence 678999999999999999984 666654321110 00000 011122233457789999999999999999
Q ss_pred CHHHHHHHhc
Q 039817 699 SMKQVLQMLE 708 (725)
Q Consensus 699 s~~evl~~L~ 708 (725)
++.+|+++|+
T Consensus 253 ~~~~il~~~~ 262 (262)
T cd05077 253 FFRAIMRDIN 262 (262)
T ss_pred CHHHHHHhcC
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=284.51 Aligned_cols=238 Identities=24% Similarity=0.276 Sum_probs=188.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|++++++....+ +..||+|.+.... ......+.+|++++++++|+||+++++.+.+++..++||||+++|+|.+
T Consensus 12 ~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 89 (285)
T cd05631 12 GFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKF 89 (285)
T ss_pred CCEEEEEEEEecC--CceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHH
Confidence 4555555554433 3578888875422 2334568899999999999999999999999999999999999999998
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++........
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05631 90 HIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDD-------RGHIRISDLGLAVQIPEGET-- 157 (285)
T ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECC-------CCCEEEeeCCCcEEcCCCCe--
Confidence 88643 4689999999999999999999999 9999999999999987 78899999999986543221
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 679 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.+..... ....+....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~s 229 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--------KREEVDRRVKEDQEEYSEKFS 229 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--------hHHHHHHHhhcccccCCccCC
Confidence 123458999999999999999999999999999999999999997543211 0111111111 123344567
Q ss_pred HHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
+.+.+|+.+||+.||++||+ +++++++
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 78999999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=291.11 Aligned_cols=247 Identities=28% Similarity=0.378 Sum_probs=193.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.+++|.+..++....+++|.+... .....+.|.+|++++.++ +|+||+++++++..++..++||||+++++|
T Consensus 16 g~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 95 (303)
T cd05088 16 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 95 (303)
T ss_pred cCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcH
Confidence 345677888888776777778899987643 233456789999999999 899999999999999999999999999999
Q ss_pred hhhhccCC----------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEE
Q 039817 522 SAFLFRQE----------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585 (725)
Q Consensus 522 ~~~l~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl 585 (725)
.+++.+.. .+++..+..++.|++.||+|||+. +++||||||+|||++. ++.+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~-------~~~~kl 165 (303)
T cd05088 96 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE-------NYVAKI 165 (303)
T ss_pred HHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC-------CCcEEe
Confidence 99996542 468899999999999999999998 9999999999999987 788999
Q ss_pred eeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHH
Q 039817 586 ADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDW 664 (725)
Q Consensus 586 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~ 664 (725)
+|||+++...... .......+..|+|||++.+..++.++||||||++++||++ |..|+....... ..+.
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~ 235 (303)
T cd05088 166 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEK 235 (303)
T ss_pred CccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------HHHH
Confidence 9999986432111 1111224567999999988889999999999999999998 888875332110 1111
Q ss_pred HHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 665 VLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 665 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.... ....+...+..+.+++.+|++.+|++||++++++++|+.+.
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 236 LPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HhcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11000 11122335678899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.28 Aligned_cols=237 Identities=23% Similarity=0.254 Sum_probs=189.2
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|+.++.+.+..+ +..||+|.+... .......+.+|++++.+++|+||+++++++..++..++||||+++|+|.+
T Consensus 7 ~~g~V~~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~ 84 (325)
T cd05594 7 TFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFF 84 (325)
T ss_pred CCEEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 4455555554433 457888888643 22334567899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.+...+++..+..++.|++.||.|||+ . +|+||||||+|||++. ++.+||+|||+++........ .
T Consensus 85 ~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~-------~~~~kL~Dfg~~~~~~~~~~~-~ 153 (325)
T cd05594 85 HLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDK-------DGHIKITDFGLCKEGIKDGAT-M 153 (325)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECC-------CCCEEEecCCCCeecCCCCcc-c
Confidence 99888889999999999999999999997 6 8999999999999987 789999999998754322211 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ......++....+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--------~~~~i--~~~~~~~p~~~~~~~ 223 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELI--LMEEIRFPRTLSPEA 223 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--------HHHHH--hcCCCCCCCCCCHHH
Confidence 23458999999999999999999999999999999999999986432110 01111 111223445567789
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
.+++.+||+.||++|+ ++.+++++
T Consensus 224 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 9999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=279.92 Aligned_cols=244 Identities=25% Similarity=0.330 Sum_probs=194.7
Q ss_pred ccHHHHHHHhccc-CCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVF-DGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~-~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.+++.++++...- .+....||||.+..... ...+.|.+|++++++++|+||+++++.+.. ...++||||+++++|.+
T Consensus 6 g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~ 84 (257)
T cd05040 6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLD 84 (257)
T ss_pred cCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHH
Confidence 4566677776544 34456799999976555 566789999999999999999999999988 88999999999999999
Q ss_pred hhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 524 FLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 524 ~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
++.+.. .+++.....++.|++.||+|||+. +++|+||||+||+++. ++.+||+|||+++........
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~-------~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 85 RLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLAS-------DDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred HHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEec-------CCEEEeccccccccccccccce
Confidence 997654 689999999999999999999999 9999999999999987 789999999999876442221
Q ss_pred -cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 601 -TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 601 -~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
......++..|+|||++.+..++.++||||||++++||++ |+.|+...... ...............+...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGERLERPEAC 226 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCCcCCCCccC
Confidence 1112446788999999998899999999999999999998 99887532211 0111111111111223345
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
+..+.+++.+|++.+|++||++.++++.|.
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=295.63 Aligned_cols=234 Identities=21% Similarity=0.214 Sum_probs=186.8
Q ss_pred cHHHHHHHhcccC-CcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFD-GQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~-~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|++++.+.+... ..+..+|+|.+.... ......+.+|++++++++||||+++++++..++..++||||+++++|.+
T Consensus 8 ~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 87 (318)
T cd05582 8 SFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 87 (318)
T ss_pred CCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHH
Confidence 4455555544332 345688999886432 2234567889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
++.+...+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++....... ...
T Consensus 88 ~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 88 RLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDE-------EGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECC-------CCcEEEeeccCCcccCCCCC-cee
Confidence 998888899999999999999999999999 9999999999999987 78899999999986543322 122
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 682 (725)
...|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... +...... ....++....+.+
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----------~~~~~i~~~~~~~p~~~~~~~ 225 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----------ETMTMILKAKLGMPQFLSPEA 225 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----------HHHHHHHcCCCCCCCCCCHHH
Confidence 345899999999999888999999999999999999999998643211 1111111 1223445567789
Q ss_pred HHHHHHccCCCCCCCCCHHH
Q 039817 683 TMVGLWCICPQPTLRPSMKQ 702 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~e 702 (725)
.+++.+||+.||++||++.+
T Consensus 226 ~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 226 QSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHhhcCHhHcCCCCC
Confidence 99999999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=303.75 Aligned_cols=238 Identities=20% Similarity=0.208 Sum_probs=187.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
.++.++.|.+..+. +..|++|.+..........+.+|++++++++|||||++++++..++..+|||||+++|+|.+++.
T Consensus 79 ~~g~vy~a~~~~~~-~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 157 (478)
T PTZ00267 79 PTTAAFVATRGSDP-KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK 157 (478)
T ss_pred CCcEEEEEEEcCCC-CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHH
Confidence 34445555544432 24567776654444445678899999999999999999999999999999999999999998875
Q ss_pred c----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-c
Q 039817 527 R----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-T 601 (725)
Q Consensus 527 ~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~ 601 (725)
. ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+...... .
T Consensus 158 ~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~-------~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 158 QRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMP-------TGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECC-------CCcEEEEeCcCceecCCcccccc
Confidence 4 34678899999999999999999998 9999999999999987 789999999999876443221 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 679 (725)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+..... .+........ ...+....
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----------~~~~~~~~~~~~~~~~~~~s 296 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----------REIMQQVLYGKYDPFPCPVS 296 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCCCccCC
Confidence 2335689999999999999999999999999999999999999864321 1111111111 12333556
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+++.+||+.+|++||++.+++.+
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 789999999999999999999998753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=280.18 Aligned_cols=242 Identities=23% Similarity=0.316 Sum_probs=189.8
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..++.++.|... ....|++|.+... ....+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.+++
T Consensus 17 g~~g~v~~~~~~---~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 92 (261)
T cd05072 17 GQFGEVWMGYYN---NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL 92 (261)
T ss_pred cCCceEEEEEec---CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHH
Confidence 344555555432 2346899987643 234678999999999999999999999999999999999999999999999
Q ss_pred ccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.+. ..+++..+..++.|+++||+|||+. +++|+||||+||+++. ++.+||+|||++............
T Consensus 93 ~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~-------~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 93 KSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSE-------SLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecC-------CCcEEECCCccceecCCCceeccC
Confidence 654 5678999999999999999999998 9999999999999987 788999999999876543322222
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
...++..|+|||++....++.++||||||+++|||++ |+.|+...... .....+.... ........+..+
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~ 233 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGY-RMPRMENCPDEL 233 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCC-CCCCCCCCCHHH
Confidence 2335678999999998889999999999999999998 88887532111 0111111110 111223456789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+++.+|++.+|++||+++++.+.|+.+
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=285.10 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=191.0
Q ss_pred cccHHHHHHHhcccC--CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFD--GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~--~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.+++|+.... .....|++|.+.... .+....|.+|++++++++|+||+++++++..++..++||||+++++|
T Consensus 15 ~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 94 (283)
T cd05090 15 ECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94 (283)
T ss_pred ccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcH
Confidence 345667777764332 245689999987433 23346789999999999999999999999999999999999999999
Q ss_pred hhhhccC-----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceE
Q 039817 522 SAFLFRQ-----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584 (725)
Q Consensus 522 ~~~l~~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~k 584 (725)
.+++... ..+++.....++.|++.||.|||+. +++|+||||+||+++. ++.+|
T Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~-------~~~~k 164 (283)
T cd05090 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE-------QLHVK 164 (283)
T ss_pred HHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC-------CCcEE
Confidence 9998532 2468889999999999999999999 9999999999999987 77899
Q ss_pred EeeccCccccCcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchH
Q 039817 585 IADFGLAKLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILT 662 (725)
Q Consensus 585 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~ 662 (725)
|+|||+++....... .......++..|+|||++.+..++.++||||||++++||++ |..|+...... ...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--------~~~ 236 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------EVI 236 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence 999999986543321 11222335678999999988889999999999999999998 77777532210 111
Q ss_pred HHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 663 DWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+.+... .....+...++.+.+++.+|++.+|++||++.+|.++|.+
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKR-QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111110 0112233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=278.93 Aligned_cols=242 Identities=28% Similarity=0.347 Sum_probs=190.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..++.++++... ....|++|.++.. ....++|.+|++++++++|+||+++++++...+..++||||+++++|.+++
T Consensus 17 g~~~~v~~~~~~---~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 92 (261)
T cd05068 17 GQFGEVWEGLWN---NTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL 92 (261)
T ss_pred cCCccEEEEEec---CCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHH
Confidence 345556655432 2357899998653 334678999999999999999999999999999999999999999999999
Q ss_pred ccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.... .+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++...........
T Consensus 93 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 93 QGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGE-------NNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcC-------CCCEEECCcceEEEccCCcccccC
Confidence 7653 689999999999999999999999 9999999999999987 788999999999876533222122
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
....+..|+|||++.+..++.++||||||++++||++ |+.|+...... .......... ....+...++.+
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~ 233 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------EVLQQVDQGY-RMPCPPGCPKEL 233 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-CCCCCCcCCHHH
Confidence 2223457999999998899999999999999999999 88777532110 0111111100 112334456889
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+++.+|++.+|++||++.++++.|+.+
T Consensus 234 ~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 234 YDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=281.41 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=189.8
Q ss_pred cccHHHHHHHhcccCC-----cceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDG-----QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~-----~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...|+.|+++.+.-.+ ....+++|.+........++|.+|+.++++++|||++++++++..++..++||||+++|
T Consensus 5 ~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g 84 (258)
T cd05078 5 QGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFG 84 (258)
T ss_pred cccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCC
Confidence 4457778877764432 23467888876555555678999999999999999999999999999999999999999
Q ss_pred ChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcccc-CCCCceEEeeccCccccCcC
Q 039817 520 TLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI-DNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 520 sL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~-~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.+.... .....+|++|||++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~ 161 (258)
T cd05078 85 SLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161 (258)
T ss_pred cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccccCCc
Confidence 999999765 4589999999999999999999999 999999999999998742110 11234799999998754322
Q ss_pred CCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
....++..|+|||++.+. .++.++||||||+++|||++|..++...... ............++.
T Consensus 162 -----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~----------~~~~~~~~~~~~~~~ 226 (258)
T cd05078 162 -----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----------QKKLQFYEDRHQLPA 226 (258)
T ss_pred -----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH----------HHHHHHHHccccCCC
Confidence 223477889999999864 5789999999999999999996443221110 011111112234555
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
.....+.+++.+||+.+|++|||++++++.|+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 56678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=261.40 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=197.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+.+|+.|++|++..++ ..||||+++... ........+|++.|+.++|+||+.|++.+.+.+...||+|||+. +|
T Consensus 11 GEG~~gvVyka~d~~t~--~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dL 87 (318)
T KOG0659|consen 11 GEGTYGVVYKARDTETG--KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DL 87 (318)
T ss_pred cCcceEEEEEEEecCCC--cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cH
Confidence 34567777778776655 468888886432 22345688999999999999999999999999999999999986 89
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
+..+..+ ..++..++..++.++++||+|||++ .|+||||||.|+|++. ++.+||+|||+++.+......
T Consensus 88 e~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~-------~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 88 EVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISS-------DGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred HHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcC-------CCcEEeecccchhccCCCCcc
Confidence 9999776 5678899999999999999999999 9999999999999988 899999999999998765443
Q ss_pred cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcc--------------ccccCcchHHHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEP--------------TLANGMILTDWV 665 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~--------------~~~~~~~~~~~~ 665 (725)
.... +-|.-|.|||.+.+. .|....|+||.||++.||+.|.+.+.....-++ ...+-..+.++.
T Consensus 158 ~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 3322 578899999988764 799999999999999999988877654332111 000011122222
Q ss_pred HHHHHc----CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCCCCccc
Q 039817 666 LYCVRT----GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVVAD 721 (725)
Q Consensus 666 ~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~p~~~~~ 721 (725)
.-.... ..+-....+...+|+..|+..||.+|+|++|+++|= -+.+.+.|-.+..
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~ 295 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSK 295 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhh
Confidence 211100 011123445679999999999999999999999873 2233444444443
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.61 Aligned_cols=237 Identities=22% Similarity=0.229 Sum_probs=189.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|++++.+.+.. .+..||||.+... .....+.+..|.+++..+ +||||+++++++..++..++||||+++++|
T Consensus 6 G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L 83 (321)
T cd05591 6 GSFGKVMLAELKG--TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDL 83 (321)
T ss_pred CCCeEEEEEEECC--CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcH
Confidence 3456666665543 3457888887643 233445678899999876 899999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
..++.+...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++....... .
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~-------~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 84 MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDA-------EGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECC-------CCCEEEeecccceecccCCc-c
Confidence 99998888899999999999999999999999 9999999999999987 78999999999875432221 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 680 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... +....... ....+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----------~~~~~i~~~~~~~p~~~~~ 221 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----------DLFESILHDDVLYPVWLSK 221 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----------HHHHHHHcCCCCCCCCCCH
Confidence 22345899999999999999999999999999999999999999743211 11111111 1123334567
Q ss_pred HHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRP-------SMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RP-------s~~evl~~ 706 (725)
.+.+++..||+.||++|| ++++++++
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 889999999999999999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=287.81 Aligned_cols=247 Identities=28% Similarity=0.349 Sum_probs=193.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.++++...-++....+++|.++.. .....+.|.+|++++.++ +||||+++++++...+..++|+||+++++|
T Consensus 11 g~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (297)
T cd05089 11 GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90 (297)
T ss_pred cCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcH
Confidence 345667777776666666667888888642 233456799999999999 799999999999999999999999999999
Q ss_pred hhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEE
Q 039817 522 SAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585 (725)
Q Consensus 522 ~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl 585 (725)
.+++.+. ..+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||
T Consensus 91 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~-------~~~~kl 160 (297)
T cd05089 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGE-------NLASKI 160 (297)
T ss_pred HHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECC-------CCeEEE
Confidence 9999653 2478899999999999999999998 9999999999999987 788999
Q ss_pred eeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHH
Q 039817 586 ADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDW 664 (725)
Q Consensus 586 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~ 664 (725)
+|||++....... .......+..|+|||.+.+..++.++||||||+++|||++ |..|+..... .+.
T Consensus 161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----------~~~ 227 (297)
T cd05089 161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----------AEL 227 (297)
T ss_pred CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------HHH
Confidence 9999986432111 1111223557999999998889999999999999999997 8888754321 111
Q ss_pred HHHHHH--cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 665 VLYCVR--TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 665 ~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
...... ....+...+..+.+++.+||+.+|.+||+++++++.|+.+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 1123334567899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=278.33 Aligned_cols=226 Identities=27% Similarity=0.398 Sum_probs=181.7
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHHHHH
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIAL 541 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ 541 (725)
..+|+|.+... ....++|.+|+.++++++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.
T Consensus 29 ~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 107 (256)
T cd05113 29 YDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK 107 (256)
T ss_pred CcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 45899988643 334578999999999999999999999999999999999999999999999764 4689999999999
Q ss_pred HHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCC
Q 039817 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP 621 (725)
Q Consensus 542 qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 621 (725)
|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++..............++..|+|||.+.+..
T Consensus 108 ~i~~~l~~lH~~---~i~H~dl~p~nili~~-------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 177 (256)
T cd05113 108 DVCEGMAYLESK---QFIHRDLAARNCLVDD-------QGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177 (256)
T ss_pred HHHHHHHHHHhC---CeeccccCcceEEEcC-------CCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCc
Confidence 999999999999 9999999999999987 788999999998865443322222233567899999999888
Q ss_pred CCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCH
Q 039817 622 VTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSM 700 (725)
Q Consensus 622 ~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 700 (725)
++.++||||||+++|||++ |..|+...... .....+.... ....+....+.+.+++.+||+.+|.+||++
T Consensus 178 ~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 248 (256)
T cd05113 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGL-RLYRPHLASEKVYAIMYSCWHEKAEERPTF 248 (256)
T ss_pred ccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 9999999999999999998 88887533211 0111111100 111233456789999999999999999999
Q ss_pred HHHHHHhc
Q 039817 701 KQVLQMLE 708 (725)
Q Consensus 701 ~evl~~L~ 708 (725)
.++++.|+
T Consensus 249 ~~ll~~~~ 256 (256)
T cd05113 249 QQLLSSIE 256 (256)
T ss_pred HHHHHhhC
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=287.88 Aligned_cols=244 Identities=22% Similarity=0.263 Sum_probs=191.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+|+.++.+.+..+ +..||+|.++.. .....+.+..|..++.++ +||||+++++++...+..++||||+++|+|.
T Consensus 7 ~~g~V~~~~~~~~--~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~ 84 (329)
T cd05588 7 SYAKVLLVELKKT--RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLM 84 (329)
T ss_pred CCeEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHH
Confidence 3455555554433 457888888643 223345688999999998 7999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+.+.+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++....... ..
T Consensus 85 ~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~-------~~~~kL~Dfg~~~~~~~~~~-~~ 153 (329)
T cd05588 85 FHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDA-------EGHIKLTDYGMCKEGIRPGD-TT 153 (329)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECC-------CCCEEECcCccccccccCCC-cc
Confidence 9998888899999999999999999999999 9999999999999987 78999999999875322211 12
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCChhHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLGATKFE 680 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 680 (725)
....||..|+|||++.+..++.++||||||+++|||++|+.||+........ .....++........ .++.....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~p~~~~~ 230 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP---DQNTEDYLFQVILEKQIRIPRSLSV 230 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc---cccchHHHHHHHHcCCCCCCCCCCH
Confidence 2356899999999999999999999999999999999999999643221100 111122232222222 34455677
Q ss_pred HHHHHHHHccCCCCCCCCC------HHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPS------MKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs------~~evl~~ 706 (725)
.+.+++.+||+.||.+||+ +++++++
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 8999999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=284.09 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=187.2
Q ss_pred ccHHHHHHHhcc---cCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNV---FDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~---~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+++.++.|... .+.....||||.+.... .....+|.+|+.++++++|+||+++++++..+...++||||+++++|
T Consensus 17 G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L 96 (277)
T cd05062 17 GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 96 (277)
T ss_pred ccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCH
Confidence 345555555432 12345679999885432 23455789999999999999999999999999999999999999999
Q ss_pred hhhhccC----------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 522 SAFLFRQ----------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 522 ~~~l~~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
.+++.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~-------~~~~~l~dfg~~ 166 (277)
T cd05062 97 KSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE-------DFTVKIGDFGMT 166 (277)
T ss_pred HHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcC-------CCCEEECCCCCc
Confidence 9998643 2357889999999999999999998 9999999999999987 788999999998
Q ss_pred cccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 592 KLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 592 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
+......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~- 237 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLRFVMEG- 237 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHcC-
Confidence 7654322211 112235678999999998899999999999999999999 5666643211 0111111100
Q ss_pred HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 670 RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 670 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.....+...+..+.+++.+|++.+|++|||+.|++++|+.
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0112334556789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=265.36 Aligned_cols=212 Identities=25% Similarity=0.238 Sum_probs=182.9
Q ss_pred ceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHH
Q 039817 462 EVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE 538 (725)
Q Consensus 462 ~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~ 538 (725)
+...|+|.|++.. ....+...+|..+|+.+.||.++++++.+.+.+..+|||||.++|-|..+|.+.+++++....-
T Consensus 69 g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arF 148 (355)
T KOG0616|consen 69 GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARF 148 (355)
T ss_pred CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHH
Confidence 4578888886532 2334567899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhccc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 618 (725)
++.||+.||+|||+. .|++|||||+|||||. +|.+||.|||.|+..... ....+||+.|+|||.++
T Consensus 149 YAAeivlAleylH~~---~iiYRDLKPENiLlD~-------~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~ 214 (355)
T KOG0616|consen 149 YAAEIVLALEYLHSL---DIIYRDLKPENLLLDQ-------NGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQ 214 (355)
T ss_pred HHHHHHHHHHHHHhc---CeeeccCChHHeeecc-------CCcEEEEeccceEEecCc----EEEecCCccccChHHhh
Confidence 999999999999999 9999999999999988 999999999999976543 34578999999999999
Q ss_pred CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCC
Q 039817 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLR 697 (725)
Q Consensus 619 ~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 697 (725)
.+.+..++|.|+|||++|||+.|.+||..... +.-+-.-+..+-.+|......+++|+...++.|-.+|
T Consensus 215 sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 215 SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------IQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------HHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 99999999999999999999999999986532 1111111222335677778889999999999999999
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=290.69 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=192.3
Q ss_pred ccccHHHHHHHhcccCCc--ceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQ--EVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~--~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.++++...-++. ...||+|.++... ....++|.+|+.+++.++|+||++++|+|... ..++|+||+++|+
T Consensus 16 g~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~ 94 (316)
T cd05108 16 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGC 94 (316)
T ss_pred ecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCC
Confidence 445677777776544433 3468999986432 34457899999999999999999999999865 5679999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 95 l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~-------~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 95 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKT-------PQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred HHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecC-------CCcEEEccccccccccCCCc
Confidence 99999765 4688999999999999999999999 9999999999999987 77899999999987654332
Q ss_pred ccc-cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 RTS-TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
... ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ........ ......+..
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~~ 235 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEK-GERLPQPPI 235 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhC-CCCCCCCCC
Confidence 211 11224668999999999999999999999999999998 88887532110 01111110 001122234
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
....+.+++.+||+.+|.+||++.+++..|..+.
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 4567899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=279.77 Aligned_cols=242 Identities=23% Similarity=0.315 Sum_probs=187.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..|+.++++++.-+ +..+++|..... .......|.+|++++++++|+||+++++++...+..++||||+++++|.++
T Consensus 6 g~~g~vy~~~~~~~--~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 83 (252)
T cd05084 6 GNFGEVFSGRLRAD--NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 83 (252)
T ss_pred ccCccEEEEEEecC--CceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHH
Confidence 34566666666443 457888877543 233456799999999999999999999999999999999999999999999
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc-
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS- 602 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~- 602 (725)
+.+. ..+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||++...........
T Consensus 84 ~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~-------~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 84 LRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTE-------KNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcC-------CCcEEECccccCcccccccccccC
Confidence 9764 4689999999999999999999999 9999999999999987 77899999999876443211111
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
.....+..|+|||.+.+..++.++||||||+++|||++ |..|+...... .....+.. ......+...+..
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~ 224 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQ-GVRLPCPELCPDA 224 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHc-CCCCCCcccCCHH
Confidence 11123457999999998899999999999999999998 77776432110 01111111 0112233445678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
+.+++.+|++.+|++|||+.+|+++|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=287.77 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=190.8
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|+.++.+.+..+ +..+|+|.++.. .....+.+.+|+.++.++ +||||+++++++..++..++||||+++|+|
T Consensus 6 G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L 83 (329)
T cd05618 6 GSYAKVLLVRLKKT--ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83 (329)
T ss_pred CCCeEEEEEEECCC--CCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCH
Confidence 34555555554433 457888887643 223345678899988876 899999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
..++.+...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++....... .
T Consensus 84 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~-------~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDS-------EGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECC-------CCCEEEeeCCccccccCCCC-c
Confidence 99998888899999999999999999999999 9999999999999987 78999999999875322211 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 679 (725)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||........ ......+++...... ..++....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~~~~~~~~~~i~~~~~~~p~~~~ 229 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN---PDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC---cccccHHHHHHHHhcCCCCCCCCCC
Confidence 2234689999999999999999999999999999999999999864322110 011112223222222 23555667
Q ss_pred HHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPS------MKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs------~~evl~~ 706 (725)
..+.+++.+||+.||++||+ +.+++++
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 88999999999999999998 5677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=279.50 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=191.3
Q ss_pred cHHHHHHHhcccC-CcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFD-GQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~-~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.|+.|++|...-. +....+++|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++++|.++
T Consensus 7 ~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~ 85 (257)
T cd05060 7 NFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKY 85 (257)
T ss_pred CceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHH
Confidence 3455555543222 2457899999875433 34568999999999999999999999876 4568999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc--
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS-- 602 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~-- 602 (725)
+.+...+++..+..++.|++.||.|||.. +++|+||||+||+++. ++.+||+|||+++..........
T Consensus 86 l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~-------~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 86 LKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVN-------RHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcC-------CCcEEeccccccceeecCCcccccc
Confidence 98878899999999999999999999998 9999999999999987 78899999999986643322211
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ......+... .....+...+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~ 226 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAMLESG-ERLPRPEECPQE 226 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcC-CcCCCCCCCCHH
Confidence 11224567999999998899999999999999999998 8888754321 1111111111 111233445678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 227 l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 227 IYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=283.18 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=191.1
Q ss_pred ccccHHHHHHHhcccCCcc--eEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQE--VEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~--~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...++++++++...-+++. ..+++|.+..... ....++..|+..+++++|+||+++++++. +...++++||+++|+
T Consensus 16 g~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gs 94 (279)
T cd05111 16 GSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGS 94 (279)
T ss_pred CccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCc
Confidence 3456677777766555543 3578888754322 23457888888999999999999999875 455789999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++.......
T Consensus 95 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~-------~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 95 LLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKS-------DSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcC-------CCcEEEcCCccceeccCCCc
Confidence 99999764 5789999999999999999999998 9999999999999987 78999999999986543322
Q ss_pred c-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 R-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
. ......++..|+|||.+.+..++.++||||||+++||+++ |+.|+...... ...+.+.. ......+..
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~~ 235 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEK-GERLAQPQI 235 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHC-CCcCCCCCC
Confidence 1 1223446778999999998899999999999999999998 88887543211 11111110 001111223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
....+.+++.+|+..+|.+|||+.|+++.|+.+..
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 45677889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=260.03 Aligned_cols=204 Identities=25% Similarity=0.387 Sum_probs=174.1
Q ss_pred HHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCc
Q 039817 479 KSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ 557 (725)
Q Consensus 479 ~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 557 (725)
++-++|+.+|+++ .||+|+++.++++.+...++|+|.|+.|-|.|+|...-.++++...+|+.|+.+|+.|||.. +
T Consensus 67 EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~ 143 (411)
T KOG0599|consen 67 EATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---N 143 (411)
T ss_pred HHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---h
Confidence 3457899999998 69999999999999999999999999999999999999999999999999999999999999 9
Q ss_pred eeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccC------CCCCCccceehh
Q 039817 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN------APVTAKVDVYSF 631 (725)
Q Consensus 558 ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~S~ 631 (725)
||||||||+|||+|+ +.++||+|||.++.+..... ....+||++|+|||.+.. ..|+...|+|+.
T Consensus 144 IVHRDLKpENILldd-------n~~i~isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 144 IVHRDLKPENILLDD-------NMNIKISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC 214 (411)
T ss_pred hhhcccChhheeecc-------ccceEEeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence 999999999999988 88999999999998765433 345779999999998853 357889999999
Q ss_pred HHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh------hHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 632 GVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA------TKFERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 632 G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
|++||-|+.|.+||--.. ++. +...+.++.+.- +..+...+|+.+||+.||.+|.|++|+++
T Consensus 215 GVImyTLLaGcpPFwHRk--------Qml----MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 215 GVIMYTLLAGCPPFWHRK--------QML----MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHHcCCCchhHHH--------HHH----HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 999999999999884211 111 233333444321 55678899999999999999999999986
Q ss_pred H
Q 039817 706 M 706 (725)
Q Consensus 706 ~ 706 (725)
|
T Consensus 283 H 283 (411)
T KOG0599|consen 283 H 283 (411)
T ss_pred C
Confidence 5
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=289.65 Aligned_cols=236 Identities=25% Similarity=0.252 Sum_probs=186.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhc-cCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|++|++|.+.- .+..||+|.+... .....+.+..|.+++.. .+||||+++++++..++..++||||+++|+|
T Consensus 6 G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L 83 (316)
T cd05592 6 GSFGKVMLAELKG--TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDL 83 (316)
T ss_pred CCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcH
Confidence 4566666666543 3457889988642 22334556777777765 4899999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++...... ..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~-------~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 84 MFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDK-------DGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECC-------CCCEEEccCcCCeECCCCC-Cc
Confidence 99998888899999999999999999999998 9999999999999987 7899999999998543322 12
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 680 (725)
.....||..|+|||.+.+..++.++||||||+++|||++|+.|+...... +...... ....++.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~ 221 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----------ELFDSILNDRPHFPRWISK 221 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHcCCCCCCCCCCH
Confidence 22345899999999999989999999999999999999999998643211 1111111 12234445667
Q ss_pred HHHHHHHHccCCCCCCCCCHH-HHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMK-QVLQ 705 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~-evl~ 705 (725)
.+.+++.+||+.+|++||++. ++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 889999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=284.46 Aligned_cols=240 Identities=24% Similarity=0.279 Sum_probs=187.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|++++.+.+..++ ..+|+|.+.... ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|.+
T Consensus 5 ~~g~Vy~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~ 82 (280)
T cd05608 5 GFGEVSACQMRATG--KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRY 82 (280)
T ss_pred CceeEEEEEEccCC--cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHH
Confidence 45566666555443 578888875422 2233567899999999999999999999999999999999999999998
Q ss_pred hhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 524 FLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 524 ~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~-------~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 83 HIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDN-------DGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCCEEEeeCccceecCCCCc
Confidence 8743 35689999999999999999999999 9999999999999987 78899999999976543322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATK 678 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 678 (725)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ........... ....+...
T Consensus 153 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 224 (280)
T cd05608 153 K-TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-------ENKELKQRILNDSVTYPDKF 224 (280)
T ss_pred c-ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-------hHHHHHHhhcccCCCCcccC
Confidence 1 223458999999999999999999999999999999999999986532211 00111111111 11233456
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
++.+.+++.+||+.||++|| ++++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 77899999999999999999 78888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=281.02 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=191.1
Q ss_pred cccHHHHHHHhcccCC-cceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCc------eeeeeec
Q 039817 445 VFSYQELREATNVFDG-QEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH------QLLVYEL 515 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~-~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~e~ 515 (725)
..+|+.++.|+...++ ....||+|.++... ....+.+.+|++.+++++|+||+++++++..... .++|+||
T Consensus 9 ~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~ 88 (273)
T cd05035 9 EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPF 88 (273)
T ss_pred cCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEec
Confidence 4556677777654433 45679999886432 2335679999999999999999999999876554 7999999
Q ss_pred ccCCChhhhhccC------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeecc
Q 039817 516 MKNGTLSAFLFRQ------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589 (725)
Q Consensus 516 ~~~gsL~~~l~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfg 589 (725)
+++++|..++... ..+++.....++.|++.||.|||+. +++||||||+||++++ ++.+||+|||
T Consensus 89 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kl~dfg 158 (273)
T cd05035 89 MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLRE-------DMTVCVADFG 158 (273)
T ss_pred cCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECC-------CCeEEECCcc
Confidence 9999999998543 3578999999999999999999998 9999999999999987 7889999999
Q ss_pred CccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHH
Q 039817 590 LAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLY 667 (725)
Q Consensus 590 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (725)
+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~~~ 230 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYLRH 230 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHc
Confidence 998654332211 112235678999999988899999999999999999999 7777643211 111111111
Q ss_pred HHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 668 CVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 668 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
. .....+......+.+++.+|++.||++|||+.||++.|+++
T Consensus 231 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 G-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01123445677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=280.23 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=190.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeecc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELM 516 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~ 516 (725)
..+|+.++++.....+....+|+|.++.. .....+.|.+|++++++++|+||+++++++... ...++++||+
T Consensus 9 ~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~ 88 (272)
T cd05075 9 EGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88 (272)
T ss_pred cccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeC
Confidence 45567777777666666567899987643 233456789999999999999999999988532 2468999999
Q ss_pred cCCChhhhhcc------CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccC
Q 039817 517 KNGTLSAFLFR------QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590 (725)
Q Consensus 517 ~~gsL~~~l~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgl 590 (725)
++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 89 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~ 158 (272)
T cd05075 89 KHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNE-------NMNVCVADFGL 158 (272)
T ss_pred CCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcC-------CCCEEECCCCc
Confidence 99999998742 23478999999999999999999998 9999999999999987 78899999999
Q ss_pred ccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHH
Q 039817 591 AKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYC 668 (725)
Q Consensus 591 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (725)
++........ ......++..|+|||...+..++.++||||||+++|||++ |+.|+..... .+ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~-~~~~ 226 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----------SE-IYDY 226 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----------HH-HHHH
Confidence 9876433221 1122335678999999999999999999999999999999 6777653211 11 1111
Q ss_pred HHcC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 669 VRTG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 669 ~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
...+ ..+...++.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1222 22334567799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=282.53 Aligned_cols=247 Identities=27% Similarity=0.344 Sum_probs=189.9
Q ss_pred ccHHHHHHHhcccC---CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFD---GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~---~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..++.++.|..... .....|++|.+.... ......|.+|+.++++++|+||+++++++.+.+..++||||+++++|
T Consensus 17 g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L 96 (277)
T cd05036 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL 96 (277)
T ss_pred CCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCH
Confidence 44566666655431 256789999886433 33456799999999999999999999999999999999999999999
Q ss_pred hhhhccCC-------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 522 SAFLFRQE-------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 522 ~~~l~~~~-------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
.+++.+.+ .+++..+..++.|++.||+|||+. +++|+||||+||+++.+. ....+||+|||+++..
T Consensus 97 ~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~----~~~~~kl~dfg~~~~~ 169 (277)
T cd05036 97 KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKG----PGRVAKIADFGMARDI 169 (277)
T ss_pred HHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccC----CCcceEeccCcccccc
Confidence 99986543 478999999999999999999999 999999999999998631 1346999999999866
Q ss_pred CcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 595 KKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 595 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
....... ......+..|+|||++.+..++.++||||||+++|||++ |..|+...... ...+.+.. ....
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~~~~~~~-~~~~ 240 (277)
T cd05036 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EVMEFVTG-GGRL 240 (277)
T ss_pred CCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHc-CCcC
Confidence 3322111 111223567999999998999999999999999999997 88877643211 11111110 0112
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
..+...+..+.+++.+|++.+|++||++.+|+++|+
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 334455678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=280.16 Aligned_cols=240 Identities=24% Similarity=0.351 Sum_probs=184.2
Q ss_pred cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCChhhhhccCCCCCHHHHH
Q 039817 461 QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTLSAFLFRQEIPTWDKRV 537 (725)
Q Consensus 461 ~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~ 537 (725)
.+..||+|.+.... ....+.|.+|++++++++||||+++++++... ...++||||+++++|.+++... .+++..+.
T Consensus 32 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~ 110 (283)
T cd05080 32 TGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLL 110 (283)
T ss_pred CCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHH
Confidence 45578999886533 23467889999999999999999999998754 3578999999999999999654 58999999
Q ss_pred HHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc--ccccccCccccchh
Q 039817 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT--STMIRGTMGYMAPE 615 (725)
Q Consensus 538 ~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE 615 (725)
.++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++......... .....++..|+|||
T Consensus 111 ~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~-------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE 180 (283)
T cd05080 111 LFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDN-------DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180 (283)
T ss_pred HHHHHHHHHHHHHHHC---CeeccccChheEEEcC-------CCcEEEeecccccccCCcchhhccCCCCCCCceeeCHh
Confidence 9999999999999999 9999999999999987 7889999999998664332211 11223566799999
Q ss_pred cccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc---cccCcchHHHHHHHHHc---CCCChhHHHHHHHHHHHc
Q 039817 616 WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT---LANGMILTDWVLYCVRT---GNLGATKFERITMVGLWC 689 (725)
Q Consensus 616 ~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~c 689 (725)
.+.+..++.++||||||++++||++|..|+......... ................. ...+...+..+.+++..|
T Consensus 181 ~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 260 (283)
T cd05080 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNC 260 (283)
T ss_pred HhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHH
Confidence 998888999999999999999999999887543211100 00000001111111111 122344567899999999
Q ss_pred cCCCCCCCCCHHHHHHHhcCCC
Q 039817 690 ICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 690 l~~dp~~RPs~~evl~~L~~~~ 711 (725)
|+.+|++|||+++|+++|+.+.
T Consensus 261 l~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 261 WETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hccChhhCCCHHHHHHHHHHhh
Confidence 9999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=288.29 Aligned_cols=242 Identities=20% Similarity=0.207 Sum_probs=189.8
Q ss_pred cHHHHHHHhcccC-CcceEEEEEEcccc----cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 447 SYQELREATNVFD-GQEVEVAVKQLEKV----TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~-~~~~~vavk~l~~~----~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+|+.++.+.+... ..+..||+|.+... .....+.+..|++++.++ +|+||+++++++..++..++||||+++|+
T Consensus 12 ~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 91 (332)
T cd05614 12 AYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGE 91 (332)
T ss_pred CCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCc
Confidence 4444454443322 24567899988542 122345688999999999 59999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~-------~~~~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 92 MFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDS-------EGHVVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECC-------CCCEEEeeCcCCccccccCCC
Confidence 999998888899999999999999999999999 9999999999999987 789999999999865443333
Q ss_pred cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChh
Q 039817 601 TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGAT 677 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 677 (725)
......||..|+|||.+.+. .++.++||||||+++|||++|+.|+....... . ...+..... ...++..
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~-~~~~~~~~~~~~~~~~~~ 233 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-------T-QSEVSRRILKCDPPFPSF 233 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-------C-HHHHHHHHhcCCCCCCCC
Confidence 33345689999999999865 47889999999999999999999986432211 1 111111111 2234445
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
....+.+++.+||+.||++|| ++++++++
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 677899999999999999999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=296.88 Aligned_cols=243 Identities=19% Similarity=0.202 Sum_probs=184.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..+++.++.+.+...+ ..||+|... ...+.+|++++++++|||||++++++..+...++|+|++. ++|.++
T Consensus 102 ~G~~g~V~~~~d~~~~--~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~ 172 (391)
T PHA03212 102 PGAEGFAFACIDNKTC--EHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCY 172 (391)
T ss_pred CCCCeEEEEEEECCCC--CEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHH
Confidence 3456667767665544 467888643 2457899999999999999999999999999999999996 689999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++............
T Consensus 173 l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~-------~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 173 LAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINH-------PGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcC-------CCCEEEEeCCccccccccccccccc
Confidence 88778899999999999999999999999 9999999999999987 7889999999997543322222233
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCc----------------------chH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM----------------------ILT 662 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~----------------------~~~ 662 (725)
..||+.|+|||++.+..++.++||||||+++|||++|+.|+.............. .+.
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 5699999999999999999999999999999999999987653321110000000 000
Q ss_pred HHHHHHHHcCC-----CC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 663 DWVLYCVRTGN-----LG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 663 ~~~~~~~~~~~-----~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........... .+ ...+..+.+|+.+||+.||++|||++|++++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 00 0235578899999999999999999999964
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=290.22 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=191.4
Q ss_pred ccccHHHHHHHhcccC---CcceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcC-Cceeeeeeccc
Q 039817 444 KVFSYQELREATNVFD---GQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQ-NHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~---~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~lV~e~~~ 517 (725)
...+|+.++.|...-. .....||+|.+..... ...+.+.+|++++.++ +|+||++++++|... ...+++|||++
T Consensus 16 G~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~ 95 (337)
T cd05054 16 GRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95 (337)
T ss_pred ccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCC
Confidence 3456677777654222 2346899999864332 2345688999999999 899999999988754 56889999999
Q ss_pred CCChhhhhccC-------------------------------------------------------------CCCCHHHH
Q 039817 518 NGTLSAFLFRQ-------------------------------------------------------------EIPTWDKR 536 (725)
Q Consensus 518 ~gsL~~~l~~~-------------------------------------------------------------~~l~~~~~ 536 (725)
+++|.+++... ..+++..+
T Consensus 96 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 175 (337)
T cd05054 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDL 175 (337)
T ss_pred CCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHH
Confidence 99999988532 25789999
Q ss_pred HHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-cccccccCccccchh
Q 039817 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPE 615 (725)
Q Consensus 537 ~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE 615 (725)
..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.+...... ......++..|+|||
T Consensus 176 ~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~-------~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 176 ISYSFQVARGMEFLASR---KCIHRDLAARNILLSE-------NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred HHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeC-------CCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 99999999999999999 9999999999999987 778999999999875433221 122234667899999
Q ss_pred cccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCC
Q 039817 616 WLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQP 694 (725)
Q Consensus 616 ~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp 694 (725)
++.+..++.++||||||++++||++ |..|+......+ .+...+... .....+....+.+.+++.+||+.+|
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFCRRLKEG-TRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------HHHHHHhcc-CCCCCCccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999998 888876432111 011111110 0112233456789999999999999
Q ss_pred CCCCCHHHHHHHhcCCCC
Q 039817 695 TLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 695 ~~RPs~~evl~~L~~~~~ 712 (725)
++||++.||+++|+.+.+
T Consensus 318 ~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 318 EDRPTFSELVEILGDLLQ 335 (337)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=280.42 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=190.5
Q ss_pred cHHHHHHHhcc---cCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNV---FDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~---~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|+.++.+... -.+++..+++|.+........+.|.+|++++++++|+||+++++++..++..++||||+++++|.+
T Consensus 17 ~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 96 (280)
T cd05092 17 AFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNR 96 (280)
T ss_pred cCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHH
Confidence 44555544321 124456889999877666667789999999999999999999999999999999999999999999
Q ss_pred hhccCC---------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeec
Q 039817 524 FLFRQE---------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADF 588 (725)
Q Consensus 524 ~l~~~~---------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Df 588 (725)
++.... .+++..+..++.|++.||+|||+. +++|+||||+||++++ ++.+||+||
T Consensus 97 ~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~-------~~~~kL~df 166 (280)
T cd05092 97 FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ-------GLVVKIGDF 166 (280)
T ss_pred HHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC-------CCCEEECCC
Confidence 986542 478999999999999999999998 9999999999999987 788999999
Q ss_pred cCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHH
Q 039817 589 GLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVL 666 (725)
Q Consensus 589 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (725)
|+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... +...
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------~~~~ 235 (280)
T cd05092 167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----------EAIE 235 (280)
T ss_pred CceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----------HHHH
Confidence 999755432211 1112235678999999999999999999999999999998 77776432111 1111
Q ss_pred HHHH--cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 667 YCVR--TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 667 ~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.... ....+...+..+.+++.+||+.||.+||++.+|++.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111 112233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=296.11 Aligned_cols=240 Identities=25% Similarity=0.354 Sum_probs=190.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC--ceeeeeecccCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--HQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~~~g 519 (725)
.+..+..+++|.+..+|-.++---+++... +....+.|..|+++|+.|+|+|||+++.++.+.. ..-+|+|.|..|
T Consensus 49 GrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSG 128 (632)
T KOG0584|consen 49 GRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSG 128 (632)
T ss_pred ccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCC
Confidence 445566677777644443222111222222 2334578999999999999999999999998654 478999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|..|+.+.+..+.+.+.+|++||++||.|||.+ .|+|||||||.+||||+.+ .|.|||+|+|||.+......
T Consensus 129 tLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~------~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 129 TLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGN------LGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCC------cCceeecchhHHHHhhcccc
Confidence 9999999999999999999999999999999997 6799999999999999875 78999999999998765433
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh---
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA--- 676 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 676 (725)
. ...||+.|||||... ..|++..|||||||+|+||+|+..|+...... ..+......|.-|.
T Consensus 202 k---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----------AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 202 K---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----------AQIYKKVTSGIKPAALS 266 (632)
T ss_pred c---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----------HHHHHHHHcCCCHHHhh
Confidence 2 367999999999988 67999999999999999999999999755432 22223233333322
Q ss_pred -hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 -TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 -~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...++++++|.+|+.. ..+|||+.|++++
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3357899999999999 9999999999964
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=284.64 Aligned_cols=247 Identities=27% Similarity=0.383 Sum_probs=191.0
Q ss_pred ccHHHHHHHhcc---cCCcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 446 FSYQELREATNV---FDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 446 ~~~~~l~~a~~~---~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..++.++.++.. -......||||.++... ....+.+.+|+++++++ +|+||+++++++...+..++||||+++++
T Consensus 46 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 125 (302)
T cd05055 46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125 (302)
T ss_pred cCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCc
Confidence 445556555532 12345679999886543 23345789999999999 79999999999999999999999999999
Q ss_pred hhhhhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 521 LSAFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 521 L~~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
|.+++.+.. .+++.++..++.|++.||.|||+. +++|+||||+||+++. +..+|++|||+++......
T Consensus 126 L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~-------~~~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTH-------GKIVKICDFGLARDIMNDS 195 (302)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcC-------CCeEEECCCcccccccCCC
Confidence 999997543 389999999999999999999998 9999999999999987 7789999999998654332
Q ss_pred Cc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 599 TR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 599 ~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .......... ....+.
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-~~~~~~ 267 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------KFYKLIKEGY-RMAQPE 267 (302)
T ss_pred ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------HHHHHHHcCC-cCCCCC
Confidence 21 1112335678999999998899999999999999999998 888875432111 0111111100 111223
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..++.+.+++.+|++.+|++|||+.|+++.|++.
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 4467899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=287.33 Aligned_cols=246 Identities=21% Similarity=0.294 Sum_probs=187.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+|+.|+.+.+..++ ..+++|.+... .....+.+.+|++++++++|+||+++++++..++..++||||+++++|.++
T Consensus 16 g~~g~V~~~~~~~~~--~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 93 (333)
T cd06650 16 GNGGVVFKVSHKPSG--LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 93 (333)
T ss_pred CCCEEEEEEEECCCC--cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHH
Confidence 345566666654443 46778876543 223446799999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.+.+.+++.....++.|++.||.|||+. .+++|+||||+|||++. ++.+||+|||++....... ...
T Consensus 94 l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~-------~~~~kL~Dfg~~~~~~~~~---~~~ 161 (333)
T cd06650 94 LKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNS-------RGEIKLCDFGVSGQLIDSM---ANS 161 (333)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcC-------CCCEEEeeCCcchhhhhhc---ccc
Confidence 98888899999999999999999999974 16999999999999987 7789999999987553321 122
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc----------cc------------------
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT----------LA------------------ 656 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~----------~~------------------ 656 (725)
..|+..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhh
Confidence 45889999999999888999999999999999999999998643211000 00
Q ss_pred -----cCcchHHHHHHHHHcCCCCh----hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 657 -----NGMILTDWVLYCVRTGNLGA----TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 657 -----~~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....... ..........+. ....++.+|+.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 242 GPDSRPPMAIFE-LLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccccccccHHH-HHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000 111111111111 234678999999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=277.25 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=204.7
Q ss_pred CCCcccccHHHHHHHhcccCCcceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 440 EINMKVFSYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 440 ~~~~~~~~~~~l~~a~~~~~~~~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
+..+.+..|.-++.|...|.|+.+ |||.+.+ .+......+++|++.|+.++|||||+||.+......+|||.|.-+
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekV--AVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD 100 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKV--AVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD 100 (864)
T ss_pred hhhhcCCceehhhhhhhhccccee--EEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence 334567788899999999999764 5665544 445556789999999999999999999999999999999999999
Q ss_pred CCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 518 NGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 518 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+|+|.+||-++ ..+.+....+++.||+.|+.|+|+. .+|||||||+|+.+.+. -|.+||.|||++-.+..
T Consensus 101 ~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEK------lGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 101 GGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEK------LGLVKLTDFGFSNKFQP 171 (864)
T ss_pred CchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeee------cCceEeeeccccccCCC
Confidence 99999999776 6789999999999999999999999 99999999999987653 78999999999987765
Q ss_pred CCCccccccccCccccchhcccCCCCC-CccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVT-AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG 675 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (725)
... .+..+|+..|.|||.+.+..|+ ++.|||||||+||-|++|+.||+.....+ ....+..+ +-.+|
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------TLTmImDC--KYtvP 239 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------TLTMIMDC--KYTVP 239 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------hhhhhhcc--cccCc
Confidence 443 3346799999999999998876 67999999999999999999998653222 11112222 23567
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....++++||..||..||++|.+.+||+..
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 7889999999999999999999999999865
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=258.38 Aligned_cols=239 Identities=23% Similarity=0.285 Sum_probs=199.6
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
+.+..|++++.|....+ ...||+|.+.+. ..+...++.+|+++-+.|+||||+++|+++.+....||++||.+.|
T Consensus 30 LgkgkFG~vYlarekks--~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~g 107 (281)
T KOG0580|consen 30 LGKGKFGNVYLAREKKS--LFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRG 107 (281)
T ss_pred ccCCccccEeEeeeccC--CcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCc
Confidence 44566777777765544 357899988643 2445678999999999999999999999999999999999999999
Q ss_pred Chhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 520 TLSAFLF--RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 520 sL~~~l~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|...|. ....+++.....++.|+|.||.|+|.. +++||||||+|+|++. .+..||+|||-+....
T Consensus 108 el~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~-------~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 108 ELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGS-------AGELKIADFGWSVHAP-- 175 (281)
T ss_pred hHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCC-------CCCeeccCCCceeecC--
Confidence 9999998 457789999999999999999999999 9999999999999988 8899999999887543
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.......+||..|++||...+..++.+.|+|++|++-||++.|.+||+....++ -+-+-...+-.++..
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e----------tYkrI~k~~~~~p~~ 244 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE----------TYKRIRKVDLKFPST 244 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH----------HHHHHHHccccCCcc
Confidence 222344679999999999999999999999999999999999999998553211 011111112345677
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......+++..|+..+|.+|.+..|++++
T Consensus 245 is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 245 ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 78899999999999999999999999876
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=292.68 Aligned_cols=237 Identities=24% Similarity=0.313 Sum_probs=181.8
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...|+.++++++..+ +..||||.+.... ....+.+.+|++++++++|+||+++++++..++..++||||+++++|.+
T Consensus 84 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 161 (353)
T PLN00034 84 SGAGGTVYKVIHRPT--GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161 (353)
T ss_pred CCCCeEEEEEEECCC--CCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccc
Confidence 344556666654433 4578999885432 2335678999999999999999999999999999999999999999865
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.. ...+..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... ...
T Consensus 162 ~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~-------~~~~kL~DfG~~~~~~~~~~-~~~ 226 (353)
T PLN00034 162 TH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINS-------AKNVKIADFGVSRILAQTMD-PCN 226 (353)
T ss_pred cc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcC-------CCCEEEcccccceecccccc-ccc
Confidence 43 346778889999999999999999 9999999999999987 78999999999986543221 112
Q ss_pred ccccCccccchhcccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH--HcCCCCh
Q 039817 604 MIRGTMGYMAPEWLRN-----APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV--RTGNLGA 676 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 676 (725)
...|+..|+|||.+.. ...+.++||||||+++|||++|+.||....... ......... .....+.
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~ 298 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--------WASLMCAICMSQPPEAPA 298 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHHHHHHhccCCCCCCC
Confidence 3458999999998743 234568999999999999999999987332111 111111111 1122334
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+.+|+.+||+.||++|||+.|++++
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 556789999999999999999999999987
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=285.83 Aligned_cols=235 Identities=25% Similarity=0.287 Sum_probs=186.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.|+.++.+.+..+ +..||||.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++|+|.
T Consensus 7 ~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~ 84 (320)
T cd05590 7 SFGKVMLARLKES--GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM 84 (320)
T ss_pred CCeEEEEEEEcCC--CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHH
Confidence 3445555544333 457888887642 233456778899998876 6999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... ..
T Consensus 85 ~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~-------~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 85 FHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDH-------EGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECC-------CCcEEEeeCCCCeecCcCCC-cc
Confidence 9998888899999999999999999999999 9999999999999987 78999999999875432211 12
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCChhHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLGATKFE 680 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 680 (725)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... + +....... ..+.....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----------~-~~~~i~~~~~~~~~~~~~ 221 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----------D-LFEAILNDEVVYPTWLSQ 221 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----------H-HHHHHhcCCCCCCCCCCH
Confidence 2345899999999999999999999999999999999999999643211 1 11111122 23445667
Q ss_pred HHHHHHHHccCCCCCCCCCH------HHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSM------KQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~------~evl~~ 706 (725)
.+.+++.+|++.||++||++ ++++++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 88999999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=279.14 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=193.3
Q ss_pred cccHHHHHHHhcccCCc-ceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQ-EVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~-~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...++.++++.....+. ...+++|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 15 ~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (268)
T cd05063 15 AGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALD 94 (268)
T ss_pred CCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHH
Confidence 34456677776654433 4578999886442 334567999999999999999999999999999999999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++. ++.+||+|||++..........
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~-------~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 95 KYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNS-------NLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcC-------CCcEEECCCccceecccccccc
Confidence 999764 5789999999999999999999999 9999999999999987 7889999999998654332211
Q ss_pred cc--ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 602 ST--MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 602 ~~--~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
.. ....+..|+|||++.+..++.++||||||+++|||++ |+.|+...... .....+... .....+...
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~-~~~~~~~~~ 235 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDG-FRLPAPMDC 235 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcC-CCCCCCCCC
Confidence 11 1223457999999998889999999999999999997 88888533211 111111110 011222345
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=280.65 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=190.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccc---ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..++.+++++...++ ..|+||.+.. ........|.+|++++++++||||+++++++...+..++|+||+++++|.
T Consensus 13 g~~~~v~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 90 (267)
T cd08228 13 GQFSEVYRATCLLDR--KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLS 90 (267)
T ss_pred CCCeeEEEEEEeCCC--CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHH
Confidence 345556666655444 4677886643 22334457899999999999999999999999999999999999999999
Q ss_pred hhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 523 AFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 523 ~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+++.. ...++...+..++.|++.||.|||+. +++|+||||+||+++. ++.++|+|||++.......
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~-------~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 91 QMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITA-------TGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred HHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcC-------CCCEEECccccceeccchh
Confidence 88853 34578899999999999999999999 9999999999999987 7789999999988764332
Q ss_pred CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC----
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL---- 674 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 674 (725)
.. .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... ..+.... ......
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---------~~~~~~~-~~~~~~~~~~ 229 (267)
T cd08228 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LFSLCQK-IEQCDYPPLP 229 (267)
T ss_pred HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---------HHHHHHH-HhcCCCCCCC
Confidence 21 12234788999999998888999999999999999999999998543211 1111111 111111
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 124557899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=276.98 Aligned_cols=243 Identities=29% Similarity=0.439 Sum_probs=193.8
Q ss_pred cHHHHHHHhcccC-CcceEEEEEEcccccCcc-HHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFD-GQEVEVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~-~~~~~vavk~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.|+.++++.+... .....+++|.+....... .+.+.+|++.+++++|+||+++++++..+...++||||+++++|.++
T Consensus 7 ~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (262)
T cd00192 7 AFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86 (262)
T ss_pred CceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHH
Confidence 3445555554433 346789999987654333 67899999999999999999999999999999999999999999999
Q ss_pred hccC---------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 525 LFRQ---------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 525 l~~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||.+....
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~-------~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 87 LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGE-------DLVVKISDFGLSRDVY 156 (262)
T ss_pred HhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECC-------CCcEEEcccccccccc
Confidence 9875 6789999999999999999999999 9999999999999987 7899999999998765
Q ss_pred cCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCC
Q 039817 596 KDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGN 673 (725)
Q Consensus 596 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (725)
.... .......++..|+|||.+....++.++||||||++++||++ |..|+...... ...+.... .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~-~~~~~ 227 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEYLRK-GYRLP 227 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHc-CCCCC
Confidence 4332 11223447889999999988889999999999999999999 57777643111 11111111 00112
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
.+...+..+.+++.+|++.+|++|||+.|++++|+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 33455688999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=281.92 Aligned_cols=241 Identities=21% Similarity=0.268 Sum_probs=187.9
Q ss_pred cHHHHHHHhcccC---CcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFD---GQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~---~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+|+.+++++..-. .....||+|.+...... ..+.|.+|+.++++++|+||+++++++......++++||+++++|.
T Consensus 17 ~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~ 96 (283)
T cd05091 17 RFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96 (283)
T ss_pred CCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHH
Confidence 3445555543322 24568999998754322 2456889999999999999999999999999999999999999999
Q ss_pred hhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEe
Q 039817 523 AFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586 (725)
Q Consensus 523 ~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~ 586 (725)
+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~-------~~~~kl~ 166 (283)
T cd05091 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD-------KLNVKIS 166 (283)
T ss_pred HHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC-------CCceEec
Confidence 998521 2478888999999999999999998 9999999999999987 7789999
Q ss_pred eccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHH
Q 039817 587 DFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDW 664 (725)
Q Consensus 587 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~ 664 (725)
|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .+.
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------~~~ 235 (283)
T cd05091 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----------QDV 235 (283)
T ss_pred ccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----------HHH
Confidence 999988654322211 122335678999999988889999999999999999998 6666643211 111
Q ss_pred HHHHHHc---CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 665 VLYCVRT---GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 665 ~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
. ..... ...+...++.+.+++..|++.+|++||++++|++.|+.
T Consensus 236 ~-~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I-EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11212 22345667889999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.12 Aligned_cols=231 Identities=27% Similarity=0.368 Sum_probs=181.8
Q ss_pred cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCC----------
Q 039817 461 QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE---------- 529 (725)
Q Consensus 461 ~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------- 529 (725)
....|++|.+.... ....+.|.+|++++++++|+||+++++++..++..++|+||+++++|.+++.+..
T Consensus 45 ~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05051 45 APVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124 (296)
T ss_pred CceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccC
Confidence 34678999986432 3346689999999999999999999999999999999999999999999997654
Q ss_pred -CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-ccccccc
Q 039817 530 -IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRG 607 (725)
Q Consensus 530 -~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g 607 (725)
.+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++........ ......+
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~-------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 194 (296)
T cd05051 125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK-------NYTIKIADFGMSRNLYSSDYYRVQGRAPL 194 (296)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecC-------CCceEEccccceeecccCcceeecCcCCC
Confidence 689999999999999999999998 9999999999999987 789999999998765332221 1223346
Q ss_pred CccccchhcccCCCCCCccceehhHHHHHHHHh--CCcCCCCCCCCccccccCcchHHHHHHHHHc------CCCChhHH
Q 039817 608 TMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF--CKRHTELHRVDEPTLANGMILTDWVLYCVRT------GNLGATKF 679 (725)
Q Consensus 608 t~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 679 (725)
+..|+|||.+.+..++.++||||||+++|||++ +..|+..... ......+...... ...+...+
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (296)
T cd05051 195 PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--------QQVIENAGHFFRDDGRQIYLPRPPNCP 266 (296)
T ss_pred CceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--------HHHHHHHHhccccccccccCCCccCCC
Confidence 778999999988889999999999999999998 4455532211 0011111111000 11122345
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+++.+++.+|++.||++|||+.||++.|+.
T Consensus 267 ~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 267 KDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=281.42 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=190.4
Q ss_pred ccHHHHHHHhcc--cCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCCCh
Q 039817 446 FSYQELREATNV--FDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~--~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL 521 (725)
.+|+.++.+... -...+..|++|.+........+.|.+|++++++++|+||+++++++.. ....++||||+++++|
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L 94 (284)
T cd05081 15 GNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSL 94 (284)
T ss_pred CCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCH
Confidence 345555555421 123456899999876655666789999999999999999999998754 3467899999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++........
T Consensus 95 ~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~-------~~~~~l~dfg~~~~~~~~~~~ 164 (284)
T cd05081 95 RDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVES-------ENRVKIGDFGLTKVLPQDKEY 164 (284)
T ss_pred HHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECC-------CCeEEECCCcccccccCCCcc
Confidence 9999764 4689999999999999999999999 9999999999999987 788999999999876433221
Q ss_pred c--ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc----cccCcchHHHHHHHHHcC--
Q 039817 601 T--STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT----LANGMILTDWVLYCVRTG-- 672 (725)
Q Consensus 601 ~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~-- 672 (725)
. .....++..|+|||.+.+..++.++||||||++++||++|..++......... ..........+.......
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05081 165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244 (284)
T ss_pred eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCc
Confidence 1 11122345699999999888999999999999999999987665322111000 000011111111212111
Q ss_pred -CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 673 -NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 673 -~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 245 LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 12234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=295.01 Aligned_cols=241 Identities=23% Similarity=0.286 Sum_probs=192.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+++.+++|.+..+ +..||||.+.... ......+.+|++++..++|+||+++++++.+++..++||||+++++|
T Consensus 11 ~G~~g~Vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (350)
T cd05573 11 RGAFGEVWLVRDKDT--GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDL 88 (350)
T ss_pred eCCcEEEEEEEECCC--CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCH
Confidence 345666666666554 3578888876432 24456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC---
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ--- 598 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~--- 598 (725)
.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++.......
T Consensus 89 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~-------~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 89 MNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDA-------DGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECC-------CCCEEeecCCCCccCcccCccc
Confidence 99998888899999999999999999999998 9999999999999987 7899999999998654433
Q ss_pred -------------------------CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcc
Q 039817 599 -------------------------TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEP 653 (725)
Q Consensus 599 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~ 653 (725)
........||..|+|||.+.+..++.++||||||+++|||++|+.|+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~- 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE- 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH-
Confidence 011223458999999999999999999999999999999999999987543111
Q ss_pred ccccCcchHHHHHHHHHcCCCCh--hHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 039817 654 TLANGMILTDWVLYCVRTGNLGA--TKFERITMVGLWCICPQPTLRPS-MKQVLQM 706 (725)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~ 706 (725)
....+.........+. ...+.+.+++.+|++ +|.+||+ ++|++++
T Consensus 238 -------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 -------TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -------HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0001111001112222 247889999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=277.54 Aligned_cols=235 Identities=24% Similarity=0.340 Sum_probs=188.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.+++++...+ +..+++|.+.. ......+.+.+|++++++++||||+++++++.+++..++||||+++++|.++
T Consensus 12 ~~~~v~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd08529 12 SFGVVFKVVRKAD--KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKL 89 (256)
T ss_pred CCeEEEEEEEcCC--CcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHH
Confidence 4445555555433 35677887653 2344567899999999999999999999999999999999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++........ .
T Consensus 90 l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~-------~~~~~l~df~~~~~~~~~~~~-~ 158 (256)
T cd08529 90 LKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDA-------YDNVKIGDLGVAKLLSDNTNF-A 158 (256)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeC-------CCCEEEcccccceeccCccch-h
Confidence 9764 5688999999999999999999998 9999999999999987 788999999998866543222 1
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---CCChhHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG---NLGATKF 679 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 679 (725)
....++..|+|||++.+..++.++||||||++++||++|+.|+...... . .......+ ..+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------~-~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----------A-LILKIIRGVFPPVSQMYS 226 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----------H-HHHHHHcCCCCCCccccC
Confidence 2245788999999999999999999999999999999999998643211 1 11111112 2333556
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 227 QQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=278.92 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=193.0
Q ss_pred cccHHHHHHHhcccCCc-ceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQ-EVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~-~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...++.+++|....++. ...|+||.+... .....++|..|+.++++++||||+++++++..+...++||||+++++|.
T Consensus 14 ~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T cd05065 14 AGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93 (269)
T ss_pred CCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHH
Confidence 34566677777665553 467999998654 2334568999999999999999999999999999999999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++.++..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++..........
T Consensus 94 ~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~-------~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 94 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNS-------NLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcC-------CCcEEECCCccccccccCcccc
Confidence 999754 5689999999999999999999998 9999999999999977 7889999999988654322211
Q ss_pred c-c-ccc--cCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 602 S-T-MIR--GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 602 ~-~-~~~--gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
. . ... .+..|+|||.+.+..++.++||||||+++||+++ |..|+...... .....+.... ....+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~~~~-~~~~~~ 234 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQDY-RLPPPM 234 (269)
T ss_pred ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCC-cCCCcc
Confidence 1 1 111 2357999999999999999999999999999886 88887533211 1111111100 112233
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..+..+.+++.+||+.+|.+||++.+|+.+|+++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=258.00 Aligned_cols=236 Identities=23% Similarity=0.293 Sum_probs=186.0
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC-----CceeeeeecccCCChhhhhccC----CCCC
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-----NHQLLVYELMKNGTLSAFLFRQ----EIPT 532 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~----~~l~ 532 (725)
+..+|+|++...+.++.+..++|++..++++|||++++++++..+ .+.+|++.|...|||.+.+... ..++
T Consensus 46 ~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~s 125 (302)
T KOG2345|consen 46 GHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVS 125 (302)
T ss_pred ccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccC
Confidence 356799998877777888999999999999999999999998643 3589999999999999998653 4689
Q ss_pred HHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc--------ccc
Q 039817 533 WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT--------STM 604 (725)
Q Consensus 533 ~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~--------~~~ 604 (725)
+.+.++|+.++++||.+||+. .++++||||||.|||+.+ .+.+++.|||.+....-.-... -..
T Consensus 126 E~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~-------~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~ 197 (302)
T KOG2345|consen 126 EAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSD-------SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAE 197 (302)
T ss_pred HHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecC-------CCceEEEeccCccccceEeechHHHHHHHHHHH
Confidence 999999999999999999997 336999999999999987 7899999999987653221111 112
Q ss_pred cccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 605 IRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 605 ~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
...|..|+|||.+. +...++++|||||||+||+|+.|..||+........++-.....+. ...-....++.
T Consensus 198 e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~------s~P~~~~yse~ 271 (302)
T KOG2345|consen 198 ERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQI------SIPNSSRYSEA 271 (302)
T ss_pred HhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccc------ccCCCCCccHH
Confidence 34788999999985 4467899999999999999999999998654322111100000000 00111237889
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.+++.+|++.||.+||++.+++..++.+.
T Consensus 272 l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 272 LHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 999999999999999999999999998754
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-33 Score=292.52 Aligned_cols=244 Identities=26% Similarity=0.343 Sum_probs=201.7
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+...+|+.++.|.+.-+ .+.+|||-+...+....+-+.+|+.+-++++|+|||+++|.|.+++.+-+.||-.+||||.
T Consensus 583 LGKGTYG~VYA~RD~~t--qvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 583 LGKGTYGTVYAARDMDT--QVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred eecCceeEEEeeccccc--eeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 34568888888877644 4788999997766666777899999999999999999999999999999999999999999
Q ss_pred hhhccC-CCC--CHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 523 AFLFRQ-EIP--TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 523 ~~l~~~-~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+.|... +++ .+...--+..||++||.|||+. .|||||||-+|+|++. -.|.+||+|||-++.+..-..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNT------ySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNT------YSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEee------ccceEEecccccchhhccCCc
Confidence 999776 555 6777888899999999999999 9999999999999975 288999999999987654433
Q ss_pred ccccccccCccccchhcccCC--CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 RTSTMIRGTMGYMAPEWLRNA--PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
. ...+-||..|||||++..+ .|..++|||||||.+.||.||++||..-..... .+. .+--.....++|.+
T Consensus 732 ~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----AMF---kVGmyKvHP~iPee 803 (1226)
T KOG4279|consen 732 C-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----AMF---KVGMYKVHPPIPEE 803 (1226)
T ss_pred c-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----hhh---hhcceecCCCCcHH
Confidence 3 3345699999999999765 588999999999999999999999964322110 000 01111224678888
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
..++.+.++++|+.+||.+||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 9999999999999999999999999985
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=291.98 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=191.8
Q ss_pred ccccHHHHHHHhccc---CCcceEEEEEEcccccC-ccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccC
Q 039817 444 KVFSYQELREATNVF---DGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
...+|+.|++++..- ......||||.++.... ...+.+.+|++++.++. |+|||+++|+|...+..++||||+++
T Consensus 46 G~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~ 125 (401)
T cd05107 46 GSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRY 125 (401)
T ss_pred cCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCC
Confidence 345677777766432 22346799999975432 23457899999999997 99999999999999999999999999
Q ss_pred CChhhhhccC----------------------------------------------------------------------
Q 039817 519 GTLSAFLFRQ---------------------------------------------------------------------- 528 (725)
Q Consensus 519 gsL~~~l~~~---------------------------------------------------------------------- 528 (725)
|+|.+++++.
T Consensus 126 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (401)
T cd05107 126 GDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIE 205 (401)
T ss_pred CcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhh
Confidence 9999998643
Q ss_pred ----------------------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCC
Q 039817 529 ----------------------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580 (725)
Q Consensus 529 ----------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~ 580 (725)
..+++.....++.|++.||.|||+. +++||||||+|||++. +
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~-------~ 275 (401)
T cd05107 206 SSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICE-------G 275 (401)
T ss_pred ccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeC-------C
Confidence 1356778889999999999999998 9999999999999987 7
Q ss_pred CceEEeeccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccC
Q 039817 581 YITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANG 658 (725)
Q Consensus 581 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~ 658 (725)
+.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.|+......
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~------- 348 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN------- 348 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-------
Confidence 78999999999865332211 1112346788999999998889999999999999999998 77776532211
Q ss_pred cchHHHHHHHHHcC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 659 MILTDWVLYCVRTG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 659 ~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+........+ ..+......+.+++.+||+.+|.+||++++|++.|+++.
T Consensus 349 ----~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 ----EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111 233345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=274.81 Aligned_cols=239 Identities=25% Similarity=0.377 Sum_probs=185.5
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
.++.++.+... ....+++|.+... ......|.+|++++++++|+||+++++++...+..++||||+++++|.+++.
T Consensus 16 ~~~~v~~~~~~---~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 91 (256)
T cd05059 16 QFGVVHLGKWR---GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR 91 (256)
T ss_pred CCceEEEeEec---CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHH
Confidence 34444444332 2346788887543 2345678999999999999999999999999999999999999999999997
Q ss_pred cC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 527 RQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 527 ~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.. ..+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||+++.............
T Consensus 92 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~-------~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 92 ERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGE-------DNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECC-------CCcEEECCcccceecccccccccCCC
Confidence 64 5689999999999999999999999 9999999999999987 78899999999986543322211112
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITM 684 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 684 (725)
.++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ ....+... .....+...+..+.+
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------VVESVSAG-YRLYRPKLAPTEVYT 232 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------HHHHHHcC-CcCCCCCCCCHHHHH
Confidence 24457999999998899999999999999999999 677775432111 11111110 011233456778999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHhc
Q 039817 685 VGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 685 l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
++.+||+.+|++|||+.|++++|.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHhC
Confidence 999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=283.47 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=191.2
Q ss_pred ccHHHHHHHhcccC---CcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFD---GQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~---~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..|+.|++|++... .....+++|.+..... ...+.+.+|++++++++||||+++++.+..++..++|+||+++++|
T Consensus 11 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (290)
T cd05045 11 GEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90 (290)
T ss_pred cCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCH
Confidence 45566666665332 1235688888764332 3346789999999999999999999999999999999999999999
Q ss_pred hhhhccC------------------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcccc
Q 039817 522 SAFLFRQ------------------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577 (725)
Q Consensus 522 ~~~l~~~------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~ 577 (725)
.+++... ..+++..++.++.|++.||.|||+. +++||||||+||++++
T Consensus 91 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~----- 162 (290)
T cd05045 91 RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAE----- 162 (290)
T ss_pred HHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcC-----
Confidence 9987532 2468899999999999999999998 9999999999999987
Q ss_pred CCCCceEEeeccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCcccc
Q 039817 578 DNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTL 655 (725)
Q Consensus 578 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~ 655 (725)
++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..|+......
T Consensus 163 --~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 236 (290)
T cd05045 163 --GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---- 236 (290)
T ss_pred --CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 788999999999865332221 1122345678999999988889999999999999999998 88877532110
Q ss_pred ccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 656 ANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+.+...... ....+......+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 237 ----~~~~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 ----RLFNLLKTGY-RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ----HHHHHHhCCC-CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1111111110 12234455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=279.49 Aligned_cols=243 Identities=28% Similarity=0.386 Sum_probs=189.2
Q ss_pred cHHHHHHHhcccC---CcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 447 SYQELREATNVFD---GQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 447 ~~~~l~~a~~~~~---~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.++.++++..... .....+++|.+... .......+.+|++++.++ +|+||+++++++..++..+++|||+++|+|
T Consensus 24 ~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L 103 (293)
T cd05053 24 AFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNL 103 (293)
T ss_pred ccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcH
Confidence 3445554443221 33467899988643 223445789999999999 799999999999999999999999999999
Q ss_pred hhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEE
Q 039817 522 SAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585 (725)
Q Consensus 522 ~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl 585 (725)
.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++. ++.+||
T Consensus 104 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~-------~~~~kL 173 (293)
T cd05053 104 RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE-------DHVMKI 173 (293)
T ss_pred HHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC-------CCeEEe
Confidence 9998532 4578999999999999999999998 9999999999999987 789999
Q ss_pred eeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHH
Q 039817 586 ADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTD 663 (725)
Q Consensus 586 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~ 663 (725)
+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .+
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~ 242 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----------EE 242 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-----------HH
Confidence 9999998654432211 112335678999999998899999999999999999997 7777653211 11
Q ss_pred HHHHHHHc---CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 664 WVLYCVRT---GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 664 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
....... ...+......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111 1233455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=280.47 Aligned_cols=245 Identities=27% Similarity=0.329 Sum_probs=183.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+|+.++++...-......+++|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|+|.++
T Consensus 6 G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 85 (269)
T cd05087 6 GWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGY 85 (269)
T ss_pred cCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHH
Confidence 34566666654333445678999886543 23345789999999999999999999999999999999999999999999
Q ss_pred hccC-----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 525 LFRQ-----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 525 l~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+... ..+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||+++.......
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~-------~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 86 LRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTA-------DLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred HHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcC-------CCcEEECCccccccccCcce
Confidence 9643 2456778889999999999999999 9999999999999987 78899999999975443322
Q ss_pred cc-ccccccCccccchhcccCC-------CCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHH--
Q 039817 600 RT-STMIRGTMGYMAPEWLRNA-------PVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYC-- 668 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 668 (725)
.. .....++..|+|||++.+. .++.++||||||+++|||++ |+.|+....... .........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~ 228 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-------VLTYTVREQQL 228 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHhhcccC
Confidence 11 1223467889999988642 35789999999999999996 988885432111 000000000
Q ss_pred -HHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 669 -VRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 669 -~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
...........+.+.+++..|+ .+|++|||++||++.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0011112234567888999998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=277.95 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=192.9
Q ss_pred ccHHHHHHHhcccCC-cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVFDG-QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~-~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..|+.++.+.....+ ....+|+|.++... ....+.|.+|+.++++++||||+++++++..++..++||||+++++|.+
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (267)
T cd05066 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94 (267)
T ss_pred cCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHH
Confidence 345667777654443 45688999886432 2345679999999999999999999999999999999999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.+. ..+++.++..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++...........
T Consensus 95 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~-------~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd05066 95 FLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNS-------NLVCKVSDFGLSRVLEDDPEAAY 164 (267)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECC-------CCeEEeCCCCcccccccccceee
Confidence 99765 4679999999999999999999999 9999999999999977 78999999999987654332211
Q ss_pred c--ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 603 T--MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 603 ~--~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
. ...++..|+|||++.+..++.++||||||++++|+++ |..|+....... ....+.... ....+...+
T Consensus 165 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~-~~~~~~~~~ 235 (267)
T cd05066 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGY-RLPAPMDCP 235 (267)
T ss_pred ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCC-cCCCCCCCC
Confidence 1 1223567999999998889999999999999999886 888875432110 111111110 112223456
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
+.+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 7889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=275.81 Aligned_cols=225 Identities=24% Similarity=0.393 Sum_probs=176.1
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCC-CCCHHHHHHHHH
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE-IPTWDKRVEIAL 541 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ 541 (725)
..|++|.+...... ...|.+|+.++++++|+||+++++++.. ...++||||+++++|.+++.+.. .+++..+..++.
T Consensus 31 ~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 108 (259)
T cd05037 31 VSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK 108 (259)
T ss_pred eeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHH
Confidence 56788877654333 6789999999999999999999999988 78899999999999999998765 789999999999
Q ss_pred HHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC-
Q 039817 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA- 620 (725)
Q Consensus 542 qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 620 (725)
|++.||+|||+. +|+||||||+||+++.+.........+||+|||++...... ....++..|+|||++...
T Consensus 109 ~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~ 180 (259)
T cd05037 109 QLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR-----EERVERIPWIAPECIRNGQ 180 (259)
T ss_pred HHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc-----cccccCCCccChhhhcCCC
Confidence 999999999998 99999999999999873211011227999999999865431 123366789999998876
Q ss_pred -CCCCccceehhHHHHHHHHhC-CcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC
Q 039817 621 -PVTAKVDVYSFGVMLLEIIFC-KRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP 698 (725)
Q Consensus 621 -~~~~ksDv~S~G~vl~elltg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 698 (725)
.++.++||||||+++|||++| ..|+...... +...........+......+.+++.+||+.+|.+||
T Consensus 181 ~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 249 (259)
T cd05037 181 ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----------EKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRP 249 (259)
T ss_pred CCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----------hHHHHHhcCCCCCCCCchHHHHHHHHHhccChhhCC
Confidence 789999999999999999995 4444332111 011111112223333347889999999999999999
Q ss_pred CHHHHHHHhc
Q 039817 699 SMKQVLQMLE 708 (725)
Q Consensus 699 s~~evl~~L~ 708 (725)
|+.+|++.|+
T Consensus 250 t~~~il~~l~ 259 (259)
T cd05037 250 SFRAILRDLN 259 (259)
T ss_pred CHHHHHHhcC
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=280.98 Aligned_cols=232 Identities=27% Similarity=0.409 Sum_probs=180.3
Q ss_pred CCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCC--------
Q 039817 459 DGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE-------- 529 (725)
Q Consensus 459 ~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------- 529 (725)
++....||+|.+... .......|.+|++++++++|+||+++++++...+..++||||+++++|.+++....
T Consensus 41 ~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 120 (295)
T cd05097 41 DGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120 (295)
T ss_pred CCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhcccccccccc
Confidence 345567999998653 23345679999999999999999999999999999999999999999999985431
Q ss_pred ----CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-cccc
Q 039817 530 ----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TSTM 604 (725)
Q Consensus 530 ----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~~~~ 604 (725)
.+++..+..++.|+++||+|||+. +++|+||||+||+++. ++.+||+|||++......... ....
T Consensus 121 ~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~-------~~~~kl~dfg~~~~~~~~~~~~~~~~ 190 (295)
T cd05097 121 NNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGN-------HYTIKIADFGMSRNLYSGDYYRIQGR 190 (295)
T ss_pred ccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcC-------CCcEEecccccccccccCcceeccCc
Confidence 368889999999999999999999 9999999999999987 778999999999765332211 1112
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhC--CcCCCCCCCCccccccCcchHHHHHHHHHc------CCCCh
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC--KRHTELHRVDEPTLANGMILTDWVLYCVRT------GNLGA 676 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 676 (725)
..++..|+|||.+.+..++.++||||||++++||+++ ..|+....... ........... ...+.
T Consensus 191 ~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 262 (295)
T cd05097 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--------VIENTGEFFRNQGRQIYLSQTP 262 (295)
T ss_pred CcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--------HHHHHHHhhhhccccccCCCCC
Confidence 3356789999999988999999999999999999984 44544321110 11111111110 11233
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
..++.+.+++.+|++.+|++||++++|++.|+
T Consensus 263 ~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 263 LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 45678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=283.56 Aligned_cols=242 Identities=23% Similarity=0.246 Sum_probs=189.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.|++++.+.+... +..+|+|.++... ....+.+.+|+.++.++ +|+||+++++++...+..++||||+++++|.
T Consensus 7 ~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (327)
T cd05617 7 SYAKVLLVRLKKN--DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLM 84 (327)
T ss_pred CCeEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHH
Confidence 3445555544333 4578888886432 23345688999999888 6999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+.+.+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....... ..
T Consensus 85 ~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~-------~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 85 FHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDA-------DGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeC-------CCCEEEeccccceeccCCCC-ce
Confidence 9998888899999999999999999999999 9999999999999987 78899999999875322211 12
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFE 680 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 680 (725)
....||..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+........ ...+.....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~p~~~~~ 228 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-----DMNTEDYLFQVILEKPIRIPRFLSV 228 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc-----ccccHHHHHHHHHhCCCCCCCCCCH
Confidence 23558999999999999999999999999999999999999996533221 11112222222222 234455667
Q ss_pred HHHHHHHHccCCCCCCCCC------HHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPS------MKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs------~~evl~~ 706 (725)
.+.+++.+||+.||++||+ +++++++
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 8899999999999999998 4577655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.08 Aligned_cols=236 Identities=26% Similarity=0.258 Sum_probs=188.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+|+.++++.+.. .+..+|||.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++++|.
T Consensus 7 ~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (318)
T cd05570 7 SFGKVLLAELKG--TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLM 84 (318)
T ss_pred CCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHH
Confidence 445555554433 3457889988643 233456678899999887 7999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++....... ..
T Consensus 85 ~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 85 FHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDS-------EGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECC-------CCcEEecccCCCeecCcCCC-cc
Confidence 9998888899999999999999999999999 9999999999999987 78999999999875322221 12
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 681 (725)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ....... .....+....+.
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~ 222 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----------ELFQSILEDEVRYPRWLSKE 222 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----------HHHHHHHcCCCCCCCcCCHH
Confidence 2345899999999999999999999999999999999999998643211 1111111 112234456778
Q ss_pred HHHHHHHccCCCCCCCCCH-----HHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSM-----KQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~-----~evl~~ 706 (725)
+.+++.+||+.||++||++ .+++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=276.83 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=186.8
Q ss_pred ccHHHHHHHhccc-CCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEE-cCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVF-DGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCI-EQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~-~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~ 522 (725)
.+|+.++++...- .+....+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+++++|.
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 85 (262)
T cd05058 6 GHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLR 85 (262)
T ss_pred cCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHH
Confidence 3455566555432 234578999998543 2334568899999999999999999999876 455688999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
+++.+. ..+++..+..++.|+++||.|||+. +++||||||+||+++. ++.+||+|||+++........
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~-------~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 86 NFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDE-------SFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcC-------CCcEEECCccccccccCCccee
Confidence 999764 4567888899999999999999998 9999999999999987 788999999999865332211
Q ss_pred --cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCCh
Q 039817 601 --TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGA 676 (725)
Q Consensus 601 --~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 676 (725)
......++..|+|||.+.+..++.++||||||+++|||++|+.++..... ..+........ ...+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----------SFDITVYLLQGRRLLQPE 225 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----------HHHHHHHHhcCCCCCCCC
Confidence 11123356789999999888999999999999999999996655432111 01111111111 11222
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
..++.+.+++..||+.+|++||++.+|++.|+++.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 34578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=279.88 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=193.6
Q ss_pred ccccHHHHHHHhcccCCcc--eEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQE--VEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~--~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.+++|+..-++.. +.||+|.++.. .....+++.+|+.++++++|+||+++++++... ..++++||+++|+
T Consensus 16 g~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~ 94 (279)
T cd05109 16 GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGC 94 (279)
T ss_pred CCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCC
Confidence 3456777887776555443 46899988643 333456789999999999999999999999754 5679999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++ ++.+||+|||+++.......
T Consensus 95 l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~-------~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 95 LLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKS-------PNHVKITDFGLARLLDIDET 164 (279)
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcC-------CCcEEECCCCceeecccccc
Confidence 99999764 5689999999999999999999999 9999999999999977 67899999999987643322
Q ss_pred cc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 RT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ......+.. ......+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~-~~~~~~~~~ 235 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLLEK-GERLPQPPI 235 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHC-CCcCCCCcc
Confidence 11 111234678999999998899999999999999999998 7777753221 111111111 111122334
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
....+.+++.+||+.||++||++.++++.|+.+...
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 567889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=278.65 Aligned_cols=244 Identities=24% Similarity=0.402 Sum_probs=189.8
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.++.++++.+..++ ..++||.+... ......+|.+|++++++++|+||+++++++..++..+++|||+++++|.+
T Consensus 14 ~~g~v~~~~~~~~~--~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 91 (267)
T cd08229 14 QFSEVYRATCLLDG--VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 91 (267)
T ss_pred CCeEEEEEeecCCC--ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHH
Confidence 34455555544443 56788876532 22344678999999999999999999999999999999999999999999
Q ss_pred hhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 524 FLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 524 ~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~-------~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 92 MIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITA-------TGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC-------CCCEEECcchhhhccccCCc
Confidence 8863 35689999999999999999999999 9999999999999987 78899999999886543322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC-ChhH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL-GATK 678 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 678 (725)
. .....++..|+|||++.+..++.++||||||+++|||++|..|+....... ......+... ..... ....
T Consensus 162 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~ 233 (267)
T cd08229 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQC-DYPPLPSDHY 233 (267)
T ss_pred c-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH------HHHhhhhhcC-CCCCCCcccc
Confidence 1 122357889999999998889999999999999999999999986432111 0111111110 01111 2245
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+.+.+++.+|++.+|++||||.+|+++++++
T Consensus 234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 234 SEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 67899999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.11 Aligned_cols=240 Identities=26% Similarity=0.336 Sum_probs=188.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..++++++.|++.- ...|++|.+... ....+.|.+|++++++++|+||+++++++. .+..++||||+++++|.++
T Consensus 16 ~g~~~~v~~~~~~~---~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 90 (262)
T cd05071 16 QGCFGEVWMGTWNG---TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDF 90 (262)
T ss_pred CCCCCcEEEEEecC---CceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHH
Confidence 34566777775432 235899998753 334568999999999999999999999875 4567899999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+.+. ..+++..+..++.|+++||+|||+. +++|+||||+||+++. ++.+||+|||.++..........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~-------~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 91 LKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE-------NLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred HhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcC-------CCcEEeccCCceeeccccccccc
Confidence 9753 4579999999999999999999998 9999999999999987 78899999999986654332222
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKF 679 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 679 (725)
....++..|+|||+..+..++.++||||||+++|||++ |..|+...... +........ ...+...+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------EVLDQVERGYRMPCPPECP 229 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----------HHHHHHhcCCCCCCccccC
Confidence 22346678999999988899999999999999999999 66666532110 111111111 12234566
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
+.+.+++.+|++.+|++||+++++++.|+..
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 7899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=282.90 Aligned_cols=236 Identities=26% Similarity=0.257 Sum_probs=185.3
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.|+.++.+.+..+ +..||+|.++... ....+.+..|.+++... +|+||+++++++..++..++||||+++|+|.
T Consensus 7 ~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~ 84 (316)
T cd05620 7 SFGKVLLAELKGK--GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLM 84 (316)
T ss_pred CCeEEEEEEECCC--CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHH
Confidence 4555666555433 4578888886431 23455677888888764 8999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++....... ..
T Consensus 85 ~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05620 85 FHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDR-------DGHIKIADFGMCKENVFGDN-RA 153 (316)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECC-------CCCEEeCccCCCeecccCCC-ce
Confidence 9998888899999999999999999999999 9999999999999987 78899999999874322111 12
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... .+.+.+. ......+......+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~--~~~~~~~~~~~~~~ 223 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIR--VDTPHYPRWITKES 223 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHH--hCCCCCCCCCCHHH
Confidence 3355899999999999999999999999999999999999998643211 1111111 11123344456788
Q ss_pred HHHHHHccCCCCCCCCCHH-HHHH
Q 039817 683 TMVGLWCICPQPTLRPSMK-QVLQ 705 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~-evl~ 705 (725)
.+++.+||+.||++||++. ++++
T Consensus 224 ~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 224 KDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHHHccCCHHHcCCChHHHHc
Confidence 9999999999999999984 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=271.03 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=187.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
+++.++++.. .++..+++|.+..... .....|.+|++++++++|+||+++++++...+..++||||+++++|.+++
T Consensus 7 ~~g~vy~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 83 (250)
T cd05085 7 NFGEVFKGTL---KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL 83 (250)
T ss_pred CCceEEEEEe---cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHH
Confidence 4455555542 2345789998765432 23457899999999999999999999999999999999999999999998
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++.............
T Consensus 84 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~-------~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 84 RKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGE-------NNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcC-------CCeEEECCCccceeccccccccCCC
Confidence 754 4678999999999999999999998 9999999999999987 7889999999987543322222122
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERIT 683 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 683 (725)
..++..|+|||++.+..++.++||||||+++||+++ |..|+...... .....+... .....+...+..+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~~ 224 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKG-YRMSCPQKCPDDVY 224 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcC-CCCCCCCCCCHHHH
Confidence 234567999999998889999999999999999998 88887533111 011111110 01123345668899
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 684 MVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 684 ~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+++.+|++.+|++||++.|++++|.+
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 250 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELAA 250 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhcC
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=274.51 Aligned_cols=240 Identities=22% Similarity=0.231 Sum_probs=187.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC-----ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG-----DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
+++.++.+.+..+ +..+++|.+..... ...+.+.+|++++++++||||+++++++..++..++|+||+++++|
T Consensus 14 ~~~~vy~~~~~~~--~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 91 (263)
T cd06625 14 AFGRVYLCYDVDT--GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSV 91 (263)
T ss_pred CceEEEEEEEcCC--CcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcH
Confidence 3444555544333 35678887653221 1235688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...+++.....++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||+++.........
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~-------~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 92 KDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDS-------AGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC-------CCCEEEeecccceecccccccc
Confidence 99998888889999999999999999999999 9999999999999987 7889999999987654322211
Q ss_pred c--cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 602 S--TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 602 ~--~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .............++....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--------AIFKIATQPTNPQLPSHVS 233 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------HHHHHhccCCCCCCCccCC
Confidence 1 22447788999999999889999999999999999999999985431110 0001111111123444567
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+++.+||+.+|.+|||+.|++++
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 234 PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 789999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=287.97 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=182.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC-----ceeeeeecccC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-----HQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~ 518 (725)
..++.++.+.+..+ +..||||.+... .......+.+|++++++++||||+++++++.... ..++||||++
T Consensus 11 G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~- 87 (338)
T cd07859 11 GSYGVVCSAIDTHT--GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME- 87 (338)
T ss_pred cCCeEEEEEEECCC--CCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-
Confidence 34555666655443 457889987642 2233457899999999999999999999986432 4799999996
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
++|.+++.....+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~-------~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 88 SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANA-------DCKLKICDFGLARVAFNDT 157 (338)
T ss_pred CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC-------CCcEEEccCcccccccccc
Confidence 68999998888899999999999999999999999 9999999999999987 8899999999998653322
Q ss_pred Ccc--ccccccCccccchhcccC--CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc-----cccC--c--------
Q 039817 599 TRT--STMIRGTMGYMAPEWLRN--APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT-----LANG--M-------- 659 (725)
Q Consensus 599 ~~~--~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~-----~~~~--~-------- 659 (725)
... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .... .
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 211 123458999999999875 67899999999999999999999998643211000 0000 0
Q ss_pred -chHHHHHHHHHcCCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 660 -ILTDWVLYCVRTGNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 660 -~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...............+ ....+.+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000 1234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.68 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=190.9
Q ss_pred ccHHHHHHHhccc---CCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVF---DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~---~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..|+.++.+.... ......|++|.+.... .....++.+|+.++++++|+||+++++++......++||||+++++|
T Consensus 17 g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (277)
T cd05032 17 GSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDL 96 (277)
T ss_pred CCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCH
Confidence 4455566555432 2345689999986432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhccC----------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 522 SAFLFRQ----------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 522 ~~~l~~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~-------~~~~kl~dfg~~ 166 (277)
T cd05032 97 KSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAE-------DLTVKIGDFGMT 166 (277)
T ss_pred HHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcC-------CCCEEECCcccc
Confidence 9998643 2468889999999999999999998 9999999999999987 789999999999
Q ss_pred cccCcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 592 KLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 592 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
+....... .......++..|+|||.+.+..++.++||||||+++||+++ |..|+...... ...+... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~-~~ 237 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVLKFVI-DG 237 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHHHHHh-cC
Confidence 86543322 11222346778999999988889999999999999999998 77777532211 1111111 00
Q ss_pred HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 670 RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 670 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1122344567889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=287.66 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=193.5
Q ss_pred ccHHHHHHHhccc-CCcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVF-DGQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~-~~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.+|+.|++++... +|+-+.||||.+...... ....|++|+.+|.+|+|+|+++|||+..+ ....||+|+++.|||.+
T Consensus 121 GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLld 199 (1039)
T KOG0199|consen 121 GSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLD 199 (1039)
T ss_pred cceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHH
Confidence 4556666665433 467789999999865544 67889999999999999999999999988 77889999999999999
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.|++. ..+.......++.|||.||.||..+ ++|||||..+|+||.. ...+||+||||.+.+......-
T Consensus 200 rLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllas-------prtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 200 RLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLAS-------PRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred HHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecc-------cceeeeecccceeccCCCCcce
Confidence 99873 4678889999999999999999999 9999999999999977 6789999999999876544332
Q ss_pred -cc-ccccCccccchhcccCCCCCCccceehhHHHHHHHHhC-CcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 602 -ST-MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC-KRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 602 -~~-~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
+. ...-.+.|.|||.+....++.+||||+|||.||||+|+ ..||.... ...+.+.+. ....-.-+...
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~iD-~~erLpRPk~c 340 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKNID-AGERLPRPKYC 340 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHhcc-ccccCCCCCCC
Confidence 22 23356789999999999999999999999999999984 45665432 111222222 11112334577
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++.++++++.||..+|.+|||+..|.+.
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHh
Confidence 8999999999999999999999999743
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=281.33 Aligned_cols=237 Identities=24% Similarity=0.249 Sum_probs=185.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhc-cCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..|++++++.+..+ +..||||.++... ....+.+..|..++.. ++||||+++++++.+++..++||||+++|+|
T Consensus 6 G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L 83 (316)
T cd05619 6 GSFGKVFLAELKGT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL 83 (316)
T ss_pred CCCEEEEEEEECCC--CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcH
Confidence 34555665554433 4578888886431 2344567788888876 4899999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...+++.....++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 84 MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDT-------DGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECC-------CCCEEEccCCcceECCCCCC-c
Confidence 99998877899999999999999999999999 9999999999999987 78899999999875322111 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
.....||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...+.+. ......+......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~--~~~~~~~~~~~~~ 222 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIR--MDNPCYPRWLTRE 222 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH--hCCCCCCccCCHH
Confidence 22345899999999999999999999999999999999999998643211 0111111 1112234445677
Q ss_pred HHHHHHHccCCCCCCCCCHH-HHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMK-QVLQ 705 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~-evl~ 705 (725)
+.+++.+||+.||++||++. ++.+
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHHc
Confidence 89999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=278.35 Aligned_cols=237 Identities=25% Similarity=0.321 Sum_probs=183.2
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|++++.+...-+ +..+|+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|.+
T Consensus 5 ~~g~Vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 82 (277)
T cd05607 5 GFGEVCAVQVKNT--GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKY 82 (277)
T ss_pred CceEEEEEEEccC--CcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHH
Confidence 4455555544433 4578888875321 2234456779999999999999999999999999999999999999999
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
++... ..+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++........
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~-------~~~~~l~Dfg~~~~~~~~~~-- 150 (277)
T cd05607 83 HIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDD-------QGNCRLSDLGLAVELKDGKT-- 150 (277)
T ss_pred HHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcC-------CCCEEEeeceeeeecCCCce--
Confidence 88654 3578999999999999999999998 9999999999999987 78899999999886543321
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC---ChhH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL---GATK 678 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 678 (725)
.....|+..|+|||++.+..++.++||||||+++|||++|+.|+....... . ...+......... ....
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~ 222 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-------A-KEELKRRTLEDEVKFEHQNF 222 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-------h-HHHHHHHhhccccccccccC
Confidence 123458899999999998889999999999999999999999986432211 0 1111111111111 1235
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
.+.+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchh
Confidence 678899999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=277.86 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=192.5
Q ss_pred cccHHHHHHHhcccC-CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFD-GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~-~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...++.+++|...-. +....|+||...... .+..+.|.+|+.++++++|+||+++++++.. +..++||||+++++|.
T Consensus 16 ~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~ 94 (270)
T cd05056 16 EGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELR 94 (270)
T ss_pred CccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHH
Confidence 345666666664332 445678999886543 3455689999999999999999999999875 5578999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++.........
T Consensus 95 ~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~-------~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 95 SYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSS-------PDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEec-------CCCeEEccCceeeeccccccee
Confidence 999764 4589999999999999999999998 9999999999999987 7889999999998665443222
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (725)
.....++..|+|||.+....++.++||||||++++|+++ |..||....... ........ .....+...+.
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~-~~~~~~~~~~~ 235 (270)
T cd05056 165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENG-ERLPMPPNCPP 235 (270)
T ss_pred cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcC-CcCCCCCCCCH
Confidence 222334567999999988889999999999999999996 888875432111 11111100 01123345567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+.+++.+|+..+|.+|||+.++++.|+++.
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 8999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=272.34 Aligned_cols=244 Identities=25% Similarity=0.247 Sum_probs=183.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCC-----ceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-----HQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~g 519 (725)
..+|+.|++|.-... +..||||+.-.. .+.--+|+++|++++|||||+|+-++.... ...+|||||+.
T Consensus 34 ~GsFg~Vyq~~~~e~--~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~- 106 (364)
T KOG0658|consen 34 SGSFGVVYQAKLRET--EEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE- 106 (364)
T ss_pred ecccceEEEEEEcCC--CceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-
Confidence 356666666665554 568999987432 222347999999999999999999987432 34589999987
Q ss_pred Chhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 520 TLSAFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 520 sL~~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+|.+++.. +..++...+.-+..|+.+||.|||+. +|+||||||+|+|+|.+ .+.+||+|||.|+.+.
T Consensus 107 tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~------tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 107 TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPD------TGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCC------CCeEEeccCCcceeec
Confidence 88888864 46678788888999999999999998 99999999999999985 7999999999999887
Q ss_pred cCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHHHH---
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLY--- 667 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~~~--- 667 (725)
...... ....+..|+|||.+.+. .|+.+.||||.|||+.||+.|+..|.+.....+-.. -+....+.+..
T Consensus 178 ~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 KGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred cCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 665543 23468899999998764 799999999999999999999999976543221000 00000000000
Q ss_pred --------HHHcCC----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 668 --------CVRTGN----LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 668 --------~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.... ......++..+|+.++++.+|.+|.++.|++.+
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 000000 222456788999999999999999999999865
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.66 Aligned_cols=246 Identities=22% Similarity=0.236 Sum_probs=188.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..+++.++.+...-......|++|.+... +.+.+|++++++++|+||+++++++......++|||++. ++|.++
T Consensus 102 ~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~ 175 (392)
T PHA03207 102 PGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTY 175 (392)
T ss_pred CCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHH
Confidence 34556666665544455678899987542 345689999999999999999999999999999999996 588899
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc-cc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-ST 603 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-~~ 603 (725)
+.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++......... ..
T Consensus 176 l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~-------~~~~~l~DfG~a~~~~~~~~~~~~~ 245 (392)
T PHA03207 176 VDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDE-------PENAVLGDFGAACKLDAHPDTPQCY 245 (392)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcC-------CCCEEEccCccccccCccccccccc
Confidence 87778899999999999999999999999 9999999999999987 7899999999998654432222 22
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc------------------cccCcchHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT------------------LANGMILTDWV 665 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~------------------~~~~~~~~~~~ 665 (725)
...||..|+|||++....++.++||||||+++|||++|+.|+......... ......+....
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 356899999999999999999999999999999999999998654322100 00000001111
Q ss_pred HHHHHc--CC--CC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 LYCVRT--GN--LG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 ~~~~~~--~~--~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...... .. .+ ......+.+++.+|++.||++|||+.|++.+
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 110000 00 00 0124567889999999999999999999987
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=274.29 Aligned_cols=240 Identities=26% Similarity=0.336 Sum_probs=186.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+++.++.+++... ..+++|.+... ....+.|.+|++++++++|+|++++++++. .+..++||||+++++|.+++
T Consensus 17 g~~~~v~~~~~~~~---~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~ 91 (260)
T cd05069 17 GCFGEVWMGTWNGT---TKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFL 91 (260)
T ss_pred cCCCeEEEEEEcCC---ceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHH
Confidence 44556666654322 35889987643 234567999999999999999999999875 45688999999999999999
Q ss_pred ccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.+. ..+++..+..++.|++.||.|||+. +++|+||||+||++++ ++.+||+|||++............
T Consensus 92 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~-------~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 92 KEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGD-------NLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcC-------CCeEEECCCccceEccCCcccccC
Confidence 754 3478999999999999999999998 9999999999999987 788999999999866433222222
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
...++..|+|||...+..++.++||||||+++|||++ |+.|+...... ......... .....+...+..+
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~ 232 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERG-YRMPCPQGCPESL 232 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-CCCCCCcccCHHH
Confidence 2335678999999998899999999999999999999 77777532110 111111110 0112234556789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.+++.+|++.+|++||++++|++.|+.
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=281.98 Aligned_cols=245 Identities=28% Similarity=0.414 Sum_probs=190.5
Q ss_pred cccHHHHHHHhcc-----cCCcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeeccc
Q 039817 445 VFSYQELREATNV-----FDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 445 ~~~~~~l~~a~~~-----~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...++.++.+... .......+++|.+.... ......+.+|+++++++ +|+||+++++++..++..++||||++
T Consensus 22 ~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 101 (314)
T cd05099 22 EGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAA 101 (314)
T ss_pred CCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCC
Confidence 3456666666542 22345678999886432 33456789999999999 69999999999999999999999999
Q ss_pred CCChhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC
Q 039817 518 NGTLSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581 (725)
Q Consensus 518 ~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~ 581 (725)
+|+|.+++... ..+++..+.+++.|++.||.|||+. +++||||||+||+++. ++
T Consensus 102 ~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~-------~~ 171 (314)
T cd05099 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTE-------DN 171 (314)
T ss_pred CCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcC-------CC
Confidence 99999999653 2478899999999999999999998 9999999999999987 78
Q ss_pred ceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCc
Q 039817 582 ITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGM 659 (725)
Q Consensus 582 ~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~ 659 (725)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--------- 242 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--------- 242 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---------
Confidence 89999999998654322211 112224567999999998899999999999999999999 7777643211
Q ss_pred chHHHHHHHHHcC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 660 ILTDWVLYCVRTG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 660 ~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+ +....... ..+...+..+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 243 --~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 --EE-LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred --HH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 11111111 233445678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=285.29 Aligned_cols=232 Identities=25% Similarity=0.248 Sum_probs=182.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHH-HHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQ-VIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.++++++++.+..+ +..||+|.+.... ....+.+..|.. +++.++||||+++++.+..++..++||||+++|+|
T Consensus 6 G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 83 (323)
T cd05575 6 GSFGKVLLAKHKAD--GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83 (323)
T ss_pred CCCeEEEEEEECCC--CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCH
Confidence 34556666665444 4578888875421 223345556655 45789999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~-------~~~~kl~Dfg~~~~~~~~~~-~ 152 (323)
T cd05575 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDS-------QGHVVLTDFGLCKEGIEHSK-T 152 (323)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECC-------CCcEEEeccCCCcccccCCC-c
Confidence 99998888899999999999999999999999 9999999999999987 78999999999875422221 2
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 680 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .+....... ....+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----------~~~~~~i~~~~~~~~~~~~~ 221 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----------AEMYDNILNKPLRLKPNISV 221 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCCCH
Confidence 2334589999999999999999999999999999999999999864321 111111111 1223345577
Q ss_pred HHHHHHHHccCCCCCCCCCHH
Q 039817 681 RITMVGLWCICPQPTLRPSMK 701 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~ 701 (725)
.+.+++.+|++.||++||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 899999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=287.04 Aligned_cols=232 Identities=26% Similarity=0.257 Sum_probs=182.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHH-HhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQV-IGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..|++++.|.+..++ ..+|+|.+... .......+..|... ++.++||||+++++.+..++..++||||+++|+|
T Consensus 6 G~~g~V~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 83 (325)
T cd05604 6 GSFGKVLLAKRKLDG--KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83 (325)
T ss_pred CCCeEEEEEEECCCC--CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCH
Confidence 345666666655444 57788887543 22334556666654 6778999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
..++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~-------~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDS-------QGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECC-------CCCEEEeecCCcccCCCCCC-C
Confidence 99998888899999999999999999999999 9999999999999987 78999999999875322211 2
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 680 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... +....... ..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 221 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----------EMYDNILHKPLVLRPGASL 221 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----------HHHHHHHcCCccCCCCCCH
Confidence 23356899999999999999999999999999999999999998643211 11111111 1122334567
Q ss_pred HHHHHHHHccCCCCCCCCCHH
Q 039817 681 RITMVGLWCICPQPTLRPSMK 701 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~ 701 (725)
.+.+++.+|++.+|.+||++.
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCC
Confidence 788999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=290.90 Aligned_cols=243 Identities=20% Similarity=0.212 Sum_probs=187.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..+ +..+|||.+.... ....+.+.+|++++++++|+||+++++++.+++..++||||+++|+
T Consensus 10 G~G~~g~Vy~~~~~~~--~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~ 87 (381)
T cd05626 10 GIGAFGEVCLACKVDT--HALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (381)
T ss_pred eecCCEEEEEEEECCC--CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence 3456777777766544 4578888886432 2345678999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT- 599 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~- 599 (725)
|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 88 L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~-------~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 88 MMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDL-------DGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECC-------CCCEEEeeCcCCccccccccc
Confidence 999998888899999999999999999999999 9999999999999987 78999999999764311000
Q ss_pred ---------------------------------------------ccccccccCccccchhcccCCCCCCccceehhHHH
Q 039817 600 ---------------------------------------------RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVM 634 (725)
Q Consensus 600 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~v 634 (725)
.......||..|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00112458999999999998899999999999999
Q ss_pred HHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC--hhHHHHHHHHHHH--ccCCCCCCCCCHHHHHHH
Q 039817 635 LLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG--ATKFERITMVGLW--CICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 635 l~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~--cl~~dp~~RPs~~evl~~ 706 (725)
+|||++|+.||........ .............+ ......+.+++.+ |+..++..||+++|++++
T Consensus 238 l~elltG~~Pf~~~~~~~~--------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET--------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH--------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999975432110 00000000011111 1345677788877 556667779999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=287.00 Aligned_cols=241 Identities=18% Similarity=0.180 Sum_probs=186.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...|+.++.+.+..+ +..+|+|.+... .....+.+.+|+++++.++||||+++++++.+++..++||||+++|+|
T Consensus 53 ~G~~g~Vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L 130 (370)
T cd05596 53 RGAFGEVQLVRHKSS--KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL 130 (370)
T ss_pred eCCCEEEEEEEECCC--CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcH
Confidence 345666666655443 457889988542 223345678999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++... .++......++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++..........
T Consensus 131 ~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~-------~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 131 VNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK-------SGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcC-------CCCEEEEeccceeeccCCCccc
Confidence 9988554 578888999999999999999999 9999999999999987 8899999999998664433222
Q ss_pred ccccccCccccchhcccCC----CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh-
Q 039817 602 STMIRGTMGYMAPEWLRNA----PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA- 676 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~----~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 676 (725)
.....||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... ....+.........+.
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMDHKNSLTFPDD 271 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcCCCcCCCCCc
Confidence 2335689999999998653 47899999999999999999999987532110 0011110000111222
Q ss_pred -hHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 039817 677 -TKFERITMVGLWCICPQPTL--RPSMKQVLQM 706 (725)
Q Consensus 677 -~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 706 (725)
..+..+.+++.+||+.+|++ ||+++|++++
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 35678899999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=276.30 Aligned_cols=245 Identities=21% Similarity=0.245 Sum_probs=189.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
...++.++++++..+ +..|++|.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.++
T Consensus 19 ~g~~g~vy~~~~~~~--~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~ 96 (267)
T cd06646 19 SGTYGDVYKARNLHT--GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI 96 (267)
T ss_pred cCCCeEEEEEEECCC--CeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 345566666665443 457888888655455566788999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.....+++..+..++.|++.||.|||+. +|+|+||+|+||+++. ++.+||+|||++......... ...
T Consensus 97 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~-------~~~~~l~dfg~~~~~~~~~~~-~~~ 165 (267)
T cd06646 97 YHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTD-------NGDVKLADFGVAAKITATIAK-RKS 165 (267)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECC-------CCCEEECcCccceeecccccc-cCc
Confidence 98778889999999999999999999998 9999999999999987 778999999999865432211 122
Q ss_pred cccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 605 IRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 605 ~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
..++..|+|||.+. ...++.++||||||++++||++|+.|+........... ...... . .............
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~~~~~~-~--~~~~~~~~~~~~~ 240 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MSKSNF-Q--PPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--eecCCC-C--CCCCccccccCHH
Confidence 45788999999874 44578899999999999999999998853321110000 000000 0 0000011234568
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
+.+++.+||+.+|++|||+++++++|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 89999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=280.28 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=191.9
Q ss_pred ccHHHHHHHhcc-----cCCcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccC
Q 039817 446 FSYQELREATNV-----FDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~-----~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
..|+.++.|... ...+...|++|.+.... ....+.+.+|+.+++++ +|+||+++++++......++||||+++
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (304)
T cd05101 26 GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105 (304)
T ss_pred cCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCC
Confidence 345555555432 12344678999886432 34456799999999999 899999999999999999999999999
Q ss_pred CChhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCc
Q 039817 519 GTLSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582 (725)
Q Consensus 519 gsL~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~ 582 (725)
++|.+++.+. ..+++..+..++.|+++||.|||+. +++||||||+||+++. ++.
T Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~-------~~~ 175 (304)
T cd05101 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTE-------NNV 175 (304)
T ss_pred CcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcC-------CCc
Confidence 9999998653 2467889999999999999999999 9999999999999987 788
Q ss_pred eEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcc
Q 039817 583 TKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMI 660 (725)
Q Consensus 583 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~ 660 (725)
+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----------- 244 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----------- 244 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----------
Confidence 9999999998764432221 122335678999999998889999999999999999998 666654221
Q ss_pred hHHHHHHHHHc--CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 039817 661 LTDWVLYCVRT--GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVG 714 (725)
Q Consensus 661 ~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 714 (725)
..+........ ...+...+..+.+++.+||+.+|++|||+.||++.|+++..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111111111 1223345678999999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.60 Aligned_cols=236 Identities=27% Similarity=0.374 Sum_probs=181.2
Q ss_pred CcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCC---------
Q 039817 460 GQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE--------- 529 (725)
Q Consensus 460 ~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------- 529 (725)
+....+|+|.+... .......|.+|++++++++|+||+++++++..++..++||||+++++|.+++....
T Consensus 44 ~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 123 (296)
T cd05095 44 NQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123 (296)
T ss_pred CceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccc
Confidence 44567999998743 33345689999999999999999999999999999999999999999999986532
Q ss_pred --CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc-ccccc
Q 039817 530 --IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-STMIR 606 (725)
Q Consensus 530 --~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~ 606 (725)
.+++..+..++.|++.||+|||+. +++|+||||+||+++. ++.+||+|||+++......... .....
T Consensus 124 ~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~-------~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 193 (296)
T cd05095 124 VVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK-------NYTIKIADFGMSRNLYSGDYYRIQGRAV 193 (296)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcC-------CCCEEeccCcccccccCCcceeccCcCc
Confidence 367789999999999999999999 9999999999999987 7889999999998654332211 11223
Q ss_pred cCccccchhcccCCCCCCccceehhHHHHHHHHh--CCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHHHH
Q 039817 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF--CKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFERI 682 (725)
Q Consensus 607 gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 682 (725)
++..|+|||....+.++.++||||||+++|||++ |..|+........ . .....+....... ...+...+..+
T Consensus 194 ~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (296)
T cd05095 194 LPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV-I---ENTGEFFRDQGRQVYLPKPALCPDSL 269 (296)
T ss_pred CccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH-H---HHHHHHHhhccccccCCCCCCCCHHH
Confidence 4678999999888889999999999999999998 5566643221110 0 0000111000000 11223455789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.+++.+||+.||++||++.+|++.|+.
T Consensus 270 ~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 270 YKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=278.64 Aligned_cols=242 Identities=27% Similarity=0.374 Sum_probs=188.1
Q ss_pred ccHHHHHHHhccc---CCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVF---DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~---~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..|+.++++.... ......||+|.+.... .+..+.|.+|+.++++++|+||+++++++..++..++||||+++++|
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 95 (288)
T cd05050 16 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95 (288)
T ss_pred cccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCH
Confidence 3456666665432 2245688999886432 23456799999999999999999999999999999999999999999
Q ss_pred hhhhccC----------------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCC
Q 039817 522 SAFLFRQ----------------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579 (725)
Q Consensus 522 ~~~l~~~----------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~ 579 (725)
.+++... ..+++..++.++.|++.||.|||+. +++||||||+||+++.
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~------- 165 (288)
T cd05050 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGE------- 165 (288)
T ss_pred HHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecC-------
Confidence 9998642 2367888999999999999999998 9999999999999977
Q ss_pred CCceEEeeccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCcccccc
Q 039817 580 NYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLAN 657 (725)
Q Consensus 580 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~ 657 (725)
++.+||+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~------- 238 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH------- 238 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence 788999999998754332211 1112234567999999998899999999999999999997 6666642211
Q ss_pred CcchHHHHHHHHHcCC---CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 658 GMILTDWVLYCVRTGN---LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 658 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.+.. .....+. .+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 ----~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----EEVI-YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 1122222 233456789999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=289.80 Aligned_cols=240 Identities=21% Similarity=0.216 Sum_probs=188.1
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|++++++.+..+ +..+|+|.+.... ....+.+.+|+.+++.++|+||+++++++...+..++||||+++|+|.
T Consensus 12 G~~g~Vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (330)
T cd05601 12 GHFGEVQVVREKAT--GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89 (330)
T ss_pred ccCEEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHH
Confidence 34556666655544 3578888886432 234567889999999999999999999999999999999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++.+. ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++..........
T Consensus 90 ~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~-------~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 90 SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDR-------TGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECC-------CCCEEeccCCCCeECCCCCcee
Confidence 999876 6789999999999999999999999 9999999999999987 8899999999998765443333
Q ss_pred ccccccCccccchhccc------CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC
Q 039817 602 STMIRGTMGYMAPEWLR------NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG 675 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~------~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (725)
.....|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ....+.........+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~ 231 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQRFLKFP 231 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCCccCCC
Confidence 33346899999999986 4567899999999999999999999986432111 000010000001111
Q ss_pred --hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 --ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 --~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......+.+++..|++ +|++||++++++++
T Consensus 232 ~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1346778899999998 99999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=280.51 Aligned_cols=235 Identities=24% Similarity=0.270 Sum_probs=182.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHH---hccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVI---GRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
.+++++.+.+.. .+..||||.+.... ....+.+.+|++++ ++++||||+++++++..++..++||||+++++
T Consensus 11 ~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 88 (324)
T cd05589 11 HFGKVLLAEYKK--TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGD 88 (324)
T ss_pred CCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCc
Confidence 444555554433 34578999886432 23345677776655 56789999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|..++.+ ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 89 L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~-------~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05589 89 LMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDT-------EGFVKIADFGLCKEGMGFGD- 156 (324)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECC-------CCcEEeCcccCCccCCCCCC-
Confidence 9988854 5689999999999999999999999 9999999999999987 78999999999875332221
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 679 (725)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... +...... .....+....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----------~~~~~i~~~~~~~p~~~~ 225 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----------EVFDSIVNDEVRYPRFLS 225 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhCCCCCCCCCC
Confidence 122355899999999999999999999999999999999999998643211 1111111 1223444567
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
..+.+++.+||+.||.+|| ++.+++++
T Consensus 226 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 7889999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=271.34 Aligned_cols=236 Identities=28% Similarity=0.388 Sum_probs=188.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
.++.++++... +..|++|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|.+++.
T Consensus 18 ~~g~v~~~~~~----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 92 (256)
T cd05039 18 EFGDVMLGDYR----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR 92 (256)
T ss_pred CCceEEEEEec----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHH
Confidence 34455544432 46789999875533 56789999999999999999999999999999999999999999999997
Q ss_pred cCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 527 RQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 527 ~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
... .+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||.++....... .
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~-------~~~~~l~d~g~~~~~~~~~~----~ 158 (256)
T cd05039 93 SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSE-------DLVAKVSDFGLAKEASQGQD----S 158 (256)
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeC-------CCCEEEcccccccccccccc----c
Confidence 664 789999999999999999999999 9999999999999987 78899999999987633221 2
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERIT 683 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 683 (725)
...+..|+|||++....++.++||||||++++|+++ |..|+...... .+...+.... ....+...++.+.
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~~ 229 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPHVEKGY-RMEAPEGCPPEVY 229 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhcCC-CCCCccCCCHHHH
Confidence 234567999999988889999999999999999997 88877532111 0111111100 1123344568899
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 684 MVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 684 ~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
+++.+|++.+|++||++++++++|+.+
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=270.33 Aligned_cols=240 Identities=27% Similarity=0.345 Sum_probs=186.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+++.++.+... .+..+++|.+.... ...+.|.+|+.++++++|+|++++++++. ....++||||+++++|.+++
T Consensus 17 g~~~~v~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~ 91 (260)
T cd05070 17 GQFGEVWMGTWN---GNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFL 91 (260)
T ss_pred ccCceEEEEEec---CCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHH
Confidence 445555555432 23458899886533 34567999999999999999999999885 45688999999999999999
Q ss_pred ccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
... ..+++..+..++.|++.||.|||+. +++|+||||+||++++ ++.+||+|||++............
T Consensus 92 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~-------~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 92 KDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGD-------GLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeC-------CceEEeCCceeeeeccCccccccc
Confidence 754 4589999999999999999999999 9999999999999987 788999999999876443222222
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
...++..|+|||.+.+..++.++||||||++++||++ |..|+..... ....+..... .....+...+..+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~~ 232 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERG-YRMPCPQDCPISL 232 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC-CCCCCCCcCCHHH
Confidence 2235668999999988889999999999999999999 7777753211 1111111110 0112344556789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.+++.+|++.+|++|||+.++.+.|++
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=280.27 Aligned_cols=255 Identities=20% Similarity=0.248 Sum_probs=184.7
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gs 520 (725)
+...+|++|++|.+........+|+|.++.. .....+.+|++++++++||||+++++++.. +...++||||+++ +
T Consensus 9 lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~ 85 (317)
T cd07868 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-D 85 (317)
T ss_pred cccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-C
Confidence 4556778888887655556678999998643 234567899999999999999999999864 4567899999875 7
Q ss_pred hhhhhccC---------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 521 LSAFLFRQ---------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 521 L~~~l~~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++... +..+.+||+|||++
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~---~~~~~~kl~DfG~a 159 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG---PERGRVKIADMGFA 159 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCC---CCcCcEEEeecCce
Confidence 87776421 2478899999999999999999999 999999999999995321 12678999999999
Q ss_pred cccCcCCCc--cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCc-c-h-----
Q 039817 592 KLLKKDQTR--TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM-I-L----- 661 (725)
Q Consensus 592 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~-~-~----- 661 (725)
+........ ......+|+.|+|||++.+ ..++.++||||+|++++||++|+.||.....+........ . +
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 876443221 1223458999999999876 4589999999999999999999999865433211100000 0 0
Q ss_pred -------HHHH-----------HHHHHcCCC------------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 662 -------TDWV-----------LYCVRTGNL------------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 662 -------~~~~-----------~~~~~~~~~------------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..|- ......... .......+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000000000 00112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=278.37 Aligned_cols=245 Identities=26% Similarity=0.345 Sum_probs=180.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..|++++.++..-......+++|.+.... ......|.+|+++++.++|+||+++++.+......++||||+++|+|.++
T Consensus 6 G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~ 85 (269)
T cd05042 6 GWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNY 85 (269)
T ss_pred cCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHH
Confidence 45666666543222344578888876432 23346789999999999999999999999999999999999999999999
Q ss_pred hccCC-----CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 525 LFRQE-----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 525 l~~~~-----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+.... ..++.....++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~-------~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 86 LRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTA-------DLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred HHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecC-------CCcEEEeccccccccccchh
Confidence 96642 246788899999999999999999 9999999999999987 78999999999875433221
Q ss_pred cc-ccccccCccccchhccc-------CCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHH--
Q 039817 600 RT-STMIRGTMGYMAPEWLR-------NAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYC-- 668 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~-------~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 668 (725)
.. .....++..|+|||++. ...++.++||||||+++|||++ |..|+...... ..+.......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~ 228 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQDI 228 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhccCc
Confidence 11 12233567799999874 3456889999999999999999 56666432110 0011111100
Q ss_pred -HHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 669 -VRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 669 -~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
......+....+.+.+++..|+ .||++|||+++|++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0011223345667788888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=274.85 Aligned_cols=234 Identities=28% Similarity=0.447 Sum_probs=181.6
Q ss_pred ceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-------CCCCH
Q 039817 462 EVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-------EIPTW 533 (725)
Q Consensus 462 ~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-------~~l~~ 533 (725)
...+++|.+.... ......|.+|++++++++||||+++++++...+..++||||+++++|.+++.+. ..+++
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (269)
T cd05044 26 PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105 (269)
T ss_pred ceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccH
Confidence 4578888875432 244668999999999999999999999999999999999999999999999642 34788
Q ss_pred HHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc-ccccccCcccc
Q 039817 534 DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYM 612 (725)
Q Consensus 534 ~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ 612 (725)
..+..++.|++.||.|||+. +++|+||||+||+++.+.. +....+|++|||+++......... .....++..|+
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 180 (269)
T cd05044 106 KELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGY--DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180 (269)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCC--CCCcceEECCcccccccccccccccCcccCCCcccc
Confidence 99999999999999999998 9999999999999987310 113389999999997654322211 11223567899
Q ss_pred chhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccC
Q 039817 613 APEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCIC 691 (725)
Q Consensus 613 aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 691 (725)
|||.+.+..++.++||||||+++|||++ |+.|+...... .....+.. ......+...++.+.+++.+||+
T Consensus 181 aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 251 (269)
T cd05044 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQHVTA-GGRLQKPENCPDKIYQLMTNCWA 251 (269)
T ss_pred CHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHHHhc-CCccCCcccchHHHHHHHHHHcC
Confidence 9999999999999999999999999998 88887532110 01111110 00112334556789999999999
Q ss_pred CCCCCCCCHHHHHHHhcC
Q 039817 692 PQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 692 ~dp~~RPs~~evl~~L~~ 709 (725)
.+|.+||++++|+++|++
T Consensus 252 ~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 252 QDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcccCCCHHHHHHHHhC
Confidence 999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=271.88 Aligned_cols=241 Identities=25% Similarity=0.349 Sum_probs=188.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
...|+.++.|... ++..+++|.+.... ...+.|.+|+.++++++|+||+++++++. .+..++||||+++++|.++
T Consensus 16 ~G~~g~v~~~~~~---~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05067 16 AGQFGEVWMGYYN---GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDF 90 (260)
T ss_pred cCccceEEeeecC---CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHH
Confidence 3455666666532 34579999887543 34568999999999999999999999874 5678999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+... ..+++.++..++.|++.||+|||+. +++|+||||+||+++. ++.++|+|||++...........
T Consensus 91 ~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~-------~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 91 LKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSE-------TLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcC-------CCCEEEccCcceeecCCCCcccc
Confidence 8654 4678999999999999999999998 9999999999999987 78899999999987653322222
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
....++..|+|||.+....++.++||||||++++|+++ |+.|+...... .......... ....+...+..
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~ 231 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGY-RMPRPDNCPEE 231 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCC-CCCCCCCCCHH
Confidence 22345678999999988889999999999999999999 88888643211 1111111100 11223345578
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+.+++.+|++.+|++||+++++++.|+.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 9999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=273.32 Aligned_cols=245 Identities=23% Similarity=0.290 Sum_probs=189.5
Q ss_pred cHHHHHHHhcccC---CcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFD---GQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~---~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+|++++.|+.... +....|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 17 ~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 96 (275)
T cd05046 17 EFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96 (275)
T ss_pred ceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHH
Confidence 4555555554322 34457899988654333 4578999999999999999999999999999999999999999999
Q ss_pred hhhccCC---------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 523 AFLFRQE---------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 523 ~~l~~~~---------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++. ++.+|++|||+++.
T Consensus 97 ~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~-------~~~~~l~~~~~~~~ 166 (275)
T cd05046 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSS-------QREVKVSLLSLSKD 166 (275)
T ss_pred HHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeC-------CCcEEEcccccccc
Confidence 9997655 689999999999999999999999 9999999999999987 78899999999875
Q ss_pred cCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 594 LKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 594 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
.............++..|+|||.+.+...+.++||||||++++||++ |..|+..... ..............
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~~~~~~~~~ 238 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNRLQAGKLEL 238 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHHHHcCCcCC
Confidence 43322222223346678999999988888999999999999999998 5666642211 00111111000011
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
..+...+..+.+++.+|++.+|++||++.|++++|++
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 2234566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=271.91 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=189.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
...++.++++++. ..+..|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.++
T Consensus 18 ~g~~g~v~~~~~~--~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 95 (268)
T cd06624 18 KGTYGIVYAARDL--STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95 (268)
T ss_pred cCCceEEEEeEec--CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHH
Confidence 3445556655543 23567999988766556677899999999999999999999999999999999999999999999
Q ss_pred hccC-CCC--CHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 525 LFRQ-EIP--TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 525 l~~~-~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+... ..+ ++..+..++.|++.||.|||+. +|+||||||+||+++.+ .+.+||+|||++.........
T Consensus 96 l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~------~~~~~l~dfg~~~~~~~~~~~- 165 (268)
T cd06624 96 LRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTY------SGVVKISDFGTSKRLAGINPC- 165 (268)
T ss_pred HHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCC------CCeEEEecchhheecccCCCc-
Confidence 9765 444 7888999999999999999998 99999999999999753 568999999998765432221
Q ss_pred ccccccCccccchhcccCC--CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHH-HHHHcCCCChhH
Q 039817 602 STMIRGTMGYMAPEWLRNA--PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL-YCVRTGNLGATK 678 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 678 (725)
.....++..|+|||++.+. .++.++||||||+++|||++|+.|+........ ..+.. .......++...
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--------AMFKVGMFKIHPEIPESL 237 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--------hHhhhhhhccCCCCCccc
Confidence 2223478899999998654 378999999999999999999999864321110 00000 011122345556
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 7789999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=277.54 Aligned_cols=236 Identities=22% Similarity=0.288 Sum_probs=188.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..++.++.+.+.. .+..|++|.+........+.+.+|+.++++++|+||+++++.+..+...++||||+++++|.+++
T Consensus 31 g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 108 (296)
T cd06654 31 GASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 108 (296)
T ss_pred CCCeEEEEEEECC--CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHH
Confidence 3445555555433 34578888887655555678999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.. ..+++.++..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++......... ....
T Consensus 109 ~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~-------~~~~kl~dfg~~~~~~~~~~~-~~~~ 176 (296)
T cd06654 109 TE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGM-------DGSVKLTDFGFCAQITPEQSK-RSTM 176 (296)
T ss_pred Hh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcC-------CCCEEECccccchhccccccc-cCcc
Confidence 54 4578999999999999999999999 9999999999999987 788999999998765432211 1223
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CCChhHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NLGATKFER 681 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 681 (725)
.++..|+|||.+.+..++.++||||||+++|||++|+.||....... ......... ..+......
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----------ALYLIATNGTPELQNPEKLSAI 245 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----------hHHHHhcCCCCCCCCccccCHH
Confidence 47889999999998889999999999999999999999986432211 000111111 123345677
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+++.+||+.+|++||++.+++++
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhC
Confidence 8999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=273.56 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=189.6
Q ss_pred cHHHHHHHhccc--CCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCCh
Q 039817 447 SYQELREATNVF--DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTL 521 (725)
Q Consensus 447 ~~~~l~~a~~~~--~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL 521 (725)
.++.++.+.... ...+..|++|.+.... ....+.+.+|++++++++|+||+++++++... ...++||||+++++|
T Consensus 16 ~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L 95 (284)
T cd05079 16 HFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95 (284)
T ss_pred CceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCH
Confidence 444554443221 1235679999986443 33456799999999999999999999999875 568899999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++.+. ..+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||+++........
T Consensus 96 ~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~-------~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05079 96 KEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVES-------EHQVKIGDFGLTKAIETDKEY 165 (284)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcC-------CCCEEECCCccccccccCccc
Confidence 9999665 4689999999999999999999999 9999999999999987 788999999999876433221
Q ss_pred --cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc----cccCcchHHHHHHHHH--cC
Q 039817 601 --TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT----LANGMILTDWVLYCVR--TG 672 (725)
Q Consensus 601 --~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~--~~ 672 (725)
......++..|+|||.+.+..++.++||||||++++||++++.+.......... ................ ..
T Consensus 166 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
T cd05079 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245 (284)
T ss_pred eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC
Confidence 112234667899999998888999999999999999999987654322111000 0011111111111111 11
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..+...+..+.+|+.+|++.+|++|||++++++.|+++
T Consensus 246 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 246 PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 22334568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=277.35 Aligned_cols=247 Identities=21% Similarity=0.255 Sum_probs=182.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..|+.++++.+..+ +..||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+++ +|.++
T Consensus 16 G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~ 92 (288)
T cd07871 16 GTYATVFKGRSKLT--ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQY 92 (288)
T ss_pred CCCEEEEEEEECCC--CCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHH
Confidence 34556666655443 4578888875432 23345788999999999999999999999999999999999985 89998
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
+... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++........ ..
T Consensus 93 l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~-------~~~~kl~DfG~~~~~~~~~~~-~~ 161 (288)
T cd07871 93 LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINE-------KGELKLADFGLARAKSVPTKT-YS 161 (288)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECC-------CCCEEECcCcceeeccCCCcc-cc
Confidence 8654 4578999999999999999999999 9999999999999987 788999999999764332211 12
Q ss_pred ccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----c--------C-cchHHHHHHH
Q 039817 604 MIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----N--------G-MILTDWVLYC 668 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----~--------~-~~~~~~~~~~ 668 (725)
...++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.... . . ....++....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 2347889999998865 5689999999999999999999999864332110000 0 0 0000000000
Q ss_pred HHcC------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 VRTG------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... .......+.+++++.+|++.||.+|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0001234578899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=271.67 Aligned_cols=237 Identities=24% Similarity=0.317 Sum_probs=188.7
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCc---------cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGD---------GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~---------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
.+++++.|.+..+ +..+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 12 ~~~~v~~a~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06628 12 SFGSVYLGMNASS--GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVP 89 (267)
T ss_pred CCeEEEEEEecCC--CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecC
Confidence 4445555555433 356788877543222 12568899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+++|.+++.....+++..+..++.|++.||+|||+. +++||||+|+||+++. ++.+||+|||+++.....
T Consensus 90 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~-------~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 90 GGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDN-------KGGIKISDFGISKKLEAN 159 (267)
T ss_pred CCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcC-------CCCEEecccCCCcccccc
Confidence 999999998878889999999999999999999998 9999999999999987 788999999999876532
Q ss_pred CCc-----cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH--HH
Q 039817 598 QTR-----TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC--VR 670 (725)
Q Consensus 598 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 670 (725)
... ......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------~~~~~~~~~~ 228 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----------QAIFKIGENA 228 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----------HHHHHHhccC
Confidence 211 111234788999999999888999999999999999999999998643211 011111 11
Q ss_pred cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 671 TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 671 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....+....+.+.+++.+||+.+|.+||++.||+++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 223445567889999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=283.79 Aligned_cols=249 Identities=28% Similarity=0.370 Sum_probs=192.8
Q ss_pred ccccHHHHHHHhcccC-----CcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecc
Q 039817 444 KVFSYQELREATNVFD-----GQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-----~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
....|+.++.|.+... .....||+|.+... .....+++.+|+++++++ +|+||++++++|..++..+++|||+
T Consensus 21 g~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 100 (334)
T cd05100 21 GEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100 (334)
T ss_pred ccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecC
Confidence 3445667776654322 23457899988643 233456899999999999 7999999999999999999999999
Q ss_pred cCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCC
Q 039817 517 KNGTLSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580 (725)
Q Consensus 517 ~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~ 580 (725)
++|+|.+++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++. +
T Consensus 101 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~-------~ 170 (334)
T cd05100 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTE-------D 170 (334)
T ss_pred CCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcC-------C
Confidence 999999998643 2478899999999999999999998 9999999999999987 7
Q ss_pred CceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccC
Q 039817 581 YITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANG 658 (725)
Q Consensus 581 ~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~ 658 (725)
+.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------- 241 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--------- 241 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---------
Confidence 789999999998654322111 112234567999999999999999999999999999998 666664321
Q ss_pred cchHHHHHHHHHc--CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 659 MILTDWVLYCVRT--GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 659 ~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
..+........ ...+......+.+++.+|++.+|++||++.|+++.|+.+...
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 242 --VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred --HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 11111111111 123334567899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=267.30 Aligned_cols=251 Identities=26% Similarity=0.292 Sum_probs=193.8
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEc-----CCceeeeeec
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE-----QNHQLLVYEL 515 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~e~ 515 (725)
+....|+-+..|++..++ ..||||++.. ......+.-.+|+++|+.++|+||+.+++.+.. -...|+|+|+
T Consensus 30 iG~GAyGvVcsA~~~~t~--~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 30 IGRGAYGVVCSAKDKRTG--EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccCcceeeEEEEEEcCCC--CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 345567777778777766 6899999873 334456778999999999999999999999865 3478999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
|+ .+|.+.++.++.++.....-++.|+++||.|+|+. +++||||||+|++++. +-..||+|||+|+...
T Consensus 108 Me-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~-------~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 108 ME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNA-------DCDLKICDFGLARYLD 176 (359)
T ss_pred Hh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeecc-------CCCEEeccccceeecc
Confidence 95 49999998888899999999999999999999999 9999999999999988 6678999999999875
Q ss_pred cCC-CccccccccCccccchhccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc------cc-Cc-----ch
Q 039817 596 KDQ-TRTSTMIRGTMGYMAPEWLR-NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL------AN-GM-----IL 661 (725)
Q Consensus 596 ~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~------~~-~~-----~~ 661 (725)
... ....+...-|..|.|||.+. ...|+.+.||||.||++.||++|++.|.+...-.+.. .. .. .-
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 431 11234456789999999875 4689999999999999999999999997654332110 00 00 00
Q ss_pred HHHHHHHHHcC-CCC--------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 662 TDWVLYCVRTG-NLG--------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 662 ~~~~~~~~~~~-~~~--------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+...+... ..+ ....+..++|+.+||..||.+|+|++|+++|
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11122222211 111 1345678899999999999999999999976
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=293.00 Aligned_cols=241 Identities=21% Similarity=0.221 Sum_probs=185.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...|++|+.|.+..+ +..+|||.+.... ......+.+|++++++++|+||+++++.+.+++..++||||+++|+|
T Consensus 11 ~G~~g~V~~a~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L 88 (376)
T cd05598 11 IGAFGEVCLVRKVDT--NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDM 88 (376)
T ss_pred eCCCeEEEEEEECCC--CCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcH
Confidence 345666666665544 4578899885422 23346688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC---
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ--- 598 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~--- 598 (725)
.+++.+.+.+++.....++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++..+....
T Consensus 89 ~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~-------~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 89 MSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDR-------DGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECC-------CCCEEEEeCCCCcccccccccc
Confidence 99998888899999999999999999999999 9999999999999987 7899999999975321000
Q ss_pred ---------------------------------------CccccccccCccccchhcccCCCCCCccceehhHHHHHHHH
Q 039817 599 ---------------------------------------TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639 (725)
Q Consensus 599 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ell 639 (725)
........||+.|+|||.+.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00011245899999999999999999999999999999999
Q ss_pred hCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC--ChhHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 039817 640 FCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL--GATKFERITMVGLWCICPQPTLRP---SMKQVLQM 706 (725)
Q Consensus 640 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~ 706 (725)
+|+.||........ ...+......... .......+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 239 ~G~~Pf~~~~~~~~--------~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAET--------QLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHH--------HHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999975432110 0000000000011 1134566777888866 5999999 89999977
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=276.80 Aligned_cols=248 Identities=25% Similarity=0.314 Sum_probs=180.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhcc---CcCCccceeeEEEc-----CCceeeeee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRT---HHKNLVQLLGFCIE-----QNHQLLVYE 514 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~~~~~lV~e 514 (725)
...|+++++|.+...+ +..||+|.+.... ......+.+|+.+++++ +||||++++++|.. ....++|||
T Consensus 11 ~G~~g~Vy~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e 89 (290)
T cd07862 11 EGAYGKVFKARDLKNG-GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 89 (290)
T ss_pred cCCCeEEEEEEEcCCC-CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEc
Confidence 3456667777654332 4578888875432 22344677788877765 69999999999863 456899999
Q ss_pred cccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 515 LMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 515 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
|++ ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 90 ~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~-------~~~~kl~Dfg~~~ 158 (290)
T cd07862 90 HVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS-------SGQIKLADFGLAR 158 (290)
T ss_pred cCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcC-------CCCEEEccccceE
Confidence 997 5899998654 4589999999999999999999999 9999999999999987 7899999999998
Q ss_pred ccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc--c---CcchHHHHH-
Q 039817 593 LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--N---GMILTDWVL- 666 (725)
Q Consensus 593 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--~---~~~~~~~~~- 666 (725)
...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........... . .....++..
T Consensus 159 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 654331 22234589999999999988999999999999999999999999875432110000 0 000000000
Q ss_pred -----HHHHc-C-----CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 -----YCVRT-G-----NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 -----~~~~~-~-----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..... . .......+.+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000 0 0011234677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=282.06 Aligned_cols=247 Identities=27% Similarity=0.359 Sum_probs=190.0
Q ss_pred cccHHHHHHHhcccC-----CcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeeccc
Q 039817 445 VFSYQELREATNVFD-----GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~-----~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...|+.++.+..... .....+|+|.+.... .....++.+|+++++++ +|+||+++++++...+..++||||++
T Consensus 28 ~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (307)
T cd05098 28 EGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 107 (307)
T ss_pred cCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCC
Confidence 345666666554221 123568999887432 33456788999999999 79999999999999999999999999
Q ss_pred CCChhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC
Q 039817 518 NGTLSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581 (725)
Q Consensus 518 ~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~ 581 (725)
+++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++. ++
T Consensus 108 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~-------~~ 177 (307)
T cd05098 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE-------DN 177 (307)
T ss_pred CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcC-------CC
Confidence 99999999653 2478899999999999999999998 9999999999999987 78
Q ss_pred ceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCc
Q 039817 582 ITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGM 659 (725)
Q Consensus 582 ~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~ 659 (725)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--------- 248 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------- 248 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---------
Confidence 89999999987654322111 111224568999999998889999999999999999998 7777643211
Q ss_pred chHHHHHHHHHc--CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 660 ILTDWVLYCVRT--GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 660 ~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+........ ...+......+.+++.+|++.+|++||++.+|++.|+.+.+
T Consensus 249 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 --EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred --HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 12334456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.90 Aligned_cols=231 Identities=25% Similarity=0.260 Sum_probs=180.7
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHH-HHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQ-VIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.|+.+++|.+..+ +..+|+|.+.... ......+..|.. +++.++||||+++++.+...+..++||||+++++|.
T Consensus 7 ~~g~Vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (321)
T cd05603 7 SFGKVLLAKRKSD--GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELF 84 (321)
T ss_pred CCEEEEEEEECCC--CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHH
Confidence 4555666655433 4578888875422 223345666655 578899999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+...++...+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++....... ..
T Consensus 85 ~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~-------~~~~kl~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05603 85 FHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDS-------QGHVVLTDFGLCKEGVEPEE-TT 153 (321)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECC-------CCCEEEccCCCCccCCCCCC-cc
Confidence 9998878889999999999999999999998 9999999999999987 78999999999875322221 12
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 681 (725)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... ...++......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~i~~~~~~~~~~~~~~ 222 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----------SQMYDNILHKPLQLPGGKTVA 222 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----------HHHHHHHhcCCCCCCCCCCHH
Confidence 334589999999999998999999999999999999999999864321 111111111 12334456678
Q ss_pred HHHHHHHccCCCCCCCCCHH
Q 039817 682 ITMVGLWCICPQPTLRPSMK 701 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~ 701 (725)
+.+++.+|++.+|.+||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 99999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=274.22 Aligned_cols=224 Identities=23% Similarity=0.286 Sum_probs=180.7
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc-CCCCCHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR-QEIPTWDKRVEIA 540 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~ 540 (725)
+..+++|.+........+.+.+|++++++++|+||+++++++..++..++||||+++++|..++.+ ...+++..+..++
T Consensus 30 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~ 109 (282)
T cd06643 30 GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVC 109 (282)
T ss_pred CeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 457888888765555667899999999999999999999999999999999999999999998865 4678999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhccc--
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR-- 618 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-- 618 (725)
.|++.||.|||+. +++||||||+||+++. ++.+||+|||++........ ......++..|+|||.+.
T Consensus 110 ~qi~~~L~~LH~~---~i~H~dlkp~nili~~-------~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 178 (282)
T cd06643 110 KQTLEALNYLHEN---KIIHRDLKAGNILFTL-------DGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCE 178 (282)
T ss_pred HHHHHHHHHHHHC---CeeecCCCcccEEEcc-------CCCEEEcccccccccccccc-ccccccccccccCHhhcccc
Confidence 9999999999999 9999999999999987 78899999999876533221 122345888999999884
Q ss_pred ---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc----CCCChhHHHHHHHHHHHccC
Q 039817 619 ---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT----GNLGATKFERITMVGLWCIC 691 (725)
Q Consensus 619 ---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~ 691 (725)
+..++.++||||||+++|||++|+.|+...... +........ ...+......+.+++.+||+
T Consensus 179 ~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (282)
T cd06643 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----------RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLE 247 (282)
T ss_pred CCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----------HHHHHHhhcCCCCCCCccccCHHHHHHHHHHcc
Confidence 456788999999999999999999987643211 111111110 11223456789999999999
Q ss_pred CCCCCCCCHHHHHHHh
Q 039817 692 PQPTLRPSMKQVLQML 707 (725)
Q Consensus 692 ~dp~~RPs~~evl~~L 707 (725)
.+|.+||++.+++++-
T Consensus 248 ~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 248 KNVDARWTTTQLLQHP 263 (282)
T ss_pred CChhhCcCHHHHhcCC
Confidence 9999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=276.40 Aligned_cols=247 Identities=20% Similarity=0.226 Sum_probs=179.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..|+.++.+.+..+ +..||||.+.... ......+.+|++++++++||||+++++++..++..++||||++ ++|.++
T Consensus 16 G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~ 92 (303)
T cd07869 16 GSYATVYKGKSKVN--GKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQY 92 (303)
T ss_pred cCCEEEEEEEECCC--CCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHH
Confidence 34555666655443 3568888876432 2234567899999999999999999999999999999999996 577777
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
+... ..++...+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... ...
T Consensus 93 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~-~~~ 161 (303)
T cd07869 93 MDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISD-------TGELKLADFGLARAKSVPSH-TYS 161 (303)
T ss_pred HHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC-------CCCEEECCCCcceeccCCCc-cCC
Confidence 7654 5688999999999999999999999 9999999999999987 78899999999875432221 112
Q ss_pred ccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc------CcchHHHHH----HHHHcC
Q 039817 604 MIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN------GMILTDWVL----YCVRTG 672 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~------~~~~~~~~~----~~~~~~ 672 (725)
...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............ ......+.. ......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 2457899999998865 45788999999999999999999999753211000000 000000000 000000
Q ss_pred C----CC---------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 N----LG---------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~----~~---------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. .+ ......+.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 00 0123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=297.33 Aligned_cols=239 Identities=22% Similarity=0.273 Sum_probs=188.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC--------ceeeeee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--------HQLLVYE 514 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------~~~lV~e 514 (725)
..+|+.|+.|.+..++ ..||||.+... .......+.+|+..+..++|+||+++++.+...+ ..++|||
T Consensus 42 ~G~fG~Vy~a~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~E 119 (496)
T PTZ00283 42 SGATGTVLCAKRVSDG--EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLD 119 (496)
T ss_pred cCCCEEEEEEEEcCCC--CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEe
Confidence 3466777777665544 57888887532 3344567889999999999999999988776432 3679999
Q ss_pred cccCCChhhhhccC----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccC
Q 039817 515 LMKNGTLSAFLFRQ----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590 (725)
Q Consensus 515 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgl 590 (725)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 120 y~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~-------~~~vkL~DFGl 189 (496)
T PTZ00283 120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCS-------NGLVKLGDFGF 189 (496)
T ss_pred CCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeC-------CCCEEEEeccc
Confidence 99999999998643 4688999999999999999999999 9999999999999987 78999999999
Q ss_pred ccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 591 AKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 591 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+......
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----------~~~~~~~~ 258 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----------EEVMHKTL 258 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHh
Confidence 9865432221 12235689999999999999999999999999999999999999864321 11111111
Q ss_pred H--cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 R--TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. ...++....+.+.+++.+||+.||.+||++.+++++
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 123445667889999999999999999999999875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=280.16 Aligned_cols=238 Identities=25% Similarity=0.262 Sum_probs=186.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCc-CCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHH-KNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|+.+++|.+.- .+..||||.+... .....+.+..|++++..++| ++|+++++++...+..++||||+++|+|
T Consensus 11 G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L 88 (324)
T cd05587 11 GSFGKVMLAERKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 88 (324)
T ss_pred ccCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcH
Confidence 3455566555433 3457899988643 23345678899999999965 5688999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~-------~~~~kL~Dfg~~~~~~~~~~-~ 157 (324)
T cd05587 89 MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDA-------EGHIKIADFGMCKENIFGGK-T 157 (324)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcC-------CCCEEEeecCcceecCCCCC-c
Confidence 99998888899999999999999999999999 9999999999999987 78999999999875322111 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
.....|+..|+|||++.+..++.++||||||+++|||++|+.|+....... ....+. .....++......
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~--~~~~~~~~~~~~~ 227 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQSIM--EHNVSYPKSLSKE 227 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHH--cCCCCCCCCCCHH
Confidence 223458999999999999999999999999999999999999986432110 011111 1122344556778
Q ss_pred HHHHHHHccCCCCCCCCCH-----HHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSM-----KQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~-----~evl~~ 706 (725)
+.+++.+|++.||.+|++. .+++++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=286.84 Aligned_cols=240 Identities=21% Similarity=0.235 Sum_probs=186.1
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|++|+.+.+..++ ..||||.+.... ......+.+|++++..++|+||+++++++..++..++||||+++|+|.
T Consensus 12 G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~ 89 (364)
T cd05599 12 GAFGEVRLVQKKDTG--HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMM 89 (364)
T ss_pred cCCEEEEEEEECCCC--CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHH
Confidence 345566666554443 478999886431 234456889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc--
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-- 600 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-- 600 (725)
+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++..+......
T Consensus 90 ~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~-------~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 90 TLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDA-------KGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECC-------CCCEEEeecccceeccccccccc
Confidence 9998888899999999999999999999999 9999999999999987 889999999998754321100
Q ss_pred -----------------------------------cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCC
Q 039817 601 -----------------------------------TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHT 645 (725)
Q Consensus 601 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~ 645 (725)
......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 001135899999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCcchHHHHHHHHHcCCCCh--hHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 039817 646 ELHRVDEPTLANGMILTDWVLYCVRTGNLGA--TKFERITMVGLWCICPQPTLRPS---MKQVLQM 706 (725)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~ 706 (725)
....... ....+.........+. ...+.+.+++.+|+. +|.+|++ +.|++++
T Consensus 240 ~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 240 CSDNPQE--------TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCHHH--------HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 6432111 0000100000011111 345678889999996 8999997 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=285.11 Aligned_cols=241 Identities=21% Similarity=0.234 Sum_probs=182.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|++|+.+.+..+ +..+|||.+.... ......+.+|+.++.+++|+||+++++.+.++...++||||+++|+|.
T Consensus 12 G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~ 89 (363)
T cd05628 12 GAFGEVRLVQKKDT--GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89 (363)
T ss_pred CCCEEEEEEEECCC--CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHH
Confidence 34556666655443 4578888886432 233456889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC---
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT--- 599 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~--- 599 (725)
+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 90 ~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~-------~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 90 TLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDS-------KGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECC-------CCCEEEeeccCcccccccccccc
Confidence 9998888899999999999999999999999 9999999999999987 78999999999875432110
Q ss_pred -------------------------------ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCC
Q 039817 600 -------------------------------RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELH 648 (725)
Q Consensus 600 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~ 648 (725)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0011246999999999999999999999999999999999999999643
Q ss_pred CCCccccccCcchHHHHHHHHHcCCCCh--hHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 039817 649 RVDEPTLANGMILTDWVLYCVRTGNLGA--TKFERITMVGLWCIC--PQPTLRPSMKQVLQM 706 (725)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~--~dp~~RPs~~evl~~ 706 (725)
.... ....+........++. ...+.+.+++.+++. .++..||+++||+++
T Consensus 240 ~~~~--------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 240 TPQE--------TYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CHHH--------HHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 2111 0011110000011121 234567777776443 334457999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=274.97 Aligned_cols=248 Identities=25% Similarity=0.312 Sum_probs=191.6
Q ss_pred cccHHHHHHHhcccC--CcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEc-CCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFD--GQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~--~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~gs 520 (725)
...|+.++.+..... +....|++|.+... .....+.+.+|+.++++++|+||+++++++.. +...++++||+++++
T Consensus 16 ~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (280)
T cd05043 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGN 95 (280)
T ss_pred ccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCc
Confidence 345566666665432 23678899988643 23345678999999999999999999999876 567899999999999
Q ss_pred hhhhhccC--------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 521 LSAFLFRQ--------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 521 L~~~l~~~--------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++. ++.+||+|||+++
T Consensus 96 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~-------~~~~kl~d~g~~~ 165 (280)
T cd05043 96 LKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDE-------ELQVKITDNALSR 165 (280)
T ss_pred HHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcC-------CCcEEECCCCCcc
Confidence 99998653 3578999999999999999999998 9999999999999987 7899999999998
Q ss_pred ccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH
Q 039817 593 LLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR 670 (725)
Q Consensus 593 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (725)
.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... ..+........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~- 236 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAYLKDGY- 236 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHcCC-
Confidence 654332211 112335678999999998889999999999999999998 8888754311 11111111110
Q ss_pred cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 671 TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 671 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
....+...++.+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11122334678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=277.15 Aligned_cols=239 Identities=26% Similarity=0.287 Sum_probs=189.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+|++++++.+..+ +..||+|.+.... ......+.+|++++++++|+||+++++.+..++..++||||+++|+|.
T Consensus 11 G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (285)
T cd05605 11 GGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88 (285)
T ss_pred CCCeEEEEEEEcCC--CceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHH
Confidence 44566666655433 4578999886422 223456789999999999999999999999999999999999999999
Q ss_pred hhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 523 AFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 523 ~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++ ++.++|+|||++........
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~-------~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 89 FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDD-------YGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred HHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECC-------CCCEEEeeCCCceecCCCCc-
Confidence 988654 4689999999999999999999999 9999999999999987 78899999999986543222
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 678 (725)
.....|+..|+|||.+.+..++.++||||+|+++|||++|+.||....... ..+.+..... ....+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--------KREEVERRVKEDQEEYSEKF 228 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--------HHHHHHHHhhhcccccCccc
Confidence 122358899999999998899999999999999999999999997532211 1111111111 12334456
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
...+.+++..|++.||++|| ++++++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 229 SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 77899999999999999999 88899765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=289.92 Aligned_cols=249 Identities=25% Similarity=0.288 Sum_probs=188.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCC-----ceeeeeeccc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-----HQLLVYELMK 517 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~ 517 (725)
...|+.|+++.+..+ +..||||.+.... ....+.+.+|+++++.++|+||+++++++...+ ..++|+||++
T Consensus 10 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 87 (372)
T cd07853 10 YGAFGVVWSVTDPRD--GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ 87 (372)
T ss_pred eCCCEEEEEEEECCC--CCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc
Confidence 445666776665443 4578999886432 234467899999999999999999999998776 7899999997
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
++|.+++.....+++..+..++.|++.||.|||+. +++||||||+|||++. ++.+||+|||+++.....
T Consensus 88 -~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~-------~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 88 -SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNS-------NCVLKICDFGLARVEEPD 156 (372)
T ss_pred -cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECC-------CCCEEeccccceeecccC
Confidence 58888887778899999999999999999999999 9999999999999987 789999999999865443
Q ss_pred CCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----ccCcchH------HHH
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----ANGMILT------DWV 665 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~~~~~~------~~~ 665 (725)
.........++..|+|||.+.+. .++.++||||||++++||++|+.||.......... ....... ...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 33323334578899999998764 57899999999999999999999986543211000 0000000 001
Q ss_pred HHHHHcC-----------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 LYCVRTG-----------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 ~~~~~~~-----------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....... .......+.+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1111110 1112335678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=270.18 Aligned_cols=243 Identities=30% Similarity=0.439 Sum_probs=191.7
Q ss_pred ccHHHHHHHhcccCC--cceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDG--QEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~--~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+|+.++.+.+...+ ....|++|.+...... ..+.+.+|++.+.+++|+||+++++++.+.+..+++|||+++++|.
T Consensus 10 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~ 89 (258)
T smart00219 10 GAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLL 89 (258)
T ss_pred CCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHH
Confidence 455666666655432 3478999998654433 5678999999999999999999999999999999999999999999
Q ss_pred hhhccCCC--CCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 523 AFLFRQEI--PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 523 ~~l~~~~~--l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
+++..... +++..+..++.|++.||+|||+. +++|+||||+||+++. ++.+||+|||+++........
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~-------~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 90 DYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGE-------NLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred HHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEcc-------CCeEEEcccCCceeccccccc
Confidence 99976543 89999999999999999999999 9999999999999987 779999999999876544222
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
......++..|+|||.+.+..++.++||||+|++++||++ |..|+..... ....+..... .....+...+
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~~~~~~ 230 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKG-YRLPKPENCP 230 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcC-CCCCCCCcCC
Confidence 2212336789999999988889999999999999999998 6666643211 0111111110 0112233456
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
..+.+++.+|++.+|++|||+.|+++.|
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 231 PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 7899999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=278.51 Aligned_cols=238 Identities=25% Similarity=0.260 Sum_probs=186.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|++++++.+.- .+..+|||.+.... ....+.+..|.+++..+ +|++|+++++++...+..++||||+++|+|
T Consensus 11 G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L 88 (323)
T cd05616 11 GSFGKVMLAERKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 88 (323)
T ss_pred CCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCH
Confidence 3455556555433 34578888876432 23345677888888877 689999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~-------~~~~kL~DfG~~~~~~~~~~-~ 157 (323)
T cd05616 89 MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDS-------EGHIKIADFGMCKENMWDGV-T 157 (323)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECC-------CCcEEEccCCCceecCCCCC-c
Confidence 99998888899999999999999999999999 9999999999999987 78999999999875432221 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .+...+. .....++....+.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~--~~~~~~p~~~s~~ 227 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIM--EHNVAYPKSMSKE 227 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHH--hCCCCCCCcCCHH
Confidence 22345899999999999999999999999999999999999999643211 1111111 1122345566788
Q ss_pred HHHHHHHccCCCCCCCCCH-----HHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSM-----KQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~-----~evl~~ 706 (725)
+.+++.+|++.+|.+|++. .++.++
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 228 AVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 9999999999999999974 666544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=275.29 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=194.3
Q ss_pred ccHHHHHHHhccc--CCcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCCC
Q 039817 446 FSYQELREATNVF--DGQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNGT 520 (725)
Q Consensus 446 ~~~~~l~~a~~~~--~~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gs 520 (725)
.+++.++.++... .+.+..+|||.+...... ..+.|.+|++++++++|+||+++++++.. +...++||||+++++
T Consensus 15 g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 94 (284)
T cd05038 15 GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94 (284)
T ss_pred CCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCC
Confidence 3456666665433 345678999998754433 46789999999999999999999999987 567899999999999
Q ss_pred hhhhhccCC-CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 95 l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 95 LRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVES-------EDLVKISDFGLAKVLPEDKD 164 (284)
T ss_pred HHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcC-------CCCEEEcccccccccccCCc
Confidence 999997654 689999999999999999999998 9999999999999987 78999999999987653322
Q ss_pred cc--ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc---ccCcchHHHHHHHHHcC--
Q 039817 600 RT--STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL---ANGMILTDWVLYCVRTG-- 672 (725)
Q Consensus 600 ~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-- 672 (725)
.. .....++..|+|||.+.+..++.++||||||++++||++|+.|+.......... .................
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc
Confidence 11 111234567999999988899999999999999999999998875432211000 00001111111111111
Q ss_pred -CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 673 -NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 673 -~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..+...+..+.+++.+|++.+|++|||+.||+++|+++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 12233457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=282.51 Aligned_cols=234 Identities=25% Similarity=0.246 Sum_probs=182.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHH-HHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQ-VIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|+.++++.+.-+ +..+|+|.+.... ......+..|.. +++.++|+||+++++++..++..++||||+++++|
T Consensus 6 G~fg~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L 83 (325)
T cd05602 6 GSFGKVLLARHKAE--EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83 (325)
T ss_pred CCCeEEEEEEECCC--CCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcH
Confidence 34556666655433 4578888875422 223344555554 46778999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...++......++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~-------~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 84 FYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDS-------QGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECC-------CCCEEEccCCCCcccccCCC-C
Confidence 99998888888899999999999999999999 9999999999999987 78999999999975432221 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 680 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... +....... ..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~ 221 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----------EMYDNILNKPLQLKPNITN 221 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----------HHHHHHHhCCcCCCCCCCH
Confidence 22355899999999999999999999999999999999999998643211 11111111 1223345677
Q ss_pred HHHHHHHHccCCCCCCCCCHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQV 703 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~ev 703 (725)
.+.+++.+|++.+|.+||++.+.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCC
Confidence 89999999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=271.24 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=191.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccc---ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..++.+++++...+ +..+++|.++. ......+.+.+|++++++++|+||+++++++..++..++||||+++++|.
T Consensus 13 g~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (267)
T cd08224 13 GQFSVVYKAICLLD--GRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLS 90 (267)
T ss_pred CCceEEEEEEEcCC--CCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHH
Confidence 34556666666533 35678887653 22334568999999999999999999999999999999999999999999
Q ss_pred hhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 523 AFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 523 ~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+++.. ...+++.++..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||+++......
T Consensus 91 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~-------~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 91 RMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITA-------TGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred HHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECC-------CCcEEEeccceeeeccCCC
Confidence 98853 24578999999999999999999999 9999999999999987 7889999999988654332
Q ss_pred CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCCh
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGA 676 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 676 (725)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..+....... ....+.
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYSLCKKIEKCDYPPLPA 230 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---------HHHHHhhhhcCCCCCCCh
Confidence 21 12234788899999999888999999999999999999999998643211 1111111111 111222
Q ss_pred -hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 677 -TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 677 -~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.....+.+++.+|++.+|++|||+.+|+++|+++.
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 45568999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.21 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=188.3
Q ss_pred ccHHHHHHHhcc--cC-CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNV--FD-GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~--~~-~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..|+.+++++.. .. .....||+|.+.... ......+.+|+.++++++|+||+++++++..++..++||||+++|+|
T Consensus 17 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 96 (288)
T cd05061 17 GSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 96 (288)
T ss_pred CCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCH
Confidence 344555554322 11 234679999876432 22345688999999999999999999999999999999999999999
Q ss_pred hhhhccC----------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 522 SAFLFRQ----------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 522 ~~~l~~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
.+++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~-------~~~~~L~Dfg~~ 166 (288)
T cd05061 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAH-------DFTVKIGDFGMT 166 (288)
T ss_pred HHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcC-------CCcEEECcCCcc
Confidence 9999642 2346778899999999999999999 9999999999999987 788999999999
Q ss_pred cccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 592 KLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 592 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
+........ ......++..|+|||.+.+..++.++||||||++++||++ |..|+..... .+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----------~~~~~~~~ 235 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----------EQVLKFVM 235 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHH
Confidence 865332221 1112235678999999998899999999999999999998 5666643211 11111111
Q ss_pred Hc--CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 039817 670 RT--GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVG 714 (725)
Q Consensus 670 ~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 714 (725)
.. ...+...++.+.+++.+|++.+|++|||+.++++.|++.....
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 11 1223344678999999999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=282.94 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=189.2
Q ss_pred ccccHHHHHHHhccc---CCcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcC-Cceeeeeeccc
Q 039817 444 KVFSYQELREATNVF---DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQ-NHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~---~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~lV~e~~~ 517 (725)
...+|+.|++|.+.- ......||||.++... ......+.+|+.++.++ +|+||+++++++... ...++||||++
T Consensus 16 G~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~ 95 (343)
T cd05103 16 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 95 (343)
T ss_pred cCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccC
Confidence 456677888776432 1235689999986532 23345788999999999 789999999988754 46789999999
Q ss_pred CCChhhhhccC-------------------------------------------------------------------CC
Q 039817 518 NGTLSAFLFRQ-------------------------------------------------------------------EI 530 (725)
Q Consensus 518 ~gsL~~~l~~~-------------------------------------------------------------------~~ 530 (725)
+|+|.+++... ..
T Consensus 96 ~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (343)
T cd05103 96 FGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKV 175 (343)
T ss_pred CCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhcc
Confidence 99999998542 13
Q ss_pred CCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-cccccccCc
Q 039817 531 PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTM 609 (725)
Q Consensus 531 l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~ 609 (725)
+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||++......... ......++.
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~-------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE-------NNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcC-------CCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 57888899999999999999999 9999999999999987 789999999999865332211 111233567
Q ss_pred cccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCChhHHHHHHHH
Q 039817 610 GYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGATKFERITMV 685 (725)
Q Consensus 610 ~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l 685 (725)
.|+|||.+.+..++.++||||||+++|||++ |..|+....... ........ ...+....+.+.++
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----------EFCRRLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----------HHHHHHhccCCCCCCCCCCHHHHHH
Confidence 8999999988899999999999999999997 777775332111 01111111 12223345678999
Q ss_pred HHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 686 GLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 686 ~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+..||+.+|++|||+.||+++|+.+.+
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=285.93 Aligned_cols=239 Identities=19% Similarity=0.192 Sum_probs=185.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.++.+.+..+ +..+|+|.+.+. .....+.+.+|+.+++.++||||+++++++..++..++||||+++|+
T Consensus 52 G~G~fg~Vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (370)
T cd05621 52 GRGAFGEVQLVRHKSS--QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGD 129 (370)
T ss_pred EecCCeEEEEEEECCC--CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCc
Confidence 3445666666665443 356788887532 22334568899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++.........
T Consensus 130 L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~-------~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 130 LVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDK-------HGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred HHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECC-------CCCEEEEecccceecccCCce
Confidence 99998654 578899999999999999999999 9999999999999987 789999999999876433222
Q ss_pred cccccccCccccchhcccCC----CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH---cCC
Q 039817 601 TSTMIRGTMGYMAPEWLRNA----PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR---TGN 673 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 673 (725)
......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... ........ ...
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-----------~~~~~i~~~~~~~~ 267 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-----------GTYSKIMDHKNSLN 267 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhCCcccC
Confidence 22345699999999998754 3788999999999999999999999643211 11111111 111
Q ss_pred CCh--hHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 039817 674 LGA--TKFERITMVGLWCICPQPTL--RPSMKQVLQM 706 (725)
Q Consensus 674 ~~~--~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 706 (725)
.+. .....+.+++..|++.++.+ ||++.|++++
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 222 34677889999999866654 8999999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=289.42 Aligned_cols=241 Identities=20% Similarity=0.185 Sum_probs=185.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...|++|+.+.+..++ ..||||.+... .....+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 11 ~G~~g~Vy~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L 88 (377)
T cd05629 11 KGAFGEVRLVQKKDTG--KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL 88 (377)
T ss_pred ecCCEEEEEEEECCCC--CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcH
Confidence 3456666666665544 46888887542 223456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+......
T Consensus 89 ~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~-------~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 89 MTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDR-------GGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECC-------CCCEEEeecccccccccccccc
Confidence 99998888899999999999999999999999 9999999999999987 789999999999643211000
Q ss_pred ---------------------------------------------cccccccCccccchhcccCCCCCCccceehhHHHH
Q 039817 601 ---------------------------------------------TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635 (725)
Q Consensus 601 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl 635 (725)
......||+.|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00013589999999999999999999999999999
Q ss_pred HHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh--hHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 039817 636 LEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA--TKFERITMVGLWCICPQPTLR---PSMKQVLQM 706 (725)
Q Consensus 636 ~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~~ 706 (725)
|||++|+.||....... ....+........++. .....+.+++.+|++ +|.+| +++.|++++
T Consensus 239 ~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSHE--------TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHHH--------HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999986432111 0000000000111122 245678899999997 66665 699999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=268.92 Aligned_cols=235 Identities=23% Similarity=0.350 Sum_probs=187.2
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
+++++.+.+..+ +..+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++
T Consensus 13 ~g~v~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~ 90 (256)
T cd08221 13 FGEATLYRRTED--DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI 90 (256)
T ss_pred CceEEEEEEcCC--CcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHH
Confidence 444444444433 346788876532 3445667899999999999999999999999999999999999999999999
Q ss_pred ccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++........ ...
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~-------~~~~kl~d~~~~~~~~~~~~-~~~ 159 (256)
T cd08221 91 VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTK-------AGLIKLGDFGISKILGSEYS-MAE 159 (256)
T ss_pred HhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeC-------CCCEEECcCcceEEcccccc-ccc
Confidence 765 4679999999999999999999998 9999999999999987 77899999999986644332 122
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC---ChhHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL---GATKFE 680 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 680 (725)
...++..|+|||.+.+..++.++||||||++++||++|+.|++.... .+..... ..+.. +.....
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------~~~~~~~-~~~~~~~~~~~~~~ 227 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------LNLVVKI-VQGNYTPVVSVYSS 227 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHH-HcCCCCCCccccCH
Confidence 34588899999999888899999999999999999999998864321 1111111 11222 234567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
.+.+++.+|++.+|.+||+++++++++
T Consensus 228 ~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 228 ELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=271.80 Aligned_cols=239 Identities=21% Similarity=0.263 Sum_probs=184.3
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR 527 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 527 (725)
++.++.|.+.. .+..+++|.++.........+.+|+.+++.++||||+++++.+..++..++|+||+++++|.+++..
T Consensus 22 ~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 99 (267)
T cd06645 22 YGDVYKARNVN--TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV 99 (267)
T ss_pred CeEEEEEEEcC--CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh
Confidence 33444443332 3457888887655445556788999999999999999999999999999999999999999999988
Q ss_pred CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccccc
Q 039817 528 QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRG 607 (725)
Q Consensus 528 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 607 (725)
.+.+++.+...++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........ ......|
T Consensus 100 ~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~-------~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 168 (267)
T cd06645 100 TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTD-------NGHVKLADFGVSAQITATIA-KRKSFIG 168 (267)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC-------CCCEEECcceeeeEccCccc-ccccccC
Confidence 88899999999999999999999999 9999999999999987 78899999999876543221 1223458
Q ss_pred Cccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC--ChhHHHHH
Q 039817 608 TMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL--GATKFERI 682 (725)
Q Consensus 608 t~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 682 (725)
+..|+|||.+. ...++.++||||||+++|||++|+.|+........ .............. .....+.+
T Consensus 169 ~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred cccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HHhhhccCCCCCcccccCCCCHHH
Confidence 89999999874 45688999999999999999999998754321110 00000000000000 11234678
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+++.+|++.+|++||++++|+++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcC
Confidence 899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.19 Aligned_cols=222 Identities=28% Similarity=0.384 Sum_probs=178.2
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEE-cCCceeeeeecccCCChhhhhccCC--CCCHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI-EQNHQLLVYELMKNGTLSAFLFRQE--IPTWDKRVE 538 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~ 538 (725)
+..+++|.++.. ...+.|.+|+.++++++|+|++++++++. .++..++||||+++++|.+++.+.. .+++..+..
T Consensus 29 ~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd05082 29 GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106 (256)
T ss_pred CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHH
Confidence 346788887542 34567999999999999999999999765 4567899999999999999997643 478999999
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhccc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 618 (725)
++.|++.||+|||+. +++||||||+||+++. ++.+||+|||+++....... ...++..|+|||++.
T Consensus 107 ~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~-------~~~~kl~dfg~~~~~~~~~~----~~~~~~~y~aPE~~~ 172 (256)
T cd05082 107 FSLDVCEAMEYLEAN---NFVHRDLAARNVLVSE-------DNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALR 172 (256)
T ss_pred HHHHHHHHHHHHHhC---CEeccccchheEEEcC-------CCcEEecCCccceeccccCC----CCccceeecCHHHHc
Confidence 999999999999999 9999999999999987 78999999999875433221 123456899999999
Q ss_pred CCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHHHHHHHHHccCCCCC
Q 039817 619 NAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFERITMVGLWCICPQPT 695 (725)
Q Consensus 619 ~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~ 695 (725)
+..++.++||||||+++|||++ |+.|+..... .+....... ....+...+..+.+++.+|++.+|+
T Consensus 173 ~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 241 (256)
T cd05082 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAA 241 (256)
T ss_pred cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChh
Confidence 8899999999999999999997 8877653211 111111111 1223345567899999999999999
Q ss_pred CCCCHHHHHHHhcCC
Q 039817 696 LRPSMKQVLQMLEGT 710 (725)
Q Consensus 696 ~RPs~~evl~~L~~~ 710 (725)
+|||++++++.|+.+
T Consensus 242 ~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 242 TRPSFLQLREQLEHI 256 (256)
T ss_pred hCcCHHHHHHHHhcC
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=273.27 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=178.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+|++++.+...-......+++|.+.... ....+.|.+|+.++++++||||+++++.|......++||||+++|+|.++
T Consensus 6 G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 85 (268)
T cd05086 6 GWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSY 85 (268)
T ss_pred CcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHH
Confidence 34555555443222333456677665432 23457899999999999999999999999999999999999999999999
Q ss_pred hccC----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC-C
Q 039817 525 LFRQ----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ-T 599 (725)
Q Consensus 525 l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~-~ 599 (725)
+.+. ...++.....++.|+++||.|||+. +++||||||+|||++. ++.+||+|||++....... .
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~-------~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 86 LSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTS-------DLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred HHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcC-------CccEEecccccccccCcchhh
Confidence 9754 3456777889999999999999998 9999999999999987 7889999999986432211 1
Q ss_pred ccccccccCccccchhcccC-------CCCCCccceehhHHHHHHHHhCC-cCCCCCCCCccccccCcchHHHHHHH---
Q 039817 600 RTSTMIRGTMGYMAPEWLRN-------APVTAKVDVYSFGVMLLEIIFCK-RHTELHRVDEPTLANGMILTDWVLYC--- 668 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~S~G~vl~elltg~-~~~~~~~~~~~~~~~~~~~~~~~~~~--- 668 (725)
.......++..|+|||++.. ..++.++||||||+++|||+++. .|+..... . ..........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~------~~~~~~~~~~~~~ 228 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-R------EVLNHVIKDQQVK 228 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-H------HHHHHHHhhcccc
Confidence 11223457889999998743 24578999999999999999754 45532211 0 0000001000
Q ss_pred HHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 669 VRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 669 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
.....+.....+.+.+++..|| .+|++||++++|++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0112233345678888999999 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=290.81 Aligned_cols=242 Identities=21% Similarity=0.191 Sum_probs=179.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+|+.|+++.+... +..||||... ...+.+|++++++++|+|||++++++..++..++|||++. ++|.+++
T Consensus 180 G~~G~Vy~a~~~~~--~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l 250 (461)
T PHA03211 180 GSEGCVFESSHPDY--PQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYL 250 (461)
T ss_pred CCCeEEEEEEECCC--CCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHH
Confidence 45566666655443 3567888532 2346789999999999999999999999999999999995 6888888
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-ccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TST 603 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~~~ 603 (725)
... ..+++..+..|+.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++........ ...
T Consensus 251 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~-------~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 251 GARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNG-------PEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECC-------CCCEEEcccCCceeccccccccccc
Confidence 654 5689999999999999999999999 9999999999999987 788999999999865433221 122
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHH----------------
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY---------------- 667 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 667 (725)
...||..|+|||++.+..++.++|||||||+||||++|..++...............+...+..
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 3568999999999999999999999999999999999886554322111000000000000000
Q ss_pred --HHH----cCCCC----------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 668 --CVR----TGNLG----------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 668 --~~~----~~~~~----------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... ....+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000 0123468889999999999999999999986
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=278.19 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=190.3
Q ss_pred ccccHHHHHHHhcccCCcc--eEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQE--VEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~--~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+++.++++.+.-.+.. ..|++|.+..... ....++.+|+.++++++|+||++++|+|... ..++++||+++|+
T Consensus 16 g~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~ 94 (303)
T cd05110 16 GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGC 94 (303)
T ss_pred ccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCC
Confidence 3455677777776555543 4688898865332 2344789999999999999999999999754 4679999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||+++.......
T Consensus 95 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~-------~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 95 LLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKS-------PNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecC-------CCceEEccccccccccCccc
Confidence 99998765 4689999999999999999999999 9999999999999977 67899999999987643322
Q ss_pred cc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 RT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...+.+.. ......+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~~ 235 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEK-GERLPQPPI 235 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHC-CCCCCCCCC
Confidence 11 112335678999999999999999999999999999997 78877532110 01111111 001112233
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
....+.+++..||..+|++||+++++++.|+.+.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 4567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=266.18 Aligned_cols=239 Identities=29% Similarity=0.395 Sum_probs=190.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..++.+++|... +...++||.+... ....+++.+|++++++++|+||+++++++......++||||+++++|.+++
T Consensus 17 g~~~~v~~~~~~---~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i 92 (261)
T cd05034 17 GQFGEVWMGTWN---GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL 92 (261)
T ss_pred CcceEEEEEEEc---CCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHH
Confidence 345566665532 2356899988753 345678999999999999999999999999989999999999999999999
Q ss_pred ccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++............
T Consensus 93 ~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~-------~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 93 KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGE-------NLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred hccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcC-------CCCEEECccccceeccchhhhhhh
Confidence 765 4689999999999999999999999 9999999999999987 789999999999876543222222
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFE 680 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 680 (725)
....+..|+|||.+.+..++.++||||||++++|+++ |+.|+..... ......... ....+...++
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 231 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----------REVLEQVERGYRMPRPPNCPE 231 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCCCCH
Confidence 2334568999999998889999999999999999998 8887753211 111111111 1123334567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.+.+++.+|++.+|++||+++++++.|+.
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 89999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=275.55 Aligned_cols=224 Identities=22% Similarity=0.345 Sum_probs=181.1
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL 541 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ 541 (725)
+..|+||.+........+.+.+|+..+++++|+||+++++.+..++..++||||+++++|.+++.. ..+++..+..++.
T Consensus 47 ~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~ 125 (292)
T cd06658 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCL 125 (292)
T ss_pred CCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHH
Confidence 457899988655555567799999999999999999999999999999999999999999998854 4589999999999
Q ss_pred HHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCC
Q 039817 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP 621 (725)
Q Consensus 542 qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 621 (725)
|++.||.|||+. +|+||||||+||+++. ++.+||+|||++......... .....++..|+|||.+.+..
T Consensus 126 qi~~~l~~LH~~---~ivH~dlkp~Nill~~-------~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 194 (292)
T cd06658 126 SVLRALSYLHNQ---GVIHRDIKSDSILLTS-------DGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLP 194 (292)
T ss_pred HHHHHHHHHHHC---CEeecCCCHHHEEEcC-------CCCEEEccCcchhhccccccc-CceeecCccccCHHHHccCC
Confidence 999999999999 9999999999999987 788999999998765432221 12245788999999998888
Q ss_pred CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CChhHHHHHHHHHHHccCCCCCCCCC
Q 039817 622 VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LGATKFERITMVGLWCICPQPTLRPS 699 (725)
Q Consensus 622 ~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPs 699 (725)
++.++||||||++++||++|+.|+....... ....+.... ... ......+.+.+++.+|++.+|.+|||
T Consensus 195 ~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 265 (292)
T cd06658 195 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDNL-PPRVKDSHKVSSVLRGFLDLMLVREPSQRAT 265 (292)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcC-CCccccccccCHHHHHHHHHHccCChhHCcC
Confidence 9999999999999999999999986432110 001111110 111 11234567889999999999999999
Q ss_pred HHHHHHH
Q 039817 700 MKQVLQM 706 (725)
Q Consensus 700 ~~evl~~ 706 (725)
++|++++
T Consensus 266 ~~~il~~ 272 (292)
T cd06658 266 AQELLQH 272 (292)
T ss_pred HHHHhhC
Confidence 9999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=270.73 Aligned_cols=236 Identities=25% Similarity=0.356 Sum_probs=185.6
Q ss_pred ceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 462 EVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 462 ~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
+..+|+|.+... .....+.+.+|+++++.++|+||+++++++...+..++||||+++++|.+++.+.+.+++.....++
T Consensus 30 ~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 109 (284)
T cd06620 30 GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIA 109 (284)
T ss_pred CcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHH
Confidence 456788876543 2344678999999999999999999999999999999999999999999999887889999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 620 (725)
.|++.||.|||+. .+++|+||+|+||+++. ++.++|+|||++........ ....++..|+|||.+.+.
T Consensus 110 ~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~-------~~~~~l~d~gl~~~~~~~~~---~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 110 VAVVEGLTYLYNV--HRIMHRDIKPSNILVNS-------RGQIKLCDFGVSGELINSIA---DTFVGTSTYMSPERIQGG 177 (284)
T ss_pred HHHHHHHHHHHHh--cCeeccCCCHHHEEECC-------CCcEEEccCCcccchhhhcc---CccccCcccCCHHHHccC
Confidence 9999999999973 17999999999999987 78899999999875432211 224588999999999888
Q ss_pred CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCCh-hHHHHHHHHHHHccCCCCCCC
Q 039817 621 PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLGA-TKFERITMVGLWCICPQPTLR 697 (725)
Q Consensus 621 ~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~l~~l~~~cl~~dp~~R 697 (725)
.++.++||||||++++|+++|+.|+.................+......... .++. ..+..+.+++.+|++.||++|
T Consensus 178 ~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (284)
T cd06620 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257 (284)
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccC
Confidence 9999999999999999999999998754332111111111222222222211 1222 255689999999999999999
Q ss_pred CCHHHHHHHhcC
Q 039817 698 PSMKQVLQMLEG 709 (725)
Q Consensus 698 Ps~~evl~~L~~ 709 (725)
||++|++++.--
T Consensus 258 pt~~e~~~~~~~ 269 (284)
T cd06620 258 PTPQQLCAMPPF 269 (284)
T ss_pred cCHHHHhcCccc
Confidence 999999998543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.18 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=186.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
+|++++.+.+..+ +..+++|.+... .......+.+|++++++++||||+++++.+..++..++||||+++++|.+++
T Consensus 13 ~~g~v~~~~~~~~--~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l 90 (308)
T cd06615 13 NGGVVTKVLHRPS--GLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 90 (308)
T ss_pred CCeEEEEEEEcCC--CeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHH
Confidence 4455555544433 356788887543 2233456899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.+.+.+++..+..++.|+++||.|||+. .+++|+||||+||+++. ++.+||+|||++....... ....
T Consensus 91 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~~~~~---~~~~ 158 (308)
T cd06615 91 KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNS-------RGEIKLCDFGVSGQLIDSM---ANSF 158 (308)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEec-------CCcEEEccCCCcccccccc---cccC
Confidence 8888899999999999999999999973 17999999999999987 7789999999987553321 1224
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc---------c----------------cCcc
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL---------A----------------NGMI 660 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~---------~----------------~~~~ 660 (725)
.++..|+|||.+.+..++.++||||||++++||++|+.|+.......... . ....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence 57889999999988889999999999999999999999875322110000 0 0000
Q ss_pred hHHHHHHHHHcC--CCC-hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 661 LTDWVLYCVRTG--NLG-ATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 661 ~~~~~~~~~~~~--~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
..+......... ..+ ......+.+++.+||+.+|++|||++||+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 011111111110 111 12456789999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=272.76 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=192.7
Q ss_pred ccHHHHHHHhcccCCc--ceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQ--EVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~--~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+++.+++|+...++. ...+++|.+.... .....++.+|+.++++++|+||+++++++.. ...++||||+++|+|.
T Consensus 18 g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~ 96 (279)
T cd05057 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLL 96 (279)
T ss_pred CCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHH
Confidence 4566777777655544 3578999886543 2345679999999999999999999999987 7889999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++. ++.+||+|||+++.........
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~-------~~~~kL~dfg~~~~~~~~~~~~ 166 (279)
T cd05057 97 DYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKT-------PQHVKITDFGLAKLLDVDEKEY 166 (279)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcC-------CCeEEECCCcccccccCcccce
Confidence 999765 4689999999999999999999998 9999999999999987 7789999999998764332211
Q ss_pred c-cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcC---CCCh
Q 039817 602 S-TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTG---NLGA 676 (725)
Q Consensus 602 ~-~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 676 (725)
. ....++..|+|||.+....++.++||||||++++|+++ |+.|+..... .+ +......+ ..+.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~-~~~~~~~~~~~~~~~ 234 (279)
T cd05057 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----------VE-IPDLLEKGERLPQPP 234 (279)
T ss_pred ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----------HH-HHHHHhCCCCCCCCC
Confidence 1 11223567999999988889999999999999999998 8888864321 11 11111111 2233
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.....+.+++.+||..+|.+||++.++++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 34567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=274.55 Aligned_cols=235 Identities=23% Similarity=0.281 Sum_probs=187.8
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
.++.++++.+..+ +..|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.+++.
T Consensus 31 ~~g~vy~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 108 (296)
T cd06655 31 ASGTVFTAIDVAT--GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT 108 (296)
T ss_pred CCeEEEEEEEcCC--CcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH
Confidence 3444555544333 45788888865555556788999999999999999999999999999999999999999999885
Q ss_pred cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccc
Q 039817 527 RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606 (725)
Q Consensus 527 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 606 (725)
+ ..+++.++..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++......... .....
T Consensus 109 ~-~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~-------~~~~kl~dfg~~~~~~~~~~~-~~~~~ 176 (296)
T cd06655 109 E-TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGM-------DGSVKLTDFGFCAQITPEQSK-RSTMV 176 (296)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCCEEEccCccchhccccccc-CCCcC
Confidence 4 4689999999999999999999999 9999999999999987 788999999998865433221 12235
Q ss_pred cCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc----CCCChhHHHHH
Q 039817 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT----GNLGATKFERI 682 (725)
Q Consensus 607 gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l 682 (725)
++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ........ ...+......+
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----------ALYLIATNGTPELQNPEKLSPIF 245 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------HHHHHHhcCCcccCCcccCCHHH
Confidence 7889999999998889999999999999999999999986543211 01111111 11233456778
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+++.+||+.+|++||++.+++++
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhhC
Confidence 999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=284.15 Aligned_cols=236 Identities=21% Similarity=0.207 Sum_probs=181.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhcc---CcCCccceeeEEEcCCceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRT---HHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
.+|++++.+.+..+ +..||||.+.... ......+..|..++.+. +||||+++++.+...+..++||||+++|
T Consensus 4 G~~g~Vy~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g 81 (330)
T cd05586 4 GTFGQVYQVRKKDT--RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81 (330)
T ss_pred CCceEEEEEEECCC--CCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCC
Confidence 34556666665444 3578888875422 12233456677777665 6999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.+...+++..+..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~-------~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 82 ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDA-------TGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred hHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECC-------CCCEEEecCCcCcCCCCCCC
Confidence 9999998888899999999999999999999999 9999999999999987 78899999999875432221
Q ss_pred ccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCCh
Q 039817 600 RTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLGA 676 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 676 (725)
. .....||..|+|||.+.+. .++.++||||||+++|||++|+.|+...... + .......+ .++.
T Consensus 152 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----------~-~~~~i~~~~~~~~~ 218 (330)
T cd05586 152 T-TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----------Q-MYRNIAFGKVRFPK 218 (330)
T ss_pred C-ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----------H-HHHHHHcCCCCCCC
Confidence 1 2234589999999998754 4899999999999999999999998643211 1 11111111 2222
Q ss_pred -hHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 039817 677 -TKFERITMVGLWCICPQPTLRP----SMKQVLQM 706 (725)
Q Consensus 677 -~~~~~l~~l~~~cl~~dp~~RP----s~~evl~~ 706 (725)
...+.+.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 3467888999999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=286.32 Aligned_cols=240 Identities=21% Similarity=0.217 Sum_probs=182.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|++|++|.+..+ +..+|+|.+.... ......+.+|++++++++|+||+++++.+.+++..++||||+++|+|.
T Consensus 12 G~~g~Vy~a~~~~~--~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~ 89 (382)
T cd05625 12 GAFGEVCLARKVDT--KALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89 (382)
T ss_pred CCCEEEEEEEECCC--CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHH
Confidence 44556666655433 4578889886432 233457889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC----
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ---- 598 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~---- 598 (725)
+++.+.+.+++.....++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++..+....
T Consensus 90 ~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~-------~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 90 SLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDR-------DGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC-------CCCEEEeECCCCccccccccccc
Confidence 9998888889999999999999999999999 9999999999999987 7899999999975321000
Q ss_pred ------------------------------------------CccccccccCccccchhcccCCCCCCccceehhHHHHH
Q 039817 599 ------------------------------------------TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636 (725)
Q Consensus 599 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ 636 (725)
........||+.|+|||.+.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00011245899999999999999999999999999999
Q ss_pred HHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC--hhHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 039817 637 EIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG--ATKFERITMVGLWCICPQPTLRPS---MKQVLQM 706 (725)
Q Consensus 637 elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~ 706 (725)
||++|+.||....... ....+.........+ ....+.+.+++.+++ .+|++|++ +.|+++|
T Consensus 240 elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 240 EMLVGQPPFLAQTPLE--------TQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHhCCCCCCCCCHHH--------HHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999997542211 000000000011111 234566777777765 59999987 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=264.91 Aligned_cols=237 Identities=27% Similarity=0.406 Sum_probs=186.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
.++.++++... .+..+++|.+... ......|.+|++++++++|+|++++++++......++||||+++++|.+++.
T Consensus 16 ~~g~v~~~~~~---~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 91 (256)
T cd05112 16 QFGLVWLGYWL---EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR 91 (256)
T ss_pred ccceEEEEEEe---CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHH
Confidence 34555555432 2346889988643 3345679999999999999999999999999999999999999999999997
Q ss_pred cC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 527 RQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 527 ~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++..............
T Consensus 92 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~-------~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 92 AQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGE-------NQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred hCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcC-------CCeEEECCCcceeecccCcccccCCC
Confidence 64 4679999999999999999999998 9999999999999987 77899999999886543322222222
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFERI 682 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 682 (725)
.++.+|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+....... ....+...++.+
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----------SEVVETINAGFRLYKPRLASQSV 230 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----------HHHHHHHhCCCCCCCCCCCCHHH
Confidence 35678999999998889999999999999999998 8887753221 111111111 111223356789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
.+++.+||+.+|++|||+.+++++|.
T Consensus 231 ~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 231 YELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHHcccChhhCCCHHHHHHhhC
Confidence 99999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=276.02 Aligned_cols=238 Identities=24% Similarity=0.263 Sum_probs=186.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|++|+.|.+..+ +..||+|.+... .....+.+..|.+++..+. |++|+++++++...+..++||||+++|+|
T Consensus 11 G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L 88 (323)
T cd05615 11 GSFGKVMLAERKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL 88 (323)
T ss_pred cCCeEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcH
Confidence 45566666655443 457899987642 2334456888999998875 67888999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 89 ~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~-------~~~ikL~Dfg~~~~~~~~~~-~ 157 (323)
T cd05615 89 MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDS-------EGHIKIADFGMCKEHMVDGV-T 157 (323)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECC-------CCCEEEeccccccccCCCCc-c
Confidence 99998888899999999999999999999999 9999999999999987 78899999999875432221 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...+.+. ......+......
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~--~~~~~~p~~~~~~ 227 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIM--EHNVSYPKSLSKE 227 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHH--hCCCCCCccCCHH
Confidence 22345899999999999999999999999999999999999998643211 0111111 1122344556778
Q ss_pred HHHHHHHccCCCCCCCCCH-----HHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSM-----KQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~-----~evl~~ 706 (725)
+.+++.+|++.+|.+|++. +++.++
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 8999999999999999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=277.91 Aligned_cols=240 Identities=20% Similarity=0.279 Sum_probs=188.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..+|+.++.+.+..++ ..|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.++
T Consensus 31 ~g~~g~v~~~~~~~~~--~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 108 (297)
T cd06659 31 EGSTGIVCIAREKHSG--RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108 (297)
T ss_pred CCCceeEEEEEEcCCC--CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHH
Confidence 3455666666655443 47888887655555567789999999999999999999999999999999999999999987
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++......... ...
T Consensus 109 ~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~-------~~~~kL~dfg~~~~~~~~~~~-~~~ 176 (297)
T cd06659 109 VSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTL-------DGRVKLSDFGFCAQISKDVPK-RKS 176 (297)
T ss_pred Hhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEcc-------CCcEEEeechhHhhccccccc-ccc
Confidence 744 5689999999999999999999999 9999999999999987 789999999998755433221 123
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHHHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKFERIT 683 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 683 (725)
..++..|+|||++.+..++.++||||||++++||++|+.|+....... ......... ..........+.+.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~ 248 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKLKNAHKISPVLR 248 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCccccCCCCHHHH
Confidence 458889999999998889999999999999999999999986432111 000000000 00011223456789
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 039817 684 MVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 684 ~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+++.+|++.+|++||++++++++
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhC
Confidence 99999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.59 Aligned_cols=255 Identities=22% Similarity=0.255 Sum_probs=183.9
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gs 520 (725)
+...+|+++++|+..-......||+|.+... .....+.+|++++++++||||+++++++.. +...++|+||+++ +
T Consensus 9 lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~ 85 (317)
T cd07867 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D 85 (317)
T ss_pred eccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence 3455678888887655556678999988643 234568899999999999999999999854 5578899999885 6
Q ss_pred hhhhhccC---------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 521 LSAFLFRQ---------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 521 L~~~l~~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++..+. +.++.+||+|||++
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~---~~~~~~kl~DfG~a 159 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG---PERGRVKIADMGFA 159 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCC---CCCCcEEEeeccce
Confidence 76666321 2478899999999999999999999 999999999999995321 12678999999999
Q ss_pred cccCcCCCc--cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccC--cch-----
Q 039817 592 KLLKKDQTR--TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANG--MIL----- 661 (725)
Q Consensus 592 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~--~~~----- 661 (725)
+........ ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.....+....... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 876543221 1223458899999999876 457899999999999999999999986543221100000 000
Q ss_pred -------HHHH-----------HHHHHcCC------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 662 -------TDWV-----------LYCVRTGN------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 662 -------~~~~-----------~~~~~~~~------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..|. ........ ........+.+++.+|++.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 00000000 001123457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=264.79 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=186.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.++.++.+.+.- +..|++|.+...... ..+.|.+|++++++++|+||+++++++......++||||+++++|.+++
T Consensus 7 ~~g~v~~~~~~~---~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l 83 (251)
T cd05041 7 NFGDVYKGVLKG---NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL 83 (251)
T ss_pred CCceEEEEEEeC---CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHH
Confidence 344455554322 567889987654333 5568999999999999999999999999999999999999999999999
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc-c
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS-T 603 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~-~ 603 (725)
.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++........... .
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~-------~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 84 RKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGE-------NNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcC-------CCcEEEeeccccccccCCcceeccc
Confidence 654 5678999999999999999999999 9999999999999987 78899999999986542221111 1
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
....+..|+|||.+.+..++.++||||||++++||++ |..|+...... .....+... .....+...+..+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~ 224 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESG-YRMPAPQLCPEEI 224 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcC-CCCCCCccCCHHH
Confidence 1223567999999988899999999999999999999 66666433211 011111110 0112334556789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.+++.+|++.+|++|||+.||++.|++
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=270.34 Aligned_cols=237 Identities=22% Similarity=0.342 Sum_probs=183.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.++.++++.+..+ +..+|+|.+... .....++|.+|++++++++||||+++++++...+..++||||+++++|..+.
T Consensus 13 ~~~~v~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 90 (279)
T cd06619 13 NGGTVYKAYHLLT--RRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR 90 (279)
T ss_pred CCeEEEEEEEcCC--CcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh
Confidence 3445555554433 356888877543 2334567999999999999999999999999999999999999999997653
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++....... ....
T Consensus 91 ----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~-------~~~~~l~dfg~~~~~~~~~---~~~~ 153 (279)
T cd06619 91 ----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNT-------RGQVKLCDFGVSTQLVNSI---AKTY 153 (279)
T ss_pred ----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECC-------CCCEEEeeCCcceeccccc---ccCC
Confidence 467888999999999999999999 9999999999999987 7899999999998654322 1224
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---CC-ChhHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG---NL-GATKFER 681 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~ 681 (725)
.++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ....... ....... .. .....+.
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG----SLMPLQL-LQCIVDEDPPVLPVGQFSEK 228 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc----ccchHHH-HHHHhccCCCCCCCCcCCHH
Confidence 588899999999998999999999999999999999999865332211 0111111 1111111 11 1235568
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
+.+++.+|++.+|++||+++|++++-
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 89999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=269.94 Aligned_cols=236 Identities=23% Similarity=0.298 Sum_probs=184.9
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
++.++++.+.. .+..|++|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||+++++|.+++.
T Consensus 17 ~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (277)
T cd06642 17 FGEVYKGIDNR--TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK 94 (277)
T ss_pred CeeEEEEEEcC--CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh
Confidence 33444444332 34578889876432 3345678999999999999999999999999999999999999999999885
Q ss_pred cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccc
Q 039817 527 RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606 (725)
Q Consensus 527 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 606 (725)
. ..+++..+..++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||++........ ......
T Consensus 95 ~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~-------~~~~~l~dfg~~~~~~~~~~-~~~~~~ 162 (277)
T cd06642 95 P-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSE-------QGDVKLADFGVAGQLTDTQI-KRNTFV 162 (277)
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeC-------CCCEEEccccccccccCcch-hhhccc
Confidence 4 5688999999999999999999998 9999999999999987 78899999999986543321 112234
Q ss_pred cCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHH
Q 039817 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG 686 (725)
Q Consensus 607 gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 686 (725)
++..|+|||.+.+..++.++||||||++++||++|+.|+....... ....... ..........+..+.+++
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~-~~~~~~~~~~~~~~~~li 233 (277)
T cd06642 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPK-NSPPTLEGQYSKPFKEFV 233 (277)
T ss_pred CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhc-CCCCCCCcccCHHHHHHH
Confidence 7889999999998899999999999999999999999876432111 0000000 001122234567789999
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 039817 687 LWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 687 ~~cl~~dp~~RPs~~evl~~ 706 (725)
.+|++.+|.+||++.+|+++
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 234 EACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHccCCcccCcCHHHHHHh
Confidence 99999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=264.95 Aligned_cols=239 Identities=23% Similarity=0.265 Sum_probs=187.2
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR 527 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 527 (725)
+++++.+.+..++ ..+++|.+........+.+.+|++++++++|+||+++++++..++..+++|||+++++|.+++..
T Consensus 16 ~~~v~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~ 93 (262)
T cd06613 16 YGDVYKARDIATG--ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV 93 (262)
T ss_pred ceEEEEeEecCCC--CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence 4444444443333 46788887655555678899999999999999999999999999999999999999999999977
Q ss_pred C-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccc
Q 039817 528 Q-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606 (725)
Q Consensus 528 ~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 606 (725)
. ..++...+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++........ ......
T Consensus 94 ~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~-------~~~~~l~d~g~~~~~~~~~~-~~~~~~ 162 (262)
T cd06613 94 TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTE-------DGDVKLADFGVSAQLTATIA-KRKSFI 162 (262)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECC-------CCCEEECccccchhhhhhhh-cccccc
Confidence 6 7889999999999999999999998 9999999999999987 78899999999886543221 112345
Q ss_pred cCccccchhcccCC---CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHHH
Q 039817 607 GTMGYMAPEWLRNA---PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFER 681 (725)
Q Consensus 607 gt~~y~aPE~~~~~---~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 681 (725)
++..|+|||.+.+. .++.++||||||++++||++|+.|+........ ........... .......+..
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred CCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhccCCCccccchhhhhHH
Confidence 78889999998776 889999999999999999999999864321110 00000000000 0112244678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+++.+||+.+|.+|||+++|+.+
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=256.97 Aligned_cols=241 Identities=24% Similarity=0.265 Sum_probs=189.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCcc--HHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDG--EKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~g 519 (725)
...+|+.|++|.+..++ ..||+|+++-..... --.-++|+.+|.+++|||||.+-.+... -+..|||||||+.
T Consensus 85 ~EGtyGiVYRakdk~t~--eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh- 161 (419)
T KOG0663|consen 85 EEGTYGVVYRAKDKKTD--EIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH- 161 (419)
T ss_pred ccCcceeEEEeccCCcc--eeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-
Confidence 45688889988887665 578999986432111 1235799999999999999999998764 4579999999998
Q ss_pred ChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 520 TLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 520 sL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+|...+..- +++...++.-+..|+++|++|||.. .|+|||||++|+|+.. .|.+||+|||||+.++...
T Consensus 162 DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~-------~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 162 DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSH-------KGILKIADFGLAREYGSPL 231 (419)
T ss_pred hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeecc-------CCcEEecccchhhhhcCCc
Confidence 888888766 4789999999999999999999999 9999999999999988 8999999999999987653
Q ss_pred CccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-------
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR------- 670 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 670 (725)
. ..+..+-|.-|+|||.+.+. .|+.+.|+||+||++.|++++++.+.....-++ .+.+...+.
T Consensus 232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--------l~~If~llGtPte~iw 302 (419)
T KOG0663|consen 232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--------LDKIFKLLGTPSEAIW 302 (419)
T ss_pred c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--------HHHHHHHhCCCccccC
Confidence 2 34445678999999998765 699999999999999999999998865432211 000111000
Q ss_pred ----------------------cCCCChh-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 671 ----------------------TGNLGAT-KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 671 ----------------------~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+... ..+.-.+|+..++..||.+|.|++|.+++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0111111 34667788999999999999999999876
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=271.75 Aligned_cols=240 Identities=26% Similarity=0.285 Sum_probs=187.8
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccC------ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTG------DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
.+|++++++.+ .++..+|||.++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 11 g~~~~v~~~~~---~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (265)
T cd06631 11 GAYGTVYCGLT---NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGG 87 (265)
T ss_pred cCCeEEEEEEE---cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCC
Confidence 44556666543 2345788888753221 12356889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC-
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ- 598 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~- 598 (725)
+|.+++.+...+++..+..++.|++.||+|||+. +++|+||+|+||+++. ++.+||+|||++.......
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 88 SISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMP-------NGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECC-------CCeEEeccchhhHhhhhccc
Confidence 9999998877889999999999999999999998 9999999999999987 7899999999987543211
Q ss_pred ----CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH-HHcCC
Q 039817 599 ----TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-VRTGN 673 (725)
Q Consensus 599 ----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 673 (725)
........++..|+|||.+.+..++.++||||||++++||++|+.|+....... ........ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~ 229 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYIGAHRGLMPR 229 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--------HHHHhhhccCCCCC
Confidence 111122458889999999998889999999999999999999999986432111 00000000 01123
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+....+.+.+++.+||+.+|.+||++.|++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 444567789999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=266.86 Aligned_cols=236 Identities=26% Similarity=0.356 Sum_probs=186.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEc-CCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~ 523 (725)
.++.++.+.+..+ +..+++|.+... .....+.+.+|++++++++|+|++++++.+.. ....++||||+++++|.+
T Consensus 12 ~~~~v~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 89 (257)
T cd08223 12 SYGEVSLVRHRTD--GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYH 89 (257)
T ss_pred CCeEEEEEEEcCC--CcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHH
Confidence 4555555555443 346888887532 23345678999999999999999999998765 446789999999999999
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
++... ..+++.++..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........ .
T Consensus 90 ~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~-------~~~~~l~df~~~~~~~~~~~-~ 158 (257)
T cd08223 90 KLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTR-------TNIIKVGDLGIARVLENQCD-M 158 (257)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEec-------CCcEEEecccceEEecccCC-c
Confidence 99753 4589999999999999999999999 9999999999999987 78999999999986643322 2
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 679 (725)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+..... ......... ....+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 227 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----------NSLVYRIIEGKLPPMPKDYS 227 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHhcCCCCCccccC
Confidence 2234578899999999999999999999999999999999998763221 111111111 112344567
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+.+++.+|++.+|++||++.+++++
T Consensus 228 ~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 228 PELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=274.28 Aligned_cols=235 Identities=21% Similarity=0.295 Sum_probs=187.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
.+++++.+.... .+..+++|.+........+.|.+|++++++++|+||+++++.+..+...++||||+++++|.+++.
T Consensus 17 ~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (280)
T cd06611 17 AFGKVYKAQHKE--TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIML 94 (280)
T ss_pred CCceEEEEEEcC--CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHH
Confidence 445555555443 346789998876555566789999999999999999999999999999999999999999999987
Q ss_pred cC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 527 RQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 527 ~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
+. ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++. ++.+||+|||++........ .....
T Consensus 95 ~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~-------~~~~~l~d~g~~~~~~~~~~-~~~~~ 163 (280)
T cd06611 95 ELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTL-------DGDVKLADFGVSAKNKSTLQ-KRDTF 163 (280)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECC-------CCCEEEccCccchhhccccc-cccee
Confidence 64 5689999999999999999999999 9999999999999987 78999999999876533222 12234
Q ss_pred ccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC-----CC
Q 039817 606 RGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN-----LG 675 (725)
Q Consensus 606 ~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 675 (725)
.++..|+|||.+. ...++.++||||||+++|||++|+.|+...... ...... .... .+
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----------~~~~~~-~~~~~~~~~~~ 231 (280)
T cd06611 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----------RVLLKI-LKSEPPTLDQP 231 (280)
T ss_pred ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----------HHHHHH-hcCCCCCcCCc
Confidence 5888999999874 345778999999999999999999998643211 111111 1111 12
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......+.+++..||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 2345688999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.15 Aligned_cols=236 Identities=24% Similarity=0.377 Sum_probs=187.2
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+++++.+.+.. .+..+++|.+... .....+.+.+|++++++++|+||+++++.+..++..++||||+++++|.++
T Consensus 12 ~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd08220 12 AFGIVHLCRRKA--DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEY 89 (256)
T ss_pred CceEEEEEEEcC--CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHH
Confidence 344455555443 3456788877532 334466899999999999999999999999999999999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +..+||+|||++........ .
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~------~~~~~l~d~~~~~~~~~~~~--~ 158 (256)
T cd08220 90 IQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKH------KMVVKIGDFGISKILSSKSK--A 158 (256)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC------CCEEEEccCCCceecCCCcc--c
Confidence 9764 3579999999999999999999999 99999999999999753 55789999999987644322 1
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFE 680 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 680 (725)
....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ........ ....+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----------ALVLKIMSGTFAPISDRYSP 227 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----------HHHHHHHhcCCCCCCCCcCH
Confidence 2244788999999999888999999999999999999999988643211 11111111 1223344677
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+++.+||+.+|.+|||+.|++++
T Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 228 DLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 89999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=277.10 Aligned_cols=239 Identities=26% Similarity=0.273 Sum_probs=196.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc---cHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD---GEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~---~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...|+.++.+....+ +..+|+|.+.+.... ..+.+.+|+++|+++. |||||.+.+.++.....++|||++.+|.
T Consensus 45 ~G~Fg~v~~~~~~~t--g~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGe 122 (382)
T KOG0032|consen 45 RGQFGVVYLCREKST--GKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGE 122 (382)
T ss_pred CCCceEEEEEEecCC--CceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCch
Confidence 344555555655555 456788887654332 3468999999999998 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+.+.+. .+++.....++.|++.++.|||+. +|+||||||+|+|+.... ++++.+|++|||++..... ..
T Consensus 123 Lfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~---~~~~~ik~~DFGla~~~~~--~~ 193 (382)
T KOG0032|consen 123 LFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD---EGSGRIKLIDFGLAKFIKP--GE 193 (382)
T ss_pred HHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc---CCCCcEEEeeCCCceEccC--Cc
Confidence 99999777 499999999999999999999998 999999999999997742 1246899999999998766 33
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC------
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL------ 674 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 674 (725)
.....+||+.|+|||.+....|+.+.||||+|+++|.|++|..||......... .....+.+
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------------~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------------LAILRGDFDFTSEP 261 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------------HHHHcCCCCCCCCC
Confidence 445577999999999999999999999999999999999999999866432211 01122221
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
-....+.+.+++..++..||.+|+|+.++++|
T Consensus 262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12457889999999999999999999999997
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=267.58 Aligned_cols=237 Identities=23% Similarity=0.273 Sum_probs=185.3
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR 527 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 527 (725)
+++++.+.... .+..+++|.+..... .+++.+|++++++++|+||+++++++..+...++++||+++++|.+++..
T Consensus 16 ~~~v~~~~~~~--~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~ 91 (256)
T cd06612 16 YGSVYKAIHKE--TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI 91 (256)
T ss_pred CeEEEEEEEcC--CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh
Confidence 33444444332 245788888864322 67899999999999999999999999999999999999999999999975
Q ss_pred C-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccc
Q 039817 528 Q-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606 (725)
Q Consensus 528 ~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 606 (725)
. ..+++..+..++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||++........ ......
T Consensus 92 ~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~-------~~~~~l~dfg~~~~~~~~~~-~~~~~~ 160 (256)
T cd06612 92 TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNE-------EGQAKLADFGVSGQLTDTMA-KRNTVI 160 (256)
T ss_pred CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECC-------CCcEEEcccccchhcccCcc-cccccc
Confidence 3 5789999999999999999999999 9999999999999987 78899999999987654322 122234
Q ss_pred cCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHH
Q 039817 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG 686 (725)
Q Consensus 607 gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 686 (725)
++..|+|||.+.+..++.++||||||++++||++|+.|+........... ...........+......+.+++
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccCCCCCCCchhhcCHHHHHHH
Confidence 78899999999988999999999999999999999999864322110000 00000000011223456789999
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 039817 687 LWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 687 ~~cl~~dp~~RPs~~evl~~ 706 (725)
.+|++.+|++|||++||+++
T Consensus 234 ~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHhcChhhCcCHHHHhcC
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=265.04 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=186.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..+++.++.++.. ....+++|.+... ....+.|.+|++++++++|+||+++.+++.. ...+++|||+++++|.++
T Consensus 16 ~g~~~~vy~~~~~---~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05073 16 AGQFGEVWMATYN---KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 90 (260)
T ss_pred CccceEEEEEEec---CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHH
Confidence 3445556655422 2345888887643 2345679999999999999999999999887 778999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++. .+.+||+|||++...........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~-------~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 91 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSA-------SLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred HHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcC-------CCcEEECCCcceeeccCCCcccc
Confidence 9764 4578899999999999999999998 9999999999999987 78999999999986543322222
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
....++..|+|||++....++.++|+||||++++|+++ |+.|+...... .......... ....+...+..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~ 231 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGY-RMPRPENCPEE 231 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCC-CCCCcccCCHH
Confidence 22335678999999998889999999999999999999 78777532211 0111111000 01223345678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+.+++.+|++.+|++||++.++.+.|+.
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=273.07 Aligned_cols=243 Identities=29% Similarity=0.417 Sum_probs=187.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccH--HHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~--~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.|+.++++.+..+ +..+|+|.+........ ....+|+.++++++|+||+++++++......++|||++++++|.++
T Consensus 11 ~~g~v~~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~ 88 (260)
T PF00069_consen 11 GFGTVYKAKNKKN--GQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDY 88 (260)
T ss_dssp SSEEEEEEEETTT--TEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHH
T ss_pred CCEEEEEEEECCC--CeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccc
Confidence 3444444544443 34788888865433322 2345699999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.....+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.++|+|||.+..... .......
T Consensus 89 l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~-------~~~~~l~Dfg~~~~~~~-~~~~~~~ 157 (260)
T PF00069_consen 89 LQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDE-------NGEVKLIDFGSSVKLSE-NNENFNP 157 (260)
T ss_dssp HHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEEST-------TSEEEESSGTTTEESTS-TTSEBSS
T ss_pred ccccccccccccccccccccccccccccc---cccccccccccccccc-------ccccccccccccccccc-ccccccc
Confidence 98778899999999999999999999999 9999999999999987 88999999999976421 1222334
Q ss_pred cccCccccchhccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHH-HHHHcCCCChhHHHHH
Q 039817 605 IRGTMGYMAPEWLR-NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL-YCVRTGNLGATKFERI 682 (725)
Q Consensus 605 ~~gt~~y~aPE~~~-~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 682 (725)
..++..|+|||.+. +...+.++||||+|+++++|++|+.|+........ ......... .............+.+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ----LEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH----HHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhh----hhhhhhcccccccccccccchhHHHH
Confidence 55888999999998 88899999999999999999999999875411110 001111111 1111111111224899
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+++.+||+.||++||++.+++++
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=267.40 Aligned_cols=244 Identities=28% Similarity=0.405 Sum_probs=188.3
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc------CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT------GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
.++.++.+.+..++ ..+++|.+.... ....+.+.+|++++++++|+||+++++++.+++..++||||+++++
T Consensus 12 ~~~~v~~~~~~~~~--~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~ 89 (268)
T cd06630 12 AFSSCYQARDVKTG--TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGS 89 (268)
T ss_pred CceEEEEEEEcCCC--cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCc
Confidence 44555555544333 467777775322 1134678999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|++.||.|||+. +++|+||+|+||+++.+ ...+||+|||++.........
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~------~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 90 VSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDST------GQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred HHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC------CCEEEEccccccccccccccc
Confidence 999998878899999999999999999999999 99999999999999762 346999999998866543211
Q ss_pred c---ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 601 T---STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 601 ~---~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
. .....++..|+|||.+.+..++.++||||+|++++||++|..|+....... .................+..
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-----HLALIFKIASATTAPSIPEH 235 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-----hHHHHHHHhccCCCCCCchh
Confidence 1 112357889999999988889999999999999999999999886432111 00000000011112334445
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+.+++.+|++.+|.+||++.+++++
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 67889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=283.26 Aligned_cols=239 Identities=19% Similarity=0.186 Sum_probs=184.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.++.+.+..+ +..+|+|.+... .....+.+.+|+.+++.++||||+++++.+..++..++||||+++|+|
T Consensus 53 ~G~fg~Vy~~~~~~~--~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L 130 (371)
T cd05622 53 RGAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 130 (371)
T ss_pred ecCCeEEEEEEECCC--CcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcH
Confidence 345566666655443 356788887532 223345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++... .++...+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.........
T Consensus 131 ~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~-------~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 131 VNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK-------SGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECC-------CCCEEEEeCCceeEcCcCCccc
Confidence 9998654 578888999999999999999999 9999999999999987 7899999999998765433322
Q ss_pred ccccccCccccchhcccCC----CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCC
Q 039817 602 STMIRGTMGYMAPEWLRNA----PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNL 674 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~----~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 674 (725)
.....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... ......... ...
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----------~~~~~i~~~~~~~~~ 268 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----------GTYSKIMNHKNSLTF 268 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----------HHHHHHHcCCCcccC
Confidence 3345699999999998754 3789999999999999999999999743211 111111111 111
Q ss_pred C--hhHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 039817 675 G--ATKFERITMVGLWCICPQPTL--RPSMKQVLQML 707 (725)
Q Consensus 675 ~--~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~L 707 (725)
+ ......+.+++.+|++.++.+ ||+++|++++.
T Consensus 269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 2 245678899999999855543 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=278.06 Aligned_cols=247 Identities=17% Similarity=0.177 Sum_probs=178.8
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
+.+++.+.+.- .+..||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++||||+++|+|.+++
T Consensus 13 ~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 90 (327)
T cd08227 13 LMTVNLARYKP--TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 90 (327)
T ss_pred eEEEEEEeecc--cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence 34444444443 34678999886432 233456778999999999999999999999999999999999999999999
Q ss_pred ccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc--
Q 039817 526 FRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-- 601 (725)
Q Consensus 526 ~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-- 601 (725)
... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+++.||+............
T Consensus 91 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~-------~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 91 CTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISV-------DGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEec-------CCcEEEcccchhhccccccccccc
Confidence 653 4589999999999999999999998 9999999999999987 7789999998654332111100
Q ss_pred ----ccccccCccccchhcccC--CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc--Cc---------chHHH
Q 039817 602 ----STMIRGTMGYMAPEWLRN--APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN--GM---------ILTDW 664 (725)
Q Consensus 602 ----~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~--~~---------~~~~~ 664 (725)
.....++..|+|||++.+ ..++.++||||||++++||++|+.|+............ .. ...+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 111236678999999875 46899999999999999999999998642211000000 00 00000
Q ss_pred HHH-H-----------------H-------HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 665 VLY-C-----------------V-------RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 665 ~~~-~-----------------~-------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... . . ..........+.+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 0 0 0000111335678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=265.29 Aligned_cols=248 Identities=26% Similarity=0.340 Sum_probs=184.3
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhc--cCcCCccceeeEEEcCC----ceeeeeecccCCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR--THHKNLVQLLGFCIEQN----HQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e~~~~gs 520 (725)
.|+||+++.. .+..||||.+.. .+++.+.+|.+++.. |+|+||+.+++.-..+. +++||.+|.++||
T Consensus 223 RyGEVwrG~w----rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GS 295 (513)
T KOG2052|consen 223 RFGEVWRGRW----RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGS 295 (513)
T ss_pred cccceeeccc----cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCc
Confidence 3455544432 245789999854 457889999999986 59999999999876543 6899999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcc-----cCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEE-----CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
|.|||.+ ..++.+..++++..+|.||+|||.+ .+|.|.|||||+.||||.. ++..-|+|+|||....
T Consensus 296 L~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk-------n~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 296 LYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-------NGTCCIADLGLAVRHD 367 (513)
T ss_pred HHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc-------CCcEEEeeceeeEEec
Confidence 9999977 6788999999999999999999965 5789999999999999987 8999999999998765
Q ss_pred cCCCcc---ccccccCccccchhcccCCC------CCCccceehhHHHHHHHHhCC----------cCCCCCCCCccccc
Q 039817 596 KDQTRT---STMIRGTMGYMAPEWLRNAP------VTAKVDVYSFGVMLLEIIFCK----------RHTELHRVDEPTLA 656 (725)
Q Consensus 596 ~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~ksDv~S~G~vl~elltg~----------~~~~~~~~~~~~~~ 656 (725)
.+.... ....+||.+|||||++.+.- --..+||||||.|+||+...- .||......++..+
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 543221 22356999999999986542 123599999999999997421 23322222211111
Q ss_pred cCcchHHHHHHHHHcCCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 657 NGMILTDWVLYCVRTGNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+.+.+-....+..++ .+....+.++++.||..+|..|.|+--+.+.|.++.+
T Consensus 448 ---eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 448 ---EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ---HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 0111111111112222 2667789999999999999999999999999987765
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=267.35 Aligned_cols=237 Identities=23% Similarity=0.280 Sum_probs=187.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.++.++++.+.- .+..+++|.+.... ......+.+|++++++++|+||+++++++.++...++|+||+++++|.+++
T Consensus 13 ~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 90 (274)
T cd06609 13 SFGEVYKAIDKR--TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL 90 (274)
T ss_pred CCeEEEEEEECC--CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHH
Confidence 344445554433 34678888875432 344567899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
... .+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.++|+|||+++....... .....
T Consensus 91 ~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~-------~~~~~l~d~g~~~~~~~~~~-~~~~~ 158 (274)
T cd06609 91 KPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSE-------EGDVKLADFGVSGQLTSTMS-KRNTF 158 (274)
T ss_pred hhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECC-------CCCEEEcccccceeeccccc-ccccc
Confidence 765 789999999999999999999998 9999999999999987 78999999999987654322 12234
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh-HHHHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT-KFERITM 684 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ 684 (725)
.++..|+|||++.+..++.++||||||+++|||++|+.|+....... ....+... ....+... ..+.+.+
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKN-NPPSLEGNKFSKPFKD 229 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHHhhhc-CCCCCcccccCHHHHH
Confidence 57888999999998889999999999999999999999986432110 00001100 01112222 5667899
Q ss_pred HHHHccCCCCCCCCCHHHHHHH
Q 039817 685 VGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 685 l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++.+||+.+|++|||+++++++
T Consensus 230 ~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 230 FVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=300.06 Aligned_cols=247 Identities=21% Similarity=0.273 Sum_probs=186.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gs 520 (725)
...|++|+.+.+... +..+++|.+.. ........|..|+.++++++|||||++++++.. ....+|||||+++++
T Consensus 23 ~GgFGtVYLAkdk~t--g~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGS 100 (1021)
T PTZ00266 23 NGRFGEVFLVKHKRT--QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD 100 (1021)
T ss_pred cCCCeEEEEEEECCC--CeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCc
Confidence 345677777776544 35677777653 233345679999999999999999999998864 456899999999999
Q ss_pred hhhhhccC----CCCCHHHHHHHHHHHHHHhhhhhcccC----CceeecCCccceEEeccCcc----------ccCCCCc
Q 039817 521 LSAFLFRQ----EIPTWDKRVEIALGIARGLLYLHEECE----TQIIHCDIKPQNVLLDNNYI----------TIDNNYI 582 (725)
Q Consensus 521 L~~~l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~----~~ivH~dik~~NIll~~~~~----------~~~~~~~ 582 (725)
|.++|... ..+++..++.|+.||+.||.|||+... .+|+||||||+||||+.+.. ..+....
T Consensus 101 L~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~i 180 (1021)
T PTZ00266 101 LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180 (1021)
T ss_pred HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCc
Confidence 99998653 568999999999999999999998521 25999999999999975321 1123556
Q ss_pred eEEeeccCccccCcCCCccccccccCccccchhcccC--CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcc
Q 039817 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN--APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMI 660 (725)
Q Consensus 583 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~ 660 (725)
+||+|||++........ .....||+.|+|||.+.+ ..++.++|||||||+||||++|+.||.....
T Consensus 181 VKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~---------- 248 (1021)
T PTZ00266 181 AKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN---------- 248 (1021)
T ss_pred eEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc----------
Confidence 99999999986543322 123458999999999854 4588999999999999999999999864321
Q ss_pred hHHHHHHHHHcCCCC-hhHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 661 LTDWVLYCVRTGNLG-ATKFERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 661 ~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
....+........++ ......+.+|+..||+.+|.+||++.|++.
T Consensus 249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111122211112222 234678999999999999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=274.63 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=196.9
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
+.+..||+|+.|.+.-+|+ .+|+|+|++.. ....+..+.|-.+|...+++.||+|+-.|++.+.+||||||++||
T Consensus 149 IgkGAfGeVrLarKk~Tg~--iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 149 IGKGAFGEVRLARKKDTGE--IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eccccceeEEEEEEccCCc--EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 4567788998888876664 78999987643 334567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc---
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK--- 596 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~--- 596 (725)
++...|.+.+.|++....-++.+++.|+.-||+. ++|||||||+|+|||. .|.+||+||||+.-+..
T Consensus 227 D~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~-------~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 227 DMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDA-------KGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred cHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecC-------CCCEeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999 9999999999999988 99999999999853211
Q ss_pred --------------------CCCc----cc-------------------cccccCccccchhcccCCCCCCccceehhHH
Q 039817 597 --------------------DQTR----TS-------------------TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633 (725)
Q Consensus 597 --------------------~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~ 633 (725)
+... .. ....||+.|+|||++.+..|....|.|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 00 0134999999999999999999999999999
Q ss_pred HHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 039817 634 MLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP---SMKQVLQM 706 (725)
Q Consensus 634 vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~ 706 (725)
|+||||.|-+||......+ ....+..|-..+ ..+-......+..+||.+|+. ||++|. .++||.+|
T Consensus 377 ImyEmLvGyPPF~s~tp~~----T~rkI~nwr~~l--~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQE----TYRKIVNWRETL--KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHhCCCCCCCCCHHH----HHHHHHHHhhhc--cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 9999999999998665432 111222222111 112223445889999999998 999996 57777765
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=266.97 Aligned_cols=240 Identities=26% Similarity=0.349 Sum_probs=187.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
+++.++.+.+.. .+..+++|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||+++++|.++
T Consensus 12 ~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (264)
T cd06626 12 TFGKVYTAVNLD--TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEEL 89 (264)
T ss_pred CCcEEEEEEECC--CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHH
Confidence 344444444333 345788888765443 3567899999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc-
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST- 603 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~- 603 (725)
+.+...+++..+..++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||++............
T Consensus 90 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~-------~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 90 LEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDH-------NGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred HhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCCEEEcccccccccCCCCCccccc
Confidence 98877789999999999999999999999 9999999999999987 788999999999876543332221
Q ss_pred --ccccCccccchhcccCCC---CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 604 --MIRGTMGYMAPEWLRNAP---VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 604 --~~~gt~~y~aPE~~~~~~---~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
...++..|+|||++.+.. .+.++||||||++++|+++|+.|+....... .. ............+...
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-------~~-~~~~~~~~~~~~~~~~ 231 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-------QI-MFHVGAGHKPPIPDSL 231 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-------HH-HHHHhcCCCCCCCccc
Confidence 245788999999998766 8899999999999999999999986432110 00 0000000111222222
Q ss_pred --HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 --FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 --~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+.+++.+|++.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 6778899999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=280.71 Aligned_cols=229 Identities=25% Similarity=0.288 Sum_probs=187.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|+.|..|... +.+...|||.+++. ..++.+..+.|.+++... +||.|+.|+..++..++.++||||..||++
T Consensus 379 GsFGkV~lae~k--~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm 456 (694)
T KOG0694|consen 379 GSFGKVLLAELK--GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDL 456 (694)
T ss_pred CcCceEEEEEEc--CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcE
Confidence 344544444433 34458899999864 345667889999998877 599999999999999999999999999994
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
. ++.+.+.+++..+.-++..|+.||+|||++ +||+||||.+|||||. +|.+||+||||++....... .
T Consensus 457 ~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~-------eGh~kiADFGlcKe~m~~g~-~ 524 (694)
T KOG0694|consen 457 M-HHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDT-------EGHVKIADFGLCKEGMGQGD-R 524 (694)
T ss_pred E-EEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcc-------cCcEEecccccccccCCCCC-c
Confidence 3 333557899999999999999999999999 9999999999999988 99999999999996543332 3
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 679 (725)
...++||+.|||||.+.+..|+.+.|.|+|||+||||+.|..||.....++ +...+. ...+|.-.+
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------------~FdsI~~d~~~yP~~ls 592 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------------VFDSIVNDEVRYPRFLS 592 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------------HHHHHhcCCCCCCCccc
Confidence 445889999999999999999999999999999999999999998664332 222222 234566778
Q ss_pred HHHHHHHHHccCCCCCCCCCH
Q 039817 680 ERITMVGLWCICPQPTLRPSM 700 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~ 700 (725)
.+.+.++.+++.++|++|.-+
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHHhccCcccccCC
Confidence 889999999999999999865
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.53 Aligned_cols=239 Identities=25% Similarity=0.260 Sum_probs=187.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+|++++.+++.-+ +..+|+|.++... ......+.+|++++++++|+||+++++.+..++..++||||+++++|.
T Consensus 11 G~~g~vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (285)
T cd05632 11 GGFGEVCACQVRAT--GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK 88 (285)
T ss_pred CCCeEEEEEEECCC--CcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHH
Confidence 44566666665543 4578889886432 223456789999999999999999999999999999999999999999
Q ss_pred hhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 523 AFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 523 ~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~-------~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 89 FHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDD-------YGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECC-------CCCEEEecCCcceecCCCCc-
Confidence 988653 4689999999999999999999998 9999999999999987 77899999999876432221
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 678 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..+.+...... ...+...
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--------KREEVDRRVLETEEVYSAKF 228 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHhhhccccccCccC
Confidence 122458999999999998899999999999999999999999986432111 01111111111 1233455
Q ss_pred HHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
...+.+|+..|++.||++||+ +++++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 677899999999999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=267.19 Aligned_cols=239 Identities=23% Similarity=0.312 Sum_probs=182.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcC------CceeeeeecccC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQ------NHQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------~~~~lV~e~~~~ 518 (725)
.+|++++.+... +.+..||+|.+... ......+.+|+.+++++ +|+||+++++++... ...++||||+++
T Consensus 17 g~~g~vy~~~~~--~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~ 93 (272)
T cd06637 17 GTYGQVYKGRHV--KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA 93 (272)
T ss_pred cCCeEEEEEEEc--CCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCC
Confidence 344555555443 33467888887643 34556789999999998 799999999998753 457899999999
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 519 GTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 519 gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++. ++.+||+|||+++....
T Consensus 94 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~-------~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 94 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE-------NAEVKLVDFGVSAQLDR 163 (272)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECC-------CCCEEEccCCCceeccc
Confidence 9999998764 4689999999999999999999998 9999999999999987 78899999999986543
Q ss_pred CCCccccccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
... ......|+..|+|||++. ...++.++||||||+++|||++|+.|+....... ...........
T Consensus 164 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--------~~~~~~~~~~~ 234 (272)
T cd06637 164 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPRNPAP 234 (272)
T ss_pred ccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhcCCCC
Confidence 222 222345888999999986 3467889999999999999999999985322110 00000000000
Q ss_pred CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..........+.+++.+||+.+|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11122345688999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=264.84 Aligned_cols=235 Identities=22% Similarity=0.304 Sum_probs=185.0
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
+++++.+.+... +..+++|.++.. .....+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++.
T Consensus 13 ~g~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 90 (255)
T cd08219 13 FGRALLVQHVNS--DQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIK 90 (255)
T ss_pred CeEEEEEEEcCC--CceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHH
Confidence 334444444333 346788876432 23345678899999999999999999999999999999999999999999886
Q ss_pred cC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 527 RQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 527 ~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
.. ..++......++.|++.||.|||+. +++|+||||+||+++. ++.++++|||++......... ...
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~-------~~~~~l~dfg~~~~~~~~~~~-~~~ 159 (255)
T cd08219 91 LQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQ-------NGKVKLGDFGSARLLTSPGAY-ACT 159 (255)
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECC-------CCcEEEcccCcceeecccccc-ccc
Confidence 43 4578999999999999999999999 9999999999999987 788999999999765433221 122
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFERI 682 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 682 (725)
..++..|+|||.+.+..++.++|+||||+++++|++|+.|+..... ......... ....+......+
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 228 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----------KNLILKVCQGSYKPLPSHYSYEL 228 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----------HHHHHHHhcCCCCCCCcccCHHH
Confidence 4588899999999988999999999999999999999999864321 111111111 112334456778
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+++.+||+.||++||++.+++..
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=300.04 Aligned_cols=248 Identities=23% Similarity=0.270 Sum_probs=188.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+++.+++|.+... +..||+|.+.... ....+.|.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 12 kGgfG~VYlA~d~~t--g~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL 89 (932)
T PRK13184 12 KGGMGEVYLAYDPVC--SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTL 89 (932)
T ss_pred cCCCEEEEEEEECCC--CcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCH
Confidence 345667777765544 4578999886432 22346799999999999999999999999999999999999999999
Q ss_pred hhhhccC-----------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccC
Q 039817 522 SAFLFRQ-----------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590 (725)
Q Consensus 522 ~~~l~~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgl 590 (725)
.+++... ...++..+++++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~-------dg~vKLiDFGL 159 (932)
T PRK13184 90 KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGL-------FGEVVILDWGA 159 (932)
T ss_pred HHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcC-------CCCEEEEecCc
Confidence 9988531 2346778899999999999999999 9999999999999987 78899999999
Q ss_pred ccccCcCCC-----------------ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcc
Q 039817 591 AKLLKKDQT-----------------RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEP 653 (725)
Q Consensus 591 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~ 653 (725)
++....... .......||+.|+|||.+.+..++.++||||||++++||++|+.|+........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 986521110 001124589999999999999999999999999999999999999865322110
Q ss_pred ccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcCCC
Q 039817 654 TLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP-SMKQVLQMLEGTS 711 (725)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~ 711 (725)
.......... ........++.+.+++.+|++.||++|| +++++++.|+...
T Consensus 240 ------~~~~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 240 ------SYRDVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred ------hhhhhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000000000 0001123456788999999999999996 6777877776654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.80 Aligned_cols=236 Identities=23% Similarity=0.271 Sum_probs=181.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-----CccHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-----GDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNG 519 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~g 519 (725)
+++.++++.+... +..+++|.+.... ....+.+.+|+.++++++|+||+++++++.+ +...++++||++++
T Consensus 14 ~~g~vy~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~ 91 (266)
T cd06651 14 AFGRVYLCYDVDT--GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGG 91 (266)
T ss_pred CCEEEEEEEEcCC--CcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCC
Confidence 4455555555444 3467788765322 1233568899999999999999999999875 35778999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.+...+++.....++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++.......
T Consensus 92 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~-------~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 92 SVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDS-------AGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECC-------CCCEEEccCCCccccccccc
Confidence 9999998877889999999999999999999998 9999999999999987 78899999999876532211
Q ss_pred --ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH---cCCC
Q 039817 600 --RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR---TGNL 674 (725)
Q Consensus 600 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 674 (725)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........ ...+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~ 230 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----------AAIFKIATQPTNPQL 230 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----------HHHHHHhcCCCCCCC
Confidence 1112244788999999999888999999999999999999999998643111 11111111 1223
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+....+.+..++ +|+..+|++||+++||+++
T Consensus 231 ~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 231 PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 334456677776 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=265.11 Aligned_cols=236 Identities=23% Similarity=0.316 Sum_probs=187.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+++++.+.+..+ +..+++|.+... .....+++.+|++++++++|+||+++++++...+..++||||+++++|.++
T Consensus 12 ~~g~~~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 89 (256)
T cd08218 12 SFGKAILVKSKED--GKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKK 89 (256)
T ss_pred CceEEEEEEEcCC--CCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHH
Confidence 3444444444433 357888887532 233456899999999999999999999999999999999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.++|+|||++......... .
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~-------~~~~~l~d~~~~~~~~~~~~~-~ 158 (256)
T cd08218 90 INAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTK-------DGTIKLGDFGIARVLNSTVEL-A 158 (256)
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcC-------CCCEEEeeccceeecCcchhh-h
Confidence 8754 3578999999999999999999998 9999999999999987 778999999999865443221 1
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFE 680 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 680 (725)
....++..|+|||++.+...+.++|+||||++++||++|+.|+..... .+.+...... ...+.....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----------KNLVLKIIRGSYPPVSSHYSY 227 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----------HHHHHHHhcCCCCCCcccCCH
Confidence 223478889999999988999999999999999999999998864321 1112221111 123345567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+++.+|++.+|.+||++.+|+++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 228 DLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 89999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=268.57 Aligned_cols=241 Identities=26% Similarity=0.301 Sum_probs=187.1
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|++++.+.+..+ +..+|||.+.... ....+.+.+|+.++++++|+|++++++.+..++..++||||+++++|.
T Consensus 11 G~~g~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~ 88 (285)
T cd05630 11 GGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88 (285)
T ss_pred CCCeEEEEEEEcCC--CceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHH
Confidence 34555655555544 3578888875432 222356789999999999999999999999999999999999999999
Q ss_pred hhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 523 AFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 523 ~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.++|+|||++........
T Consensus 89 ~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~-------~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 89 FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDD-------HGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECC-------CCCEEEeeccceeecCCCcc-
Confidence 998644 4588999999999999999999998 9999999999999987 77899999999876543221
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+........ .......... . ....+.....
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----~~~~~~~~~~-~-~~~~~~~~~~ 230 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKE-V-QEEYSEKFSP 230 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----HHHHHhhhhh-h-hhhcCccCCH
Confidence 1223589999999999999999999999999999999999999975322110 0000111111 1 1123344567
Q ss_pred HHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
.+.+++..||+.||++||| ++|++++
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 7899999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.44 Aligned_cols=239 Identities=21% Similarity=0.264 Sum_probs=187.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
.++.++++.+..+ +..|++|.+........+.+.+|+.++++++|+||+++++++..++..++||||+++++|.+++.
T Consensus 31 ~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 108 (297)
T cd06656 31 ASGTVYTAIDIAT--GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 108 (297)
T ss_pred CCeEEEEEEECCC--CCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH
Confidence 3445555554333 45788898865555556778999999999999999999999999999999999999999999985
Q ss_pred cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccc
Q 039817 527 RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606 (725)
Q Consensus 527 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 606 (725)
+ ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++......... .....
T Consensus 109 ~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~-------~~~~~l~Dfg~~~~~~~~~~~-~~~~~ 176 (297)
T cd06656 109 E-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGM-------DGSVKLTDFGFCAQITPEQSK-RSTMV 176 (297)
T ss_pred h-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCCEEECcCccceEccCCccC-cCccc
Confidence 4 4578999999999999999999998 9999999999999987 789999999998765433221 12234
Q ss_pred cCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHH
Q 039817 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG 686 (725)
Q Consensus 607 gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 686 (725)
++..|+|||.+.+..++.++||||||+++|++++|+.|+........... ...........+......+.+++
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------eccCCCCCCCCccccCHHHHHHH
Confidence 78899999999988899999999999999999999999865432111000 00000000112234456788999
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 039817 687 LWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 687 ~~cl~~dp~~RPs~~evl~~ 706 (725)
.+||+.+|++||++++++++
T Consensus 250 ~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=269.73 Aligned_cols=245 Identities=22% Similarity=0.233 Sum_probs=183.2
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
++.++++.+..+ +..|++|.+.... ....+.+.+|++++++++|+||+++++++..+...++||||+++++|..++
T Consensus 14 ~~~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~ 91 (286)
T cd07847 14 YGVVFKCRNRET--GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELE 91 (286)
T ss_pred CeEEEEEEECCC--CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHH
Confidence 444555544333 4578888775332 234467889999999999999999999999999999999999999999888
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.....+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++......... ....
T Consensus 92 ~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~~~~~~~-~~~~ 160 (286)
T cd07847 92 KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITK-------QGQIKLCDFGFARILTGPGDD-YTDY 160 (286)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcC-------CCcEEECccccceecCCCccc-ccCc
Confidence 7777899999999999999999999998 9999999999999987 788999999999876543221 1123
Q ss_pred ccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc----CcchHHHHHHHHHcC------CC
Q 039817 606 RGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTG------NL 674 (725)
Q Consensus 606 ~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~------~~ 674 (725)
.++..|+|||.+.+ ..++.++||||||++++||++|+.|+......+..... ...... ........ ..
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-HQQIFSTNQFFKGLSI 239 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH-HhhhcccccccccccC
Confidence 46788999999876 56789999999999999999999998643321100000 000000 00000000 00
Q ss_pred ------------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 ------------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ------------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......+.+++.+||+.+|++||++.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 01234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=267.88 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=187.0
Q ss_pred cccHHHHHHHhcccC-CcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC------ceeeeeec
Q 039817 445 VFSYQELREATNVFD-GQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN------HQLLVYEL 515 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~-~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~e~ 515 (725)
...++.+++|..... +.+..||||.+... .....+++.+|++++++++||||+++++++.... ..++++||
T Consensus 9 ~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (273)
T cd05074 9 KGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPF 88 (273)
T ss_pred CCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEec
Confidence 345566776665433 45678999988643 2334567899999999999999999999986542 24789999
Q ss_pred ccCCChhhhhccC------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeecc
Q 039817 516 MKNGTLSAFLFRQ------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589 (725)
Q Consensus 516 ~~~gsL~~~l~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfg 589 (725)
+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 89 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~-------~~~~kl~dfg 158 (273)
T cd05074 89 MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNE-------NMTVCVADFG 158 (273)
T ss_pred CCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcC-------CCCEEECccc
Confidence 9999999887532 2468899999999999999999998 9999999999999977 7889999999
Q ss_pred CccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHH
Q 039817 590 LAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLY 667 (725)
Q Consensus 590 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (725)
+++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.|+..... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~ 230 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYLIK 230 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHHHc
Confidence 99865432211 1122335678999999998889999999999999999999 6676643211 011111110
Q ss_pred HHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 668 CVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 668 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
. .....+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 231 ~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 G-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01122234567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=265.77 Aligned_cols=236 Identities=22% Similarity=0.289 Sum_probs=186.3
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
|+.++.|.+... +..|++|.+.... ......+.+|+.++++++|+||+++++.+..+...++||||+++++|.+++.
T Consensus 17 ~~~vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~ 94 (277)
T cd06640 17 FGEVFKGIDNRT--QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR 94 (277)
T ss_pred CeEEEEEEEccC--CEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh
Confidence 444444544333 4578888876432 3445678999999999999999999999999999999999999999999986
Q ss_pred cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccc
Q 039817 527 RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606 (725)
Q Consensus 527 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 606 (725)
. ..+++.....++.|++.||.|||+. +++|+||+|+||+++. ++.++|+|||++......... .....
T Consensus 95 ~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~-------~~~~~l~dfg~~~~~~~~~~~-~~~~~ 162 (277)
T cd06640 95 A-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSE-------QGDVKLADFGVAGQLTDTQIK-RNTFV 162 (277)
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcC-------CCCEEEcccccceeccCCccc-ccccc
Confidence 4 5688899999999999999999998 9999999999999987 778999999999765433221 22234
Q ss_pred cCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHH
Q 039817 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG 686 (725)
Q Consensus 607 gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 686 (725)
++..|+|||.+.+..++.++||||||+++|||++|..|+........ .... .......+....+..+.+++
T Consensus 163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~li 233 (277)
T cd06640 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------LFLI-PKNNPPTLTGEFSKPFKEFI 233 (277)
T ss_pred CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------hhhh-hcCCCCCCchhhhHHHHHHH
Confidence 78889999999888899999999999999999999998864321110 0000 00011223335677899999
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 039817 687 LWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 687 ~~cl~~dp~~RPs~~evl~~ 706 (725)
.+||+.+|++||++++++++
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHcccCcccCcCHHHHHhC
Confidence 99999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=263.65 Aligned_cols=236 Identities=26% Similarity=0.328 Sum_probs=189.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-----CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-----GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..++.+++|++..+ +..|++|.+.... .+..+.+.+|++++++++|+||+++++++..+...++|+||+++++
T Consensus 11 g~~~~vy~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (258)
T cd06632 11 GSFGSVYEGLNLDD--GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88 (258)
T ss_pred cCCceEEEEEEcCC--CcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCc
Confidence 34556666665433 3568888775432 2345679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++.......
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~-------~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 89 LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDT-------NGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCCEEEccCccceeccccc--
Confidence 999998877789999999999999999999998 9999999999999987 7899999999988654332
Q ss_pred cccccccCccccchhcccCCC-CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH---HcCCCCh
Q 039817 601 TSTMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV---RTGNLGA 676 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 676 (725)
......++..|+|||.+.... ++.++|+||||+++++|++|+.|+..... .+...... .....+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~ 225 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----------VAAVFKIGRSKELPPIPD 225 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----------HHHHHHHHhcccCCCcCC
Confidence 122345788899999987766 89999999999999999999999864321 11111111 1123344
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+.+.+++.+||+.+|.+||++++++++
T Consensus 226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 226 HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 556789999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=277.22 Aligned_cols=189 Identities=26% Similarity=0.353 Sum_probs=159.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-cC-----CccceeeEEEcCCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HK-----NLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...+|+.|.+|++..++ ..||||++++. ..-..+-..|+.+|..|+ |. |+|++++++...++.|||+|.++
T Consensus 195 GkGtFGQVvk~~d~~T~--e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~ 271 (586)
T KOG0667|consen 195 GKGSFGQVVKAYDHKTG--EIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS 271 (586)
T ss_pred cccccceeEEEEecCCC--cEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh
Confidence 45678888888887665 57888888764 334556678999999986 43 89999999999999999999997
Q ss_pred CCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 518 NGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 518 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
. +|.++|..+ ..++...+..|+.||+.||..||+. +|||+||||+||||.+-. ...+||+|||.++...
T Consensus 272 ~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~-----r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 272 T-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPK-----RSRIKVIDFGSSCFES 342 (586)
T ss_pred h-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCC-----cCceeEEecccccccC
Confidence 6 999999876 5688999999999999999999999 999999999999997632 5589999999998754
Q ss_pred cCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCC
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELH 648 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~ 648 (725)
.... ....+..|+|||++.+.+|+.+.|+||||||+.||++|.+.|...
T Consensus 343 q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 343 QRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred Ccce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 3322 234677899999999999999999999999999999998877543
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=269.17 Aligned_cols=236 Identities=23% Similarity=0.292 Sum_probs=184.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
.++.++++.+..+ +..+++|.+........+.+.+|++++++++|+||+++++.+..++..++||||+++++|..++.
T Consensus 24 ~~g~vy~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 101 (292)
T cd06644 24 AFGKVYKAKNKET--GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIML 101 (292)
T ss_pred CCeEEEEEEECCC--CceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHH
Confidence 4445555544333 35788888876656667789999999999999999999999999999999999999999998876
Q ss_pred cC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 527 RQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 527 ~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
+. ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++........ .....
T Consensus 102 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~-------~~~~kl~dfg~~~~~~~~~~-~~~~~ 170 (292)
T cd06644 102 ELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTL-------DGDIKLADFGVSAKNVKTLQ-RRDSF 170 (292)
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcC-------CCCEEEccCccceecccccc-cccee
Confidence 53 5689999999999999999999998 9999999999999976 78899999999875432211 11234
Q ss_pred ccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CCCh
Q 039817 606 RGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NLGA 676 (725)
Q Consensus 606 ~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 676 (725)
.++..|+|||.+. ...++.++||||||+++|||++|+.|+...... .......... ..+.
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----------RVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----------HHHHHHhcCCCccCCCCc
Confidence 4788999999984 345788999999999999999999988643211 1111111111 1123
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+.+++.+||+.+|++||++++++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 445678999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=272.44 Aligned_cols=248 Identities=19% Similarity=0.245 Sum_probs=183.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+|+.++++++..+ +..||+|.++... ......+.+|++++++++|+||+++++++..++..++||||+++ +|.+
T Consensus 16 ~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~ 92 (309)
T cd07872 16 EGTYATVFKGRSKLT--ENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQ 92 (309)
T ss_pred ccCCEEEEEEEecCC--CCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHH
Confidence 345666776665444 3468888876432 23345688999999999999999999999999999999999986 8888
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++........ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~~-~ 161 (309)
T cd07872 93 YMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINE-------RGELKLADFGLARAKSVPTKT-Y 161 (309)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC-------CCCEEECccccceecCCCccc-c
Confidence 87654 4578999999999999999999999 9999999999999987 788999999999764332221 1
Q ss_pred cccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----cCcchHHHH-------HHHH
Q 039817 603 TMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----NGMILTDWV-------LYCV 669 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----~~~~~~~~~-------~~~~ 669 (725)
....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+.... .......|- ....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 22347889999998865 4688999999999999999999999865432110000 000000000 0000
Q ss_pred HcCC--------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 RTGN--------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~~~~--------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... ......+.+.+++.+|++.||.+|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 001235678899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=266.67 Aligned_cols=241 Identities=23% Similarity=0.336 Sum_probs=186.7
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~ 522 (725)
.++.++++.+..++ ..+++|.+.. ......+.+.+|++++++++|+||+++++++.. +...+++|||+++++|.
T Consensus 12 ~~~~v~~~~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~ 89 (265)
T cd08217 12 SFGTVRKVRRKSDG--KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLA 89 (265)
T ss_pred CCeEEEEeeecCCC--CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHH
Confidence 45555666555444 4677787753 233445678899999999999999999998764 45678999999999999
Q ss_pred hhhcc----CCCCCHHHHHHHHHHHHHHhhhhhccc--CCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 523 AFLFR----QEIPTWDKRVEIALGIARGLLYLHEEC--ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 523 ~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+++.. ...+++..++.++.|++.||.|||..+ ..+++|+||+|+||+++. ++.+||+|||++.....
T Consensus 90 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~-------~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 90 QLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA-------NNNVKLGDFGLAKILGH 162 (265)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec-------CCCEEEecccccccccC
Confidence 99865 357899999999999999999999221 229999999999999987 78999999999987654
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
.... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... .+.+.... .....++.
T Consensus 163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~ 232 (265)
T cd08217 163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIKE-GKFRRIPY 232 (265)
T ss_pred Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHhc-CCCCCCcc
Confidence 4321 12235788999999999888999999999999999999999998753211 11111111 01123444
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+.+++.+|++.+|++||++.+|+++
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 567889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=258.41 Aligned_cols=251 Identities=23% Similarity=0.225 Sum_probs=187.8
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCC-ccceeeEEEcCC------ceeeeeec
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKN-LVQLLGFCIEQN------HQLLVYEL 515 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~~lV~e~ 515 (725)
..+|+.+++|...-+| ..||+|++.-... .......+|+.++++++|+| ||+|++++...+ ..++|+||
T Consensus 21 eGtyg~Vykar~~~~g--~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~ 98 (323)
T KOG0594|consen 21 EGTYGVVYKARSKRTG--KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF 98 (323)
T ss_pred CCCceEEEEEEEecCC--CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence 4567777777777666 5677777653322 24456789999999999999 999999999877 78899999
Q ss_pred ccCCChhhhhccCC----CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 516 MKNGTLSAFLFRQE----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 516 ~~~gsL~~~l~~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
++. +|.+++.... .++...+..++.|+++||+|||+. +|+||||||+||||++ .+.+||+|||+|
T Consensus 99 ~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~-------~G~lKlaDFGlA 167 (323)
T KOG0594|consen 99 LDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISS-------SGVLKLADFGLA 167 (323)
T ss_pred ecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECC-------CCcEeeeccchH
Confidence 976 8999987653 467788999999999999999999 9999999999999988 899999999999
Q ss_pred cccCcCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--------------cc
Q 039817 592 KLLKKDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--------------LA 656 (725)
Q Consensus 592 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--------------~~ 656 (725)
+.+.-.... .+...+|.-|.|||.+.+. .|+...||||+||++.||++++..|.......+. ..
T Consensus 168 ra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 966533222 3345588899999999876 7999999999999999999988887654321100 00
Q ss_pred cCcchHHHHHHHHHcCCCCh-------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCC
Q 039817 657 NGMILTDWVLYCVRTGNLGA-------TKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGT 710 (725)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~ 710 (725)
....+.++-.. +....-+. .......+++.+|++.+|.+|.|++.++.| +..+
T Consensus 247 ~v~~~~~~k~~-f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAP-FPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred Ccccccccccc-CcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00000000000 00000000 112468889999999999999999999987 5543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=273.04 Aligned_cols=238 Identities=22% Similarity=0.221 Sum_probs=181.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|++|+.+....+ +..||+|.+.+. .....+.|.+|+.++..++|+||+++++++.+++..++||||+++|+|.
T Consensus 12 G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (331)
T cd05597 12 GAFGEVAVVKMKNT--GQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLL 89 (331)
T ss_pred cCCeEEEEEEECCC--CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHH
Confidence 34555555554443 357889988542 2233456889999999999999999999999999999999999999999
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++..........
T Consensus 90 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 90 TLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDK-------NGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECC-------CCCEEEEECCceeecCCCCCcc
Confidence 99976 45789999999999999999999999 9999999999999987 7899999999987654433322
Q ss_pred ccccccCccccchhcccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CC
Q 039817 602 STMIRGTMGYMAPEWLRN-----APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GN 673 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 673 (725)
.....||+.|+|||.+.. ..++.++||||||+++|||++|+.||...... +........ ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----------~~~~~i~~~~~~~~ 228 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----------ETYGKIMNHKEHFQ 228 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----------HHHHHHHcCCCccc
Confidence 233458999999999863 45788999999999999999999998643211 111111110 11
Q ss_pred CC---hhHHHHHHHHHHHccCCCCC--CCCCHHHHHHH
Q 039817 674 LG---ATKFERITMVGLWCICPQPT--LRPSMKQVLQM 706 (725)
Q Consensus 674 ~~---~~~~~~l~~l~~~cl~~dp~--~RPs~~evl~~ 706 (725)
++ ...++.+.+++.+|+..+++ .||++++++++
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11 12466788888887765443 48899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=267.62 Aligned_cols=234 Identities=21% Similarity=0.310 Sum_probs=185.7
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR 527 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 527 (725)
++.++.+.+.. .+..+++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.+++..
T Consensus 32 ~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 109 (285)
T cd06648 32 TGIVCIATDKS--TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH 109 (285)
T ss_pred CeEEEEEEECC--CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh
Confidence 34444444332 2357888887655455567789999999999999999999999999999999999999999999976
Q ss_pred CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccccc
Q 039817 528 QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRG 607 (725)
Q Consensus 528 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 607 (725)
..+++..+..++.|++.||+|||+. +++||||+|+||+++. ++.+||+|||++......... .....|
T Consensus 110 -~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~~l~d~g~~~~~~~~~~~-~~~~~~ 177 (285)
T cd06648 110 -TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTS-------DGRVKLSDFGFCAQVSKEVPR-RKSLVG 177 (285)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcC-------CCcEEEcccccchhhccCCcc-cccccC
Confidence 5689999999999999999999999 9999999999999987 789999999988755433221 122448
Q ss_pred CccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCC--ChhHHHHHH
Q 039817 608 TMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNL--GATKFERIT 683 (725)
Q Consensus 608 t~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~l~ 683 (725)
+..|+|||.+.+..++.++||||||++++||++|+.|+...... ......... ... .......+.
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----------QAMKRIRDNLPPKLKNLHKVSPRLR 246 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----------HHHHHHHhcCCCCCcccccCCHHHH
Confidence 88999999998888999999999999999999999998642211 111111111 111 112457899
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 039817 684 MVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 684 ~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+++.+||+.+|++||++.+++++
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 247 SFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHHcccChhhCcCHHHHccC
Confidence 99999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=271.21 Aligned_cols=239 Identities=18% Similarity=0.176 Sum_probs=183.9
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
|+.++.+.+... +..|++|.+.... ....+.+.+|++++++++|+||+++++.+..++..++||||+++++|.++
T Consensus 14 ~~~v~~~~~~~~--~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~ 91 (305)
T cd05609 14 YGAVYLVRHKET--RQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATL 91 (305)
T ss_pred CeeEEEEEECCC--CcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHH
Confidence 334444444333 3568888775432 23345788999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC------
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ------ 598 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~------ 598 (725)
+.....+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++......
T Consensus 92 l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~-------~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (305)
T cd05609 92 LKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITS-------MGHIKLTDFGLSKIGLMSLTTNLYE 161 (305)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECC-------CCCEEEeeCCCccccCcCccccccc
Confidence 98878899999999999999999999998 9999999999999987 7899999999987421100
Q ss_pred --------CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH
Q 039817 599 --------TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670 (725)
Q Consensus 599 --------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (725)
........++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----------~~~~~~~~~ 230 (305)
T cd05609 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----------EELFGQVIS 230 (305)
T ss_pred cccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHh
Confidence 0011123477889999999888899999999999999999999999863321 111111111
Q ss_pred c----CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 671 T----GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 671 ~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
. .......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 11111346778999999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=277.39 Aligned_cols=245 Identities=23% Similarity=0.236 Sum_probs=179.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC------ceeeeeeccc
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN------HQLLVYELMK 517 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~e~~~ 517 (725)
..|+.++.+.+... +..||||.+... .......+.+|+.++++++||||+++++++...+ ..++||||++
T Consensus 32 G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (359)
T cd07876 32 GAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD 109 (359)
T ss_pred CCCEEEEEEEEcCC--CceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC
Confidence 34556666655433 457899988542 2334567889999999999999999999987543 4699999997
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+ +|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 110 ~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~-------~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 110 A-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS-------DCTLKILDFGLARTACTN 176 (359)
T ss_pred c-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECC-------CCCEEEecCCCccccccC
Confidence 6 5666553 3478889999999999999999999 9999999999999987 789999999999764332
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc------cc-cCcch----HHHHH
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT------LA-NGMIL----TDWVL 666 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~------~~-~~~~~----~~~~~ 666 (725)
.. .....+|..|+|||.+.+..++.++||||||+++|||++|+.||......... .. ..... ...+.
T Consensus 177 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 177 FM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred cc--CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 21 22345889999999999999999999999999999999999999754221100 00 00000 00011
Q ss_pred HHHHc-CC--------------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 667 YCVRT-GN--------------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 667 ~~~~~-~~--------------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
..... .. ......+.+.+++.+||+.||++|||+.|++++-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 11000 00 0011245689999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=263.20 Aligned_cols=235 Identities=21% Similarity=0.235 Sum_probs=187.8
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
++.++.+++.. .+..+++|.+.... ....+.+.+|++++++++|+||+++++.+..+...++|+||+++++|.++
T Consensus 6 ~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 83 (262)
T cd05572 6 FGRVELVKVKS--KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTI 83 (262)
T ss_pred ceEEEEEEECC--CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHH
Confidence 33444444433 34578888875432 23456799999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.+...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++....... ....
T Consensus 84 l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~-------~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 84 LRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDS-------NGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcC-------CCCEEEeeCCcccccCccc--cccc
Confidence 98887899999999999999999999998 9999999999999987 7899999999998765432 1122
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH---HHcCCCChhHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC---VRTGNLGATKFER 681 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 681 (725)
..++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+. .+..... ......+....+.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 222 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---------MEIYNDILKGNGKLEFPNYIDKA 222 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---------HHHHHHHhccCCCCCCCcccCHH
Confidence 457889999999988889999999999999999999999987543211 1111111 1122344445688
Q ss_pred HHHHHHHccCCCCCCCCC-----HHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPS-----MKQVLQ 705 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs-----~~evl~ 705 (725)
+.+++.+||+.+|++||+ ++|+++
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=279.33 Aligned_cols=239 Identities=20% Similarity=0.226 Sum_probs=182.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|+.|+.+.+..+ +..||+|.+... .......+.+|++++.+++|+||+++++.+..++..++||||+++|+|.+
T Consensus 13 ~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~ 90 (360)
T cd05627 13 AFGEVRLVQKKDT--GHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMT 90 (360)
T ss_pred CCEEEEEEEECCC--CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHH
Confidence 4455555554433 457888887542 23345678899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC----
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT---- 599 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~---- 599 (725)
++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 91 ~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~-------~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 91 LLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDA-------KGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECC-------CCCEEEeeccCCcccccccccccc
Confidence 998888899999999999999999999999 9999999999999987 78999999999875432110
Q ss_pred ------------------------------ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCC
Q 039817 600 ------------------------------RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHR 649 (725)
Q Consensus 600 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~ 649 (725)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00112458999999999999999999999999999999999999996543
Q ss_pred CCccccccCcchHHHHHHHHHcCCCCh--hHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 039817 650 VDEPTLANGMILTDWVLYCVRTGNLGA--TKFERITMVGLWCICPQPTLRPS---MKQVLQM 706 (725)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~ 706 (725)
... ....+........++. ...+.+.+++.+++ .+|.+|++ +.|+++|
T Consensus 241 ~~~--------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQE--------TYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHH--------HHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 211 0000110000011121 24567888888876 49999984 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=263.09 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=183.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc----------cCccHHHHHHHHHHHhc-cCcCCccceeeEEEcCCceeeeeec
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV----------TGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYEL 515 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~----------~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~ 515 (725)
.++.++.+..... .+..+++|.+... .......+.+|+.++.+ ++|+||+++++++.+++..++||||
T Consensus 12 ~~~~v~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 90 (269)
T cd08528 12 AFGCVYKVRKKNN-GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDL 90 (269)
T ss_pred CCceEEEEEEcCC-CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEec
Confidence 3444444444331 2357788876421 12234557889988875 7999999999999999999999999
Q ss_pred ccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccC
Q 039817 516 MKNGTLSAFLFR----QEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590 (725)
Q Consensus 516 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgl 590 (725)
+++++|.+++.. ...+++..++.++.|++.||.|||+ . +++|+||+|+||+++. ++.+||+|||+
T Consensus 91 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~-------~~~~~l~dfg~ 160 (269)
T cd08528 91 IEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGE-------DDKVTITDFGL 160 (269)
T ss_pred CCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECC-------CCcEEEecccc
Confidence 999999988743 3568899999999999999999996 5 7999999999999987 78999999999
Q ss_pred ccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH
Q 039817 591 AKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670 (725)
Q Consensus 591 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (725)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIVEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHhhccC
Confidence 98754432 223345888999999999888999999999999999999999987533211 01111111000
Q ss_pred cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 671 TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 671 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
.........+.+.+++.+|++.||++||++.||..+|+
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00111134578999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=264.37 Aligned_cols=227 Identities=26% Similarity=0.369 Sum_probs=183.5
Q ss_pred cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHH
Q 039817 461 QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVE 538 (725)
Q Consensus 461 ~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~ 538 (725)
.+..+++|.+.... ....+++.+|++++++++|+||+++++.+..++..++|+||+++++|.+++... ..++......
T Consensus 25 ~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 104 (265)
T cd06605 25 TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK 104 (265)
T ss_pred CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHH
Confidence 34678888876543 344567999999999999999999999999999999999999999999999876 7789999999
Q ss_pred HHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcc
Q 039817 539 IALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617 (725)
Q Consensus 539 i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 617 (725)
++.|++.||.|||+ . +++|+||||+||+++. ++.+||+|||.+......... ...++..|+|||.+
T Consensus 105 ~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~-------~~~~~l~d~g~~~~~~~~~~~---~~~~~~~y~~PE~~ 171 (265)
T cd06605 105 IAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNS-------RGQIKLCDFGVSGQLVNSLAK---TFVGTSSYMAPERI 171 (265)
T ss_pred HHHHHHHHHHHHcCCC---CeecCCCCHHHEEECC-------CCCEEEeecccchhhHHHHhh---cccCChhccCHHHH
Confidence 99999999999999 7 9999999999999987 788999999998765332211 14578899999999
Q ss_pred cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCChh-HHHHHHHHHHHccCCCC
Q 039817 618 RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLGAT-KFERITMVGLWCICPQP 694 (725)
Q Consensus 618 ~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~l~~l~~~cl~~dp 694 (725)
.+..++.++||||||+++++|++|+.|+....... ....+.+....... ..+.. ....+.+++.+|+..+|
T Consensus 172 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 245 (265)
T cd06605 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP------DGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDP 245 (265)
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc------ccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCc
Confidence 98899999999999999999999999986542211 11122222221111 12222 56779999999999999
Q ss_pred CCCCCHHHHHHH
Q 039817 695 TLRPSMKQVLQM 706 (725)
Q Consensus 695 ~~RPs~~evl~~ 706 (725)
++|||+.+++++
T Consensus 246 ~~Rpt~~~ll~~ 257 (265)
T cd06605 246 RERPSYKELLEH 257 (265)
T ss_pred hhCcCHHHHhhC
Confidence 999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=272.82 Aligned_cols=237 Identities=21% Similarity=0.232 Sum_probs=181.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.|++|+.+... +.+..+|+|.+.+. .......|.+|+.++..++|+||+++++.+..++..++||||+++|+|.+
T Consensus 13 ~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~ 90 (332)
T cd05623 13 AFGEVAVVKLK--NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLT 90 (332)
T ss_pred CCeEEEEEEEC--CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHH
Confidence 34444444433 23457888887532 22234458899999999999999999999999999999999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++...........
T Consensus 91 ~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~-------~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 91 LLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDM-------NGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECC-------CCCEEEeecchheecccCCccee
Confidence 99763 6789999999999999999999999 9999999999999987 78899999999976543333223
Q ss_pred cccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCC
Q 039817 603 TMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNL 674 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 674 (725)
....||+.|+|||++. ...++.++||||||+++|||++|+.||...... +........ ...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----------~~~~~i~~~~~~~~~ 229 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----------ETYGKIMNHKERFQF 229 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----------HHHHHHhCCCccccC
Confidence 3356899999999986 346889999999999999999999998643211 111111110 111
Q ss_pred C---hhHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 039817 675 G---ATKFERITMVGLWCICPQPTL--RPSMKQVLQM 706 (725)
Q Consensus 675 ~---~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 706 (725)
+ ....+.+.+++.+|+..++.+ |++++|++++
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1 234667888999888654444 6899999888
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=279.54 Aligned_cols=230 Identities=27% Similarity=0.373 Sum_probs=188.4
Q ss_pred ceEEEEEEccc-ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHHH
Q 039817 462 EVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEI 539 (725)
Q Consensus 462 ~~~vavk~l~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i 539 (725)
+.+||||.+.. ...+..++|++|+-+|.+++||||++|+|+|.... ..||++||+.|+|.+|++.+ ..+-.+..+.|
T Consensus 725 KipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw 803 (1177)
T KOG1025|consen 725 KIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNW 803 (1177)
T ss_pred cceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHH
Confidence 35889998864 34556789999999999999999999999998876 88999999999999999765 57888999999
Q ss_pred HHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc-ccccCccccchhccc
Q 039817 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST-MIRGTMGYMAPEWLR 618 (725)
Q Consensus 540 ~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~ 618 (725)
..|||+||.|||++ +++||||.++|+||.. -..+||.|||+++....+...-.. ...-.+.|||-|.+.
T Consensus 804 ~~QIAkgM~YLe~q---rlVHrdLaaRNVLVks-------P~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~ 873 (1177)
T KOG1025|consen 804 CYQIAKGMKYLEEQ---RLVHRDLAARNVLVKS-------PNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR 873 (1177)
T ss_pred HHHHHHHHHHHHhc---chhhhhhhhhheeecC-------CCeEEEEecchhhccCcccccccccccccCcHHHHHHHhh
Confidence 99999999999999 9999999999999987 778999999999988765544332 233467899999999
Q ss_pred CCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCC
Q 039817 619 NAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLR 697 (725)
Q Consensus 619 ~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 697 (725)
...++.++|||||||.+||++| |..|++....++ +.+.++.-. +-.-|......+..++.+||..|+..|
T Consensus 874 ~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~ge-RLsqPpiCtiDVy~~mvkCwmid~~~r 944 (1177)
T KOG1025|consen 874 IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGE-RLSQPPICTIDVYMVMVKCWMIDADSR 944 (1177)
T ss_pred ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhccc-cCCCCCCccHHHHHHHHHHhccCcccC
Confidence 9999999999999999999997 777776432211 122222111 123445667788999999999999999
Q ss_pred CCHHHHHHHhcCCC
Q 039817 698 PSMKQVLQMLEGTS 711 (725)
Q Consensus 698 Ps~~evl~~L~~~~ 711 (725)
|+++++...+....
T Consensus 945 p~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 945 PTFKELAEEFSRMA 958 (1177)
T ss_pred ccHHHHHHHHHHHh
Confidence 99999998886543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=273.16 Aligned_cols=238 Identities=21% Similarity=0.228 Sum_probs=183.1
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|++++.+.+... +..+|+|.+... .......+.+|+.++..++|+||+++++++..++..++||||+++|+|.
T Consensus 12 G~fg~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~ 89 (331)
T cd05624 12 GAFGEVAVVKMKHT--ERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLL 89 (331)
T ss_pred CCCeEEEEEEECCC--CCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHH
Confidence 34555555544433 456888887542 2223455889999999999999999999999999999999999999999
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++.+ ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.........
T Consensus 90 ~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~-------~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 90 TLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDM-------NGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcC-------CCCEEEEeccceeeccCCCcee
Confidence 99977 46789999999999999999999999 9999999999999987 7889999999998765443333
Q ss_pred ccccccCccccchhcccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CC
Q 039817 602 STMIRGTMGYMAPEWLRN-----APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GN 673 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 673 (725)
.....|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... +........ ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----------~~~~~i~~~~~~~~ 228 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----------ETYGKIMNHEERFQ 228 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----------HHHHHHHcCCCccc
Confidence 333568999999999875 46788999999999999999999998643211 111111110 11
Q ss_pred CC---hhHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 039817 674 LG---ATKFERITMVGLWCICPQPTL--RPSMKQVLQM 706 (725)
Q Consensus 674 ~~---~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 706 (725)
++ ...++.+.+++.+|+..++++ |+++++++++
T Consensus 229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11 134678889999998876554 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.06 Aligned_cols=248 Identities=23% Similarity=0.247 Sum_probs=186.9
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.++++.+.-+ +..|++|.+... .....+.+.+|++++++++|+||+++++++..++..++||||++++.|..+
T Consensus 13 ~~~~v~~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~ 90 (288)
T cd07833 13 AYGVVLKCRNKAT--GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELL 90 (288)
T ss_pred CCeeEEEEEeCCC--CcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHH
Confidence 3444555544333 457899987643 233457899999999999999999999999999999999999999888777
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.+...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++.............
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~-------~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 91 EASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSE-------SGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC-------CCCEEEEeeecccccCCCccccccC
Confidence 76667789999999999999999999999 9999999999999987 8899999999998765544322233
Q ss_pred cccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc----CcchHHHHH-------------
Q 039817 605 IRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVL------------- 666 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~----~~~~~~~~~------------- 666 (725)
..++..|+|||++.+. .++.++||||||+++|||++|+.++............ .........
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 4578889999999887 8899999999999999999999888643211000000 000000000
Q ss_pred -----HHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 -----YCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 -----~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........+...+..+.+++.+||+.+|++||++++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000001122336789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=249.86 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=205.6
Q ss_pred ccccHHHHHHHhcccCC--------------cceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCc
Q 039817 444 KVFSYQELREATNVFDG--------------QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNH 508 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~--------------~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 508 (725)
...+|.++++-|...-| .++++|||++++..+..+....+|++++.+.+ |+||++|+.+|+++..
T Consensus 71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 34568888888865443 34578999999888888999999999999985 9999999999999999
Q ss_pred eeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeec
Q 039817 509 QLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADF 588 (725)
Q Consensus 509 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Df 588 (725)
+|||||-|.+|+|..+|.+++.+++.+..++..+|+.||.+||.+ +|.|||+||+|||-... +.---+||+||
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~p----n~vsPvKiCDf 223 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESP----NKVSPVKICDF 223 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCC----CCcCceeeecc
Confidence 999999999999999999999999999999999999999999999 99999999999997652 22445899999
Q ss_pred cCccccC--cCCCcc----ccccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc
Q 039817 589 GLAKLLK--KDQTRT----STMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN 657 (725)
Q Consensus 589 gla~~~~--~~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~ 657 (725)
.|..-+. .+-+.. ....+|+..|||||+.. ...|+.+.|.||||||||-|++|..||.....++-....
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8875432 222211 22356889999999763 346899999999999999999999999887665443332
Q ss_pred Cc---chHHHHHHHHHcCCCCh------hHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 658 GM---ILTDWVLYCVRTGNLGA------TKFERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 658 ~~---~~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
+. .=.+.+.+.++.+.+.- ....+..+++...+..++.+|.++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22 22344555566665432 45667888999999999999999999987
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=265.94 Aligned_cols=221 Identities=23% Similarity=0.220 Sum_probs=182.1
Q ss_pred ceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHH
Q 039817 462 EVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE 538 (725)
Q Consensus 462 ~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~ 538 (725)
+..+++|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+++++|.+++.+...++...+..
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~ 105 (290)
T cd05580 26 GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF 105 (290)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHH
Confidence 4578888875422 2345678999999999999999999999999999999999999999999998888899999999
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhccc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 618 (725)
++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||+++..... .....++..|+|||.+.
T Consensus 106 ~~~qil~~l~~lH~~---~i~H~dl~p~nili~~-------~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~ 171 (290)
T cd05580 106 YAAQVVLALEYLHSL---DIVYRDLKPENLLLDS-------DGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIIL 171 (290)
T ss_pred HHHHHHHHHHHHHHC---CEecCCCCHHHEEECC-------CCCEEEeeCCCccccCCC----CCCCCCCccccChhhhc
Confidence 999999999999998 9999999999999987 788999999999876543 22345888999999998
Q ss_pred CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC
Q 039817 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP 698 (725)
Q Consensus 619 ~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 698 (725)
+...+.++||||||+++++|++|+.|+...... ...... ......++......+.+++.+||+.+|.+||
T Consensus 172 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKI--LEGKVRFPSFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH--hcCCccCCccCCHHHHHHHHHHccCCHHHcc
Confidence 888999999999999999999999998643210 000011 0112234445678899999999999999999
Q ss_pred -----CHHHHHHH
Q 039817 699 -----SMKQVLQM 706 (725)
Q Consensus 699 -----s~~evl~~ 706 (725)
+++|++++
T Consensus 242 ~~~~~~~~~l~~~ 254 (290)
T cd05580 242 GNLKNGVNDIKNH 254 (290)
T ss_pred CcccCCHHHHHcC
Confidence 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=276.34 Aligned_cols=245 Identities=23% Similarity=0.205 Sum_probs=179.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeecc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELM 516 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~ 516 (725)
..+|+.++.+.+...+ ..||||.+... .....+.+.+|+.+++.++|+||+++++++... ...++||||+
T Consensus 34 ~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~ 111 (364)
T cd07875 34 SGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111 (364)
T ss_pred cCCCeEEEEEEECCCC--cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCC
Confidence 3445566666554443 46888888643 233456788999999999999999999987643 3579999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++ +|.+++. ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 112 ~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 112 DA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS-------DCTLKILDFGLARTAGT 178 (364)
T ss_pred CC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECC-------CCcEEEEeCCCccccCC
Confidence 75 6777764 3478899999999999999999999 9999999999999987 78999999999986543
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc------cc-Ccc----hHHHH
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL------AN-GMI----LTDWV 665 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~------~~-~~~----~~~~~ 665 (725)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.......... .. ... +....
T Consensus 179 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 179 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 221 223458899999999999999999999999999999999999986432111000 00 000 00000
Q ss_pred HHHHHc-C--------------------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 LYCVRT-G--------------------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 ~~~~~~-~--------------------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...... . .........+++++.+|++.||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0 0001123568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=266.85 Aligned_cols=245 Identities=23% Similarity=0.279 Sum_probs=180.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+++++++++.-+ +..|++|.+... .....+.+.+|+.++++++|+||+++++++..++..++||||++ ++|.++
T Consensus 12 ~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~ 88 (285)
T cd07861 12 TYGVVYKGRNKKT--GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKY 88 (285)
T ss_pred CceEEEEEEECCC--CcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHH
Confidence 4555666654433 457888887532 22334678999999999999999999999999999999999998 588888
Q ss_pred hccC---CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 525 LFRQ---EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 525 l~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........ .
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~~~~~~-~ 157 (285)
T cd07861 89 LDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDN-------KGVIKLADFGLARAFGIPVR-V 157 (285)
T ss_pred HhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcC-------CCcEEECcccceeecCCCcc-c
Confidence 7543 4689999999999999999999999 9999999999999987 78999999999876533221 1
Q ss_pred ccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc--------------ccCcchHHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL--------------ANGMILTDWVL 666 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~--------------~~~~~~~~~~~ 666 (725)
.....++..|+|||.+.+. .++.++||||||++++||++|+.|+.......... .......++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 1223467889999988654 57899999999999999999999886432110000 00000000000
Q ss_pred HHHHc---C---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 YCVRT---G---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 ~~~~~---~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... . .......+++.+++.+||+.||.+|||+.+|+++
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 -TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred -hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 0 0011245678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=263.26 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=184.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC----------ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG----------DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~----------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
.++.++.+.+.-+ +..+|+|.++.... ...+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 13 ~~~~vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 90 (272)
T cd06629 13 TYGRVYLALNVTT--GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYV 90 (272)
T ss_pred CceEEEEEeecCC--CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecC
Confidence 4455555554333 45788887642111 11246889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++++|.+++.+...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||+++....
T Consensus 91 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~-------~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 91 PGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDA-------DGICKISDFGISKKSDD 160 (272)
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcC-------CCeEEEeeccccccccc
Confidence 9999999998888899999999999999999999998 9999999999999987 78999999999986543
Q ss_pred CCCcc-ccccccCccccchhcccCCC--CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC
Q 039817 597 DQTRT-STMIRGTMGYMAPEWLRNAP--VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN 673 (725)
Q Consensus 597 ~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (725)
..... .....++..|+|||.+.... ++.++|+||||++++|+++|..|+....... ...+ .........
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~ 232 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------AMFK-LGNKRSAPP 232 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-------HHHH-hhccccCCc
Confidence 22111 22345788999999987654 8899999999999999999999985322110 0000 000000111
Q ss_pred C----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 L----GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. .......+.+++.+|++.+|++||++++|+++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 12346789999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=278.77 Aligned_cols=180 Identities=23% Similarity=0.283 Sum_probs=148.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+++.+++|.+... +..||+|..... ....|+.++++++|+||+++++++..+...++|+|++. ++|.+++
T Consensus 77 G~~g~Vy~~~~~~~--~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l 147 (357)
T PHA03209 77 GSEGRVFVATKPGQ--PDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYL 147 (357)
T ss_pred CCCeEEEEEEECCC--CceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHH
Confidence 45566666665433 456788865322 24579999999999999999999999999999999996 5888887
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++...... ....
T Consensus 148 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~-------~~~~kl~DfG~a~~~~~~~--~~~~ 215 (357)
T PHA03209 148 TKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFIND-------VDQVCIGDLGAAQFPVVAP--AFLG 215 (357)
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC-------CCCEEEecCccccccccCc--cccc
Confidence 654 6789999999999999999999999 9999999999999987 7889999999997533221 1123
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCC
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTE 646 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~ 646 (725)
..||..|+|||.+.+..++.++||||||+++|||+++..++.
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 458999999999999999999999999999999998766553
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=259.18 Aligned_cols=222 Identities=27% Similarity=0.420 Sum_probs=176.2
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC--CCCCHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--EIPTWDKRVEI 539 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i 539 (725)
+..+++|.+... ...+.+.+|+.++++++|+|++++++++..+ ..++||||+++++|.+++... ..+++..+..+
T Consensus 29 ~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 105 (254)
T cd05083 29 GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF 105 (254)
T ss_pred CCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHH
Confidence 346888887542 2356799999999999999999999998765 478999999999999999754 35789999999
Q ss_pred HHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccC
Q 039817 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN 619 (725)
Q Consensus 540 ~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 619 (725)
+.|++.||.|||+. +++||||||+||+++. ++.+||+|||++....... .....+..|+|||.+.+
T Consensus 106 ~~qi~~al~~lH~~---~~~H~dl~p~nili~~-------~~~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~ 171 (254)
T cd05083 106 SLDVAEGMEYLESK---KLVHRDLAARNILVSE-------DGVAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKH 171 (254)
T ss_pred HHHHHHHHHHHHhC---CeeccccCcceEEEcC-------CCcEEECCCccceeccccC----CCCCCCceecCHHHhcc
Confidence 99999999999998 9999999999999987 7889999999987543221 11224567999999998
Q ss_pred CCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC
Q 039817 620 APVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP 698 (725)
Q Consensus 620 ~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 698 (725)
..++.++|+||||++++||++ |+.|+...... ...+..... .....+...++.+.+++.+|++.+|++||
T Consensus 172 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 242 (254)
T cd05083 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--------EVKECVEKG-YRMEPPEGCPADVYVLMTSCWETEPKKRP 242 (254)
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--------HHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcCCChhhCc
Confidence 899999999999999999998 88777533211 011111110 01122334567889999999999999999
Q ss_pred CHHHHHHHhcC
Q 039817 699 SMKQVLQMLEG 709 (725)
Q Consensus 699 s~~evl~~L~~ 709 (725)
+++++++.|++
T Consensus 243 ~~~~l~~~l~~ 253 (254)
T cd05083 243 SFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHcc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=276.44 Aligned_cols=245 Identities=24% Similarity=0.233 Sum_probs=179.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeecc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELM 516 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~ 516 (725)
..+|+.++.+.+... +..||||.+... .....+.+.+|+.+++.++|+||+++++++... ...++||||+
T Consensus 27 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~ 104 (355)
T cd07874 27 SGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104 (355)
T ss_pred ecCCEEEEEEEecCC--CceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhh
Confidence 344556666655433 356888988643 223346788999999999999999999998643 3569999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++ +|.+.+. ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 105 ~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~-------~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 105 DA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS-------DCTLKILDFGLARTAGT 171 (355)
T ss_pred cc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECC-------CCCEEEeeCcccccCCC
Confidence 76 6666664 3478899999999999999999999 9999999999999987 78999999999986543
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc------cc-Cc----chHHHH
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL------AN-GM----ILTDWV 665 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~------~~-~~----~~~~~~ 665 (725)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.......... .. .. .+....
T Consensus 172 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 172 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred ccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 221 223458899999999999999999999999999999999999986432111000 00 00 000000
Q ss_pred HHHHHc---------------C------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 LYCVRT---------------G------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 ~~~~~~---------------~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...... . .........+++++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 0 0011234578999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=263.59 Aligned_cols=236 Identities=22% Similarity=0.250 Sum_probs=182.2
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-----CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-----GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNG 519 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~g 519 (725)
.++.++.+.+..+ +..|+||.+.... ....+.+.+|++++++++|+||+++++++.+. ...++||||++++
T Consensus 14 ~~g~v~~~~~~~~--~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~ 91 (265)
T cd06652 14 AFGRVYLCYDADT--GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGG 91 (265)
T ss_pred CceEEEEEEEcCC--CcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCC
Confidence 4555555555433 3578888764221 12245788999999999999999999998764 4678999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.+...+++....+++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++.......
T Consensus 92 ~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~-------~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 92 SIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDS-------VGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecC-------CCCEEECcCccccccccccc
Confidence 9999998777789999999999999999999999 9999999999999987 78899999999886532211
Q ss_pred --ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH---cCCC
Q 039817 600 --RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR---TGNL 674 (725)
Q Consensus 600 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 674 (725)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ...... ....
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~-~~~~~~~~~~~~~ 230 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------AA-IFKIATQPTNPVL 230 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----------HH-HHHHhcCCCCCCC
Confidence 1112244888999999998888999999999999999999999998643111 00 111111 1223
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+......+.+++.+|+. +|++||+++||+++
T Consensus 231 ~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 231 PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 44556678889999985 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=266.31 Aligned_cols=247 Identities=26% Similarity=0.296 Sum_probs=178.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhcc---CcCCccceeeEEEc-----CCceeeeee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRT---HHKNLVQLLGFCIE-----QNHQLLVYE 514 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~~~~~lV~e 514 (725)
..+++++++|.+..+ +..||+|.+.... ......+.+|+++++++ +|+||+++++++.. ....++|||
T Consensus 10 ~g~~g~v~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 87 (288)
T cd07863 10 VGAYGTVYKARDPHS--GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFE 87 (288)
T ss_pred ecCCeEEEEEEECCC--CcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEc
Confidence 345566666665544 4578888875422 22234567788877765 69999999999864 345789999
Q ss_pred cccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 515 LMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 515 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
|+++ +|.+++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++
T Consensus 88 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~-------~~~~kl~dfg~~~ 156 (288)
T cd07863 88 HVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTS-------GGQVKLADFGLAR 156 (288)
T ss_pred cccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC-------CCCEEECccCccc
Confidence 9985 888888654 3589999999999999999999999 9999999999999987 7889999999998
Q ss_pred ccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----cCcchHHHHHH
Q 039817 593 LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----NGMILTDWVLY 667 (725)
Q Consensus 593 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 667 (725)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.++........... .......+...
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 6643221 1224578899999999988999999999999999999999998854321110000 00000000000
Q ss_pred HH-HcC-----------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 668 CV-RTG-----------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 668 ~~-~~~-----------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. ... .......+.+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000 0111345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=264.58 Aligned_cols=247 Identities=23% Similarity=0.255 Sum_probs=184.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.+++|++.-+ +..|++|.+.... ....+.+.+|+.++++++|+||+++++++..+...++||||+ +++|.++
T Consensus 12 ~~~~v~~~~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~ 88 (286)
T cd07832 12 AHGIVFKAKDRET--GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEV 88 (286)
T ss_pred CCcEEEEEEECCC--CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHH
Confidence 3445555554333 4578888876433 334568999999999999999999999999999999999999 9999999
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
+... ..+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.++|+|||++............
T Consensus 89 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~-------~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 89 LRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISA-------DGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcC-------CCcEEEeeeeecccccCCCCCccc
Confidence 8654 6689999999999999999999999 9999999999999987 788999999999876544322223
Q ss_pred ccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccc---c--ccCc---------chHHHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT---L--ANGM---------ILTDWVLYC 668 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~---~--~~~~---------~~~~~~~~~ 668 (725)
...++..|+|||.+.+. .++.++||||+|++++||++|+.++......... . .... .+.++....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 34588899999998654 4689999999999999999997766433210000 0 0000 000000000
Q ss_pred HHc------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 VRT------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~~~------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... ........+.+.+++.+|++.+|++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 00111335788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=253.50 Aligned_cols=242 Identities=22% Similarity=0.290 Sum_probs=198.3
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+...+|+.+++|....+| ..||||.+.- ..+.+++..|+.+|.+.+.+++|++||.+.....+++|||||..||..
T Consensus 41 LGEGSYGSV~KAIH~EsG--~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiS 116 (502)
T KOG0574|consen 41 LGEGSYGSVHKAIHRESG--HVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSIS 116 (502)
T ss_pred hcCCcchHHHHHHHhccC--cEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHH
Confidence 456789999999988765 5789998853 456889999999999999999999999999999999999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+.+..+ +.+++..+..++...++||+|||.. .-+|||||+.||||+. ++.+||+|||.+-.+...-. .
T Consensus 117 DI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT-------~G~AKLADFGVAGQLTDTMA-K 185 (502)
T KOG0574|consen 117 DIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNT-------DGIAKLADFGVAGQLTDTMA-K 185 (502)
T ss_pred HHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcc-------cchhhhhhccccchhhhhHH-h
Confidence 998654 7899999999999999999999998 8899999999999987 89999999999976543222 2
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
...+.||+.|||||+++.-.|+.++||||||+...||.-|++|+..-..-.... +..... -..-.-+......
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---MIPT~P----PPTF~KPE~WS~~ 258 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---MIPTKP----PPTFKKPEEWSSE 258 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---eccCCC----CCCCCChHhhhhH
Confidence 223569999999999999999999999999999999999999986432211000 000000 0001123356778
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.++++.||-+.|++|-|+.++++|
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 9999999999999999999998876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.34 Aligned_cols=236 Identities=19% Similarity=0.184 Sum_probs=178.7
Q ss_pred cceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC--CCCCHHHH
Q 039817 461 QEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--EIPTWDKR 536 (725)
Q Consensus 461 ~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~ 536 (725)
.+..||||.+... .....+.+.+|++++++++|+||+++++++...+..+++|||+++++|.+++.+. ..+++...
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~ 103 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI 103 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHH
Confidence 3567899987643 3445578999999999999999999999999999999999999999999999754 45788999
Q ss_pred HHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc------cccccccCcc
Q 039817 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR------TSTMIRGTMG 610 (725)
Q Consensus 537 ~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~ 610 (725)
..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||.+......... ......++..
T Consensus 104 ~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~-------~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (314)
T cd08216 104 AFILKDVLNALDYIHSK---GFIHRSVKASHILLSG-------DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173 (314)
T ss_pred HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEec-------CCceEEecCccceeecccccccccccccccccccccc
Confidence 99999999999999999 9999999999999987 789999999988754322111 1122346778
Q ss_pred ccchhcccC--CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc----------CcchH--------------HH
Q 039817 611 YMAPEWLRN--APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----------GMILT--------------DW 664 (725)
Q Consensus 611 y~aPE~~~~--~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~----------~~~~~--------------~~ 664 (725)
|+|||.+.. ..++.++||||||++++||++|+.||............ ..... ..
T Consensus 174 y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
T cd08216 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHP 253 (314)
T ss_pred ccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccccc
Confidence 999999875 35889999999999999999999998643211100000 00000 00
Q ss_pred HHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 665 VLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 665 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.................+.+++.+||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 254 NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000111122345678999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=267.80 Aligned_cols=242 Identities=23% Similarity=0.246 Sum_probs=180.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEE-----cCCceeeeeecccC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCI-----EQNHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~-----~~~~~~lV~e~~~~ 518 (725)
...++.++++.+...+ ..+++|.+... .....++.+|+.+++++ +|+||+++++++. .++..++||||+++
T Consensus 28 ~g~~~~vy~~~~~~~~--~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 104 (286)
T cd06638 28 KGTYGKVFKVLNKKNG--SKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNG 104 (286)
T ss_pred cCCCcEEEEEEECCCC--ceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCC
Confidence 3455666666655443 46788877543 22346788999999999 6999999999884 34568999999999
Q ss_pred CChhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 519 GTLSAFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 519 gsL~~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++..
T Consensus 105 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~-------~~~~kl~dfg~~~~~ 174 (286)
T cd06638 105 GSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT-------EGGVKLVDFGVSAQL 174 (286)
T ss_pred CCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC-------CCCEEEccCCceeec
Confidence 999988752 35678899999999999999999998 9999999999999987 778999999998865
Q ss_pred CcCCCccccccccCccccchhcccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRN-----APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
...... .....|+..|+|||.+.. ..++.++||||||+++|||++|+.|+........ .........
T Consensus 175 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~~~~~~~~ 246 (286)
T cd06638 175 TSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFKIPRNPP 246 (286)
T ss_pred ccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------HhhccccCC
Confidence 432221 122358899999998753 4578899999999999999999999864321110 000000000
Q ss_pred HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 670 RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 670 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
.....+......+.+++.+|++.+|++|||+.||++++
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00011222356799999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=260.47 Aligned_cols=239 Identities=26% Similarity=0.323 Sum_probs=191.8
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.++.+++|++..+ +..++||.+..... ...+.+.+|++.+.+++|+||+++++++..++..++||||+++++|.+++
T Consensus 13 ~~~~v~~~~~~~~--~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 90 (264)
T cd06623 13 SSGVVYKVRHKPT--GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL 90 (264)
T ss_pred CCeEEEEEEEcCC--CcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHH
Confidence 3444455554443 45678888765433 45678999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
.....++...+..++.|+++||.|||+ . +++|+||+|+||+++. ++.++|+|||++.......... ..
T Consensus 91 ~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~-------~~~~~l~df~~~~~~~~~~~~~-~~ 159 (264)
T cd06623 91 KKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINS-------KGEVKIADFGISKVLENTLDQC-NT 159 (264)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECC-------CCCEEEccCccceecccCCCcc-cc
Confidence 887889999999999999999999999 8 9999999999999987 7899999999998765433222 23
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChh-HHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGAT-KFER 681 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~ 681 (725)
..++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...+....... ....+.. .++.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--------SFFELMQAICDGPPPSLPAEEFSPE 231 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--------CHHHHHHHHhcCCCCCCCcccCCHH
Confidence 34788999999999889999999999999999999999998654321 11111111111 1122333 5678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+++.+|++.+|++||++.|++++
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=256.57 Aligned_cols=236 Identities=25% Similarity=0.358 Sum_probs=188.9
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR 527 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 527 (725)
++.++++++.. .+..+++|.+........+.+.+|++.+++++|+|++++++++..+...++++||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 90 (253)
T cd05122 13 FGEVYKARHKR--TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS 90 (253)
T ss_pred ceEEEEEEECC--CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhh
Confidence 34444444433 3457888988765555677899999999999999999999999999999999999999999999977
Q ss_pred C-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccc
Q 039817 528 Q-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606 (725)
Q Consensus 528 ~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 606 (725)
. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||.+........ .....
T Consensus 91 ~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~-------~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 91 TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTS-------DGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEcc-------CCeEEEeecccccccccccc--cccee
Confidence 6 6789999999999999999999998 9999999999999987 78899999999987654432 22345
Q ss_pred cCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh--HHHHHHH
Q 039817 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT--KFERITM 684 (725)
Q Consensus 607 gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ 684 (725)
++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ....... ......... ....+.+
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~-~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--------ALFKIAT-NGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--------HHHHHHh-cCCCCcCcccccCHHHHH
Confidence 7889999999988889999999999999999999999886432111 0000000 101111112 2578999
Q ss_pred HHHHccCCCCCCCCCHHHHHHH
Q 039817 685 VGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 685 l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++.+|++.||++|||+.|++++
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=262.91 Aligned_cols=237 Identities=24% Similarity=0.364 Sum_probs=186.2
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+++++++.+..++ ..+++|.+... .....+.+.+|++++++++|+||+++++.+..++..++|+||+++++|.++
T Consensus 12 ~~~~v~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (257)
T cd08225 12 SFGKIYLAKAKSDS--EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKR 89 (257)
T ss_pred CcceEEEEEEcCCC--ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHH
Confidence 44555655554444 45788877532 234456788999999999999999999999999999999999999999999
Q ss_pred hccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+.+.. .+++..+..++.|+++||.|||+. +++|+||||+||+++.+ ...+||+|||.+......... .
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~------~~~~~l~d~~~~~~~~~~~~~-~ 159 (257)
T cd08225 90 INRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKN------GMVAKLGDFGIARQLNDSMEL-A 159 (257)
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCC------CCeEEecccccchhccCCccc-c
Confidence 97643 579999999999999999999998 99999999999999862 346799999999866433221 1
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFE 680 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 680 (725)
....|+..|+|||.+.+..++.++||||||++++||++|+.|+..... .+........ .........
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----------HQLVLKICQGYFAPISPNFSR 228 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHhcccCCCCCCCCCH
Confidence 223488899999999888899999999999999999999999853321 1122221111 112234456
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+++.+|++.+|++|||+.|++++
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 89999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=263.08 Aligned_cols=246 Identities=23% Similarity=0.266 Sum_probs=182.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCc-----cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGD-----GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.++.++++.+..+ +..|+||.+...... ....+..|++++++++|+||+++++++.+++..++||||+ +++|
T Consensus 12 ~~~~vy~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 88 (298)
T cd07841 12 TYAVVYKARDKET--GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDL 88 (298)
T ss_pred cccEEEEEEECCC--CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCH
Confidence 4455555554433 457888888643322 3456788999999999999999999999999999999999 8999
Q ss_pred hhhhccCC-CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||+++........
T Consensus 89 ~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~-------~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 89 EKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIAS-------DGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcC-------CCCEEEccceeeeeccCCCcc
Confidence 99998775 789999999999999999999999 9999999999999987 789999999999876543221
Q ss_pred cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--c---ccCcchHHHHH-----HH-
Q 039817 601 TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--L---ANGMILTDWVL-----YC- 668 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--~---~~~~~~~~~~~-----~~- 668 (725)
. ....++..|+|||.+.+ ..++.++||||||++++||++|..++......... . ........+.. ..
T Consensus 159 ~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 159 M-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred c-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 1 22236778999998854 46789999999999999999997766533211000 0 00000000000 00
Q ss_pred --HHcCC-----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 --VRTGN-----LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 --~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..... ........+.+++.+||+.+|++|||++||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 112335678999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=265.89 Aligned_cols=236 Identities=24% Similarity=0.285 Sum_probs=180.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcC-----CceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQ-----NHQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-----~~~~lV~e~~~~g 519 (725)
-+|+.+++++...+ +..+++|.+.... .....+.+|+.++.++ +|+|++++++++... +..++||||++++
T Consensus 33 g~~~~vy~~~~~~~--~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~ 109 (291)
T cd06639 33 GTYGKVYKVTNKKD--GSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGG 109 (291)
T ss_pred CCCeEEEEEEECCC--CCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCC
Confidence 34555666655433 4578888875432 2346788999999998 899999999998754 3589999999999
Q ss_pred Chhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 520 TLSAFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 520 sL~~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++....
T Consensus 110 sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~-------~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 110 SVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTT-------EGGVKLVDFGVSAQLT 179 (291)
T ss_pred cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcC-------CCCEEEeecccchhcc
Confidence 99998853 35689999999999999999999998 9999999999999987 7789999999988654
Q ss_pred cCCCccccccccCccccchhcccCC-----CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNA-----PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (725)
..... .....++..|+|||.+... .++.++||||||+++|||++|+.|+....... .+.....
T Consensus 180 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-----------~~~~~~~ 247 (291)
T cd06639 180 STRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-----------TLFKIPR 247 (291)
T ss_pred ccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----------HHHHHhc
Confidence 32221 1223478899999987643 36899999999999999999999986432110 1111111
Q ss_pred cC----CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 671 TG----NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 671 ~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. ..+......+.+++.+|++.+|++||++.|++++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 1122345679999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=260.67 Aligned_cols=227 Identities=23% Similarity=0.270 Sum_probs=182.9
Q ss_pred ceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHH
Q 039817 462 EVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE 538 (725)
Q Consensus 462 ~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~ 538 (725)
+..+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++||||+++++|.+++.+...+++..+..
T Consensus 18 ~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 97 (265)
T cd05579 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI 97 (265)
T ss_pred CCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHH
Confidence 45789998864333 445678999999999999999999999999999999999999999999998877899999999
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-------ccccccccCccc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-------RTSTMIRGTMGY 611 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~-------~~~~~~~gt~~y 611 (725)
++.|++.||+|||+. +++|+||+|+||+++. ++.+||+|||++........ .......++..|
T Consensus 98 i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~-------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (265)
T cd05579 98 YIAEIVLALEYLHSN---GIIHRDLKPDNILIDS-------NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167 (265)
T ss_pred HHHHHHHHHHHHHHc---CeecCCCCHHHeEEcC-------CCCEEEEecccchhcccCcccccccccccccCcccCccc
Confidence 999999999999999 9999999999999987 78999999999876433321 112234477889
Q ss_pred cchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhH--HHHHHHHHHH
Q 039817 612 MAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATK--FERITMVGLW 688 (725)
Q Consensus 612 ~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~l~~l~~~ 688 (725)
+|||.......+.++||||||++++||++|+.|+...... +....... ....+... ...+.+++.+
T Consensus 168 ~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (265)
T cd05579 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----------EIFQNILNGKIEWPEDVEVSDEAIDLISK 236 (265)
T ss_pred cCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhcCCcCCCccccCCHHHHHHHHH
Confidence 9999998888999999999999999999999998643211 11111111 11122222 6788999999
Q ss_pred ccCCCCCCCCCHHHHHHHhcC
Q 039817 689 CICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 689 cl~~dp~~RPs~~evl~~L~~ 709 (725)
|++.+|++|||+.++.+.|+.
T Consensus 237 ~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 237 LLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HhcCCHhhcCCCccHHHHhcC
Confidence 999999999999766666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=267.33 Aligned_cols=246 Identities=22% Similarity=0.232 Sum_probs=179.7
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.++++.+.-++ ..+++|.+... .......+.+|++++++++|+||+++++++.+.+..++|+||+++ +|.++
T Consensus 12 ~~~~vy~~~~~~~g--~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 88 (284)
T cd07839 12 TYGTVFKAKNRETH--EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKY 88 (284)
T ss_pred CCeEEEEEEECCCC--cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHH
Confidence 34555556554444 46788877532 223345688999999999999999999999999999999999985 78887
Q ss_pred hcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 525 LFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 525 l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
+.. ...+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||+++........ ..
T Consensus 89 ~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~-------~~~~~l~dfg~~~~~~~~~~~-~~ 157 (284)
T cd07839 89 FDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINK-------NGELKLADFGLARAFGIPVRC-YS 157 (284)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcC-------CCcEEECccchhhccCCCCCC-cC
Confidence 754 46789999999999999999999999 9999999999999987 788999999999865432211 12
Q ss_pred ccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc------cCcchHHHHH--H---HHHc
Q 039817 604 MIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA------NGMILTDWVL--Y---CVRT 671 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~------~~~~~~~~~~--~---~~~~ 671 (725)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+........... .......+.. . ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 23467899999998764 478999999999999999999988643221110000 0000000000 0 0000
Q ss_pred C---------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 G---------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~---------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. .......+.+.+++.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=263.70 Aligned_cols=222 Identities=25% Similarity=0.371 Sum_probs=180.9
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCC-CCCHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE-IPTWDKRVEIA 540 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~ 540 (725)
+..+++|.+..... ..+.+.+|++.+++++|+|++++++.+...+..++|+||+++++|.+++.... .+++..+..++
T Consensus 44 ~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~ 122 (286)
T cd06614 44 GKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVC 122 (286)
T ss_pred CcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHH
Confidence 45788888865433 56789999999999999999999999999999999999999999999998776 89999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 620 (725)
.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++........ ......++..|+|||.+.+.
T Consensus 123 ~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~-------~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~ 191 (286)
T cd06614 123 REVLQGLEYLHSQ---NVIHRDIKSDNILLSK-------DGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRK 191 (286)
T ss_pred HHHHHHHHHHHhC---CeeeCCCChhhEEEcC-------CCCEEECccchhhhhccchh-hhccccCCcccCCHhHhcCC
Confidence 9999999999998 9999999999999987 78899999999875543221 11223477889999999888
Q ss_pred CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CC--ChhHHHHHHHHHHHccCCCCCC
Q 039817 621 PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NL--GATKFERITMVGLWCICPQPTL 696 (725)
Q Consensus 621 ~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~l~~l~~~cl~~dp~~ 696 (725)
.++.++||||||+++|+|++|+.|+....... ......... .. .......+.+++.+|++.+|.+
T Consensus 192 ~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 260 (286)
T cd06614 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-----------ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEK 260 (286)
T ss_pred CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-----------HHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhh
Confidence 89999999999999999999999876432110 011111111 11 1124578999999999999999
Q ss_pred CCCHHHHHHH
Q 039817 697 RPSMKQVLQM 706 (725)
Q Consensus 697 RPs~~evl~~ 706 (725)
||++.+++++
T Consensus 261 Rpt~~~il~~ 270 (286)
T cd06614 261 RPSAEELLQH 270 (286)
T ss_pred CcCHHHHhhC
Confidence 9999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=262.97 Aligned_cols=240 Identities=24% Similarity=0.316 Sum_probs=182.0
Q ss_pred HHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCChhhhh
Q 039817 449 QELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 449 ~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l 525 (725)
++++.+.+.. .+..+++|.+.... ......+.+|++++++++|+||+++++++... +..++||||+++++|.+++
T Consensus 15 ~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 92 (287)
T cd06621 15 GSVTKCRLKN--TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY 92 (287)
T ss_pred eEEEEEEECC--CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHH
Confidence 3344444332 34678888876432 23467799999999999999999999998653 4689999999999999886
Q ss_pred cc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 526 FR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 526 ~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.. ...++...+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++........
T Consensus 93 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~-------~~~~~l~dfg~~~~~~~~~~-- 160 (287)
T cd06621 93 KKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTR-------KGQVKLCDFGVSGELVNSLA-- 160 (287)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEec-------CCeEEEeecccccccccccc--
Confidence 53 34578899999999999999999999 9999999999999987 77899999999875533221
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH---HcCCCC--h
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV---RTGNLG--A 676 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--~ 676 (725)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .......++.... ...... .
T Consensus 161 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 161 -GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---GPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred -ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---ChHHHHHHHhcCCchhhccCCCCCC
Confidence 123477889999999988999999999999999999999999875432100 0111111111100 000111 2
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+.+.+++.+||+.+|.+|||+.||+++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 346789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=262.55 Aligned_cols=236 Identities=26% Similarity=0.247 Sum_probs=190.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.|+.++.+.+..+ +..+++|.+.... ....+.+.+|++++++++||||+++++.+.+++..++|+||+++++|.+
T Consensus 12 ~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (258)
T cd05578 12 AFGKVCIVQKRDT--KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRY 89 (258)
T ss_pred CCceEEEEEEccC--CcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHH
Confidence 4555566655433 3468888876432 2346789999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
++.....+++..+..++.|+++||.|||+. +++|+||+|+||++++ ++.++|+|||++........ ..
T Consensus 90 ~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~-------~~~~~l~d~~~~~~~~~~~~--~~ 157 (258)
T cd05578 90 HLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDE-------QGHVHITDFNIATKVTPDTL--TT 157 (258)
T ss_pred HHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcC-------CCCEEEeecccccccCCCcc--cc
Confidence 998777889999999999999999999998 9999999999999987 78899999999886544321 12
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH--HcCCCChhHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV--RTGNLGATKFER 681 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 681 (725)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... .+...... .....+...+..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~ 228 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---------RDQIRAKQETADVLYPATWSTE 228 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---------HHHHHHHhccccccCcccCcHH
Confidence 3447889999999988889999999999999999999999987543211 11111111 223445556789
Q ss_pred HHHHHHHccCCCCCCCCCH--HHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSM--KQVLQ 705 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~--~evl~ 705 (725)
+.+++.+||+.||.+||++ +|+++
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=267.11 Aligned_cols=247 Identities=22% Similarity=0.257 Sum_probs=183.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.++++.+.. .+..+++|.+..... ...+.+.+|++++++++|+||+++++++..++..++||||+++++|.++
T Consensus 13 ~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 90 (286)
T cd07846 13 SYGMVMKCKHKE--TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL 90 (286)
T ss_pred CCeEEEEEEECC--CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHH
Confidence 344555555432 346789998754322 2356788999999999999999999999999999999999999999988
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
......+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++........ ....
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~-------~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07846 91 EKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQ-------SGVVKLCDFGFARTLAAPGE-VYTD 159 (286)
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECC-------CCcEEEEeeeeeeeccCCcc-ccCc
Confidence 87766789999999999999999999998 9999999999999987 78999999999886544322 1222
Q ss_pred cccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--cc-cCcchHHHHHHHHH---------c
Q 039817 605 IRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--LA-NGMILTDWVLYCVR---------T 671 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~---------~ 671 (725)
..++..|+|||++.+ ..++.++||||||++++||++|+.++......+.. .. ....+......... .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 347889999999875 45788999999999999999999888643211000 00 00000000000000 0
Q ss_pred CC---------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 GN---------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~~---------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. ......+.+.+++.+||+.+|++||++++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 011335679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=262.98 Aligned_cols=237 Identities=23% Similarity=0.329 Sum_probs=183.4
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
|+.++.+.+.. .+..+|+|.+... .......+.+|++++++++|+||+++++.+..++..++||||+++++|..++.
T Consensus 14 ~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 91 (286)
T cd06622 14 YGSVYKVLHRP--TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYA 91 (286)
T ss_pred CeEEEEEEEcC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHH
Confidence 44444444332 3457888877543 23335679999999999999999999999999999999999999999999987
Q ss_pred cC---CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 527 RQ---EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 527 ~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.. ..+++..+..++.|++.||.|||+. .+++|+||||+||+++. ++.+||+|||++........ .
T Consensus 92 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~~~~~~---~ 159 (286)
T cd06622 92 GGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNG-------NGQVKLCDFGVSGNLVASLA---K 159 (286)
T ss_pred hccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECC-------CCCEEEeecCCcccccCCcc---c
Confidence 64 3789999999999999999999963 28999999999999987 78899999999876533221 2
Q ss_pred ccccCccccchhcccCC------CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCC
Q 039817 604 MIRGTMGYMAPEWLRNA------PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLG 675 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~------~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 675 (725)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .....+..... ....+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~ 231 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--------NIFAQLSAIVDGDPPTLP 231 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--------hHHHHHHHHhhcCCCCCC
Confidence 23477889999998544 3588999999999999999999998643211 11111111111 12344
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....+.+.+++.+|++.+|++||++++++.+
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 4567889999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=279.51 Aligned_cols=243 Identities=22% Similarity=0.216 Sum_probs=174.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC--------Cceeeeeeccc
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--------NHQLLVYELMK 517 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~lV~e~~~ 517 (725)
.+|+.|++|.+... +..||||.+... .....+|+.++++++|+|||++++++... ...++||||++
T Consensus 77 G~fg~Vy~~~~~~~--~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~ 150 (440)
T PTZ00036 77 GSFGVVYEAICIDT--SEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP 150 (440)
T ss_pred CCCEEEEEEEECCC--CCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC
Confidence 34555665554433 357899987532 22345799999999999999999986432 24668999998
Q ss_pred CCChhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 518 NGTLSAFLF----RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 518 ~gsL~~~l~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+ +|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.+ .+.+||+|||+++.
T Consensus 151 ~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~------~~~vkL~DFGla~~ 220 (440)
T PTZ00036 151 Q-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPN------THTLKLCDFGSAKN 220 (440)
T ss_pred c-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCC------CCceeeeccccchh
Confidence 5 6766654 346789999999999999999999999 99999999999999862 45799999999986
Q ss_pred cCcCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHHHHH
Q 039817 594 LKKDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLYC 668 (725)
Q Consensus 594 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 668 (725)
...... .....|++.|+|||.+.+. .++.++||||||+++|||++|..||........... ......+.....
T Consensus 221 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 221 LLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred ccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 543322 1224578999999998754 689999999999999999999999865422110000 000000000000
Q ss_pred ---HHc------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 ---VRT------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ---~~~------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... ..++...++++.+|+.+||+.||.+|||+.|++++
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 01122345678999999999999999999999965
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=267.55 Aligned_cols=232 Identities=25% Similarity=0.317 Sum_probs=185.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccH---HHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE---KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~---~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|+.||=|.+..+ ...||||++.-.-.+.. ..++.|++.|.+++|||+|.+.|++..+...+||||||-| |-.|
T Consensus 38 SFGAVYfArd~~n--~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsD 114 (948)
T KOG0577|consen 38 SFGAVYFARDVRN--SEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASD 114 (948)
T ss_pred ccceeEEeeccCc--cceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHH
Confidence 4555555555443 35899999864433333 3578999999999999999999999999999999999975 7777
Q ss_pred hhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
.+.- ++++-+..+..|..+.+.||+|||+. +.||||||+.||||++ .+.|||+|||.|.+....
T Consensus 115 lleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse-------~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 115 LLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSE-------PGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred HHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecC-------CCeeeeccccchhhcCch-----
Confidence 7754 36788889999999999999999999 9999999999999988 899999999999875433
Q ss_pred cccccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--C-Ch
Q 039817 603 TMIRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--L-GA 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~ 676 (725)
..+.||+.|||||+|. .+.|+.|+||||||++-.||.-.++|.... ....-+.-...... + ..
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-----------NAMSALYHIAQNesPtLqs~ 248 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----------NAMSALYHIAQNESPTLQSN 248 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-----------hHHHHHHHHHhcCCCCCCCc
Confidence 3367999999999985 678999999999999999999888876532 11111111111111 1 23
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
+..+.+++++..||++-|.+|||.++++++-
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 6678899999999999999999999999874
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=264.04 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=179.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.+++|.+..+ +..|+||.+... .....+.+.+|++++++++|+||+++++++..++..++||||+. ++|.++
T Consensus 12 ~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~ 88 (284)
T cd07860 12 TYGVVYKARNKLT--GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKF 88 (284)
T ss_pred CceEEEEEEECCC--CCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHH
Confidence 4455555555433 346888877532 22334678999999999999999999999999999999999996 589888
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++. ++.+||+|||++......... .
T Consensus 89 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~-------~~~~~l~dfg~~~~~~~~~~~-~ 157 (284)
T cd07860 89 MDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINT-------EGAIKLADFGLARAFGVPVRT-Y 157 (284)
T ss_pred HHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC-------CCCEEEeeccchhhcccCccc-c
Confidence 8653 5689999999999999999999998 9999999999999987 788999999998765432211 1
Q ss_pred cccccCccccchhcccCCC-CCCccceehhHHHHHHHHhCCcCCCCCCCCccccc--------cCc------chHHHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--------NGM------ILTDWVLY 667 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--------~~~------~~~~~~~~ 667 (725)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+........... ... ...++...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2233678899999887644 68899999999999999999998864321110000 000 00000000
Q ss_pred HHHcC------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 668 CVRTG------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 668 ~~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... .........+.+++.+|++.||++|||+++++++
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 238 -FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred -cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 0011234667899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=269.26 Aligned_cols=249 Identities=18% Similarity=0.219 Sum_probs=180.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.+|+.++.|.+...+ ..||+|.+.. ......+.+.+|+.+++.++|+||+++++++..++..++|+||+++++|.+
T Consensus 11 ~~~~~v~~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (328)
T cd08226 11 CNLTSVYLARHTPTG--TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS 88 (328)
T ss_pred cCceeEEEEEEcCCC--cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence 456666666665444 4667776643 223334678999999999999999999999999999999999999999999
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+|++||+.+..........
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~-------~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG-------DGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeC-------CCcEEEechHHHhhhhccCccc
Confidence 98764 4588999999999999999999998 9999999999999987 7889999998654322211110
Q ss_pred ------ccccccCccccchhcccCC--CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc---c------C-cch--
Q 039817 602 ------STMIRGTMGYMAPEWLRNA--PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA---N------G-MIL-- 661 (725)
Q Consensus 602 ------~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~---~------~-~~~-- 661 (725)
.....++..|+|||++.+. .++.++||||||++++||++|+.|+........... . . ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0112245679999998763 478999999999999999999999864321110000 0 0 000
Q ss_pred --HHH-----------------------HHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 662 --TDW-----------------------VLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 662 --~~~-----------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... +................+.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 000000011122456778999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=282.86 Aligned_cols=252 Identities=17% Similarity=0.224 Sum_probs=178.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCc------CCccceeeEEEcC-Cceeeeeecc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHH------KNLVQLLGFCIEQ-NHQLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H------~niv~l~g~~~~~-~~~~lV~e~~ 516 (725)
...+|+.|++|.+... +..||||.++... ...+++..|++++++++| .+++++++++..+ ...++|||++
T Consensus 138 G~G~fg~V~~a~~~~~--~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~ 214 (467)
T PTZ00284 138 GEGTFGKVVEAWDRKR--KEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY 214 (467)
T ss_pred EeccCEEEEEEEEcCC--CeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc
Confidence 3456677777765443 4678999886432 234456677777777654 4588999988764 5788999988
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccC---------CCCceEEe
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITID---------NNYITKIA 586 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~---------~~~~~kl~ 586 (725)
+++|.+++.+...+++..+..|+.|++.||.|||+ . +|+||||||+|||++.+...++ +...+||+
T Consensus 215 -g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~ 290 (467)
T PTZ00284 215 -GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC 290 (467)
T ss_pred -CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceEEEC
Confidence 66899999888889999999999999999999997 5 8999999999999986321100 12359999
Q ss_pred eccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc----ccCcchH
Q 039817 587 DFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL----ANGMILT 662 (725)
Q Consensus 587 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~----~~~~~~~ 662 (725)
|||++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+... .......
T Consensus 291 DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~ 366 (467)
T PTZ00284 291 DLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS 366 (467)
T ss_pred CCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Confidence 9998764322 1233568999999999999999999999999999999999999997543211000 0000000
Q ss_pred HHHH--------HHHHc-C------------------CC-ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 663 DWVL--------YCVRT-G------------------NL-GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 663 ~~~~--------~~~~~-~------------------~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+|.. ..... + .. .....+.+.+|+.+||+.||++|||++|+++|
T Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 367 EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 0100 00000 0 00 00123567899999999999999999999974
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=263.22 Aligned_cols=244 Identities=23% Similarity=0.272 Sum_probs=180.5
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
+++++++.+..+ +..|++|.+.... ....+.+.+|++++++++|+|++++++++.+++..++||||++ ++|.+++
T Consensus 12 ~~~vy~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~ 88 (283)
T cd07835 12 YGVVYKARDKLT--GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYM 88 (283)
T ss_pred CeEEEEEEEcCC--CCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHH
Confidence 445555554443 3567888775332 2334678899999999999999999999999999999999995 6899998
Q ss_pred ccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||+++........ ..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~-------~~~~~l~df~~~~~~~~~~~~-~~ 157 (283)
T cd07835 89 DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDR-------EGALKLADFGLARAFGVPVRT-YT 157 (283)
T ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcC-------CCcEEEeecccccccCCCccc-cC
Confidence 7665 789999999999999999999998 9999999999999987 789999999999765432211 12
Q ss_pred ccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc---------cC-----cchHHHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA---------NG-----MILTDWVLYC 668 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~---------~~-----~~~~~~~~~~ 668 (725)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+........... .. ..+.+... .
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP-T 236 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh-h
Confidence 22467889999987654 578999999999999999999998864321110000 00 00000000 0
Q ss_pred HHcC------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 VRTG------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... .......+.+.+++.+|++.+|++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0112334678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=285.39 Aligned_cols=228 Identities=29% Similarity=0.402 Sum_probs=187.1
Q ss_pred ceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCC----------
Q 039817 462 EVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE---------- 529 (725)
Q Consensus 462 ~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------- 529 (725)
...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|..++..++|.||++.|+|.++|.+.+
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 6789999997543 34567899999999998 79999999999999999999999999999999997665
Q ss_pred ------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 530 ------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 530 ------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.++....+.++.|||.||+||++. +++||||.++|||+.. +..+||+|||+++...........
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~-------~~~~kIaDFGlar~~~~~~~y~~~ 477 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITK-------NKVIKIADFGLARDHYNKDYYRTK 477 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecC-------CCEEEEccccceeccCCCCceEec
Confidence 378889999999999999999999 9999999999999987 789999999999965544433322
Q ss_pred ccc--cCccccchhcccCCCCCCccceehhHHHHHHHHhCC-cCCCCCCCCccccccCcchHHHHHHHHHcC---CCChh
Q 039817 604 MIR--GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK-RHTELHRVDEPTLANGMILTDWVLYCVRTG---NLGAT 677 (725)
Q Consensus 604 ~~~--gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 677 (725)
... -+..|||||.+....++.||||||||++||||+|.. .|+.... ...+. .+..+.| ..|..
T Consensus 478 ~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----------~~~~l-~~~l~~G~r~~~P~~ 546 (609)
T KOG0200|consen 478 SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----------PTEEL-LEFLKEGNRMEQPEH 546 (609)
T ss_pred CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC----------cHHHH-HHHHhcCCCCCCCCC
Confidence 212 345699999999999999999999999999999844 5553211 01122 2233333 34556
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..+++.++++.||+.+|++||++.|+++.|+..
T Consensus 547 c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 547 CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 688999999999999999999999999999873
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=262.98 Aligned_cols=246 Identities=19% Similarity=0.233 Sum_probs=181.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.++.++.+.+..+ +..||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||++ ++|.+++
T Consensus 18 ~~g~vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l 94 (301)
T cd07873 18 TYATVYKGRSKLT--DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYL 94 (301)
T ss_pred cCEEEEEEEEcCC--CcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHH
Confidence 4455555554433 3578889875332 3334568899999999999999999999999999999999998 5898888
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++......... ...
T Consensus 95 ~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kl~dfg~~~~~~~~~~~-~~~ 163 (301)
T cd07873 95 DDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINE-------RGELKLADFGLARAKSIPTKT-YSN 163 (301)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECC-------CCcEEECcCcchhccCCCCCc-ccc
Confidence 654 5688999999999999999999999 9999999999999987 788999999999764332211 122
Q ss_pred cccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc--------ccCcchHHHHHH-HHHcCC-
Q 039817 605 IRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL--------ANGMILTDWVLY-CVRTGN- 673 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~~~- 673 (725)
..++..|+|||.+.+. .++.++||||||+++|||++|+.|+......+... ............ ......
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 3468899999988654 57889999999999999999999986543211000 000000000000 000000
Q ss_pred ----------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 ----------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ----------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........+.+++.+|++.||.+|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011235578899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=263.69 Aligned_cols=237 Identities=21% Similarity=0.199 Sum_probs=185.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCc---cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGD---GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.++.++.+.+.. .+..+++|.+...... ..+.+.+|++++++++|+||+++++.+..++..++||||+.+++|.+
T Consensus 13 ~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (316)
T cd05574 13 DVGRVFLVRLKG--TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFR 90 (316)
T ss_pred ccEEEEEEEEcC--CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHH
Confidence 344455554433 3457899988653322 44678999999999999999999999999999999999999999999
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
++.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.++|+|||++.........
T Consensus 91 ~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~-------~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 91 LLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHE-------SGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred HHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcC-------CCCEEEeecchhhccccccccc
Confidence 98754 5689999999999999999999998 9999999999999987 788999999998754321110
Q ss_pred ---------------------------cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcc
Q 039817 601 ---------------------------TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEP 653 (725)
Q Consensus 601 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~ 653 (725)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~- 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE- 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence 0112347889999999998889999999999999999999999986443211
Q ss_pred ccccCcchHHHHHHHHH-cCCCCh--hHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 039817 654 TLANGMILTDWVLYCVR-TGNLGA--TKFERITMVGLWCICPQPTLRPS----MKQVLQM 706 (725)
Q Consensus 654 ~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~l~~l~~~cl~~dp~~RPs----~~evl~~ 706 (725)
....... ....+. ..++.+.+++.+|++.+|++||+ ++|++++
T Consensus 240 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 240 ----------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ----------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 0111111 111222 25788999999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=262.86 Aligned_cols=239 Identities=23% Similarity=0.299 Sum_probs=186.3
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+++++++.... .+..+++|.+.... ....+.+.+|++.+++++|+||+++++.+..++..++|+|++++++|.+++
T Consensus 13 ~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~ 90 (267)
T cd06610 13 ATAVVYAAICLP--NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM 90 (267)
T ss_pred CCeEEEEEEEcC--CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHH
Confidence 344555555333 34578888875422 235678999999999999999999999999999999999999999999999
Q ss_pred ccC---CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc--
Q 039817 526 FRQ---EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-- 600 (725)
Q Consensus 526 ~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-- 600 (725)
... ..+++.....++.|++.||.|||+. +++|+||+|+||++++ ++.+||+|||++.........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~-------~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 91 KSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGE-------DGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred HHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcC-------CCCEEEcccchHHHhccCccccc
Confidence 764 4589999999999999999999998 9999999999999987 778999999998765543222
Q ss_pred -cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC---
Q 039817 601 -TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG--- 675 (725)
Q Consensus 601 -~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 675 (725)
......++..|+|||.+... .++.++|+||||++++||++|+.|+....... ...+.... ......
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~--~~~~~~~~~ 231 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQN--DPPSLETGA 231 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcC--CCCCcCCcc
Confidence 12234588899999998776 78999999999999999999999986432111 01111100 001111
Q ss_pred --hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 --ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 --~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....+.+.+++.+|++.||++||++++++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1345778999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=263.87 Aligned_cols=248 Identities=22% Similarity=0.192 Sum_probs=191.8
Q ss_pred ccHHHHHHHhcccC-CcceEEEEEEccccc----CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCC
Q 039817 446 FSYQELREATNVFD-GQEVEVAVKQLEKVT----GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~-~~~~~vavk~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
..++.++.+++... ..+..++||.+.... ....+.+.+|++++.++ +|+||+++++.+..+...++||||++++
T Consensus 11 G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (288)
T cd05583 11 GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGG 90 (288)
T ss_pred CCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCC
Confidence 34555555554432 244678899876421 23345688999999999 6999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.....+++..+..++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||+++.......
T Consensus 91 ~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 91 ELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDS-------EGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred cHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECC-------CCCEEEEECccccccccccc
Confidence 9999998777889999999999999999999998 9999999999999987 77899999999886544332
Q ss_pred ccccccccCccccchhcccCCC--CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCCh
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAP--VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGA 676 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 676 (725)
.......++..|+|||.+.+.. .+.++||||||++++||++|..|+...... ....+...... .....+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-------NSQSEISRRILKSKPPFPK 233 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-------chHHHHHHHHHccCCCCCc
Confidence 2222345788999999987665 788999999999999999999998643211 11111111111 1123344
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.....+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 4567889999999999999999998888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=264.12 Aligned_cols=238 Identities=22% Similarity=0.279 Sum_probs=185.9
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR 527 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 527 (725)
++.++++.+..+ +..+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+++++|.+++.+
T Consensus 32 ~g~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 109 (293)
T cd06647 32 SGTVYTAIDVAT--GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 109 (293)
T ss_pred CeEEEEEEEcCC--CCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh
Confidence 444444443333 356888887654455567899999999999999999999999999999999999999999999865
Q ss_pred CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccccc
Q 039817 528 QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRG 607 (725)
Q Consensus 528 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 607 (725)
. .+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++......... .....+
T Consensus 110 ~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~-------~~~~kL~dfg~~~~~~~~~~~-~~~~~~ 177 (293)
T cd06647 110 T-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGM-------DGSVKLTDFGFCAQITPEQSK-RSTMVG 177 (293)
T ss_pred c-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcC-------CCCEEEccCcceecccccccc-cccccC
Confidence 3 578999999999999999999999 9999999999999987 778999999998765433221 122357
Q ss_pred CccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHH
Q 039817 608 TMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGL 687 (725)
Q Consensus 608 t~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 687 (725)
+..|+|||.+....++.++||||||+++||+++|+.||........... . ..........+......+.+++.
T Consensus 178 ~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~---~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----I---ATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----h---hcCCCCCCCCccccCHHHHHHHH
Confidence 8889999999888899999999999999999999999865432211000 0 00000000112234567889999
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 039817 688 WCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 688 ~cl~~dp~~RPs~~evl~~ 706 (725)
+||+.+|++||++.+++.+
T Consensus 251 ~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-31 Score=296.62 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=195.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEc--ccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l--~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
....|+.++.|.+.-+|+. .|+|-+ ........+.+.+|+.++..|.|||+|+++|+-.+.+..+|.||||++|+|
T Consensus 1244 g~G~fG~VYtavN~~tGel--lAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1244 GGGTFGKVYTAVNLDTGEL--LAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred CCcceeeeEEeecCCccch--hhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence 3456777777777666654 455544 344455567789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
.+.+...+..++.....+..|++.|+.|||+. +||||||||.||+|+. ++.+|++|||.|..+......
T Consensus 1322 a~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~-------~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1322 ASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDF-------NGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeec-------CCcEEeecccceeEecCchhcC
Confidence 99998888888888888899999999999999 9999999999999988 889999999999987654311
Q ss_pred --cccccccCccccchhcccCC---CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC
Q 039817 601 --TSTMIRGTMGYMAPEWLRNA---PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG 675 (725)
Q Consensus 601 --~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (725)
......||+-|||||.+.+. ...-+.||||+|||++||+||++||...+.+-. +.- -........+|
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-------IMy-~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-------IMY-HVAAGHKPQIP 1463 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-------HHh-HHhccCCCCCc
Confidence 12235699999999999754 356689999999999999999999975443210 000 01111234456
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
.....+-.+++..|++.||++|-++.|++++=
T Consensus 1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 66778889999999999999999999988773
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=260.84 Aligned_cols=238 Identities=26% Similarity=0.305 Sum_probs=179.3
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCC------ceeeeeecccCCC
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQN------HQLLVYELMKNGT 520 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~------~~~lV~e~~~~gs 520 (725)
++.++.+.+..+ +..+++|.+.... ...+.|.+|+++++++ +|+||+++++++.... ..++||||+++++
T Consensus 19 ~~~v~~~~~~~~--~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 95 (275)
T cd06608 19 YGKVYKARHKKT--GQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS 95 (275)
T ss_pred CeEEEEEEECCC--CcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCc
Confidence 444555554333 3567888776433 3456799999999999 7999999999997644 4899999999999
Q ss_pred hhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 521 LSAFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 521 L~~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 96 L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~-------~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 96 VTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTK-------NAEVKLVDFGVSAQLDS 165 (275)
T ss_pred HHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEcc-------CCeEEECCCccceeccc
Confidence 9999865 35789999999999999999999999 9999999999999987 78899999999876543
Q ss_pred CCCccccccccCccccchhcccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRN-----APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
... ......++..|+|||.+.. ..++.++||||||++++||++|+.|+....... ............
T Consensus 166 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~ 237 (275)
T cd06608 166 TLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------ALFKIPRNPPPT 237 (275)
T ss_pred chh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------HHHHhhccCCCC
Confidence 221 1223448889999998753 346789999999999999999999986321110 011100000000
Q ss_pred CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+....+.+.+++.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 01112345689999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=262.04 Aligned_cols=238 Identities=24% Similarity=0.256 Sum_probs=185.7
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.|++++.+.+..+ +..+++|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|.+
T Consensus 5 ~~g~vy~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 82 (277)
T cd05577 5 GFGEVCACQVKAT--GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKY 82 (277)
T ss_pred CceeEEEEEEcCC--CcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHH
Confidence 3455555554443 3467888775321 2335567899999999999999999999999999999999999999999
Q ss_pred hhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
++.+.. .+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++........
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~-------~~~~~l~dfg~~~~~~~~~~-- 150 (277)
T cd05577 83 HIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDD-------HGNVRISDLGLAVELKGGKK-- 150 (277)
T ss_pred HHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECC-------CCCEEEccCcchhhhccCCc--
Confidence 997664 789999999999999999999999 9999999999999987 78899999999876543211
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH--HcCCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV--RTGNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 679 (725)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ....+.... .....+....
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 222 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--------EKEELKRRTLEMAVEYPDKFS 222 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--------cHHHHHhccccccccCCccCC
Confidence 122347788999999988889999999999999999999999986543211 011111111 1122334557
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
+.+.+++.+||+.+|.+|| ++.+++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 7899999999999999999 77777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=259.26 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=187.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.++.+.+..+ +..+++|.+... ......++.+|++++++++|+||+++++++......++||||+++++|.++
T Consensus 12 ~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 89 (256)
T cd08530 12 SYGSVYKVKRLSD--NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKA 89 (256)
T ss_pred CceeEEEEEECCC--CCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHH
Confidence 4455555554433 356788877543 233456788999999999999999999999999999999999999999999
Q ss_pred hcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 525 LFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 525 l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
+.+ ...+++..++.++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||+++.......
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~-------~~~~kl~d~g~~~~~~~~~~- 158 (256)
T cd08530 90 ISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVA-------NDLVKIGDLGISKVLKKNMA- 158 (256)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEec-------CCcEEEeeccchhhhccCCc-
Confidence 866 35689999999999999999999999 9999999999999987 77899999999987654421
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (725)
....++..|+|||.+.+..++.++|+||||++++||++|+.|+...... ....... .......+.....
T Consensus 159 --~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~~~~~~~~~~ 227 (256)
T cd08530 159 --KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------DLRYKVQ-RGKYPPIPPIYSQ 227 (256)
T ss_pred --ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHh-cCCCCCCchhhCH
Confidence 1234788999999999999999999999999999999999998643211 0111111 0011223345667
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+++.+|++.+|++||++.+++++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 228 DLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 89999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=261.65 Aligned_cols=236 Identities=22% Similarity=0.240 Sum_probs=181.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhc---cCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGR---THHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+|+.++.+.+.- .+..+|+|.+.... ......+.+|..++.. .+|+||+.+++.+..++..++||||+++++
T Consensus 6 ~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 83 (279)
T cd05633 6 GFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGD 83 (279)
T ss_pred CCeEEEEEEECC--CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCC
Confidence 345555555443 34578888775432 1222334555544443 479999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++..+..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 84 L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~-------~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 84 LHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDE-------HGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECC-------CCCEEEccCCcceeccccCc-
Confidence 999998888899999999999999999999999 9999999999999987 78899999999875533221
Q ss_pred cccccccCccccchhccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH--HHcCCCChh
Q 039817 601 TSTMIRGTMGYMAPEWLR-NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC--VRTGNLGAT 677 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 677 (725)
....|+..|+|||.+. +..++.++||||||++++||++|..||....... ....... .....++..
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~~ 221 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------KHEIDRMTLTVNVELPDS 221 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---------HHHHHHHhhcCCcCCccc
Confidence 2235889999999886 4568999999999999999999999986442211 0111111 112234455
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
....+.+++.+|++.||++|| +++|++++
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 678899999999999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=258.54 Aligned_cols=238 Identities=21% Similarity=0.273 Sum_probs=185.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccC---cCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..++.++++.+..+ +..+++|.+... .....+++.+|++++++++ |+|++++++++..+...++||||+++++|
T Consensus 12 g~~g~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06917 12 GAYGAVYRGKHVPT--GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV 89 (277)
T ss_pred cCCceEEEEEEcCC--CcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcH
Confidence 34555566555433 457888887543 3344567889999999986 99999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.. ..+++.....++.|+++||.|||+. +++|+||+|+||+++. ++.++|+|||++.........
T Consensus 90 ~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~-------~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 90 RTLMKA-GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTN-------TGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred HHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcC-------CCCEEEccCCceeecCCCccc-
Confidence 999865 4789999999999999999999999 9999999999999987 788999999999876543322
Q ss_pred ccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh-hHH
Q 039817 602 STMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA-TKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 679 (725)
.....|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+......... ..... .....++. ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--------~~~~~-~~~~~~~~~~~~ 228 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--------MLIPK-SKPPRLEDNGYS 228 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--------hcccc-CCCCCCCcccCC
Confidence 2234588899999988754 5789999999999999999999998643221100 00000 00111222 255
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+++.+|++.||++||++.+++++
T Consensus 229 ~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 229 KLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 688999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=254.31 Aligned_cols=237 Identities=23% Similarity=0.321 Sum_probs=189.7
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
++.++.+++... +..+++|.+..... ...+.+.+|++++++++|+|++++++++..++..++||||+++++|.+++
T Consensus 13 ~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 90 (254)
T cd06627 13 FGVVYKGLNLET--GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQII 90 (254)
T ss_pred CeEEEEEEEcCC--CcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHH
Confidence 344444444333 35688888865443 45568999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.....+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++......... ....
T Consensus 91 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~-------~~~~~l~d~~~~~~~~~~~~~-~~~~ 159 (254)
T cd06627 91 KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTK-------DGVVKLADFGVATKLNDVSKD-DASV 159 (254)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECC-------CCCEEEeccccceecCCCccc-cccc
Confidence 8888899999999999999999999999 9999999999999987 788999999999876543322 2234
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMV 685 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 685 (725)
.++..|+|||...+..++.++||||+|+++++|++|+.|+....... ..+..........+....+.+.++
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~ 230 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA---------ALFRIVQDDHPPLPEGISPELKDF 230 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH---------HHHHHhccCCCCCCCCCCHHHHHH
Confidence 57889999999988888999999999999999999999886432100 000011111223444567889999
Q ss_pred HHHccCCCCCCCCCHHHHHHH
Q 039817 686 GLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 686 ~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+|++.+|++||++.+++.+
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=258.55 Aligned_cols=238 Identities=26% Similarity=0.312 Sum_probs=191.8
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~ 522 (725)
.++.++.+.+.. .+..|++|.+.... ....+.+.+|++.+++++|+||+++++.+... ...++|+||+++++|.
T Consensus 12 ~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (260)
T cd06606 12 SFGSVYLALDKD--TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLS 89 (260)
T ss_pred CceEEEEEEECC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHH
Confidence 344455554443 34578888876443 24567899999999999999999999999988 8899999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-c
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-T 601 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~ 601 (725)
+++.+...+++..+..++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||.+......... .
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~-------~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 90 SLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDS-------DGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcC-------CCCEEEcccccEEeccccccccc
Confidence 9998878899999999999999999999998 9999999999999987 789999999999876554321 1
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH---HcCCCChhH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV---RTGNLGATK 678 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 678 (725)
.....++..|+|||.+.....+.++||||||+++++|++|+.|+...... ........ ....++...
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----------MAALYKIGSSGEPPEIPEHL 229 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----------HHHHHhccccCCCcCCCccc
Confidence 12345788999999998888999999999999999999999998754310 11111111 112344455
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+.+++.+|++.+|++||++.+++++
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 7889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=261.44 Aligned_cols=226 Identities=20% Similarity=0.294 Sum_probs=180.6
Q ss_pred cceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
.+..|+||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++.. ..+++.....++
T Consensus 44 ~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~ 122 (292)
T cd06657 44 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVC 122 (292)
T ss_pred CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHH
Confidence 4567888887654445566799999999999999999999999999999999999999999998744 467999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 620 (725)
.|++.||+|||+. +++|+||+|+||+++. ++.++|+|||++........ ......++..|+|||.+.+.
T Consensus 123 ~ql~~~l~~lH~~---givH~dl~p~Nilv~~-------~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~ 191 (292)
T cd06657 123 LAVLKALSVLHAQ---GVIHRDIKSDSILLTH-------DGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRL 191 (292)
T ss_pred HHHHHHHHHHHHC---CeecCCCCHHHEEECC-------CCCEEEcccccceecccccc-cccccccCccccCHHHhcCC
Confidence 9999999999999 9999999999999987 77899999999876543321 12234578899999999888
Q ss_pred CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-CCCChhHHHHHHHHHHHccCCCCCCCCC
Q 039817 621 PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT-GNLGATKFERITMVGLWCICPQPTLRPS 699 (725)
Q Consensus 621 ~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPs 699 (725)
.++.++||||||++++||++|..|+....... ........... ..........+.+++.+||+.+|.+||+
T Consensus 192 ~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~ 263 (292)
T cd06657 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT 263 (292)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcC
Confidence 89999999999999999999999986432110 01111111100 0011234567889999999999999999
Q ss_pred HHHHHHH
Q 039817 700 MKQVLQM 706 (725)
Q Consensus 700 ~~evl~~ 706 (725)
+.+++++
T Consensus 264 ~~~ll~~ 270 (292)
T cd06657 264 AAELLKH 270 (292)
T ss_pred HHHHhcC
Confidence 9999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=262.23 Aligned_cols=239 Identities=24% Similarity=0.278 Sum_probs=183.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+++.++++.+..+ +..+++|.+..... .....+.+|++++++++|+|++++++++..++..++||||+++ +|.+
T Consensus 37 ~~~~v~~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~ 113 (317)
T cd06635 37 SFGAVYFARDVRT--NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASD 113 (317)
T ss_pred CCeEEEEEEEcCC--CcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHH
Confidence 3444454444333 45788888754322 2345788999999999999999999999999999999999975 7777
Q ss_pred hhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
.+.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++......
T Consensus 114 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~-------~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 114 LLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTE-------PGQVKLADFGSASIASPA----- 178 (317)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECC-------CCCEEEecCCCccccCCc-----
Confidence 7654 46689999999999999999999999 9999999999999977 788999999998754322
Q ss_pred cccccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCCh
Q 039817 603 TMIRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGA 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 676 (725)
....++..|+|||++. .+.++.++||||||++++||++|+.|+...... ......... .....
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~ 247 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQNESPTLQSN 247 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHHhccCCCCCCc
Confidence 1234788999999873 456889999999999999999999987543111 111111111 11122
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVG 714 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 714 (725)
...+.+.+++.+|++.+|.+||++.++++++-.....+
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 45677999999999999999999999999876554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=257.93 Aligned_cols=237 Identities=23% Similarity=0.317 Sum_probs=185.3
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.|+.++++.+..+ +..+|+|.+.... ....+.|.+|++++++++|+||+++++++..++..++||||+++++|.+++
T Consensus 16 ~~~~vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i 93 (277)
T cd06641 16 SFGEVFKGIDNRT--QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL 93 (277)
T ss_pred CCeEEEEEEECCC--CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHH
Confidence 3445555544333 4578888765322 233467899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++. ++.++|+|||++......... ....
T Consensus 94 ~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~-------~~~~~l~dfg~~~~~~~~~~~-~~~~ 161 (277)
T cd06641 94 EP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSE-------HGEVKLADFGVAGQLTDTQIK-RNTF 161 (277)
T ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECC-------CCCEEEeecccceecccchhh-hccc
Confidence 64 4689999999999999999999998 9999999999999987 788999999998765432211 1223
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMV 685 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 685 (725)
.++..|+|||.+.+..++.++||||||++++||++|..|+...... .....+ .......++......+.++
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLI-PKNNPPTLEGNYSKPLKEF 232 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHH-hcCCCCCCCcccCHHHHHH
Confidence 4788899999998888999999999999999999999988532211 001111 0001112333456788999
Q ss_pred HHHccCCCCCCCCCHHHHHHH
Q 039817 686 GLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 686 ~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+|++.+|.+||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=260.94 Aligned_cols=238 Identities=20% Similarity=0.209 Sum_probs=181.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHH-hccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVI-GRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..++.+++|++..++ ..||||.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++++|
T Consensus 7 g~~~~v~~a~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 84 (260)
T cd05611 7 GAFGSVYLAKKRSTG--DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC 84 (260)
T ss_pred CCCeeEEEEEecCCC--CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCH
Confidence 345666667665544 4788888764321 2223455565554 455899999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||+++.....
T Consensus 85 ~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~~~~---- 150 (260)
T cd05611 85 ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQ-------TGHLKLTDFGLSRNGLEN---- 150 (260)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC-------CCcEEEeecccceecccc----
Confidence 99998878899999999999999999999998 9999999999999987 788999999998754331
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 679 (725)
....++..|+|||.+.+..++.++||||||++++||++|..|+....... .......... .........
T Consensus 151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 221 (260)
T cd05611 151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--------VFDNILSRRINWPEEVKEFCS 221 (260)
T ss_pred -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcccCCCCcccccCC
Confidence 22347888999999988888999999999999999999999986432110 0000000000 011222356
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
..+.+++.+||+.+|++||++.++.+.|+
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 78999999999999999998766655553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=262.98 Aligned_cols=232 Identities=26% Similarity=0.311 Sum_probs=179.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.++.++.+++..+ +..|++|.+..... ...+++.+|++++++++||||++++++|..++..++||||++ |+|.+
T Consensus 27 ~~g~vy~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~ 103 (307)
T cd06607 27 SFGAVYFARDVRT--NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASD 103 (307)
T ss_pred CCeEEEEEEEcCC--CcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHH
Confidence 4445555554433 45788887753322 233578899999999999999999999999999999999997 57766
Q ss_pred hhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++.......
T Consensus 104 ~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~-------~~~~kL~dfg~~~~~~~~~---- 169 (307)
T cd06607 104 ILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTE-------PGTVKLADFGSASLVSPAN---- 169 (307)
T ss_pred HHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECC-------CCCEEEeecCcceecCCCC----
Confidence 6653 46789999999999999999999998 9999999999999987 7889999999987653321
Q ss_pred cccccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCC-Ch
Q 039817 603 TMIRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNL-GA 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~ 676 (725)
...++..|+|||.+. ...++.++||||||+++|||++|+.|+...... ......... ... ..
T Consensus 170 -~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~ 237 (307)
T cd06607 170 -SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQNDSPTLSSN 237 (307)
T ss_pred -CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----------HHHHHHhcCCCCCCCch
Confidence 234778899999874 456889999999999999999999988543211 001111101 111 12
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
...+.+.+++.+||+.+|++||++.+|+.+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 3456799999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=269.96 Aligned_cols=244 Identities=23% Similarity=0.244 Sum_probs=178.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeecc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELM 516 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~ 516 (725)
..+|+.++++.+..+ +..||||.+.... ....+.+.+|++++++++|+||+++++++... ...++++|++
T Consensus 25 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (343)
T cd07878 25 SGAYGSVCSAYDTRL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM 102 (343)
T ss_pred cCCCeEEEEEEECCC--CCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC
Confidence 345666666665443 4578999886432 22345688999999999999999999988643 3568999988
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 103 -~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~-------~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 103 -GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNE-------DCELRILDFGLARQADD 170 (343)
T ss_pred -CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECC-------CCCEEEcCCccceecCC
Confidence 678988774 45689999999999999999999999 9999999999999987 78999999999986543
Q ss_pred CCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHH--------
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTD-------- 663 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~-------- 663 (725)
.. ....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ......+
T Consensus 171 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 171 EM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred Cc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 21 22458899999999876 5789999999999999999999999864321100000 0000000
Q ss_pred HHHHHHHc-CCCCh--------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 664 WVLYCVRT-GNLGA--------TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 664 ~~~~~~~~-~~~~~--------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........ ...+. ...+.+.+++.+|++.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00110 123457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=260.93 Aligned_cols=243 Identities=22% Similarity=0.217 Sum_probs=188.3
Q ss_pred cHHHHHHHhcccC-CcceEEEEEEccccc----CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 447 SYQELREATNVFD-GQEVEVAVKQLEKVT----GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~-~~~~~vavk~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+|+.++.+.+... ..+..||+|.+.... ....+.+.+|++++.++ +|+||+++++.+..+...++||||+++++
T Consensus 12 ~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (290)
T cd05613 12 AYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGE 91 (290)
T ss_pred CcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCc
Confidence 4555555554332 345678999886422 22346788999999999 69999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.....+++.....++.|+++||.|||+. +++||||+|+||+++. ++.+||+|||++.........
T Consensus 92 L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~-------~~~~kl~dfg~~~~~~~~~~~ 161 (290)
T cd05613 92 LFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDS-------NGHVVLTDFGLSKEFHEDEVE 161 (290)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECC-------CCCEEEeeCccceeccccccc
Confidence 999998888889999999999999999999998 9999999999999987 789999999999876543333
Q ss_pred cccccccCccccchhcccCC--CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChh
Q 039817 601 TSTMIRGTMGYMAPEWLRNA--PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGAT 677 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 677 (725)
......|+..|+|||.+... .++.++||||||+++|+|++|+.|+...... ....+....... ....+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 234 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-------NSQAEISRRILKSEPPYPQE 234 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-------ccHHHHHHHhhccCCCCCcc
Confidence 22334588899999998753 4678999999999999999999998643211 111122222111 1233445
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
....+.+++.+|++.+|++|| ++++++.+
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 667889999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=250.70 Aligned_cols=227 Identities=21% Similarity=0.221 Sum_probs=183.5
Q ss_pred CcceEEEEEEcccccCc---cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC--CCCCHH
Q 039817 460 GQEVEVAVKQLEKVTGD---GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--EIPTWD 534 (725)
Q Consensus 460 ~~~~~vavk~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~ 534 (725)
+.....|+|.+.+..-. .......|-++|+.++||.|+.||+.++.++..++|||||+||+|...++++ +.+++.
T Consensus 100 ~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~ 179 (459)
T KOG0610|consen 100 GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSES 179 (459)
T ss_pred CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchh
Confidence 33467899998764332 3345678999999999999999999999999999999999999999999887 678999
Q ss_pred HHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc------------------
Q 039817 535 KRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK------------------ 596 (725)
Q Consensus 535 ~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~------------------ 596 (725)
.+.-++..|+.||+|||-. +||.|||||+||||.+ +|.+-|+||.|+.....
T Consensus 180 ~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvre-------dGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~ 249 (459)
T KOG0610|consen 180 AARFYAAEVLLALEYLHML---GIVYRDLKPENILVRE-------DGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPS 249 (459)
T ss_pred hHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEec-------CCcEEeeeccccccCCCCCeeeccCCCCCCCCCcc
Confidence 9999999999999999999 9999999999999988 89999999998743210
Q ss_pred ---------------CCC----------------------ccccccccCccccchhcccCCCCCCccceehhHHHHHHHH
Q 039817 597 ---------------DQT----------------------RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639 (725)
Q Consensus 597 ---------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ell 639 (725)
... .....++||-.|+|||++.+.....+.|.|+|||++|||+
T Consensus 250 ~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmL 329 (459)
T KOG0610|consen 250 CRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEML 329 (459)
T ss_pred cccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHH
Confidence 000 0011256999999999999999999999999999999999
Q ss_pred hCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh--hHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 039817 640 FCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA--TKFERITMVGLWCICPQPTLRPS----MKQVLQM 706 (725)
Q Consensus 640 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dp~~RPs----~~evl~~ 706 (725)
.|..||......+ .+..-+.+ ...++. ..+..+++||++.|.+||++|.- +.||.+|
T Consensus 330 yG~TPFKG~~~~~-------Tl~NIv~~---~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 330 YGTTPFKGSNNKE-------TLRNIVGQ---PLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hCCCCcCCCCchh-------hHHHHhcC---CCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 9999998765432 11111111 112222 45678999999999999999998 8888875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=258.96 Aligned_cols=239 Identities=24% Similarity=0.298 Sum_probs=180.1
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEc------CCceeeeeecccC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIE------QNHQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~lV~e~~~~ 518 (725)
.+|+.++.+.+... +..+++|.+... .....++..|+.+++++ +|+||+++++++.. .+..+++|||+++
T Consensus 27 g~~~~v~~~~~~~~--~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~ 103 (282)
T cd06636 27 GTYGQVYKGRHVKT--GQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGA 103 (282)
T ss_pred CCCeEEEEEEEcCC--CcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCC
Confidence 34555555555433 357888887543 23446788999999998 79999999999853 4578999999999
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 519 GTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 519 gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
|+|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~-------~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 104 GSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTE-------NAEVKLVDFGVSAQLDR 173 (282)
T ss_pred CcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCCEEEeeCcchhhhhc
Confidence 9999998653 4578888999999999999999999 9999999999999987 77899999999876532
Q ss_pred CCCccccccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
... ......++..|+|||.+. ...++.++||||||+++|||++|+.|+........ .. ........
T Consensus 174 ~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-------~~-~~~~~~~~ 244 (282)
T cd06636 174 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------LF-LIPRNPPP 244 (282)
T ss_pred ccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-------hh-hHhhCCCC
Confidence 221 122345888999999875 34678899999999999999999999854321110 00 00000000
Q ss_pred CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......+..+.+++.+||+.||.+||++.|++++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 11112356789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=259.43 Aligned_cols=246 Identities=22% Similarity=0.236 Sum_probs=180.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~ 522 (725)
.++.+++|++..+ +..+++|.++... ......+.+|++++.+++||||+++++++... +..++||||+++ +|.
T Consensus 17 ~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~ 93 (293)
T cd07843 17 TYGVVYRARDKKT--GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLK 93 (293)
T ss_pred CCeEEEEEEECCC--CcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHH
Confidence 3455555555433 4578888876432 22234678899999999999999999999877 899999999985 999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++.........
T Consensus 94 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~-------~~~~~l~d~g~~~~~~~~~~~- 162 (293)
T cd07843 94 SLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNN-------RGILKICDFGLAREYGSPLKP- 162 (293)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECC-------CCcEEEeecCceeeccCCccc-
Confidence 888765 4589999999999999999999999 9999999999999987 789999999999876543211
Q ss_pred ccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----ccCcchHHHHH---------
Q 039817 602 STMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----ANGMILTDWVL--------- 666 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~~~~~~~~~~--------- 666 (725)
.....++..|+|||.+.+. .++.++|+||||++++||++|+.|+.......... ........|..
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 1223467889999998754 46899999999999999999999886432111000 00000000000
Q ss_pred -------HHHHcCCCChh-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 -------YCVRTGNLGAT-KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 -------~~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......++.. ..+.+.+++.+|++.+|++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000111222 36778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=256.42 Aligned_cols=244 Identities=20% Similarity=0.232 Sum_probs=176.6
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
++.++.+.+..++ ..+++|.+.... ......+.+|++++++++|+||+++++++..++..++|+||++ ++|.+++.
T Consensus 18 ~~~v~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~ 94 (291)
T cd07870 18 YATVYKGISRING--QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMI 94 (291)
T ss_pred CEEEEEEEEcCCC--cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHH
Confidence 4444555444433 468888875433 2334567899999999999999999999999999999999996 57776665
Q ss_pred cC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 527 RQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 527 ~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||+++........ ....
T Consensus 95 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~-------~~~~~l~Dfg~~~~~~~~~~~-~~~~ 163 (291)
T cd07870 95 QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISY-------LGELKLADFGLARAKSIPSQT-YSSE 163 (291)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcC-------CCcEEEeccccccccCCCCCC-CCCc
Confidence 43 5678888999999999999999999 9999999999999987 788999999998764332211 1223
Q ss_pred ccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc---------Cc------chHHHHHHHH
Q 039817 606 RGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN---------GM------ILTDWVLYCV 669 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~---------~~------~~~~~~~~~~ 669 (725)
.++..|+|||.+.+. .++.++||||||++++||++|+.|++........... .. ....+.....
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 468899999998754 5788999999999999999999998643221000000 00 0000000000
Q ss_pred HcCCCC---------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 RTGNLG---------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~~~~~~---------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....+ ......+.+++.+|++.||++|||++|++.+
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 244 -LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred -cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 0124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=256.45 Aligned_cols=246 Identities=20% Similarity=0.247 Sum_probs=178.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.++.++++.+..+ +..|+||.+.... ......+.+|++++++++|+||+++++++..++..++||||+++ +|.+++
T Consensus 17 ~~~~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~ 93 (291)
T cd07844 17 SYATVYKGRSKLT--GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYM 93 (291)
T ss_pred CCeEEEEEEEcCC--CcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHH
Confidence 4455555554433 3578999875432 22335678999999999999999999999999999999999985 899988
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
.+. ..+++.....++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||+++........ ...
T Consensus 94 ~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~-------~~~~kl~dfg~~~~~~~~~~~-~~~ 162 (291)
T cd07844 94 DDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISE-------RGELKLADFGLARAKSVPSKT-YSN 162 (291)
T ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcC-------CCCEEECccccccccCCCCcc-ccc
Confidence 764 4678999999999999999999999 9999999999999987 788999999998754322111 112
Q ss_pred cccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc------cCcchHHHHH-----------
Q 039817 605 IRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA------NGMILTDWVL----------- 666 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~------~~~~~~~~~~----------- 666 (725)
..++..|+|||.+.+ ..++.++||||+|+++|||++|+.|+........... .......+..
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 236788999998865 4588999999999999999999998864331100000 0000000000
Q ss_pred ------HHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 ------YCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 ------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...............+.+++.+|++.+|++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000001112677899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=253.91 Aligned_cols=234 Identities=18% Similarity=0.193 Sum_probs=178.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...|+.++.+.+..++ ..+++|.+....... .|+.....+ +|+||+++++.+..++..++||||+++++|.+
T Consensus 26 ~g~~g~v~~~~~~~~~--~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 26 DGKFGKVSVLKHKPTQ--KLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred CCCceEEEEEEEcCCC--cEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 3445566666554443 467787775432111 122222222 79999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC-ceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY-ITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~-~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.....+++..+..++.|+++||.|||+. +++||||||+||+++. ++ .++|+|||++.......
T Consensus 99 ~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~-------~~~~~~l~dfg~~~~~~~~~---- 164 (267)
T PHA03390 99 LLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDR-------AKDRIYLCDYGLCKIIGTPS---- 164 (267)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeC-------CCCeEEEecCccceecCCCc----
Confidence 998877899999999999999999999999 9999999999999987 55 89999999987654322
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
...++..|+|||++.+..++.++||||||++++||++|+.|+....... .....+...............+.+
T Consensus 165 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 165 -CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE------LDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred -cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch------hhHHHHHHhhcccCCcccccCHHH
Confidence 2347889999999998899999999999999999999999987432211 111122221111122333567889
Q ss_pred HHHHHHccCCCCCCCCC-HHHHHHH
Q 039817 683 TMVGLWCICPQPTLRPS-MKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs-~~evl~~ 706 (725)
.+++.+||+.+|.+||+ ++|++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcC
Confidence 99999999999999995 6988854
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=254.63 Aligned_cols=236 Identities=24% Similarity=0.358 Sum_probs=189.2
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.++.+.+.. .+..+++|.+..... ...+.+.+|++++++++|+|++++++.+..++..++|+||+++++|.++
T Consensus 12 ~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (258)
T cd08215 12 SFGKVYLVRRKS--DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQK 89 (258)
T ss_pred CCeEEEEEEEcC--CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHH
Confidence 344444444433 345788888765432 4567799999999999999999999999999999999999999999999
Q ss_pred hccC----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 525 LFRQ----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 525 l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
+.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++........
T Consensus 90 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~-------~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 90 IKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTS-------NGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred HHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcC-------CCcEEECCccceeecccCcc-
Confidence 9764 6789999999999999999999999 9999999999999987 78899999999987654431
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 678 (725)
......++..|+|||...+..++.++||||+|+++++|++|+.|+..... .+....... ...++...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 227 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----------LELALKILKGQYPPIPSQY 227 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----------HHHHHHHhcCCCCCCCCCC
Confidence 12234578899999999888899999999999999999999998854321 111111111 12334456
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+.+++.+|++.+|++|||+.+++++
T Consensus 228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 228 SSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 6789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=262.67 Aligned_cols=253 Identities=20% Similarity=0.225 Sum_probs=183.5
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCCh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTL 521 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL 521 (725)
.++.+++|.+...+.+..+|+|.+.... ....+.+.+|+.++++++||||+++++++... +..++||||+++ +|
T Consensus 12 ~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l 90 (316)
T cd07842 12 TYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DL 90 (316)
T ss_pred CcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CH
Confidence 4555666665543456789999887532 33456788999999999999999999999988 789999999986 66
Q ss_pred hhhhccC-----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 522 SAFLFRQ-----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 522 ~~~l~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
.+++... ..++...+..++.|++.||.|||+. +|+||||||+||+++.+. +.++.+||+|||+++....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~---~~~~~~kl~Dfg~~~~~~~ 164 (316)
T cd07842 91 WQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEG---PERGVVKIGDLGLARLFNA 164 (316)
T ss_pred HHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCC---CccceEEECCCccccccCC
Confidence 6665322 3678899999999999999999999 999999999999997621 2368899999999987543
Q ss_pred CCC--ccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc--cCcchHHHHH-----
Q 039817 597 DQT--RTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--NGMILTDWVL----- 666 (725)
Q Consensus 597 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--~~~~~~~~~~----- 666 (725)
... .......++..|+|||.+.+. .++.++||||||++++||++|+.|+........... ....+...+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 244 (316)
T cd07842 165 PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTP 244 (316)
T ss_pred CcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCC
Confidence 322 112234578889999988664 578999999999999999999999875543320000 0000000000
Q ss_pred ------------------HHHHcCCCC-----------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 ------------------YCVRTGNLG-----------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 ------------------~~~~~~~~~-----------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........+ ......+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 245 TEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred chhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000111 0234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=255.34 Aligned_cols=237 Identities=22% Similarity=0.228 Sum_probs=185.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc-----cCccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV-----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~ 518 (725)
..++.++.+++..++ ..+++|.+... ..+..+.+.+|++++++++|+||+++++++... ...++|+||+++
T Consensus 13 g~~g~v~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~ 90 (264)
T cd06653 13 GAFGEVYLCYDADTG--RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPG 90 (264)
T ss_pred CCCeEEEEEEEcCCC--CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCC
Confidence 345566666665444 46778876321 123345789999999999999999999998764 467899999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
++|.+++.....+++.....++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++......
T Consensus 91 ~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~-------~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 91 GSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDS-------AGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcC-------CCCEEECcccccccccccc
Confidence 99999998777789999999999999999999999 9999999999999987 7789999999998653211
Q ss_pred C--ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH---cCC
Q 039817 599 T--RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR---TGN 673 (725)
Q Consensus 599 ~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 673 (725)
. .......++..|+|||.+.+..++.++||||||++++||++|+.|+..... ...+..... ...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~ 229 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----------MAAIFKIATQPTKPM 229 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----------HHHHHHHHcCCCCCC
Confidence 1 111234578899999999988899999999999999999999999863211 111111111 123
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++....+.+.+++.+|++ +|.+||++.+++.+
T Consensus 230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 455677889999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=258.72 Aligned_cols=224 Identities=21% Similarity=0.291 Sum_probs=173.9
Q ss_pred cceEEEEEEcc--cccCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhhhccCCC-CCHHHH
Q 039817 461 QEVEVAVKQLE--KVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEI-PTWDKR 536 (725)
Q Consensus 461 ~~~~vavk~l~--~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-l~~~~~ 536 (725)
+...+|+|++. ..+.+....|.+|+..|.+|+ |.+||+|++|-..++.+||||||-+ .+|..+|.+... ++-..+
T Consensus 384 ~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~l 462 (677)
T KOG0596|consen 384 DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFL 462 (677)
T ss_pred CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHH
Confidence 34455666543 345666788999999999995 9999999999999999999999865 599999987643 332377
Q ss_pred HHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc-ccccCccccchh
Q 039817 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST-MIRGTMGYMAPE 615 (725)
Q Consensus 537 ~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE 615 (725)
..+..|++.++.++|++ +|||.||||.|+|+- .|.+||+|||+|..+..+...... ..+||+.||+||
T Consensus 463 k~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV--------kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPE 531 (677)
T KOG0596|consen 463 KFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV--------KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPE 531 (677)
T ss_pred HHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE--------eeeEEeeeechhcccCccccceeeccccCcccccCHH
Confidence 78889999999999999 999999999999986 689999999999988877665533 366999999999
Q ss_pred cccCC-----------CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-C--CCCh-hHHH
Q 039817 616 WLRNA-----------PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT-G--NLGA-TKFE 680 (725)
Q Consensus 616 ~~~~~-----------~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~-~~~~ 680 (725)
.+... +.+.+|||||+||+||+|+.|+.||...... ...+...... . .++. ....
T Consensus 532 Al~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----------~aKl~aI~~P~~~Iefp~~~~~~ 601 (677)
T KOG0596|consen 532 ALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----------IAKLHAITDPNHEIEFPDIPEND 601 (677)
T ss_pred HHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH----------HHHHHhhcCCCccccccCCCCch
Confidence 88532 3567899999999999999999999632210 0001111100 0 1222 1122
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+++++++.||+.||++|||+.|++++
T Consensus 602 ~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 602 ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 39999999999999999999999986
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=263.26 Aligned_cols=240 Identities=22% Similarity=0.328 Sum_probs=194.1
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+....|+.+++|.+. ..+...|-|.++..++...+.|+-|+++|+..+||+||+|++.+...+.++++.|||.||-.+
T Consensus 40 LGDGAFGKVyKA~nk--et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 40 LGDGAFGKVYKAVNK--ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hcCccchhhhhhhcc--cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 345678899999887 344566778888777788889999999999999999999999999999999999999999999
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
..+.. .+.+++.++.-++.|++.||.|||++ +|||||||+.|||++. +|.++|+|||.+-..... ...
T Consensus 118 aimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~Tl-------dGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 118 AIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTL-------DGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred HHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEe-------cCcEeeecccccccchhH-Hhh
Confidence 88755 47899999999999999999999999 9999999999999988 889999999997543211 122
Q ss_pred ccccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC---
Q 039817 602 STMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--- 673 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 673 (725)
...+.||+.|||||+.. ..+|+.++||||||+.|.||.-+.+|-.... ....+.......+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----------pMRVllKiaKSePPTL 255 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----------PMRVLLKIAKSEPPTL 255 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----------hHHHHHHHhhcCCCcc
Confidence 23467999999999763 5689999999999999999998777654211 1111111111111
Q ss_pred -CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 -LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 -~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
-|......+.+++..||.+||..||++.++++|
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 123556778999999999999999999999976
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=258.94 Aligned_cols=246 Identities=22% Similarity=0.256 Sum_probs=177.6
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
+++++++.+..+ +..|++|.+.... ....+.+.+|++++++++|+||+++++++..+...++||||++ ++|.+++
T Consensus 15 ~~~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~ 91 (294)
T PLN00009 15 YGVVYKARDRVT--NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHM 91 (294)
T ss_pred CEEEEEEEecCC--CcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHH
Confidence 444555554333 4568888875432 2334678999999999999999999999999999999999996 4788887
Q ss_pred ccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.+ +..+||+|||++........ ...
T Consensus 92 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~------~~~~kl~dfg~~~~~~~~~~-~~~ 161 (294)
T PLN00009 92 DSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRR------TNALKLADFGLARAFGIPVR-TFT 161 (294)
T ss_pred HhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECC------CCEEEEcccccccccCCCcc-ccc
Confidence 5543 357788889999999999999999 99999999999999752 56799999999976543211 112
Q ss_pred ccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc--------------cCcchHHHHHHH
Q 039817 604 MIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--------------NGMILTDWVLYC 668 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~ 668 (725)
...++..|+|||++.+ ..++.++||||||+++|+|++|+.|+........... ....+.++....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF 241 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence 2346788999998865 4578999999999999999999998864321110000 000000000000
Q ss_pred HH--cC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 VR--TG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~~--~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. .. .......+++.+++.+|++.+|++||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 0012345678999999999999999999999974
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=254.06 Aligned_cols=236 Identities=22% Similarity=0.233 Sum_probs=180.8
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHH---hccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVI---GRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+|+.++.|.+.- .+..||+|.+..... .....+..|..++ +..+|+||+++++.+..++..++||||+++++
T Consensus 6 ~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~ 83 (278)
T cd05606 6 GFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 83 (278)
T ss_pred CCeEEEEEEEec--CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCc
Confidence 344555444432 345789998764321 2223345554443 44579999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 84 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~-------~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 84 LHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE-------HGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECC-------CCCEEEccCcCccccCccCC-
Confidence 999998888899999999999999999999998 9999999999999987 78899999999875533221
Q ss_pred cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH--HcCCCChh
Q 039817 601 TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV--RTGNLGAT 677 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 677 (725)
....|+..|+|||.+.++ .++.++||||+|++++||++|+.|+........ ....... ....++..
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 221 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---------HEIDRMTLTMAVELPDS 221 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch---------HHHHHHhhccCCCCCCc
Confidence 123588999999998754 689999999999999999999999875422110 0011111 11233444
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
....+.+++.+|++.+|.+|| ++.+++++
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 568899999999999999999 99999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=267.20 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=196.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
....|.+++.|+...++ ..||||.+.+... .....+.+|+++|+.+.|||||+++.+.+....+|+||||+.+|.+
T Consensus 65 g~g~f~~V~La~~~~t~--~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~ 142 (596)
T KOG0586|consen 65 GKGNFAKVKLARHILTG--TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGEL 142 (596)
T ss_pred ccceeEEEEeeEecCCC--ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchh
Confidence 34556677777777664 5788998876433 3345689999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+|+.+.+.........++.|+.+|++|||++ .|+|||||++||||+. +.++||+|||++..+.... .
T Consensus 143 ~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~-------~mnikIaDfgfS~~~~~~~--~ 210 (596)
T KOG0586|consen 143 FDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDE-------NMNIKIADFGFSTFFDYGL--M 210 (596)
T ss_pred HHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhccccc-------ccceeeeccccceeecccc--c
Confidence 99999998888899999999999999999999 9999999999999988 7889999999998776332 2
Q ss_pred ccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (725)
....+|++.|.|||.+.+.++ .++.|+||+|++||-|+.|..||+.....+ +.+.+. ...-.++.....
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------Lr~rvl--~gk~rIp~~ms~ 280 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------LRPRVL--RGKYRIPFYMSC 280 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--------ccchhe--eeeecccceeec
Confidence 344679999999999998876 478999999999999999999998643221 111110 011234445567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+++++++-.+|.+|++++++.++
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhhh
Confidence 88899999999999999999999865
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=239.77 Aligned_cols=227 Identities=25% Similarity=0.352 Sum_probs=178.0
Q ss_pred CcceEEEEEEcccc-cCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHH
Q 039817 460 GQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKR 536 (725)
Q Consensus 460 ~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~ 536 (725)
..+..+|||.+... +....+.++..++++.+-+ .|.||+.+|+|..+....+.||.|.. .+++.+.+- +++++...
T Consensus 115 s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~il 193 (391)
T KOG0983|consen 115 STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERIL 193 (391)
T ss_pred ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhh
Confidence 34578999998654 3445567888999887765 89999999999999999999999964 455555443 67888889
Q ss_pred HHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhc
Q 039817 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEW 616 (725)
Q Consensus 537 ~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~ 616 (725)
-++...+++||.||.++ .+|+|||+||+|||+|+ .|++|++|||++-.+.... ..+...|-+.|||||.
T Consensus 194 Gk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe-------~GniKlCDFGIsGrlvdSk--AhtrsAGC~~YMaPER 262 (391)
T KOG0983|consen 194 GKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDE-------RGNIKLCDFGISGRLVDSK--AHTRSAGCAAYMAPER 262 (391)
T ss_pred hhhHHHHHHHHHHHHHh--cceeecccCccceEEcc-------CCCEEeecccccceeeccc--ccccccCCccccCccc
Confidence 99999999999999877 48999999999999988 8999999999997654332 2233458889999999
Q ss_pred ccC---CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC--hhHHHHHHHHHHHccC
Q 039817 617 LRN---APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG--ATKFERITMVGLWCIC 691 (725)
Q Consensus 617 ~~~---~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~ 691 (725)
+.- ..|+.++||||||+.|+||.||+.|+.....+... +...+... ...++ ....+.+++++..||+
T Consensus 263 idp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~------ltkvln~e--PP~L~~~~gFSp~F~~fv~~CL~ 334 (391)
T KOG0983|consen 263 IDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV------LTKVLNEE--PPLLPGHMGFSPDFQSFVKDCLT 334 (391)
T ss_pred cCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH------HHHHHhcC--CCCCCcccCcCHHHHHHHHHHhh
Confidence 863 47899999999999999999999999876544321 11111100 01111 1356789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 039817 692 PQPTLRPSMKQVLQM 706 (725)
Q Consensus 692 ~dp~~RPs~~evl~~ 706 (725)
+|+.+||...+++++
T Consensus 335 kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 335 KDHRKRPKYNKLLEH 349 (391)
T ss_pred cCcccCcchHHHhcC
Confidence 999999999999876
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.06 Aligned_cols=247 Identities=24% Similarity=0.258 Sum_probs=183.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~ 522 (725)
.++.+++++..-. +..+++|.+.... ....+.+.+|++++++++|+|++++++++... +..++||||+++ +|.
T Consensus 11 ~~~~vy~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 87 (287)
T cd07840 11 TYGQVYKARNKKT--GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLT 87 (287)
T ss_pred CCeEEEEEEECCC--CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHH
Confidence 3455555554433 4578899886542 33446788999999999999999999999988 899999999985 898
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++.+. ..+++..+..++.|+++||+|||+. +++|+||+|+||++++ ++.+||+|||++..........
T Consensus 88 ~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~-------~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 88 GLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINN-------DGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcC-------CCCEEEccccceeeccCCCccc
Confidence 888765 5789999999999999999999998 9999999999999987 8899999999998765443222
Q ss_pred ccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----cCcchHHH--------HHH
Q 039817 602 STMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----NGMILTDW--------VLY 667 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----~~~~~~~~--------~~~ 667 (725)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.|++.......... .......+ ...
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223346788999998764 4678999999999999999999998864332110000 00000000 000
Q ss_pred HHH--------cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 668 CVR--------TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 668 ~~~--------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... ...+.....+.+.+++.+|++.+|.+||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 000111125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=258.32 Aligned_cols=247 Identities=21% Similarity=0.221 Sum_probs=176.8
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCc-----eeeeeecccC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNH-----QLLVYELMKN 518 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~-----~~lV~e~~~~ 518 (725)
.++.++++.+..+ +..|++|.+.... ......+.+|+.+++++ +|+||+++++++...+. .++||||+++
T Consensus 13 ~~g~vy~~~~~~~--~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 90 (295)
T cd07837 13 TYGKVYKARDKNT--GKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS 90 (295)
T ss_pred CCeEEEEEEECCC--CcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc
Confidence 4455666655443 3567888765322 22346788999999999 57999999999987665 8999999986
Q ss_pred CChhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 519 GTLSAFLFRQ-----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 519 gsL~~~l~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.+ ++.+||+|||+++.
T Consensus 91 -~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~------~~~~kl~dfg~~~~ 160 (295)
T cd07837 91 -DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQ------KGLLKIADLGLGRA 160 (295)
T ss_pred -CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecC------CCeEEEeeccccee
Confidence 788887543 3579999999999999999999999 99999999999999763 67899999999886
Q ss_pred cCcCCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc--------------ccC
Q 039817 594 LKKDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL--------------ANG 658 (725)
Q Consensus 594 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~--------------~~~ 658 (725)
....... .....+++.|+|||++.+ ..++.++||||||+++|||++|..|+.......... ...
T Consensus 161 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 5332211 112236778999998865 457899999999999999999998886432110000 000
Q ss_pred cchHHHHHHHH-H---cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 659 MILTDWVLYCV-R---TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 659 ~~~~~~~~~~~-~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+..... . .........+.+.+++.+||+.||.+||+++|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 0 000011345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=263.48 Aligned_cols=244 Identities=24% Similarity=0.240 Sum_probs=180.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeeccc
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELMK 517 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~~ 517 (725)
..++.++.+.+..+ +..||+|.+... .....+.+.+|+.++++++|+||+++++++... ...++||||++
T Consensus 27 g~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~ 104 (353)
T cd07850 27 GAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD 104 (353)
T ss_pred CCCEEEEEEEECCC--CCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC
Confidence 34555666665544 357899987542 233445788999999999999999999998643 35799999997
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+ +|.+.+... ++...+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++.....
T Consensus 105 ~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~-------~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 105 A-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS-------DCTLKILDFGLARTAGTS 171 (353)
T ss_pred C-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECC-------CCCEEEccCccceeCCCC
Confidence 5 888887544 88899999999999999999999 9999999999999987 788999999999865433
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc------cc-cCcchHHH----HH
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT------LA-NGMILTDW----VL 666 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~------~~-~~~~~~~~----~~ 666 (725)
.. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+......... .. ......+. ..
T Consensus 172 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 FM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 22 12234788999999999999999999999999999999999988643211000 00 00000000 00
Q ss_pred HHHHcCC---------------C-------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 YCVRTGN---------------L-------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 ~~~~~~~---------------~-------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....... . .....+.+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0 11235678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=258.53 Aligned_cols=239 Identities=23% Similarity=0.275 Sum_probs=190.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..++.++++++.-+ +..+++|.+... .....+.+.+|++++++++ |+||+++++++..++..++|||++++++|
T Consensus 12 g~~~~vy~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (280)
T cd05581 12 GSFSTVVLAKEKET--NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGEL 89 (280)
T ss_pred CCceEEEEEEEcCC--CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcH
Confidence 34555666655443 456777876542 2234567899999999998 99999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC--
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-- 599 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~-- 599 (725)
.+++.+...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.++++|||++........
T Consensus 90 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~-------~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 90 LQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDK-------DMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECC-------CCCEEecCCccccccCCccccc
Confidence 99998888899999999999999999999998 9999999999999987 78999999999886543321
Q ss_pred -----------------ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchH
Q 039817 600 -----------------RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILT 662 (725)
Q Consensus 600 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~ 662 (725)
.......++..|+|||......++.++||||||++++++++|+.|+...... . ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~ 231 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------L-TF 231 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------H-HH
Confidence 1112345788999999998888999999999999999999999998744310 0 00
Q ss_pred HHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 039817 663 DWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSM----KQVLQM 706 (725)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~----~evl~~ 706 (725)
.... .....++...++.+.+++.+||+.+|.+||++ ++++++
T Consensus 232 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111 12234555667889999999999999999999 777764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=244.71 Aligned_cols=229 Identities=25% Similarity=0.289 Sum_probs=176.9
Q ss_pred eEEEEEEccc-ccCccHHHHHHHHHHHhccCcCCccceeeEEEcC-CceeeeeecccCCChhhhhc-----cC---CCCC
Q 039817 463 VEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-NHQLLVYELMKNGTLSAFLF-----RQ---EIPT 532 (725)
Q Consensus 463 ~~vavk~l~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~-----~~---~~l~ 532 (725)
+.|-||.++. .++-+...|+.|.-.+..++|||+.++.+++.+. ...+++|.++.-|+|+.||. +. +.++
T Consensus 315 q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvt 394 (563)
T KOG1024|consen 315 QEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVT 394 (563)
T ss_pred HHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchh
Confidence 3455555543 2333445688899999999999999999999864 57899999999999999997 21 3567
Q ss_pred HHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc-CcCCCccccccccCccc
Q 039817 533 WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTMIRGTMGY 611 (725)
Q Consensus 533 ~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~-~~~~~~~~~~~~gt~~y 611 (725)
-.+...++.|++.|++|||+. ++||.||.++|+++|+ ..++||+|-.+++-+ ..+..........+..|
T Consensus 395 t~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd-------~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkW 464 (563)
T KOG1024|consen 395 TIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD-------QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKW 464 (563)
T ss_pred HHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh-------heeEEeccchhccccCcccccccCCCCCCcccc
Confidence 788999999999999999999 9999999999999988 899999999999854 33332222223357789
Q ss_pred cchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHcc
Q 039817 612 MAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCI 690 (725)
Q Consensus 612 ~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 690 (725)
|+||.+.+..|+.++||||||++||||+| |+.|+..-++. .+..++.+-.+ -.-|-..++++..++.-||
T Consensus 465 MslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--------Em~~ylkdGyR-laQP~NCPDeLf~vMacCW 535 (563)
T KOG1024|consen 465 MSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--------EMEHYLKDGYR-LAQPFNCPDELFTVMACCW 535 (563)
T ss_pred cCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--------HHHHHHhccce-ecCCCCCcHHHHHHHHHHH
Confidence 99999999999999999999999999997 55665422111 11111111110 1234467899999999999
Q ss_pred CCCCCCCCCHHHHHHHhcCC
Q 039817 691 CPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 691 ~~dp~~RPs~~evl~~L~~~ 710 (725)
...|++||+++|++.-|.+.
T Consensus 536 allpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 536 ALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred hcCcccCCCHHHHHHHHHHH
Confidence 99999999999999988653
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=260.79 Aligned_cols=240 Identities=21% Similarity=0.264 Sum_probs=176.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC--------ceeeeeec
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--------HQLLVYEL 515 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------~~~lV~e~ 515 (725)
..++.+++|.+..+ +..||||.+... .......+.+|++++++++||||++++++|.... ..++||||
T Consensus 23 g~~~~v~~~~~~~~--~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~ 100 (310)
T cd07865 23 GTFGEVFKARHKKT--KQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF 100 (310)
T ss_pred CCCEEEEEEEECCC--CcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcC
Confidence 34555666655543 457888877532 2223445678999999999999999999987654 45999999
Q ss_pred ccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 516 MKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 516 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
+++ +|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++...
T Consensus 101 ~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~-------~~~~kl~dfg~~~~~ 169 (310)
T cd07865 101 CEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITK-------DGILKLADFGLARAF 169 (310)
T ss_pred CCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECC-------CCcEEECcCCCcccc
Confidence 975 788777654 3689999999999999999999999 9999999999999987 789999999999865
Q ss_pred CcCCCc---cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH--
Q 039817 595 KKDQTR---TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-- 668 (725)
Q Consensus 595 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 668 (725)
...... ......++..|+|||.+.+. .++.++||||||++++||++|+.++........ ...+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~--------~~~~~~~~~ 241 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ--------LTLISQLCG 241 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHHHhC
Confidence 432221 11223467889999988654 478899999999999999999988764321100 0000000
Q ss_pred ---------------HHcCCC-------------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 ---------------VRTGNL-------------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ---------------~~~~~~-------------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...... .......+.+++.+||+.||.+|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 00123567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=257.19 Aligned_cols=239 Identities=23% Similarity=0.260 Sum_probs=178.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCC----------ceeeeee
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN----------HQLLVYE 514 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----------~~~lV~e 514 (725)
.++.+++++..-+ +..|++|.++... ......+.+|++++++++||||+++++++.... ..++|+|
T Consensus 19 ~~g~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e 96 (302)
T cd07864 19 TYGQVYKARDKDT--GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE 96 (302)
T ss_pred CCEEEEEEEECCC--CcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEc
Confidence 4455555555433 3467888875432 333457789999999999999999999987654 7899999
Q ss_pred cccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 515 LMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 515 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
|+++ +|.+.+... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++ ++.+||+|||++..
T Consensus 97 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~-------~~~~kl~dfg~~~~ 165 (302)
T cd07864 97 YMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNN-------KGQIKLADFGLARL 165 (302)
T ss_pred ccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC-------CCcEEeCccccccc
Confidence 9986 676766554 5689999999999999999999999 9999999999999987 78999999999987
Q ss_pred cCcCCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-
Q 039817 594 LKKDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT- 671 (725)
Q Consensus 594 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 671 (725)
.............++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ....+......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--------~~~~~~~~~~~~ 237 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--------QLELISRLCGSP 237 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHhCCC
Confidence 65433222222335778999998864 457899999999999999999998886432110 00000000000
Q ss_pred ---------------------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 ---------------------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ---------------------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......+..+.+++..||+.+|.+||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011235678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=255.48 Aligned_cols=237 Identities=23% Similarity=0.323 Sum_probs=178.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHH-HhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQV-IGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..|++++++.+..+ +..||+|.++... ......+..|+.. ++.++|+||+++++++..++..++||||++ ++|.+
T Consensus 12 g~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~ 88 (283)
T cd06617 12 GAYGVVDKMRHVPT--GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDK 88 (283)
T ss_pred cCCeEEEEEEEcCC--CcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHH
Confidence 34566666665533 4678899876432 2344567777776 555789999999999999999999999997 58877
Q ss_pred hhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 524 FLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 524 ~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
++.. ...+++..+..++.|++.||.|||+. .+++||||||+||+++. ++.+||+|||++........
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~-------~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 89 FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINR-------NGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECC-------CCCEEEeecccccccccccc
Confidence 7643 24689999999999999999999974 27999999999999987 78999999999986543221
Q ss_pred ccccccccCccccchhcccC----CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CC
Q 039817 600 RTSTMIRGTMGYMAPEWLRN----APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GN 673 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 673 (725)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... .+........ ..
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------~~~~~~~~~~~~~~ 227 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----------FQQLKQVVEEPSPQ 227 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----------HHHHHHHHhcCCCC
Confidence 122347888999998865 45688999999999999999999998532211 0111111111 11
Q ss_pred CC-hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 LG-ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ~~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+ ...++.+.+++.+||+.+|++||++++++++
T Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 2345789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=258.12 Aligned_cols=248 Identities=25% Similarity=0.241 Sum_probs=179.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gs 520 (725)
...++.++++.+..++ ..||+|.+.... ......+.+|++++++++|+||+++++++... +..++||||+++ +
T Consensus 17 ~g~~~~v~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~ 93 (309)
T cd07845 17 EGTYGIVYRARDTTSG--EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-D 93 (309)
T ss_pred ecCCEEEEEEEECCCC--cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-C
Confidence 3455666666655444 467888775322 22234567899999999999999999998765 468999999975 7
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 94 l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~-------~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 94 LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTD-------KGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC-------CCCEEECccceeeecCCccC
Confidence 88887653 6789999999999999999999999 9999999999999987 78999999999987653321
Q ss_pred ccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc--cc--CcchHHHHHHHH-----
Q 039817 600 RTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL--AN--GMILTDWVLYCV----- 669 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~----- 669 (725)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... .. .... .......
T Consensus 164 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (309)
T cd07845 164 P-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPL 241 (309)
T ss_pred C-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC-hhhchhhhcccc
Confidence 1 122235778999999865 467899999999999999999999886432111000 00 0000 0000000
Q ss_pred ------HcCCC------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 670 ------RTGNL------GATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 670 ------~~~~~------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
..... .....+.+.+++.+|++.||++|||++|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00000 011356678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=249.44 Aligned_cols=206 Identities=22% Similarity=0.174 Sum_probs=165.9
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL 541 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ 541 (725)
+..+++|.+.... .+.+|...+....||||+++++++...+..++||||+++++|.+++.+...+++..+..++.
T Consensus 18 ~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ 92 (237)
T cd05576 18 QQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAA 92 (237)
T ss_pred CcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHH
Confidence 3468999886432 34455566666679999999999999999999999999999999998777899999999999
Q ss_pred HHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCC
Q 039817 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP 621 (725)
Q Consensus 542 qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 621 (725)
|+++||.|||+. +++||||||+||+++. ++.++++|||.+....... ....++..|+|||.+....
T Consensus 93 ql~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~ 158 (237)
T cd05576 93 EMVVALDALHRE---GIVCRDLNPNNILLDD-------RGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVGGISE 158 (237)
T ss_pred HHHHHHHHHHhC---CeeccCCCHHHEEEcC-------CCCEEEecccchhcccccc----ccCCcCccccCCcccCCCC
Confidence 999999999998 9999999999999987 7789999999876554321 1223567799999998888
Q ss_pred CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCH
Q 039817 622 VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSM 700 (725)
Q Consensus 622 ~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 700 (725)
++.++||||+|++++||++|+.++........ .. .....+....+.+.+++.+|++.||++||++
T Consensus 159 ~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 159 ETEACDWWSLGAILFELLTGKTLVECHPSGIN---TH-----------TTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CCchhhHHHHHHHHHHHHHCcchhhcCchhcc---cc-----------cccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 99999999999999999999987653211100 00 0112334456778999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=262.78 Aligned_cols=242 Identities=24% Similarity=0.264 Sum_probs=182.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCcc--------------HHHHHHHHHHHhccCcCCccceeeEEEcCCcee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDG--------------EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL 510 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 510 (725)
..+++.++++.+... +..||||.+....... ...+.+|++++++++|+||+++++++..++..+
T Consensus 19 ~G~~g~vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 96 (335)
T PTZ00024 19 EGTYGKVEKAYDTLT--GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN 96 (335)
T ss_pred CCCceeEEEEEECCC--CCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEE
Confidence 345666666665543 4567888775432211 125789999999999999999999999999999
Q ss_pred eeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccC
Q 039817 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590 (725)
Q Consensus 511 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgl 590 (725)
+||||++ ++|.+++.....+++.....++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||+
T Consensus 97 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~-------~~~~kl~dfg~ 165 (335)
T PTZ00024 97 LVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINS-------KGICKIADFGL 165 (335)
T ss_pred EEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECC-------CCCEEECCccc
Confidence 9999997 59999998777899999999999999999999998 9999999999999987 78999999999
Q ss_pred ccccCcCC-------------CccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc
Q 039817 591 AKLLKKDQ-------------TRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA 656 (725)
Q Consensus 591 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~ 656 (725)
+....... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--- 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ--- 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 98654111 1111123367789999998764 468999999999999999999998864432110
Q ss_pred cCcchHHHHHHHHHc-------------------C-------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 657 NGMILTDWVLYCVRT-------------------G-------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 657 ~~~~~~~~~~~~~~~-------------------~-------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
...+...... . .......+.+.+++.+|++.+|++||+++|++.+-
T Consensus 243 -----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 243 -----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred -----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 0000000000 0 00112356788999999999999999999999754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=255.90 Aligned_cols=213 Identities=18% Similarity=0.157 Sum_probs=158.4
Q ss_pred HHHHHHhccCcCCccceeeEEEcCC----ceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCce
Q 039817 483 REVQVIGRTHHKNLVQLLGFCIEQN----HQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558 (725)
Q Consensus 483 ~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 558 (725)
.+...+..++|+|++++++.+.... ..++++|++.. ++.+.+......++..+..++.|++.||.|||+. +|
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i 147 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GI 147 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3344556678999999999876543 34677777654 6666665555568888999999999999999999 99
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC------ccccccccCccccchhcccCCCCCCccceehhH
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT------RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G 632 (725)
+||||||+|||++. ++.+||+|||+++.+..... .......||+.|+|||.+.+..++.++||||||
T Consensus 148 iHrDiKp~Nill~~-------~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG 220 (294)
T PHA02882 148 SHGDIKPENIMVDG-------NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLG 220 (294)
T ss_pred ecCCCCHHHEEEcC-------CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHH
Confidence 99999999999987 77899999999986643221 111224599999999999999999999999999
Q ss_pred HHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 633 ~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
++++||++|+.||.......... .....++..+...........++.+.+++..|++.+|++||++.++++.|+
T Consensus 221 ~~l~el~~g~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 221 YCMLKWAGIKLPWKGFGHNGNLI--HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhCCCCCCccccchHHH--HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 99999999999997553221100 001112222221111112234678999999999999999999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=248.85 Aligned_cols=232 Identities=25% Similarity=0.235 Sum_probs=184.8
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
++.++.+++.. .+..+++|.+..... .....+..|++++++++|+||+++++.+..++..++||||+++++|.++
T Consensus 6 ~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 83 (250)
T cd05123 6 FGKVLLVRKKD--TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSH 83 (250)
T ss_pred ceEEEEEEECC--CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHH
Confidence 33444444432 345788887754322 2456789999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.....+++.....++.|++.||.|||+. +++|+||+|+||+++. ++.++|+|||++........ ....
T Consensus 84 l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~-------~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 84 LSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDA-------DGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcC-------CCcEEEeecCcceecccCCC-cccC
Confidence 98887899999999999999999999998 9999999999999987 77899999999986544321 1223
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITM 684 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 684 (725)
..++..|+|||.+.+...+.++|+||||++++|+++|+.|+..... ......+.. ....++...+..+.+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~--~~~~~~~~~~~~l~~ 222 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK--DPLRFPEFLSPEARD 222 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc--CCCCCCCCCCHHHHH
Confidence 4578899999999888889999999999999999999999864321 011111111 123445555788999
Q ss_pred HHHHccCCCCCCCCCHHH
Q 039817 685 VGLWCICPQPTLRPSMKQ 702 (725)
Q Consensus 685 l~~~cl~~dp~~RPs~~e 702 (725)
++.+|+..||++||++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 223 LISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHhcCCHhhCCCccc
Confidence 999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=263.67 Aligned_cols=248 Identities=22% Similarity=0.274 Sum_probs=183.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEc----CCceeeeeecccCCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIE----QNHQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~gs 520 (725)
.++.++.+++..+ +..|++|.+.... ....+.+.+|+.++++++|+||+++++++.. ....++||||+. ++
T Consensus 17 ~~g~v~~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~ 93 (334)
T cd07855 17 AYGVVCSAIDTRS--GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SD 93 (334)
T ss_pred CCeEEEEEEEcCC--CCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hh
Confidence 3445555555444 3578889876432 2345678899999999999999999998763 346799999996 58
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.....+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||++.........
T Consensus 94 l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~-------~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 94 LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNE-------DCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC-------CCcEEecccccceeecccCcC
Confidence 999998778899999999999999999999998 9999999999999987 889999999999765432221
Q ss_pred c---ccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc------------ccCcchHHH
Q 039817 601 T---STMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL------------ANGMILTDW 664 (725)
Q Consensus 601 ~---~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~------------~~~~~~~~~ 664 (725)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .......+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 1 122458889999998865 468899999999999999999999986532211000 000000111
Q ss_pred HHHHHHc----CCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 665 VLYCVRT----GNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 665 ~~~~~~~----~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
+...... ...+ ...++.+.+++.+|++.+|++||++++++.+-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 1111110 1111 22467899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=264.45 Aligned_cols=215 Identities=22% Similarity=0.264 Sum_probs=180.0
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
....+||++.+. ...-.+|+.++.+. +|+||+++.+.+.++.+.++|||.+.++-|.+.+...+... ..+.+|+
T Consensus 347 ~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~ 421 (612)
T KOG0603|consen 347 DQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWA 421 (612)
T ss_pred ccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHH
Confidence 345677777654 22335677777766 79999999999999999999999999998888887766555 8888999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEec-cCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLD-NNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN 619 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~-~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 619 (725)
.+++.++.|||++ +++||||||+|||++ + .++++|+|||.++....+ ....+-|..|.|||.+..
T Consensus 422 ~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~-------~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~ 487 (612)
T KOG0603|consen 422 AELVSAVDYLHEQ---GVVHRDLKPGNILLDGS-------AGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAI 487 (612)
T ss_pred HHHHHHHHHHHhc---CeeecCCChhheeecCC-------CCcEEEEEechhhhCchh----hcccchhhcccChhhhcc
Confidence 9999999999999 999999999999995 4 789999999999976655 122346788999999999
Q ss_pred CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCC
Q 039817 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPS 699 (725)
Q Consensus 620 ~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 699 (725)
..+++++|+||||++||+|++|+.|+.....+ ..+...+..+......++..++|+.+||+.||.+||+
T Consensus 488 ~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~ 556 (612)
T KOG0603|consen 488 QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLG 556 (612)
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcC
Confidence 99999999999999999999999999865432 2344445556666778889999999999999999999
Q ss_pred HHHHHHH
Q 039817 700 MKQVLQM 706 (725)
Q Consensus 700 ~~evl~~ 706 (725)
|.++..+
T Consensus 557 ~~~i~~h 563 (612)
T KOG0603|consen 557 ADEIGAH 563 (612)
T ss_pred hhhhccC
Confidence 9999876
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=262.96 Aligned_cols=251 Identities=25% Similarity=0.287 Sum_probs=185.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcC-----CceeeeeecccCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-----NHQLLVYELMKNG 519 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~g 519 (725)
.++.++.+.+.. .+..|+||.+... .......+.+|+.++++++|+||+++++++... ...++||||+. +
T Consensus 17 ~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~ 93 (337)
T cd07858 17 AYGIVCSAKNSE--TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-T 93 (337)
T ss_pred CCeEEEEEEecC--CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-C
Confidence 455556555543 3457888887642 233455678999999999999999999988754 35799999997 6
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.....+++.....++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++.......
T Consensus 94 ~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~-------~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 94 DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNA-------NCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcC-------CCCEEECcCccccccCCCcc
Confidence 8999998878899999999999999999999999 9999999999999987 78899999999986543321
Q ss_pred ccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--------------c--ccCcchH
Q 039817 600 RTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--------------L--ANGMILT 662 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--------------~--~~~~~~~ 662 (725)
......++..|+|||.+.+ ..++.++||||||+++++|++|+.|+......... . .......
T Consensus 164 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 164 -FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred -cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 1222347888999998765 46899999999999999999999998643211000 0 0000000
Q ss_pred HHHHHHHHcCC-----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCC
Q 039817 663 DWVLYCVRTGN-----LGATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTS 711 (725)
Q Consensus 663 ~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~ 711 (725)
.++........ ......+.+.+++.+||+.+|++|||++|++++ ++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 11100000000 011345678999999999999999999999988 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=254.66 Aligned_cols=222 Identities=24% Similarity=0.299 Sum_probs=174.3
Q ss_pred ceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc-CCCCCHHHHH
Q 039817 462 EVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR-QEIPTWDKRV 537 (725)
Q Consensus 462 ~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~ 537 (725)
+..+++|.+... .....+.+.+|++++++++|+|++++++++..++..++||||+. |+|.+++.. ...+++..+.
T Consensus 40 ~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~ 118 (308)
T cd06634 40 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA 118 (308)
T ss_pred CcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHH
Confidence 356788877532 22234568899999999999999999999999999999999997 578777643 4568999999
Q ss_pred HHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcc
Q 039817 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617 (725)
Q Consensus 538 ~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 617 (725)
.++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++...... ....++..|+|||.+
T Consensus 119 ~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~-------~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~ 183 (308)
T cd06634 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSE-------PGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVI 183 (308)
T ss_pred HHHHHHHHHHHHHHhC---CcccCCCCHHhEEECC-------CCcEEECCcccceeecCc-----ccccCCccccCHHHH
Confidence 9999999999999998 9999999999999977 788999999998765432 223478899999987
Q ss_pred c---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---CCChhHHHHHHHHHHHccC
Q 039817 618 R---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG---NLGATKFERITMVGLWCIC 691 (725)
Q Consensus 618 ~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~ 691 (725)
. ...++.++||||||+++|||++|+.|+...... +......... .........+.+++.+||+
T Consensus 184 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 252 (308)
T cd06634 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252 (308)
T ss_pred hhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----------HHHHHHhhcCCCCcCcccccHHHHHHHHHHhh
Confidence 4 356788999999999999999999987543211 0111111111 1122456778999999999
Q ss_pred CCCCCCCCHHHHHHHhcCC
Q 039817 692 PQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 692 ~dp~~RPs~~evl~~L~~~ 710 (725)
.+|++||++.+++++.--.
T Consensus 253 ~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 253 KIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred CCcccCCCHHHHhhCcccc
Confidence 9999999999999885433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=247.63 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=196.1
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCcc-----HHHHHHHHHHHhccCcCCccceeeEEE-cCCceeeeeecc
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDG-----EKSFLREVQVIGRTHHKNLVQLLGFCI-EQNHQLLVYELM 516 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~-----~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~ 516 (725)
+.+..|+||++|.+......++|+|..+.+.-.+. .+...+|.++-+.|+||.||++|+++. +.+.+|-|.||+
T Consensus 471 LGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYc 550 (775)
T KOG1151|consen 471 LGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYC 550 (775)
T ss_pred hccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeec
Confidence 35678999999999887766666665564432222 234678999999999999999999997 456889999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++.+|+-||..++.++++....|+.||+.||.||.+. .++|||-||||.||||.+. +.-+.+||.||||++++..
T Consensus 551 eGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~G----tacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 551 EGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNG----TACGEIKITDFGLSKIMDD 625 (775)
T ss_pred CCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecC----cccceeEeeecchhhhccC
Confidence 9999999999999999999999999999999999986 6799999999999999764 3478999999999999876
Q ss_pred CCCcc------ccccccCccccchhcccC----CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHH
Q 039817 597 DQTRT------STMIRGTMGYMAPEWLRN----APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL 666 (725)
Q Consensus 597 ~~~~~------~~~~~gt~~y~aPE~~~~----~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (725)
+.... .....||..|++||.+.- .+++.|.||||.||++|..+.|+.||.-.......+...-.+.
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk---- 701 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK---- 701 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc----
Confidence 54432 234679999999998853 3578899999999999999999999974432211111100000
Q ss_pred HHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 667 YCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 667 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
..-..-+..+....+...+|++||+..-++|....++..
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 000011122245567889999999999999998888765
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=257.21 Aligned_cols=232 Identities=25% Similarity=0.302 Sum_probs=179.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+++.++.+++..+ +..|++|.+..... ...+.+.+|++++++++|+|++++++++.+++..++||||+. ++|.
T Consensus 32 g~~g~v~~~~~~~~--~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~ 108 (313)
T cd06633 32 GSFGAVYFATNSHT--NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSAS 108 (313)
T ss_pred CCCeEEEEEEECCC--CcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHH
Confidence 35556666665444 35678888754322 233568899999999999999999999999999999999996 4777
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++......
T Consensus 109 ~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~-------~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 109 DLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTE-------PGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECC-------CCCEEEeecCCCcccCCC----
Confidence 77654 45689999999999999999999998 9999999999999977 778999999998643221
Q ss_pred ccccccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---CCC
Q 039817 602 STMIRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG---NLG 675 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 675 (725)
....++..|+|||++. ...++.++||||||++++||++|..|+...... .......... ...
T Consensus 175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~ 242 (313)
T cd06633 175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQNDSPTLQS 242 (313)
T ss_pred -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCCCCc
Confidence 2245788999999984 456889999999999999999999988643211 1111111111 111
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......+.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2334578999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=242.66 Aligned_cols=256 Identities=21% Similarity=0.238 Sum_probs=192.0
Q ss_pred cccccHHHHHHHhcccCCc--ceEEEEEEcccccCc--cHHHHHHHHHHHhccCcCCccceeeEEEc-CCceeeeeeccc
Q 039817 443 MKVFSYQELREATNVFDGQ--EVEVAVKQLEKVTGD--GEKSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQLLVYELMK 517 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~--~~~vavk~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~ 517 (725)
+.+.+|+.+++|...-... ...+|+|+++..... ......+|+.+++.++|+|++.|..++.. +...+|++||.+
T Consensus 32 Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE 111 (438)
T KOG0666|consen 32 IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE 111 (438)
T ss_pred ecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh
Confidence 5678899999996655544 348899999754322 23457799999999999999999999887 778999999999
Q ss_pred CCChhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 518 NGTLSAFLFRQ-----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 518 ~gsL~~~l~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
. +|...++-+ +.++-..+..|+.||+.|+.|||++ -|+||||||.|||+..+. .+.|.+||+|+|+++
T Consensus 112 h-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdg---perG~VKIaDlGlaR 184 (438)
T KOG0666|consen 112 H-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDG---PERGRVKIADLGLAR 184 (438)
T ss_pred h-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccC---CccCeeEeecccHHH
Confidence 8 777776432 4678889999999999999999999 999999999999997642 226999999999999
Q ss_pred ccCcCCCcc--ccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 593 LLKKDQTRT--STMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 593 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
++.+.-... ...++-|.-|.|||.+.+. .|+++.|||+.||++.||++-.+.|...+...... .....+.+.+.+
T Consensus 185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~--~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 185 LFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTK--NPFQHDQLDRIF 262 (438)
T ss_pred HhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccC--CCchHHHHHHHH
Confidence 887653322 2235578899999998875 68999999999999999999998887654332211 011111111111
Q ss_pred Hc-C-----------CCCh--------------------------hHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 670 RT-G-----------NLGA--------------------------TKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 670 ~~-~-----------~~~~--------------------------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
.- + .+|. ...+...+|+.++|+.||.+|.|+++.+++.
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 10 0 0000 1122367788999999999999999998875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=250.80 Aligned_cols=246 Identities=22% Similarity=0.278 Sum_probs=180.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.++.+++|++..+ +..|+||.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+++ +|.+++
T Consensus 12 ~~~~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 88 (284)
T cd07836 12 TYATVYKGRNRTT--GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYM 88 (284)
T ss_pred CceEEEEEEECCC--CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHH
Confidence 3445556665433 45788888764332 2346788999999999999999999999999999999999985 888887
Q ss_pred ccC---CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 526 FRQ---EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 526 ~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
... ..+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||++........ ..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~-------~~~~~l~d~g~~~~~~~~~~-~~ 157 (284)
T cd07836 89 DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINK-------RGELKLADFGLARAFGIPVN-TF 157 (284)
T ss_pred HhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECC-------CCcEEEeecchhhhhcCCcc-cc
Confidence 653 3589999999999999999999998 9999999999999987 78899999999976533221 11
Q ss_pred cccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc--c--CcchHHHHHHHHH----cCC
Q 039817 603 TMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--N--GMILTDWVLYCVR----TGN 673 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~----~~~ 673 (725)
....++..|++||.+.+. .++.++||||||+++|||++|+.|+......+.... . ............. ...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 223467889999988654 568899999999999999999998865432110000 0 0000000000000 000
Q ss_pred -----------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 -----------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 -----------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.......+.+++.+|++.||.+||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=257.11 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=180.7
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCC-----ceeeeeecccCCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-----HQLLVYELMKNGT 520 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~gs 520 (725)
.++.++.+.+..+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.... ..++|+||+++ +
T Consensus 17 ~~g~vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 93 (336)
T cd07849 17 AYGMVCSATHKPT--GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-D 93 (336)
T ss_pred CCeEEEEEEEcCC--CCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-C
Confidence 3455555555433 4578999886432 234466889999999999999999999876543 57999999975 7
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++........
T Consensus 94 l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~-------~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 94 LYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNT-------NCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECC-------CCCEEECcccceeeccccccc
Confidence 877774 45689999999999999999999999 9999999999999987 789999999998865432221
Q ss_pred c--ccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----ccC---cch----HHHH
Q 039817 601 T--STMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----ANG---MIL----TDWV 665 (725)
Q Consensus 601 ~--~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~~---~~~----~~~~ 665 (725)
. .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......... ... ... ....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 1 122457889999998754 568899999999999999999999886432110000 000 000 0000
Q ss_pred HHHHHc----CCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCC
Q 039817 666 LYCVRT----GNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTS 711 (725)
Q Consensus 666 ~~~~~~----~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~ 711 (725)
...... ...+ ....+.+.+++.+||+.+|++|||+.|++++ ++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 0000 1234678899999999999999999999998 65544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-29 Score=258.71 Aligned_cols=237 Identities=24% Similarity=0.349 Sum_probs=179.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.+|++++++.+.. .+..+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||++. +|.+
T Consensus 15 G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~ 91 (288)
T cd06616 15 GAFGTVNKMLHKP--SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDK 91 (288)
T ss_pred CCceEEEEEEECC--CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHH
Confidence 3445555544433 34678999886432 234567899999999996 99999999999999999999999874 5544
Q ss_pred hh---c--cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 524 FL---F--RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 524 ~l---~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+. . ....+++.....++.|++.||+|||+. .+++||||||+||+++. ++.+||+|||+++......
T Consensus 92 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~-------~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 92 FYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDR-------NGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEcc-------CCcEEEeecchhHHhccCC
Confidence 32 2 235789999999999999999999963 28999999999999987 7789999999997654322
Q ss_pred CccccccccCccccchhcccCC---CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-----
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNA---PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR----- 670 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 670 (725)
.. ....++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ..+.+.....
T Consensus 163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~~~~ 230 (288)
T cd06616 163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQLTQVVKGDPPI 230 (288)
T ss_pred cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHHhhhcCCCCCc
Confidence 11 223478899999998765 689999999999999999999999864321 0111111110
Q ss_pred -cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 671 -TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 671 -~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........+..+.+++.+|++.+|++|||+++|+++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112356789999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=248.56 Aligned_cols=244 Identities=22% Similarity=0.237 Sum_probs=176.8
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccC-cCCccceeeEEEcC--CceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQ--NHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~ 522 (725)
.++.++++++..+ +..+|+|.+.... ........+|+..+.++. |+|++++++++.++ +..++|+||++ ++|.
T Consensus 11 ~~~~v~~~~~~~~--~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 87 (282)
T cd07831 11 TFSEVLKAQSRKT--GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLY 87 (282)
T ss_pred ccceEEEEEEcCC--CcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHH
Confidence 3445555554433 4568888876432 223344568999999985 99999999999987 88999999997 4787
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++. +.+||+|||+++........
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~--------~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 88 ELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD--------DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC--------CCeEEEecccccccccCCCc-
Confidence 777654 5789999999999999999999999 9999999999999963 68999999999866433221
Q ss_pred ccccccCccccchhccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHHHHHHHcC----
Q 039817 602 STMIRGTMGYMAPEWLR-NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLYCVRTG---- 672 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~---- 672 (725)
....++..|+|||.+. +..++.++||||||+++|||++|..|+......+.... .......+........
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 2234788999999764 45678999999999999999999998865322110000 0000000000000000
Q ss_pred CC-----------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NL-----------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~-----------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. ....++.+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 11346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=255.37 Aligned_cols=236 Identities=24% Similarity=0.357 Sum_probs=178.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+++++++.+... +..||||.+.... .....++..|+.++.+.+ |+||+++++++..+...++||||+++ +|.+.
T Consensus 27 ~~~~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l 103 (296)
T cd06618 27 TCGQVYKMRFKKT--GHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKL 103 (296)
T ss_pred CCeEEEEEEECCC--CeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHH
Confidence 3444555544332 4678999886432 234456778888777775 99999999999999999999999864 67776
Q ss_pred hcc-CCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFR-QEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~-~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+.. ...+++..+..++.|++.||+|||+ . +|+||||+|+||+++. ++.+||+|||++.........
T Consensus 104 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~-------~~~~kL~dfg~~~~~~~~~~~-- 171 (296)
T cd06618 104 LKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDA-------SGNVKLCDFGISGRLVDSKAK-- 171 (296)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcC-------CCCEEECccccchhccCCCcc--
Confidence 654 3578999999999999999999997 5 8999999999999987 789999999998765432221
Q ss_pred cccccCccccchhcccCCC----CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCC-
Q 039817 603 TMIRGTMGYMAPEWLRNAP----VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLG- 675 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~----~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~- 675 (725)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+....... +......... ..+
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----------EVLTKILQEEPPSLPP 241 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----------HHHHHHhcCCCCCCCC
Confidence 2234778899999987553 7889999999999999999999986432110 1111111111 111
Q ss_pred -hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 676 -ATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 676 -~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
....+.+.+++.+||+.||++||++.+++++-
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 13467899999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=259.12 Aligned_cols=245 Identities=24% Similarity=0.290 Sum_probs=178.5
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcC--CceeeeeecccCCChh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQ--NHQLLVYELMKNGTLS 522 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~ 522 (725)
++.++++.+.. .+..+++|++... .......+.+|+.+++++ +|+||+++++++... ...++||||++ ++|.
T Consensus 20 ~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 96 (337)
T cd07852 20 YGIVWKAIDRR--TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLH 96 (337)
T ss_pred CeeEEEEEEcC--CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHH
Confidence 34444444332 3467899987532 233445678899999999 999999999998754 36899999998 5999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc--
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-- 600 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-- 600 (725)
+++... .+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++.........
T Consensus 97 ~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~-------~~~~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 97 AVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNS-------DCRVKLADFGLARSLSELEENPE 165 (337)
T ss_pred HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC-------CCcEEEeeccchhcccccccccc
Confidence 988665 788999999999999999999998 9999999999999987 889999999999865433221
Q ss_pred --cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc----ccCcchHH--------HH
Q 039817 601 --TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL----ANGMILTD--------WV 665 (725)
Q Consensus 601 --~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~----~~~~~~~~--------~~ 665 (725)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... .......+ ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFA 245 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhH
Confidence 2223458889999998764 467899999999999999999999885432111000 00000000 00
Q ss_pred HHHH---HcC------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 LYCV---RTG------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 ~~~~---~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... ... .........+.+++.+|++.+|++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 246 ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 000 0011235678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=235.85 Aligned_cols=210 Identities=24% Similarity=0.259 Sum_probs=171.8
Q ss_pred HHHHHHHHHhcc-CcCCccceeeEEEc----CCceeeeeecccCCChhhhhccCC--CCCHHHHHHHHHHHHHHhhhhhc
Q 039817 480 SFLREVQVIGRT-HHKNLVQLLGFCIE----QNHQLLVYELMKNGTLSAFLFRQE--IPTWDKRVEIALGIARGLLYLHE 552 (725)
Q Consensus 480 ~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~ 552 (725)
..++|+++--+. .|+|||.++++++. ...+++|||+|+||.|...+..++ .++++++..|..||+.|+.|||+
T Consensus 100 KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~ 179 (400)
T KOG0604|consen 100 KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS 179 (400)
T ss_pred HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh
Confidence 457899877665 69999999999874 346789999999999999998764 58999999999999999999999
Q ss_pred ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhH
Q 039817 553 ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632 (725)
Q Consensus 553 ~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G 632 (725)
. +|.||||||+|+|..... .+-.+||+|||+|+.-.... .....+-|+.|.|||++-..+|+...|+||+|
T Consensus 180 ~---nIAHRDlKpENLLyt~t~----~na~lKLtDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlg 250 (400)
T KOG0604|consen 180 M---NIAHRDLKPENLLYTTTS----PNAPLKLTDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLG 250 (400)
T ss_pred c---chhhccCChhheeeecCC----CCcceEecccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchh
Confidence 9 999999999999987643 27789999999999755432 23345679999999999999999999999999
Q ss_pred HHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC--Ch----hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL--GA----TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 633 ~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
|++|-|++|.+||..... ..+..-.+..+..+.+ +. ..++...++++.+|..+|.+|.|+.|++.+
T Consensus 251 VimYIlLCGyPPFYS~hg--------~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 251 VIMYILLCGYPPFYSNHG--------LAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHHHHhhcCCCcccccCC--------ccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 999999999999975432 1222223333433432 22 456788899999999999999999999976
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=257.98 Aligned_cols=246 Identities=22% Similarity=0.252 Sum_probs=183.2
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.++++.+.. .+..+++|.+..... .....+.+|++++++++|+||+++++++..++..++|+||+++ +|.++
T Consensus 11 ~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~ 87 (283)
T cd05118 11 TYGVVYKARDKL--TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKL 87 (283)
T ss_pred CCceEEEEEcCC--CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHH
Confidence 344455555433 345688888764332 2456788999999999999999999999999999999999986 88888
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
+... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||.+........ ...
T Consensus 88 l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~-------~~~~~l~df~~~~~~~~~~~-~~~ 156 (283)
T cd05118 88 IKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINT-------EGVLKLADFGLARSFGSPVR-PYT 156 (283)
T ss_pred HHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECC-------CCcEEEeeeeeeEecCCCcc-ccc
Confidence 7664 5789999999999999999999999 9999999999999987 78899999999987654431 112
Q ss_pred ccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc------c-----cCcchHHHHHHH---
Q 039817 604 MIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL------A-----NGMILTDWVLYC--- 668 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~------~-----~~~~~~~~~~~~--- 668 (725)
...++..|+|||.+.+. .++.++||||||+++++|++|+.++.......... . ......+.....
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 23477889999998776 78999999999999999999998885433211000 0 000000000000
Q ss_pred HHcC------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 VRTG------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... .......+.+.+++.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 0111346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=256.40 Aligned_cols=252 Identities=25% Similarity=0.286 Sum_probs=189.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCC-----ceeeeeecccCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-----HQLLVYELMKNG 519 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~g 519 (725)
.+++++++.+... +..++||.+.... ....+.+.+|++++++++|+||+++++++...+ ..++||||+++
T Consensus 12 ~~~~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~- 88 (330)
T cd07834 12 AYGVVCSAVDKRT--GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET- 88 (330)
T ss_pred CCeEEEEEEeCCC--CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-
Confidence 4455555554332 4578999886543 344567999999999999999999999998775 78999999984
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.+...+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 89 ~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~-------~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 89 DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNS-------NCDLKICDFGLARGVDPDED 158 (330)
T ss_pred hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC-------CCCEEEcccCceEeeccccc
Confidence 8999998878899999999999999999999999 9999999999999987 78999999999987654331
Q ss_pred --ccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--------------c--ccCcc
Q 039817 600 --RTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--------------L--ANGMI 660 (725)
Q Consensus 600 --~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--------------~--~~~~~ 660 (725)
.......++..|+|||.+.+. .++.++||||||+++++|++|+.|+......... . .....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 112223478889999999887 8899999999999999999999998644321100 0 00000
Q ss_pred hHHHHHHHHHcCC-----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCC
Q 039817 661 LTDWVLYCVRTGN-----LGATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTS 711 (725)
Q Consensus 661 ~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~ 711 (725)
..+++........ ........+.+++.+||+.+|.+||++++++++ +++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1111111000000 011245678999999999999999999999986 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=250.10 Aligned_cols=245 Identities=24% Similarity=0.287 Sum_probs=178.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhcc---CcCCccceeeEEEcCCc-----eeeeeecc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRT---HHKNLVQLLGFCIEQNH-----QLLVYELM 516 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~-----~~lV~e~~ 516 (725)
.++.++.+.+.. .+..+++|.+.... ......+.+|+.+++++ +|+|++++++++...+. .+++|||+
T Consensus 11 ~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~ 88 (287)
T cd07838 11 AYGTVYKARDLN--TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV 88 (287)
T ss_pred CceEEEEEEECC--CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhc
Confidence 344555555543 34578888875322 22234677888877665 59999999999998776 89999999
Q ss_pred cCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 517 KNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 517 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
++ +|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||++...
T Consensus 89 ~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~-------~~~~~l~dfg~~~~~ 157 (287)
T cd07838 89 DQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTS-------DGQVKIADFGLARIY 157 (287)
T ss_pred cc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEcc-------CCCEEEeccCcceec
Confidence 75 898888664 3589999999999999999999999 9999999999999987 789999999999876
Q ss_pred CcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc--c---cCcchHHHH----
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL--A---NGMILTDWV---- 665 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~--~---~~~~~~~~~---- 665 (725)
...... ....++..|+|||.+.+..++.++||||||++++||++|..++......+... . .......+.
T Consensus 158 ~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 443221 12336788999999999999999999999999999999988876432211000 0 000000000
Q ss_pred --HHHHHc------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 --LYCVRT------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 --~~~~~~------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...... ........+.+.+++.+||+.||.+||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000 00011335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=269.61 Aligned_cols=219 Identities=18% Similarity=0.260 Sum_probs=162.6
Q ss_pred cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhh
Q 039817 477 GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-----EIPTWDKRVEIALGIARGLLYLH 551 (725)
Q Consensus 477 ~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qia~gL~yLH 551 (725)
....+.+|++++++++|+|||++++++...+..++|+|++.. +|.+++... ..........|+.|++.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999864 676666432 22345677889999999999999
Q ss_pred cccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehh
Q 039817 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631 (725)
Q Consensus 552 ~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~ 631 (725)
+. +|+||||||+|||++. ++.+||+|||+++.+............|+..|+|||.+.+..++.++|||||
T Consensus 285 ~~---gIiHrDLKP~NILl~~-------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 354 (501)
T PHA03210 285 DK---KLIHRDIKLENIFLNC-------DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354 (501)
T ss_pred hC---CeecCCCCHHHEEECC-------CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence 99 9999999999999987 7889999999998765443333334568999999999999999999999999
Q ss_pred HHHHHHHHhCCcCCCCCCCCccccc-------------cCcchHHHHHHHHHcCCC---Ch---------hHHHHHHHHH
Q 039817 632 GVMLLEIIFCKRHTELHRVDEPTLA-------------NGMILTDWVLYCVRTGNL---GA---------TKFERITMVG 686 (725)
Q Consensus 632 G~vl~elltg~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~---~~---------~~~~~l~~l~ 686 (725)
|+++|||++|..++........... .-......+...+....+ +. .....+.+++
T Consensus 355 Gvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li 434 (501)
T PHA03210 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPL 434 (501)
T ss_pred HHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHH
Confidence 9999999998865432211110000 000000001111100000 00 1234567789
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 039817 687 LWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 687 ~~cl~~dp~~RPs~~evl~~ 706 (725)
.+||+.||++|||+.|++++
T Consensus 435 ~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 435 VKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhccCcccCcCHHHHhhC
Confidence 99999999999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=243.89 Aligned_cols=222 Identities=29% Similarity=0.329 Sum_probs=183.8
Q ss_pred cceEEEEEEcccccCcc-HHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHH
Q 039817 461 QEVEVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEI 539 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i 539 (725)
.+..+++|.+....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.....+++..+..+
T Consensus 13 ~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~ 92 (244)
T smart00220 13 TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFY 92 (244)
T ss_pred CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHH
Confidence 34678999987654444 78899999999999999999999999999999999999999999999987766899999999
Q ss_pred HHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccC
Q 039817 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN 619 (725)
Q Consensus 540 ~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 619 (725)
+.+++.++.|||+. +++|+||+|+||+++. ++.++|+|||.+....... ......++..|++||.+.+
T Consensus 93 ~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~-------~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~ 160 (244)
T smart00220 93 ARQILSALEYLHSN---GIIHRDLKPENILLDE-------DGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLG 160 (244)
T ss_pred HHHHHHHHHHHHHc---CeecCCcCHHHeEECC-------CCcEEEccccceeeecccc--ccccccCCcCCCCHHHHcc
Confidence 99999999999999 9999999999999987 7899999999998765432 2223447889999999988
Q ss_pred CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh--h---HHHHHHHHHHHccCCCC
Q 039817 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA--T---KFERITMVGLWCICPQP 694 (725)
Q Consensus 620 ~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~l~~l~~~cl~~dp 694 (725)
..++.++||||||+++++|++|..|+..... . .............. . ....+.+++.+|+..+|
T Consensus 161 ~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 161 KGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------L----LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------H----HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence 8899999999999999999999988864211 1 11111111121111 1 56789999999999999
Q ss_pred CCCCCHHHHHH
Q 039817 695 TLRPSMKQVLQ 705 (725)
Q Consensus 695 ~~RPs~~evl~ 705 (725)
++||++.++++
T Consensus 230 ~~Rp~~~~~~~ 240 (244)
T smart00220 230 EKRLTAEEALQ 240 (244)
T ss_pred hhccCHHHHhh
Confidence 99999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=250.11 Aligned_cols=246 Identities=24% Similarity=0.268 Sum_probs=183.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++.++.++...+ +..+++|.+.... ....+.+..|++++++++|+||+++++++...+..++||||++ ++|.++
T Consensus 11 ~~~~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~ 87 (282)
T cd07829 11 TYGVVYKARDKKT--GEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKY 87 (282)
T ss_pred CcceEEEeeecCC--CcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHH
Confidence 3455555555443 4578888876542 3345678899999999999999999999999999999999998 589999
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
+.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++. ++.+||+|||+++........ ..
T Consensus 88 i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~-------~~~~~l~d~g~~~~~~~~~~~-~~ 156 (282)
T cd07829 88 LDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINR-------DGVLKLADFGLARAFGIPLRT-YT 156 (282)
T ss_pred HHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcC-------CCCEEEecCCcccccCCCccc-cC
Confidence 9876 5789999999999999999999999 9999999999999987 789999999999876443221 11
Q ss_pred ccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----ccCcchHHHH--------HHHH
Q 039817 604 MIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----ANGMILTDWV--------LYCV 669 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~ 669 (725)
...++..|+|||.+.+. .++.++||||||++++||++|+.++.......... ........|. ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 22356789999998766 88999999999999999999988885432111000 0000000000 0000
Q ss_pred H---cC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 R---TG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~---~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. .. .........+.+++..||+.+|++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 00 0001225679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=237.87 Aligned_cols=238 Identities=22% Similarity=0.274 Sum_probs=186.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
....|+.+.+.+..-+ ++.+|||+++.... ...++++.|.++..+- +.||||+++|.+-.++..++.||.|.- ||
T Consensus 73 G~G~fG~V~KM~hk~s--g~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-Sl 149 (361)
T KOG1006|consen 73 GNGAFGTVNKMLHKPS--GKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SL 149 (361)
T ss_pred cCCcchhhhhhhcCcc--CcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hH
Confidence 4456777777665544 46889999976543 5667899999977665 799999999999999999999999974 77
Q ss_pred hhhhc-----cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 522 SAFLF-----RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 522 ~~~l~-----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+.+.. ++..+++...-+|..-.+.||.||.+. ..|||||+||+||||+. .|.+||+|||++-.+..
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr-------~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDR-------HGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEec-------CCCEeeecccchHhHHH
Confidence 76653 346789999999999999999999876 58999999999999988 89999999999876543
Q ss_pred CCCccccccccCccccchhcccCC--CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNA--PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
.. ..+.-.|-..|||||.+... .|+.+|||||||+.|+|+.||+.|+..... ..+++.+.. .+..
T Consensus 221 Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------vfeql~~Vv-~gdp 287 (361)
T KOG1006|consen 221 SI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------VFEQLCQVV-IGDP 287 (361)
T ss_pred HH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------HHHHHHHHH-cCCC
Confidence 22 22334577889999999643 589999999999999999999999864321 223333322 2222
Q ss_pred Ch--------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GA--------TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~--------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+. +....+++++..|+.+|..+||+..++.++
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 21 356789999999999999999999988754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=249.52 Aligned_cols=207 Identities=26% Similarity=0.378 Sum_probs=168.4
Q ss_pred cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhhc
Q 039817 477 GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR----QEIPTWDKRVEIALGIARGLLYLHE 552 (725)
Q Consensus 477 ~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~ 552 (725)
...++..|+.++++++||||+++++++.+....++||||+++++|.+++.. ...+++..+..++.|+++||.|||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 344677899999999999999999999999999999999999999998853 3568999999999999999999999
Q ss_pred ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhH
Q 039817 553 ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632 (725)
Q Consensus 553 ~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G 632 (725)
. +++|+||+|+||+++. +.+||+|||+++........ .....++..|+|||.+.+..++.++|+||||
T Consensus 125 ~---~i~h~~l~~~nili~~--------~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG 192 (260)
T cd08222 125 R---RILHRDLKAKNIFLKN--------NLLKIGDFGVSRLLMGSCDL-ATTFTGTPYYMSPEALKHQGYDSKSDIWSLG 192 (260)
T ss_pred c---CccccCCChhheEeec--------CCEeecccCceeecCCCccc-ccCCCCCcCccCHHHHccCCCCchhhHHHHH
Confidence 8 9999999999999964 45999999998765433221 1224478899999999888889999999999
Q ss_pred HHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 633 ~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+++++|++|..++..... ......... ....+......+.+++.+|++.+|++||++.|++++
T Consensus 193 ~~~~~l~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 193 CILYEMCCLAHAFEGQNF-----------LSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHhCCCCCCCccH-----------HHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 999999999998853211 111111111 112334566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=255.25 Aligned_cols=249 Identities=25% Similarity=0.262 Sum_probs=179.8
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhcc-CcCCccceeeEEEcC----CceeeeeecccCC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQ----NHQLLVYELMKNG 519 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~~~lV~e~~~~g 519 (725)
.++.++.+.+.....+..+|+|.+.... ....+.+.+|+++++++ +|+||+++++.+... ...++++||++ +
T Consensus 12 ~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~ 90 (332)
T cd07857 12 AYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-A 90 (332)
T ss_pred CCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-C
Confidence 4455555555444335679999876422 22356788999999999 599999999976533 45788899887 5
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++.......
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~-------~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 91 DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNA-------DCELKICDFGLARGFSENPG 160 (332)
T ss_pred CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcC-------CCCEEeCcCCCceecccccc
Confidence 8999998888899999999999999999999999 9999999999999987 78899999999986543221
Q ss_pred c---cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc--------ccCcchHH----
Q 039817 600 R---TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL--------ANGMILTD---- 663 (725)
Q Consensus 600 ~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~--------~~~~~~~~---- 663 (725)
. ......|+..|+|||.+.+ ..++.++||||||+++++|++|+.|+.......... ........
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence 1 1122458889999998765 468999999999999999999998886432110000 00000000
Q ss_pred ----HHHHHHHcCC-----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 664 ----WVLYCVRTGN-----LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 664 ----~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......... ........+.+++.+|++.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 001234678999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=246.05 Aligned_cols=245 Identities=24% Similarity=0.270 Sum_probs=180.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++++++|+.... +..|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+ +++|.++
T Consensus 11 ~~g~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~ 87 (283)
T cd07830 11 TFGSVYLARNKET--GELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQL 87 (283)
T ss_pred CceEEEEEEECCC--CcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHH
Confidence 3445555554332 45789998764322 23334567999999998 999999999999999999999999 7899998
Q ss_pred hccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+.... .+++..+..++.|++++|.|||+. +++|+||+|+||+++. ++.+||+|||++.........
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~-------~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 88 MKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSG-------PEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred HHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcC-------CCCEEEeecccceeccCCCCc--
Confidence 87764 789999999999999999999998 9999999999999987 889999999999865432221
Q ss_pred cccccCccccchhccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----ccCcchHHHHHHHHHc-----
Q 039817 603 TMIRGTMGYMAPEWLR-NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----ANGMILTDWVLYCVRT----- 671 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~----- 671 (725)
....++..|+|||.+. ...++.++|+||||++++||++|+.++.......... ........|.......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2234788899999875 4567899999999999999999998885443211000 0000000000000000
Q ss_pred ----------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 ----------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ----------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..........+.+++.+|++.+|++|||++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00001124679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=253.17 Aligned_cols=248 Identities=25% Similarity=0.284 Sum_probs=175.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCC--------ceeeeeec
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--------HQLLVYEL 515 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------~~~lV~e~ 515 (725)
..++.++.+++.-++ ..++||.+.... ......+.+|++++++++|+||+++++++.... ..++|+||
T Consensus 19 g~~~~v~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~ 96 (311)
T cd07866 19 GTFGEVYKARQIKTG--RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPY 96 (311)
T ss_pred CCCEEEEEEEECCCC--cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEec
Confidence 345566666654443 467888775332 222356789999999999999999999875433 46999999
Q ss_pred ccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 516 MKNGTLSAFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 516 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
++. +|...+.. ...+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||+++..
T Consensus 97 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~-------~~~~~l~dfg~~~~~ 165 (311)
T cd07866 97 MDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDN-------QGILKIADFGLARPY 165 (311)
T ss_pred CCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC-------CCCEEECcCccchhc
Confidence 986 66666654 35789999999999999999999999 9999999999999987 789999999999865
Q ss_pred CcCCCcc----------ccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----cc-
Q 039817 595 KKDQTRT----------STMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----AN- 657 (725)
Q Consensus 595 ~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~- 657 (725)
....... .....++..|+|||.+.+ ..++.++||||||++++||++|+.++.......... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 4322111 112346788999998765 458899999999999999999999886432210000 00
Q ss_pred --CcchHHHH--HHH---HHcCCCC-------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 658 --GMILTDWV--LYC---VRTGNLG-------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 658 --~~~~~~~~--~~~---~~~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......+. ... ......+ ....+.+.+++.+|++.+|++|||+.|++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 000 0000000 1123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=256.60 Aligned_cols=249 Identities=22% Similarity=0.255 Sum_probs=179.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC------ceeeeeeccc
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN------HQLLVYELMK 517 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~e~~~ 517 (725)
..++.+++|.+.. .+..||||.+... .......+.+|++++++++|+||+++++++.... ..++|+||+.
T Consensus 26 g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (342)
T cd07879 26 GAYGSVCSAIDKR--TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ 103 (342)
T ss_pred cCCeEEEEEEeCC--CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc
Confidence 3445555555433 3457888887542 2223456889999999999999999999987543 4689999997
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||+++.....
T Consensus 104 ~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~-------~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 104 T-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNE-------DCELKILDFGLARHADAE 170 (342)
T ss_pred c-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCCEEEeeCCCCcCCCCC
Confidence 5 777665 24688999999999999999999999 9999999999999987 789999999998764322
Q ss_pred CCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHH-------
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWV------- 665 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~------- 665 (725)
. ....++..|+|||.+.+ ..++.++||||||++++||++|+.||........... .......+.
T Consensus 171 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 171 M----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred C----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 1 22346788999999876 4688999999999999999999999874321100000 000000000
Q ss_pred -HHHHHc-CCCC--------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCCCC
Q 039817 666 -LYCVRT-GNLG--------ATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTSEV 713 (725)
Q Consensus 666 -~~~~~~-~~~~--------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~~~ 713 (725)
...... ...+ ......+.+++.+||+.||++||++++++.+ ++...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000 0000 1234568899999999999999999999976 7766543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=272.78 Aligned_cols=174 Identities=29% Similarity=0.490 Sum_probs=132.6
Q ss_pred eeeeeecccCCChhhhhccCCCC-CHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 509 QLLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 509 ~~lV~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
+||-||||+..+|.+++.++... .-...++++.+|++||.|+|+. +||||||||.||+||+ ...|||+|
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~-------~~~VKIGD 740 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDS-------RNSVKIGD 740 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcC-------CCCeeecc
Confidence 36778888887777777665544 4578899999999999999999 9999999999999987 88999999
Q ss_pred ccCccccC-----------------cCCCccccccccCccccchhcccCC---CCCCccceehhHHHHHHHHhCCcCCCC
Q 039817 588 FGLAKLLK-----------------KDQTRTSTMIRGTMGYMAPEWLRNA---PVTAKVDVYSFGVMLLEIIFCKRHTEL 647 (725)
Q Consensus 588 fgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~S~G~vl~elltg~~~~~~ 647 (725)
||+|.... .......+...||.-|+|||.+.+. .|+.|+|+||+|||++||+. ||..
T Consensus 741 FGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T 817 (1351)
T KOG1035|consen 741 FGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT 817 (1351)
T ss_pred cccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc
Confidence 99998621 0111123446799999999998755 59999999999999999982 3432
Q ss_pred CCCCccccccCcchHHHHHHHHHcCCCCh------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 648 HRVDEPTLANGMILTDWVLYCVRTGNLGA------TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. +. ...+...++.+.+|. +..+.-.+++.|++++||.+|||+.|+++.
T Consensus 818 s----------ME-Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 818 S----------ME-RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred h----------HH-HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 2 11 111222233454444 355667889999999999999999999864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=252.93 Aligned_cols=247 Identities=22% Similarity=0.238 Sum_probs=177.5
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC--------------Cceeee
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--------------NHQLLV 512 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------------~~~~lV 512 (725)
+++.++.+.+..+ +..|++|.+........+.+.+|++++++++|+||+++++.+... ...++|
T Consensus 17 ~~g~vy~~~~~~~--~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv 94 (342)
T cd07854 17 SNGLVFSAVDSDC--DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIV 94 (342)
T ss_pred CCEEEEEEEECCC--CcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEE
Confidence 3444555554433 457888888665556677899999999999999999999876543 357899
Q ss_pred eecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 513 YELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 513 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
|||++ ++|.+++.. ..+++.....++.|++.||.|||+. +++||||||+||+++.+ +..+|++|||+++
T Consensus 95 ~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~------~~~~kl~dfg~~~ 163 (342)
T cd07854 95 QEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTE------DLVLKIGDFGLAR 163 (342)
T ss_pred eeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCC------CceEEECCcccce
Confidence 99998 489888753 4688999999999999999999999 99999999999999752 5679999999997
Q ss_pred ccCcCCCcc--ccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----------cC
Q 039817 593 LLKKDQTRT--STMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----------NG 658 (725)
Q Consensus 593 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----------~~ 658 (725)
......... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||........... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07854 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243 (342)
T ss_pred ecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 653221111 122346888999998654 5678899999999999999999999964321110000 00
Q ss_pred cchHHHHHHHHH----cCCC-----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 659 MILTDWVLYCVR----TGNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 659 ~~~~~~~~~~~~----~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
............ .... ......++.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000000 0000 11234678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=243.45 Aligned_cols=239 Identities=24% Similarity=0.252 Sum_probs=190.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|+|+......-+ +..+|.|.|.+. ..+++...++|-.+|.+++.+.||.+--.++..+.++||+..|.+|+|+
T Consensus 196 GGFGEV~acqvraT--GKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLk 273 (591)
T KOG0986|consen 196 GGFGEVCACQVRAT--GKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLK 273 (591)
T ss_pred ccccceeEEEEecc--hhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCcee
Confidence 34555544333222 234456655432 3456677889999999999999999999999999999999999999999
Q ss_pred hhhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 523 AFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 523 ~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
-+|...+ .+++....-++.+|+.||+|||.. .||.||+||+|||||+ .|+++|+|.|||..+.....-
T Consensus 274 fHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd-------~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 274 FHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDD-------HGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeecc-------CCCeEeeccceEEecCCCCcc
Confidence 9998765 789999999999999999999999 9999999999999988 899999999999987655432
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 678 (725)
....||.+|||||++.++.|+...|.||+||+||||+.|+.||....... -.+.+.+... ...++...
T Consensus 344 --~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------k~eEvdrr~~~~~~ey~~kF 413 (591)
T KOG0986|consen 344 --RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------KREEVDRRTLEDPEEYSDKF 413 (591)
T ss_pred --ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------hHHHHHHHHhcchhhccccc
Confidence 23369999999999999999999999999999999999999997654321 1112222222 23456677
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
.++...+....|++||.+|. .+++|.+|
T Consensus 414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 88899999999999999995 45566543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=250.75 Aligned_cols=243 Identities=23% Similarity=0.242 Sum_probs=177.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEc-CCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~ 522 (725)
-.++.++++.+..+ +..|++|.+... .....+.+.+|++++++++||||+++++++.. ....++|+||+. ++|.
T Consensus 21 g~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~ 97 (328)
T cd07856 21 GAFGLVCSARDQLT--GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG-TDLH 97 (328)
T ss_pred cCCeEEEEEEECCC--CCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHH
Confidence 34555566655544 456788876432 23345678899999999999999999999875 567899999985 5888
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.. ..+++.....++.|+++||.|||+. +++|+||+|+||+++. ++.+||+|||++.......
T Consensus 98 ~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~-------~~~~~l~dfg~~~~~~~~~---- 162 (328)
T cd07856 98 RLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINE-------NCDLKICDFGLARIQDPQM---- 162 (328)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECC-------CCCEEeCccccccccCCCc----
Confidence 88754 4578888889999999999999999 9999999999999987 7889999999987543221
Q ss_pred cccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc-------------cccC---cchHHHH
Q 039817 603 TMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT-------------LANG---MILTDWV 665 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~-------------~~~~---~~~~~~~ 665 (725)
....++..|+|||.+.+ ..++.++||||||++++||++|+.|+......... .... ....+..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 12346788999998765 56899999999999999999999988643211000 0000 0000000
Q ss_pred HHHHHcCCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 LYCVRTGNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 ~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.........+ ....+.+.+++.+|++.+|++||++++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000001111 1234689999999999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=247.25 Aligned_cols=243 Identities=24% Similarity=0.260 Sum_probs=175.4
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC------CceeeeeecccC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELMKN 518 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~~~ 518 (725)
.++.++.+.+.. .+..||+|++.... ....+.+.+|++++++++|+||+++++++... ...+++++++ +
T Consensus 29 ~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~ 105 (345)
T cd07877 29 AYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 105 (345)
T ss_pred CCeEEEEEEEcC--CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-c
Confidence 444555554433 34578999886432 22346788999999999999999999988643 3467888887 6
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 106 ~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~-------~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 106 ADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE-------DCELKILDFGLARHTDDE- 173 (345)
T ss_pred cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC-------CCCEEEeccccccccccc-
Confidence 799887754 4689999999999999999999999 9999999999999987 788999999998864322
Q ss_pred CccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHH--------H
Q 039817 599 TRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDW--------V 665 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~--------~ 665 (725)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.|+........... ........ .
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 174 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred ---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 122347888999998866 5688999999999999999999998854321110000 00000000 0
Q ss_pred HHHHHc-CCCC--------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 666 LYCVRT-GNLG--------ATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 666 ~~~~~~-~~~~--------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
...... ...+ ......+.+++.+|++.||.+||++.+++++=
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000000 0000 12345788999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=249.53 Aligned_cols=242 Identities=24% Similarity=0.284 Sum_probs=176.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC------ceeeeeecccC
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN------HQLLVYELMKN 518 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~e~~~~ 518 (725)
.++.++.+.+..+ +..||||.+... .....+.+.+|++++++++|+||+++++++.... ..++||||+ +
T Consensus 27 ~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~ 103 (343)
T cd07880 27 AYGTVCSALDRRT--GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-G 103 (343)
T ss_pred CCeEEEEEEECCC--CcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-C
Confidence 4445555554333 457899987532 2223456889999999999999999999987653 358999999 6
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||++.......
T Consensus 104 ~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~-------~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 104 TDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNE-------DCELKILDFGLARQTDSEM 172 (343)
T ss_pred CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC-------CCCEEEeecccccccccCc
Confidence 689888754 5689999999999999999999998 9999999999999987 7889999999998654321
Q ss_pred CccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc---c-cCcchHHHHH-------
Q 039817 599 TRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL---A-NGMILTDWVL------- 666 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~---~-~~~~~~~~~~------- 666 (725)
....++..|+|||.+.+ ..++.++|+||||++++++++|+.|+.......... . ......++..
T Consensus 173 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 173 ----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 22346888999999876 458899999999999999999999986432110000 0 0000000000
Q ss_pred -HHHHc-C--------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 -YCVRT-G--------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 -~~~~~-~--------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..... . .........+.+++.+|++.||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0 0111234568899999999999999999999943
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=253.70 Aligned_cols=243 Identities=23% Similarity=0.270 Sum_probs=177.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCc------eeeeeeccc
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH------QLLVYELMK 517 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~e~~~ 517 (725)
..++.++.+.+..+ +..|+||.+... .....+.+.+|+.++++++|+||+++++++...+. .++|+||+
T Consensus 26 g~~g~vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~- 102 (343)
T cd07851 26 GAYGQVCSAFDTKT--GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM- 102 (343)
T ss_pred CCceEEEEEEECCC--CcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-
Confidence 34455555554433 457889887542 22234567889999999999999999998876554 89999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+++|.+++.. ..+++..+..++.|+++||.|||+. +|+|+||||+||+++. ++.+||+|||++......
T Consensus 103 ~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~-------~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 103 GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNE-------DCELKILDFGLARHTDDE 171 (343)
T ss_pred CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC-------CCCEEEcccccccccccc
Confidence 4699988865 4689999999999999999999998 9999999999999987 788999999999865432
Q ss_pred CCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc--c--CcchHHH--------
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--N--GMILTDW-------- 664 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--~--~~~~~~~-------- 664 (725)
.....++..|+|||.+.+ ..++.++||||||++++|+++|+.|+........... . ......+
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 122347788999998865 4678999999999999999999998864322110000 0 0000000
Q ss_pred HHHHHHc---C---C---CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 665 VLYCVRT---G---N---LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 665 ~~~~~~~---~---~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....... . . ......+.+.+++.+|++.+|++|||+.||+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000 0 0 001235688999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=255.21 Aligned_cols=259 Identities=23% Similarity=0.295 Sum_probs=192.6
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeec
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYEL 515 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~ 515 (725)
+....|+.|+++.+..+|+ .||||..... .....+...+|+++|+++.|+|||++.+.=++. ....+||||
T Consensus 21 LG~Ga~g~V~rgrnketG~--~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 21 LGKGAFGNVYRGRNKETGR--LVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hcCCccceeeeeccccccc--chhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 3456678888877776664 6788887653 344567789999999999999999999986654 367899999
Q ss_pred ccCCChhhhhccC---CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 516 MKNGTLSAFLFRQ---EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 516 ~~~gsL~~~l~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
|.+|||...|.+. ..+++...+.++.+++.||.|||+. +|+||||||.||++-.. .|+...-||+|||.|+
T Consensus 99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~G---edgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIG---EDGQSIYKLTDFGAAR 172 (732)
T ss_pred cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeec---CCCceEEeeecccccc
Confidence 9999999999765 5789999999999999999999999 99999999999998653 2346678999999999
Q ss_pred ccCcCCCccccccccCccccchhccc-CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc----------ccCcc-
Q 039817 593 LLKKDQTRTSTMIRGTMGYMAPEWLR-NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL----------ANGMI- 660 (725)
Q Consensus 593 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~----------~~~~~- 660 (725)
....+. ....+.||..|++||... .+.|+...|.||||+++||.+||..||........-. .....
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 877655 445577999999999998 4889999999999999999999999997544321000 00000
Q ss_pred --------hHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC--CHHHHHHHhcCCC
Q 039817 661 --------LTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP--SMKQVLQMLEGTS 711 (725)
Q Consensus 661 --------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP--s~~evl~~L~~~~ 711 (725)
..+|-..+-....+......++.+.+..++..+|++|- ...+....+..++
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 00000000000112224556777777788888888887 5555555555443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=236.59 Aligned_cols=236 Identities=22% Similarity=0.282 Sum_probs=181.3
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccC-c-CC----ccceeeEEEcCCceeeeeecccCCChhhhhccC--CCCCH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-H-KN----LVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--EIPTW 533 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H-~n----iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~ 533 (725)
+..||||+++... ...+.-+-|++++.++. + |+ +|++.+++...++.++|+|.+. -|+.++|..+ .+++.
T Consensus 114 ~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG-~S~~dFlk~N~y~~fpi 191 (415)
T KOG0671|consen 114 KEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLG-LSTFDFLKENNYIPFPI 191 (415)
T ss_pred CceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccC-hhHHHHhccCCccccch
Confidence 5789999988753 45566788999999993 3 33 7899999999999999999994 4999999876 46788
Q ss_pred HHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcc-------------ccCCCCceEEeeccCccccCcCCCc
Q 039817 534 DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI-------------TIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 534 ~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~-------------~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.++..|+.|+++++++||+. .++|-||||+|||+.++.. -...+..+||+|||.|.......
T Consensus 192 ~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-- 266 (415)
T KOG0671|consen 192 DHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-- 266 (415)
T ss_pred HHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--
Confidence 99999999999999999999 9999999999999854421 11235678999999998755443
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcc-----cc----ccCcchHHHHHHHHHc
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEP-----TL----ANGMILTDWVLYCVRT 671 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~-----~~----~~~~~~~~~~~~~~~~ 671 (725)
..+..|..|.|||++.+-.++.++||||+||+|.|+.+|...|..+...+. .+ ...+............
T Consensus 267 --s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~ 344 (415)
T KOG0671|consen 267 --STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRR 344 (415)
T ss_pred --ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhc
Confidence 335578999999999999999999999999999999999999987763320 00 0001111101111111
Q ss_pred CCC---------------------------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 GNL---------------------------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~~~---------------------------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+ ...+..+|.+|+..||..||.+|+|+.|++.+
T Consensus 345 ~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 345 GRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred ccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 111 11455679999999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=265.49 Aligned_cols=135 Identities=25% Similarity=0.291 Sum_probs=115.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..|+.|+.+.+... +..||||.+.... ......+..|+.+++.++|+||+++++.+...+..+|||||+++++|.
T Consensus 15 G~fg~Vy~a~~~~~--~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~ 92 (669)
T cd05610 15 GAFGKVYLGRKKNN--SKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVK 92 (669)
T ss_pred CCCeEEEEEEECCC--CcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHH
Confidence 34556666655433 4578888876432 223467889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
+++...+.+++..+..|+.||+.||.|||.. +|+||||||+||||+. ++.+||+|||+++
T Consensus 93 ~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~-------~g~vkL~DFGls~ 152 (669)
T cd05610 93 SLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISN-------EGHIKLTDFGLSK 152 (669)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcC-------CCCEEEEeCCCCc
Confidence 9998778889999999999999999999998 9999999999999987 7889999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=228.29 Aligned_cols=224 Identities=26% Similarity=0.263 Sum_probs=185.9
Q ss_pred cceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHH
Q 039817 461 QEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRV 537 (725)
Q Consensus 461 ~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~ 537 (725)
.+..+|+|+|++.-- +....-+.|-++|...+||.+..|.-.++..+++|+||||..+|.|.-+|.+.+.+++....
T Consensus 192 t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtR 271 (516)
T KOG0690|consen 192 TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTR 271 (516)
T ss_pred cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhh
Confidence 345788898876432 23344578889999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcc
Q 039817 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617 (725)
Q Consensus 538 ~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 617 (725)
-+...|+.||.|||++ +||.||||.+|.|||. ++.+||+||||++.--.. ......++||+.|+|||++
T Consensus 272 FYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDk-------DGHIKitDFGLCKE~I~~-g~t~kTFCGTPEYLAPEVl 340 (516)
T KOG0690|consen 272 FYGAEIVSALGYLHSR---NIVYRDLKLENLLLDK-------DGHIKITDFGLCKEEIKY-GDTTKTFCGTPEYLAPEVL 340 (516)
T ss_pred hhhHHHHHHhhhhhhC---Ceeeeechhhhheecc-------CCceEeeecccchhcccc-cceeccccCChhhcCchhh
Confidence 9999999999999999 9999999999999988 899999999999864322 2334558899999999999
Q ss_pred cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCC
Q 039817 618 RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLR 697 (725)
Q Consensus 618 ~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 697 (725)
....|..+.|.|-+|||+|||++|+.||...+.+. +-+ ......-.+|....++...|+.-.|.+||++|
T Consensus 341 eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------LFe--LIl~ed~kFPr~ls~eAktLLsGLL~kdP~kR 410 (516)
T KOG0690|consen 341 EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------LFE--LILMEDLKFPRTLSPEAKTLLSGLLKKDPKKR 410 (516)
T ss_pred ccccccceeehhhhhHHHHHHHhccCcccccchhH--------HHH--HHHhhhccCCccCCHHHHHHHHHHhhcChHhh
Confidence 99999999999999999999999999997553221 111 12223446677788888999999999999999
Q ss_pred C-----CHHHHHH
Q 039817 698 P-----SMKQVLQ 705 (725)
Q Consensus 698 P-----s~~evl~ 705 (725)
. .+.||.+
T Consensus 411 LGgGpdDakEi~~ 423 (516)
T KOG0690|consen 411 LGGGPDDAKEIMR 423 (516)
T ss_pred cCCCchhHHHHHh
Confidence 5 4555554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=259.12 Aligned_cols=228 Identities=26% Similarity=0.314 Sum_probs=171.5
Q ss_pred cceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CC---CCHHH
Q 039817 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EI---PTWDK 535 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~---l~~~~ 535 (725)
++++||||++-. ...+-..+|+..|..- +|||||++++.-.+....||..|.|.. +|++++... .. ..-..
T Consensus 532 e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~ 607 (903)
T KOG1027|consen 532 EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDID 607 (903)
T ss_pred CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhccccc
Confidence 467999999843 2334457999999887 699999999988889999999999975 999999874 11 11134
Q ss_pred HHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc--ccccccCccccc
Q 039817 536 RVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT--STMIRGTMGYMA 613 (725)
Q Consensus 536 ~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~a 613 (725)
.+.++.|+++||+|||+. +||||||||+||||+... .++..+++|+|||+++....+.... .....||.||+|
T Consensus 608 ~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~--~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~A 682 (903)
T KOG1027|consen 608 PISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPS--ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQA 682 (903)
T ss_pred HHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccC--CCcceeEEecccccccccCCCcchhhcccCCCCcccccC
Confidence 578899999999999998 999999999999998632 1336789999999999876654432 234569999999
Q ss_pred hhcccCCCCCCccceehhHHHHHHHHhC-CcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCC
Q 039817 614 PEWLRNAPVTAKVDVYSFGVMLLEIIFC-KRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICP 692 (725)
Q Consensus 614 PE~~~~~~~~~ksDv~S~G~vl~elltg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 692 (725)
||.+.+..-+.+.||||+|||+|+.++| ..||......+.-+..... .+ ..+......+..+||.+|+++
T Consensus 683 PE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~------~L---~~L~~~~d~eA~dLI~~ml~~ 753 (903)
T KOG1027|consen 683 PEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY------TL---VHLEPLPDCEAKDLISRMLNP 753 (903)
T ss_pred HHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc------ce---eeeccCchHHHHHHHHHhcCC
Confidence 9999998888899999999999999998 5666543221100000000 00 001111112788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 039817 693 QPTLRPSMKQVLQM 706 (725)
Q Consensus 693 dp~~RPs~~evl~~ 706 (725)
+|..||++.+|+.|
T Consensus 754 dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 754 DPQLRPSATDVLNH 767 (903)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999854
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=227.21 Aligned_cols=230 Identities=25% Similarity=0.281 Sum_probs=173.9
Q ss_pred ceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEcC------CceeeeeecccCCChhhhhccCCCCCH
Q 039817 462 EVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELMKNGTLSAFLFRQEIPTW 533 (725)
Q Consensus 462 ~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~l~~ 533 (725)
...||+|++.. ......+...+|..++..+.|+||++++.++.-. ...|+|||+|.. +|...+. ..++.
T Consensus 41 ~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH 117 (369)
T KOG0665|consen 41 GRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MELDH 117 (369)
T ss_pred cCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH--Hhcch
Confidence 35678887643 2234456678999999999999999999998743 367999999975 8888876 45677
Q ss_pred HHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccc
Q 039817 534 DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMA 613 (725)
Q Consensus 534 ~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 613 (725)
.....|+.|++.|++|||+. +|+||||||+||++.. +..+||.|||+++....+ ...+....+..|.|
T Consensus 118 ~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~-------~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyra 185 (369)
T KOG0665|consen 118 ETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNS-------DCTLKILDFGLARTEDTD--FMMTPYVVTRYYRA 185 (369)
T ss_pred HHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecc-------hhheeeccchhhcccCcc--cccCchhheeeccC
Confidence 88999999999999999999 9999999999999987 789999999999975544 34555668899999
Q ss_pred hhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcc-c-----ccc-Ccc----hHHHHHHHHHc----------C
Q 039817 614 PEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEP-T-----LAN-GMI----LTDWVLYCVRT----------G 672 (725)
Q Consensus 614 PE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~-~-----~~~-~~~----~~~~~~~~~~~----------~ 672 (725)
||.+.+..+.+.+||||.||++.||++|+..|.+...-++ . +.. ... +..-++...+. .
T Consensus 186 pevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~ 265 (369)
T KOG0665|consen 186 PEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSE 265 (369)
T ss_pred chheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhh
Confidence 9999999999999999999999999999988764322110 0 000 000 00000000000 0
Q ss_pred CCC-----------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLG-----------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~-----------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.++ ......+++++.+||-.+|++|.+++++++|
T Consensus 266 ~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 266 LFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 1234468889999999999999999999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-27 Score=242.35 Aligned_cols=228 Identities=24% Similarity=0.288 Sum_probs=181.4
Q ss_pred ceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHH
Q 039817 462 EVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVE 538 (725)
Q Consensus 462 ~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~ 538 (725)
++.||||.+.+ .....+.++++|+.+|.+++||.||.+--.|+..+..++|||-+.+.=|+-.|... +++++..-.-
T Consensus 589 GrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkF 668 (888)
T KOG4236|consen 589 GRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKF 668 (888)
T ss_pred CceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHH
Confidence 45778888764 34566788999999999999999999999999999999999999876666666443 6788888888
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhccc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 618 (725)
++.||+.||.|||.+ +|+|+||||+||||... +.-..+||+|||.|+++++...+ ....||+.|+|||+++
T Consensus 669 lvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~----~~FPQvKlCDFGfARiIgEksFR--rsVVGTPAYLaPEVLr 739 (888)
T KOG4236|consen 669 LVTQILVALRYLHFK---NIVHCDLKPENVLLASA----SPFPQVKLCDFGFARIIGEKSFR--RSVVGTPAYLAPEVLR 739 (888)
T ss_pred HHHHHHHHHHHhhhc---ceeeccCCchheeeccC----CCCCceeeccccceeecchhhhh--hhhcCCccccCHHHHh
Confidence 999999999999999 99999999999999874 33668999999999998765443 3356999999999999
Q ss_pred CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC
Q 039817 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP 698 (725)
Q Consensus 619 ~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 698 (725)
++.|+..-|+||.||++|--++|..||.....-. ++..-..++. ....=.+..+..++||...||..-.+|-
T Consensus 740 nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn----dQIQNAaFMy----Pp~PW~eis~~AidlIn~LLqVkm~kRy 811 (888)
T KOG4236|consen 740 NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN----DQIQNAAFMY----PPNPWSEISPEAIDLINNLLQVKMRKRY 811 (888)
T ss_pred hccccccccceeeeEEEEEEecccccCCCccchh----HHhhcccccc----CCCchhhcCHHHHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999997432211 1111011100 0011125567788899999999999998
Q ss_pred CHHHHHHH
Q 039817 699 SMKQVLQM 706 (725)
Q Consensus 699 s~~evl~~ 706 (725)
|.++-+.+
T Consensus 812 svdk~lsh 819 (888)
T KOG4236|consen 812 SVDKSLSH 819 (888)
T ss_pred chHhhccc
Confidence 88776543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=250.76 Aligned_cols=238 Identities=24% Similarity=0.297 Sum_probs=189.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEE-----cCCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCI-----EQNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~-----~~~~~~lV~e~~~ 517 (725)
...+|+.++++++.-.++..+++|+.. .....+++..|.++++.. +|||++.++|++. .+++++||||||.
T Consensus 28 g~Gtygkv~k~k~~~~~~~aa~kI~~~---~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~ 104 (953)
T KOG0587|consen 28 GNGTYGKVYKGRHVKTGQLAAIKIMDP---TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCG 104 (953)
T ss_pred eeccceeEEEEeeeecCceeeeEeecC---CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccC
Confidence 345677777777777777766666655 345567788999999987 7999999999987 3578999999999
Q ss_pred CCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 518 NGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 518 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+||..|.+... ..+.|..+.-|+..+++||.|||.. .++|||||-.|||++. ++.+|+.|||++....
T Consensus 105 gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~-------e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 105 GGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTE-------NAEVKLVDFGVSAQLD 174 (953)
T ss_pred CccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEec-------cCcEEEeeeeeeeeee
Confidence 99999998654 6789999999999999999999999 9999999999999988 8999999999988655
Q ss_pred cCCCccccccccCccccchhcccCC-----CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNA-----PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (725)
....+..+ ..||+.|||||++... .|+.++|+||||++..||--|.+|.-.... ...+....+
T Consensus 175 sT~grRnT-~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------mraLF~IpR 242 (953)
T KOG0587|consen 175 STVGRRNT-FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFLIPR 242 (953)
T ss_pred cccccccC-cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------hhhhccCCC
Confidence 43333333 4599999999998643 578899999999999999999888753221 111111111
Q ss_pred cCC----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 671 TGN----LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 671 ~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... -+....+++.++|..|+.+|..+||++.++++|
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111 123567889999999999999999999998876
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=220.49 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=185.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC--------Cceeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--------NHQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~lV~e~ 515 (725)
...+|+|+++|...-.++.++++.+.++.....-...-++|+++|..++|+|++.++..|... ..++|||++
T Consensus 26 gqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ 105 (376)
T KOG0669|consen 26 GQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDF 105 (376)
T ss_pred CCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHH
Confidence 456899999999888777644444444444333345568999999999999999999998642 357999999
Q ss_pred ccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 516 MKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 516 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
++. +|.-.|... ..++..++.++..++..||.|+|.. .|+|||+|+.|+|++. ++.+||+|||+++.+
T Consensus 106 ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~-------dgilklADFGlar~f 174 (376)
T KOG0669|consen 106 CEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITK-------DGILKLADFGLARAF 174 (376)
T ss_pred hhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcC-------CceEEeeccccccce
Confidence 987 787777665 6789999999999999999999999 9999999999999987 899999999999866
Q ss_pred CcCCCc---cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--------------cc
Q 039817 595 KKDQTR---TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--------------LA 656 (725)
Q Consensus 595 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--------------~~ 656 (725)
...... .-+...-|..|++||.+.+ ..+.++.|||.-||++.||.++.+.+......... ..
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 432221 1223446889999999876 47899999999999999999999877643321100 00
Q ss_pred cCcchHHHHHHHHHcCCCCh-------------hHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 657 NGMILTDWVLYCVRTGNLGA-------------TKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
+-..+ .+.+.+...+++. ...+...+|+..++..||.+||++++++.+-
T Consensus 255 ~~d~l--pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 255 NVDNL--PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred Ccccc--hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 00000 0111111111211 1123567889999999999999999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=207.32 Aligned_cols=190 Identities=27% Similarity=0.413 Sum_probs=154.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccc-ccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEK-VTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~-~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+..|+.+.+.....+ +..+|||++.. .+.+..+..++|+.+..+- ..|.+|+++|........++.||.|.- ||+
T Consensus 56 rGayG~vekmrh~~s--g~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sld 132 (282)
T KOG0984|consen 56 RGAYGVVEKMRHIQS--GTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLD 132 (282)
T ss_pred CCccchhhheeeccC--CeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHH
Confidence 334555555444444 46889999864 3455667889999987765 799999999999899999999999975 887
Q ss_pred hhh----ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 523 AFL----FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 523 ~~l----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
.+- .+...+++...-+|+..+++||.|||++ ..++|||+||+|||++. .+++|++|||++-.+.+.-
T Consensus 133 kfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~-------~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 133 KFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINY-------DGQVKICDFGISGYLVDSI 203 (282)
T ss_pred HHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEcc-------CCcEEEcccccceeehhhh
Confidence 764 3457789999999999999999999998 68999999999999988 8999999999998765432
Q ss_pred CccccccccCccccchhccc----CCCCCCccceehhHHHHHHHHhCCcCCCCC
Q 039817 599 TRTSTMIRGTMGYMAPEWLR----NAPVTAKVDVYSFGVMLLEIIFCKRHTELH 648 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~----~~~~~~ksDv~S~G~vl~elltg~~~~~~~ 648 (725)
. .+...|-..|||||.+. ...|+.||||||||+.+.||.+++.|++..
T Consensus 204 A--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 204 A--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred H--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 1 22234777899999885 347899999999999999999999998754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=198.12 Aligned_cols=238 Identities=25% Similarity=0.256 Sum_probs=180.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcc--cccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLE--KVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+++++|.+.-+++ .||+|+++ ..++......++|+-+++.++|+|||++++....+....+|+|||.. .|
T Consensus 11 gegtygtvfkarn~~t~e--ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dl 87 (292)
T KOG0662|consen 11 GEGTYGTVFKARNRETHE--IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DL 87 (292)
T ss_pred cCCcceeeEecccCCccc--eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HH
Confidence 346788888888766554 67777654 44445567889999999999999999999999999999999999976 78
Q ss_pred hhhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+|... ++.++......++.|+++||.+.|+. ++.|||+||+|.|++. ++..|++|||+++.++-.-..
T Consensus 88 kkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~-------ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 88 KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINR-------NGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEecc-------CCcEEecccchhhhcCCceEe
Confidence 877754 36788899999999999999999999 9999999999999987 899999999999987654322
Q ss_pred cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCC-cCCCCCCCCccccccCcchHHHHHHHHH-cCC----
Q 039817 601 TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCK-RHTELHRVDEPTLANGMILTDWVLYCVR-TGN---- 673 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---- 673 (725)
-. ...-|.-|.+|.++.+. .|+...|+||-||++.|+.... +.|...+.++ ++...+. -+.
T Consensus 158 ys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-----------qlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 158 YS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-----------QLKRIFRLLGTPTED 225 (292)
T ss_pred ee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-----------HHHHHHHHhCCCccc
Confidence 21 23367889999998765 6899999999999999998644 4444332221 1111111 000
Q ss_pred ----------------CCh---------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 ----------------LGA---------TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ----------------~~~---------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++. .....=++++.+.+.-+|.+|.++++.+++
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 000 112234567777888899999999998876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=251.41 Aligned_cols=248 Identities=19% Similarity=0.161 Sum_probs=157.1
Q ss_pred ccccHHHHHHHhcccC--CcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeE------EEcCCceeeeeec
Q 039817 444 KVFSYQELREATNVFD--GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGF------CIEQNHQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~--~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~~~~~~~lV~e~ 515 (725)
...+|+.|++|+..-+ ..+..||||++.... ..+.+..| .+.+..+.+++.++.. +..+...++||||
T Consensus 141 G~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey 216 (566)
T PLN03225 141 GEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRY 216 (566)
T ss_pred eeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEe
Confidence 3456778888776544 125678999875322 11222222 1222223333322221 2456788999999
Q ss_pred ccCCChhhhhccCCC--------------------CCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcc
Q 039817 516 MKNGTLSAFLFRQEI--------------------PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~ 575 (725)
+++++|.+++..... .....+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 217 ~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~~~-- 291 (566)
T PLN03225 217 EGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEG-- 291 (566)
T ss_pred cCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEeCC--
Confidence 999999998865421 11234567999999999999998 99999999999999852
Q ss_pred ccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC----------------------CCCCccceehhHH
Q 039817 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA----------------------PVTAKVDVYSFGV 633 (725)
Q Consensus 576 ~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDv~S~G~ 633 (725)
++.+||+|||+++..............+++.|+|||.+... .++.++|||||||
T Consensus 292 ----~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 292 ----SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred ----CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 57899999999986544333333445688999999965322 2445679999999
Q ss_pred HHHHHHhCCcCCCCCCCCcc--ccccCcchHHHHHHHHHcCCCCh----------hHHHHHHHHHHHccCCCCCCCCCHH
Q 039817 634 MLLEIIFCKRHTELHRVDEP--TLANGMILTDWVLYCVRTGNLGA----------TKFERITMVGLWCICPQPTLRPSMK 701 (725)
Q Consensus 634 vl~elltg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~l~~l~~~cl~~dp~~RPs~~ 701 (725)
+||||+++..+.+....... ..........|..... ..... .......+|+.+||+.||++|||++
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE--PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc--cccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 99999987655432100000 0000111111211100 01110 1122345899999999999999999
Q ss_pred HHHHH
Q 039817 702 QVLQM 706 (725)
Q Consensus 702 evl~~ 706 (725)
|+++|
T Consensus 446 e~L~H 450 (566)
T PLN03225 446 AALAH 450 (566)
T ss_pred HHhCC
Confidence 99987
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=224.56 Aligned_cols=216 Identities=27% Similarity=0.284 Sum_probs=177.9
Q ss_pred cceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHH
Q 039817 461 QEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKR 536 (725)
Q Consensus 461 ~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~ 536 (725)
....+|||.|++. ..++.+--+.|-++|+.. +-|.++++..+++.-+++++||||+.+|+|--+++.-+.+.+..+
T Consensus 373 tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~A 452 (683)
T KOG0696|consen 373 TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVA 452 (683)
T ss_pred cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchh
Confidence 3446788887653 123344456788888876 578999999999999999999999999999999988889999999
Q ss_pred HHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhc
Q 039817 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEW 616 (725)
Q Consensus 537 ~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~ 616 (725)
.-++..||-||-+||++ +||.||||.+|||||. ++.+||+|||+++.---+. .....++||+.|+|||.
T Consensus 453 vFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~-------eGHiKi~DFGmcKEni~~~-~TTkTFCGTPdYiAPEI 521 (683)
T KOG0696|consen 453 VFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDS-------EGHIKIADFGMCKENIFDG-VTTKTFCGTPDYIAPEI 521 (683)
T ss_pred hhhhHHHHHHhhhhhcC---CeeeeeccccceEecc-------CCceEeeecccccccccCC-cceeeecCCCcccccce
Confidence 99999999999999999 9999999999999988 8999999999998532222 22345789999999999
Q ss_pred ccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHHHHHHHHHHccCCCCC
Q 039817 617 LRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFERITMVGLWCICPQPT 695 (725)
Q Consensus 617 ~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dp~ 695 (725)
+...+|....|.|||||+||||+.|+.||+.++.++ .+..... .-.++...+.+...+....+.+.|.
T Consensus 522 i~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-----------lF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~ 590 (683)
T KOG0696|consen 522 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----------LFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPG 590 (683)
T ss_pred EEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-----------HHHHHHHccCcCcccccHHHHHHHHHHhhcCCc
Confidence 999999999999999999999999999998765332 1111111 2356677778888888999999999
Q ss_pred CCC
Q 039817 696 LRP 698 (725)
Q Consensus 696 ~RP 698 (725)
+|.
T Consensus 591 kRL 593 (683)
T KOG0696|consen 591 KRL 593 (683)
T ss_pred ccc
Confidence 994
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=232.13 Aligned_cols=223 Identities=22% Similarity=0.233 Sum_probs=190.5
Q ss_pred EEEEEccc---ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHH
Q 039817 465 VAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL 541 (725)
Q Consensus 465 vavk~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ 541 (725)
.|+|.+++ .+....+....|-++|...+.|.||++|--+.+....|++||-|-+|.|...|.+++.++.....-++.
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~a 527 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVA 527 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHH
Confidence 44555443 345566778999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCC
Q 039817 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP 621 (725)
Q Consensus 542 qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 621 (725)
.+++|+.|||.+ +||.|||||+|.+||. +|-+||.|||.|+.+.... ..-.++||+.|.|||.+.++.
T Consensus 528 cv~EAfeYLH~k---~iIYRDLKPENllLd~-------~Gy~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnKG 595 (732)
T KOG0614|consen 528 CVLEAFEYLHRK---GIIYRDLKPENLLLDN-------RGYLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKG 595 (732)
T ss_pred HHHHHHHHHHhc---CceeccCChhheeecc-------CCceEEeehhhHHHhccCC--ceeeecCCcccccchhhhccC
Confidence 999999999999 9999999999999988 8999999999999876443 334578999999999999999
Q ss_pred CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCC--
Q 039817 622 VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPS-- 699 (725)
Q Consensus 622 ~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-- 699 (725)
.+.+.|.||||++++||++|++||...+ .+..-..+..-+..-.+|........+++++....+|.+|.-
T Consensus 596 HD~avDyWaLGIli~ELL~G~pPFs~~d--------pmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~ 667 (732)
T KOG0614|consen 596 HDRAVDYWALGILIYELLTGSPPFSGVD--------PMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQ 667 (732)
T ss_pred cchhhHHHHHHHHHHHHHcCCCCCCCCc--------hHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccc
Confidence 9999999999999999999999998654 233333444444445667777888889999999999999975
Q ss_pred ---HHHHHHHh
Q 039817 700 ---MKQVLQML 707 (725)
Q Consensus 700 ---~~evl~~L 707 (725)
+.+|.+|-
T Consensus 668 ~~gI~DIkkH~ 678 (732)
T KOG0614|consen 668 KGGINDIKKHR 678 (732)
T ss_pred cCChHHHHhhh
Confidence 67777763
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=236.82 Aligned_cols=236 Identities=21% Similarity=0.221 Sum_probs=159.8
Q ss_pred cceEEEEEEcccccCccHHHH--------------HHHHHHHhccCcCCc-----cceeeEEEc--------CCceeeee
Q 039817 461 QEVEVAVKQLEKVTGDGEKSF--------------LREVQVIGRTHHKNL-----VQLLGFCIE--------QNHQLLVY 513 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f--------------~~E~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~ 513 (725)
.+..||||++........++| ..|+.++.+++|.++ ++++++|.. .+..+|||
T Consensus 185 ~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~ 264 (507)
T PLN03224 185 KKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVW 264 (507)
T ss_pred cCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEE
Confidence 346799999864333333333 346677777766554 778888764 35689999
Q ss_pred ecccCCChhhhhccC------------------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEE
Q 039817 514 ELMKNGTLSAFLFRQ------------------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVL 569 (725)
Q Consensus 514 e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIl 569 (725)
||+++++|.++++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+
T Consensus 265 Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NIL 341 (507)
T PLN03224 265 KFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLL 341 (507)
T ss_pred EcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEE
Confidence 999999999988642 1235778889999999999999998 9999999999999
Q ss_pred eccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCC----------------------CCCccc
Q 039817 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP----------------------VTAKVD 627 (725)
Q Consensus 570 l~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~ksD 627 (725)
++. ++.+||+|||+++..............+++.|+|||.+.... ...+.|
T Consensus 342 l~~-------~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~D 414 (507)
T PLN03224 342 VTV-------DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFD 414 (507)
T ss_pred ECC-------CCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccc
Confidence 987 778999999999765433222222223578999999875322 123479
Q ss_pred eehhHHHHHHHHhCCc-CCCCCCCCcccc-ccCcchHHHHHHHHHcCCC--ChhHHHHHHHHHHHccCCCC---CCCCCH
Q 039817 628 VYSFGVMLLEIIFCKR-HTELHRVDEPTL-ANGMILTDWVLYCVRTGNL--GATKFERITMVGLWCICPQP---TLRPSM 700 (725)
Q Consensus 628 v~S~G~vl~elltg~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dp---~~RPs~ 700 (725)
|||+||+++||+++.. ++.......... .....+..|.........+ .....+...+++.+++..+| .+|+|+
T Consensus 415 vwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa 494 (507)
T PLN03224 415 SYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV 494 (507)
T ss_pred hhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH
Confidence 9999999999999875 443211100000 0011111121110011111 12345678889999999766 689999
Q ss_pred HHHHHH
Q 039817 701 KQVLQM 706 (725)
Q Consensus 701 ~evl~~ 706 (725)
+|+++|
T Consensus 495 ~eaL~H 500 (507)
T PLN03224 495 GQALSH 500 (507)
T ss_pred HHHhCC
Confidence 999986
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=247.60 Aligned_cols=245 Identities=23% Similarity=0.251 Sum_probs=192.5
Q ss_pred ccccHHHHHHHhcccCCc---------ceEEEEEEccc---ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceee
Q 039817 444 KVFSYQELREATNVFDGQ---------EVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~---------~~~vavk~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 511 (725)
.+-.|..++...++.-|+ +..+|+|++.+ ........|+.|-.+|..-..+-|+.+.-.|.++..+|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 344555555554444332 34567777765 233445678899999998889999999999999999999
Q ss_pred eeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 512 VYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 512 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
|||||+||+|-..+.+...++++-+.-++..|+.||.-||+. ++|||||||+|||||. .|.+||+|||-+
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~-------~GHikLADFGsC 222 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDK-------SGHIKLADFGSC 222 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecc-------cCcEeeccchhH
Confidence 999999999999998888899999999999999999999999 9999999999999988 999999999999
Q ss_pred cccCcCCCccccccccCccccchhccc----C-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHH
Q 039817 592 KLLKKDQTRTSTMIRGTMGYMAPEWLR----N-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL 666 (725)
Q Consensus 592 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (725)
-.+..+..-.....+|||.|.+||+++ + +.|....|.||+||++|||+.|..||......+.. .-+.
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY--------~KIm 294 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY--------GKIM 294 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH--------HHHh
Confidence 888777666666678999999999985 3 57899999999999999999999999754322110 0011
Q ss_pred HHHHcCCCC--hhHHHHHHHHHHHccCCCCCCCCC---HHHHHHHh
Q 039817 667 YCVRTGNLG--ATKFERITMVGLWCICPQPTLRPS---MKQVLQML 707 (725)
Q Consensus 667 ~~~~~~~~~--~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~L 707 (725)
.....-.+| ...++...+||...+. +|+.|.. ++++..|-
T Consensus 295 ~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 295 NHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred chhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 111112333 3467788888888764 6778887 88888764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=212.11 Aligned_cols=237 Identities=23% Similarity=0.259 Sum_probs=190.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+.+|..+..+....+ .+.+|+|.+++.- ..+.+=...|-.+..+. +||.+|-+..++..+..+++|.||.++|+
T Consensus 260 rgsyakvl~~~~~~t--~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggd 337 (593)
T KOG0695|consen 260 RGSYAKVLLVRLKKT--DQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGD 337 (593)
T ss_pred Ccchhhhhheehccc--ceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcc
Confidence 445666555544433 3567787776432 22233356677777765 79999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|--++.+++.++++.+.-+...|.-||.|||+. +||.||||.+|+|+|. .+.+|+.|+|+++.--.+..
T Consensus 338 lmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvllda-------eghikltdygmcke~l~~gd- 406 (593)
T KOG0695|consen 338 LMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDA-------EGHIKLTDYGMCKEGLGPGD- 406 (593)
T ss_pred eeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEcc-------CCceeecccchhhcCCCCCc-
Confidence 999999999999999999999999999999999 9999999999999988 89999999999986443332
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 678 (725)
....++||+.|.|||.+.+..|....|.|++|++++||+.|+.||+....+.+ .+...+++.+.+.. -.+|...
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~----d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP----DMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc----ccchhHHHHHHHhhhccccccee
Confidence 23457899999999999999999999999999999999999999987654442 33444555554443 3456666
Q ss_pred HHHHHHHHHHccCCCCCCCC
Q 039817 679 FERITMVGLWCICPQPTLRP 698 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RP 698 (725)
.-+...+++.-+++||++|.
T Consensus 483 svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhc
Confidence 67778888899999999984
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-26 Score=215.47 Aligned_cols=250 Identities=28% Similarity=0.307 Sum_probs=188.1
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCC-----ceeeeeecccC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-----HQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~ 518 (725)
..|+-++..|+-.+| ..|+.|++..... ...+.+.+|+++|..++|.|++..++...-.. +.|+++|.|..
T Consensus 64 GAFGVVWsVTDPRdg--rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS 141 (449)
T KOG0664|consen 64 GAFGVVWSVTDPRSG--KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS 141 (449)
T ss_pred cceeEEEeccCCCCc--cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh
Confidence 345667777777665 4578888754322 23467899999999999999999999876543 67899999965
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+|.+.+-....++-+.+.-++.||++||.|||+. +|+||||||.|.|++. +-..||+|||+++....+.
T Consensus 142 -DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNS-------NCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 142 -DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNS-------NCILKICDFGLARTWDQRD 210 (449)
T ss_pred -hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEecc-------CceEEecccccccccchhh
Confidence 8999998888999999999999999999999999 9999999999999988 7789999999999888777
Q ss_pred CccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccc-----cccCcchH------HHHH
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT-----LANGMILT------DWVL 666 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~-----~~~~~~~~------~~~~ 666 (725)
...++...-|..|.|||.+.+. .|+.+.||||.||++.||+-.+..|.....-++- +.....+. +-..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 7777777789999999999875 6899999999999999999777666543221100 00000000 0011
Q ss_pred HHHHcCCC-------------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 667 YCVRTGNL-------------GATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 667 ~~~~~~~~-------------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
..+.++.. +.....+...+..+++..||++|.+..+.+.++.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111 0122234566778899999999999999988763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-25 Score=259.94 Aligned_cols=203 Identities=18% Similarity=0.207 Sum_probs=144.9
Q ss_pred hccCc-CCccceeeEEE-------cCCceeeeeecccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCcee
Q 039817 489 GRTHH-KNLVQLLGFCI-------EQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQII 559 (725)
Q Consensus 489 ~~l~H-~niv~l~g~~~-------~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~iv 559 (725)
++++| .||++++++|. +....++++|+++ ++|.++|... ..+++.++..++.||++||.|||++ +|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 45666 68889999882 3346778899874 5999999754 5689999999999999999999999 999
Q ss_pred ecCCccceEEeccCcc------------ccCCCCceEEeeccCccccCcCCC---------------ccccccccCcccc
Q 039817 560 HCDIKPQNVLLDNNYI------------TIDNNYITKIADFGLAKLLKKDQT---------------RTSTMIRGTMGYM 612 (725)
Q Consensus 560 H~dik~~NIll~~~~~------------~~~~~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y~ 612 (725)
||||||+||||+.... ..+.++.+|++|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999964110 002256778888888875321100 0001134788899
Q ss_pred chhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCC
Q 039817 613 APEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICP 692 (725)
Q Consensus 613 aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 692 (725)
|||++.+..++.++|||||||+||||++|..++.... ......... .. .............++.+||++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~L~~ 251 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRHR-VL-PPQILLNWPKEASFCLWLLHP 251 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHHh-hc-ChhhhhcCHHHHHHHHHhCCC
Confidence 9999999999999999999999999999877654211 001111000 00 000011234567888999999
Q ss_pred CCCCCCCHHHHHHH
Q 039817 693 QPTLRPSMKQVLQM 706 (725)
Q Consensus 693 dp~~RPs~~evl~~ 706 (725)
+|.+||+|.||+++
T Consensus 252 ~P~~Rps~~eil~h 265 (793)
T PLN00181 252 EPSCRPSMSELLQS 265 (793)
T ss_pred ChhhCcChHHHhhc
Confidence 99999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=205.28 Aligned_cols=195 Identities=37% Similarity=0.566 Sum_probs=167.8
Q ss_pred ceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEI 539 (725)
Q Consensus 462 ~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i 539 (725)
+..+++|.+...... ..+.+.+|++.+++++|++++++++++......++++|++++++|.+++... ..+++..+..+
T Consensus 18 ~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 97 (215)
T cd00180 18 GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRI 97 (215)
T ss_pred CcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHH
Confidence 567888888654332 3578999999999999999999999999999999999999999999999766 57899999999
Q ss_pred HHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccC
Q 039817 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN 619 (725)
Q Consensus 540 ~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 619 (725)
+.++++++.|||+. +++|+||+|.||+++.. +..++|+|||.+........ ......+...|++||.+..
T Consensus 98 ~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~------~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~ 167 (215)
T cd00180 98 LLQILEGLEYLHSN---GIIHRDLKPENILLDSD------NGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLG 167 (215)
T ss_pred HHHHHHHHHHHHhC---CeeccCCCHhhEEEeCC------CCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcc
Confidence 99999999999999 99999999999999752 46899999999986644321 1222447788999999987
Q ss_pred C-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCC
Q 039817 620 A-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRP 698 (725)
Q Consensus 620 ~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 698 (725)
. ..+.+.|+|++|+++++| ..+.+++.+|++.+|.+||
T Consensus 168 ~~~~~~~~D~~~lg~~~~~l-----------------------------------------~~~~~~l~~~l~~~p~~R~ 206 (215)
T cd00180 168 KGYYSEKSDIWSLGVILYEL-----------------------------------------PELKDLIRKMLQKDPEKRP 206 (215)
T ss_pred cCCCCchhhhHHHHHHHHHH-----------------------------------------HHHHHHHHHHhhCCcccCc
Confidence 7 888999999999999998 5677899999999999999
Q ss_pred CHHHHHHHh
Q 039817 699 SMKQVLQML 707 (725)
Q Consensus 699 s~~evl~~L 707 (725)
++.+++++|
T Consensus 207 ~~~~l~~~~ 215 (215)
T cd00180 207 SAKEILEHL 215 (215)
T ss_pred CHHHHhhCC
Confidence 999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=225.68 Aligned_cols=179 Identities=25% Similarity=0.338 Sum_probs=150.5
Q ss_pred EEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 464 EVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 464 ~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
.+|+|.|++.+ .......+.|-.+|..-+.+-||+||-.|.+++.+|+||||+++|++-.+|-+.+.+++....-++
T Consensus 656 lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYI 735 (1034)
T KOG0608|consen 656 LYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYI 735 (1034)
T ss_pred HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHH
Confidence 34556665432 223345678999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc---------CcCCC------------
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL---------KKDQT------------ 599 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~---------~~~~~------------ 599 (725)
..+..|+++.|+. ++|||||||+|||||. +|.+||.||||+.-+ .....
T Consensus 736 AEltcAiesVHkm---GFIHRDiKPDNILIDr-------dGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~ 805 (1034)
T KOG0608|consen 736 AELTCAIESVHKM---GFIHRDIKPDNILIDR-------DGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEW 805 (1034)
T ss_pred HHHHHHHHHHHhc---cceecccCccceEEcc-------CCceeeeeccccccceeccccccccCCCccccccCCCchhh
Confidence 9999999999998 9999999999999988 899999999998532 11000
Q ss_pred ------------c--------cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCc
Q 039817 600 ------------R--------TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDE 652 (725)
Q Consensus 600 ------------~--------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~ 652 (725)
+ .....+||..|+|||++....++.-.|.||.||+|+||+.|+.||......+
T Consensus 806 ~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 806 ADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred ccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 0 0012459999999999999999999999999999999999999997665443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=212.70 Aligned_cols=252 Identities=24% Similarity=0.255 Sum_probs=185.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-----c---CCccceeeEEEc----CCceee
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-----H---KNLVQLLGFCIE----QNHQLL 511 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~g~~~~----~~~~~l 511 (725)
....|++|+.|.+... ...||+|..+.. ..-.+.-+.||++|++++ | .+||+|+++|.. +.+.+|
T Consensus 87 GWGHFSTVWLawDtq~--~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCM 163 (590)
T KOG1290|consen 87 GWGHFSTVWLAWDTQN--KRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCM 163 (590)
T ss_pred cccccceeEEEeeccC--CeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEE
Confidence 3456777787776654 467899988653 445566789999999874 3 369999999985 458999
Q ss_pred eeecccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcc--------------
Q 039817 512 VYELMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI-------------- 575 (725)
Q Consensus 512 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~-------------- 575 (725)
|+|++.. +|..+|... +.++...+.+|+.||+.||.|||.+| +|||-||||+|||+..+..
T Consensus 164 VfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~ 240 (590)
T KOG1290|consen 164 VFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAREAGEATT 240 (590)
T ss_pred Eehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhhhccccc
Confidence 9999954 788888655 67899999999999999999999997 9999999999999921100
Q ss_pred ---------------------------------------------------------------------c----------
Q 039817 576 ---------------------------------------------------------------------T---------- 576 (725)
Q Consensus 576 ---------------------------------------------------------------------~---------- 576 (725)
.
T Consensus 241 ~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~ 320 (590)
T KOG1290|consen 241 SLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERST 320 (590)
T ss_pred cCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcc
Confidence 0
Q ss_pred ------------------------------------------------------------------cCCCCceEEeeccC
Q 039817 577 ------------------------------------------------------------------IDNNYITKIADFGL 590 (725)
Q Consensus 577 ------------------------------------------------------------------~~~~~~~kl~Dfgl 590 (725)
...+..+||+|||-
T Consensus 321 ~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGN 400 (590)
T KOG1290|consen 321 LEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGN 400 (590)
T ss_pred cccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccc
Confidence 00012457777777
Q ss_pred ccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHH----
Q 039817 591 AKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL---- 666 (725)
Q Consensus 591 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~---- 666 (725)
|+......+. -..|..|+|||++.+..|+..+||||++|+++||+||-..|+.+..+..... +.++...+.
T Consensus 401 ACW~~khFT~----DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD-EDHiA~i~ELLG~ 475 (590)
T KOG1290|consen 401 ACWVHKHFTE----DIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD-EDHIALIMELLGK 475 (590)
T ss_pred hhhhhhhhch----hhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc-HHHHHHHHHHHhh
Confidence 7654433322 2357889999999999999999999999999999999999987665542221 112111111
Q ss_pred ---HHHHcC--------------------------------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 ---YCVRTG--------------------------------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 ---~~~~~~--------------------------------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+ ..+.+....+.+++.-||+.+|++|||+.+.+++
T Consensus 476 iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 476 IPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred ccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 111111 1233667789999999999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=200.50 Aligned_cols=161 Identities=21% Similarity=0.185 Sum_probs=124.7
Q ss_pred CChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 519 GTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 519 gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
|+|.+++... ..+++..+..|+.|+++||.|||+. + ||+||+++. ++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~-------~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTW-------DGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcC-------ccceee--ccceEeeccc
Confidence 6899999764 5699999999999999999999998 4 999999987 778898 9998865432
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC-----
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----- 672 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 672 (725)
. ..|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ......... ....
T Consensus 63 ~------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~~~~~-~~~~~~~~~ 129 (176)
T smart00750 63 Q------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS------AILEILLNG-MPADDPRDR 129 (176)
T ss_pred c------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHHHHHH-hccCCcccc
Confidence 2 248899999999999999999999999999999999999986432111 111111111 1111
Q ss_pred CCChhHHH--HHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 673 NLGATKFE--RITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 673 ~~~~~~~~--~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..+....+ .+.+++.+||+.+|++||++.|+++++...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 01112233 699999999999999999999999998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-24 Score=219.64 Aligned_cols=242 Identities=21% Similarity=0.247 Sum_probs=178.9
Q ss_pred HHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC------cCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 449 QELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH------HKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 449 ~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+.|..|.+.-.+ ..||||++.... --.+.=+.|+++|++|. .-|+++|+-.|.+.+++|||+|.+. .+|.
T Consensus 446 s~Vvra~D~~r~--~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLR 521 (752)
T KOG0670|consen 446 STVVRARDQARG--QEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLR 521 (752)
T ss_pred eeeeeccccCCC--CeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHH
Confidence 344444443333 389999996532 22234468999999985 2489999999999999999999875 4899
Q ss_pred hhhccC---CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 523 AFLFRQ---EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 523 ~~l~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+.|.+. ..|....+..++.|+.-||.+|..- +|+|.||||.||||+++ ...+||||||.|........
T Consensus 522 evLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~------k~iLKLCDfGSA~~~~enei 592 (752)
T KOG0670|consen 522 EVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES------KNILKLCDFGSASFASENEI 592 (752)
T ss_pred HHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC------cceeeeccCccccccccccc
Confidence 999765 3577889999999999999999997 99999999999999875 77899999999987765543
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc---------cccCcc----------
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT---------LANGMI---------- 660 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~---------~~~~~~---------- 660 (725)
.. ..-+..|.|||.+.+.+|+-..|+||.||.||||.||+..|.......-- ....+.
T Consensus 593 tP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHF 669 (752)
T KOG0670|consen 593 TP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHF 669 (752)
T ss_pred cH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhc
Confidence 22 22355799999999999999999999999999999999888654322100 000000
Q ss_pred ----------------------------hHHHHHHHHHcCCCCh---hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 661 ----------------------------LTDWVLYCVRTGNLGA---TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 661 ----------------------------~~~~~~~~~~~~~~~~---~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+....+.....++. .....+.+|+..|+..||++|.|..|+++|
T Consensus 670 D~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 670 DQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred ccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 0011111111111222 345578889999999999999999999876
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-24 Score=225.34 Aligned_cols=237 Identities=22% Similarity=0.277 Sum_probs=190.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|+++++|.+..+++-.+|+|-+| ....+.+-..+|+-+++..+|+|||.++|.+...+..+++|||+.+|+|++
T Consensus 24 gsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQd 101 (829)
T KOG0576|consen 24 GSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQD 101 (829)
T ss_pred cCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccc
Confidence 456899999999998887554444444 456667778899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.-+-...+++.++...++...+||.|||.. +=+|||||-.||++++ .+.+|++|||.+-.+..--. ...
T Consensus 102 iy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd-------~gDvklaDfgvsaqitati~-Krk 170 (829)
T KOG0576|consen 102 IYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTD-------EGDVKLADFGVSAQITATIA-KRK 170 (829)
T ss_pred eeeecccchhHHHHHHHhhhhccchhhhcC---Ccccccccccceeecc-------cCceeecccCchhhhhhhhh-hhh
Confidence 999999999999999999999999999999 8899999999999988 89999999999876543222 233
Q ss_pred ccccCccccchhcc---cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC-----
Q 039817 604 MIRGTMGYMAPEWL---RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG----- 675 (725)
Q Consensus 604 ~~~gt~~y~aPE~~---~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 675 (725)
.+.||+.|||||+. ..+.|..++|||+.|+...|+---..|-... +...+..++.+..+.
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl------------hpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL------------HPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc------------chHHHHHHhhccCCCCCccc
Confidence 46799999999986 4567999999999999999886545443211 111122222222111
Q ss_pred --hhHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 676 --ATKFERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 676 --~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
....+.+-++++.|+.++|++||+++.++.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 145677889999999999999999987765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=219.16 Aligned_cols=186 Identities=25% Similarity=0.333 Sum_probs=153.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCc--------cHHHHHHHHHHHhccC---cCCccceeeEEEcCCceeeeee
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGD--------GEKSFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYE 514 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~--------~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e 514 (725)
..|+.++.|+.... ...|.||.+.+..-- ..-..-.|+++|++++ |+||++++++|++++.+||+||
T Consensus 572 GAyGkV~lai~K~n--~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te 649 (772)
T KOG1152|consen 572 GAYGKVNLAIHKEN--NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETE 649 (772)
T ss_pred cccceEEEeeeccc--ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEec
Confidence 34666666665544 578889988643110 1112447999999997 9999999999999999999999
Q ss_pred ccc-CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 515 LMK-NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 515 ~~~-~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
-.. +.+|.+++..+..+++.....|+.||+.|++|||++ +|||||||-+|+.++. +|-+||+|||.+..
T Consensus 650 ~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~-------~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 650 VHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDS-------NGFVKLIDFGSAAY 719 (772)
T ss_pred CCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEec-------CCeEEEeeccchhh
Confidence 874 679999999999999999999999999999999999 9999999999999987 89999999999876
Q ss_pred cCcCCCccccccccCccccchhcccCCCCC-CccceehhHHHHHHHHhCCcCCC
Q 039817 594 LKKDQTRTSTMIRGTMGYMAPEWLRNAPVT-AKVDVYSFGVMLLEIIFCKRHTE 646 (725)
Q Consensus 594 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~S~G~vl~elltg~~~~~ 646 (725)
.... ....++||.+|.|||++.+.+|- ..-|||++|++||-++....|+.
T Consensus 720 ~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 5433 23347799999999999988875 45899999999999987766653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=198.39 Aligned_cols=176 Identities=32% Similarity=0.483 Sum_probs=153.4
Q ss_pred ceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCC-CCHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEI-PTWDKRVEI 539 (725)
Q Consensus 462 ~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-l~~~~~~~i 539 (725)
+..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|++++++|.+++..... +++..+..+
T Consensus 24 ~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 103 (225)
T smart00221 24 GELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFY 103 (225)
T ss_pred CcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHH
Confidence 457899998765444 577899999999999999999999999999999999999999999999987766 899999999
Q ss_pred HHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcc-c
Q 039817 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL-R 618 (725)
Q Consensus 540 ~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~-~ 618 (725)
+.+++.++.+||+. +++|+||+|+||+++. ++.++|+|||.+...............++..|++||.+ .
T Consensus 104 ~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~-------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 173 (225)
T smart00221 104 LRQILEALEYLHSL---GIVHRDLKPENILLGM-------DGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLG 173 (225)
T ss_pred HHHHHHHHHHHHhC---CeecCCCCHHHEEEcC-------CCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcC
Confidence 99999999999999 9999999999999987 68999999999987655431122234577889999998 6
Q ss_pred CCCCCCccceehhHHHHHHHHhCCcCCCC
Q 039817 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTEL 647 (725)
Q Consensus 619 ~~~~~~ksDv~S~G~vl~elltg~~~~~~ 647 (725)
...++.++|||+||++++||++|+.||..
T Consensus 174 ~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 174 GKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 67788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=187.24 Aligned_cols=244 Identities=19% Similarity=0.231 Sum_probs=178.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEcC--CceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQ--NHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~~~~gs 520 (725)
.+..|+|++.+.+.-+.+ .+.||.|+.. ..+.+.+|+.+|..|+ ||||++|++...+. ....||+||..+.+
T Consensus 47 GRGKYSEVFeg~~~~~~e--K~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~D 121 (338)
T KOG0668|consen 47 GRGKYSEVFEGINITNNE--KCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTD 121 (338)
T ss_pred cCccHhhHhcccccCCCc--eEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcccc
Confidence 456788888877665544 5677777643 4567899999999997 99999999998764 46789999999876
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
..... ..++-..+.-.+.++++||.|+|+. +|+|||+||.|+++|.. ....+|+|+|||..+......
T Consensus 122 fk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~------~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 122 FKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHE------LRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred HHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechh------hceeeeeecchHhhcCCCcee
Confidence 55443 4456667788899999999999999 99999999999999874 667999999999987655433
Q ss_pred cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc------cCcchHHHHHHHHH---
Q 039817 601 TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA------NGMILTDWVLYCVR--- 670 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~--- 670 (725)
.. ...+..|--||.+-. ..|+-.-|+|||||++.+|+..+.||.-.......+. ....+..++.....
T Consensus 190 nV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 190 NV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred ee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 22 224556788998754 5688899999999999999999999864433221110 00111111111100
Q ss_pred --------cCC-C---------Ch-hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 671 --------TGN-L---------GA-TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 671 --------~~~-~---------~~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... - .. -..++..+++.+.|..|-++|||++|.+.+
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000 0 00 123678899999999999999999998865
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=175.68 Aligned_cols=106 Identities=26% Similarity=0.637 Sum_probs=90.3
Q ss_pred eecCCCCCCccceeeecc----cceEEeeCceeeeeeeeeccCCCCCceEEEEEEcCCCcEEEEEecCCCCCCceEEecc
Q 039817 167 WYTSTRGDQNVSLIFNQS----TSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNFQQWVHNKRDGNGWAVVWEA 242 (725)
Q Consensus 167 w~~~~~~~~~~~~~~~~~----~~~~~~~n~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~~~~~~~~W~~~~~~ 242 (725)
|++|+|++..+..++.+. ..+.|+.+.++.++++...+ .+.++|++||.+|++++|.|.+. .+.|..+|++
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~----~s~~~r~~ld~~G~l~~~~w~~~-~~~W~~~~~~ 75 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSN----SSVLSRLVLDSDGQLQRYIWNES-TQSWSVFWSA 75 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCC----CceEEEEEEeeeeEEEEEEEecC-CCcEEEEEEe
Confidence 788889888877666654 33478899999999987654 45789999999999999999875 4679999999
Q ss_pred ccCCCCcccccCCCCeeecCCCCceeeccCCCCCcCC
Q 039817 243 ITEPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPVD 279 (725)
Q Consensus 243 ~~~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~p~~ 279 (725)
|.++||+|+.||+||+|+ .+..+.|.||+||+|++
T Consensus 76 p~d~Cd~y~~CG~~g~C~--~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 76 PKDQCDVYGFCGPNGICN--SNNSPKCSCLPGFEPKN 110 (110)
T ss_pred cccCCCCccccCCccEeC--CCCCCceECCCCcCCCc
Confidence 999999999999999995 45678999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-21 Score=185.11 Aligned_cols=249 Identities=16% Similarity=0.245 Sum_probs=176.7
Q ss_pred CCCCcccccHHHHHHHhc-----cc--------CCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeE-E
Q 039817 439 PEINMKVFSYQELREATN-----VF--------DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGF-C 503 (725)
Q Consensus 439 ~~~~~~~~~~~~l~~a~~-----~~--------~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~-~ 503 (725)
+...++..++.+.+.... .| .+....+++|.+... ....++|.+|..---.| .|.||+.-|+. |
T Consensus 13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 334455666666554332 22 245677888887542 34567899998765555 69999987775 6
Q ss_pred EcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCce
Q 039817 504 IEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583 (725)
Q Consensus 504 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~ 583 (725)
+..+...+++||++.|+|..-+... .+-+..-.+++.|+++||.|+|++ ++||||||.+|||+-.. +..++
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~-----df~rv 162 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDA-----DFYRV 162 (378)
T ss_pred hcCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecC-----CccEE
Confidence 6777888999999999999888653 466778889999999999999999 99999999999998652 25699
Q ss_pred EEeeccCccccCcCCCccccccccCccccchhcccCC-----CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccC
Q 039817 584 KIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA-----PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANG 658 (725)
Q Consensus 584 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~ 658 (725)
||+|||+.+..+.- .....-+..|.+||..... ...+.+|||.||++++..+||+.|+.......
T Consensus 163 KlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d------ 232 (378)
T KOG1345|consen 163 KLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD------ 232 (378)
T ss_pred EeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC------
Confidence 99999998854321 1122245579999976432 35778999999999999999999998443332
Q ss_pred cchHHHHHHHHHc-CCCCh---hHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 659 MILTDWVLYCVRT-GNLGA---TKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 659 ~~~~~~~~~~~~~-~~~~~---~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
....+|.....+. ...|. ...+++.++.++-+.+++++|-...++.++.
T Consensus 233 ~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 233 KPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred chHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1122222221111 11222 4567888889999999999996655555543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=195.44 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=187.0
Q ss_pred cccccHHHHHHHhccc-CCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVF-DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~-~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
....+|+.+++|+..- +.....||+|.+..+ +....+.+|++.|..+ -+.||+++.+++..++...+|+||++...
T Consensus 44 igeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~ 121 (418)
T KOG1167|consen 44 IGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDR 121 (418)
T ss_pred ccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccC
Confidence 3467889999988765 446678999999754 3456689999999998 59999999999999999999999999988
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC--
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ-- 598 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~-- 598 (725)
..+++. .++...+...+..+..||.|+|+. +||||||||+|+|.+.. .+.-.|.|||||.......
T Consensus 122 f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~------t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 122 FRDLYR---SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRR------TQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred HHHHHh---cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccc------cCCceEEechhHHHHHhhhhh
Confidence 877774 456888999999999999999999 99999999999998763 5677899999997210000
Q ss_pred -----------C----------------------c------c--ccccccCccccchhccc-CCCCCCccceehhHHHHH
Q 039817 599 -----------T----------------------R------T--STMIRGTMGYMAPEWLR-NAPVTAKVDVYSFGVMLL 636 (725)
Q Consensus 599 -----------~----------------------~------~--~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~G~vl~ 636 (725)
. . . .....||+||.|||++. ....+++.||||-|++++
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 0 0 0 01134999999999875 456789999999999999
Q ss_pred HHHhCCcCCCCCCCCccccccCcc------hHH--------------------HHHHHHH--------cCC--------C
Q 039817 637 EIIFCKRHTELHRVDEPTLANGMI------LTD--------------------WVLYCVR--------TGN--------L 674 (725)
Q Consensus 637 elltg~~~~~~~~~~~~~~~~~~~------~~~--------------------~~~~~~~--------~~~--------~ 674 (725)
-+++++.||.....+...+.+... +.+ .....+. ... .
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 999999999755444332211000 000 0000000 000 0
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....+..+.+++.+|++.||.+|.|+++.++|
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01223478899999999999999999999976
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=160.48 Aligned_cols=100 Identities=29% Similarity=0.454 Sum_probs=87.1
Q ss_pred ceeeCCCCeeeeCCCeEEEeeeeCCCCC-EEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcCCCceEEE
Q 039817 33 NIIAGTNSTWPSTSGDFAFGFYPLVSGL-FLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKI 111 (725)
Q Consensus 33 ~l~~~~~~~lvS~~g~F~lGFf~~~~~~-~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~~~~~~ws 111 (725)
.|+. +++|+|++|.|++|||...... .+.+|||.+++ +++||+|||+.|...++.+.|+.+|+|+|.|.+|.++|+
T Consensus 3 ~l~~--~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~ 79 (116)
T cd00028 3 PLSS--GQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWS 79 (116)
T ss_pred CcCC--CCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEE
Confidence 4444 7899999999999999776665 99999999887 899999999999767789999999999999999999998
Q ss_pred eccC---ceeEEEEecCCCeEEecCCC
Q 039817 112 YNGT---LTVSALMQDSGNFLYSNANG 135 (725)
Q Consensus 112 ~~~~---~~~~a~LldsGNlVl~~~~~ 135 (725)
++.. ...+|+|+|+|||||++.++
T Consensus 80 S~~~~~~~~~~~~L~ddGnlvl~~~~~ 106 (116)
T cd00028 80 SNTTRVNGNYVLVLLDDGNLVLYDSDG 106 (116)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCCC
Confidence 7753 45679999999999998654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=157.34 Aligned_cols=96 Identities=30% Similarity=0.456 Sum_probs=86.0
Q ss_pred CCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcCCCceEEEeccC---
Q 039817 39 NSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGT--- 115 (725)
Q Consensus 39 ~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~~~~~~ws~~~~--- 115 (725)
+++|+|++|.|++|||......++.+|||++.+ +++||+|||+.|+.+++.|.|..+|+|+|.+.+|.++|+++..
T Consensus 7 ~~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~ 85 (114)
T smart00108 7 GQTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGAN 85 (114)
T ss_pred CCEEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCCC
Confidence 789999999999999987777799999999987 8999999999999887899999999999999999999987653
Q ss_pred ceeEEEEecCCCeEEecCCC
Q 039817 116 LTVSALMQDSGNFLYSNANG 135 (725)
Q Consensus 116 ~~~~a~LldsGNlVl~~~~~ 135 (725)
....|+|+|+|||||++..+
T Consensus 86 ~~~~~~L~ddGnlvl~~~~~ 105 (114)
T smart00108 86 GNYVLVLLDDGNLVIYDSDG 105 (114)
T ss_pred CceEEEEeCCCCEEEECCCC
Confidence 44679999999999997653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-20 Score=176.92 Aligned_cols=217 Identities=22% Similarity=0.330 Sum_probs=165.3
Q ss_pred cccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCC--CCCHHHHHHHHHHHHHHh
Q 039817 470 LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE--IPTWDKRVEIALGIARGL 547 (725)
Q Consensus 470 l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~gL 547 (725)
+........+.|..|.-.|+-+.||||+.++|.|.......++..||+.|||...|+.+. ..+..+.++++.++|+|+
T Consensus 223 vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargm 302 (448)
T KOG0195|consen 223 VREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGM 302 (448)
T ss_pred hhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhH
Confidence 333344445679999999999999999999999999999999999999999999998874 357789999999999999
Q ss_pred hhhhcccCCcee-ecCCccceEEeccCccccCCCCceEEe--eccCccccCcCCCccccccccCccccchhcccCCCC--
Q 039817 548 LYLHEECETQII-HCDIKPQNVLLDNNYITIDNNYITKIA--DFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-- 622 (725)
Q Consensus 548 ~yLH~~~~~~iv-H~dik~~NIll~~~~~~~~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-- 622 (725)
+|||+.. +++ ---|.+..+++|+ +.+++|+ |--.+. +. ....-.+.||+||.++.++-
T Consensus 303 aflhsle--p~ipr~~lns~hvmide-------dltarismad~kfsf--qe------~gr~y~pawmspealqrkped~ 365 (448)
T KOG0195|consen 303 AFLHSLE--PMIPRFYLNSKHVMIDE-------DLTARISMADTKFSF--QE------VGRAYSPAWMSPEALQRKPEDL 365 (448)
T ss_pred HHHhhcc--hhhhhhhcccceEEecc-------hhhhheecccceeee--ec------cccccCcccCCHHHHhcCchhc
Confidence 9999862 344 4468889999988 5566653 221111 10 11124578999999987643
Q ss_pred -CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHH
Q 039817 623 -TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMK 701 (725)
Q Consensus 623 -~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 701 (725)
-.++|+|||.+++|||.|...||..-..-+. ++. .+.+ -.+..++......+.+|+.-|+..||.+||.++
T Consensus 366 n~raadmwsfaillwel~trevpfadlspmec----gmk---iale-glrv~ippgis~hm~klm~icmnedpgkrpkfd 437 (448)
T KOG0195|consen 366 NIRAADMWSFAILLWELNTREVPFADLSPMEC----GMK---IALE-GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD 437 (448)
T ss_pred chhhhhHHHHHHHHHHhhccccccccCCchhh----hhh---hhhc-cccccCCCCccHHHHHHHHHHhcCCCCcCCCcc
Confidence 3469999999999999999999875432221 111 1111 123467778888999999999999999999999
Q ss_pred HHHHHhcCCC
Q 039817 702 QVLQMLEGTS 711 (725)
Q Consensus 702 evl~~L~~~~ 711 (725)
.|+-+||+..
T Consensus 438 mivpilekm~ 447 (448)
T KOG0195|consen 438 MIVPILEKMI 447 (448)
T ss_pred eehhhHHHhc
Confidence 9999998753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=190.74 Aligned_cols=212 Identities=26% Similarity=0.411 Sum_probs=162.8
Q ss_pred HhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCce-eecCCcc
Q 039817 488 IGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQI-IHCDIKP 565 (725)
Q Consensus 488 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~i-vH~dik~ 565 (725)
|+.+.|.|+.+++|.+..+...+.|.+|+..|+|.|.+... ..+++.-...++.+++.||.|||.. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 45789999999999999999999999999999999999874 5789999999999999999999998 55 9999999
Q ss_pred ceEEeccCccccCCCCceEEeeccCccccCcC-CCccccccccCccccchhcccCC-------CCCCccceehhHHHHHH
Q 039817 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKD-QTRTSTMIRGTMGYMAPEWLRNA-------PVTAKVDVYSFGVMLLE 637 (725)
Q Consensus 566 ~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~S~G~vl~e 637 (725)
+|+++|. .+.+||+|||+....... .............|.|||.+... ..+.+.||||||++++|
T Consensus 78 ~nClvd~-------~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 78 SNCLVDS-------RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred ccceeee-------eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 9999988 899999999998876431 11111112245579999998753 24778999999999999
Q ss_pred HHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCC-h-hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 638 IIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLG-A-TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 638 lltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+++.+.||......... ..+...+...... ..+. . +..+.+..++..||..+|.+||++++|...++.+..
T Consensus 151 i~~r~~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHhccCccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99999999865433211 1111111110000 0011 1 334478999999999999999999999999987765
Q ss_pred C
Q 039817 713 V 713 (725)
Q Consensus 713 ~ 713 (725)
.
T Consensus 227 ~ 227 (484)
T KOG1023|consen 227 G 227 (484)
T ss_pred c
Confidence 4
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.6e-20 Score=205.65 Aligned_cols=213 Identities=23% Similarity=0.269 Sum_probs=168.1
Q ss_pred HHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceee
Q 039817 481 FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIH 560 (725)
Q Consensus 481 f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 560 (725)
+..|+-+-..++|+|++..+..+.+.....-+|||++. +|..++.+...+....+..++.|+..|+.|||+. +|.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---Giah 443 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAH 443 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---Ccee
Confidence 55677777889999999888888777766666999999 9999998877888899999999999999999999 9999
Q ss_pred cCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc---cccccccCccccchhcccCCCCCCc-cceehhHHHHH
Q 039817 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR---TSTMIRGTMGYMAPEWLRNAPVTAK-VDVYSFGVMLL 636 (725)
Q Consensus 561 ~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k-sDv~S~G~vl~ 636 (725)
||+|++|+++.. ++.+||+|||.+..+...... ....+.|+..|+|||.+.+..|.+. .||||.|+++.
T Consensus 444 rdlK~enll~~~-------~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~ 516 (601)
T KOG0590|consen 444 RDLKLENLLVTE-------NGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYI 516 (601)
T ss_pred ccCccccEEEec-------CCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEE
Confidence 999999999988 889999999999876554433 2334779999999999999988865 89999999999
Q ss_pred HHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 637 EIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 637 elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
.|++|+.||......+.... ......+.........+....+.+.+.++.++|+.+|.+|.|+++|++
T Consensus 517 ~m~~~~~~Wk~a~~~~~~~~-~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 517 CMILGRFPWKVAKKSDNSFK-TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred EEecCCCccccccccccchh-hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99999999987655432210 000000000000001122245677889999999999999999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-18 Score=179.47 Aligned_cols=157 Identities=19% Similarity=0.138 Sum_probs=115.7
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc-----cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV-----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
+.+..|+.+++|...... +..||||++... .....+.|.+|+++|++++|+|+++.+.. .+..+|||||++
T Consensus 26 IG~G~fg~Vy~a~~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~ 101 (365)
T PRK09188 26 LKRDVFSTVERGYFAGDP-GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTE 101 (365)
T ss_pred EeecCcEEEEEEEEcCCC-CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccC
Confidence 345678888888765432 234788886532 12235679999999999999999853322 246799999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCC-ccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI-KPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~di-k~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+++|... .... ...++.|+++||.|||+. +|+|||| ||+|||++. ++.+||+|||+++.+..
T Consensus 102 G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~-------~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 102 GVPLHLA-RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGP-------DGEAAVIDFQLASVFRR 164 (365)
T ss_pred CCCHHHh-Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcC-------CCCEEEEECccceeccc
Confidence 9999732 1111 246789999999999999 9999999 999999976 67899999999997654
Q ss_pred CCCccc-------cccccCccccchhcccCC
Q 039817 597 DQTRTS-------TMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 597 ~~~~~~-------~~~~gt~~y~aPE~~~~~ 620 (725)
...... +...++..|+|||.+...
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 322111 234578889999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-16 Score=168.93 Aligned_cols=230 Identities=30% Similarity=0.381 Sum_probs=175.7
Q ss_pred eEEEEEEcccccCc---cHHHHHHHHHHHhccCcC-CccceeeEEEcCCceeeeeecccCCChhhhhccCC---CCCHHH
Q 039817 463 VEVAVKQLEKVTGD---GEKSFLREVQVIGRTHHK-NLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE---IPTWDK 535 (725)
Q Consensus 463 ~~vavk~l~~~~~~---~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~l~~~~ 535 (725)
..+++|.+...... ....|.+|+.+++.+.|+ +++++++.+......++++|++.+++|.+++.... .+....
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 102 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHH
Confidence 46788887654333 367899999999999887 79999999977777899999999999997776654 789999
Q ss_pred HHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC-ceEEeeccCccccCcCCCc-----cccccccCc
Q 039817 536 RVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY-ITKIADFGLAKLLKKDQTR-----TSTMIRGTM 609 (725)
Q Consensus 536 ~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~-~~kl~Dfgla~~~~~~~~~-----~~~~~~gt~ 609 (725)
...+..|++.++.|+|+. +++|||+||+||+++. .. .+++.|||+++........ ......|+.
T Consensus 103 ~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~-------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~ 172 (384)
T COG0515 103 ALFILAQILSALEYLHSK---GIIHRDIKPENILLDR-------DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172 (384)
T ss_pred HHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecC-------CCCeEEEeccCcceecCCCCcccccccccccccccc
Confidence 999999999999999999 9999999999999987 55 7999999999865443322 224456999
Q ss_pred cccchhcccC---CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCChh----HH
Q 039817 610 GYMAPEWLRN---APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGAT----KF 679 (725)
Q Consensus 610 ~y~aPE~~~~---~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~ 679 (725)
.|+|||.+.+ .......|+||+|++++++++|..|+....... ......+.+...... ...... ..
T Consensus 173 ~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (384)
T COG0515 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS----ATSQTLKIILELPTPSLASPLSPSNPELIS 248 (384)
T ss_pred ccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc----cHHHHHHHHHhcCCcccccccCccccchhh
Confidence 9999999987 678999999999999999999999955443210 001111111111100 001111 12
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+++..++..+|..|.++.+....
T Consensus 249 ~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 249 KAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 578889999999999999999887764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8e-18 Score=188.41 Aligned_cols=227 Identities=22% Similarity=0.216 Sum_probs=165.4
Q ss_pred EEEEEEcccc-cCccHHHHHHHHHHHh--ccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 464 EVAVKQLEKV-TGDGEKSFLREVQVIG--RTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 464 ~vavk~l~~~-~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
.|.||.+-+. ..-..+.|.++++-++ .++|||.+++.-+-..+...|||-+|..+ +|.|.|..+..+..-+..-|+
T Consensus 48 ~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWia 126 (1431)
T KOG1240|consen 48 LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIA 126 (1431)
T ss_pred eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHH
Confidence 3777776433 3455677776666554 45899999998888788888999999977 899999888788888899999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc--cCcCCCccccc----cccCccccch
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL--LKKDQTRTSTM----IRGTMGYMAP 614 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~--~~~~~~~~~~~----~~gt~~y~aP 614 (725)
.|++.||.-+|+. +|+|||||.+||||+. -..+.|+||...+. +.++....... .+.-..|+||
T Consensus 127 FQLL~al~qcH~~---gVcHGDIKsENILiTS-------WNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAP 196 (1431)
T KOG1240|consen 127 FQLLKALSQCHKL---GVCHGDIKSENILITS-------WNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAP 196 (1431)
T ss_pred HHHHHHHHHHHHc---CccccccccceEEEee-------echhhhhcccccCCccCCCCCcccceEEEecCCceeeecCh
Confidence 9999999999999 9999999999999987 77789999988763 33333322221 1233479999
Q ss_pred hcccCC-----------CCCCccceehhHHHHHHHHhC-CcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 615 EWLRNA-----------PVTAKVDVYSFGVMLLEIIFC-KRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 615 E~~~~~-----------~~~~ksDv~S~G~vl~elltg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
|.+-.. ..+++.||||+||++.||++. +++|+...--.... .+....+.+.+. .+...+
T Consensus 197 ERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~-~~~~~~e~~Le~--------Ied~~~ 267 (1431)
T KOG1240|consen 197 ERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS-GNADDPEQLLEK--------IEDVSL 267 (1431)
T ss_pred HhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc-cCccCHHHHHHh--------CcCccH
Confidence 987431 267889999999999999986 45554221111000 011111222211 223478
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
+++++.|++.||.+|.++++.++--.++
T Consensus 268 Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 268 RNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 9999999999999999999999876554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=169.02 Aligned_cols=256 Identities=19% Similarity=0.197 Sum_probs=184.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCc----CCccceeeEE-EcCCceeeeeecccC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHH----KNLVQLLGFC-IEQNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~lV~e~~~~ 518 (725)
....|++|+.+.+...+ ...+|+|.-..........+..|+.++..+.+ +++..+++.. ..+...++||+.. +
T Consensus 27 G~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G 104 (322)
T KOG1164|consen 27 GEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-G 104 (322)
T ss_pred cccCCceEEEEEecCCC-CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-C
Confidence 34567888888876665 55677776654433333378899999998873 5888999888 4777899999988 4
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc--cc
Q 039817 519 GTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK--LL 594 (725)
Q Consensus 519 gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~--~~ 594 (725)
.+|.+..... +.++..+...|+.|++.+|.+||+. +++||||||.|+++..... .....+.|.|||+++ .+
T Consensus 105 ~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~--~~~~~~~llDfGlar~~~~ 179 (322)
T KOG1164|consen 105 PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSR--SEVRTLYLLDFGLARRFKY 179 (322)
T ss_pred ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCC--cccceEEEEecCCCccccc
Confidence 5999987544 6789999999999999999999999 9999999999999986310 012579999999998 43
Q ss_pred CcCCC------cc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHH
Q 039817 595 KKDQT------RT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY 667 (725)
Q Consensus 595 ~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (725)
..... +. ....+||..|.+++...+...+.+.|+||++.++.|++.|..|+........ ..........
T Consensus 180 ~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~~~~~~~~~~ 255 (322)
T KOG1164|consen 180 VGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----KSKFEKDPRK 255 (322)
T ss_pred cCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----HHHHHHHhhh
Confidence 22221 11 1235699999999999999999999999999999999999988854432210 0111111111
Q ss_pred HHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 668 CVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 668 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
... .......+..+.++...+-..+..++|....+...|+...
T Consensus 256 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 256 LLT-DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred hcc-ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 111 1012233455666666666689999999999999886653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.3e-17 Score=162.88 Aligned_cols=200 Identities=21% Similarity=0.236 Sum_probs=146.2
Q ss_pred CcCCccceeeEEEc---------------------------CCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHH
Q 039817 492 HHKNLVQLLGFCIE---------------------------QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIA 544 (725)
Q Consensus 492 ~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia 544 (725)
+|||||++.++|.+ +...|+||.-.+. +|.+++..+. .+.....-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 69999999987643 2356888887765 8998886554 45566777899999
Q ss_pred HHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC-----CCccccccccCccccchhcccC
Q 039817 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD-----QTRTSTMIRGTMGYMAPEWLRN 619 (725)
Q Consensus 545 ~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~ 619 (725)
+|+.|||++ +|.|||+|++|||+.-+. |+-....|+|||.+--.... ........-|...-||||....
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~Eldd---D~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDD---DEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecC---CCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999 999999999999986542 44567789999987532221 1111122347778999998864
Q ss_pred CC------CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCC
Q 039817 620 AP------VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQ 693 (725)
Q Consensus 620 ~~------~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 693 (725)
.+ --.|+|.|+.|.+.||++....||.... ++.+.....+..+-..++...+..+++++...++.|
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--------em~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--------EMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRD 497 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--------hheechhhhhhhhCCCCcccCChHHHHHHHHHhcCC
Confidence 32 2358999999999999998888887521 233332233333345566677889999999999999
Q ss_pred CCCCCCHHHHHHHh
Q 039817 694 PTLRPSMKQVLQML 707 (725)
Q Consensus 694 p~~RPs~~evl~~L 707 (725)
|.+|++..-....|
T Consensus 498 pskRvsp~iAANvl 511 (598)
T KOG4158|consen 498 PSKRVSPNIAANVL 511 (598)
T ss_pred ccccCCccHHHhHH
Confidence 99999886665554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-16 Score=167.59 Aligned_cols=168 Identities=29% Similarity=0.434 Sum_probs=130.0
Q ss_pred ceeeeeecccCCChhhhhccC---CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceE
Q 039817 508 HQLLVYELMKNGTLSAFLFRQ---EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584 (725)
Q Consensus 508 ~~~lV~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~k 584 (725)
..++.|+++...+|.+||.+. ...++....+++.|++.|+.| + +.+|+|+||.||+... +..+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~-------d~q~k 396 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSD-------DDQLK 396 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhcccccccccc-------chhhh
Confidence 578999999999999999765 356888999999999999999 5 8999999999999876 66899
Q ss_pred EeeccCccccCcCC-----CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccC
Q 039817 585 IADFGLAKLLKKDQ-----TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANG 658 (725)
Q Consensus 585 l~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~ 658 (725)
|.|||+........ ....+...||..||+||.+.+..|+.|+||||||++|+|++. -...++.
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------- 465 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------- 465 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------
Confidence 99999988765544 223344569999999999999999999999999999999995 2222221
Q ss_pred cchHHHHHHHHHcCCCChhH---HHHHHHHHHHccCCCCCCCCCHHHH
Q 039817 659 MILTDWVLYCVRTGNLGATK---FERITMVGLWCICPQPTLRPSMKQV 703 (725)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~---~~~l~~l~~~cl~~dp~~RPs~~ev 703 (725)
.-+...++.+.+++.. .+.-..|+.+++...|.+||++.++
T Consensus 466 ----~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 ----IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ----HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 1122223344555321 2234568889999999999955444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-16 Score=167.40 Aligned_cols=196 Identities=22% Similarity=0.166 Sum_probs=164.0
Q ss_pred HHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCce
Q 039817 480 SFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558 (725)
Q Consensus 480 ~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 558 (725)
....|-.++..++ ||.+|++.-.+..+...+++.++..+|.|...+.+...+...........++-++.++|+. +|
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~i 118 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GI 118 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HH
Confidence 4456777888886 9999999999999999999999999999999998888888888888889999999999999 99
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHH
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~el 638 (725)
+|||+|++||+++. +|.+|+.|||+++..-..... +||..|||||.+. ....++|.||||++++||
T Consensus 119 iyrd~k~enilld~-------~Ghi~~tdfglske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~fel 184 (612)
T KOG0603|consen 119 AYRDYKLENVLLLL-------EGHIKLTDFGLSKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFEL 184 (612)
T ss_pred HHhcccccceeecc-------cCccccCCchhhhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHH
Confidence 99999999999988 899999999999976544332 6899999999998 567899999999999999
Q ss_pred HhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHHHHHHHHHHccCCCCCCCCCH--HHHHHHh
Q 039817 639 IFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFERITMVGLWCICPQPTLRPSM--KQVLQML 707 (725)
Q Consensus 639 ltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~--~evl~~L 707 (725)
++|..||.. +....... +..++.+.....++++..++..+|..|.-. ..+.+++
T Consensus 185 ltg~~pf~~---------------~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 185 LTGTLPFGG---------------DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhCCCCCch---------------HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 999999875 11222222 345667778888889999999999999644 3444444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-15 Score=141.66 Aligned_cols=194 Identities=21% Similarity=0.223 Sum_probs=156.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCc-CCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHH-KNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...+|++|+.|...-+|+. ||||.=.+. ..--++..|.+++..++| ..|..+..+..++..-.||||.+. .||+
T Consensus 24 GsGSFGdIy~~~~i~~ge~--VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLG-PsLE 98 (341)
T KOG1163|consen 24 GSGSFGDIYLGISITSGEE--VAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLG-PSLE 98 (341)
T ss_pred cCCchhheeeeeeccCCce--EEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeeccC-ccHH
Confidence 3468999999998877765 566643322 222357889999999976 568888888889999999999985 5898
Q ss_pred hhhc-cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 523 AFLF-RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 523 ~~l~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
+.+. ..+.++.++++-++.|++.-++|+|.. +++||||||+|+|+.-+.. ...+.++|||+++.+....+.
T Consensus 99 dLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh----~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 99 DLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRH----CNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred HHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccc----cceEEEEeccchhhhccccccc
Confidence 8874 457899999999999999999999999 9999999999999876432 567899999999976543322
Q ss_pred -----cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCC
Q 039817 601 -----TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHR 649 (725)
Q Consensus 601 -----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~ 649 (725)
......||..|.+-....+...+.+.|+-|+|.+|.+..-|..||..-.
T Consensus 172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 2223559999999888888888899999999999999999999998654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.8e-15 Score=146.38 Aligned_cols=196 Identities=20% Similarity=0.232 Sum_probs=162.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...+|++|+.+++...+ .+||||.=.. ....-+++.|.+.++.| ..+.|...+-|-.++.+-.||+|.+. .||+
T Consensus 37 GeGsFG~lf~G~Nl~nn--e~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLG-PSLE 111 (449)
T KOG1165|consen 37 GEGSFGVLFLGKNLYNN--EPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLG-PSLE 111 (449)
T ss_pred ccCcceeeecccccccC--ceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhC-cCHH
Confidence 45689999999998875 5778885432 23345688999999988 57899999999999999999999985 4999
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
|...- .+.++.+++.-+|.|++.-++|+|++ .+|.|||||+|+||.... -.....+.|+|||+|+.+....+..
T Consensus 112 DLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~--~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 112 DLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPG--TKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred HHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCC--CCCCceEEEEeccchhhhcCccccc
Confidence 98753 47899999999999999999999999 999999999999997522 2235678999999999876543322
Q ss_pred ------ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCC
Q 039817 602 ------STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHR 649 (725)
Q Consensus 602 ------~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~ 649 (725)
....-||..||+-....+.+.+.+-|+-|||-|+++.+-|..||..-.
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 223559999999999999999999999999999999999999998654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.1e-15 Score=148.08 Aligned_cols=146 Identities=14% Similarity=0.152 Sum_probs=110.3
Q ss_pred ceEEEEEEcccccCccHHH---------HHHHHHHHhccCcCCccceeeEEEcC--------CceeeeeecccCCChhhh
Q 039817 462 EVEVAVKQLEKVTGDGEKS---------FLREVQVIGRTHHKNLVQLLGFCIEQ--------NHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~---------f~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~lV~e~~~~gsL~~~ 524 (725)
...++||.+........+. +.+|++.+.+++|++|..+..++... ...+|||||+++.+|.++
T Consensus 54 ~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~ 133 (232)
T PRK10359 54 YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDM 133 (232)
T ss_pred CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHh
Confidence 3468999886543333322 67999999999999999999986633 357899999999999887
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
.. ++. ....+++.+|..+|+. +++|||+||+||+++. ++ ++|+|||.......+....
T Consensus 134 ~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~-------~g-i~liDfg~~~~~~e~~a~d--- 191 (232)
T PRK10359 134 PE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK-------NG-LRIIDLSGKRCTAQRKAKD--- 191 (232)
T ss_pred hh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC-------CC-EEEEECCCcccccchhhHH---
Confidence 42 222 3466999999999999 9999999999999986 56 9999999887553222111
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ell 639 (725)
.+.....+..++|+|+||+.+.-..
T Consensus 192 ----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 192 ----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ----------HHHHHhHhcccccccceeEeehHHH
Confidence 1334455678999999999887654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-15 Score=130.49 Aligned_cols=81 Identities=32% Similarity=0.506 Sum_probs=58.2
Q ss_pred CCeEEEEeCCCCCCC---CCceEEEcccccEEEEcCCCceEEEe-ccC----ceeEEEEecCCCeEEecCCC-----Ccc
Q 039817 72 ERTLVWSANRDDPAQ---VGSSINLTVTGQLVLTHSNGTQFKIY-NGT----LTVSALMQDSGNFLYSNANG-----SVD 138 (725)
Q Consensus 72 ~~tvVWvANr~~Pv~---~~s~l~l~~~G~LvL~~~~~~~~ws~-~~~----~~~~a~LldsGNlVl~~~~~-----~~d 138 (725)
++||||+|||+.|+. ...+|.|+.||+|+|.+.+++.+|++ +.. ....|+|+|+|||||++..+ ++|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 479999999999994 34689999999999999999999988 322 36789999999999999665 899
Q ss_pred CCCCceEEeeecCC
Q 039817 139 YSTGRFVLEIQMDG 152 (725)
Q Consensus 139 ~s~g~~~~~~~~~g 152 (725)
++++++.+.++...
T Consensus 81 ~ptdt~L~~q~l~~ 94 (114)
T PF01453_consen 81 YPTDTLLPGQKLGD 94 (114)
T ss_dssp SSS-EEEEEET--T
T ss_pred CCccEEEeccCccc
Confidence 99999999988443
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.1e-15 Score=141.08 Aligned_cols=180 Identities=14% Similarity=0.043 Sum_probs=127.1
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCcc----HHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeeccc
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDG----EKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~----~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
+++-.|++++.+. +.+..++.+.+.....-. ...|.+|+++|++++ |+++++++++ +..+++|||++
T Consensus 10 l~~~~f~~v~~~~----~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 10 LKSDTFGRILLVR----GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ecCCCcceEEEee----cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 4555666666333 234566666665433211 125889999999995 5889999886 45699999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCC-ccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI-KPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~di-k~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+.+|.+.+.. ....++.|++.+|.++|+. +|+|||| ||+|||++. ++.++|+|||++.....
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~-------~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQE-------DGSPAVIDFQLAVRGNP 144 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcC-------CCCEEEEECCCceecCC
Confidence 9998754421 1245788999999999999 9999999 799999976 77899999999986543
Q ss_pred CCCc----cc--------cccccCccccchhcccCC-CCC-CccceehhHHHHHHHHhCCcCCCC
Q 039817 597 DQTR----TS--------TMIRGTMGYMAPEWLRNA-PVT-AKVDVYSFGVMLLEIIFCKRHTEL 647 (725)
Q Consensus 597 ~~~~----~~--------~~~~gt~~y~aPE~~~~~-~~~-~ksDv~S~G~vl~elltg~~~~~~ 647 (725)
.... .. .....++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 3210 00 012256677777643211 223 567889999999999999987643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-15 Score=145.18 Aligned_cols=136 Identities=17% Similarity=0.140 Sum_probs=101.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCc--c-------HHHH-----------------HHHHHHHhccCcCCcc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGD--G-------EKSF-----------------LREVQVIGRTHHKNLV 497 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~niv 497 (725)
...++++++.|.+. ++..||||.++..... . ...| ..|++.+.++.|+++.
T Consensus 6 g~G~~~~Vy~a~~~---~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 6 STGKEANVYHATTA---NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred ccccceEEEEEECC---CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 34567777777764 3567888887643211 1 1122 3499999999888775
Q ss_pred ceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhh-hcccCCceeecCCccceEEeccCccc
Q 039817 498 QLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYL-HEECETQIIHCDIKPQNVLLDNNYIT 576 (725)
Q Consensus 498 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivH~dik~~NIll~~~~~~ 576 (725)
....+.. ...+|||||+++++|...+.....++......++.|++.+|.|| |+. +|+||||||+||+++.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~---- 153 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD---- 153 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC----
Confidence 4333322 22389999999988776654556789999999999999999999 687 9999999999999973
Q ss_pred cCCCCceEEeeccCccccC
Q 039817 577 IDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 577 ~~~~~~~kl~Dfgla~~~~ 595 (725)
+.++|+|||++....
T Consensus 154 ----~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 ----GKLYIIDVSQSVEHD 168 (190)
T ss_pred ----CcEEEEEccccccCC
Confidence 469999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.1e-15 Score=142.43 Aligned_cols=137 Identities=16% Similarity=0.082 Sum_probs=102.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCcc--------------------------HHHHHHHHHHHhccCcCCcc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDG--------------------------EKSFLREVQVIGRTHHKNLV 497 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~--------------------------~~~f~~E~~~l~~l~H~niv 497 (725)
...+++.++.|++. ++..||||.+....... ...+..|.+.+.+++|+++.
T Consensus 6 g~G~~~~Vy~a~~~---~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 6 STGKEANVYHARTG---DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ecCCCcEEEEEEcC---CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 34567777778765 35678888876432110 11245789999999999875
Q ss_pred ceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccc
Q 039817 498 QLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYIT 576 (725)
Q Consensus 498 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~ 576 (725)
....+... ..+|||||++++++.........++......++.|++.++.+||+ . +|+||||||+||+++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~----- 152 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH----- 152 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-----
Confidence 55444333 248999999988665443344567888999999999999999999 8 999999999999996
Q ss_pred cCCCCceEEeeccCccccCc
Q 039817 577 IDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 577 ~~~~~~~kl~Dfgla~~~~~ 596 (725)
++.++|+|||++....+
T Consensus 153 ---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 ---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ---CCCEEEEEcccceecCC
Confidence 45799999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.1e-14 Score=136.19 Aligned_cols=118 Identities=19% Similarity=0.211 Sum_probs=91.1
Q ss_pred EEEEcccccCccHHHHHHHHHHHhcc-----CcCCccceeeEEEcCC---c-eeeeeec--ccCCChhhhhccCCCCCHH
Q 039817 466 AVKQLEKVTGDGEKSFLREVQVIGRT-----HHKNLVQLLGFCIEQN---H-QLLVYEL--MKNGTLSAFLFRQEIPTWD 534 (725)
Q Consensus 466 avk~l~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV~e~--~~~gsL~~~l~~~~~l~~~ 534 (725)
+||.+........+.+.+|+++++++ .||||++++|++.++. . ..+|+|| +++++|.+++.+. .+++.
T Consensus 28 ~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~ 106 (210)
T PRK10345 28 CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED 106 (210)
T ss_pred EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh
Confidence 46666544344567899999999999 5799999999998864 3 3378999 5589999999654 45544
Q ss_pred HHHHHHHHHHHHh-hhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 535 KRVEIALGIARGL-LYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 535 ~~~~i~~qia~gL-~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
..++.|++.++ .|||+. +|+||||||+||+++... +++..++|+||+.+.
T Consensus 107 --~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~---~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 107 --VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRIS---ESEVIPVVCDNIGES 157 (210)
T ss_pred --HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccC---CCCCcEEEEECCCCc
Confidence 35678888777 999999 999999999999997521 125589999955443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.2e-14 Score=143.11 Aligned_cols=224 Identities=19% Similarity=0.198 Sum_probs=135.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccc-ccCccHHHHHHHHHHHhccC----------cCCccceeeEEEc--------
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTH----------HKNLVQLLGFCIE-------- 505 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~-~~~~~~~~f~~E~~~l~~l~----------H~niv~l~g~~~~-------- 505 (725)
..+++.++.+++..+++..+|++-.+.. ......+++++|.-.+..+. |-.++.-++....
T Consensus 22 ~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~ 101 (288)
T PF14531_consen 22 KGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFE 101 (288)
T ss_dssp EETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEE
T ss_pred cCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCccee
Confidence 3445555666666666554444444433 22334567777776665543 2233333333221
Q ss_pred -C---C-----ceeeeeecccCCChhhhhc---cC-C---CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEE
Q 039817 506 -Q---N-----HQLLVYELMKNGTLSAFLF---RQ-E---IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVL 569 (725)
Q Consensus 506 -~---~-----~~~lV~e~~~~gsL~~~l~---~~-~---~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIl 569 (725)
. . ..+++|+-+ .++|.+.+. .. . .+....+..+..|+++.+++||.. +++|+||+|+|++
T Consensus 102 ~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfl 177 (288)
T PF14531_consen 102 RGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFL 177 (288)
T ss_dssp ECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEE
T ss_pred cCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEE
Confidence 1 1 225666666 358877753 21 1 234456677889999999999999 9999999999999
Q ss_pred eccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccC--------CCCCCccceehhHHHHHHHHhC
Q 039817 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN--------APVTAKVDVYSFGVMLLEIIFC 641 (725)
Q Consensus 570 l~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~S~G~vl~elltg 641 (725)
++. +|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|.++
T Consensus 178 l~~-------~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 178 LDQ-------DGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp E-T-------TS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred EcC-------CCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 988 899999999887755432221 224577999997643 2578899999999999999999
Q ss_pred CcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCC
Q 039817 642 KRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLR 697 (725)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 697 (725)
+.|+.......... . .-..-. +.++.++.|+..+|+.+|.+|
T Consensus 247 ~lPf~~~~~~~~~~---~----------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPE---W----------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSG---G----------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccccc---c----------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99998654332110 0 011222 678899999999999999988
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.5e-14 Score=139.45 Aligned_cols=204 Identities=19% Similarity=0.270 Sum_probs=141.6
Q ss_pred HHHHHhccCcCCccceeeEEEcC-----CceeeeeecccCCChhhhhccC----CCCCHHHHHHHHHHHHHHhhhhhccc
Q 039817 484 EVQVIGRTHHKNLVQLLGFCIEQ-----NHQLLVYELMKNGTLSAFLFRQ----EIPTWDKRVEIALGIARGLLYLHEEC 554 (725)
Q Consensus 484 E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~ 554 (725)
-...|-++.|.|||++..|..+. .+..++.|||.-|+|..+|.+. ..+......+|+.||..||.|||+ |
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 34455667799999999988643 3578999999999999999754 467888889999999999999999 7
Q ss_pred CCceeecCCccceEEeccCccccCCCCceEEeeccCccccC---cCCCccccccccCccccchhcccCCCCCCccceehh
Q 039817 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK---KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631 (725)
Q Consensus 555 ~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~ 631 (725)
.|+|+|+++..+.|++.. ++.+|++--.-...-. .........-.+.++|.+||+-..-..+.++|||+|
T Consensus 196 ~PpiihgnlTc~tifiq~-------ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQH-------NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred CCccccCCcchhheeecC-------CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 889999999999999986 7778875322111100 000011112336789999998887788899999999
Q ss_pred HHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 632 GVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 632 G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
|+..+||.-+..-........ ..+.....-+ . .-...+-+.++.+|++.+|..||+|.+++.|.
T Consensus 269 gmcAlemailEiq~tnseS~~---~~ee~ia~~i-~--------~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 269 GMCALEMAILEIQSTNSESKV---EVEENIANVI-I--------GLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred hHHHHHHHHheeccCCCccee---ehhhhhhhhe-e--------eccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 999999976554321111000 0000000000 0 00112234577789999999999999998775
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-12 Score=149.29 Aligned_cols=193 Identities=22% Similarity=0.173 Sum_probs=148.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC---cCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|+.|+..- +..||+|.=+.... -+|.-=.+++.||+ -+-|..+.....-.+..+||+||.+.|+
T Consensus 707 G~g~y~~vy~a~~~~---~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 707 GEGSYGSVYVATHSN---GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred ccccceEEEEeecCC---CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence 456788888877654 67888887654332 23333344455555 2234444445556778899999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC-C
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ-T 599 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~-~ 599 (725)
|.+++...+..+|...+.++.|+++.+.+||.. +|||+||||+|+||......-.+...++|+|||.+.-+.--. .
T Consensus 781 lld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~ 857 (974)
T KOG1166|consen 781 LLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG 857 (974)
T ss_pred HHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC
Confidence 999999889999999999999999999999999 999999999999996544433446779999999986432211 1
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCC
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHT 645 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~ 645 (725)
......++|-++-.+|...+.+++-..|-|-|+.+++-|+.|+..-
T Consensus 858 ~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 858 TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 2334466888999999999999999999999999999999988654
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.6e-13 Score=103.43 Aligned_cols=59 Identities=20% Similarity=0.329 Sum_probs=49.6
Q ss_pred CceEEEeecccCCCCCccccccccccChhhHHHHhcccCcccceeeec----ceeeccccccccc
Q 039817 304 DFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVWRE----VVCLKKKMPLLNA 364 (725)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~----~~C~~~~~~l~~~ 364 (725)
.++|++++++++|+... .....++++++|++.||+||||+||+|.+ ++|++|.++|+|+
T Consensus 4 ~d~F~~l~~~~~p~~~~--~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDN--AIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CCEEEEECCeeCCCCcc--eeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 36999999999999752 12225689999999999999999999963 8999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.7e-12 Score=124.60 Aligned_cols=100 Identities=22% Similarity=0.383 Sum_probs=88.5
Q ss_pred HHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCce
Q 039817 479 KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558 (725)
Q Consensus 479 ~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 558 (725)
..+.+|++++..++|+++.....++...+..++||||+++++|.+++..... .+..++.+++.+|.+||+. ++
T Consensus 44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i 116 (211)
T PRK14879 44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GI 116 (211)
T ss_pred HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---Cc
Confidence 4578899999999999998888888888889999999999999999865432 8889999999999999999 99
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+|+|++|.||+++ ++.++|+|||++..
T Consensus 117 ~H~Dl~p~Nil~~--------~~~~~liDf~~a~~ 143 (211)
T PRK14879 117 IHGDLTTSNMILS--------GGKIYLIDFGLAEF 143 (211)
T ss_pred ccCCCCcccEEEE--------CCCEEEEECCcccC
Confidence 9999999999996 35689999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.9e-12 Score=125.23 Aligned_cols=135 Identities=19% Similarity=0.131 Sum_probs=99.1
Q ss_pred ccccHHHHHHHh-cccCCcceEEEEEEcccccCc------------------------cHHHHHHHHHHHhccCcC--Cc
Q 039817 444 KVFSYQELREAT-NVFDGQEVEVAVKQLEKVTGD------------------------GEKSFLREVQVIGRTHHK--NL 496 (725)
Q Consensus 444 ~~~~~~~l~~a~-~~~~~~~~~vavk~l~~~~~~------------------------~~~~f~~E~~~l~~l~H~--ni 496 (725)
...+++.++.|+ +..+ +..||||.+...... ....+..|++.+.++.|. .+
T Consensus 37 g~G~~g~Vy~a~~~~~~--g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~ 114 (237)
T smart00090 37 STGKEANVYHALDFDGS--GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPV 114 (237)
T ss_pred ccCcceeEEEEEecCCC--CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 345667777776 3333 467888877542210 112356899999999753 33
Q ss_pred cceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCc-eeecCCccceEEeccCcc
Q 039817 497 VQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ-IIHCDIKPQNVLLDNNYI 575 (725)
Q Consensus 497 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivH~dik~~NIll~~~~~ 575 (725)
.+++++ ...++||||+++.+|.........+.......++.|++.+|.+||+. + ++||||||+||+++
T Consensus 115 p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~---- 183 (237)
T smart00090 115 PKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH---- 183 (237)
T ss_pred CeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE----
Confidence 444443 23589999999999887765555566667789999999999999999 9 99999999999996
Q ss_pred ccCCCCceEEeeccCccccC
Q 039817 576 TIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 576 ~~~~~~~~kl~Dfgla~~~~ 595 (725)
++.++|+|||.+....
T Consensus 184 ----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 ----DGKVVIIDVSQSVELD 199 (237)
T ss_pred ----CCCEEEEEChhhhccC
Confidence 3579999999987544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.1e-13 Score=150.09 Aligned_cols=227 Identities=23% Similarity=0.270 Sum_probs=168.8
Q ss_pred eEEEEEEccccc--CccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhhh-ccCC-CCCHHHHH
Q 039817 463 VEVAVKQLEKVT--GDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL-FRQE-IPTWDKRV 537 (725)
Q Consensus 463 ~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l-~~~~-~l~~~~~~ 537 (725)
..+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++.||..++++.+.+ +... ..+....-
T Consensus 47 ~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~ 126 (601)
T KOG0590|consen 47 SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSAS 126 (601)
T ss_pred ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchh
Confidence 455666654332 222334445776666675 999999999999999999999999999999988 4443 56677788
Q ss_pred HHHHHHHHHhhhhh-cccCCceeecCCccceEEeccCccccCCCC-ceEEeeccCccccCc--CCCcccccccc-Ccccc
Q 039817 538 EIALGIARGLLYLH-EECETQIIHCDIKPQNVLLDNNYITIDNNY-ITKIADFGLAKLLKK--DQTRTSTMIRG-TMGYM 612 (725)
Q Consensus 538 ~i~~qia~gL~yLH-~~~~~~ivH~dik~~NIll~~~~~~~~~~~-~~kl~Dfgla~~~~~--~~~~~~~~~~g-t~~y~ 612 (725)
..+.|+..++.|+| .. ++.|+||||+|.+++. .+ ..|++|||+|..+.. ..........| ++.|+
T Consensus 127 ~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~-------s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~ 196 (601)
T KOG0590|consen 127 RYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDE-------SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYG 196 (601)
T ss_pred hhhhhhccCccccCccc---ccccCCCCCccchhcc-------CCCcccCCCchhhccccccCCcceeeecccCCCCCCC
Confidence 89999999999999 77 9999999999999987 66 899999999987765 33333344568 99999
Q ss_pred chhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHHHHHHHHHHHcc
Q 039817 613 APEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKFERITMVGLWCI 690 (725)
Q Consensus 613 aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl 690 (725)
|||...+. ...+..|+||.|+++.-+++|..|++......... ..|...... .............++..+++
T Consensus 197 a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l 270 (601)
T KOG0590|consen 197 APEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNKGRFTQLPWNSISDQAHDLLHKIL 270 (601)
T ss_pred CcccccchhhcCCCcccccccccccccccCCCCccccccccccc------eeecccccccccCccccCChhhhhcccccc
Confidence 99998874 55678999999999999999999998665443211 111111100 01112234556677888888
Q ss_pred CCCCCCCCCHHHHHH
Q 039817 691 CPQPTLRPSMKQVLQ 705 (725)
Q Consensus 691 ~~dp~~RPs~~evl~ 705 (725)
..+|..|.+.+++..
T Consensus 271 ~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 271 KENPSNRLSIEELKL 285 (601)
T ss_pred cCCchhccccccccc
Confidence 899999999887754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-11 Score=121.78 Aligned_cols=97 Identities=20% Similarity=0.335 Sum_probs=83.4
Q ss_pred HHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCce
Q 039817 479 KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558 (725)
Q Consensus 479 ~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 558 (725)
..+.+|++++.+++|+++.....++...+..++||||+++++|.+++..... .++.+++.+|.+||+. ++
T Consensus 42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi 111 (199)
T TIGR03724 42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GI 111 (199)
T ss_pred HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---Ce
Confidence 5678899999999998876666666677778999999999999998754321 8899999999999999 99
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+|+|++|.||+++ ++.+++.|||++..
T Consensus 112 ~H~Dl~~~Nil~~--------~~~~~liDfg~a~~ 138 (199)
T TIGR03724 112 VHGDLTTSNIIVR--------DDKLYLIDFGLGKY 138 (199)
T ss_pred ecCCCCcceEEEE--------CCcEEEEECCCCcC
Confidence 9999999999996 45799999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.1e-12 Score=145.60 Aligned_cols=138 Identities=22% Similarity=0.228 Sum_probs=106.6
Q ss_pred HHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC--------------CccccccccCc
Q 039817 544 ARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ--------------TRTSTMIRGTM 609 (725)
Q Consensus 544 a~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~--------------~~~~~~~~gt~ 609 (725)
+.+++|||+. +|+|||+||+|.+|+. -+.+|+.|||+.+...... ......++||+
T Consensus 153 vla~Eylh~y---givhrdlkpdnllIT~-------mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTP 222 (1205)
T KOG0606|consen 153 VLAVEYLHSY---GIVHRDLKPDNLLITS-------MGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTP 222 (1205)
T ss_pred hHHhHhhccC---CeecCCCCCCcceeee-------cccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCc
Confidence 8899999999 9999999999999987 8999999999987532110 01122357999
Q ss_pred cccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHc
Q 039817 610 GYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWC 689 (725)
Q Consensus 610 ~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 689 (725)
.|.|||++..+.|....|.|++|+++||.+-|..||.....++ .+...+.....-..-......+.++++...
T Consensus 223 eyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-------lfg~visd~i~wpE~dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 223 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQVISDDIEWPEEDEALPPEAQDLIEQL 295 (1205)
T ss_pred cccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-------HHhhhhhhhccccccCcCCCHHHHHHHHHH
Confidence 9999999999999999999999999999999999998765432 112222222222222445567888999999
Q ss_pred cCCCCCCCC
Q 039817 690 ICPQPTLRP 698 (725)
Q Consensus 690 l~~dp~~RP 698 (725)
|+.+|.+|-
T Consensus 296 L~qnp~~Rl 304 (1205)
T KOG0606|consen 296 LRQNPLCRL 304 (1205)
T ss_pred HHhChHhhc
Confidence 999999995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-11 Score=139.04 Aligned_cols=97 Identities=18% Similarity=0.284 Sum_probs=87.8
Q ss_pred HHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCce
Q 039817 479 KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558 (725)
Q Consensus 479 ~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 558 (725)
+.+.+|++++++++|++++....++......++||||+++++|.+++. ....++.|++++|.|||+. ++
T Consensus 381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---gi 449 (535)
T PRK09605 381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GI 449 (535)
T ss_pred HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CC
Confidence 568899999999999999998888888888899999999999999884 4678999999999999999 99
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
+||||||+||+++ ++.++|+|||+++..
T Consensus 450 iHrDlkp~NILl~--------~~~~~liDFGla~~~ 477 (535)
T PRK09605 450 VHGDLTTSNFIVR--------DDRLYLIDFGLGKYS 477 (535)
T ss_pred ccCCCChHHEEEE--------CCcEEEEeCcccccC
Confidence 9999999999993 568999999999753
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.9e-12 Score=103.59 Aligned_cols=72 Identities=22% Similarity=0.386 Sum_probs=59.8
Q ss_pred CceEEEeecccCCCCCccccccccccChhhHHHHhcccCcccceeee--cceeecccccccccccCCCCCcccceeeecc
Q 039817 304 DFTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVWR--EVVCLKKKMPLLNARRSNPSTNKMAAFIKVP 381 (725)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~--~~~C~~~~~~l~~~~~~~~~~~~~~~ylkv~ 381 (725)
.+.|+.++++++|+.. +.. ..+++++|++.|++||+|+||+|. ++.|++|..++.+.+... ..+..+|||+|
T Consensus 11 ~~~f~~~~~~~~~~~~---~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~--~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNA---SAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLS--SGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCch---hhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeec--CCCcEEEEEeC
Confidence 4689999999999775 333 678999999999999999999996 489999999998877654 33578999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.5e-11 Score=109.45 Aligned_cols=115 Identities=22% Similarity=0.235 Sum_probs=97.5
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCc--CCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHH--KNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
..+++|....... ...+.+|+..+..++| .++++++++...++..+++|||++++.+..+ +......++
T Consensus 22 ~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~ 92 (155)
T cd05120 22 EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIA 92 (155)
T ss_pred CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHH
Confidence 4678888755432 5679999999999976 5899999999888899999999998877654 567778899
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
.+++++|.+||.....+++|+|++|+||+++. .+.+++.|||.++.
T Consensus 93 ~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-------~~~~~l~Df~~~~~ 138 (155)
T cd05120 93 EQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-------GKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHhCCCceEEEecCCCcceEEEEC-------CcEEEEEecccccC
Confidence 99999999999964457999999999999986 67899999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.7e-11 Score=119.13 Aligned_cols=102 Identities=17% Similarity=0.225 Sum_probs=81.9
Q ss_pred HHHHHHHHHHHhccCcCCc--cceeeEEEcCC----ceeeeeecccC-CChhhhhccCCCCCHHHHHHHHHHHHHHhhhh
Q 039817 478 EKSFLREVQVIGRTHHKNL--VQLLGFCIEQN----HQLLVYELMKN-GTLSAFLFRQEIPTWDKRVEIALGIARGLLYL 550 (725)
Q Consensus 478 ~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yL 550 (725)
...+.+|++++.+++|+++ ++.+++..... ..++|+|++++ .+|.+++... .++.. .+.+++.+|.+|
T Consensus 84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~l 158 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARF 158 (239)
T ss_pred hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHH
Confidence 3568899999999998875 67777755432 23599999997 6999888543 34433 367899999999
Q ss_pred hcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 551 H~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
|+. +|+|+||||.|||++. ++.++|+|||.+...
T Consensus 159 H~~---GI~HrDlkp~NILv~~-------~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 159 HDA---GVYHADLNAHNILLDP-------DGKFWLIDFDRGELR 192 (239)
T ss_pred HHC---CCCCCCCCchhEEEcC-------CCCEEEEECCCcccC
Confidence 999 9999999999999986 568999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.2e-11 Score=118.38 Aligned_cols=130 Identities=16% Similarity=0.117 Sum_probs=94.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC----------------------ccHHHHHHHHHHHhccCcCC--ccce
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG----------------------DGEKSFLREVQVIGRTHHKN--LVQL 499 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~----------------------~~~~~f~~E~~~l~~l~H~n--iv~l 499 (725)
...++++++++... ++..|+||.+..... .....+..|..++.+++|++ +.+.
T Consensus 24 ~~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~ 100 (198)
T cd05144 24 GVGKESDVYLALDP---DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKP 100 (198)
T ss_pred ccCcceEEEEEEcC---CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCce
Confidence 34455666665542 356788886543210 01123678899999998874 4455
Q ss_pred eeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCC
Q 039817 500 LGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579 (725)
Q Consensus 500 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~ 579 (725)
++. ...++||||+++++|.+.... .....++.+++.++.++|+. +++|+||||+||+++.
T Consensus 101 ~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~------- 160 (198)
T cd05144 101 IDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD------- 160 (198)
T ss_pred eec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC-------
Confidence 442 455899999999999776431 34567889999999999998 9999999999999987
Q ss_pred CCceEEeeccCccccCc
Q 039817 580 NYITKIADFGLAKLLKK 596 (725)
Q Consensus 580 ~~~~kl~Dfgla~~~~~ 596 (725)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 78999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.5e-10 Score=122.18 Aligned_cols=163 Identities=17% Similarity=0.230 Sum_probs=121.9
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL 541 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ 541 (725)
+.+|.|...+..++.......+-++.|+.++||||++++......+..|||+|-+. .|..++.+.. .....--+.
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~ 111 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLF 111 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHH
Confidence 34666666655444445567888999999999999999999999999999999875 4666664433 445556689
Q ss_pred HHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCC
Q 039817 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP 621 (725)
Q Consensus 542 qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 621 (725)
||+.||.+||+.| +++|++|..+.|+|+. .|..||++|.++.....-.. ......--..|..|+.+....
T Consensus 112 qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~-------~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 112 QILAALSFLNDDC--NLVHGNVCKDSVFVNE-------SGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHhccC--CeeeccEeeeeEEEcC-------CCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 9999999999765 8999999999999988 89999999998865433221 111112223466776554322
Q ss_pred CCCccceehhHHHHHHHHhC
Q 039817 622 VTAKVDVYSFGVMLLEIIFC 641 (725)
Q Consensus 622 ~~~ksDv~S~G~vl~elltg 641 (725)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999988
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-10 Score=93.65 Aligned_cols=66 Identities=15% Similarity=0.139 Sum_probs=55.7
Q ss_pred ceEEEeecccCCCCCccccccccccChhhHHHHhcc---cCcccceeee--cceeecccccc-cccccCCCCCcccceee
Q 039817 305 FTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMD---DCFCAAGVWR--EVVCLKKKMPL-LNARRSNPSTNKMAAFI 378 (725)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~A~~~~--~~~C~~~~~~l-~~~~~~~~~~~~~~~yl 378 (725)
..|+++.++++|+.. .++++||++.|++ ||||+||+|. +.+|++|.++| .+.++.. ..+.++|+
T Consensus 9 g~fl~~~~~klpd~~--------~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~--~~g~~Ly~ 78 (80)
T cd00129 9 GTTLIKIALKIKTTK--------ANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEF--SHGFDLYE 78 (80)
T ss_pred CeEEEeecccCCccc--------ccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhcc--CCCceeEe
Confidence 478999999998764 2689999999999 9999999994 46999999999 8887765 45678888
Q ss_pred ec
Q 039817 379 KV 380 (725)
Q Consensus 379 kv 380 (725)
|.
T Consensus 79 r~ 80 (80)
T cd00129 79 NK 80 (80)
T ss_pred EC
Confidence 73
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.9e-10 Score=110.45 Aligned_cols=133 Identities=18% Similarity=0.162 Sum_probs=87.8
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc--cHHHH----------------------HHHHHHHhccCcCC--ccc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD--GEKSF----------------------LREVQVIGRTHHKN--LVQ 498 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~--~~~~f----------------------~~E~~~l~~l~H~n--iv~ 498 (725)
..+++.++.|.+. .+..||||.+...... ....+ ..|.+.+.++++.. +.+
T Consensus 7 ~G~~g~Vy~a~~~---~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 83 (187)
T cd05119 7 TGKEADVYLALDG---DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPK 83 (187)
T ss_pred cccceeEEEEECC---CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCc
Confidence 4456667777654 3467899987542211 11111 35566666664432 444
Q ss_pred eeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCcccc
Q 039817 499 LLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITI 577 (725)
Q Consensus 499 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~ 577 (725)
.++. ...++||||++++.+........... .....++.+++.++.++|. . +|+|+||||+||+++
T Consensus 84 ~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~------ 149 (187)
T cd05119 84 PIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD------ 149 (187)
T ss_pred eEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE------
Confidence 4443 24689999999955432211111111 6678899999999999999 7 999999999999997
Q ss_pred CCCCceEEeeccCccccCc
Q 039817 578 DNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 578 ~~~~~~kl~Dfgla~~~~~ 596 (725)
++.++|+|||.+.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 45799999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.4e-10 Score=123.36 Aligned_cols=240 Identities=18% Similarity=0.152 Sum_probs=169.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEc--ccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQL--EKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l--~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+++++.+...-..+...+|+|+- .....+....=.+|+...+++ .|+|.++.....+..+..++-.|++. .+|.
T Consensus 127 g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~ 205 (524)
T KOG0601|consen 127 GSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQ 205 (524)
T ss_pred CCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhH
Confidence 3455555555533444556677762 222233333445677777777 49999999899999999999999987 5888
Q ss_pred hhhccCC-CCCHHHHHHHHHHHHH----HhhhhhcccCCceeecCCccceEEeccCccccCCC-CceEEeeccCccccCc
Q 039817 523 AFLFRQE-IPTWDKRVEIALGIAR----GLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN-YITKIADFGLAKLLKK 596 (725)
Q Consensus 523 ~~l~~~~-~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~-~~~kl~Dfgla~~~~~ 596 (725)
.+.+... .++....+....+..+ ||.++|.. .++|-|+||.||++.. + ...+++|||+...+..
T Consensus 206 ~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~-------~~~s~~~~df~~v~~i~~ 275 (524)
T KOG0601|consen 206 SYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTS-------DWTSCKLTDFGLVSKISD 275 (524)
T ss_pred HhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccc-------ccceeecCCcceeEEccC
Confidence 8877664 4777888888888888 99999999 9999999999999977 5 7889999999987765
Q ss_pred CCCccc----cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 597 DQTRTS----TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 597 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
...... ....|...|++||... +.++.++|+|++|.++.+..++................+..+ ..
T Consensus 276 ~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i---------p~ 345 (524)
T KOG0601|consen 276 GNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI---------PL 345 (524)
T ss_pred CccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC---------ch
Confidence 542211 1235777899999775 457899999999999999998887765543332211111110 11
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+-.....++...+..+++.+|..|++.+.+..+
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111223455568889999999999998776643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-08 Score=105.14 Aligned_cols=210 Identities=16% Similarity=0.198 Sum_probs=145.7
Q ss_pred HHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEE----cCCceeeeeecccC-CChhhhhc
Q 039817 452 REATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI----EQNHQLLVYELMKN-GTLSAFLF 526 (725)
Q Consensus 452 ~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~~~l~ 526 (725)
++++...+| -.+.+|++.....+.......-++.++++.|.|+|++..++. .+..+++||+|.++ ++|.++.+
T Consensus 293 yk~~s~~DG--~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F 370 (655)
T KOG3741|consen 293 YKATSNVDG--NAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYF 370 (655)
T ss_pred EeeeeccCC--ceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHc
Confidence 444545544 467888885443344434556788999999999999999887 34578999999986 68877765
Q ss_pred cC---------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 527 RQ---------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 527 ~~---------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
.. ...++..+|.++.|+..||.++|+. ++.-+-|.+.+|+++. +.+++|+..|..
T Consensus 371 ~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G-------~~RIriS~C~i~ 440 (655)
T KOG3741|consen 371 ANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTG-------KMRIRISGCGIM 440 (655)
T ss_pred cCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeC-------cceEEEecccce
Confidence 32 2346789999999999999999999 9999999999999976 668889888887
Q ss_pred cccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 592 KLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 592 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
.....+.... +.+ ..+-|.=.||.+++.|.+|...-...... .+.. .
T Consensus 441 Dvl~~d~~~~---------------le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~----------~~s~-----~ 487 (655)
T KOG3741|consen 441 DVLQEDPTEP---------------LES---QQQNDLRDLGLLLLALATGTENSNRTDST----------QSSH-----L 487 (655)
T ss_pred eeecCCCCcc---------------hhH---HhhhhHHHHHHHHHHHhhcccccccccch----------HHHH-----H
Confidence 7665544111 111 23567888999999999987543211110 0000 0
Q ss_pred CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 672 GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 672 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
..+......++++++.-....++++ -++.+++.++
T Consensus 488 ~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 1122244566677777777777776 5666666554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-08 Score=111.17 Aligned_cols=103 Identities=19% Similarity=0.200 Sum_probs=72.1
Q ss_pred HHHHHHHHhccC----cCCccceeeEEE-cCCceeeeeecccCCChhhhhccC-CCCCHHHHHHHHHHHHH-Hhhhhhcc
Q 039817 481 FLREVQVIGRTH----HKNLVQLLGFCI-EQNHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIAR-GLLYLHEE 553 (725)
Q Consensus 481 f~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~-gL~yLH~~ 553 (725)
|.+|++.+.+++ |.+-+.+-..+. .....+|||||+++++|.+..... ... .+.+++.+++. .+..+|..
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 455666555542 333333333332 244679999999999998876432 112 24556666666 46788888
Q ss_pred cCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 554 ~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+++|+|+||.||+++. ++.+++.|||++..+..
T Consensus 277 ---g~~H~D~hPgNilv~~-------~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLK-------DGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECC-------CCcEEEEeCCCeeECCH
Confidence 9999999999999977 78899999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.8e-08 Score=93.13 Aligned_cols=113 Identities=20% Similarity=0.103 Sum_probs=80.5
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCcc-ceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLV-QLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
+..+++|....... ....+..|+++++.+.+.+++ +++.+. ....++||||+++.++.+.. .....++
T Consensus 21 ~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~--------~~~~~~~ 89 (170)
T cd05151 21 NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED--------FSDPENL 89 (170)
T ss_pred CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc--------ccCHHHH
Confidence 45688888654321 234578899999998765544 555543 23457999999998876531 1123457
Q ss_pred HHHHHHhhhhhccc--CCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 541 LGIARGLLYLHEEC--ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 541 ~qia~gL~yLH~~~--~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
.+++++|+.||... ...++|+|++|.||+++. +.++++||+.+..
T Consensus 90 ~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~--------~~~~liDf~~a~~ 136 (170)
T cd05151 90 EKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD--------GRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC--------CeEEEEecccccC
Confidence 88999999999982 223699999999999973 3689999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.69 E-value=6.8e-08 Score=93.06 Aligned_cols=100 Identities=12% Similarity=0.138 Sum_probs=76.0
Q ss_pred HHHHHHHhccCc--CCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhh-hcccCCce
Q 039817 482 LREVQVIGRTHH--KNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYL-HEECETQI 558 (725)
Q Consensus 482 ~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~i 558 (725)
.+|++.|+++.. -++.+++++ ..-+|||||+.+..+..-..+...++.....++..+++.+|..| |+. ++
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---gl 146 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NL 146 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 389999999853 466677764 56789999998754432222223345556778889999999999 787 99
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+|+||++.||+++ ++.+.|+|||.+....+
T Consensus 147 VHGDLs~~NIL~~--------~~~v~iIDF~qav~~~h 176 (197)
T cd05146 147 VHADLSEYNMLWH--------DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred ecCCCCHHHEEEE--------CCcEEEEECCCceeCCC
Confidence 9999999999996 35699999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2e-08 Score=108.60 Aligned_cols=225 Identities=22% Similarity=0.223 Sum_probs=156.2
Q ss_pred cceEEEEEEcccccCccHHH--HHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHH
Q 039817 461 QEVEVAVKQLEKVTGDGEKS--FLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRV 537 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~--f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~ 537 (725)
.+..+++|.+.+.......+ -+.|+-+...+ .|.+.++....+......++=-||++++++...+.-...++...++
T Consensus 290 ~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~ 369 (524)
T KOG0601|consen 290 GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRL 369 (524)
T ss_pred CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhh
Confidence 34566777665432222222 24566666665 5888998888888888888999999999998888555677889999
Q ss_pred HHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccc-cchhc
Q 039817 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGY-MAPEW 616 (725)
Q Consensus 538 ~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y-~aPE~ 616 (725)
++..|++.++.++|+. .++|+|+||+||++..+ .+.-+++|||....+.-.. ......+..| .+++.
T Consensus 370 ~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~------~~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~ 437 (524)
T KOG0601|consen 370 RLTAQILTALNVIHSK---LFVHLDVKPSNILISND------GFFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEIL 437 (524)
T ss_pred hhHHHHHhccccccch---hhhcccccccceeeccc------hhhhhccccccccccceec---ccccccccccccchhh
Confidence 9999999999999998 99999999999999762 2778999999886421111 1111122334 35556
Q ss_pred ccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCC
Q 039817 617 LRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTL 696 (725)
Q Consensus 617 ~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~ 696 (725)
.....+..+.|++|||.-+.|.+++....+.......... + .....+... ..+..+...++.+++..
T Consensus 438 ~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~-~-----------~~p~~~~~~-~~~q~~~kv~~~~~~~~ 504 (524)
T KOG0601|consen 438 LEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRS-G-----------DTPNLPGLK-LQLQVLLKVMINPDRKR 504 (524)
T ss_pred ccccccccccccccccccccccccCcccCcccccceeeec-c-----------cccCCCchH-HhhhhhhhhhcCCcccc
Confidence 6677889999999999999999988865543221110000 0 001122222 56667777889999999
Q ss_pred CCCHHHHHHHhcCC
Q 039817 697 RPSMKQVLQMLEGT 710 (725)
Q Consensus 697 RPs~~evl~~L~~~ 710 (725)
||.+.++..+.+-.
T Consensus 505 ~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 505 RPSAVELSLHSEFY 518 (524)
T ss_pred chhhhhhcccchhh
Confidence 99998888776544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-08 Score=116.24 Aligned_cols=188 Identities=19% Similarity=0.191 Sum_probs=139.3
Q ss_pred CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEec
Q 039817 492 HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLD 571 (725)
Q Consensus 492 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~ 571 (725)
+||-+++..--+.......||++|..+++|...|+.....+..-....+..+..+++|||.. .+.|+|++|.|++..
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhc
Confidence 34545544434445667899999999999999998877666666666777888999999997 799999999999987
Q ss_pred cCccccCCCCceEEeeccCccccC---------------------cCC---------CccccccccCccccchhcccCCC
Q 039817 572 NNYITIDNNYITKIADFGLAKLLK---------------------KDQ---------TRTSTMIRGTMGYMAPEWLRNAP 621 (725)
Q Consensus 572 ~~~~~~~~~~~~kl~Dfgla~~~~---------------------~~~---------~~~~~~~~gt~~y~aPE~~~~~~ 621 (725)
. ++..++.||+...... ... ........+|..|.+||...+..
T Consensus 939 ~-------~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~ 1011 (1205)
T KOG0606|consen 939 Y-------DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR 1011 (1205)
T ss_pred c-------cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc
Confidence 7 7888999997432211 000 01112345899999999999999
Q ss_pred CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC-----CCChhHHHHHHHHHHHccCCCCCC
Q 039817 622 VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG-----NLGATKFERITMVGLWCICPQPTL 696 (725)
Q Consensus 622 ~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~ 696 (725)
....+|.|+.|++++|.++|..|+....... +.+-+..+ ..+.+...+..+++...+..+|.+
T Consensus 1012 hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1012 HGSAADWWSSGVCLFEVLTGIPPFNAETPQQ------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred CCCcchhhhhhhhhhhhhcCCCCCCCcchhh------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchh
Confidence 9999999999999999999999997654322 11111122 223356677888888899999999
Q ss_pred CCCHH
Q 039817 697 RPSMK 701 (725)
Q Consensus 697 RPs~~ 701 (725)
|..|.
T Consensus 1080 r~~a~ 1084 (1205)
T KOG0606|consen 1080 RLGAK 1084 (1205)
T ss_pred ccCcc
Confidence 98776
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.3e-07 Score=86.25 Aligned_cols=97 Identities=21% Similarity=0.360 Sum_probs=79.6
Q ss_pred HHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCce
Q 039817 479 KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558 (725)
Q Consensus 479 ~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 558 (725)
+.-.+|++++.+++--.|...+=+..+.+...|+|||.++..|.+.+... +..++..+-+-+.-||.. +|
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---gi 113 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GI 113 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---Ce
Confidence 34678999999987665555555666777888999999999999998655 356777777788889999 99
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+|+||.++||++.. ..+.++||||+..
T Consensus 114 vHGDLTtsNiIl~~--------~~i~~IDfGLg~~ 140 (204)
T COG3642 114 VHGDLTTSNIILSG--------GRIYFIDFGLGEF 140 (204)
T ss_pred ecCCCccceEEEeC--------CcEEEEECCcccc
Confidence 99999999999974 3499999999874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.6e-07 Score=91.75 Aligned_cols=111 Identities=16% Similarity=0.150 Sum_probs=84.6
Q ss_pred HHHHHHHHHhccCcCC--ccceeeEEEc-----CCceeeeeecccCC-Chhhhhcc--CCCCCHHHHHHHHHHHHHHhhh
Q 039817 480 SFLREVQVIGRTHHKN--LVQLLGFCIE-----QNHQLLVYELMKNG-TLSAFLFR--QEIPTWDKRVEIALGIARGLLY 549 (725)
Q Consensus 480 ~f~~E~~~l~~l~H~n--iv~l~g~~~~-----~~~~~lV~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~qia~gL~y 549 (725)
.+.+|.+.+.+++..+ .++++++.+. ....+||+|++++. +|.+++.. ....+...+..++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4789999999885444 4455666653 23578999999986 89999853 2445667788999999999999
Q ss_pred hhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 550 LHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 550 LH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
||.. +|+|+|++++|||++.+....++...+.++||+.+..
T Consensus 154 LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999 9999999999999975210012357899999998863
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.5e-08 Score=107.35 Aligned_cols=152 Identities=18% Similarity=0.263 Sum_probs=103.9
Q ss_pred HHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-------cc-ccccccCcc
Q 039817 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-------RT-STMIRGTMG 610 (725)
Q Consensus 539 i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~-------~~-~~~~~gt~~ 610 (725)
=+.+++.||.|+|.. ..+||++|.|++|.++. .+..||++|+.+........ .. .........
T Consensus 104 nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na-------~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~ 174 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNA-------NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLN 174 (700)
T ss_pred hhhcccchhhhhccC--cceeecccchhheeecc-------CcceeeccchhhhccCCCCccccccCCCCCChhhccCcc
Confidence 345667999999987 58999999999999987 88999999998765433111 00 111235568
Q ss_pred ccchhcccCCCCCCccceehhHHHHHHHH-hCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHc
Q 039817 611 YMAPEWLRNAPVTAKVDVYSFGVMLLEII-FCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWC 689 (725)
Q Consensus 611 y~aPE~~~~~~~~~ksDv~S~G~vl~ell-tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 689 (725)
|.|||++.+...+.++|+||+|++++-+. .|+..+.......... ...... ......+....+.++++=+.++
T Consensus 175 f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~~~~~-~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 175 FLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FSRNLL-NAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hhhccc-ccccccccccCcHHHHHHHHHH
Confidence 99999999988899999999999999999 4444443322111000 000000 0001122345667778888889
Q ss_pred cCCCCCCCCCHHHHHH
Q 039817 690 ICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 690 l~~dp~~RPs~~evl~ 705 (725)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998877654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-06 Score=80.99 Aligned_cols=109 Identities=22% Similarity=0.326 Sum_probs=83.0
Q ss_pred HHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccC-CChhhhhccCC-CCCHHHH-HHHHHHHHHHhhhhhccc
Q 039817 478 EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKN-GTLSAFLFRQE-IPTWDKR-VEIALGIARGLLYLHEEC 554 (725)
Q Consensus 478 ~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~-gsL~~~l~~~~-~l~~~~~-~~i~~qia~gL~yLH~~~ 554 (725)
.+..++|++.+.+++--.|.-..=++.+...-.|+|||+++ .++.+++.... ....+.. ..++.++-+.+.-||..
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n- 132 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN- 132 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC-
Confidence 45678999999988755554444456666667799999987 57888886652 2233333 78889999999999999
Q ss_pred CCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 555 ~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
.|+|+||..+||+|..+. ....+.++|||++..
T Consensus 133 --diiHGDLTTSNill~~~~----~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 133 --DIIHGDLTTSNILLRSDG----NQITPILIDFGLSSV 165 (229)
T ss_pred --CeecccccccceEEecCC----CcCceEEEeecchhc
Confidence 999999999999997742 255668999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.1e-06 Score=85.66 Aligned_cols=125 Identities=20% Similarity=0.275 Sum_probs=92.9
Q ss_pred eEEEEEEcccccC-ccHHHHHHHHHHHhccCc--CCccceeeEEEcCC---ceeeeeecccCCChhhhhccCCCCCHHHH
Q 039817 463 VEVAVKQLEKVTG-DGEKSFLREVQVIGRTHH--KNLVQLLGFCIEQN---HQLLVYELMKNGTLSAFLFRQEIPTWDKR 536 (725)
Q Consensus 463 ~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~~gsL~~~l~~~~~l~~~~~ 536 (725)
..+++|....... .....+..|+++++.+++ .++.+++.+..... ..++||||+++.++.+.+.. ..++...+
T Consensus 23 ~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~ 101 (223)
T cd05154 23 RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEER 101 (223)
T ss_pred cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHH
Confidence 4677887654322 135678999999999975 44677888877643 66899999999988876642 45677788
Q ss_pred HHHHHHHHHHhhhhhccc-----------------------------------------------------CCceeecCC
Q 039817 537 VEIALGIARGLLYLHEEC-----------------------------------------------------ETQIIHCDI 563 (725)
Q Consensus 537 ~~i~~qia~gL~yLH~~~-----------------------------------------------------~~~ivH~di 563 (725)
..++.+++++|.+||+.. ...++|+|+
T Consensus 102 ~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~ 181 (223)
T cd05154 102 RALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDY 181 (223)
T ss_pred HHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCC
Confidence 888888888888888521 246799999
Q ss_pred ccceEEeccCccccCCCCceEEeeccCccc
Q 039817 564 KPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 564 k~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
++.||+++.+ ++..+.|+||+.+..
T Consensus 182 ~~~Nil~~~~-----~~~~~~iID~e~~~~ 206 (223)
T cd05154 182 RLGNVLFHPD-----EPRVVAVLDWELATL 206 (223)
T ss_pred CcccEEEcCC-----CCcEEEEEecccccc
Confidence 9999999762 134578999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.1e-07 Score=101.13 Aligned_cols=103 Identities=16% Similarity=0.201 Sum_probs=63.5
Q ss_pred HHHHHHHHhccC----cCCccceeeEEEc-CCceeeeeecccCCChhhhh--ccCC----CCCHHHHHHHHHHHHHHhhh
Q 039817 481 FLREVQVIGRTH----HKNLVQLLGFCIE-QNHQLLVYELMKNGTLSAFL--FRQE----IPTWDKRVEIALGIARGLLY 549 (725)
Q Consensus 481 f~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~----~l~~~~~~~i~~qia~gL~y 549 (725)
|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.+.- ...+ .+.......++.|+
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi------ 276 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV------ 276 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH------
Confidence 445555555543 4444444344332 45678999999999998752 2222 12222233333443
Q ss_pred hhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 550 LHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 550 LH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+.. +++|+|+||.||+++.+. ...+.+++.|||+...+..
T Consensus 277 -f~~---GffHaDpHPGNIlv~~~g---~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -FRD---GFFHADMHPGNIFVSYDP---PENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -HhC---CeeeCCCChHHeEEecCC---CCCCeEEEEecceEEECCH
Confidence 334 999999999999998721 0124899999999987644
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.24 E-value=4.2e-06 Score=82.47 Aligned_cols=110 Identities=21% Similarity=0.276 Sum_probs=88.4
Q ss_pred HHHHHHHHHHHhccCc--CCccceeeEEEcCC----ceeeeeecccC-CChhhhhccCCCCCHHHHHHHHHHHHHHhhhh
Q 039817 478 EKSFLREVQVIGRTHH--KNLVQLLGFCIEQN----HQLLVYELMKN-GTLSAFLFRQEIPTWDKRVEIALGIARGLLYL 550 (725)
Q Consensus 478 ~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yL 550 (725)
.....+|.+.+.+++. -...+.+++..... ..+||+|++++ .+|.+++......+......++.++++.+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4467889888888853 44567777776532 45899999998 48999997755577778899999999999999
Q ss_pred hcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 551 H~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
|+. +|+|+|+++.|||++.+. +...+.++||+.++..
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCC----CceeEEEEcchhceeC
Confidence 999 999999999999998732 2458999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.5e-06 Score=68.70 Aligned_cols=58 Identities=19% Similarity=0.363 Sum_probs=46.4
Q ss_pred ceEEEeecccCCCCCccccccccccChhhHHHHhcc-cCcccceeee--cceeeccc-ccccccc
Q 039817 305 FTVEAIDDADIPNGDLRDMARITTTDVNECRKAVMD-DCFCAAGVWR--EVVCLKKK-MPLLNAR 365 (725)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~A~~~~--~~~C~~~~-~~l~~~~ 365 (725)
..|+.++++.+++.. .......++++|++.|++ +|+|.|+.|. ++.|++|. .++.+..
T Consensus 4 ~~f~~~~~~~l~~~~---~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFS---RIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCc---ceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 468889999988543 222456799999999999 9999999996 68999998 6666654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.09 E-value=8.1e-06 Score=78.43 Aligned_cols=100 Identities=20% Similarity=0.246 Sum_probs=66.4
Q ss_pred HHHHHHHHHHhccCcC--CccceeeEEEcCCceeeeeeccc--CCChhhhhccCCCCCHHHHHHHHHHHHHHhhh-hhcc
Q 039817 479 KSFLREVQVIGRTHHK--NLVQLLGFCIEQNHQLLVYELMK--NGTLSAFLFRQEIPTWDKRVEIALGIARGLLY-LHEE 553 (725)
Q Consensus 479 ~~f~~E~~~l~~l~H~--niv~l~g~~~~~~~~~lV~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~y-LH~~ 553 (725)
....+|.+.|.++... ++.+++.+- .-.|||||++ +..+....... ++......++.+++..+.. +|..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc
Confidence 4567899999999765 566776552 4579999999 54444332211 1134566777888886666 4677
Q ss_pred cCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 554 ~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+|+|+|+.+.||++++ + .+.|+|||.+....
T Consensus 127 ---givHGDLs~~NIlv~~-------~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 127 ---GIVHGDLSEYNILVDD-------G-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ---TEEESS-STTSEEEET-------T-CEEE--GTTEEETT
T ss_pred ---CceecCCChhhEEeec-------c-eEEEEecCcceecC
Confidence 9999999999999985 3 89999999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.4e-05 Score=80.12 Aligned_cols=169 Identities=15% Similarity=0.196 Sum_probs=111.9
Q ss_pred CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCc
Q 039817 530 IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTM 609 (725)
Q Consensus 530 ~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~ 609 (725)
...|...++.+..+|.+.+-||+. +.+-+|+.++|+|+++ +..+.|.|-....+-.+ ........|..
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd-------~~~V~LVdsDsfqi~~n--g~~~~cpVg~~ 180 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSD-------DSKVVLVDSDSFQINAN--GTLHLCPVGVS 180 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeec-------CceEEEEcccceeeccC--CceEecccCcc
Confidence 468999999999999999999999 9999999999999987 77888887654333211 12222345888
Q ss_pred cccchhccc-----CCCCCCccceehhHHHHHHHHhC-CcCCCCCCCCc--ccccc-CcchHHHHHHH-HHcCC------
Q 039817 610 GYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFC-KRHTELHRVDE--PTLAN-GMILTDWVLYC-VRTGN------ 673 (725)
Q Consensus 610 ~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg-~~~~~~~~~~~--~~~~~-~~~~~~~~~~~-~~~~~------ 673 (725)
.|.+||... +..-+..+|.|-||+++++++.| +.|+..-.... +...+ ....-.++... .+.+.
T Consensus 181 eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~ 260 (637)
T COG4248 181 EFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRS 260 (637)
T ss_pred ccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCC
Confidence 999999764 34567889999999999999998 66775422111 10000 00000000000 01111
Q ss_pred CCh-hHHHHHHHHHHHccCCC--CCCCCCHHHHHHHhcCC
Q 039817 674 LGA-TKFERITMVGLWCICPQ--PTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 674 ~~~-~~~~~l~~l~~~cl~~d--p~~RPs~~evl~~L~~~ 710 (725)
.+. ..+..+..+..+|+... +.-|||++..+..|..+
T Consensus 261 ~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 261 IPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred CChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 111 33456777888888753 56899999888777543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=8e-05 Score=71.86 Aligned_cols=102 Identities=23% Similarity=0.296 Sum_probs=82.0
Q ss_pred HHHHHHHhccCc-CCccceeeEEEcCCceeeeeecccCCChhhh---hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCc
Q 039817 482 LREVQVIGRTHH-KNLVQLLGFCIEQNHQLLVYELMKNGTLSAF---LFRQEIPTWDKRVEIALGIARGLLYLHEECETQ 557 (725)
Q Consensus 482 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 557 (725)
..|.-++..+++ +++.+++|+|- .++|.||.+.+++... +..--..+|..|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888876 69999999993 3679999987766421 212234689999999999999999999865546
Q ss_pred eeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 558 ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
+.-.|++++|+-+++ ++.+|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~-------~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVND-------DGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeC-------CCcEEEEechhcchh
Confidence 888999999999987 788999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.9e-05 Score=73.55 Aligned_cols=110 Identities=15% Similarity=0.149 Sum_probs=85.2
Q ss_pred CccHHHHHHHHHHHhccCcC--CccceeeEEE-c----CCceeeeeecccC-CChhhhhccC--CCCCHHHHHHHHHHHH
Q 039817 475 GDGEKSFLREVQVIGRTHHK--NLVQLLGFCI-E----QNHQLLVYELMKN-GTLSAFLFRQ--EIPTWDKRVEIALGIA 544 (725)
Q Consensus 475 ~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~-~----~~~~~lV~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~qia 544 (725)
+.++..|.+|...|.++... .+.++. ++. . ..+-.||+|-+++ -+|.+++... ...+...+..++.+++
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va 138 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVA 138 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHH
Confidence 44678899999999998633 345555 433 2 1246799997764 6999998664 3457778899999999
Q ss_pred HHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 545 ~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
..+.-||+. ++.|+|+.+.||+++.+ +...++++||.-++.
T Consensus 139 ~~ia~LH~~---Gv~Hgdly~khIll~~~-----g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 139 LAFKKMHSV---NRQHGCCYVRHIYVKTE-----GKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHC---CCcCCCCCHhheeecCC-----CCeeEEEEEhhccch
Confidence 999999999 99999999999999852 144599999987764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=2.3e-05 Score=85.55 Aligned_cols=182 Identities=15% Similarity=0.122 Sum_probs=124.9
Q ss_pred HHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCC-ccceeeEEEcCCceeeeeecccCC-C-hhhh
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKN-LVQLLGFCIEQNHQLLVYELMKNG-T-LSAF 524 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g-s-L~~~ 524 (725)
|.++.+..-....+.++.|-|.|...-.....+..-++++|.+++||| .++.++-+..++...++++++..+ + ....
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~ 326 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM 326 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC
Confidence 444444433333344444444443222333366778999999999999 778888888888999999999876 2 2111
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
......+..-+...+...-+++++|||+. .=+|+| ||+.. +...|..+|+....+.... ....
T Consensus 327 ~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s--------~~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 327 TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGS--------EEEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----ccccc--------ccccccccccCCcccCccc--cccc
Confidence 11112233345556677788999999997 568888 88765 4568999999887665433 2233
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCC
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTE 646 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~ 646 (725)
..+++.++|||......+..+.|+|++|+---++--|..|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 558999999999999999999999999987666665555443
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00019 Score=63.23 Aligned_cols=77 Identities=23% Similarity=0.359 Sum_probs=55.6
Q ss_pred EEEcccccEEEEcCC-CceEEEeccC----ceeEEEEecCCCeEEecCCC----Ccc--CCCCceEEeeecCCCeEEeee
Q 039817 91 INLTVTGQLVLTHSN-GTQFKIYNGT----LTVSALMQDSGNFLYSNANG----SVD--YSTGRFVLEIQMDGNVVLSAF 159 (725)
Q Consensus 91 l~l~~~G~LvL~~~~-~~~~ws~~~~----~~~~a~LldsGNlVl~~~~~----~~d--~s~g~~~~~~~~~g~~~~~~~ 159 (725)
+.+..+|+||+.+.. +.++|+++.. ....+.|.++|||||.+.++ +.+ ...+.+.+.|+.+|+++++-
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~- 102 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD- 102 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCCCCceEEEEeCCCCEEEEC-
Confidence 344578999998765 5899987642 22578999999999988765 122 35788999999999998753
Q ss_pred ecCCCceeec
Q 039817 160 RFADPAYWYT 169 (725)
Q Consensus 160 ~~~~~~yw~~ 169 (725)
....+.|.+
T Consensus 103 -~~~~~~W~S 111 (114)
T smart00108 103 -SDGNFLWQS 111 (114)
T ss_pred -CCCCEEeCC
Confidence 233456654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00033 Score=61.93 Aligned_cols=75 Identities=24% Similarity=0.371 Sum_probs=54.7
Q ss_pred Ecc-cccEEEEcCC-CceEEEeccC----ceeEEEEecCCCeEEecCCC----CccC--CCCceEEeeecCCCeEEeeee
Q 039817 93 LTV-TGQLVLTHSN-GTQFKIYNGT----LTVSALMQDSGNFLYSNANG----SVDY--STGRFVLEIQMDGNVVLSAFR 160 (725)
Q Consensus 93 l~~-~G~LvL~~~~-~~~~ws~~~~----~~~~a~LldsGNlVl~~~~~----~~d~--s~g~~~~~~~~~g~~~~~~~~ 160 (725)
... +|+||+.+.. ++++|+++.. ..+.+.|.++|||||.+.++ +.+. ..+.+.+.|+.+|++.++-.
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~- 104 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDS- 104 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccCCCCceEEEEeCCCCEEEECC-
Confidence 344 8999998764 5899987642 44678999999999998765 2222 36889999999999998532
Q ss_pred cCCCceeec
Q 039817 161 FADPAYWYT 169 (725)
Q Consensus 161 ~~~~~yw~~ 169 (725)
...+.|.+
T Consensus 105 -~~~~~W~S 112 (116)
T cd00028 105 -DGNFLWQS 112 (116)
T ss_pred -CCCEEEcC
Confidence 23556654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00011 Score=58.84 Aligned_cols=46 Identities=22% Similarity=0.448 Sum_probs=36.0
Q ss_pred ecccCCCCCccccccccccChhhHHHHhcccCcccceeee--cceeecccc
Q 039817 311 DDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVWR--EVVCLKKKM 359 (725)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~--~~~C~~~~~ 359 (725)
.++++++.+ +......+.++|+..|+.+|+|.||.|. ++.|+++..
T Consensus 10 ~~~~~~g~d---~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGD---LSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CCCccccCC---cceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 466666665 3333456899999999999999999995 589998865
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0007 Score=65.87 Aligned_cols=68 Identities=22% Similarity=0.246 Sum_probs=53.4
Q ss_pred CceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEe
Q 039817 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586 (725)
Q Consensus 507 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~ 586 (725)
...+|+|||++|..|.+... ++. .++..+++++.-||+. ++.|+|.+|.|++++. +.+++.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~--------~~i~iI 176 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN--------NGIRII 176 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC--------CcEEEE
Confidence 34568999999988876542 121 3556778889999999 9999999999999975 348999
Q ss_pred eccCccc
Q 039817 587 DFGLAKL 593 (725)
Q Consensus 587 Dfgla~~ 593 (725)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0019 Score=65.50 Aligned_cols=59 Identities=8% Similarity=0.076 Sum_probs=42.8
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..+.||...... .....+|+++++.+. +--+.+++++...++..++|||++++.+|...
T Consensus 23 ~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 23 PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 356677665432 345778999998884 44466888888777778999999999877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0029 Score=55.55 Aligned_cols=82 Identities=22% Similarity=0.314 Sum_probs=50.8
Q ss_pred eeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEe-CCCCCCCCCceEEEcccccEEEEcCCCceEEEecc-Ccee
Q 039817 41 TWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSA-NRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNG-TLTV 118 (725)
Q Consensus 41 ~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvA-Nr~~Pv~~~s~l~l~~~G~LvL~~~~~~~~ws~~~-~~~~ 118 (725)
.+.+.+|.+.|-|-..+. |-| |.. ..++||.. +..........+.|..+|||||.|..+.++|++.. ....
T Consensus 13 p~~~~s~~~~L~l~~dGn----Lvl-~~~--~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~ptdt 85 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN----LVL-YDS--NGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDYPTDT 85 (114)
T ss_dssp EEEECETTEEEEEETTSE----EEE-EET--TTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTSSS-E
T ss_pred ccccccccccceECCCCe----EEE-EcC--CCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCCCccE
Confidence 444434666665543221 222 222 25779999 43444435678999999999999999999997753 3445
Q ss_pred EEEEec--CCCeE
Q 039817 119 SALMQD--SGNFL 129 (725)
Q Consensus 119 ~a~Lld--sGNlV 129 (725)
....++ .||++
T Consensus 86 ~L~~q~l~~~~~~ 98 (114)
T PF01453_consen 86 LLPGQKLGDGNVT 98 (114)
T ss_dssp EEEEET--TSEEE
T ss_pred EEeccCcccCCCc
Confidence 556666 77777
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00072 Score=79.11 Aligned_cols=199 Identities=18% Similarity=0.177 Sum_probs=134.7
Q ss_pred HHHHHHHHhccCcCCccceeeEEEcCCce----eeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCC
Q 039817 481 FLREVQVIGRTHHKNLVQLLGFCIEQNHQ----LLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECET 556 (725)
Q Consensus 481 f~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 556 (725)
..-|++.+.++.|+|++.+++|-.+.... .+..|++..-++...+..-...+......+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 34567778889999999999998765433 34556777888888887778889999999999999999999997
Q ss_pred ceeecCCccceEEeccCccccCCCCceEEe--eccCccccCcCCCccccccccCccccchhcccCCCCCCc--cceehhH
Q 039817 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIA--DFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK--VDVYSFG 632 (725)
Q Consensus 557 ~ivH~dik~~NIll~~~~~~~~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k--sDv~S~G 632 (725)
...|.-+..+-..- ...++.+.+.++ ||+..+.......... ..-+..+.+||.........+ .|+|.+|
T Consensus 306 ~l~~v~L~~s~~~~----~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKE----STVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ccceeEEecccccc----cccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHH
Confidence 55554444432211 122446666766 8887776543322211 223456778887766655444 7999999
Q ss_pred HHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 633 ~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
.....+..|..+......- ... ++......+......|+..++++|+++.+++.+.
T Consensus 380 ll~~~~~~~~~i~~~~~~~----------~~~---------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVP----------VSL---------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHhhhhhcCcccccccch----------hhh---------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999999777654422110 000 0111111456677789999999999999999876
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0024 Score=63.60 Aligned_cols=98 Identities=17% Similarity=0.192 Sum_probs=67.9
Q ss_pred HHHHHHHHHHhccCcC--CccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCC
Q 039817 479 KSFLREVQVIGRTHHK--NLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECET 556 (725)
Q Consensus 479 ~~f~~E~~~l~~l~H~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 556 (725)
....+|.++|.+|+.. .+.+.+++ +.-.+|||+.++-.|...-. +....-.++..|.+-+.-+-..
T Consensus 154 l~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~--- 221 (304)
T COG0478 154 LAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRR--- 221 (304)
T ss_pred HHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHc---
Confidence 4467899999998654 66666554 45679999999865543321 2333344444444444444455
Q ss_pred ceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 557 ~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
++||+|+.+-||++++ ++.+.++||-.+....
T Consensus 222 GiVHGDlSefNIlV~~-------dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 222 GIVHGDLSEFNILVTE-------DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CccccCCchheEEEec-------CCCEEEEeCcccccCC
Confidence 9999999999999988 8899999998776543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0094 Score=59.50 Aligned_cols=54 Identities=15% Similarity=0.181 Sum_probs=39.1
Q ss_pred EEEEEcccccCccHHHHHHHHHHHhccCcCC--ccceeeEEEcCCceeeeeecccCCC
Q 039817 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHKN--LVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 465 vavk~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|.... ........+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 25 ~VlR~~~~--~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 25 WMLKLYNP--GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred EEEEeCCC--CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 44565543 223456789999999986443 4778888888888889999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.01 Score=57.66 Aligned_cols=100 Identities=19% Similarity=0.223 Sum_probs=69.8
Q ss_pred cHHHHHHHHHHHhccC------cCCccceeeEEEcCCceeeeeecccC------CChhhhhccCCCCCHHHHHHHHHHHH
Q 039817 477 GEKSFLREVQVIGRTH------HKNLVQLLGFCIEQNHQLLVYELMKN------GTLSAFLFRQEIPTWDKRVEIALGIA 544 (725)
Q Consensus 477 ~~~~f~~E~~~l~~l~------H~niv~l~g~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~l~~~~~~~i~~qia 544 (725)
..+++.+|+.-+.++. +.+|.+++|+.+++.-.-+|+|.+.+ .+|.+++.+. .++. ...+.+.
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~--- 128 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALD--- 128 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHH---
Confidence 4567777877766665 88999999999999999999998753 3678888443 3443 3333333
Q ss_pred HHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 545 ~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
+-..||-+. .|+.+|++|.||++.... ++...+.|+|
T Consensus 129 ~f~~~l~~~---~Iv~~dl~~~NIv~~~~~---~~~~~lvlID 165 (199)
T PF10707_consen 129 EFKRYLLDH---HIVIRDLNPHNIVVQRRD---SGEFRLVLID 165 (199)
T ss_pred HHHHHHHHc---CCeecCCCcccEEEEecC---CCceEEEEEe
Confidence 344566666 899999999999997742 1122456665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.019 Score=68.90 Aligned_cols=58 Identities=12% Similarity=0.260 Sum_probs=40.3
Q ss_pred EEEEEEccccc-CccHHHHHHHHHHHhccC-cCCc--cceeeEEEcC---CceeeeeecccCCCh
Q 039817 464 EVAVKQLEKVT-GDGEKSFLREVQVIGRTH-HKNL--VQLLGFCIEQ---NHQLLVYELMKNGTL 521 (725)
Q Consensus 464 ~vavk~l~~~~-~~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV~e~~~~gsL 521 (725)
.+.+|+..... ......+.+|+++++.+. |.++ .+++++|.+. +..++||||+++..+
T Consensus 67 ~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 67 RYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred eEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 34555543221 123457889999999995 6665 7888888764 467899999998654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.018 Score=57.87 Aligned_cols=46 Identities=15% Similarity=0.091 Sum_probs=30.7
Q ss_pred cHHHHHHHHHHHhccCcC---CccceeeEEEcC---CceeeeeecccCCChh
Q 039817 477 GEKSFLREVQVIGRTHHK---NLVQLLGFCIEQ---NHQLLVYELMKNGTLS 522 (725)
Q Consensus 477 ~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~e~~~~gsL~ 522 (725)
....+.+|.+++..+... -+.++++..... ...+++||+++|.++.
T Consensus 31 ~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 31 YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence 355789999999888532 344555544332 2357899999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.025 Score=56.39 Aligned_cols=59 Identities=17% Similarity=0.240 Sum_probs=40.3
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcC--CccceeeEEEc---CCceeeeeecccCCChhh
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHK--NLVQLLGFCIE---QNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lV~e~~~~gsL~~ 523 (725)
..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|+++++..+..
T Consensus 21 ~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 21 GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 36777776433 4567788999999888543 35677775543 235689999999988777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.025 Score=55.89 Aligned_cols=100 Identities=16% Similarity=0.188 Sum_probs=65.5
Q ss_pred HHHHHHHhccC--cCCccceeeEEEcCCceeeeeecccCCC-hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCce
Q 039817 482 LREVQVIGRTH--HKNLVQLLGFCIEQNHQLLVYELMKNGT-LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558 (725)
Q Consensus 482 ~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gs-L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 558 (725)
..|+..|+++. +-.+.+-+++. .-.|||||+.... -.-.|.. -.+.......+..++++.+.-|-.. .++
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~--a~L 188 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKE--AGL 188 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHh--cCc
Confidence 35666666663 33444444443 3469999997531 1111211 1223335677778888888887762 289
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
||+||..=|||+. ++.+.|+|++.+....+
T Consensus 189 VHgDLSEyNiL~~--------~~~p~iID~~QaV~~~h 218 (268)
T COG1718 189 VHGDLSEYNILVH--------DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ccccchhhheEEE--------CCeEEEEECccccccCC
Confidence 9999999999997 46799999999886553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.019 Score=63.87 Aligned_cols=103 Identities=19% Similarity=0.207 Sum_probs=64.7
Q ss_pred HHHHHHHHhccC----cCCccceeeEEE-cCCceeeeeecccCCChhhhhcc-CCCCCHHHHHHHHHHHHHH-hhhhhcc
Q 039817 481 FLREVQVIGRTH----HKNLVQLLGFCI-EQNHQLLVYELMKNGTLSAFLFR-QEIPTWDKRVEIALGIARG-LLYLHEE 553 (725)
Q Consensus 481 f~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~g-L~yLH~~ 553 (725)
+.+|...+.+++ +..-+++=..+. -.....|+|||++|-.+.+.... ....+-+. ++..++++ +..+-..
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 445555555542 222233333333 35678999999999999888522 23344333 33322222 2222223
Q ss_pred cCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 554 ~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++.|.|.+|.||+++. ++.+-+.|||+...+..
T Consensus 285 ---gffHaDpHpGNi~v~~-------~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRS-------DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEec-------CCcEEEEcCcceecCCH
Confidence 8999999999999987 78999999999876654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.031 Score=62.08 Aligned_cols=109 Identities=17% Similarity=0.231 Sum_probs=65.6
Q ss_pred HHHHHHHHhcc----CcCCc---cceeeEEE-cCCceeeeeecccCCChhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhh
Q 039817 481 FLREVQVIGRT----HHKNL---VQLLGFCI-EQNHQLLVYELMKNGTLSAFLF-RQEIPTWDKRVEIALGIARGLLYLH 551 (725)
Q Consensus 481 f~~E~~~l~~l----~H~ni---v~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qia~gL~yLH 551 (725)
|.+|.+...+. .|-++ |++=.++. ....+.|+||||+|..+.|.-. +...++...+.. .+.++ |++
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~---~l~~~--~~~ 315 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILN---KLVEA--YLE 315 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHH---HHHHH--HHH
Confidence 55666655443 35551 11222222 2457899999999988876642 122334333333 33222 222
Q ss_pred cccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 552 ~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
.....+++|+|-+|.||++..+. +.+..+.+.|||+...+...
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~---~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNP---EGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCC---CCCccEEEEcccccccccHH
Confidence 22223899999999999998532 23789999999998876543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.13 Score=53.76 Aligned_cols=44 Identities=9% Similarity=0.125 Sum_probs=35.4
Q ss_pred HHHHHHHHHHHhccCc---CCccceeeEEEc---CCceeeeeecccCCCh
Q 039817 478 EKSFLREVQVIGRTHH---KNLVQLLGFCIE---QNHQLLVYELMKNGTL 521 (725)
Q Consensus 478 ~~~f~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lV~e~~~~gsL 521 (725)
...|..|.+.++.+.. -.+.+++++|.. .+..+||||++++.++
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 4589999999999853 368899998864 3678999999998765
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.063 Score=58.19 Aligned_cols=49 Identities=24% Similarity=0.302 Sum_probs=38.1
Q ss_pred HHHHHHHHHHhccCcCCccceeeEEEcCC-ceeeeeecccCCChhhhhccC
Q 039817 479 KSFLREVQVIGRTHHKNLVQLLGFCIEQN-HQLLVYELMKNGTLSAFLFRQ 528 (725)
Q Consensus 479 ~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~ 528 (725)
.+++-....++.++|+|+-..+.+-.... +..+|+|++. .||++.+..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence 45667778889999999999999887654 4667889884 5888888554
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.1 Score=53.28 Aligned_cols=30 Identities=20% Similarity=0.287 Sum_probs=24.9
Q ss_pred CceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 556 ~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
..++|+|+.|.||+++. ++ +.|+||+.+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~-------~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTP-------QG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeC-------CC-CEEEeccccCc
Confidence 46899999999999976 33 68999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.086 Score=55.02 Aligned_cols=120 Identities=15% Similarity=0.179 Sum_probs=68.9
Q ss_pred EEEEEEcccccCccHHHHHHHHHHHhccCcCC--ccceeeE------EEcCCceeeeeecccCCChhh----hh------
Q 039817 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKN--LVQLLGF------CIEQNHQLLVYELMKNGTLSA----FL------ 525 (725)
Q Consensus 464 ~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e~~~~gsL~~----~l------ 525 (725)
.+.+|.... ........|++++..+++.. +.+++.. ...++..++|++|++|..+.. ..
T Consensus 39 ~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~ 115 (296)
T cd05153 39 RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEA 115 (296)
T ss_pred cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHH
Confidence 466676643 33456778888888885433 4454442 123456689999999876532 00
Q ss_pred ----cc---C--------CCCCHHHHH----------HHHHHHHHHhhhhhc----ccCCceeecCCccceEEeccCccc
Q 039817 526 ----FR---Q--------EIPTWDKRV----------EIALGIARGLLYLHE----ECETQIIHCDIKPQNVLLDNNYIT 576 (725)
Q Consensus 526 ----~~---~--------~~l~~~~~~----------~i~~qia~gL~yLH~----~~~~~ivH~dik~~NIll~~~~~~ 576 (725)
+. . ....|.... .....+...+.++.+ ..+..++|+|+.|.||+++.
T Consensus 116 La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~---- 191 (296)
T cd05153 116 LARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDG---- 191 (296)
T ss_pred HHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeC----
Confidence 00 0 001221111 011123334444443 12347999999999999986
Q ss_pred cCCCCceEEeeccCccc
Q 039817 577 IDNNYITKIADFGLAKL 593 (725)
Q Consensus 577 ~~~~~~~kl~Dfgla~~ 593 (725)
+..+.|.||+.+..
T Consensus 192 ---~~~~~iIDfe~a~~ 205 (296)
T cd05153 192 ---DELSGVIDFYFACT 205 (296)
T ss_pred ---CceEEEeehhhhcC
Confidence 55568999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.29 Score=49.01 Aligned_cols=31 Identities=19% Similarity=0.343 Sum_probs=25.6
Q ss_pred CceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 556 ~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
..++|+|+.+.|||++.. +..+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~------~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEE------KNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCC------CCCEEEEEcccCC
Confidence 479999999999999751 3569999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.0085 Score=72.17 Aligned_cols=156 Identities=12% Similarity=-0.005 Sum_probs=106.2
Q ss_pred HHHHHHHHhccCcCCccceeeEEE--cCCceeeeeecccCCChhhhhccC----CCCCHHHHHHHHHHH-HHHhhhhhcc
Q 039817 481 FLREVQVIGRTHHKNLVQLLGFCI--EQNHQLLVYELMKNGTLSAFLFRQ----EIPTWDKRVEIALGI-ARGLLYLHEE 553 (725)
Q Consensus 481 f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi-a~gL~yLH~~ 553 (725)
...|...++...|+++.....-.. +..+.+.+++|+..|.+...|-+. ..+. +.......++ +....-.|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld-~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD-RSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch-hchHHHHHHHHHhccchhhhc
Confidence 344555555567888776554433 345778999999999999988654 1122 2222333333 4555554544
Q ss_pred cC--CceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehh
Q 039817 554 CE--TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631 (725)
Q Consensus 554 ~~--~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~ 631 (725)
.. .-.+|+++|+-|.++.. +.++|++++|+.+...+..... ....+++.|+.|+....-.++.++|+|..
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVt-------ny~v~~gk~gLdKIknp~~sf~-Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVT-------NYNVKLGKGGLDKIKNPVLSFF-GLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred ccCCccchhhhhhhhccceec-------CCcccccccccccccCchHhhh-hhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence 22 24689999999999977 8899999999999543332222 22347778999998888889999999999
Q ss_pred HHHHHHHHhCCcCC
Q 039817 632 GVMLLEIIFCKRHT 645 (725)
Q Consensus 632 G~vl~elltg~~~~ 645 (725)
|.-+|+..-|..++
T Consensus 1427 s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHhcccHHH
Confidence 99999887665543
|
|
| >smart00223 APPLE APPLE domain | Back alignment and domain information |
|---|
Probab=93.80 E-value=0.064 Score=43.45 Aligned_cols=46 Identities=20% Similarity=0.345 Sum_probs=37.3
Q ss_pred ecccCCCCCccccccccccChhhHHHHhcccCcccceeee--cc---eeecccc
Q 039817 311 DDADIPNGDLRDMARITTTDVNECRKAVMDDCFCAAGVWR--EV---VCLKKKM 359 (725)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~--~~---~C~~~~~ 359 (725)
.++++++.+ ...+...+.++|++.|..+=.|.||.|. +. .|+++..
T Consensus 7 ~~~df~G~D---l~~~~~~~~~~Cq~~Ct~~~~C~~FTf~~~~~~~~~C~LK~s 57 (79)
T smart00223 7 KNVDFRGSD---INTVYVPSAQVCQKRCTSHPRCLFFTFSTNEPPEEKCLLKDS 57 (79)
T ss_pred cCccccCce---eeeeecCCHHHHHHhhcCCCCccEEEeeCCCCCCCEeEeCcC
Confidence 467777776 5666778999999999999999999994 35 8988753
|
Four-fold repeat in plasma kallikrein and coagulation factor XI. Factor XI apple 3 mediates binding to platelets. Factor XI apple 1 binds high-molecular-mass kininogen. Apple 4 in factor XI mediates dimer formation and binds to factor XIIa. Mutations in apple 4 cause factor XI deficiency, an inherited bleeding disorder. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.56 E-value=0.15 Score=49.48 Aligned_cols=139 Identities=16% Similarity=0.185 Sum_probs=84.2
Q ss_pred EEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHH
Q 039817 464 EVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALG 542 (725)
Q Consensus 464 ~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~q 542 (725)
+..+|++....-. ...-|..+.+++++++- |+++..= .+...-++.|.|-... ..-..++.-
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~ND--n~~~yGvIlE~Cy~~~-------------i~~~N~i~a 149 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKND--NNYKYGVILERCYKIK-------------INFSNFITA 149 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeecC--CCceeEEEEeeccCcc-------------cchhHHHHH
Confidence 3455666555544 45668889999998864 5555421 2334557888774311 111222232
Q ss_pred HHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCC
Q 039817 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV 622 (725)
Q Consensus 543 ia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 622 (725)
-..+|.-.|+. ..+.+|+|..|+||+-|. .|.+||.|=+.-.. .+..|.--| ....
T Consensus 150 gi~~L~~fH~~-~~~~lHGD~np~NiM~D~-------~G~lKlVDP~~Ll~-------------~~V~~vN~~---Y~~l 205 (308)
T PF07387_consen 150 GIKDLMDFHSE-NQHCLHGDCNPDNIMCDK-------FGYLKLVDPVCLLE-------------NQVNMVNIE---YESL 205 (308)
T ss_pred hHHHHHHhhcc-CCCeecCCCChhheeecC-------CCCEEecChhhhhh-------------heeeEEeee---cccc
Confidence 24567777854 348999999999999877 89999998653221 111232211 2335
Q ss_pred CCccceehhHHHHHHHHhCCc
Q 039817 623 TAKVDVYSFGVMLLEIIFCKR 643 (725)
Q Consensus 623 ~~ksDv~S~G~vl~elltg~~ 643 (725)
++++.+-+|=.-++++....+
T Consensus 206 T~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 206 TQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred ChHHHHHHHHHHHHHHHHHHh
Confidence 677777777777777765444
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.51 Score=50.42 Aligned_cols=120 Identities=19% Similarity=0.189 Sum_probs=67.4
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcCCc-cceeeEEEcCCceeeeeecccCCChhhh-----------------
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNL-VQLLGFCIEQNHQLLVYELMKNGTLSAF----------------- 524 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~----------------- 524 (725)
..+.+|.......... .-.+|..+++.+...++ .++++.+..+ .|+||+++.+|...
T Consensus 66 ~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~ 140 (344)
T PLN02236 66 RKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLRE 140 (344)
T ss_pred CeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHH
Confidence 4566776644322222 23679999988864444 4666766443 58999987666421
Q ss_pred hccCC------CCCHHHHHHHHHHH-----------------HHHhhhh----hc-ccCCceeecCCccceEEeccCccc
Q 039817 525 LFRQE------IPTWDKRVEIALGI-----------------ARGLLYL----HE-ECETQIIHCDIKPQNVLLDNNYIT 576 (725)
Q Consensus 525 l~~~~------~l~~~~~~~i~~qi-----------------a~gL~yL----H~-~~~~~ivH~dik~~NIll~~~~~~ 576 (725)
+++.. ...|.+..++..++ ...+..| .. .....++|+|+++.||+++++
T Consensus 141 lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~--- 217 (344)
T PLN02236 141 FHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEE--- 217 (344)
T ss_pred HhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCC---
Confidence 11111 11123222322111 1112222 11 223478999999999999752
Q ss_pred cCCCCceEEeeccCccc
Q 039817 577 IDNNYITKIADFGLAKL 593 (725)
Q Consensus 577 ~~~~~~~kl~Dfgla~~ 593 (725)
+..+.++||..+..
T Consensus 218 ---~~~~~lID~Eya~~ 231 (344)
T PLN02236 218 ---TRAITIIDYEYASY 231 (344)
T ss_pred ---CCcEEEEeehhccc
Confidence 45799999988763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.03 E-value=0.4 Score=49.46 Aligned_cols=31 Identities=32% Similarity=0.593 Sum_probs=24.9
Q ss_pred CceeecCCccceEEeccCccccCCCCc-eEEeeccCccc
Q 039817 556 TQIIHCDIKPQNVLLDNNYITIDNNYI-TKIADFGLAKL 593 (725)
Q Consensus 556 ~~ivH~dik~~NIll~~~~~~~~~~~~-~kl~Dfgla~~ 593 (725)
+.++|+|+++.||+++. ++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~-------~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDE-------DARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeC-------CCCEEEEECcHhccc
Confidence 46899999999999975 333 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.93 E-value=0.42 Score=49.91 Aligned_cols=109 Identities=22% Similarity=0.323 Sum_probs=63.9
Q ss_pred HHHHHHHHHHHhccCc--CCccceeeEEEcCC--ceeeeeecccCCChhhhhccC-------------------------
Q 039817 478 EKSFLREVQVIGRTHH--KNLVQLLGFCIEQN--HQLLVYELMKNGTLSAFLFRQ------------------------- 528 (725)
Q Consensus 478 ~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~------------------------- 528 (725)
.....+|.++|+.+.- --..+.++.|.++. ..+.||+|.++..+...+...
T Consensus 65 ~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~ 144 (321)
T COG3173 65 AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAG 144 (321)
T ss_pred hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcC
Confidence 3455678888877643 33456677887776 779999999884322211100
Q ss_pred ----C---------CCCHHHHHHH--------HHHHHHHhhhhhcc-----cCCceeecCCccceEEeccCccccCCCCc
Q 039817 529 ----E---------IPTWDKRVEI--------ALGIARGLLYLHEE-----CETQIIHCDIKPQNVLLDNNYITIDNNYI 582 (725)
Q Consensus 529 ----~---------~l~~~~~~~i--------~~qia~gL~yLH~~-----~~~~ivH~dik~~NIll~~~~~~~~~~~~ 582 (725)
. ...|...++. .-...+-..+|+.. ..+.++|+|+++.||+++. ..-
T Consensus 145 ~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~-------~~~ 217 (321)
T COG3173 145 LPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDP-------GRP 217 (321)
T ss_pred CCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeC-------CCe
Confidence 0 0011111110 01112223344332 2357999999999999987 344
Q ss_pred eEEeeccCccc
Q 039817 583 TKIADFGLAKL 593 (725)
Q Consensus 583 ~kl~Dfgla~~ 593 (725)
+-|.||+++..
T Consensus 218 ~gVlDwe~~~l 228 (321)
T COG3173 218 TGVLDWELATL 228 (321)
T ss_pred eEEEecccccc
Confidence 88999999875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.78 E-value=0.46 Score=46.80 Aligned_cols=31 Identities=29% Similarity=0.493 Sum_probs=20.5
Q ss_pred CceeecCCccceEEe-ccCccccCCCCceEEeeccCccc
Q 039817 556 TQIIHCDIKPQNVLL-DNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 556 ~~ivH~dik~~NIll-~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
..+.|+|+.+.||++ +. ++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~-------~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNK-------DGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSS-------SSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccC-------CCeEEEecHHHHhh
Confidence 368899999999999 44 78999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.55 E-value=0.51 Score=48.80 Aligned_cols=57 Identities=14% Similarity=0.177 Sum_probs=35.8
Q ss_pred CcceEEEEEEcccccCccHHHHHHHHHHHhccC---cCCccceeeEEEcCCceeeeeecccCC
Q 039817 460 GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 460 ~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
.++..+-||.-. ......|..|.+-|+.|. --.+.+++++...++..+||+||++.+
T Consensus 38 ~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 344566777654 334567899999888884 445789999988888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF14295 PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A | Back alignment and domain information |
|---|
Probab=92.02 E-value=0.1 Score=38.15 Aligned_cols=25 Identities=28% Similarity=0.402 Sum_probs=17.6
Q ss_pred cccChhhHHHHhcccCcccceeeec
Q 039817 327 TTTDVNECRKAVMDDCFCAAGVWRE 351 (725)
Q Consensus 327 ~~~~~~~C~~~Cl~nCsC~A~~~~~ 351 (725)
...+.++|++.|.++=.|.++.|..
T Consensus 14 ~~~s~~~C~~~C~~~~~C~~~~~~~ 38 (51)
T PF14295_consen 14 TASSPEECQAACAADPGCQAFTFNP 38 (51)
T ss_dssp ----HHHHHHHHHTSTT--EEEEET
T ss_pred cCCCHHHHHHHccCCCCCCEEEEEC
Confidence 5568999999999999999999954
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.88 E-value=1.9 Score=45.47 Aligned_cols=32 Identities=28% Similarity=0.444 Sum_probs=26.0
Q ss_pred CCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 555 ~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+.+++|+|+.+.||+++. +...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~-------~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEG-------DRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEEC-------CceEEEEecccccC
Confidence 448999999999999975 44457999998753
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.70 E-value=2.9 Score=45.36 Aligned_cols=55 Identities=13% Similarity=0.039 Sum_probs=36.6
Q ss_pred eEEEEEEcccc-----c--CccHHHHHHHHHHHhccC---cCCccceeeEEEcCCceeeeeecccCC
Q 039817 463 VEVAVKQLEKV-----T--GDGEKSFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 463 ~~vavk~l~~~-----~--~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
..|.||.-... . +...+.+..|.+.|..+. ..++.+++.+ +.+..++||||+++.
T Consensus 52 ~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~ 116 (401)
T PRK09550 52 KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDH 116 (401)
T ss_pred eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCc
Confidence 46888874311 1 234567788888888763 3457777777 335578999999864
|
|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
Probab=90.53 E-value=0.17 Score=35.42 Aligned_cols=32 Identities=25% Similarity=0.687 Sum_probs=25.4
Q ss_pred CCCCcc-cccCCCCeeecCCCCceeeccCCCCCc
Q 039817 245 EPCTVN-TICGVFGFCTSDNNKEVTCECLRGYSP 277 (725)
Q Consensus 245 ~~Cd~~-~~CG~~g~C~~~~~~~~~C~Cl~GF~p 277 (725)
+.|... ..|++++.|. |...+-.|.|++||+.
T Consensus 3 dEC~~~~~~C~~~~~C~-N~~Gsy~C~C~~Gy~~ 35 (42)
T PF07645_consen 3 DECAEGPHNCPENGTCV-NTEGSYSCSCPPGYEL 35 (42)
T ss_dssp STTTTTSSSSSTTSEEE-EETTEEEEEESTTEEE
T ss_pred cccCCCCCcCCCCCEEE-cCCCCEEeeCCCCcEE
Confidence 567774 4799999997 4556779999999983
|
Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=90.23 E-value=0.86 Score=44.15 Aligned_cols=84 Identities=24% Similarity=0.364 Sum_probs=56.0
Q ss_pred HHHHHHHHHhccC---cCCc--cceeeEEEcC------------------CceeeeeecccCCChhhhhccCCCCCHHHH
Q 039817 480 SFLREVQVIGRTH---HKNL--VQLLGFCIEQ------------------NHQLLVYELMKNGTLSAFLFRQEIPTWDKR 536 (725)
Q Consensus 480 ~f~~E~~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~ 536 (725)
-|..|.+.+.+|+ +.++ |+.+||..-. ....||.||.+... ...
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~ 166 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ 166 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc
Confidence 4667777776664 3344 6777765311 12357778776532 223
Q ss_pred HHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 537 ~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
.+-+.++.+-|.-+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~------------~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR------------GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHC---CeeeccCcccccc------------CCEEEecccC
Confidence 34456777788889998 9999999999976 2489999864
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=89.65 E-value=1.2 Score=43.63 Aligned_cols=70 Identities=20% Similarity=0.251 Sum_probs=48.3
Q ss_pred HHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC---cCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 449 QELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 449 ~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
++|..|-..-+| ..++-||.-. ......|..|+.-|..|. .-++.+++.+-...++.++|+||++-+.++
T Consensus 27 G~inea~~v~dg-~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 27 GDINEAWRLRDG-TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceeEeecC-CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 444444444333 3466677542 234567889988777764 355778888888899999999999987775
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=88.97 E-value=2 Score=45.51 Aligned_cols=31 Identities=19% Similarity=0.308 Sum_probs=25.8
Q ss_pred ceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 557 ~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
-++|.|+.+.||+++++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~------~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNED------EGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCC------CCcEEEEcccccCC
Confidence 57899999999999742 46799999988754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.98 E-value=1.5 Score=46.13 Aligned_cols=71 Identities=17% Similarity=0.183 Sum_probs=54.6
Q ss_pred ceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 508 HQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 508 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
..+++|++.. ++|. ..+...+++...|+.+.++-+.-+..+ -+.-|||+.-.||||+ +|++.|+|
T Consensus 300 y~yl~~kdhg-t~is----~ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId--------~GnvtLID 364 (488)
T COG5072 300 YLYLHFKDHG-TPIS----IIKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID--------EGNVTLID 364 (488)
T ss_pred EEEEEEecCC-ceee----eeecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee--------cCceEEEE
Confidence 4456666643 2322 223457899999999999888888776 3788999999999997 57899999
Q ss_pred ccCccc
Q 039817 588 FGLAKL 593 (725)
Q Consensus 588 fgla~~ 593 (725)
|-+++.
T Consensus 365 fklsRl 370 (488)
T COG5072 365 FKLSRL 370 (488)
T ss_pred eeeeec
Confidence 999995
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 725 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-102
Identities = 111/316 (35%), Positives = 164/316 (51%), Gaps = 52/316 (16%)
Query: 434 PKPKPPEI---NMKVFSYQELREATNVF--------------------DGQEVEVAVKQL 470
P + PE+ +K FS +EL+ A++ F DG V AVK+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLV--AVKRL 62
Query: 471 EKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF--- 526
++ G E F EV++I H+NL++L GFC+ +LLVY M NG++++ L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 527 RQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585
+ P W KR IALG ARGL YLH+ C+ +IIH D+K N+LLD + +
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA-------VV 175
Query: 586 ADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHT 645
DFGLAKL+ T +T +RGT+G++APE+L + K DV+ +GVMLLE+I +R
Sbjct: 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
Query: 646 ELHRVDEPTLANGMILTDWVLYCVRTGNLG------------ATKFERITMVGLWCICPQ 693
+L R + ++L DWV ++ L + E++ V L C
Sbjct: 236 DLAR---LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292
Query: 694 PTLRPSMKQVLQMLEG 709
P RP M +V++MLEG
Sbjct: 293 PMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 5e-93
Identities = 97/314 (30%), Positives = 147/314 (46%), Gaps = 52/314 (16%)
Query: 432 PSPKPKPPEINMKVFSYQELREATNVFDGQEV------------------EVAVKQLEKV 473
+L EATN FD + + +VA+K+
Sbjct: 15 ALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE 74
Query: 474 TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP-- 531
+ G + F E++ + H +LV L+GFC E+N +L+Y+ M+NG L L+ ++P
Sbjct: 75 SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134
Query: 532 --TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589
+W++R+EI +G ARGL YLH IIH D+K N+LL D N++ KI DFG
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILL-------DENFVPKITDFG 184
Query: 590 LAKL-LKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELH 648
++K + DQT ST+++GT+GY+ PE+ +T K DVYSFGV+L E++ C R
Sbjct: 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL-CAR----- 238
Query: 649 RVDEPTLANGMI-LTDWVLYCVRTGNLGA------------TKFERITMVGLWCICPQPT 695
+L M+ L +W + G L + + C+
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 696 LRPSMKQVLQMLEG 709
RPSM VL LE
Sbjct: 299 DRPSMGDVLWKLEY 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 4e-92
Identities = 99/317 (31%), Positives = 147/317 (46%), Gaps = 61/317 (19%)
Query: 436 PKPPEINMKVFSYQELREATNVFD-----------GQ------------EVEVAVKQLEK 472
+ + FS+ EL+ TN FD G+ VAVK+L
Sbjct: 5 LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA 64
Query: 473 VT----GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ 528
+ + ++ F +E++V+ + H+NLV+LLGF + + LVY M NG+L L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 529 EIP---TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585
+ +W R +IA G A G+ +LHE IH DIK N+LL D + KI
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL-------DEAFTAKI 174
Query: 586 ADFGLAKLL-KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRH 644
+DFGLA+ K QT ++ I GT YMAPE LR +T K D+YSFGV+LLEII
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPA 233
Query: 645 TELHRVDEPTLANGMILTDWV---------LYCV---RTGNLGATKFERITMVGLWCICP 692
+ HR + +L D + + + +T E + V C+
Sbjct: 234 VDEHREPQ-------LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHE 286
Query: 693 QPTLRPSMKQVLQMLEG 709
+ RP +K+V Q+L+
Sbjct: 287 KKNKRPDIKKVQQLLQE 303
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-58
Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 38/267 (14%)
Query: 464 EVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
+VAVK L + + FLREV ++ R H N+V +G + + +V E + G+L
Sbjct: 62 DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 522 SAFLFRQEIP---TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L + +R+ +A +A+G+ YLH I+H ++K N+L+ D
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLV-------D 173
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
Y K+ DFGL++ LK +S GT +MAPE LR+ P K DVYSFGV+L E+
Sbjct: 174 KKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232
Query: 639 IFCKR-HTELHRVDEPTLANGMILTDWVLYCVRTGNL-------GATKFERITMVGLWCI 690
++ L+ V+ V + I C
Sbjct: 233 ATLQQPWGNLNPAQ-------------VVAAVGFKCKRLEIPRNLNPQVAAIIE---GCW 276
Query: 691 CPQPTLRPSMKQVLQMLEGTSEVGVPP 717
+P RPS ++ +L + VPP
Sbjct: 277 TNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 9e-58
Identities = 73/314 (23%), Positives = 113/314 (35%), Gaps = 64/314 (20%)
Query: 446 FSYQELREATNVFDGQEV-----------------EVAVKQLEKVTGDGEKSFLREVQV- 487
+ L + EV VAVK ++S+ E +V
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPI---QDKQSWQNEYEVY 70
Query: 488 -IGRTHHKNLVQLLGFCIEQNHQ----LLVYELMKNGTLSAFLFRQEIPTWDKRVEIALG 542
+ H+N++Q +G L+ + G+LS FL + W++ IA
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS-WNELCHIAET 129
Query: 543 IARGLLYLHEECETQ-------IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595
+ARGL YLHE+ I H DIK +NVLL NN IADFGLA +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-------KNNLTACIADFGLALKFE 182
Query: 596 KDQTRTSTMIR-GTMGYMAPEWLRNAP-----VTAKVDVYSFGVMLLEIIFCKRHTELHR 649
++ T + GT YMAPE L A ++D+Y+ G++L E+ +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 650 VDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLW---------------CICPQP 694
+ I L ++ + K +R + W C
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQE--VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 695 TLRPSMKQVLQMLE 708
R S V + +
Sbjct: 301 EARLSAGCVGERIT 314
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-57
Identities = 76/257 (29%), Positives = 117/257 (45%), Gaps = 31/257 (12%)
Query: 464 EVAVKQL----EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
EVAVK ++ ++ +E ++ H N++ L G C+++ + LV E + G
Sbjct: 32 EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91
Query: 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID- 578
L+ L + IP D V A+ IARG+ YLH+E IIH D+K N+L+ D
Sbjct: 92 PLNRVLSGKRIP-PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL 150
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
+N I KI DFGLA+ + ++ G +MAPE +R + + DV+S+GV+L E+
Sbjct: 151 SNKILKITDFGLAREWHRTTKMSAA---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207
Query: 639 IFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL-------GATKFERITMVGLWCIC 691
+ + P G+ V Y V L F ++ M W
Sbjct: 208 LTGE---------VPF--RGIDGLA-VAYGVAMNKLALPIPSTCPEPFAKL-MEDCW--N 252
Query: 692 PQPTLRPSMKQVLQMLE 708
P P RPS +L L
Sbjct: 253 PDPHSRPSFTNILDQLT 269
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-56
Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 44/258 (17%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VA+KQ+E + K+F+ E++ + R +H N+V+L G C+ N LV E + G+L
Sbjct: 33 DVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88
Query: 524 FLFRQEIP---TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
L E T + L ++G+ YLH +IH D+KP N+LL +
Sbjct: 89 VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL--- 145
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
KI DFG A D T +G+ +MAPE + + K DV+S+G++L E+I
Sbjct: 146 ---KICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198
Query: 641 CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERIT--------MVGL--WCI 690
+ +P + + + + R + L C
Sbjct: 199 RR---------KPF--DEIGGPAFRIMWA------VHNGTRPPLIKNLPKPIESLMTRCW 241
Query: 691 CPQPTLRPSMKQVLQMLE 708
P+ RPSM+++++++
Sbjct: 242 SKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-53
Identities = 67/302 (22%), Positives = 114/302 (37%), Gaps = 46/302 (15%)
Query: 431 QPSPKPKPPEINMKVFSYQE---------LREATNVFDGQEVEVAVKQLEKVTGDGE--- 478
PK + P + Y++ + + V D V A+K L +GE
Sbjct: 6 SEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVV--AIKSLILGDSEGETEM 63
Query: 479 ----KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP-TW 533
+ F REV ++ +H N+V+L G +V E + G L L + P W
Sbjct: 64 IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 534 DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593
++ + L IA G+ Y+ I+H D++ N+ L + + K+ADFGL+
Sbjct: 122 SVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLD--ENAPVCAKVADFGLS-- 176
Query: 594 LKKDQTRTSTMIRGTMGYMAPEWL--RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVD 651
+ + + + G +MAPE + T K D YSF ++L I+ +
Sbjct: 177 --QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE--------- 225
Query: 652 EPTLANGMILTD-WVLYCVRTGNL----GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706
P + + +R L R+ V C P RP +++
Sbjct: 226 GPF--DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
Query: 707 LE 708
L
Sbjct: 284 LS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-53
Identities = 69/273 (25%), Positives = 106/273 (38%), Gaps = 51/273 (18%)
Query: 460 GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+ +K+L + + +++FL+EV+V+ H N+++ +G + + E +K G
Sbjct: 33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92
Query: 520 TLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
TL + + W +RV A IA G+ YLH IIH D+ N L +
Sbjct: 93 TLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCL-------VR 142
Query: 579 NNYITKIADFGLAKLL-------------KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
N +ADFGLA+L+ KK + + G +MAPE + K
Sbjct: 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK 202
Query: 626 VDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMV 685
VDV+SFG++L EII D L M L F
Sbjct: 203 VDVFSFGIVLCEIIGRV------NADPDYLPRTMDFG-----------LNVRGFLDRYCP 245
Query: 686 G----------LWCICPQPTLRPSMKQVLQMLE 708
+ C P RPS ++ LE
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 63/268 (23%), Positives = 113/268 (42%), Gaps = 49/268 (18%)
Query: 464 EVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
EVA++ + E+ D K+F REV +T H+N+V +G C+ H ++ L K TL
Sbjct: 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 522 SAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
+ + +I +K +IA I +G+ YLH + I+H D+K +NV DN +
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNGKV----- 168
Query: 581 YITKIADFGLAKLLKK----DQTRTSTMIRGTMGYMAPEWLRNA---------PVTAKVD 627
I DFGL + + + G + ++APE +R P + D
Sbjct: 169 ---VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225
Query: 628 VYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA-------TKFE 680
V++ G + E+ + P + +++ + TG +
Sbjct: 226 VFALGTIWYELHARE---------WPF--KTQ-PAEAIIWQMGTGMKPNLSQIGMGKEIS 273
Query: 681 RITMVGLWCICPQPTLRPSMKQVLQMLE 708
I + +C + RP+ +++ MLE
Sbjct: 274 DILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-52
Identities = 67/259 (25%), Positives = 115/259 (44%), Gaps = 36/259 (13%)
Query: 464 EVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
+VAVK L T ++F EV V+ +T H N++ +G+ +V + + +L
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSL 106
Query: 522 SAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
L E K ++IA ARG+ YLH + IIH D+K N+ L +
Sbjct: 107 YHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFL-------HED 156
Query: 581 YITKIADFGLAKLLKKDQ-TRTSTMIRGTMGYMAPEWLRNA---PVTAKVDVYSFGVMLL 636
KI DFGLA + + + G++ +MAPE +R P + + DVY+FG++L
Sbjct: 157 NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 637 EIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE-------RITMVGLWC 689
E++ + P + + D ++ V G+L + R+ + C
Sbjct: 217 ELMTGQ---------LPY--SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
Query: 690 ICPQPTLRPSMKQVLQMLE 708
+ + RPS ++L +E
Sbjct: 266 LKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 55/265 (20%), Positives = 96/265 (36%), Gaps = 53/265 (20%)
Query: 464 EVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNG 519
++ VK L + + F E + H N++ +LG C H L+ M G
Sbjct: 35 DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94
Query: 520 TLSAFLFRQEIP--TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
+L L + V+ AL +ARG+ +LH E I + ++V+ I
Sbjct: 95 SLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVM-------I 146
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP---VTAKVDVYSFGVM 634
D + +I+ + + S ++APE L+ P D++SF V+
Sbjct: 147 DEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
Query: 635 LLEIIFCKR-HTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERIT--------MV 685
L E++ + +L ++ + V L R T +
Sbjct: 201 LWELVTREVPFADLSNME-------------IGMKVALEGL------RPTIPPGISPHVS 241
Query: 686 GLWCIC--PQPTLRPSMKQVLQMLE 708
L IC P RP ++ +LE
Sbjct: 242 KLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-47
Identities = 61/297 (20%), Positives = 99/297 (33%), Gaps = 62/297 (20%)
Query: 458 FDGQEVEVAVKQLEKVTGDGEKSFLREVQV--IGRTHHKNLVQLLGFCIE-----QNHQL 510
D + V AVK ++F+ E + + H N+ + + + L
Sbjct: 34 LDERPV--AVKVFSF---ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEE------CETQIIHCDIK 564
LV E NG+L +L W +A + RGL YLH E + I H D+
Sbjct: 89 LVMEYYPNGSLXKYLSLHTSD-WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLL-------KKDQTRTSTMIRGTMGYMAPEWL 617
+NVL+ N+ I+DFGL+ L ++ + GT+ YMAPE L
Sbjct: 148 SRNVLV-------KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200
Query: 618 RNA-------PVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDE---------PTLANGMI 660
A +VD+Y+ G++ EI C V E
Sbjct: 201 EGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED 260
Query: 661 LTDWVLY---------CVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ V + +L + C R + + + +
Sbjct: 261 MQVLVSREKQRPKFPEAWKENSLAVRSLKETIE---DCWDQDAEARLTAQXAEERMA 314
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 62/277 (22%), Positives = 104/277 (37%), Gaps = 43/277 (15%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQV--IGRTHHKNLVQLLGFCIEQNHQ----LLVYELMK 517
VAVK EKS+ RE ++ H+N++ + + H L+ +
Sbjct: 33 NVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89
Query: 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ-----IIHCDIKPQNVLLDN 572
G+L +L + + I L IA GL +LH E I H D+K +N+L
Sbjct: 90 MGSLYDYLQLTTLD-TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL--- 145
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTR---TSTMIRGTMGYMAPEWLRNAPVTA----- 624
+ N IAD GLA + + + + GT YMAPE L
Sbjct: 146 ----VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 625 -KVDVYSFGVMLLEIIFCKRHTELHRVDE-------PTLANGMILTDWVLYCVRTGNLGA 676
+VD+++FG++L E+ + + P + + V + N+
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN 261
Query: 677 TKFERITMVGLW-----CICPQPTLRPSMKQVLQMLE 708
F T+ L C P+ R + ++ + L
Sbjct: 262 RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 43/277 (15%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQV--IGRTHHKNLVQLLGFCIEQNHQ----LLVYELMK 517
+VAVK E S+ RE ++ H+N++ + I+ L+ + +
Sbjct: 62 KVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118
Query: 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ-----IIHCDIKPQNVLLDN 572
NG+L +L + +++A GL +LH E + I H D+K +N+L
Sbjct: 119 NGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL--- 174
Query: 573 NYITIDNNYITKIADFGLAKLL---KKDQTRTSTMIRGTMGYMAPEWL------RNAPVT 623
+ N IAD GLA + GT YM PE L +
Sbjct: 175 ----VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDE-------PTLANGMILTDWVLYCVRTGNLGA 676
D+YSFG++L E+ + + P+ + + + V +
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 677 TKFERITMVGLW-----CICPQPTLRPSMKQVLQMLE 708
+ + C P R + +V + L
Sbjct: 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 51/281 (18%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQV--IGRTHHKNLVQLLGFCIEQNHQ----LLVYELMK 517
EVAVK E+S+ RE ++ H+N++ + + N LV + +
Sbjct: 67 EVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123
Query: 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ-----IIHCDIKPQNVLLDN 572
+G+L +L + T + +++AL A GL +LH E I H D+K +N+L
Sbjct: 124 HGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL--- 179
Query: 573 NYITIDNNYITKIADFGLAKLL---KKDQTRTSTMIRGTMGYMAPEWLRNA------PVT 623
+ N IAD GLA GT YMAPE L ++
Sbjct: 180 ----VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN-GMILTDWVLYCVRTGNLGATKFERI 682
+ D+Y+ G++ EI ++ L ++ +D + +R + + R
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGG--IHEDYQLPYYDLVPSDPSVEEMRK--VVCEQKLRP 291
Query: 683 TMVGLWCICP---------------QPTLRPSMKQVLQMLE 708
+ W C R + ++ + L
Sbjct: 292 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 67/329 (20%), Positives = 120/329 (36%), Gaps = 66/329 (20%)
Query: 413 FGSI---VIYYH----PLTRPYMCVQPSPKPKPP-EINMKVFSYQ---------ELREAT 455
F SI + + PLT+ V PK +N + E+
Sbjct: 75 FPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSG- 133
Query: 456 NVFDGQEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYE 514
VAVK E + D + FL+E +++ + H N+V+L+G C ++ +V E
Sbjct: 134 -RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192
Query: 515 LMKNGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
L++ G FL +++ A G+ YL + IH D+ +N L+
Sbjct: 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLV--- 246
Query: 574 YITIDNNYITKIADFGLAKLLKKDQ-TRTSTM----IRGTMGYMAPEWLRNAPVTAKVDV 628
+ KI+DFG+++ + + ++ + APE L +++ DV
Sbjct: 247 ----TEKNVLKISDFGMSREEADGVYAASGGLRQVPVK----WTAPEALNYGRYSSESDV 298
Query: 629 YSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-----LGATKF 679
+SFG++L E +L + V G
Sbjct: 299 WSFGILLWETF--------------SLGASPYPNLSNQQ-TREFVEKGGRLPCPELCP-- 341
Query: 680 ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + + C +P RPS + Q L+
Sbjct: 342 DAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 41/255 (16%)
Query: 413 FGSI---VIYY--------HPLTRPYMCVQPSPKPKPP------EINMKVFSYQ------ 449
F ++ V ++ L P E+ + +
Sbjct: 172 FNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGG 231
Query: 450 ---ELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
E+ E + + VAVK L++ T + E+ FL+E V+ H NLVQLLG C +
Sbjct: 232 QYGEVYEGV--WKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTRE 288
Query: 507 NHQLLVYELMKNGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
++ E M G L +L ++ + + +A I+ + YL ++ IH ++
Sbjct: 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLA 345
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTA 624
+N L + N++ K+ADFGL++L+ D + + + APE L +
Sbjct: 346 ARNCL-------VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 625 KVDVYSFGVMLLEII 639
K DV++FGV+L EI
Sbjct: 399 KSDVWAFGVLLWEIA 413
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 68/325 (20%), Positives = 120/325 (36%), Gaps = 58/325 (17%)
Query: 419 YYHPLTRPYMCVQPSPKPKPP-EINMKVFSYQE-----------LREATNVFDGQEVEVA 466
++H P P + + L DG VA
Sbjct: 5 HHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA 64
Query: 467 VKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQ--LLVYELMKNGTLSA 523
VK L+ G +S + +E+ ++ +H+++++ G C + LV E + G+L
Sbjct: 65 VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD 124
Query: 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583
+L + + + A I G+ YLH + IH D+ +NVLL DN+ +
Sbjct: 125 YL-PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLL-------DNDRLV 173
Query: 584 KIADFGLAKLLKKDQ----TRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
KI DFGLAK + + R + + APE L+ DV+SFGV L E
Sbjct: 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 638 II-FCKRHTELHRVDEPTLAN---GMILTDWVLYCVRTGNLGATKFER----------IT 683
++ C + M + + + G ER +
Sbjct: 230 LLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERG-------ERLPRPDKCPAEVY 281
Query: 684 MVGLWCICPQPTLRPSMKQVLQMLE 708
+ C + + RP+ + ++ +L+
Sbjct: 282 HLMKNCWETEASFRPTFENLIPILK 306
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 13/194 (6%)
Query: 450 ELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
RE + E EV +K L+K + +SF ++ + HK+LV G C+ +
Sbjct: 28 VRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87
Query: 510 LLVYELMKNGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
+LV E +K G+L +L + I K +E+A +A + +L E +IH ++ +N
Sbjct: 88 ILVQEFVKFGSLDTYLKKNKNCINILWK-LEVAKQLAAAMHFLEEN---TLIHGNVCAKN 143
Query: 568 VLLDN-NYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAK 625
+LL N K++D G++ + I ++ PE + N
Sbjct: 144 ILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-LQERIP----WVPPECIENPKNLNLA 198
Query: 626 VDVYSFGVMLLEII 639
D +SFG L EI
Sbjct: 199 TDKWSFGTTLWEIC 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 68/330 (20%), Positives = 127/330 (38%), Gaps = 64/330 (19%)
Query: 420 YHPLTRPYMCVQPSPKPKPPEINMKVFSYQELR----------------EATNVFDGQEV 463
Y T + Q + + + F + L+ + D
Sbjct: 12 YDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE 71
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ--LLVYELMKNGTL 521
VAVK+L+ T + + F RE++++ H N+V+ G C + L+ E + G+L
Sbjct: 72 VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 522 SAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
+L ++ D ++ I +G+ YL + + IH D+ +N+L+ +N
Sbjct: 132 RDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILV-------EN 180
Query: 580 NYITKIADFGLAKLLKKDQ----TRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
KI DFGL K+L +D+ + I + APE L + + DV+SFGV
Sbjct: 181 ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAPESLTESKFSVASDVWSFGV 236
Query: 634 MLLEII-FCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGNLGATKFER------- 681
+L E+ + ++ + N MI+ ++ ++ R
Sbjct: 237 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH-LIELLKNN-------GRLPRPDGC 288
Query: 682 ---ITMVGLWCICPQPTLRPSMKQVLQMLE 708
I M+ C RPS + + ++
Sbjct: 289 PDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 63/274 (22%), Positives = 117/274 (42%), Gaps = 34/274 (12%)
Query: 453 EATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ--L 510
+ D VAVK+L+ T + + F RE++++ H N+V+ G C +
Sbjct: 30 RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
L+ E + G+L +L ++ D ++ I +G+ YL + + IH D+ +N+
Sbjct: 90 LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNI 145
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQ----TRTSTM--IRGTMGYMAPEWLRNAPV 622
L+ +N KI DFGL K+L +D+ + I + APE L +
Sbjct: 146 LV-------ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAPESLTESKF 194
Query: 623 TAKVDVYSFGVMLLEII-FCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-LGA 676
+ DV+SFGV+L E+ + ++ + N MI+ ++ ++ L
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH-LIELLKNNGRLPR 253
Query: 677 TKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ I M+ C RPS + + ++
Sbjct: 254 PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 60/263 (22%), Positives = 98/263 (37%), Gaps = 36/263 (13%)
Query: 454 ATNVFDGQEVEVAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI---EQNH 508
+ EV A + K+T + F E +++ H N+V+ +
Sbjct: 45 GLDTETTVEV--AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102
Query: 509 QLLVY-ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
+++ ELM +GTL +L R ++ I +GL +LH IIH D+K N
Sbjct: 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDN 161
Query: 568 VLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVD 627
+ + KI D GLA L + + + GT +MAPE VD
Sbjct: 162 IFITG------PTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEEK-YDESVD 211
Query: 628 VYSFGVMLLEIIFCKR-HTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG 686
VY+FG+ +LE+ + ++E +T G A+ +
Sbjct: 212 VYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTS--------GVKPASFDKVAIPEV 259
Query: 687 ----LWCICPQPTLRPSMKQVLQ 705
CI R S+K +L
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLN 282
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 47/274 (17%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ--LLVYELM 516
D VAVKQL+ D ++ F RE+Q++ H +V+ G Q LV E +
Sbjct: 49 DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108
Query: 517 KNGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
+G L FL ++ D + + I +G+ YL + +H D+ +N+L+
Sbjct: 109 PSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILV---- 160
Query: 575 ITIDNNYITKIADFGLAKLLKKDQ----TRTSTM--IRGTMGYMAPEWLRNAPVTAKVDV 628
++ KIADFGLAKLL D+ R I + APE L + + + DV
Sbjct: 161 ---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAPESLSDNIFSRQSDV 213
Query: 629 YSFGVMLLEII-FCKR---HTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER--- 681
+SFGV+L E+ +C + + + L+ +L + G +R
Sbjct: 214 WSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR-LLELLEEG-------QRLPA 265
Query: 682 -------ITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + C P P RPS + L+
Sbjct: 266 PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/306 (20%), Positives = 129/306 (42%), Gaps = 43/306 (14%)
Query: 431 QPSPKPKPPEINMKVFSYQE-----------LREATNVFDGQEVEVAVKQLEKVTGDGEK 479
+P+ + P + L D +VAVK L+ +G
Sbjct: 8 KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 67
Query: 480 S-FLREVQVIGRTHHKNLVQLLGFCIEQNHQ--LLVYELMKNGTLSAFLFRQEIP-TWDK 535
+ +E++++ +H+N+V+ G C E L+ E + +G+L +L + + +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 536 RVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595
+++ A+ I +G+ YL Q +H D+ +NVL+ ++ + KI DFGL K ++
Sbjct: 128 QLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV-------ESEHQVKIGDFGLTKAIE 177
Query: 596 KDQ----TRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII-FCKRHTELH 648
D+ + + + APE L + DV+SFGV L E++ +C +
Sbjct: 178 TDKEYYTVKDDRDSPVF----WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233
Query: 649 RVDEPTLAN---GMILTDWVLYCVRTGN-LGATKF--ERITMVGLWCICPQPTLRPSMKQ 702
+ + M +T ++ ++ G L + + + C QP+ R S +
Sbjct: 234 ALFLKMIGPTHGQMTVTR-LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292
Query: 703 VLQMLE 708
+++ E
Sbjct: 293 LIEGFE 298
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 57/185 (30%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 457 VFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
V+ + VAVK L++ T + E+ FL+E V+ H NLVQLLG C + ++ E M
Sbjct: 33 VWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91
Query: 517 KNGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
G L +L ++ + + +A I+ + YL ++ IH D+ +N L
Sbjct: 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCL----- 143
Query: 575 ITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVM 634
+ N++ K+ADFGL++L+ D + + + APE L + K DV++FGV+
Sbjct: 144 --VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 635 LLEII 639
L EI
Sbjct: 202 LWEIA 206
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-34
Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
VA+K L+ T E FL+E QV+ + H+ LVQL E+ +V E M G+L
Sbjct: 208 TTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSL 265
Query: 522 SAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
FL + + V++A IA G+ Y+ +H D++ N+L +
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANIL-------VGE 315
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
N + K+ADFGLA+L++ ++ + + + APE T K DV+SFG++L E+
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
VA+K L+ T E FL+E QV+ + H+ LVQL E+ +V E M G+L
Sbjct: 291 TTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSL 348
Query: 522 SAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
FL + + V++A IA G+ Y+ +H D++ N+L +
Sbjct: 349 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANIL-------VGE 398
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
N + K+ADFGLA+L++ ++ + + + APE T K DV+SFG++L E+
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 48/271 (17%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
D ++VAVK L +V + ++ FL E +I + +H+N+V+ +G ++ + ++ ELM
Sbjct: 57 DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMA 116
Query: 518 NGTLSAFLFRQEIPTWDKR--------VEIALGIARGLLYLHEECETQIIHCDIKPQNVL 569
G L +FL R+ P + + +A IA G YL E IH DI +N L
Sbjct: 117 GGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 172
Query: 570 LDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTM----IRGTMGYMAPEWLRNAPVTA 624
L + KI DFG+A+ + + R ++ +M PE T+
Sbjct: 173 LTCP----GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WMPPEAFMEGIFTS 224
Query: 625 KVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-LGATKF 679
K D +SFGV+L EI +L + VL V +G + K
Sbjct: 225 KTDTWSFGVLLWEIF--------------SLGYMPYPSKSNQE-VLEFVTSGGRMDPPKN 269
Query: 680 --ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + C QP RP+ +L+ +E
Sbjct: 270 CPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 7e-33
Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 23/191 (12%)
Query: 457 VFDGQ---EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
V G + +VA+K + + E F+ E +V+ + H LVQL G C+EQ LV
Sbjct: 24 VHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82
Query: 514 ELMKNGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
E M++G LS +L ++ + + + + L + G+ YL E +IH D+ +N L
Sbjct: 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCL--- 136
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRTSTM----IRGTMGYMAPEWLRNAPVTAKVDV 628
+ N + K++DFG+ + + DQ +ST ++ + +PE + ++K DV
Sbjct: 137 ----VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WASPEVFSFSRYSSKSDV 188
Query: 629 YSFGVMLLEII 639
+SFGV++ E+
Sbjct: 189 WSFGVLMWEVF 199
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 46/267 (17%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLL-VYELM 516
DG+++ AVK L ++T GE S FL E ++ H N++ LLG C+ L V M
Sbjct: 50 DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109
Query: 517 KNGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
K+G L F+ PT + L +A+G+ YL + +H D+ +N +
Sbjct: 110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCM------ 160
Query: 576 TIDNNYITKIADFGLAKLLKKD-----QTRTSTM--IRGTMGYMAPEWLRNAPVTAKVDV 628
+D + K+ADFGLA+ + +T ++ +MA E L+ T K DV
Sbjct: 161 -LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALESLQTQKFTTKSDV 215
Query: 629 YSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-LGATKF--ER 681
+SFGV+L E++ T + D + + G L ++ +
Sbjct: 216 WSFGVLLWELM--------------TRGAPPYPDVNTFD-ITVYLLQGRRLLQPEYCPDP 260
Query: 682 ITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ V L C P+ +RPS +++ +
Sbjct: 261 LYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 48/191 (25%), Positives = 97/191 (50%), Gaps = 23/191 (12%)
Query: 457 VFDGQ---EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
V G+ + +VA+K +++ + ++ F+ E +V+ H+ LVQL G C +Q ++
Sbjct: 40 VKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98
Query: 514 ELMKNGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
E M NG L +L + + +E+ + + YL + Q +H D+ +N L
Sbjct: 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCL--- 152
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRTSTM----IRGTMGYMAPEWLRNAPVTAKVDV 628
+++ + K++DFGL++ + D+ +S +R + PE L + ++K D+
Sbjct: 153 ----VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSKFSSKSDI 204
Query: 629 YSFGVMLLEII 639
++FGV++ EI
Sbjct: 205 WAFGVLMWEIY 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 59/283 (20%), Positives = 115/283 (40%), Gaps = 56/283 (19%)
Query: 453 EATNVFDGQEVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQN---- 507
EA N D A+K++ + + +REV+ + + H +V+ +E+N
Sbjct: 23 EAKNKVDDCNY--AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80
Query: 508 -----HQLLVY---ELMKNGTLSAFLFRQ---EIPTWDKRVEIALGIARGLLYLHEECET 556
++ +Y +L + L ++ + E + I L IA + +LH +
Sbjct: 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK--- 137
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR---------- 606
++H D+KP N+ ++ + K+ DFGL + +D+ + +
Sbjct: 138 GLMHRDLKPSNIFFT------MDDVV-KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 607 -GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWV 665
GT YM+PE + + KVD++S G++L E++ T++ RV
Sbjct: 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-YPFSTQMERVR-------------T 236
Query: 666 LYCVRTGN---LGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705
L VR L K+ ++ + P P RP +++
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 46/191 (24%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 457 VFDGQ---EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
V G+ + +VAVK +++ + ++ F +E Q + + H LV+ G C ++ +V
Sbjct: 24 VKLGKWKGQYDVAVKMIKEGSMSEDE-FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82
Query: 514 ELMKNGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
E + NG L +L + + +E+ + G+ +L Q IH D+ +N L
Sbjct: 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCL--- 136
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQ--TRTSTM--IRGTMGYMAPEWLRNAPVTAKVDV 628
+D + K++DFG+ + + DQ + T ++ + APE ++K DV
Sbjct: 137 ----VDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK----WSAPEVFHYFKYSSKSDV 188
Query: 629 YSFGVMLLEII 639
++FG+++ E+
Sbjct: 189 WAFGILMWEVF 199
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 15/180 (8%)
Query: 464 EVAVKQL-EKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
+VA+K + E K F REV + H+N+V ++ E + LV E ++ T
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
LS ++ + D + I G+ + H+ +I+H DIKPQN+L ID+N
Sbjct: 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNIL-------IDSN 147
Query: 581 YITKIADFGLAKLLKKDQTRTST-MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
KI DFG+AK L + + T T + GT+ Y +PE + D+YS G++L E++
Sbjct: 148 KTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 63/285 (22%), Positives = 105/285 (36%), Gaps = 55/285 (19%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLV 512
F G+ V AVK++ D L E++++ + H N+++ +
Sbjct: 33 FQGSFQGRPV--AVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87
Query: 513 YELMKNGTL-------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
EL N L + ++ + + IA G+ +LH +IIH D+KP
Sbjct: 88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKP 143
Query: 566 QNVLLDN------NYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR---GTMGYMAPEW 616
QN+L+ + T N I+DFGL K L Q+ T + GT G+ APE
Sbjct: 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL 203
Query: 617 LRNA-------PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669
L + +T +D++S G + I K H + I+
Sbjct: 204 LEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGK---HPFGDKYSRESNII-------- 251
Query: 670 RTGNLGATKFERITMVGL---------WCICPQPTLRPSMKQVLQ 705
G + + + L I P RP+ +VL+
Sbjct: 252 -RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 48/271 (17%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
D ++VAVK L +V + ++ FL E +I + +H+N+V+ +G ++ + ++ ELM
Sbjct: 98 DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 157
Query: 518 NGTLSAFLFRQEIPTWDKR--------VEIALGIARGLLYLHEECETQIIHCDIKPQNVL 569
G L +FL R+ P + + +A IA G YL E IH DI +N L
Sbjct: 158 GGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 213
Query: 570 LDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTM----IRGTMGYMAPEWLRNAPVTA 624
L + KI DFG+A+ + + R ++ +M PE T+
Sbjct: 214 LTCP----GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK----WMPPEAFMEGIFTS 265
Query: 625 KVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-LGATKF 679
K D +SFGV+L EI +L + VL V +G + K
Sbjct: 266 KTDTWSFGVLLWEIF--------------SLGYMPYPSKSNQE-VLEFVTSGGRMDPPKN 310
Query: 680 --ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + C QP RP+ +L+ +E
Sbjct: 311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 62/260 (23%), Positives = 101/260 (38%), Gaps = 34/260 (13%)
Query: 458 FDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELM 516
FD ++V AVK++ + REVQ++ H N+++ ++ Q + EL
Sbjct: 46 FDNRDV--AVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100
Query: 517 KNGTLSAFLFRQEIPTWDKRV-EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
TL ++ +++ + GL +LH I+H D+KP N+L+
Sbjct: 101 -AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMP-- 154
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEWLR---NAPVTAKVDVYS 630
I+DFGL K L + S + GT G++APE L T VD++S
Sbjct: 155 NAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFS 214
Query: 631 FGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG---- 686
G + + + H + IL + +L E+ V
Sbjct: 215 AGCVFY-YVISEGS---HPFGKSLQRQANIL-------LGACSLDCLHPEKHEDVIAREL 263
Query: 687 -LWCICPQPTLRPSMKQVLQ 705
I P RPS K VL+
Sbjct: 264 IEKMIAMDPQKRPSAKHVLK 283
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 59/272 (21%), Positives = 113/272 (41%), Gaps = 50/272 (18%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL--- 510
A + DG+ +K+++ + REV+ + + H N+V G ++
Sbjct: 30 AKHRIDGKTY--VIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83
Query: 511 -------------LVYELMKNGTLSAFLFRQEIPTWDKRV--EIALGIARGLLYLHEECE 555
+ E GTL ++ ++ DK + E+ I +G+ Y+H +
Sbjct: 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-- 141
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE 615
++I+ D+KP N+ L D + KI DFGL LK D RT + GT+ YM+PE
Sbjct: 142 -KLINRDLKPSNIFLV------DTKQV-KIGDFGLVTSLKNDGKRTRSK--GTLRYMSPE 191
Query: 616 WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG 675
+ + +VD+Y+ G++L E++ + +R G +
Sbjct: 192 QISSQDYGKEVDLYALGLILAELLHVCDT--------AFETSKFFTD------LRDGIIS 237
Query: 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQML 707
++ + + +P RP+ ++L+ L
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-32
Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
+VAVK + K ++FL E V+ H LV+L ++ ++ E M G+L
Sbjct: 212 HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSL 269
Query: 522 SAFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
FL E K ++ + IA G+ ++ + IH D++ N+L +
Sbjct: 270 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANIL-------VSA 319
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+ + KIADFGLA++++ ++ + + + APE + T K DV+SFG++L+EI+
Sbjct: 320 SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 48/268 (17%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLL-VYELM 516
DG+++ AVK L ++T GE S FL E ++ H N++ LLG C+ L V M
Sbjct: 114 DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173
Query: 517 KNGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
K+G L F+ R E + + L +A+G+ +L + +H D+ +N +
Sbjct: 174 KHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCM----- 224
Query: 575 ITIDNNYITKIADFGLAKLLKKD-----QTRTSTM--IRGTMGYMAPEWLRNAPVTAKVD 627
+D + K+ADFGLA+ + +T ++ +MA E L+ T K D
Sbjct: 225 --LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK----WMALESLQTQKFTTKSD 278
Query: 628 VYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-LGATKF--E 680
V+SFGV+L E++ T + D + + G L ++ +
Sbjct: 279 VWSFGVLLWELM--------------TRGAPPYPDVNTFD-ITVYLLQGRRLLQPEYCPD 323
Query: 681 RITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ V L C P+ +RPS +++ +
Sbjct: 324 PLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 61/267 (22%), Positives = 114/267 (42%), Gaps = 46/267 (17%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQN-HQLLVYELM 516
++ A+K L ++T + FLRE ++ +H N++ L+G + ++ M
Sbjct: 46 AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105
Query: 517 KNGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
+G L F+ Q PT + L +ARG+ YL E + +H D+ +N +
Sbjct: 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCM------ 156
Query: 576 TIDNNYITKIADFGLAKLLKKD-----QTRTSTM--IRGTMGYMAPEWLRNAPVTAKVDV 628
+D ++ K+ADFGLA+ + Q ++ + A E L+ T K DV
Sbjct: 157 -LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----WTALESLQTYRFTTKSDV 211
Query: 629 YSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-LGATKF--ER 681
+SFGV+L E++ T + D + + + G L ++ +
Sbjct: 212 WSFGVLLWELL--------------TRGAPPYRHIDPFD-LTHFLAQGRRLPQPEYCPDS 256
Query: 682 ITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ V C P +RP+ + ++ +E
Sbjct: 257 LYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 60/286 (20%)
Query: 453 EATNVFDGQ-EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
E N+ + ++ VAVK L+ T K F RE +++ H+++V+ G C + + ++
Sbjct: 35 ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 94
Query: 512 VYELMKNGTLSAFLFRQEIPTWDKR-----------------VEIALGIARGLLYLHEEC 554
V+E MK+G L+ FL R P + IA IA G++YL +
Sbjct: 95 VFEYMKHGDLNKFL-RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ- 152
Query: 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ---TRTSTM--IRGTM 609
+H D+ +N L + N + KI DFG+++ + TM IR
Sbjct: 153 --HFVHRDLATRNCL-------VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR--- 200
Query: 610 GYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWV 665
+M PE + T + DV+SFGV+L EI T + T+ V
Sbjct: 201 -WMPPESIMYRKFTTESDVWSFGVILWEIF--------------TYGKQPWFQLSNTE-V 244
Query: 666 LYCVRTGN-LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ C+ G L + + + V L C +P R ++K++ ++L
Sbjct: 245 IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 22/188 (11%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ ++ V +K +E +G + IG H ++V+LLG C + Q LV + +
Sbjct: 39 ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLP 97
Query: 518 NGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G+L + + + + IA+G+ YL E ++H ++ +NVLL
Sbjct: 98 LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLL------ 148
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTM-----IRGTMGYMAPEWLRNAPVTAKVDVYSF 631
+ ++ADFG+A LL D + I+ +MA E + T + DV+S+
Sbjct: 149 -KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMALESIHFGKYTHQSDVWSY 203
Query: 632 GVMLLEII 639
GV + E++
Sbjct: 204 GVTVWELM 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 24/189 (12%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ ++ VA+K+L + T L E V+ + ++ +LLG C+ Q L+ +LM
Sbjct: 41 EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMP 99
Query: 518 NGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
G L ++ + I + + + IA+G+ YL + ++H D+ +NVL+
Sbjct: 100 FGCLLDYVREHKDNIGSQY-LLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLV----- 150
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTM-----IRGTMGYMAPEWLRNAPVTAKVDVYS 630
KI DFGLAKLL ++ I+ +MA E + + T + DV+S
Sbjct: 151 --KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDVWS 204
Query: 631 FGVMLLEII 639
+GV + E++
Sbjct: 205 YGVTVWELM 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 57/284 (20%)
Query: 453 EATNVFDGQ-EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
E N+ Q ++ VAVK L++ + + F RE +++ H+++V+ G C E L+
Sbjct: 61 ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 512 VYELMKNGTLSAFL---------------FRQEIPTWDKRVEIALGIARGLLYLHEECET 556
V+E M++G L+ FL + + +A +A G++YL
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL--- 177
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTM----IRGTMGY 611
+H D+ +N L + + KI DFG+++ + D R IR +
Sbjct: 178 HFVHRDLATRNCL-------VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR----W 226
Query: 612 MAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLY 667
M PE + T + DV+SFGV+L EI T + T+ +
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIF--------------TYGKQPWYQLSNTE-AID 271
Query: 668 CVRTGN-LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
C+ G L + + + C +P R S+K V L+
Sbjct: 272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 25/192 (13%)
Query: 457 VFDGQ---EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
V+ G +VAVK L++ + + FL E ++ + H+ LV+L ++ ++
Sbjct: 29 VWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQE-PIYIIT 86
Query: 514 ELMKNGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLD 571
E M+NG+L FL T +K +++A IA G+ ++ E IH D++ N+L
Sbjct: 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL-- 141
Query: 572 NNYITIDNNYITKIADFGLAKLLKKDQTRTST----MIRGTMGYMAPEWLRNAPVTAKVD 627
+ + KIADFGLA+L++ ++ I+ + APE + T K D
Sbjct: 142 -----VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPEAINYGTFTIKSD 192
Query: 628 VYSFGVMLLEII 639
V+SFG++L EI+
Sbjct: 193 VWSFGILLTEIV 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 52/273 (19%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
D E VA+K + + E+ FL E V+ + ++V+LLG + L++ ELM
Sbjct: 52 DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMT 111
Query: 518 NGTLSAFL----------FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
G L ++L P+ K +++A IA G+ YL+ + +H D+ +N
Sbjct: 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARN 168
Query: 568 VLLDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTM----IRGTMGYMAPEWLRNAPV 622
+ + ++ KI DFG+ + + + D R +R +M+PE L++
Sbjct: 169 CM-------VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----WMSPESLKDGVF 217
Query: 623 TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-LGAT 677
T DV+SFGV+L EI TLA G+ VL V G L
Sbjct: 218 TTYSDVWSFGVVLWEIA--------------TLAEQPYQGLSNEQ-VLRFVMEGGLLDKP 262
Query: 678 KF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + + C P +RPS +++ ++
Sbjct: 263 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 55/189 (29%), Positives = 98/189 (51%), Gaps = 22/189 (11%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
++V VA+K L+ + ++ FL E ++G+ H N+++L G ++V E M+
Sbjct: 74 GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133
Query: 518 NGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
NG+L FL T + V + G+ G+ YL + +H D+ +NVL
Sbjct: 134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVL------- 183
Query: 577 IDNNYITKIADFGLAKLLKKDQ----TRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYS 630
+D+N + K++DFGL+++L+ D T T IR + APE + ++ DV+S
Sbjct: 184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR----WTAPEAIAFRTFSSASDVWS 239
Query: 631 FGVMLLEII 639
FGV++ E++
Sbjct: 240 FGVVMWEVL 248
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 58/269 (21%), Positives = 104/269 (38%), Gaps = 50/269 (18%)
Query: 454 ATNVFDGQEVEVAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
+ DG++ +K+ + +++ + REV V+ H N+VQ E +
Sbjct: 43 VKSTEDGRQY--VIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100
Query: 512 VYELMKNGTLSAFLFRQ------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
V + + G L + Q E D + I L ++H+ +I+H DIK
Sbjct: 101 VMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQICLALKHVHDR---KILHRDIKS 153
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
QN+ L + + ++ DFG+A++L I GT Y++PE N P K
Sbjct: 154 QNIFLT------KDGTV-QLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNK 205
Query: 626 VDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI--- 682
D+++ G +L E+ K A M ++ + +G F +
Sbjct: 206 SDIWALGCVLYELCTLKH---------AFEAGSMKN---LVLKIISG-----SFPPVSLH 248
Query: 683 ---TMVGL--WCICPQPTLRPSMKQVLQM 706
+ L P RPS+ +L+
Sbjct: 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 46/178 (25%), Positives = 72/178 (40%), Gaps = 15/178 (8%)
Query: 464 EVAVKQL-EKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
VA+K + E ++ D RE + GR ++V + F + L+
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
L+A L RQ + V I I L H H D+KP+N+L + +
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENIL-------VSAD 170
Query: 581 YITKIADFGLAKLLKKDQTRTST-MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+ DFG+A D+ T GT+ YMAPE + T + D+Y+ +L E
Sbjct: 171 DFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 61/277 (22%), Positives = 105/277 (37%), Gaps = 57/277 (20%)
Query: 459 DGQEVEVAVKQL-EKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQ------NHQL 510
DG V+VAVK L + + FLRE + H ++ +L+G + +
Sbjct: 48 DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107
Query: 511 LVYELMKNGTLSAFLFRQEIPTWDKR-------VEIALGIARGLLYLHEECETQIIHCDI 563
++ MK+G L AFL + V + IA G+ YL IH D+
Sbjct: 108 VILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDL 163
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD---QTRTSTM--IRGTMGYMAPEWLR 618
+N + + + +ADFGL++ + + ++ ++ ++A E L
Sbjct: 164 AARNCM-------LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK----WLALESLA 212
Query: 619 NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN- 673
+ T DV++FGV + EI+ T G+ + + + GN
Sbjct: 213 DNLYTVHSDVWAFGVTMWEIM--------------TRGQTPYAGIENAE-IYNYLIGGNR 257
Query: 674 LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
L E + + C P RPS + LE
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 21/198 (10%)
Query: 452 REATNVFDGQEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH-- 508
+ G++V A+KQ + ++ + + E+Q++ + +H N+V
Sbjct: 31 LRWIHQDTGEQV--AIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88
Query: 509 ----QLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHC 561
LL E + G L +L + E K I I+ L YLHE +IIH
Sbjct: 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHR 145
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP 621
D+KP+N++L I KI D G AK L + + T GT+ Y+APE L
Sbjct: 146 DLKPENIVLQPG----PQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPELLEQKK 199
Query: 622 VTAKVDVYSFGVMLLEII 639
T VD +SFG + E I
Sbjct: 200 YTVTVDYWSFGTLAFECI 217
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 61/276 (22%), Positives = 111/276 (40%), Gaps = 56/276 (20%)
Query: 459 DGQEVEVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-----HQLL 511
DG ++VAVK + + + + FL E + H N+++LLG CIE + ++
Sbjct: 59 DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118
Query: 512 VYELMKNGTLSAFLFRQEIPTWDKR-------VEIALGIARGLLYLHEECETQIIHCDIK 564
+ MK G L +L + ++ + IA G+ YL +H D+
Sbjct: 119 ILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLA 174
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTM----IRGTMGYMAPEWLRN 619
+N +L ++ +ADFGL+K + D R + ++ ++A E L +
Sbjct: 175 ARNCML-------RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----WIAIESLAD 223
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN-L 674
T+K DV++FGV + EI T G+ + + + G+ L
Sbjct: 224 RVYTSKSDVWAFGVTMWEIA--------------TRGMTPYPGVQNHE-MYDYLLHGHRL 268
Query: 675 GATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + + + C P RP+ + LE
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 52/189 (27%), Positives = 102/189 (53%), Gaps = 16/189 (8%)
Query: 456 NVFDGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYE 514
+ +E+ VA+K L+ + ++ FL E ++G+ H N+++L G + ++V E
Sbjct: 67 KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 515 LMKNGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
M+NG+L +FL R+ + V + GIA G+ YL + +H D+ +N+L
Sbjct: 127 YMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNIL--- 179
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQ--TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYS 630
I++N + K++DFGL ++L+ D T+ + + + +PE + T+ DV+S
Sbjct: 180 ----INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235
Query: 631 FGVMLLEII 639
+G++L E++
Sbjct: 236 YGIVLWEVM 244
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 56/278 (20%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELM 516
+ ++VAVK L+ EK + E++++ H+N+V LLG C L++ E
Sbjct: 73 EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC 132
Query: 517 KNGTLSAFL--------------FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
G L FL + + + +A+G+ +L + IH D
Sbjct: 133 CYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRD 189
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD---QTRTSTM--IRGTMGYMAPEWL 617
+ +NVLL N ++ KI DFGLA+ + D + + ++ +MAPE +
Sbjct: 190 VAARNVLL-------TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK----WMAPESI 238
Query: 618 RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTGN 673
+ T + DV+S+G++L EI +L G+++ V+ G
Sbjct: 239 FDCVYTVQSDVWSYGILLWEIF--------------SLGLNPYPGILVNSKFYKLVKDGY 284
Query: 674 -LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ F + I + C +PT RP+ +Q+ L+
Sbjct: 285 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-30
Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 457 VFDG--QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVY 513
V G + +VAVK ++ ++FL E V+ + H NLVQLLG +E+ L +V
Sbjct: 209 VMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266
Query: 514 ELMKNGTLSAFLF--RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLD 571
E M G+L +L + + D ++ +L + + YL +H D+ +NVL
Sbjct: 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVL-- 321
Query: 572 NNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631
+ + + K++DFGL K+ + T + + + APE LR + K DV+SF
Sbjct: 322 -----VSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 372
Query: 632 GVMLLEII 639
G++L EI
Sbjct: 373 GILLWEIY 380
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 68/286 (23%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQV---IGRTHHKNLVQLLGFCIEQNHQLLVYE 514
+ VAVK L+ E+ + E++V +G H N+V LLG C L++ E
Sbjct: 50 SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMNIVNLLGACTIGGPTLVITE 107
Query: 515 LMKNGTLSAFL------------------FRQEIPTWDKRVEIALGIARGLLYLHEECET 556
G L FL + + + + +A+G+ +L
Sbjct: 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SK 164
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT---RTSTM--IRGTMGY 611
IH D+ +N+L + + ITKI DFGLA+ +K D + + ++ +
Sbjct: 165 NCIHRDLAARNIL-------LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK----W 213
Query: 612 MAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLY 667
MAPE + N T + DV+S+G+ L E+ +L + GM +
Sbjct: 214 MAPESIFNCVYTFESDVWSYGIFLWELF--------------SLGSSPYPGMPVDSKFYK 259
Query: 668 CVRTGNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
++ G A + + C P RP+ KQ++Q++E
Sbjct: 260 MIKEGFRMLSPEHAP--AEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 15/185 (8%)
Query: 459 DGQEVEVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516
VAVK L E + L E V+ + + +V+++G C ++ +LV E+
Sbjct: 41 KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMA 99
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
+ G L+ +L + +E+ ++ G+ YL E +H D+ +NVLL
Sbjct: 100 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLL------ 150
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTM--GYMAPEWLRNAPVTAKVDVYSFGVM 634
+ KI+DFGL+K L+ D+ G + APE + ++K DV+SFGV+
Sbjct: 151 -VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209
Query: 635 LLEII 639
+ E
Sbjct: 210 MWEAF 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 54/186 (29%), Positives = 97/186 (52%), Gaps = 17/186 (9%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
++++VA+K L++ T + +RE Q++ + + +V+L+G C + +LV E+
Sbjct: 34 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAG 92
Query: 518 NGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
G L FL R+EIP + E+ ++ G+ YL E+ +H D+ +NVLL
Sbjct: 93 GGPLHKFLVGKREEIPVSN-VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLL----- 143
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTM--GYMAPEWLRNAPVTAKVDVYSFGV 633
N + KI+DFGL+K L D + + G + APE + +++ DV+S+GV
Sbjct: 144 --VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 201
Query: 634 MLLEII 639
+ E +
Sbjct: 202 TMWEAL 207
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 21/187 (11%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
G+++ VAVK +K K F+ E ++ H ++V+L+G E+ ++ EL
Sbjct: 37 KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYP 95
Query: 518 NGTLSAFLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G L +L R + V +L I + + YL +H DI +N+L+
Sbjct: 96 YGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILV------ 146
Query: 577 IDNNYITKIADFGLAKLLKKDQ-TRTSTM---IRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
+ K+ DFGL++ ++ + + S I+ +M+PE + T DV+ F
Sbjct: 147 -ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPESINFRRFTTASDVWMFA 201
Query: 633 VMLLEII 639
V + EI+
Sbjct: 202 VCMWEIL 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 54/187 (28%), Positives = 100/187 (53%), Gaps = 22/187 (11%)
Query: 461 QEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+EV VA+K L+ + ++ FL E ++G+ H N+++L G + +++ E M+NG
Sbjct: 72 KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 131
Query: 520 TLSAFLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L FL ++ + + V + GIA G+ YL +H D+ +N+L ++
Sbjct: 132 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNIL-------VN 181
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMG------YMAPEWLRNAPVTAKVDVYSFG 632
+N + K++DFGL+++L+ D T T T G + APE + T+ DV+SFG
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRWTAPEAISYRKFTSASDVWSFG 237
Query: 633 VMLLEII 639
+++ E++
Sbjct: 238 IVMWEVM 244
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 17/190 (8%)
Query: 453 EATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLV 512
++ + + A+K++ + + E+ + HKN+VQ LG E +
Sbjct: 40 AGRDLSNQVRI--AIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97
Query: 513 YELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVL 569
E + G+LSA L + P D I I GL YLH+ QI+H DIK NVL
Sbjct: 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVL 154
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV--TAKVD 627
++ + + KI+DFG +K L T T GT+ YMAPE + P D
Sbjct: 155 INT------YSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 628 VYSFGVMLLE 637
++S G ++E
Sbjct: 208 IWSLGCTIIE 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 60/312 (19%), Positives = 114/312 (36%), Gaps = 63/312 (20%)
Query: 426 PYMCVQPSPKPKPPEINMKVFSYQELRE-----------ATNVFDGQEVEVAVKQ--LEK 472
P QP +P + +++ ++ A + DG V A+K+ +
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV--ALKKVQIFD 69
Query: 473 VTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--- 528
+ + ++E+ ++ + +H N+++ IE N +V EL G LS +
Sbjct: 70 LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 129
Query: 529 -----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583
E W V++ L ++H +++H DIKP NV + +
Sbjct: 130 KRLIPERTVWKYFVQLCSA----LEHMHSR---RVMHRDIKPANVFITATGVV------- 175
Query: 584 KIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKR 643
K+ D GL + T +++ GT YM+PE + K D++S G +L E+ +
Sbjct: 176 KLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 644 HTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGL---------WCICPQP 694
+++ +L I + + CI P P
Sbjct: 235 PFYGDKMNLYSLCK-KIEQC--------------DYPPLPSDHYSEELRQLVNMCINPDP 279
Query: 695 TLRPSMKQVLQM 706
RP + V +
Sbjct: 280 EKRPDVTYVYDV 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 19/191 (9%)
Query: 456 NVFDGQEVEVAVKQLEKVTGDGEKS---FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLV 512
+ G+ V VAVK L+ ++ F+REV + H+NL++L G + + +V
Sbjct: 40 DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MV 98
Query: 513 YELMKNGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
EL G+L L + A+ +A G+ YL + + IH D+ +N+LL
Sbjct: 99 TELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVAEGMGYLESK---RFIHRDLAARNLLL 154
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGY--MAPEWLRNAPVTAKVDV 628
+ KI DFGL + L ++ + + APE L+ + D
Sbjct: 155 -------ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 207
Query: 629 YSFGVMLLEII 639
+ FGV L E+
Sbjct: 208 WMFGVTLWEMF 218
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 59/280 (21%), Positives = 100/280 (35%), Gaps = 60/280 (21%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
Q VA+K L+ + F E + R H N+V LLG + +++
Sbjct: 36 GEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCS 95
Query: 518 NGTLSAFLFRQEIPTWDKR-----------------VEIALGIARGLLYLHEECETQIIH 560
+G L FL P D V + IA G+ YL ++H
Sbjct: 96 HGDLHEFL-VMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVH 151
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD---QTRTSTM--IRGTMGYMAPE 615
D+ +NVL + + KI+D GL + + + +++ IR +MAPE
Sbjct: 152 KDLATRNVL-------VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR----WMAPE 200
Query: 616 WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRT 671
+ + D++S+GV+L E+ + G D V+ +R
Sbjct: 201 AIMYGKFSIDSDIWSYGVVLWEVF--------------SYGLQPYCGYSNQD-VVEMIRN 245
Query: 672 GN-LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
L + + + C P+ RP K + L
Sbjct: 246 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ + VA+K + T D + FL+E + + H ++V+L+G E ++ EL
Sbjct: 40 ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCT 98
Query: 518 NGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
G L +FL + + D + A ++ L YL + + +H DI +NVL
Sbjct: 99 LGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVL------ 148
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTM----IRGTMGYMAPEWLRNAPVTAKVDVYSF 631
+ +N K+ DFGL++ ++ ++ I+ +MAPE + T+ DV+ F
Sbjct: 149 -VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFTSASDVWMF 203
Query: 632 GVMLLEII 639
GV + EI+
Sbjct: 204 GVCMWEIL 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 457 VFDG--QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVY 513
V G + +VAVK ++ ++FL E V+ + H NLVQLLG +E+ L +V
Sbjct: 37 VMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94
Query: 514 ELMKNGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLD 571
E M G+L +L + + D ++ +L + + YL +H D+ +NVL
Sbjct: 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVL-- 149
Query: 572 NNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631
+ + + K++DFGL K+ + T + + + APE LR + K DV+SF
Sbjct: 150 -----VSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 200
Query: 632 GVMLLEII 639
G++L EI
Sbjct: 201 GILLWEIY 208
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 35/188 (18%), Positives = 71/188 (37%), Gaps = 15/188 (7%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+ +K + + ++ + + ++ + QN +LV EL GTL
Sbjct: 97 KFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLN 156
Query: 524 FLFRQEIPTW-----DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
+ + + A+ + + +H+ +IIH DIKP N +L N ++ D
Sbjct: 157 AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213
Query: 579 NNYIT----KIADFGLAKLLK--KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
+ + D G + +K T + T G+ E L N P ++D +
Sbjct: 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVA 272
Query: 633 VMLLEIIF 640
+ ++F
Sbjct: 273 ATVYCMLF 280
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 21/202 (10%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
+ G + AVK++ E + E+ +V L G E +
Sbjct: 77 MKDKQTGFQC--AVKKVRL-----EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
EL++ G+L + + D+ + GL YLH +I+H D+K NVLL ++
Sbjct: 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSD 186
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTM-G---YMAPEWLRNAPVTAKVDVY 629
+ DFG A L+ D S + + G +MAPE + P AKVD++
Sbjct: 187 GSRA------ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 630 SFGVMLLEIIFCKR-HTELHRV 650
S M+L ++ T+ R
Sbjct: 241 SSCCMMLHMLNGCHPWTQYFRG 262
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 22/188 (11%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ ++ VA+K+L + T L E V+ + ++ +LLG C+ Q L+ +LM
Sbjct: 41 EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMP 99
Query: 518 NGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G L ++ ++ + + IA+G+ YL + ++H D+ +NVL+
Sbjct: 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLV------ 150
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTM-----IRGTMGYMAPEWLRNAPVTAKVDVYSF 631
KI DFGLAKLL ++ I+ +MA E + + T + DV+S+
Sbjct: 151 -KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDVWSY 205
Query: 632 GVMLLEII 639
GV + E++
Sbjct: 206 GVTVWELM 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 13/183 (7%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ + VA+K + T D + FL+E + + H ++V+L+G E ++ EL
Sbjct: 415 ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCT 473
Query: 518 NGTLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G L +FL R+ + A ++ L YL + + +H DI +NVL
Sbjct: 474 LGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVL------- 523
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
+ +N K+ DFGL++ ++ ++ + + +MAPE + T+ DV+ FGV +
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 637 EII 639
EI+
Sbjct: 584 EIL 586
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 53/275 (19%)
Query: 454 ATNVFDGQEVEVAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLG-FCIEQNHQL 510
DG+ + K+ +T ++ + EV ++ H N+V+ N L
Sbjct: 25 IRRKSDGKIL--VWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 511 -LVYELMKNGTLSAFLFRQ--------EIPTWDKRVEIALGIARGLLYLHEECET--QII 559
+V E + G L++ + + E ++ L L H + ++
Sbjct: 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA----LKECHRRSDGGHTVL 138
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN 619
H D+KP NV LD K+ DFGLA++L D + T + GT YM+PE +
Sbjct: 139 HRDLKPANVFLDGKQNV-------KLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679
K D++S G +L E+ P A + +R G KF
Sbjct: 191 MSYNEKSDIWSLGCLLYELC-ALMP--------PFTAFSQ---KELAGKIREG-----KF 233
Query: 680 ERI------TMVGL--WCICPQPTLRPSMKQVLQM 706
RI + + + + RPS++++L+
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 21/186 (11%)
Query: 464 EVAVKQL-EKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL----LVYELM 516
+VAVK L + D F RE Q +H +V + + +V E +
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
TL + + T + +E+ + L + H+ IIH D+KP N++
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIM------- 148
Query: 577 IDNNYITKIADFGLAKLLKKDQ---TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
I K+ DFG+A+ + T+T+ +I GT Y++PE R V A+ DVYS G
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 634 MLLEII 639
+L E++
Sbjct: 208 VLYEVL 213
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 40/203 (19%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
++ E+ G+ A+K ++K + S E+ V+ + H+N+V L
Sbjct: 21 AFSEVFLVKQRLTGKLF--ALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78
Query: 507 NHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHE 552
H LV +L+ G L ++ + +Q + + YLHE
Sbjct: 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ--------------VLSAVKYLHE 124
Query: 553 ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYM 612
I+H D+KP+N+L + N I DFGL+K+ + T GT GY+
Sbjct: 125 N---GIVHRDLKPENLLYLTP----EENSKIMITDFGLSKMEQNGIMST---ACGTPGYV 174
Query: 613 APEWLRNAPVTAKVDVYSFGVML 635
APE L P + VD +S GV+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 63/295 (21%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELM 516
+ V VAVK L+ + + S + E++++ HKN++ LLG C + ++ E
Sbjct: 64 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 123
Query: 517 KNGTLSAFL----------------FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIH 560
G L +L +E T+ V +ARG+ YL + + IH
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 180
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD---QTRTSTM--IRGTMGYMAPE 615
D+ +NVL + N + KIADFGLA+ + + T+ ++ +MAPE
Sbjct: 181 RDLAARNVL-------VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK----WMAPE 229
Query: 616 WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRT 671
L + T + DV+SFGV++ EI TL G+ + + + ++
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIF--------------TLGGSPYPGIPVEE-LFKLLKE 274
Query: 672 GNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVVAD 721
G+ T + M+ C P+ RP+ KQ+++ L+ + D
Sbjct: 275 GHRMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 60/298 (20%), Positives = 92/298 (30%), Gaps = 53/298 (17%)
Query: 431 QPSPKPKPPEINMKVF---SYQELRE-----------ATNVFDGQEVEVAVKQLEK--VT 474
+ P + F S+Q L + DG+ AVK+
Sbjct: 39 ETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLY--AVKRSMSPFRG 96
Query: 475 GDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTW 533
L EV + H V+L E L EL +L
Sbjct: 97 PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP 155
Query: 534 DKRV-EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592
+ +V L +LH + ++H D+KP N+ L K+ DFGL
Sbjct: 156 EAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPR-----GRC--KLGDFGLLV 205
Query: 593 LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDE 652
L G YMAPE L+ DV+S G+ +LE+
Sbjct: 206 ELGTAGA-GEVQE-GDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL-------- 254
Query: 653 PTLANGMILTDWVLYCVRTGNLGATKFERITMVG----LWCICPQPTLRPSMKQVLQM 706
P G +R G L ++ + + P P LR + + +L +
Sbjct: 255 PHGGEGW-------QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 24/198 (12%)
Query: 452 REATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGF--CIEQNH 508
+ G A+K + +RE +V+ + +HKN+V+L H
Sbjct: 26 FRGRHKKTGDLF--AIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83
Query: 509 QLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKP 565
++L+ E G+L L E + + G+ +L E I+H +IKP
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKP 140
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV--- 622
N++ D + K+ DFG A+ L+ D+ S + GT Y+ P+ A +
Sbjct: 141 GNIMRVIGE---DGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAVLRKD 195
Query: 623 -----TAKVDVYSFGVML 635
A VD++S GV
Sbjct: 196 HQKKYGATVDLWSIGVTF 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 63/282 (22%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELM 516
+ V VAVK L+ + + S + E++++ HKN++ LLG C + ++ E
Sbjct: 110 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169
Query: 517 KNGTLSAFL----------------FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIH 560
G L +L +E T+ V +ARG+ YL + + IH
Sbjct: 170 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIH 226
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT---RTSTM--IRGTMGYMAPE 615
D+ +NVL + N + KIADFGLA+ + T+ ++ +MAPE
Sbjct: 227 RDLAARNVL-------VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK----WMAPE 275
Query: 616 WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRT 671
L + T + DV+SFGV++ EI TL G+ + + + ++
Sbjct: 276 ALFDRVYTHQSDVWSFGVLMWEIF--------------TLGGSPYPGIPVEE-LFKLLKE 320
Query: 672 GNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
G+ T + M+ C P+ RP+ KQ+++ L+
Sbjct: 321 GHRMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 41/205 (20%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
++ +R + G E A K + ++ + RE ++ + H N+V+L
Sbjct: 18 AFSVVRRCVHKTTGLEF--AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75
Query: 505 EQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYL 550
E++ LV++L+ G L ++ +Q I + Y
Sbjct: 76 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------------ILESIAYC 121
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H I+H ++KP+N+LL + K+ADFGLA + + GT G
Sbjct: 122 HSN---GIVHRNLKPENLLLASK----AKGAAVKLADFGLAIEVNDSE-AWHGFA-GTPG 172
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVML 635
Y++PE L+ P + VD+++ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 65/281 (23%), Positives = 117/281 (41%), Gaps = 59/281 (20%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGR-THHKNLVQLLGFCIEQNHQL-LVYEL 515
VAVK L++ E + E++++ HH N+V LLG C + L ++ E
Sbjct: 54 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113
Query: 516 MKNGTLSAFL----------------FRQEIPTWDKRVEIALGIARGLLYLHEECETQII 559
K G LS +L ++ T + + + +A+G+ +L + I
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG-----YMAP 614
H D+ +N+L + + KI DFGLA+ + KD +R +MAP
Sbjct: 171 HRDLAARNIL-------LSEKNVVKICDFGLARDIYKD----PDYVRKGDARLPLKWMAP 219
Query: 615 EWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVR 670
E + + T + DV+SFGV+L EI +L G+ + + ++
Sbjct: 220 ETIFDRVYTIQSDVWSFGVLLWEIF--------------SLGASPYPGVKIDEEFCRRLK 265
Query: 671 TGN-LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
G + A + + L C +P+ RP+ ++++ L
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 52/207 (25%), Positives = 77/207 (37%), Gaps = 47/207 (22%)
Query: 452 REATNVFDGQEVEVAVK-----QLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
R N GQ+ AVK + G + RE + H ++V+LL
Sbjct: 41 RRCINRETGQQF--AVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98
Query: 507 NHQLLVYELMKNGTL------------------SAFLFRQEIPTWDKRVEIALGIARGLL 548
+V+E M L ++ RQ I L
Sbjct: 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ--------------ILEALR 144
Query: 549 YLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGT 608
Y H+ IIH D+KP VLL + +N+ K+ FG+A L + + GT
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASK----ENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 609 MGYMAPEWLRNAPVTAKVDVYSFGVML 635
+MAPE ++ P VDV+ GV+L
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 55/278 (19%), Positives = 100/278 (35%), Gaps = 46/278 (16%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ---- 509
+ DG A+K++ + RE + +H N+++L+ +C+ +
Sbjct: 48 VEGLHDGHFY--ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105
Query: 510 LLVYELMKNGTLSAFLFRQEIPTW----DKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
L+ K GTL + R + D+ + + LGI RGL +H H D+KP
Sbjct: 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKP 162
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR--------GTMGYMAPEWL 617
N+LL + + + D G + + T+ Y APE
Sbjct: 163 TNILLGD-----EGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215
Query: 618 ---RNAPVTAKVDVYSFGVMLLEIIFCKR--HTELHRVDEPTLA--NGMILTDWVLYCVR 670
+ + + DV+S G +L ++F + + D LA N + + +
Sbjct: 216 SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSA 275
Query: 671 TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
L + + P RP + +L LE
Sbjct: 276 LWQL-------LN----SMMTVDPHQRPHIPLLLSQLE 302
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 60/279 (21%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELM 516
DG ++ A+K++++ + F E++V+ + HH N++ LLG C + + L E
Sbjct: 49 DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108
Query: 517 KNGTLSAFL----------------FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIH 560
+G L FL + + + A +ARG+ YL ++ Q IH
Sbjct: 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIH 165
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM----IRGTMGYMAPEW 616
D+ +N+L + NY+ KIADFGL++ ++ TM +R +MA E
Sbjct: 166 RDLAARNIL-------VGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR----WMAIES 212
Query: 617 LRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRTG 672
L + T DV+S+GV+L EI+ +L GM + + + G
Sbjct: 213 LNYSVYTTNSDVWSYGVLLWEIV--------------SLGGTPYCGMTCAE-LYEKLPQG 257
Query: 673 N-LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
L + + + C +P RPS Q+L L
Sbjct: 258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 42/196 (21%), Positives = 86/196 (43%), Gaps = 30/196 (15%)
Query: 464 EVAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNL--VQLLGFCIEQNHQLLVYELMKNG 519
A+K LE+ S+ E+ + + + ++L + I + +V E N
Sbjct: 54 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NI 112
Query: 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
L+++L +++ +R + + +H+ I+H D+KP N L+ + +
Sbjct: 113 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGML---- 165
Query: 580 NYITKIADFGLAKLLKKDQTRT--STMIRGTMGYMAPEWLRNAP-----------VTAKV 626
K+ DFG+A ++ D T + + GT+ YM PE +++ ++ K
Sbjct: 166 ----KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 627 DVYSFGVMLLEIIFCK 642
DV+S G +L + + K
Sbjct: 221 DVWSLGCILYYMTYGK 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-28
Identities = 51/186 (27%), Positives = 96/186 (51%), Gaps = 17/186 (9%)
Query: 459 DGQEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
++++VA+K L + + +RE Q++ + + +V+L+G C + +LV E+
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAG 418
Query: 518 NGTLSAFL--FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
G L FL R+EIP + E+ ++ G+ YL E+ +H ++ +NVLL
Sbjct: 419 GGPLHKFLVGKREEIPVSN-VAELLHQVSMGMKYLEEK---NFVHRNLAARNVLL----- 469
Query: 576 TIDNNYITKIADFGLAKLLKKDQT--RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
N + KI+DFGL+K L D + + + + + APE + +++ DV+S+GV
Sbjct: 470 --VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 527
Query: 634 MLLEII 639
+ E +
Sbjct: 528 TMWEAL 533
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 73/291 (25%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQV---IGRTHHKNLVQLLGFCIEQNHQLLVYE 514
G ++VAVK L++ E+ + E+++ +G H+N+V LLG C L++E
Sbjct: 72 TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGACTLSGPIYLIFE 129
Query: 515 LMKNGTLSAFL-----------------------FRQEIPTWDKRVEIALGIARGLLYLH 551
G L +L + T++ + A +A+G+ +L
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189
Query: 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT---RTSTM--IR 606
+ +H D+ +NVL+ + + KI DFGLA+ + D R + ++
Sbjct: 190 FK---SCVHRDLAARNVLVTHGKVV-------KICDFGLARDIMSDSNYVVRGNARLPVK 239
Query: 607 GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILT 662
+MAPE L T K DV+S+G++L EI +L G+ +
Sbjct: 240 ----WMAPESLFEGIYTIKSDVWSYGILLWEIF--------------SLGVNPYPGIPVD 281
Query: 663 DWVLYCVRTGNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
++ G AT E I ++ C RPS + L
Sbjct: 282 ANFYKLIQNGFKMDQPFYAT--EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 43/195 (22%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 464 EVAVKQ--LEKVTGDGEKSFLREVQVIG--RTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
A+K LE+ S+ E+ + + H +++L + I + +V E N
Sbjct: 35 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 93
Query: 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
L+++L +++ +R + + +H+ I+H D+KP N L+ + +
Sbjct: 94 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGML---- 146
Query: 580 NYITKIADFGLAKLLKKDQTRTS-TMIRGTMGYMAPEWLRNAP-----------VTAKVD 627
K+ DFG+A ++ D T GT+ YM PE +++ ++ K D
Sbjct: 147 ----KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 202
Query: 628 VYSFGVMLLEIIFCK 642
V+S G +L + + K
Sbjct: 203 VWSLGCILYYMTYGK 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 70/287 (24%), Positives = 115/287 (40%), Gaps = 66/287 (22%)
Query: 459 DGQEVEVAVKQL-EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
VAVK L E+ + D + F RE ++ + N+V+LLG C L++E M
Sbjct: 74 YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 518 NGTLSAFL------------------------FRQEIPTWDKRVEIALGIARGLLYLHEE 553
G L+ FL + +++ IA +A G+ YL E
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD---QTRTSTM--IRGT 608
+ +H D+ +N L + N + KIADFGL++ + + + IR
Sbjct: 194 ---KFVHRDLATRNCL-------VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR-- 241
Query: 609 MGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDW 664
+M PE + T + DV+++GV+L EI + GM +
Sbjct: 242 --WMPPESIFYNRYTTESDVWAYGVVLWEIF--------------SYGLQPYYGMAHEE- 284
Query: 665 VLYCVRTGN-LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
V+Y VR GN L + + + C P RPS + ++L+
Sbjct: 285 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 44/184 (23%), Positives = 75/184 (40%), Gaps = 27/184 (14%)
Query: 464 EVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-----LVYELM 516
V +K L +GD E + E Q + H ++VQ+ F + +V E +
Sbjct: 108 PVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
+L Q++P + + L I L YLH +++ D+KP+N++L +
Sbjct: 167 GGQSLKRSK-GQKLP-VAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQL- 220
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
K+ D G + + GT G+ APE +R P A D+Y+ G L
Sbjct: 221 -------KLIDLGAVSRI----NSFGYLY-GTPGFQAPEIVRTGPTVAT-DIYTVGRTLA 267
Query: 637 EIIF 640
+
Sbjct: 268 ALTL 271
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 40/205 (19%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
++ +R V GQE A + ++ + RE ++ H N+V+L
Sbjct: 23 AFSVVRRCVKVLAGQEY--AAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80
Query: 505 EQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYL 550
E+ H L+++L+ G L ++ +Q I +L+
Sbjct: 81 EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ--------------ILEAVLHC 126
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H+ ++H ++KP+N+LL + K+ADFGLA ++ +Q GT G
Sbjct: 127 HQM---GVVHRNLKPENLLLASK----LKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVML 635
Y++PE LR P VD+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 66/287 (22%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
VAVK L++ E L E V+ + +H ++++L G C + LL+ E K
Sbjct: 50 RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 109
Query: 518 NGTLSAFL------------------------FRQEIPTWDKRVEIALGIARGLLYLHEE 553
G+L FL + T + A I++G+ YL E
Sbjct: 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169
Query: 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT---RTSTM--IRGT 608
+++H D+ +N+L+ KI+DFGL++ + ++ + R+ ++
Sbjct: 170 ---KLVHRDLAARNILV-------AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK-- 217
Query: 609 MGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDW 664
+MA E L + T + DV+SFGV+L EI+ TL G+
Sbjct: 218 --WMAIESLFDHIYTTQSDVWSFGVLLWEIV--------------TLGGNPYPGIPPER- 260
Query: 665 VLYCVRTGN-LGATKF--ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ ++TG+ + E + + L C +P RP + + LE
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 65/308 (21%), Positives = 115/308 (37%), Gaps = 91/308 (29%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
++ ++ +A N D + A+K++ + L EV ++ +H+ +V+ +E+
Sbjct: 18 AFGQVVKARNALDSRYY--AIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLER 74
Query: 507 NHQL-------------LVYELMKNGTL---------------SAFLFRQEIPTWDKRVE 538
+ + + E +NGTL LFRQ
Sbjct: 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ---------- 124
Query: 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598
I L Y+H + IIH D+KP N+ +D ++ + KI DFGLAK + +
Sbjct: 125 ----ILEALSYIHSQ---GIIHRDLKPMNIFID------ESRNV-KIGDFGLAKNVHRSL 170
Query: 599 TRT--------------STMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKR 643
++ I GT Y+A E L K+D+YS G++ E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-YPF 228
Query: 644 HTELHRVDEPTLANGMILTDWVLYCVRTGN------LGATKFERITMVGLWCICPQPTLR 697
T + RV+ +L +R+ + K + + I P R
Sbjct: 229 STGMERVN-------------ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 698 PSMKQVLQ 705
P + +L
Sbjct: 276 PGARTLLN 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 52/281 (18%), Positives = 91/281 (32%), Gaps = 60/281 (21%)
Query: 454 ATNVFDGQEVEVAVKQ--LEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQL 510
DG A+K+ E++ LREV H ++V+ E +H L
Sbjct: 30 CVKRLDGCIY--AIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87
Query: 511 LVYELMKNGTLSAFLFRQEIPTW----DKRVEIALGIARGLLYLHEECETQIIHCDIKPQ 566
+ E G+L+ + + ++ L + RGL Y+H ++H DIKP
Sbjct: 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPS 144
Query: 567 NVLLDNN------------YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAP 614
N+ + N + KI D G + Q G ++A
Sbjct: 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----GDSRFLAN 199
Query: 615 E-WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN 673
E N K D+++ + ++ P + + +R G
Sbjct: 200 EVLQENYTHLPKADIFALALTVVCAA-GAEPL-------PRNGDQW-------HEIRQGR 244
Query: 674 L---------GATKFERITMVGLWCICPQPTLRPSMKQVLQ 705
L T+ + I P P RPS +++
Sbjct: 245 LPRIPQVLSQEFTELLK------VMIHPDPERRPSAMALVK 279
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 41/200 (20%)
Query: 452 REATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
R + G E A K + ++ + RE ++ + H N+V+L E++
Sbjct: 46 RRCVHKTTGLEF--AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103
Query: 510 LLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECE 555
LV++L+ G L ++ +Q I + Y H
Sbjct: 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------------ILESIAYCHSN-- 147
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE 615
I+H ++KP+N+LL + K+ADFGLA + + GT GY++PE
Sbjct: 148 -GIVHRNLKPENLLLASK----AKGAAVKLADFGLAIEVNDSE-AWHGFA-GTPGYLSPE 200
Query: 616 WLRNAPVTAKVDVYSFGVML 635
L+ P + VD+++ GV+L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 69/285 (24%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQV---IGRTHHKNLVQLLGFCIEQNHQLLVYE 514
+ +VAVK L+ + + S + E+++ IG+ HKN++ LLG C + ++ E
Sbjct: 98 PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVE 155
Query: 515 LMKNGTLSAFLFRQEIPTWDKR-----------------VEIALGIARGLLYLHEECETQ 557
G L +L + P + V A +ARG+ YL + +
Sbjct: 156 YASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---K 211
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT---RTSTM--IRGTMGYM 612
IH D+ +NVL + + + KIADFGLA+ + T+ ++ +M
Sbjct: 212 CIHRDLAARNVL-------VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WM 260
Query: 613 APEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYC 668
APE L + T + DV+SFGV+L EI TL G+ + + +
Sbjct: 261 APEALFDRIYTHQSDVWSFGVLLWEIF--------------TLGGSPYPGVPVEE-LFKL 305
Query: 669 VRTGNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
++ G+ T + M+ C P+ RP+ KQ+++ L+
Sbjct: 306 LKEGHRMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 51/214 (23%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--------VTGDGEKSFLREVQVIGRTHHKNLVQ 498
+ E++ A ++V A++ + K D + E++++ + +H +++
Sbjct: 147 ACGEVKLAFERKTCKKV--AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 499 LLGFCIEQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIA 544
+ F + +V ELM+ G L F Q +
Sbjct: 205 IKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------------ML 249
Query: 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604
+ YLHE IIH D+KP+NVLL + + + + KI DFG +K+L + + T+
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQ----EEDCLIKITDFGHSKIL-GETSLMRTL 301
Query: 605 IRGTMGYMAPEWLRN---APVTAKVDVYSFGVML 635
GT Y+APE L + A VD +S GV+L
Sbjct: 302 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 46/225 (20%), Positives = 92/225 (40%), Gaps = 44/225 (19%)
Query: 502 FCIEQNHQLLVY---ELMKNGTLSAFLFRQ---EIPTWDKRVEIALGIARGLLYLHEECE 555
+ ++ +Y +L + L ++ R+ E + I + IA + +LH +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR--------- 606
++H D+KP N+ ++ + K+ DFGL + +D+ + +
Sbjct: 184 -GLMHRDLKPSNIFFT------MDDVV-KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 607 --GTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDW 664
GT YM+PE + + KVD++S G++L E + T++ RV
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE-LLYSFSTQMERVR------------- 281
Query: 665 VLYCVRTGNLG---ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706
++ VR K+ + M+ + P PT RP +++
Sbjct: 282 IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 42/196 (21%), Positives = 85/196 (43%), Gaps = 30/196 (15%)
Query: 464 EVAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNL--VQLLGFCIEQNHQLLVYELMKNG 519
A+K LE+ S+ E+ + + + ++L + I + +V E N
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 140
Query: 520 TLSAFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L+++L ++ I W+++ + + +H+ I+H D+KP N L+ + +
Sbjct: 141 DLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGML--- 193
Query: 579 NNYITKIADFGLAKLLKKDQTRTS-TMIRGTMGYMAPEWLRNAP-----------VTAKV 626
K+ DFG+A ++ D T G + YM PE +++ ++ K
Sbjct: 194 -----KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 627 DVYSFGVMLLEIIFCK 642
DV+S G +L + + K
Sbjct: 249 DVWSLGCILYYMTYGK 264
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 51/214 (23%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--------VTGDGEKSFLREVQVIGRTHHKNLVQ 498
+ E++ A ++V A+K + K D + E++++ + +H +++
Sbjct: 22 ACGEVKLAFERKTCKKV--AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 499 LLGFCIEQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIA 544
+ F + +V ELM+ G L F Q +
Sbjct: 80 IKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------------ML 124
Query: 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604
+ YLHE IIH D+KP+NVLL + + + + KI DFG +K+L + + T+
Sbjct: 125 LAVQYLHEN---GIIHRDLKPENVLLSSQ----EEDCLIKITDFGHSKIL-GETSLMRTL 176
Query: 605 IRGTMGYMAPEWLRN---APVTAKVDVYSFGVML 635
GT Y+APE L + A VD +S GV+L
Sbjct: 177 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 42/204 (20%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE 505
SY + + E AVK ++K D E++++ R H N++ L +
Sbjct: 34 SYSVCKRCIHKATNMEF--AVKIIDKSKRDPT----EEIEILLRYGQHPNIITLKDVYDD 87
Query: 506 QNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLH 551
+ +V ELMK G L ++ + I + + YLH
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT--------------ITKTVEYLH 133
Query: 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGY 611
+ ++H D+KP N+L + N +I DFG AK L+ + T T +
Sbjct: 134 AQ---GVVHRDLKPSNILYVDES---GNPESIRICDFGFAKQLRAENGLLMTPC-YTANF 186
Query: 612 MAPEWLRNAPVTAKVDVYSFGVML 635
+APE L A D++S GV+L
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLL 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 42/191 (21%)
Query: 464 EVAVKQLEK--VTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
E A K L+K D L E+ V+ ++ L + +L+ E G
Sbjct: 56 EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 521 L----------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
+ L +Q I G+ YLH+ I+H D+K
Sbjct: 116 IFSLCLPELAEMVSENDVIRLIKQ--------------ILEGVYYLHQN---NIVHLDLK 158
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTA 624
PQN+LL + KI DFG+++ + M GT Y+APE L P+T
Sbjct: 159 PQNILLSSI----YPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEILNYDPITT 212
Query: 625 KVDVYSFGVML 635
D+++ G++
Sbjct: 213 ATDMWNIGIIA 223
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 24/198 (12%)
Query: 452 REATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGF--CIEQNH 508
+ G A+K + +RE +V+ + +HKN+V+L H
Sbjct: 26 FRGRHKKTGDLF--AIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83
Query: 509 QLLVYELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKP 565
++L+ E G+L L E + + G+ +L E I+H +IKP
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKP 140
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV--- 622
N++ D + K+ DFG A+ L+ D+ S GT Y+ P+ A +
Sbjct: 141 GNIMRVIGE---DGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYERAVLRKD 195
Query: 623 -----TAKVDVYSFGVML 635
A VD++S GV
Sbjct: 196 HQKKYGATVDLWSIGVTF 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 42/205 (20%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
S+ E+ + + QE AVK + K + LREV+++ + H N+++L
Sbjct: 34 SFGEVLKCKDRITQQEY--AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 505 EQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYL 550
+ + +V EL G L +A + +Q + G+ Y+
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ--------------VFSGITYM 137
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H+ I+H D+KP+N+LL++ + + KI DFGL+ +++ + I GT
Sbjct: 138 HKH---NIVHRDLKPENILLESK----EKDCDIKIIDFGLSTCFQQNT-KMKDRI-GTAY 188
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVML 635
Y+APE LR K DV+S GV+L
Sbjct: 189 YIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 42/204 (20%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE 505
S+ R+ + Q AVK + K E + +E+ + H N+V+L +
Sbjct: 23 SFSICRKCVHKKSNQAF--AVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHD 77
Query: 506 QNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLH 551
Q H LV EL+ G L ++++ R+ + + ++H
Sbjct: 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK--------------LVSAVSHMH 123
Query: 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGY 611
+ ++H D+KP+N+L + ++N KI DFG A+L D T T+ Y
Sbjct: 124 DV---GVVHRDLKPENLLFTDE----NDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHY 175
Query: 612 MAPEWLRNAPVTAKVDVYSFGVML 635
APE L D++S GV+L
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVIL 199
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-27
Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 74/288 (25%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
+Y E+ + E A+K + K V+ L EV V+ H N+++L F
Sbjct: 49 AYGEVLLCRDKVTHVER--AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106
Query: 505 EQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYL 550
++ + LV E K G L +A + +Q + G+ YL
Sbjct: 107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ--------------VLSGVTYL 152
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H+ I+H D+KP+N+LL++ + + + KI DFGL+ + + + + GT
Sbjct: 153 HKH---NIVHRDLKPENLLLESK----EKDALIKIVDFGLSAVFENQKKMKERL--GTAY 203
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670
Y+APE LR K DV+S GV+L I+ + D+ L V
Sbjct: 204 YIAPEVLRK-KYDEKCDVWSIGVILF-ILLAGYPPFGGQTDQEILRK-----------VE 250
Query: 671 TGNLGATKFERITMVGLW-------------CICPQPTLRPSMKQVLQ 705
G F+ W + R S +Q L+
Sbjct: 251 KGKY---TFDSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-27
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 42/200 (21%)
Query: 452 REATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
+ + QE AVK + K + LREV+++ + H N+++L + +
Sbjct: 39 LKCKDRITQQEY--AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96
Query: 510 LLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECE 555
+V EL G L +A + +Q + G+ Y+H+
Sbjct: 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ--------------VFSGITYMHKH-- 140
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE 615
I+H D+KP+N+LL++ + + KI DFGL+ +++ + GT Y+APE
Sbjct: 141 -NIVHRDLKPENILLESK----EKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPE 193
Query: 616 WLRNAPVTAKVDVYSFGVML 635
LR K DV+S GV+L
Sbjct: 194 VLRG-TYDEKCDVWSAGVIL 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 42/192 (21%)
Query: 464 EVAVKQLEK------VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
E A K ++K G + REV ++ H N++ L + +L+ EL+
Sbjct: 32 EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVS 91
Query: 518 NGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
G L + +Q I G+ YLH + +I H D+
Sbjct: 92 GGELFDFLAEKESLTEDEATQFLKQ--------------ILDGVHYLHSK---RIAHFDL 134
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
KP+N++L + + N I K+ DFG+A ++ + GT ++APE + P+
Sbjct: 135 KPENIMLLDK--NVPNPRI-KLIDFGIAHKIEAGNEFKNIF--GTPEFVAPEIVNYEPLG 189
Query: 624 AKVDVYSFGVML 635
+ D++S GV+
Sbjct: 190 LEADMWSIGVIT 201
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 43/206 (20%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
S+ E+ + GQE AVK + K ++S LREVQ++ + H N+++L F
Sbjct: 38 SFGEVILCKDKITGQEC--AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95
Query: 504 IEQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLY 549
++ + LV E+ G L +A + RQ + G+ Y
Sbjct: 96 EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ--------------VLSGITY 141
Query: 550 LHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTM 609
+H+ +I+H D+KP+N+LL++ + +I DFGL+ + + + GT
Sbjct: 142 MHKN---KIVHRDLKPENLLLESK----SKDANIRIIDFGLSTHFEASKKMKDKI--GTA 192
Query: 610 GYMAPEWLRNAPVTAKVDVYSFGVML 635
Y+APE L K DV+S GV+L
Sbjct: 193 YYIAPEVLHG-TYDEKCDVWSTGVIL 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 41/203 (20%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+ + + A+K L+K +K E+ V+ R H N+++L
Sbjct: 65 ATSIVYRCKQKGTQKPY--ALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 507 NHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHE 552
LV EL+ G L +A +Q I + YLHE
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ--------------ILEAVAYLHE 166
Query: 553 ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYM 612
I+H D+KP+N+L + KIADFGL+K+++ + GT GY
Sbjct: 167 N---GIVHRDLKPENLLYATP----APDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217
Query: 613 APEWLRNAPVTAKVDVYSFGVML 635
APE LR +VD++S G++
Sbjct: 218 APEILRGCAYGPEVDMWSVGIIT 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 14/178 (7%)
Query: 464 EVAVKQLEK------VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
E A K ++K G + REV ++ + H N++ L + +L+ EL+
Sbjct: 39 EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
G L FL ++E + ++ I G+ YLH + +I H D+KP+N++L + I
Sbjct: 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK--NI 153
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635
+I K+ DFGLA ++ + GT ++APE + P+ + D++S GV+
Sbjct: 154 PIPHI-KLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 42/191 (21%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL-- 521
++A K ++ ++ E+ V+ + H NL+QL +N +LV E + G L
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175
Query: 522 -------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
+ +Q I G+ ++H+ I+H D+KP+N+
Sbjct: 176 RIIDESYNLTELDTILFMKQ--------------ICEGIRHMHQM---YILHLDLKPENI 218
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
L N D I KI DFGLA+ K + GT ++APE + V+ D+
Sbjct: 219 LCVNR----DAKQI-KIIDFGLARRYKPREKLKVNF--GTPEFLAPEVVNYDFVSFPTDM 271
Query: 629 YSFGV---MLL 636
+S GV MLL
Sbjct: 272 WSVGVIAYMLL 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 465 VAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
+A+K L K E REV++ H N+++L G+ + L+ E GT+
Sbjct: 37 LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 96
Query: 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
L + + +A L Y H + ++IH DIKP+N+LL +
Sbjct: 97 YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSA------GE 147
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
+ KIADFG + +R + + GT+ Y+ PE + KVD++S GV+ E +
Sbjct: 148 L-KIADFGWSVHA--PSSRRTDLC-GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 14/178 (7%)
Query: 464 EVAVKQLEK------VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
E A K ++K G + REV ++ + H N++ L + +L+ EL+
Sbjct: 39 EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVS 98
Query: 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
G L FL ++E + ++ I G+ YLH + +I H D+KP+N++L + I
Sbjct: 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK--NI 153
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635
+I K+ DFGLA ++ + GT ++APE + P+ + D++S GV+
Sbjct: 154 PIPHI-KLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 43/203 (21%), Positives = 79/203 (38%), Gaps = 40/203 (19%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
S+ E++ A A K++ K + F +E++++ H N+++L +
Sbjct: 21 SWGEVKIAVQKGTRIRR--AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78
Query: 507 NHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHE 552
LV EL G L +A + + + + Y H+
Sbjct: 79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD--------------VLSAVAYCHK 124
Query: 553 ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYM 612
+ H D+KP+N L + + K+ DFGLA K + + + GT Y+
Sbjct: 125 L---NVAHRDLKPENFLFLTD----SPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYV 175
Query: 613 APEWLRNAPVTAKVDVYSFGVML 635
+P+ L + D +S GVM+
Sbjct: 176 SPQVLEG-LYGPECDEWSAGVMM 197
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 49/215 (22%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE 505
++ ++ N+ QE AVK +EK G REV+++ + H+N+++L+ F E
Sbjct: 25 AHARVQTCINLITSQEY--AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82
Query: 506 QNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLH 551
++ LV+E M+ G++ ++ + + +A L +LH
Sbjct: 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD--------------VASALDFLH 128
Query: 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR----- 606
+ I H D+KP+N+L ++ + KI DF L +K + +
Sbjct: 129 NK---GIAHRDLKPENILCEHP----NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 607 -GTMGYMAPEWLRNAPVTAK-----VDVYSFGVML 635
G+ YMAPE + A D++S GV+L
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 41/187 (21%), Positives = 73/187 (39%), Gaps = 39/187 (20%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM------- 516
K + + + E+ ++ + HH L+ L ++ +L+ E +
Sbjct: 78 VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 137
Query: 517 ----KNGTLS----AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
++ +S RQ GL ++HE I+H DIKP+N+
Sbjct: 138 RIAAEDYKMSEAEVINYMRQ--------------ACEGLKHMHEH---SIVHLDIKPENI 180
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
+ + + + KI DFGLA L D+ T T + APE + PV D+
Sbjct: 181 MCETK----KASSV-KIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDM 233
Query: 629 YSFGVML 635
++ GV+
Sbjct: 234 WAIGVLG 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 34/187 (18%), Positives = 67/187 (35%), Gaps = 40/187 (21%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM------- 516
K ++ G + +E+ ++ H+N++ L ++++E +
Sbjct: 32 TYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90
Query: 517 ----KNGTLS----AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
L+ Q + L +LH I H DI+P+N+
Sbjct: 91 RINTSAFELNEREIVSYVHQ--------------VCEALQFLHSH---NIGHFDIRPENI 133
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
+ ++ I KI +FG A+ LK Y APE ++ V+ D+
Sbjct: 134 IYQTR----RSSTI-KIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTATDM 186
Query: 629 YSFGVML 635
+S G ++
Sbjct: 187 WSLGTLV 193
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 44/187 (23%), Positives = 75/187 (40%), Gaps = 39/187 (20%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM------- 516
A K + +++ +E+Q + H LV L + N +++YE M
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243
Query: 517 ----KNGTLS----AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNV 568
++ +S RQ + +GL ++HE +H D+KP+N+
Sbjct: 244 KVADEHNKMSEDEAVEYMRQ--------------VCKGLCHMHEN---NYVHLDLKPENI 286
Query: 569 LLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDV 628
+ +N + K+ DFGL L Q+ T GT + APE PV D+
Sbjct: 287 MFTTK----RSNEL-KLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDM 339
Query: 629 YSFGVML 635
+S GV+
Sbjct: 340 WSVGVLS 346
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 464 EVAVKQLEK------VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ A K ++K G + REV ++ H N++ L + +L+ EL+
Sbjct: 38 QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577
G L FL +E T ++ E I G+ YLH QI H D+KP+N++L + +
Sbjct: 98 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR--NV 152
Query: 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635
I KI DFGLA + + GT ++APE + P+ + D++S GV+
Sbjct: 153 PKPRI-KIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 22/190 (11%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LV 512
A +V GQEV A++Q+ ++ + E+ V+ + N+V L +L +V
Sbjct: 39 AMDVATGQEV--AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-SYLVGDELWVV 95
Query: 513 YELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVL 569
E + G+L+ + + +IA + L +LH Q+IH DIK N+L
Sbjct: 96 MEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNIL 148
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY 629
L + K+ DFG + +Q++ STM+ GT +MAPE + KVD++
Sbjct: 149 LGMDGSV-------KLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 630 SFGVMLLEII 639
S G+M +E+I
Sbjct: 201 SLGIMAIEMI 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 53/216 (24%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK-------------VTGDGEKSFLREVQVIGRTHH 493
+Y E+ E A+K ++K + E+ ++ H
Sbjct: 48 AYGEVLLCKEKNGHSEK--AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 494 KNLVQLLGFCIEQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEI 539
N+++L ++ + LV E + G L +A + +Q
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ----------- 154
Query: 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599
I G+ YLH+ I+H DIKP+N+LL+N ++ KI DFGL+ KD
Sbjct: 155 ---ILSGICYLHKH---NIVHRDIKPENILLENK----NSLLNIKIVDFGLSSFFSKDYK 204
Query: 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635
+ GT Y+APE L+ K DV+S GV++
Sbjct: 205 LRDRL--GTAYYIAPEVLKK-KYNEKCDVWSCGVIM 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 58/219 (26%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---------VTGDGEKSFLREVQVIGR-THHKNL 496
+R + +E AVK ++ + ++ L+EV ++ + + H N+
Sbjct: 29 VSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 497 VQLLGFCIEQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALG 542
+QL LV++LMK G L + + R
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA-------------- 132
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602
+ + LH+ I+H D+KP+N+LLD++ I K+ DFG + L + +
Sbjct: 133 LLEVICALHKL---NIVHRDLKPENILLDDDM-NI------KLTDFGFSCQLDPGE-KLR 181
Query: 603 TMIRGTMGYMAPEWLRNAPVTA------KVDVYSFGVML 635
+ GT Y+APE + + +VD++S GV++
Sbjct: 182 EVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 45/189 (23%), Positives = 90/189 (47%), Gaps = 20/189 (10%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
A G++V AVK ++ + EV ++ H N+V++ + ++
Sbjct: 64 AREKHSGRQV--AVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLL 570
E ++ G L+ + + + +IA + + L YLH + +IH DIK ++LL
Sbjct: 122 EFLQGGALTDIVSQVRL----NEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYS 630
+ K++DFG + KD + +++ GT +MAPE + + +VD++S
Sbjct: 175 TLDGRV-------KLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWS 226
Query: 631 FGVMLLEII 639
G+M++E++
Sbjct: 227 LGIMVIEMV 235
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 48/190 (25%), Positives = 76/190 (40%), Gaps = 44/190 (23%)
Query: 465 VAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
+A+K L K E RE+++ H N++++ + ++ L+ E G L
Sbjct: 42 MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
Query: 522 --------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
SA + +A L Y HE ++IH DIKP+N
Sbjct: 102 YKELQKHGRFDEQRSATFMEE--------------LADALHYCHER---KVIHRDIKPEN 144
Query: 568 VLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVD 627
+L+ + KIADFG + R TM GT+ Y+ PE + KVD
Sbjct: 145 LLMGYK------GEL-KIADFGWSVH--APSLRRRTMC-GTLDYLPPEMIEGKTHDEKVD 194
Query: 628 VYSFGVMLLE 637
++ GV+ E
Sbjct: 195 LWCAGVLCYE 204
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 61/284 (21%), Positives = 103/284 (36%), Gaps = 53/284 (18%)
Query: 453 EATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQNHQL- 510
EA +V G+E A+K+L + ++ ++EV + + + H N+VQ +
Sbjct: 46 EAQDVGSGREY--ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103
Query: 511 ----LVYELM--KNGTLSAFLFRQEIPTW---DKRVEIALGIARGLLYLHEECETQIIHC 561
L G L FL + E D ++I R + ++H + IIH
Sbjct: 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHR 162
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI-----------RGTMG 610
D+K +N+LL N K+ DFG A + + + T
Sbjct: 163 DLKVENLLLSNQ-----GTI--KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM 215
Query: 611 YMAPE---WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--NGMI-LTDW 664
Y PE N P+ K D+++ G +L + F + E D L NG +
Sbjct: 216 YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRIVNGKYSIPPH 271
Query: 665 VLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+L I + P R S+ +V+ L+
Sbjct: 272 DTQYTVFHSL-------IR----AMLQVNPEERLSIAEVVHQLQ 304
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 53/201 (26%), Positives = 83/201 (41%), Gaps = 45/201 (22%)
Query: 453 EATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
A ++ G EV A+K ++K + EV++ + H ++++L + + N+
Sbjct: 29 RAESIHTGLEV--AIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86
Query: 510 LLVYELMKNGTL---------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEEC 554
LV E+ NG + + Q I G+LYLH
Sbjct: 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ--------------IITGMLYLHSH- 131
Query: 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAP 614
I+H D+ N+LL N N KIADFGLA LK + T+ GT Y++P
Sbjct: 132 --GILHRDLTLSNLLLTRN-----MN--IKIADFGLATQLKMPHEKHYTLC-GTPNYISP 181
Query: 615 EWLRNAPVTAKVDVYSFGVML 635
E + + DV+S G M
Sbjct: 182 EIATRSAHGLESDVWSLGCMF 202
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 45/203 (22%)
Query: 452 REATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL 510
G E +K + K + + E++V+ H N++++ + ++
Sbjct: 39 HLVEERSSGLER--VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96
Query: 511 LVYELMKNGTL------------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHE 552
+V E + G L A L +Q + L Y H
Sbjct: 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ--------------MMNALAYFHS 142
Query: 553 ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYM 612
+ ++H D+KP+N+L + + KI DFGLA+L K D+ T+ GT YM
Sbjct: 143 Q---HVVHKDLKPENILFQDT----SPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYM 193
Query: 613 APEWLRNAPVTAKVDVYSFGVML 635
APE + VT K D++S GV++
Sbjct: 194 APEVFKR-DVTFKCDIWSAGVVM 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 48/218 (22%), Positives = 91/218 (41%), Gaps = 57/218 (26%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--------VTGDGEKSFLREVQVIGR-THHKNLV 497
+R + G E AVK +E + ++ RE ++ + H +++
Sbjct: 106 VSSVVRRCVHRATGHEF--AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 498 QLLGFCIEQNHQLLVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGI 543
L+ + LV++LM+ G L + + R +
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS--------------L 209
Query: 544 ARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603
+ +LH I+H D+KP+N+LLD+N I +++DFG + L+ + +
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNM-QI------RLSDFGFSCHLEPGE-KLRE 258
Query: 604 MIRGTMGYMAPEWLRNAPVTA------KVDVYSFGVML 635
+ GT GY+APE L+ + +VD+++ GV+L
Sbjct: 259 LC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 6e-24
Identities = 26/296 (8%), Positives = 61/296 (20%), Gaps = 64/296 (21%)
Query: 452 REATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFC----- 503
+V ++ A+K + + R ++ +
Sbjct: 79 FLVRDVERLEDF--ALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 504 ---------------------IEQNHQLLVYELMK------NGTLSAFLFRQEIPTWDKR 536
+ LL+ TL +
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596
+ + R L + ++H P N+ + + + D K
Sbjct: 197 HILTAQLIRLAANLQSKG---LVHGHFTPDNLFI-------MPDGRLMLGDVSAL---WK 243
Query: 597 DQTRTSTMIRGTMGYMAPEWL--RNAPVTAKVDVYSFGVMLLEII-----FCKRHTELHR 649
TR + Y E+L A T ++ + G+ + + F +
Sbjct: 244 VGTRGPASS-VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 650 VDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705
+ I + R + ++
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTL--IGR----FLNFDRRRRLLPLEAME 352
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 36/287 (12%), Positives = 92/287 (32%), Gaps = 54/287 (18%)
Query: 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGE----KSFLREVQVIGRTHHKNLVQ 498
+ V + E + + +E + ++ L + + F+ ++ K +++
Sbjct: 103 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 162
Query: 499 LLGFC--IEQNHQLLVYELMKN------GTLSAFLFRQEIPTWDKRVEIALGIARGLLYL 550
+ + + +Y M++ L + + R+++ L + R L L
Sbjct: 163 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H ++H ++P +++LD + + F +D R + + G
Sbjct: 223 HHYG---LVHTYLRPVDIVLD------QRGGV-FLTGFEHL---VRDGARVVSS--VSRG 267
Query: 611 YMAPEWL-----------RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEP-TLANG 658
+ PE R +T D ++ G+++ I C P T
Sbjct: 268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW-CADL--------PITKDAA 318
Query: 659 MILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705
+ ++W+ + + + R Q ++
Sbjct: 319 LGGSEWIFRSCKNIPQPVRAL--LE----GFLRYPKEDRLLPLQAME 359
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 54/245 (22%), Positives = 91/245 (37%), Gaps = 58/245 (23%)
Query: 422 PLTRPYMCVQPSPKPKPPEINMKVFS---YQELR-----------EATNVFDGQEVEVAV 467
+ P P + PE+ + S Y R E ++ + A
Sbjct: 14 GVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVF--AG 71
Query: 468 KQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL--- 521
K + K + + E+ + H+++V GF + + +V EL + +L
Sbjct: 72 KIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL 131
Query: 522 -----------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLL 570
+ + RQ I G YLH ++IH D+K N+ L
Sbjct: 132 HKRRKALTEPEARYYLRQ--------------IVLGCQYLHRN---RVIHRDLKLGNLFL 174
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYS 630
+ + KI DFGLA ++ D R + GT Y+APE L + +VDV+S
Sbjct: 175 NEDLEV-------KIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDVWS 226
Query: 631 FGVML 635
G ++
Sbjct: 227 IGCIM 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 52/210 (24%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE 505
++ E + GQ+ A+K L +EV + + ++V +L
Sbjct: 41 VNGKVLECFHRRTGQKC--ALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYEN 93
Query: 506 QNHQ----LLVYELMKNGTL----------------SAFLFRQEIPTWDKRVEIALGIAR 545
+H L++ E M+ G L +A + R I
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD--------------IGT 139
Query: 546 GLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605
+ +LH I H D+KP+N+L + + + + K+ DFG AK ++ +T
Sbjct: 140 AIQFLHSH---NIAHRDVKPENLLYTSK----EKDAVLKLTDFGFAKETTQNALQT---P 189
Query: 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635
T Y+APE L D++S GV++
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 23/194 (11%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
A N G A K +E + + + ++ E++++ H +V+LLG ++
Sbjct: 38 AKNKETGALA--AAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLL 570
E G + A + + +I + + L +LH + +IIH D+K NVL+
Sbjct: 96 EFCPGGAVDAIMLELDRGL--TEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLM 150
Query: 571 DNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-----WLRNAPVTAK 625
++ADFG++ K + + I GT +MAPE +++ P K
Sbjct: 151 -------TLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDYK 202
Query: 626 VDVYSFGVMLLEII 639
D++S G+ L+E+
Sbjct: 203 ADIWSLGITLIEMA 216
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 46/201 (22%)
Query: 453 EATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
E ++ + A K + K + + E+ + H+++V G E N
Sbjct: 33 EISDADTKEVF--AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDF 89
Query: 510 L-LVYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEEC 554
+ +V EL + +L + + RQ I G YLH
Sbjct: 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ--------------IVLGCQYLHRN- 134
Query: 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAP 614
++IH D+K N+ L+ + KI DFGLA ++ D R + GT Y+AP
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEV-------KIGDFGLATKVEYDGERKKVLC-GTPNYIAP 184
Query: 615 EWLRNAPVTAKVDVYSFGVML 635
E L + +VDV+S G ++
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIM 205
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LV 512
A + GQ V A+KQ+ + ++E+ ++ + ++V+ G +N L +V
Sbjct: 48 AIHKETGQIV--AIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIV 102
Query: 513 YELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVL 569
E G++S + + EIA +GL YLH + IH DIK N+L
Sbjct: 103 MEYCGAGSVSDIIRLRNKTL--TEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNIL 157
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY 629
L+ K+ADFG+A L + +T+I GT +MAPE ++ D++
Sbjct: 158 LNTEGHA-------KLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIW 209
Query: 630 SFGVMLLEII 639
S G+ +E+
Sbjct: 210 SLGITAIEMA 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 51/234 (21%), Positives = 78/234 (33%), Gaps = 60/234 (25%)
Query: 452 REATNVFDGQEVEVAVKQLEK-----VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
R A A+K + K + + EV+++ + HH N+ +L ++
Sbjct: 43 RVAIENQTRAIR--AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALG------------------------ 542
+ LV EL G L L + K +
Sbjct: 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES 160
Query: 543 ----------------IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586
I L YLH + I H DIKP+N L + ++ K+
Sbjct: 161 LDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFST-----NKSFEIKLV 212
Query: 587 DFGLAKLLKKDQTRTSTMIR---GTMGYMAPEWLRNA--PVTAKVDVYSFGVML 635
DFGL+K K + GT ++APE L K D +S GV+L
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 39/204 (19%)
Query: 464 EVAVKQLEK-----------------VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
A+K+ EK F E+Q+I ++ + G
Sbjct: 56 FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIAR--------GLLYLHEECETQI 558
+ ++YE M+N ++ F + + I + + + Y+H E I
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNI 173
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
H D+KP N+L+D N + K++DFG ++ + + + S RGT +M PE+
Sbjct: 174 CHRDVKPSNILMD------KNGRV-KLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFS 223
Query: 619 NAPVT--AKVDVYSFGVMLLEIIF 640
N AKVD++S G+ L + +
Sbjct: 224 NESSYNGAKVDIWSLGICLYVMFY 247
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 51/205 (24%)
Query: 452 REATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFC----IEQ 506
+ N ++ A+K L+ REV++ R + ++V+++ +
Sbjct: 79 LQIFNKRTQEKF--ALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131
Query: 507 NHQLLVYELMKNGTL----------------SAFLFRQEIPTWDKRVEIALGIARGLLYL 550
L+V E + G L ++ + + I + YL
Sbjct: 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS--------------IGEAIQYL 177
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H I H D+KP+N+L + N I K+ DFG AK + T+ T
Sbjct: 178 HSI---NIAHRDVKPENLLYTSK----RPNAILKLTDFGFAKETTSHNSLTTPC--YTPY 228
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVML 635
Y+APE L D++S GV++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 58/186 (31%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A K+L K G + + E +++ + H + +V L + E L LV +M G +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI 272
Query: 522 SAFLFR--QEIPTWD-KRV-----EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
++ ++ P + R +I G L +LH+ II+ D+KP+NVLLD
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPENVLLD-- 323
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
D+ + +I+D GLA LK QT+T GT G+MAPE L VD ++ GV
Sbjct: 324 ----DDGNV-RISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGV 377
Query: 634 MLLEII 639
L E+I
Sbjct: 378 TLYEMI 383
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-22
Identities = 43/178 (24%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 465 VAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+A K + +RE+QV+ + +V G + E M G+L
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 524 FLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNN 580
L ++ +++ ++++ + +GL YL E+ +I+H D+KP N+L+++ I
Sbjct: 121 VL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI----- 171
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
K+ DFG++ L + GT YM+PE L+ + + D++S G+ L+E+
Sbjct: 172 ---KLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 5e-22
Identities = 60/184 (32%), Positives = 91/184 (49%), Gaps = 27/184 (14%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A K+LEK GE L E Q++ + + + +V L + E L LV LM G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL 271
Query: 522 SAFLFRQEIPTWD-KRV-----EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
++ + R EI G L LH E +I++ D+KP+N+LLD
Sbjct: 272 KFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRE---RIVYRDLKPENILLD---- 320
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635
D+ +I +I+D GLA + + QT + GT+GYMAPE ++N T D ++ G +L
Sbjct: 321 --DHGHI-RISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLL 375
Query: 636 LEII 639
E+I
Sbjct: 376 YEMI 379
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 37/198 (18%)
Query: 457 VFDGQEVE----VAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQL- 510
VF G + VA+K ++ + E +E+ V+ + + + G ++ +L
Sbjct: 38 VFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-SYLKDTKLW 96
Query: 511 LVYE---------LMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHC 561
++ E L++ G L +I T I I +GL YLH E + IH
Sbjct: 97 IIMEYLGGGSALDLLEPGPLD----ETQIAT------ILREILKGLDYLHSE---KKIHR 143
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP 621
DIK NVLL + K+ADFG+A L Q + +T + GT +MAPE ++ +
Sbjct: 144 DIKAANVLLSEHGEV-------KLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 195
Query: 622 VTAKVDVYSFGVMLLEII 639
+K D++S G+ +E+
Sbjct: 196 YDSKADIWSLGITAIELA 213
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 35/188 (18%), Positives = 66/188 (35%), Gaps = 24/188 (12%)
Query: 465 VAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
V V++ LE + + E+ V +H N+V I N +V M G+
Sbjct: 55 VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 523 AFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
L + IA G+ + L Y+H +H +K ++L+
Sbjct: 115 D-LICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILI-------SV 163
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIR------GTMGYMAPEWLR--NAPVTAKVDVYSF 631
+ ++ + R + + +++PE L+ AK D+YS
Sbjct: 164 DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223
Query: 632 GVMLLEII 639
G+ E+
Sbjct: 224 GITACELA 231
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 2e-21
Identities = 26/213 (12%), Positives = 68/213 (31%), Gaps = 27/213 (12%)
Query: 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGE----KSFLREVQVIGRTHHKNLVQ 498
+ V + E + + +E + ++ L + + F+ ++ K +++
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167
Query: 499 LLGF--CIEQNHQLLVYELMKN------GTLSAFLFRQEIPTWDKRVEIALGIARGLLYL 550
+ + + +Y M++ L + + R+++ L + R L L
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H ++H ++P +++LD + + F
Sbjct: 228 HHYG---LVHTYLRPVDIVLD------QRGGV-FLTGFEHLVRDGASAVSPIGRGFAPPE 277
Query: 611 YMAPEWLRNAP-----VTAKVDVYSFGVMLLEI 638
A L +T D ++ G+ + I
Sbjct: 278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 32/202 (15%)
Query: 457 VFDGQEVE----VAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLG-----FCIEQ 506
V+ G+ V+ A+K + VTGD E+ +E+ ++ + HH+N+ G
Sbjct: 40 VYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98
Query: 507 NHQL-LVYELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCD 562
+ QL LV E G+++ + + T + IA I RGL +LH+ ++IH D
Sbjct: 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE-WIAYICREILRGLSHLHQH---KVIHRD 154
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-----WL 617
IK QNVLL N K+ DFG++ L + R +T I GT +MAPE
Sbjct: 155 IKGQNVLL-------TENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDEN 206
Query: 618 RNAPVTAKVDVYSFGVMLLEII 639
+A K D++S G+ +E+
Sbjct: 207 PDATYDFKSDLWSLGITAIEMA 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 27/187 (14%)
Query: 465 VAVKQLEKVTGDGE-KSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
+AVK++ + E K L ++ V+ R+ +VQ G + + ELM + +
Sbjct: 50 MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFD 108
Query: 523 AFLFRQEIPTWDKRVE------IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YI 575
F + D + I L + L +L E +IIH DIKP N+LLD + I
Sbjct: 109 KFY-KYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNI 165
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE----WLRNAPVTAKVDVYSF 631
K+ DFG++ L +T G YMAPE + DV+S
Sbjct: 166 --------KLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSL 215
Query: 632 GVMLLEI 638
G+ L E+
Sbjct: 216 GITLYEL 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 44/206 (21%), Positives = 72/206 (34%), Gaps = 52/206 (25%)
Query: 454 ATNVFDGQEVEVAVKQLEK------VTGDGEKSFLREVQVIGRTHHK--NLVQLLGFCIE 505
V D V A+K +EK EV ++ + +++LL +
Sbjct: 62 GIRVSDNLPV--AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119
Query: 506 QNHQLLVYE-----------LMKNGTLS----AFLFRQEIPTWDKRVEIALGIARGLLYL 550
+ +L+ E + + G L F Q + + +
Sbjct: 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ--------------VLEAVRHC 165
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H ++H DIK +N+L+D N + K+ DFG LLK GT
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGEL------KLIDFGSGALLKDTVYTDFD---GTRV 213
Query: 611 YMAPEWLRNAPVTA-KVDVYSFGVML 635
Y PEW+R V+S G++L
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 46/243 (18%), Positives = 76/243 (31%), Gaps = 65/243 (26%)
Query: 430 VQPSPKPKPPEINMKVFSYQELRE-----------ATNVFDGQEVEVAVKQLEK------ 472
P+P P + Y+ + D +V A+K + +
Sbjct: 15 GTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV--AIKVIPRNRVLGW 72
Query: 473 VTGDGEKSFLREVQ----VIGRTHHKNLVQLLGFCIEQNHQLLVYE-----------LMK 517
+ EV V H +++LL + Q +LV E + +
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 518 NGTLS----AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN 573
G L F Q + + + H ++H DIK +N+L+D
Sbjct: 133 KGPLGEGPSRCFFGQ--------------VVAAIQHCHSRG---VVHRDIKDENILIDL- 174
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT-AKVDVYSFG 632
K+ DFG LL + GT Y PEW+ V+S G
Sbjct: 175 ----RRGCA-KLIDFGSGALLHDEPYTDFD---GTRVYSPPEWISRHQYHALPATVWSLG 226
Query: 633 VML 635
++L
Sbjct: 227 ILL 229
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 28/187 (14%)
Query: 465 VAVKQLEKVTGDGE-KSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
+AVK++ E K L ++ + RT V G + + ELM + +L
Sbjct: 35 MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLD 93
Query: 523 AFLFRQEIPTWDKRVE------IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YI 575
F +++ + + IA+ I + L +LH + +IH D+KP NVL++ +
Sbjct: 94 KFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQV 149
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE----WLRNAPVTAKVDVYSF 631
K+ DFG++ L D + G YMAPE L + K D++S
Sbjct: 150 --------KMCDFGISGYLVDDVAKD-IDA-GCKPYMAPERINPELNQKGYSVKSDIWSL 199
Query: 632 GVMLLEI 638
G+ ++E+
Sbjct: 200 GITMIEL 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKN---LVQLLGFCIEQNHQL-LVYELMKN 518
A+K L+K GE L E ++ + +V + + +L + +LM
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNG 276
Query: 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
G L L + + + A I GL ++H +++ D+KP N+LLD +
Sbjct: 277 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLD------E 327
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL-RNAPVTAKVDVYSFGVMLLE 637
+ ++ +I+D GLA K + S GT GYMAPE L + + D +S G ML +
Sbjct: 328 HGHV-RISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383
Query: 638 II 639
++
Sbjct: 384 LL 385
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL------LVYELMK 517
EVA+K KV D ++ RE+Q++ H N+V L F + LV E +
Sbjct: 66 EVAIK---KVLQD-KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 518 NGTLSAFL-----FRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKPQNVL 569
T+ +Q +P + I L + R L Y+H I H DIKPQN+L
Sbjct: 122 E-TVYRASRHYAKLKQTMPM----LLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLL 173
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDV 628
LD + + K+ DFG AK+L + S + + Y APE + A T +D+
Sbjct: 174 LD------PPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDI 225
Query: 629 YSFGVMLLEII 639
+S G ++ E++
Sbjct: 226 WSTGCVMAELM 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 31/198 (15%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL--- 510
A G+ V A+K KV D ++ RE+Q++ + H N+V+L F +
Sbjct: 73 AKLCDSGELV--AIK---KVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 511 ---LVYELMKNGTLSAFL-----FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
LV + + T+ +Q +P ++ + R L Y+H I H D
Sbjct: 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRD 181
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV 622
IKPQN+LLD + + K+ DFG AK L + + S + + Y APE + A
Sbjct: 182 IKPQNLLLDP------DTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELIFGATD 233
Query: 623 -TAKVDVYSFGVMLLEII 639
T+ +DV+S G +L E++
Sbjct: 234 YTSSIDVWSAGCVLAELL 251
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 56/208 (26%)
Query: 454 ATNVFDGQEVEVAVKQLEK----VTGDGEKSFL----REVQVIGRTHHKNLVQLLGFCIE 505
A + +EV VK ++K E L E+ ++ R H N++++L E
Sbjct: 43 AVDKEKNKEV--VVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-FE 99
Query: 506 QNHQL-LVYELMKNG---------------TLSAFLFRQEIPTWDKRVEIALGIARGLLY 549
LV E +G L++++FRQ + + Y
Sbjct: 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ--------------LVSAVGY 145
Query: 550 LHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RTSTMIRGT 608
L + IIH DIK +N+++ + K+ DFG A L++ + T GT
Sbjct: 146 LRLKD---IIHRDIKDENIVIAED-----FT--IKLIDFGSAAYLERGKLFYTFC---GT 192
Query: 609 MGYMAPEWLRNAPVT-AKVDVYSFGVML 635
+ Y APE L P +++++S GV L
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 54/201 (26%), Positives = 84/201 (41%), Gaps = 49/201 (24%)
Query: 454 ATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL- 510
A ++ G+EV A+K ++K + + REV+++ +H N+V+L IE L
Sbjct: 34 ARHILTGREV--AIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE-VIETEKTLY 90
Query: 511 LVYELMKNGTLSAFL--------------FRQEIPTWDKRVEIALGIARGLLYLHEECET 556
L+ E G + +L FRQ I + Y H++
Sbjct: 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ--------------IVSAVQYCHQKR-- 134
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RTSTMIRGTMGYMAPE 615
I+H D+K +N+LLD + N KIADFG + G Y APE
Sbjct: 135 -IVHRDLKAENLLLDAD-----MN--IKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE 183
Query: 616 WLRNAPVT-AKVDVYSFGVML 635
+ +VDV+S GV+L
Sbjct: 184 LFQGKKYDGPEVDVWSLGVIL 204
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 26/185 (14%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQL-LVYELMKNGT 520
+AVKQ+ + +G+ E K L ++ V+ ++H +VQ G N + + ELM GT
Sbjct: 53 IAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG-TFITNTDVFIAMELM--GT 108
Query: 521 LSAFLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
+ L ++ +R+ ++ + I + L YL E+ +IH D+KP N+LLD +
Sbjct: 109 CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLD------E 160
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-----WLRNAPVTAKVDVYSFGV 633
I K+ DFG++ L D+ + + G YMAPE + DV+S G+
Sbjct: 161 RGQI-KLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 634 MLLEI 638
L+E+
Sbjct: 218 SLVEL 222
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 32/185 (17%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLG-FCIEQNHQLL--VYELMKNG 519
A+K LEK + + RE V+ R H V+L F Q+ + L KNG
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF---QDDEKLYFGLSYAKNG 115
Query: 520 TLSAFLFRQEI-PTWDKRV---EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-Y 574
L ++ + R EI + YLH + IIH D+KP+N+LL+ + +
Sbjct: 116 ELLKYIRKIGSFDETCTRFYTAEIVSALE----YLHGK---GIIHRDLKPENILLNEDMH 168
Query: 575 ITIDNNYITKIADFGLAKLLKK--DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
I +I DFG AK+L Q R ++ + GT Y++PE L D+++ G
Sbjct: 169 I--------QITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKSACKSSDLWALG 219
Query: 633 VMLLE 637
++ +
Sbjct: 220 CIIYQ 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 64/267 (23%), Positives = 112/267 (41%), Gaps = 48/267 (17%)
Query: 465 VAVKQ--LEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
VA+K+ LEK + L+E+Q + + HH N+V +L LV +L+ G++
Sbjct: 43 VAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYT-SFVVKDELWLVMKLLSGGSV 100
Query: 522 SAFLFRQEIPTWDKR------VEIAL---GIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
+ + + + + IA + GL YLH+ IH D+K N+LL
Sbjct: 101 LD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLG- 155
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTM-G---YMAPEWL-RNAPVTAKVD 627
++ + +IADFG++ L T +R T G +MAPE + + K D
Sbjct: 156 -----EDGSV-QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209
Query: 628 VYSFGVMLLEII-----FCKRHTELHRVDEPTLANGMILTDW--VLYCVRTGNLGATKFE 680
++SFG+ +E+ + K P + L + L K+
Sbjct: 210 IWSFGITAIELATGAAPYHKYP--------PMKVLMLTLQNDPPSLETGVQDKEMLKKYG 261
Query: 681 R--ITMVGLWCICPQPTLRPSMKQVLQ 705
+ M+ L C+ P RP+ ++L+
Sbjct: 262 KSFRKMISL-CLQKDPEKRPTAAELLR 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 33/197 (16%)
Query: 457 VFDGQEVE----VAVKQL---EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
V+ ++V VA+K++ K + + + ++EV+ + + H N +Q G C + H
Sbjct: 70 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHT 128
Query: 510 L-LVYELMKNGTLSAFLFRQEIPTWDKRVEIAL---GIARGLLYLHEECETQIIHCDIKP 565
LV E G+ S L + P + VEIA G +GL YLH +IH D+K
Sbjct: 129 AWLVMEYC-LGSASDLLEVHKKPL--QEVEIAAVTHGALQGLAYLHSH---NMIHRDVKA 182
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE---WLRNAPV 622
N+LL + K+ DFG A ++ ++ + GT +MAPE +
Sbjct: 183 GNILL-------SEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMDEGQY 230
Query: 623 TAKVDVYSFGVMLLEII 639
KVDV+S G+ +E+
Sbjct: 231 DGKVDVWSLGITCIELA 247
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 53/217 (24%)
Query: 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFL--REVQVIGRTHHKNLVQLL 500
MKV S ++L +E+ ++ + H N+V+L
Sbjct: 43 MKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL- 101
Query: 501 GFCIE------QNHQLLVYELMKNGTL-------------SAFLFRQEIPTWDKRVEIAL 541
+E ++H +V+EL+ G + + F F+
Sbjct: 102 ---VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQD------------- 145
Query: 542 GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601
+ +G+ YLH + +IIH DIKP N+L+ + + KIADFG++ K
Sbjct: 146 -LIKGIEYLHYQ---KIIHRDIKPSNLLVGED----GH---IKIADFGVSNEFKGSDALL 194
Query: 602 STMIRGTMGYMAPEWLRNAPVT---AKVDVYSFGVML 635
S GT +MAPE L +DV++ GV L
Sbjct: 195 SN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 49/198 (24%), Positives = 72/198 (36%), Gaps = 44/198 (22%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVY 513
+ + V AVK +E+ E RE+ H N+V+ + H ++
Sbjct: 39 MRDKLTKELV--AVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFKEVILTPTHLAIIM 95
Query: 514 ELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQII 559
E G L + F F+Q + G+ Y H QI
Sbjct: 96 EYASGGELYERICNAGRFSEDEARFFFQQ--------------LLSGVSYCHSM---QIC 138
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RTSTMIRGTMGYMAPEWLR 618
H D+K +N LLD + KI DFG +K +++ GT Y+APE L
Sbjct: 139 HRDLKLENTLLDGSP---APR--LKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLL 190
Query: 619 NAPVT-AKVDVYSFGVML 635
DV+S GV L
Sbjct: 191 RQEYDGKIADVWSCGVTL 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 35/203 (17%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSF----LREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
G V A+K KV D F L+ +Q + HH N+VQL + +
Sbjct: 42 GKEKSTGMSV--AIK---KVIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94
Query: 510 -------LLVYELMKNGTLSAFL-----FRQEIPTWDKRVEIALGIARGLLYLHEECETQ 557
+V E + TL + P +V + R + LH
Sbjct: 95 DRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIGCLHLPS-VN 151
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617
+ H DIKP NVL++ + + K+ DFG AK L + + + + Y APE +
Sbjct: 152 VCHRDIKPHNVLVN------EADGTLKLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELI 203
Query: 618 RNAPV-TAKVDVYSFGVMLLEII 639
T VD++S G + E++
Sbjct: 204 FGNQHYTTAVDIWSVGCIFAEMM 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 36/190 (18%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLG-FCIEQNHQLL--VYELMKNG 519
A+K + K V + ++ +E+Q++ H LV L F Q+ + + V +L+ G
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF---QDEEDMFMVVDLLLGG 100
Query: 520 TLSAFLFRQEIPTWDKRV-----EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN- 573
L + +Q + ++ V E+ + L YL + +IIH D+KP N+LLD +
Sbjct: 101 DLR-YHLQQNVHFKEETVKLFICELVMA----LDYLQNQ---RIIHRDMKPDNILLDEHG 152
Query: 574 YITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV---TAKVDVYS 630
++ I DF +A +L ++ T+ +TM GT YMAPE + + VD +S
Sbjct: 153 HV--------HITDFNIAAMLPRE-TQITTMA-GTKPYMAPEMFSSRKGAGYSFAVDWWS 202
Query: 631 FGVMLLEIIF 640
GV E++
Sbjct: 203 LGVTAYELLR 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 54/210 (25%)
Query: 452 REATNVFDGQEVEVAVKQLEK----VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN 507
+E + AVK L+K +GE + +E+Q++ R HKN++QL+ +
Sbjct: 22 KEVLDSETLCRR--AVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79
Query: 508 HQ--LLVYELMKNGTLSAF---------------LFRQEIPTWDKRVEIALGIARGLLYL 550
Q +V E G F Q + GL YL
Sbjct: 80 KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ--------------LIDGLEYL 125
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR---G 607
H + I+H DIKP N+LL T+ KI+ G+A+ L R G
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGG-TL------KISALGVAEAL--HPFAADDTCRTSQG 173
Query: 608 TMGYMAPEWLRNAPV--TAKVDVYSFGVML 635
+ + PE KVD++S GV L
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 17/101 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
EI++ L +LH++ II+ D+KP+N++L++ ++ K+ DFGL K
Sbjct: 129 EISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHV--------KLTDFGLCKESIH 173
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
D T T T GT+ YMAPE L + VD +S G ++ +
Sbjct: 174 DGTVTHTFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 57/202 (28%), Positives = 84/202 (41%), Gaps = 49/202 (24%)
Query: 454 ATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
A N + V AVK ++ E +E+ + +H+N+V+ G E N Q L
Sbjct: 26 AVNRVTEEAV--AVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 512 VYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ 557
E G L + F Q + G++YLH
Sbjct: 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ--------------LMAGVVYLHGI---G 125
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR---GTMGYMAP 614
I H DIKP+N+LLD DN KI+DFGLA + + ++ GT+ Y+AP
Sbjct: 126 ITHRDIKPENLLLDER----DN---LKISDFGLATVFR--YNNRERLLNKMCGTLPYVAP 176
Query: 615 EWLRNAPVT-AKVDVYSFGVML 635
E L+ VDV+S G++L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 17/101 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
E+AL L +LH II+ D+KP+N+LLD +I K+ DFGL+K
Sbjct: 134 ELALA----LDHLHSL---GIIYRDLKPENILLDEEGHI--------KLTDFGLSKESID 178
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+ + + GT+ YMAPE + T D +SFGV++ E
Sbjct: 179 HEKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 17/106 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
EI L YLH +++ DIK +N++LD + +I KI DFGL K
Sbjct: 113 EIVSA----LEYLHSR---DVVYRDIKLENLMLDKDGHI--------KITDFGLCKEGIS 157
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK 642
D T GT Y+APE L + VD + GV++ E++ +
Sbjct: 158 DGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 56/183 (30%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL--VYELMKNGT 520
A+K L+K V D L E +V+ + H L L Q H L V E G
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL--KYSFQTHDRLCFVMEYANGGE 234
Query: 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDN 579
L L R+ + + D+ I L YLH E +++ D+K +N++LD + +I
Sbjct: 235 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI---- 288
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII 639
KI DFGL K KD T GT Y+APE L + VD + GV++ E++
Sbjct: 289 ----KITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
Query: 640 FCK 642
+
Sbjct: 344 CGR 346
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 37/101 (36%), Positives = 50/101 (49%), Gaps = 17/101 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
EIA L YLH I++ D+KP+N+LLD+ +I + DFGL K +
Sbjct: 147 EIASA----LGYLHSL---NIVYRDLKPENILLDSQGHI--------VLTDFGLCKENIE 191
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+ TST GT Y+APE L P VD + G +L E
Sbjct: 192 HNSTTSTFC-GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 57/202 (28%), Positives = 84/202 (41%), Gaps = 49/202 (24%)
Query: 454 ATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511
A N + V AVK ++ E +E+ + +H+N+V+ G E N Q L
Sbjct: 26 AVNRVTEEAV--AVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 512 VYELMKNGTL--------------SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ 557
E G L + F Q + G++YLH
Sbjct: 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ--------------LMAGVVYLHGI---G 125
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR---GTMGYMAP 614
I H DIKP+N+LLD DN KI+DFGLA + + ++ GT+ Y+AP
Sbjct: 126 ITHRDIKPENLLLDER----DN---LKISDFGLATVFR--YNNRERLLNKMCGTLPYVAP 176
Query: 615 EWLRNAPVT-AKVDVYSFGVML 635
E L+ VDV+S G++L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 39/101 (38%), Positives = 53/101 (52%), Gaps = 17/101 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
EIA+G L +L + II+ D+K NV+LD+ +I KIADFG+ K
Sbjct: 129 EIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHI--------KIADFGMCKENIW 173
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
D T T GT Y+APE + P VD ++FGV+L E
Sbjct: 174 DGVTTKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 38/101 (37%), Positives = 52/101 (51%), Gaps = 17/101 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
EI+L L YLHE II+ D+K NVLLD+ +I K+ D+G+ K +
Sbjct: 118 EISLA----LNYLHER---GIIYRDLKLDNVLLDSEGHI--------KLTDYGMCKEGLR 162
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
TST GT Y+APE LR VD ++ GV++ E
Sbjct: 163 PGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 21/177 (11%), Positives = 43/177 (24%), Gaps = 43/177 (24%)
Query: 464 EVAVKQLEKVTGDGEKS---FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
+VA+ ++ + L + R + ++L + L+V E ++ G+
Sbjct: 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
L P+ + +A H + P V
Sbjct: 118 LQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVR----------- 161
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
++ G L M + D+ G L
Sbjct: 162 ----VSIDGDVVL-------------AYPATM-------PDANPQDDIRGIGASLYA 194
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 33/206 (16%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE 505
Y E+ EA N+ + ++V VK L+ V +K RE++++ N++ L I
Sbjct: 48 KYSEVFEAINITNNEKV--VVKILKPVK---KKKIKREIKILENLRGGPNIITLA--DIV 100
Query: 506 QNHQ-----LLVYELMKNGTLSAFLFRQEIPTW-DKRVEIAL-GIARGLLYLHEECETQI 558
++ L+ + F+Q T D + + I + L Y H I
Sbjct: 101 KDPVSRTPALVFEHVNNTD------FKQLYQTLTDYDIRFYMYEILKALDYCHSM---GI 151
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
+H D+KP NV++D+ + ++ D+GLA+ Q + + + PE L
Sbjct: 152 MHRDVKPHNVMIDH------EHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLV 203
Query: 619 NAPV-TAKVDVYSFGVMLLEIIFCKR 643
+ + +D++S G ML +IF K
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 17/101 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
EI L++LH++ II+ D+K NVLLD+ + K+ADFG+ K
Sbjct: 132 EIISA----LMFLHDK---GIIYRDLKLDNVLLDHEGHC--------KLADFGMCKEGIC 176
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+ T+T GT Y+APE L+ VD ++ GV+L E
Sbjct: 177 NGVTTATFC-GTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 38/101 (37%), Positives = 52/101 (51%), Gaps = 17/101 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
EI+L L YLHE II+ D+K NVLLD+ +I K+ D+G+ K +
Sbjct: 161 EISLA----LNYLHER---GIIYRDLKLDNVLLDSEGHI--------KLTDYGMCKEGLR 205
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
TST GT Y+APE LR VD ++ GV++ E
Sbjct: 206 PGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 39/101 (38%), Positives = 53/101 (52%), Gaps = 17/101 (16%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
EI LG L +LH + I++ D+K N+LLD + +I KIADFG+ K
Sbjct: 126 EIILG----LQFLHSK---GIVYRDLKLDNILLDKDGHI--------KIADFGMCKENML 170
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+T+T GT Y+APE L VD +SFGV+L E
Sbjct: 171 GDAKTNTFC-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 5e-16
Identities = 38/96 (39%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 543 IARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKKDQTRT 601
IA GL +L + II+ D+K NV+LD+ +I KIADFG+ K D T
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHI--------KIADFGMCKENIWDGVTT 499
Query: 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
T GT Y+APE + P VD ++FGV+L E
Sbjct: 500 KTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 52/203 (25%)
Query: 454 ATNVFDGQEVEVAVKQLEKV----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
+ G +V AVK L + K RE+Q + H ++++L I
Sbjct: 30 GEHQLTGHKV--AVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKLYQ-VISTPTD 85
Query: 510 L-LVYELMKNGTLSAFL--------------FRQEIPTWDKRVEIALGIARGLLYLHEEC 554
+V E + G L ++ F+Q I + Y H
Sbjct: 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ--------------ILSAVDYCHRHM 131
Query: 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RTSTMIRGTMGYMA 613
++H D+KP+NVLLD + N KIADFGL+ ++ + RTS G+ Y A
Sbjct: 132 ---VVHRDLKPENVLLDAH-----MN--AKIADFGLSNMMSDGEFLRTSC---GSPNYAA 178
Query: 614 PEWLRNAPVT-AKVDVYSFGVML 635
PE + +VD++S GV+L
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVIL 201
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 36/198 (18%)
Query: 464 EVAVKQLEKV-----TGDGEKSFLREVQVIGRTHH-----KNLVQLLGF----CIEQNHQ 509
VA+K + + E L+ V T ++++LL H
Sbjct: 46 HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV 105
Query: 510 LLVYELMKNGTLSAFLFRQE---IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQ 566
++V+E++ L A + + E IP + +I+ + GL Y+H C IIH DIKP+
Sbjct: 106 VMVFEVLGE-NLLALIKKYEHRGIPLIYVK-QISKQLLLGLDYMHRRC--GIIHTDIKPE 161
Query: 567 NVLLDNNYITIDNNYITKIADFGLAKLLKKD-----QTRTSTMIRGTMGYMAPEWLRNAP 621
NVL++ + I KIAD G A + QTR Y +PE L AP
Sbjct: 162 NVLMEIVDSPENLIQI-KIADLGNACWYDEHYTNSIQTRE---------YRSPEVLLGAP 211
Query: 622 VTAKVDVYSFGVMLLEII 639
D++S ++ E+I
Sbjct: 212 WGCGADIWSTACLIFELI 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 30/188 (15%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A+K L K + F E ++ + +VQL + + + L +V E M G L
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL 156
Query: 522 SAFLFRQEIPTWDKRV---EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITI 577
+ ++P R E+ L + +H IH D+KP N+LLD + ++
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALD----AIHS---MGFIHRDVKPDNMLLDKSGHL-- 207
Query: 578 DNNYITKIADFGLAK-LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK----VDVYSFG 632
K+ADFG + K+ R T + GT Y++PE L++ D +S G
Sbjct: 208 ------KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 633 VMLLEIIF 640
V L E++
Sbjct: 261 VFLYEMLV 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 48/190 (25%), Positives = 81/190 (42%), Gaps = 31/190 (16%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A+K L K + F E V+ K + L + + ++ L LV + G L
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL 161
Query: 522 SAFLFRQEIPTWDKRV-----EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YI 575
L + E ++ E+ + I +H+ +H DIKP N+L+D N +I
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAID----SVHQL---HYVHRDIKPDNILMDMNGHI 214
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK-----VDVYS 630
++ADFG L +D T S++ GT Y++PE L+ D +S
Sbjct: 215 --------RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 631 FGVMLLEIIF 640
GV + E+++
Sbjct: 267 LGVCMYEMLY 276
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 20/101 (19%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
E+ L + YLH + II+ D+KP+N+LLD N +I KI DFG AK
Sbjct: 114 EVCLALE----YLHSK---DIIYRDLKPENILLDKNGHI--------KITDFGFAK---Y 155
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
T T+ GT Y+APE + P +D +SFG+++ E
Sbjct: 156 VPDVTYTLC-GTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 195
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 51/202 (25%)
Query: 454 ATNVFDGQEVEVAVKQLEKV----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
AT+ Q+V A+K + + + + RE+ + H ++++L I
Sbjct: 28 ATHYKTQQKV--ALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKLYDV-ITTPTD 83
Query: 510 L-LVYE---------LMKNGTLS----AFLFRQEIPTWDKRVEIALGIARGLLYLHEECE 555
+ +V E +++ ++ F+Q I + Y H
Sbjct: 84 IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQ--------------IICAIEYCHRHK- 128
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RTSTMIRGTMGYMAP 614
I+H D+KP+N+LLD+N N KIADFGL+ ++ +TS G+ Y AP
Sbjct: 129 --IVHRDLKPENLLLDDN-----LN--VKIADFGLSNIMTDGNFLKTSC---GSPNYAAP 176
Query: 615 EWLRNAPVT-AKVDVYSFGVML 635
E + +VDV+S G++L
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVL 198
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 38/206 (18%), Positives = 69/206 (33%), Gaps = 74/206 (35%)
Query: 452 REATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFC----IEQ 506
+ N ++ A+K L+ REV++ R + ++V+++ +
Sbjct: 35 LQIFNKRTQEKF--ALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87
Query: 507 NHQLLVYELMKNGTL----------------SAFLFRQEIPTWDKRVEIALGIARGLLYL 550
L+V E + G L ++ + + I + YL
Sbjct: 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS--------------IGEAIQYL 133
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK-LLKKDQTRTSTMIRGTM 609
H I H D+KP+N+L + N I K+ DFG AK +
Sbjct: 134 HSI---NIAHRDVKPENLLYTSK----RPNAILKLTDFGFAKETTGE------------- 173
Query: 610 GYMAPEWLRNAPVTAKVDVYSFGVML 635
Y D++S GV++
Sbjct: 174 KY-----------DKSCDMWSLGVIM 188
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 20/104 (19%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKL-LK 595
EI L L +LH+ II+ DIK +N+LLD+N ++ + DFGL+K +
Sbjct: 167 EIVLA----LEHLHKL---GIIYRDIKLENILLDSNGHV--------VLTDFGLSKEFVA 211
Query: 596 KDQTRTSTMIRGTMGYMAPEWLRNAPV--TAKVDVYSFGVMLLE 637
+ R GT+ YMAP+ +R VD +S GV++ E
Sbjct: 212 DETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 20/101 (19%)
Query: 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YITIDNNYITKIADFGLAKLLKK 596
+I L YLH +I+ D+KP+N+L+D YI ++ DFG AK +
Sbjct: 149 QIVLTFE----YLHSL---DLIYRDLKPENLLIDQQGYI--------QVTDFGFAK---R 190
Query: 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
+ RT T+ GT +APE + + VD ++ GV++ E
Sbjct: 191 VKGRTWTL-CGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 52/203 (25%)
Query: 454 ATNVFDGQEVEVAVKQLEKV----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ 509
+ G +V AVK L + K RE+Q + H ++++L I
Sbjct: 35 GKHELTGHKV--AVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKLYQV-ISTPSD 90
Query: 510 L-LVYELMKNGTLSAFL--------------FRQEIPTWDKRVEIALGIARGLLYLHEEC 554
+ +V E + G L ++ F+Q I G+ Y H
Sbjct: 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ--------------ILSGVDYCHRHM 136
Query: 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RTSTMIRGTMGYMA 613
++H D+KP+NVLLD + N KIADFGL+ ++ + RTS G+ Y A
Sbjct: 137 ---VVHRDLKPENVLLDAH-----MN--AKIADFGLSNMMSDGEFLRTSC---GSPNYAA 183
Query: 614 PEWLRNAPVT-AKVDVYSFGVML 635
PE + +VD++S GV+L
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVIL 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 49/238 (20%), Positives = 99/238 (41%), Gaps = 48/238 (20%)
Query: 432 PSPKPKPPEINM-------KVFSYQELR---EAT--NVFDGQEVE----VAVKQLEKVTG 475
+ P +++ + Y+ + E T V+ + VA+K ++
Sbjct: 13 EAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRL 69
Query: 476 DGEK-----SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEI 530
+ E+ + +REV ++ H+N+++L + L++E +N L ++
Sbjct: 70 EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM----- 123
Query: 531 PTWDKRVEIALG--------IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
DK ++++ + G+ + H + +H D+KPQN+LL + +
Sbjct: 124 ---DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVS--DASETPV 175
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEII 639
KI DFGLA+ R T T+ Y PE L + + VD++S + E++
Sbjct: 176 LKIGDFGLAR-AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 47/231 (20%), Positives = 87/231 (37%), Gaps = 65/231 (28%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL--- 510
++ G+ A+K KV D RE+ ++ H N+++L+ + +
Sbjct: 26 VFDIESGKRF--ALK---KVLQDPRYK-NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79
Query: 511 -----------------------------------LVYELMKNGTLSAFL-----FRQEI 530
++ E + + TL L + I
Sbjct: 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSI 138
Query: 531 PTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589
P + I + + R + ++H I H DIKPQN+L+++ + K+ DFG
Sbjct: 139 P--MNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNS------KDNTLKLCDFG 187
Query: 590 LAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEII 639
AK L + + + + Y APE + A T +D++S G + E+I
Sbjct: 188 SAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 48/192 (25%), Positives = 73/192 (38%), Gaps = 33/192 (17%)
Query: 466 AVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTL 521
A+K + K + F E V+ + + QL F + + L LV E G L
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL 148
Query: 522 SAFLFRQEIPTWDKRV-----EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNN-YI 575
L + + EI + I +H +H DIKP N+LLD +I
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAID----SVHRL---GYVHRDIKPDNILLDRCGHI 201
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY------ 629
++ADFG L+ D T S + GT Y++PE L+ Y
Sbjct: 202 --------RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDW 253
Query: 630 -SFGVMLLEIIF 640
+ GV E+ +
Sbjct: 254 WALGVFAYEMFY 265
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 18/180 (10%)
Query: 465 VAVKQLEKVTGDGE---KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
VA+K+ + D K LRE++++ + H NLV LL + LV+E + T+
Sbjct: 31 VAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV 88
Query: 522 SAFLFRQEIPTWDKRV-EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
L R + + V I + + + H+ IH D+KP+N+L I +
Sbjct: 89 LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENIL-------ITKH 138
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEII 639
+ K+ DFG A+LL + T Y +PE L VDV++ G + E++
Sbjct: 139 SVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 27/202 (13%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCI 504
+ + A + + V A+K+L + + K RE+ ++ +HKN++ LL
Sbjct: 37 AQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94
Query: 505 EQNHQL------LVYELMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQ 557
Q +V ELM + L + + E+ +R+ L + G+ +LH
Sbjct: 95 PQKSLEEFQDVYIVMELM-DANLCQVI-QMEL--DHERMSYLLYQMLCGIKHLHS---AG 147
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617
IIH D+KP N+++ ++ KI DFGLA+ + T T Y APE +
Sbjct: 148 IIHRDLKPSNIVV-------KSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVI 198
Query: 618 RNAPVTAKVDVYSFGVMLLEII 639
VD++S G ++ E+I
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMI 220
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 48/198 (24%)
Query: 527 RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586
++ T + + + +A+G+ +L + IH D+ +N+LL + KI
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVV-------KIC 235
Query: 587 DFGLAKLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII------ 639
DFGLA+ + KD R + +MAPE + + T + DV+SFGV+L EI
Sbjct: 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
Query: 640 ---------FCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCI 690
FC+R E R+ P + Y M L C
Sbjct: 296 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEM------YQT--------------M--LDCW 333
Query: 691 CPQPTLRPSMKQVLQMLE 708
+P+ RP+ ++++ L
Sbjct: 334 HGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 31/127 (24%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 459 DGQEVEVAVKQLEKVTGDGE-KSFLREVQV-IGRTHHKNLVQLLGFCIEQNHQLLV-YEL 515
VAVK L++ E ++ + E+++ I HH N+V LLG C + L+V E
Sbjct: 49 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 108
Query: 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
K G LS +L KR E +G + + I D+K + + ++
Sbjct: 109 CKFGNLSTYL-------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQS 161
Query: 576 TIDNNYI 582
+ + ++
Sbjct: 162 SASSGFV 168
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 22/186 (11%)
Query: 465 VAVKQLEKVTGDGEK-----SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
VA+K +V D + S LRE+ ++ HKN+V+L LV+E
Sbjct: 30 VALK---RVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85
Query: 520 TLSAFLFRQEIPTWDKRV-EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L + + V + +GL + H ++H D+KPQN+L I+
Sbjct: 86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLL-------IN 135
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLE 637
N K+A+FGLA+ R + T+ Y P+ L A + + +D++S G + E
Sbjct: 136 RNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194
Query: 638 IIFCKR 643
+ R
Sbjct: 195 LANAGR 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 34/193 (17%)
Query: 465 VAVKQL----EKVTGDGEKSF----LREV---QVIGRTHHKNLVQLLGFCIEQNHQL--- 510
VA+K + G +REV + + H N+V+L+ C
Sbjct: 37 VALKSVRVPNGG---GGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93
Query: 511 --LVYELMKNGTLSAFLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQ 566
LV+E + L +L + P ++ RGL +LH I+H D+KP+
Sbjct: 94 VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPE 149
Query: 567 NVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKV 626
N+L + + K+ADFGLA++ T ++ T+ Y APE L + V
Sbjct: 150 NIL-------VTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRAPEVLLQSTYATPV 200
Query: 627 DVYSFGVMLLEII 639
D++S G + E+
Sbjct: 201 DMWSVGCIFAEMF 213
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 18/180 (10%)
Query: 465 VAVKQLEKVTGDGE---KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
VA+K+ + D + K +RE++++ + H+NLV LL C ++ LV+E + + T+
Sbjct: 53 VAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110
Query: 522 SAFLFRQEIPTWDKRV-EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
L + V + I G+ + H IIH DIKP+N+L + +
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENIL-------VSQS 160
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEII 639
+ K+ DFG A+ L T Y APE L VDV++ G ++ E+
Sbjct: 161 GVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 465 VAVKQLEKVTGDGEK-----SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
A+K K+ + E + +RE+ ++ H N+V+L + +LV+E +
Sbjct: 29 FALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 520 TLSAFLFRQEIPTWDKRV-EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L L E L + G+ Y H+ +++H D+KPQN+L I+
Sbjct: 86 -LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLL-------IN 134
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLE 637
KIADFGLA+ R T T+ Y AP+ L + + +D++S G + E
Sbjct: 135 REGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
Query: 638 II 639
++
Sbjct: 194 MV 195
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 22/182 (12%)
Query: 465 VAVKQLEKVTGDGEK-----SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
VA+K ++ D E + +RE+ ++ HH N+V L+ + LV+E M+
Sbjct: 48 VALK---RIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD 104
Query: 520 TLSAFLFRQEIPTWDKRV-EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L L + D ++ + RG+ + H+ +I+H D+KPQN+L I+
Sbjct: 105 -LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLL-------IN 153
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLE 637
++ K+ADFGLA+ R+ T T+ Y AP+ L + + VD++S G + E
Sbjct: 154 SDGALKLADFGLAR-AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212
Query: 638 II 639
+I
Sbjct: 213 MI 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 33/202 (16%)
Query: 457 VFDGQEVEVAVKQLEKVTGDGEKSF-----------LREVQVIGRTHHKNLVQLLGFCIE 505
D + + VA+K++ DG LRE++++ HH N++ L +
Sbjct: 41 GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100
Query: 506 QNHQL-----LVYELMKNGT-LSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQI 558
LV ELM T L+ + Q I + ++ I GL LHE +
Sbjct: 101 FEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGV 155
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
+H D+ P N+LL +N I DF LA+ D +T + Y APE +
Sbjct: 156 VHRDLHPGNILL-------ADNNDITICDFNLAREDTADANKTHYVT--HRWYRAPELVM 206
Query: 619 NAPV-TAKVDVYSFGVMLLEII 639
T VD++S G ++ E+
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMF 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 57/252 (22%), Positives = 86/252 (34%), Gaps = 67/252 (26%)
Query: 465 VAVK-----QLEKVTGDGEKSFLREVQVIGRTH--HKNLVQLLG-FCIE---QNHQLLVY 513
VA+K + T E L+ V+ + +VQLL F I H +V+
Sbjct: 65 VAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVF 124
Query: 514 ELMKNGTLSAFLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVLLD 571
E++ + L ++ + +I + +GL YLH +C +IIH DIKP+N+LL
Sbjct: 125 EVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLS 181
Query: 572 NNYITIDNNYI------------------------------------------TKIADFG 589
N I KIAD G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241
Query: 590 LAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEII-----FCKRH 644
A + K T T Y + E L + D++S M E+ F
Sbjct: 242 NACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297
Query: 645 TELHRVDEPTLA 656
E + DE +A
Sbjct: 298 GEEYTRDEDHIA 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 21/181 (11%)
Query: 465 VAVKQLEKVTGDGEKSF----LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
VA+K ++ + E+ +REV ++ H N+V L + LV+E +
Sbjct: 30 VALK---EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 85
Query: 521 LSAFLFRQEIPTWDKRVEIALG-IARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579
L +L V++ L + RGL Y H + +++H D+KPQN+L I+
Sbjct: 86 LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLL-------INE 135
Query: 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEI 638
K+ADFGLA+ K T+T T+ Y P+ L + + ++D++ G + E+
Sbjct: 136 RGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 194
Query: 639 I 639
Sbjct: 195 A 195
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 47/192 (24%), Positives = 83/192 (43%), Gaps = 27/192 (14%)
Query: 464 EVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQL-LVYELMKNGT 520
+ A+KQ+E G S RE+ ++ H N++ L + + ++ L+++ ++
Sbjct: 50 DYALKQIEG---TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDL 106
Query: 521 LSAFLFRQEIPTWDKRVEIALG--------IARGLLYLHEECETQIIHCDIKPQNVLLDN 572
F + K V++ G I G+ YLH ++H D+KP N+L+
Sbjct: 107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMG 163
Query: 573 NYITIDNNYITKIADFGLAKL----LKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVD 627
KIAD G A+L LK ++ T Y APE L A T +D
Sbjct: 164 EG---PERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPELLLGARHYTKAID 218
Query: 628 VYSFGVMLLEII 639
+++ G + E++
Sbjct: 219 IWAIGCIFAELL 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 51/190 (26%), Positives = 89/190 (46%), Gaps = 31/190 (16%)
Query: 465 VAVKQLEKVTGDGEK-----SFLREV---QVIGRTHHKNLVQLL----GFCIEQNHQL-L 511
VA+K +V + S +REV + + H N+V+L ++ +L L
Sbjct: 40 VALK---RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 512 VYELMKNGTLSAFLFRQEIPTWDKRV--EIALGIARGLLYLHEECETQIIHCDIKPQNVL 569
V+E + L+ +L + P ++ + RGL +LH ++H D+KPQN+L
Sbjct: 97 VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 152
Query: 570 LDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY 629
+ ++ K+ADFGLA++ TS ++ T+ Y APE L + VD++
Sbjct: 153 -------VTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLW 203
Query: 630 SFGVMLLEII 639
S G + E+
Sbjct: 204 SVGCIFAEMF 213
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 26/186 (13%)
Query: 465 VAVKQLEKVTGDGEKSF----LREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520
VA+K +V D E+ +RE+ ++ H+N+V+L +N LV+E M +
Sbjct: 33 VALK---EVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DND 88
Query: 521 LSAFLFRQEIPTWDKRVEIALG------IARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
L ++ + + + +E+ L + +GL + HE +I+H D+KPQN+L
Sbjct: 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLL----- 140
Query: 575 ITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGV 633
I+ K+ DFGLA+ T + T+ Y AP+ L + + +D++S G
Sbjct: 141 --INKRGQLKLGDFGLAR-AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGC 197
Query: 634 MLLEII 639
+L E+I
Sbjct: 198 ILAEMI 203
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 40/208 (19%)
Query: 456 NVFDGQEVE----VAVKQLEKVTGDGEK-SF----LREVQVIGRTHHKNLVQLLGFCIEQ 506
VF + + VA+K KV + EK F LRE++++ H+N+V L+ C +
Sbjct: 32 EVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88
Query: 507 NHQL--------LVYELMKNGTLSAFLFRQEIPTWDKRV-EIALGIARGLLYLHEECETQ 557
LV++ ++ L+ L + + + + GL Y+H +
Sbjct: 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---K 144
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL---KKDQTR--TSTMIRGTMGYM 612
I+H D+K NVL I + + K+ADFGLA+ K Q T+ ++ T+ Y
Sbjct: 145 ILHRDMKAANVL-------ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--TLWYR 195
Query: 613 APEWLRNAPV-TAKVDVYSFGVMLLEII 639
PE L +D++ G ++ E+
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMW 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 47/226 (20%), Positives = 84/226 (37%), Gaps = 70/226 (30%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGE---KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL 510
A + + V A+K K+ K LRE+++I R H N+V++ QL
Sbjct: 30 AVDNDCDKRV--AIK---KIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 511 --------------LVYELM--------KNGTLSA----FLFRQEIPTWDKRVEIALGIA 544
+V E M + G L Q +
Sbjct: 85 TDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ--------------LL 130
Query: 545 RGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604
RGL Y+H ++H D+KP N+ ++ + + KI DFGLA+++ + +
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINT------EDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 605 IRGTMGYMAPEWLRNAP--------VTAKVDVYSFGVMLLEIIFCK 642
+ +W R +P T +D+++ G + E++ K
Sbjct: 182 ----SEGLVTKWYR-SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 27/195 (13%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLL-----GFCIEQ 506
A + + V A+K+L + + K RE+ ++ +HKN++ LL +E+
Sbjct: 81 AYDAVLDRNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138
Query: 507 NHQL-LVYELMKNGTLSAFLFRQEIPTWDKRVEIAL-GIARGLLYLHEECETQIIHCDIK 564
+ LV ELM + + E+ +R+ L + G+ +LH IIH D+K
Sbjct: 139 FQDVYLVMELM--DANLCQVIQMEL--DHERMSYLLYQMLCGIKHLHS---AGIIHRDLK 191
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTA 624
P N+++ ++ KI DFGLA+ + T T Y APE +
Sbjct: 192 PSNIVV-------KSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKE 242
Query: 625 KVDVYSFGVMLLEII 639
VD++S G ++ E++
Sbjct: 243 NVDIWSVGCIMGEMV 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 43/177 (24%)
Query: 478 EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLV--------YELMKNGT---LSAFLF 526
E L ++ + + N++ +L +NH + YEL+K S L
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLV 202
Query: 527 RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586
R+ A I + L LH+ +IIHCD+KP+N+LL + I K+
Sbjct: 203 RK----------FAHSILQCLDALHKN---RIIHCDLKPENILLKQQ----GRSGI-KVI 244
Query: 587 DFGLAKLLKKD-----QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEI 638
DFG + + Q+R Y APE + A +D++S G +L E+
Sbjct: 245 DFGSSCYEHQRVYTYIQSRF---------YRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 51/216 (23%)
Query: 447 SYQELREATNVFDGQEVEVAVKQL---EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGF- 502
+Y + A + + V A+K++ E T + LRE++++ R H+N++ +
Sbjct: 39 AYGMVCSAYDNLNKVRV--AIKKISPFEHQT-YC-QRTLREIKILLRFRHENIIGINDII 94
Query: 503 ---CIEQNHQL-LVYELM--------KNGTLS----AFLFRQEIPTWDKRVEIALGIARG 546
IEQ + +V +LM K LS + Q I RG
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ--------------ILRG 140
Query: 547 LLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606
L Y+H ++H D+KP N+LL + KI DFGLA++ D T +
Sbjct: 141 LKYIHS---ANVLHRDLKPSNLLL-------NTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 607 --GTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEII 639
T Y APE + N+ T +D++S G +L E++
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 30/203 (14%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLL---- 500
+Y + A + G++V A+K+L + K RE+ ++ H+N++ LL
Sbjct: 36 AYGSVCSAIDKRSGEKV--AIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93
Query: 501 -GFCIEQNHQL-LVYELMKNGT-LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ 557
+ + LV M T L + + + +K + + +GL Y+H
Sbjct: 94 PASSLRNFYDFYLVMPFM--QTDLQKIM-GLKF-SEEKIQYLVYQMLKGLKYIHS---AG 146
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617
++H D+KP N+ + + + KI DFGLA+ + T T Y APE +
Sbjct: 147 VVHRDLKPGNLAV-------NEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVI 195
Query: 618 RNAPV-TAKVDVYSFGVMLLEII 639
+ VD++S G ++ E++
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEML 218
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 27/202 (13%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCI 504
+Y + A + G +V A+K+L + K RE++++ H+N++ LL
Sbjct: 37 AYGAVCSAVDGRTGAKV--AIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94
Query: 505 EQNHQL------LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558
LV M L + +++ D+ + + +GL Y+H I
Sbjct: 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKL-GEDRIQFLVYQMLKGLRYIHA---AGI 149
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
IH D+KP N+ + + + KI DFGLA+ + T T Y APE +
Sbjct: 150 IHRDLKPGNLAV-------NEDCELKILDFGLARQADSEMTGYVV----TRWYRAPEVIL 198
Query: 619 NAPV-TAKVDVYSFGVMLLEII 639
N T VD++S G ++ E+I
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMI 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 21/183 (11%)
Query: 465 VAVKQLEKVTGDGEK-----SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
VA+K+++ K + LRE++++ H N++ LL +++ LV++ M+
Sbjct: 38 VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD 97
Query: 520 TLSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L + + ++ L +GL YLH+ I+H D+KP N+L +D
Sbjct: 98 -LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLL-------LD 146
Query: 579 NNYITKIADFGLAKLL-KKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLL 636
N + K+ADFGLAK ++ T ++ T Y APE L A + VD+++ G +L
Sbjct: 147 ENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELLFGARMYGVGVDMWAVGCILA 204
Query: 637 EII 639
E++
Sbjct: 205 ELL 207
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 47/176 (26%), Positives = 71/176 (40%), Gaps = 41/176 (23%)
Query: 478 EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM---------KNGT--LSAFLF 526
E L + +V L + +NH LV+E++ +S L
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLT 159
Query: 527 RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586
R+ A + LL+L E IIHCD+KP+N+LL N + I KI
Sbjct: 160 RK----------FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP----KRSAI-KIV 203
Query: 587 DFGLAKLLKKD-----QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
DFG + L + Q+R Y +PE L P +D++S G +L+E
Sbjct: 204 DFGSSCQLGQRIYQYIQSRF---------YRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 51/214 (23%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLL---- 500
+Y + A + G V AVK+L + K RE++++ H+N++ LL
Sbjct: 41 AYGSVCAAFDTKTGLRV--AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98
Query: 501 -GFCIEQNHQL-LVYELM--------KNGTLS----AFLFRQEIPTWDKRVEIALGIARG 546
+E+ + + LV LM K L+ FL Q I RG
Sbjct: 99 PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------------ILRG 144
Query: 547 LLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIR 606
L Y+H IIH D+KP N+ + + + KI DFGLA+ + T
Sbjct: 145 LKYIHS---ADIIHRDLKPSNLAV-------NEDCELKILDFGLARHTADEMTGYVA--- 191
Query: 607 GTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEII 639
T Y APE + N VD++S G ++ E++
Sbjct: 192 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 40/185 (21%), Positives = 73/185 (39%), Gaps = 51/185 (27%)
Query: 482 LREVQVIGRTHHKNLVQLLGFCIEQNHQL-----LVYELM--------KNGTLSA----F 524
LRE++++ H+N++ + + + ++ ELM LS +
Sbjct: 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584
Q R + LH + +IH D+KP N+L+ ++N K
Sbjct: 117 FIYQ--------------TLRAVKVLHG---SNVIHRDLKPSNLLI-------NSNCDLK 152
Query: 585 IADFGLAKLLKKDQTRTSTMIRG---------TMGYMAPEWLRNAPV-TAKVDVYSFGVM 634
+ DFGLA+++ + S T Y APE + + + +DV+S G +
Sbjct: 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212
Query: 635 LLEII 639
L E+
Sbjct: 213 LAELF 217
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 46/206 (22%), Positives = 85/206 (41%), Gaps = 44/206 (21%)
Query: 465 VAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-----LVYELMK 517
VA+K++ ++ D K LRE+ ++ R +++L I + +V E+
Sbjct: 54 VAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA- 112
Query: 518 NGT-LSAFLFRQEIPTWDKRVE-IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
+ L LF+ I ++ ++ I + G ++HE + IIH D+KP N LL
Sbjct: 113 -DSDLKK-LFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLL----- 162
Query: 576 TIDNNYITKIADFGLAKLLKKDQTRTSTMIRG---------------------TMGYMAP 614
+ + K+ DFGLA+ + ++ T Y AP
Sbjct: 163 --NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220
Query: 615 EWLRNAPV-TAKVDVYSFGVMLLEII 639
E + T +D++S G + E++
Sbjct: 221 ELILLQENYTKSIDIWSTGCIFAELL 246
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 73/233 (31%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCI----EQN 507
A + + + V A+K++ +V D K LRE+ ++ R +H ++V++L I E+
Sbjct: 72 AYDKLEKRVV--AIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129
Query: 508 HQL-LVYELM---------KNGTLSA----FLFRQEIPTWDKRVEIALGIARGLLYLHEE 553
+L +V E+ L+ L + G+ Y+H
Sbjct: 130 DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN--------------LLVGVKYVHS- 174
Query: 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG--- 610
I+H D+KP N L ++ + K+ DFGLA+ + + S +
Sbjct: 175 --AGILHRDLKPANCL-------VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 611 -----------------------YMAPEWLRNAPV-TAKVDVYSFGVMLLEII 639
Y APE + T +DV+S G + E++
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 47/227 (20%), Positives = 88/227 (38%), Gaps = 64/227 (28%)
Query: 454 ATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGR-THHKNLVQLLG-FCIEQNHQ 509
+ + G+ V AVK++ + + RE+ ++ + H+N+V LL + +
Sbjct: 28 SIDRRTGEVV--AVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85
Query: 510 L-LVYELM--------KNGTLSA----FLFRQEIPTWDKRVEIALGIARGLLYLHEECET 556
+ LV++ M + L ++ Q + + + YLH
Sbjct: 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--------------LIKVIKYLHS---G 128
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG------ 610
++H D+KP N+LL + K+ADFGL++ + T+ +
Sbjct: 129 GLLHRDMKPSNILL-------NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 611 --------------YMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCK 642
Y APE L + T +D++S G +L EI+ K
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 39/180 (21%), Positives = 68/180 (37%), Gaps = 34/180 (18%)
Query: 478 EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLV--------YELMKNGTLSAFLFRQE 529
E + L++++ + + V + + H + +E +K +
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPY----- 120
Query: 530 IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT------ 583
P R +A + L +LHE Q+ H D+KP+N+L N+ N
Sbjct: 121 -PLPHVR-HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 584 ------KIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
++ADFG A D +T++ T Y PE + DV+S G +L E
Sbjct: 176 VKNTSIRVADFGSATF---DHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 40/174 (22%), Positives = 62/174 (35%), Gaps = 48/174 (27%)
Query: 494 KNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF-------RQEIPTWDKRVEIALGIARG 546
N+V+ G + +H L++E L L+ D + + I +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEP-----LGPSLYEIITRNNYNGFHIEDIK-LYCIEILKA 149
Query: 547 LLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT------------------KIADF 588
L YL + + H D+KP+N+LLD+ Y + K+ DF
Sbjct: 150 LNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 589 GLAKLLKKD-----QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLE 637
G A TR Y APE + N D++SFG +L E
Sbjct: 207 GCATFKSDYHGSIINTRQ---------YRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 40/184 (21%), Positives = 64/184 (34%), Gaps = 42/184 (22%)
Query: 478 EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF-------RQEI 530
E L + VQ+L + H +V+EL L +
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL-----LGLSTYDFIKENGFLPF 115
Query: 531 PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT------- 583
R ++A I + + +LH ++ H D+KP+N+L + T N
Sbjct: 116 RLDHIR-KMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 584 -----KIADFGLAKLLKKD-----QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGV 633
K+ DFG A + TR Y APE + + DV+S G
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTRH---------YRAPEVILALGWSQPCDVWSIGC 222
Query: 634 MLLE 637
+L+E
Sbjct: 223 ILIE 226
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.3 bits (129), Expect = 4e-08
Identities = 33/241 (13%), Positives = 67/241 (27%), Gaps = 46/241 (19%)
Query: 19 SLPQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYP---LVSGLFLVGIWFDKISERTL 75
+ T+ + + AG S + F LV +W +
Sbjct: 8 PFNGVGTSVLPAYQTLSAG--QYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFS 65
Query: 76 VWSANRDDPAQVGSSIN----LTVTGQLVLTHSNGTQFKIYNGTLTVSALMQDSGNFLYS 131
R+ A + + L + + ++ + F + ++QD GN +
Sbjct: 66 STIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLV 125
Query: 132 NANGSVD----------------------------YSTGRFVLEIQMDGNVVLSAFRFAD 163
++ + Y G L Q DGN+V +
Sbjct: 126 DSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVA--YGPNG 183
Query: 164 PAYWYTSTRGDQNVSLIFNQSTSF-LYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGN 222
A W T+G V +F + +Y + + T + + +G+
Sbjct: 184 AATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS------AVLRLQANGS 237
Query: 223 F 223
Sbjct: 238 I 238
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 28/179 (15%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHH-KNLVQLLGFCIE 505
++ ELR N++ + V A+K LE + E + + + Q+ F
Sbjct: 21 NFGELRLGKNLYTNEYV--AIK-LEPMKSRA-PQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKR--VEIALGIARGLL----YLHEECETQII 559
+ +V EL+ G LF D+ ++ L IA L+ Y+H + +I
Sbjct: 77 GKYNAMVLELL--GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LI 127
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT------RTSTMIRGTMGYM 612
+ D+KP+N L+ I I DF LAK +T R + GT YM
Sbjct: 128 YRDVKPENFLIGRPG-NKTQQVIHII-DFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 7e-07
Identities = 36/223 (16%), Positives = 67/223 (30%), Gaps = 14/223 (6%)
Query: 430 VQPSPKPKPPEINMKVFSYQELREATNVFDGQEVEVA-VKQLEKVTGDGEKSFLREVQVI 488
V S + EI ++ +EL + + + + V G L+
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 489 GRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLL 548
T + F +Q +L +E G + R ++ + I + L
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFE---FGGIDLEQMRTKLSSLATAKSILHQLTASLA 175
Query: 549 YLHEECETQIIHCDIKPQNVLLDNNYIT----IDNNYITKIADFGLAKLLKKDQTRTSTM 604
+ H D+ NVLL + N + I GL ++ D T +
Sbjct: 176 VAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL-QVSIIDYTLSRLE 232
Query: 605 IRGTMGYM---APEWLRNAPVTAKVDVYSFGVMLLEIIFCKRH 644
G + + E L + D+Y + + H
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYH 275
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-06
Identities = 23/83 (27%), Positives = 33/83 (39%), Gaps = 13/83 (15%)
Query: 97 GQLVLTHSNGTQF--KIYNGTLTVSALMQDSGNF-LYSNANGSVDYS-----TGRFVLEI 148
LVL +N + A++Q G + +N N +V S G +VL +
Sbjct: 40 CNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVL 99
Query: 149 QMDGNVVLSAFRFADPAYWYTST 171
Q D NVV+ A W T T
Sbjct: 100 QPDRNVVIY-----GDALWATQT 117
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-05
Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 3/82 (3%)
Query: 113 NGTLTVSALMQDSGNFLYSNANGSVDYSTGRFVLEIQMDGNVVLSAFRFADPAYWYTSTR 172
N + + L++ + + + T + +Q D N+VL + W T+T
Sbjct: 1 NNIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVL---YDNNNPIWATNTG 57
Query: 173 GDQNVSLIFNQSTSFLYVRNKT 194
G N Q L V
Sbjct: 58 GLGNGCRAVLQPDGVLVVITNE 79
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-06
Identities = 18/85 (21%), Positives = 29/85 (34%), Gaps = 13/85 (15%)
Query: 97 GQLVLTHSNGTQFKI--YNGTLTVSALMQDSGNFLYSNANGSVDYST------GRFVLEI 148
LVL + + MQ GN + + + +++ G +V +
Sbjct: 29 CNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVL 88
Query: 149 QMDGNVVLSAFRFADPAYWYTSTRG 173
Q D NVV+ A W T T
Sbjct: 89 QKDRNVVIY-----GTARWATGTNI 108
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-06
Identities = 15/89 (16%), Positives = 26/89 (29%), Gaps = 13/89 (14%)
Query: 97 GQLVLTHSNGTQF--KIYNGTLTVSALMQDSGNFLYSNANGSV------DYSTGRFVLEI 148
LV + + + GN + + N + G++ L +
Sbjct: 30 CNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVL 89
Query: 149 QMDGNVVLSAFRFADPAYWYTSTRGDQNV 177
Q DG V+ P W G + V
Sbjct: 90 QKDGRFVIY-----GPVLWSLGPNGCRRV 113
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 9e-06
Identities = 21/97 (21%), Positives = 34/97 (35%), Gaps = 15/97 (15%)
Query: 87 VGSSINLTVT--GQLVLTHSNGTQF--KIYNGTLTVSALMQDSGNFLYSNANGSVDYST- 141
VG S L + VL S + + ++GN + + + V + T
Sbjct: 18 VGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK 77
Query: 142 -----GRFVLEIQMDGNVVLSAFRFADPAYWYTSTRG 173
+VL +Q D NVV+ P W T +
Sbjct: 78 TNGKEDHYVLVLQQDRNVVIY-----GPVVWATGSGP 109
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 45/209 (21%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLV-QLLGFCIE 505
S+ + E TN+ + Q+V A+K E D E + + + F E
Sbjct: 22 SFGVIFEGTNLLNNQQV--AIKF-EPRRSDA-PQLRDEYRTYKLLAGCTGIPNVYYFGQE 77
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKR--VEIALGIARGLL----YLHEECETQII 559
H +LV +L+ G L ++ V+ A+ +L +HE+ ++
Sbjct: 78 GLHNVLVIDLL--GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LV 128
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT------RTSTMIRGTMGYMA 613
+ DIKP N L+ + + N I + DFG+ K + T R + GT YM+
Sbjct: 129 YRDIKPDNFLIGRPN-SKNANMIYVV-DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 614 PEWLRNAPVTAKVDVYSFGVMLLEIIFCK 642
+ + D+ + G + + F +
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMY--FLR 213
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 44/204 (21%), Positives = 80/204 (39%), Gaps = 30/204 (14%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDG-----EKSFLREVQVIGRTHHKNLVQLLG 501
S+ ++ T++ G+EV A+K E V E + +Q + +
Sbjct: 21 SFGDIYLGTDIAAGEEV--AIKL-ECVKTKHPQLHIESKIYKMMQ-----GGVGIPTIRW 72
Query: 502 FCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQII 559
E ++ ++V EL+ G LF + + + +A + + Y+H I
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFI 127
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT------RTSTMIRGTMGYMA 613
H D+KP N L+ + I DFGLAK + +T R + + GT Y +
Sbjct: 128 HRDVKPDNFLMGLG----KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 614 PEWLRNAPVTAKVDVYSFGVMLLE 637
+ + D+ S G +L+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMY 207
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-05
Identities = 20/85 (23%), Positives = 32/85 (37%), Gaps = 15/85 (17%)
Query: 97 GQLVLTHSNGTQFKIYNGTL----TVSALMQDSGNF-LYSNANGSV-----DYSTGRFVL 146
LVLT + T +GT + SG + + +V G +VL
Sbjct: 34 CNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVL 93
Query: 147 EIQMDGNVVLSAFRFADPAYWYTST 171
+Q++G V+ PA W T+
Sbjct: 94 ILQINGQAVVY-----GPAVWSTAA 113
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 20/95 (21%), Positives = 30/95 (31%), Gaps = 28/95 (29%)
Query: 77 WSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNGTLTVSALMQDSGNFLYSNANGS 136
W++N + G L G V+ + G S++
Sbjct: 41 WASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLW-------------------ASHSVR- 80
Query: 137 VDYSTGRFVLEIQMDGNVVLSAFRFADPAYWYTST 171
G +VL +Q DGNVV+ W T T
Sbjct: 81 ---GNGNYVLVLQEDGNVVIY-----GSDIWSTGT 107
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-05
Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 9/82 (10%)
Query: 97 GQLVLTHSNGTQF--KIYNGTLTVSALMQDSGNFLYSNANGSV-----DYSTGRFVLEIQ 149
LVL +N + MQ+ GN + + + ++ + G + L +Q
Sbjct: 29 CNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQ 88
Query: 150 MDGNVVLSAFRFADPAYWYTST 171
D NVV+ + ++ A W T T
Sbjct: 89 RDRNVVI--YDNSNNAIWATHT 108
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 18/99 (18%), Positives = 37/99 (37%), Gaps = 11/99 (11%)
Query: 125 SGNFLYSNANGSVDYSTGRFVLEIQMDGNVVLSAFRFADPAYWYTSTRGDQNVSLIFNQS 184
SG+ L + + + G ++ IQ D N+VL + A W + T G + ++ Q+
Sbjct: 6 SGHQLDTGGS----LAEGGYLFIIQNDCNLVL---YDNNRAVWASGTNGKASGCVLKMQN 58
Query: 185 TSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNF 223
L + + + + T + + N
Sbjct: 59 DGNLVIYSGSRAIWASNTNRQNGN----YYLILQRDRNV 93
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 47/211 (22%), Positives = 81/211 (38%), Gaps = 32/211 (15%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDG-----EKSFLREVQVIGRTHHKNLVQLLG 501
S+ E+ TN+ +EV A+K E V E R +Q + +
Sbjct: 19 SFGEIYLGTNIQTNEEV--AIKL-ENVKTKHPQLLYESKIYRILQ-----GGTGIPNVRW 70
Query: 502 FCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKR--VEIALGIARGLLYLHEECETQII 559
F +E ++ +LV +L+ G LF + + +A + + ++H + +
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT------RTSTMIRGTMGYMA 613
H DIKP N L+ I DFGLAK + T R + + GT Y +
Sbjct: 126 HRDIKPDNFLMGLG----RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 614 PEWLRNAPVTAKVDVYSFGVMLLEIIFCKRH 644
+ + D+ S G +L+ F +
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMY--FLRGS 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 16/70 (22%), Positives = 28/70 (40%), Gaps = 14/70 (20%)
Query: 549 YLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT------RTS 602
Y+HE +H DIK N+LL + + + +AD+GL+ +
Sbjct: 166 YIHENE---YVHGDIKAANLLLGYK----NPDQVY-LADYGLSYRYCPNGNHKQYQENPR 217
Query: 603 TMIRGTMGYM 612
GT+ +
Sbjct: 218 KGHNGTIEFT 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 16/70 (22%), Positives = 28/70 (40%), Gaps = 14/70 (20%)
Query: 549 YLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT------RTS 602
Y+HE +H DIK N+LL+ + + + + D+GLA +
Sbjct: 167 YIHEHE---YVHGDIKASNLLLNYK----NPDQVY-LVDYGLAYRYCPEGVHKAYAADPK 218
Query: 603 TMIRGTMGYM 612
GT+ +
Sbjct: 219 RCHDGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 12/70 (17%), Positives = 28/70 (40%), Gaps = 14/70 (20%)
Query: 549 YLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT------RTS 602
+LHE +H ++ +N+ +D D + +T +A +G A +
Sbjct: 174 FLHENE---YVHGNVTAENIFVDPE----DQSQVT-LAGYGFAFRYCPSGKHVAYVEGSR 225
Query: 603 TMIRGTMGYM 612
+ G + ++
Sbjct: 226 SPHEGDLEFI 235
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 3e-04
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 12/86 (13%)
Query: 93 LTVTGQLVLTHSNGT-QFKIYNGTLTVSALMQDSGNF-LYSNANGSV-----DYSTGRFV 145
+ LVL Q + + G + + ++ G +V
Sbjct: 30 MQGDCNLVLYGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYV 89
Query: 146 LEIQMDGNVVLSAFRFADPAYWYTST 171
L +Q DG V+ PA + TS+
Sbjct: 90 LILQDDGFGVIY-----GPAIFETSS 110
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 5e-04
Identities = 21/162 (12%), Positives = 47/162 (29%), Gaps = 22/162 (13%)
Query: 16 SFCSLPQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTL 75
L + + + + ++ + G ++ + ++
Sbjct: 88 GNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSI---------LYSTQGNDNHP 138
Query: 76 VWSANRDDPAQVGSSINLTVTGQLVLTHSNGT--QFKIYNGTLTVSALMQDSGNF-LYSN 132
+++ LVL + A++Q +G + +N
Sbjct: 139 QTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN 198
Query: 133 ANGSV-----DYSTGRFVLEIQMDGNVVLSAFRFADPAYWYT 169
N +V S GR+V +Q D N+ + A W T
Sbjct: 199 QNIAVWTSGNSRSAGRYVFVLQPDRNLAIY-----GGALWTT 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 725 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.98 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.98 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.82 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.74 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.7 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.66 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.59 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.57 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.56 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.54 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.45 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.44 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.4 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.23 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.1 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.09 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.05 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 98.97 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 98.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.77 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.76 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.56 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.54 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.49 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.48 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.46 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.38 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.31 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.19 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.04 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 97.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.29 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.09 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.85 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.62 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 93.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.16 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 88.74 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 81.59 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=404.73 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=199.8
Q ss_pred cccccHHHHHHHhccc---CCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 443 MKVFSYQELREATNVF---DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
+...+|++|++|...- ...+..||||.++....+..++|.+|+++|++++|||||+++|+|.+++..+||||||++|
T Consensus 49 LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G 128 (329)
T 4aoj_A 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 128 (329)
T ss_dssp EEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred EccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 3456788888886432 2356789999998777777789999999999999999999999999999999999999999
Q ss_pred ChhhhhccC---------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceE
Q 039817 520 TLSAFLFRQ---------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584 (725)
Q Consensus 520 sL~~~l~~~---------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~k 584 (725)
+|.+++.+. ..++|.++++|+.|||+||.|||+. +|+||||||+||||+. ++.+|
T Consensus 129 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~-------~~~~K 198 (329)
T 4aoj_A 129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ-------GLVVK 198 (329)
T ss_dssp BHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET-------TTEEE
T ss_pred cHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC-------CCcEE
Confidence 999999653 3589999999999999999999998 9999999999999987 88999
Q ss_pred EeeccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchH
Q 039817 585 IADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILT 662 (725)
Q Consensus 585 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~ 662 (725)
|+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||..... ....
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~ 270 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEAI 270 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHHH
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence 9999999976443322 2334569999999999999999999999999999999999 8999864321 1111
Q ss_pred HHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 663 DWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
..+.. -.....+...++.+.+|+.+||+.||++||||+||+++|+.+.+
T Consensus 271 ~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111 11234555678899999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=400.37 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=204.5
Q ss_pred ccccHHHHHHHhccc---CCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVF---DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.... ...+..||||.++....+..++|.+|+++|++++|||||+++|+|.+++..+||||||++|+
T Consensus 22 G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~ 101 (299)
T 4asz_A 22 GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 101 (299)
T ss_dssp EC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCc
Confidence 456778888876432 23467899999987766777899999999999999999999999999999999999999999
Q ss_pred hhhhhccC-------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 521 LSAFLFRQ-------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 521 L~~~l~~~-------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
|.++|.+. ..++|.++.+|+.|||+||.|||++ +|+||||||+||||+. ++.+||+|
T Consensus 102 L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~-------~~~~Ki~D 171 (299)
T 4asz_A 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE-------NLLVKIGD 171 (299)
T ss_dssp HHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GGCEEECC
T ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECC-------CCcEEECC
Confidence 99999653 3689999999999999999999999 9999999999999987 88999999
Q ss_pred ccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHH
Q 039817 588 FGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWV 665 (725)
Q Consensus 588 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 665 (725)
||+++........ ......||+.|||||.+.+..++.|+|||||||+||||+| |+.||..... .+ +
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----------~~-~ 239 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----------NE-V 239 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HH-H
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------HH-H
Confidence 9999876543332 2233568999999999999999999999999999999998 8999864321 11 1
Q ss_pred HHHHHc---CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 666 LYCVRT---GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 666 ~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
...... ...+...++.+.+|+.+||+.||++||||+||++.|+++.+
T Consensus 240 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 240 IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 122222 23455678899999999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=396.53 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=202.4
Q ss_pred ccccHHHHHHHhccc---CCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 444 KVFSYQELREATNVF---DGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~---~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...+|++|++|...- ...+..||||.++.. .....++|.+|+.++++++|||||+++|+|.+++..+||||||++|
T Consensus 35 G~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G 114 (308)
T 4gt4_A 35 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHG 114 (308)
T ss_dssp EECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSC
T ss_pred ccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCC
Confidence 456788888876422 234578999999654 3345678999999999999999999999999999999999999999
Q ss_pred ChhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCce
Q 039817 520 TLSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583 (725)
Q Consensus 520 sL~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~ 583 (725)
+|.++|... ..++|..+.+|+.|||+||+|||+. +||||||||+||||++ ++.+
T Consensus 115 ~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~-------~~~~ 184 (308)
T 4gt4_A 115 DLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD-------KLNV 184 (308)
T ss_dssp BHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GGCE
T ss_pred cHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC-------CCCE
Confidence 999999643 3589999999999999999999999 9999999999999987 8899
Q ss_pred EEeeccCccccCcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcch
Q 039817 584 KIADFGLAKLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMIL 661 (725)
Q Consensus 584 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~ 661 (725)
||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----------- 253 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----------- 253 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----------
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----------
Confidence 9999999987644332 22334569999999999999999999999999999999998 7888864321
Q ss_pred HHHHHHHHHcC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 662 TDWVLYCVRTG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 662 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
.+ +......+ ..+...++.+.+|+.+||+.||++||||+||+++|+...++
T Consensus 254 ~~-~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 254 QD-VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp HH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred HH-HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 11 12222222 34556788999999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=387.24 Aligned_cols=246 Identities=27% Similarity=0.380 Sum_probs=193.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|++|++|+.. ..||||.++.. ..+..++|.+|++++++++|||||+++|+|.+ +..+||||||++|+|
T Consensus 45 G~G~fG~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL 118 (307)
T 3omv_A 45 GSGSFGTVYKGKWH-----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSL 118 (307)
T ss_dssp CCCSSSEEEEEESS-----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBH
T ss_pred eeCCCcEEEEEEEC-----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCH
Confidence 45677888877532 24788887643 33445789999999999999999999999865 568999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT- 599 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~- 599 (725)
.++|... ..++|.++..|+.|||+||+|||+. +||||||||+||||+. ++.+||+|||+|+.......
T Consensus 119 ~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~-------~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 119 YKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHE-------GLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp HHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEET-------TEEEEECCCSSCBC-------
T ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECC-------CCcEEEeeccCceecccCCcc
Confidence 9999765 5799999999999999999999998 9999999999999987 88999999999987654322
Q ss_pred ccccccccCccccchhcccC---CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----
Q 039817 600 RTSTMIRGTMGYMAPEWLRN---APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG---- 672 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 672 (725)
.......||+.|||||++.+ .+++.|+|||||||+||||+||+.||...... ..+......+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-----------~~~~~~~~~~~~~p 257 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-----------DQIIFMVGRGYASP 257 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----------HHHHHHHHTTCCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-----------HHHHHHHhcCCCCC
Confidence 22344679999999999863 46899999999999999999999999643211 1111112111
Q ss_pred ---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 039817 673 ---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPP 717 (725)
Q Consensus 673 ---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~p~ 717 (725)
..+...++.+.+|+.+||+.||++||||.||+++|+.+. .+.|.
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~-~~lpk 304 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ-HSLPK 304 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH-TTCCC
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh-ccCCC
Confidence 223456788999999999999999999999999998653 34444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=381.98 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=200.7
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+...+|+.|++|.+..++ ..||||.+........+.+.+|+++|++++|||||++++++.+++..+||||||++|+|.
T Consensus 82 iG~G~fG~V~~a~~~~tg--~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 159 (346)
T 4fih_A 82 IGEGSTGIVCIATVRSSG--KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159 (346)
T ss_dssp EEECSSCEEEEEEETTTC--CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred eecCcCeEEEEEEECCCC--CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence 345678888888877655 578999887666666778999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+ ..+++..+..++.||+.||.|||++ +|+||||||+||||+. ++.+||+|||+++.+...... .
T Consensus 160 ~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~-------~g~vKl~DFGla~~~~~~~~~-~ 227 (346)
T 4fih_A 160 DIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTH-------DGRVKLSDFGFCAQVSKEVPR-R 227 (346)
T ss_dssp HHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TCCEEECCCTTCEECCSSSCC-B
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECC-------CCCEEEecCcCceecCCCCCc-c
Confidence 99865 5689999999999999999999999 9999999999999987 889999999999976544332 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CCChhH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NLGATK 678 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 678 (725)
...+||+.|||||.+.+..|+.++|||||||++|||++|+.||..... .+.+....... ......
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~i~~~~~~~~~~~~~~ 296 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LKAMKMIRDNLPPRLKNLHKV 296 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSSCCCCSCGGGS
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHcCCCCCCCccccC
Confidence 346799999999999999999999999999999999999999964321 11111111111 122355
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++.+.+|+.+||+.||++|||++|+++|
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 7889999999999999999999999886
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=379.43 Aligned_cols=243 Identities=22% Similarity=0.217 Sum_probs=196.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|.+..++ ..||||.++... .+.+|++++++++|||||++++++.+++..+|||||+++|+|.+
T Consensus 67 G~G~fG~Vy~a~~~~~g--~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 139 (336)
T 4g3f_A 67 GRGSFGEVHRMKDKQTG--FQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139 (336)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred ccCCCeEEEEEEECCCC--CEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence 45678888888877655 578999886432 13579999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC-ceEEeeccCccccCcCCCcc-
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY-ITKIADFGLAKLLKKDQTRT- 601 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~-~~kl~Dfgla~~~~~~~~~~- 601 (725)
+|.+.+.+++..+..++.||+.||.|||++ +|+||||||+||||+. ++ .+||+|||+|+.+..+....
T Consensus 140 ~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~-------~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 140 LIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSS-------DGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECT-------TSCCEEECCCTTCEEC--------
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeC-------CCCEEEEeeCCCCeEccCCCcccc
Confidence 998888999999999999999999999999 9999999999999987 55 69999999999765433211
Q ss_pred ---ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 602 ---STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 602 ---~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
.....||+.|||||.+.+..++.++|||||||++|||++|+.||....... ..............++...
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-------LCLKIASEPPPIREIPPSC 282 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-------CHHHHHHSCCGGGGSCTTS
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHHcCCCCchhcCccC
Confidence 223569999999999999999999999999999999999999997543221 1111111000011244566
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
++.+.+++.+||+.||++|||+.|++++|...
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 78899999999999999999999999988653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=374.56 Aligned_cols=238 Identities=26% Similarity=0.350 Sum_probs=192.5
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEc----CCceeeeeecc
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE----QNHQLLVYELM 516 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~ 516 (725)
+...+|+.|++|.+..+ +..||||.+... .....+.|.+|++++++++|||||++++++.. ++..+||||||
T Consensus 34 iG~G~fg~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 34 IGRGSFKTVYKGLDTET--TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEECSSEEEEEEEETTT--CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EecCcCcEEEEEEECCC--CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 34567888888877654 467889988543 33345679999999999999999999999875 34679999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCc--eeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ--IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
++|+|.+++.+...+++..+..++.||+.||+|||++ + |+||||||+||||+.. ++.+||+|||+|+..
T Consensus 112 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~------~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 112 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGP------TGSVKIGDLGLATLK 182 (290)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESST------TSCEEECCTTGGGGC
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECC------CCCEEEEeCcCCEeC
Confidence 9999999999888999999999999999999999997 6 9999999999999742 678999999999864
Q ss_pred CcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
... ......||+.|||||.+.+ .++.++|||||||++|||+||+.||..... ...+......+..
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----------~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----------AAQIYRRVTSGVK 247 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----------HHHHHHHHTTTCC
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----------HHHHHHHHHcCCC
Confidence 332 2234579999999998865 699999999999999999999999964321 1112222222222
Q ss_pred ----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 ----GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+...++.+.+|+.+||+.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22345679999999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=378.71 Aligned_cols=239 Identities=23% Similarity=0.306 Sum_probs=194.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|++|++|.+..++ ..||||.+... .....+.|.+|+++|++++|||||++++++.+++..+|||||+++|+|
T Consensus 33 G~G~fg~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L 110 (350)
T 4b9d_A 33 GEGSFGKAILVKSTEDG--RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL 110 (350)
T ss_dssp ------CEEEEEETTTC--CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 45678888888877665 56888887543 333456899999999999999999999999999999999999999999
Q ss_pred hhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 522 SAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 522 ~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
.++|... ..+++..+..|+.||+.||.|||++ +|+||||||+||||+. ++.+||+|||+|+.......
T Consensus 111 ~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~-------~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 111 FKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTK-------DGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECT-------TCCEEECSTTEESCCCHHHH
T ss_pred HHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECC-------CCCEEEcccccceeecCCcc
Confidence 9999654 4578999999999999999999999 9999999999999987 78999999999997653221
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChh
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGAT 677 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 677 (725)
......||+.|||||.+.+..|+.++|||||||+||||++|+.||..... .+.+...... ...+..
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------~~~~~~i~~~~~~~~~~~ 248 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----------KNLVLKIISGSFPPVSLH 248 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHTCCCCCCTT
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHcCCCCCCCcc
Confidence 12335699999999999999999999999999999999999999974321 1222222221 123446
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.++.+.+|+.+||+.||++|||++|++++
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 67889999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=383.88 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=201.9
Q ss_pred ccccHHHHHHHhcccC---CcceEEEEEEcccccC-ccHHHHHHHHHHHhccC-cCCccceeeEEEcC-Cceeeeeeccc
Q 039817 444 KVFSYQELREATNVFD---GQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQ-NHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~---~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~-~~~~lV~e~~~ 517 (725)
...+|++|++|..... .....||||.+..... ...++|.+|+++|++++ |||||+++|+|.+. +..+||||||+
T Consensus 73 G~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~ 152 (353)
T 4ase_A 73 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 152 (353)
T ss_dssp EECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCT
T ss_pred ecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCC
Confidence 4467788888765433 2346899999975433 34567999999999995 59999999999764 57899999999
Q ss_pred CCChhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC
Q 039817 518 NGTLSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581 (725)
Q Consensus 518 ~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~ 581 (725)
+|+|.++|.+. ..+++..+..++.|||+||.|||++ +||||||||+||||+. ++
T Consensus 153 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~-------~~ 222 (353)
T 4ase_A 153 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE-------KN 222 (353)
T ss_dssp TEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GG
T ss_pred CCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCC-------CC
Confidence 99999999643 3479999999999999999999999 9999999999999987 88
Q ss_pred ceEEeeccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCc
Q 039817 582 ITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGM 659 (725)
Q Consensus 582 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~ 659 (725)
.+||+|||+|+....+... ......||+.|||||.+.+..++.++|||||||+||||+| |+.||.......
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------- 295 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------- 295 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 9999999999976554333 2334669999999999999999999999999999999998 899986543211
Q ss_pred chHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 660 ILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+...+.. -.....+...++++.+++.+||+.||++|||++||+++|+.+++
T Consensus 296 ~~~~~i~~-g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 296 EFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 11111111 11234455677899999999999999999999999999987643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=370.53 Aligned_cols=238 Identities=21% Similarity=0.250 Sum_probs=201.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..++ ..||||.+.+. .....+.+.+|+++|++++|||||++++++.+++..+|||||+++|+
T Consensus 41 G~G~fg~V~~a~~~~~~--~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~ 118 (311)
T 4aw0_A 41 GEGSFSTVVLARELATS--REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118 (311)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred ecccCeEEEEEEECCCC--CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence 45678888888877655 57888988642 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+.+.+++..+..++.||+.||.|||++ +|+||||||+||||+. ++.+||+|||+|+.+......
T Consensus 119 L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~-------~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE-------DMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TSCEEECCCTTCEECCTTTTC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcC-------CCCEEEEEcCCceecCCCCCc
Confidence 999998888999999999999999999999999 9999999999999987 889999999999977544332
Q ss_pred -cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhH
Q 039817 601 -TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATK 678 (725)
Q Consensus 601 -~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 678 (725)
.....+||+.|||||.+.+..++.++||||+||++|||++|+.||..... .+...... ....++...
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~i~~~~~~~p~~~ 257 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------GLIFAKIIKLEYDFPEKF 257 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHTCCCCCTTC
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcCCCCCCccc
Confidence 23346799999999999999999999999999999999999999964321 11111111 123456667
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVL 704 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl 704 (725)
.+.+.+|+.+||+.||++|||++|++
T Consensus 258 s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 78899999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=370.10 Aligned_cols=253 Identities=24% Similarity=0.271 Sum_probs=189.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHH--HHHHHHhccCcCCccceeeEEEcCC----ceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFL--REVQVIGRTHHKNLVQLLGFCIEQN----HQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~--~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~~ 517 (725)
...+|++|++|+. .+..||||++... ..+++. .|+..+.+++|||||+++|+|.+++ ..+||||||+
T Consensus 12 G~G~fG~Vy~~~~----~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 12 GKGRFGEVWRGKW----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EECSSSEEEEEEE----TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred eeCCCeEEEEEEE----CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 4567888888764 2568999998643 233444 4556667899999999999998764 5799999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhccc-----CCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEEC-----ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
+|+|.++|.+ ..++|..+.+++.|+++||+|||+++ .++|+||||||+||||+. ++.+||+|||+++
T Consensus 85 ~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~-------~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 85 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-------NGTCCIADLGLAV 156 (303)
T ss_dssp TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT-------TSCEEECCCTTCE
T ss_pred CCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC-------CCCEEEEeCCCCc
Confidence 9999999965 46899999999999999999999863 458999999999999987 8899999999998
Q ss_pred ccCcCCCc---cccccccCccccchhcccCC------CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc---cCcc
Q 039817 593 LLKKDQTR---TSTMIRGTMGYMAPEWLRNA------PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA---NGMI 660 (725)
Q Consensus 593 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~---~~~~ 660 (725)
........ ......||+.|||||++.+. .++.|+|||||||+||||+||+.|+........... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76443322 12235699999999998754 467899999999999999999988754332211110 0111
Q ss_pred hHHHHHHHHHcC----CCCh-----hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 661 LTDWVLYCVRTG----NLGA-----TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 661 ~~~~~~~~~~~~----~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
..+.+....... .++. +..+.+.+|+.+||+.||++||||.||+++|+.+.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 122222222222 2222 45678999999999999999999999999998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.44 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=200.5
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+...+|+.|++|.+..++ ..||||.+........+.+.+|+++|++++|||||++++++.+++..+||||||++|+|.
T Consensus 159 iG~G~fG~V~~a~~~~tg--~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~ 236 (423)
T 4fie_A 159 IGEGSTGIVCIATVRSSG--KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 236 (423)
T ss_dssp EEECSSCEEEEEEETTTC--CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred eccCcCcEEEEEEECCCC--CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHH
Confidence 345678888888877655 578999987666666778999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.. ..+++..+..++.||+.||.|||++ +||||||||+||||+. ++.+||+|||+|+.+...... .
T Consensus 237 ~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~-------~g~vKl~DFGla~~~~~~~~~-~ 304 (423)
T 4fie_A 237 DIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTH-------DGRVKLSDFGFCAQVSKEVPR-R 304 (423)
T ss_dssp HHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECT-------TCCEEECCCTTCEECCSSCCC-B
T ss_pred HHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcC-------CCCEEEecCccceECCCCCcc-c
Confidence 99864 4689999999999999999999999 9999999999999987 889999999999876544332 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CCChhH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NLGATK 678 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 678 (725)
...+||+.|||||.+.+..|+.++|||||||++|||++|+.||..... .+.+....... ......
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~i~~~~~~~~~~~~~~ 373 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LKAMKMIRDNLPPRLKNLHKV 373 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCCCCCSCTTSS
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHcCCCCCCcccccC
Confidence 345799999999999999999999999999999999999999964321 11111111111 122345
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++.+.+|+.+||+.||++|||++|+++|
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 7889999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=357.63 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=185.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..++ ..||||.+.+. .....+.+.+|++++++++|||||++++++.+++..++||||+ +|+
T Consensus 22 G~G~fg~V~~~~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~ 98 (275)
T 3hyh_A 22 GEGSFGKVKLAYHTTTG--QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNE 98 (275)
T ss_dssp EC---CCEEEEECTTTC--CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEE
T ss_pred ecCcCeEEEEEEECCCC--CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCC
Confidence 45678888888776554 57899988543 2334567999999999999999999999999999999999999 679
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+.+.+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.......
T Consensus 99 L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~-------~~~vkl~DFGla~~~~~~~~- 167 (275)
T 3hyh_A 99 LFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDE-------HLNVKIADFGLSNIMTDGNF- 167 (275)
T ss_dssp HHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECT-------TCCEEECCSSCC---------
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECC-------CCCEEEeecCCCeecCCCCc-
Confidence 999998888999999999999999999999999 9999999999999987 78999999999987644322
Q ss_pred cccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 678 (725)
.....||+.|||||.+.+..+ +.++||||+||++|||++|+.||..... ........ ....++...
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----------~~~~~~i~~~~~~~p~~~ 235 (275)
T 3hyh_A 168 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----------PVLFKNISNGVYTLPKFL 235 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHTCCCCCTTS
T ss_pred -cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCC
Confidence 233569999999999998876 5799999999999999999999964321 11111111 123445567
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++.+.+|+.+||+.||++|||++|++++
T Consensus 236 s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 236 SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 7889999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.68 Aligned_cols=241 Identities=20% Similarity=0.207 Sum_probs=193.0
Q ss_pred ccccHHHHHHHhcccC-CcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFD-GQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|+.|.+..+ ..+..||||.+.+. .......+.+|+++|++++|||||++++++.+++..+|||||+++|+
T Consensus 33 G~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~ 112 (304)
T 3ubd_A 33 GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGD 112 (304)
T ss_dssp ECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCE
T ss_pred ecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCC
Confidence 4567888888877554 34678999998643 22334578999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+.+.+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+|+........
T Consensus 113 L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~-------~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 113 LFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDE-------EGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECT-------TSCEEEESSEEEEC-----CC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcC-------CCCEEecccccceeccCCCcc
Confidence 999999888999999999999999999999999 9999999999999987 889999999999865433222
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 679 (725)
.....||+.|||||.+.+..++.++|||||||++|||++|+.||..... .+...... ....++...+
T Consensus 183 -~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------~~~~~~i~~~~~~~p~~~s 250 (304)
T 3ubd_A 183 -AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----------KETMTMILKAKLGMPQFLS 250 (304)
T ss_dssp -CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCTTSC
T ss_pred -ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----------HHHHHHHHcCCCCCCCcCC
Confidence 2335699999999999999999999999999999999999999974321 11111111 1234556678
Q ss_pred HHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
+.+.+|+.+||+.||++||| ++|+++|
T Consensus 251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 89999999999999999998 5788764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=348.08 Aligned_cols=237 Identities=23% Similarity=0.372 Sum_probs=179.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCC------------cee
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN------------HQL 510 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------------~~~ 510 (725)
.+.+|++|++|.+..++ ..||||.+..... ...+.+.+|+++|++++|||||++++++.+.+ ..+
T Consensus 14 G~G~fg~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ 91 (299)
T 4g31_A 14 GRGGFGVVFEAKNKVDD--CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY 91 (299)
T ss_dssp EECC--EEEEEEETTTC--CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEE
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEE
Confidence 45678888888876655 5788998864332 34567999999999999999999999987654 368
Q ss_pred eeeecccCCChhhhhccCCC---CCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 511 LVYELMKNGTLSAFLFRQEI---PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 511 lV~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
+||||+++|+|.+++.+... .++..+..++.||++||+|||++ +|+||||||+||||+. ++.+||+|
T Consensus 92 ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~-------~~~vKl~D 161 (299)
T 4g31_A 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTM-------DDVVKVGD 161 (299)
T ss_dssp EEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TCCEEECC
T ss_pred EEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECC-------CCcEEEcc
Confidence 99999999999999987644 35667889999999999999999 9999999999999987 78999999
Q ss_pred ccCccccCcCCCcc-----------ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc
Q 039817 588 FGLAKLLKKDQTRT-----------STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA 656 (725)
Q Consensus 588 fgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~ 656 (725)
||+|+......... .....||+.|||||.+.+..++.++|||||||++|||++ ||....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------- 231 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------- 231 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-------
Confidence 99998765432211 123469999999999999999999999999999999996 543210
Q ss_pred cCcchHHHHHHHHHcCCCCh---hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 657 NGMILTDWVLYCVRTGNLGA---TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. .............+. ...+.+.+|+.+||+.||++|||+.|++++
T Consensus 232 ---~-~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 ---E-RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ---H-HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---H-HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 111112223344443 233457889999999999999999999984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=345.40 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=190.8
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEc------CCceeeeee
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIE------QNHQLLVYE 514 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lV~e 514 (725)
+...+|+.|++|.+..++ ..||||.+.... ....+.+.+|+++|++++|||||++++++.. .+..+||||
T Consensus 62 lG~G~fG~V~~a~~~~t~--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE 139 (398)
T 4b99_A 62 IGNGAYGVVSSARRRLTG--QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD 139 (398)
T ss_dssp EEECSSCEEEEEEETTTC--CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred EecccCeEEEEEEECCCC--CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence 345778889988887665 578999986432 2334678999999999999999999999764 357899999
Q ss_pred cccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 515 LMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 515 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
||+ |+|.+++.+.+.+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+
T Consensus 140 ~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~-------~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 140 LME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNE-------NCELKIGDFGMARGL 208 (398)
T ss_dssp CCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TCCEEECCCTTCBCC
T ss_pred CCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCC-------CCCEEEeecceeeec
Confidence 996 68999999889999999999999999999999999 9999999999999987 889999999999876
Q ss_pred CcCCC---ccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccc-----------ccc-C
Q 039817 595 KKDQT---RTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT-----------LAN-G 658 (725)
Q Consensus 595 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~-----------~~~-~ 658 (725)
..... .......||+.|||||.+.+. .++.++||||+||++|||++|+.||......... ... .
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 43321 223346799999999998875 5699999999999999999999999754211100 000 0
Q ss_pred cchHHHHHHHHHc----CCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 659 MILTDWVLYCVRT----GNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 659 ~~~~~~~~~~~~~----~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
............. ...+ ....+.+.+|+.+||+.||++|||++|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000 0000 1234678899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.68 Aligned_cols=250 Identities=19% Similarity=0.198 Sum_probs=190.7
Q ss_pred cccccHHHHHHHhcccC-CcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVFD-GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~-~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+...+|++|++|++..+ +.+..||||.+... .....+.+|+++|+++ +|||||++++++.+++..+|||||+++|+
T Consensus 29 lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~ 106 (361)
T 4f9c_A 29 IGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHES 106 (361)
T ss_dssp EEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCC
T ss_pred EecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCccc
Confidence 35678889998887543 55788999998653 3456789999999998 69999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ .+.+||+|||+|+........
T Consensus 107 L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~------~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 107 FLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRR------LKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp HHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT------TTEEEECCCTTCEECTTCSCG
T ss_pred HHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCC------CCeEEECcCCCCcccCCcccc
Confidence 999993 589999999999999999999999 99999999999999862 478999999999865432110
Q ss_pred ---------------------------cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCc
Q 039817 601 ---------------------------TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDE 652 (725)
Q Consensus 601 ---------------------------~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~ 652 (725)
......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.....+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 11234699999999999775 58999999999999999999999996443221
Q ss_pred cccc----------------------------cCcchHHHHHHHHH-----------------cCCCChhHHHHHHHHHH
Q 039817 653 PTLA----------------------------NGMILTDWVLYCVR-----------------TGNLGATKFERITMVGL 687 (725)
Q Consensus 653 ~~~~----------------------------~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~l~~ 687 (725)
.... .............. ........++.+.+|+.
T Consensus 255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~ 334 (361)
T 4f9c_A 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD 334 (361)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence 1000 00000000000000 00001123467889999
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 039817 688 WCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 688 ~cl~~dp~~RPs~~evl~~ 706 (725)
+||+.||++|||++|+++|
T Consensus 335 ~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 335 KLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHTCSCTTTSCCHHHHHTS
T ss_pred HHCcCChhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=356.61 Aligned_cols=239 Identities=22% Similarity=0.299 Sum_probs=199.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|.+..++ ..||+|.+........+.+.+|+++|++++|||||++++++.+++..+||||||++|+|.+
T Consensus 166 G~G~fg~V~~~~~~~tg--~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~ 243 (573)
T 3uto_A 166 GTGAFGVVHRVTERATG--NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243 (573)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred eeccCeEEEEEEECCCC--CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHH
Confidence 34577888888776655 4689998876555567789999999999999999999999999999999999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+|.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+ ..+.+||+|||+++.+..... .
T Consensus 244 ~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~-----~~~~vKl~DFG~a~~~~~~~~--~ 313 (573)
T 3uto_A 244 KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTK-----RSNELKLIDFGLTAHLDPKQS--V 313 (573)
T ss_dssp HHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSS-----SCCCEEECCCSSCEECCTTSE--E
T ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCC-----CCCCEEEeeccceeEccCCCc--e
Confidence 99654 6799999999999999999999999 99999999999999862 257899999999997754332 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CC----h
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LG----A 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~ 676 (725)
....||+.|||||.+.+..++.++||||+||++|||++|+.||..... .+.+ ..+.... ++ .
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----------~~~~-~~i~~~~~~~~~~~~~ 381 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----------DETL-RNVKSCDWNMDDSAFS 381 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHH-HHHHTTCCCCCSGGGT
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHH-HHHHhCCCCCCccccc
Confidence 345699999999999999999999999999999999999999974321 1111 1122222 22 2
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..++.+.+|+.+||+.||.+|||+.|+++|
T Consensus 382 ~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 382 GISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 356789999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=350.61 Aligned_cols=241 Identities=22% Similarity=0.241 Sum_probs=195.2
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHH---HHHHhccCcCCccceeeEEEcCCceeeeeecc
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLRE---VQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E---~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
+...+|++|+.|.+..++ ..||||.+.+. .......+.+| +.+++.++|||||++++++.+.+..||||||+
T Consensus 197 LG~G~fG~V~la~~~~tg--~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~ 274 (689)
T 3v5w_A 197 IGRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 274 (689)
T ss_dssp EEECSSEEEEEEEETTTC--CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EecccCeEEEEEEECCCC--CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecC
Confidence 355678888888876554 57899988542 12333344444 66777889999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++|+|.++|.+.+.+++..+..++.||+.||.|||+. +||||||||+||||+. ++.+||+|||+|+....
T Consensus 275 ~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~-------~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 275 NGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE-------HGHVRISDLGLACDFSK 344 (689)
T ss_dssp CSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECSS
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeC-------CCCEEecccceeeecCC
Confidence 9999999999888999999999999999999999999 9999999999999987 88999999999987654
Q ss_pred CCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHH-HHHcCCC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY-CVRTGNL 674 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 674 (725)
... ...+||+.|||||++.. ..|+.++|||||||+||||++|+.||....... ..+.... ......+
T Consensus 345 ~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--------~~~i~~~i~~~~~~~ 413 (689)
T 3v5w_A 345 KKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--------KHEIDRMTLTMAVEL 413 (689)
T ss_dssp CCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--------HHHHHHHHHHCCCCC
T ss_pred CCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhhcCCCCCC
Confidence 332 23579999999999964 579999999999999999999999997543211 1111111 1122345
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
+...++.+.+|+.+||+.||.+|++ ++||++|
T Consensus 414 p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 6677889999999999999999998 7888764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=326.00 Aligned_cols=259 Identities=41% Similarity=0.724 Sum_probs=206.3
Q ss_pred cccccHHHHHHHhcccC------------------CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEE
Q 039817 443 MKVFSYQELREATNVFD------------------GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFC 503 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~------------------~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 503 (725)
.+.|++.++..+.+.|. .++..||||.+.... ......|.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45666666666666553 235679999986543 22334799999999999999999999999
Q ss_pred EcCCceeeeeecccCCChhhhhccCC----CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCC
Q 039817 504 IEQNHQLLVYELMKNGTLSAFLFRQE----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN 579 (725)
Q Consensus 504 ~~~~~~~lV~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~ 579 (725)
...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+.++|+||||||+|||++.
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~------- 169 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE------- 169 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT-------
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC-------
Confidence 99999999999999999999997653 4899999999999999999999987789999999999999987
Q ss_pred CCceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCc
Q 039817 580 NYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM 659 (725)
Q Consensus 580 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~ 659 (725)
++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ ...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~ 246 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND---DDV 246 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT---SCS
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc---cch
Confidence 78999999999987765544444456699999999999888899999999999999999999999963221110 111
Q ss_pred chHHHHHHHHH------------cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 660 ILTDWVLYCVR------------TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 660 ~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
...+++..... .........+.+.+++.+||+.||.+|||+.||+++|++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp BHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 22222222111 12334567789999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=328.28 Aligned_cols=252 Identities=29% Similarity=0.444 Sum_probs=190.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|+.|++|.. .+..||||.+.... ....++|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 47 ~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 122 (309)
T 3p86_A 47 AGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122 (309)
T ss_dssp ECSSEEEEEEEE----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHH
T ss_pred cCCCeEEEEEEE----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHH
Confidence 345666666643 34578999886543 233467999999999999999999999999999999999999999999
Q ss_pred hhhccCCC---CCHHHHHHHHHHHHHHhhhhhcccCCc--eeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 523 AFLFRQEI---PTWDKRVEIALGIARGLLYLHEECETQ--IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 523 ~~l~~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~--ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+++.+... +++..+..++.|+++||.|||+. + |+||||||+||+++. ++.+||+|||+++.....
T Consensus 123 ~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~-------~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDK-------KYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp HHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECT-------TCCEEECCCC--------
T ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeC-------CCcEEECCCCCCcccccc
Confidence 99987653 89999999999999999999998 8 999999999999987 789999999999865433
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.. ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.........+..
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 193 FL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHHSCCCCCCCTT
T ss_pred cc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCCCCCCCcc
Confidence 22 123356899999999999999999999999999999999999998643211 111111111122345556
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCCCCc
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVV 719 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~p~~~ 719 (725)
..+.+.+++.+||+.||++|||++|+++.|+.+.+-..||+.
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 778899999999999999999999999999998765555443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=324.80 Aligned_cols=254 Identities=32% Similarity=0.577 Sum_probs=207.5
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+...+|+.++++... ++..||||.+........+.+.+|++++++++||||+++++++..++..++||||+++|+|.
T Consensus 47 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 47 IGHGVFGKVYKGVLR---DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp SCBCSSSEEEEEECT---TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred eecCCCeeEEEEEEC---CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 345567777777642 35689999988766677789999999999999999999999999999999999999999999
Q ss_pred hhhccCC----CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 523 AFLFRQE----IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 523 ~~l~~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+++.... .+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 124 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE-------NFVPKITDFGISKKGTELD 193 (321)
T ss_dssp GGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECT-------TCCEEECCCTTCEECSSSS
T ss_pred HHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECC-------CCCEEEeeccccccccccc
Confidence 9997653 589999999999999999999999 9999999999999987 7899999999998654322
Q ss_pred C-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc------
Q 039817 599 T-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT------ 671 (725)
Q Consensus 599 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 671 (725)
. .......||..|+|||.+.+..++.++||||||+++|||++|+.|+....... ......+.......
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-----MVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-----CCCHHHHTHHHHTTTCCCSS
T ss_pred ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-----HHHHHHHhhhccccccHHHh
Confidence 2 22233458999999999998899999999999999999999999987544322 12222332222211
Q ss_pred ------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 039817 672 ------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVG 714 (725)
Q Consensus 672 ------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 714 (725)
........+.+.+++.+||+.||++|||+.||+++|+.+.++.
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 1234467888999999999999999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.92 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=200.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..|+.++++.+..+ +..||+|.+........+.|.+|++++++++||||+++++++.+++..++||||+++++|.+++
T Consensus 21 G~~g~V~~~~~~~~--~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 98 (310)
T 3s95_A 21 GCFGQAIKVTHRET--GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII 98 (310)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred CCCEEEEEEEECCC--CcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHH
Confidence 45556666665443 4578999887666667788999999999999999999999999999999999999999999999
Q ss_pred cc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc---
Q 039817 526 FR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT--- 601 (725)
Q Consensus 526 ~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~--- 601 (725)
.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++.........
T Consensus 99 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 99 KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRE-------NKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp HHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECT-------TSCEEECCCTTCEECC---------
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECC-------CCCEEEeecccceeccccccccccc
Confidence 87 46789999999999999999999999 9999999999999987 7899999999998764432221
Q ss_pred ----------ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 602 ----------STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 602 ----------~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
.....||+.|+|||.+.+..++.++||||||+++|||++|..++.......... .........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--~~~~~~~~~----- 241 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--GLNVRGFLD----- 241 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--SBCHHHHHH-----
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--hhhhhcccc-----
Confidence 113469999999999999999999999999999999999999886543322111 112222211
Q ss_pred CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 672 GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 672 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
...+...++.+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 12344556678999999999999999999999999988753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=321.24 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=199.8
Q ss_pred cccHHHHHHHhcccCCc-----ceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDGQ-----EVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~-----~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
..+|+.++++.+...++ ...||+|.+........+.|.+|++++++++||||+++++++..++..++||||++++
T Consensus 18 ~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 97 (289)
T 4fvq_A 18 QGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFG 97 (289)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTC
T ss_pred cCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCC
Confidence 44566677776655543 3679999998776777788999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCC-CCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccc-cCCCCceEEeeccCccccCcC
Q 039817 520 TLSAFLFRQEI-PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT-IDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 520 sL~~~l~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~-~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|.+++.+... +++..+..++.|+++||.|||+. +|+||||||+|||++.+... ....+.+||+|||++......
T Consensus 98 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 174 (289)
T 4fvq_A 98 SLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174 (289)
T ss_dssp BHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc
Confidence 99999987644 89999999999999999999999 99999999999999873210 001122999999998754322
Q ss_pred CCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
....++..|+|||.+.+ ..++.++||||||+++|||++|..++..... ..............+.
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~~~~~~ 239 (289)
T 4fvq_A 175 -----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD----------SQRKLQFYEDRHQLPA 239 (289)
T ss_dssp -----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----------HHHHHHHHHTTCCCCC
T ss_pred -----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc----------hHHHHHHhhccCCCCC
Confidence 22447889999999987 7799999999999999999997665543211 1111222222344555
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCCCCcc
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVGVPPVVA 720 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~p~~~~ 720 (725)
...+.+.+++.+||+.||++|||+.|++++|+.+..-..++..+
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~ 283 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence 56678999999999999999999999999999987755444443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=329.01 Aligned_cols=250 Identities=28% Similarity=0.359 Sum_probs=200.4
Q ss_pred ccccHHHHHHHhccc-----CCcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecc
Q 039817 444 KVFSYQELREATNVF-----DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~-----~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
...+|+.|+.|.+.. ...+..||||.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 90 G~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~ 169 (370)
T 2psq_A 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169 (370)
T ss_dssp SCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 345677777776432 2356789999997542 23456799999999999 8999999999999999999999999
Q ss_pred cCCChhhhhccCC----------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCC
Q 039817 517 KNGTLSAFLFRQE----------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580 (725)
Q Consensus 517 ~~gsL~~~l~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~ 580 (725)
++|+|.+++.... .+++..+..++.|+++||.|||+. +|+||||||+|||++. +
T Consensus 170 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~-------~ 239 (370)
T 2psq_A 170 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE-------N 239 (370)
T ss_dssp TTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT-------T
T ss_pred CCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC-------C
Confidence 9999999997542 478999999999999999999999 9999999999999987 7
Q ss_pred CceEEeeccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccC
Q 039817 581 YITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANG 658 (725)
Q Consensus 581 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~ 658 (725)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~------- 312 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------- 312 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 89999999999866543322 2233457889999999999999999999999999999999 88888643211
Q ss_pred cchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 659 MILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+...+.. ......+....+.+.+++.+||+.||.+|||+.|++++|+.+..
T Consensus 313 -~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 -ELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -GHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 01123445667889999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.46 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=200.2
Q ss_pred ccccHHHHHHHhcccCC-cceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDG-QEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~-~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.|+.+....++ .+..||||.+... .....+.|.+|++++++++||||+++++++..++..++||||+++++|
T Consensus 58 G~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 137 (325)
T 3kul_A 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137 (325)
T ss_dssp EETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBH
T ss_pred EeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcH
Confidence 34567777777766554 3567999998754 334456799999999999999999999999999999999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 138 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDS-------NLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp HHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCCSSCEECC----C
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECC-------CCCEEECCCCcccccccCccc
Confidence 9999655 6799999999999999999999999 9999999999999987 789999999999876543322
Q ss_pred c--ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCC
Q 039817 601 T--STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLG 675 (725)
Q Consensus 601 ~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 675 (725)
. .....+|..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+....... ....+
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~ 276 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----------RDVISSVEEGYRLPAP 276 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------HHHHHHHHTTCCCCCC
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----------HHHHHHHHcCCCCCCC
Confidence 2 222346778999999998899999999999999999999 8888854321 111111111 12334
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
...++.+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 45678899999999999999999999999999987644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=312.94 Aligned_cols=238 Identities=22% Similarity=0.277 Sum_probs=197.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|+.|+.|.+..++ ..||||.+........+.+.+|+.++++++||||+++++++..++..++||||+++++|.+
T Consensus 29 g~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (297)
T 3fxz_A 29 GQGASGTVYTAMDVATG--QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106 (297)
T ss_dssp EEETTEEEEEEEBTTTC--CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHH
T ss_pred ccCCCeEEEEEEECCCC--cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHH
Confidence 44567777777665544 5788998876666667889999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
++.+. .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++......... ..
T Consensus 107 ~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~-~~ 174 (297)
T 3fxz_A 107 VVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGM-------DGSVKLTDFGFCAQITPEQSK-RS 174 (297)
T ss_dssp HHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TCCEEECCCTTCEECCSTTCC-BC
T ss_pred HHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECC-------CCCEEEeeCCCceecCCcccc-cC
Confidence 99654 689999999999999999999999 9999999999999987 789999999999876544332 23
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc----CCCChhHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT----GNLGATKF 679 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 679 (725)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... ...+....
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------RALYLIATNGTPELQNPEKLS 243 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------HHHHHHHHHCSCCCSCGGGSC
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhCCCCCCCCccccC
Confidence 356999999999999999999999999999999999999998643211 111111111 12344567
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 789999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.31 Aligned_cols=237 Identities=22% Similarity=0.317 Sum_probs=197.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.++.|.+..++ ..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 24 G~G~~g~V~~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L 101 (328)
T 3fe3_A 24 GKGNFAKVKLARHILTG--REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV 101 (328)
T ss_dssp EECSSEEEEEEEETTTC--CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred eeCCCEEEEEEEECCCC--CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcH
Confidence 34567777777766555 46888888643 333456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++...+.+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 102 ~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~-------~~~~kl~DFG~a~~~~~~~--~ 169 (328)
T 3fe3_A 102 FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDA-------DMNIKIADFGFSNEFTVGG--K 169 (328)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TSCEEECSTTCCGGGSSSC--G
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcC-------CCCEEEeeccCceecCCCC--c
Confidence 99998888899999999999999999999999 9999999999999987 7899999999998664432 2
Q ss_pred ccccccCccccchhcccCCCCC-CccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVT-AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATK 678 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~-~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 678 (725)
.....||+.|+|||.+.+..+. .++||||||+++|||++|+.||..... .+ ....... ...+...
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~-~~~~i~~~~~~~p~~~ 237 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----------KE-LRERVLRGKYRIPFYM 237 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHCCCCCCTTS
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----------HH-HHHHHHhCCCCCCCCC
Confidence 3345699999999999888775 789999999999999999999964321 11 1112222 2345556
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+.+++.+||+.||.+|||++|++++
T Consensus 238 s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 238 STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 7889999999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.33 Aligned_cols=223 Identities=20% Similarity=0.294 Sum_probs=187.4
Q ss_pred cceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
.+..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.+ ..+++..+..++
T Consensus 69 ~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~ 147 (321)
T 2c30_A 69 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVC 147 (321)
T ss_dssp TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHH
T ss_pred CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHH
Confidence 3568999998776667778899999999999999999999999999999999999999999999864 568999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 620 (725)
.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++......... .....||..|+|||.+.+.
T Consensus 148 ~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~ 216 (321)
T 2c30_A 148 EAVLQALAYLHAQ---GVIHRDIKSDSILLTL-------DGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRS 216 (321)
T ss_dssp HHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHC---CeecCCCCHHHEEECC-------CCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCC
Confidence 9999999999999 9999999999999987 789999999999876543322 2335699999999999999
Q ss_pred CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CCChhHHHHHHHHHHHccCCCCCC
Q 039817 621 PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NLGATKFERITMVGLWCICPQPTL 696 (725)
Q Consensus 621 ~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~ 696 (725)
.++.++||||||+++|||++|+.|+..... .+......... ......++.+.+++.+||+.||++
T Consensus 217 ~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 285 (321)
T 2c30_A 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----------VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQE 285 (321)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTT
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhh
Confidence 999999999999999999999999864321 11111111111 112245678999999999999999
Q ss_pred CCCHHHHHHH
Q 039817 697 RPSMKQVLQM 706 (725)
Q Consensus 697 RPs~~evl~~ 706 (725)
|||+.|++++
T Consensus 286 Rps~~ell~h 295 (321)
T 2c30_A 286 RATAQELLDH 295 (321)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhcC
Confidence 9999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.37 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=188.8
Q ss_pred ccccHHHHHHHhcccC-CcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFD-GQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|++|+++..... ..+..||||.++.. .....+.|.+|++++++++||||+++++++..++..++||||+++++|
T Consensus 54 G~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 133 (373)
T 2qol_A 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133 (373)
T ss_dssp EECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcH
Confidence 4456777777776543 34678999998754 233456899999999999999999999999999999999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++.+. ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 134 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 134 DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINS-------NLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp HHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TCCEEECCC------------
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcC-------CCCEEECcCccccccccCCcc
Confidence 9999776 4689999999999999999999999 9999999999999987 789999999999876543322
Q ss_pred cc--cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 601 TS--TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 601 ~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....+... .....+..
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~~~-~~~~~~~~ 274 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVDEG-YRLPPPMD 274 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHHTT-EECCCCTT
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-CCCCCCcc
Confidence 11 12235678999999999999999999999999999998 88888543211 111111110 11233445
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+..+.+++.+||+.||++||++.||+++|+.+.
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 6788999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=337.45 Aligned_cols=246 Identities=26% Similarity=0.316 Sum_probs=200.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
...|++|+++.... .+..||||.+... ....++|.+|+++|++++|||||+++++|...+..++||||+++|+|.++
T Consensus 230 ~G~fg~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 306 (495)
T 1opk_A 230 GGQYGEVYEGVWKK--YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 306 (495)
T ss_dssp GGTTSSEEEEEEGG--GTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred CCCCeEEEEEEEcC--CCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHH
Confidence 44566666665542 3578999999754 34578899999999999999999999999999999999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+... ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++..........
T Consensus 307 l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~-------~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 307 LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGE-------NHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp HHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG-------GGCEEECCTTCEECCTTCCEECC
T ss_pred HHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECC-------CCcEEEeecccceeccCCceeec
Confidence 9754 4689999999999999999999999 9999999999999987 78999999999997654433333
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
....++..|+|||.+....++.++||||||+++|||++ |+.|+...... ...+.+... .....+...++.
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~ 447 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKD-YRMERPEGCPEK 447 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTT-CCCCCCTTCCHH
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-CCCCCCCCCCHH
Confidence 33446789999999998899999999999999999999 88887643211 111111110 112334556788
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.68 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=193.4
Q ss_pred ccccHHHHHHHhcccCCcc--eEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQE--VEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~--~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|++|.+..+++. ..||+|.+... .....++|.+|++++++++||||++++++|..+. .++|+||+++|+
T Consensus 24 G~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~ 102 (327)
T 3poz_A 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGC 102 (327)
T ss_dssp EEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCB
T ss_pred eeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCc
Confidence 3456777787776555543 46799988543 3456678999999999999999999999998765 789999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 103 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~-------~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKT-------PQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp HHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEE-------TTEEEECCTTHHHHHTTTCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECC-------CCCEEEccCcceeEccCCcc
Confidence 99999774 6789999999999999999999999 9999999999999987 78999999999987654333
Q ss_pred cc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 RT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.. .....+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....+.. ......+..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~~ 243 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEK-GERLPQPPI 243 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHT-TCCCCCCTT
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--------HHHHHHHc-CCCCCCCcc
Confidence 22 223447889999999999999999999999999999999 99988643221 11111111 112234455
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
....+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 6778999999999999999999999999997653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=305.78 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=193.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.++.|.+... +..||+|.+.... ....+.|.+|+.++++++||||+++++++..++..++||||+++++|
T Consensus 21 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L 98 (294)
T 4eqm_A 21 GGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98 (294)
T ss_dssp EETTEEEEEEEETTT--CSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred cCCCEEEEEEEECCC--CCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCH
Confidence 345566666665544 3568888874322 23346789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.........
T Consensus 99 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 99 SEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDS-------NKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TSCEEECCCSSSTTC-------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCCEEEEeCCCccccccccccc
Confidence 99998888899999999999999999999999 9999999999999987 7899999999998765544333
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC------CCC
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG------NLG 675 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 675 (725)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +......... ...
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----------SIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----------HHHHHHHSSCCCCHHHHSC
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHhhccCCCcchhcc
Confidence 34456999999999999999999999999999999999999999653211 1111111111 112
Q ss_pred hhHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcCCCC
Q 039817 676 ATKFERITMVGLWCICPQPTLRP-SMKQVLQMLEGTSE 712 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~~ 712 (725)
...++.+.+++.+|++.||.+|| +++++.+.|+.+..
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 24567899999999999999998 99999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.04 Aligned_cols=255 Identities=37% Similarity=0.573 Sum_probs=202.5
Q ss_pred CcccccHHHHHHHhcccCC-----------------------cceEEEEEEcccc----cCccHHHHHHHHHHHhccCcC
Q 039817 442 NMKVFSYQELREATNVFDG-----------------------QEVEVAVKQLEKV----TGDGEKSFLREVQVIGRTHHK 494 (725)
Q Consensus 442 ~~~~~~~~~l~~a~~~~~~-----------------------~~~~vavk~l~~~----~~~~~~~f~~E~~~l~~l~H~ 494 (725)
....|++.++.++++.|+. .+..||||.+... .....+.|.+|++++++++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3467888888888887752 2347899988642 233457899999999999999
Q ss_pred CccceeeEEEcCCceeeeeecccCCChhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEec
Q 039817 495 NLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFR---QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLD 571 (725)
Q Consensus 495 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~ 571 (725)
||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 999999999999999999999999999999864 35689999999999999999999999 999999999999998
Q ss_pred cCccccCCCCceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCC
Q 039817 572 NNYITIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRV 650 (725)
Q Consensus 572 ~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~ 650 (725)
. ++.+||+|||+++......... .....|+..|+|||.+.+ .++.++||||||+++|||++|+.|+.....
T Consensus 168 ~-------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 168 E-------AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp T-------TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred C-------CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 7 7899999999998765433222 223568999999998865 488999999999999999999999875433
Q ss_pred CccccccCcchHHHH-------HHHHH--cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 651 DEPTLANGMILTDWV-------LYCVR--TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 651 ~~~~~~~~~~~~~~~-------~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
... .....+.. ..... ....+....+.+.+++.+||+.||.+|||+.+|+++|+++.
T Consensus 240 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 240 PQL----LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SSB----TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hHH----HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 210 00011100 00000 01234466788999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.80 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=196.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+|+.++.+... .+..||||.+... ....+++.+|++++++++||||+++++++..++..++||||+++++|.+++
T Consensus 19 G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 94 (268)
T 3sxs_A 19 GQFGVVKLGKWK---GQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL 94 (268)
T ss_dssp ETTEEEEEEEET---TTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred CCCceEEEEEec---CceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHH
Confidence 345555555332 3456999998754 345678999999999999999999999999999999999999999999999
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++.............
T Consensus 95 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~-------~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 95 RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDR-------DLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp HHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECT-------TCCEEECCTTCEEECCTTCEEECCS
T ss_pred HHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECC-------CCCEEEccCccceecchhhhhcccC
Confidence 765 4589999999999999999999999 9999999999999987 7899999999998765544333334
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFER 681 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 681 (725)
..++..|+|||.+.+..++.++||||||++++||++ |+.|+..... .+........ ...+...++.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----------SEVVLKVSQGHRLYRPHLASDT 233 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HHHHHHHHTTCCCCCCTTSCHH
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----------HHHHHHHHcCCCCCCCCcChHH
Confidence 456778999999998889999999999999999999 8888864321 1111111111 1233345678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999999999999999999999998865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.42 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=196.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+|+.++.+.+. ++..||+|.+... ....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++
T Consensus 21 G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 96 (269)
T 4hcu_A 21 GQFGLVHLGYWL---NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL 96 (269)
T ss_dssp CSSCEEEEEEET---TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred CCccEEEEEEec---CCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHH
Confidence 345555555543 3456899998754 345678999999999999999999999999999999999999999999999
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
... ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++............
T Consensus 97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 97 RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGE-------NQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp HTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG-------GGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcC-------CCCEEeccccccccccccccccccC
Confidence 665 5689999999999999999999999 9999999999999987 7889999999998765433333333
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFER 681 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 681 (725)
..++..|+|||.+.+..++.++||||||++++||++ |+.|+..... .+....... ....+....+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------SEVVEDISTGFRLYKPRLASTH 235 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTTCCCCCCTTSCHH
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----------HHHHHHHhcCccCCCCCcCCHH
Confidence 457788999999998999999999999999999999 8888864321 111111111 12234455778
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+.+++.+||+.||++|||++|++++|+++.+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=309.54 Aligned_cols=237 Identities=23% Similarity=0.227 Sum_probs=195.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+|+.|+.+.+..+ +..||||.+.+. .....+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 16 G~fg~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~ 93 (337)
T 1o6l_A 16 GTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93 (337)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHH
T ss_pred CCCeEEEEEEECCC--CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 44555666655433 457899988643 3445678999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... ..
T Consensus 94 ~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~-------~g~vkL~DFG~a~~~~~~~~-~~ 162 (337)
T 1o6l_A 94 FHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDK-------DGHIKITDFGLCKEGISDGA-TM 162 (337)
T ss_dssp HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TSCEEECCCTTCBCSCCTTC-CB
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECC-------CCCEEEeeccchhhcccCCC-cc
Confidence 9998888899999999999999999999999 9999999999999987 78999999999986433222 22
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH-HHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-VRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 681 (725)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ....... .....++....+.
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~s~~ 231 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------ERLFELILMEEIRFPRTLSPE 231 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCTTSCHH
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCCCHH
Confidence 345699999999999999999999999999999999999999864321 1111111 1223455567788
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
+.+++.+||+.||++|| +++|+++|
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999999 89999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.51 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=186.5
Q ss_pred cccHHHHHHHhcccCC-cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDG-QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~-~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|++|++|.+...+ ....||+|.+.... ....+.|.+|+.++++++||||+++++++. ++..++||||+++++|.
T Consensus 25 ~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~ 103 (281)
T 1mp8_A 25 EGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELR 103 (281)
T ss_dssp ECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHH
T ss_pred ecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHH
Confidence 4566777777665443 45789999986533 334567999999999999999999999984 56789999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.........
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~ 173 (281)
T 1mp8_A 104 SFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSS-------NDCVKLGDFGLSRYMEDSTYYK 173 (281)
T ss_dssp HHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE-------TTEEEECC--------------
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECC-------CCCEEECccccccccCcccccc
Confidence 999765 4689999999999999999999999 9999999999999987 7899999999998765543333
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (725)
.....+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... ....+.. ......+...++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~-~~~~~~~~~~~~ 244 (281)
T 1mp8_A 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIEN-GERLPMPPNCPP 244 (281)
T ss_dssp -----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHT-TCCCCCCTTCCH
T ss_pred cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHc-CCCCCCCCCCCH
Confidence 333457789999999998899999999999999999997 888886432211 1111111 011234456678
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8999999999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.57 Aligned_cols=241 Identities=22% Similarity=0.312 Sum_probs=195.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.++++.+..++ ..+|+|.+... .....+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 20 G~G~fg~V~~~~~~~~~--~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (444)
T 3soa_A 20 GKGAFSVVRRCVKVLAG--QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97 (444)
T ss_dssp EEC--CEEEEEEETTTT--EEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBH
T ss_pred ccCCCeEEEEEEECCCC--cEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCH
Confidence 34567777777766555 46777776543 233456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+. .++.+||+|||+++........
T Consensus 98 ~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~----~~~~vkL~DFG~a~~~~~~~~~- 169 (444)
T 3soa_A 98 FEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKL----KGAAVKLADFGLAIEVEGEQQA- 169 (444)
T ss_dssp HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSS----TTCCEEECCCSSCBCCCTTCCB-
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccC----CCCcEEEccCceeEEecCCCce-
Confidence 99999888999999999999999999999999 999999999999998631 2678999999999876543322
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC--C----
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL--G---- 675 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---- 675 (725)
.....||+.|+|||.+.+..++.++||||||+++|+|++|..||..... .+ .......+.. +
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----------~~-~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----------HR-LYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HH-HHHHHHHTCCCCCTTTT
T ss_pred eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----------HH-HHHHHHhCCCCCCcccc
Confidence 2335699999999999999999999999999999999999999864321 11 1122222221 1
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...++.+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2456789999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.64 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=196.1
Q ss_pred ccHHHHHHHhcc---cCCcceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcCC-ceeeeeecccCC
Q 039817 446 FSYQELREATNV---FDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQN-HQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~---~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~lV~e~~~~g 519 (725)
..|+.|++|... -...+..||||.+..... ...+.+.+|+++++++ +||||+++++++.+.+ ..++||||+++|
T Consensus 33 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g 112 (359)
T 3vhe_A 33 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 112 (359)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTE
T ss_pred CCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCC
Confidence 455666666532 223457899999975432 3346799999999999 8999999999998765 489999999999
Q ss_pred ChhhhhccCCC------------------------------------------------------------------CCH
Q 039817 520 TLSAFLFRQEI------------------------------------------------------------------PTW 533 (725)
Q Consensus 520 sL~~~l~~~~~------------------------------------------------------------------l~~ 533 (725)
+|.+++..... +++
T Consensus 113 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 192 (359)
T 3vhe_A 113 NLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192 (359)
T ss_dssp EHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCH
T ss_pred cHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCH
Confidence 99999976532 889
Q ss_pred HHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-cccccccCcccc
Q 039817 534 DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYM 612 (725)
Q Consensus 534 ~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ 612 (725)
..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++........ ......||..|+
T Consensus 193 ~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~-------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 262 (359)
T 3vhe_A 193 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE-------KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GGCEEECCCGGGSCTTSCTTCEEC--CEECGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcC-------CCcEEEEeccceeeecccccchhccccCCCceeE
Confidence 99999999999999999999 9999999999999987 789999999999876443322 223455889999
Q ss_pred chhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccC
Q 039817 613 APEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCIC 691 (725)
Q Consensus 613 aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 691 (725)
|||.+.+..++.++||||||+++|||++ |+.|+....... .....+ ........+....+.+.+++.+||+
T Consensus 263 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRL-KEGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHH-HHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------HHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 9999999999999999999999999998 999986543221 111111 1111233445567789999999999
Q ss_pred CCCCCCCCHHHHHHHhcCCC
Q 039817 692 PQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 692 ~dp~~RPs~~evl~~L~~~~ 711 (725)
.||.+|||++||+++|+.+.
T Consensus 335 ~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 335 GEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp SSGGGSCCHHHHHHHHHHHH
T ss_pred CChhhCCCHHHHHHHHHHHH
Confidence 99999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=340.30 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=198.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...+|++|+++.....+.+..||||.++... ....++|.+|+++|++++|||||+++++|.. +..++||||+++|+|.
T Consensus 345 G~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~ 423 (613)
T 2ozo_A 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLH 423 (613)
T ss_dssp EECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHH
T ss_pred ecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHH
Confidence 4567788888877666677889999997643 3457889999999999999999999999976 5689999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+..++.|+++||.|||+. +|+||||||+||||+. ++.+||+|||+++.........
T Consensus 424 ~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~-------~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 424 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVN-------RHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE-------TTEEEECCCSTTTTCC------
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcC-------CCcEEEeeccCcccccCCCcee
Confidence 999765 5689999999999999999999999 9999999999999987 7899999999998765433221
Q ss_pred c--cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 602 S--TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 602 ~--~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... .....+.. ......+...
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~-~~~~~~p~~~ 564 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQ-GKRMECPPEC 564 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHT-TCCCCCCTTC
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHc-CCCCCCCCcC
Confidence 1 12335688999999999999999999999999999998 99998653221 11111111 0112344567
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
++.+.+|+.+||+.||++||++.+|++.|+.+
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 78999999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=315.83 Aligned_cols=254 Identities=27% Similarity=0.297 Sum_probs=192.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCC----ceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN----HQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~~~gs 520 (725)
..+|+.|++|... +..||||.+... ......+..|+.++++++||||+++++++.... ..++||||+++|+
T Consensus 34 ~G~~g~Vy~~~~~----~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~ 108 (322)
T 3soc_A 34 RGRFGCVWKAQLL----NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS 108 (322)
T ss_dssp CSTTCEEEEEEET----TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred ccCceEEEEEEEC----CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCC
Confidence 3456667777543 478999998643 233455677999999999999999999998754 3699999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhccc-------CCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEEC-------ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
|.+++... .+++..+..++.|+++||.|||+.+ .++|+||||||+|||++. ++.+||+|||+++.
T Consensus 109 L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~-------~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 109 LSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-------NLTACIADFGLALK 180 (322)
T ss_dssp HHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT-------TCCEEECCCTTCEE
T ss_pred HHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC-------CCeEEEccCCcccc
Confidence 99999654 5899999999999999999999862 348999999999999987 78999999999987
Q ss_pred cCcCCCc-cccccccCccccchhcccCC-----CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----ccCcchH
Q 039817 594 LKKDQTR-TSTMIRGTMGYMAPEWLRNA-----PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----ANGMILT 662 (725)
Q Consensus 594 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~~~~~~ 662 (725)
....... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.......... .......
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 6543322 22235689999999999863 45678899999999999999999987543322110 0011112
Q ss_pred HHHHHHHHcCC---CC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 663 DWVLYCVRTGN---LG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 663 ~~~~~~~~~~~---~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.......... .+ ...++.+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22221111111 11 134567999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.90 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=194.3
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
+|++|+++... ....||||.++.. ....+.|.+|++++++++|||||++++++. .+..++||||+++|+|.+++.
T Consensus 200 ~fg~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~ 274 (454)
T 1qcf_A 200 QFGEVWMATYN---KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLK 274 (454)
T ss_dssp SSEEEEEEEET---TTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHH
T ss_pred CceEEEEEEEC---CccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHH
Confidence 44455554432 2467999999754 346788999999999999999999999986 667899999999999999997
Q ss_pred cC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 527 RQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 527 ~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
.. ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++............
T Consensus 275 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~-------~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 275 SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSA-------SLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp SHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECT-------TCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECC-------CCcEEEeeCCCceEcCCCceeccCC
Confidence 65 3689999999999999999999999 9999999999999987 7899999999998765432222223
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFER 681 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 681 (725)
..++..|+|||.+....++.++||||||+++|||++ |+.|+..... .+....... ....+...++.
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------PEVIRALERGYRMPRPENCPEE 413 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------HHHHHHHHHTCCCCCCTTSCHH
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCCCCHH
Confidence 446788999999998999999999999999999999 8888864321 111111111 12234456788
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+.+++.+||+.||++|||+++|++.|+.+..
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.37 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=193.7
Q ss_pred ccHHHHHHHhcc--cCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCCh
Q 039817 446 FSYQELREATNV--FDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~--~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL 521 (725)
.+|+.++.+... -...+..||||.+........+.|.+|++++++++||||+++++++... ...++||||+++++|
T Consensus 21 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L 100 (295)
T 3ugc_A 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100 (295)
T ss_dssp CSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBH
T ss_pred cCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCH
Confidence 344555555421 1234578999999876666667899999999999999999999999653 568999999999999
Q ss_pred hhhhccCC-CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++........
T Consensus 101 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~ 170 (295)
T 3ugc_A 101 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN-------ENRVKIGDFGLTKVLPQDKEF 170 (295)
T ss_dssp HHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE-------TTEEEECCCCSCC--------
T ss_pred HHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcC-------CCeEEEccCcccccccCCcce
Confidence 99997764 589999999999999999999999 9999999999999987 789999999999876543321
Q ss_pred --cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc----ccCcchHHHHHHHHHc---
Q 039817 601 --TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL----ANGMILTDWVLYCVRT--- 671 (725)
Q Consensus 601 --~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~--- 671 (725)
......++..|+|||.+.+..++.++||||||+++|||++|..|+.......... ................
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (295)
T 3ugc_A 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250 (295)
T ss_dssp -----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCc
Confidence 1222346778999999999999999999999999999999998876432110000 0011111122222222
Q ss_pred CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 672 GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 672 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
...+...++.+.+++.+||+.||++|||++|++++|+.+.
T Consensus 251 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 2234456788999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.23 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=194.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...|+.++++.+..++ ..||+|.+... .....+.+.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 39 ~G~~g~V~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~ 116 (362)
T 2bdw_A 39 KGAFSVVRRCVHKTTG--LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116 (362)
T ss_dssp EETTEEEEEEEETTTC--CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred cCCCeEEEEEEECCCC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHH
Confidence 4456667777665444 57888887543 2334567899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+. .++.+||+|||+++....... .
T Consensus 117 ~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~----~~~~~kl~DfG~a~~~~~~~~--~ 187 (362)
T 2bdw_A 117 EDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKA----KGAAVKLADFGLAIEVNDSEA--W 187 (362)
T ss_dssp HHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSS----TTCCEEECCCTTCBCCTTCCS--C
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCC----CCCCEEEeecCcceEecCCcc--c
Confidence 9998888899999999999999999999999 999999999999998631 245799999999987653322 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CC----h
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LG----A 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~ 676 (725)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+ +......+. .+ .
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----------~~-~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------HR-LYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHTCCCCCTTGGG
T ss_pred ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----------HH-HHHHHHhCCCCCCccccc
Confidence 235699999999999999999999999999999999999999864321 11 111122222 11 2
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..++.+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 256 TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 346789999999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.84 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=194.3
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
+|+.++.+... .+..||||.+... ....+++.+|++++++++|+||+++++++..++..++||||+++++|.+++.
T Consensus 36 ~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 111 (283)
T 3gen_A 36 QFGVVKYGKWR---GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR 111 (283)
T ss_dssp -CEEEEEEEET---TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHH
T ss_pred CCceEEEEEEc---CCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHH
Confidence 34445544332 3457999998754 3356789999999999999999999999999999999999999999999997
Q ss_pred c-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 527 R-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 527 ~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
. ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.............
T Consensus 112 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~-------~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 112 EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND-------QGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp CGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECT-------TSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcC-------CCCEEEccccccccccccccccccCC
Confidence 7 46799999999999999999999999 9999999999999987 78999999999987654332223334
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFERI 682 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 682 (725)
.++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+....... ....+....+.+
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------SETAEHIAQGLRLYRPHLASEKV 250 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HHHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----------hHHHHHHhcccCCCCCCcCCHHH
Confidence 46788999999998899999999999999999998 8888864321 111111111 122334556789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+++.+||+.||.+|||++|++++|+++.
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 99999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.04 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=199.2
Q ss_pred cccHHHHHHHhcccC-----CcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeeccc
Q 039817 445 VFSYQELREATNVFD-----GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~-----~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
..+|+.|++|.+... .....||||.+.... ....+.+.+|+++++++ +||||+++++++..++..++||||++
T Consensus 79 ~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~ 158 (382)
T 3tt0_A 79 EGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 158 (382)
T ss_dssp ECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred cCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecC
Confidence 345666666664322 344689999987543 33446799999999999 89999999999999999999999999
Q ss_pred CCChhhhhccCC----------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC
Q 039817 518 NGTLSAFLFRQE----------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581 (725)
Q Consensus 518 ~gsL~~~l~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~ 581 (725)
+|+|.+++.... .+++..+..++.|+++||.|||+. +|+||||||+|||++. ++
T Consensus 159 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-------~~ 228 (382)
T 3tt0_A 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE-------DN 228 (382)
T ss_dssp TCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TC
T ss_pred CCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcC-------CC
Confidence 999999997643 489999999999999999999999 9999999999999987 78
Q ss_pred ceEEeeccCccccCcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCc
Q 039817 582 ITKIADFGLAKLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGM 659 (725)
Q Consensus 582 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~ 659 (725)
.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||++++||++ |+.|+.....
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--------- 299 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------- 299 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---------
Confidence 999999999987654332 22233457889999999999999999999999999999999 8888864321
Q ss_pred chHHHHHHHHHc---CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 660 ILTDWVLYCVRT---GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 660 ~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+ +...... ...+....+.+.+++.+||+.||++|||++||+++|+.+..
T Consensus 300 --~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 --EE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp --HH-HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 1222222 23344567889999999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.61 Aligned_cols=249 Identities=27% Similarity=0.348 Sum_probs=196.6
Q ss_pred cccHHHHHHHhccc---CCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVF---DGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~---~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.|++|...- ...+..||||.+... .......+.+|+.++++++||||+++++++......++||||+++|+
T Consensus 81 ~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 160 (367)
T 3l9p_A 81 HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160 (367)
T ss_dssp CCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred eCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCC
Confidence 44566677666332 234568999998643 33445679999999999999999999999999999999999999999
Q ss_pred hhhhhccC-------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 521 LSAFLFRQ-------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 521 L~~~l~~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+|||++.+. .+..+||+|||+++.
T Consensus 161 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~----~~~~~kL~DFG~a~~ 233 (367)
T 3l9p_A 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG----PGRVAKIGDFGMARD 233 (367)
T ss_dssp HHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS----TTCCEEECCCHHHHH
T ss_pred HHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC----CCceEEECCCccccc
Confidence 99999653 3589999999999999999999999 999999999999998521 145699999999985
Q ss_pred cCcCC-CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 594 LKKDQ-TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 594 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
..... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..|+..... .+........
T Consensus 234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----------~~~~~~i~~~ 302 (367)
T 3l9p_A 234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----------QEVLEFVTSG 302 (367)
T ss_dssp HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------HHHHHHHHTT
T ss_pred cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcC
Confidence 43222 122223457899999999999999999999999999999998 8888864321 1111111111
Q ss_pred --CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 672 --GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 672 --~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
...+...+..+.+|+.+||+.||++|||+.||+++|+.+.
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2234456778999999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=342.27 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=197.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|++|+++.......+..||||.++... ....++|.+|++++++++|||||++++++.. +..++||||+++|+|
T Consensus 378 G~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L 456 (635)
T 4fl3_A 378 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPL 456 (635)
T ss_dssp EECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred ccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCH
Confidence 4456777777765555566889999987533 3346789999999999999999999999964 568899999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
.+++.....+++..+..|+.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++.+......
T Consensus 457 ~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~-------~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 457 NKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVT-------QHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp HHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE-------TTEEEECCTTHHHHTTC-----
T ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeC-------CCCEEEEEcCCccccccCcccc
Confidence 99998888899999999999999999999999 9999999999999987 789999999999876543322
Q ss_pred -cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCC
Q 039817 601 -TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLG 675 (725)
Q Consensus 601 -~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 675 (725)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+...... ...+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------------~~~~~i~~~~~~~~p 594 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------------EVTAMLEKGERMGCP 594 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------------HHHHHHHTTCCCCCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCCCCCC
Confidence 2223446788999999999999999999999999999998 99998643211 11222222 2345
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
...++.+.+|+.+||+.||++||++++|++.|+.+
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 56778999999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=323.83 Aligned_cols=228 Identities=27% Similarity=0.369 Sum_probs=183.3
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccC--CCCCHHHHHHHH
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQ--EIPTWDKRVEIA 540 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~ 540 (725)
..||||.+.... ...++|.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++... ..+++..+..++
T Consensus 209 ~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~ 286 (452)
T 1fmk_A 209 TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286 (452)
T ss_dssp EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHH
T ss_pred ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHH
Confidence 569999997543 356789999999999999999999999876 6789999999999999999753 568999999999
Q ss_pred HHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC
Q 039817 541 LGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620 (725)
Q Consensus 541 ~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 620 (725)
.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++..............++..|+|||.+.+.
T Consensus 287 ~qi~~~l~~LH~~---~ivHrDlkp~Nill~~-------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 356 (452)
T 1fmk_A 287 AQIASGMAYVERM---NYVHRDLRAANILVGE-------NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356 (452)
T ss_dssp HHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GGCEEECCCCTTC--------------CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHhC---CeeCCCCChhhEEECC-------CCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC
Confidence 9999999999999 9999999999999987 78999999999987654433333334577899999999989
Q ss_pred CCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHHHHHHHHHHccCCCCCCC
Q 039817 621 PVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFERITMVGLWCICPQPTLR 697 (725)
Q Consensus 621 ~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~R 697 (725)
.++.++||||||+++|||++ |+.|+..... .+........ ...+...++.+.+++.+||+.||++|
T Consensus 357 ~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 425 (452)
T 1fmk_A 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425 (452)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999 8888764321 1111111111 23345667889999999999999999
Q ss_pred CCHHHHHHHhcCCCCC
Q 039817 698 PSMKQVLQMLEGTSEV 713 (725)
Q Consensus 698 Ps~~evl~~L~~~~~~ 713 (725)
||+++|++.|+.+..-
T Consensus 426 pt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 426 PTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCHHHHHHHHHTTTSC
T ss_pred cCHHHHHHHHHHHhcc
Confidence 9999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=306.75 Aligned_cols=252 Identities=19% Similarity=0.192 Sum_probs=196.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCC--ceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--HQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~~~gsL 521 (725)
..+|+.|++|.+..+ +..||||.+.... ....+.+.+|++++++++||||+++++++.... ..++||||+++++|
T Consensus 19 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L 96 (319)
T 4euu_A 19 QGATANVFRGRHKKT--GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96 (319)
T ss_dssp ECSSEEEEEEEETTT--CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBH
T ss_pred CCCCeEEEEEEECCC--CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCH
Confidence 345666777666544 4578999986533 344677899999999999999999999998765 77999999999999
Q ss_pred hhhhccCC---CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 522 SAFLFRQE---IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 522 ~~~l~~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+..+. ++.+.+||+|||+++......
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~---~~~~~~kL~Dfg~a~~~~~~~ 170 (319)
T 4euu_A 97 YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGE---DGQSVYKLTDFGAARELEDDE 170 (319)
T ss_dssp HHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECT---TSCEEEEECCCTTCEECCTTC
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccC---CCCceEEEccCCCceecCCCC
Confidence 99997653 389999999999999999999999 999999999999982110 126789999999998765443
Q ss_pred CccccccccCccccchhccc--------CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH
Q 039817 599 TRTSTMIRGTMGYMAPEWLR--------NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (725)
.. ....||..|+|||.+. +..++.++||||||+++|||++|+.||....... ...+.+.....
T Consensus 171 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~ 241 (319)
T 4euu_A 171 QF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-------RNKEVMYKIIT 241 (319)
T ss_dssp CB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG-------GCHHHHHHHHH
T ss_pred ce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc-------hhHHHHHHHhc
Confidence 22 2345899999999886 5788999999999999999999999996433211 11111111111
Q ss_pred c--------------------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 671 T--------------------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 671 ~--------------------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
. ..+.....+.+.+++.+||+.||++|||++|++++.....-.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 1 123346778899999999999999999999999999875543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=308.23 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=197.3
Q ss_pred ccHHHHHHHhccc---CCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVF---DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~---~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|+.+++|++.. ...+..||||.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 113 (314)
T 2ivs_A 34 GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113 (314)
T ss_dssp CSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred cCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCH
Confidence 4455666665422 2345789999986532 33456799999999999999999999999999999999999999999
Q ss_pred hhhhccCC------------------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcccc
Q 039817 522 SAFLFRQE------------------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577 (725)
Q Consensus 522 ~~~l~~~~------------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~ 577 (725)
.+++.... .+++..+..++.|+++||.|||+. +|+||||||+||+++.
T Consensus 114 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~----- 185 (314)
T 2ivs_A 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE----- 185 (314)
T ss_dssp HHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET-----
T ss_pred HHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcC-----
Confidence 99997643 278999999999999999999999 9999999999999987
Q ss_pred CCCCceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCcccc
Q 039817 578 DNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTL 655 (725)
Q Consensus 578 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~ 655 (725)
++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 186 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---- 259 (314)
T 2ivs_A 186 --GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---- 259 (314)
T ss_dssp --TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred --CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 7889999999998765433221 223457788999999998889999999999999999999 88888643221
Q ss_pred ccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 656 ANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.....+.. ......+...++.+.+++.+||+.||++|||+.|++++|+++.
T Consensus 260 ----~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 260 ----RLFNLLKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp ----GHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHhhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111 1112344466788999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.79 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=198.7
Q ss_pred cccHHHHHHHhcccC---CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFD---GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~---~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...|+.++++.+.-. ..+..||||.+.... ....+.|.+|++++++++||||+++++++..++..++||||+++++
T Consensus 57 ~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 136 (343)
T 1luf_A 57 EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGD 136 (343)
T ss_dssp ECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred ecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCc
Confidence 345666666665432 345789999997543 3345679999999999999999999999999999999999999999
Q ss_pred hhhhhccC------------------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccc
Q 039817 521 LSAFLFRQ------------------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576 (725)
Q Consensus 521 L~~~l~~~------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~ 576 (725)
|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+||+++.
T Consensus 137 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~---- 209 (343)
T 1luf_A 137 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGE---- 209 (343)
T ss_dssp HHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG----
T ss_pred HHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECC----
Confidence 99999753 4689999999999999999999999 9999999999999987
Q ss_pred cCCCCceEEeeccCccccCcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccc
Q 039817 577 IDNNYITKIADFGLAKLLKKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPT 654 (725)
Q Consensus 577 ~~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~ 654 (725)
++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 210 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---- 282 (343)
T 1luf_A 210 ---NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH---- 282 (343)
T ss_dssp ---GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----
T ss_pred ---CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh----
Confidence 78999999999986543322 12223457889999999998899999999999999999999 8888864321
Q ss_pred cccCcchHHHHHHHHHcC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 655 LANGMILTDWVLYCVRTG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+ +......+ ..+...++.+.+++.+||+.||++|||+.+|+++|+++.+
T Consensus 283 -------~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 283 -------EE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp -------HH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------HH-HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 11 11222222 2345567889999999999999999999999999998765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=311.88 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=194.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC------ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG------DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...+|+.|+++.+..++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 21 G~G~fg~V~~~~~~~~~--~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 98 (361)
T 2yab_A 21 GSGQFAIVKKCREKSTG--LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVS 98 (361)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eeCcCEEEEEEEECCCC--CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCC
Confidence 34567777777765544 5788888764322 235789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+. .....+||+|||+++.....
T Consensus 99 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~---~~~~~vkl~DFG~a~~~~~~ 172 (361)
T 2yab_A 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKN---IPIPHIKLIDFGLAHEIEDG 172 (361)
T ss_dssp SCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTT---SSSCCEEECCCSSCEECCTT
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCC---CCccCEEEEecCCceEcCCC
Confidence 999999998888899999999999999999999999 999999999999997621 00127999999999876543
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CC
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LG 675 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 675 (725)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|..||..... .+ ....+.... ++
T Consensus 173 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----------~~-~~~~i~~~~~~~~ 238 (361)
T 2yab_A 173 VE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QE-TLANITAVSYDFD 238 (361)
T ss_dssp CC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HH-HHHHHHTTCCCCC
T ss_pred Cc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----------HH-HHHHHHhcCCCCC
Confidence 22 2335699999999999999999999999999999999999999964321 11 111122222 22
Q ss_pred h----hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 A----TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. ...+.+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 345678999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=322.15 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=193.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..|++|+++.... .+..||||.+.... ....+.|.+|++++++++||||+++++++..++..++||||+++|+|.++
T Consensus 125 G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 202 (377)
T 3cbl_A 125 GNFGEVFSGRLRA--DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202 (377)
T ss_dssp ETTEEEEEEEETT--TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred CCCCeEEEEEEec--CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHH
Confidence 4556666665543 34689999986532 22345789999999999999999999999999999999999999999999
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc-
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS- 602 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~- 602 (725)
+... ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++..........
T Consensus 203 l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~-------~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 203 LRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTE-------KNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp HHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCGGGCEECTTSEEECCS
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcC-------CCcEEECcCCCceecCCCceeecC
Confidence 9765 4689999999999999999999999 9999999999999987 78999999999986543221111
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCChhH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGATK 678 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 678 (725)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+...... ...+...
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~~~~~~~ 340 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------------QQTREFVEKGGRLPCPELC 340 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------------HHHHHHHHTTCCCCCCTTC
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCCCCCCC
Confidence 11235678999999998889999999999999999998 8888764321 111111222 2334456
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
++.+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 778999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=315.15 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=185.3
Q ss_pred ccccHHHHHHHhcccCCc-ceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCce------eeeee
Q 039817 444 KVFSYQELREATNVFDGQ-EVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ------LLVYE 514 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~-~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~------~lV~e 514 (725)
...+|+.+++|.+...++ ...||||.+... .....+.|.+|++++++++||||+++++++...... ++|||
T Consensus 32 g~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e 111 (323)
T 3qup_A 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111 (323)
T ss_dssp EEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEE
T ss_pred cccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEE
Confidence 345677777776655443 247999998653 344567899999999999999999999999877655 99999
Q ss_pred cccCCChhhhhccCC------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeec
Q 039817 515 LMKNGTLSAFLFRQE------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADF 588 (725)
Q Consensus 515 ~~~~gsL~~~l~~~~------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Df 588 (725)
|+++++|.+++.... .+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~-------~~~~kl~Df 181 (323)
T 3qup_A 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE-------DMTVCVADF 181 (323)
T ss_dssp CCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT-------TSCEEECCC
T ss_pred eccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC-------CCCEEEeec
Confidence 999999999996432 589999999999999999999999 9999999999999987 789999999
Q ss_pred cCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHH
Q 039817 589 GLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVL 666 (725)
Q Consensus 589 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (725)
|+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....+.
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~ 253 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------IYNYLI 253 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHH
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--------HHHHHh
Confidence 999876443322 2223447788999999999999999999999999999999 888886432211 111111
Q ss_pred HHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 667 YCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 667 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
. ......+...++.+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 254 ~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 254 G-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp T-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 01123344667889999999999999999999999999988754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=314.80 Aligned_cols=240 Identities=21% Similarity=0.235 Sum_probs=192.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|+.|++|.+..++ ..||+|.+........+.|.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 98 G~G~~g~Vy~a~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~ 175 (373)
T 2x4f_A 98 GGGRFGQVHKCEETATG--LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175 (373)
T ss_dssp C-----CEEEEEETTTC--CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHH
T ss_pred ecCcCEEEEEEEEcCCC--cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHH
Confidence 34567777777665544 5789998876555567789999999999999999999999999999999999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++. +.++.+||+|||+++....... .
T Consensus 176 ~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-----~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 176 RIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVN-----RDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEE-----TTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEec-----CCCCcEEEEeCCCceecCCccc--c
Confidence 98765 4689999999999999999999999 9999999999999954 1267899999999987654332 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-CCCC----hh
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT-GNLG----AT 677 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~ 677 (725)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.+...... ...+ ..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~~~~i~~~~~~~~~~~~~~ 314 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----------AETLNNILACRWDLEDEEFQD 314 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCCCSCSGGGTT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhccCCCChhhhcc
Confidence 234589999999999988999999999999999999999999864321 1111111111 1111 23
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+.+|+.+||+.||.+|||+.|++++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 46789999999999999999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=307.16 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=197.8
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+|+.+++++......+..||||.+.... ....+.+.+|++++++++||||+++++++ ..+..++||||+++++|.+
T Consensus 20 ~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~ 98 (287)
T 1u59_A 20 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK 98 (287)
T ss_dssp CCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHH
T ss_pred ccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHH
Confidence 445677777765555567889999997543 33467799999999999999999999999 5567899999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc-
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT- 601 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~- 601 (725)
++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++.........
T Consensus 99 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~-------~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 99 FLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVN-------RHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp HHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEE-------TTEEEECCCTTCEECTTCSCEEC
T ss_pred HHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcC-------CCCEEECcccceeeeccCcceee
Confidence 99755 5689999999999999999999999 9999999999999987 7899999999998765433221
Q ss_pred -ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 602 -STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 602 -~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....+.. ......+...+
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~-~~~~~~~~~~~ 239 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQ-GKRMECPPECP 239 (287)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHT-TCCCCCCTTCC
T ss_pred ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhc-CCcCCCCCCcC
Confidence 122346889999999988889999999999999999998 99998643211 11111111 01123455677
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.+.+++.+||+.||++||++.+++++|+++.
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=310.65 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=195.0
Q ss_pred cHHHHHHHhcc---cCCcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 447 SYQELREATNV---FDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 447 ~~~~l~~a~~~---~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
+|+.|+.|... ..+.+..||||.+... .....+.+.+|+++++++ +||||+++++++...+..++||||+++|+|
T Consensus 57 ~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 136 (344)
T 1rjb_A 57 AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136 (344)
T ss_dssp SSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred CCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcH
Confidence 34455555432 2345678999998643 234567899999999999 899999999999999999999999999999
Q ss_pred hhhhccCC-----------------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccC
Q 039817 522 SAFLFRQE-----------------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578 (725)
Q Consensus 522 ~~~l~~~~-----------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~ 578 (725)
.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.
T Consensus 137 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~------ 207 (344)
T 1rjb_A 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTH------ 207 (344)
T ss_dssp HHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEET------
T ss_pred HHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcC------
Confidence 99997653 278999999999999999999999 9999999999999987
Q ss_pred CCCceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccc
Q 039817 579 NNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLA 656 (725)
Q Consensus 579 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~ 656 (725)
++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 208 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 282 (344)
T 1rjb_A 208 -GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 282 (344)
T ss_dssp -TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred -CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH----
Confidence 7899999999998765443322 223457889999999998999999999999999999998 888886543211
Q ss_pred cCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 657 NGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.....+.. ......+...++.+.+++.+||+.||.+|||+.||+++|+.+.+
T Consensus 283 ---~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 283 ---NFYKLIQN-GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp ---HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11111111 11123344567889999999999999999999999999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=302.29 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=191.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccC------ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTG------DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
.+|+.|+++.+..++ ..||+|.+..... ...+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 22 G~~g~V~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 99 (326)
T 2y0a_A 22 GQFAVVKKCREKSTG--LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGG 99 (326)
T ss_dssp CSSEEEEEEEETTTC--CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred CCCeEEEEEEECCCC--cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCC
Confidence 455666666655443 5788888754322 24678999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.+. .....+||+|||+++.......
T Consensus 100 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~---~~~~~~kl~Dfg~a~~~~~~~~ 173 (326)
T 2y0a_A 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN---VPKPRIKIIDFGLAHKIDFGNE 173 (326)
T ss_dssp BHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS---SSSCCEEECCCTTCEECCTTSC
T ss_pred CHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCC---CCCCCEEEEECCCCeECCCCCc
Confidence 9999998888899999999999999999999999 999999999999998721 0123799999999987643322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCCh--
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGA-- 676 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-- 676 (725)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.|+..... .+....... ....+.
T Consensus 174 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QETLANVSAVNYEFEDEY 240 (326)
T ss_dssp --CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHHHHTCCCCCHHH
T ss_pred --cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----------HHHHHHHHhcCCCcCccc
Confidence 2234599999999999999999999999999999999999999864321 111111111 111221
Q ss_pred --hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 --TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 --~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..++.+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 335678999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.64 Aligned_cols=265 Identities=16% Similarity=0.136 Sum_probs=203.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.+++.++++.+..+ +..||||.+... ...+.+.+|+++++++ +|+|++++++++..+...++||||+ +++|.++
T Consensus 21 G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 95 (298)
T 1csn_A 21 GSFGVIFEGTNLLN--NQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDL 95 (298)
T ss_dssp CSSCEEEEEEETTT--TEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred cCCEEEEEEEECCC--CcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHH
Confidence 44556666665433 467899987543 2345688999999999 7999999999999999999999999 9999999
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc---
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR--- 600 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~--- 600 (725)
+... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.+.. +....+||+|||+++........
T Consensus 96 l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~ 170 (298)
T 1csn_A 96 LDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNS--KNANMIYVVDFGMVKFYRDPVTKQHI 170 (298)
T ss_dssp HHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSS--TTTTCEEECCCTTCEESBCTTTCCBC
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCC--CCCCeEEEEECccccccccccccccc
Confidence 9865 4699999999999999999999999 9999999999999976321 11345999999999876543321
Q ss_pred ---cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC---C
Q 039817 601 ---TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN---L 674 (725)
Q Consensus 601 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 674 (725)
......||..|+|||.+.+..++.++||||||+++|||++|+.||........ ......+........ .
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 171 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHHHHHHHHHHSCHHHH
T ss_pred cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-----HHHHHHHHhhccCccHHHH
Confidence 12345699999999999999999999999999999999999999976432211 011111111111111 1
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC--CCCCCCccccCCC
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE--VGVPPVVADAQMF 725 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~--~~~p~~~~~~~~~ 725 (725)
....++.+.+++.+||+.||++|||+++|++.|+++.+ -.....+.+|++|
T Consensus 246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 298 (298)
T 1csn_A 246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298 (298)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCCC
Confidence 12346789999999999999999999999999998753 2344666777764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=315.35 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=196.4
Q ss_pred ccccHHHHHHHhcccCCcc--eEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQE--VEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~--~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|++|.+..++.. ..|++|.+.... ....+.+.+|+.++++++||||+++++++. ++..++||||+++|+
T Consensus 22 G~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~ 100 (325)
T 3kex_A 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGS 100 (325)
T ss_dssp ECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCB
T ss_pred eecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCC
Confidence 3456777888877655543 458888875432 334467889999999999999999999986 567899999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 101 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~-------~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 101 LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKS-------PSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp SHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESS-------SSCEEECSCSGGGGSCCCTT
T ss_pred HHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECC-------CCeEEECCCCcccccCcccc
Confidence 99999775 5789999999999999999999999 9999999999999987 78899999999997654433
Q ss_pred cc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 RT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..+.+.. ......+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~-~~~~~~~~~ 241 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEK-GERLAQPQI 241 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHT-TCBCCCCTT
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHc-CCCCCCCCc
Confidence 22 234557889999999999999999999999999999999 999987543211 1111111 112233444
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
....+.+++.+||+.||.+|||+.|++++|+.+.
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 5667889999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.63 Aligned_cols=237 Identities=26% Similarity=0.347 Sum_probs=191.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCC-ceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-HQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~ 524 (725)
..|++|+++... +..||||.++.. ...+.|.+|++++++++||||+++++++.+.+ ..++||||+++|+|.++
T Consensus 204 G~fg~V~~~~~~----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~ 277 (450)
T 1k9a_A 204 GEFGDVMLGDYR----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277 (450)
T ss_dssp CSSEEEEEEEET----TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHH
T ss_pred cCCeeEEEEEec----CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHH
Confidence 445555555432 458999999753 35678999999999999999999999988765 78999999999999999
Q ss_pred hccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+.+.. .+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 278 l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~-------~~~~kl~DfG~a~~~~~~~---- 343 (450)
T 1k9a_A 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSE-------DNVAKVSDFGLTKEASSTQ---- 343 (450)
T ss_dssp HHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT-------TSCEEECCCTTCEECC-------
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECC-------CCCEEEeeCCCcccccccc----
Confidence 97653 479999999999999999999999 9999999999999987 7899999999998543221
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....+... .....+...++.
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~-~~~~~p~~~~~~ 414 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKG-YKMDAPDGCPPA 414 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTT-CCCCCCTTCCHH
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcC-CCCCCCCcCCHH
Confidence 12347889999999999999999999999999999998 998886443211 11111110 112344566789
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.13 Aligned_cols=244 Identities=25% Similarity=0.277 Sum_probs=191.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...+|++|+.|.+..++ ..||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++++|.
T Consensus 16 G~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (323)
T 3tki_A 16 GEGAYGEVQLAVNRVTE--EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93 (323)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGG
T ss_pred ecCCCEEEEEEEECCCC--cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHH
Confidence 34567777777665544 568888875332 233467899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-cc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RT 601 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~-~~ 601 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+..... ..
T Consensus 94 ~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~-------~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 94 DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE-------RDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp GGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCCTTCEECEETTEECC
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeC-------CCCEEEEEeeccceeccCCcccc
Confidence 9998888899999999999999999999999 9999999999999987 78999999999986543322 12
Q ss_pred ccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (725)
.....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+... ...........+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~ 236 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEK-KTYLNPWKKIDS 236 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS------HHHHHHHTT-CTTSTTGGGSCH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHhcc-cccCCccccCCH
Confidence 234569999999999987765 778999999999999999999997543221 111111100 000111134567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 88999999999999999999999886
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.20 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=197.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+++.++++.......+..||||.+.... ....+++.+|++++++++||||+++++++ ..+..++||||+++++|.
T Consensus 27 ~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~ 105 (291)
T 1xbb_A 27 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLN 105 (291)
T ss_dssp ECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHH
T ss_pred cccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHH
Confidence 445667777755555567789999986543 23357899999999999999999999999 567789999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc-
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT- 601 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~- 601 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.........
T Consensus 106 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~~ 175 (291)
T 1xbb_A 106 KYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVT-------QHYAKISDFGLSKALRADENYYK 175 (291)
T ss_dssp HHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE-------TTEEEECCCTTCEECCTTCSEEE
T ss_pred HHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeC-------CCcEEEccCCcceeeccCCCccc
Confidence 9998888899999999999999999999999 9999999999999987 7899999999998765443322
Q ss_pred -ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCCh
Q 039817 602 -STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGA 676 (725)
Q Consensus 602 -~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 676 (725)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+...... ...+.
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------~~~~~~~~~~~~~~~~ 243 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------------EVTAMLEKGERMGCPA 243 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------------HHHHHHHTTCCCCCCT
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------------HHHHHHHcCCCCCCCC
Confidence 122346788999999988889999999999999999999 99988643211 11111211 23445
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
..++.+.+++.+||+.||++||++.+|++.|+++.
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 66788999999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.05 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=193.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
....|+.++.+.+..++ ..||||.+........+.+.+|++++.++ +||||+++++++.+++..++||||+++++|.
T Consensus 22 g~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 99 (316)
T 2ac3_A 22 GEGAHARVQTCINLITS--QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL 99 (316)
T ss_dssp CCCSSEEEEEEECSSSC--CEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred cCCceEEEEEEEEcCCC--cEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHH
Confidence 44566777777765444 57899998776666778899999999985 7999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC---
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT--- 599 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~--- 599 (725)
+++.+...+++..+..++.|++.||.|||+. +|+||||||+||+++.+. ....+||+|||++........
T Consensus 100 ~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~----~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 100 SHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPN----QVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSS----SSCSEEECCTTCCC----------
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCC----CcCceEEEEccCccccccCCcccc
Confidence 9998888899999999999999999999999 999999999999998731 123499999999986542211
Q ss_pred ---ccccccccCccccchhcccC-----CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCc---chHHHHHHH
Q 039817 600 ---RTSTMIRGTMGYMAPEWLRN-----APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM---ILTDWVLYC 668 (725)
Q Consensus 600 ---~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 668 (725)
.......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .....+...
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 11123458999999999875 5688999999999999999999999976543221110000 011122222
Q ss_pred HHcCCC--Ch----hHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCCCCCCCCCccc
Q 039817 669 VRTGNL--GA----TKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTSEVGVPPVVAD 721 (725)
Q Consensus 669 ~~~~~~--~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~~~~~p~~~~~ 721 (725)
...+.. +. ...+.+.+++.+||+.||++|||+.|++++ +.+.......|.|..
T Consensus 253 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~ 313 (316)
T 2ac3_A 253 IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMV 313 (316)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-------------
T ss_pred HhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCccc
Confidence 333322 21 245689999999999999999999999986 344433333443433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=310.36 Aligned_cols=246 Identities=22% Similarity=0.239 Sum_probs=194.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.|+.+.+..+ +..+|||.+++.. ....+.+.+|..++.++ +|||||++++++..++..++||||+++|+
T Consensus 62 ~G~fG~V~~~~~~~~--~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~ 139 (396)
T 4dc2_A 62 RGSYAKVLLVRLKKT--DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD 139 (396)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred eCCCeEEEEEEECCC--CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCc
Confidence 445666666665433 4678999886532 23345688999999887 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+.+.+++..+..++.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++.......
T Consensus 140 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~-------~g~ikL~DFGla~~~~~~~~- 208 (396)
T 4dc2_A 140 LMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDS-------EGHIKLTDYGMCKEGLRPGD- 208 (396)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TSCEEECCCTTCBCCCCTTC-
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECC-------CCCEEEeecceeeecccCCC-
Confidence 999998888899999999999999999999999 9999999999999987 88999999999986332222
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 678 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .....+.+...... ..++...
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~---~~~~~~~~~~~i~~~~~~~p~~~ 285 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQIRIPRSL 285 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------CCHHHHHHHHHHCCCCCCTTS
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc---chhhHHHHHHHHhccccCCCCcC
Confidence 233456999999999999999999999999999999999999999754322211 11112222222222 3455667
Q ss_pred HHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSM------KQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~------~evl~~ 706 (725)
...+.+|+.+||+.||++||++ +||+++
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 7889999999999999999985 677654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.89 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=198.1
Q ss_pred ccHHHHHHHhcc---cCCcceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 446 FSYQELREATNV---FDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 446 ~~~~~l~~a~~~---~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
.+|+.+++|+.. -...+..||||.+..... ...+.+.+|+++++++ +||||+++++++..++..++||||+++|+
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 113 (313)
T 1t46_A 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113 (313)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred cCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCC
Confidence 345556665532 234567899999875433 3457799999999999 99999999999999999999999999999
Q ss_pred hhhhhccCC------------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCc
Q 039817 521 LSAFLFRQE------------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582 (725)
Q Consensus 521 L~~~l~~~~------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~ 582 (725)
|.+++.... .+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.
T Consensus 114 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~ 183 (313)
T 1t46_A 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH-------GRI 183 (313)
T ss_dssp HHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET-------TTE
T ss_pred HHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC-------CCC
Confidence 999997653 489999999999999999999999 9999999999999987 789
Q ss_pred eEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcc
Q 039817 583 TKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMI 660 (725)
Q Consensus 583 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~ 660 (725)
+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.|+....... .
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~ 256 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-------K 256 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-------H
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-------H
Confidence 9999999998765543322 223447789999999999999999999999999999999 888886543211 1
Q ss_pred hHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 661 LTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
....... ......+...++.+.+++.+||+.||.+|||+.|++++|+++.
T Consensus 257 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 FYKMIKE-GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcc-CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111111 1112234456788999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.58 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=192.8
Q ss_pred ccHHHHHHHhccc-CCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVF-DGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~-~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.+++.++++.... .+.+..||||.+... .....+.|.+|++++++++||||+++++++.+ +..++||||+++++|.+
T Consensus 23 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~ 101 (281)
T 3cc6_A 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGH 101 (281)
T ss_dssp CSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHH
T ss_pred cCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHH
Confidence 3455666665432 345678999998754 23346789999999999999999999999865 45689999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.+. ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||++...........
T Consensus 102 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~~ 171 (281)
T 3cc6_A 102 YLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVAS-------PECVKLGDFGLSRYIEDEDYYKA 171 (281)
T ss_dssp HHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEE-------TTEEEECCCCGGGCC--------
T ss_pred HHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECC-------CCcEEeCccCCCccccccccccc
Confidence 99765 4689999999999999999999999 9999999999999987 78999999999987655443333
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....+.. ......+...++.
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~-~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEK-GDRLPKPDLCPPV 242 (281)
T ss_dssp -CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHH-TCCCCCCTTCCHH
T ss_pred ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhc-CCCCCCCCCCCHH
Confidence 34557889999999998899999999999999999998 999986432211 1111111 1112334456788
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.88 Aligned_cols=239 Identities=18% Similarity=0.232 Sum_probs=195.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..+|+.|++|.+..++ ..||+|.+..........+.+|++++++++||||+++++++.+.+..++||||+++|+|.++
T Consensus 61 ~G~~g~Vy~~~~~~~~--~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~ 138 (387)
T 1kob_A 61 SGAFGVVHRCVEKATG--RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 138 (387)
T ss_dssp EETTEEEEEEEETTTC--CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHH
T ss_pred cCCCEEEEEEEECCCC--CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHH
Confidence 4466777777665444 57888888765555567899999999999999999999999999999999999999999999
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ ..+.+||+|||+++....... ..
T Consensus 139 l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~-----~~~~vkL~DFG~a~~~~~~~~--~~ 208 (387)
T 1kob_A 139 IAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETK-----KASSVKIIDFGLATKLNPDEI--VK 208 (387)
T ss_dssp TTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESST-----TCCCEEECCCTTCEECCTTSC--EE
T ss_pred HHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecC-----CCCceEEEecccceecCCCcc--ee
Confidence 9766 4789999999999999999999999 99999999999999752 257899999999987654332 22
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-----CCCChhH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT-----GNLGATK 678 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 678 (725)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+........ .......
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~ 277 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------LETLQNVKRCDWEFDEDAFSSV 277 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHHHHCCCCCCSSTTTTS
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCCccccccC
Confidence 34689999999999999999999999999999999999999864321 1111111111 1112245
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+.+++.+||+.||++|||+.|++++
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 6789999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=310.83 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=193.6
Q ss_pred ccccHHHHHHHhcccCCcce--EEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEV--EVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~--~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|++|.+..+++.+ .|++|.+... .....+.+.+|+.++++++||||+++++++..+. .++|+||+++|+
T Consensus 24 G~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~ 102 (327)
T 3lzb_A 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGC 102 (327)
T ss_dssp EECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCB
T ss_pred eeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCc
Confidence 34567778888766665543 5788887543 3456788999999999999999999999998765 789999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 103 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~-------~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKT-------PQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEE-------TTEEEECCTTC---------
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcC-------CCCEEEccCcceeEccCccc
Confidence 99999764 6789999999999999999999999 9999999999999987 78899999999987644332
Q ss_pred cc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 RT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.. .....+|..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....+. .......+..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~-~~~~~~~~~~ 243 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILE-KGERLPQPPI 243 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHH-TTCCCCCCTT
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHH-cCCCCCCCcc
Confidence 22 223446788999999999999999999999999999999 999886542211 111111 1112234445
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
....+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 67789999999999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.33 Aligned_cols=234 Identities=21% Similarity=0.236 Sum_probs=193.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+|+.|+.+.+..+ +..||+|.+.+. .....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 17 G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~ 94 (318)
T 1fot_A 17 GSFGRVHLIRSRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94 (318)
T ss_dssp CSSCEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CCCEEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHH
Confidence 34555565555433 457899988643 2345677899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++..... .
T Consensus 95 ~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~-------~g~~kL~Dfg~a~~~~~~----~ 160 (318)
T 1fot_A 95 SLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDK-------NGHIKITDFGFAKYVPDV----T 160 (318)
T ss_dssp HHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECT-------TSCEEECCCSSCEECSSC----B
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcC-------CCCEEEeecCcceecCCc----c
Confidence 9999888899999999999999999999999 9999999999999987 889999999999865432 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 681 (725)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...... ....++....+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~i~~~~~~~p~~~~~~ 229 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------MKTYEKILNAELRFPPFFNED 229 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHCCCCCCTTSCHH
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCCCCCCHH
Confidence 235699999999999999999999999999999999999999964321 11111111 123345566788
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
+.+++.+||+.||++|| +++|+++|
T Consensus 230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 99999999999999999 89999865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.92 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=187.3
Q ss_pred ccccHHHHHHHhccc-CCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEc-CCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVF-DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~-~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~gs 520 (725)
...+|+.|++++... ++....||||.+.... ....+.|.+|+.++++++||||+++++++.. ++..++||||+++|+
T Consensus 98 G~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~ 177 (373)
T 3c1x_A 98 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 177 (373)
T ss_dssp ECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCB
T ss_pred eeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCC
Confidence 345677777776543 3456789999986533 3456789999999999999999999999765 567899999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 178 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~-------~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 178 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDE-------KFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TCCEEECCC-----------
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECC-------CCCEEEeecccccccccccc
Confidence 99999765 5689999999999999999999999 9999999999999987 78999999999986543322
Q ss_pred c---cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhC-CcCCCCCCCCccccccCcchHHHHHHHHHcCCCC
Q 039817 600 R---TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC-KRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG 675 (725)
Q Consensus 600 ~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (725)
. ......++..|+|||.+.+..++.++||||||+++|||++| ..|+...... .....+.. ......+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--------~~~~~~~~-~~~~~~p 318 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------DITVYLLQ-GRRLLQP 318 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--------CHHHHHHT-TCCCCCC
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--------HHHHHHHc-CCCCCCC
Confidence 1 12234477889999999999999999999999999999994 5555433211 11111111 0111233
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
...++.+.+++.+||+.||++|||++|++++|+.+.
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 456678999999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.46 Aligned_cols=250 Identities=15% Similarity=0.148 Sum_probs=191.1
Q ss_pred cccHHHHHHHhcccC-CcceEEEEEEcccccCc-----------cHHHHHHHHHHHhccCcCCccceeeEEEc----CCc
Q 039817 445 VFSYQELREATNVFD-GQEVEVAVKQLEKVTGD-----------GEKSFLREVQVIGRTHHKNLVQLLGFCIE----QNH 508 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~-~~~~~vavk~l~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~ 508 (725)
..+|+.|++|.+... .....+|||.+...... ....+.+|+..++.++|+||+++++++.. ...
T Consensus 47 ~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 126 (345)
T 2v62_A 47 SGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSY 126 (345)
T ss_dssp -----CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEE
T ss_pred ecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcE
Confidence 345667777766542 23457888887643321 12346788889999999999999999987 678
Q ss_pred eeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeec
Q 039817 509 QLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADF 588 (725)
Q Consensus 509 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Df 588 (725)
.++||||+ +++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+.+||+||
T Consensus 127 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-----~~~~~kL~Df 197 (345)
T 2v62_A 127 RFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK-----NPDQVYLADY 197 (345)
T ss_dssp EEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS-----STTSEEECCC
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC-----CCCcEEEEeC
Confidence 99999999 999999998878899999999999999999999999 99999999999999872 1349999999
Q ss_pred cCccccCcCCCc------cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchH
Q 039817 589 GLAKLLKKDQTR------TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILT 662 (725)
Q Consensus 589 gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~ 662 (725)
|+++.+...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ . .
T Consensus 198 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~------~-~ 270 (345)
T 2v62_A 198 GLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV------A-V 270 (345)
T ss_dssp TTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH------H-H
T ss_pred CCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH------H-H
Confidence 999876433211 11335699999999999999999999999999999999999999964322211 0 1
Q ss_pred HHHHHHHHcCCCCh---------hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 663 DWVLYCVRTGNLGA---------TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 663 ~~~~~~~~~~~~~~---------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
........ ...+. ..++.+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 271 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLL-DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHH-HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhc-ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111 11222 34568999999999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.15 Aligned_cols=242 Identities=22% Similarity=0.194 Sum_probs=186.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|+++++|.+..++ ..||||.+... .....+.+.+|++++++++||||+++++++..++..++||||++++.+.
T Consensus 12 ~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~ 89 (292)
T 3o0g_A 12 EGTYGTVFKAKNRETH--EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK 89 (292)
T ss_dssp ECSSSEEEEEEETTTC--CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred CCCCeEEEEEEECCCC--ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHH
Confidence 3456666666665443 56888887543 2334578899999999999999999999999999999999999875444
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
.+......+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++........ .
T Consensus 90 ~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~-~ 158 (292)
T 3o0g_A 90 YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINR-------NGELKLANFGLARAFGIPVRC-Y 158 (292)
T ss_dssp HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECCSCCSC-C
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC-------CCCEEEeecccceecCCcccc-c
Confidence 4444467899999999999999999999999 9999999999999987 789999999999876433222 2
Q ss_pred cccccCccccchhcccCCC-CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc----------
Q 039817 603 TMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---------- 671 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 671 (725)
....||..|+|||.+.+.. ++.++||||||++++||++|+.|+....... .....+......
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-------DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-------HHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-------HHHHHHHHHhCCCChhhhhhhc
Confidence 3345899999999997765 7999999999999999999998864332111 001111111000
Q ss_pred -----------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 -----------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 -----------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........+.+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00112346788999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=302.71 Aligned_cols=237 Identities=20% Similarity=0.293 Sum_probs=191.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gs 520 (725)
..+++.++++... +..||||.+... .....+.|.+|++++++++||||+++++++... +..++||||+++|+
T Consensus 20 ~G~~g~V~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 95 (271)
T 3kmu_A 20 ENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95 (271)
T ss_dssp EETTEEEEEEEET----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCB
T ss_pred CCCcceEEEEEEC----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCc
Confidence 3456666666653 567888887643 234456799999999999999999999999887 78899999999999
Q ss_pred hhhhhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCc--eeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 521 LSAFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQ--IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 521 L~~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
|.+++.... .+++..+..++.|+++||.|||+. + ++||||||+||+++. ++.+||.|||+......
T Consensus 96 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~-------~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 96 LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDE-------DMTARISMADVKFSFQS 165 (271)
T ss_dssp HHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECT-------TSCEEEEGGGSCCTTSC
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcC-------CcceeEEeccceeeecc
Confidence 999998764 589999999999999999999998 7 999999999999987 78899999988765332
Q ss_pred CCCccccccccCccccchhcccCCCCCC---ccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH---
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTA---KVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--- 670 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 670 (725)
. ...||+.|+|||.+.+...+. ++||||||+++|||++|+.|+..... .+.......
T Consensus 166 ~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~ 228 (271)
T 3kmu_A 166 P------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----------MEIGMKVALEGL 228 (271)
T ss_dssp T------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----------HHHHHHHHHSCC
T ss_pred c------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----------HHHHHHHHhcCC
Confidence 2 234789999999998765544 79999999999999999999864321 111111121
Q ss_pred cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 671 TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 671 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
....+...++.+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 223455667889999999999999999999999999987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.93 Aligned_cols=246 Identities=22% Similarity=0.265 Sum_probs=178.7
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
+...+|+.++++.+..+ +..||||.+.. .....+.+|++++++++ ||||+++++++.++...++||||+++|+|
T Consensus 19 lG~G~~g~V~~~~~~~~--~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 19 LGEGSFSICRKCVHKKS--NQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SEEETTEEEEEEEETTT--CCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred cccCCCeEEEEEEECCC--CCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 34556777777776544 45789998854 34577889999999997 99999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++.+. ....+||+|||+++........
T Consensus 94 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~----~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 94 FERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDEN----DNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC--------CEEEECCCTTCEECCC-----
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCC----CcccEEEeccccceecCCCCCc-
Confidence 99999888999999999999999999999999 999999999999997621 1348999999999865443222
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh-----
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA----- 676 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 676 (725)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||........ ... ...+......+....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~-~~~~~~~i~~~~~~~~~~~~ 240 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----CTS-AVEIMKKIKKGDFSFEGEAW 240 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------CCC-HHHHHHHHTTTCCCCCSHHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----ccc-HHHHHHHHHcCCCCCCcccc
Confidence 2334589999999999999999999999999999999999999975433210 111 112222333333221
Q ss_pred -hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 -TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 -~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..++.+.+|+.+||+.||++|||++|++++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 346789999999999999999999999866
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.67 Aligned_cols=237 Identities=15% Similarity=0.194 Sum_probs=192.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..+|+.++++.+..+ +..+|+|.+... ......+.+|++++++++||||+++++++.+.+..++||||+++++|.++
T Consensus 15 ~G~~g~Vy~~~~~~~--~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~ 91 (321)
T 1tki_A 15 RGEFGIVHRCVETSS--KKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFER 91 (321)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHH
T ss_pred cCCCeEEEEEEECCC--CcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHH
Confidence 345566666665443 457888887643 34556789999999999999999999999999999999999999999999
Q ss_pred hccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 525 LFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 525 l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ .++.+||+|||+++....... ..
T Consensus 92 l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~-----~~~~~kl~Dfg~a~~~~~~~~--~~ 161 (321)
T 1tki_A 92 INTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTR-----RSSTIKIIEFGQARQLKPGDN--FR 161 (321)
T ss_dssp HTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSS-----SCCCEEECCCTTCEECCTTCE--EE
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccC-----CCCCEEEEECCCCeECCCCCc--cc
Confidence 9766 4789999999999999999999999 99999999999999862 267899999999987654322 23
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC--Ch----h
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL--GA----T 677 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~ 677 (725)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.... ...... +. .
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~~-i~~~~~~~~~~~~~~ 229 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----------QQIIEN-IMNAEYTFDEEAFKE 229 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHH-HHHTCCCCCHHHHTT
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----------HHHHHH-HHcCCCCCChhhhcc
Confidence 35689999999999988899999999999999999999999964321 111111 112221 21 3
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.++.+.+++.+||+.||++|||+.|++++
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 45789999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.11 Aligned_cols=245 Identities=27% Similarity=0.319 Sum_probs=199.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
...++.++.+.+.. .+..||+|.+... ....+.+.+|++++++++||||+++++++..++..++||||+++++|.++
T Consensus 23 ~G~~g~V~~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 99 (288)
T 3kfa_A 23 GGQYGEVYEGVWKK--YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99 (288)
T ss_dssp GGTTCSEEEEEEGG--GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHH
T ss_pred CCCceeEEEeEecC--CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHH
Confidence 34455566555543 3468899998653 44567899999999999999999999999999999999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++...........
T Consensus 100 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~-------~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGE-------NHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp HHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECG-------GGCEEECCCCGGGTSCSSSSEEE
T ss_pred HHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcC-------CCCEEEccCccceeccCCccccc
Confidence 9764 4589999999999999999999999 9999999999999987 78899999999987765544444
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ...+.+.. ......+...++.
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~ 240 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEK-DYRMERPEGCPEK 240 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHT-TCCCCCCTTCCHH
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhc-cCCCCCCCCCCHH
Confidence 44557889999999998999999999999999999999 88887643211 11111111 1112334456788
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.+++.+|++.||.+|||+.|++++|+.+.
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=308.52 Aligned_cols=239 Identities=23% Similarity=0.280 Sum_probs=190.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc-----cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV-----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
..+|+.|+++.+..++ ..||||.+... .....+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 34 ~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 111 (351)
T 3c0i_A 34 KGPFSVVRRCINRETG--QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA 111 (351)
T ss_dssp ECSSEEEEEEEETTTC--CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSC
T ss_pred eCCCEEEEEEEECCCC--CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCC
Confidence 4456677777665544 56788877431 2235678999999999999999999999999999999999999999
Q ss_pred ChhhhhccC----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 520 TLSAFLFRQ----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 520 sL~~~l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+|.+++.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+. ....+||+|||+++...
T Consensus 112 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~----~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 112 DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKE----NSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp BHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSS----TTCCEEECCCTTCEECC
T ss_pred CHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCC----CCCcEEEecCcceeEec
Confidence 999888543 3589999999999999999999999 999999999999998631 14569999999998765
Q ss_pred cCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC-
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL- 674 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 674 (725)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... +........+..
T Consensus 185 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------------~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 185 ESGLV-AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------------ERLFEGIIKGKYK 250 (351)
T ss_dssp TTSCB-CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------------HHHHHHHHHTCCC
T ss_pred CCCee-ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------------HHHHHHHHcCCCC
Confidence 43221 223469999999999999999999999999999999999999996431 011111122221
Q ss_pred -C----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 -G----ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 -~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. ...++.+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 1345789999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=297.02 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=190.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCcc-------HHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDG-------EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~-------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
..+|+.++++.+..+ +..||||.+....... .+.+.+|++++++++||||+++++++.+.. ++||||++
T Consensus 29 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~ 104 (287)
T 4f0f_A 29 KGGFGLVHKGRLVKD--KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVP 104 (287)
T ss_dssp CCSSSCEEEEEETTT--CCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCT
T ss_pred cCCceeEEEEEEcCC--ceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecC
Confidence 345666666665443 4578999885433222 167899999999999999999999986654 69999999
Q ss_pred CCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCc--eeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 518 NGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQ--IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 518 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
+++|.+++.+. ..+++..+..++.|++.||.|||+. + |+||||||+||+++.+.. +....+||+|||+++..
T Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~--~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE--NAPVCAKVADFGLSQQS 179 (287)
T ss_dssp TCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT--TCSCCEEECCCTTCBCC
T ss_pred CCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC--CCceeEEeCCCCccccc
Confidence 99998888665 5789999999999999999999998 8 999999999999976211 11234999999999854
Q ss_pred CcCCCccccccccCccccchhcc--cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWL--RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
... .....|+..|+|||.+ ....++.++||||||+++|||++|+.||....... ..............
T Consensus 180 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 180 VHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------IKFINMIREEGLRP 249 (287)
T ss_dssp SSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH------HHHHHHHHHSCCCC
T ss_pred ccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH------HHHHHHHhccCCCC
Confidence 332 2335689999999998 44567899999999999999999999997543221 11111111111123
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..+...++.+.+++.+||+.||++|||++|+++.|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 34556778899999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.33 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=194.8
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+++.++.+.+. .+..||+|.+.... ...+.+.+|++++++++||||+++++++..++..++||||+++++|.+++
T Consensus 19 G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 94 (267)
T 3t9t_A 19 GQFGLVHLGYWL---NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL 94 (267)
T ss_dssp ETTEEEEEEEET---TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHH
T ss_pred CCceeEEEEEec---CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHH
Confidence 344555555443 34579999987543 34578999999999999999999999999999999999999999999999
Q ss_pred ccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++.............
T Consensus 95 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~-------~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 95 RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGE-------NQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECG-------GGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred hhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECC-------CCCEEEccccccccccccccccccc
Confidence 765 5689999999999999999999999 9999999999999987 7889999999998764432222233
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFER 681 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 681 (725)
..++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+....... ....+...++.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------SEVVEDISTGFRLYKPRLASTH 233 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTTCCCCCCTTSCHH
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----------HHHHHHHhcCCcCCCCccCcHH
Confidence 457788999999998899999999999999999999 7888764321 111111111 12234455778
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.+++.+||+.||++|||++|++++|+++.
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=309.41 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=196.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+++.+++|.+..++....|+||.+... .....+.+.+|+++++++ +||||+++++++...+..++||||+++++|
T Consensus 34 g~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 113 (327)
T 1fvr_A 34 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 113 (327)
T ss_dssp ECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred ecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCH
Confidence 345677788887777777777899998643 334456799999999999 899999999999999999999999999999
Q ss_pred hhhhccCC----------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEE
Q 039817 522 SAFLFRQE----------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585 (725)
Q Consensus 522 ~~~l~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl 585 (725)
.+++.+.. .+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||
T Consensus 114 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-------~~~~kL 183 (327)
T 1fvr_A 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE-------NYVAKI 183 (327)
T ss_dssp HHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG-------GGCEEE
T ss_pred HHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcC-------CCeEEE
Confidence 99997654 689999999999999999999999 9999999999999987 789999
Q ss_pred eeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHH
Q 039817 586 ADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDW 664 (725)
Q Consensus 586 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~ 664 (725)
+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+
T Consensus 184 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----------~~- 249 (327)
T 1fvr_A 184 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------AE- 249 (327)
T ss_dssp CCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HH-
T ss_pred cccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----------HH-
Confidence 9999987433221 1122346789999999998889999999999999999998 9998864321 11
Q ss_pred HHHHHHc---CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 665 VLYCVRT---GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 665 ~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
....... ...+...++.+.+++.+||+.||.+|||++|++++|+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 250 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111 2234456788999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.27 Aligned_cols=239 Identities=25% Similarity=0.255 Sum_probs=191.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...+|+.|+.|.+..+ +..||||.+.+. .....+.+.+|.++++++ +||||+++++++...+..++||||+++|
T Consensus 32 G~G~fg~V~~~~~~~~--~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg 109 (353)
T 3txo_A 32 GKGSFGKVMLARVKET--GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGG 109 (353)
T ss_dssp EEETTEEEEEEEETTT--CCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeCCCEEEEEEEEcCC--CCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCC
Confidence 3445666666665543 457899988643 234456788999999988 7999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 110 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~-------~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDH-------EGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TSCEEECCCTTCBCSCC---
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECC-------CCCEEEccccceeecccCCc
Confidence 9999998888899999999999999999999999 9999999999999987 88999999999986433222
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATK 678 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 678 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...... ....++...
T Consensus 180 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~ 247 (353)
T 3txo_A 180 -TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----------DDLFEAILNDEVVYPTWL 247 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCTTS
T ss_pred -cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCC
Confidence 22345699999999999988999999999999999999999999974321 11111111 122345556
Q ss_pred HHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSM------KQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~------~evl~~ 706 (725)
.+.+.+++.+||+.||++||++ +|+++|
T Consensus 248 ~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 7889999999999999999998 777753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.29 Aligned_cols=247 Identities=28% Similarity=0.351 Sum_probs=183.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc----CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT----GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.++++.+. +..||||.+.... ....+.+.+|++++++++||||+++++++..++..++||||+++++
T Consensus 17 ~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (271)
T 3dtc_A 17 IGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP 92 (271)
T ss_dssp EETTEEEEEEEET----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEE
T ss_pred cCCCeEEEEEEEc----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCC
Confidence 3455566666542 4578898876432 2335679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcccc-CCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI-DNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~-~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++. .+.+++..+..++.|+++||.|||+....+|+||||||+||+++.+.... ..++.+||+|||+++.......
T Consensus 93 L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 171 (271)
T 3dtc_A 93 LNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171 (271)
T ss_dssp HHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc
Confidence 999985 45789999999999999999999998222299999999999998632111 0267899999999986543322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH---cCCCCh
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR---TGNLGA 676 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 676 (725)
....|+..|+|||.+.+..++.++||||||++++||++|+.|+...... ........ ....+.
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 172 ---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----------AVAYGVAMNKLALPIPS 237 (271)
T ss_dssp -------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----------HHHHHHHTSCCCCCCCT
T ss_pred ---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHhhhcCCCCCCCCc
Confidence 2345899999999999999999999999999999999999998643211 11111111 123345
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
..++.+.+++.+||+.||++|||+.|++++|+.+
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 6678899999999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=310.54 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=191.9
Q ss_pred ccccHHHHHHHhcccCC--cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDG--QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~--~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|++|....++ ....||||.+.... ......|.+|++++++++||||+++++++...+..++||||+++++
T Consensus 53 G~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 132 (333)
T 1mqb_A 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 132 (333)
T ss_dssp EECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred ecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCc
Confidence 34567777777655433 35679999987532 2345679999999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 133 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~-------~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 133 LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNS-------NLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp HHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TCCEEECCCCC---------
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECC-------CCcEEECCCCcchhhccccc
Confidence 99999765 6789999999999999999999999 9999999999999987 78999999999987654322
Q ss_pred cc--ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CC
Q 039817 600 RT--STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GN 673 (725)
Q Consensus 600 ~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 673 (725)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+ +...... ..
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----------~~-~~~~~~~~~~~~ 270 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----------HE-VMKAINDGFRLP 270 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HH-HHHHHHTTCCCC
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----------HH-HHHHHHCCCcCC
Confidence 21 122346778999999999999999999999999999999 8888853321 11 1111221 22
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+...++.+.+++.+||+.||++||++.+++++|+.+.
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 34456788999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=313.31 Aligned_cols=242 Identities=21% Similarity=0.204 Sum_probs=184.8
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..+|+.++.+.+..++ ..||||.+... ....+.+.+|+.++++++||||+++++++..++..++||||+++|+|.++
T Consensus 30 ~G~~g~V~~~~~~~~~--~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 106 (361)
T 3uc3_A 30 SGNFGVARLMRDKLTK--ELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYER 106 (361)
T ss_dssp SSTTSSEEEEEETTTC--CEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred cCCCEEEEEEEECCCC--cEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHH
Confidence 4456677777665544 57899988653 33456789999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+...+.+++..+..++.|++.||.|||+. +|+||||||+||+++.+ ....+||+|||+++...... ....
T Consensus 107 l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~-----~~~~~kl~Dfg~a~~~~~~~--~~~~ 176 (361)
T 3uc3_A 107 ICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHS--QPKS 176 (361)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSS-----SSCCEEECCCCCC-------------
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC-----CCceEEEeecCccccccccC--CCCC
Confidence 98888899999999999999999999999 99999999999999862 24459999999998533222 1223
Q ss_pred cccCccccchhcccCCCCCCc-cceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-CCCCh--hHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAK-VDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT-GNLGA--TKFE 680 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~k-sDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~ 680 (725)
..||+.|+|||.+.+..+..+ +||||||+++|||++|+.||....... ............ ...+. ...+
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-------DYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-------CHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-------HHHHHHHHHhcCCCCCCCcCCCCH
Confidence 459999999999988887766 899999999999999999997543211 112222222111 12222 3467
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+|+.+||+.||++|||+.|++++
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 89999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=310.75 Aligned_cols=246 Identities=28% Similarity=0.371 Sum_probs=196.6
Q ss_pred ccHHHHHHHhccc-----CCcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccC
Q 039817 446 FSYQELREATNVF-----DGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~~-----~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
.+|+.|+.|.+.. ...+..||||.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 46 G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 125 (334)
T 2pvf_A 46 GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125 (334)
T ss_dssp CSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTT
T ss_pred cCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCC
Confidence 4566666665432 2345789999987543 23456799999999999 899999999999999999999999999
Q ss_pred CChhhhhccCC----------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCc
Q 039817 519 GTLSAFLFRQE----------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582 (725)
Q Consensus 519 gsL~~~l~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~ 582 (725)
++|.+++.... .+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.
T Consensus 126 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-------~~~ 195 (334)
T 2pvf_A 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE-------NNV 195 (334)
T ss_dssp CBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCC
T ss_pred CcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcC-------CCC
Confidence 99999997653 378999999999999999999999 9999999999999987 789
Q ss_pred eEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcc
Q 039817 583 TKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMI 660 (725)
Q Consensus 583 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~ 660 (725)
+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------- 265 (334)
T 2pvf_A 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---------- 265 (334)
T ss_dssp EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------
T ss_pred EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----------
Confidence 9999999998765433221 223447788999999988889999999999999999999 8888864321
Q ss_pred hHHHHHHHHH--cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 661 LTDWVLYCVR--TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 661 ~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+....... ....+......+.+++.+||+.||.+|||+.|++++|+.+.+
T Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 -EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp -HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111 123445567889999999999999999999999999988754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.67 Aligned_cols=252 Identities=15% Similarity=0.138 Sum_probs=190.0
Q ss_pred cHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
+|+.|+.|.+..+ +..||||.+.... ....+.+.+|++++++++|||||++++++..++..++||||+++|+|.++
T Consensus 39 ~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 116 (389)
T 3gni_B 39 DLMTVNLARYKPT--GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDL 116 (389)
T ss_dssp TTEEEEEEEETTT--CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred CceEEEEEEEcCC--CCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHH
Confidence 5666777776554 4578888876432 33456788999999999999999999999999999999999999999999
Q ss_pred hccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC---
Q 039817 525 LFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT--- 599 (725)
Q Consensus 525 l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~--- 599 (725)
+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||.+........
T Consensus 117 l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~-------~~~~kl~dfg~~~~~~~~~~~~~ 186 (389)
T 3gni_B 117 ICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISV-------DGKVYLSGLRSNLSMISHGQRQR 186 (389)
T ss_dssp HHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TCCEEECCGGGCEECEETTEECS
T ss_pred HhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC-------CCCEEEcccccceeecccccccc
Confidence 9765 6789999999999999999999999 9999999999999987 78999999999875432211
Q ss_pred ---ccccccccCccccchhcccC--CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCc-chHHHH--------
Q 039817 600 ---RTSTMIRGTMGYMAPEWLRN--APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM-ILTDWV-------- 665 (725)
Q Consensus 600 ---~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~-~~~~~~-------- 665 (725)
.......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ......
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (389)
T 3gni_B 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266 (389)
T ss_dssp CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------
T ss_pred ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccc
Confidence 11122358899999999987 6799999999999999999999999975432221100000 000000
Q ss_pred -------------------H--------HHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCC
Q 039817 666 -------------------L--------YCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGT 710 (725)
Q Consensus 666 -------------------~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~ 710 (725)
. ........+....+.+.+|+.+||+.||++|||++|++++ ++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0 0000001222345679999999999999999999999976 5544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.74 Aligned_cols=241 Identities=25% Similarity=0.317 Sum_probs=184.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhc--cCcCCccceeeEEEcC----CceeeeeecccC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR--THHKNLVQLLGFCIEQ----NHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~lV~e~~~~ 518 (725)
..+|+.|+++.. .+..||||.+.. ...+.+..|.+++.. ++||||+++++++... ...++||||+++
T Consensus 18 ~G~~g~V~~~~~----~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~ 90 (301)
T 3q4u_A 18 KGRYGEVWRGSW----QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 90 (301)
T ss_dssp ECSSEEEEEEEE----TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTT
T ss_pred cCCCcEEEEEEE----CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccC
Confidence 345556666544 356799999854 345667778777766 7999999999997643 458999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhh--------cccCCceeecCCccceEEeccCccccCCCCceEEeeccC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLH--------EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgl 590 (725)
|+|.+++. ...+++..+..++.|+++||.||| +. +|+||||||+|||++. ++.+||+|||+
T Consensus 91 g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~-------~~~~kl~Dfg~ 159 (301)
T 3q4u_A 91 GSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKK-------NGQCCIADLGL 159 (301)
T ss_dssp CBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECT-------TSCEEECCCTT
T ss_pred CCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcC-------CCCEEEeeCCC
Confidence 99999994 457899999999999999999999 76 9999999999999987 78999999999
Q ss_pred ccccCcCCCcc---ccccccCccccchhcccCC------CCCCccceehhHHHHHHHHhC----------CcCCCCCCCC
Q 039817 591 AKLLKKDQTRT---STMIRGTMGYMAPEWLRNA------PVTAKVDVYSFGVMLLEIIFC----------KRHTELHRVD 651 (725)
Q Consensus 591 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDv~S~G~vl~elltg----------~~~~~~~~~~ 651 (725)
++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.|+......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98654433221 1224699999999999876 445799999999999999999 5555433221
Q ss_pred ccccccCcchHHHHHHHHH----cCCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 652 EPTLANGMILTDWVLYCVR----TGNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~----~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
. ... ........ ....+ ....+.+.+++.+||+.||++|||+.||+++|+++
T Consensus 240 ~------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 D------PSF-EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp S------CCH-HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred C------cch-hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 111 11111111 11122 24678899999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.58 Aligned_cols=250 Identities=16% Similarity=0.152 Sum_probs=193.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+|++|+.+.+..+ +..||||.+.... ..+.+.+|+++++++ +|+||+++++++..++..++||||+ +++|.+
T Consensus 19 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~ 93 (330)
T 2izr_A 19 CGNFGELRLGKNLYT--NEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLED 93 (330)
T ss_dssp C-CTTSEEEEEETTT--TEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHH
T ss_pred ccCCceEEEEEECCC--CcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHH
Confidence 445677777776544 4678999876432 334689999999999 9999999999999999999999999 899999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc--
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-- 600 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-- 600 (725)
++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+.. .....+||+|||+++........
T Consensus 94 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~--~~~~~~kl~DFg~a~~~~~~~~~~~ 168 (330)
T 2izr_A 94 LFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGN--KTQQVIHIIDFALAKEYIDPETKKH 168 (330)
T ss_dssp HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGG--TCTTSEEECCCTTCEESBCTTTCCB
T ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCC--CCCceEEEEEcccceeeecCCCCcc
Confidence 99764 6799999999999999999999999 9999999999999987211 01123999999999876443321
Q ss_pred ----cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC--
Q 039817 601 ----TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL-- 674 (725)
Q Consensus 601 ----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 674 (725)
......||..|+|||.+.+..++.++||||||+++|||++|+.||........ ......+.........
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 169 IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-----KERYQKIGDTKRATPIEV 243 (330)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-----HHHHHHHHHHHHHSCHHH
T ss_pred ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-----HHHHHHHHhhhccCCHHH
Confidence 12345699999999999999999999999999999999999999976532210 0011111111111110
Q ss_pred -ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 675 -GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 675 -~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
....+ .+.+++..||+.||.+||++++|++.|+.+
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 01123 899999999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.47 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=196.9
Q ss_pred cccHHHHHHHhcccCCc---ceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDGQ---EVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~---~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
..+|+.|+.+.+...+. ...||+|.+..... ...+.+.+|+++++++ +||||+++++++..++..++||||+++|
T Consensus 56 ~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g 135 (333)
T 2i1m_A 56 AGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135 (333)
T ss_dssp ECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred cCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCC
Confidence 34566777776554432 35799999875432 3456799999999999 8999999999999999999999999999
Q ss_pred ChhhhhccC--------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEE
Q 039817 520 TLSAFLFRQ--------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585 (725)
Q Consensus 520 sL~~~l~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl 585 (725)
+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||
T Consensus 136 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~-------~~~~kl 205 (333)
T 2i1m_A 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN-------GHVAKI 205 (333)
T ss_dssp EHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG-------GGEEEB
T ss_pred cHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC-------CCeEEE
Confidence 999998642 3579999999999999999999999 9999999999999987 789999
Q ss_pred eeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHH
Q 039817 586 ADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTD 663 (725)
Q Consensus 586 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~ 663 (725)
+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~ 278 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-------KFYK 278 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-------HHHH
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-------HHHH
Confidence 9999998664433222 223447789999999998899999999999999999998 888876432211 1111
Q ss_pred HHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 664 WVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.... ......+...++.+.+++.+||+.||.+|||+.||+++|+.+
T Consensus 279 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 LVKD-GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhc-CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111 111223444567899999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.15 Aligned_cols=235 Identities=24% Similarity=0.300 Sum_probs=182.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccC--------------------------ccHHHHHHHHHHHhccCcCCccce
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTG--------------------------DGEKSFLREVQVIGRTHHKNLVQL 499 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--------------------------~~~~~f~~E~~~l~~l~H~niv~l 499 (725)
.+|+.|++|.+..+ +..||||.+..... ...+.+.+|++++++++||||+++
T Consensus 24 G~~g~Vy~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 101 (298)
T 2zv2_A 24 GSYGVVKLAYNEND--NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL 101 (298)
T ss_dssp --CCEEEEEEETTT--TEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCEEEEEEEECCC--CcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeE
Confidence 44556666655443 45788888754321 123568999999999999999999
Q ss_pred eeEEEc--CCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcccc
Q 039817 500 LGFCIE--QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITI 577 (725)
Q Consensus 500 ~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~ 577 (725)
++++.. .+..++||||+++++|.+++. ...+++..+..++.|+++||.|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~----- 172 (298)
T 2zv2_A 102 VEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGE----- 172 (298)
T ss_dssp EEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-----
T ss_pred EEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECC-----
Confidence 999986 568899999999999998764 45789999999999999999999999 9999999999999987
Q ss_pred CCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCC---CCCccceehhHHHHHHHHhCCcCCCCCCCCccc
Q 039817 578 DNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP---VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT 654 (725)
Q Consensus 578 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~ 654 (725)
++.+||+|||+++........ .....||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.....
T Consensus 173 --~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---- 245 (298)
T 2zv2_A 173 --DGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---- 245 (298)
T ss_dssp --TSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred --CCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH----
Confidence 789999999999876543222 23346899999999997665 37789999999999999999999864321
Q ss_pred cccCcchHHHHHHHHHcCC----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 655 LANGMILTDWVLYCVRTGN----LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..... ...... .....++.+.+++.+||+.||++|||+.|++++
T Consensus 246 -------~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 -------MCLHS-KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -------HHHHH-HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -------HHHHH-HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 11111 111111 122456789999999999999999999999764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.79 Aligned_cols=246 Identities=22% Similarity=0.240 Sum_probs=193.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.|+.+.+..+ +..||||.+.+.. ....+.+.+|..++.++ +||||+++++++...+..++||||+++|+
T Consensus 19 ~G~fg~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~ 96 (345)
T 3a8x_A 19 RGSYAKVLLVRLKKT--DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD 96 (345)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred ecCCeEEEEEEECCC--CCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCc
Confidence 345556666655433 4678999886542 22345688999999987 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 97 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~-------~g~~kL~DFG~a~~~~~~~~- 165 (345)
T 3a8x_A 97 LMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDS-------EGHIKLTDYGMCKEGLRPGD- 165 (345)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TSCEEECCGGGCBCSCCTTC-
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECC-------CCCEEEEeccccccccCCCC-
Confidence 999998888899999999999999999999999 9999999999999987 78999999999986432222
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 678 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .......+..... ...++...
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHCCCCCCTTS
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc---ccccHHHHHHHHHcCCCCCCCCC
Confidence 223456999999999999999999999999999999999999999653221110 0011122222222 23455567
Q ss_pred HHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSM------KQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~------~evl~~ 706 (725)
...+.+++.+||+.||++||++ .|+++|
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 7889999999999999999995 677754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.73 Aligned_cols=249 Identities=19% Similarity=0.213 Sum_probs=187.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCc---cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGD---GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..++.++++.+..+ +..||||.+...... ..+.+.+|++++++++||||+++++++..++..++||||+++++|.
T Consensus 45 G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 122 (309)
T 2h34_A 45 GGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLA 122 (309)
T ss_dssp CSSSEEEEEEETTT--TEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHH
T ss_pred CCCeeEEEEEEcCC--CeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHH
Confidence 34556666655443 467899998654322 2467899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++...........
T Consensus 123 ~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~-------~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 123 AMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSA-------DDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TSCEEECSCCC------------
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcC-------CCCEEEecCccCccccccccccc
Confidence 9998878899999999999999999999999 9999999999999987 78999999999987654433333
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC-----CCChh
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG-----NLGAT 677 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 677 (725)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ..+..
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------------SVMGAHINQAIPRPSTVRPG 260 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------------HHHHHHHHSCCCCGGGTSTT
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------------HHHHHHhccCCCCccccCCC
Confidence 345689999999999999999999999999999999999999864321 1111111111 12234
Q ss_pred HHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcCCCCCCCCCC
Q 039817 678 KFERITMVGLWCICPQPTLRP-SMKQVLQMLEGTSEVGVPPV 718 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~~~~~p~~ 718 (725)
.++.+.+++.+||+.||++|| +++++++.|+...+...+..
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 567899999999999999999 99999999998776544433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.76 Aligned_cols=237 Identities=21% Similarity=0.277 Sum_probs=192.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+|+.++.|.+.. .+..+|+|.+........+.+.+|++++++++||||+++++++..++..++||||+++++|.+++
T Consensus 20 G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 97 (277)
T 3f3z_A 20 GSWGEVKIAVQKG--TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV 97 (277)
T ss_dssp ETTEEEEEEEETT--TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred cCCEEEEEEEeCC--CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHH
Confidence 4455555555443 34678999987766677889999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
.....+++..+..++.|++.||.|||+. +|+||||||+||++..+ +.++.+||+|||++........ ....
T Consensus 98 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~----~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 168 (277)
T 3f3z_A 98 VHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTD----SPDSPLKLIDFGLAARFKPGKM--MRTK 168 (277)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSS----STTCCEEECCCTTCEECCTTSC--BCCC
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecC----CCCCcEEEEecccceeccCccc--hhcc
Confidence 8888899999999999999999999999 99999999999999432 1278899999999987654322 2234
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CCh----hHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LGA----TKF 679 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~----~~~ 679 (725)
.||+.|+|||.+.+. ++.++||||||++++||++|+.|+..... .+.... ...+. .+. ..+
T Consensus 169 ~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~-~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 169 VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-----------SEVMLK-IREGTFTFPEKDWLNVS 235 (277)
T ss_dssp CSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHH-HHHCCCCCCHHHHTTSC
T ss_pred CCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-----------HHHHHH-HHhCCCCCCchhhhcCC
Confidence 589999999988654 89999999999999999999999864321 111111 22222 222 346
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 789999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.26 Aligned_cols=240 Identities=23% Similarity=0.273 Sum_probs=186.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.|++|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+++ +|
T Consensus 30 G~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l 105 (311)
T 3niz_A 30 GEGTYGVVYKAKDS---QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL 105 (311)
T ss_dssp EECSSCEEEEEEET---TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EH
T ss_pred cCCCCeEEEEEEEC---CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CH
Confidence 34566777777652 35689999886432 23356789999999999999999999999999999999999985 78
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 106 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~-------~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 106 KKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINS-------DGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp HHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEETTSCCC-
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECC-------CCCEEEccCcCceecCCCcc-
Confidence 7777655 5689999999999999999999999 9999999999999987 78999999999987643322
Q ss_pred cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--------
Q 039817 601 TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT-------- 671 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 671 (725)
......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+......
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--------LPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--------HHHHHHHHCCCCTTTSGG
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHHHHHCCCChHHhhh
Confidence 2223458999999999876 5689999999999999999999999975433221 1111110000
Q ss_pred ---------CC-----------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 ---------GN-----------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ---------~~-----------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. ......+++.+|+.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 011234678899999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.26 Aligned_cols=239 Identities=23% Similarity=0.222 Sum_probs=186.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|+.+.+..+ +..||||.+... .......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 157 G~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~ 234 (446)
T 4ejn_A 157 GKGTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 234 (446)
T ss_dssp EEETTEEEEEEEETTT--CCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCB
T ss_pred eeCcCEEEEEEEEcCC--CCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCc
Confidence 3456777777766544 457899988642 33445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++.+...+++..+..++.|++.||.|||+ . +|+||||||+||||+. ++.+||+|||+++.......
T Consensus 235 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~-------~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 235 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDK-------DGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECS-------SSCEEECCCCCCCTTCC---
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECC-------CCCEEEccCCCceeccCCCc
Confidence 99999888889999999999999999999998 7 9999999999999987 78999999999986433222
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH-HHcCCCChhH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-VRTGNLGATK 678 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 678 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+..... .....++...
T Consensus 305 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~ 372 (446)
T 4ejn_A 305 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------EKLFELILMEEIRFPRTL 372 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCTTS
T ss_pred -ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----------HHHHHHHHhCCCCCCccC
Confidence 22345699999999999999999999999999999999999999964321 1111111 1223455567
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
.+.+.+|+.+||+.||.+|| +++|+++|
T Consensus 373 ~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 78899999999999999999 99999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.38 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=197.6
Q ss_pred ccccHHHHHHHhcccCC-cceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCce-eeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDG-QEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ-LLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~-~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV~e~~~~gs 520 (725)
...+|+.+++|...-++ ....+|+|.+..... ...+.|.+|++++++++||||+++++++...+.. ++||||+.+++
T Consensus 30 g~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~ 109 (298)
T 3pls_A 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGD 109 (298)
T ss_dssp EEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCB
T ss_pred ccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCC
Confidence 44567777777654433 345799999875433 3457899999999999999999999999876655 99999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 110 L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~-------~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 110 LLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDE-------SFTVKVADFGLARDILDREY 179 (298)
T ss_dssp HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT-------TCCEEECCTTSSCTTTTGGG
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC-------CCcEEeCcCCCcccccCCcc
Confidence 99999774 6789999999999999999999999 9999999999999987 78999999999986543321
Q ss_pred ---ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 600 ---RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 600 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......... ......+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~ 251 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-------FDLTHFLAQ-GRRLPQPE 251 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-------GGHHHHHHT-TCCCCCCT
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-------HHHHHHhhc-CCCCCCCc
Confidence 1122345788999999999999999999999999999999977765433211 111111111 11123344
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
..++.+.+++.+||+.||.+|||+++++++|+.+.
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 56778999999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.54 Aligned_cols=237 Identities=22% Similarity=0.320 Sum_probs=195.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|+.|.+..++ ..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 25 G~G~fg~V~~a~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~ 102 (476)
T 2y94_A 25 GVGTFGKVKVGKHELTG--HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE 102 (476)
T ss_dssp ECCSSSCEEEEEETTTC--CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEE
T ss_pred eeCCCeEEEEEEECCCC--CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 34566777777766554 57888988543 22345679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 103 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~-------~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 103 LFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDA-------HMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp HHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECT-------TCCEEECCCSSCEECCTTCC-
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEec-------CCCeEEEeccchhhcccccc-
Confidence 999998888899999999999999999999999 9999999999999987 78999999999987654322
Q ss_pred cccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--CCChh
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--NLGAT 677 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 677 (725)
.....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ..... ....+ ..+..
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----------~~~~~-~i~~~~~~~p~~ 238 (476)
T 2y94_A 172 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----------PTLFK-KICDGIFYTPQY 238 (476)
T ss_dssp -BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----------HHHHH-HHHTTCCCCCTT
T ss_pred -ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----------HHHHH-HHhcCCcCCCcc
Confidence 223469999999999988765 6899999999999999999999974321 11111 11222 23445
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+.+++.+||+.||++|||++|++++
T Consensus 239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 239 LNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 56789999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.73 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=184.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCc----eeeeeeccc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH----QLLVYELMK 517 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lV~e~~~ 517 (725)
...|+.++.|.+..+ +..||||.+..... ...+.|.+|++++++++||||+++++++..... .++||||++
T Consensus 22 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~ 99 (311)
T 3ork_A 22 FGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99 (311)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred cCCCEEEEEEEECCC--CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCC
Confidence 345666666665544 46789998865422 234578999999999999999999999886554 399999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 100 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISA-------TNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-------TSCEEECCCSCC------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcC-------CCCEEEeeccCccccccc
Confidence 999999998888899999999999999999999999 9999999999999987 788999999999876543
Q ss_pred CCc--cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC
Q 039817 598 QTR--TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG 675 (725)
Q Consensus 598 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (725)
... ......||..|+|||.+.+..++.++||||||+++|||++|+.||..... .+...........+
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVREDPIP 238 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHCCCCC
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhcCCCCC
Confidence 222 12235589999999999999999999999999999999999999864321 12222222222222
Q ss_pred h-----hHHHHHHHHHHHccCCCCCCCCCHHH-HHHHhcCCC
Q 039817 676 A-----TKFERITMVGLWCICPQPTLRPSMKQ-VLQMLEGTS 711 (725)
Q Consensus 676 ~-----~~~~~l~~l~~~cl~~dp~~RPs~~e-vl~~L~~~~ 711 (725)
. ..++.+.+++.+||+.||++||++.+ +.+.|....
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 2 24577999999999999999996555 445555443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.62 Aligned_cols=238 Identities=21% Similarity=0.277 Sum_probs=192.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|+.|.+..++ ..||||.+... .....+.+.+|++++++++||||+++++++..++..++||||+ +|+
T Consensus 18 G~G~~g~V~~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~ 94 (336)
T 3h4j_B 18 GEGSFGKVKLATHYKTQ--QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGE 94 (336)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEE
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCc
Confidence 34556667777665444 57888887532 2334567999999999999999999999999999999999999 689
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++........
T Consensus 95 l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~-------~~~~kl~DFG~s~~~~~~~~- 163 (336)
T 3h4j_B 95 LFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDD-------NLNVKIADFGLSNIMTDGNF- 163 (336)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECT-------TCCEEECCSSCTBTTTTSBT-
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcC-------CCCEEEEEeccceeccCCcc-
Confidence 999998888899999999999999999999999 9999999999999987 78999999999987654322
Q ss_pred cccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
.....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ... ......+...+
T Consensus 164 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--~i~--------~~~~~~p~~~s 232 (336)
T 3h4j_B 164 -LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--KVN--------SCVYVMPDFLS 232 (336)
T ss_dssp -TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--CCC--------SSCCCCCTTSC
T ss_pred -cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--HHH--------cCCCCCcccCC
Confidence 223469999999999988776 689999999999999999999997543322110 000 00112344566
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+.+++.+||+.||.+|||++|++++
T Consensus 233 ~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 233 PGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 788999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=303.71 Aligned_cols=235 Identities=20% Similarity=0.157 Sum_probs=195.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.|+.+.+..+ +..||||.+... .....+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 51 ~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L 128 (350)
T 1rdq_E 51 TGSFGRVMLVKHKES--GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128 (350)
T ss_dssp ECSSCEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred cCcCcEEEEEEECCC--CCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcH
Confidence 445667777766544 457899988542 234567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 129 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~-------~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQ-------QGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECSSC----
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECC-------CCCEEEcccccceeccCC----
Confidence 99998878899999999999999999999999 9999999999999987 789999999999876432
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 680 (725)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...... ....++....+
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~~~ 263 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------IQIYEKIVSGKVRFPSHFSS 263 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCTTCCH
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCCCH
Confidence 2234699999999999999999999999999999999999999964321 11111111 12234556678
Q ss_pred HHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
.+.+++.+||+.||.+||+ ++||+++
T Consensus 264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 8999999999999999998 8888865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.95 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=194.2
Q ss_pred ccHHHHHHHhcc--cCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCC
Q 039817 446 FSYQELREATNV--FDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGT 520 (725)
Q Consensus 446 ~~~~~l~~a~~~--~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gs 520 (725)
..++.++.+... -...+..||||.+... .....+.+.+|++++++++||||+++++++... ...++||||+++++
T Consensus 32 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 111 (302)
T 4e5w_A 32 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 111 (302)
T ss_dssp CSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCB
T ss_pred CCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCc
Confidence 344555554411 1234578999998643 334567899999999999999999999999876 66899999999999
Q ss_pred hhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 112 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~ 181 (302)
T 4e5w_A 112 LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVES-------EHQVKIGDFGLTKAIETDKE 181 (302)
T ss_dssp HHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE-------TTEEEECCCTTCEECCTTCC
T ss_pred HHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcC-------CCCEEECcccccccccCCCc
Confidence 9999954 46799999999999999999999999 9999999999999987 78999999999987654432
Q ss_pred c--cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc---cccCcchHHHHHHHHHc---
Q 039817 600 R--TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT---LANGMILTDWVLYCVRT--- 671 (725)
Q Consensus 600 ~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~--- 671 (725)
. ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+......... .................
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (302)
T 4e5w_A 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261 (302)
T ss_dssp EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCC
T ss_pred ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCC
Confidence 2 122345888899999999888999999999999999999999876432110000 00011111222222222
Q ss_pred CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 672 GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 672 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
...+...++.+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 262 LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2234466788999999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=326.24 Aligned_cols=242 Identities=26% Similarity=0.343 Sum_probs=195.8
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..|++|+++... ....||||.+.... ...++|.+|+++|++++|+||+++++++.+ +..+|||||+++|+|.+++
T Consensus 278 G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l 352 (535)
T 2h8h_A 278 GCFGEVWMGTWN---GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 352 (535)
T ss_dssp CSSEEEEEEEET---TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHH
T ss_pred CCCeEEEEEEEC---CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHH
Confidence 456666666543 23569999997543 356789999999999999999999999876 6789999999999999999
Q ss_pred ccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
... ..+++..++.|+.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++...........
T Consensus 353 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~-------~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 353 KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE-------NLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp SHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GGCEEECCTTSTTTCCCHHHHTTC
T ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcC-------CCcEEEcccccceecCCCceeccc
Confidence 753 5689999999999999999999999 9999999999999987 789999999999876543222222
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKFE 680 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 680 (725)
...++..|+|||.+....++.++||||||++||||++ |+.|+..... .+........ ...+....+
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----------~~~~~~i~~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------REVLDQVERGYRMPCPPECPE 491 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCCTTCCH
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCCCCCCH
Confidence 3446788999999998999999999999999999999 8888754321 1111111111 123446678
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
.+.+|+.+||+.||++|||+++|+++|+.+..-
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 899999999999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.31 Aligned_cols=237 Identities=28% Similarity=0.417 Sum_probs=182.5
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
+|+.++++... +..||||.+.. ....+.|.+|++++++++||||+++++++. +..++||||+++++|.+++.
T Consensus 20 ~~g~V~~~~~~----~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~ 91 (307)
T 2eva_A 20 AFGVVCKAKWR----AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLH 91 (307)
T ss_dssp SSSEEEEEEET----TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHH
T ss_pred CCceEEEEEEC----CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHh
Confidence 44445555432 46799999864 345678999999999999999999999887 45899999999999999998
Q ss_pred cCC---CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC-ceEEeeccCccccCcCCCccc
Q 039817 527 RQE---IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY-ITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 527 ~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~-~~kl~Dfgla~~~~~~~~~~~ 602 (725)
... .+++..++.++.|+++||.|||+....+|+||||||+||+++. ++ .+||+|||++.......
T Consensus 92 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~-------~~~~~kl~Dfg~~~~~~~~~---- 160 (307)
T 2eva_A 92 GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA-------GGTVLKICDFGTACDIQTHM---- 160 (307)
T ss_dssp CSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET-------TTTEEEECCCCC------------
T ss_pred ccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC-------CCCEEEEccccccccccccc----
Confidence 764 4688999999999999999999932238999999999999986 44 48999999997654321
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH--HcCCCChhHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV--RTGNLGATKFE 680 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 680 (725)
....|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ........ .........++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~ 231 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---------FRIMWAVHNGTRPPLIKNLPK 231 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---------HHHHHHHHTTCCCCCBTTCCH
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---------HHHHHHHhcCCCCCcccccCH
Confidence 22358999999999999999999999999999999999999986432211 11111111 11233445677
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+.+++.+||+.||++|||++|++++|+.+.
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 8999999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=308.42 Aligned_cols=239 Identities=23% Similarity=0.288 Sum_probs=194.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.|+.+.+..+ +..||+|.+... .....+.+.+|++++++++|||||++++++...+..++||||+++|+|
T Consensus 25 ~G~fG~V~~~~~~~~--~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L 102 (384)
T 4fr4_A 25 KGSFGKVCIVQKNDT--KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL 102 (384)
T ss_dssp CCTTCCEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred eCCCeEEEEEEECCC--CCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcH
Confidence 345666766665543 457899987542 244567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 103 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~-------~g~vkL~DFG~a~~~~~~~--~ 170 (384)
T 4fr4_A 103 RYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDE-------HGHVHITDFNIAAMLPRET--Q 170 (384)
T ss_dssp HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECCTTC--C
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECC-------CCCEEEeccceeeeccCCC--c
Confidence 99999888899999999999999999999999 9999999999999987 8899999999998765332 2
Q ss_pred ccccccCccccchhcccC---CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH-HHcCCCChh
Q 039817 602 STMIRGTMGYMAPEWLRN---APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-VRTGNLGAT 677 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 677 (725)
.....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........ ......+..
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------~~~~~~~~~~~~~~~p~~ 242 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--------SKEIVHTFETTVVTYPSA 242 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--------HHHHHHHHHHCCCCCCTT
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--------HHHHHHHHhhcccCCCCc
Confidence 234569999999999864 458999999999999999999999997543221 11111111 112345556
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPS-MKQVLQ 705 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs-~~evl~ 705 (725)
..+.+.+|+.+||+.||.+||+ +++|++
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 7789999999999999999998 777775
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.70 Aligned_cols=259 Identities=14% Similarity=0.101 Sum_probs=189.9
Q ss_pred ccccHHHHHHHhcccCC---cceEEEEEEcccccCcc-----------HHHHHHHHHHHhccCcCCccceeeEEEcC---
Q 039817 444 KVFSYQELREATNVFDG---QEVEVAVKQLEKVTGDG-----------EKSFLREVQVIGRTHHKNLVQLLGFCIEQ--- 506 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~---~~~~vavk~l~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~l~g~~~~~--- 506 (725)
...+|+.|++|.+..++ .+..||||.+....... ...+..|+..+++++|+||+++++++...
T Consensus 44 G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 123 (364)
T 3op5_A 44 GQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNG 123 (364)
T ss_dssp CCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETT
T ss_pred ecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCC
Confidence 34566777777654432 34678999876432211 12234555667778899999999999865
Q ss_pred -CceeeeeecccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceE
Q 039817 507 -NHQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584 (725)
Q Consensus 507 -~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~k 584 (725)
...+|||||+ +++|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.+ .++.+|
T Consensus 124 ~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~-----~~~~~k 194 (364)
T 3op5_A 124 KSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK-----NPDQVY 194 (364)
T ss_dssp EEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS-----CTTCEE
T ss_pred cceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC-----CCCeEE
Confidence 4589999999 99999999776 6799999999999999999999999 99999999999999831 278999
Q ss_pred EeeccCccccCcCCCcc------ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc-
Q 039817 585 IADFGLAKLLKKDQTRT------STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN- 657 (725)
Q Consensus 585 l~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~- 657 (725)
|+|||+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....+......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~ 274 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHH
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHH
Confidence 99999998764432211 12345999999999999999999999999999999999999999854322110000
Q ss_pred CcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 658 GMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.......+.......-.....++.+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 275 KIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 000000011111100011233568899999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=304.73 Aligned_cols=238 Identities=24% Similarity=0.271 Sum_probs=178.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
...|+.+++|.+.. .+..||||.+... ...+.+.+|++++++++||||+++++++..++..++||||+++++|.++
T Consensus 63 ~G~~g~Vy~~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 138 (349)
T 2w4o_A 63 RGATSIVYRCKQKG--TQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR 138 (349)
T ss_dssp ECSSEEEEEEEETT--TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred eCCCEEEEEEEECC--CCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHH
Confidence 34556666666543 3457899998753 2456788999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.....+++..+..++.|++.||.|||+. +|+||||||+|||++.. +.++.+||+|||+++....... ...
T Consensus 139 l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~----~~~~~~kl~Dfg~a~~~~~~~~--~~~ 209 (349)
T 2w4o_A 139 IVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATP----APDAPLKIADFGLSKIVEHQVL--MKT 209 (349)
T ss_dssp HTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSS----STTCCEEECCCC---------------
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecC----CCCCCEEEccCccccccCcccc--ccc
Confidence 98888899999999999999999999999 99999999999999752 2278899999999987543321 223
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC------CChhH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN------LGATK 678 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 678 (725)
..||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... +.......... .....
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----------QFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp ---CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----------HHHHHHHHTTCCCCCTTTTTTS
T ss_pred ccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----------HHHHHHHHhCCCccCCchhhhC
Confidence 45899999999999999999999999999999999999998643221 11111121211 11345
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+.+++.+||+.||++|||+.|++++
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6789999999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.47 Aligned_cols=240 Identities=20% Similarity=0.231 Sum_probs=191.2
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
+|++|+.+... ..+..||||.+.+. .....+.+.+|+.++.+++||||+++++++.+++..+|||||+++|+|.+
T Consensus 86 ~fG~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~ 163 (437)
T 4aw2_A 86 AFGEVAVVKLK--NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163 (437)
T ss_dssp SSEEEEEEEET--TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHH
T ss_pred CCEEEEEEEEc--CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHH
Confidence 44444444433 23467899988642 12233458999999999999999999999999999999999999999999
Q ss_pred hhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.+ ...+++..+..++.|++.||.|||+. +|+||||||+||||+. ++.+||+|||+++..........
T Consensus 164 ~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~-------~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDM-------NGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp HHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECCTTSCEEC
T ss_pred HHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcC-------CCCEEEcchhhhhhcccCCCccc
Confidence 9987 47899999999999999999999999 9999999999999987 88999999999987655544444
Q ss_pred cccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh-
Q 039817 603 TMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA- 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 676 (725)
....||+.|+|||++. ...++.++||||||+++|||++|+.||...... .....+........++.
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKERFQFPTQ 305 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTHHHHCCCCSS
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--------HHHHhhhhccccccCCcc
Confidence 4467999999999987 567899999999999999999999999753211 11111111111223332
Q ss_pred --hHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 039817 677 --TKFERITMVGLWCICPQPTL--RPSMKQVLQM 706 (725)
Q Consensus 677 --~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 706 (725)
...+.+.+|+.+||+.+|++ ||+++|++++
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 36788999999999998888 9999999976
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=302.31 Aligned_cols=240 Identities=22% Similarity=0.211 Sum_probs=185.3
Q ss_pred cccHHHHHHHhcccC-CcceEEEEEEccccc----CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFD-GQEVEVAVKQLEKVT----GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~-~~~~~vavk~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
..+|+.++.+.+... ..+..||+|.+.... ......+.+|++++++++||||+++++++..++..++||||++++
T Consensus 27 ~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 106 (327)
T 3a62_A 27 KGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG 106 (327)
T ss_dssp EETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTE
T ss_pred eCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCC
Confidence 345566666555332 345789999986532 234456889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~ 176 (327)
T 3a62_A 107 ELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNH-------QGHVKLTDFGLCKESIHDGT 176 (327)
T ss_dssp EHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECT-------TSCEEECCCSCC--------
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECC-------CCcEEEEeCCcccccccCCc
Confidence 9999998888899999999999999999999999 9999999999999987 78999999999986433222
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATK 678 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 678 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...... ....++...
T Consensus 177 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~i~~~~~~~p~~~ 244 (327)
T 3a62_A 177 -VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----------KKTIDKILKCKLNLPPYL 244 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHTCCCCCTTS
T ss_pred -cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhCCCCCCCCC
Confidence 12234689999999999999999999999999999999999999964321 11111111 123455566
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
.+.+.+++.+||+.||++|| ++.|+++|
T Consensus 245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 78899999999999999999 78888875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.35 Aligned_cols=237 Identities=22% Similarity=0.235 Sum_probs=193.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.|+.|.+..+ +..||||.+... .....+.+..|.+++.++ +||||+++++++...+..++||||+++|+
T Consensus 27 ~G~fg~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~ 104 (345)
T 1xjd_A 27 KGSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 104 (345)
T ss_dssp ECSSSEEEEEEETTT--TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred eCCCeEEEEEEECCC--CCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCc
Confidence 345666666665433 467899988653 234566788999999987 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~-------~g~vkL~DFG~a~~~~~~~~- 173 (345)
T 1xjd_A 105 LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDK-------DGHIKIADFGMCKENMLGDA- 173 (345)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TSCEEECCCTTCBCCCCTTC-
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECC-------CCCEEEeEChhhhhcccCCC-
Confidence 999998878899999999999999999999999 9999999999999987 78999999999986433222
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 679 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...... ....++....
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~s 242 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----------EELFHSIRMDNPFYPRWLE 242 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCTTSC
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----------HHHHHHHHhCCCCCCcccC
Confidence 22345699999999999999999999999999999999999999964321 11111111 1233455567
Q ss_pred HHHHHHHHHccCCCCCCCCCHH-HHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMK-QVLQ 705 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~-evl~ 705 (725)
+.+.+++.+||+.||++||++. +|++
T Consensus 243 ~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 243 KEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 8899999999999999999997 7764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.79 Aligned_cols=247 Identities=21% Similarity=0.274 Sum_probs=191.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEE----cCCceeeeeecccCCChh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI----EQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~e~~~~gsL~ 522 (725)
.|+.++.+.+..+ +..||||.+........+.+.+|++++++++||||+++++++. .....++||||+++++|.
T Consensus 41 ~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 118 (317)
T 2buj_A 41 GFSYVDLVEGLHD--GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118 (317)
T ss_dssp -CEEEEEEEETTT--CCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHH
T ss_pred CCeEEEEEEecCC--CcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHH
Confidence 3444555554433 4578999887655566778999999999999999999999997 344789999999999999
Q ss_pred hhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 523 AFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 523 ~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||++.......
T Consensus 119 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~-------~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGD-------EGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TSCEEECCCSSCEESCEEE
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcC-------CCCEEEEecCcchhccccc
Confidence 99875 46789999999999999999999999 9999999999999987 7899999999987653221
Q ss_pred Ccc--------ccccccCccccchhcccCCC---CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHH
Q 039817 599 TRT--------STMIRGTMGYMAPEWLRNAP---VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY 667 (725)
Q Consensus 599 ~~~--------~~~~~gt~~y~aPE~~~~~~---~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (725)
... .....|+..|+|||.+.+.. ++.++||||||+++|||++|+.|+....... .........
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~ 262 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG------DSVALAVQN 262 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT------SCHHHHHHC
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc------chhhHHhhc
Confidence 110 11234799999999987553 6899999999999999999999986421111 111111111
Q ss_pred HHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 668 CVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 668 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
..........++.+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 263 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 263 -QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11112233456789999999999999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.34 Aligned_cols=257 Identities=25% Similarity=0.313 Sum_probs=198.7
Q ss_pred ccHHHHHHHhcc--cCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEE--cCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNV--FDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI--EQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~--~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~gsL 521 (725)
.+|+.|+++... -...+..||||.+........+.+.+|++++++++|+||+++++++. .....++||||+++++|
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L 113 (327)
T 3lxl_A 34 GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113 (327)
T ss_dssp ETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBH
T ss_pred CCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCH
Confidence 345555555421 12345789999998766666778999999999999999999999987 45568999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++........
T Consensus 114 ~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~-------~~~~kl~Dfg~~~~~~~~~~~ 183 (327)
T 3lxl_A 114 RDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVES-------EAHVKIADFGLAKLLPLDKDY 183 (327)
T ss_dssp HHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE-------TTEEEECCGGGCEECCTTCSE
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECC-------CCCEEEcccccceecccCCcc
Confidence 9999764 5689999999999999999999999 9999999999999987 789999999999876543322
Q ss_pred --cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc---ccCcchHHHHHHHHHc---C
Q 039817 601 --TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL---ANGMILTDWVLYCVRT---G 672 (725)
Q Consensus 601 --~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~---~ 672 (725)
......++..|+|||.+.+..++.++||||||++++||++|+.|+.......... ................ .
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lxl_A 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263 (327)
T ss_dssp EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCC
T ss_pred ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCC
Confidence 1223457888999999998889999999999999999999999986432211000 0011111122222222 2
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
..+...++.+.+++.+||+.||++|||++|++++|+.+..
T Consensus 264 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 264 PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3344667889999999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.54 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=193.5
Q ss_pred ccccHHHHHHHhcccC-CcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEE-cCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFD-GQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCI-EQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~~gs 520 (725)
...+|+.+++|+...+ +....+|+|.+..... ...+.+.+|++++++++||||+++++++. .++..++||||+++++
T Consensus 34 g~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~ 113 (298)
T 3f66_A 34 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 113 (298)
T ss_dssp EEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCB
T ss_pred eecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCC
Confidence 3456777777765433 4556799999875333 34567999999999999999999999965 4567899999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 114 L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~-------~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 114 LRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDE-------KFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp HHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT-------TCCEEECSCGGGCCCSCGGG
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECC-------CCCEEECcccccccccccch
Confidence 99999764 5689999999999999999999999 9999999999999987 78999999999987644322
Q ss_pred c---cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 600 R---TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 600 ~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
. ......+|..|+|||.+.+..++.++||||||++++||++|..|+....... ........ ......+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-------~~~~~~~~-~~~~~~~~ 255 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQ-GRRLLQPE 255 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-------THHHHHHT-TCCCCCCT
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-------HHHHHHhc-CCCCCCCc
Confidence 1 1223457789999999999999999999999999999999665543222111 11111111 11122234
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
..++.+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 456789999999999999999999999999988653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=296.00 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=192.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|+.+++|.+..++ ..||+|.+... .....+.+.+|++++++++||||+++++++..++..++||||+++++|.
T Consensus 16 ~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 93 (284)
T 3kk8_A 16 KGAFSVVRRCVHKTTG--LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 93 (284)
T ss_dssp EETTEEEEEEEETTTC--CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CcCCeEEEEEEEcCCC--ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHH
Confidence 3456666666655444 46788877543 2334567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.+. ..+.+||+|||++........ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~----~~~~~kl~Dfg~~~~~~~~~~--~ 164 (284)
T 3kk8_A 94 EDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKA----KGAAVKLADFGLAIEVNDSEA--W 164 (284)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSS----TTCCEEECCCTTCEECCSSCB--C
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCC----CCCcEEEeeceeeEEcccCcc--c
Confidence 9998888899999999999999999999999 999999999999998632 145699999999986654322 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CC----h
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LG----A 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~ 676 (725)
....|++.|+|||.+.+..++.++||||||++++||++|+.|+..... .. .......+. .+ .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------~~-~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------HR-LYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHTCCCCCTTTTT
T ss_pred cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----------hH-HHHHHHhccccCCchhhc
Confidence 234589999999999999999999999999999999999999864321 11 111111111 11 2
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+.+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 456789999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.68 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=189.9
Q ss_pred cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcC--CceeeeeecccCCChhhhhccCCCCCHHHHH
Q 039817 461 QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ--NHQLLVYELMKNGTLSAFLFRQEIPTWDKRV 537 (725)
Q Consensus 461 ~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~ 537 (725)
.+..||||.+.... ....+.|.+|++++++++||||+++++++... ...++||||+++++|.+++.+. .+++..+.
T Consensus 59 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 137 (318)
T 3lxp_A 59 TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLL 137 (318)
T ss_dssp CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHH
T ss_pred CCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHH
Confidence 45789999987543 23456799999999999999999999999874 5789999999999999999665 48999999
Q ss_pred HHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc--cccccccCccccchh
Q 039817 538 EIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR--TSTMIRGTMGYMAPE 615 (725)
Q Consensus 538 ~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE 615 (725)
.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++........ ......++..|+|||
T Consensus 138 ~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~-------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE 207 (318)
T 3lxp_A 138 LFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDN-------DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207 (318)
T ss_dssp HHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHH
T ss_pred HHHHHHHHHHHHHHhC---CccCCCCchheEEEcC-------CCCEEECCccccccccccccccccccCCCCCceeeChH
Confidence 9999999999999999 9999999999999987 789999999999876544321 122345788899999
Q ss_pred cccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc---cCcchHHHHHHHHHc---CCCChhHHHHHHHHHHHc
Q 039817 616 WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA---NGMILTDWVLYCVRT---GNLGATKFERITMVGLWC 689 (725)
Q Consensus 616 ~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~c 689 (725)
.+.+..++.++||||||++++||++|+.|+........... ........+...... ...+...++.+.+++.+|
T Consensus 208 ~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 287 (318)
T 3lxp_A 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNC 287 (318)
T ss_dssp HHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHH
Confidence 99988899999999999999999999998864321110000 000011111222222 233445678899999999
Q ss_pred cCCCCCCCCCHHHHHHHhcCCCC
Q 039817 690 ICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 690 l~~dp~~RPs~~evl~~L~~~~~ 712 (725)
|+.||++|||+.|+++.|+.+.+
T Consensus 288 l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 288 WETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999988754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.16 Aligned_cols=238 Identities=24% Similarity=0.257 Sum_probs=194.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.|+.+.+. ..+..||||.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++|+
T Consensus 30 ~G~fg~V~~~~~~--~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~ 107 (353)
T 2i0e_A 30 KGSFGKVMLSERK--GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 107 (353)
T ss_dssp EETTEEEEEEEET--TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCc
Confidence 3455666666544 33568999998643 234567789999999988 89999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 108 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~-------~g~vkL~DFG~a~~~~~~~~- 176 (353)
T 2i0e_A 108 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDS-------EGHIKIADFGMCKENIWDGV- 176 (353)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TSCEEECCCTTCBCCCCTTC-
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcC-------CCcEEEEeCCcccccccCCc-
Confidence 999998878899999999999999999999999 9999999999999987 78999999999986432222
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 679 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...... ....++....
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~s 245 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------DELFQSIMEHNVAYPKSMS 245 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCTTSC
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHhCCCCCCCCCC
Confidence 22345699999999999999999999999999999999999999964321 11111111 1234455677
Q ss_pred HHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
+.+.+++.+||+.||.+||+ +++++++
T Consensus 246 ~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 88999999999999999995 5888765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=302.55 Aligned_cols=236 Identities=23% Similarity=0.391 Sum_probs=184.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCC----------------
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN---------------- 507 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---------------- 507 (725)
..+|+.|++|.+..++ ..||||.+.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 16 ~G~~g~V~~a~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (332)
T 3qd2_B 16 RGGFGVVFEAKNKVDD--CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDE 93 (332)
T ss_dssp CC-CSEEEEEEETTTC--CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------
T ss_pred CCCCeEEEEEEEcCCC--cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccc
Confidence 3456667777665444 578999886432 345678999999999999999999999986543
Q ss_pred -----------------------------------------ceeeeeecccCCChhhhhccCCC---CCHHHHHHHHHHH
Q 039817 508 -----------------------------------------HQLLVYELMKNGTLSAFLFRQEI---PTWDKRVEIALGI 543 (725)
Q Consensus 508 -----------------------------------------~~~lV~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi 543 (725)
..++||||+++++|.+++.+... .++..++.++.|+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi 173 (332)
T 3qd2_B 94 STDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI 173 (332)
T ss_dssp --------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHH
T ss_pred cccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHH
Confidence 27999999999999999987643 4667789999999
Q ss_pred HHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-----------ccccccccCcccc
Q 039817 544 ARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-----------RTSTMIRGTMGYM 612 (725)
Q Consensus 544 a~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~y~ 612 (725)
+.||.|||+. +|+||||||+||+++. ++.+||+|||+++....... .......||+.|+
T Consensus 174 ~~aL~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 174 AEAVEFLHSK---GLMHRDLKPSNIFFTM-------DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHhC---CeeecCCCcccEEEeC-------CCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999 9999999999999987 78999999999987654421 1122345999999
Q ss_pred chhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh---hHHHHHHHHHHHc
Q 039817 613 APEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA---TKFERITMVGLWC 689 (725)
Q Consensus 613 aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~c 689 (725)
|||.+.+..++.++||||||+++|||++|..++... ............+. ...+.+.+++.+|
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------------VRIITDVRNLKFPLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------------HHHHHHHHTTCCCHHHHHHCHHHHHHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------------HHHHHHhhccCCCcccccCChhHHHHHHHH
Confidence 999999999999999999999999999986654211 11112222333332 3346778999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 039817 690 ICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 690 l~~dp~~RPs~~evl~~ 706 (725)
|+.||++|||++|++++
T Consensus 310 l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 310 LSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCSSGGGSCCHHHHHHS
T ss_pred ccCCCCcCCCHHHHhhc
Confidence 99999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.04 Aligned_cols=246 Identities=22% Similarity=0.211 Sum_probs=197.4
Q ss_pred cccHHHHHHHhccc-CCcceEEEEEEccccc----CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccC
Q 039817 445 VFSYQELREATNVF-DGQEVEVAVKQLEKVT----GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~-~~~~~~vavk~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
...|+.|+.+.+.. ...+..||||.+.... ....+.+.+|+++++++ +|+||+++++++..++..++||||+++
T Consensus 64 ~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 143 (355)
T 1vzo_A 64 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 143 (355)
T ss_dssp ETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred cCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCC
Confidence 44566777766543 2356789999886432 23456688999999999 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
++|.+++.....+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 144 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 144 GELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS-------NGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp CBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TSCEEESCSSEEEECCGGG
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC-------CCcEEEeeCCCCeecccCC
Confidence 99999998888899999999999999999999999 9999999999999987 7899999999998765444
Q ss_pred CccccccccCccccchhcccC--CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCC
Q 039817 599 TRTSTMIRGTMGYMAPEWLRN--APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLG 675 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 675 (725)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......... .....+
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-------SQAEISRRILKSEPPYP 286 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-------CHHHHHHHHHHCCCCCC
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-------hHHHHHHHHhccCCCCC
Confidence 433444669999999999985 357899999999999999999999997543211 1112222221 123455
Q ss_pred hhHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 039817 676 ATKFERITMVGLWCICPQPTLRP-----SMKQVLQML 707 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~L 707 (725)
....+.+.+|+.+||+.||++|| +++|++++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 56778899999999999999999 999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=292.93 Aligned_cols=236 Identities=25% Similarity=0.304 Sum_probs=190.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+++.++.+.+..+ +..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 20 G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 97 (279)
T 3fdn_A 20 GKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY 97 (279)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHH
T ss_pred CCCeEEEEEEEccC--CcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHH
Confidence 44555666655433 457888887532 2234567999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++....... .
T Consensus 98 ~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~-------~~~~~l~Dfg~~~~~~~~~---~ 164 (279)
T 3fdn_A 98 RELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGS-------AGELKIADFGWSVHAPSSR---R 164 (279)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECT-------TSCEEECSCCEESCC--------
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcC-------CCCEEEEeccccccCCccc---c
Confidence 9998878899999999999999999999999 9999999999999987 7899999999986543322 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHH-HHHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY-CVRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 681 (725)
....|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+.... .......+....+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----------QETYKRISRVEFTFPDFVTEG 233 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCCCCCTTSCHH
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----------HHHHHHHHhCCCCCCCcCCHH
Confidence 234589999999999999999999999999999999999999864321 111111 11223445566788
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
+.+++.+||+.||++|||++|++++-
T Consensus 234 ~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCc
Confidence 99999999999999999999999763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.92 Aligned_cols=242 Identities=19% Similarity=0.178 Sum_probs=192.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|+.+.+..+ +..||+|.+.+. .....+.+.+|+++++.++|||||++++++.+++..++||||+++|+
T Consensus 78 G~G~fG~V~~~~~~~~--~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~ 155 (410)
T 3v8s_A 78 GRGAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155 (410)
T ss_dssp EECSSEEEEEEEETTT--CCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EcCCCEEEEEEEECCC--CcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3445666666655433 457899988542 22334568899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 156 L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~-------~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 156 LVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK-------SGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp HHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECCTTSEE
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECC-------CCCEEEeccceeEeeccCCcc
Confidence 9999865 4689999999999999999999999 9999999999999987 889999999999876554433
Q ss_pred cccccccCccccchhcccCCC----CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 601 TSTMIRGTMGYMAPEWLRNAP----VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...... .....+.........+.
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTHHHHCCCCT
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------hHHHHHHhccccccCCC
Confidence 334567999999999998665 789999999999999999999999743211 11111111111122332
Q ss_pred --hHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 039817 677 --TKFERITMVGLWCICPQPTL--RPSMKQVLQM 706 (725)
Q Consensus 677 --~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 706 (725)
...+.+.+|+.+||+.+|++ ||+++||++|
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 46788999999999999998 9999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.96 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=197.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..++.++.+.+.. .+..||||.+... .....+.+.+|++++++++||||+++++++..++..++||||+++++|.
T Consensus 25 G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 102 (284)
T 2vgo_A 25 GKFGNVYLAREKQ--NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELY 102 (284)
T ss_dssp CSSEEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHH
T ss_pred CCCeEEEEEEEcC--CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHH
Confidence 3455555555433 3467899988542 2334578999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||++....... .
T Consensus 103 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~kl~Dfg~~~~~~~~~---~ 169 (284)
T 2vgo_A 103 KELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGY-------KGELKIADFGWSVHAPSLR---R 169 (284)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECT-------TCCEEECCCTTCEECSSSC---B
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcC-------CCCEEEecccccccCcccc---c
Confidence 9998878899999999999999999999999 9999999999999987 7889999999987654322 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 681 (725)
....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... +...... .....+....+.
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----------ETHRRIVNVDLKFPPFLSDG 238 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----------HHHHHHHTTCCCCCTTSCHH
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----------HHHHHHhccccCCCCcCCHH
Confidence 2345899999999999999999999999999999999999998643211 1111111 122344556788
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH--hcCCCCCCCCCCccc
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM--LEGTSEVGVPPVVAD 721 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~~~~~p~~~~~ 721 (725)
+.+++.+|++.||.+|||++|++++ +........||....
T Consensus 239 ~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~~~~ 280 (284)
T 2vgo_A 239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280 (284)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCCC--
T ss_pred HHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCcccc
Confidence 9999999999999999999999974 344333444444433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=300.34 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=195.2
Q ss_pred ccHHHHHHHhccc---CCcceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcCC-ceeeeeecccCC
Q 039817 446 FSYQELREATNVF---DGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQN-HQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~lV~e~~~~g 519 (725)
.+|+.+++|.... ...+..||||.+..... ...+.+.+|+++++++ +||||+++++++...+ ..++||||++++
T Consensus 38 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~ 117 (316)
T 2xir_A 38 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117 (316)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTE
T ss_pred CCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCC
Confidence 3455555554321 23457899999875432 3446799999999999 7999999999998755 589999999999
Q ss_pred ChhhhhccCCC----------------CCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCce
Q 039817 520 TLSAFLFRQEI----------------PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYIT 583 (725)
Q Consensus 520 sL~~~l~~~~~----------------l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~ 583 (725)
+|.+++..... +++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+
T Consensus 118 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~-------~~~~ 187 (316)
T 2xir_A 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE-------KNVV 187 (316)
T ss_dssp EHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GGCE
T ss_pred cHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC-------CCCE
Confidence 99999976543 78999999999999999999999 9999999999999987 7889
Q ss_pred EEeeccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcch
Q 039817 584 KIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMIL 661 (725)
Q Consensus 584 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~ 661 (725)
||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..
T Consensus 188 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~ 260 (316)
T 2xir_A 188 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EF 260 (316)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-------HH
T ss_pred EECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH-------HH
Confidence 99999999876543322 2223457889999999999999999999999999999998 888886543221 11
Q ss_pred HHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 662 TDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
...+.. ......+....+.+.+++.+||+.||.+|||+.||+++|+.+.
T Consensus 261 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 261 CRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcc-CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 1112334456778999999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.01 Aligned_cols=239 Identities=21% Similarity=0.297 Sum_probs=191.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccC------ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTG------DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
.+|+.+++|.+..+ +..||||.+..... ...+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 23 G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 100 (321)
T 2a2a_A 23 GQFAIVKKCREKST--GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG 100 (321)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred cCCEEEEEEEECCC--CeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCC
Confidence 45566666665543 45788888764322 13678999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.+.. ....+||+|||++........
T Consensus 101 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~---~~~~~kl~Dfg~~~~~~~~~~ 174 (321)
T 2a2a_A 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI---PIPHIKLIDFGLAHEIEDGVE 174 (321)
T ss_dssp BHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS---SSCCEEECCCTTCEECCTTCC
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCC---CcCCEEEccCccceecCcccc
Confidence 9999998888899999999999999999999999 9999999999999987210 012799999999987654322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CC--
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LG-- 675 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 675 (725)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.|+..... .+.... ..... .+
T Consensus 175 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~-i~~~~~~~~~~ 240 (321)
T 2a2a_A 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QETLAN-ITSVSYDFDEE 240 (321)
T ss_dssp --CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHH-HHTTCCCCCHH
T ss_pred --ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHH-HHhcccccChh
Confidence 2234589999999999999999999999999999999999999864321 111111 11111 12
Q ss_pred --hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 --ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 --~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...++.+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1345678999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=298.14 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=185.1
Q ss_pred ccHHHHHHHhcccC-CcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCC-----ceeeeeeccc
Q 039817 446 FSYQELREATNVFD-GQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN-----HQLLVYELMK 517 (725)
Q Consensus 446 ~~~~~l~~a~~~~~-~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~ 517 (725)
.+|+.+++|....+ +.+..||||.+.... ....+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 45 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~ 124 (313)
T 3brb_A 45 GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124 (313)
T ss_dssp -CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCT
T ss_pred cCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEeccc
Confidence 34555666654432 345689999986432 334567999999999999999999999998755 3599999999
Q ss_pred CCChhhhhc------cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 518 NGTLSAFLF------RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 518 ~gsL~~~l~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
+++|.+++. ....+++..++.++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~-------~~~~kl~Dfg~~ 194 (313)
T 3brb_A 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD-------DMTVCVADFGLS 194 (313)
T ss_dssp TCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT-------TSCEEECSCSCC
T ss_pred CCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC-------CCcEEEeecCcc
Confidence 999999984 335689999999999999999999999 9999999999999987 789999999999
Q ss_pred cccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 592 KLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 592 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
+........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .....+.. .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~-~ 265 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------EMYDYLLH-G 265 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHT-T
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--------HHHHHHHc-C
Confidence 876443221 2223457889999999999999999999999999999999 77777543211 11111111 0
Q ss_pred HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 670 RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 670 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.....+...++.+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112344556788999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=295.07 Aligned_cols=240 Identities=26% Similarity=0.364 Sum_probs=193.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+++.++.+... .+..||||.+... ....+.|.+|++++++++||||+++++++. .+..++||||+++++|.+++
T Consensus 24 G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l 98 (279)
T 1qpc_A 24 GQFGEVWMGYYN---GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFL 98 (279)
T ss_dssp ETTEEEEEEEET---TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHT
T ss_pred CCCeEEEEEEEc---CCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHH
Confidence 445556655532 3457999998654 345678999999999999999999999986 45689999999999999999
Q ss_pred ccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.... .+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++............
T Consensus 99 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 99 KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSD-------TLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp TSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TSCEEECCCTTCEECSSSCEECCT
T ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcC-------CCCEEECCCcccccccCccccccc
Confidence 7653 689999999999999999999999 9999999999999987 789999999999876554333333
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKFE 680 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 680 (725)
...++..|+|||.+.+..++.++||||||++++||++ |+.|+..... .+....... ....+...++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----------PEVIQNLERGYRMVRPDNCPE 237 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----------HHHHHHHhcccCCCCcccccH
Confidence 3457788999999998889999999999999999999 8888754321 111111111 1223445678
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+.+++.+|++.||++|||++++++.|+.+.
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 8999999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.35 Aligned_cols=235 Identities=23% Similarity=0.361 Sum_probs=191.6
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEc----------------CCcee
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE----------------QNHQL 510 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----------------~~~~~ 510 (725)
.++.++++.+..+ +..||+|.+.... +.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~g~V~~~~~~~~--~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (284)
T 2a19_B 23 GFGQVFKAKHRID--GKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLF 96 (284)
T ss_dssp SSCCEEEEEETTT--CCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEE
T ss_pred CceEEEEEEEcCC--CeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEE
Confidence 4455555554433 4578999886432 357899999999999999999999864 44579
Q ss_pred eeeecccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeec
Q 039817 511 LVYELMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADF 588 (725)
Q Consensus 511 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Df 588 (725)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+||
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kl~Df 166 (284)
T 2a19_B 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD-------TKQVKIGDF 166 (284)
T ss_dssp EEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE-------TTEEEECCC
T ss_pred EEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC-------CCCEEECcc
Confidence 999999999999999654 5789999999999999999999999 9999999999999987 789999999
Q ss_pred cCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH
Q 039817 589 GLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC 668 (725)
Q Consensus 589 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (725)
|++........ .....|+..|+|||.+.+..++.++||||||+++|||++|..++... ......
T Consensus 167 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------------~~~~~~ 230 (284)
T 2a19_B 167 GLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------------SKFFTD 230 (284)
T ss_dssp TTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------------HHHHHH
T ss_pred hhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------------HHHHHH
Confidence 99987654332 22345899999999999999999999999999999999998876421 112222
Q ss_pred HHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 669 VRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 669 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
......+...+..+.+++.+||+.||.+|||+.|++++|+.+..-
T Consensus 231 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 231 LRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 334555666677899999999999999999999999999887654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=302.25 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=190.2
Q ss_pred cccHHHHHHHhcc-cCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNV-FDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~-~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+++.++++... -++....||||.+... .....+.+.+|++++++++||||+++++++..+. .++|+||+++++
T Consensus 28 ~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~ 106 (291)
T 1u46_A 28 DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGS 106 (291)
T ss_dssp ----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCB
T ss_pred CCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCC
Confidence 3456667776643 3455678999988643 2344678999999999999999999999998765 889999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~-------~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 107 LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLAT-------RDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp HHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEE-------TTEEEECCCTTCEECCC-CC
T ss_pred HHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcC-------CCCEEEcccccccccccccc
Confidence 99999764 5689999999999999999999999 9999999999999987 78999999999987654332
Q ss_pred cc--ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CC
Q 039817 600 RT--STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GN 673 (725)
Q Consensus 600 ~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 673 (725)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+........ ..
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------SQILHKIDKEGERLP 245 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTSCCCCC
T ss_pred chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----------HHHHHHHHccCCCCC
Confidence 21 223457888999999988889999999999999999999 8988864321 1112221111 12
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+...++.+.+++.+||+.||++|||+.+++++|+++.+
T Consensus 246 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 334567889999999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=299.53 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=194.6
Q ss_pred ccHHHHHHHhccc---CCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVF---DGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..++.+++|.... ...+..||||.+..... .....|.+|++++++++|+||+++++++..++..++||||+++++|
T Consensus 36 G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 115 (322)
T 1p4o_A 36 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115 (322)
T ss_dssp CSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred CCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcH
Confidence 3455555554431 13356899999875432 3445799999999999999999999999999999999999999999
Q ss_pred hhhhccC----------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 522 SAFLFRQ----------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 522 ~~~l~~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 116 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~-------~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE-------DFTVKIGDFGMT 185 (322)
T ss_dssp HHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT-------TCCEEECCTTCC
T ss_pred HHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC-------CCeEEECcCccc
Confidence 9998652 3568999999999999999999999 9999999999999987 789999999999
Q ss_pred cccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 592 KLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 592 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
+........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+ .....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~-~~~~~ 253 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----------EQ-VLRFV 253 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----------HH-HHHHH
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----------HH-HHHHH
Confidence 865433222 1223346889999999999999999999999999999999 7777754321 11 11112
Q ss_pred HcC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 670 RTG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 670 ~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
..+ ..+...++.+.+++.+||+.||.+|||+.|++++|+++.+
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 222 2344567789999999999999999999999999988654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=299.79 Aligned_cols=240 Identities=23% Similarity=0.286 Sum_probs=184.8
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+|+.|++|.+..+ +..||||.+.... ....+.+.+|++++++++||||+++++++..++..++||||++ ++|.+
T Consensus 15 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~ 91 (317)
T 2pmi_A 15 NGTYATVYKGLNKTT--GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKK 91 (317)
T ss_dssp ----CEEEEEECSSS--CCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHH
T ss_pred CCCCEEEEEEEECCC--CcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHH
Confidence 345556666655443 4678888886432 3345789999999999999999999999999999999999998 59999
Q ss_pred hhccC------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 524 FLFRQ------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 524 ~l~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 92 ~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~-------~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 92 YMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINK-------RGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp HHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCSSCEETTSC
T ss_pred HHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcC-------CCCEEECcCccceecCCC
Confidence 88643 3589999999999999999999999 9999999999999987 789999999999876433
Q ss_pred CCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-------
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV------- 669 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 669 (725)
... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+....
T Consensus 162 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 162 VNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--------QLKLIFDIMGTPNESL 232 (317)
T ss_dssp CCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCSCCTTT
T ss_pred ccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHhCCCChhH
Confidence 221 223458999999999876 468999999999999999999999986532111 000000000
Q ss_pred -------------------------HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 -------------------------RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 -------------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..........+.+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0001112345679999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.93 Aligned_cols=239 Identities=27% Similarity=0.400 Sum_probs=179.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.+|+.|+++... ..||||.+... .....+.|.+|++++++++|+||+++++++ .....++||||+++++|.+
T Consensus 35 G~~g~Vy~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~ 108 (289)
T 3og7_A 35 GSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYH 108 (289)
T ss_dssp CSSEEEEEEESS-----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHH
T ss_pred CCCeEEEEEEEc-----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHH
Confidence 345555555432 24888887543 233456799999999999999999999965 5566899999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-cc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RT 601 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~-~~ 601 (725)
++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++....... ..
T Consensus 109 ~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 109 HLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHE-------DNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp HHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET-------TTEEEECCCC-------------
T ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC-------CCCEEEccceecccccccccccc
Confidence 99654 5789999999999999999999999 9999999999999987 78999999999986543221 22
Q ss_pred ccccccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC-----
Q 039817 602 STMIRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN----- 673 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 673 (725)
.....||..|+|||.+. +..++.++||||||+++|||++|+.||...... +.+......+.
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----------DQIIEMVGRGSLSPDL 247 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-----------HHHHHHHHHTSCCCCT
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-----------HHHHHHhcccccCcch
Confidence 23356899999999986 567888999999999999999999998643211 11222222221
Q ss_pred --CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 674 --LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 674 --~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.....++.+.+++.+||+.||.+|||+.|++++|+.+.
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 22355688999999999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.59 Aligned_cols=237 Identities=26% Similarity=0.346 Sum_probs=187.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEc----CCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE----QNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~ 517 (725)
...+|+.+++|.+.. .+..||+|.+... .....+.+.+|++++++++||||+++++++.. +...++||||++
T Consensus 35 g~G~~g~Vy~~~~~~--~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 112 (290)
T 1t4h_A 35 GRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112 (290)
T ss_dssp EECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred cCCCCeEEEEeEecC--CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecC
Confidence 345566677766553 3467888877543 33445679999999999999999999999875 356899999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCc--eeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ--IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+++|.+++.....+++..+..++.|++.||.|||+. + |+||||||+||+++.+ ++.+||+|||++....
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~------~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGP------TGSVKIGDLGLATLKR 183 (290)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESST------TSCEEECCTTGGGGCC
T ss_pred CCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECC------CCCEEEeeCCCccccc
Confidence 999999998878899999999999999999999998 7 9999999999999732 7799999999997644
Q ss_pred cCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC-
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL- 674 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 674 (725)
... .....|+..|+|||.+.+ .++.++||||||++++||++|+.|+...... .........+..
T Consensus 184 ~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 184 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----------AQIYRRVTSGVKP 248 (290)
T ss_dssp TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----------HHHHHHHTTTCCC
T ss_pred ccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----------HHHHHHHhccCCc
Confidence 332 223458999999998874 5899999999999999999999998643221 111122222211
Q ss_pred ---ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 ---GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+....+.+.+++.+||+.||.+|||++|++++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 22334679999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=290.68 Aligned_cols=264 Identities=17% Similarity=0.167 Sum_probs=198.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEE-EcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFC-IEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+++.++++.+..+ +..||||.+.... ..+.+.+|++++++++|++++..++++ ..++..++||||+ +++|.+
T Consensus 19 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~ 93 (296)
T 3uzp_A 19 SGSFGDIYLGTDIAA--GEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLED 93 (296)
T ss_dssp EETTEEEEEEEETTT--TEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHH
T ss_pred cCCCeEEEEEEEcCC--CcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHH
Confidence 345566666665443 4578899876432 335689999999999988877766666 5667789999999 899999
Q ss_pred hhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc--
Q 039817 524 FLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-- 600 (725)
Q Consensus 524 ~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-- 600 (725)
++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++.+||+|||+++........
T Consensus 94 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~----~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (296)
T 3uzp_A 94 LFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLG----KKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCG----GGTTCEEECCCTTCEECBCTTTCCB
T ss_pred HHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecC----CCCCeEEEeeCCCcccccccccccc
Confidence 9974 46799999999999999999999999 99999999999999521 11788999999999876544321
Q ss_pred ----cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC---
Q 039817 601 ----TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--- 673 (725)
Q Consensus 601 ----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 673 (725)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .......+........
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-----KRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-----SSSHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh-----hhhhhhhhcccccCCchHH
Confidence 1234569999999999999999999999999999999999999997643221 1111111111111111
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC--CCCCCccccCCC
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV--GVPPVVADAQMF 725 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~--~~p~~~~~~~~~ 725 (725)
.....++.+.+++.+||+.||++|||+++|++.|+.+.+- .....+.+|+++
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 1123457899999999999999999999999999886532 233445666653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.41 Aligned_cols=232 Identities=24% Similarity=0.228 Sum_probs=180.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..+ +..||||++.... ......+..|+..+.++ +|+||+++++++.+++..++||||+ +++
T Consensus 66 G~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~ 142 (311)
T 3p1a_A 66 GHGSYGEVFKVRSKED--GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142 (311)
T ss_dssp EEETTEEEEEEEETTT--SCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCB
T ss_pred ccCCCeEEEEEEECCC--CeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCC
Confidence 3455667777665544 4578999875432 22334566777766665 8999999999999999999999999 568
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 143 L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~-------~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 143 LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGP-------RGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp HHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECG-------GGCEEECCCTTCEECC----
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECC-------CCCEEEccceeeeecccCCC
Confidence 98888664 5699999999999999999999999 9999999999999987 78999999999987643322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC----
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG---- 675 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 675 (725)
.....||+.|+|||.+.+ .++.++||||||+++|||++|..++..... ......+..+
T Consensus 213 --~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------------~~~~~~~~~~~~~~ 274 (311)
T 3p1a_A 213 --GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------------WQQLRQGYLPPEFT 274 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------------HHHHTTTCCCHHHH
T ss_pred --CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------------HHHHhccCCCcccc
Confidence 233458999999999876 789999999999999999999877653211 1111112222
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....+.+.+++.+||+.||++|||++|++++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 2345789999999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.26 Aligned_cols=238 Identities=24% Similarity=0.343 Sum_probs=171.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..++.++++.+..+ +..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 22 G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 99 (278)
T 3cok_A 22 GSFAGVYRAESIHT--GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMN 99 (278)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHH
T ss_pred CCceEEEEEEEccC--CceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHH
Confidence 44556666655444 357888888542 2233578999999999999999999999999999999999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+..++.|+++||.|||+. +++||||||+||+++. ++.+||+|||++.........
T Consensus 100 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~-------~~~~kl~dfg~~~~~~~~~~~- 168 (278)
T 3cok_A 100 RYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTR-------NMNIKIADFGLATQLKMPHEK- 168 (278)
T ss_dssp HHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECT-------TCCEEECCCTTCEECC------
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC-------CCCEEEEeecceeeccCCCCc-
Confidence 999876 6789999999999999999999999 9999999999999987 789999999999876433221
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
.....|+..|+|||.+.+..++.++||||||++++||++|+.|+.......... ... ......+......
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~--------~~~~~~~~~~~~~ 238 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN--KVV--------LADYEMPSFLSIE 238 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------CC--------SSCCCCCTTSCHH
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH--HHh--------hcccCCccccCHH
Confidence 123458999999999999899999999999999999999999987543221100 000 0011234445678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+++.+||+.||++|||+++++++
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcC
Confidence 8999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=304.78 Aligned_cols=232 Identities=22% Similarity=0.276 Sum_probs=190.8
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC--------ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG--------DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
..+|+.|++|.+..+ +..||||.+..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 34 ~G~~g~Vy~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 111 (335)
T 3dls_A 34 SGAFGFVWTAVDKEK--NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKH 111 (335)
T ss_dssp SSSSCSEEEEEETTT--TEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecCCEEEEEEEECCC--CcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeC
Confidence 345666676765544 46788998865321 13346788999999999999999999999999999999999
Q ss_pred cCC-ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 517 KNG-TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 517 ~~g-sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
..| +|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 112 ~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 112 GSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAE-------DFTIKLIDFGSAAYLE 181 (335)
T ss_dssp TTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TSCEEECCCTTCEECC
T ss_pred CCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcC-------CCcEEEeecccceECC
Confidence 777 9999999888899999999999999999999999 9999999999999987 7899999999998765
Q ss_pred cCCCccccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
.... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .....
T Consensus 182 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------------~~~~~ 243 (335)
T 3dls_A 182 RGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE----------------AAIHP 243 (335)
T ss_dssp TTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT----------------TCCCC
T ss_pred CCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh----------------hccCC
Confidence 4332 223558999999999988776 7899999999999999999999864321110 01122
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+....+.+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33456788999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.62 Aligned_cols=246 Identities=15% Similarity=0.149 Sum_probs=192.3
Q ss_pred cccHHHHHHHhcccCC------cceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccc---------------eeeEE
Q 039817 445 VFSYQELREATNVFDG------QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQ---------------LLGFC 503 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~------~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~---------------l~g~~ 503 (725)
..+|+.+++|.+..++ .+..||||.+... +.+.+|++++++++||||++ +++++
T Consensus 52 ~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~ 126 (352)
T 2jii_A 52 RDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFG 126 (352)
T ss_dssp EETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEE
T ss_pred CCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhcc
Confidence 3456777777765532 3678999988643 46889999999999999998 67777
Q ss_pred Ec-CCceeeeeecccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCC
Q 039817 504 IE-QNHQLLVYELMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580 (725)
Q Consensus 504 ~~-~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~ 580 (725)
.. ++..++||||+ +++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. +
T Consensus 127 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~-------~ 195 (352)
T 2jii_A 127 VHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP-------E 195 (352)
T ss_dssp EETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET-------T
T ss_pred ccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC-------C
Confidence 76 67889999999 99999999876 7899999999999999999999999 9999999999999987 5
Q ss_pred C--ceEEeeccCccccCcCCCc------cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCc
Q 039817 581 Y--ITKIADFGLAKLLKKDQTR------TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDE 652 (725)
Q Consensus 581 ~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~ 652 (725)
+ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 5 8999999999876543221 1123468999999999999999999999999999999999999997543221
Q ss_pred cccccCcchHHHHHHHHHcC-CCC------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 653 PTLANGMILTDWVLYCVRTG-NLG------ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~-~~~------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.............. .+. ...++.+.+++.+||+.||++|||+++|++.|+++.+
T Consensus 276 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 276 ------EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp ------HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 11111111111111 111 1236889999999999999999999999999988753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.02 Aligned_cols=240 Identities=25% Similarity=0.226 Sum_probs=183.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc-----cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV-----TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
.+|+.|+.|.+..+ +..||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 37 G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~ 114 (345)
T 3hko_A 37 GSYGVVRVAIENQT--RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH 114 (345)
T ss_dssp CSSCEEEEEEETTT--CCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred cCCeEEEEEEECCC--CceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCc
Confidence 34555555554433 457888887532 34556789999999999999999999999999999999999999999
Q ss_pred hhhhhccC----------------------------------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceee
Q 039817 521 LSAFLFRQ----------------------------------------EIPTWDKRVEIALGIARGLLYLHEECETQIIH 560 (725)
Q Consensus 521 L~~~l~~~----------------------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 560 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+|
T Consensus 115 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH 191 (345)
T 3hko_A 115 LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICH 191 (345)
T ss_dssp HHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred HHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99998521 1125677889999999999999999 9999
Q ss_pred cCCccceEEeccCccccCCCCceEEeeccCccccCcCCC---ccccccccCccccchhcccC--CCCCCccceehhHHHH
Q 039817 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT---RTSTMIRGTMGYMAPEWLRN--APVTAKVDVYSFGVML 635 (725)
Q Consensus 561 ~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~G~vl 635 (725)
|||||+||+++.+ +.+.+||+|||+++.+..... .......||+.|+|||.+.+ ..++.++||||||+++
T Consensus 192 ~Dlkp~NIll~~~-----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 192 RDIKPENFLFSTN-----KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp CCCCGGGEEESCS-----SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred cCCChhhEEEecC-----CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 9999999999862 245899999999986543221 12234569999999999865 6789999999999999
Q ss_pred HHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC-CCh----hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 636 LEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN-LGA----TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 636 ~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
|||++|+.||..... .+.......... .+. ...+.+.+++.+||+.||.+|||+.|++++
T Consensus 267 ~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 267 HLLLMGAVPFPGVND-----------ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHCCCCCCCCCh-----------HHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999864321 112222222111 111 246789999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=296.62 Aligned_cols=239 Identities=22% Similarity=0.242 Sum_probs=184.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|+.+++|.+ ..+..||+|.+... .....+.+.+|++++++++||||+++++++..++..++||||+++ +|.
T Consensus 12 ~G~~g~V~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~ 87 (288)
T 1ob3_A 12 EGTYGVVYKAQN---NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLK 87 (288)
T ss_dssp EETTEEEEEEEE---TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHH
T ss_pred cCCCEEEEEEEc---CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHH
Confidence 345666676665 23567899988543 233457889999999999999999999999999999999999986 899
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++....... .
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 88 KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINR-------EGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TSCEEECCTTHHHHHCC-----
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC-------CCCEEEeECccccccCcccc-c
Confidence 988764 6789999999999999999999999 9999999999999987 78999999999986543221 1
Q ss_pred ccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC--------
Q 039817 602 STMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG-------- 672 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 672 (725)
.....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||....... ....+.......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--------QLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCCCTTTSTTG
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHHCCCChhhchhh
Confidence 2234589999999998764 58999999999999999999999986432110 000011100000
Q ss_pred -------------------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 -------------------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 -------------------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......+.+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112346788999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=299.30 Aligned_cols=245 Identities=22% Similarity=0.372 Sum_probs=185.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+++.++++.+..+ +..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 43 G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (310)
T 2wqm_A 43 GQFSEVYRAACLLD--GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120 (310)
T ss_dssp C--CEEEEEEETTT--CCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHH
T ss_pred CCCceEEEEEEcCC--CceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHH
Confidence 44566666665444 457899988642 2334567899999999999999999999999999999999999999999
Q ss_pred hhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 523 AFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 523 ~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||+++. ++.+||+|||+++......
T Consensus 121 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~-------~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITA-------TGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TSCEEECCC----------
T ss_pred HHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcC-------CCCEEEEeccceeeecCCC
Confidence 99864 46689999999999999999999999 9999999999999987 7899999999998664432
Q ss_pred CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC----
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL---- 674 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 674 (725)
.. .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... .......
T Consensus 191 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------~~~~~~-~~~~~~~~~~~ 259 (310)
T 2wqm_A 191 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYSLCK-KIEQCDYPPLP 259 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---------HHHHHH-HHHTTCSCCCC
T ss_pred cc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---------HHHHHH-HhhcccCCCCc
Confidence 21 22345899999999999999999999999999999999999998643221 111111 1122221
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEV 713 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 713 (725)
.....+.+.+++.+||+.||.+|||+.+|+++|+.+.+.
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 134567899999999999999999999999999987653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.63 Aligned_cols=240 Identities=24% Similarity=0.321 Sum_probs=189.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+|+.++.+.+..+ +..||||.+..... .+.+|++++.++ +||||+++++++.+++..++||||+++|+|.+
T Consensus 32 ~G~~g~V~~~~~~~~--~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~ 105 (342)
T 2qr7_A 32 VGSYSVCKRCIHKAT--NMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLD 105 (342)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred eCCCEEEEEEEECCC--CCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 344555666655433 46889999865432 245788889888 79999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||+..+. ...+.+||+|||+++........ ..
T Consensus 106 ~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~---~~~~~~kl~Dfg~a~~~~~~~~~-~~ 178 (342)
T 2qr7_A 106 KILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDES---GNPESIRICDFGFAKQLRAENGL-LM 178 (342)
T ss_dssp HHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSS---CSGGGEEECCCTTCEECBCTTCC-BC
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCC---CCcCeEEEEECCCcccCcCCCCc-ee
Confidence 999888899999999999999999999999 999999999999985421 11346999999999876543322 22
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC------hh
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG------AT 677 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 677 (725)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ...+......+... ..
T Consensus 179 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~-~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--------T-PEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--------C-HHHHHHHHHHCCCCCCSTTTTT
T ss_pred ccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--------C-HHHHHHHHccCCcccCcccccc
Confidence 356899999999998888899999999999999999999999743211 1 11122222223222 34
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+.+|+.+||+.||++|||+.|++++
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 67889999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.55 Aligned_cols=237 Identities=20% Similarity=0.291 Sum_probs=183.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCc--CCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHH--KNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.|+++.+ ..+..||||.+... ..+..+.+.+|++++++++| +||+++++++..++..++||| +.+++
T Consensus 19 ~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~ 94 (343)
T 3dbq_A 19 SGGSSKVFQVLN---EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 94 (343)
T ss_dssp CCSSEEEEEEEC---TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEE
T ss_pred cCCCeEEEEEEe---CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCC
Confidence 345666666654 23567899987543 33345779999999999976 999999999999999999999 56789
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 95 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~--------~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 95 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV--------DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp HHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE--------TTEEEECCCSSSCCC------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE--------CCcEEEeecccccccCccccc
Confidence 999999888999999999999999999999999 999999999999996 457999999999876544332
Q ss_pred -cccccccCccccchhcccC-----------CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH
Q 039817 601 -TSTMIRGTMGYMAPEWLRN-----------APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC 668 (725)
Q Consensus 601 -~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (725)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------~~~~~~~ 233 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------ISKLHAI 233 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----------HHHHHHH
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----------HHHHHHH
Confidence 2234569999999999864 67899999999999999999999999642211 1111111
Q ss_pred H---HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 V---RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. .....+....+.+.+++.+||+.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 1123344455788999999999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=309.74 Aligned_cols=241 Identities=22% Similarity=0.205 Sum_probs=190.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|++|+.+.+..+ +..||||.+.+.. ....+.+.+|.+++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 71 ~G~fG~V~~~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L 148 (412)
T 2vd5_A 71 RGAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL 148 (412)
T ss_dssp ECSSCEEEEEEETTT--CCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eCCCeEEEEEEECCC--CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcH
Confidence 345566666655433 4578999886421 22344588999999999999999999999999999999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 149 ~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~-------~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDR-------CGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp HHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECCTTSCE
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecC-------CCCEEEeechhheeccCCCcc
Confidence 9999765 4799999999999999999999999 9999999999999987 889999999999876554433
Q ss_pred cccccccCccccchhccc-------CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC
Q 039817 601 TSTMIRGTMGYMAPEWLR-------NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN 673 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~-------~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (725)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||....... ....+........
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--------TYGKIVHYKEHLS 290 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHHCC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcccCcC
Confidence 333457999999999987 4578999999999999999999999996532111 1111111111122
Q ss_pred CC---hhHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 039817 674 LG---ATKFERITMVGLWCICPQPTLR---PSMKQVLQM 706 (725)
Q Consensus 674 ~~---~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~~ 706 (725)
.+ ...++.+.+|+.+||+ +|.+| |+++|+++|
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 22 3466789999999999 99998 699999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.27 Aligned_cols=242 Identities=26% Similarity=0.290 Sum_probs=191.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
.++++++.|.+..+ +..||||.+.... ....+.+.+|++++++++||||+++++++.+++..++||||+++++|.++
T Consensus 18 G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 95 (276)
T 2yex_A 18 GAYGEVQLAVNRVT--EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDR 95 (276)
T ss_dssp CSSSEEEEEEETTT--CCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGG
T ss_pred CCCcEEEEEEECCC--CcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHH
Confidence 34555566655443 3578888875432 34457899999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-cccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RTST 603 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~-~~~~ 603 (725)
+.....+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........ ....
T Consensus 96 l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 96 IEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE-------RDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp SBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCCTTCEECEETTEECCBC
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEcc-------CCCEEEeeCCCccccCCCcchhccc
Confidence 98888899999999999999999999999 9999999999999987 78899999999986543322 1123
Q ss_pred ccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
...|+..|+|||.+.+..+ +.++||||||++++||++|+.|+....... .....+... ...........+.+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEK-KTYLNPWKKIDSAP 238 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS------HHHHHHHTT-CTTSTTGGGSCHHH
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHhhhc-ccccCchhhcCHHH
Confidence 3558999999999987665 778999999999999999999997543221 111111100 00011122456788
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+++.+||+.||++|||++|++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcC
Confidence 999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=301.27 Aligned_cols=253 Identities=24% Similarity=0.272 Sum_probs=185.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc--CcCCccceeeEEEcC----CceeeeeecccC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT--HHKNLVQLLGFCIEQ----NHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~----~~~~lV~e~~~~ 518 (725)
..+|++|+++... +..||||.+... ....+..|.+++..+ +||||+++++++... ...++||||+++
T Consensus 47 ~G~~g~V~~~~~~----~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 119 (337)
T 3mdy_A 47 KGRYGEVWMGKWR----GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHEN 119 (337)
T ss_dssp EETTEEEEEEEET----TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTT
T ss_pred cCCCeEEEEEEEC----CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCC
Confidence 3456666666543 578999988532 345566677776654 899999999999877 678999999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhccc-----CCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEEC-----ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
|+|.+++... .+++..+..++.|++.||.|||+.+ .++|+||||||+|||++. ++.+||+|||+++.
T Consensus 120 g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~-------~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 120 GSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK-------NGTCCIADLGLAVK 191 (337)
T ss_dssp CBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT-------TSCEEECCCTTCEE
T ss_pred CcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC-------CCCEEEEeCCCcee
Confidence 9999999654 6899999999999999999999862 348999999999999987 78999999999986
Q ss_pred cCcCCCcc---ccccccCccccchhcccCCCCCCc------cceehhHHHHHHHHhCCcCCCCCCCCccccc---cCcch
Q 039817 594 LKKDQTRT---STMIRGTMGYMAPEWLRNAPVTAK------VDVYSFGVMLLEIIFCKRHTELHRVDEPTLA---NGMIL 661 (725)
Q Consensus 594 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDv~S~G~vl~elltg~~~~~~~~~~~~~~~---~~~~~ 661 (725)
........ .....||..|+|||.+.+.....+ +||||||+++|||++|..++........... .....
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 64433221 123468999999999988776665 9999999999999999544422111100000 00111
Q ss_pred HHHHHHHHHc----CCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 662 TDWVLYCVRT----GNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 662 ~~~~~~~~~~----~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.......... ...+ ....+.+.+++.+||+.||++|||+.||+++|+.+.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 1112221111 1222 2567889999999999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.21 Aligned_cols=238 Identities=23% Similarity=0.292 Sum_probs=194.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...|+.++++.+..+ +..+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|
T Consensus 51 ~G~~g~Vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 128 (335)
T 2owb_A 51 KGGFAKCFEISDADT--KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL 128 (335)
T ss_dssp EETTEEEEEEEETTT--CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred eCCCeEEEEEEECCC--CCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCH
Confidence 345566666655433 4578888875432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++........
T Consensus 129 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-------~~~~kl~Dfg~~~~~~~~~~~- 197 (335)
T 2owb_A 129 LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNE-------DLEVKIGDFGLATKVEYDGER- 197 (335)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT-------TCCEEECCCTTCEECCSTTCC-
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcC-------CCCEEEeeccCceecccCccc-
Confidence 99998878899999999999999999999999 9999999999999987 788999999999876433222
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHH-HHHcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY-CVRTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 680 (725)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+.... ......++....+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 266 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KETYLRIKKNEYSIPKHINP 266 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCCCCCTTSCH
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----------HHHHHHHhcCCCCCCccCCH
Confidence 2335589999999999999999999999999999999999999864321 111111 1122344556677
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+++.+||+.||++|||++|++++
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.00 Aligned_cols=237 Identities=23% Similarity=0.298 Sum_probs=193.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
.+|+.++++.+..+ +..+|+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 G~~g~Vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (294)
T 2rku_A 26 GGFAKCFEISDADT--KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLL 103 (294)
T ss_dssp ETTEEEEEEEETTT--CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHH
T ss_pred cCCEEEEEEEECCC--CceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 45556666655433 3578888875432 234567899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|+++||.|||+. +++||||||+||+++. ++.+||+|||++......... .
T Consensus 104 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~kl~dfg~~~~~~~~~~~-~ 172 (294)
T 2rku_A 104 ELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNE-------DLEVKIGDFGLATKVEYDGER-K 172 (294)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEECCSTTCC-B
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcC-------CCCEEEEeccCceecccCccc-c
Confidence 9998878899999999999999999999999 9999999999999987 789999999999876433222 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH-HHcCCCChhHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-VRTGNLGATKFER 681 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 681 (725)
....|+..|+|||.+.+..++.++||||||++++||++|+.|+..... .+..... ......+....+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KETYLRIKKNEYSIPKHINPV 241 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTTCCCCCTTSCHH
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhhccCCCccccCHH
Confidence 234589999999999998999999999999999999999999864321 1111111 1122345566778
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHcccChhhCcCHHHHhhC
Confidence 9999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.70 Aligned_cols=248 Identities=22% Similarity=0.223 Sum_probs=184.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+++.++++.+..+ +..||||.+..... ...+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 13 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 90 (311)
T 4agu_A 13 EGSYGVVFKCRNRDT--GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLH 90 (311)
T ss_dssp ECSSEEEEEEEETTT--CCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred ecCCeEEEEEEeCCC--CcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHH
Confidence 344556666665443 45789998754332 23567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++......... .
T Consensus 91 ~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~-~ 159 (311)
T 4agu_A 91 ELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITK-------HSVIKLCDFGFARLLTGPSDY-Y 159 (311)
T ss_dssp HHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECC-------
T ss_pred HHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcC-------CCCEEEeeCCCchhccCcccc-c
Confidence 9998888899999999999999999999999 9999999999999987 789999999999876533222 2
Q ss_pred cccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc----CcchHHHHHHHHHc------
Q 039817 603 TMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN----GMILTDWVLYCVRT------ 671 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~------ 671 (725)
....|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+............ ....... ......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH-QQVFSTNQYFSG 238 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH-HHHHHTCGGGTT
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc-cccccccccccc
Confidence 23458999999999876 67899999999999999999999998654321100000 0000000 000000
Q ss_pred CCCC------------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 GNLG------------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~~~~------------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+ ....+.+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 1345568899999999999999999999976
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.59 Aligned_cols=251 Identities=18% Similarity=0.190 Sum_probs=190.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEE-EcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFC-IEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+++.++.+.+..++ ..||||.+.... ..+.+.+|++++++++|++++..++.+ ..++..++||||+ +++|.+
T Consensus 19 ~G~~g~V~~~~~~~~~--~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~ 93 (296)
T 4hgt_A 19 SGSFGDIYLGTDIAAG--EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLED 93 (296)
T ss_dssp ECSSSEEEEEEETTTT--EEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHH
T ss_pred CCCCeEEEEEEEcCCC--ceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHH
Confidence 3456666777655444 578888764322 234588999999999988877777766 5677889999999 899999
Q ss_pred hhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc--
Q 039817 524 FLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-- 600 (725)
Q Consensus 524 ~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~-- 600 (725)
++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++.+||+|||+++........
T Consensus 94 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~----~~~~~~kL~Dfg~a~~~~~~~~~~~ 166 (296)
T 4hgt_A 94 LFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLG----KKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp HHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCG----GGTTCEEECCCTTCEECBCTTTCCB
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeecc----CCCCeEEEecCccceeccCcccCcc
Confidence 9974 46799999999999999999999999 99999999999999321 11788999999999876543321
Q ss_pred ----cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC---
Q 039817 601 ----TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--- 673 (725)
Q Consensus 601 ----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 673 (725)
......||..|+|||.+.+..++.++||||||+++|||++|+.||....... ................
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-----KRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-----SSSHHHHHHHHHHHSCHHH
T ss_pred CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh-----hhhhhhhhhcccccchhhh
Confidence 1224568999999999999999999999999999999999999997643322 1111111111111111
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.....++.+.+++.+||+.||++|||+++|++.|+++.+
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 112335789999999999999999999999999988754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.80 Aligned_cols=245 Identities=21% Similarity=0.259 Sum_probs=181.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...|+.|++|.+..+ +..||||.+.... ....+.+.+|++++++++||||+++++++..++..++||||+++ +|.
T Consensus 44 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~ 120 (329)
T 3gbz_A 44 EGTYGEVYKAIDTVT--NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLK 120 (329)
T ss_dssp ECSSSEEEEEEETTT--TEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHH
T ss_pred ecCCeEEEEEEECCC--CceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHH
Confidence 345666777765544 4578999886432 22345688999999999999999999999999999999999985 999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+.. +..+.+||+|||+++........ .
T Consensus 121 ~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~--~~~~~~kl~Dfg~a~~~~~~~~~-~ 194 (329)
T 3gbz_A 121 KYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA--SETPVLKIGDFGLARAFGIPIRQ-F 194 (329)
T ss_dssp HHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-------CCEEEECCTTHHHHHC-------
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC--CccceEEECcCCCccccCCcccc-c
Confidence 9998888899999999999999999999999 9999999999999964211 12567999999999876433222 2
Q ss_pred cccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---------
Q 039817 603 TMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--------- 672 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 672 (725)
....+|..|+|||.+.+. .++.++||||||+++|||++|+.||....... .+.. +.......
T Consensus 195 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~-~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-------QLFK-IFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -----CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH-HHHHHCCCCTTTSTTGG
T ss_pred CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-------HHHH-HHHHhCCCchhhhhhhh
Confidence 234579999999999874 58999999999999999999999986432110 0000 00000000
Q ss_pred -------C------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 -------N------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 -------~------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. +.....+.+.+|+.+||+.||++|||++|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 001145778999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.10 Aligned_cols=237 Identities=19% Similarity=0.284 Sum_probs=184.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccC--cCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTH--HKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.|+++.+. .+..||||.+... .....+.+.+|++++++++ |+||+++++++..++..++||| +.+++
T Consensus 66 ~G~fg~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~ 141 (390)
T 2zmd_A 66 SGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 141 (390)
T ss_dssp CCSSEEEEEEECT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEE
T ss_pred cCCCeEEEEEEcC---CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCC
Confidence 3456666666543 2567899988543 3344578999999999996 5999999999999999999999 56789
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 142 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~--------~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 142 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV--------DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp HHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES--------SSCEEECCCSSSCCC------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE--------CCeEEEEecCccccccCCCcc
Confidence 999998888899999999999999999999999 999999999999995 468999999999876543322
Q ss_pred c-ccccccCccccchhcccC-----------CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH
Q 039817 601 T-STMIRGTMGYMAPEWLRN-----------APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC 668 (725)
Q Consensus 601 ~-~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (725)
. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ...+...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----------~~~~~~~ 280 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------ISKLHAI 280 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----------HHHHHHH
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----------HHHHHHH
Confidence 1 234569999999999865 46899999999999999999999999643211 1111111
Q ss_pred HH---cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 VR---TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. ....+....+.+.+|+.+||+.||++|||+.|++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 112333446789999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.07 Aligned_cols=247 Identities=28% Similarity=0.366 Sum_probs=191.5
Q ss_pred ccHHHHHHHhccc---CCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVF---DGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~---~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+++.++++.... ...+..||||.+... .......+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 41 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 120 (327)
T 2yfx_A 41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120 (327)
T ss_dssp -CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEH
T ss_pred CCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcH
Confidence 3455555555321 234568999998643 234456799999999999999999999999999999999999999999
Q ss_pred hhhhccC-------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 522 SAFLFRQ-------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 522 ~~~l~~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.+. .+..+||+|||+++..
T Consensus 121 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~----~~~~~kl~Dfg~~~~~ 193 (327)
T 2yfx_A 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG----PGRVAKIGDFGMARDI 193 (327)
T ss_dssp HHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS----TTCCEEECCCHHHHHH
T ss_pred HHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCC----CcceEEECcccccccc
Confidence 9999765 3478999999999999999999999 999999999999998521 2567999999999754
Q ss_pred CcCCC-ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc-
Q 039817 595 KKDQT-RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT- 671 (725)
Q Consensus 595 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 671 (725)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+ .......
T Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------~~-~~~~~~~~ 261 (327)
T 2yfx_A 194 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----------QE-VLEFVTSG 261 (327)
T ss_dssp HC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------HH-HHHHHHTT
T ss_pred ccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----------HH-HHHHHhcC
Confidence 33222 12223457889999999998899999999999999999998 8888754321 11 1111111
Q ss_pred --CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 672 --GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 672 --~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
...+...++.+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 2234456778999999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.76 Aligned_cols=239 Identities=22% Similarity=0.306 Sum_probs=188.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEE--cCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCI--EQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~gsL 521 (725)
.+++.++++.+..+ +..|++|.+... .....+.+.+|++++++++||||+++++++. .+...++||||+++++|
T Consensus 17 G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L 94 (279)
T 2w5a_A 17 GSYGRCQKIRRKSD--GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 94 (279)
T ss_dssp CSSSEEEEEEETTT--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEH
T ss_pred CCCcEEEEEEECCC--CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCH
Confidence 34555666655433 457888887643 2334567999999999999999999999885 46688999999999999
Q ss_pred hhhhccC----CCCCHHHHHHHHHHHHHHhhhhhcccCCc-----eeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 522 SAFLFRQ----EIPTWDKRVEIALGIARGLLYLHEECETQ-----IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 522 ~~~l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
.+++... ..+++..++.++.|++.||.|||+. + |+||||||+||+++. ++.+||+|||+++
T Consensus 95 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~-------~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 95 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDG-------KQNVKLGDFGLAR 164 (279)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECS-------SSCEEECCCCHHH
T ss_pred HHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcC-------CCCEEEecCchhe
Confidence 9999653 3589999999999999999999998 7 999999999999987 7899999999998
Q ss_pred ccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 593 LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 593 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+ +......+
T Consensus 165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~-~~~~i~~~ 231 (279)
T 2w5a_A 165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----------KE-LAGKIREG 231 (279)
T ss_dssp HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHT
T ss_pred eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----------HH-HHHHHhhc
Confidence 76543221 2234589999999999998999999999999999999999999864321 11 11112222
Q ss_pred ---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 673 ---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 673 ---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
.++...++.+.+++.+||+.||++|||+.||++++..
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 3445667889999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=300.20 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=191.0
Q ss_pred CcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCC--ceeeeeecccCCChhhhhccC-CCCCHHHH
Q 039817 460 GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--HQLLVYELMKNGTLSAFLFRQ-EIPTWDKR 536 (725)
Q Consensus 460 ~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~ 536 (725)
..+..||||.+........+.|.+|++++++++||||+++++++...+ ..++||||+++++|.+++... ..+++..+
T Consensus 68 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 147 (326)
T 2w1i_A 68 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 147 (326)
T ss_dssp SCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHH
T ss_pred CCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHH
Confidence 346789999998766666788999999999999999999999987654 789999999999999999776 46899999
Q ss_pred HHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc--ccccccCccccch
Q 039817 537 VEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT--STMIRGTMGYMAP 614 (725)
Q Consensus 537 ~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~aP 614 (725)
..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++......... .....++..|+||
T Consensus 148 ~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~-------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 217 (326)
T 2w1i_A 148 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN-------ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217 (326)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEE-------TTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcC-------CCcEEEecCcchhhccccccccccccCCCCceeEECc
Confidence 99999999999999999 9999999999999987 7899999999998765443221 1223467789999
Q ss_pred hcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc-c---ccCcchHHHHHHHHHc---CCCChhHHHHHHHHHH
Q 039817 615 EWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT-L---ANGMILTDWVLYCVRT---GNLGATKFERITMVGL 687 (725)
Q Consensus 615 E~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~ 687 (725)
|.+.+..++.++||||||++++||++|..|+......... . .........+...... ...+...++.+.+++.
T Consensus 218 E~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 297 (326)
T 2w1i_A 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT 297 (326)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Confidence 9999888999999999999999999999887532110000 0 0001111122222222 2234456788999999
Q ss_pred HccCCCCCCCCCHHHHHHHhcCCC
Q 039817 688 WCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 688 ~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+||+.||++|||+.||++.|+.+.
T Consensus 298 ~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 298 ECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.19 Aligned_cols=235 Identities=24% Similarity=0.294 Sum_probs=187.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.+++|.+..+ +..||||.+..... ...+.+.+|++++++++||||+++++++..++..++||||++ |+
T Consensus 63 G~G~~g~Vy~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~ 139 (348)
T 1u5q_A 63 GHGSFGAVYFARDVRN--SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS 139 (348)
T ss_dssp EECSSEEEEEEEETTT--TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred ccCCCEEEEEEEEccC--CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CC
Confidence 3445666666665443 46789998864322 233578999999999999999999999999999999999998 57
Q ss_pred hhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 140 l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSE-------PGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEET-------TTEEEECCCTTCBSSSSB--
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECC-------CCCEEEeeccCceecCCC--
Confidence 8887753 46789999999999999999999999 9999999999999987 789999999999875432
Q ss_pred ccccccccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---C
Q 039817 600 RTSTMIRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG---N 673 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 673 (725)
....||+.|+|||.+. ...++.++||||||+++|||++|+.|+..... .+.+....... .
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----------~~~~~~~~~~~~~~~ 273 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQNESPAL 273 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCCCCC
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHHhcCCCCC
Confidence 2245899999999984 56789999999999999999999999864321 11122222211 1
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
.....++.+.+++.+||+.||++|||+++++++.
T Consensus 274 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 274 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 2234567899999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=292.21 Aligned_cols=237 Identities=23% Similarity=0.302 Sum_probs=189.2
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..|+.++.+.+..+ +..||+|.+........+.+.+|++++++++||||+++++++...+..++||||+++++|.+++
T Consensus 20 G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 97 (304)
T 2jam_A 20 GAFSEVFLVKQRLT--GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI 97 (304)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCCceEEEEEECCC--CCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHH
Confidence 34555666655444 3578999887655555677999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccccc
Q 039817 526 FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMI 605 (725)
Q Consensus 526 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 605 (725)
...+.+++..+..++.|++.||.|||+. +|+||||||+||++..+ +.++.+||+|||+++...... ....
T Consensus 98 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~----~~~~~~kl~Dfg~~~~~~~~~---~~~~ 167 (304)
T 2jam_A 98 LERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTP----EENSKIMITDFGLSKMEQNGI---MSTA 167 (304)
T ss_dssp HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSS----STTCCEEBCSCSTTCCCCCBT---THHH
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecC----CCCCCEEEccCCcceecCCCc---cccc
Confidence 8878899999999999999999999999 99999999999999431 227889999999997654321 2234
Q ss_pred ccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC------CCChhHH
Q 039817 606 RGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG------NLGATKF 679 (725)
Q Consensus 606 ~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 679 (725)
.|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+.. .....+ ......+
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~-~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----------SKLF-EKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp HSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHH-HHHHHCCCCCCTTTTTTSC
T ss_pred cCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----------HHHH-HHHHcCCCCCCccccccCC
Confidence 589999999999999999999999999999999999999864321 1111 111122 1223456
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 789999999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=315.66 Aligned_cols=239 Identities=26% Similarity=0.338 Sum_probs=190.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.|+.|.+..++ ..||||.+... .......+.+|++++++++||||+++++++......++||||+++|+|
T Consensus 46 G~G~~g~V~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 123 (494)
T 3lij_A 46 GSGAYGEVLLCRDKVTH--VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123 (494)
T ss_dssp ECC---EEEEEEETTTC--CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred ecCCCEEEEEEEECCCC--cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcH
Confidence 44567777777765544 56788877543 244567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++... .++.+||+|||+++.......
T Consensus 124 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~----~~~~~kl~DfG~a~~~~~~~~-- 194 (494)
T 3lij_A 124 FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKE----KDALIKIVDFGLSAVFENQKK-- 194 (494)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS----TTCCEEECCCTTCEECBTTBC--
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCC----CCCcEEEEECCCCeECCCCcc--
Confidence 99998888899999999999999999999999 999999999999997631 256799999999987654322
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC------
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG------ 675 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 675 (725)
.....||+.|+|||.+. ..++.++||||||+++|+|++|+.||..... .+ +......+...
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~-~~~~i~~~~~~~~~~~~ 261 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----------QE-ILRKVEKGKYTFDSPEW 261 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHTCCCCCSGGG
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----------HH-HHHHHHhCCCCCCchhc
Confidence 23345999999999886 5689999999999999999999999964321 11 11122222211
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...++.+.+++.+||+.||.+|||+.|++++
T Consensus 262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1346789999999999999999999999865
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.29 Aligned_cols=239 Identities=23% Similarity=0.313 Sum_probs=185.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+|+.++.+.+..+ +..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 32 ~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 109 (285)
T 3is5_A 32 SGAFGDVHLVEERSS--GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLE 109 (285)
T ss_dssp ECSSCEEEEEEETTT--CCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHH
T ss_pred cCCCeEEEEEEEccC--CceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHH
Confidence 345666666665444 4567888876433 3456789999999999999999999999999999999999999999999
Q ss_pred hhccC----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 524 FLFRQ----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 524 ~l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.+ +.++.+||+|||+++.......
T Consensus 110 ~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~----~~~~~~kl~Dfg~a~~~~~~~~ 182 (285)
T 3is5_A 110 RIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDT----SPHSPIKIIDFGLAELFKSDEH 182 (285)
T ss_dssp HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSS----STTCCEEECCCCCCCC------
T ss_pred HHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecC----CCCCCEEEEeeecceecCCccc
Confidence 98543 6789999999999999999999999 99999999999999653 2267899999999987654322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCC---
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLG--- 675 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 675 (725)
.....|+..|+|||.+. ..++.++||||||++++||++|+.||...... +....... .....
T Consensus 183 --~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 183 --STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----------EVQQKATYKEPNYAVEC 248 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------HHHHHHHHCCCCCCC--
T ss_pred --CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----------HHHhhhccCCccccccc
Confidence 23345899999999886 56899999999999999999999998643211 11111111 11111
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....+.+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1246788999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=291.71 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=190.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|+.++.|.+.. .+..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+
T Consensus 31 g~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (295)
T 2clq_A 31 GKGTYGIVYAGRDLS--NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108 (295)
T ss_dssp EECSSSEEEEEEETT--TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred eecCcEEEEEEEECC--CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence 344566666666543 346889999877666667889999999999999999999999999999999999999999999
Q ss_pred hhccC---CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 524 FLFRQ---EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 524 ~l~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.. ++.+||+|||++........
T Consensus 109 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~------~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTY------SGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp HHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT------TCCEEECCTTTCEESCC----
T ss_pred HHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECC------CCCEEEeecccccccCCCCC-
Confidence 99765 2457889999999999999999999 99999999999999753 67899999999987643322
Q ss_pred cccccccCccccchhcccCCC--CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAP--VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK 678 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (725)
......|+..|+|||.+.+.. ++.++||||||+++|||++|+.|+....... ..............++...
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 251 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-------AAMFKVGMFKVHPEIPESM 251 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-------HHHHHHHHHCCCCCCCTTS
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-------HHHHhhccccccccccccC
Confidence 122345899999999987643 8899999999999999999999986432111 0000011111123455567
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+.+++.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7889999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=309.00 Aligned_cols=251 Identities=19% Similarity=0.196 Sum_probs=195.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCC--ceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN--HQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~~~gsL 521 (725)
..+|+.|++|.+..+ +..||||.+.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++|+|
T Consensus 19 ~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L 96 (396)
T 4eut_A 19 QGATANVFRGRHKKT--GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96 (396)
T ss_dssp ECSSEEEEEEEETTT--CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEH
T ss_pred cCCCeEEEEEEECCC--CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCH
Confidence 445666777766544 4578999986533 344677899999999999999999999998765 67999999999999
Q ss_pred hhhhccCC---CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 522 SAFLFRQE---IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 522 ~~~l~~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+..+. ++++.+||+|||+++......
T Consensus 97 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~---~~~~~~kL~DFG~a~~~~~~~ 170 (396)
T 4eut_A 97 YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGE---DGQSVYKLTDFGAARELEDDE 170 (396)
T ss_dssp HHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECT---TSCEEEEECCGGGCEECCCGG
T ss_pred HHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecC---CCceeEEEecCCCceEccCCC
Confidence 99997653 389999999999999999999999 999999999999982110 126789999999998765432
Q ss_pred CccccccccCccccchhcccC--------CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH
Q 039817 599 TRTSTMIRGTMGYMAPEWLRN--------APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (725)
. .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ...+.+.....
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~ 241 (396)
T 4eut_A 171 Q--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-------RNKEVMYKIIT 241 (396)
T ss_dssp G--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-------TCHHHHHHHHH
T ss_pred c--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-------chHHHHHHHhc
Confidence 2 223458999999999865 567889999999999999999999996433211 11111222211
Q ss_pred c--------------------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 671 T--------------------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 671 ~--------------------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
. ..+.....+.+.+++.+||+.||++||+++|+++.|+.+++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1 12234677889999999999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=313.11 Aligned_cols=241 Identities=27% Similarity=0.301 Sum_probs=197.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|+.+.+..+ +..||||.+... .......+.+|++++++++|||||++++++.+.+..++||||+++|+
T Consensus 193 G~G~fG~Vy~a~~~~t--g~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~ 270 (576)
T 2acx_A 193 GKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270 (576)
T ss_dssp EEETTEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeCCCEEEEEEEECCC--CCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 4456777777776544 457899988542 23456778999999999999999999999999999999999999999
Q ss_pred hhhhhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 521 LSAFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 521 L~~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 271 L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~-------~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDD-------HGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp HHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TSCEEECCCTTCEECCTTC
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeC-------CCCeEEEecccceecccCc
Confidence 999997654 489999999999999999999999 9999999999999987 7899999999998765432
Q ss_pred CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCCh
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGA 676 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 676 (725)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..... ...++.
T Consensus 341 ~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--------~~~~i~~~i~~~~~~~p~ 410 (576)
T 2acx_A 341 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--------KREEVERLVKEVPEEYSE 410 (576)
T ss_dssp C--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--------CHHHHHHHHHHCCCCCCT
T ss_pred c--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--------hHHHHHHHhhcccccCCc
Confidence 2 223469999999999999899999999999999999999999997543211 1111222222 234455
Q ss_pred hHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
...+.+.+|+.+||+.||.+|| +++||++|
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 6778999999999999999999 78999865
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=286.34 Aligned_cols=239 Identities=24% Similarity=0.323 Sum_probs=187.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc------CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT------GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
..|+.++++.+..+ +..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 16 G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 93 (283)
T 3bhy_A 16 GQFAIVRKCRQKGT--GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGG 93 (283)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred cCceEEEEEEEcCC--CCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCC
Confidence 34555555555433 4578888775432 124678999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.+. .....+||+|||++........
T Consensus 94 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~---~~~~~~kl~dfg~~~~~~~~~~ 167 (283)
T 3bhy_A 94 ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKN---VPNPRIKLIDFGIAHKIEAGNE 167 (283)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS---SSSCCEEECCCTTCEECC----
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCC---CCCCceEEEecccceeccCCCc
Confidence 9999998878899999999999999999999999 999999999999998731 1133899999999987644322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CC--
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LG-- 675 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 675 (725)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+...... +... ...... .+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------~~~~-~~~~~~~~~~~~ 233 (283)
T 3bhy_A 168 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-----------ETLT-NISAVNYDFDEE 233 (283)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----------HHHH-HHHTTCCCCCHH
T ss_pred --ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----------HHHH-HhHhcccCCcch
Confidence 22345899999999999999999999999999999999999998643211 1111 111111 11
Q ss_pred --hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 --ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 --~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...++.+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1335678999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.74 Aligned_cols=240 Identities=21% Similarity=0.281 Sum_probs=186.8
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+++.++.+.+..+ +..||||.+... ......++.+|+..+.++ +||||+++++++.+++..++||||+++++|
T Consensus 21 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 98 (289)
T 1x8b_A 21 SGEFGSVFKCVKRLD--GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 98 (289)
T ss_dssp EETTEEEEEEEETTT--CCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred CCCceEEEEEEEcCC--CceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcH
Confidence 345566666665444 457888887643 334567789999999999 999999999999999999999999999999
Q ss_pred hhhhccC----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccc------------cCCCCceEE
Q 039817 522 SAFLFRQ----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT------------IDNNYITKI 585 (725)
Q Consensus 522 ~~~l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~------------~~~~~~~kl 585 (725)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.+... .+....+||
T Consensus 99 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl 175 (289)
T 1x8b_A 99 ADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175 (289)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CCCEEE
T ss_pred HHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEE
Confidence 9999764 6689999999999999999999999 99999999999999853100 012568999
Q ss_pred eeccCccccCcCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHH
Q 039817 586 ADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDW 664 (725)
Q Consensus 586 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 664 (725)
+|||++........ ..|+..|+|||.+.+. .++.++||||||++++||++|..++..... ...
T Consensus 176 ~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----------~~~ 239 (289)
T 1x8b_A 176 GDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-----------WHE 239 (289)
T ss_dssp CCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----------HHH
T ss_pred cccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----------HHH
Confidence 99999987654322 3489999999999766 566899999999999999999876542210 000
Q ss_pred HHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 665 VLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 665 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.. ......+....+.+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 240 IRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 100 01123444567889999999999999999999999876
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=314.46 Aligned_cols=238 Identities=26% Similarity=0.363 Sum_probs=192.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|+.|+++.+..++ ..||||.+... .......+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 32 ~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~ 109 (486)
T 3mwu_A 32 KGSFGEVLKCKDRITQ--QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109 (486)
T ss_dssp CCSSSEEEEEEETTTC--CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred ecCCEEEEEEEECCCC--CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHH
Confidence 4566777777665444 57888887532 3445678999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.. +.++.+||+|||+++....... .
T Consensus 110 ~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~----~~~~~~kl~Dfg~a~~~~~~~~--~ 180 (486)
T 3mwu_A 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESK----EKDCDIKIIDFGLSTCFQQNTK--M 180 (486)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSS----STTCCEEECSCSCTTTBCCC-----
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecC----CCCCCEEEEECCcCeECCCCCc--c
Confidence 9998888899999999999999999999999 99999999999999753 2267899999999987654322 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC------h
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG------A 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 676 (725)
....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .+.. .....+... .
T Consensus 181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~-~~i~~~~~~~~~~~~~ 247 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----------YDIL-KRVETGKYAFDLPQWR 247 (486)
T ss_dssp -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHH-HHHHHTCCCSCSGGGG
T ss_pred CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHH-HHHHhCCCCCCCcccC
Confidence 23459999999999876 589999999999999999999999964321 1111 112222221 2
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..++.+.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 346789999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.36 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=185.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+++.++++.+..+ +..||||.+..... ...+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 35 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (331)
T 4aaa_A 35 EGSYGMVMKCRNKDT--GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILD 112 (331)
T ss_dssp GGTTSSEEEEEETTT--CCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred ecCCEEEEEEEECCC--CceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHH
Confidence 345666666665544 45788888754332 23456889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++........ .
T Consensus 113 ~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~-~ 181 (331)
T 4aaa_A 113 DLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQ-------SGVVKLCDFGFARTLAAPGEV-Y 181 (331)
T ss_dssp HHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TSCEEECCCTTC-----------
T ss_pred HHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcC-------CCcEEEEeCCCceeecCCccc-c
Confidence 9988888899999999999999999999999 9999999999999987 789999999999865443221 2
Q ss_pred cccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHHHHHHHcC-----
Q 039817 603 TMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLYCVRTG----- 672 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~----- 672 (725)
....|+..|+|||.+.+. .++.++||||||+++|||++|+.||........... ....... ........
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR-HQELFNKNPVFAG 260 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH-HHHHHHHCGGGTT
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh-hhhHhhhcccccc
Confidence 234589999999999875 789999999999999999999999865432110000 0000000 00000000
Q ss_pred -CC------------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 -NL------------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 -~~------------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. ....++.+.+|+.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 01345789999999999999999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=293.77 Aligned_cols=239 Identities=26% Similarity=0.313 Sum_probs=185.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-----CccHHHHHHHHHHHhccC---cCCccceeeEEEcCC-----ceee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-----GDGEKSFLREVQVIGRTH---HKNLVQLLGFCIEQN-----HQLL 511 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-----~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~-----~~~l 511 (725)
..+|++|++|.+..++ ..||||.+.... ......+.+|++++++++ ||||+++++++.... ..++
T Consensus 19 ~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~l 96 (308)
T 3g33_A 19 VGAYGTVYKARDPHSG--HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 96 (308)
T ss_dssp CSSSCCEEEEECTTTC--CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEE
T ss_pred cCCCeEEEEEEECCCC--cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEE
Confidence 4566777777765554 578888875322 222457788888887765 999999999998755 4789
Q ss_pred eeecccCCChhhhhccCCC--CCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeecc
Q 039817 512 VYELMKNGTLSAFLFRQEI--PTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589 (725)
Q Consensus 512 V~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfg 589 (725)
||||++ ++|.+++..... +++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 97 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~-------~~~~kl~Dfg 165 (308)
T 3g33_A 97 VFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTS-------GGTVKLADFG 165 (308)
T ss_dssp EEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECT-------TSCEEECSCS
T ss_pred Eehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcC-------CCCEEEeeCc
Confidence 999998 599999987643 89999999999999999999999 9999999999999987 7899999999
Q ss_pred CccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 590 LAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 590 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+....
T Consensus 166 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~ 235 (308)
T 3g33_A 166 LARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--------QLGKIFDLI 235 (308)
T ss_dssp CTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--------HHHHHHHHH
T ss_pred cccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHh
Confidence 9987643322 234568999999999999999999999999999999999999986432111 011111111
Q ss_pred HcCC-------------------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 RTGN-------------------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~~~~-------------------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... ......+.+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000 011345788999999999999999999999876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=301.42 Aligned_cols=233 Identities=26% Similarity=0.260 Sum_probs=180.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHH-HhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQV-IGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
..+|+.|+.+.+.. .+..+|||.+.+.. ....+.+.+|..+ ++.++||||+++++++...+..++||||+++|+
T Consensus 48 ~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~ 125 (373)
T 2r5t_A 48 KGSFGKVLLARHKA--EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGE 125 (373)
T ss_dssp CCTTCEEEEEEETT--TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCc
Confidence 34566666666543 34678999886533 2334567778777 567899999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 126 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~-------~g~ikL~DFG~a~~~~~~~~- 194 (373)
T 2r5t_A 126 LFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDS-------QGHIVLTDFGLCKENIEHNS- 194 (373)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TSCEEECCCCBCGGGBCCCC-
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECC-------CCCEEEeeCccccccccCCC-
Confidence 999998888899999999999999999999999 9999999999999987 88999999999986432222
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 679 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+....... ...++....
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~~~~~~ 263 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----------AEMYDNILNKPLQLKPNIT 263 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----------HHHHHHHHHSCCCCCSSSC
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHhcccCCCCCCC
Confidence 22345699999999999999999999999999999999999999964321 111111111 223455667
Q ss_pred HHHHHHHHHccCCCCCCCCCHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMK 701 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~ 701 (725)
..+.+++.+||+.||.+||++.
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHHHHHcccCHHhCCCCC
Confidence 8899999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=326.24 Aligned_cols=246 Identities=21% Similarity=0.303 Sum_probs=195.0
Q ss_pred ccccHHHHHHHhcccCC-cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDG-QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~-~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.|++|.....+ ....||||.+.... ....+.|.+|+.++++++||||+++++++. ++..++||||+++|+|
T Consensus 399 G~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L 477 (656)
T 2j0j_A 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGEL 477 (656)
T ss_dssp ECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred eeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcH
Confidence 34567777777665433 45789999986533 334467999999999999999999999985 4568999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 478 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~-------~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 478 RSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSS-------NDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp HHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE-------TTEEEECCCCCCCSCCC----
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeC-------CCCEEEEecCCCeecCCCcce
Confidence 9999765 4689999999999999999999999 9999999999999987 789999999999877554433
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChh
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGAT 677 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 677 (725)
......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .+....... ....+..
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~~~~ 616 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------NDVIGRIENGERLPMPPN 616 (656)
T ss_dssp ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHHTCCCCCCTT
T ss_pred eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHcCCCCCCCcc
Confidence 3334457789999999998899999999999999999997 8888764321 111111111 1234556
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.++.+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 6788999999999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=286.69 Aligned_cols=235 Identities=21% Similarity=0.311 Sum_probs=184.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..++.++.+.+..+ +..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 22 G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 99 (276)
T 2h6d_A 22 GTFGKVKIGEHQLT--GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99 (276)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred CCCeEEEEEEECCC--CceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHH
Confidence 34555666655443 357888887542 2344568999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........ .
T Consensus 100 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~~l~dfg~~~~~~~~~~--~ 167 (276)
T 2h6d_A 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDA-------HMNAKIADFGLSNMMSDGEF--L 167 (276)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECT-------TSCEEECCCCGGGCCCC------
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECC-------CCCEEEeecccccccCCCcc--e
Confidence 9998878899999999999999999999999 9999999999999987 78999999999987654322 1
Q ss_pred cccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CCCChhHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GNLGATKF 679 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 679 (725)
....++..|+|||.+.+..+ +.++||||||++++||++|+.|+..... .. ....... ...+....
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~-~~~~~~~~~~~~~~~~~ 235 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----------PT-LFKKIRGGVFYIPEYLN 235 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHCCCCCCTTSC
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----------HH-HHHHhhcCcccCchhcC
Confidence 23458899999999987765 6899999999999999999999864321 11 1111112 23444557
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 236 RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 789999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.57 Aligned_cols=231 Identities=13% Similarity=0.084 Sum_probs=176.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccc---ccCccHHHHHHHH---HHHhccCcCCcccee-------eEEEcCC---
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREV---QVIGRTHHKNLVQLL-------GFCIEQN--- 507 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~---~~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~~~~~~--- 507 (725)
...+|++|++|++..+ +..||||.+.. ......+.|.+|+ +.+++++|||||+++ +++...+
T Consensus 82 G~G~~g~V~~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 159 (377)
T 3byv_A 82 GQEDPYAYLEATDQET--GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 159 (377)
T ss_dssp EEETTEEEEEEEC-CC--CCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCS
T ss_pred ecCCCEEEEEEEECCC--CcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcc
Confidence 3456778888776544 45789998863 2334567899999 555666899999999 6666553
Q ss_pred --------------ceeeeeecccCCChhhhhccCCCCC-------HHHHHHHHHHHHHHhhhhhcccCCceeecCCccc
Q 039817 508 --------------HQLLVYELMKNGTLSAFLFRQEIPT-------WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQ 566 (725)
Q Consensus 508 --------------~~~lV~e~~~~gsL~~~l~~~~~l~-------~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~ 566 (725)
..++||||+ +|+|.+++.+...++ +..+..|+.|++.||.|||+. +|+||||||+
T Consensus 160 ~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~ 235 (377)
T 3byv_A 160 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPV 235 (377)
T ss_dssp EEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred ccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 278999999 579999997654343 488889999999999999999 9999999999
Q ss_pred eEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC-----------CCCCccceehhHHHH
Q 039817 567 NVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA-----------PVTAKVDVYSFGVML 635 (725)
Q Consensus 567 NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~S~G~vl 635 (725)
|||++. ++.+||+|||+++.... ......| ..|+|||.+.+. .++.++||||||+++
T Consensus 236 NIll~~-------~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 236 DIVLDQ-------RGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp GEEECT-------TCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred HEEEcC-------CCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999987 78999999999985332 2223457 999999999887 899999999999999
Q ss_pred HHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 636 LEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 636 ~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
|||++|+.||......... ... .......++.+.+++.+||+.||++|||+.|++++
T Consensus 304 ~elltg~~Pf~~~~~~~~~----~~~----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGS----EWI----------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHSSCCC------CCS----GGG----------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHCCCCCcccccccch----hhh----------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999998654322110 000 01112345778999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=305.33 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=182.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--------CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--------GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 515 (725)
...+|+.|++|.+..++ ..||||.+.... ......+.+|++++++++||||+++++++.. +..++||||
T Consensus 144 G~G~~g~V~~a~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~ 220 (419)
T 3i6u_A 144 GSGACGEVKLAFERKTC--KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLEL 220 (419)
T ss_dssp EECSSSEEEEEEETTTC--CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEEC
T ss_pred eeCCCeEEEEEEECCCC--cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEc
Confidence 34566777777665544 578888875421 1122358899999999999999999999854 457899999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+. .+..+||+|||+++...
T Consensus 221 ~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~----~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 221 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE----EDCLIKITDFGHSKILG 293 (419)
T ss_dssp CTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS----SSCCEEECCSSTTTSCC
T ss_pred CCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC----CcceEEEeecccceecC
Confidence 99999999999888999999999999999999999999 999999999999997631 25579999999998765
Q ss_pred cCCCccccccccCccccchhcccC---CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRN---APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.+. ...+
T Consensus 294 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-------~~~~~----i~~~ 360 (419)
T 3i6u_A 294 ETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-------SLKDQ----ITSG 360 (419)
T ss_dssp -------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-------CHHHH----HHTT
T ss_pred CCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-------HHHHH----HhcC
Confidence 432 2233569999999999853 578889999999999999999999997543221 11111 1112
Q ss_pred CCC------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLG------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... ....+.+.+++.+||+.||++|||++|++++
T Consensus 361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 211 1345789999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=309.43 Aligned_cols=186 Identities=26% Similarity=0.380 Sum_probs=147.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC-----Cceeeeeecc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-----NHQLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~ 516 (725)
...+|+.|++|.+..++ ..||||++.... ....+.+.+|++++++++|||||++++++... ...++||||+
T Consensus 62 G~G~~g~V~~~~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 139 (458)
T 3rp9_A 62 GTGSYGHVCEAYDKLEK--RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA 139 (458)
T ss_dssp ------CEEEEEECC----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC
T ss_pred eecCCeEEEEEEECCCC--cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc
Confidence 44567777777766544 578999886432 23456799999999999999999999999543 5789999998
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+ ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++....
T Consensus 140 ~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~-------~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 140 D-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQ-------DCSVKVCDFGLARTVDY 208 (458)
T ss_dssp S-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TCCEEECCCTTCBCTTS
T ss_pred c-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECC-------CCCEeecccccchhccC
Confidence 5 69999998888899999999999999999999999 9999999999999987 78999999999987643
Q ss_pred CCC--------------------------ccccccccCccccchhcc-cCCCCCCccceehhHHHHHHHHhCC
Q 039817 597 DQT--------------------------RTSTMIRGTMGYMAPEWL-RNAPVTAKVDVYSFGVMLLEIIFCK 642 (725)
Q Consensus 597 ~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~S~G~vl~elltg~ 642 (725)
... .......||+.|+|||.+ ....++.++|||||||++|||++|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 221 112234689999999976 5667999999999999999999943
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=302.25 Aligned_cols=240 Identities=22% Similarity=0.236 Sum_probs=182.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhc-cCcCCccceeeEEEc----CCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE----QNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~lV~e~~~~g 519 (725)
..+|+.|+.+.+..+ +..||||.+.. ...+.+|++++.+ .+||||+++++++.. ....+|||||+++|
T Consensus 72 ~G~~g~V~~~~~~~~--~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg 144 (400)
T 1nxk_A 72 LGINGKVLQIFNKRT--QEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144 (400)
T ss_dssp EETTEEEEEEEETTT--CCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSE
T ss_pred eccCeEEEEEEECCC--CCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCC
Confidence 445666666665443 45789998853 3467889998855 589999999999875 56789999999999
Q ss_pred ChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 520 TLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 520 sL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.+ +.++.+||+|||+++.....
T Consensus 145 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~----~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 145 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSK----RPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSS----STTCCEEECCCTTCEECC--
T ss_pred cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecC----CCCccEEEEecccccccCCC
Confidence 999999875 3589999999999999999999999 99999999999999863 12678999999999865432
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC--
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG-- 675 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 675 (725)
.. .....||..|+|||++.+..++.++||||||+++|||++|+.||........ .......+.. .....+
T Consensus 218 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~i~~--~~~~~~~~ 289 (400)
T 1nxk_A 218 NS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKTRIRM--GQYEFPNP 289 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS----CCSHHHHHHH--TCCCCCTT
T ss_pred Cc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc----cHHHHHHHHc--CcccCCCc
Confidence 21 2335689999999999999999999999999999999999999975432210 0111111111 111111
Q ss_pred --hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 --ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 --~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....+.+.+|+.+||+.||++|||+.|++++
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2456789999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.47 Aligned_cols=249 Identities=23% Similarity=0.247 Sum_probs=181.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccC-cCCccceeeEEEcCC--ceeeeeecccC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQN--HQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lV~e~~~~ 518 (725)
...+|+.|+.|.+..++ ..||||.+... .....+.+.+|+.++.++. ||||+++++++...+ ..++||||++
T Consensus 18 G~G~~g~V~~~~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~- 94 (388)
T 3oz6_A 18 GKGAYGIVWKSIDRRTG--EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME- 94 (388)
T ss_dssp ------CEEEEEETTTC--CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-
T ss_pred eeCCCeEEEEEEECCCC--CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-
Confidence 34567777777766554 57899988543 2334567889999999997 999999999998544 6899999998
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 95 ~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~-------~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 95 TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNA-------ECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEESSSCC
T ss_pred cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcC-------CCCEEecCCcccccccccc
Confidence 589988865 5789999999999999999999999 9999999999999987 7899999999998653211
Q ss_pred --------------------CccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc--
Q 039817 599 --------------------TRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-- 655 (725)
Q Consensus 599 --------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-- 655 (725)
........||+.|+|||.+.+ ..++.++||||||++++||++|+.||..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111223569999999999876 678999999999999999999999996543111000
Q ss_pred --------------ccCcchHHHHHHHHH---------------------cCCCChhHHHHHHHHHHHccCCCCCCCCCH
Q 039817 656 --------------ANGMILTDWVLYCVR---------------------TGNLGATKFERITMVGLWCICPQPTLRPSM 700 (725)
Q Consensus 656 --------------~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 700 (725)
............... .........+.+.+|+.+||+.||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 000000000000000 000111335678999999999999999999
Q ss_pred HHHHHH
Q 039817 701 KQVLQM 706 (725)
Q Consensus 701 ~evl~~ 706 (725)
+|+++|
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999988
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.28 Aligned_cols=236 Identities=26% Similarity=0.368 Sum_probs=182.1
Q ss_pred cHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC-CceeeeeecccCCChhhhh
Q 039817 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-NHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 447 ~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l 525 (725)
.++.++.+.. .+..||||.+... ...+.|.+|++++++++||||+++++++.+. +..++||||+++++|.+++
T Consensus 33 ~~g~V~~~~~----~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 106 (278)
T 1byg_A 33 EFGDVMLGDY----RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 106 (278)
T ss_dssp SSCEEEEEEE----TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHH
T ss_pred CCceEEEEEE----cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHH
Confidence 3444554443 2568999998743 3567899999999999999999999997654 5789999999999999999
Q ss_pred ccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 526 FRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 526 ~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
.+.. .+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++....... .
T Consensus 107 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~~l~Dfg~~~~~~~~~----~ 172 (278)
T 1byg_A 107 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSE-------DNVAKVSDFGLTKEASSTQ----D 172 (278)
T ss_dssp HHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT-------TSCEEECCCCC-------------
T ss_pred HhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeC-------CCcEEEeeccccccccccc----c
Confidence 7653 388999999999999999999999 9999999999999987 7899999999988654321 1
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
...++..|+|||.+.+..++.++||||||++++||++ |+.|+....... ....+... .....+...++.+
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~l 243 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKG-YKMDAPDGCPPAV 243 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTT-CCCCCCTTCCHHH
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcC-CCCCCcccCCHHH
Confidence 2347889999999998899999999999999999998 888886432111 11111100 0123344567889
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=289.46 Aligned_cols=239 Identities=23% Similarity=0.306 Sum_probs=192.1
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF 524 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 524 (725)
..++.++++.+..+ +..||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.++
T Consensus 33 G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 110 (303)
T 3a7i_A 33 GSFGEVFKGIDNRT--QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 110 (303)
T ss_dssp CSSSEEEEEEETTT--CCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHH
T ss_pred cCCeEEEEEEECCC--CcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHH
Confidence 44556666655433 4578888876433 34567899999999999999999999999999999999999999999999
Q ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 525 LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 525 l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
+.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++......... ...
T Consensus 111 ~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~kl~Dfg~~~~~~~~~~~-~~~ 178 (303)
T 3a7i_A 111 LEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSE-------HGEVKLADFGVAGQLTDTQIK-RNT 178 (303)
T ss_dssp HTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECBTTBCC-BCC
T ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECC-------CCCEEEeecccceecCccccc-cCc
Confidence 864 5689999999999999999999999 9999999999999987 789999999999876543222 233
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITM 684 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 684 (725)
..|+..|+|||.+.+..++.++||||||++++||++|+.|+...... .....+. .......+...+..+.+
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIP-KNNPPTLEGNYSKPLKE 249 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHH-HSCCCCCCSSCCHHHHH
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--------HHHHHhh-cCCCCCCccccCHHHHH
Confidence 45899999999999999999999999999999999999998643211 0011111 11112334456778999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHh
Q 039817 685 VGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 685 l~~~cl~~dp~~RPs~~evl~~L 707 (725)
++.+||+.||++|||+.|++++.
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCH
T ss_pred HHHHHcCCChhhCcCHHHHhhCh
Confidence 99999999999999999998763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=309.47 Aligned_cols=246 Identities=24% Similarity=0.227 Sum_probs=180.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~ 515 (725)
...+|+.|+.|.+..++ ..||||.+... .....+.+.+|++++++++||||+++++++... ...++||||
T Consensus 71 G~G~~g~V~~a~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~ 148 (464)
T 3ttj_A 71 GSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148 (464)
T ss_dssp EECSSCEEEEEEETTTT--EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeC
Confidence 44567777777766554 56899988643 334456789999999999999999999999754 356999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
++++ |.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 149 ~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~-------~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 149 MDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS-------DCTLKILDFGLARTAG 215 (464)
T ss_dssp CSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TSCEEECCCCCC----
T ss_pred CCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeC-------CCCEEEEEEEeeeecC
Confidence 9874 6666643 489999999999999999999999 9999999999999987 7899999999998765
Q ss_pred cCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----c------CcchHHH
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----N------GMILTDW 664 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----~------~~~~~~~ 664 (725)
... ......||+.|+|||.+.+..++.++||||||++++||++|+.||........... . ...+...
T Consensus 216 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 216 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp -CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 432 22335689999999999999999999999999999999999999975431110000 0 0000000
Q ss_pred HHHHHHcC----CC------C-----------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 665 VLYCVRTG----NL------G-----------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 665 ~~~~~~~~----~~------~-----------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........ .. + ....+.+.+|+.+||+.||++|||++|+++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111000 00 0 0125678999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.70 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=190.6
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+|+.|+++.+..+ +..||+|.+... .....+.+.+|++++++++||||+++++++..++..++||||+++++|.+
T Consensus 43 ~G~~g~V~~~~~~~~--~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 120 (360)
T 3eqc_A 43 AGNGGVVFKVSHKPS--GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120 (360)
T ss_dssp ECSSCEEEEEEETTT--CCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred CCCCeEEEEEEECCC--CcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHH
Confidence 345666666665543 457888887643 23345679999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc
Q 039817 524 FLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST 603 (725)
Q Consensus 524 ~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 603 (725)
++.+...+++..+..++.|++.||.|||+.+ +|+||||||+||+++. ++.+||+|||++....... ..
T Consensus 121 ~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~---~~ 188 (360)
T 3eqc_A 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNS-------RGEIKLCDFGVSGQLIDSM---AN 188 (360)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECT-------TCCEEECCCCCCHHHHHHC-----
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECC-------CCCEEEEECCCCccccccc---cc
Confidence 9988888999999999999999999999831 7999999999999987 7889999999987543221 12
Q ss_pred ccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc----------------------------
Q 039817 604 MIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL---------------------------- 655 (725)
Q Consensus 604 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~---------------------------- 655 (725)
...||..|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 3458999999999999999999999999999999999999986532211000
Q ss_pred ---ccCcchHHHHHHHHHcCC---CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 656 ---ANGMILTDWVLYCVRTGN---LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 656 ---~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......+.......... ......+.+.+|+.+||+.||++|||++|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000001111111111111 111346689999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=296.81 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=186.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhc--cCcCCccceeeEEEcCC----ceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR--THHKNLVQLLGFCIEQN----HQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e~~~~g 519 (725)
..++.++++.. .+..||||.+.. ...+.+.+|++++.. ++||||+++++++.... ..++||||+++|
T Consensus 53 G~~g~Vy~~~~----~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g 125 (342)
T 1b6c_B 53 GRFGEVWRGKW----RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 125 (342)
T ss_dssp ETTEEEEEEEE----TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTC
T ss_pred CCCcEEEEEEE----cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCC
Confidence 44555665554 257899999853 345678899999887 78999999999998876 789999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhh--------cccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLH--------EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
+|.+++.+ ..+++..++.++.|++.||.||| +. +|+||||||+||+++. ++.+||+|||++
T Consensus 126 ~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~-------~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 126 SLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK-------NGTCCIADLGLA 194 (342)
T ss_dssp BHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT-------TSCEEECCCTTC
T ss_pred cHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC-------CCCEEEEECCCc
Confidence 99999965 46899999999999999999999 66 9999999999999987 789999999999
Q ss_pred cccCcCCCc---cccccccCccccchhcccCCC------CCCccceehhHHHHHHHHhC----------CcCCCCCCCCc
Q 039817 592 KLLKKDQTR---TSTMIRGTMGYMAPEWLRNAP------VTAKVDVYSFGVMLLEIIFC----------KRHTELHRVDE 652 (725)
Q Consensus 592 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDv~S~G~vl~elltg----------~~~~~~~~~~~ 652 (725)
+........ ......||..|+|||.+.+.. ++.++||||||+++|||++| ..|+.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 866443322 122346899999999987652 33689999999999999999 44543322111
Q ss_pred cccccCcchHHHHHHHHHc----CCCC-----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 653 PTLANGMILTDWVLYCVRT----GNLG-----ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~----~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
..... ....... ..++ ....+.+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 275 ------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 275 ------PSVEE-MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp ------CCHHH-HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------ccHHH-HHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 11111 2222211 1222 255678999999999999999999999999998764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.17 Aligned_cols=234 Identities=21% Similarity=0.303 Sum_probs=189.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCcc-----------------HHHHHHHHHHHhccCcCCccceeeEEEcCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDG-----------------EKSFLREVQVIGRTHHKNLVQLLGFCIEQN 507 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~-----------------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 507 (725)
..+++.++.|.+ .+..||||.+....... .+.|.+|++++++++||||+++++++.+.+
T Consensus 41 ~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 116 (348)
T 2pml_X 41 QGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD 116 (348)
T ss_dssp CCSSCCEEEEEE----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSS
T ss_pred CCCCeEEEEEEc----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 345666777766 56789999886432111 188999999999999999999999999999
Q ss_pred ceeeeeecccCCChhhh------hcc--CCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccC
Q 039817 508 HQLLVYELMKNGTLSAF------LFR--QEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITID 578 (725)
Q Consensus 508 ~~~lV~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~ 578 (725)
..++||||+++++|.++ +.. ...+++..+..++.|++.||.|||+ . +|+|+||||+||+++.
T Consensus 117 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~------ 187 (348)
T 2pml_X 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK------ 187 (348)
T ss_dssp EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT------
T ss_pred eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC------
Confidence 99999999999999999 665 4678999999999999999999998 8 9999999999999987
Q ss_pred CCCceEEeeccCccccCcCCCccccccccCccccchhcccCC-CCCC-ccceehhHHHHHHHHhCCcCCCCCCCCccccc
Q 039817 579 NNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA-PVTA-KVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA 656 (725)
Q Consensus 579 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~ 656 (725)
++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||++++||++|+.|+.......
T Consensus 188 -~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 259 (348)
T 2pml_X 188 -NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---- 259 (348)
T ss_dssp -TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH----
T ss_pred -CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH----
Confidence 789999999999875433 22335589999999999877 6666 9999999999999999999997543211
Q ss_pred cCcchHHHHHHHHHcC--CCC-------------------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 657 NGMILTDWVLYCVRTG--NLG-------------------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 657 ~~~~~~~~~~~~~~~~--~~~-------------------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+ .......+ ..+ ...++.+.+++.+||+.||.+|||+.|++++
T Consensus 260 ------~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ------E-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ------H-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ------H-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 11111111 111 3456789999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=313.64 Aligned_cols=239 Identities=26% Similarity=0.345 Sum_probs=194.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|+.+.+..++ ..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 35 g~G~~g~V~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 112 (484)
T 3nyv_A 35 GKGSFGEVILCKDKITG--QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112 (484)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred ecCCCEEEEEEEECCCC--CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCC
Confidence 34567777777766554 46888887543 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.. +.++.+||+|||+++.......
T Consensus 113 L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~----~~~~~~kl~Dfg~a~~~~~~~~- 184 (484)
T 3nyv_A 113 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESK----SKDANIRIIDFGLSTHFEASKK- 184 (484)
T ss_dssp HHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSS----STTCCEEECCTTHHHHBCCCCS-
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecC----CCCCcEEEEeeeeeEEcccccc-
Confidence 999998888999999999999999999999999 99999999999999642 2278899999999987654322
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC-----
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG----- 675 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 675 (725)
.....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .+ .......+...
T Consensus 185 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~-~~~~i~~~~~~~~~~~ 250 (484)
T 3nyv_A 185 -MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----------YD-ILKKVEKGKYTFELPQ 250 (484)
T ss_dssp -HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHCCCCCCSGG
T ss_pred -cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----------HH-HHHHHHcCCCCCCCcc
Confidence 233459999999999876 689999999999999999999999964321 11 11112222211
Q ss_pred -hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 -ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 -~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...++.+.+|+.+||+.||.+|||+.|++++
T Consensus 251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 251 WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 2456789999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.97 Aligned_cols=240 Identities=21% Similarity=0.273 Sum_probs=184.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEc--------CCceeeee
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--------QNHQLLVY 513 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~lV~ 513 (725)
...+|+.|+.|.+..++ ..||||.+... .......+.+|++++++++||||+++++++.. .+..++||
T Consensus 26 g~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~ 103 (351)
T 3mi9_A 26 GQGTFGEVFKARHRKTG--QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103 (351)
T ss_dssp SSCSTTSEEEEEETTTC--CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEE
T ss_pred ecCCCcEEEEEEECCCC--CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEE
Confidence 34567777777765444 57899987543 23345678999999999999999999999987 44689999
Q ss_pred ecccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 514 ELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 514 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
||+++ +|.+.+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 104 e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~-------~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 104 DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITR-------DGVLKLADFGLAR 172 (351)
T ss_dssp ECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCE
T ss_pred eccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcC-------CCCEEEccchhcc
Confidence 99986 676666554 6799999999999999999999999 9999999999999987 7899999999998
Q ss_pred ccCcCCC---ccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH
Q 039817 593 LLKKDQT---RTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC 668 (725)
Q Consensus 593 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (725)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ....+...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~ 244 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--------QLALISQL 244 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHH
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHH
Confidence 7643221 12233558999999999876 458999999999999999999999987532110 01111111
Q ss_pred HHcCCCCh--------------------------------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 VRTGNLGA--------------------------------TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~~~~~~~~--------------------------------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. +..+. ...+.+.+|+.+||+.||++|||++|++++
T Consensus 245 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 245 C--GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp H--CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred h--CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 00000 013568899999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=323.36 Aligned_cols=239 Identities=24% Similarity=0.239 Sum_probs=196.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...+|+.|+.|.+..+ +..||||.+++. .....+.+..|.+++..+ +|+||+++++++.+.+..+|||||+++|
T Consensus 350 G~G~fG~V~~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg 427 (674)
T 3pfq_A 350 GKGSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427 (674)
T ss_dssp SBTTTBCEEEEEESSS--CCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSC
T ss_pred ccCCCEEEEEEEECCC--CcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCC
Confidence 3456667776665543 457899988642 344567789999999987 7999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.+.+.+++..+..++.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++.......
T Consensus 428 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~-------~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDS-------EGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECS-------SSCEEECCCTTCEECCCTTC
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcC-------CCcEEEeecceeeccccCCc
Confidence 9999998888899999999999999999999999 9999999999999987 88999999999986433322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATK 678 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 678 (725)
......||+.|+|||++.+..++.++||||||++||||++|+.||..... .+...... ....++...
T Consensus 498 -~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~ 565 (674)
T 3pfq_A 498 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------DELFQSIMEHNVAYPKSM 565 (674)
T ss_dssp -CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHSSCCCCCTTS
T ss_pred -ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHhCCCCCCccC
Confidence 23346699999999999999999999999999999999999999975321 11111111 123455667
Q ss_pred HHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSM-----KQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~-----~evl~~ 706 (725)
.+.+.+|+.+||+.||++||++ +||+++
T Consensus 566 s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 8899999999999999999997 777754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-32 Score=292.30 Aligned_cols=235 Identities=23% Similarity=0.356 Sum_probs=187.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccC--------ccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecc
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTG--------DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--------~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
.+++.|++|.+..+ +..||||.+..... ...+.+.+|+.+++++ +||||+++++++......++||||+
T Consensus 105 G~~g~Vy~a~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 182 (365)
T 2y7j_A 105 GVSSVVRRCVHRAT--GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182 (365)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCC
T ss_pred CCCEEEEEEEECCC--CcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeC
Confidence 34556666655443 45788887754321 1145688999999999 7999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++.....
T Consensus 183 ~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~-------~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 183 RKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDD-------NMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC-------CCCEEEEecCcccccCC
Confidence 9999999998878899999999999999999999999 9999999999999987 78999999999987654
Q ss_pred CCCccccccccCccccchhcccC------CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRN------APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (725)
... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .. ......
T Consensus 253 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----------~~-~~~~i~ 318 (365)
T 2y7j_A 253 GEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----------IL-MLRMIM 318 (365)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHH
T ss_pred Ccc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----------HH-HHHHHH
Confidence 322 233568999999999863 3588999999999999999999999864321 11 111112
Q ss_pred cCCCCh------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 671 TGNLGA------TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 671 ~~~~~~------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.... ..+..+.+++.+||+.||++|||+.|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 222211 234568999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.34 Aligned_cols=242 Identities=25% Similarity=0.288 Sum_probs=173.9
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEc--------CCceeeeeecc
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIE--------QNHQLLVYELM 516 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--------~~~~~lV~e~~ 516 (725)
..|+.++++.+..+ +..||||.+........+.+.+|+.++.++. ||||+++++++.. ....++||||+
T Consensus 39 G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~ 116 (337)
T 3ll6_A 39 GGFAFVYEAQDVGS--GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116 (337)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC
T ss_pred CCceEEEEEEECCC--CcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec
Confidence 34555666655433 4578999886655566678999999999996 9999999999952 33578999999
Q ss_pred cCCChhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhhcccCCc--eeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 517 KNGTLSAFLFR---QEIPTWDKRVEIALGIARGLLYLHEECETQ--IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 517 ~~gsL~~~l~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
+ |+|.+++.. ...+++..++.++.|++.||.|||+. + |+||||||+|||++. ++.+||+|||++
T Consensus 117 ~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~-------~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 117 K-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSN-------QGTIKLCDFGSA 185 (337)
T ss_dssp S-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECT-------TSCEEBCCCTTC
T ss_pred C-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECC-------CCCEEEecCccc
Confidence 6 699998864 46799999999999999999999998 7 999999999999987 789999999999
Q ss_pred cccCcCCCcc-----------ccccccCccccchhcc---cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc
Q 039817 592 KLLKKDQTRT-----------STMIRGTMGYMAPEWL---RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN 657 (725)
Q Consensus 592 ~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~ 657 (725)
+......... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.|+.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----- 260 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----- 260 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----
Confidence 8765432211 1124489999999998 56678999999999999999999999986432211
Q ss_pred CcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 658 GMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.... .............+.+++.+||+.||.+|||+.|++++|+.+.+
T Consensus 261 ------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ------IVNG-KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------hhcC-cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 01112222344568899999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=293.53 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=188.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.|+++.+..+ +..||||.+... .......+.+|+.++.++ +||||+++++++...+..++||||+++|+|
T Consensus 39 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (327)
T 3lm5_A 39 RGKFAVVRQCISKST--GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI 116 (327)
T ss_dssp EETTEEEEEEEETTT--CCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred CCCCeEEEEEEECCC--CCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcH
Confidence 445666666665544 357888887643 234467899999999999 579999999999999999999999999999
Q ss_pred hhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 522 SAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 522 ~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.. ..++.+||+|||+++.......
T Consensus 117 ~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~----~~~~~~kL~Dfg~a~~~~~~~~ 189 (327)
T 3lm5_A 117 FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSI----YPLGDIKIVDFGMSRKIGHACE 189 (327)
T ss_dssp GGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCB----TTBCCEEECCGGGCEEC-----
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecC----CCCCcEEEeeCccccccCCccc
Confidence 9999654 6789999999999999999999999 99999999999999762 1267899999999987643322
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCC----C
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGN----L 674 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~ 674 (725)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... +....... ... .
T Consensus 190 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~ 256 (327)
T 3lm5_A 190 --LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-----------ETYLNISQVNVDYSEET 256 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------HHHHHHHHTCCCCCTTT
T ss_pred --cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----------HHHHHHHhcccccCchh
Confidence 22345899999999999999999999999999999999999998643211 11111111 111 1
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+.+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 22456789999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.11 Aligned_cols=242 Identities=23% Similarity=0.244 Sum_probs=195.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|+.+.+..+ +..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 194 G~G~fG~Vy~a~~~~t--g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~ 271 (543)
T 3c4z_A 194 GRGGFGEVFACQMKAT--GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD 271 (543)
T ss_dssp EECSSSEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred eeCCCeEEEEEEECCC--CcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCC
Confidence 3456777777766544 457899988543 23445779999999999999999999999999999999999999999
Q ss_pred hhhhhccC----CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 521 LSAFLFRQ----EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 521 L~~~l~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 272 L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~-------~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDD-------DGNVRISDLGLAVELKA 341 (543)
T ss_dssp HHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TSCEEECCCTTCEECCT
T ss_pred HHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeC-------CCCEEEeecceeeeccC
Confidence 99998754 3689999999999999999999999 9999999999999987 88999999999987654
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLG 675 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 675 (725)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...+...... ....++
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-------~~~~~~~~i~~~~~~~p 413 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-------ENKELKQRVLEQAVTYP 413 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-------CHHHHHHHHHHCCCCCC
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-------hHHHHHHHHhhcccCCC
Confidence 3322 223469999999999999999999999999999999999999997543211 1111111111 123455
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSM-----KQVLQ 705 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~ 705 (725)
...+..+.+++.+||+.||++||++ ++|++
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 6677899999999999999999965 67765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.37 Aligned_cols=256 Identities=20% Similarity=0.225 Sum_probs=178.5
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gs 520 (725)
+...+|+.|++|...-...+..||||.+... .....+.+|++++++++||||+++++++.. ....++||||+++ +
T Consensus 29 lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~ 105 (405)
T 3rgf_A 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-D 105 (405)
T ss_dssp CC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-E
T ss_pred eeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-C
Confidence 4556788888887654455678999999643 334678999999999999999999999954 6788999999985 7
Q ss_pred hhhhhccC---------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 521 LSAFLFRQ---------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 521 L~~~l~~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||||..+. +.++.+||+|||++
T Consensus 106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~---~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG---PERGRVKIADMGFA 179 (405)
T ss_dssp HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSS---TTTTCEEECCTTCC
T ss_pred HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCC---CCCCcEEEEECCCc
Confidence 87777422 2489999999999999999999999 999999999999994310 12789999999999
Q ss_pred cccCcCCC--ccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc-CcchHHHHHH
Q 039817 592 KLLKKDQT--RTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN-GMILTDWVLY 667 (725)
Q Consensus 592 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~-~~~~~~~~~~ 667 (725)
+....... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.....+...... .......+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87654322 122335689999999999874 5899999999999999999999999754432110000 0000000000
Q ss_pred HHH------------------------cCC------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 668 CVR------------------------TGN------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 668 ~~~------------------------~~~------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
... ... ......+.+.+|+.+||+.||.+|||++|++++=
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000 000 0001145688999999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-33 Score=305.24 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=185.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC-----Cceeeeeecc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-----NHQLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~ 516 (725)
...+|+.|++|.+..+ +..||||++.... ....+.+.+|++++++++|+||+++++++... ...++||||+
T Consensus 35 G~G~~g~V~~a~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 112 (432)
T 3n9x_A 35 GRGSYGYVYLAYDKNT--EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA 112 (432)
T ss_dssp EEETTEEEEEEEETTT--TEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC
T ss_pred eecCCEEEEEEEECCC--CcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC
Confidence 3456777777776544 4678999986532 23456799999999999999999999999876 5789999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+ ++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 113 ~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~-------~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 113 D-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQ-------DCSVKVCDFGLARTINS 181 (432)
T ss_dssp S-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEEC--
T ss_pred C-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECC-------CCCEEEccCCCcccccc
Confidence 7 59999998888899999999999999999999999 9999999999999987 78999999999987644
Q ss_pred CCCc---------------------cccccccCccccchhcc-cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc
Q 039817 597 DQTR---------------------TSTMIRGTMGYMAPEWL-RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT 654 (725)
Q Consensus 597 ~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~ 654 (725)
.... ......||+.|+|||.+ ....++.++|||||||++|||++|..|+.........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 3211 12345689999999986 5667999999999999999999865554322111000
Q ss_pred cccC--------------cc---hHHHH-----------------------HHHHHcCC----CC-----hhHHHHHHHH
Q 039817 655 LANG--------------MI---LTDWV-----------------------LYCVRTGN----LG-----ATKFERITMV 685 (725)
Q Consensus 655 ~~~~--------------~~---~~~~~-----------------------~~~~~~~~----~~-----~~~~~~l~~l 685 (725)
.... .. ..+.+ ........ .+ ....+.+.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 0000 00 00000 01110000 00 1245678999
Q ss_pred HHHccCCCCCCCCCHHHHHHH
Q 039817 686 GLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 686 ~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+||+.||++|||++|++++
T Consensus 342 l~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=286.32 Aligned_cols=238 Identities=26% Similarity=0.368 Sum_probs=190.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...++.++.+.+..+ +..||||.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 32 ~G~~g~V~~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 109 (287)
T 2wei_A 32 KGSFGEVLKCKDRIT--QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109 (287)
T ss_dssp EETTEEEEEEEETTT--CCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CCCCEEEEEEEEcCC--CcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHH
Confidence 345566666665443 457788887543 3345678999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+...+++..+..++.|++.||.|||+. +++|+||||+||+++.+. .+..+||+|||++.........
T Consensus 110 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~----~~~~~kL~Dfg~~~~~~~~~~~-- 180 (287)
T 2wei_A 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKE----KDCDIKIIDFGLSTCFQQNTKM-- 180 (287)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS----TTCCEEECSTTGGGTBCCCSSC--
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCC----CcccEEEeccCcceeecCCCcc--
Confidence 9998878899999999999999999999999 999999999999997631 2567999999999876543221
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC------h
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG------A 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 676 (725)
....++..|+|||.+.+ .++.++||||||+++++|++|+.|+..... .+ .......+... .
T Consensus 181 ~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~-~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----------YD-ILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHCCCCCCSGGGT
T ss_pred ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----------HH-HHHHHHcCCCCCCchhhh
Confidence 22347889999998875 489999999999999999999999864321 11 11112222211 2
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..++.+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 346789999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-33 Score=292.65 Aligned_cols=237 Identities=22% Similarity=0.295 Sum_probs=185.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
..++.++.+.+..+ +..||+|.+........+.+.+|++++++++||||+++++++..++..++||||+++++|.+++
T Consensus 30 G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 107 (302)
T 2j7t_A 30 GAFGKVYKAKNKET--GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM 107 (302)
T ss_dssp STTCCEEEEEETTT--CCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHH
T ss_pred CCCeEEEEEEEcCC--CcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHH
Confidence 44556666655433 4578999987766667789999999999999999999999999999999999999999999998
Q ss_pred cc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 FR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
.. ...+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++....... .....
T Consensus 108 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~-~~~~~ 176 (302)
T 2j7t_A 108 LELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTL-------EGDIRLADFGVSAKNLKTL-QKRDS 176 (302)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECT-------TSCEEECCCHHHHHHHHHH-HC---
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECC-------CCCEEEEECCCCccccccc-ccccc
Confidence 75 46789999999999999999999999 9999999999999987 7889999999876432111 11122
Q ss_pred cccCccccchhcc-----cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CCC
Q 039817 605 IRGTMGYMAPEWL-----RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NLG 675 (725)
Q Consensus 605 ~~gt~~y~aPE~~-----~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 675 (725)
..|+..|+|||.+ ....++.++||||||+++|||++|+.|+..... ........... ..+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~ 245 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKSDPPTLLTP 245 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCCCCCSSG
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----------HHHHHHHhccCCcccCCc
Confidence 4589999999998 466789999999999999999999999864321 11111111111 123
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 3456789999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=285.75 Aligned_cols=235 Identities=24% Similarity=0.301 Sum_probs=188.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFL 525 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 525 (725)
.+|+.++.+.+..+ +..||||.+... ...+.+.+|++++++++||||+++++++...+..++||||+++++|.+++
T Consensus 40 G~~g~Vy~~~~~~~--~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 115 (314)
T 3com_A 40 GSYGSVYKAIHKET--GQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII 115 (314)
T ss_dssp ---CEEEEEEETTT--CCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred CCCeEEEEEEECCC--CCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHH
Confidence 34555555554433 457899988653 34678999999999999999999999999999999999999999999999
Q ss_pred c-cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccc
Q 039817 526 F-RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM 604 (725)
Q Consensus 526 ~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 604 (725)
. ....+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++......... ...
T Consensus 116 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~kl~dfg~~~~~~~~~~~-~~~ 184 (314)
T 3com_A 116 RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNT-------EGHAKLADFGVAGQLTDTMAK-RNT 184 (314)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TCCEEECCCTTCEECBTTBSC-BCC
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECC-------CCCEEEeecccchhhhhhccc-cCc
Confidence 6 356789999999999999999999999 9999999999999987 788999999999866443221 223
Q ss_pred cccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CCChhHHH
Q 039817 605 IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NLGATKFE 680 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 680 (725)
..|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........... ..+...+.
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----------MRAIFMIPTNPPPTFRKPELWSD 253 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCCCCCSSGGGSCH
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhcCCCcccCCcccCCH
Confidence 4589999999999999999999999999999999999999864321 11111111111 11234567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+.+++.+||+.||.+|||+.+++++
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhC
Confidence 89999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=296.95 Aligned_cols=250 Identities=23% Similarity=0.245 Sum_probs=185.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCC------ceeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN------HQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~e~ 515 (725)
...+|+.|+.|.+..++ ..||||.+.... ....+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 34 G~G~~g~V~~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~ 111 (367)
T 1cm8_A 34 GSGAYGAVCSAVDGRTG--AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 111 (367)
T ss_dssp ------CEEEEEETTTC--CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred eecCCeEEEEEEECCCC--CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEec
Confidence 34456777777665444 578999985432 233567899999999999999999999998653 45999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 112 ~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~-------~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 112 M-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNE-------DCELKILDFGLARQAD 179 (367)
T ss_dssp C-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEECC
T ss_pred C-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcC-------CCCEEEEeeecccccc
Confidence 9 7899999865 5689999999999999999999999 9999999999999987 7899999999998754
Q ss_pred cCCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHH-------
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTD------- 663 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~------- 663 (725)
.. .....+|..|+|||.+.+ ..++.++||||+|++++||++|+.||........... ......+
T Consensus 180 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 180 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 32 223458999999999877 6899999999999999999999999975432110000 0000000
Q ss_pred -HHHHHHHc-C--------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCC
Q 039817 664 -WVLYCVRT-G--------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTS 711 (725)
Q Consensus 664 -~~~~~~~~-~--------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~ 711 (725)
........ . .......+.+.+|+.+||+.||++|||++|++++ ++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00000000 0 0112345778999999999999999999999986 55443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-34 Score=296.74 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=170.9
Q ss_pred HHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhc
Q 039817 448 YQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLF 526 (725)
Q Consensus 448 ~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 526 (725)
++.++.+.+.. .+..||||.+.... ....+++.+|++++++++||||+++++++...+..++||||+++++|.+++.
T Consensus 28 ~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 105 (303)
T 2vwi_A 28 TAVVQAAYCAP--KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK 105 (303)
T ss_dssp CCCEEEEEC------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHH
T ss_pred ceEEEEEEECC--CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHH
Confidence 34444444332 34578999886432 3345678999999999999999999999999999999999999999999986
Q ss_pred c--------CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 527 R--------QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 527 ~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
. ...+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++.......
T Consensus 106 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 106 HIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGE-------DGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp HHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECT-------TCCEEECCCHHHHHCC---
T ss_pred HHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcC-------CCCEEEEeccchheeccCC
Confidence 3 35689999999999999999999999 9999999999999987 7899999999987654322
Q ss_pred C----ccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHH-------
Q 039817 599 T----RTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL------- 666 (725)
Q Consensus 599 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~------- 666 (725)
. .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ ......
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-------LMLTLQNDPPSLE 248 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHTSSCCCTT
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-------HHHHhccCCCccc
Confidence 1 11223458999999999875 5689999999999999999999999875432110 000000
Q ss_pred HHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 667 YCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 667 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.............+.+.+++.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000011223445678999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=309.15 Aligned_cols=238 Identities=24% Similarity=0.299 Sum_probs=190.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC-------------ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG-------------DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLL 511 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 511 (725)
..+|+.|+.|.+..+ +..||||.+..... ...+.+.+|++++++++||||+++++++..+...++
T Consensus 46 ~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 123 (504)
T 3q5i_A 46 SGAYGEVLLCKEKNG--HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123 (504)
T ss_dssp C--CEEEEEEEETTT--CCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEEECCC--CcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 445667777766544 35778888754321 345679999999999999999999999999999999
Q ss_pred eeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 512 VYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 512 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+. ....+||+|||++
T Consensus 124 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~----~~~~~kl~Dfg~a 196 (504)
T 3q5i_A 124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKN----SLLNIKIVDFGLS 196 (504)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTT----CCSSEEECCCTTC
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCC----CCccEEEEECCCC
Confidence 999999999999998888899999999999999999999999 999999999999998731 1347999999999
Q ss_pred cccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 592 KLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 592 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
+....... .....||+.|+|||.+. ..++.++||||+|+++|+|++|+.||..... .+ +......
T Consensus 197 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~-~~~~i~~ 261 (504)
T 3q5i_A 197 SFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-----------QD-IIKKVEK 261 (504)
T ss_dssp EECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHH
T ss_pred EEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----------HH-HHHHHHc
Confidence 87654322 23345999999999987 4689999999999999999999999974321 11 1222222
Q ss_pred CCCC------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 GNLG------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~~~~------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+... ...++.+.+|+.+||+.||.+|||++|++++
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3222 1345789999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-32 Score=290.81 Aligned_cols=250 Identities=23% Similarity=0.269 Sum_probs=185.7
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-----cCCccceeeEEEcCCceeeeeecccCCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-----HKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
.+|+.|++|.+..+ +..||||.+... ....+.+..|++++++++ ||||+++++++...+..++||||+ +++
T Consensus 46 G~~g~V~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~ 121 (360)
T 3llt_A 46 GTFGRVLLCQHIDN--KKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPS 121 (360)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCB
T ss_pred cCCeEEEEEEECCC--CeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCC
Confidence 45566666655433 457899998642 344567888999999886 999999999999999999999999 889
Q ss_pred hhhhhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcc------------------ccCCC
Q 039817 521 LSAFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI------------------TIDNN 580 (725)
Q Consensus 521 L~~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~------------------~~~~~ 580 (725)
|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.+.. ....+
T Consensus 122 L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (360)
T 3llt_A 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198 (360)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESC
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCC
Confidence 999997653 589999999999999999999999 9999999999999974210 00126
Q ss_pred CceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc----c
Q 039817 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL----A 656 (725)
Q Consensus 581 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~----~ 656 (725)
+.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .
T Consensus 199 ~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 274 (360)
T 3llt_A 199 TGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274 (360)
T ss_dssp CCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHh
Confidence 789999999998654322 23458999999999999999999999999999999999999996532111000 0
Q ss_pred cCcchHHHHHHHHH-----------------------------cCCCC---hhHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 039817 657 NGMILTDWVLYCVR-----------------------------TGNLG---ATKFERITMVGLWCICPQPTLRPSMKQVL 704 (725)
Q Consensus 657 ~~~~~~~~~~~~~~-----------------------------~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl 704 (725)
.............. ....+ ....+.+.+|+.+||+.||++|||++|++
T Consensus 275 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 275 IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354 (360)
T ss_dssp TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 00000000000000 00000 01126688999999999999999999998
Q ss_pred HH
Q 039817 705 QM 706 (725)
Q Consensus 705 ~~ 706 (725)
++
T Consensus 355 ~h 356 (360)
T 3llt_A 355 KH 356 (360)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=283.93 Aligned_cols=235 Identities=23% Similarity=0.316 Sum_probs=188.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc---------CccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeec
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT---------GDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYEL 515 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~---------~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 515 (725)
..++.++++.+..+ +..||||.+.... ....+.+.+|++++++++ ||||+++++++..++..++||||
T Consensus 28 G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (298)
T 1phk_A 28 GVSSVVRRCIHKPT--CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105 (298)
T ss_dssp CSSEEEEEEEETTT--TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCceEEEEEEEcCc--CceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEec
Confidence 34555666655433 4678999885432 122456889999999995 99999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++....
T Consensus 106 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~-------~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 106 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD-------DMNIKLTDFGFSCQLD 175 (298)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcC-------CCcEEEecccchhhcC
Confidence 99999999998878899999999999999999999999 9999999999999987 7889999999998765
Q ss_pred cCCCccccccccCccccchhccc------CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLR------NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
.... .....++..|+|||.+. ...++.++||||||++++||++|+.|+..... ..... ..
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~-~~ 241 (298)
T 1phk_A 176 PGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----------MLMLR-MI 241 (298)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHH-HH
T ss_pred CCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----------HHHHH-HH
Confidence 4322 22345899999999885 45688999999999999999999999864321 11111 11
Q ss_pred HcCCC------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 RTGNL------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~~~~~------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+.. ....++.+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11111 12456789999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=291.55 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=182.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHH--hccCcCCccceeeEEEc-----CCceeeeeecccC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVI--GRTHHKNLVQLLGFCIE-----QNHQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l--~~l~H~niv~l~g~~~~-----~~~~~lV~e~~~~ 518 (725)
.+|+.|+++.. .+..||||.+... ....+..|.+++ ..++|+||+++++.+.. ....++||||+++
T Consensus 24 G~~g~Vy~~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 96 (336)
T 3g2f_A 24 GRYGAVYKGSL----DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN 96 (336)
T ss_dssp CSSEEEEEEEE----TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTT
T ss_pred CCCeEEEEEEE----CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCC
Confidence 45556666533 3568999998642 345555565554 45899999999986643 2356899999999
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhccc------CCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEEC------ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
|+|.+++.... .++..+..++.|+++||.|||+.+ .++|+||||||+|||++. ++.+||+|||+++
T Consensus 97 g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~-------~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 97 GSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN-------DGTCVISDFGLSM 168 (336)
T ss_dssp CBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT-------TSCEEECCCTTCE
T ss_pred CcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC-------CCcEEEeecccee
Confidence 99999996554 489999999999999999999873 338999999999999987 7899999999998
Q ss_pred ccCcCCC-------ccccccccCccccchhcccC-------CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc-
Q 039817 593 LLKKDQT-------RTSTMIRGTMGYMAPEWLRN-------APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN- 657 (725)
Q Consensus 593 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~- 657 (725)
....... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.|+............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 7653321 11223459999999999976 45667899999999999999998877543322211000
Q ss_pred -----CcchHHHHHHHHHc----CCCC------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 658 -----GMILTDWVLYCVRT----GNLG------ATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 658 -----~~~~~~~~~~~~~~----~~~~------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.....+........ ..++ ...++.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 00011111111111 1111 135668999999999999999999999999998865
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=289.31 Aligned_cols=249 Identities=20% Similarity=0.224 Sum_probs=182.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEE--------------cCCcee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI--------------EQNHQL 510 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--------------~~~~~~ 510 (725)
..+++.+++|.+..+ +..||||.+........+.+.+|++++++++||||+++++++. +....+
T Consensus 21 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (320)
T 2i6l_A 21 CGGNGLVFSAVDNDC--DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98 (320)
T ss_dssp -----CEEEEEETTT--TEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEE
T ss_pred cCCCeEEEEEEECCC--CeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCcee
Confidence 345666666665443 4688999887665566788999999999999999999999874 346789
Q ss_pred eeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccC
Q 039817 511 LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590 (725)
Q Consensus 511 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgl 590 (725)
+||||++ |+|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+||+++.+ ++.+||+|||+
T Consensus 99 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~------~~~~kl~Dfg~ 167 (320)
T 2i6l_A 99 IVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE------DLVLKIGDFGL 167 (320)
T ss_dssp EEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT------TTEEEECCCTT
T ss_pred EEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC------CCeEEEccCcc
Confidence 9999998 599999854 5689999999999999999999999 99999999999999742 67899999999
Q ss_pred ccccCcCCCc--cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc---cc-CcchHH
Q 039817 591 AKLLKKDQTR--TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL---AN-GMILTD 663 (725)
Q Consensus 591 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~---~~-~~~~~~ 663 (725)
++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... .. ......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 9876432221 1223457889999998865 678999999999999999999999987543211000 00 000000
Q ss_pred H-----------HHHHHHcCCC-----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 664 W-----------VLYCVRTGNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 664 ~-----------~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. .......... .....+.+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 0000000000 11346789999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=291.66 Aligned_cols=241 Identities=24% Similarity=0.277 Sum_probs=184.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc-----cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD-----GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...|+.++.+.+..+ +..||||.+...... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 20 ~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 96 (346)
T 1ua2_A 20 EGQFATVYKARDKNT--NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET- 96 (346)
T ss_dssp EETTEEEEEEECSSC--CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-
T ss_pred ecCCEEEEEEEECCC--CcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-
Confidence 345666666665443 457899988643211 134688999999999999999999999999999999999986
Q ss_pred ChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 520 TLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 520 sL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~-------~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 97 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE-------NGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TCCEEECCCGGGSTTTSCC
T ss_pred CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcC-------CCCEEEEecccceeccCCc
Confidence 888888765 4689999999999999999999999 9999999999999987 7899999999998765432
Q ss_pred CccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC-----
Q 039817 599 TRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----- 672 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 672 (725)
. ......+|+.|+|||.+.+. .++.++||||||+++|||++|..++....... ....+.......
T Consensus 167 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--------~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 167 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--------QLTRIFETLGTPTEEQW 237 (346)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHHHCCCCTTTS
T ss_pred c-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHHHcCCCChhhh
Confidence 2 22334589999999998754 58999999999999999999998876432110 000011100000
Q ss_pred -------------C---C-----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 673 -------------N---L-----GATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 673 -------------~---~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
. . .....+.+.+++.+||+.||++|||++|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 0 022347899999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=287.03 Aligned_cols=238 Identities=26% Similarity=0.327 Sum_probs=183.8
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc--------CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT--------GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
.+|+.++.|.+..+ +..||||.+.... ......+.+|++++++++||||+++++++..++ .++||||++
T Consensus 21 G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~ 97 (322)
T 2ycf_A 21 GACGEVKLAFERKT--CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELME 97 (322)
T ss_dssp CSSEEEEEEEETTT--TEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCT
T ss_pred CCCEEEEEEEEcCC--CcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCC
Confidence 34555666655433 4678999885422 122345889999999999999999999987665 899999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.+. .+..+||+|||+++.....
T Consensus 98 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~----~~~~~kl~Dfg~~~~~~~~ 170 (322)
T 2ycf_A 98 GGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE----EDCLIKITDFGHSKILGET 170 (322)
T ss_dssp TEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS----SSCCEEECCCTTCEECCCC
T ss_pred CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCC----CCCeEEEccCccceecccc
Confidence 999999998888899999999999999999999999 999999999999998631 1446999999999876432
Q ss_pred CCccccccccCccccchhccc---CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 598 QTRTSTMIRGTMGYMAPEWLR---NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
. ......|+..|+|||.+. ...++.++||||||+++|||++|+.|+....... .+...+. .+..
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~----~~~~ 237 (322)
T 2ycf_A 171 S--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-------SLKDQIT----SGKY 237 (322)
T ss_dssp H--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-------CHHHHHH----HTCC
T ss_pred c--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-------HHHHHHH----hCcc
Confidence 2 122345899999999874 5678999999999999999999999997543221 1111111 1111
Q ss_pred C------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 G------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. ....+.+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1 1345788999999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=300.73 Aligned_cols=189 Identities=22% Similarity=0.275 Sum_probs=156.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc------CcCCccceeeEEEcCCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT------HHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...+|+.|++|.+..+ +..||||.+... ....+.+.+|+++++.+ .|+||+++++++...+..++||||++
T Consensus 106 G~G~fg~V~~a~~~~~--~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 182 (429)
T 3kvw_A 106 GKGSFGQVVKAYDHKV--HQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS 182 (429)
T ss_dssp EESSSEEEEEEEETTT--TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC
T ss_pred ccCccEEEEEEEECCC--CcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC
Confidence 3456777777766544 468999998653 33456788898888876 57799999999999999999999997
Q ss_pred CCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 518 NGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 518 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +...+||+|||+++...
T Consensus 183 -~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~-----~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 183 -MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQ-----GRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp -CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESST-----TSCCEEECCCTTCEETT
T ss_pred -CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccC-----CCcceEEeecccceecC
Confidence 5899998765 3589999999999999999999999 99999999999999872 12339999999997644
Q ss_pred cCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCC
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELH 648 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~ 648 (725)
... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 254 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 254 QRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ccc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 322 2345899999999999999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.7e-32 Score=281.79 Aligned_cols=238 Identities=25% Similarity=0.274 Sum_probs=184.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc----CccHHHHHHHHHHHhccCcCCccceeeEEE--cCCceeeeeecccC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT----GDGEKSFLREVQVIGRTHHKNLVQLLGFCI--EQNHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~ 518 (725)
..+|+.++++.+..+ +..||+|.+.... ....+.+.+|++++++++|+||+++++++. +....++||||+++
T Consensus 15 ~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 92 (305)
T 2wtk_C 15 EGSYGKVKEVLDSET--LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC 92 (305)
T ss_dssp ECSSCEEEEEEBTTT--CCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSE
T ss_pred cCCCeEEEEEEECCC--CcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccC
Confidence 345556666655433 4578888886432 345678999999999999999999999984 45688999999998
Q ss_pred CChhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 519 GTLSAFLFR--QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 519 gsL~~~l~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+ |.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++.....
T Consensus 93 ~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~-------~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 93 G-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTT-------GGTLKISALGVAEALHP 161 (305)
T ss_dssp E-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCCTTCEECCT
T ss_pred C-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcC-------CCcEEeeccccccccCc
Confidence 6 7777654 35789999999999999999999999 9999999999999987 78999999999987643
Q ss_pred CCC-ccccccccCccccchhcccCCC--CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cC
Q 039817 597 DQT-RTSTMIRGTMGYMAPEWLRNAP--VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TG 672 (725)
Q Consensus 597 ~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 672 (725)
... .......|+..|+|||.+.+.. .+.++||||||+++|||++|+.|+..... .+....... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~i~~~~~ 230 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----------YKLFENIGKGSY 230 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHCCC
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----------HHHHHHHhcCCC
Confidence 222 1223355899999999987644 37799999999999999999999864321 111111111 12
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+....+.+.+++.+||+.||.+|||++|++++
T Consensus 231 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3444567889999999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=295.18 Aligned_cols=246 Identities=23% Similarity=0.221 Sum_probs=177.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC------ceeeeeecc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN------HQLLVYELM 516 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~e~~ 516 (725)
..+|+.|+.|.+..++ ..||||.+... .....+.+.+|+.++++++||||+++++++...+ ..++||||+
T Consensus 35 ~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~ 112 (371)
T 2xrw_A 35 SGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112 (371)
T ss_dssp ECSSEEEEEEEETTTT--EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECC
T ss_pred ecCCEEEEEEEECCCC--ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcC
Confidence 4456667777665443 57899988643 2334567899999999999999999999998655 679999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++ +|.+++. ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 113 ~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~-------~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 113 DA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS-------DCTLKILDFGLARTAGT 179 (371)
T ss_dssp SE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TSCEEECCCCC------
T ss_pred CC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcC-------CCCEEEEEeeccccccc
Confidence 85 7888875 3589999999999999999999999 9999999999999987 78999999999986543
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--ccc--C-------cchHHHH
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--LAN--G-------MILTDWV 665 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--~~~--~-------~~~~~~~ 665 (725)
.. ......||..|+|||.+.+..++.++||||||+++|||++|+.||......... ... . ..+....
T Consensus 180 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 180 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 22 122346899999999999999999999999999999999999998654321100 000 0 0000000
Q ss_pred HHHHHcC-CC--------------C------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 666 LYCVRTG-NL--------------G------ATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 666 ~~~~~~~-~~--------------~------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
....... .. + ....+.+.+|+.+||+.||++|||++|++++=
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 1111000 00 0 12356899999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=290.85 Aligned_cols=248 Identities=19% Similarity=0.174 Sum_probs=190.3
Q ss_pred cccHHHHHHHhccc---CCcceEEEEEEcccccCccHHHHHHHHHHHhccC---cCCccceeeEEEcCCceeeeeecccC
Q 039817 445 VFSYQELREATNVF---DGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
..+|+.|++|+..- ...+..||||.+.. ....++..|++++.+++ |+||+++++++..++..++||||+++
T Consensus 75 ~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 151 (365)
T 3e7e_A 75 EGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151 (365)
T ss_dssp ECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCS
T ss_pred ccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCC
Confidence 34566666664211 23356789999864 34667888888888886 99999999999999999999999999
Q ss_pred CChhhhhcc-----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccc----cCCCCceEEeecc
Q 039817 519 GTLSAFLFR-----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT----IDNNYITKIADFG 589 (725)
Q Consensus 519 gsL~~~l~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~----~~~~~~~kl~Dfg 589 (725)
|+|.+++.. ...+++..+..|+.|+++||.|||+. +|+||||||+||||+.+... .+.++.+||+|||
T Consensus 152 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG 228 (365)
T 3e7e_A 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228 (365)
T ss_dssp CBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCT
T ss_pred CcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCc
Confidence 999999973 46799999999999999999999999 99999999999999762110 0126789999999
Q ss_pred CccccCcCC-CccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH
Q 039817 590 LAKLLKKDQ-TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC 668 (725)
Q Consensus 590 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (725)
+++...... ........||..|+|||.+.+..++.++||||||+++|||++|+.|+............. .
T Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~------- 299 (365)
T 3e7e_A 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL--F------- 299 (365)
T ss_dssp TCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSC--C-------
T ss_pred hhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechh--c-------
Confidence 997653221 222334569999999999999999999999999999999999999986543322111000 0
Q ss_pred HHcCCCChhHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhcCCCC
Q 039817 669 VRTGNLGATKFERITMVGLWCICPQPTLR-PSMKQVLQMLEGTSE 712 (725)
Q Consensus 669 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Ps~~evl~~L~~~~~ 712 (725)
.. ....+.+.+++..|++.+|.+| |+++++.+.|+...+
T Consensus 300 ---~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 300 ---RR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---TT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---cc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 00 1235677889999999999998 688888888877543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=291.13 Aligned_cols=240 Identities=21% Similarity=0.265 Sum_probs=178.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..+|+.|++|.+..++ ..||||.+...... ....+.+|++++++++||||+++++++..++..++||||++ ++|.+
T Consensus 12 ~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~ 88 (324)
T 3mtl_A 12 EGTYATVYKGKSKLTD--NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQ 88 (324)
T ss_dssp ECSSEEEEEEEETTTC--CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHH
T ss_pred CCCCEEEEEEEECCCC--cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHH
Confidence 3455666666654443 57899988643221 22246689999999999999999999999999999999998 48888
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++....... ..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~-------~~~~kl~Dfg~a~~~~~~~~-~~ 157 (324)
T 3mtl_A 89 YLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINE-------RGELKLADFGLARAKSIPTK-TY 157 (324)
T ss_dssp HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECT-------TCCEEECSSSEEECC--------
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECC-------CCCEEEccCcccccccCCcc-cc
Confidence 88765 5689999999999999999999999 9999999999999987 78999999999986543322 12
Q ss_pred cccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc----------
Q 039817 603 TMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---------- 671 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 671 (725)
....||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--------QLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCCCTTTSTTGG
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhCCCChHhchhhh
Confidence 23458999999999876 568999999999999999999999996543111 00111110000
Q ss_pred -------CCC-----------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 -------GNL-----------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 -------~~~-----------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... .....+.+.+|+.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 01234678899999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=287.68 Aligned_cols=236 Identities=25% Similarity=0.342 Sum_probs=180.8
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEc------CCceeeeeecccC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIE------QNHQLLVYELMKN 518 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~lV~e~~~~ 518 (725)
..++.++.|.+..+ +..||||.+... ....+.+.+|+++++++ +||||+++++++.. .+..++||||+++
T Consensus 35 G~~g~Vy~~~~~~~--~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 111 (326)
T 2x7f_A 35 GTYGQVYKGRHVKT--GQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA 111 (326)
T ss_dssp ETTEEEEEEEETTT--CCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTT
T ss_pred CCCEEEEEEEECCC--CCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCC
Confidence 45566666665443 357888888643 34567899999999999 89999999999986 4678999999999
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 519 GTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 519 gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++.....
T Consensus 112 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~-------~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 112 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE-------NAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECT-------TCCEEECCCTTTC----
T ss_pred CcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcC-------CCCEEEeeCcCceecCc
Confidence 9999999765 5689999999999999999999999 9999999999999987 78899999999986543
Q ss_pred CCCccccccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT 671 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (725)
.... .....|+..|+|||.+. +..++.++||||||+++|||++|+.|+..... ..........
T Consensus 182 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~ 249 (326)
T 2x7f_A 182 TVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFLIPRN 249 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHS
T ss_pred Cccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----------HHHHHHhhcC
Confidence 3221 22345899999999987 56789999999999999999999999854321 1111111111
Q ss_pred C---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 G---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. ......++.+.+++.+||+.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 1123456789999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-33 Score=292.64 Aligned_cols=239 Identities=26% Similarity=0.384 Sum_probs=183.6
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
..++.++++... ..+++|.+... .....+.|.+|+.++++++|+||+++++++...+..++||||+++++|.+
T Consensus 44 G~~g~V~~~~~~-----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 118 (319)
T 2y4i_B 44 GRFGQVYHGRWH-----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118 (319)
T ss_dssp SSSSEEEEEEES-----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHH
T ss_pred CCceEEEEEEEc-----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHH
Confidence 445555555442 13788887542 23345678899999999999999999999999999999999999999999
Q ss_pred hhccCC-CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC---
Q 039817 524 FLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT--- 599 (725)
Q Consensus 524 ~l~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~--- 599 (725)
++...+ .+++..+..++.|++.||.|||+. +|+||||||+||+++ ++.+||+|||+++.......
T Consensus 119 ~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~--------~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 119 VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD--------NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp HTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC----------CCEECCCSCCC----------
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe--------CCCEEEeecCCcccccccccccc
Confidence 998764 789999999999999999999999 999999999999996 45899999999876532111
Q ss_pred -ccccccccCccccchhcccC---------CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 600 -RTSTMIRGTMGYMAPEWLRN---------APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 600 -~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
.......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ..... .
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~~~~~-~ 255 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----------AIIWQ-M 255 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----------HHHHH-H
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHH-h
Confidence 11223458899999999864 45788999999999999999999998643211 11111 1
Q ss_pred HcCC----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 670 RTGN----LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 670 ~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
..+. .....++.+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111 112345678999999999999999999999999999865
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=277.60 Aligned_cols=201 Identities=18% Similarity=0.197 Sum_probs=156.7
Q ss_pred cccccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCC-----CceEEEccc
Q 039817 22 QMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQV-----GSSINLTVT 96 (725)
Q Consensus 22 ~~~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~-----~s~l~l~~~ 96 (725)
+++.|+|++||+|++ +++|||++|+|+||||+.+ ++|| |+ +.+ ||||||||+||.+ ++.|+|+.+
T Consensus 11 ~~~~~~l~~g~~l~~--~~~l~S~~g~F~lgf~~~~--~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSA--GQYLLSPNQRFKLLLQGDG--NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CTTSSEECTTEEBCT--TCEEECTTSSEEEEECTTS--CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred cccCCEecCCCEecC--CCEEEcCCCcEEEEEECCC--CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 556799999999987 8999999999999999543 5777 77 778 9999999999987 568999999
Q ss_pred ccEEE--EcCCCceEEEeccCc--------eeEEEEecCCCeEEecCC----------------------------CCcc
Q 039817 97 GQLVL--THSNGTQFKIYNGTL--------TVSALMQDSGNFLYSNAN----------------------------GSVD 138 (725)
Q Consensus 97 G~LvL--~~~~~~~~ws~~~~~--------~~~a~LldsGNlVl~~~~----------------------------~~~d 138 (725)
|+||| .|++|++||+++.+. .++|+|+|+|||||++.. +..|
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~~~~lWqS~ptdtlLpg~~~~~~l~~g~~L~S~~d 160 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV 160 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEEEEEEEESCTTSCCCCSCTTCEEECSSEEECTTCE
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecCCceeeCcccccccccccccccccccCcccccCCC
Confidence 99999 788899999987532 468999999999999610 1357
Q ss_pred CCCCceEEeeecCCCeEEeeeecCCCceeecCCCCCCccceeeecccceEEeeCce-eeeeeeeeccCCCCCceEEEEEE
Q 039817 139 YSTGRFVLEIQMDGNVVLSAFRFADPAYWYTSTRGDQNVSLIFNQSTSFLYVRNKT-TIRYPMTTQVPTPTEDYYHRATI 217 (725)
Q Consensus 139 ~s~g~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~n~~-~~~~~~~~~~~~~~~~~~~r~~l 217 (725)
|++|.|++.|+++|++.+ ++....+||++++++.....+.....+.+.+.++.+ .+.++... . ...+|++|
T Consensus 161 ps~G~fsl~l~~dGnlvL--y~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~---~---~~~~rl~L 232 (276)
T 3m7h_A 161 YGAGASKLVFQGDGNLVA--YGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTG---G---HASAVLRL 232 (276)
T ss_dssp EEETTEEEEECTTSCEEE--ECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCT---T---CTTCEEEE
T ss_pred CCCceEEEeecCCceEEE--EeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCC---C---CCCEEEEE
Confidence 889999999999997655 444468899999887655556666677777665543 33332221 1 12379999
Q ss_pred cCCCcEEEEEecCCCCCCceEEecccc
Q 039817 218 SDHGNFQQWVHNKRDGNGWAVVWEAIT 244 (725)
Q Consensus 218 ~~~G~l~~~~~~~~~~~~W~~~~~~~~ 244 (725)
+.||++++|.|. ..|..+|..|.
T Consensus 233 d~dGnLvly~~~----~~Wqsf~~~P~ 255 (276)
T 3m7h_A 233 QANGSIAILDEK----PVWARFGFQPT 255 (276)
T ss_dssp CTTSCEEEEEEE----EEEESSSCCTT
T ss_pred cCCccEEEEcCC----CeEEccCccCC
Confidence 999999999982 24887777664
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=301.22 Aligned_cols=250 Identities=18% Similarity=0.180 Sum_probs=191.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCc-CCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHH-KNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
....|++|+++.+..++ ..||||.+.... ...++.+|+++++.++| +++..+..++...+..+|||||+ +++|.
T Consensus 16 G~G~fG~Vy~a~~~~~~--~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~ 90 (483)
T 3sv0_A 16 GSGSFGEIYLGTNIQTN--EEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (483)
T ss_dssp EECSSCEEEEEEETTTC--CEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred eeCCCEEEEEEEECCCC--cEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHH
Confidence 45567777777765544 578888765432 23458899999999976 56666667777888899999999 89999
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 523 ~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
+++.. ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.+ +.++.+||+|||+++.+......
T Consensus 91 ~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~----~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 91 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLG----RRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCG----GGTTCEEECCCTTCEECBCTTTCC
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecC----CCCCeEEEEeCCcceeccCCcccc
Confidence 99975 46799999999999999999999999 99999999999999521 12789999999999876543321
Q ss_pred -----cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--
Q 039817 601 -----TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN-- 673 (725)
Q Consensus 601 -----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 673 (725)
......||..|+|||.+.+..++.++||||||++||||++|+.||........ ......+........
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-----~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----KQKYEKISEKKVATSIE 238 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-----HHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-----HHHHHHHhhccccccHH
Confidence 12245699999999999999999999999999999999999999976433210 001111111111111
Q ss_pred -CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 674 -LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 674 -~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
+....++++.+++..||+.+|++||++++|+++|+.+
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1123456899999999999999999999999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.32 Aligned_cols=243 Identities=21% Similarity=0.230 Sum_probs=185.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEc--CCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIE--QNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~e~~~~gsL 521 (725)
..+|++|++|.+..+ +..||||.+.. ...+.+.+|++++++++ |+||+++++++.. ....++||||+++++|
T Consensus 46 ~G~~g~V~~~~~~~~--~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l 120 (330)
T 3nsz_A 46 RGKYSEVFEAINITN--NEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 120 (330)
T ss_dssp ECSSEEEEEEEETTT--CCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCH
T ss_pred ccCCeEEEEEEECCC--CcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhH
Confidence 345666666665544 35789998863 34678999999999997 9999999999997 6678999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ ...+||+|||+++.......
T Consensus 121 ~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~------~~~~kl~Dfg~a~~~~~~~~-- 186 (330)
T 3nsz_A 121 KQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHE------HRKLRLIDWGLAEFYHPGQE-- 186 (330)
T ss_dssp HHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT------TTEEEECCCTTCEECCTTCC--
T ss_pred HHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCC------CCEEEEEeCCCceEcCCCCc--
Confidence 99984 388999999999999999999999 99999999999999862 34899999999987654332
Q ss_pred ccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccC--cchHHHHHHHHHcCC-----
Q 039817 602 STMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANG--MILTDWVLYCVRTGN----- 673 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~----- 673 (725)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............. ...............
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 223458899999999877 678999999999999999999999985432221100000 000000111111110
Q ss_pred ---------------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 ---------------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ---------------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......+.+.+|+.+||+.||++|||++|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111246789999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-32 Score=289.85 Aligned_cols=248 Identities=20% Similarity=0.178 Sum_probs=178.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCc-------eeeeeecc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH-------QLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-------~~lV~e~~ 516 (725)
...+|+.|+++.+..++ ..||||.+... ......+.+|++.++.++||||+++++++...+. .++||||+
T Consensus 32 g~G~~g~V~~~~~~~~~--~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~ 108 (360)
T 3e3p_A 32 GQGTFGTVQLGKEKSTG--MSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108 (360)
T ss_dssp -------CEEEEETTTC--CEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECC
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecc
Confidence 44567788877765544 57899987543 3344567788999999999999999999976443 78999999
Q ss_pred cCCChhhh----hccCCCCCHHHHHHHHHHHHHHhhhhh--cccCCceeecCCccceEEeccCccccCCCCceEEeeccC
Q 039817 517 KNGTLSAF----LFRQEIPTWDKRVEIALGIARGLLYLH--EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGL 590 (725)
Q Consensus 517 ~~gsL~~~----l~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgl 590 (725)
+++ |.+. +.....+++..+..++.|++.||.||| +. +|+||||||+|||++.. ++.+||+|||+
T Consensus 109 ~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~------~~~~kl~Dfg~ 178 (360)
T 3e3p_A 109 PDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA------DGTLKLCDFGS 178 (360)
T ss_dssp SCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT------TTEEEECCCTT
T ss_pred ccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC------CCcEEEeeCCC
Confidence 974 4333 345577899999999999999999999 87 99999999999999752 67899999999
Q ss_pred ccccCcCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHH
Q 039817 591 AKLLKKDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWV 665 (725)
Q Consensus 591 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~ 665 (725)
++........ ....||..|+|||.+.+. .++.++||||||+++|||++|+.||........... ......+..
T Consensus 179 a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 9876543322 234589999999998655 489999999999999999999999975432110000 000000000
Q ss_pred HHHHH------------------cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 LYCVR------------------TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 ~~~~~------------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..... .........+.+.+|+.+||+.||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 001112256789999999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=293.82 Aligned_cols=247 Identities=25% Similarity=0.255 Sum_probs=176.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCc-----------cHHHHHHHHHHHhccCcCCccceeeEEEc-----CC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGD-----------GEKSFLREVQVIGRTHHKNLVQLLGFCIE-----QN 507 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~ 507 (725)
...+|+.++.+.+. ++..||||.+...... ..+.+.+|++++++++||||+++++++.. ..
T Consensus 31 g~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 107 (362)
T 3pg1_A 31 SSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107 (362)
T ss_dssp EEETTEEEEEEECT---TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred ccCCCEEEEEEECC---CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence 34556666666542 3678999988543222 13789999999999999999999999854 33
Q ss_pred ceeeeeecccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEe
Q 039817 508 HQLLVYELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586 (725)
Q Consensus 508 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~ 586 (725)
..++||||++ |+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+
T Consensus 108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~-------~~~~kl~ 176 (362)
T 3pg1_A 108 KLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD-------NNDITIC 176 (362)
T ss_dssp EEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TCCEEEC
T ss_pred eEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC-------CCCEEEE
Confidence 6799999998 5888877655 4789999999999999999999999 9999999999999987 7889999
Q ss_pred eccCccccCcCCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----ccCcc
Q 039817 587 DFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----ANGMI 660 (725)
Q Consensus 587 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----~~~~~ 660 (725)
|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... .....
T Consensus 177 Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 177 DFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999985443322 223458899999999876 678999999999999999999999997542111000 00000
Q ss_pred hHH-------HHHHHHHcC--C--------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 661 LTD-------WVLYCVRTG--N--------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 661 ~~~-------~~~~~~~~~--~--------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... ......... . ......+.+.+|+.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 000000000 0 011235678999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-33 Score=303.24 Aligned_cols=245 Identities=10% Similarity=-0.023 Sum_probs=170.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhcc--CcCCcccee-------eEEEcC-----
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRT--HHKNLVQLL-------GFCIEQ----- 506 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l--~H~niv~l~-------g~~~~~----- 506 (725)
...+|+.|+++.+..+ +..||||.+..... ...+.+.+|+++++.+ +||||++++ +++...
T Consensus 71 G~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~ 148 (371)
T 3q60_A 71 RVGDRSVVFLVRDVER--LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148 (371)
T ss_dssp EECSSEEEEEEEETTT--TEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSS
T ss_pred cCCCCEEEEEEEECCC--CceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCe
Confidence 3456777777776544 46889998876432 3345678886555544 699988755 444433
Q ss_pred ------------CceeeeeecccCCChhhhhccC-CCCCHHHH------HHHHHHHHHHhhhhhcccCCceeecCCccce
Q 039817 507 ------------NHQLLVYELMKNGTLSAFLFRQ-EIPTWDKR------VEIALGIARGLLYLHEECETQIIHCDIKPQN 567 (725)
Q Consensus 507 ------------~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~qia~gL~yLH~~~~~~ivH~dik~~N 567 (725)
...++||||++ |+|.+++... ..+++..+ ..++.|+++||+|||+. +|+||||||+|
T Consensus 149 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~N 224 (371)
T 3q60_A 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDN 224 (371)
T ss_dssp SBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred eeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHH
Confidence 23799999999 8999999764 34566666 78889999999999999 99999999999
Q ss_pred EEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccC--CCCCCccceehhHHHHHHHHhCCcCC
Q 039817 568 VLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN--APVTAKVDVYSFGVMLLEIIFCKRHT 645 (725)
Q Consensus 568 Ill~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~G~vl~elltg~~~~ 645 (725)
||++. ++.+||+|||+++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 225 Ill~~-------~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 225 LFIMP-------DGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp EEECT-------TSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred EEECC-------CCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99987 7899999999998654321 13447799999999987 68999999999999999999999999
Q ss_pred CCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 646 ELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.................... ............++.+.+|+.+||+.||++|||+.|++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPG-TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCC-CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCcccccchhhhhhhhcc-ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 76533221100000000000 0000001112456789999999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=294.96 Aligned_cols=245 Identities=20% Similarity=0.215 Sum_probs=179.5
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC-----------------
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ----------------- 506 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----------------- 506 (725)
...+|+.|++|.+..++ ..||||++.... ....+|++++++++||||+++++++...
T Consensus 16 G~G~fg~V~~a~~~~~~--~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (383)
T 3eb0_A 16 GTGSFGIVCEVFDIESG--KRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKL 89 (383)
T ss_dssp ECC-CEEEEEEEETTTC--CEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------
T ss_pred EeccCEEEEEEEECCCC--CEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccc
Confidence 34566777777765544 578999875432 2234799999999999999999998542
Q ss_pred ---------------------CceeeeeecccCCChhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeec
Q 039817 507 ---------------------NHQLLVYELMKNGTLSAFLF----RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHC 561 (725)
Q Consensus 507 ---------------------~~~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~ 561 (725)
...++||||+++ +|.+.+. ....+++..+..++.|+++||.|||+. +|+||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~ 165 (383)
T 3eb0_A 90 GGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHR 165 (383)
T ss_dssp --------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECS
T ss_pred cccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccC
Confidence 347899999995 7766664 457899999999999999999999999 99999
Q ss_pred CCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHh
Q 039817 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIF 640 (725)
Q Consensus 562 dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~ellt 640 (725)
||||+|||++.+ ++.+||+|||+++....... .....+|..|+|||.+.+. .++.++||||+|+++|||++
T Consensus 166 Dikp~Nil~~~~------~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 166 DIKPQNLLVNSK------DNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp CCCGGGEEEETT------TTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred ccCHHHEEEcCC------CCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999732 67899999999987644332 2234589999999998765 58999999999999999999
Q ss_pred CCcCCCCCCCCccccc----cCcchHHHHHHHHH---c------------CCCChhHHHHHHHHHHHccCCCCCCCCCHH
Q 039817 641 CKRHTELHRVDEPTLA----NGMILTDWVLYCVR---T------------GNLGATKFERITMVGLWCICPQPTLRPSMK 701 (725)
Q Consensus 641 g~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~---~------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 701 (725)
|+.||........... ......+....... . ..++...++.+.+|+.+||+.||++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 9999975422110000 00000000000000 0 001223456789999999999999999999
Q ss_pred HHHHH
Q 039817 702 QVLQM 706 (725)
Q Consensus 702 evl~~ 706 (725)
|++++
T Consensus 318 e~l~h 322 (383)
T 3eb0_A 318 EAMAH 322 (383)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=287.69 Aligned_cols=237 Identities=20% Similarity=0.284 Sum_probs=182.5
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccC--cCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTH--HKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
.+|+.++++.+. .+..||||.+... .....+.+.+|++++++++ |+||+++++++..++..++||| +.+++|
T Consensus 39 G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L 114 (313)
T 3cek_A 39 GGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDL 114 (313)
T ss_dssp CSSEEEEEEECT---TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEH
T ss_pred CCCEEEEEEEcC---CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcH
Confidence 455666666542 3567899988543 2334578999999999997 5999999999999999999999 667899
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.....+++..+..++.|+++||.|||+. +|+||||||+||+++ ++.+||+|||+++.........
T Consensus 115 ~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~--------~~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 115 NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV--------DGMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp HHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE--------TTEEEECCCSSSCC--------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE--------CCeEEEeeccccccccCccccc
Confidence 99998888899999999999999999999999 999999999999995 4689999999998765433221
Q ss_pred -ccccccCccccchhcccC-----------CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 602 -STMIRGTMGYMAPEWLRN-----------APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 602 -~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
.....|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ........
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----------~~~~~~~~ 253 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------ISKLHAII 253 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----------HHHHHHHH
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----------HHHHHHHH
Confidence 223458999999999875 47888999999999999999999998643211 11111111
Q ss_pred H---cCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 039817 670 R---TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQML 707 (725)
Q Consensus 670 ~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 707 (725)
. ....+....+.+.+++.+||+.||++|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1 1223344567899999999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=293.65 Aligned_cols=244 Identities=24% Similarity=0.252 Sum_probs=170.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeecc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELM 516 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~ 516 (725)
..+|+.+++|.+..+ +..||||.+.... ....+.+.+|++++++++||||+++++++... ...++|+|++
T Consensus 39 ~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~ 116 (367)
T 2fst_X 39 SGAYGSVCAAFDTKT--GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 116 (367)
T ss_dssp ----CCEEEEEETTT--TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC
T ss_pred ecCCeEEEEEEECCC--CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc
Confidence 445666777765544 4679999986432 23456788999999999999999999998754 5679999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 117 -~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~-------~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 117 -GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE-------DCELKILDFGLARHTAD 184 (367)
T ss_dssp -CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TCCEEECC---------
T ss_pred -CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECC-------CCCEEEeeccccccccc
Confidence 6799998865 5789999999999999999999999 9999999999999987 78999999999986543
Q ss_pred CCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----c-------CcchHH
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----N-------GMILTD 663 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----~-------~~~~~~ 663 (725)
. .....||..|+|||.+.+ ..++.++||||||++++||++|+.||........... . ......
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 2 223468999999999877 6789999999999999999999999975432110000 0 000000
Q ss_pred HHHHHHHc-CCCC--------hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 664 WVLYCVRT-GNLG--------ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 664 ~~~~~~~~-~~~~--------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........ ...+ ....+.+.+|+.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00111110 0000 1224678999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=287.78 Aligned_cols=248 Identities=23% Similarity=0.275 Sum_probs=185.2
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcC-----CceeeeeecccC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-----NHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~ 518 (725)
..+|+.|+.|.+..+ +..||||.+..... ...+.+.+|++++++++||||+++++++... ...++||||+++
T Consensus 37 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~ 114 (364)
T 3qyz_A 37 EGAYGMVCSAYDNLN--KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114 (364)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE
T ss_pred cCCCeEEEEEEECCC--CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc
Confidence 345666666665443 46789999864332 2346789999999999999999999999764 368999999984
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 115 -~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~-------~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 115 -DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNT-------TCDLKICDFGLARVADPDH 182 (364)
T ss_dssp -EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEECCGGG
T ss_pred -CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECC-------CCCEEEEeCcceEecCCCC
Confidence 89998865 4689999999999999999999999 9999999999999987 7889999999998765432
Q ss_pred Ccc--ccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----cCcchHH-------
Q 039817 599 TRT--STMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----NGMILTD------- 663 (725)
Q Consensus 599 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----~~~~~~~------- 663 (725)
... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........... .......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 221 233569999999998754 4589999999999999999999999975432211000 0000000
Q ss_pred HHHHHHH----cCCC-----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 664 WVLYCVR----TGNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 664 ~~~~~~~----~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....... .... .......+.+|+.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000 01235678999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=292.11 Aligned_cols=244 Identities=21% Similarity=0.220 Sum_probs=181.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCce------eeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQ------LLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~------~lV~e~ 515 (725)
...+|+.|++|.+..+ +..||||.+.... ....+.+.+|+.++++++||||+++++++...+.. ++||||
T Consensus 51 G~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 128 (371)
T 4exu_A 51 GSGAYGSVCSAIDKRS--GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF 128 (371)
T ss_dssp EECSSEEEEEEEETTT--TEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEEC
T ss_pred ecCCCeEEEEEEECCC--CCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcc
Confidence 3456777777766554 4578999886532 22356789999999999999999999999877654 999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
++ ++|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~-------~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 129 MQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNE-------DCELKILDFGLARHAD 195 (371)
T ss_dssp CC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TCCEEECSTTCC----
T ss_pred cc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECC-------CCCEEEEecCcccccc
Confidence 98 588888743 489999999999999999999999 9999999999999987 7899999999998654
Q ss_pred cCCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----------------cC
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----------------NG 658 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----------------~~ 658 (725)
.. .....||+.|+|||.+.+ ..++.++||||||++++||++|+.||........... ..
T Consensus 196 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 196 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 32 223458999999999887 6899999999999999999999999975421110000 00
Q ss_pred cchHHHHHHHHHcCC-----CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 659 MILTDWVLYCVRTGN-----LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 659 ~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+......... ......+.+.+|+.+||+.||++|||+.|++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000000 011235789999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=286.10 Aligned_cols=238 Identities=21% Similarity=0.288 Sum_probs=171.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC-cc-HHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG-DG-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+|+.++++.+..+ +..||||.+..... .. .+.+.++...++.++||||+++++++..++..++||||+++ +|.
T Consensus 17 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~ 93 (290)
T 3fme_A 17 RGAYGVVEKMRHVPS--GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLD 93 (290)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHH
T ss_pred CCCCeEEEEEEecCC--CeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chH
Confidence 345566666665443 46789998864322 22 23344555567888999999999999999999999999985 887
Q ss_pred hhhcc----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 523 AFLFR----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 523 ~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 94 KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINA-------LGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECT-------TCCEEBCCC----------
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECC-------CCCEEEeecCCcccccccc
Confidence 77653 46799999999999999999999984 28999999999999987 7899999999998765432
Q ss_pred CccccccccCccccchhcc----cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC-
Q 039817 599 TRTSTMIRGTMGYMAPEWL----RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN- 673 (725)
Q Consensus 599 ~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 673 (725)
.. ....|++.|+|||.+ .+..++.++||||||++++||++|+.|+...... ............
T Consensus 165 ~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~~~~~~ 232 (290)
T 3fme_A 165 AK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----------FQQLKQVVEEPSP 232 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----------HHHHHHHHHSCCC
T ss_pred cc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----------HHHHHHHhccCCC
Confidence 22 223589999999996 5667899999999999999999999998643211 111222222211
Q ss_pred --CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 --LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 --~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....++.+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 122456789999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=280.55 Aligned_cols=251 Identities=22% Similarity=0.241 Sum_probs=187.0
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCC------ccceeeEEEcCCceeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKN------LVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
.+|+.++++.+.. ..+..||||.+... ....+.+.+|++++++++|+| ++++++++...+..++||||+ ++
T Consensus 25 G~~g~V~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 101 (339)
T 1z57_A 25 GAFGKVVECIDHK-AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GL 101 (339)
T ss_dssp ETTEEEEEEEETT-TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CC
T ss_pred CCCeEEEEEEecC-CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CC
Confidence 4555666655422 23468999998643 234567899999999987765 999999999999999999999 88
Q ss_pred ChhhhhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccc------------cCCCCceEE
Q 039817 520 TLSAFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT------------IDNNYITKI 585 (725)
Q Consensus 520 sL~~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~------------~~~~~~~kl 585 (725)
+|.+++.... .+++..+..++.|+++||.|||+. +|+||||||+|||++.+... ...++.+||
T Consensus 102 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl 178 (339)
T 1z57_A 102 STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178 (339)
T ss_dssp BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEE
T ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceE
Confidence 9999997664 688999999999999999999999 99999999999999762100 000457999
Q ss_pred eeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc---------
Q 039817 586 ADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--------- 656 (725)
Q Consensus 586 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--------- 656 (725)
+|||+++...... ....||..|+|||.+.+..++.++||||||+++|||++|+.|+...........
T Consensus 179 ~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 254 (339)
T 1z57_A 179 VDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLP 254 (339)
T ss_dssp CCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCC
T ss_pred eeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999998644322 234589999999999999999999999999999999999999875432110000
Q ss_pred ---------------------cCcchHHHHHHH----HHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 657 ---------------------NGMILTDWVLYC----VRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 657 ---------------------~~~~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
............ ...........+.+.+++.+||+.||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 255 KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 000000000000 00011223456789999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.51 Aligned_cols=253 Identities=22% Similarity=0.262 Sum_probs=186.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCC------ccceeeEEEcCCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKN------LVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...+|+.++++.+...+ +..||||.+... ....+.+.+|++++++++|++ ++.+++++...+..++||||+
T Consensus 28 g~G~~g~V~~~~~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~- 104 (355)
T 2eu9_A 28 GEGTFGKVVECLDHARG-KSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL- 104 (355)
T ss_dssp EEETTEEEEEEEETTTT-TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-
T ss_pred eccCCeEEEEEEecCCC-ceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-
Confidence 34456677777665443 367999998643 344667899999999998776 999999999999999999999
Q ss_pred CCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcc------------ccCCCCce
Q 039817 518 NGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI------------TIDNNYIT 583 (725)
Q Consensus 518 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~------------~~~~~~~~ 583 (725)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+.. ..+.++.+
T Consensus 105 ~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (355)
T 2eu9_A 105 GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181 (355)
T ss_dssp CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCE
T ss_pred CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcE
Confidence 55676666554 4689999999999999999999999 9999999999999943210 00127889
Q ss_pred EEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCc
Q 039817 584 KIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGM 659 (725)
Q Consensus 584 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~ 659 (725)
||+|||+++...... ....||..|+|||.+.+..++.++||||||+++|||++|+.||........... ...
T Consensus 182 kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (355)
T 2eu9_A 182 RVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP 257 (355)
T ss_dssp EECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999999998644322 234589999999999999999999999999999999999999975432110000 000
Q ss_pred chH--------------------------HHHHHHH----HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 660 ILT--------------------------DWVLYCV----RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 660 ~~~--------------------------~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
... ....... ............+.+|+.+||+.||++|||+.|++++
T Consensus 258 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 258 IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000000 0001122345689999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=284.78 Aligned_cols=240 Identities=25% Similarity=0.314 Sum_probs=184.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhcc---CcCCccceeeEEE-----cCCceeeeee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRT---HHKNLVQLLGFCI-----EQNHQLLVYE 514 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~-----~~~~~~lV~e 514 (725)
...|+.++++.+.. ..+..||||.+.... ......+.+|+.+++++ +||||+++++++. .....++|||
T Consensus 21 ~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 99 (326)
T 1blx_A 21 EGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99 (326)
T ss_dssp EETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEE
T ss_pred ccccEEEEEEEecC-CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEe
Confidence 34566666666532 234678999875432 22234677888887776 8999999999997 5567899999
Q ss_pred cccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 515 LMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 515 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
|++ |+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 100 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~-------~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 100 HVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS-------SGQIKLADFGLAR 168 (326)
T ss_dssp CCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TCCEEECSCCSCC
T ss_pred cCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcC-------CCCEEEecCcccc
Confidence 998 6999999765 3489999999999999999999999 9999999999999987 7899999999998
Q ss_pred ccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-
Q 039817 593 LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT- 671 (725)
Q Consensus 593 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 671 (725)
...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+......
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~~ 238 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--------QLGKILDVIGLP 238 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCC
T ss_pred cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHHHcCCC
Confidence 764322 2233558999999999999999999999999999999999999986532110 00011110000
Q ss_pred ------------------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 ------------------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ------------------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........+.+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01112356788999999999999999999999965
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=277.22 Aligned_cols=234 Identities=25% Similarity=0.384 Sum_probs=176.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEc-------------CCceeee
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE-------------QNHQLLV 512 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-------------~~~~~lV 512 (725)
..|+.++.|.+..+ +..||||.+... ....+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 17 G~~g~V~~~~~~~~--~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv 93 (303)
T 1zy4_A 17 GAFGQVVKARNALD--SRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQ 93 (303)
T ss_dssp CSSEEEEEEEETTT--CCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEE
T ss_pred CCcEEEEEEEEcCC--CeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEE
Confidence 34555555554433 457899988543 3445789999999999999999999998865 3567999
Q ss_pred eecccCCChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCc
Q 039817 513 YELMKNGTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591 (725)
Q Consensus 513 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla 591 (725)
|||+++++|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~-------~~~~kl~dfg~~ 163 (303)
T 1zy4_A 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDE-------SRNVKIGDFGLA 163 (303)
T ss_dssp EECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TSCEEECCCCCC
T ss_pred EecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcC-------CCCEEEeeCcch
Confidence 9999999999999754 4578899999999999999999999 9999999999999987 789999999999
Q ss_pred cccCcCC-------------CccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc
Q 039817 592 KLLKKDQ-------------TRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN 657 (725)
Q Consensus 592 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~ 657 (725)
+...... ........|+..|+|||.+.+. .++.++||||||+++|||++ |+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-------- 232 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-------- 232 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--------
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--------
Confidence 8764321 1112234589999999999764 78999999999999999997 332110
Q ss_pred CcchHHHHHHHHHc------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 658 GMILTDWVLYCVRT------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 658 ~~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+.. ..... ...+...++.+.+++.+||+.||.+|||+.|++++
T Consensus 233 --~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 --ERVNIL-KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHH-HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hHHHHH-HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 001111 11111 12333556778999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=288.11 Aligned_cols=249 Identities=23% Similarity=0.231 Sum_probs=185.4
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC--------cCCccceeeEEE----cCCceeeee
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH--------HKNLVQLLGFCI----EQNHQLLVY 513 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~----~~~~~~lV~ 513 (725)
.+|+.|++|.+..+ +..||||.+... ....+.+.+|++++++++ |+||+++++++. .+...++||
T Consensus 48 G~~g~V~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~ 124 (397)
T 1wak_A 48 GHFSTVWLSWDIQG--KKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVF 124 (397)
T ss_dssp CSSEEEEEEEETTT--TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCCeeEEEEEecCC--CeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEE
Confidence 44556666655433 467999998643 334577899999999986 788999999998 556889999
Q ss_pred ecccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccc---------------
Q 039817 514 ELMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT--------------- 576 (725)
Q Consensus 514 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~--------------- 576 (725)
||+. ++|.+++.+. ..+++..+..++.|++.||.|||+++ +|+||||||+|||++.+...
T Consensus 125 e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~ 201 (397)
T 1wak_A 125 EVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201 (397)
T ss_dssp CCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC------
T ss_pred eccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcC
Confidence 9995 5666655443 56899999999999999999999853 79999999999999863100
Q ss_pred ---------------------------cCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCcccee
Q 039817 577 ---------------------------IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVY 629 (725)
Q Consensus 577 ---------------------------~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~ 629 (725)
......+||+|||+++...... ....||..|+|||.+.+..++.++|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Diw 277 (397)
T 1wak_A 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLEVLIGSGYNTPADIW 277 (397)
T ss_dssp ---------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCCHHHHHTSCCCTHHHHH
T ss_pred CCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccCChhhcCCCCCcHHHHH
Confidence 0012479999999998764332 234589999999999999999999999
Q ss_pred hhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHH----------------------------------------HHH
Q 039817 630 SFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVL----------------------------------------YCV 669 (725)
Q Consensus 630 S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~ 669 (725)
|||+++|||++|+.||.......... .......+. ...
T Consensus 278 slG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (397)
T 1wak_A 278 STACMAFELATGDYLFEPHSGEEYTR--DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV 355 (397)
T ss_dssp HHHHHHHHHHHSSCSCCCCCCSSSCH--HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHH
T ss_pred HHHHHHHHHhhCCCCCCCCcccccCc--hHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhh
Confidence 99999999999999997544322100 000000000 011
Q ss_pred HcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 RTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+......+.+|+.+||+.||++|||++|++++
T Consensus 356 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 356 EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 1123345667889999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=294.20 Aligned_cols=229 Identities=25% Similarity=0.290 Sum_probs=168.9
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCC-------CH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP-------TW 533 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l-------~~ 533 (725)
+..||||++.. +..+.+.+|+++++++ +|||||++++++..++..++||||++ |+|.+++...... ++
T Consensus 39 g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~ 114 (434)
T 2rio_A 39 GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKE 114 (434)
T ss_dssp SSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------
T ss_pred CeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccc
Confidence 46899998854 2346788999999986 89999999999999999999999996 6999999766432 23
Q ss_pred HHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcc------ccCCCCceEEeeccCccccCcCCCc---cccc
Q 039817 534 DKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI------TIDNNYITKIADFGLAKLLKKDQTR---TSTM 604 (725)
Q Consensus 534 ~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~------~~~~~~~~kl~Dfgla~~~~~~~~~---~~~~ 604 (725)
..++.++.|++.||.|||+. +|+||||||+|||++.+.. ..+.+..+||+|||+++........ ....
T Consensus 115 ~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~ 191 (434)
T 2rio_A 115 YNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191 (434)
T ss_dssp CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----------
T ss_pred hhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecC
Confidence 34678999999999999999 9999999999999975310 0122568999999999876543322 1223
Q ss_pred cccCccccchhcccC-------CCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcC----
Q 039817 605 IRGTMGYMAPEWLRN-------APVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTG---- 672 (725)
Q Consensus 605 ~~gt~~y~aPE~~~~-------~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 672 (725)
..||+.|+|||.+.+ ..++.++||||||+++|||++ |+.|+....... ...........
T Consensus 192 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---------~~i~~~~~~~~~~~~ 262 (434)
T 2rio_A 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---------SNIIRGIFSLDEMKC 262 (434)
T ss_dssp ---CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---------HHHHHTCCCCCCCTT
T ss_pred CCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---------HHHhcCCCCcccccc
Confidence 569999999999875 678999999999999999999 888885432111 00110000000
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......+.+.+++.+||+.||.+|||+.||+++
T Consensus 263 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 263 LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1122456889999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=284.54 Aligned_cols=248 Identities=22% Similarity=0.254 Sum_probs=183.3
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcC-----CceeeeeecccC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-----NHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~ 518 (725)
..+|+.++.|.+..+ +..||||.+.... ......+.+|++++++++||||+++++++... ...++||||++
T Consensus 21 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~- 97 (353)
T 2b9h_A 21 EGAYGVVCSATHKPT--GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ- 97 (353)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-
T ss_pred CCCCeEEEEEEECCC--CcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-
Confidence 345556666655433 4689999986432 23356788999999999999999999998764 67899999998
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 98 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~-------~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 98 TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINS-------NCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT-------TCCEEECCCTTCEECC---
T ss_pred ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcC-------CCcEEEEeccccccccccc
Confidence 589998865 5689999999999999999999999 9999999999999987 7899999999998764322
Q ss_pred Ccc---------ccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccc-----------cc
Q 039817 599 TRT---------STMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTL-----------AN 657 (725)
Q Consensus 599 ~~~---------~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~-----------~~ 657 (725)
... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 111 122458999999998764 678999999999999999999999987543110000 00
Q ss_pred --CcchHHHHHHHHHcC-CC--------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 658 --GMILTDWVLYCVRTG-NL--------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 658 --~~~~~~~~~~~~~~~-~~--------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
............... .. .....+.+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000011111100 00 12345678999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=291.48 Aligned_cols=249 Identities=22% Similarity=0.187 Sum_probs=179.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCc------eeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH------QLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~e~~~ 517 (725)
...+|+.|+.|.+... ..+|+|++..... ...+|++++++++||||+++++++...+. .++||||++
T Consensus 49 G~G~~g~V~~a~~~~~---~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 49 GNGSFGVVFQAKLVES---DEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121 (394)
T ss_dssp EEETTEEEEEEEETTT---EEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred eeCCCeEEEEEEECCC---CeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence 3456677777765433 2378887754322 22479999999999999999999965443 789999999
Q ss_pred CCChhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 518 NGTLSAFL---FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 518 ~gsL~~~l---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
++.+.... .....+++..+..++.|+++||.|||+. +|+||||||+|||++.. ++.+||+|||+++..
T Consensus 122 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~------~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 122 ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPP------SGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT------TTEEEECCCTTCEEC
T ss_pred ccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCC------CCcEEEeeCCCcccc
Confidence 75444332 2356789999999999999999999999 99999999999999832 789999999999876
Q ss_pred CcCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHHHHH-
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLYC- 668 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~~~~- 668 (725)
...... ....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||........... ......+.....
T Consensus 193 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 443322 234589999999998764 589999999999999999999999975432110000 000000000000
Q ss_pred --HHcCC------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCC
Q 039817 669 --VRTGN------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGT 710 (725)
Q Consensus 669 --~~~~~------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~ 710 (725)
..... +.....+.+.+|+.+||+.||.+|||+.|+++| ++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00000 111245689999999999999999999999986 5544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=289.63 Aligned_cols=244 Identities=22% Similarity=0.188 Sum_probs=177.5
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC------CceeeeeecccC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~~~ 518 (725)
..+|+.|++|.+..+ +..||||.+.... +.+.+|++++++++|+|||++++++... ...++||||+++
T Consensus 64 ~G~fg~Vy~~~~~~~--~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~ 137 (420)
T 1j1b_A 64 NGSFGVVYQAKLCDS--GELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137 (420)
T ss_dssp ECSSEEEEEEEETTT--CCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE
T ss_pred eCCCEEEEEEEECCC--CcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc
Confidence 345666666665443 4578999885432 2245799999999999999999998542 136799999986
Q ss_pred CChhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 519 GTLSAFLF----RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 519 gsL~~~l~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
+|.+.+. ....+++..+..++.|+++||.|||+. +|+||||||+||||+.+ .+.+||+|||+++..
T Consensus 138 -~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~------~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 138 -TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPD------TAVLKLCDFGSAKQL 207 (420)
T ss_dssp -EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETT------TTEEEECCCTTCEEC
T ss_pred -cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCC------CCeEEeccchhhhhc
Confidence 5555543 346789999999999999999999999 99999999999999852 467899999999876
Q ss_pred CcCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHHHHHH
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLYCV 669 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 669 (725)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........... ......+.+....
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 44322 2234589999999998764 789999999999999999999999975421110000 0000000000000
Q ss_pred H---cCC------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 R---TGN------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~---~~~------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. ... ++....+.+.+|+.+||+.||++|||+.|+++|
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 000 112335789999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.51 Aligned_cols=244 Identities=21% Similarity=0.217 Sum_probs=182.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEcCCc------eeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH------QLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~e~ 515 (725)
...+|+.|+.|.+..+ +..||||.+.... ....+.+.+|+.++++++||||+++++++...+. .++||||
T Consensus 33 g~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~ 110 (353)
T 3coi_A 33 GSGAYGSVCSAIDKRS--GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF 110 (353)
T ss_dssp EECSSEEEEEEEETTT--TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEEC
T ss_pred ecCCCeEEEEEEECCC--CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecc
Confidence 3455667777766544 4678999986532 2234678999999999999999999999987654 4999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
++ ++|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 111 ~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~-------~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 111 MQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNE-------DCELKILDFGLARHAD 177 (353)
T ss_dssp CS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECT-------TCCEEECSTTCTTC--
T ss_pred cc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECC-------CCcEEEeecccccCCC
Confidence 98 588888743 489999999999999999999999 9999999999999987 7899999999998654
Q ss_pred cCCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchH--------
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILT-------- 662 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~-------- 662 (725)
.. .....+|..|+|||.+.+ ..++.++||||||++++||++|+.||........... ......
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 32 223458999999999876 6789999999999999999999999975431110000 000000
Q ss_pred HHHHHHHHc---------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 663 DWVLYCVRT---------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 663 ~~~~~~~~~---------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......... ........+.+.+++.+||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 01122456789999999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.46 Aligned_cols=232 Identities=21% Similarity=0.298 Sum_probs=182.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc------cHHHHHHHHHHHhcc----CcCCccceeeEEEcCCceeeeee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD------GEKSFLREVQVIGRT----HHKNLVQLLGFCIEQNHQLLVYE 514 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~------~~~~f~~E~~~l~~l----~H~niv~l~g~~~~~~~~~lV~e 514 (725)
..+++.++++.+..+ +..||||.+...... ....+.+|+.++.++ +|+||+++++++...+..++|+|
T Consensus 41 ~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e 118 (312)
T 2iwi_A 41 KGGFGTVFAGHRLTD--RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118 (312)
T ss_dssp EETTEEEEEEECTTT--CCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEE
T ss_pred cCCCEEEEEEEEccC--CeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEE
Confidence 344556666654433 457899998643321 233466899999988 89999999999999999999999
Q ss_pred c-ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 515 L-MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 515 ~-~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+ +++++|.+++.+...+++..+..++.|+++||.|||+. +|+||||||+||+++.+ ++.+||+|||+++.
T Consensus 119 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~------~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 119 RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLR------RGCAKLIDFGSGAL 189 (312)
T ss_dssp CCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETT------TTEEEECCCSSCEE
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCC------CCeEEEEEcchhhh
Confidence 9 78999999998888899999999999999999999999 99999999999999831 78899999999987
Q ss_pred cCcCCCccccccccCccccchhcccCCCCC-CccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 594 LKKDQTRTSTMIRGTMGYMAPEWLRNAPVT-AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 594 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
..... .....|+..|+|||.+.+..+. .++||||||+++|||++|+.|+..... . .....
T Consensus 190 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------------~--~~~~~ 250 (312)
T 2iwi_A 190 LHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------------I--LEAEL 250 (312)
T ss_dssp CCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------H--HHTCC
T ss_pred cccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------------H--hhhcc
Confidence 65432 2234589999999998876664 589999999999999999999863210 0 01122
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+......+.+++.+||+.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3445567789999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=287.58 Aligned_cols=232 Identities=21% Similarity=0.304 Sum_probs=188.1
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc------cHHHHHHHHHHHhccC--cCCccceeeEEEcCCceeeeeecc
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD------GEKSFLREVQVIGRTH--HKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
..+|+.+++|.+..+ +..||||.+...... ..+.+.+|++++++++ |+||+++++++..++..++|+|++
T Consensus 53 ~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 130 (320)
T 3a99_A 53 SGGFGSVYSGIRVSD--NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130 (320)
T ss_dssp SSSSCEEEEEEETTT--TEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECC
T ss_pred eCCCeEEEEEEECCC--CcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcC
Confidence 345666777765543 468899988653221 2356788999999996 599999999999999999999999
Q ss_pred cC-CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 517 KN-GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 517 ~~-gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
.+ ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+ ++.+||+|||+++...
T Consensus 131 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~------~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 131 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN------RGELKLIDFGSGALLK 201 (320)
T ss_dssp SSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT------TTEEEECCCTTCEECC
T ss_pred CCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC------CCCEEEeeCccccccc
Confidence 86 89999998888899999999999999999999999 99999999999999832 6789999999998765
Q ss_pred cCCCccccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
... .....||..|+|||.+.+..+ +.++||||||+++|||++|+.|+..... ........
T Consensus 202 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------------~~~~~~~~ 262 (320)
T 3a99_A 202 DTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------IIRGQVFF 262 (320)
T ss_dssp SSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------HHHCCCCC
T ss_pred ccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------------hhcccccc
Confidence 432 223458999999999887665 6789999999999999999999864210 00111223
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+...++.+.+++.+||+.||++|||++||+++
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34556789999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=282.78 Aligned_cols=190 Identities=26% Similarity=0.327 Sum_probs=155.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-cC-----CccceeeEEEcCCceeeeeecccC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HK-----NLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
..+|+.|++|.+..+ +..||||.+... ....+++..|+++++.++ |+ +|+++++++...+..++||||+++
T Consensus 64 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (382)
T 2vx3_A 64 KGSFGQVVKAYDRVE--QEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY 140 (382)
T ss_dssp EETTEEEEEEEETTT--TEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC
T ss_pred ecCCEEEEEEEEcCC--CcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC
Confidence 345666666665443 467999998643 234567888999988874 55 499999999999999999999974
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 519 GTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 519 gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
+|.+++... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++. +.++.+||+|||+++....
T Consensus 141 -~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~-----~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 141 -NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCN-----PKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp -BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESS-----TTSCCEEECCCTTCEETTC
T ss_pred -CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEec-----CCCCcEEEEeccCceeccc
Confidence 999999765 4689999999999999999999942 128999999999999965 2267899999999987643
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELH 648 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~ 648 (725)
.. ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 214 ~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 214 RI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22 2345899999999999999999999999999999999999999754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=289.92 Aligned_cols=224 Identities=24% Similarity=0.290 Sum_probs=168.8
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCC-CCCHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQE-IPTWDKRVEI 539 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i 539 (725)
+..||||++.... ...+.+|+++++++ +|||||++++++.+....++||||++ |+|.+++.... .+.+..+..+
T Consensus 48 ~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i 123 (432)
T 3p23_A 48 NRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITL 123 (432)
T ss_dssp SSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHH
T ss_pred CeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHH
Confidence 4579999986432 23367899999999 79999999999999999999999997 59999997663 4556677899
Q ss_pred HHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC--ccccccccCccccchhcc
Q 039817 540 ALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT--RTSTMIRGTMGYMAPEWL 617 (725)
Q Consensus 540 ~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~ 617 (725)
+.|+++||.|||+. +|+||||||+|||++.+.. ++...+||+|||+++....... .......||+.|+|||.+
T Consensus 124 ~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l 198 (432)
T 3p23_A 124 LQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNA--HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198 (432)
T ss_dssp HHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBT--TTBCCEEECCTTEEECC------------CCSCTTSCCGGGT
T ss_pred HHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCC--CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhh
Confidence 99999999999999 9999999999999964211 2255789999999987654322 122335699999999999
Q ss_pred c---CCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcC-----CCChhHHHHHHHHHHH
Q 039817 618 R---NAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTG-----NLGATKFERITMVGLW 688 (725)
Q Consensus 618 ~---~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~ 688 (725)
. ...++.++||||||+++|||++ |..|+....... ........ .........+.+|+.+
T Consensus 199 ~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 266 (432)
T 3p23_A 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------------ANILLGACSLDCLHPEKHEDVIARELIEK 266 (432)
T ss_dssp SCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH------------HHHHTTCCCCTTSCTTCHHHHHHHHHHHH
T ss_pred hcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH------------HHHHhccCCccccCccccccHHHHHHHHH
Confidence 7 4567889999999999999999 777775322111 11111111 1122445678899999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 039817 689 CICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 689 cl~~dp~~RPs~~evl~~ 706 (725)
||+.||.+|||++||+++
T Consensus 267 ~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 267 MIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HSCSSGGGSCCHHHHHTS
T ss_pred HHhCCHhhCCCHHHHHhC
Confidence 999999999999999954
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=278.50 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=168.4
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc-c-HHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD-G-EKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~-~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
..+++.++++.+..+ +..||||.+...... . .+.+.++..+++.++||||+++++++..++..++||||+ ++.+.
T Consensus 35 ~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~ 111 (318)
T 2dyl_A 35 SGTCGQVWKMRFRKT--GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE 111 (318)
T ss_dssp -----CEEEEEETTT--CCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHH
T ss_pred ecCCeeEEEEEEecC--CeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHH
Confidence 345666666665544 457899988643222 2 233445556778889999999999999999999999999 44555
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 523 ~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+... ...+++..+..++.|+++||.|||+ . +|+|+||||+||+++. ++.+||+|||++........
T Consensus 112 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~-------~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 112 KLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDE-------RGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECT-------TSCEEECCCTTC---------
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECC-------CCCEEEEECCCchhccCCcc-
Confidence 55433 4678999999999999999999998 5 8999999999999987 78999999999976544322
Q ss_pred cccccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--
Q 039817 601 TSTMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN-- 673 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 673 (725)
.....++..|+|||.+. ...++.++||||||+++|||++|+.|+...... .+..........
T Consensus 181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----------FEVLTKVLQEEPPL 249 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----------HHHHHHHHHSCCCC
T ss_pred -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----------HHHHHHHhccCCCC
Confidence 22345899999999984 557889999999999999999999998643211 111222222111
Q ss_pred CC--hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 LG--ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ~~--~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+ ...++.+.+++.+||+.||.+|||++|++++
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 2356789999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=281.60 Aligned_cols=242 Identities=20% Similarity=0.197 Sum_probs=162.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHH-HHhccCcCCccceeeEEEc----CCceeeeeecccC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQ-VIGRTHHKNLVQLLGFCIE----QNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~ 518 (725)
...+|+.+++|.+..++ ..||||.+... ....+|+. .++.++|+||+++++++.. +...++||||+++
T Consensus 38 G~G~~g~V~~~~~~~~~--~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 38 GLGVNGKVLECFHRRTG--QKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeCCCeEEEEEEECCCC--CEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 34456666766665443 57899988542 22233333 4566799999999999976 4458999999999
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 519 GTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 519 gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
|+|.+++.+. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.+. .++.+||+|||+++....
T Consensus 111 g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~----~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKE----KDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS----TTCCEEECCCTTCEEC--
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecC----CCceEEEeccccceeccc
Confidence 9999999876 3689999999999999999999999 999999999999997631 256799999999986543
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNL 674 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 674 (725)
.. .....+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.......... ........... ....
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 184 NA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCTTT
T ss_pred cc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhhccccccCchh
Confidence 22 223458999999999988889999999999999999999999996543221100 00000000000 0011
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
....++.+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12456789999999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=281.57 Aligned_cols=250 Identities=21% Similarity=0.232 Sum_probs=186.0
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-----------cCCccceeeEEEcCC----ce
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-----------HKNLVQLLGFCIEQN----HQ 509 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~~~----~~ 509 (725)
..+|+.|+.|.+..+ +..||||.+... ....+.+.+|++++++++ |+||+++++++...+ ..
T Consensus 29 ~G~~g~V~~~~~~~~--~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 105 (373)
T 1q8y_A 29 WGHFSTVWLAKDMVN--NTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV 105 (373)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEE
T ss_pred ecCCeEEEEEEecCC--CcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceE
Confidence 345566666665543 467899988642 334567899999999886 899999999998654 78
Q ss_pred eeeeecccCCChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEee
Q 039817 510 LLVYELMKNGTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIAD 587 (725)
Q Consensus 510 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~D 587 (725)
++||||+ +++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.+.. .+..+.+||+|
T Consensus 106 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~-~~~~~~~kl~D 181 (373)
T 1q8y_A 106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS-PENLIQIKIAD 181 (373)
T ss_dssp EEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET-TTTEEEEEECC
T ss_pred EEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC-CcCcceEEEcc
Confidence 9999999 88999999764 45899999999999999999999842 7999999999999964210 01245899999
Q ss_pred ccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHH--
Q 039817 588 FGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWV-- 665 (725)
Q Consensus 588 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~-- 665 (725)
||+++...... ....||..|+|||.+.+..++.++||||||+++|||++|+.||........... ...+....
T Consensus 182 fg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~ 256 (373)
T 1q8y_A 182 LGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD-DDHIAQIIEL 256 (373)
T ss_dssp CTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH-HHHHHHHHHH
T ss_pred cccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh-HHHHHHHHHh
Confidence 99998764332 224589999999999999999999999999999999999999975432210000 00000000
Q ss_pred -------------------------------------HHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 666 -------------------------------------LYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 666 -------------------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........++....+.+.+|+.+||+.||++|||++|++++
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 00111223455678899999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=280.08 Aligned_cols=245 Identities=22% Similarity=0.271 Sum_probs=166.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHH-HHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQ-VIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.++++.+..+ +..||||.+.... .....++..|+. +++.++||||+++++++..++..++||||+++ +|
T Consensus 31 g~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l 107 (327)
T 3aln_A 31 GRGAYGSVNKMVHKPS--GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SF 107 (327)
T ss_dssp EECSSEEEEEEEETTT--TEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EH
T ss_pred ccCCCEEEEEEEEcCC--CCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-Ch
Confidence 3456667777765544 4678999886542 233445666666 67778999999999999999999999999985 88
Q ss_pred hhhhcc-----CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 522 SAFLFR-----QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 522 ~~~l~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~-------~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 108 DKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDR-------SGNIKLCDFGISGQLVD 178 (327)
T ss_dssp HHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEET-------TTEEEECCCSSSCC---
T ss_pred HHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcC-------CCCEEEccCCCceeccc
Confidence 887753 56789999999999999999999984 37999999999999987 78999999999987644
Q ss_pred CCCccccccccCccccchhcc----cCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC
Q 039817 597 DQTRTSTMIRGTMGYMAPEWL----RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (725)
... .....|+..|+|||.+ .+..++.++||||||+++|||++|+.|+................. . .....
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~-~~~~~ 252 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD---P-PQLSN 252 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC---C-CCCCC
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC---C-CCCCC
Confidence 322 2223589999999998 456789999999999999999999999875322111000000000 0 00000
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......+.+.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1112456789999999999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=302.58 Aligned_cols=249 Identities=23% Similarity=0.255 Sum_probs=185.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEc------CCceeeeeecc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE------QNHQLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lV~e~~ 516 (725)
...+|+.++.|.+..+ +..||||.+... .....+.|.+|++++++++||||+++++++.. ++..++||||+
T Consensus 23 G~G~fG~Vyla~~~~t--g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~ 100 (676)
T 3qa8_A 23 GTGGFGYVLRWIHQDT--GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100 (676)
T ss_dssp CBCSSSBCCCCCCTTT--TCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECC
T ss_pred eeCCCeEEEEEEECCC--CcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeC
Confidence 3455667777766544 356899988643 33445679999999999999999999999765 67789999999
Q ss_pred cCCChhhhhccCC---CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 517 KNGTLSAFLFRQE---IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 517 ~~gsL~~~l~~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.+. ....+||+|||+++.
T Consensus 101 ~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g----~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 101 EGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGP----QRLIHKIIDLGYAKE 173 (676)
T ss_dssp SSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCS----SSCEEEECSCCCCCB
T ss_pred CCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCC----CceeEEEcccccccc
Confidence 9999999997653 689999999999999999999999 999999999999998631 144599999999987
Q ss_pred cCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcc-----------c-cccCcc-
Q 039817 594 LKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEP-----------T-LANGMI- 660 (725)
Q Consensus 594 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~-----------~-~~~~~~- 660 (725)
...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ . ......
T Consensus 174 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~ 251 (676)
T 3qa8_A 174 LDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251 (676)
T ss_dssp TTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred cccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence 654332 2335689999999999999999999999999999999999999864211000 0 000000
Q ss_pred -hHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHH
Q 039817 661 -LTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQV 703 (725)
Q Consensus 661 -~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev 703 (725)
...+.........+....++.+.+++.+||+.||++|||+.|+
T Consensus 252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000000112334578899999999999999999999773
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=298.83 Aligned_cols=229 Identities=21% Similarity=0.275 Sum_probs=176.3
Q ss_pred ccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCc-----eeeeeecccCC
Q 039817 446 FSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNH-----QLLVYELMKNG 519 (725)
Q Consensus 446 ~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV~e~~~~g 519 (725)
.+|+.|+.+.+... .+..||||.+.... ....+.|.+|++++++++||||+++++++...+. .+|||||++++
T Consensus 91 G~~g~Vy~a~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~ 169 (681)
T 2pzi_A 91 GGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169 (681)
T ss_dssp ETTEEEEEEEEGGG-TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCE
T ss_pred CCCeEEEEEEEcCC-CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCC
Confidence 34555555554321 24679999886432 3345678999999999999999999999987765 69999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.. .+++..+..++.|+++||.|||+. +|+||||||+|||++. + .+||+|||+++.....
T Consensus 170 ~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~-------~-~~kl~DFG~a~~~~~~-- 234 (681)
T 2pzi_A 170 SLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTE-------E-QLKLIDLGAVSRINSF-- 234 (681)
T ss_dssp ECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECS-------S-CEEECCCTTCEETTCC--
T ss_pred cHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeC-------C-cEEEEecccchhcccC--
Confidence 99998755 789999999999999999999999 9999999999999975 3 7999999999876443
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
....||+.|+|||.+.+.. +.++||||||++++||++|..++........ ... .......
T Consensus 235 ---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--~~~--------------~~~~~~~ 294 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--PED--------------DPVLKTY 294 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--CTT--------------CHHHHHC
T ss_pred ---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--ccc--------------ccccccC
Confidence 2345899999999987654 8899999999999999999887764322110 000 0001234
Q ss_pred HHHHHHHHHccCCCCCCCC-CHHHHHHHhcCC
Q 039817 680 ERITMVGLWCICPQPTLRP-SMKQVLQMLEGT 710 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~ 710 (725)
+.+.+++.+||+.||++|| +++++.+.|.++
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 6788999999999999999 566666666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=265.19 Aligned_cols=222 Identities=12% Similarity=0.071 Sum_probs=169.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc---cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD---GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+|+.+++|.+..+ +..||||.+...... ..+.|.+|++.+++++||||+++++++..++..++||||+++++|
T Consensus 41 ~G~~g~Vy~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L 118 (286)
T 3uqc_A 41 GVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL 118 (286)
T ss_dssp BSTTCEEEEEEETTT--TEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEH
T ss_pred ccCCeEEEEEEecCC--CceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCH
Confidence 345667777766443 468999998754332 246799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+. .....+.+++.|++.||.|||+. +|+||||||+|||++. ++.+||++++
T Consensus 119 ~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~-------~g~~kl~~~~------------ 174 (286)
T 3uqc_A 119 QEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSI-------DGDVVLAYPA------------ 174 (286)
T ss_dssp HHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEET-------TSCEEECSCC------------
T ss_pred HHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcC-------CCCEEEEecc------------
Confidence 9999543 35567889999999999999999 9999999999999987 7889987433
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFER 681 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (725)
|++| ++.++||||||+++|||++|+.||....................... .......++.
T Consensus 175 ---------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ---------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP---ADIDRDIPFQ 235 (286)
T ss_dssp ---------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH---HHHCTTSCHH
T ss_pred ---------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh---hhcccCCCHH
Confidence 3333 68899999999999999999999986543221100000000000000 0011234567
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 682 ITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 682 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+.+++.+||+.||++| |+.|+++.|+.+..
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 8999999999999999 99999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-29 Score=258.25 Aligned_cols=219 Identities=20% Similarity=0.234 Sum_probs=165.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHH-hccCcCCccceeeEEEc----CCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVI-GRTHHKNLVQLLGFCIE----QNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~g 519 (725)
..+|+.++.+.+..+ +..||||.++. ...+.+|++++ +.++||||+++++++.. ....++||||++++
T Consensus 28 ~G~~g~V~~~~~~~~--~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~ 100 (299)
T 3m2w_A 28 LGINGKVLQIFNKRT--QEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 100 (299)
T ss_dssp EETTEEEEEEEETTT--CCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSC
T ss_pred cCCCeEEEEEEEcCC--CcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCC
Confidence 345556666655443 45789998853 35678899988 45699999999999987 67789999999999
Q ss_pred ChhhhhccCC--CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 520 TLSAFLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 520 sL~~~l~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.+. .++.+||+|||++....
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~----~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKR----PNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp BHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS----TTCCEEECCCTTCEECT--
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCC----CCCcEEEeccccccccc--
Confidence 9999997653 689999999999999999999999 999999999999998631 25789999999987532
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCC--
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG-- 675 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 675 (725)
+..++.++||||||+++|||++|+.||................. ......+
T Consensus 172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~------~~~~~~~~~ 224 (299)
T 3m2w_A 172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------MGQYEFPNP 224 (299)
T ss_dssp ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC------TTCCSSCHH
T ss_pred ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh------hccccCCch
Confidence 13467799999999999999999999965432110000000000 0000111
Q ss_pred --hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 --ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 --~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...++.+.+++.+||+.||.+|||+.|++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1346789999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=277.05 Aligned_cols=230 Identities=16% Similarity=0.122 Sum_probs=167.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc---CccHHHHHHHHHHHhccCc-CCccce---------eeEE-------
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT---GDGEKSFLREVQVIGRTHH-KNLVQL---------LGFC------- 503 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~H-~niv~l---------~g~~------- 503 (725)
...+|+.|++|++..+++ .||||.+.... ....+.|.+|+.+++.++| +|...+ ....
T Consensus 87 G~G~fG~Vy~a~~~~~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (413)
T 3dzo_A 87 GQEDPYAYLEATDQETGE--SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164 (413)
T ss_dssp EEETTEEEEEEEETTTCC--EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---
T ss_pred ccCCCEEEEEEEecCCCC--ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCc
Confidence 456788888888776654 78888876322 2336789999999999977 322111 1111
Q ss_pred -----Ec-----CCceeeeeecccCCChhhhhc------c-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccc
Q 039817 504 -----IE-----QNHQLLVYELMKNGTLSAFLF------R-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQ 566 (725)
Q Consensus 504 -----~~-----~~~~~lV~e~~~~gsL~~~l~------~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~ 566 (725)
.. ....+++|+++ +++|.+++. . ...+++..++.++.|+++||.|||+. +|+||||||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~ 240 (413)
T 3dzo_A 165 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPV 240 (413)
T ss_dssp ------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred cccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccc
Confidence 11 12346666655 579998884 1 23467889999999999999999999 9999999999
Q ss_pred eEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcc----------cCCCCCCccceehhHHHHH
Q 039817 567 NVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL----------RNAPVTAKVDVYSFGVMLL 636 (725)
Q Consensus 567 NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDv~S~G~vl~ 636 (725)
||||+. ++.+||+|||+++..... .....| ..|+|||.+ .+..++.++||||||+++|
T Consensus 241 NILl~~-------~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 241 DIVLDQ-------RGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp GEEECT-------TCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred eEEEec-------CCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999987 778999999998865433 233457 999999999 5556888999999999999
Q ss_pred HHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 039817 637 EIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705 (725)
Q Consensus 637 elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 705 (725)
||++|+.||......... ... . . .....++.+.+|+.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~~---~~~--------~-~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGS---EWI--------F-R--SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCS---GGG--------G-S--SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhH---HHH--------H-h--hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999754322110 000 0 0 01133577999999999999999999777653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-29 Score=268.87 Aligned_cols=233 Identities=13% Similarity=0.048 Sum_probs=169.6
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--------CccHHHHHHHHHHHhccC---------cCCccceeeEE---
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--------GDGEKSFLREVQVIGRTH---------HKNLVQLLGFC--- 503 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~niv~l~g~~--- 503 (725)
...+|++|++|.+ .+..||||.+.... ....+.+.+|++++++++ |+|||++.+.+
T Consensus 29 G~G~~g~V~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~ 104 (336)
T 2vuw_A 29 GEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ 104 (336)
T ss_dssp EEETTEEEEEEEE----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEE
T ss_pred cccCceEEEEEEe----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEec
Confidence 3456777777765 34789999986542 233478999999998886 66666666654
Q ss_pred --------------Ec-------------CCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhh-cccC
Q 039817 504 --------------IE-------------QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLH-EECE 555 (725)
Q Consensus 504 --------------~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~ 555 (725)
.. .+..++||||+++|++.+.+.+ +.+++..+..++.|++.||.||| +.
T Consensus 105 ~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~-- 181 (336)
T 2vuw_A 105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASL-- 181 (336)
T ss_dssp SSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred CCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 22 6789999999999977777644 56899999999999999999999 88
Q ss_pred CceeecCCccceEEeccCccc-------------cCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCC
Q 039817 556 TQIIHCDIKPQNVLLDNNYIT-------------IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV 622 (725)
Q Consensus 556 ~~ivH~dik~~NIll~~~~~~-------------~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 622 (725)
+|+||||||+|||++.+... ......+||+|||+++..... ...||+.|+|||.+.+..
T Consensus 182 -~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~- 253 (336)
T 2vuw_A 182 -RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG- 253 (336)
T ss_dssp -CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-
T ss_pred -CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCC-
Confidence 99999999999999873100 000128999999999865432 235999999999998766
Q ss_pred CCccceehhHHH-HHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CC----ChhHHHHHHHHHHHccCCC
Q 039817 623 TAKVDVYSFGVM-LLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NL----GATKFERITMVGLWCICPQ 693 (725)
Q Consensus 623 ~~ksDv~S~G~v-l~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~----~~~~~~~l~~l~~~cl~~d 693 (725)
+.++||||++.+ .+++++|..|+..... ............ .. ....++.+.+|+.+||+.|
T Consensus 254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLW----------LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp SHHHHHHHHHHHHHTTCTTSCCTHHHHHH----------HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred ccceehhhhhCCCCcccccccCCCcchhh----------hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 889999998776 7778888887742100 000111111110 11 1246788999999999976
Q ss_pred CCCCCCHHHHH-HH
Q 039817 694 PTLRPSMKQVL-QM 706 (725)
Q Consensus 694 p~~RPs~~evl-~~ 706 (725)
|++|++ +|
T Consensus 324 -----sa~e~l~~H 332 (336)
T 2vuw_A 324 -----SATDLLCQH 332 (336)
T ss_dssp -----SHHHHHHHC
T ss_pred -----CHHHHHhcC
Confidence 999998 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-27 Score=267.10 Aligned_cols=152 Identities=18% Similarity=0.145 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCC
Q 039817 478 EKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECET 556 (725)
Q Consensus 478 ~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 556 (725)
.++|.+|+++|+++ +|+||+++++++++++..||||||++|++|.++|.+.+.++.. +|+.||++||+|||++
T Consensus 285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~--- 358 (569)
T 4azs_A 285 KYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ--- 358 (569)
T ss_dssp HHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---
Confidence 46799999999999 7999999999999999999999999999999999988888764 5889999999999999
Q ss_pred ceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHH
Q 039817 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636 (725)
Q Consensus 557 ~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ 636 (725)
+||||||||+||||+. ++.+||+|||+++......... ....||+.|+|||.+.+. +..++|+||+|++++
T Consensus 359 GIIHRDIKPeNILL~~-------dg~vKL~DFGlAr~~~~~~~~~-~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~ 429 (569)
T 4azs_A 359 GFWHDDVRPWNVMVDA-------RQHARLIDFGSIVTTPQDCSWP-TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPF 429 (569)
T ss_dssp TCEESCCCGGGEEECT-------TSCEEECCCTTEESCC---CCS-HHHHHHHHHHHHHHC------------------C
T ss_pred CceeccCchHhEEECC-------CCCEEEeecccCeeCCCCCccc-cCceechhhccHHHhCCC-CCCcccccccccchh
Confidence 9999999999999987 8899999999999765543332 335699999999998764 677899999999988
Q ss_pred HHHhCCcC
Q 039817 637 EIIFCKRH 644 (725)
Q Consensus 637 elltg~~~ 644 (725)
++.++..+
T Consensus 430 ~l~~~~~~ 437 (569)
T 4azs_A 430 NLPQPWSN 437 (569)
T ss_dssp CCCTTHHH
T ss_pred hhccccch
Confidence 87665544
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=203.53 Aligned_cols=183 Identities=15% Similarity=0.183 Sum_probs=131.8
Q ss_pred ccccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEE
Q 039817 23 MTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLT 102 (725)
Q Consensus 23 ~~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~ 102 (725)
++.|+|++||+|+. +++| ++|.|+|||++.+. +. +|.. +||||+|||+.| .++.|+|+.+|||||.
T Consensus 6 ~~~~~i~~g~~L~~--g~~l--~~g~f~l~f~~~gn----l~-ly~~---~~~vW~an~~~~--~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHA--AQSL--ELSSFRFTMQSDCN----LV-LFDS---DVRVWASNTAGA--TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCT--TCEE--CSTTEEEEECTTSC----EE-EEES---SSEEECCCCCSC--SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECC--CCEE--EcCCEEEEECCCCc----EE-EEEC---CEEEEECCCCCC--CCeEEEEcCCCcEEEE
Confidence 45699999999987 7888 59999999985443 22 3443 799999999999 5678999999999999
Q ss_pred cCCCceEEEeccC---ceeEEEEecCCCeEEecCC--CCc----------------------------------cCCCCc
Q 039817 103 HSNGTQFKIYNGT---LTVSALMQDSGNFLYSNAN--GSV----------------------------------DYSTGR 143 (725)
Q Consensus 103 ~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~--~~~----------------------------------d~s~g~ 143 (725)
|++|+++|+++.. ....|+|+|+|||||++.. +++ ||++|.
T Consensus 72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~G~ 151 (236)
T 1dlp_A 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSP 151 (236)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECSEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBCSS
T ss_pred cCCCcEEEeCCccccCCcEEEEEeCCCCEEEecCCEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeecCc
Confidence 9999999987653 2357999999999997520 122 445588
Q ss_pred eEEeeecCCCeEEeeeecCCCceeecCCCCCCc-cceeeecccce-EEeeCceeeeeeeeeccCCCCCceEEEEEEcCCC
Q 039817 144 FVLEIQMDGNVVLSAFRFADPAYWYTSTRGDQN-VSLIFNQSTSF-LYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHG 221 (725)
Q Consensus 144 ~~~~~~~~g~~~~~~~~~~~~~yw~~~~~~~~~-~~~~~~~~~~~-~~~~n~~~~~~~~~~~~~~~~~~~~~r~~l~~~G 221 (725)
|++.|+++|++.+ ++. ...||++++++... .......++.+ .+..+..+++..+.... . ..+|++|+.||
T Consensus 152 ~~l~l~~dG~LvL--~~~-~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~----~-~~~rl~Ld~dG 223 (236)
T 1dlp_A 152 YRLSMETDCNLVL--FDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRS----A-GRYVFVLQPDR 223 (236)
T ss_dssp CEEEEETTTEEEE--EBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCCCS----S-SCCEEEECSSS
T ss_pred EEEEECCCCcEEE--EcC-CEeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeCCCCC----C-CCEEEEEcCCC
Confidence 9999999995444 443 46899998875432 12334445554 34334444444443221 1 34799999999
Q ss_pred cEEEEE
Q 039817 222 NFQQWV 227 (725)
Q Consensus 222 ~l~~~~ 227 (725)
++++|.
T Consensus 224 ~l~ly~ 229 (236)
T 1dlp_A 224 NLAIYG 229 (236)
T ss_dssp CEEEEC
T ss_pred cEEEeC
Confidence 999994
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-21 Score=220.72 Aligned_cols=147 Identities=16% Similarity=0.210 Sum_probs=125.7
Q ss_pred HHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCce
Q 039817 479 KSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558 (725)
Q Consensus 479 ~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 558 (725)
+.|.+|++++++++||||+++..++...+..+|||||+++++|.+++.+ +..++.|+++||.|||+. +|
T Consensus 384 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gI 452 (540)
T 3en9_A 384 SRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DV 452 (540)
T ss_dssp HHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TE
T ss_pred HHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cC
Confidence 4589999999999999999777777788888999999999999999976 568999999999999999 99
Q ss_pred eecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc------ccccccCccccchhcccC--CCCCCccceeh
Q 039817 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT------STMIRGTMGYMAPEWLRN--APVTAKVDVYS 630 (725)
Q Consensus 559 vH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S 630 (725)
+||||||+|||++ . .+||+|||+++......... .....||+.|+|||++.. ..|+.+.|+|+
T Consensus 453 iHrDiKp~NILl~--------~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws 523 (540)
T 3en9_A 453 IHNDLTTSNFIFD--------K-DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWE 523 (540)
T ss_dssp ECTTCCTTSEEES--------S-SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHH
T ss_pred ccCCCCHHHEEEC--------C-eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHH
Confidence 9999999999996 3 89999999999875432221 124569999999999986 56888899999
Q ss_pred hHHHHHHHHhCCcCC
Q 039817 631 FGVMLLEIIFCKRHT 645 (725)
Q Consensus 631 ~G~vl~elltg~~~~ 645 (725)
..+-.++.+.++.++
T Consensus 524 ~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 524 IILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHTCSCC
T ss_pred HHHHHHHHHHhcccc
Confidence 998888887666554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-17 Score=146.56 Aligned_cols=98 Identities=12% Similarity=0.120 Sum_probs=78.7
Q ss_pred ccccccCCCCceeeCCCCeee--eCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEE
Q 039817 23 MTTNNIELGSNIIAGTNSTWP--STSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLV 100 (725)
Q Consensus 23 ~~~~~i~~g~~l~~~~~~~lv--S~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~Lv 100 (725)
++.++|.+|++|.+ |++|+ |++|.|+|+|+..+. . +||++ +++||+|||+.| ..++.++|..+||||
T Consensus 6 ~~~~~l~~g~~L~~--g~~l~~~S~~g~~~L~~~~dgn--l---vly~~---~~~vW~sn~~~~-~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHA--TESLEILFGTHVYRFIMQTDCN--L---VLYDN---NNPIWATNTGGL-GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEET--TCEEEEEETTEEEEEEECTTSC--E---EEEET---TEEEEECCCTTS-CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcC--CCEEEEeCCCCCEEEEEecCCC--E---EEEEC---CEEEEeCCCccC-CCceEEEEccCCEEE
Confidence 45689999999987 88999 999999999997543 2 57875 799999999977 345789999999999
Q ss_pred EEcCCCceEEEeccC---ceeEEEEecCCCeEEe
Q 039817 101 LTHSNGTQFKIYNGT---LTVSALMQDSGNFLYS 131 (725)
Q Consensus 101 L~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~ 131 (725)
|.|.++.++|++... +...++|+|+|||||+
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~ 108 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY 108 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEE
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEE
Confidence 999999999987632 2345666666666665
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-16 Score=137.02 Aligned_cols=95 Identities=19% Similarity=0.275 Sum_probs=80.1
Q ss_pred cccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcCC
Q 039817 26 NNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSN 105 (725)
Q Consensus 26 ~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~~ 105 (725)
|+|.+||.|.. |++|+| |.|.|.|...+. |.++. ..++||+|||+.|..+++.|+|+.||||||.|++
T Consensus 2 n~L~~g~~L~~--g~~L~s--g~y~l~~q~DgN----Lvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 2 NILDNNEGLYA--GQSLDV--EPYHFIMQDDCN----LVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CEECTTEEECT--TCEEEE--TTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEEcC--CCEEEE--CCEEEEECCCCe----EEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEEECCC
Confidence 67899999987 899988 889998863322 55543 3689999999999988899999999999999999
Q ss_pred CceEEEeccC---ceeEEEEecCCCeEEec
Q 039817 106 GTQFKIYNGT---LTVSALMQDSGNFLYSN 132 (725)
Q Consensus 106 ~~~~ws~~~~---~~~~a~LldsGNlVl~~ 132 (725)
++++|+++.+ ....|+|+|+|||||++
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEE
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEEC
Confidence 9999987643 34679999999999985
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-17 Score=171.15 Aligned_cols=135 Identities=16% Similarity=0.027 Sum_probs=103.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccC------------------ccHHHHHHHHHHHhccCcCCccceeeEEEcC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTG------------------DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~------------------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 506 (725)
..++++++.+.+ ..+..||||.+..... .....+.+|++++++++ | +++.+++..
T Consensus 100 ~G~~g~Vy~~~~---~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~- 172 (282)
T 1zar_A 100 EGKESAVFNCYS---EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW- 172 (282)
T ss_dssp ECSSEEEEEEEE---TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-
T ss_pred cCCCceEEEEEe---CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-
Confidence 345666666665 3456899998853221 13457899999999999 5 677775544
Q ss_pred CceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEe
Q 039817 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586 (725)
Q Consensus 507 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~ 586 (725)
+..++||||+++++|.+ +.. .....++.|+++||.|||+. +|+||||||+|||++ ++.+||+
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~--------~~~vkl~ 234 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS--------EEGIWII 234 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE--------TTEEEEC
T ss_pred cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE--------CCcEEEE
Confidence 56699999999999998 522 23457999999999999999 999999999999996 4679999
Q ss_pred eccCccccCcCCCccccccccCccccchhccc
Q 039817 587 DFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618 (725)
Q Consensus 587 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 618 (725)
|||+++. +..++|||++.
T Consensus 235 DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE--------------TTSTTHHHHHH
T ss_pred ECCCCeE--------------CCCCCHHHHHH
Confidence 9999973 33478899875
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=6.2e-15 Score=129.22 Aligned_cols=94 Identities=17% Similarity=0.297 Sum_probs=75.1
Q ss_pred ccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcC
Q 039817 25 TNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHS 104 (725)
Q Consensus 25 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~ 104 (725)
.|||.+||+|.. +++|+ +|.|+|+|+..+ +.. +|+ ..++||+|||+.|. .++.++|..+|||||.|.
T Consensus 2 ~dtl~~gq~L~~--g~~L~--~g~~~L~~~~dg--nlv---ly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHA--DHSLQ--AGAYTLTIQNKC--NLV---KYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEET--TEEEE--ETTEEEEECTTS--CEE---EEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECC--CCEEE--CCCEEEEEcCCC--cEE---EEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEEECC
Confidence 489999999987 88998 899999997443 333 365 38999999999884 456899999999999999
Q ss_pred CCceEEEeccC---ceeEEEEecCCCeEEe
Q 039817 105 NGTQFKIYNGT---LTVSALMQDSGNFLYS 131 (725)
Q Consensus 105 ~~~~~ws~~~~---~~~~a~LldsGNlVl~ 131 (725)
++.++|++... ....++|+|+|||||+
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~ 98 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIY 98 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEE
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEE
Confidence 89999987642 2346777777777776
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=9.4e-15 Score=126.78 Aligned_cols=95 Identities=14% Similarity=0.243 Sum_probs=74.8
Q ss_pred ccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcC
Q 039817 25 TNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHS 104 (725)
Q Consensus 25 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~ 104 (725)
+|+|.+||.|.. |++|+ ++|.|+|+|+..+. . |||+ ..++||+||++.|- .++.++|..+|||||.|.
T Consensus 1 ~d~l~~g~~L~~--g~~l~-~~~~~~l~~~~dGn--l---vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFT--GHSLE-VGPSYRLIMQGDCN--F---VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECT--TCEEE-ETTTEEEEECTTSC--E---EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECC--CCEEE-ECCCEEEEEcCCCc--E---EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEEECC
Confidence 478999999987 88999 99999999975543 2 6776 37999999998773 456899999999999999
Q ss_pred CCceEEEeccC---ceeEEEEecCCCeEEe
Q 039817 105 NGTQFKIYNGT---LTVSALMQDSGNFLYS 131 (725)
Q Consensus 105 ~~~~~ws~~~~---~~~~a~LldsGNlVl~ 131 (725)
++.++|++... +...++|+|+|||||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~ 98 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIY 98 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEE
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEE
Confidence 99999986632 2235666666666665
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.4e-14 Score=124.87 Aligned_cols=93 Identities=14% Similarity=0.302 Sum_probs=69.1
Q ss_pred ccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcC
Q 039817 25 TNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHS 104 (725)
Q Consensus 25 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~ 104 (725)
+|||.+||+|.. |++| ++|.|+|+|+..+. . +||++ +++||+||++.+ ..++.++|..+|||||.|
T Consensus 1 tdtl~~gq~L~~--g~~L--~~~~~~L~~~~dgn--l---vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDT--GGSL--AEGGYLFIIQNDCN--L---VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECT--TCEE--EETTEEEEECTTSC--E---EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECC--CCEE--eCCCEEEEEcCCCc--E---EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEEEc-
Confidence 489999999987 8899 58999999986654 2 35765 689999999864 234689999999999999
Q ss_pred CCceEEEeccC---ceeEEEEecCCCeEEe
Q 039817 105 NGTQFKIYNGT---LTVSALMQDSGNFLYS 131 (725)
Q Consensus 105 ~~~~~ws~~~~---~~~~a~LldsGNlVl~ 131 (725)
++.++|++... ....++|+++|||||.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~ 96 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIY 96 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEE
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEE
Confidence 88899986531 1223455555555544
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.8e-14 Score=122.79 Aligned_cols=94 Identities=14% Similarity=0.229 Sum_probs=76.9
Q ss_pred cccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcCC
Q 039817 26 NNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSN 105 (725)
Q Consensus 26 ~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~~ 105 (725)
+||.+||.|.. |++|+ +|.|+|+|+..+ +..| |.. .++||+||++.+ ..++.+.|..+|||||.|.+
T Consensus 2 ntL~~gq~L~~--g~~L~--~g~~~L~~q~dG--nLvl---y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 2 NILYSGETLSP--GEFLN--NGRYVFIMQEDC--NLVL---YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CEEETTEEECT--TCEEE--ETTEEEEECTTS--CEEE---EET---TEEEEECCCTTS-SSSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEeCC--CCEEE--CCCEEEEEcCCC--cEEE---EeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEECCC
Confidence 68999999976 88996 799999997544 3433 654 589999999876 34568999999999999999
Q ss_pred CceEEEeccC---ceeEEEEecCCCeEEec
Q 039817 106 GTQFKIYNGT---LTVSALMQDSGNFLYSN 132 (725)
Q Consensus 106 ~~~~ws~~~~---~~~~a~LldsGNlVl~~ 132 (725)
+.++|+++.. ....|+|+|+|||||++
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEE
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEEC
Confidence 9999987642 23579999999999996
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.2e-13 Score=117.93 Aligned_cols=97 Identities=11% Similarity=0.143 Sum_probs=75.4
Q ss_pred cccccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEE
Q 039817 22 QMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVL 101 (725)
Q Consensus 22 ~~~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL 101 (725)
..+.|||.+||.|.. |++|+| |.|.|-|.. .++ |.+ |.. ++||++|++.. ..++.+.|..+|||||
T Consensus 3 ~~~~dtL~~gq~L~~--g~~L~s--g~~~L~~q~--dGn--Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNLvl 68 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYG--DGRLTA--KNHQLVMQG--DCN--LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGELII 68 (110)
T ss_dssp CCBTTEEETTCEEET--TEEEEC--SSCEEEECT--TSC--EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCEEE
T ss_pred ccccCEECCCCEecC--CCEEEe--CCEEEEEcC--CCe--EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcEEE
Confidence 346799999999987 889998 458885532 233 333 654 48999999863 2346899999999999
Q ss_pred EcCCCceEEEeccC---ceeEEEEecCCCeEEec
Q 039817 102 THSNGTQFKIYNGT---LTVSALMQDSGNFLYSN 132 (725)
Q Consensus 102 ~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~ 132 (725)
.|.++.++|+++.. ....|+|+|+|||||++
T Consensus 69 ~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 69 KDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC
T ss_pred EeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec
Confidence 99999999987642 33679999999999995
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=4.3e-14 Score=143.58 Aligned_cols=132 Identities=20% Similarity=0.186 Sum_probs=95.1
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCc------------------------cHHHHHHHHHHHhccCcCCc--c
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGD------------------------GEKSFLREVQVIGRTHHKNL--V 497 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~------------------------~~~~f~~E~~~l~~l~H~ni--v 497 (725)
...+++.|+.|.+..++....||||.+...... ....+.+|++.+.+++|+++ .
T Consensus 56 g~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 135 (258)
T 1zth_A 56 STGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVP 135 (258)
T ss_dssp EECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred eecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 345566677776544443333899976432111 11368899999999998864 4
Q ss_pred ceeeEEEcCCceeeeeecccC-C----ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhh-cccCCceeecCCccceEEec
Q 039817 498 QLLGFCIEQNHQLLVYELMKN-G----TLSAFLFRQEIPTWDKRVEIALGIARGLLYLH-EECETQIIHCDIKPQNVLLD 571 (725)
Q Consensus 498 ~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivH~dik~~NIll~ 571 (725)
.++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+||||||+|||++
T Consensus 136 ~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~ 205 (258)
T 1zth_A 136 QPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYI 205 (258)
T ss_dssp CEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEES
T ss_pred eEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEc
Confidence 44442 367899999953 4 66666532 235577899999999999999 88 999999999999996
Q ss_pred cCccccCCCCceEEeeccCcccc
Q 039817 572 NNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 572 ~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
. .++|+|||++...
T Consensus 206 --------~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 206 --------D-KVYFIDMGQAVTL 219 (258)
T ss_dssp --------S-SEEECCCTTCEET
T ss_pred --------C-cEEEEECcccccC
Confidence 3 7999999999764
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.40 E-value=2.3e-12 Score=112.17 Aligned_cols=99 Identities=12% Similarity=0.115 Sum_probs=77.5
Q ss_pred ccccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEE
Q 039817 23 MTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLT 102 (725)
Q Consensus 23 ~~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~ 102 (725)
.+.|+|.+||.|.. ++.|.+ |.|.|-|... ++ |.++..+ ..++||.+|++.+- .++.+.|..+|||||.
T Consensus 4 ~~~~tL~~gq~L~~--g~~L~~--g~~~L~~q~d--GN--LvL~~~~--~~~~vWssnt~~~~-~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 4 RVRNVLFSSQVMYD--NAQLAT--RDYSLVMRDD--CN--LVLTKGS--KTNIVWESGTSGRG-QHCFMRLGHSGELDIT 72 (113)
T ss_dssp CCSSEEETTCEEET--TCEEEE--TTEEEEECTT--SC--EEEEETT--TTEEEEECCCTTSC-SSCEEEECTTSCEEEE
T ss_pred ccCCEeCCCCEECC--CCEeEc--CCEEEEEcCC--CE--EEEEECC--CCEEEEECCcccCC-cCEEEEEeCCCcEEEE
Confidence 46799999999987 788874 8888888533 22 4453321 37899999998763 3568999999999999
Q ss_pred cCCCceEEEeccC---ceeEEEEecCCCeEEec
Q 039817 103 HSNGTQFKIYNGT---LTVSALMQDSGNFLYSN 132 (725)
Q Consensus 103 ~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~ 132 (725)
|.+++++|+++.. ....|+|+|+|||||++
T Consensus 73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~ 105 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG 105 (113)
T ss_dssp CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC
T ss_pred CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec
Confidence 9999999987652 33689999999999985
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.23 E-value=9.8e-12 Score=107.35 Aligned_cols=93 Identities=17% Similarity=0.297 Sum_probs=73.0
Q ss_pred cccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEc
Q 039817 24 TTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTH 103 (725)
Q Consensus 24 ~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~ 103 (725)
+.|||.+||.|.. |+.| .+|.|.|.|...+ +.- .|.. +|.+|+..+ ..+..++|..+|||||.|
T Consensus 2 ~~dtL~~gq~L~~--g~~L--~~g~~~L~~q~dG--NLv---l~~~------~Wssnt~~~-~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 2 GTNYLLSGQTLDT--EGHL--KNGDFDLVMQDDC--NLV---LYNG------NWQSNTANN-GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCSEEETTCEECT--TCEE--EETTEEEEECTTS--CEE---EETT------TEECCCTTS-CSSCEEEECTTSCEEEEC
T ss_pred ccCCcCCCCCcCC--CCEe--ECCCEEEEEecCC--eEE---EEeC------eEEcCCCCC-CCcEEEEEcCCCeEEEEe
Confidence 5699999999976 8888 5799999885433 222 2432 699998865 345789999999999999
Q ss_pred CCCceEEEeccC---ceeEEEEecCCCeEEec
Q 039817 104 SNGTQFKIYNGT---LTVSALMQDSGNFLYSN 132 (725)
Q Consensus 104 ~~~~~~ws~~~~---~~~~a~LldsGNlVl~~ 132 (725)
.++.++|+++.. ....|+|+|+|||||++
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe
Confidence 999999987643 34579999999999985
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.3e-10 Score=100.49 Aligned_cols=80 Identities=19% Similarity=0.254 Sum_probs=64.3
Q ss_pred CCceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC------CccCCCCceEEeeecCCCeEEe
Q 039817 87 VGSSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG------SVDYSTGRFVLEIQMDGNVVLS 157 (725)
Q Consensus 87 ~~s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~------~~d~s~g~~~~~~~~~g~~~~~ 157 (725)
....|.|..+|||||.+ .++++|+++.. ....++|+|+|||||++.++ ..++++|.|++.|+++|++.++
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~ 98 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY 98 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEE
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEE
Confidence 35689999999999998 58899988753 23579999999999998764 4577889999999999996653
Q ss_pred eeecCCCceeecCCC
Q 039817 158 AFRFADPAYWYTSTR 172 (725)
Q Consensus 158 ~~~~~~~~yw~~~~~ 172 (725)
+. .||.++.+
T Consensus 99 --~~---~~W~S~~~ 108 (110)
T 3a0c_A 99 --GP---VVWATGSG 108 (110)
T ss_dssp --CS---EEEECSCC
T ss_pred --CC---CEecCCCc
Confidence 32 79987654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.09 E-value=3.3e-10 Score=98.09 Aligned_cols=94 Identities=15% Similarity=0.204 Sum_probs=70.8
Q ss_pred ccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcC
Q 039817 25 TNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHS 104 (725)
Q Consensus 25 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~ 104 (725)
+|+|.+||.|.. |+.| .+|.|.|-|.. .++.- + |.. .. ||.+|+..+ ..+..+.|..+|||||.|.
T Consensus 2 ~~~l~~gq~L~~--g~~L--~~g~~~L~~q~--dGnLv--l-~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHT--DNQL--SYESAAFVMQG--DCNLV--L-YNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECT--TCEE--EETTEEEEECT--TSCEE--E-ECS---SC-CEECCCTTS-CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCC--CCEE--ecCCEEEEEcc--CCeEE--E-ECC---CC-EEECCcccC-CcCEEEEEcCCCcEEEEeC
Confidence 578999999977 8888 37889998853 33332 2 543 23 999999876 3357899999999999998
Q ss_pred CCc-eEEEeccC-----ceeEEEEecCCCeEEec
Q 039817 105 NGT-QFKIYNGT-----LTVSALMQDSGNFLYSN 132 (725)
Q Consensus 105 ~~~-~~ws~~~~-----~~~~a~LldsGNlVl~~ 132 (725)
++. ++|+++.. ....++|+|+|||||.+
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~ 101 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG 101 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec
Confidence 875 59976631 23578999999999984
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.05 E-value=7.8e-11 Score=124.54 Aligned_cols=139 Identities=12% Similarity=0.092 Sum_probs=86.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--------------CccHHHHH--------HHHHHHhccCcCCccceee
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--------------GDGEKSFL--------REVQVIGRTHHKNLVQLLG 501 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--------------~~~~~~f~--------~E~~~l~~l~H~niv~l~g 501 (725)
...++++|+.|.+ .++..||||.++... .......+ .|...|.++++..+....-
T Consensus 104 G~Gk~a~VY~a~d---~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p 180 (397)
T 4gyi_A 104 GVGKESDIMIVAD---EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEP 180 (397)
T ss_dssp EECSSEEEEEEEC---TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCE
T ss_pred eeCCceEEEEEEC---CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCee
Confidence 3455666666654 345678999764211 01112233 3445555554433321111
Q ss_pred EEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCC--
Q 039817 502 FCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDN-- 579 (725)
Q Consensus 502 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~-- 579 (725)
+.. ...+|||||+++++|.+.... .....++.|++.+|.|||+. +||||||||.|||++++....+.
T Consensus 181 ~~~--~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~ 249 (397)
T 4gyi_A 181 IAQ--SRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSS 249 (397)
T ss_dssp EEE--ETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTS
T ss_pred eec--cCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccccc
Confidence 111 223799999999888765422 23457889999999999998 99999999999999874311111
Q ss_pred -CCceEEeeccCccccCc
Q 039817 580 -NYITKIADFGLAKLLKK 596 (725)
Q Consensus 580 -~~~~kl~Dfgla~~~~~ 596 (725)
...+.|+||+.+....+
T Consensus 250 ~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 250 ITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EEEEEEECCCTTCEETTS
T ss_pred cccceEEEEeCCcccCCC
Confidence 12489999998875443
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=98.97 E-value=2.3e-09 Score=93.88 Aligned_cols=77 Identities=26% Similarity=0.312 Sum_probs=62.7
Q ss_pred ceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC------CccCCCCceEEeeecCCCeEEeee
Q 039817 89 SSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG------SVDYSTGRFVLEIQMDGNVVLSAF 159 (725)
Q Consensus 89 s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~------~~d~s~g~~~~~~~~~g~~~~~~~ 159 (725)
..|.+..+|+|+|.+. ++++|+++.. ....|+|+|+|||||++.++ ..|+++|.|.+.|+++|++.++
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~-- 108 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY-- 108 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEE--
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEE--
Confidence 4688889999999987 8999988753 23689999999999998665 4588899999999999996653
Q ss_pred ecCCCceeecCC
Q 039817 160 RFADPAYWYTST 171 (725)
Q Consensus 160 ~~~~~~yw~~~~ 171 (725)
. ..||.+++
T Consensus 109 ~---~~~W~Sg~ 117 (119)
T 1b2p_A 109 G---DALWATQT 117 (119)
T ss_dssp E---SEEEECCC
T ss_pred C---ccEeCCCC
Confidence 3 37998765
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.85 E-value=9.1e-09 Score=89.32 Aligned_cols=85 Identities=20% Similarity=0.243 Sum_probs=64.3
Q ss_pred CCCCCCCC-ceEEEcccccEEEEcC-CCceEEEeccC---ceeEEEEecCCCeEEecCCC------CccCCCCceEEeee
Q 039817 81 RDDPAQVG-SSINLTVTGQLVLTHS-NGTQFKIYNGT---LTVSALMQDSGNFLYSNANG------SVDYSTGRFVLEIQ 149 (725)
Q Consensus 81 r~~Pv~~~-s~l~l~~~G~LvL~~~-~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~------~~d~s~g~~~~~~~ 149 (725)
.+.|+.++ ..|.+..||||||.+. .++++|+++.. ....++|+++|||||++.++ ...-..|.|.+.++
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~ 96 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQ 96 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCCSSSCCEEEEC
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcCCCCCEEEEEc
Confidence 34555543 4889999999999988 58999987753 24689999999999998765 11123467999999
Q ss_pred cCCCeEEeeeecCCCceeecC
Q 039817 150 MDGNVVLSAFRFADPAYWYTS 170 (725)
Q Consensus 150 ~~g~~~~~~~~~~~~~yw~~~ 170 (725)
.+|++.++- ++.|.++
T Consensus 97 ~dGnlvly~-----~~~W~s~ 112 (113)
T 3mez_B 97 INGQAVVYG-----PAVWSTA 112 (113)
T ss_dssp TTSCEEEEC-----SEEEESC
T ss_pred CCceEEEec-----CCEecCC
Confidence 999999862 5678765
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=2.3e-08 Score=87.23 Aligned_cols=82 Identities=22% Similarity=0.344 Sum_probs=64.3
Q ss_pred CceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC-----CccC-CCCceEEeeecCCCeEEee
Q 039817 88 GSSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG-----SVDY-STGRFVLEIQMDGNVVLSA 158 (725)
Q Consensus 88 ~s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~-----~~d~-s~g~~~~~~~~~g~~~~~~ 158 (725)
...|.+..+|||+|.+ .++++|+++.. ....++|+++|||||++.++ ++++ ++|.|.+.|+++|++.++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~- 98 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY- 98 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEE-
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEE-
Confidence 4578888999999998 58899987743 24679999999999998654 4554 578999999999996653
Q ss_pred eecCCCceeecCCCCCC
Q 039817 159 FRFADPAYWYTSTRGDQ 175 (725)
Q Consensus 159 ~~~~~~~yw~~~~~~~~ 175 (725)
.. .||.+++|...
T Consensus 99 -~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 99 -GP---VLWSLGPNGCR 111 (115)
T ss_dssp -CS---EEECSSTTCBC
T ss_pred -CC---CEEECCCCCCc
Confidence 22 79999887543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.5e-08 Score=102.66 Aligned_cols=119 Identities=13% Similarity=0.072 Sum_probs=92.5
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
+..+++|............+.+|+++++.++ |..+.++++++...+..++||||++|.+|.+.+. +......++
T Consensus 37 ~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~ 111 (263)
T 3tm0_A 37 NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKII 111 (263)
T ss_dssp SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHH
T ss_pred CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHH
Confidence 3578888876432233446899999999984 6778899999999889999999999999987642 223345788
Q ss_pred HHHHHHhhhhhcc--------------------------------------------------------cCCceeecCCc
Q 039817 541 LGIARGLLYLHEE--------------------------------------------------------CETQIIHCDIK 564 (725)
Q Consensus 541 ~qia~gL~yLH~~--------------------------------------------------------~~~~ivH~dik 564 (725)
.+++++|..||+. ....++|+|++
T Consensus 112 ~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~ 191 (263)
T 3tm0_A 112 ELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLG 191 (263)
T ss_dssp HHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCC
T ss_pred HHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCC
Confidence 9999999999981 01469999999
Q ss_pred cceEEeccCccccCCCCceEEeeccCcc
Q 039817 565 PQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 565 ~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
+.||++++ ...+.|+||+.+.
T Consensus 192 ~~Nil~~~-------~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 192 DSNIFVKD-------GKVSGFIDLGRSG 212 (263)
T ss_dssp TTSEEEET-------TEEEEECCCTTCE
T ss_pred cCcEEEEC-------CcEEEEEEchhcc
Confidence 99999975 4556799998764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.76 E-value=2.3e-08 Score=86.40 Aligned_cols=77 Identities=21% Similarity=0.321 Sum_probs=60.6
Q ss_pred CceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCCC---------ccCCCCceEEeeecCCCeE
Q 039817 88 GSSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANGS---------VDYSTGRFVLEIQMDGNVV 155 (725)
Q Consensus 88 ~s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~~---------~d~s~g~~~~~~~~~g~~~ 155 (725)
...|.+..||||||.+.++ +|+++.. ....++|+|+|||||.+.++. .....|.|.+.++.+|++.
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlv 98 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVT 98 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEE
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEE
Confidence 3478999999999999877 9987643 236899999999999987541 1234578999999999999
Q ss_pred EeeeecCCCceeecCC
Q 039817 156 LSAFRFADPAYWYTST 171 (725)
Q Consensus 156 ~~~~~~~~~~yw~~~~ 171 (725)
++. +++|.+++
T Consensus 99 ly~-----~~~W~s~t 109 (111)
T 3mez_A 99 IYG-----PAIWSTPA 109 (111)
T ss_dssp EEC-----SEEEECCC
T ss_pred Eec-----cCEEccCC
Confidence 863 67898764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=3e-07 Score=79.20 Aligned_cols=78 Identities=26% Similarity=0.272 Sum_probs=59.5
Q ss_pred CceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC-----C-ccCCCCceEEeeecCCCeEEee
Q 039817 88 GSSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG-----S-VDYSTGRFVLEIQMDGNVVLSA 158 (725)
Q Consensus 88 ~s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~-----~-~d~s~g~~~~~~~~~g~~~~~~ 158 (725)
...|.|..||||||.+. ++++|+++.. ....++|+++|||||++.++ + .....+.+.+.++.+|++.++-
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEE
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEEC
Confidence 45789999999999987 7899987753 24689999999999998765 1 2223356899999999998762
Q ss_pred eecCCCceeecCC
Q 039817 159 FRFADPAYWYTST 171 (725)
Q Consensus 159 ~~~~~~~yw~~~~ 171 (725)
++.|.+++
T Consensus 99 -----~~~W~s~t 106 (109)
T 3dzw_A 99 -----TARWATGT 106 (109)
T ss_dssp -----SCCCCCCC
T ss_pred -----CCEEeCCC
Confidence 26777654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.54 E-value=9.3e-08 Score=96.44 Aligned_cols=112 Identities=15% Similarity=0.090 Sum_probs=82.9
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcCC--ccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKN--LVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
..+++|..... ....+.+|+++++.+++.+ +.+++++...++..++||||+++.+|. ... . ....++
T Consensus 45 ~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~---~---~~~~~~ 113 (264)
T 1nd4_A 45 PVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH---L---APAEKV 113 (264)
T ss_dssp CCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC---C---CHHHHH
T ss_pred CeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc---C---CHhHHH
Confidence 45777876432 2346789999999986544 556899988888899999999998884 211 1 123677
Q ss_pred HHHHHHhhhhhccc-------------------------------------------------------CCceeecCCcc
Q 039817 541 LGIARGLLYLHEEC-------------------------------------------------------ETQIIHCDIKP 565 (725)
Q Consensus 541 ~qia~gL~yLH~~~-------------------------------------------------------~~~ivH~dik~ 565 (725)
.++++.|..||+.. ...++|+|++|
T Consensus 114 ~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~ 193 (264)
T 1nd4_A 114 SIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACL 193 (264)
T ss_dssp HHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCG
T ss_pred HHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCC
Confidence 78888888888642 12399999999
Q ss_pred ceEEeccCccccCCCCceEEeeccCcc
Q 039817 566 QNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 566 ~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
.||+++. +..++|+||+.+.
T Consensus 194 ~Nil~~~-------~~~~~liD~~~a~ 213 (264)
T 1nd4_A 194 PNIMVEN-------GRFSGFIDCGRLG 213 (264)
T ss_dssp GGEEEET-------TEEEEECCCTTCE
T ss_pred CcEEEEC-------CcEEEEEcchhcc
Confidence 9999975 5556799999875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.3e-06 Score=88.39 Aligned_cols=101 Identities=12% Similarity=0.149 Sum_probs=77.2
Q ss_pred ccccccCCCCc----eeeCCCCeeeeCCCeEEEeeeeC---CCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcc
Q 039817 23 MTTNNIELGSN----IIAGTNSTWPSTSGDFAFGFYPL---VSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTV 95 (725)
Q Consensus 23 ~~~~~i~~g~~----l~~~~~~~lvS~~g~F~lGFf~~---~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~ 95 (725)
..+||+.+|+. |.. |++|+| ..+++.|+|.. ..+.++| |.+ ..+++|.+++.++-. ..+.|..
T Consensus 134 ~ptdtlLpg~~~~~~l~~--g~~L~S-~~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~~~--~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAP--GSELVQ-GVVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGKGA--VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECS--SEEECT-TCEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTTTC--CEEEECT
T ss_pred cccccccccccccccccc--Cccccc-CCCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCCcc--EEEEEcC
Confidence 56799999999 654 778865 46888888742 3444443 332 268999999988732 6889999
Q ss_pred cccEEEEcCCCceEEEecc--CceeEEEEecCCCeEEecC
Q 039817 96 TGQLVLTHSNGTQFKIYNG--TLTVSALMQDSGNFLYSNA 133 (725)
Q Consensus 96 ~G~LvL~~~~~~~~ws~~~--~~~~~a~LldsGNlVl~~~ 133 (725)
+|+|++.|.++.++|++.. .....|+|+++||||+.+.
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~ 243 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE 243 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE
T ss_pred CCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC
Confidence 9999999998889998763 2346899999999999975
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.48 E-value=3.3e-07 Score=78.80 Aligned_cols=83 Identities=18% Similarity=0.271 Sum_probs=61.1
Q ss_pred CCCCCCCC-ceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCCC------ccCCCCceEEeeec
Q 039817 81 RDDPAQVG-SSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANGS------VDYSTGRFVLEIQM 150 (725)
Q Consensus 81 r~~Pv~~~-s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~~------~d~s~g~~~~~~~~ 150 (725)
.+.|+.++ -.|.+..||||||.++ +|+++.. ....++|+++|||||.+.++. .....+.+.+.++.
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~ 89 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHP 89 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCCEEEEET
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcC
Confidence 34445443 4789999999999985 6987643 246789999999999987641 11234568899999
Q ss_pred CCCeEEeeeecCCCceeecCCC
Q 039817 151 DGNVVLSAFRFADPAYWYTSTR 172 (725)
Q Consensus 151 ~g~~~~~~~~~~~~~yw~~~~~ 172 (725)
+|++.++. ++.|.++++
T Consensus 90 dGNlvly~-----~~~W~s~t~ 106 (109)
T 3r0e_A 90 DGRLVVFG-----PSVFKIDPW 106 (109)
T ss_dssp TTEEEEEC-----SEEEEECTT
T ss_pred CCeEEEEe-----cCEECCCCc
Confidence 99998862 578888765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.46 E-value=5.6e-07 Score=77.50 Aligned_cols=76 Identities=22% Similarity=0.200 Sum_probs=58.0
Q ss_pred CceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC-----C-ccCCCCceEEeeecCCCeEEee
Q 039817 88 GSSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG-----S-VDYSTGRFVLEIQMDGNVVLSA 158 (725)
Q Consensus 88 ~s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~-----~-~d~s~g~~~~~~~~~g~~~~~~ 158 (725)
+..|.+..||||||.+. .++|+++.. ....++|+|+|||||++.++ + ..-..|.|.+.++.+|++.++-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec
Confidence 35788999999999876 589987643 23589999999999998765 1 1223567999999999999862
Q ss_pred eecCCCceeecC
Q 039817 159 FRFADPAYWYTS 170 (725)
Q Consensus 159 ~~~~~~~yw~~~ 170 (725)
++.|.++
T Consensus 103 -----~~~W~t~ 109 (110)
T 3r0e_B 103 -----PAIFETS 109 (110)
T ss_dssp -----SEEEESC
T ss_pred -----CCEecCC
Confidence 4678764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.38 E-value=9.2e-07 Score=93.92 Aligned_cols=124 Identities=15% Similarity=0.221 Sum_probs=90.0
Q ss_pred eEEEEEEcc--ccc-CccHHHHHHHHHHHhccC--cCCccceeeEEEcC---CceeeeeecccCCChhhhhccCCCCCHH
Q 039817 463 VEVAVKQLE--KVT-GDGEKSFLREVQVIGRTH--HKNLVQLLGFCIEQ---NHQLLVYELMKNGTLSAFLFRQEIPTWD 534 (725)
Q Consensus 463 ~~vavk~l~--~~~-~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~l~~~ 534 (725)
..+.+|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++||||+++..+.+... ..++..
T Consensus 62 ~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~--~~l~~~ 139 (359)
T 3dxp_A 62 QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL--PGMSPA 139 (359)
T ss_dssp CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC--TTCCHH
T ss_pred ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc--ccCCHH
Confidence 356666654 221 122456889999999987 45688999998876 45899999999988754221 236778
Q ss_pred HHHHHHHHHHHHhhhhhccc-------------------------------------------------------CCcee
Q 039817 535 KRVEIALGIARGLLYLHEEC-------------------------------------------------------ETQII 559 (725)
Q Consensus 535 ~~~~i~~qia~gL~yLH~~~-------------------------------------------------------~~~iv 559 (725)
.+..++.++++.|..||... ...++
T Consensus 140 ~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lv 219 (359)
T 3dxp_A 140 ERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIV 219 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEE
T ss_pred HHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEE
Confidence 88999999999999999720 25799
Q ss_pred ecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 560 H~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
|+|+++.||+++.+ +...+.|.||+.+..
T Consensus 220 HgD~~~~Nil~~~~-----~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 220 HGDYRLDNLMFHPT-----EPRVLAVLDWELSTL 248 (359)
T ss_dssp CSSCSGGGEEECSS-----SSCEEEECCCTTCEE
T ss_pred eCCCCCCcEEEeCC-----CCcEEEEECcccccc
Confidence 99999999999862 123468999998864
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.6e-06 Score=72.60 Aligned_cols=68 Identities=28% Similarity=0.387 Sum_probs=54.2
Q ss_pred ceEEEcccccEEEEcCCCceEEEeccC----ceeEEEEecCCCeEEecCCC------CccCCCCceEEeeecCCCeEEe
Q 039817 89 SSINLTVTGQLVLTHSNGTQFKIYNGT----LTVSALMQDSGNFLYSNANG------SVDYSTGRFVLEIQMDGNVVLS 157 (725)
Q Consensus 89 s~l~l~~~G~LvL~~~~~~~~ws~~~~----~~~~a~LldsGNlVl~~~~~------~~d~s~g~~~~~~~~~g~~~~~ 157 (725)
-+|.+..||||||.+. ++++|++++. ....+.|.++|||||.+.++ ......+.+.+.|+.+|++.++
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEE
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEE
Confidence 3688889999999874 6789987642 34578999999999998876 2334567889999999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.19 E-value=9.1e-07 Score=91.57 Aligned_cols=170 Identities=21% Similarity=0.239 Sum_probs=105.0
Q ss_pred EEEEEcccccCccHHHHHHHHHHHhccC-cCC--ccceeeEEEcCC---ceeeeeecccCCChhhhhccCCCCCHHHHHH
Q 039817 465 VAVKQLEKVTGDGEKSFLREVQVIGRTH-HKN--LVQLLGFCIEQN---HQLLVYELMKNGTLSAFLFRQEIPTWDKRVE 538 (725)
Q Consensus 465 vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~ 538 (725)
+.+|.... ......+.+|+++++.+. +.. +.+++......+ ..++|||++++.+|.+... ..++..++..
T Consensus 43 ~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~ 118 (304)
T 3sg8_A 43 FIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQ 118 (304)
T ss_dssp EEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHH
T ss_pred EEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHH
Confidence 56665432 234567899999999884 333 445555544333 3578999999988865432 2356677778
Q ss_pred HHHHHHHHhhhhhcc-------------------------------------------------------cCCceeecCC
Q 039817 539 IALGIARGLLYLHEE-------------------------------------------------------CETQIIHCDI 563 (725)
Q Consensus 539 i~~qia~gL~yLH~~-------------------------------------------------------~~~~ivH~di 563 (725)
++.++++.|..||+. ..+.++|+|+
T Consensus 119 ~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~ 198 (304)
T 3sg8_A 119 AAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDF 198 (304)
T ss_dssp HHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCC
T ss_pred HHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCC
Confidence 888888888888851 1146899999
Q ss_pred ccceEEeccCccccCCCCceEEeeccCccccCcCCCcccc-------------ccccCccccc-hhcccCCCCCCcccee
Q 039817 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTST-------------MIRGTMGYMA-PEWLRNAPVTAKVDVY 629 (725)
Q Consensus 564 k~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~-------------~~~gt~~y~a-PE~~~~~~~~~ksDv~ 629 (725)
++.||+++.+ ....+.|+||+.+..-......... ......+... |+.... .....+.|
T Consensus 199 ~~~N~l~~~~-----~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~ 271 (304)
T 3sg8_A 199 SSDHILFDTE-----KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYW 271 (304)
T ss_dssp CGGGEEEETT-----TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHH
T ss_pred CcccEEEeCC-----CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHH
Confidence 9999999862 1345789999988653211000000 0000111112 222211 11225789
Q ss_pred hhHHHHHHHHhCCcCC
Q 039817 630 SFGVMLLEIIFCKRHT 645 (725)
Q Consensus 630 S~G~vl~elltg~~~~ 645 (725)
+++.+++++.+|..++
T Consensus 272 ~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 272 SFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCHHH
Confidence 9999999999888765
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.04 E-value=2.9e-05 Score=76.85 Aligned_cols=78 Identities=26% Similarity=0.320 Sum_probs=57.6
Q ss_pred ceEEEcccccEEEEcCCCceEEEeccC--ceeEEEEecCCCeEEecCCC-----Ccc-CCCCceEEeeecCCCeEEeeee
Q 039817 89 SSINLTVTGQLVLTHSNGTQFKIYNGT--LTVSALMQDSGNFLYSNANG-----SVD-YSTGRFVLEIQMDGNVVLSAFR 160 (725)
Q Consensus 89 s~l~l~~~G~LvL~~~~~~~~ws~~~~--~~~~a~LldsGNlVl~~~~~-----~~d-~s~g~~~~~~~~~g~~~~~~~~ 160 (725)
..|.+..+|+|+|.+. +++||.++.. ....++|+++|||||.+.++ +.+ ..++.+.+.|+.+|+++++ .
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~--~ 104 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIY--G 104 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEE--C
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEe--c
Confidence 4566677899999886 7899987643 34578999999999998765 222 2357789999999999885 1
Q ss_pred cCCCceeecCCC
Q 039817 161 FADPAYWYTSTR 172 (725)
Q Consensus 161 ~~~~~yw~~~~~ 172 (725)
..+|.+..+
T Consensus 105 ---~~~W~S~~~ 113 (236)
T 1dlp_A 105 ---PGLWDSGTS 113 (236)
T ss_dssp ---SEEEECSCC
T ss_pred ---CCEEECCCC
Confidence 267776533
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=97.90 E-value=1.2e-05 Score=69.34 Aligned_cols=83 Identities=23% Similarity=0.302 Sum_probs=66.9
Q ss_pred CceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC------CccCCCCceEEeeecCCCeEEee
Q 039817 88 GSSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG------SVDYSTGRFVLEIQMDGNVVLSA 158 (725)
Q Consensus 88 ~s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~------~~d~s~g~~~~~~~~~g~~~~~~ 158 (725)
...|.+..+|+|+|.+. ++++|+++.. ..+.|+|+|+|||||++ ++ ..|+++|.|.+.|+++|++.+
T Consensus 20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl-- 95 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVI-- 95 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEE--
T ss_pred CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEE--
Confidence 35889999999999987 7899987743 34689999999999998 44 357788999999999999665
Q ss_pred eecCCCceeecCCCCC
Q 039817 159 FRFADPAYWYTSTRGD 174 (725)
Q Consensus 159 ~~~~~~~yw~~~~~~~ 174 (725)
+.....+||.++.+.+
T Consensus 96 ~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 96 YDNSNNAIWATHTNVG 111 (112)
T ss_dssp ECTTSCEEEECCCCCC
T ss_pred ECCCCceEEECCCccC
Confidence 3444578999887754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00028 Score=71.17 Aligned_cols=115 Identities=17% Similarity=0.132 Sum_probs=80.4
Q ss_pred EEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHH
Q 039817 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALG 542 (725)
Q Consensus 464 ~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~q 542 (725)
.+.+|.-.. .....+.+|...|+.+. +--+.++++++..++..++|||++++.++.+..... ......+..+
T Consensus 52 ~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~ 124 (272)
T 4gkh_A 52 ELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDA 124 (272)
T ss_dssp CEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHH
T ss_pred EEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHH
Confidence 456665432 23567889999998884 444778999999999999999999998876654321 1223345555
Q ss_pred HHHHhhhhhcc-------------------------------------------------------cCCceeecCCccce
Q 039817 543 IARGLLYLHEE-------------------------------------------------------CETQIIHCDIKPQN 567 (725)
Q Consensus 543 ia~gL~yLH~~-------------------------------------------------------~~~~ivH~dik~~N 567 (725)
+++.|..||.. ..+.++|+|+.+.|
T Consensus 125 l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~N 204 (272)
T 4gkh_A 125 LAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDN 204 (272)
T ss_dssp HHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTS
T ss_pred HHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCe
Confidence 55555555531 11248999999999
Q ss_pred EEeccCccccCCCCceEEeeccCcc
Q 039817 568 VLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 568 Ill~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
|+++. ...+-|+||+.+.
T Consensus 205 il~~~-------~~~~~viDwe~a~ 222 (272)
T 4gkh_A 205 LIFDE-------GKLIGCIDVGRVG 222 (272)
T ss_dssp EEEET-------TEEEEECCCTTCE
T ss_pred EEEEC-------CeEEEEEECcccc
Confidence 99976 5566799998875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00092 Score=68.85 Aligned_cols=121 Identities=20% Similarity=0.219 Sum_probs=78.3
Q ss_pred EEEEEcccccCccHHHHHHHHHHHhccCcC---CccceeeEEE-cCCceeeeeecccCCChhhhhccCCCCCHHHHHHHH
Q 039817 465 VAVKQLEKVTGDGEKSFLREVQVIGRTHHK---NLVQLLGFCI-EQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIA 540 (725)
Q Consensus 465 vavk~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~ 540 (725)
+.+|.-. .......+.+|+++|+.+++. .+.+++.++. ..+..++|||++++.+|.+... ..++...+..++
T Consensus 42 ~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~ 117 (306)
T 3tdw_A 42 WVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLA 117 (306)
T ss_dssp EEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHH
T ss_pred EEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHH
Confidence 4555532 223456789999999999653 3567777775 4556789999999988876321 122344445555
Q ss_pred HHHHHHhhhhhcc---------------------------------------------------------cCCceeecCC
Q 039817 541 LGIARGLLYLHEE---------------------------------------------------------CETQIIHCDI 563 (725)
Q Consensus 541 ~qia~gL~yLH~~---------------------------------------------------------~~~~ivH~di 563 (725)
.++++.|..||+. ..+.++|+|+
T Consensus 118 ~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~ 197 (306)
T 3tdw_A 118 LQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDL 197 (306)
T ss_dssp HHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCC
T ss_pred HHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCC
Confidence 5555555555532 2235799999
Q ss_pred ccceEEeccCccccCCCCc-eEEeeccCccc
Q 039817 564 KPQNVLLDNNYITIDNNYI-TKIADFGLAKL 593 (725)
Q Consensus 564 k~~NIll~~~~~~~~~~~~-~kl~Dfgla~~ 593 (725)
++.||+++.+. +++. +.|+||+.+..
T Consensus 198 ~~~N~l~~~~~----~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 198 SPDHFLTNLNS----RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SGGGEEECTTC----SSCCEEEECCCTTCEE
T ss_pred CcccEEEecCC----CCCceEEEEehhhcCC
Confidence 99999997521 1234 58999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00052 Score=72.32 Aligned_cols=62 Identities=3% Similarity=-0.049 Sum_probs=41.7
Q ss_pred ceEEEEEEccccc---CccHHHHHHHHHHHhccC-c--CCccceeeEEEcC---CceeeeeecccCCChhh
Q 039817 462 EVEVAVKQLEKVT---GDGEKSFLREVQVIGRTH-H--KNLVQLLGFCIEQ---NHQLLVYELMKNGTLSA 523 (725)
Q Consensus 462 ~~~vavk~l~~~~---~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~---~~~~lV~e~~~~gsL~~ 523 (725)
+..+.+|.-.... ......+.+|+.+++.++ + -.+.++++++... +..++||||+++..+.+
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 3456677654321 111246788999999885 3 3577888888765 35689999999877654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.16 E-value=0.021 Score=54.45 Aligned_cols=98 Identities=10% Similarity=-0.010 Sum_probs=61.7
Q ss_pred CChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 519 GTLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 519 gsL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
-||.+.|... .+++++++|.++.|.+++|.-+-... .-..+=+.|..|+|.. +|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~-------dG~V~f~~-~~s~----- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWR-------DGAVTLAP-AADD----- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEET-------TSCEEECC-C--------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEec-------CCceeccc-cccc-----
Confidence 3788888754 78999999999999999987762210 1112334567888876 66766653 1110
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHh
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt 640 (725)
.....+.|||... ...+.+.=|||+|++||..+-
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122466888763 345678899999999999983
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.032 Score=57.21 Aligned_cols=56 Identities=21% Similarity=0.213 Sum_probs=43.7
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccC---cCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTH---HKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+.+|.... .....|..|.+.|+.+. ...+.++++++...+..++||||+++..+
T Consensus 60 ~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 60 QTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp CEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4566776543 23567899999999884 35688999998888899999999998765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.028 Score=58.32 Aligned_cols=31 Identities=23% Similarity=0.262 Sum_probs=26.6
Q ss_pred CCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 555 ~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
...++|+|+++.||+++. +..+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~-------~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGE-------NEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECG-------GGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeC-------CCcEEEEehhhcc
Confidence 458999999999999976 5679999999765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.49 E-value=0.034 Score=59.20 Aligned_cols=30 Identities=23% Similarity=0.355 Sum_probs=25.0
Q ss_pred CceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 556 ~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
..++|+|+.+.||+++. + .+++.||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~-------~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASE-------H-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECS-------S-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeC-------C-CeEEEeCccccc
Confidence 47999999999999975 2 489999987764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.09 E-value=0.062 Score=56.64 Aligned_cols=124 Identities=18% Similarity=0.165 Sum_probs=72.3
Q ss_pred ceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhh----------------
Q 039817 462 EVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAF---------------- 524 (725)
Q Consensus 462 ~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~---------------- 524 (725)
...+.+++-... ......+.+|.++++.+. +.-..++++.+.++ +||||+++.+|..-
T Consensus 82 ~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La 156 (379)
T 3feg_A 82 PREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMA 156 (379)
T ss_dssp CSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHH
T ss_pred CCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHH
Confidence 346677765322 234566779999998885 33346777776543 99999998655321
Q ss_pred -hccC-----CCCC--HHHHHHHHHHHHH-------------------Hhhhhhc-----ccCCceeecCCccceEEecc
Q 039817 525 -LFRQ-----EIPT--WDKRVEIALGIAR-------------------GLLYLHE-----ECETQIIHCDIKPQNVLLDN 572 (725)
Q Consensus 525 -l~~~-----~~l~--~~~~~~i~~qia~-------------------gL~yLH~-----~~~~~ivH~dik~~NIll~~ 572 (725)
|+.. +... |.+..++..++.. .+..|.+ .....++|+|+.+.||+++.
T Consensus 157 ~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~ 236 (379)
T 3feg_A 157 QFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLS 236 (379)
T ss_dssp HHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEES
T ss_pred HHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcC
Confidence 1111 1122 3445555444322 1222221 12347999999999999976
Q ss_pred CccccCCCCceEEeeccCccc
Q 039817 573 NYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 573 ~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+. +..+.+.++||..+..
T Consensus 237 ~~---~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 237 EP---ENADSLMLVDFEYSSY 254 (379)
T ss_dssp CC------CCEEECCCTTCEE
T ss_pred CC---CccCcEEEEecccCCc
Confidence 21 0136789999988753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.09 Score=56.39 Aligned_cols=80 Identities=10% Similarity=0.033 Sum_probs=46.0
Q ss_pred CCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccccccccCccccchhcccCC---CCCCccceehh
Q 039817 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA---PVTAKVDVYSF 631 (725)
Q Consensus 555 ~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~S~ 631 (725)
...++|+|+++.|||++. +. ++|+||+.+..-............-...|.+|+..... .-....++...
T Consensus 231 ~~~liHGDl~~~Nil~~~-------~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQ-------DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRT 302 (420)
T ss_dssp CCEEECSCCSGGGEEECS-------SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeC-------CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHH
Confidence 348999999999999976 33 99999998875321111000000011346666654311 11122445577
Q ss_pred HHHHHHHHhCC
Q 039817 632 GVMLLEIIFCK 642 (725)
Q Consensus 632 G~vl~elltg~ 642 (725)
...+|+.++++
T Consensus 303 ~~~~~~~y~~~ 313 (420)
T 2pyw_A 303 IEQTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 77777777653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.46 E-value=0.06 Score=57.98 Aligned_cols=53 Identities=15% Similarity=0.167 Sum_probs=34.1
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcCCc-cceeeEEEcCCceeeeeecccCCCh
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNL-VQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+.+|+.... .....+..|..+++.+...++ .++++.+.+ .+|+||+++.+|
T Consensus 106 ~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 106 NKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp SEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred ceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 45666665321 222566789999998854444 677776643 289999986444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.33 E-value=0.16 Score=52.32 Aligned_cols=36 Identities=28% Similarity=0.315 Sum_probs=27.2
Q ss_pred CCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 555 ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 555 ~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
...++|+|+.+.||+++.+. ++...+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~---~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPER---EGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTS---CGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCc---CCCCCeEEEeCCCcCc
Confidence 34899999999999997521 0015789999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=93.29 E-value=0.42 Score=48.04 Aligned_cols=57 Identities=16% Similarity=0.115 Sum_probs=38.2
Q ss_pred cceEEEEEEcccccCccHHHHHHHHHHHhccCcC---CccceeeEEEcCCceeeeeecccCCCh
Q 039817 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHK---NLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
++..+.+|.-..........|..|++.|+.|... -+.+++++. ..++||||++.+..
T Consensus 38 DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 38 DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 4567888876554444556788999999988422 345555542 34789999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=93.11 E-value=0.17 Score=51.48 Aligned_cols=30 Identities=23% Similarity=0.248 Sum_probs=24.5
Q ss_pred CceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 556 ~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
..++|+|+.+.||+.+ ++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil~~--------~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFLDT--------GERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEEEC--------SSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEEEC--------CCCEEEEecccccC
Confidence 4689999999999943 45689999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.15 E-value=0.41 Score=51.72 Aligned_cols=54 Identities=17% Similarity=0.119 Sum_probs=32.2
Q ss_pred eEEEEEEcccccCccHHHHHHHHHHHhccCcCCc-cceeeEEEcCCceeeeeecccCCCh
Q 039817 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNL-VQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 463 ~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
..+.+|........ .-...+|..++..+...++ .++++.+.. .+||||+++.+|
T Consensus 134 ~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 134 AKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred ceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 45566655322111 1112589999998865444 577877732 259999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.40 E-value=0.37 Score=50.41 Aligned_cols=29 Identities=21% Similarity=0.412 Sum_probs=24.0
Q ss_pred CceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 556 ~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
..++|+|+++.|||++. + .+.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~-------~-~~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTN-------K-CLRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC---------CEEECCCTTCE
T ss_pred eEEEeCCCCcccEEecC-------C-cEEEEEecCCC
Confidence 47999999999999864 2 48999998775
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=88.74 E-value=0.18 Score=39.68 Aligned_cols=33 Identities=18% Similarity=0.433 Sum_probs=29.0
Q ss_pred cccChhhHHHHhcccCcccceeee--cceeecccc
Q 039817 327 TTTDVNECRKAVMDDCFCAAGVWR--EVVCLKKKM 359 (725)
Q Consensus 327 ~~~~~~~C~~~Cl~nCsC~A~~~~--~~~C~~~~~ 359 (725)
..+++++|+..|+.+=.|.||.|+ ...|+++.+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 456899999999999999999996 589998864
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=81.59 E-value=0.78 Score=30.30 Aligned_cols=30 Identities=23% Similarity=0.585 Sum_probs=22.9
Q ss_pred CCCCcccccCCCCeeecCCCCceeeccCCCCC
Q 039817 245 EPCTVNTICGVFGFCTSDNNKEVTCECLRGYS 276 (725)
Q Consensus 245 ~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~ 276 (725)
+.|. ...|-..|.|.. ...+-.|.|++||.
T Consensus 4 d~C~-~~pC~ngg~C~~-~~~~~~C~C~~G~~ 33 (39)
T 1edm_B 4 DQCE-SNPCLNGGSCKD-DINSYECWCPFGFE 33 (39)
T ss_dssp CTTT-TCCCCTTCEEEE-ETTEEEEECCTTCC
T ss_pred ccCC-CCCCCCCCEeEc-CCCceEeECCCCCc
Confidence 5676 467999999964 33456899999996
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 725 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-13 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-08 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-07 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 7e-05 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 7e-04 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 0.002 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-56
Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 22/255 (8%)
Query: 460 GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+V V + + T ++F EV V+ +T H N++ +G+ +V + +
Sbjct: 30 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 88
Query: 520 TLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
+L L E K ++IA A+G+ YLH + IIH D+K N+ L
Sbjct: 89 SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFL-------H 138
Query: 579 NNYITKIADFGLAKLLKKDQ-TRTSTMIRGTMGYMAPEWLR---NAPVTAKVDVYSFGVM 634
+ KI DFGLA + + + + G++ +MAPE +R P + + DVY+FG++
Sbjct: 139 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198
Query: 635 LLEIIFCKR-HTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQ 693
L E++ + ++ ++ D+ G L VR+ + + + C+ +
Sbjct: 199 LYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP-----KAMKRLMAECLKKK 253
Query: 694 PTLRPSMKQVLQMLE 708
RP Q+L +E
Sbjct: 254 RDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-55
Identities = 69/252 (27%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VA+K + + E+ F+ E +V+ + H LVQL G C+EQ LV+E M++G LS
Sbjct: 31 KVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89
Query: 524 FLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
+L Q + + + + L + G+ YL E C +IH D+ +N L+ N +
Sbjct: 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI------ 140
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK 642
K++DFG+ + + DQ +ST + + + +PE + ++K DV+SFGV++ E+
Sbjct: 141 -KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 643 RHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQ 702
+ +R + + + I T + LY R + + + C +P RP+ +
Sbjct: 200 KIPYENRSNSEVVED--ISTGFRLYKPRLAS------THVYQIMNHCWKERPEDRPAFSR 251
Query: 703 VLQMLEGTSEVG 714
+L+ L +E G
Sbjct: 252 LLRQLAEIAESG 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-54
Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 22/247 (8%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VAVK L++ +FL E ++ + H+ LV+L + ++ E M+NG+L
Sbjct: 39 KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD 96
Query: 524 FLFRQEIP--TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
FL T +K +++A IA G+ ++ E IH D++ N+L+ +
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSC----- 148
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
KIADFGLA+L++ ++ + + + APE + T K DV+SFG++L EI+
Sbjct: 149 --KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206
Query: 642 KRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMK 701
R + + N + + + VR N E + + C +P RP+
Sbjct: 207 GRIPYPGMTNPEVIQN--LERGYRM--VRPDNCP----EELYQLMRLCWKERPEDRPTFD 258
Query: 702 QVLQMLE 708
+ +LE
Sbjct: 259 YLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 55/246 (22%), Positives = 110/246 (44%), Gaps = 20/246 (8%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
+VA+K +++ E F+ E +V+ H+ LVQL G C +Q ++ E M NG L
Sbjct: 30 DVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88
Query: 524 FLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYI 582
+L + +E+ + + YL + +H D+ +N L+++ +
Sbjct: 89 YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVV------ 139
Query: 583 TKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCK 642
K++DFGL++ + D+ +S + + + PE L + ++K D+++FGV++ EI
Sbjct: 140 -KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 643 RHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQ 702
+ + T + I LY + E++ + C + RP+ K
Sbjct: 199 KMPYERFTNSETAEH--IAQGLRLYRPHLAS------EKVYTIMYSCWHEKADERPTFKI 250
Query: 703 VLQMLE 708
+L +
Sbjct: 251 LLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 2e-52
Identities = 63/300 (21%), Positives = 128/300 (42%), Gaps = 55/300 (18%)
Query: 446 FSYQELREATNVFD-------------------------------GQEVEVAVKQLEK-V 473
F++++ EA F +E+ VA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 474 TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP-T 532
T + FL E ++G+ H N++ L G + +++ E M+NG+L +FL + + T
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 533 WDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592
+ V + GIA G+ YL + +H D+ +N+L+ ++N + K++DFGL++
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILV-------NSNLVCKVSDFGLSR 176
Query: 593 LLKKDQT----RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELH 648
L+ D + ++ + + + APE ++ T+ DV+S+G+++ E++
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 649 RVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
++ + I D+ L + + L C RP Q++ L+
Sbjct: 237 MTNQDVIN--AIEQDYRLPPPMDCP------SALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-52
Identities = 63/249 (25%), Positives = 98/249 (39%), Gaps = 24/249 (9%)
Query: 463 VEVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE----QNHQLLVYELM 516
VEVA +L K+T + F E +++ H N+V+ + +LV ELM
Sbjct: 35 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94
Query: 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
+GTL +L R ++ I +GL +LH IIH D+K N+ +
Sbjct: 95 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFIT----- 148
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
KI D GLA L + + + GT +MAPE VDVY+FG+ +L
Sbjct: 149 -GPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 203
Query: 637 EIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTL 696
E+ + N + V V+ + + + CI
Sbjct: 204 EMATSEYPY-------SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDE 256
Query: 697 RPSMKQVLQ 705
R S+K +L
Sbjct: 257 RYSIKDLLN 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 50/294 (17%), Positives = 101/294 (34%), Gaps = 49/294 (16%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIE 505
+ + + ++ G + A K + +RE+QV+ + +V G
Sbjct: 18 NGGVVFKVSHKPSGLVM--ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
+ E M G+L L + ++++ + +GL YL E+ +I+H D+KP
Sbjct: 76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKP 133
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
N+L+ ++ K+ DFG++ L + GT YM+PE L+ + +
Sbjct: 134 SNILV-------NSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 183
Query: 626 VDVYSFGVMLLEIIFCKR----------------HTELHRVDEPTLANGMILTDWVLYCV 669
D++S G+ L+E+ + E + P
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 670 RTGNLGATKFERITMVGLW------------------CICPQPTLRPSMKQVLQ 705
+ + + C+ P R +KQ++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-50
Identities = 57/266 (21%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIE 505
++ +R+ ++++VA+K L++ T + + +RE Q++ + + +V+L+G C +
Sbjct: 21 NFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 79
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
+LV E+ G L FL + E+ ++ G+ YL E+ +H D+
Sbjct: 80 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLA 136
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT--RTSTMIRGTMGYMAPEWLRNAPV 622
+NVLL N + I+DFGL+K L D + + + + + APE +
Sbjct: 137 ARNVLLVNRHYAK-------ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 623 TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682
+++ DV+S+GV + E + + +A I + C +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA--FIEQGKRMECPPECP------PEL 241
Query: 683 TMVGLWCICPQPTLRPSMKQVLQMLE 708
+ C + RP V Q +
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-50
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 27/248 (10%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQL-LVYELMKNGTLS 522
+VAVK ++ ++FL E V+ + H NLVQLLG +E+ L +V E M G+L
Sbjct: 32 KVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89
Query: 523 AFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
+L + + D ++ +L + + YL +H D+ +NVL+ + +
Sbjct: 90 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA---- 142
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
K++DFGL K + T + + + APE LR + K DV+SFG++L EI
Sbjct: 143 ---KVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
Query: 641 CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSM 700
R + + + + + + V C +RPS
Sbjct: 196 FGRVPYPRIPLKDVVPR--VEKGYKMDAPDGCP------PAVYEVMKNCWHLDAAMRPSF 247
Query: 701 KQVLQMLE 708
Q+ + LE
Sbjct: 248 LQLREQLE 255
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 59/266 (22%), Positives = 106/266 (39%), Gaps = 23/266 (8%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCI 504
++ +++ VAVK L+ D L E V+ + + +V+++G C
Sbjct: 19 NFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 77
Query: 505 EQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
E +LV E+ + G L+ +L + +E+ ++ G+ YL E +H D+
Sbjct: 78 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLA 134
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT--RTSTMIRGTMGYMAPEWLRNAPV 622
+NVLL + KI+DFGL+K L+ D+ + T + + + APE +
Sbjct: 135 ARNVLLVTQHYA-------KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 623 TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682
++K DV+SFGV++ E + A M+ + A +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--MLEKGERM------GCPAGCPREM 239
Query: 683 TMVGLWCICPQPTLRPSMKQVLQMLE 708
+ C RP V L
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 67/258 (25%), Positives = 117/258 (45%), Gaps = 28/258 (10%)
Query: 459 DGQEVEVAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQLLVYELM 516
DG+++ AVK L ++T GE FL E ++ H N++ LLG C+ + L+V M
Sbjct: 52 DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111
Query: 517 KNGTLSAFLF-RQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575
K+G L F+ PT + L +A+G+ + +H D+ +N +LD +
Sbjct: 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFT 168
Query: 576 TIDNNYITKIADFGLAKLLKKDQ---TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
K+ADFGLA+ + + T + + +MA E L+ T K DV+SFG
Sbjct: 169 V-------KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 221
Query: 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF--ERITMVGLWCI 690
V+L E++ + D +Y ++ L ++ + + V L C
Sbjct: 222 VLLWELMTRGAPPY----------PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 271
Query: 691 CPQPTLRPSMKQVLQMLE 708
P+ +RPS +++ +
Sbjct: 272 HPKAEMRPSFSELVSRIS 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-49
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 22/247 (8%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523
VA+K L+ T ++FL+E QV+ + H+ LVQL + +V E M G+L
Sbjct: 43 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD 100
Query: 524 FLFRQE--IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
FL + + V++A IA G+ Y+ +H D++ N+L+ N +
Sbjct: 101 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVC----- 152
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
K+ADFGLA+L++ ++ + + + APE T K DV+SFG++L E+
Sbjct: 153 --KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210
Query: 642 KRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMK 701
R V+ L + + + C E + + C +P RP+ +
Sbjct: 211 GRVPYPGMVNREVLD--QVERGYRMPCPPECP------ESLHDLMCQCWRKEPEERPTFE 262
Query: 702 QVLQMLE 708
+ LE
Sbjct: 263 YLQAFLE 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-49
Identities = 70/318 (22%), Positives = 121/318 (38%), Gaps = 52/318 (16%)
Query: 427 YMCVQPSPKPKPP--EINMKVFSYQEL------------REATNVFDGQEVEVAVKQLEK 472
Y+ + P+ P E S+ + + + VAVK L+
Sbjct: 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 473 VTGDGE-KSFLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEI 530
E ++ + E++V+ +H N+V LLG C L++ E G L FL R+
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 531 P------------------TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDN 572
+ + + +A+G+ +L + IH D+ +N+LL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL-- 178
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSF 631
+ ITKI DFGLA+ +K D R + +MAPE + N T + DV+S+
Sbjct: 179 -----THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
Query: 632 GVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCIC 691
G+ L E+ + MI + + + + C
Sbjct: 234 GIFLWELFSLGSSPYPGMPVDSKFYK-MIKEGFRMLSPEHAP------AEMYDIMKTCWD 286
Query: 692 PQPTLRPSMKQVLQMLEG 709
P RP+ KQ++Q++E
Sbjct: 287 ADPLKRPTFKQIVQLIEK 304
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-49
Identities = 60/264 (22%), Positives = 101/264 (38%), Gaps = 32/264 (12%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
+ + A + A+K L K E REV++ H N+++L G+
Sbjct: 18 KFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 75
Query: 504 IEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ L+ E GT+ L + + +A L Y H + ++IH DI
Sbjct: 76 HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDI 132
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
KP+N+LL + KIADFG + + T + GT+ Y+ PE +
Sbjct: 133 KPENLLL-------GSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF--ER 681
KVD++S GV+ E + K E + E + F E
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQE------------TYKRISRVEFTFPDFVTEG 230
Query: 682 ITMVGLWCICPQPTLRPSMKQVLQ 705
+ + P+ RP +++VL+
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (430), Expect = 3e-48
Identities = 68/278 (24%), Positives = 111/278 (39%), Gaps = 50/278 (17%)
Query: 464 EVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
VAVK L++ + D + F RE ++ + N+V+LLG C L++E M G L+
Sbjct: 45 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104
Query: 523 AFLFRQEIP------------------------TWDKRVEIALGIARGLLYLHEECETQI 558
FL + +++ IA +A G+ YL E
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK-DQTRTSTMIRGTMGYMAPEWL 617
+H D+ +N L+ N + KIADFGL++ + D + + +M PE +
Sbjct: 162 VHRDLATRNCLV-------GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214
Query: 618 RNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677
T + DV+++GV+L EI E V+Y VR GN+ A
Sbjct: 215 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-----------EVIYYVRDGNILAC 263
Query: 678 KF---ERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712
+ + C P RPS + ++L+ E
Sbjct: 264 PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-48
Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 43/276 (15%)
Query: 459 DGQEVEVAVKQLEKVTGDGE-KSFLREVQVIGR-THHKNLVQLLGFCIEQNHQLLVYELM 516
G ++VAVK L++ E ++ + E++++ + H+N+V LLG C L++E
Sbjct: 64 TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 123
Query: 517 KNGTLSAFLFRQEIP-----------------------TWDKRVEIALGIARGLLYLHEE 553
G L +L + T++ + A +A+G+ +L +
Sbjct: 124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183
Query: 554 CETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS-TMIRGTMGYM 612
+H D+ +NVL+ + + I DFGLA+ + D R + +M
Sbjct: 184 ---SCVHRDLAARNVLVTHGKVVK-------ICDFGLARDIMSDSNYVVRGNARLPVKWM 233
Query: 613 APEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG 672
APE L T K DV+S+G++L EI + + ++
Sbjct: 234 APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK-------LIQNGFKM 286
Query: 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ E I ++ C RPS + L
Sbjct: 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 6e-48
Identities = 55/269 (20%), Positives = 102/269 (37%), Gaps = 39/269 (14%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
S+ + A +V + + V A+K++ + + + ++EV+ + + H N +Q G
Sbjct: 27 SFGAVYFARDVRNSEVV--AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84
Query: 504 IEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ ++ LV E ++ + + G +GL YLH +IH D+
Sbjct: 85 LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDV 141
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR---NA 620
K N+LL + K+ DFG A ++ + GT +MAPE +
Sbjct: 142 KAGNILL-------SEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEG 189
Query: 621 PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680
KVDV+S G+ +E+ K LY + A +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMS------------ALYHIAQNESPALQSG 237
Query: 681 RIT----MVGLWCICPQPTLRPSMKQVLQ 705
+ C+ P RP+ + +L+
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 54/272 (19%), Positives = 110/272 (40%), Gaps = 35/272 (12%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
SY ++ DG+ + K+L+ +T ++ + EV ++ H N+V+ I
Sbjct: 16 SYGRCQKIRRKSDGKIL--VWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73
Query: 505 EQNHQLL--VYELMKNGTLSAFLFR----QEIPTWDKRVEIALGIARGLLYLHE--ECET 556
++ + L V E + G L++ + + ++ + + + + L H +
Sbjct: 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 133
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEW 616
++H D+KP NV LD K+ DFGLA++L D + + T YM+PE
Sbjct: 134 TVLHRDLKPANVFLDGKQNV-------KLGDFGLARILNHDTSFAKAFVG-TPYYMSPEQ 185
Query: 617 LRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676
+ K D++S G +L E+ E + +R G
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------------LAGKIREGKFRR 233
Query: 677 TKF---ERITMVGLWCICPQPTLRPSMKQVLQ 705
+ + + + + + RPS++++L+
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-47
Identities = 59/262 (22%), Positives = 107/262 (40%), Gaps = 22/262 (8%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE 505
+Y E++ A N + V AVK ++ D ++ +E+ + +H+N+V+ G E
Sbjct: 17 AYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
N Q L E G L + + G++YLH I H DIKP
Sbjct: 75 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKP 131
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKD-QTRTSTMIRGTMGYMAPEWLRNAPV-T 623
+N+LL D KI+DFGLA + + + + R + GT+ Y+APE L+
Sbjct: 132 ENLLL-------DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERIT 683
VDV+S G++L ++ + + + + Y + + +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 684 MVGLWCICPQPTLRPSMKQVLQ 705
+ P+ R ++ + +
Sbjct: 242 ----KILVENPSARITIPDIKK 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 1e-47
Identities = 66/248 (26%), Positives = 113/248 (45%), Gaps = 21/248 (8%)
Query: 463 VEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522
+ VAVK L++ T + E+ FL+E V+ H NLVQLLG C + ++ E M G L
Sbjct: 43 LTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 523 AFLFRQEIP--TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580
+L + + +A I+ + YL ++ IH D+ +N L+ N++
Sbjct: 102 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLV---- 154
Query: 581 YITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF 640
K+ADFGL++L+ D + + + APE L + K DV++FGV+L E I
Sbjct: 155 ---KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE-IA 210
Query: 641 CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSM 700
+ +D + ++ D+ + E++ + C P+ RPS
Sbjct: 211 TYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCP------EKVYELMRACWQWNPSDRPSF 263
Query: 701 KQVLQMLE 708
++ Q E
Sbjct: 264 AEIHQAFE 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 58/278 (20%), Positives = 103/278 (37%), Gaps = 45/278 (16%)
Query: 464 EVAVKQLEKVTGDGEKSFLREVQV--IGRTHHKNLVQLLGFCIEQNHQL----LVYELMK 517
EVAVK E+S+ RE ++ H+N++ + + N LV + +
Sbjct: 28 EVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84
Query: 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEEC-----ETQIIHCDIKPQNVLLDN 572
+G+L +L R + + +++AL A GL +LH E + I H D+K +N+L+
Sbjct: 85 HGSLFDYLNRYTVT-VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 573 NYITIDNNYITKIADFGLAKLLKKDQTRTS---TMIRGTMGYMAPEWL------RNAPVT 623
N IAD GLA GT YMAPE L ++
Sbjct: 144 NGTC-------CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLG-------- 675
+ D+Y+ G++ EI +H + ++ +D + +R
Sbjct: 197 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSVEEMRKVVCEQKLRPNIP 255
Query: 676 -----ATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + C R + ++ + L
Sbjct: 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-47
Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 46/275 (16%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
++ ++ +A N A K ++ + + + ++ E+ ++ H N+V+LL +
Sbjct: 24 AFGKVYKAQNKETSVLA--AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE 81
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
N+ ++ E G + A + E P T + + L YLH+ +IIH D+K
Sbjct: 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKA 138
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL-----RNA 620
N+L + K+ADFG++ + R + I GT +MAPE + ++
Sbjct: 139 GNILF-------TLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 621 PVTAKVDVYSFGVMLLEIIFCKR----------HTELHRVDEPTLANGMILTDWVLYCVR 670
P K DV+S G+ L+E+ + ++ + + PTLA + ++
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 671 TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705
C+ R + Q+LQ
Sbjct: 251 -----------------KCLEKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-46
Identities = 72/300 (24%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 439 PEINMKVFSYQEL---------REATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVI 488
P ++ +Q++ +A DG ++ A+K++++ + D + F E++V+
Sbjct: 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64
Query: 489 GR-THHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP---------------- 531
+ HH N++ LLG C + + L E +G L FL + +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 532 TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591
+ + + A +ARG+ YL ++ Q IH D+ +N+L+ NY+ KIADFGL+
Sbjct: 125 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA-------KIADFGLS 174
Query: 592 KLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVD 651
+ ++ TM R + +MA E L + T DV+S+GV+L EI+
Sbjct: 175 RG--QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232
Query: 652 EPT---LANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
L G L + + + + C +P RPS Q+L L
Sbjct: 233 AELYEKLPQGYRLEKPLNCD-----------DEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-46
Identities = 60/256 (23%), Positives = 98/256 (38%), Gaps = 24/256 (9%)
Query: 459 DGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYEL 515
G+ V VAVK L+ + F+REV + H+NL++L G + +V EL
Sbjct: 33 SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTEL 91
Query: 516 MKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNY 574
G+L L + + A+ +A G+ YL + IH D+ +N+LL
Sbjct: 92 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLL---- 144
Query: 575 ITIDNNYITKIADFGLAKLLKK--DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFG 632
+ KI DFGL + L + D + + APE L+ + D + FG
Sbjct: 145 ---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 633 VMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICP 692
V L E+ + + NG + + + I V + C
Sbjct: 202 VTLWEMFTYGQEPWIGL-------NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAH 254
Query: 693 QPTLRPSMKQVLQMLE 708
+P RP+ + L
Sbjct: 255 KPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+ + A +V GQEV A++Q+ ++ + E+ V+ + N+V L +
Sbjct: 32 ASGTVYTAMDVATGQEV--AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQ 566
+ +V E + G+L+ + + + + + L +LH Q+IH DIK
Sbjct: 90 DELWVVMEYLAGGSLTDVVTETCMD-EGQIAAVCRECLQALEFLHSN---QVIHRDIKSD 145
Query: 567 NVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKV 626
N+LL + K+ DFG + +Q++ STM+ GT +MAPE + KV
Sbjct: 146 NILL-------GMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 627 DVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG 686
D++S G+M +E+I + + + P A +I T+ L A + +
Sbjct: 198 DIWSLGIMAIEMIEGEP---PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN--- 251
Query: 687 LWCICPQPTLRPSMKQVLQ 705
C+ R S K++LQ
Sbjct: 252 -RCLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-46
Identities = 56/252 (22%), Positives = 103/252 (40%), Gaps = 21/252 (8%)
Query: 459 DGQEVEVAVKQLEKVTGDGEKS-FLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
+ + VA+K + T D + FL+E + + H ++V+L+G E N ++ EL
Sbjct: 32 ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCT 90
Query: 518 NGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYIT 576
G L +FL ++ + A ++ L YL + +H DI +NVL+ +N
Sbjct: 91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCV 147
Query: 577 IDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
K+ DFGL++ ++ ++ + + +MAPE + T+ DV+ FGV +
Sbjct: 148 -------KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 200
Query: 637 EIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTL 696
EI+ + + G I L + + C P+
Sbjct: 201 EILMHGVKPFQGVKNNDVI--GRIENGERLPMPPNCP------PTLYSLMTKCWAYDPSR 252
Query: 697 RPSMKQVLQMLE 708
RP ++ L
Sbjct: 253 RPRFTELKAQLS 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 9e-46
Identities = 56/273 (20%), Positives = 113/273 (41%), Gaps = 36/273 (13%)
Query: 447 SYQELREATNVFDGQEV--EVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
++ + + + +G++V VA+K+L + T K L E V+ + ++ +LLG C
Sbjct: 21 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 80
Query: 504 IEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ QL+ + L ++ + + IA+G+ YL + +++H D+
Sbjct: 81 LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDL 137
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPV 622
+NVL+ KI DFGLAKLL ++ + + + +MA E + +
Sbjct: 138 AARNVLVKTPQHV-------KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 623 TAKVDVYSFGVMLLEIIFCKRH-------TELHRVDEPTLANGMILTDWVLYCVRTGNLG 675
T + DV+S+GV + E++ +E+ + L G L +
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----LEKGERLPQPPICT------- 239
Query: 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ M+ + C RP ++++
Sbjct: 240 ----IDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 61/256 (23%), Positives = 117/256 (45%), Gaps = 28/256 (10%)
Query: 461 QEVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519
+EV VA+K L+ T FL E ++G+ H N+++L G + +++ E M+NG
Sbjct: 35 KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 94
Query: 520 TLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITID 578
L FL ++ + + V + GIA G+ YL +H D+ +N+L+++N +
Sbjct: 95 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVC-- 149
Query: 579 NNYITKIADFGLAKLLKKDQTRTSTM--IRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLL 636
K++DFGL+++L+ D T T + + + APE + T+ DV+SFG+++
Sbjct: 150 -----KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 204
Query: 637 EIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE---RITMVGLWCICPQ 693
E++ + V+ + G T + I + + C +
Sbjct: 205 EVMTYGERPYWELSNH-----------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQE 253
Query: 694 PTLRPSMKQVLQMLEG 709
RP ++ +L+
Sbjct: 254 RARRPKFADIVSILDK 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (411), Expect = 5e-45
Identities = 54/260 (20%), Positives = 101/260 (38%), Gaps = 19/260 (7%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
++ + T G A K + +++ +E+Q + H LV L +
Sbjct: 38 AFGVVHRVTERATGNNF--AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
N +++YE M G L + + + D+ VE + +GL ++HE +H D+KP
Sbjct: 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKP 152
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
+N++ + K+ DFGL L Q+ T GT + APE PV
Sbjct: 153 ENIMFTT-----KRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYY 205
Query: 626 VDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMV 685
D++S GV+ ++ + ++ + DW + + + I
Sbjct: 206 TDMWSVGVLSYILLS--GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR-- 261
Query: 686 GLWCICPQPTLRPSMKQVLQ 705
+ P R ++ Q L+
Sbjct: 262 --KLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (399), Expect = 3e-43
Identities = 55/287 (19%), Positives = 104/287 (36%), Gaps = 30/287 (10%)
Query: 431 QPSPKPKPPEINMKVFSYQELRE-----------ATNVFDGQEVEVAVKQLEKVTGDGEK 479
+ P+P + Y L E G+ K + +
Sbjct: 14 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF--VAKFINTPYPLDKY 71
Query: 480 SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP-TWDKRVE 538
+ E+ ++ + HH L+ L ++ +L+ E + G L + ++ + + +
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131
Query: 539 IALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598
GL ++HE I+H DIKP+N++ + KI DFGLA L D+
Sbjct: 132 YMRQACEGLKHMHEH---SIVHLDIKPENIMCETK-----KASSVKIIDFGLATKLNPDE 183
Query: 599 TRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANG 658
+ T + APE + PV D+++ GV+ ++ D TL N
Sbjct: 184 IV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL-SGLSPFAGEDDLETLQN- 239
Query: 659 MILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705
+ DW ++ + I + +P R ++ L+
Sbjct: 240 VKRCDWEFDEDAFSSVSPEAKDFIK----NLLQKEPRKRLTVHDALE 282
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 43/281 (15%)
Query: 450 ELREATNVFDGQEVEVAVKQLEK-VTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQN 507
E + +VAVK L+ T + E++++ HKN++ LLG C +
Sbjct: 33 EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92
Query: 508 HQLLVYELMKNGTLSAFLFRQEIP----------------TWDKRVEIALGIARGLLYLH 551
++ E G L +L + P + V A +ARG+ YL
Sbjct: 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152
Query: 552 EECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTM-IRGTMG 610
+ + IH D+ +NVL+ + + KIADFGLA+ + T R +
Sbjct: 153 SK---KCIHRDLAARNVLVTEDNVM-------KIADFGLARDIHHIDYYKKTTNGRLPVK 202
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670
+MAPE L + T + DV+SFGV+L EI P + + + ++
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--------PYPGVPV---EELFKLLK 251
Query: 671 TGN---LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708
G+ + + M+ C P+ RP+ KQ+++ L+
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 4e-42
Identities = 59/260 (22%), Positives = 112/260 (43%), Gaps = 18/260 (6%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDG-EKSFLREVQVIGRTHHKNLVQLLGFCIE 505
++ E+ A + + V A+K + K +G E S E+ V+ + H N+V L
Sbjct: 21 AFSEVILAEDKRTQKLV--AIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
H L+ +L+ G L + + T + + + YLH+ I+H D+KP
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKP 135
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
+N+L + +D + I+DFGL+K+ ++ GT GY+APE L P +
Sbjct: 136 ENLLYYS----LDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQKPYSKA 189
Query: 626 VDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMV 685
VD +S GV+ ++ + ++ L ++ ++ ++ + + I
Sbjct: 190 VDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR-- 245
Query: 686 GLWCICPQPTLRPSMKQVLQ 705
+ P R + +Q LQ
Sbjct: 246 --HLMEKDPEKRFTCEQALQ 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 30/268 (11%)
Query: 459 DGQEVEVAVKQLEKVTGDGEK-SFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517
D E VA+K + + E+ FL E V+ + ++V+LLG + L++ ELM
Sbjct: 47 DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMT 106
Query: 518 NGTLSAFLFRQE----------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQN 567
G L ++L P+ K +++A IA G+ YL+ + +H D+ +N
Sbjct: 107 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARN 163
Query: 568 VLLDNNYITIDNNYITKIADFGLAKLL-KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKV 626
+ + ++ KI DFG+ + + + D R + +M+PE L++ T
Sbjct: 164 CM-------VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 216
Query: 627 DVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVG 686
DV+SFGV+L EI +E L ++ +L + + +
Sbjct: 217 DVWSFGVVLWEIATLAEQPYQGLSNEQVLR--FVMEGGLLDKPDNCP------DMLFELM 268
Query: 687 LWCICPQPTLRPSMKQVLQMLEGTSEVG 714
C P +RPS +++ ++ E G
Sbjct: 269 RMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-41
Identities = 40/260 (15%), Positives = 90/260 (34%), Gaps = 20/260 (7%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+ + + K + KV G + +E+ ++ H+N++ L
Sbjct: 17 EFGIVHRCVETSSKKTY--MAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFESM 73
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
++++E + + + + V + L +LH I H DI+P
Sbjct: 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRP 130
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAK 625
+N++ + KI +FG A+ LK Y APE ++ V+
Sbjct: 131 ENIIYQT-----RRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTA 183
Query: 626 VDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMV 685
D++S G ++ ++ + L ++ + N I+ + + +
Sbjct: 184 TDMWSLGTLVYVLL-SGINPFLAETNQQIIEN--IMNAEYTFDEEAFKEISIEAMDFVD- 239
Query: 686 GLWCICPQPTLRPSMKQVLQ 705
+ + R + + LQ
Sbjct: 240 --RLLVKERKSRMTASEALQ 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 64/268 (23%), Positives = 114/268 (42%), Gaps = 43/268 (16%)
Query: 464 EVAVKQLEKVTGDGE-KSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQL-LVYELMKNGT 520
VAVK L++ E ++ + E++++ HH N+V LLG C + L ++ E K G
Sbjct: 45 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104
Query: 521 LSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
LS +L + + T + + + +A+G+ +L + IH D+
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVT 623
+N+LL + KI DFGLA+ + KD R + +MAPE + + T
Sbjct: 162 ARNILLSEKNVV-------KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 624 AKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN---LGATKFE 680
+ DV+SFGV+L EI G+ + + ++ G
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPY----------PGVKIDEEFCRRLKEGTRMRAPDYTTP 264
Query: 681 RITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ L C +P+ RP+ ++++ L
Sbjct: 265 EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 54/266 (20%), Positives = 96/266 (36%), Gaps = 26/266 (9%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
S+ + A + +E A+K LEK + + RE V+ R H V+L
Sbjct: 20 SFSTVVLARELATSREY--AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 77
Query: 504 IEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ KNG L ++ + I L YLH + IIH D+
Sbjct: 78 QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDL 134
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPV 622
KP+N+LL + + +I DFG AK+L + + + GT Y++PE L
Sbjct: 135 KPENILL-------NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 623 TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682
D+++ G ++ +++ R L I+ + F +
Sbjct: 188 CKSSDLWALGCIIYQLVAGLP---PFRAGNEYLIFQKIIKL-------EYDFPEKFFPKA 237
Query: 683 TMVGLWCICPQPTLRPSMKQVLQMLE 708
+ + T R +++
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 59/265 (22%), Positives = 103/265 (38%), Gaps = 22/265 (8%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE------KSFLREVQVIGRTHHKNLVQLL 500
+ +++ G + A K ++K + REV ++ H N++ L
Sbjct: 22 QFAVVKKCREKSTGLQY--AAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 501 GFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIH 560
+ +L+ EL+ G L FL +E T ++ E I G+ YLH I H
Sbjct: 80 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAH 136
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA 620
D+KP+N++L + KI DFGLA + D I GT ++APE +
Sbjct: 137 FDLKPENIMLLDRN---VPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 621 PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680
P+ + D++S GV+ ++ E + ++ + A F
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 681 RITMVGLWCICPQPTLRPSMKQVLQ 705
R + P R +++ LQ
Sbjct: 252 R------RLLVKDPKKRMTIQDSLQ 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (352), Expect = 1e-37
Identities = 56/275 (20%), Positives = 111/275 (40%), Gaps = 36/275 (13%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDG---------EKSFLREVQVIGRTH-HKNL 496
+R + +E AVK ++ G ++ L+EV ++ + H N+
Sbjct: 15 VSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 497 VQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECET 556
+QL LV++LMK G L +L + + + +I + + LH+
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN-- 130
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEW 616
I+H D+KP+N+LL D++ K+ DFG + L + + GT Y+APE
Sbjct: 131 -IVHRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAPEI 180
Query: 617 LRNAPV------TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR 670
+ + +VD++S GV++ ++ + L MI++ +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 671 TGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQ 705
+ + + + + QP R + ++ L
Sbjct: 238 EWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 1e-37
Identities = 55/270 (20%), Positives = 98/270 (36%), Gaps = 24/270 (8%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE---KSFLREVQVIGRTHHKNLVQLLGFC 503
E+ A ++ ++V AVK L F RE Q +H +V +
Sbjct: 19 GMSEVHLARDLRLHRDV--AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76
Query: 504 IEQNHQL----LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQII 559
+ +V E + TL + + T + +E+ + L + H+ II
Sbjct: 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---II 133
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN 619
H D+KP N+++ + T+T+ +I GT Y++PE R
Sbjct: 134 HRDVKPANIMISATN----AVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQARG 188
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679
V A+ DVYS G +L E++ + ++A + D + R L
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSARHEGLS---- 242
Query: 680 ERITMVGLWCICPQPTLRP-SMKQVLQMLE 708
+ V L + P R + ++ L
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 52/268 (19%), Positives = 102/268 (38%), Gaps = 29/268 (10%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFC-- 503
++ + N ++ A+K L+ REV++ R + ++V+++
Sbjct: 24 INGKVLQIFNKRTQEKF--ALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 504 --IEQNHQLLVYELMKNGTLSAFLFRQEIP--TWDKRVEIALGIARGLLYLHEECETQII 559
+ L+V E + G L + + + T + EI I + YLH I
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIA 133
Query: 560 HCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRN 619
H D+KP+N+L + N I K+ DFG AK + T+ T Y+APE L
Sbjct: 134 HRDVKPENLLYTSK----RPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187
Query: 620 APVTAKVDVYSFGVMLLEIIFCKR--HTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677
D++S GV++ ++ ++ P + + + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 678 KFERITMVGLWCICPQPTLRPSMKQVLQ 705
I + +PT R ++ + +
Sbjct: 248 VKMLIR----NLLKTEPTQRMTITEFMN 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (342), Expect = 3e-36
Identities = 45/269 (16%), Positives = 92/269 (34%), Gaps = 20/269 (7%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI-E 505
S+ ++ T++ G+EV A+K E ++ + + +C E
Sbjct: 19 SFGDIYLGTDIAAGEEV--AIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
++ ++V EL+ F F + + +A + + Y+H + IH D+KP
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKP 131
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT------STMIRGTMGYMAPEWLRN 619
N L+ + I DFGLAK + +T + + GT Y +
Sbjct: 132 DNFLMGLG----KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679
+ + D+ S G +L+ + + I + + G
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 680 ERITMVGLWCICPQPTLRPSMKQVLQMLE 708
+ +C + +P + Q+
Sbjct: 248 FATYL--NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 57/264 (21%), Positives = 99/264 (37%), Gaps = 31/264 (11%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRT-HHKNLVQLLGF 502
S+ ++ A Q A+K L+K + D + + E +V+ H L +
Sbjct: 14 SFGKVFLAEFKKTNQFF--AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 71
Query: 503 CIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
+ + V E + G L + + A I GL +L I++ D
Sbjct: 72 FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL---HSKGIVYRD 128
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPV 622
+K N+L +D + KIADFG+ K +T+T GT Y+APE L
Sbjct: 129 LKLDNIL-------LDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKY 180
Query: 623 TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682
VD +SFGV+L E++ + +E + + +R N ++
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------------LFHSIRMDNPFYPRWLEK 228
Query: 683 TMVGL--WCICPQPTLRPSMKQVL 704
L +P R ++ +
Sbjct: 229 EAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 5e-35
Identities = 41/270 (15%), Positives = 85/270 (31%), Gaps = 20/270 (7%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE 505
S+ + E TN+ + Q+V A+K + + E + + + F E
Sbjct: 17 SFGVIFEGTNLLNNQQV--AIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72
Query: 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKP 565
H +LV +L+ + A + + +HE+ +++ DIKP
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKP 129
Query: 566 QNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT------STMIRGTMGYMAPEWLRN 619
N L+ N + DFG+ K + T+ + GT YM+
Sbjct: 130 DNFLIGRPNSKNANM--IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATK- 678
+ + D+ + G + + + + + I +R G +
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 247
Query: 679 FERITMVGLWCICPQPTLRPSMKQVLQMLE 708
F + + P + +
Sbjct: 248 FYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-35
Identities = 66/284 (23%), Positives = 108/284 (38%), Gaps = 37/284 (13%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDG-----EKSFLREVQVIGRTHHKNLVQLLG 501
+ + +A + Q V A+K+++ ++ LRE++++ H N++ LL
Sbjct: 10 QFATVYKARDKNTNQIV--AIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67
Query: 502 FCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHC 561
+++ LV++ M+ + T L +GL YLH+ I+H
Sbjct: 68 AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHR 124
Query: 562 DIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNA- 620
D+KP N+LL D N + K+ADFGLAK T T Y APE L A
Sbjct: 125 DLKPNNLLL-------DENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGAR 176
Query: 621 PVTAKVDVYSFGVMLLEII--------------FCKRHTELHRVDEPTLANGMILTDWVL 666
VD+++ G +L E++ + L E + L D+V
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 667 YCVRTGNLGATKFERITMVGL----WCICPQPTLRPSMKQVLQM 706
+ G F L P R + Q L+M
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 8e-35
Identities = 49/269 (18%), Positives = 94/269 (34%), Gaps = 40/269 (14%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE------KSFLREVQVIGR--THHKNLVQ 498
+ + V D V A+K +EK EV ++ + + +++
Sbjct: 16 GFGSVYSGIRVSDNLPV--AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 499 LLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQ 557
LL + + +L+ E + + + + + +
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---HNCG 130
Query: 558 IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL 617
++H DIK +N+L+D N + K+ DFG LLK T GT Y PEW+
Sbjct: 131 VLHRDIKDENILIDLNRGEL------KLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 618 RNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676
R V+S G++L +++ E DE + + V
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRV----------- 227
Query: 677 TKFERITMVGLWCICPQPTLRPSMKQVLQ 705
+ WC+ +P+ RP+ +++
Sbjct: 228 --SSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 133 bits (336), Expect = 1e-34
Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 22/205 (10%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVI---GRTHHKNLVQLL 500
+ E+ G+ A+K L+K GE L E ++ +V +
Sbjct: 16 GFGEVYGCRKADTGKMY--AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73
Query: 501 GFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIH 560
+ + +LM G L L + + + A I GL ++H +++
Sbjct: 74 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVY 130
Query: 561 CDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWL-RN 619
D+KP N+LL D + +I+D GLA K + GT GYMAPE L +
Sbjct: 131 RDLKPANILL-------DEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180
Query: 620 APVTAKVDVYSFGVMLLEIIFCKRH 644
+ D +S G ML +++
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 43/288 (14%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDG--EKSFLREVQV---IGRTHHKNLVQLLG 501
+Y ++ +A ++ +G VA+K++ TG+ S +REV V + H N+V+L
Sbjct: 19 AYGKVFKARDLKNGGRF-VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77
Query: 502 FCI-----EQNHQLLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECE 555
C + LV+E + + E + ++ + RGL +LH
Sbjct: 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR- 136
Query: 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE 615
++H D+KPQN+L + ++ K+ADFGLA++ TS + T+ Y APE
Sbjct: 137 --VVHRDLKPQNIL-------VTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPE 185
Query: 616 WLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM--ILTDWVLYCVRTGN 673
L + VD++S G + E +F ++ D L + I R
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAE-MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 674 LGATKFERITMVGL----------------WCICPQPTLRPSMKQVLQ 705
L F + + C+ P R S L
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (322), Expect = 3e-33
Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
S+ + + +G+ A+K L+K V + E ++ H ++++ G
Sbjct: 16 SFGRVHLIRSRHNGRYY--AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 73
Query: 504 IEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ ++ + ++ G L + L + + A + L YLH + II+ D+
Sbjct: 74 QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDL 130
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
KP+N+LL D N KI DFG AK + + GT Y+APE + P
Sbjct: 131 KPENILL-------DKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTKPYN 179
Query: 624 AKVDVYSFGVMLLEIIFCKRH 644
+D +SFG+++ E++
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 59/314 (18%), Positives = 111/314 (35%), Gaps = 61/314 (19%)
Query: 432 PSPKPKPPEINMKVFSYQELR-----------EATNVFDGQEVEVAVKQLEKVTGDGEKS 480
P P P+ SY + + +A G+ V A+K++ + ++
Sbjct: 10 PGQGPDRPQE----VSYTDTKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQ----DKRF 59
Query: 481 FLREVQVIGRTHHKNLVQLLGFCIEQN------HQLLVYELMKNGTLSAFLF---RQEIP 531
RE+Q++ + H N+V+L F + LV + + ++
Sbjct: 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 532 TWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLA 591
+ R L Y+H I H DIKPQN+LLD + + K+ DFG A
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLD------PDTAVLKLCDFGSA 170
Query: 592 KLLKKDQTRTSTMIRGTMGYMAP-EWLRNAPVTAKVDVYSFGVMLLEIIFCKR----HTE 646
K L + + S + Y AP T+ +DV+S G +L E++ + +
Sbjct: 171 KQLVRGEPNVSYICS--RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228
Query: 647 LHRVDEPTLANGMILTDWVLYC------VRTGNLGATKFERITMVGL---------WCIC 691
+ ++ E G + + + + A + ++ +
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288
Query: 692 PQPTLRPSMKQVLQ 705
PT R + +
Sbjct: 289 YTPTARLTPLEACA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 40/287 (13%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE-KSFLREVQVIGRTHHKNLVQLLGFCIE 505
+Y + A + + V A+K++ + LRE++++ R H+N++ +
Sbjct: 20 AYGMVCSAYDNVNKVRV--AIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77
Query: 506 QNHQLLVYELMKN---GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
+ + + G L + + + D I RGL Y+H ++H D
Sbjct: 78 PTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRD 134
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR--TSTMIRGTMGYMAPEWLRN- 619
+KP N+LL + KI DFGLA++ D T T Y APE + N
Sbjct: 135 LKPSNLLL-------NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 620 APVTAKVDVYSFGVMLLEIIFCK-------------RHTELHRVDEPTLANGMILTDWVL 666
T +D++S G +L E++ + + N +I
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 667 YCVRTGNLGATKFERIT------MVGL--WCICPQPTLRPSMKQVLQ 705
Y + + + R+ + L + P R ++Q L
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (312), Expect = 3e-32
Identities = 48/263 (18%), Positives = 89/263 (33%), Gaps = 31/263 (11%)
Query: 464 EVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521
A+K++ EK + +RE+ ++ H N+V+L + +LV+E +
Sbjct: 28 TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87
Query: 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581
+ L + G+ Y H+ ++H D+KPQN+L I+
Sbjct: 88 KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLL-------INREG 137
Query: 582 ITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFC 641
KIADFGLA+ + + I + + + +D++S G + E++
Sbjct: 138 ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
Query: 642 KR--------------HTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERITMVGL 687
L + N L + L F +
Sbjct: 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESG 257
Query: 688 -----WCICPQPTLRPSMKQVLQ 705
+ P R + KQ L+
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALE 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 55/281 (19%), Positives = 95/281 (33%), Gaps = 34/281 (12%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGD--GEKSFLREVQVIGRTHHKNLVQLLGFCI 504
+Y + +A N + V A+K++ D S LRE+ ++ HKN+V+L
Sbjct: 14 TYGTVFKAKNRETHEIV--ALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH 71
Query: 505 EQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIK 564
LV+E F + + +GL + H ++H D+K
Sbjct: 72 SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLK 128
Query: 565 PQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTA 624
PQN+L I+ N K+A+FGLA+ S + +
Sbjct: 129 PQNLL-------INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 625 KVDVYSFGVMLLEIIFCKR---------------HTELHRVDEPTLANGMILTDWVLYCV 669
+D++S G + E+ R L E + L D+ Y +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 670 RTGNLGATK-FERITMVGL----WCICPQPTLRPSMKQVLQ 705
++ G + P R S ++ LQ
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 59/282 (20%), Positives = 104/282 (36%), Gaps = 36/282 (12%)
Query: 447 SYQELREATNVFDGQEVEVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
+Y + +A N G+ V A+K++ + T + +RE+ ++ +H N+V+LL
Sbjct: 14 TYGVVYKARNKLTGEVV--ALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 505 EQNHQLLVYELMKNGTLSAFLFRQEIP-TWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+N LV+E + + +GL + H ++H D+
Sbjct: 72 TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDL 128
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAP-V 622
KPQN+L I+ K+ADFGLA+ + + T+ Y APE L
Sbjct: 129 KPQNLL-------INTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGCKYY 180
Query: 623 TAKVDVYSFGVMLLEIIFCKR--------------HTELHRVDEPTLANGMILTDWVLYC 668
+ VD++S G + E++ + L DE + D+
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 669 VRTGNLGATK-FERITMVGL----WCICPQPTLRPSMKQVLQ 705
+ +K + G + P R S K L
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 47/201 (23%), Positives = 77/201 (38%), Gaps = 16/201 (7%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
++ ++ G+ A+K L K + D + E +V+ T H L L
Sbjct: 17 TFGKVILVREKATGRYY--AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 504 IEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ V E G L L R+ + T ++ I L +++ DI
Sbjct: 75 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA---LEYLHSRDVVYRDI 131
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
K +N++L D + KI DFGL K D GT Y+APE L +
Sbjct: 132 KLENLML-------DKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDNDYG 183
Query: 624 AKVDVYSFGVMLLEIIFCKRH 644
VD + GV++ E++ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-29
Identities = 54/295 (18%), Positives = 104/295 (35%), Gaps = 48/295 (16%)
Query: 447 SYQELREATNVFDGQEVEVAVKQL--EKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
++ E+ +A + GQ+V A+K++ E + LRE++++ H+N+V L+ C
Sbjct: 22 TFGEVFKARHRKTGQKV--ALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79
Query: 505 EQ--------NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECET 556
+ LV++ ++ T + + + G L+
Sbjct: 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG---LYYIHRN 136
Query: 557 QIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL---KKDQTRTSTMIRGTMGYMA 613
+I+H D+K NVL+ + + K+ADFGLA+ K Q T T+ Y
Sbjct: 137 KILHRDMKAANVLI-------TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 614 PEWLRNA-PVTAKVDVYSFGVMLLEIIFCKR----HTELHRVDEPTLANGMILTDWVLYC 668
PE L +D++ G ++ E+ +TE H++ + G I +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 669 VRTGNLGATKFERITMVGLW------------------CICPQPTLRPSMKQVLQ 705
+ + + + P R L
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (282), Expect = 9e-28
Identities = 44/200 (22%), Positives = 80/200 (40%), Gaps = 19/200 (9%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK---VTGDGEKSFLREVQVIGRTHHKNLVQLLGFC 503
S+ + + G A+K L+K V + L E +++ + LV+L
Sbjct: 53 SFGRVMLVKHKESGNHY--AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110
Query: 504 IEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ ++ +V E + G + + L R + A I YLH +I+ D+
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDL 167
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVT 623
KP+N+L+D + DFG A K + + GT +APE + +
Sbjct: 168 KPENLLIDQQGYIQ-------VTDFGFA----KRVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 624 AKVDVYSFGVMLLEIIFCKR 643
VD ++ GV++ E+
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 4e-27
Identities = 61/289 (21%), Positives = 100/289 (34%), Gaps = 48/289 (16%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCI 504
+Y + A + G +V A+K+L + K RE++++ H+N++ LL
Sbjct: 30 AYGAVCSAVDGRTGAKV--AIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87
Query: 505 EQNHQ------LLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558
LV M GT L + E D+ + + +GL Y+H I
Sbjct: 88 PDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---I 142
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
IH D+KP N+ ++ + KI DFGLA+ T T Y APE +
Sbjct: 143 IHRDLKPGNLA-------VNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVIL 191
Query: 619 N-APVTAKVDVYSFGVMLLEIIFCK-------------RHTELHRVDEPTLANGMILTDW 664
N T VD++S G ++ E+I K ++ + +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 665 VLYCVRTGNLGATKFERITMVG--------LWCICPQPTLRPSMKQVLQ 705
Y L F I + R + + L
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 1e-25
Identities = 55/291 (18%), Positives = 108/291 (37%), Gaps = 51/291 (17%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGR-THHKNLVQLLGFCIE 505
Y E+ EA N+ + ++V VK L+ V +K RE++++ N++ L +
Sbjct: 47 KYSEVFEAINITNNEKV--VVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 101
Query: 506 QNHQL--LVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDI 563
+ LV+E + N Q + +D R I + L Y H I+H D+
Sbjct: 102 PVSRTPALVFEHVNNTDFKQLY--QTLTDYDIR-FYMYEILKALDYCHSMG---IMHRDV 155
Query: 564 KPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPE-WLRNAPV 622
KP NV++D+ + ++ D+GLA+ Q + + + PE +
Sbjct: 156 KPHNVMIDH------EHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMY 207
Query: 623 TAKVDVYSFGVMLLEIIFCKR--HTELHRVDEPTLANGMILTDWVLYCVRTGNL------ 674
+D++S G ML +IF K D+ ++ T+ + + N+
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 675 -------GATKFERITMVGLW-------------CICPQPTLRPSMKQVLQ 705
++ER + R + ++ ++
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 452 REATNVFDGQEVEVAVKQLEKVT----GDGEKSFLREVQVIGR-THHKNLVQLLGFCIEQ 506
R+ + G+ A+K L+K T + E QV+ LV L +
Sbjct: 44 RKISGHDTGKLY--AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101
Query: 507 NHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQ 566
L+ + + G L L ++E T E+ + + +L L + II+ DIK +
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLHKLGIIYRDIKLE 158
Query: 567 NVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR--NAPVTA 624
N+LLD+N + + DFGL+K D+T + GT+ YMAP+ +R ++
Sbjct: 159 NILLDSNGHVV-------LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 211
Query: 625 KVDVYSFGVMLLEIIFCKR 643
VD +S GV++ E++
Sbjct: 212 AVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 5e-25
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 25/204 (12%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCI 504
+ + A + + V A+K+L + K RE+ ++ +HKN++ LL
Sbjct: 29 AQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 505 ------EQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558
E LV ELM ++ + + G+ +LH I
Sbjct: 87 PQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAG---I 140
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
IH D+KP N I + ++ KI DFGLA+ + T T Y APE +
Sbjct: 141 IHRDLKPSN-------IVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 619 NAPVTAKVDVYSFGVMLLEIIFCK 642
VD++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.5 bits (236), Expect = 9e-22
Identities = 55/288 (19%), Positives = 105/288 (36%), Gaps = 32/288 (11%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ 506
+ + A ++ + V A+K + ++ E++++ R + + +
Sbjct: 25 HFSTVWLAKDMVNNTHV--AMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANH 81
Query: 507 NHQLLVY----------------ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYL 550
+LL + L +N + +I+ + GL Y+
Sbjct: 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 141
Query: 551 HEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMG 610
H C IIH DIKP+NVL++ + I KIAD G A + T T
Sbjct: 142 HRRC--GIIHTDIKPENVLMEIVDSPENLIQI-KIADLGNACWYDEHYT----NSIQTRE 194
Query: 611 YMAPEWLRNAPVTAKVDVYSFGVMLLEII-----FCKRHTELHRVDEPTLANGM-ILTDW 664
Y +PE L AP D++S ++ E+I F + D+ +A + +L +
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 665 VLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712
Y +R G T F ++ L + + + + ++
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 1e-21
Identities = 58/288 (20%), Positives = 101/288 (35%), Gaps = 46/288 (15%)
Query: 447 SYQELREATNVFDGQEVEVAVKQLEKVTGDGE--KSFLREVQVIGRTHHKNLVQLLGFCI 504
+Y + A + G V AVK+L + K RE++++ H+N++ LL
Sbjct: 30 AYGSVCAAFDTKTGLRV--AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87
Query: 505 ------EQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQI 558
E N LV LM G + + + T D + I RGL Y+H I
Sbjct: 88 PARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---I 142
Query: 559 IHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLR 618
IH D+KP N+ ++ + KI DFGLA+ + T + L
Sbjct: 143 IHRDLKPSNLA-------VNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIMLN 192
Query: 619 NAPVTAKVDVYSFGVMLLEIIFCKR----HTELHRVDEPTLANGM----ILTDWVLYCVR 670
VD++S G ++ E++ + + ++ G +L R
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 671 TGNLGATKFERITMVGLW-------------CICPQPTLRPSMKQVLQ 705
T+ ++ ++ + R + Q L
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.9 bits (178), Expect = 2e-15
Identities = 30/204 (14%), Positives = 55/204 (26%), Gaps = 54/204 (26%)
Query: 457 VFDGQEVEVAVKQLEKVTGD----------GEKSFLREVQVIGRTHHKNLVQLLGFCI-- 504
+ + E VK + G+ F R + L +L G +
Sbjct: 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78
Query: 505 --EQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCD 562
++ EL+ + E+ I + + I+H D
Sbjct: 79 VYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGD 128
Query: 563 IKPQNVLLDNNYITIDNNYITKIADFGLAK---------LLKKDQTRTSTMIRGTMGYMA 613
+ NVL+ I I DF + +L++D T T
Sbjct: 129 LSQYNVLVSEEGI--------WIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRT-- 178
Query: 614 PEWLRNAPVTAKVDVYSFGVMLLE 637
+ D+ S +L+
Sbjct: 179 -----------EKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.0 bits (166), Expect = 2e-14
Identities = 18/114 (15%), Positives = 33/114 (28%), Gaps = 14/114 (12%)
Query: 65 IWFDKISERTLVWSANRDDPAQVGS-SINLTVTGQLVLTHSNGT--QFKIYNGTLTVSAL 121
I + + + Q+ +++ LVL + A+
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 122 MQDSGNFLYSNANGSV------DYSTGRFVLEIQMDGNVVLSAFRFADPAYWYT 169
+Q +G S GR+V +Q D N+ + A W T
Sbjct: 72 LQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIY-----GGALWTT 120
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.0 bits (158), Expect = 2e-13
Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 13/115 (11%)
Query: 65 IWFDKISERTLVWSANRDDPAQVGSS-INLTVTGQLVLTHSNGTQFKI-YNGTLTVSALM 122
I F E + + + ++ S + LVL S+ + G A++
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 123 QDSGNFLYSNANGSV------DYSTGRFVLEIQMDGNVVLSAFRFADPAYWYTST 171
Q G + A ++ S G +VL +Q D V + P W + T
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIY-----GPGLWDSGT 112
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 50.3 bits (120), Expect = 3e-08
Identities = 16/93 (17%), Positives = 27/93 (29%), Gaps = 12/93 (12%)
Query: 45 TSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHS 104
+ F LV VW++N + G L G V+ +
Sbjct: 17 DVEPYHFIMQ---EDCNLVLYDHSTS-----VWASNTGILGKKGCKAVLQSDGNFVVYDA 68
Query: 105 NGT---QFKIYNGTLTVSALMQDSGNF-LYSNA 133
G G ++Q+ GN +Y +
Sbjct: 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD 101
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.9 bits (116), Expect = 1e-07
Identities = 13/111 (11%), Positives = 36/111 (32%), Gaps = 6/111 (5%)
Query: 113 NGTLTVSALMQDSGNFLYSNANGSVDYSTGRFVLEIQMDGNVVLSAFRFADPAYWYTSTR 172
N + + L++ + + + T + +Q D N+VL + +P + +
Sbjct: 1 NNIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVL--YDNNNPIWATNTGG 58
Query: 173 GDQNVSLIFNQSTSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNF 223
+ + + N+ + Q P + ++ + N
Sbjct: 59 LGNGCRAVLQPDGVLVVITNENVTVW----QSPVAGKAGHYVLVLQPDRNV 105
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.8 bits (95), Expect = 7e-05
Identities = 18/83 (21%), Positives = 28/83 (33%), Gaps = 13/83 (15%)
Query: 97 GQLVLTHSNGTQF--KIYNGTLTVSALMQDSGNFLYSNANGSVDYSTG------RFVLEI 148
LVL +N + A++Q G + + + +VL +
Sbjct: 40 CNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVL 99
Query: 149 QMDGNVVLSAFRFADPAYWYTST 171
Q D NVV+ A W T T
Sbjct: 100 QPDRNVVIY-----GDALWATQT 117
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 37.7 bits (87), Expect = 7e-04
Identities = 20/83 (24%), Positives = 31/83 (37%), Gaps = 13/83 (15%)
Query: 97 GQLVLTHSNGTQFKIYNGTLTVSAL--MQDSGNFLYSNANGSVDYSTG------RFVLEI 148
LVL + + G L+ S MQ GN + N + +++ +V +
Sbjct: 29 CNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCIL 88
Query: 149 QMDGNVVLSAFRFADPAYWYTST 171
Q D NVV+ W T T
Sbjct: 89 QKDRNVVIY-----GTDRWATGT 106
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 36.1 bits (83), Expect = 0.002
Identities = 24/99 (24%), Positives = 34/99 (34%), Gaps = 8/99 (8%)
Query: 127 NFLYSNANGSVD--YSTGRFVLEIQMDGNVVLSAFRFADPAYWYTSTRGDQNVSLIFNQS 184
N LYS S + G FV +Q D N+VL D W T+T G + Q+
Sbjct: 2 NILYSGETLSTGEFLNYGSFVFIMQEDCNLVL---YDVDKPIWATNTGGLSRSCFLSMQT 58
Query: 185 TSFLYVRNKTTIRYPMTTQVPTPTEDYYHRATISDHGNF 223
L V N T ++ + + N
Sbjct: 59 DGNLVVYNP---SNKPIWASNTGGQNGNYVCILQKDRNV 94
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 35.9 bits (82), Expect = 0.003
Identities = 15/120 (12%), Positives = 39/120 (32%), Gaps = 15/120 (12%)
Query: 25 TNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDP 84
++ + G + G + G + F + LV ++ VW++ +
Sbjct: 1 SDRLNSGHQLDTGGSLA----EGGYLFIIQNDCN---LVLYDNNRA-----VWASGTNGK 48
Query: 85 AQVGSSINLTVTGQLVLTHSNGT--QFKIYNGTLTVSALMQDSGNFLYSNANGSVDYSTG 142
G + + G LV+ + ++Q N + + + + ++T
Sbjct: 49 -ASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATH 107
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 725 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.62 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.6 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.52 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.5 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.48 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.33 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.14 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.82 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.45 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.37 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.35 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.32 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.19 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.66 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.86 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.02 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 91.83 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 91.26 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 87.34 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 85.78 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.43 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 85.37 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.23 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.63 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.35 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 82.28 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.77 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.95 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=371.60 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=190.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|... ++..||||.+... ....++|.+|++++++++|||||+++|+|..++..++||||+++|+|.+
T Consensus 14 G~G~fg~Vy~~~~~---~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 14 GSGQFGLVHLGYWL---NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp ECCSSCCEEEEEET---TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred eeCCCeEEEEEEEC---CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 35567778877643 3457999999753 4556889999999999999999999999999999999999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++... ..+++..+..++.|+|+||.|||+. +|+||||||+|||++. ++.+||+|||+++..........
T Consensus 90 ~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~-------~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGE-------NQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp HHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECG-------GGCEEECSCC-------------
T ss_pred HhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecC-------CCCeEecccchheeccCCCceee
Confidence 98765 6689999999999999999999999 9999999999999987 88999999999987765544444
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHHHH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFERI 682 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 682 (725)
....||..|+|||.+.+..++.|+||||||+++|||+|++.|+...... ......+.. ......+...++++
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~-~~~~~~p~~~~~~l 231 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDIST-GFRLYKPRLASTHV 231 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-------HHHHHHHHH-TCCCCCCTTSCHHH
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHh-cCCCCCccccCHHH
Confidence 4456899999999999999999999999999999999976655432211 111111111 11123445567889
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 683 TMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 683 ~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.+|+.+||+.||++||||+||+++|+++.
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-44 Score=374.33 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=192.9
Q ss_pred ccccHHHHHHHhcccCC-cceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDG-QEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~-~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|++|++|....++ ....||||.+... .....+.|.+|+++|++++|||||+++|+|.+++..++||||+++|+|
T Consensus 35 G~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L 114 (299)
T d1jpaa_ 35 GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 114 (299)
T ss_dssp EECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEH
T ss_pred eeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcc
Confidence 45678888888776654 3567999998653 334456899999999999999999999999999999999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++... ..+++..+..++.|||+||.|||+. +|+||||||+||||+. ++.+||+|||+++........
T Consensus 115 ~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~-------~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 115 DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNS-------NLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp HHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TCCEEECCC------------
T ss_pred eeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECC-------CCcEEECCcccceEccCCCCc
Confidence 9988775 5789999999999999999999999 9999999999999987 889999999999876543322
Q ss_pred c----ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHH--cCC
Q 039817 601 T----STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVR--TGN 673 (725)
Q Consensus 601 ~----~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 673 (725)
. .....||+.|+|||.+.++.++.++|||||||++|||+| |+.|+..... .+....... ...
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----------~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----------QDVINAIEQDYRLP 253 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTTCCCC
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCC
Confidence 1 112457899999999999999999999999999999998 7888764321 111111111 123
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+...++.+.+|+.+||+.||++||||+||+++|+.+++
T Consensus 254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 445667889999999999999999999999999987653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-44 Score=368.06 Aligned_cols=245 Identities=27% Similarity=0.320 Sum_probs=205.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|++..+ +..||||.++.. ....++|.+|+++|++++|||||+++|+|.+++..++||||+++|+|.+
T Consensus 26 G~G~fg~Vy~a~~~~~--~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~ 102 (287)
T d1opja_ 26 GGGQYGEVYEGVWKKY--SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 102 (287)
T ss_dssp TTTTTSSEEEEEEGGG--TEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred eeCCCeEEEEEEECCC--CeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHH
Confidence 4467788888876543 468999998754 4456789999999999999999999999999999999999999999999
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
++.+. ..+++..+..|+.|+++||.|||++ +|+||||||+||||+. ++.+||+|||+++.........
T Consensus 103 ~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~-------~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 103 YLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGE-------NHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp HHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GGCEEECCCCCTTTCCSSSSEE
T ss_pred HhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECC-------CCcEEEccccceeecCCCCcee
Confidence 99654 6789999999999999999999999 9999999999999987 7899999999999876655544
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCChhH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGATK 678 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 678 (725)
.....|+..|+|||++.+..++.|+||||||+++|||++|+.|+...... . .+...... ...+...
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----------~-~~~~~i~~~~~~~~~~~~ 241 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------S-QVYELLEKDYRMERPEGC 241 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------H-HHHHHHHTTCCCCCCTTC
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----------H-HHHHHHhcCCCCCCCccc
Confidence 44556899999999999999999999999999999999988776532211 1 11222222 2344567
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
++.+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 7899999999999999999999999999988753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=367.78 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=200.6
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+...+|++|++|+....+....||||.++.. +....++|.+|+++|++++|||||+++|+|.. +..+|||||+++|+
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~ 93 (277)
T d1xbba_ 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGP 93 (277)
T ss_dssp EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCc
Confidence 4467788888887665666788999998643 23345689999999999999999999999965 46789999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.||++||.|||+. +|+||||||+||||+. ++.+||+|||+++........
T Consensus 94 L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~-------~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 94 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVT-------QHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE-------TTEEEECCCTTCEECCTTCSE
T ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccc-------cCcccccchhhhhhccccccc
Confidence 999999888999999999999999999999999 9999999999999987 889999999999876544332
Q ss_pred c--ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---CCC
Q 039817 601 T--STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNL 674 (725)
Q Consensus 601 ~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 674 (725)
. .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+ +...... ...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----------~~-~~~~i~~~~~~~~ 231 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------SE-VTAMLEKGERMGC 231 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HH-HHHHHHTTCCCCC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----------HH-HHHHHHcCCCCCC
Confidence 2 223568999999999999999999999999999999998 8888864321 11 1222222 234
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
+...++.+.+|+.+||+.||++|||+++|+++|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 55667899999999999999999999999998865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=366.71 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=201.6
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
+...+|++|++|+..-.+++..||||.++... ....++|.+|+++|++++|||||+++|+|.. +..+|||||+++|+|
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL 95 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence 45678889999887666777899999987543 3345789999999999999999999999865 468999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||||+. ++.+||+|||+++........
T Consensus 96 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~-------~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 96 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVN-------RHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEE-------TTEEEECCCTTCEECTTCSCE
T ss_pred HHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeecc-------CCceeeccchhhhcccccccc
Confidence 9998654 6799999999999999999999999 9999999999999987 889999999999977544332
Q ss_pred c--ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 601 T--STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 601 ~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
. .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+...+.. ......+..
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~-~~~~~~p~~ 236 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQ-GKRMECPPE 236 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHT-TCCCCCCTT
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHc-CCCCCCCCc
Confidence 2 223458899999999999999999999999999999998 89888643211 11111111 011244566
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.++.+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 778999999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=363.61 Aligned_cols=241 Identities=26% Similarity=0.379 Sum_probs=198.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|... .+..||||.++.. ....++|.+|++++++++|||||+++|++.+ +..++||||+++|+|.+
T Consensus 22 G~G~fg~Vy~~~~~---~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~ 96 (272)
T d1qpca_ 22 GAGQFGEVWMGYYN---GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD 96 (272)
T ss_dssp EEETTEEEEEEEET---TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHH
T ss_pred ecCCCcEEEEEEEC---CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHH
Confidence 45678888888743 3467999999754 3456789999999999999999999998854 56789999999999999
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
++... ..+++..+.+|+.||++||.|||+. +|+||||||+||||+. ++.+||+|||+++.........
T Consensus 97 ~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~-------~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSD-------TLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp HTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TSCEEECCCTTCEECSSSCEEC
T ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeec-------ccceeeccccceEEccCCcccc
Confidence 88655 3689999999999999999999999 9999999999999987 8899999999999876554444
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCCChhH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNLGATK 678 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 678 (725)
.....||..|+|||.+.++.++.++||||||+++|||+||+.|+...... .+ +...... ...+...
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----------~~-~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------PE-VIQNLERGYRMVRPDNC 235 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------HH-HHHHHHTTCCCCCCTTC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----------HH-HHHHHHhcCCCCCcccC
Confidence 44566899999999999899999999999999999999977766533211 11 1111222 2334566
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
++.+.+|+.+||+.||++||||+||+++|+..
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 78899999999999999999999999999853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=355.83 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=203.9
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+...+|++|+++... ++..||||.++.. ....++|++|++++++++|||||+++|+|.+++..++||||+++|+|.
T Consensus 12 iG~G~fg~Vy~~~~~---~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 12 LGTGQFGVVKYGKWR---GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCEETTEEEEEEEET---TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred EecCCCeEEEEEEEC---CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 456778888888853 4568999998764 445688999999999999999999999999999999999999999999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++... ..+++..+.+++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++.........
T Consensus 88 ~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~-------~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 88 NYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVND-------QGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp HHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECT-------TCCEEECCCSSCCBCSSSSCCC
T ss_pred HhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcC-------CCcEEECcchhheeccCCCcee
Confidence 997654 6789999999999999999999999 9999999999999987 7899999999998776554444
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKFE 680 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (725)
.....||..|+|||.+.+..++.|+||||||+++|||+| |+.||...... .+...+.. ......+...++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~-~~~~~~p~~~~~ 228 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQ-GLRLYRPHLASE 228 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHT-TCCCCCCTTCCH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHh-CCCCCCcccccH
Confidence 445668999999999999999999999999999999998 78787643211 11111111 112244556678
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 681 RITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 681 ~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+.+|+.+||+.||++|||++||+++|.++
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 899999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=362.46 Aligned_cols=239 Identities=23% Similarity=0.297 Sum_probs=200.5
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+...+|++|++|.+..++ ..||||.+........+.+.+|++++++++|||||++++++.+++..++||||+++|+|.
T Consensus 28 iG~G~fg~Vy~a~~~~~~--~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~ 105 (293)
T d1yhwa1 28 IGQGASGTVYTAMDVATG--QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (293)
T ss_dssp CCCSSSCEEEEEEBTTTC--CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred EecCcCcEEEEEEECCCC--CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHH
Confidence 346678889998877665 478999887666666788999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
+++.+ +.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+...... .
T Consensus 106 ~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~-------~~~vkl~DFG~a~~~~~~~~~-~ 173 (293)
T d1yhwa1 106 DVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGM-------DGSVKLTDFGFCAQITPEQSK-R 173 (293)
T ss_dssp HHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TCCEEECCCTTCEECCSTTCC-B
T ss_pred HHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECC-------CCcEeeccchhheeecccccc-c
Confidence 98765 4689999999999999999999999 9999999999999987 789999999999876543322 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC----CCChhH
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG----NLGATK 678 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 678 (725)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.+....... ..+...
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNGTPELQNPEKL 242 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHHCSCCCSSGGGS
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----------HHHHHHHHhCCCCCCCCcccC
Confidence 345699999999999999999999999999999999999999964321 11122222221 223456
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
++.+.+|+.+||+.||++|||++|+++|
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 7889999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=357.49 Aligned_cols=237 Identities=24% Similarity=0.304 Sum_probs=198.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..+ +..||||.+.+. .....+.+.+|++++++++|||||++++++.+++..++||||+++|+
T Consensus 15 G~G~fg~Vy~~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~ 92 (263)
T d2j4za1 15 GKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92 (263)
T ss_dssp EECSSEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred ecCCCcEEEEEEECCC--CcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 3456777887776644 457899987532 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+...+++..+..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 93 L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~-------~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 93 VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGS-------AGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TSCEEECCCCSCSCCCCCC--
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecC-------CCCEeecccceeeecCCCc--
Confidence 999998888899999999999999999999999 9999999999999987 7899999999998654332
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH-HHcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-VRTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 679 (725)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+..... .....++...+
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~s 228 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----------QETYKRISRVEFTFPDFVT 228 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTTCCCCCTTSC
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCCCCCccCC
Confidence 2335699999999999999999999999999999999999999964321 1111111 11234555677
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+.+.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 229 EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 899999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=355.54 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=191.1
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+...+|++|++|+.. ..||||.++.. ..+..+.|.+|++++++++|||||+++|++.+ +..++||||+++|+
T Consensus 16 lG~G~fg~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 16 IGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS 89 (276)
T ss_dssp EEECSSCEEEEEESS-----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred EeeCCCcEEEEEEEC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence 345677778777532 24899988543 44556789999999999999999999999754 56899999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..|+.|+++||+|||++ +|+||||||+||||+. ++.+||+|||+++.......
T Consensus 90 L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~-------~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 90 LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHE-------DLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp HHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET-------TSSEEECCCCCSCC------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcC-------CCCEEEccccceeeccccCC
Confidence 99999765 5699999999999999999999999 9999999999999987 88999999999987654332
Q ss_pred -ccccccccCccccchhcccC---CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---
Q 039817 600 -RTSTMIRGTMGYMAPEWLRN---APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG--- 672 (725)
Q Consensus 600 -~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 672 (725)
.......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...... ..+......+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-----------~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----------DQIIFMVGRGYLS 228 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----------HHHHHHHHHTSCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-----------HHHHHHHhcCCCC
Confidence 22334669999999999864 35899999999999999999999998643211 1111112222
Q ss_pred ----CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 673 ----NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 673 ----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
..+...++.+.+|+.+||+.||++|||++||+++|+.+.
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 123345678999999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=358.65 Aligned_cols=241 Identities=24% Similarity=0.269 Sum_probs=194.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...+|++|++|.+..++ ..||||.+.... .+..+.|.+|++++++++|||||++++++.+++..+|||||+++|+|.
T Consensus 14 G~G~fg~V~~~~~~~~~--~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~ 91 (271)
T d1nvra_ 14 GEGAYGEVQLAVNRVTE--EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91 (271)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGG
T ss_pred ecCcCeEEEEEEECCCC--CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHH
Confidence 35678888888876655 578888875432 334567999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC-cc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT-RT 601 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~-~~ 601 (725)
+++.+...+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+|+....... ..
T Consensus 92 ~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~-------~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 92 DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE-------RDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp GGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT-------TCCEEECCCTTCEECEETTEECC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECC-------CCCEEEccchhheeeccCCcccc
Confidence 9998888999999999999999999999999 9999999999999987 78899999999997654332 22
Q ss_pred ccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---CCChh
Q 039817 602 STMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG---NLGAT 677 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 677 (725)
.....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....... .. ........ .....
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---------~~-~~~~~~~~~~~~~~~~ 231 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------QE-YSDWKEKKTYLNPWKK 231 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---------HH-HHHHHTTCTTSTTGGG
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---------HH-HHHHhcCCCCCCcccc
Confidence 334679999999999988776 578999999999999999999997543221 00 11111111 11234
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.++.+.+|+.+||+.||++|||++|++++
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 56788999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=360.52 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=195.3
Q ss_pred ccccHHHHHHHhcccCC--cceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDG--QEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~--~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|...-++ ....||||.+.... ....++|.+|++++++++|||||+++|++.+.+..++||||+.+++
T Consensus 16 G~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~ 95 (283)
T d1mqba_ 16 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95 (283)
T ss_dssp EECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred eeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCc
Confidence 45678888888755433 34689999986433 3345679999999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||||+. ++.+||+|||+++.......
T Consensus 96 l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~-------~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 96 LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNS-------NLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp HHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TCCEEECCCCC---------
T ss_pred chhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECC-------CCeEEEcccchhhcccCCCc
Confidence 99988655 6799999999999999999999999 9999999999999987 88999999999987654332
Q ss_pred c--cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---CCC
Q 039817 600 R--TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT---GNL 674 (725)
Q Consensus 600 ~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 674 (725)
. ......||..|+|||.+.++.++.++||||||+++|||++++.|+...... .+ +...... ...
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------~~-~~~~i~~~~~~~~ 234 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------HE-VMKAINDGFRLPT 234 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------HH-HHHHHHTTCCCCC
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----------HH-HHHHHhccCCCCC
Confidence 2 222355899999999999999999999999999999999987776533211 11 1122222 234
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+...++.+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 55667889999999999999999999999999988754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=355.79 Aligned_cols=246 Identities=26% Similarity=0.344 Sum_probs=194.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|... +...||||.+... ....++|.+|+.++++++|+|||+++|+|.+ +..++||||+++|+|..
T Consensus 26 G~G~fg~Vy~~~~~---~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~ 100 (285)
T d1fmka3 26 GQGCFGEVWMGTWN---GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 100 (285)
T ss_dssp EECSSCEEEEEEET---TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred eeCCCeEEEEEEEC---CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhh
Confidence 45677788877653 2346999999654 4567889999999999999999999999854 56789999999999999
Q ss_pred hhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 524 FLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 524 ~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
++... ..++|..+..++.||+.||+|||+. +|+||||||+||||+. ++.+||+|||+++.........
T Consensus 101 ~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~-------~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 101 FLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE-------NLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp HHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG-------GGCEEECCCCTTC---------
T ss_pred hhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECC-------CCcEEEcccchhhhccCCCcee
Confidence 98754 5789999999999999999999999 9999999999999987 7899999999998775544444
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChhHH
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGATKF 679 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 679 (725)
.....||+.|+|||++..+.++.++||||||+++|||++|+.|+...... .+.+..... ....+...+
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----------~~~~~~i~~~~~~~~~~~~~ 240 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQVERGYRMPCPPECP 240 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------HHHHHHHHTTCCCCCCTTSC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----------HHHHHHHHhcCCCCCCcccC
Confidence 44466899999999999999999999999999999999987776543221 111111111 224556677
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEGTSEVG 714 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 714 (725)
+++.+++.+||+.||++||||++|+++|+......
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 89999999999999999999999999999876443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=357.11 Aligned_cols=238 Identities=26% Similarity=0.348 Sum_probs=191.9
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEc----CCceeeeeecc
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE----QNHQLLVYELM 516 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~ 516 (725)
+.+.+|++|++|++..+ +..||+|.+... .....+.|.+|+++|++++|||||++++++.. +...++||||+
T Consensus 17 iG~G~fg~Vy~~~~~~~--~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 17 IGRGSFKTVYKGLDTET--TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEECSSEEEEEEEETTT--CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred EecCcCcEEEEEEECCC--CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 35667888888887654 457888887543 33445679999999999999999999999875 34578999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCc--eeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQ--IIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
++|+|.+++.+...+++..+..++.|+++||+|||++ + |+||||||+|||++.+ ++.+||+|||+++..
T Consensus 95 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~------~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 95 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGP------TGSVKIGDLGLATLK 165 (270)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESST------TSCEEECCTTGGGGC
T ss_pred CCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCC------CCCEEEeecCcceec
Confidence 9999999998888999999999999999999999998 6 9999999999999642 678999999999864
Q ss_pred CcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
.... .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||...... ..+......+..
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----------~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----------AQIYRRVTSGVK 230 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----------HHHHHHHTTTCC
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----------HHHHHHHHcCCC
Confidence 4322 234569999999998875 5999999999999999999999999643211 112222222222
Q ss_pred ----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 ----GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+....+++.+|+.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 22345679999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-43 Score=365.61 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=198.8
Q ss_pred ccccHHHHHHHhcccC---CcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccC
Q 039817 444 KVFSYQELREATNVFD---GQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~---~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
...+|++|++|+.... +....||||.+... .......|.+|+.++.++ +|||||+++|++.+.+..++||||+++
T Consensus 46 G~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~ 125 (325)
T d1rjba_ 46 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125 (325)
T ss_dssp EECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCC
Confidence 4567888888876543 34568999998543 344567899999999998 899999999999999999999999999
Q ss_pred CChhhhhccCC-----------------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcc
Q 039817 519 GTLSAFLFRQE-----------------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575 (725)
Q Consensus 519 gsL~~~l~~~~-----------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~ 575 (725)
|+|.++|...+ .+++..+..++.|+++||.|||+. +|+||||||+|||++.
T Consensus 126 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~--- 199 (325)
T d1rjba_ 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTH--- 199 (325)
T ss_dssp CBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEET---
T ss_pred CcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcccccc---
Confidence 99999996542 478999999999999999999999 9999999999999987
Q ss_pred ccCCCCceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCcc
Q 039817 576 TIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEP 653 (725)
Q Consensus 576 ~~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~ 653 (725)
++.+||+|||+|+......... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.......
T Consensus 200 ----~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~- 274 (325)
T d1rjba_ 200 ----GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA- 274 (325)
T ss_dssp ----TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred ----CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-
Confidence 8899999999998765543322 233558999999999999999999999999999999998 788886433211
Q ss_pred ccccCcchHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 039817 654 TLANGMILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLE 708 (725)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 708 (725)
.+...+.. ......+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus 275 ------~~~~~~~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 ------NFYKLIQN-GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ------HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------HHHHHHhc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11111111 1122345566789999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=361.72 Aligned_cols=240 Identities=22% Similarity=0.273 Sum_probs=197.6
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
+...+|++|++|.+..++ ..||||.+........+.|.+|++++++++|||||++++++.+++..++||||+++|+|.
T Consensus 20 iG~G~fg~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~ 97 (288)
T d2jfla1 20 LGDGAFGKVYKAQNKETS--VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97 (288)
T ss_dssp EEEETTEEEEEEEETTTC--CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred EeeCCCcEEEEEEECCCC--eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHH
Confidence 345678888888776554 578999997766677788999999999999999999999999999999999999999999
Q ss_pred hhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++.+ .+.+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 98 ~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~-------~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 98 AVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTL-------DGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECHHHHH-H
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECC-------CCCEEEEechhhhccCCCcc-c
Confidence 99765 46799999999999999999999999 9999999999999987 78999999999976533211 1
Q ss_pred ccccccCccccchhccc-----CCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc----C
Q 039817 602 STMIRGTMGYMAPEWLR-----NAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT----G 672 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 672 (725)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .+...... .
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----------~~~~i~~~~~~~~ 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----------VLLKIAKSEPPTL 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----------HHHHHHHSCCCCC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----------HHHHHHcCCCCCC
Confidence 22356999999999984 4568999999999999999999999986542211 11111111 1
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..+...++.+.+|+.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234567889999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=356.25 Aligned_cols=241 Identities=22% Similarity=0.329 Sum_probs=183.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEc--CCceeeeeecccCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--QNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~g 519 (725)
...+|++|++|.+..++ ..||||.+.... ....+.|.+|++++++++|||||++++++.+ ++..++||||+++|
T Consensus 13 G~G~fg~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g 90 (269)
T d2java1 13 GTGSYGRCQKIRRKSDG--KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90 (269)
T ss_dssp EECSSEEEEEEEETTTC--CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTE
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCC
Confidence 35567788888776655 478999886432 3345679999999999999999999999865 45689999999999
Q ss_pred Chhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhhccc--CCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 520 TLSAFLFR----QEIPTWDKRVEIALGIARGLLYLHEEC--ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 520 sL~~~l~~----~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
+|.+++.+ ...+++..++.++.|++.||.|||+.. ..+|+||||||+|||++. ++.+||+|||+++.
T Consensus 91 ~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~-------~~~vkl~DFG~a~~ 163 (269)
T d2java1 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-------KQNVKLGDFGLARI 163 (269)
T ss_dssp EHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT-------TSCEEECCHHHHHH
T ss_pred cHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC-------CCcEEEeeccceee
Confidence 99999864 367999999999999999999999862 124999999999999987 78999999999998
Q ss_pred cCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC-
Q 039817 594 LKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG- 672 (725)
Q Consensus 594 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 672 (725)
....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+ +......+
T Consensus 164 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----------~~-~~~~i~~~~ 230 (269)
T d2java1 164 LNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----------KE-LAGKIREGK 230 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HH-HHHHHHHTC
T ss_pred cccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----------HH-HHHHHHcCC
Confidence 7544332 2345699999999999999999999999999999999999999864321 11 11112222
Q ss_pred --CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 --NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 --~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.++...++.+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 3455677899999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=355.50 Aligned_cols=237 Identities=22% Similarity=0.259 Sum_probs=195.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..++ ..||||.+... .....+.+.+|++++++++|||||++++++.+++..++||||+++|+
T Consensus 17 G~G~fg~Vy~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~ 94 (288)
T d1uu3a_ 17 GEGSFSTVVLARELATS--REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94 (288)
T ss_dssp EECSSCEEEEEEETTTC--CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred eeCCCeEEEEEEECCCC--CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCC
Confidence 35567888888776554 56888887532 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++...+.+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.+......
T Consensus 95 L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~-------~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 95 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE-------DMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TSCEEECCCTTCEECC-----
T ss_pred HHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCC-------CceEEecccccceecccCCcc
Confidence 999998888999999999999999999999999 9999999999999987 789999999999977543322
Q ss_pred -cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCCChh
Q 039817 601 -TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNLGAT 677 (725)
Q Consensus 601 -~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 677 (725)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+ +..... ...++..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------~~-~~~~i~~~~~~~p~~ 232 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------YL-IFQKIIKLEYDFPEK 232 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHTTCCCCCTT
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----------HH-HHHHHHcCCCCCCcc
Confidence 23345699999999999999999999999999999999999999974321 11 111122 2345566
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVL 704 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl 704 (725)
.++.+.+|+.+||+.||++|||++|++
T Consensus 233 ~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 233 FFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 788999999999999999999999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=353.48 Aligned_cols=241 Identities=23% Similarity=0.285 Sum_probs=184.5
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
+...+|++|++|.+..++ ..||||.+.... ....+.+.+|++++++++|||||++++++.+++..+|||||+++|+|
T Consensus 17 lG~G~fg~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L 94 (307)
T d1a06a_ 17 LGTGAFSEVILAEDKRTQ--KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 94 (307)
T ss_dssp SBSGGGGGEEEEEETTTC--CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EeeccCeEEEEEEECCCC--CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 345688999998876554 578999886432 23346788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||+... +.++.+||+|||+++.......
T Consensus 95 ~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~----~~~~~vkl~DFG~a~~~~~~~~-- 165 (307)
T d1a06a_ 95 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSL----DEDSKIMISDFGLSKMEDPGSV-- 165 (307)
T ss_dssp HHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSS----STTCCEEECCC-------------
T ss_pred HHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeeccc----CCCceEEEeccceeEEccCCCe--
Confidence 99999888999999999999999999999999 99999999999999652 2378899999999986643322
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC------CC
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN------LG 675 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 675 (725)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+ +........ ..
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------~~-~~~~i~~~~~~~~~~~~ 233 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----------AK-LFEQILKAEYEFDSPYW 233 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HH-HHHHHHTTCCCCCTTTT
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----------HH-HHHHHhccCCCCCCccc
Confidence 2235699999999999999999999999999999999999999964321 11 111121221 22
Q ss_pred hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...++.+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 3566889999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=352.90 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=190.1
Q ss_pred ccccHHHHHHHhcccC-CcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFD-GQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|++|++|..... +....||||.++.... ...+.|.+|++++++++|||||+++|++. .+..++||||+++|+|
T Consensus 16 G~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l 94 (273)
T d1mp8a_ 16 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGEL 94 (273)
T ss_dssp EECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEH
T ss_pred eeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcH
Confidence 4567888888876554 3467899999875433 33567999999999999999999999996 4678999999999999
Q ss_pred hhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++........
T Consensus 95 ~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~-------~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 95 RSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSS-------NDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp HHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE-------TTEEEECC-------------
T ss_pred HhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecC-------CCcEEEccchhheeccCCcce
Confidence 9987654 5789999999999999999999999 9999999999999988 789999999999876655444
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
......||+.|+|||.+.+..++.++||||||+++|||++ |..|+...... .+...+.. ......+...+
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~~-~~~~~~~~~~~ 235 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIEN-GERLPMPPNCP 235 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHT-TCCCCCCTTCC
T ss_pred eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHHc-CCCCCCCCCCC
Confidence 4455668999999999999999999999999999999998 77777643221 11111111 11124455677
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+.+.+|+.+||+.||++|||++||+++|+.++
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 89999999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-42 Score=355.60 Aligned_cols=235 Identities=23% Similarity=0.281 Sum_probs=193.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..+ +..||||.+..... ...+.|.+|+++|++++|||||++++++.+++..++||||+++|+
T Consensus 24 G~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 101 (309)
T d1u5ra_ 24 GHGSFGAVYFARDVRN--SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101 (309)
T ss_dssp EECSSSEEEEEEETTT--TEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred ecCCCeEEEEEEECCC--CcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCc
Confidence 4567888888877655 45789998865432 234578999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|..++...+.+++..+..++.||++||.|||+. +|+||||||+||||+. ++.+||+|||+++.....
T Consensus 102 l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~-------~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 102 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSE-------PGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEET-------TTEEEECCCTTCBSSSSB---
T ss_pred hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECC-------CCCEEEeecccccccCCC---
Confidence 988888888899999999999999999999999 9999999999999987 889999999999865432
Q ss_pred cccccccCccccchhcccC---CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC---CC
Q 039817 601 TSTMIRGTMGYMAPEWLRN---APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG---NL 674 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 674 (725)
....||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... .+.+....... ..
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~~ 235 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQNESPALQ 235 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCCCCCS
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhCCCCCCC
Confidence 23469999999999863 4689999999999999999999999864321 11122222211 12
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
+...++.+.+|+.+||+.||++|||++|+++|
T Consensus 236 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 23457889999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=360.79 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=194.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...+|+.|++|.+..+ +..||+|.++.. .....+.+.+|+++|++++|||||+++++|.+++..++||||+++|+|.
T Consensus 15 G~G~fg~V~~~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~ 92 (322)
T d1s9ja_ 15 GAGNGGVVFKVSHKPS--GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92 (322)
T ss_dssp ECCSSCCEEEEEETTT--TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHH
T ss_pred ecCCCeEEEEEEECCC--CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHH
Confidence 4567778888776544 467899988643 3344578999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 523 AFLFRQEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 523 ~~l~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
+++.+.+.+++..+..++.|+++||.|||+ . +|+||||||+|||++. ++.+||+|||+|+......
T Consensus 93 ~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~-------~~~vkl~DFGla~~~~~~~--- 159 (322)
T d1s9ja_ 93 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNS-------RGEIKLCDFGVSGQLIDSM--- 159 (322)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECT-------TCCEEECCCCCCHHHHHHT---
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECC-------CCCEEEeeCCCccccCCCc---
Confidence 999888889999999999999999999996 4 7999999999999987 7899999999998654322
Q ss_pred ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCcccccc------------------------
Q 039817 602 STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLAN------------------------ 657 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~------------------------ 657 (725)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||............
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 22356999999999999999999999999999999999999999754322110000
Q ss_pred -------CcchHHHHHHHHHcC--CCC-hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 658 -------GMILTDWVLYCVRTG--NLG-ATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 658 -------~~~~~~~~~~~~~~~--~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.....+......... ..+ ...+.++.+|+.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000001111111000 011 1235678999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=355.09 Aligned_cols=247 Identities=28% Similarity=0.392 Sum_probs=201.0
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccc-cCccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
+...+|++|++|+...++...+||||++... .....++|.+|+++|+++ +|||||+++|+|.+++..++||||+++|+
T Consensus 18 iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~ 97 (309)
T d1fvra_ 18 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97 (309)
T ss_dssp EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred EeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCc
Confidence 3557789999999888888889999998643 344566899999999998 79999999999999999999999999999
Q ss_pred hhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceE
Q 039817 521 LSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITK 584 (725)
Q Consensus 521 L~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~k 584 (725)
|.++|++. ..+++..+.+++.|||+||.|||+. +|+||||||+|||++. ++.+|
T Consensus 98 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~-------~~~~k 167 (309)
T d1fvra_ 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE-------NYVAK 167 (309)
T ss_dssp HHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG-------GGCEE
T ss_pred HHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcC-------CCceE
Confidence 99999654 5689999999999999999999999 9999999999999987 78999
Q ss_pred EeeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHH
Q 039817 585 IADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDW 664 (725)
Q Consensus 585 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 664 (725)
|+|||+++....... .....||..|+|||.+.++.++.++||||||+++|||++|..++..... ..+
T Consensus 168 l~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----------~~~- 234 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------CAE- 234 (309)
T ss_dssp ECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----------HHH-
T ss_pred Ecccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC----------HHH-
Confidence 999999986543322 2234589999999999999999999999999999999998765432211 111
Q ss_pred HHHHHHc---CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 665 VLYCVRT---GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 665 ~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+...... ...+...++++.+|+.+||+.||++||||+||+++|+++.+
T Consensus 235 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 235 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111222 23445667899999999999999999999999999988653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=352.76 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=200.7
Q ss_pred ccccHHHHHHHhccc---CCcceEEEEEEcccccCc-cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 444 KVFSYQELREATNVF---DGQEVEVAVKQLEKVTGD-GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...+|++|++|+... ..++..||||++.....+ ..++|.+|++++++++||||++++++|...+..++||||+++|
T Consensus 22 G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g 101 (301)
T d1lufa_ 22 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 101 (301)
T ss_dssp EECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCC
Confidence 456788888887543 234578999999754333 4567999999999999999999999999999999999999999
Q ss_pred ChhhhhccC------------------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCcc
Q 039817 520 TLSAFLFRQ------------------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYI 575 (725)
Q Consensus 520 sL~~~l~~~------------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~ 575 (725)
+|.+++... ..+++..++.|+.|+++||+|||+. +|+||||||+||||+.
T Consensus 102 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~--- 175 (301)
T d1lufa_ 102 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGE--- 175 (301)
T ss_dssp BHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG---
T ss_pred cHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECC---
Confidence 999998642 2478999999999999999999999 9999999999999987
Q ss_pred ccCCCCceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc
Q 039817 576 TIDNNYITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT 654 (725)
Q Consensus 576 ~~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~ 654 (725)
++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++|..++......
T Consensus 176 ----~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--- 248 (301)
T d1lufa_ 176 ----NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--- 248 (301)
T ss_dssp ----GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred ----CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH---
Confidence 7899999999998664433222 23456889999999999999999999999999999999997544322111
Q ss_pred cccCcchHHHHHHHHHcC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 655 LANGMILTDWVLYCVRTG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
.+.. .....+ ..+...++++.+|+.+||+.||++||||.||+++|+++.+
T Consensus 249 -------~e~~-~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 -------EEVI-YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -------HHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------HHHH-HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111 222222 2445677899999999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-41 Score=356.34 Aligned_cols=240 Identities=22% Similarity=0.284 Sum_probs=199.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|.+..++ ..||||.+........+.+.+|++++++++|||||++++++.+++..+|||||+++|+|.+
T Consensus 35 G~G~fg~Vy~~~~~~~g--~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~ 112 (350)
T d1koaa2 35 GTGAFGVVHRVTERATG--NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112 (350)
T ss_dssp EEETTEEEEEEEETTTT--EEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred ecCcCeEEEEEEECCCC--CEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHH
Confidence 45678888888876554 5789999876655667789999999999999999999999999999999999999999999
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+ .++.+||+|||+++....... .
T Consensus 113 ~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~-----~~~~vkL~DFG~a~~~~~~~~--~ 182 (350)
T d1koaa2 113 KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTK-----RSNELKLIDFGLTAHLDPKQS--V 182 (350)
T ss_dssp HHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESST-----TSCCEEECCCTTCEECCTTSC--E
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccC-----CCCeEEEeecchheecccccc--c
Confidence 99654 6799999999999999999999999 99999999999999752 267899999999987654332 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH-cCCCC----hh
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR-TGNLG----AT 677 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~ 677 (725)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+..... ....+ ..
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~~~~~~~~ 251 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----------DETLRNVKSCDWNMDDSAFSG 251 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHTCCCSCCGGGGG
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCCcccccC
Confidence 335699999999999999999999999999999999999999964321 111111111 11111 23
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.++.+.+|+.+||+.||++|||++|+++|
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 56789999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=349.11 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=191.0
Q ss_pred ccccHHHHHHHhcc-cCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 444 KVFSYQELREATNV-FDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~-~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...+|++|++|... -.++.+.||||.+... ..+..++|.+|++++++++|||||+++|+|.+ ...++||||+++|
T Consensus 17 G~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~ 95 (273)
T d1u46a_ 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLG 95 (273)
T ss_dssp C----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred ecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCc
Confidence 34668888888654 4456678999998643 23445689999999999999999999999975 4678999999999
Q ss_pred ChhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 520 TLSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 520 sL~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
+|.+++..+ ..+++..+..++.|+|+||.|||++ +|+||||||+||+|+. ++.+||+|||+++......
T Consensus 96 ~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~-------~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 96 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLAT-------RDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp BHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEE-------TTEEEECCCTTCEECCC-C
T ss_pred chhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccc-------ccceeeccchhhhhcccCC
Confidence 999987654 5699999999999999999999999 9999999999999988 7899999999999765443
Q ss_pred Ccc--ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHc---C
Q 039817 599 TRT--STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRT---G 672 (725)
Q Consensus 599 ~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 672 (725)
... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||..... .+........ .
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----------~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------SQILHKIDKEGERL 234 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTSCCCC
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----------HHHHHHHHhCCCCC
Confidence 322 223457889999999999999999999999999999998 7888763321 1112222222 2
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 039817 673 NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEG 709 (725)
Q Consensus 673 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 709 (725)
..+...+..+.+|+.+||+.||++|||++||++.|++
T Consensus 235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 3344567889999999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=351.66 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=200.9
Q ss_pred ccccHHHHHHHhcccC-CcceEEEEEEcccc-cCccHHHHHHHHHHHhccCcCCccceeeEEEc-CCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFD-GQEVEVAVKQLEKV-TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-~~~~~vavk~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~gs 520 (725)
...+|++|++|+.... +....||||.++.. .....++|.+|++++++++|||||+++|+|.. ++..++||||+++|+
T Consensus 36 G~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~ 115 (311)
T d1r0pa_ 36 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115 (311)
T ss_dssp EEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCB
T ss_pred eecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCc
Confidence 4567888888876543 45678999999743 34455789999999999999999999999875 568899999999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+++++.|+++||.|||+. +|+||||||+||||++ ++.+||+|||+++.......
T Consensus 116 l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~-------~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDE-------KFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT-------TCCEEECSSGGGCCTTTTTC
T ss_pred hhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECC-------CCCEEEecccchhhcccccc
Confidence 99998765 4678899999999999999999999 9999999999999987 88999999999997654332
Q ss_pred cc---ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCCCh
Q 039817 600 RT---STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGA 676 (725)
Q Consensus 600 ~~---~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (725)
.. .....||..|+|||.+....++.++||||||+++|||++|+.|+....... .....+... .....+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------~~~~~i~~g-~~~~~p~ 257 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQG-RRLLQPE 257 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTT-CCCCCCT
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcC-CCCCCcc
Confidence 22 223568999999999999999999999999999999999888876432211 112222111 1223444
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
..++.+.+|+.+||+.||++||||.||+++|+++.+
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 566789999999999999999999999999988754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=352.14 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=195.2
Q ss_pred ccccHHHHHHHhcccCCc--ceEEEEEEccc-ccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQ--EVEVAVKQLEK-VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~--~~~vavk~l~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|....+++ ...||||.+.. ...+..++|.+|++++++++|||||+++|+|.++ ..++++||+.+|+
T Consensus 18 G~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~ 96 (317)
T d1xkka_ 18 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGC 96 (317)
T ss_dssp EECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCB
T ss_pred ecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCc
Confidence 456788888888776665 34789999864 3445678899999999999999999999999875 5678889999999
Q ss_pred hhhhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 521 LSAFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 521 L~~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
|.+++... ..+++..+.+++.|||+||.|||+. +|+||||||+||||+. ++.+||+|||+++.......
T Consensus 97 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~-------~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 97 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKT-------PQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp HHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEE-------TTEEEECCCSHHHHTTTTCC
T ss_pred ccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCC-------CCCeEeeccccceecccccc
Confidence 99888765 6789999999999999999999999 9999999999999987 88999999999997655433
Q ss_pred cc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChh
Q 039817 600 RT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGAT 677 (725)
Q Consensus 600 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (725)
.. .....||..|+|||.+.++.++.++||||||+++|||+| |+.|+...... .+...+.. ......+..
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------~~~~~i~~-~~~~~~p~~ 237 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEK-GERLPQPPI 237 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------GHHHHHHH-TCCCCCCTT
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHc-CCCCCCCcc
Confidence 32 233568999999999999999999999999999999998 66776543211 11122211 112234556
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 678 KFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 678 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.++.+.+|+.+||+.||++|||+.||+++|+.+
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 778899999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-40 Score=351.49 Aligned_cols=242 Identities=19% Similarity=0.247 Sum_probs=200.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|.+..++ ..||||.+........+.+.+|+++|++++|||||++++++.+++..+|||||+++|+|.+
T Consensus 38 G~G~fg~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~ 115 (352)
T d1koba_ 38 GSGAFGVVHRCVEKATG--RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115 (352)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHH
Confidence 45678888888876654 5789998876555556788999999999999999999999999999999999999999998
Q ss_pred hhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++.+. ..+++..+..|+.||+.||.|||+. +|+||||||+||||+.. .++.+||+|||+++....... .
T Consensus 116 ~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~-----~~~~vkL~DFGla~~~~~~~~--~ 185 (352)
T d1koba_ 116 RIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETK-----KASSVKIIDFGLATKLNPDEI--V 185 (352)
T ss_dssp HTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESST-----TCCCEEECCCTTCEECCTTSC--E
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccccccccccc-----CCCeEEEeecccceecCCCCc--e
Confidence 87665 4699999999999999999999999 99999999999999752 278999999999997754432 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC------CCh
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN------LGA 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 676 (725)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.+.. ..... ...
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~-i~~~~~~~~~~~~~ 253 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------LETLQN-VKRCDWEFDEDAFS 253 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHH-HHHCCCCCCSSTTT
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHH-HHhCCCCCCccccc
Confidence 335689999999999999999999999999999999999999964321 111111 11221 123
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcC
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM--LEG 709 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~ 709 (725)
..++.+.+|+.+||+.||++|||++|+++| +++
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 467889999999999999999999999986 554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=344.74 Aligned_cols=239 Identities=26% Similarity=0.344 Sum_probs=186.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEc-CCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE-QNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~ 522 (725)
...+|+.|++|.. ++..||||.++. ....++|.+|++++++++|||||+++|+|.+ .+..++||||+++|+|.
T Consensus 16 G~G~fg~Vy~~~~----~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~ 89 (262)
T d1byga_ 16 GKGEFGDVMLGDY----RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89 (262)
T ss_dssp EECSSCEEEEEEE----TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred ecCCCeEEEEEEE----CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence 3456777777764 245799999965 3456789999999999999999999999965 46689999999999999
Q ss_pred hhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 523 AFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 523 ~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
+++.+. ..+++..+++|+.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 90 ~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~-------~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 90 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSE-------DNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp HHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT-------TSCEEECCCCC----------
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecC-------CCCEeecccccceecCCCC--
Confidence 999765 3589999999999999999999999 9999999999999987 8899999999998654322
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccCcchHHHHHHHHHcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANGMILTDWVLYCVRTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (725)
....++..|+|||++.++.++.++||||||+++|||+| |+.|+..... ..+...+.. ......+...+
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~~~~~~i~~-~~~~~~~~~~~ 226 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEK-GYKMDAPDGCP 226 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHHTT-TCCCCCCTTCC
T ss_pred --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHc-CCCCCCCccCC
Confidence 22457889999999999999999999999999999998 5665543221 111222211 11234555667
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 680 ERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
+++.+|+.+||+.||++||||.+|+++|+.+.
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 89999999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=343.18 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=196.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc------CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT------GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...+|+.|++|.+.-++ ..||||.+.+.. ....+.|.+|+++|++++|||||++++++.+++..+|||||++
T Consensus 19 G~G~fg~Vy~~~~~~~~--~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (293)
T d1jksa_ 19 GSGQFAVVKKCREKSTG--LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96 (293)
T ss_dssp EECSSEEEEEEEETTTC--CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 45677888888776544 578899875321 2246789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|+|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+. .....+||+|||+++.....
T Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~---~~~~~vkl~DfG~a~~~~~~ 170 (293)
T d1jksa_ 97 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN---VPKPRIKIIDFGLAHKIDFG 170 (293)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSS---SSSCCEEECCCTTCEECTTS
T ss_pred CccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCC---CcccceEecchhhhhhcCCC
Confidence 999999998888899999999999999999999999 999999999999998732 11346999999999876543
Q ss_pred CCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CC
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LG 675 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 675 (725)
.. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.. ....... .+
T Consensus 171 ~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------~~~~-~~i~~~~~~~~ 236 (293)
T d1jksa_ 171 NE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QETL-ANVSAVNYEFE 236 (293)
T ss_dssp CB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHH-HHHHTTCCCCC
T ss_pred cc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----------HHHH-HHHHhcCCCCC
Confidence 22 2234589999999999999999999999999999999999999974321 1111 1112222 22
Q ss_pred h----hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 676 A----TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 676 ~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
. ..++.+.+|+.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 345678999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-41 Score=348.34 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=190.1
Q ss_pred ccccHHHHHHHhcccC---CcceEEEEEEccccc-CccHHHHHHHHHHHhcc-CcCCccceeeEEEcC-Cceeeeeeccc
Q 039817 444 KVFSYQELREATNVFD---GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQ-NHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~---~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~lV~e~~~ 517 (725)
...+|++|++|+.... ..+..||||.+.... ....+.+.+|...+.++ +|+|||++++++.+. ...++||||++
T Consensus 22 G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~ 101 (299)
T d1ywna1 22 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 101 (299)
T ss_dssp EECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCT
T ss_pred eecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecC
Confidence 4567888888876543 245689999986433 33456788999988887 799999999998765 46899999999
Q ss_pred CCChhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCC
Q 039817 518 NGTLSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNY 581 (725)
Q Consensus 518 ~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~ 581 (725)
+|+|.+++... ..+++..+..++.||++||.|||+. +|+||||||+||||+. ++
T Consensus 102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~-------~~ 171 (299)
T d1ywna1 102 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE-------KN 171 (299)
T ss_dssp TCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG-------GG
T ss_pred CCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC-------CC
Confidence 99999999643 2478999999999999999999999 9999999999999987 78
Q ss_pred ceEEeeccCccccCcCCCc-cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCc-CCCCCCCCccccccCc
Q 039817 582 ITKIADFGLAKLLKKDQTR-TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKR-HTELHRVDEPTLANGM 659 (725)
Q Consensus 582 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~-~~~~~~~~~~~~~~~~ 659 (725)
.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|.. |+.......
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------- 244 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------- 244 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-------
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 9999999999876544332 2334569999999999999999999999999999999999765 454322111
Q ss_pred chHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 660 ILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
.....+.. ......+...++++.+++.+||+.||++|||++||+++|+.++
T Consensus 245 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 245 EFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhc-CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111111 1123445566788999999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=345.38 Aligned_cols=239 Identities=23% Similarity=0.234 Sum_probs=200.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|+.|++|.+..++ ..||||.+.+. .....+.+.+|+++|++++|||||++++++.+++..++||||+++|+
T Consensus 14 G~G~fg~V~~~~~~~~~--~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~ 91 (337)
T d1o6la_ 14 GKGTFGKVILVREKATG--RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91 (337)
T ss_dssp EECSSEEEEEEEETTTC--CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred ecCcCeEEEEEEECCCC--CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCc
Confidence 34567777777766554 57899988642 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 92 L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~-------~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 92 LFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDK-------DGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TSCEEECCCTTCBCSCCTTC-
T ss_pred hhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecC-------CCCEEEeecccccccccCCc-
Confidence 999999889999999999999999999999999 9999999999999987 78999999999987644332
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHH-HHHcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLY-CVRTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 679 (725)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... +.... ......++...+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----------~~~~~i~~~~~~~p~~~s 229 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------RLFELILMEEIRFPRTLS 229 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----------HHHHHHHHCCCCCCTTSC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----------HHHHHHhcCCCCCCccCC
Confidence 233456999999999999999999999999999999999999999754311 11111 112234566778
Q ss_pred HHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
+.+.+|+.+||+.||++||+ ++|+++|
T Consensus 230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 88999999999999999994 8888875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-40 Score=341.87 Aligned_cols=236 Identities=21% Similarity=0.241 Sum_probs=199.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..++ ..||||.+... .....+.+.+|+.++++++|||||++++++.+++..++||||+++|+
T Consensus 13 G~G~fg~Vy~a~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 90 (316)
T d1fota_ 13 GTGSFGRVHLIRSRHNG--RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 90 (316)
T ss_dssp EECSSCEEEEEEETTTC--CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred ecCcCcEEEEEEECCCC--CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcc
Confidence 34567788888776554 57899988532 33456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|..++.....+++..+..++.|++.||.|||++ +|+||||||+||||+. ++.+||+|||+++......
T Consensus 91 l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~-------~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 91 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDK-------NGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp HHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECT-------TSCEEECCCSSCEECSSCB--
T ss_pred ccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcC-------CCCEEEecCccceEecccc--
Confidence 999999999999999999999999999999999 9999999999999987 8899999999998765332
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 679 (725)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+...... .....+...+
T Consensus 159 --~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~s 225 (316)
T d1fota_ 159 --YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------MKTYEKILNAELRFPPFFN 225 (316)
T ss_dssp --CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHCCCCCCTTSC
T ss_pred --ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----------HHHHHHHHcCCCCCCCCCC
Confidence 235699999999999999999999999999999999999999964321 11111111 1234555677
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
+.+.+++.+||+.||.+|| |++++++|
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 8899999999999999996 99999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=342.93 Aligned_cols=247 Identities=27% Similarity=0.360 Sum_probs=198.4
Q ss_pred ccccHHHHHHHhcccC-----CcceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecc
Q 039817 444 KVFSYQELREATNVFD-----GQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-----~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 516 (725)
...+|++|++|+.... .....||||.++.... ....++.+|+..+.++ +|||||+++++|.+++..++||||+
T Consensus 22 G~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~ 101 (299)
T d1fgka_ 22 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 101 (299)
T ss_dssp C-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred eecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEcc
Confidence 4567888888775433 3456899999965433 3457899999999998 8999999999999999999999999
Q ss_pred cCCChhhhhccC----------------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCC
Q 039817 517 KNGTLSAFLFRQ----------------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580 (725)
Q Consensus 517 ~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~ 580 (725)
++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. +
T Consensus 102 ~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~-------~ 171 (299)
T d1fgka_ 102 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE-------D 171 (299)
T ss_dssp TTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT-------T
T ss_pred CCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC-------C
Confidence 999999999654 3479999999999999999999999 9999999999999987 7
Q ss_pred CceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHh-CCcCCCCCCCCccccccC
Q 039817 581 YITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIF-CKRHTELHRVDEPTLANG 658 (725)
Q Consensus 581 ~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~ellt-g~~~~~~~~~~~~~~~~~ 658 (725)
+.+||+|||+++......... .....+++.|+|||.+.++.++.|+||||||+++|||++ |..|+.....
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-------- 243 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------- 243 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--------
Confidence 899999999999775543332 334568999999999999999999999999999999998 5666643211
Q ss_pred cchHHHHHHHHHc---CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 659 MILTDWVLYCVRT---GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 659 ~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
+.+...... ...+...++++.+|+.+||+.||++|||+.||++.|+++.+
T Consensus 244 ----~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ----EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 112222222 23445667889999999999999999999999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=343.38 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=201.6
Q ss_pred ccccHHHHHHHhccc---CCcceEEEEEEcccccC-ccHHHHHHHHHHHhcc-CcCCccceeeEEEcCCceeeeeecccC
Q 039817 444 KVFSYQELREATNVF---DGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRT-HHKNLVQLLGFCIEQNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~---~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 518 (725)
...+|++|++|+... ...+..||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+++..++||||+++
T Consensus 32 G~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~ 111 (311)
T d1t46a_ 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 111 (311)
T ss_dssp EECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCC
Confidence 456788888887532 35667999999975433 3455799999999999 799999999999999999999999999
Q ss_pred CChhhhhccCC------------------CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCC
Q 039817 519 GTLSAFLFRQE------------------IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNN 580 (725)
Q Consensus 519 gsL~~~l~~~~------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~ 580 (725)
|+|.+++.+.. .+++..+..++.||++||+|||++ +++||||||+||+++. +
T Consensus 112 g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~-------~ 181 (311)
T d1t46a_ 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH-------G 181 (311)
T ss_dssp EEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET-------T
T ss_pred CCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccccc-------c
Confidence 99999996542 578999999999999999999999 9999999999999987 7
Q ss_pred CceEEeeccCccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCc
Q 039817 581 YITKIADFGLAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGM 659 (725)
Q Consensus 581 ~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~ 659 (725)
+.+|++|||+++......... .....||+.|+|||.+.++.++.++||||||+++|||+|++.|+....... .
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~------~ 255 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------S 255 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS------H
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH------H
Confidence 899999999999776543322 234668999999999999999999999999999999999665554322211 1
Q ss_pred chHHHHHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 660 ILTDWVLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.+...+.. -.....+...++.+.+|+.+||+.||++||||+||+++|++.
T Consensus 256 ~~~~~i~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 KFYKMIKE-GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhc-CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111211 112234445678999999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-40 Score=341.69 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=200.6
Q ss_pred ccccHHHHHHHhcccC---CcceEEEEEEccccc-CccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 444 KVFSYQELREATNVFD---GQEVEVAVKQLEKVT-GDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~---~~~~~vavk~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...+|++|++|+.... .....||||+++... ......|.+|++++++++|||||+++|+|..++..++||||+++|
T Consensus 29 G~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 108 (308)
T d1p4oa_ 29 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRG 108 (308)
T ss_dssp EECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCC
Confidence 3467888888876432 234689999997532 334456999999999999999999999999999999999999999
Q ss_pred ChhhhhccC----------CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeecc
Q 039817 520 TLSAFLFRQ----------EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFG 589 (725)
Q Consensus 520 sL~~~l~~~----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfg 589 (725)
+|.+++... ..+++..+.+++.|+|+||.|||+. +|+||||||+|||++. ++++||+|||
T Consensus 109 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~-------~~~~Kl~DFG 178 (308)
T d1p4oa_ 109 DLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE-------DFTVKIGDFG 178 (308)
T ss_dssp BHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT-------TCCEEECCTT
T ss_pred CHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC-------CceEEEeecc
Confidence 999998643 3468999999999999999999999 9999999999999987 8899999999
Q ss_pred CccccCcCCCcc-ccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH
Q 039817 590 LAKLLKKDQTRT-STMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC 668 (725)
Q Consensus 590 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (725)
+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+||+.++.... ...+... .
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~----------~~~~~~~-~ 247 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----------SNEQVLR-F 247 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----------CHHHHHH-H
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC----------CHHHHHH-H
Confidence 998765443322 233458999999999999999999999999999999999975443221 1112222 2
Q ss_pred HHcC---CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 039817 669 VRTG---NLGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE 712 (725)
Q Consensus 669 ~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 712 (725)
...+ ..+...++.+.+++.+||+.||++||||+||+++|++..+
T Consensus 248 i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2222 2344567889999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.7e-40 Score=335.08 Aligned_cols=244 Identities=23% Similarity=0.280 Sum_probs=192.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC---ccHHHHHHHHHHHhccCcCCccceeeEEEcCC----ceeeeeecc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG---DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN----HQLLVYELM 516 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~ 516 (725)
...+|++|++|.+..++ ..||||.+..... ...+.|.+|++++++++|||||++++++...+ ..+|||||+
T Consensus 16 G~G~fg~Vy~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~ 93 (277)
T d1o6ya_ 16 GFGGMSEVHLARDLRLH--RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93 (277)
T ss_dssp EECSSEEEEEEEETTTT--EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred eeCCCeEEEEEEECCCC--CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECC
Confidence 45677888888876654 5789999864332 23457999999999999999999999998654 378999999
Q ss_pred cCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 517 KNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 517 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++..+|+|||.++....
T Consensus 94 ~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~-------~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 94 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISA-------TNAVKVMDFGIARAIAD 163 (277)
T ss_dssp CEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET-------TSCEEECCCTTCEECC-
T ss_pred CCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCc-------cccceeehhhhhhhhcc
Confidence 9999999998888999999999999999999999999 9999999999999987 78899999999876543
Q ss_pred CCC--ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCCC
Q 039817 597 DQT--RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGNL 674 (725)
Q Consensus 597 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (725)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...........
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVREDPI 232 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHCCCC
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----------HHHHHHHHhcCCC
Confidence 322 222345699999999999999999999999999999999999999964321 1222222333222
Q ss_pred C-----hhHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcCC
Q 039817 675 G-----ATKFERITMVGLWCICPQPTLRP-SMKQVLQMLEGT 710 (725)
Q Consensus 675 ~-----~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~ 710 (725)
+ ...++.+.+++.+||+.||.+|| |++++++.|.++
T Consensus 233 ~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 2 24568899999999999999999 899999988754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=337.61 Aligned_cols=253 Identities=24% Similarity=0.272 Sum_probs=188.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHH--HHHHhccCcCCccceeeEEEcCC----ceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLRE--VQVIGRTHHKNLVQLLGFCIEQN----HQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E--~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~~ 517 (725)
.+.+|++|++|+. ++..||||.+... ..+++..| +..+++++|||||+++|+|.+.+ ..++||||++
T Consensus 12 G~G~fg~Vy~~~~----~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 12 GKGRFGEVWRGKW----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp ECCSSSEEEEEEE----TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred eeCCCeEEEEEEE----CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 3456777777764 3568999998642 33444444 44556789999999999998654 5789999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhccc-----CCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEEC-----ETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
+|+|.++|.+. .++|..++.++.|+|.||.|||+.. ..+|+||||||+||||+. ++.+||+|||+++
T Consensus 85 ~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-------~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 85 HGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-------NGTCCIADLGLAV 156 (303)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-------TSCEEECCCTTCE
T ss_pred CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-------CCCeEEEecCccc
Confidence 99999999764 6899999999999999999999731 349999999999999987 8899999999998
Q ss_pred ccCcCCCc---cccccccCccccchhcccCCC------CCCccceehhHHHHHHHHhCCcCCCCCCCCccccc---cCcc
Q 039817 593 LLKKDQTR---TSTMIRGTMGYMAPEWLRNAP------VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA---NGMI 660 (725)
Q Consensus 593 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~---~~~~ 660 (725)
........ ......||+.|+|||++.+.. ++.|+||||||++||||+||..|+........... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76443322 123456999999999987642 57789999999999999999988754332221111 0111
Q ss_pred hHHHHHHHHHcCC----CCh-----hHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 039817 661 LTDWVLYCVRTGN----LGA-----TKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTS 711 (725)
Q Consensus 661 ~~~~~~~~~~~~~----~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 711 (725)
..+.......... ++. +....+.+|+.+||+.||++|||+.||+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 2222333332222 211 34567999999999999999999999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-39 Score=341.22 Aligned_cols=236 Identities=20% Similarity=0.163 Sum_probs=198.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 520 (725)
...+|++|++|.+..++ ..||||.+... .....+.+.+|+++|++++|||||++++++......++||||+.+|+
T Consensus 50 G~G~fg~Vy~a~~~~~g--~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~ 127 (350)
T d1rdqe_ 50 GTGSFGRVMLVKHKESG--NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127 (350)
T ss_dssp EECSSCEEEEEEETTTC--CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred ecCcCcEEEEEEECCCC--CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccc
Confidence 45678888888876655 47899987532 23456779999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|.+++.+.+.+++..+..++.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++......
T Consensus 128 l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~-------~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQ-------QGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TSCEEECCCTTCEECSSCB--
T ss_pred hhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCC-------CCCEEeeeceeeeeccccc--
Confidence 999998888999999999999999999999999 9999999999999987 7899999999998765332
Q ss_pred cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH-HcCCCChhHH
Q 039817 601 TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV-RTGNLGATKF 679 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 679 (725)
....||+.|||||.+.+..++.++|||||||++|||++|+.||..... ........ .....+...+
T Consensus 196 --~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~i~~~~~~~p~~~s 262 (350)
T d1rdqe_ 196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------IQIYEKIVSGKVRFPSHFS 262 (350)
T ss_dssp --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCTTCC
T ss_pred --ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----------HHHHHHHhcCCCCCCccCC
Confidence 235699999999999999999999999999999999999999964321 11111111 1234455677
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 680 ERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 680 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
+.+.+++.+||+.||.+|+ |++|+++|
T Consensus 263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 8899999999999999994 89999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=337.69 Aligned_cols=238 Identities=22% Similarity=0.241 Sum_probs=196.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHHHHHHh-ccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLREVQVIG-RTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
...+|++|++|.+..+ +..||||.+.+. .....+.+..|..++. .++|||||++++++.+++..++||||+++|
T Consensus 11 G~G~fg~Vy~~~~~~t--~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g 88 (320)
T d1xjda_ 11 GKGSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88 (320)
T ss_dssp EECSSSEEEEEEETTT--TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecCCCcEEEEEEECCC--CCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCC
Confidence 3456788888877655 467899988642 2344566778887776 589999999999999999999999999999
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 89 ~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~-------~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 89 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDK-------DGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT-------TSCEEECCCTTCBCCCCTTC
T ss_pred cHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecC-------CCceeccccchhhhcccccc
Confidence 9999998888899999999999999999999999 9999999999999987 88999999999986554332
Q ss_pred ccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH-HHcCCCChhH
Q 039817 600 RTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC-VRTGNLGATK 678 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 678 (725)
. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +..... ......+...
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-----------~~~~~i~~~~~~~p~~~ 226 (320)
T d1xjda_ 159 K-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----------ELFHSIRMDNPFYPRWL 226 (320)
T ss_dssp C-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------HHHHHHHHCCCCCCTTS
T ss_pred c-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----------HHHHHHHcCCCCCCccC
Confidence 2 23356999999999999999999999999999999999999999743211 111111 1223445566
Q ss_pred HHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 039817 679 FERITMVGLWCICPQPTLRPSMK-QVLQ 705 (725)
Q Consensus 679 ~~~l~~l~~~cl~~dp~~RPs~~-evl~ 705 (725)
++.+.+|+.+||+.||++|||+. |+++
T Consensus 227 s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 78899999999999999999995 7764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-39 Score=333.86 Aligned_cols=244 Identities=23% Similarity=0.251 Sum_probs=189.7
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc-----cHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCC
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD-----GEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNG 519 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 519 (725)
..+|++|++|.+..++ ..||||++...... ..+.+.+|++++++++|||||++++++..++..++||||++++
T Consensus 8 ~G~fg~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~ 85 (299)
T d1ua2a_ 8 EGQFATVYKARDKNTN--QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD 85 (299)
T ss_dssp EETTEEEEEEECSSCC--SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEE
T ss_pred cCcCeEEEEEEECCCC--cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcch
Confidence 4567778888776544 57899988543221 2346899999999999999999999999999999999999998
Q ss_pred ChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCC
Q 039817 520 TLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQT 599 (725)
Q Consensus 520 sL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~ 599 (725)
++...+.....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 86 ~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~-------~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 86 LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE-------NGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp HHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TCCEEECCCGGGSTTTSCCC
T ss_pred HHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecC-------CCccccccCccccccCCCcc
Confidence 8888887778899999999999999999999999 9999999999999987 88999999999987654432
Q ss_pred ccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcC------
Q 039817 600 RTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTG------ 672 (725)
Q Consensus 600 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 672 (725)
.. ....||+.|+|||.+.. ..++.++|||||||++|||++|+.||......+ ....+.......
T Consensus 156 ~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--------~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 156 AY-THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--------QLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp CC-CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHHHCCCCTTTSS
T ss_pred cc-cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--------HHHHHHHhcCCCChhhcc
Confidence 22 23458999999999865 467999999999999999999998886432110 000011100000
Q ss_pred ---------------CC-----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcC
Q 039817 673 ---------------NL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEG 709 (725)
Q Consensus 673 ---------------~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~ 709 (725)
.. .....+.+.+|+.+||+.||++|||++|+++| |..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00 01235678999999999999999999999985 543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-39 Score=333.95 Aligned_cols=238 Identities=15% Similarity=0.197 Sum_probs=196.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
...+|++|++|.+..++ ..||||.+... ......+.+|+++|++++|||||++++++.+++..+|||||+++|+|.+
T Consensus 14 G~G~fg~Vy~~~~~~~~--~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~ 90 (321)
T d1tkia_ 14 GRGEFGIVHRCVETSSK--KTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90 (321)
T ss_dssp EECSSEEEEEEEETTTT--EEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred ecCCCeEEEEEEECCCC--cEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHH
Confidence 45678888888776654 57899988653 3345678899999999999999999999999999999999999999999
Q ss_pred hhccCC-CCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCccc
Q 039817 524 FLFRQE-IPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRTS 602 (725)
Q Consensus 524 ~l~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 602 (725)
++...+ .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ +...+||+|||+++....... .
T Consensus 91 ~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~-----~~~~ikl~DFG~~~~~~~~~~--~ 160 (321)
T d1tkia_ 91 RINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTR-----RSSTIKIIEFGQARQLKPGDN--F 160 (321)
T ss_dssp HHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSS-----SCCCEEECCCTTCEECCTTCE--E
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCC-----CceEEEEcccchhhccccCCc--c
Confidence 998764 799999999999999999999999 99999999999999862 266899999999987644322 2
Q ss_pred cccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--CCh----
Q 039817 603 TMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--LGA---- 676 (725)
Q Consensus 603 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---- 676 (725)
....+++.|+|||.+.+..++.++||||+||++|||++|+.||..... .+.... ..... ++.
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----------~~~~~~-i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----------QQIIEN-IMNAEYTFDEEAFK 228 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHH-HHHTCCCCCHHHHT
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----------HHHHHH-HHhCCCCCChhhcc
Confidence 334589999999999999999999999999999999999999975421 111122 22222 222
Q ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 677 TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 677 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
..++++.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 245678999999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-39 Score=341.66 Aligned_cols=239 Identities=22% Similarity=0.237 Sum_probs=192.4
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc---cCccHHHHHHH---HHHHhccCcCCccceeeEEEcCCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV---TGDGEKSFLRE---VQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~---~~~~~~~f~~E---~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...+|+.|++|.+..++ ..||||.+... .......+.+| +++++.++|||||++++++.+++..++||||++
T Consensus 13 G~G~fg~Vy~~~~~~t~--~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~ 90 (364)
T d1omwa3 13 GRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90 (364)
T ss_dssp EECSSCEEEEEEETTTC--CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecC
Confidence 45677888888776554 57899987532 12233445554 667777889999999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|+|.+++.+...+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 91 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~-------~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 91 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE-------HGHVRISDLGLACDFSKK 160 (364)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECS-------SSCEEECCCTTCEECSSS
T ss_pred CCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcC-------CCcEEEeeeceeeecCCC
Confidence 999999998888899999999999999999999999 9999999999999987 789999999999876543
Q ss_pred CCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH--cCCC
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--TGNL 674 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 674 (725)
.. ....||+.|+|||.+.. ..++.++|||||||++|||++|+.||....... . ..+..... ....
T Consensus 161 ~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~-~~~~~~~~~~~~~~ 228 (364)
T d1omwa3 161 KP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--------K-HEIDRMTLTMAVEL 228 (364)
T ss_dssp CC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--------H-HHHHHHSSSCCCCC
T ss_pred cc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--------H-HHHHHhcccCCCCC
Confidence 22 23569999999999874 568999999999999999999999997543221 1 11111111 1233
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 039817 675 GATKFERITMVGLWCICPQPTLRPS-----MKQVLQM 706 (725)
Q Consensus 675 ~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 706 (725)
+...++.+.+|+.+||+.||++||| ++|+++|
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 4466788999999999999999999 6888864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=339.19 Aligned_cols=248 Identities=22% Similarity=0.249 Sum_probs=194.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhcc-CcCCccceeeEEEc----CCceeeeeecccC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRT-HHKNLVQLLGFCIE----QNHQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~e~~~~ 518 (725)
...+|+.|++|.+..++ ..||||.++. .+.+.+|++++.++ +|||||++++++.+ +...++|||||++
T Consensus 21 G~G~fg~Vy~a~~~~~~--~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 21 GLGINGKVLQIFNKRTQ--EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EECSSCEEEEEEETTTC--CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred eeccCeEEEEEEECCCC--CEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 45678888888876654 5789998853 35678999987765 89999999999875 4578999999999
Q ss_pred CChhhhhccC--CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCc
Q 039817 519 GTLSAFLFRQ--EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKK 596 (725)
Q Consensus 519 gsL~~~l~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~ 596 (725)
|+|.+++.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +..+.+||+|||+++....
T Consensus 94 g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~----~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSK----RPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCS----STTCCEEECCCTTCEECCC
T ss_pred CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccc----cccccccccccceeeeccC
Confidence 9999999764 4689999999999999999999999 99999999999999863 2267899999999987654
Q ss_pred CCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--C
Q 039817 597 DQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN--L 674 (725)
Q Consensus 597 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 674 (725)
... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+......+. +
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--------~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 167 HNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------SPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------CCCSCSSSC
T ss_pred CCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--------HHHHHHHHhcCCCCC
Confidence 332 2335699999999999999999999999999999999999999975432210 000111111111 1
Q ss_pred C----hhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCCCCCC
Q 039817 675 G----ATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTSEVGV 715 (725)
Q Consensus 675 ~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~~~~~ 715 (725)
+ ...++++.+|+.+||+.||++|||+.|+++| +.+..+.+.
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 283 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence 1 1345789999999999999999999999986 544433333
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-38 Score=325.60 Aligned_cols=236 Identities=24% Similarity=0.318 Sum_probs=192.9
Q ss_pred cccHHHHHHHhcccCCcceEEEEEEcccccCc---------cHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeee
Q 039817 445 VFSYQELREATNVFDGQEVEVAVKQLEKVTGD---------GEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYE 514 (725)
Q Consensus 445 ~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~---------~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 514 (725)
..+|+.|++|.+..+ +..+|||.+...... ..+.+.+|+.++++++ |||||++++++.+++..+||||
T Consensus 13 ~G~~g~V~~~~~~~~--~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE 90 (277)
T d1phka_ 13 RGVSSVVRRCIHKPT--CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD 90 (277)
T ss_dssp ECSSEEEEEEEETTT--TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCcCeEEEEEEECCC--CCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEE
Confidence 456777887776554 467899988543211 1246889999999997 9999999999999999999999
Q ss_pred cccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 515 LMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 515 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
|+++|+|.+++..+..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 91 ~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~-------~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 91 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD-------DMNIKLTDFGFSCQL 160 (277)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT-------TCCEEECCCTTCEEC
T ss_pred cCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcC-------CCCeEEccchheeEc
Confidence 999999999998888999999999999999999999999 9999999999999987 889999999999876
Q ss_pred CcCCCccccccccCccccchhcccC------CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHH
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRN------APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYC 668 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (725)
..... .....||..|+|||++.+ ..++.++||||+|+++|||++|+.||..... .. ....
T Consensus 161 ~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----------~~-~~~~ 226 (277)
T d1phka_ 161 DPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----------ML-MLRM 226 (277)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHH
T ss_pred cCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----------HH-HHHH
Confidence 54322 234569999999999853 3568899999999999999999999974321 11 1111
Q ss_pred HHcCC------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 669 VRTGN------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 669 ~~~~~------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
...+. .....++.+.+|+.+||+.||++|||++||+++
T Consensus 227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11221 122567889999999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=323.30 Aligned_cols=246 Identities=23% Similarity=0.266 Sum_probs=188.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.|++|.+..++ ..||||.++.. .....+++.+|++++++++|||||++++++.+++..++||||+.++.+
T Consensus 11 G~G~fg~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~ 88 (298)
T d1gz8a_ 11 GEGTYGVVYKARNKLTG--EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK 88 (298)
T ss_dssp EECSSSEEEEEEETTTC--CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred ecCcCeEEEEEEECCCC--CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh
Confidence 34567888888877665 46899988543 233467899999999999999999999999999999999999987555
Q ss_pred hhhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 522 SAFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 522 ~~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
...... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 89 ~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~-------~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 89 KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINT-------EGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TSCEEECSTTHHHHHCCCSB-
T ss_pred hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecc-------cCcceeccCCcceeccCCcc-
Confidence 444333 36799999999999999999999999 9999999999999987 78999999999987654332
Q ss_pred cccccccCccccchhcccCCC-CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHH---------
Q 039817 601 TSTMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVR--------- 670 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 670 (725)
......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... .+.. ......
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-------~~~~-i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-------QLFR-IFRTLGTPDEVVWPG 229 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHH-HHHHHCCCCTTTSTT
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-------HHHH-HHHhcCCCchhhccc
Confidence 223346999999999877655 5789999999999999999999986432110 0000 000000
Q ss_pred -------cCCC-----------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCC
Q 039817 671 -------TGNL-----------GATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGT 710 (725)
Q Consensus 671 -------~~~~-----------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~ 710 (725)
.... .....+.+.+|+.+||+.||++|||++|++++ ++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000 01234678999999999999999999999997 6544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=325.60 Aligned_cols=233 Identities=21% Similarity=0.304 Sum_probs=190.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC------ccHHHHHHHHHHHhccC--cCCccceeeEEEcCCceeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG------DGEKSFLREVQVIGRTH--HKNLVQLLGFCIEQNHQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~------~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~ 515 (725)
...+|+.|++|.+..++ ..||||.+..... .....+.+|+.++++++ |||||++++++..++..++||||
T Consensus 13 G~G~fg~Vy~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~ 90 (273)
T d1xwsa_ 13 GSGGFGSVYSGIRVSDN--LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 90 (273)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred eeCCCeEEEEEEECCCC--CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEe
Confidence 45678888888876554 5789998754221 12234779999999986 89999999999999999999999
Q ss_pred ccC-CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 516 MKN-GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 516 ~~~-gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
+.+ +++.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++.+ .+.+||+|||+++..
T Consensus 91 ~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~------~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 91 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN------RGELKLIDFGSGALL 161 (273)
T ss_dssp CSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT------TTEEEECCCTTCEEC
T ss_pred ccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecC------CCeEEECccccceec
Confidence 976 68888888888899999999999999999999999 99999999999999853 578999999999865
Q ss_pred CcCCCccccccccCccccchhcccCCCC-CCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRNAPV-TAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN 673 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (725)
.... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... + ......
T Consensus 162 ~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i--~~~~~~ 222 (273)
T d1xwsa_ 162 KDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------I--IRGQVF 222 (273)
T ss_dssp CSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------H--HHCCCC
T ss_pred cccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------H--hhcccC
Confidence 4332 233569999999999987765 5678999999999999999999864210 0 011223
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.+...++.+.+|+.+||+.||++|||++|++++
T Consensus 223 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 445567889999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-37 Score=318.61 Aligned_cols=241 Identities=21% Similarity=0.229 Sum_probs=188.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.|++|.+. .+..||||.+... .....+.|.+|+.+|++++|||||++++++..++..++++|++.++.+
T Consensus 11 G~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 11 GEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred ecCCCcEEEEEEeC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 35577888888764 3467999998543 233467899999999999999999999999999999999999999888
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
..+....+.+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++.........
T Consensus 88 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~-------~~~~kl~DfG~a~~~~~~~~~- 156 (286)
T d1ob3a_ 88 KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINR-------EGELKIADFGLARAFGIPVRK- 156 (286)
T ss_dssp HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TSCEEECCTTHHHHHCC-----
T ss_pred HHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcC-------CCCEEecccccceecccCccc-
Confidence 88888788999999999999999999999998 9999999999999987 789999999999876543322
Q ss_pred ccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---------
Q 039817 602 STMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--------- 671 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 671 (725)
.....+++.|+|||.+.+. .++.++||||||++++||++|+.||......+ ...........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--------QLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCCCTTTSTTG
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--------HHHHHHHhhCCCChhhccch
Confidence 2234588999999998754 56899999999999999999999986432110 00000000000
Q ss_pred ------------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 ------------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ------------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........+.+.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00112345688999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=318.41 Aligned_cols=245 Identities=22% Similarity=0.201 Sum_probs=199.6
Q ss_pred ccccHHHHHHHhcccC-CcceEEEEEEcccc----cCccHHHHHHHHHHHhccCc-CCccceeeEEEcCCceeeeeeccc
Q 039817 444 KVFSYQELREATNVFD-GQEVEVAVKQLEKV----TGDGEKSFLREVQVIGRTHH-KNLVQLLGFCIEQNHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~-~~~~~vavk~l~~~----~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~ 517 (725)
...+|++|++|.+... ..+..||||.+... .....+.+.+|++++++++| |||+++++++......++||||+.
T Consensus 33 G~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~ 112 (322)
T d1vzoa_ 33 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYIN 112 (322)
T ss_dssp EETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeeccc
Confidence 4567888888877553 45678999988542 22345678999999999965 899999999999999999999999
Q ss_pred CCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcC
Q 039817 518 NGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKD 597 (725)
Q Consensus 518 ~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~ 597 (725)
+|+|.+++...+.++......++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 113 ~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~-------~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 113 GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS-------NGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TSCEEESCSSEEEECCGG
T ss_pred ccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecC-------CCCEEEeeccchhhhccc
Confidence 999999998888889999999999999999999999 9999999999999987 789999999999877555
Q ss_pred CCccccccccCccccchhcccCC--CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH--HcCC
Q 039817 598 QTRTSTMIRGTMGYMAPEWLRNA--PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV--RTGN 673 (725)
Q Consensus 598 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 673 (725)
.........|++.|+|||.+.+. .++.++|||||||+||||++|+.||....... ....+.... ....
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--------~~~~i~~~~~~~~~~ 254 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--------SQAEISRRILKSEPP 254 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--------CHHHHHHHHHHCCCC
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHhcccCCCC
Confidence 44444456699999999998754 47889999999999999999999997553221 111122211 1234
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 039817 674 LGATKFERITMVGLWCICPQPTLRP-----SMKQVLQM 706 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 706 (725)
.+...++++.+|+.+||+.||++|| |++|+++|
T Consensus 255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 4567788999999999999999999 58999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-36 Score=314.47 Aligned_cols=246 Identities=24% Similarity=0.289 Sum_probs=188.0
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhcc---CcCCccceeeEEEc-----CCceeeee
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRT---HHKNLVQLLGFCIE-----QNHQLLVY 513 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~~~~~lV~ 513 (725)
...+|++|++|.+..++ +..||||.+... .......+.+|+++++.+ +||||+++++++.. ....+++|
T Consensus 16 G~G~fg~V~~a~~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~ 94 (305)
T d1blxa_ 16 GEGAYGKVFKARDLKNG-GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94 (305)
T ss_dssp EEETTEEEEEEEETTTT-TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEE
T ss_pred ecccCeEEEEEEEECCC-CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEE
Confidence 45678888888775543 357899988542 222344577888877765 79999999999863 34689999
Q ss_pred ecccCCChhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcc
Q 039817 514 ELMKNGTLSAFLFR-QEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 514 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
||++++.+...... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. .+.+||+|||+++
T Consensus 95 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~-------~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 95 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS-------SGQIKLADFGLAR 164 (305)
T ss_dssp ECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TCCEEECSCCSCC
T ss_pred EeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcC-------CCCeeecchhhhh
Confidence 99999877655544 36789999999999999999999999 9999999999999987 7899999999998
Q ss_pred ccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc-
Q 039817 593 LLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT- 671 (725)
Q Consensus 593 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 671 (725)
...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||....... ....+......
T Consensus 165 ~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~ 234 (305)
T d1blxa_ 165 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--------QLGKILDVIGLP 234 (305)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCC
T ss_pred hhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--------HHHHHHHhhCCC
Confidence 654332 2234569999999999999999999999999999999999999996442110 00000000000
Q ss_pred ------------------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCC
Q 039817 672 ------------------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGT 710 (725)
Q Consensus 672 ------------------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~ 710 (725)
........+.+.+|+.+||+.||++|||++|+++| |+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 01112345678899999999999999999999986 5444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=311.28 Aligned_cols=243 Identities=19% Similarity=0.225 Sum_probs=185.9
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccc--ccCccHHHHHHHHHHHhccCcCCccceeeEEEc--------CCceeeee
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEK--VTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIE--------QNHQLLVY 513 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~lV~ 513 (725)
...+|++|++|.+..++ ..||||++.. ......+.+.+|+++|++++|+||+++++++.. ++..++||
T Consensus 19 G~G~fg~Vy~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~ 96 (318)
T d3blha1 19 GQGTFGEVFKARHRKTG--QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96 (318)
T ss_dssp EECSSSEEEEEEETTTC--CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEE
T ss_pred ecCcCeEEEEEEECCCC--CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEE
Confidence 45678888888876554 5788888743 334456789999999999999999999999865 34679999
Q ss_pred ecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 514 ELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 514 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
||++++.+..+......++...+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 97 e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~-------~~~~kl~dfg~~~~ 166 (318)
T d3blha1 97 DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITR-------DGVLKLADFGLARA 166 (318)
T ss_dssp ECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TSCEEECCCTTCEE
T ss_pred eccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecC-------CCcEEeeecceeee
Confidence 9999988887777778899999999999999999999999 9999999999999987 88999999999986
Q ss_pred cCcCCCc---cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHH
Q 039817 594 LKKDQTR---TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCV 669 (725)
Q Consensus 594 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (725)
....... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... .........
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~--------~~~~i~~~~ 238 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--------QLALISQLC 238 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHH
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH--------HHHHHHHhc
Confidence 6543221 12234599999999998765 68999999999999999999999986432110 000111100
Q ss_pred Hc--------------------C-CCCh---------hHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 RT--------------------G-NLGA---------TKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ~~--------------------~-~~~~---------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.. . .... ...+.+++|+.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 0 0000 113467789999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-35 Score=309.33 Aligned_cols=253 Identities=22% Similarity=0.248 Sum_probs=186.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC-ccHHHHHHHHHHHhccCcCCccceeeEEEcCC----ceeeeeecccC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG-DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN----HQLLVYELMKN 518 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~~~ 518 (725)
...+|+.|++|.+..++ ..||||.+..... ...+.+++|+++|++++||||+++++++.... ..+++++++.+
T Consensus 17 G~G~fg~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~ 94 (345)
T d1pmea_ 17 GEGAYGMVCSAYDNVNK--VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 94 (345)
T ss_dssp C---CCCEEEEEETTTC--SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCC
T ss_pred eeccCeEEEEEEECCCC--cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecC
Confidence 44677888888876655 5789999865432 33567899999999999999999999997653 23455566778
Q ss_pred CChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCC
Q 039817 519 GTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQ 598 (725)
Q Consensus 519 gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~ 598 (725)
|+|.+++.. +.+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 95 g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~-------~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 95 ADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNT-------TCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEECCGGG
T ss_pred Cchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECC-------CCCEEEcccCceeeccCCC
Confidence 999999965 4689999999999999999999999 9999999999999987 7899999999998764432
Q ss_pred Cc--cccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc--------------cCcch
Q 039817 599 TR--TSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA--------------NGMIL 661 (725)
Q Consensus 599 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~--------------~~~~~ 661 (725)
.. ......||+.|+|||.+.. ..++.++||||+|++++||++|+.||........... .....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 22 1234568999999999854 4678999999999999999999999865431110000 00000
Q ss_pred HHHHHHHHHc----CCC-----ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCC
Q 039817 662 TDWVLYCVRT----GNL-----GATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTS 711 (725)
Q Consensus 662 ~~~~~~~~~~----~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~ 711 (725)
. ....... ... ......++++|+.+||+.||++|||++|++++ |+...
T Consensus 244 ~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 244 K--ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp H--HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred h--hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0 0000000 000 01233578899999999999999999999987 65443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-35 Score=310.51 Aligned_cols=252 Identities=22% Similarity=0.241 Sum_probs=185.3
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCC------ceeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQN------HQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~e~ 515 (725)
...+|+.|++|++..++ ..||||.+... .....+.+.+|+++|++++|||||++++++...+ +.++||||
T Consensus 27 G~G~fg~V~~~~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 104 (346)
T d1cm8a_ 27 GSGAYGAVCSAVDGRTG--AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104 (346)
T ss_dssp ------CEEEEEETTTC--CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEec
Confidence 45678888888876654 57899998643 2233567899999999999999999999998654 56999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+ +.+|..++ +...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+|++|||+++...
T Consensus 105 ~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~-------~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 105 M-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNE-------DCELKILDFGLARQAD 172 (346)
T ss_dssp C-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT-------TCCEEECCCTTCEECC
T ss_pred c-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccc-------ccccccccccceeccC
Confidence 9 44666665 446799999999999999999999999 9999999999999987 8899999999998764
Q ss_pred cCCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccc--------------cc-cCc
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPT--------------LA-NGM 659 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~--------------~~-~~~ 659 (725)
... +...||+.|+|||.+.+ ..++.++||||+||++|||++|+.|+......... .. ...
T Consensus 173 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 SEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp SSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred Ccc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 432 33558999999999876 45789999999999999999999998654211100 00 000
Q ss_pred chHHHHHHHHHcC------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCCCC
Q 039817 660 ILTDWVLYCVRTG------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTSEV 713 (725)
Q Consensus 660 ~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~~~ 713 (725)
............. .......+.+.+|+.+||+.||++|||++|+++| |+.+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 0000000000000 0112335678899999999999999999999997 7765443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-35 Score=304.32 Aligned_cols=251 Identities=18% Similarity=0.173 Sum_probs=187.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccce-eeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQL-LGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...+|++|++|.+..++ ..||||.+.... ..+++..|++++++++|+|++.. .++..+++..++||||+++ +|.
T Consensus 16 G~G~fG~Vy~a~~~~~~--~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~ 90 (299)
T d1ckia_ 16 GSGSFGDIYLGTDIAAG--EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE 90 (299)
T ss_dssp EECSSSEEEEEEETTTT--EEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHH
T ss_pred eeCCCcEEEEEEECCCC--CEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chh
Confidence 45678888888876655 578888775432 23468899999999987765555 5555677888999999965 555
Q ss_pred hhh-ccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 523 AFL-FRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 523 ~~l-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
+.+ ...+.+++..+..++.|++.||+|||++ +|+||||||+|||++.. +.+..+||+|||+++.+......
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~----~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 91 DLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLG----KKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCG----GGTTCEEECCCSSCEECBCTTTCC
T ss_pred hhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhcccccc----CCCceeeeeccCcceecccccccc
Confidence 544 4557899999999999999999999999 99999999999998652 22678999999999976543321
Q ss_pred -----cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc--CC
Q 039817 601 -----TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--GN 673 (725)
Q Consensus 601 -----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 673 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .............. ..
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK----RQKYERISEKKMSTPIEV 239 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHHHHHSCHHH
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH----HHHHHHhhcccCCCChhH
Confidence 22345699999999999999999999999999999999999999976443221 11111111111110 01
Q ss_pred CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 039817 674 LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGT 710 (725)
Q Consensus 674 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 710 (725)
.....++++.+++..|++.+|++||+++++.+.|+.+
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1223457789999999999999999999998888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-35 Score=304.40 Aligned_cols=267 Identities=16% Similarity=0.131 Sum_probs=201.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCc-CCccceeeEEEcCCceeeeeecccCCChh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHH-KNLVQLLGFCIEQNHQLLVYELMKNGTLS 522 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 522 (725)
...+|++|++|.+..++ ..||||.+... .....+.+|++.++.++| +|++.+++++.++...++||||+ +++|.
T Consensus 14 G~G~fG~Vy~a~~~~~~--~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~ 88 (293)
T d1csna_ 14 GEGSFGVIFEGTNLLNN--QQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE 88 (293)
T ss_dssp EECSSCEEEEEEETTTT--EEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred ecCCCeEEEEEEECCCC--CEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHH
Confidence 45678888888877654 57888877543 233457889999999965 89999999999999999999999 57999
Q ss_pred hhhccC-CCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc-
Q 039817 523 AFLFRQ-EIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR- 600 (725)
Q Consensus 523 ~~l~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~- 600 (725)
+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+.. ...+.+||+|||+++.+......
T Consensus 89 ~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~--~~~~~vkl~DFG~a~~~~~~~~~~ 163 (293)
T d1csna_ 89 DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNS--KNANMIYVVDFGMVKFYRDPVTKQ 163 (293)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSS--TTTTCEEECCCTTCEESBCTTTCC
T ss_pred HHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCccc--ccCCceEEcccceeEEcccCcccc
Confidence 988665 5789999999999999999999999 9999999999999975321 12578999999999876543221
Q ss_pred -----cccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHcCC--
Q 039817 601 -----TSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRTGN-- 673 (725)
Q Consensus 601 -----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 673 (725)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......+........
T Consensus 164 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-----~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 164 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYERIGEKKQSTPLR 238 (293)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHHHHHHHHHHSCHH
T ss_pred ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-----HHHHHHHHhccCCCChH
Confidence 12235699999999999999999999999999999999999999975443221 001111111111111
Q ss_pred -CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC--CCCCCCccccCCC
Q 039817 674 -LGATKFERITMVGLWCICPQPTLRPSMKQVLQMLEGTSE--VGVPPVVADAQMF 725 (725)
Q Consensus 674 -~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~--~~~p~~~~~~~~~ 725 (725)
+....++++.+++..|++.+|++||+++.+.+.|+.+.+ -.....+.||.+|
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 112345678999999999999999999999888876532 1222344566553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-35 Score=304.19 Aligned_cols=243 Identities=22% Similarity=0.196 Sum_probs=192.8
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccc--cCccHHHHHHHHHHHhccCcCCccceeeEEEcCCceeeeeecccCCCh
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKV--TGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
...+|+.|++|++..++ ..||||.++.. .....+.+.+|+.++++++||||+++++++...+..++|+|++.+++|
T Consensus 11 G~G~fg~V~~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l 88 (292)
T d1unla_ 11 GEGTYGTVFKAKNRETH--EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88 (292)
T ss_dssp EECSSSEEEEEEETTTC--CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHH
T ss_pred ecCcCeEEEEEEECCCC--cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccc
Confidence 34567888888877554 56888887533 334467899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCcc
Q 039817 522 SAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTRT 601 (725)
Q Consensus 522 ~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 601 (725)
..++...+.+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||.++........
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~-------~~~~kl~DFG~a~~~~~~~~~- 157 (292)
T d1unla_ 89 KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINR-------NGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT-------TCCEEECCCTTCEECCSCCSC-
T ss_pred ccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCccccccc-------CCceeeeecchhhcccCCCcc-
Confidence 99998888999999999999999999999999 9999999999999987 778999999999876543322
Q ss_pred ccccccCccccchhcccCCC-CCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHHHHHHHHc---------
Q 039817 602 STMIRGTMGYMAPEWLRNAP-VTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDWVLYCVRT--------- 671 (725)
Q Consensus 602 ~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 671 (725)
.....++..|+|||.+.... ++.++|||||||+++||++|+.|+........ ....+......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-------QLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-------HHHHHHHHHCCCCTTTCTTG
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-------HHHHHHhhcCCCChhhhhhh
Confidence 22234778899999887654 68999999999999999999999754322110 00001110000
Q ss_pred ------------------CCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 672 ------------------GNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 672 ------------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
........+.+.+|+.+||+.||++|||++||++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112345678899999999999999999999885
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-35 Score=310.26 Aligned_cols=246 Identities=22% Similarity=0.179 Sum_probs=181.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccCcCCccceeeEEEcC------Cceeeeeeccc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ------NHQLLVYELMK 517 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~~ 517 (725)
...+|++|++|.+..++ ..||||.+..... .+.+|+++|++++|+|||++++++... ...+|||||++
T Consensus 29 G~G~fg~Vy~a~~~~~~--~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~ 102 (350)
T d1q5ka_ 29 GNGSFGVVYQAKLCDSG--ELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102 (350)
T ss_dssp EEETTEEEEEEEETTTC--CEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred eeCcCeEEEEEEECCCC--CEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence 45678888888877554 5789998865432 234799999999999999999998643 34689999998
Q ss_pred CCChhhh---hccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCcccc
Q 039817 518 NGTLSAF---LFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLL 594 (725)
Q Consensus 518 ~gsL~~~---l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~ 594 (725)
++.+... ......+++..+..++.||+.||+|||+. +|+||||||+|||++.+ ...+||+|||+++..
T Consensus 103 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~------~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 103 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPD------TAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTT------TCCEEECCCTTCEEC
T ss_pred CccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecC------CCceeEecccchhhc
Confidence 7644333 23456799999999999999999999999 99999999999999862 358999999999876
Q ss_pred CcCCCccccccccCccccchhcccC-CCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc----cCcchHHHHHHHH
Q 039817 595 KKDQTRTSTMIRGTMGYMAPEWLRN-APVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA----NGMILTDWVLYCV 669 (725)
Q Consensus 595 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 669 (725)
...... ....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........... ......+......
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 543322 23458999999998765 5789999999999999999999999965432110000 0000000000000
Q ss_pred ---HcCC------------CChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 670 ---RTGN------------LGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 670 ---~~~~------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.... ......+.+.+|+.+||+.||++|||+.|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 011345678999999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-34 Score=304.08 Aligned_cols=244 Identities=20% Similarity=0.226 Sum_probs=185.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEc--CCceeeeeecccCCC
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIE--QNHQLLVYELMKNGT 520 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~e~~~~gs 520 (725)
...+|++|++|++..++ ..||||.++. ...+++.+|+++|++++ ||||+++++++.. ....++||||+++++
T Consensus 44 G~G~fg~V~~a~~~~~~--~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~ 118 (328)
T d3bqca1 44 GRGKYSEVFEAINITNN--EKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118 (328)
T ss_dssp EECSSEEEEEEEETTTT--EEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCB
T ss_pred ecCcCeEEEEEEECCCC--CEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCc
Confidence 45678888888876554 6799999864 34678999999999995 9999999999985 456899999999999
Q ss_pred hhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccCcCCCc
Q 039817 521 LSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLKKDQTR 600 (725)
Q Consensus 521 L~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~~~~~~ 600 (725)
|..+. +.+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +..+||+|||+++.......
T Consensus 119 L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~------~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 119 FKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHE------HRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp GGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT------TTEEEECCGGGCEECCTTCC-
T ss_pred HHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCC------CCeeeecccccceeccCCCc-
Confidence 98764 4689999999999999999999999 99999999999999862 45799999999987654332
Q ss_pred cccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccC--cchHHHHHHHHHcC-----
Q 039817 601 TSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANG--MILTDWVLYCVRTG----- 672 (725)
Q Consensus 601 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~----- 672 (725)
.....+|..|+|||.+.+. .++.++||||+|++++||++|+.|+............. ..-...........
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 2334589999999998765 57999999999999999999999986543221100000 00000000000000
Q ss_pred ---------------------CCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 673 ---------------------NLGATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 673 ---------------------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
.......+++.+|+.+||+.||++|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111235678999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=298.46 Aligned_cols=246 Identities=23% Similarity=0.213 Sum_probs=176.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEccccc--CccHHHHHHHHHHHhccCcCCccceeeEEEc------CCceeeeeec
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVT--GDGEKSFLREVQVIGRTHHKNLVQLLGFCIE------QNHQLLVYEL 515 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lV~e~ 515 (725)
...+|+.|++|.+..++ ..||||++.... ....+.+.+|+.++++++|||||++++++.. ....++||||
T Consensus 26 G~G~fg~V~~~~d~~t~--~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey 103 (355)
T d2b1pa1 26 GSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103 (355)
T ss_dssp SCC--CEEEEEEETTTT--EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred ecCcCeEEEEEEECCCC--CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEec
Confidence 45577888888776544 678999986432 3334578999999999999999999999964 3678999999
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+.++.+... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+|++|||+++...
T Consensus 104 ~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~-------~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 104 MDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS-------DCTLKILDFGLARTAG 170 (355)
T ss_dssp CSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT-------TCCEEECCCCC-----
T ss_pred cchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccc-------ccceeeechhhhhccc
Confidence 987655443 24589999999999999999999999 9999999999999987 7889999999988654
Q ss_pred cCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc-----cC------cchHHH
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA-----NG------MILTDW 664 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~-----~~------~~~~~~ 664 (725)
.... .....+|+.|+|||.+.+..++.++||||+||+++||++|+.||........... .. ......
T Consensus 171 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 171 TSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cccc--cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 4322 2334589999999999999999999999999999999999999864421110000 00 000000
Q ss_pred HHHHHHcCC---------------C------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 039817 665 VLYCVRTGN---------------L------GATKFERITMVGLWCICPQPTLRPSMKQVLQM 706 (725)
Q Consensus 665 ~~~~~~~~~---------------~------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 706 (725)
......... . .....+.+.+|+.+||+.||++|||++||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111111000 0 01345678999999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-33 Score=296.29 Aligned_cols=252 Identities=21% Similarity=0.225 Sum_probs=184.6
Q ss_pred cccccHHHHHHHhcccCCcceEEEEEEcccccC--ccHHHHHHHHHHHhccCcCCccceeeEEEcC-----Cceeeeeec
Q 039817 443 MKVFSYQELREATNVFDGQEVEVAVKQLEKVTG--DGEKSFLREVQVIGRTHHKNLVQLLGFCIEQ-----NHQLLVYEL 515 (725)
Q Consensus 443 ~~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~ 515 (725)
+...+|+.|++|.+..++ ..||||.+..... ...+.+.+|+++|++++|||||++++++... ...+++++|
T Consensus 26 LG~G~fg~Vy~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~ 103 (348)
T d2gfsa1 26 VGSGAYGSVCAAFDTKTG--LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103 (348)
T ss_dssp CGGGTTSSEEEEEETTTT--EEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EecCCCeEEEEEEECCCC--CEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence 345678888888876654 6799999865432 3345789999999999999999999998743 345677888
Q ss_pred ccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEEeeccCccccC
Q 039817 516 MKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKLLK 595 (725)
Q Consensus 516 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~~~ 595 (725)
+.+|+|.+++.. +.+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+|++|||++....
T Consensus 104 ~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~-------~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 104 LMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE-------DCELKILDFGLARHTD 172 (348)
T ss_dssp CCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT-------TCCEEECCC----CCT
T ss_pred ecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccc-------cccccccccchhcccC
Confidence 889999999854 5699999999999999999999999 9999999999999987 8899999999997654
Q ss_pred cCCCccccccccCccccchhcccCC-CCCCccceehhHHHHHHHHhCCcCCCCCCCCccccc------------cCcchH
Q 039817 596 KDQTRTSTMIRGTMGYMAPEWLRNA-PVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLA------------NGMILT 662 (725)
Q Consensus 596 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~------------~~~~~~ 662 (725)
.. .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||........... ......
T Consensus 173 ~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp GG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 32 2234588999999987665 568999999999999999999999864321110000 000000
Q ss_pred HHHHHHHHc-CCC--------ChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCC
Q 039817 663 DWVLYCVRT-GNL--------GATKFERITMVGLWCICPQPTLRPSMKQVLQM--LEGTS 711 (725)
Q Consensus 663 ~~~~~~~~~-~~~--------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~ 711 (725)
......... ... .....+.+.+|+.+||+.||++|||++|+++| +.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000 000 01234678899999999999999999999985 55443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.6e-29 Score=269.28 Aligned_cols=254 Identities=20% Similarity=0.178 Sum_probs=178.7
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccCccHHHHHHHHHHHhccC-----------cCCccceeeEEEcC--Ccee
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-----------HKNLVQLLGFCIEQ--NHQL 510 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~~--~~~~ 510 (725)
...+|+.|++|.+..++ ..||||++.... ...+.+.+|++++++++ |+||+++++++... ...+
T Consensus 22 G~G~fg~Vy~~~~~~~g--~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 98 (362)
T d1q8ya_ 22 GWGHFSTVWLAKDMVNN--THVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 98 (362)
T ss_dssp EECSSEEEEEEEETTTT--EEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEE
T ss_pred eeCCCeEEEEEEECCCC--CEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccccee
Confidence 34567788888776655 578999986532 23467889999988875 57899999998754 4556
Q ss_pred eeeecccCCChhhh-h--ccCCCCCHHHHHHHHHHHHHHhhhhhc-ccCCceeecCCccceEEeccCccccCCCCceEEe
Q 039817 511 LVYELMKNGTLSAF-L--FRQEIPTWDKRVEIALGIARGLLYLHE-ECETQIIHCDIKPQNVLLDNNYITIDNNYITKIA 586 (725)
Q Consensus 511 lV~e~~~~gsL~~~-l--~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl~ 586 (725)
++++++..+..... . .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.+... .....+|++
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~-~~~~~~kl~ 174 (362)
T d1q8ya_ 99 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP-ENLIQIKIA 174 (362)
T ss_dssp EEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT-TTEEEEEEC
T ss_pred eeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc-cccceeeEe
Confidence 66666654432222 2 233678899999999999999999997 6 89999999999999763110 001348999
Q ss_pred eccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHHHHHHhCCcCCCCCCCCccccccCcchHHH--
Q 039817 587 DFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVMLLEIIFCKRHTELHRVDEPTLANGMILTDW-- 664 (725)
Q Consensus 587 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl~elltg~~~~~~~~~~~~~~~~~~~~~~~-- 664 (725)
|||.+....... ....||+.|+|||.+.+..++.++||||+|++++||++|+.||.......... ....+...
T Consensus 175 dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~-~~~~~~~~~~ 249 (362)
T d1q8ya_ 175 DLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-DDDHIAQIIE 249 (362)
T ss_dssp CCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C-HHHHHHHHHH
T ss_pred eccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc-hhHHHHHHHH
Confidence 999998654322 23458999999999999999999999999999999999999986432211000 00000000
Q ss_pred -------------------------------------HHHHHHcCCCChhHHHHHHHHHHHccCCCCCCCCCHHHHHHH-
Q 039817 665 -------------------------------------VLYCVRTGNLGATKFERITMVGLWCICPQPTLRPSMKQVLQM- 706 (725)
Q Consensus 665 -------------------------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~- 706 (725)
...............+.+.+|+.+||+.||.+|||++|+++|
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000011122334567889999999999999999999999987
Q ss_pred -hcC
Q 039817 707 -LEG 709 (725)
Q Consensus 707 -L~~ 709 (725)
++.
T Consensus 330 ~f~~ 333 (362)
T d1q8ya_ 330 WLKD 333 (362)
T ss_dssp GGTT
T ss_pred ccCC
Confidence 553
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.62 E-value=1.4e-15 Score=129.25 Aligned_cols=95 Identities=17% Similarity=0.256 Sum_probs=78.9
Q ss_pred cccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcCC
Q 039817 26 NNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSN 105 (725)
Q Consensus 26 ~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~~ 105 (725)
|+|.+||.|.. |++|+ +|.|.|+|...+. |.++. ..++||+||++.|...++.+.|+.+|+|||.|++
T Consensus 2 ~~L~~g~~L~~--g~~l~--~g~~~l~~q~dgn----Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 2 NLLTNGEGLYA--GQSLD--VEPYHFIMQEDCN----LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CEEETTCEEET--TCEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS
T ss_pred CCccCCCEEeC--CCEEE--eCCEEEEecCCCe----EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC
Confidence 68999999987 88886 4889999974322 44433 3689999999999998899999999999999999
Q ss_pred CceEEEecc---CceeEEEEecCCCeEEec
Q 039817 106 GTQFKIYNG---TLTVSALMQDSGNFLYSN 132 (725)
Q Consensus 106 ~~~~ws~~~---~~~~~a~LldsGNlVl~~ 132 (725)
|+++|+++. .....|+|+|+|||||.+
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~ 99 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYG 99 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEEC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEEC
Confidence 999998753 244579999999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.60 E-value=9.9e-17 Score=152.96 Aligned_cols=163 Identities=13% Similarity=0.056 Sum_probs=110.2
Q ss_pred ccccHHHHHHHhcccCCcceEEEEEEcccccC------------------ccHHHHHHHHHHHhccCcCCccceeeEEEc
Q 039817 444 KVFSYQELREATNVFDGQEVEVAVKQLEKVTG------------------DGEKSFLREVQVIGRTHHKNLVQLLGFCIE 505 (725)
Q Consensus 444 ~~~~~~~l~~a~~~~~~~~~~vavk~l~~~~~------------------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 505 (725)
...+|++|++|++. ++..||||.++.... .....+..|...+.+++|.+++..+++.
T Consensus 9 G~G~~g~Vy~a~~~---~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-- 83 (191)
T d1zara2 9 GEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-- 83 (191)
T ss_dssp EECSSEEEEEEEET---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE--
T ss_pred eeCcceEEEEEECC---CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec--
Confidence 34567778877652 356789997642110 0113355788899999999999988663
Q ss_pred CCceeeeeecccCCChhhhhccCCCCCHHHHHHHHHHHHHHhhhhhcccCCceeecCCccceEEeccCccccCCCCceEE
Q 039817 506 QNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVEIALGIARGLLYLHEECETQIIHCDIKPQNVLLDNNYITIDNNYITKI 585 (725)
Q Consensus 506 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~dik~~NIll~~~~~~~~~~~~~kl 585 (725)
..+++|||+++..+.+ ++......++.|++++|.|||+. +|+||||||+|||+++ ..++|
T Consensus 84 --~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~--------~~~~l 143 (191)
T d1zara2 84 --GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSE--------EGIWI 143 (191)
T ss_dssp --TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEET--------TEEEE
T ss_pred --CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeC--------CCEEE
Confidence 2379999999865543 34455678999999999999999 9999999999999985 34899
Q ss_pred eeccCccccCcCCCccccccccCccccchhcccCCCCCCccceehhHHHH
Q 039817 586 ADFGLAKLLKKDQTRTSTMIRGTMGYMAPEWLRNAPVTAKVDVYSFGVML 635 (725)
Q Consensus 586 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G~vl 635 (725)
+|||+|....+...... ....... -.|++ .+.|..++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~~--l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREI--LERDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHH--HHHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHH--HHHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 99999976543322110 0000000 01222 35678899999975443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.52 E-value=1.9e-14 Score=123.27 Aligned_cols=97 Identities=13% Similarity=0.266 Sum_probs=75.5
Q ss_pred ccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcC
Q 039817 25 TNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHS 104 (725)
Q Consensus 25 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~ 104 (725)
+|+|.+||.|.. |++|+| |.|+|+|...+. |.|+. ..++||.||++.|.. ++.+.|..+|+|+|.++
T Consensus 1 tDtL~~gq~L~~--g~~l~~--g~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~~~-~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDT--GGSLAE--GGYLFIIQNDCN----LVLYD----NNRAVWASGTNGKAS-GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECT--TCEEEE--TTEEEEECTTSC----EEEEE----TTEEEEECCCTTSCS-SEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecC--CCEEEE--CCEEEEEcCCCC----EEEEc----CCcEEEEccCccCCC-CcEEEEeccccEEEEec
Confidence 589999999987 889975 999999975433 45544 368999999998854 46899999999999997
Q ss_pred CCceEEEecc---CceeEEEEecCCCeEEecCCC
Q 039817 105 NGTQFKIYNG---TLTVSALMQDSGNFLYSNANG 135 (725)
Q Consensus 105 ~~~~~ws~~~---~~~~~a~LldsGNlVl~~~~~ 135 (725)
++ .+|+++. .....|+|+|+|||||++.++
T Consensus 68 ~~-~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~ 100 (112)
T d1xd5a_ 68 SR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSN 100 (112)
T ss_dssp TE-EEEECCCCCSCCCCEEEECTTSCEEEECTTS
T ss_pred CC-eEEEEeeccCCCceEEEEcCCCCEEEECCCC
Confidence 54 5554432 234579999999999997543
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.50 E-value=4.9e-14 Score=119.49 Aligned_cols=96 Identities=14% Similarity=0.199 Sum_probs=77.5
Q ss_pred ccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcC
Q 039817 25 TNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHS 104 (725)
Q Consensus 25 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~ 104 (725)
.|+|.+||.|.. |++|. +|.|.|.|...+. |.|+. ..++||.||++.|- ..+.+.|..+|+|+|.++
T Consensus 1 ~~~L~~g~~L~~--G~~l~--ng~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLST--GEFLN--YGSFVFIMQEDCN----LVLYD----VDKPIWATNTGGLS-RSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECT--TCEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCTTSC-SSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecC--CCEEE--cCCEEEEECCCCe----EEEEe----CCceeeEeCCCCCC-CccEEEEeccceEEEECC
Confidence 378899999976 88885 6999999985543 55654 35789999999883 345799999999999999
Q ss_pred CCceEEEeccC---ceeEEEEecCCCeEEecC
Q 039817 105 NGTQFKIYNGT---LTVSALMQDSGNFLYSNA 133 (725)
Q Consensus 105 ~~~~~ws~~~~---~~~~a~LldsGNlVl~~~ 133 (725)
+|.++|+++.. ...+|+|+|+|||||.+.
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~ 99 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGT 99 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEEC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeCC
Confidence 99999987632 345689999999999953
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.48 E-value=2.5e-14 Score=123.42 Aligned_cols=92 Identities=17% Similarity=0.232 Sum_probs=77.5
Q ss_pred EEeccCCCCeEEEEeCCCCCCCCCc-eEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC-----
Q 039817 65 IWFDKISERTLVWSANRDDPAQVGS-SINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG----- 135 (725)
Q Consensus 65 Iw~~~~~~~tvVWvANr~~Pv~~~s-~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~----- 135 (725)
|||.++++++.+|++|++.|+..+. +|.+..||||+|.+. +.++|+++.. ..+.|+|+|+|||||++.++
T Consensus 12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence 8999999999999999999998765 899999999999986 5678866532 34679999999999998876
Q ss_pred -CccCCCCceEEeeecCCCeEEe
Q 039817 136 -SVDYSTGRFVLEIQMDGNVVLS 157 (725)
Q Consensus 136 -~~d~s~g~~~~~~~~~g~~~~~ 157 (725)
..+.+.|.|.+.|+++|++.++
T Consensus 91 S~t~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 91 SGNSRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp CCCCCSSSCCEEEECSSSCEEEE
T ss_pred eCCCCCCCcEEEEECCCCcEEEe
Confidence 4567789999999999999885
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.33 E-value=4.2e-13 Score=114.30 Aligned_cols=102 Identities=22% Similarity=0.296 Sum_probs=85.4
Q ss_pred EEeccCCCCeEEEEeCCCCCCCCCc-eEEEcccccEEEEcCCCceEEEecc--CceeEEEEecCCCeEEecCCC------
Q 039817 65 IWFDKISERTLVWSANRDDPAQVGS-SINLTVTGQLVLTHSNGTQFKIYNG--TLTVSALMQDSGNFLYSNANG------ 135 (725)
Q Consensus 65 Iw~~~~~~~tvVWvANr~~Pv~~~s-~l~l~~~G~LvL~~~~~~~~ws~~~--~~~~~a~LldsGNlVl~~~~~------ 135 (725)
|||.-.++.+..|+.+.+.++.++. +|.+..||||||.+ ++.++|+++. .....+.|+|+|||||++.++
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 7887777888889999999998765 89999999999988 4678997664 345679999999999998775
Q ss_pred CccCCCCceEEeeecCCCeEEeeeecCCCceeecCCC
Q 039817 136 SVDYSTGRFVLEIQMDGNVVLSAFRFADPAYWYTSTR 172 (725)
Q Consensus 136 ~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~ 172 (725)
..+.+.|.|.+.|+++|++.++ +.++|.+++.
T Consensus 82 ~t~~~~g~y~l~Lq~DGNlvlY-----~~~~Wssgt~ 113 (115)
T d1dlpa1 82 GTKGSIGNYVLVLQPDRTVTIY-----GPGLWDSGTS 113 (115)
T ss_dssp CCCCCSSCCEEEECSSSCEEEE-----CSEEEECSCC
T ss_pred CCCCCCCCEEEEECCCCcEEEe-----CCCeecCCCC
Confidence 5678899999999999998875 3578988754
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.14 E-value=1.5e-10 Score=98.98 Aligned_cols=92 Identities=12% Similarity=0.138 Sum_probs=70.4
Q ss_pred cccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccEEEEcCC
Q 039817 26 NNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQLVLTHSN 105 (725)
Q Consensus 26 ~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~~ 105 (725)
++|.++|+|. ..+..|.|.|.|...+. |.+ |. ..++||.||+..|.. .+.+.|..+|+|+|.|.+
T Consensus 15 ~~l~~~q~l~------~~~~~~~y~l~mQ~DGN----LVL-y~---~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESLE------ILFGTHVYRFIMQTDCN----LVL-YD---NNNPIWATNTGGLGN-GCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEEE------EEETTEEEEEEECTTSC----EEE-EE---TTEEEEECCCTTSCS-SCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeEE------EecCCceEEEEECCCCc----EEE-EE---CCeEEEEecCCCCCc-ceEEEEEeCCCEEEECCC
Confidence 5666666662 46779999999875443 333 43 368899999987743 468999999999999999
Q ss_pred CceEEEeccC---ceeEEEEecCCCeEEec
Q 039817 106 GTQFKIYNGT---LTVSALMQDSGNFLYSN 132 (725)
Q Consensus 106 ~~~~ws~~~~---~~~~a~LldsGNlVl~~ 132 (725)
|.++|+++.. ....++|+|+|||||.+
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEEE
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEEC
Confidence 9999986542 33468999999999974
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.82 E-value=1.1e-09 Score=92.74 Aligned_cols=93 Identities=13% Similarity=0.133 Sum_probs=67.6
Q ss_pred CCcccccccCCCCceeeCCCCeeeeCCCeEEEeeeeCCCCCEEEEEEeccCCCCeEEEEeCCCCCCCCCceEEEcccccE
Q 039817 20 LPQMTTNNIELGSNIIAGTNSTWPSTSGDFAFGFYPLVSGLFLVGIWFDKISERTLVWSANRDDPAQVGSSINLTVTGQL 99 (725)
Q Consensus 20 ~~~~~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~ylgIw~~~~~~~tvVWvANr~~Pv~~~s~l~l~~~G~L 99 (725)
+...+.+|+.++|+|. +|.|.|.|...+. |.++. ..++||.+|... ...+.+.|..+|||
T Consensus 9 ~~~~~~~tl~~~~~l~----------~g~~~l~~q~DGN----LvL~~----~~~~vW~s~t~~--~~~~~l~l~~dGNL 68 (115)
T d1dlpa1 9 HEGSHPQTLHAAQSLE----------LSSFRFTMQSDCN----LVLFD----SDVRVWASNTAG--ATGCRAVLQSDGLL 68 (115)
T ss_dssp SSSCSCSCCCTTCEEC----------STTEEEEECTTSC----EEEEE----SSSEEECCCCCS--CSCCBCCBCSSSCB
T ss_pred CCCCCcceecCCCcEE----------cCCEEEEECCCCe----EEEEc----CCeeEEEcccCC--CCceEEEEeccCCE
Confidence 4445557777777663 4668777764433 44543 256899999754 33568999999999
Q ss_pred EEEcCCCceEEEecc---CceeEEEEecCCCeEEec
Q 039817 100 VLTHSNGTQFKIYNG---TLTVSALMQDSGNFLYSN 132 (725)
Q Consensus 100 vL~~~~~~~~ws~~~---~~~~~a~LldsGNlVl~~ 132 (725)
||.|.+++++|++.. .....++|+++|||||.+
T Consensus 69 vl~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~ 104 (115)
T d1dlpa1 69 VILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG 104 (115)
T ss_dssp CCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC
T ss_pred EEEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC
Confidence 999999999997653 234569999999999984
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.45 E-value=3.6e-07 Score=77.45 Aligned_cols=76 Identities=26% Similarity=0.329 Sum_probs=59.4
Q ss_pred eEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC------CccCCCCceEEeeecCCCeEEeeee
Q 039817 90 SINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG------SVDYSTGRFVLEIQMDGNVVLSAFR 160 (725)
Q Consensus 90 ~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~------~~d~s~g~~~~~~~~~g~~~~~~~~ 160 (725)
+|.+-.||||||.+. +.++|+++.. ..+.+.|.++|||||.+.++ ...-+.|.|.+.|+++|++.++
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlY--- 108 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY--- 108 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEE---
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCCcCCCCceEEEEcCCCCEEEE---
Confidence 577889999999875 5688977643 24679999999999999876 2345668899999999999885
Q ss_pred cCCCceeecCC
Q 039817 161 FADPAYWYTST 171 (725)
Q Consensus 161 ~~~~~yw~~~~ 171 (725)
.++.|.+++
T Consensus 109 --g~~~W~S~T 117 (119)
T d1b2pa_ 109 --GDALWATQT 117 (119)
T ss_dssp --ESEEEECCC
T ss_pred --CCCEeccCC
Confidence 245787654
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.37 E-value=7.1e-07 Score=74.44 Aligned_cols=77 Identities=25% Similarity=0.258 Sum_probs=59.3
Q ss_pred ceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC------CccCCCCceEEeeecCCCeEEeee
Q 039817 89 SSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG------SVDYSTGRFVLEIQMDGNVVLSAF 159 (725)
Q Consensus 89 s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~------~~d~s~g~~~~~~~~~g~~~~~~~ 159 (725)
-+|.+..||||||.+ .+.++|+++.. ..+.+.|.++|||||.+.++ ....+.+.|.+.|+.+|++.++
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly-- 97 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY-- 97 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEE--
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEe--
Confidence 368888999999987 56789987642 23579999999999998876 3345678889999999999986
Q ss_pred ecCCCceeecCC
Q 039817 160 RFADPAYWYTST 171 (725)
Q Consensus 160 ~~~~~~yw~~~~ 171 (725)
+++.|.+..
T Consensus 98 ---~~~~W~S~t 106 (108)
T d1jpca_ 98 ---GTDRWATGT 106 (108)
T ss_dssp ---ECCCCCCCC
T ss_pred ---CCCcccCCC
Confidence 234676543
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.35 E-value=9.8e-07 Score=73.62 Aligned_cols=77 Identities=31% Similarity=0.422 Sum_probs=58.8
Q ss_pred ceEEEcccccEEEEcCCCceEEEeccC----ceeEEEEecCCCeEEecCCC------CccCCCCceEEeeecCCCeEEee
Q 039817 89 SSINLTVTGQLVLTHSNGTQFKIYNGT----LTVSALMQDSGNFLYSNANG------SVDYSTGRFVLEIQMDGNVVLSA 158 (725)
Q Consensus 89 s~l~l~~~G~LvL~~~~~~~~ws~~~~----~~~~a~LldsGNlVl~~~~~------~~d~s~g~~~~~~~~~g~~~~~~ 158 (725)
-++.+-.||||||.. +++++|+++.. ....+.|.++|||||.+.++ ......|.+.+.|+++|++.++
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly- 98 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY- 98 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEE-
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEE-
Confidence 467788999999986 56789987642 34578999999999999876 2334578889999999999875
Q ss_pred eecCCCceeecCC
Q 039817 159 FRFADPAYWYTST 171 (725)
Q Consensus 159 ~~~~~~~yw~~~~ 171 (725)
+.+.|.+.+
T Consensus 99 ----~~~~W~S~t 107 (109)
T d1kj1a_ 99 ----GSDIWSTGT 107 (109)
T ss_dssp ----CCEEEECCC
T ss_pred ----CCCEecCCC
Confidence 235776543
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.32 E-value=6.8e-07 Score=75.94 Aligned_cols=59 Identities=15% Similarity=0.173 Sum_probs=46.0
Q ss_pred CeEEEEeCCCCCCCCCceEEEcccccEEEEcCCCceEEEecc---CceeEEEEecCCCeEEec
Q 039817 73 RTLVWSANRDDPAQVGSSINLTVTGQLVLTHSNGTQFKIYNG---TLTVSALMQDSGNFLYSN 132 (725)
Q Consensus 73 ~tvVWvANr~~Pv~~~s~l~l~~~G~LvL~~~~~~~~ws~~~---~~~~~a~LldsGNlVl~~ 132 (725)
..+||.+|-... ..++.+.|..+|||||.|.++.++|++.. .....+.|+++|||||.+
T Consensus 53 ~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 53 DDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp TBCCSCCCCCSS-CSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC
T ss_pred CcEEEEEccccC-CCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC
Confidence 456898874322 23468999999999999999999997764 234468999999999984
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.19 E-value=3.4e-06 Score=70.78 Aligned_cols=82 Identities=24% Similarity=0.301 Sum_probs=61.7
Q ss_pred CceEEEcccccEEEEcCCCceEEEeccC---ceeEEEEecCCCeEEecCCC-----CccCCCCceEEeeecCCCeEEeee
Q 039817 88 GSSINLTVTGQLVLTHSNGTQFKIYNGT---LTVSALMQDSGNFLYSNANG-----SVDYSTGRFVLEIQMDGNVVLSAF 159 (725)
Q Consensus 88 ~s~l~l~~~G~LvL~~~~~~~~ws~~~~---~~~~a~LldsGNlVl~~~~~-----~~d~s~g~~~~~~~~~g~~~~~~~ 159 (725)
.-.|.+..||||||.+ ++.++|+++.. ..+.+.|..+|||||.+.++ ...-..+.+.+.|+.+|++.++
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly-- 96 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIY-- 96 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETTEEEEECCCCCSCCCCEEEECTTSCEEEE--
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecCCeEEEEeeccCCCceEEEEcCCCCEEEE--
Confidence 3478888999999987 56789976632 34679999999999998654 3344567889999999999875
Q ss_pred ecCCCceeecCCC
Q 039817 160 RFADPAYWYTSTR 172 (725)
Q Consensus 160 ~~~~~~yw~~~~~ 172 (725)
.....+.|.+.+.
T Consensus 97 ~~~~~~~W~S~t~ 109 (112)
T d1xd5a_ 97 DNSNNAIWATHTN 109 (112)
T ss_dssp CTTSCEEEECCCC
T ss_pred CCCCcEEecCCCc
Confidence 3344567877643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.53 E-value=0.00011 Score=71.41 Aligned_cols=121 Identities=14% Similarity=0.108 Sum_probs=81.5
Q ss_pred CcceEEEEEEcccccCccHHHHHHHHHHHhccC-cCCccceeeEEEcCCceeeeeecccCCChhhhhccCCCCCHHHHHH
Q 039817 460 GQEVEVAVKQLEKVTGDGEKSFLREVQVIGRTH-HKNLVQLLGFCIEQNHQLLVYELMKNGTLSAFLFRQEIPTWDKRVE 538 (725)
Q Consensus 460 ~~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~ 538 (725)
+++..+.+|+...........+.+|...+..++ +--+.+++.+...++..++||+++++.++.+..... .....
T Consensus 35 ~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~ 109 (263)
T d1j7la_ 35 GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-----QSPEK 109 (263)
T ss_dssp CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-----SCHHH
T ss_pred eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-----ccHHH
Confidence 344456778776544444556788998888774 444678888888888999999999998876544211 11223
Q ss_pred HHHHHHHHhhhhhccc--------------------------------------------------------CCceeecC
Q 039817 539 IALGIARGLLYLHEEC--------------------------------------------------------ETQIIHCD 562 (725)
Q Consensus 539 i~~qia~gL~yLH~~~--------------------------------------------------------~~~ivH~d 562 (725)
++.++++.+..||+.. ...++|+|
T Consensus 110 ~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD 189 (263)
T d1j7la_ 110 IIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGD 189 (263)
T ss_dssp HHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSC
T ss_pred HHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEee
Confidence 3444444455454310 12489999
Q ss_pred CccceEEeccCccccCCCCceEEeeccCcc
Q 039817 563 IKPQNVLLDNNYITIDNNYITKIADFGLAK 592 (725)
Q Consensus 563 ik~~NIll~~~~~~~~~~~~~kl~Dfgla~ 592 (725)
+.|.||++++ +..+-|.||+.+.
T Consensus 190 ~~~~Nil~~~-------~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 190 LGDSNIFVKD-------GKVSGFIDLGRSG 212 (263)
T ss_dssp CCTTSEEEET-------TEEEEECCCTTCE
T ss_pred ccCcceeecC-------CceEEEeechhcc
Confidence 9999999976 5556799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.66 E-value=0.0031 Score=60.20 Aligned_cols=57 Identities=12% Similarity=0.032 Sum_probs=40.0
Q ss_pred EEEEEEcccccCccHHHHHHHHHHHhccCc--CCccceeeEEEcCCceeeeeecccCCChhh
Q 039817 464 EVAVKQLEKVTGDGEKSFLREVQVIGRTHH--KNLVQLLGFCIEQNHQLLVYELMKNGTLSA 523 (725)
Q Consensus 464 ~vavk~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 523 (725)
.+.+|.-... ....+..|.+.++.+.. -.+.+++++..+++..++|||++++.++.+
T Consensus 37 ~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 37 VLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred EEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 4566665432 23346788888877743 346778888888889999999998866543
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.86 E-value=0.0024 Score=38.80 Aligned_cols=32 Identities=31% Similarity=0.832 Sum_probs=26.0
Q ss_pred CCCCcccccCCCCeeecCCCCceeeccCCCCCcC
Q 039817 245 EPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPV 278 (725)
Q Consensus 245 ~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~p~ 278 (725)
|.|.+-..|| +|.|+ |-...-.|.|-+||+|.
T Consensus 2 dECsignpCG-nGTCt-NviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCG-NGTCK-NVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSS-SSCEE-ECSSSEEECCSSSSCCC
T ss_pred CccccCCccC-Cceee-ecccceEEeecCCcCCC
Confidence 6799999998 68897 34456689999999974
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.02 E-value=0.037 Score=56.28 Aligned_cols=30 Identities=23% Similarity=0.317 Sum_probs=25.1
Q ss_pred CceeecCCccceEEeccCccccCCCCceEEeeccCccc
Q 039817 556 TQIIHCDIKPQNVLLDNNYITIDNNYITKIADFGLAKL 593 (725)
Q Consensus 556 ~~ivH~dik~~NIll~~~~~~~~~~~~~kl~Dfgla~~ 593 (725)
..++|+|+.+.|||+++ ..++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~--------~~~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASE--------HETKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECS--------SCEEECCCTTCEE
T ss_pred cceeccCCcCCceeEcC--------CceEEechhhccc
Confidence 36899999999999975 2489999988764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.13 E-value=0.15 Score=49.91 Aligned_cols=59 Identities=12% Similarity=0.049 Sum_probs=35.8
Q ss_pred cceEEEEEEcccccCccHHHHHHHHHHHhccCcCCc--cceee-----EEEcCCceeeeeecccCCC
Q 039817 461 QEVEVAVKQLEKVTGDGEKSFLREVQVIGRTHHKNL--VQLLG-----FCIEQNHQLLVYELMKNGT 520 (725)
Q Consensus 461 ~~~~vavk~l~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~e~~~~gs 520 (725)
++..+++|..... ....+++..|...+..|....+ +..+. ....++..+.++++++|..
T Consensus 45 dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 45 DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 3455777776543 3356778889998888753332 11111 2234566788999988643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=91.83 E-value=0.17 Score=51.23 Aligned_cols=41 Identities=17% Similarity=0.199 Sum_probs=29.1
Q ss_pred cHHHHHHHHHHHhccCcCCc-cceeeEEEcCCceeeeeecccCCCh
Q 039817 477 GEKSFLREVQVIGRTHHKNL-VQLLGFCIEQNHQLLVYELMKNGTL 521 (725)
Q Consensus 477 ~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 521 (725)
......+|..+++.+.-.++ .++++++.+ .+|+||+++.+|
T Consensus 87 ~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 87 TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 34456789999998853344 588888754 589999987544
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.26 E-value=0.051 Score=35.38 Aligned_cols=31 Identities=29% Similarity=0.847 Sum_probs=24.7
Q ss_pred CCCCc-ccccCCCCeeecCCCCceeeccCCCCC
Q 039817 245 EPCTV-NTICGVFGFCTSDNNKEVTCECLRGYS 276 (725)
Q Consensus 245 ~~Cd~-~~~CG~~g~C~~~~~~~~~C~Cl~GF~ 276 (725)
|.|.. ...|..+|.|.. ...+-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n-~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCIN-TLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEE-CSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeEC-CCCCEEeECCCCCc
Confidence 56765 467999999974 44567999999996
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.34 E-value=0.15 Score=32.35 Aligned_cols=30 Identities=33% Similarity=0.832 Sum_probs=23.0
Q ss_pred CCCCcccccCCCCeeecCCCCceeeccCCCCC
Q 039817 245 EPCTVNTICGVFGFCTSDNNKEVTCECLRGYS 276 (725)
Q Consensus 245 ~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~ 276 (725)
|.|. ...|...|.|.. ....-.|.|++||+
T Consensus 1 D~C~-~~PC~ngg~C~~-~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKD-GLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECC-CSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEEC-CCCCEEEECCCCCC
Confidence 4565 477999999974 34567899999996
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.78 E-value=0.2 Score=31.80 Aligned_cols=30 Identities=23% Similarity=0.585 Sum_probs=24.1
Q ss_pred CCCCcccccCCCCeeecCCCCceeeccCCCCC
Q 039817 245 EPCTVNTICGVFGFCTSDNNKEVTCECLRGYS 276 (725)
Q Consensus 245 ~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~ 276 (725)
|+|. ...|-..|.|.. ...+-+|.|++||+
T Consensus 4 d~C~-~~PC~ngg~C~~-~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 4 DQCE-SNPCLNGGSCKD-DINSYECWCPFGFE 33 (39)
T ss_dssp CTTT-TCCCCTTCEEEE-ETTEEEEECCTTCC
T ss_pred ccCC-CCCCCCCcEEEc-CCCCEEEECCCCCC
Confidence 6676 577999999974 44567999999996
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.43 E-value=0.2 Score=31.77 Aligned_cols=30 Identities=27% Similarity=0.676 Sum_probs=23.1
Q ss_pred CCCCcccccCCCCeeecCCCCceeeccCCCCC
Q 039817 245 EPCTVNTICGVFGFCTSDNNKEVTCECLRGYS 276 (725)
Q Consensus 245 ~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~ 276 (725)
|+|. ...|...|.|.. ...+-.|.|++||+
T Consensus 2 d~C~-~~PC~n~g~C~~-~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLD-QIGEFQCICMPGYE 31 (39)
T ss_dssp CTTT-TCCCCSSCEEEE-CSSCEEEECCTTEE
T ss_pred cCCc-CCCCCCCCEEEC-CCCCEEEeCCCCCc
Confidence 4563 467999999974 44567999999996
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.37 E-value=0.22 Score=32.03 Aligned_cols=31 Identities=19% Similarity=0.610 Sum_probs=23.4
Q ss_pred CCCCcccccCCCCeeecCCCCceeeccCCCCCcC
Q 039817 245 EPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPV 278 (725)
Q Consensus 245 ~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~p~ 278 (725)
|.|...+.| ..+|. |...+-.|.|++||+..
T Consensus 2 dEC~~~~~C--~~~C~-n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCV-NLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEE-CSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeE-CCCCCEEeECCCCCeEC
Confidence 578777777 45897 44567799999999853
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.23 E-value=0.19 Score=32.84 Aligned_cols=31 Identities=26% Similarity=0.858 Sum_probs=22.9
Q ss_pred CCCCcc-cccCCCCeeecCCCCceeeccCCCCCc
Q 039817 245 EPCTVN-TICGVFGFCTSDNNKEVTCECLRGYSP 277 (725)
Q Consensus 245 ~~Cd~~-~~CG~~g~C~~~~~~~~~C~Cl~GF~p 277 (725)
|.|... ..| .++.|. |...+-.|.|++||+.
T Consensus 4 dEC~~~~~~C-~~~~C~-Nt~Gsy~C~C~~Gy~~ 35 (44)
T d1lmja1 4 DECRISPDLC-GRGQCV-NTPGDFECKCDEGYES 35 (44)
T ss_dssp CTTTTCSSTT-TTSCEE-EETTEEEECCCSSEEE
T ss_pred cccCCCCCCC-CCCEeE-cCCCCeEEeCCCCCcc
Confidence 568664 446 478997 4556779999999984
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.63 E-value=0.15 Score=33.20 Aligned_cols=32 Identities=22% Similarity=0.606 Sum_probs=24.0
Q ss_pred CCCCcccccCCCCeeecCCCCceeeccCCCCCcC
Q 039817 245 EPCTVNTICGVFGFCTSDNNKEVTCECLRGYSPV 278 (725)
Q Consensus 245 ~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~p~ 278 (725)
|.|.....| -.+.|. |...+-.|.|++||+..
T Consensus 4 dEC~~~~~~-c~~~C~-Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLDPTTC-ISGNCV-NTPGSYICDCPPDFELN 35 (43)
T ss_dssp CGGGSTTSS-BTSEEE-EETTEEEEECCTTCEEC
T ss_pred cccCCCCcC-cCCEeE-CCCCCEEEecCCCCEEC
Confidence 568776655 478997 34466799999999864
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.35 E-value=0.28 Score=31.86 Aligned_cols=31 Identities=26% Similarity=0.605 Sum_probs=23.4
Q ss_pred CCCCcccccCCCCeeecCCCCceeeccCCCCCc
Q 039817 245 EPCTVNTICGVFGFCTSDNNKEVTCECLRGYSP 277 (725)
Q Consensus 245 ~~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~p 277 (725)
|.|.... |+..+.|. |...+-.|.|++||+.
T Consensus 6 dEC~~~~-~~~~~~C~-Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 6 DECKEPD-VCKHGQCI-NTDGSYRCECPFGYIL 36 (43)
T ss_dssp CSSSSTT-SCSSSCCC-CCSSCCCCCCCTTEEE
T ss_pred eccCCcC-CCCCCEeE-CCCCCeEeECCCCccc
Confidence 6787654 55789997 4455678999999974
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=82.28 E-value=0.51 Score=32.11 Aligned_cols=28 Identities=32% Similarity=0.702 Sum_probs=22.3
Q ss_pred cccccCCCCeeec-CCCCceeeccCCCCC
Q 039817 249 VNTICGVFGFCTS-DNNKEVTCECLRGYS 276 (725)
Q Consensus 249 ~~~~CG~~g~C~~-~~~~~~~C~Cl~GF~ 276 (725)
..+.|-..|.|.. ......+|.|++||.
T Consensus 10 ~~~~C~NgG~C~~~~~~~~~~C~C~~gy~ 38 (53)
T d3egfa_ 10 YDGYCLNGGVCMHIESLDSYTCNCVIGYS 38 (53)
T ss_dssp SSCCSCSSCEEEEESSSSCEEEECCTTCC
T ss_pred CCCCCCCCcEeeccCCCCCeEeECCCCCc
Confidence 4678999999964 234578999999996
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.77 E-value=0.29 Score=31.54 Aligned_cols=27 Identities=26% Similarity=0.616 Sum_probs=20.4
Q ss_pred ccccCCCCeeecCCCCceeeccCCCCCcC
Q 039817 250 NTICGVFGFCTSDNNKEVTCECLRGYSPV 278 (725)
Q Consensus 250 ~~~CG~~g~C~~~~~~~~~C~Cl~GF~p~ 278 (725)
++.|. +|.|. |.-.+-.|.|++||++.
T Consensus 9 ~~~C~-~~~C~-Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 9 PLLCR-GGVCH-NTEGSYRCECPPGHQLS 35 (42)
T ss_dssp SSTTT-TSEEE-EETTEEEEESCTTSCCC
T ss_pred CCCCC-CCEeE-CCCCCeEEeCCCCCeEC
Confidence 45674 78997 34456789999999964
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.95 E-value=0.41 Score=29.44 Aligned_cols=29 Identities=31% Similarity=0.773 Sum_probs=22.1
Q ss_pred CCCcccccCCCCeeecCCCCceeeccCCCCC
Q 039817 246 PCTVNTICGVFGFCTSDNNKEVTCECLRGYS 276 (725)
Q Consensus 246 ~Cd~~~~CG~~g~C~~~~~~~~~C~Cl~GF~ 276 (725)
+|. ...|-..|.|.. ...+-+|.|++||.
T Consensus 2 ~C~-~~PC~ngg~C~~-~~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 2 ECA-SSPCLHNGRCLD-KINEFQCECPTGFT 30 (35)
T ss_dssp TTT-TCCSTTTCEEEE-CSSCEEEECCTTEE
T ss_pred CCC-CCCCCCCcEEEC-CCCCeEEECCCCCC
Confidence 453 467999999974 44567999999986
|